PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Braly, P				Braly, P			Preventing cervical cancer	NATURE MEDICINE			English	Editorial Material											Braly, P (corresponding author), LOUISIANA STATE UNIV,MED CTR,DEPT OBSTET & GYNECOL,NEW ORLEANS,LA 70112, USA.							BORYSIEWICZ IK, 1996, LANCET, V347, P1523; HAYWARD RA, 1988, ARCH INTERN MED, V148, P1177, DOI 10.1001/archinte.148.5.1177; Lehtinen M, 1996, BMJ-BRIT MED J, V312, P537, DOI 10.1136/bmj.312.7030.537; MANDELBLATT J, 1986, JAMA-J AM MED ASSOC, V256, P367, DOI 10.1001/jama.256.3.367; *NIH, 1996, CONS DEV C STAT CERV; Parker SL, 1996, CA-CANCER J CLIN, V46, P5, DOI 10.3322/canjclin.46.1.5; PROKOPCZYK B, 1996, P AM ASS CANC RES, V37; SUZICH JA, 1995, P NATL ACAD SCI USA, V92, P11553, DOI 10.1073/pnas.92.25.11553	8	19	19	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUL	1996	2	7					749	751		10.1038/nm0796-749	http://dx.doi.org/10.1038/nm0796-749			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UU680	8673918	Bronze			2022-12-25	WOS:A1996UU68000028
J	Burmeister, M; Novak, T; Liang, MY; Basu, S; Ploder, L; Hawes, NL; Vidgen, D; Hoover, F; Goldman, D; Kalnins, VI; Roderick, TH; Taylor, BA; Hankin, MH; McInnes, RR				Burmeister, M; Novak, T; Liang, MY; Basu, S; Ploder, L; Hawes, NL; Vidgen, D; Hoover, F; Goldman, D; Kalnins, VI; Roderick, TH; Taylor, BA; Hankin, MH; McInnes, RR			Ocular retardation mouse caused by Chx10 homeobox null allele: Impaired retinal progenitor proliferation and bipolar cell differentiation	NATURE GENETICS			English	Article							RAT RETINA; MAMMALIAN RETINA; PROTEIN; LOCUS; GENE; MICE; EYE; EXPRESSION; ANTIBODIES; DISRUPTION	Ocular retardation (or) is a murine eye mutation causing microphthalmia, a thin hypocellular retina and optic nerve aplasia. Here we show that mice carrying the or(j) allele have a premature stop codon in the homeobox of the Chx10 gene, a gene expressed at high levels in uncommitted retinal progenitor cells and mature bipolar cells. No CHX10 protein was detectable in the retinal neuroepithelium of or(j) homozygotes. The loss of CHX10 leads both to reduced proliferation of retinal progenitors and to a specific absence of differentiated bipolar cells. Other major retinal cell types were present and correctly positioned in the mutant retina, although rod outer segments were short and retinal lamination was incomplete. These results indicate that Chx10 is an essential component in the network of genes required for the development of the mammalian eye, with profound effects on retinal progenitor proliferation and bipolar cell specification or differentiation.	HOSP SICK CHILDREN, DEPT PEDIAT, TORONTO, ON M5G 1X8, CANADA; HOSP SICK CHILDREN, DEPT GENET, TORONTO, ON M5G 1X8, CANADA; UNIV MICHIGAN, DEPT BIOL CHEM, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, DEPT PSYCHIAT, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, DEPT HUMAN GENET, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, MENTAL HLTH RES INST, ANN ARBOR, MI 48109 USA; UNIV TORONTO, DEPT MOLEC & MED GENET, TORONTO, ON M5S 1A8, CANADA; MED COLL OHIO, DEPT ANAT & NEUROBIOL, TOLEDO, OH 43614 USA; JACKSON LAB, BAR HARBOR, ME 04609 USA; UNIV TORONTO, DEPT ANAT & CELL BIOL, TORONTO, ON M5S 1A8, CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Toronto; Jackson Laboratory; University of Toronto			Burmeister, Margit/A-3157-2013	Burmeister, Margit/0000-0002-1914-2434	NATIONAL CANCER INSTITUTE [R01CA033093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026777, R55NS026777] Funding Source: NIH RePORTER; NCI NIH HHS [CA33093] Funding Source: Medline; NIGMS NIH HHS [GM18684] Funding Source: Medline; NINDS NIH HHS [NS26777] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS JC, 1981, J HISTOCHEM CYTOCHEM, V29, P775, DOI 10.1177/29.6.7252134; BARNSTABLE CJ, 1983, COLD SPRING HARB SYM, V48, P863, DOI 10.1101/SQB.1983.048.01.089; BARNSTABLE CJ, 1980, NATURE, V286, P231, DOI 10.1038/286231a0; BARNSTABLE CJ, 1985, DEV BRAIN RES, V20, P286, DOI 10.1016/0165-3806(85)90116-6; BASCOM RA, 1992, NEURON, V8, P1171, DOI 10.1016/0896-6273(92)90137-3; BRITTIS PA, 1992, SCIENCE, V255, P733, DOI 10.1126/science.1738848; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; CONDIE BG, 1994, NATURE, V371, P537, DOI 10.1038/371537a0; CONDIE BG, 1993, DEVELOPMENT, V119, P579; CONDIE BG, 1994, NATURE, V370, P304, DOI 10.1038/370304a0; Dickson Barry, 1993, P1327; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; DOLLE P, 1993, CELL, V75, P431, DOI 10.1016/0092-8674(93)90378-4; DRAGER UC, 1984, J NEUROSCI, V4, P2025; DUBOULE D, 1995, CURR OPIN GENET DEV, V5, P525, DOI 10.1016/0959-437X(95)90058-O; ERICKSON PA, 1987, EXP EYE RES, V44, P37, DOI 10.1016/S0014-4835(87)80023-4; FRANZ T, 1991, ANAT EMBRYOL, V184, P355, DOI 10.1007/BF00957897; GRAHAM A, 1994, NATURE, V372, P684, DOI 10.1038/372684a0; GREFERATH U, 1990, J COMP NEUROL, V301, P433, DOI 10.1002/cne.903010308; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; HANKIN MH, 1994, J NEUROBIOL, V25, P472, DOI 10.1002/neu.480250503; HAWES NL, 1980, MOUSE NEWS LETT, V63, P20; HAWES NL, 1990, MOUSE GENOME, V87, P93; Hentsch B, 1996, GENE DEV, V10, P70, DOI 10.1101/gad.10.1.70; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; HOOVER F, 1992, EXP EYE RES, V54, P561, DOI 10.1016/0014-4835(92)90135-F; HUI CC, 1994, DEV BIOL, V162, P402, DOI 10.1006/dbio.1994.1097; Humason G. L., 1979, ANIMAL TISSUE TECHNI; IKEDA H, 1985, J VIROL, V55, P768, DOI 10.1128/JVI.55.3.768-777.1985; INOUE A, 1992, J BIOL CHEM, V267, P10613; KASTNER P, 1994, CELL, V78, P987, DOI 10.1016/0092-8674(94)90274-7; KODAMA R, 1994, CURR OPIN GENET DEV, V4, P703, DOI 10.1016/0959-437X(94)90137-R; KONYUKHOV BV, 1975, DEV BIOL, V45, P1, DOI 10.1016/0012-1606(75)90235-3; KONYUKHOV BV, 1966, FOLIA BIOL-PRAGUE, V12, P116; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; LINSER P, 1981, P NATL ACAD SCI-BIOL, V78, P7190, DOI 10.1073/pnas.78.11.7190; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; REH TA, 1993, J NEUROBIOL, V24, P949, DOI 10.1002/neu.480240708; ROBB RM, 1978, INVEST OPHTH VIS SCI, V17, P468; SHAW G, 1984, EUR J CELL BIOL, V33, P95; Sidman RL, 1961, STRUCTURE EYE, P487; SILVER J, 1979, DEV BIOL, V68, P175, DOI 10.1016/0012-1606(79)90252-5; SORIANO E, 1991, J HISTOCHEM CYTOCHEM, V39, P1565, DOI 10.1177/39.11.1918930; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; STRACHAN T, 1994, CURR OPIN GENET DEV, V4, P427, DOI 10.1016/0959-437X(94)90032-9; SVENDSEN PC, 1995, DEVELOPMENT, V121, P1253; TAYLOR BA, 1992, CYTOGENET CELL GENET, V60, P250, DOI 10.1159/000133351; TAYLOR BA, 1975, NATURE, V256, P644, DOI 10.1038/256644a0; TAYLOR RG, 1993, GENOMICS, V16, P231, DOI 10.1006/geno.1993.1164; THEILER K, 1976, ANAT EMBRYOL, V150, P85; TRUSLOVE GM, 1962, J EMBRYOL EXP MORPH, V10, P652; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; Wolff Tanya, 1993, P1277; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	58	421	426	0	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1996	12	4					376	384		10.1038/ng0496-376	http://dx.doi.org/10.1038/ng0496-376			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UC553	8630490				2022-12-25	WOS:A1996UC55300015
J	Coyle, B; Coffey, R; Armour, JAL; Gausden, E; Hochberg, Z; Grossman, A; Britton, K; Pembrey, M; Reardon, W; Trembath, R				Coyle, B; Coffey, R; Armour, JAL; Gausden, E; Hochberg, Z; Grossman, A; Britton, K; Pembrey, M; Reardon, W; Trembath, R			Pendred syndrome (goitre and sensorineural hearing loss) maps to chromosome 7 in the region containing the nonsyndromic deafness gene DFNB4	NATURE GENETICS			English	Letter									UNIV LEICESTER,DEPT GENET,LEICESTER LE1 7RH,LEICS,ENGLAND; UNIV LEICESTER,DEPT MED & THERAPEUT,LEICESTER LE1 7RH,LEICS,ENGLAND; UNIV LONDON,INST CHILD HLTH,DEPT CLIN GENET & FETAL MED,LONDON WC1N 1EH,ENGLAND; RAMBAM MED CTR,DEPT PAEDIAT,DIV ENDOCRINOL,IL-31096 HAIFA,ISRAEL; ST BARTHOLOMEWS HOSP,DEPT ENDOCRINOL,LONDON EC1A 7BE,ENGLAND; ST BARTHOLOMEWS HOSP,DEPT NUCL MED,LONDON EC1A 7BE,ENGLAND	University of Leicester; University of Leicester; University of London; University College London; Rambam Health Care Campus; Technion Israel Institute of Technology; University of London; Queen Mary University London; University of London; Queen Mary University London				Reardon, Willie/0000-0001-7329-9179; Coyle, Beth/0000-0003-2957-1862; Armour, John/0000-0002-8558-8506; Trembath, Richard/0000-0003-0550-3400				BALDWIN CT, 1995, HUM MOL GENET, V4, P1637, DOI 10.1093/hmg/4.9.1637; BILLERBECK AEC, 1994, THYROID, V4, P279, DOI 10.1089/thy.1994.4.279; Brain WR, 1927, Q J MED, V20, P303, DOI 10.1093/qjmed/os-20.79.303; Chaib H, 1996, HUM MOL GENET, V5, P155, DOI 10.1093/hmg/5.1.155; CREMERS FPM, 1989, GENOMICS, V4, P41, DOI 10.1016/0888-7543(89)90312-1; FRASER GR, 1960, Q J MED, V29, P279; FRASER GR, 1965, ANN HUM GENET, V28, P201; FRIEDMAN TB, 1995, NAT GENET, V9, P86, DOI 10.1038/ng0195-86; FUKUSHIMA K, 1995, HUM MOL GENET, V4, P1643, DOI 10.1093/hmg/4.9.1643; GAUSDEN E, IN PRESS CLIN ENDOCR; Gorlin R, 1995, GENETIC DEAFNESS ITS; GUAPAY G, 1994, NAT GENET, V7, P246; GUILFORD P, 1994, HUM MOL GENET, V3, P989, DOI 10.1093/hmg/3.6.989; GUILFORD P, 1994, NAT GENET, V6, P24, DOI 10.1038/ng0194-24; JAIN PK, 1995, HUM MOL GENET, V4, P2391, DOI 10.1093/hmg/4.12.2391; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; OTT J, 1991, ANAL HUMAN GENETIC L, P203; PENDRED V, 1896, LANCET, V2, P523; REARDON W, 1992, J MED GENET, V29, P521, DOI 10.1136/jmg.29.8.521; REARDON W, IN PRESS GENETICS HE; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; Veske A, 1996, HUM MOL GENET, V5, P165, DOI 10.1093/hmg/5.1.165	24	96	107	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1996	12	4					421	423		10.1038/ng0496-421	http://dx.doi.org/10.1038/ng0496-421			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UC553	8630497				2022-12-25	WOS:A1996UC55300022
J	Jensen, RA; Thompson, ME; Jetton, TL; Szabo, CI; vanderMeer, R; Helou, B; Tronick, SR; Page, DL; King, MC; Holt, JT				Jensen, RA; Thompson, ME; Jetton, TL; Szabo, CI; vanderMeer, R; Helou, B; Tronick, SR; Page, DL; King, MC; Holt, JT			BRCA1 is secreted and exhibits properties of a granin	NATURE GENETICS			English	Article							CHROMOGRANIN-A; PROTEIN-I; CELLS; PANCREASTATIN; CULTURE; GROWTH	Germline mutations in BRCA1 are responsible for most cases of inherited breast and ovarian cancer. However, the function of the BRCA1 protein has remained elusive. We now show that BRCA1 encodes a 190-kD protein with sequence homology and biochemical analogy to the granin protein family. Interestingly, BRCA2 also includes a motif similar to the granin consensus at the C terminus of the protein. Both BRCA1 and the granins localize to secretory vesicles, are secreted by a regulated pathway, are posttranslationally glycosylated and are responsive to hormones. As a regulated secretory protein, BRCA1 appears to function by a mechanism not previously described for tumour suppressor gene products.	VANDERBILT UNIV,SCH MED,DEPT CELL BIOL,NASHVILLE,TN 37232; VANDERBILT UNIV,SCH MED,DEPT MOLEC PHYSIOL & BIOPHYS,NASHVILLE,TN 37232; VANDERBILT UNIV,SCH MED,DEPT PREVENT MED,NASHVILLE,TN 37232; UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT GENET,SEATTLE,WA 98195; SANTA CRUZ BIOTECHNOL,SANTA CRUZ,CA 95060	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Jensen, RA (corresponding author), VANDERBILT UNIV,SCH MED,DEPT PATHOL,221 KIRKLAND HALL,NASHVILLE,TN 37232, USA.		Jensen, Roy A/B-9739-2011	Jensen, Roy A/0000-0003-4430-2281; King, Mary-Claire/0000-0001-9426-1743	NCI NIH HHS [F32-CA66293, R29-CA62161, T32-CA09592] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA062161, T32CA009592] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CHEN YM, 1995, SCIENCE, V270, P789, DOI 10.1126/science.270.5237.789; FASCIOTTO BH, 1989, ENDOCRINOLOGY, V125, P1617, DOI 10.1210/endo-125-3-1617; FAZIOLI F, 1993, MOL CELL BIOL, V13, P5814, DOI 10.1128/MCB.13.9.5814; FISCHERCOLBRIE R, 1991, J NEUROENDOCRINOL, V121, P125; GAFFNEY EV, 1982, CELL TISSUE RES, V227, P563, DOI 10.1007/BF00204786; GORR SU, 1989, AM J PHYSIOL, V257, pE247, DOI 10.1152/ajpendo.1989.257.2.E247; GUDAS JM, 1995, CANCER RES, V55, P4561; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Holt JT, 1996, NAT GENET, V12, P298, DOI 10.1038/ng0396-298; HUTTNER WB, 1991, TRENDS BIOCHEM SCI, V16, P27, DOI 10.1016/0968-0004(91)90012-K; JENSEN RA, 1992, BIOCHEMISTRY-US, V31, P10887, DOI 10.1021/bi00159a032; JETTON TL, 1994, J BIOL CHEM, V269, P3641; KONECKI DS, 1987, J BIOL CHEM, V262, P17026; LANE TF, 1995, GENE DEV, V9, P2712, DOI 10.1101/gad.9.21.2712; MARQUIS ST, 1995, NAT GENET, V11, P17, DOI 10.1038/ng0995-17; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; STAMPFER M, 1980, IN VITRO CELL DEV B, V16, P415; THOMPSON ME, 1992, ENDOCRINOLOGY, V131, P318, DOI 10.1210/en.131.1.318; TOOZE SA, 1990, CELL, V60, P837, DOI 10.1016/0092-8674(90)90097-X; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	20	199	208	0	11	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1996	12	3					303	308		10.1038/ng0396-303	http://dx.doi.org/10.1038/ng0396-303			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TY183	8589722				2022-12-25	WOS:A1996TY18300020
J	Nagano, A; Koga, R; Ogawa, M; Kurano, Y; Kawada, J; Okada, R; Hayashi, YK; Tsukahara, T; Arahata, K				Nagano, A; Koga, R; Ogawa, M; Kurano, Y; Kawada, J; Okada, R; Hayashi, YK; Tsukahara, T; Arahata, K			Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy	NATURE GENETICS			English	Article							X-CHROMOSOME; FACTOR-VIII; LINKAGE; GENE; LOCALIZATION; SKELETAL; PROTEIN; MUSCLE	Mutations in the STA gene at the Xq28 locus have been found in patients with X-linked Emery-Dreifuss muscular dystrophy (EDMD). This gene encodes a hitherto unknown protein named 'emerin'. To elucidate the subcellular localization of emerin, we raised two antisera against synthetic peptide fragments predicted from emerin cDNA. Using both antisera, we found positive nuclear membrane staining in skeletal, cardiac and smooth muscles in the normal controls and in patients with neuromuscular diseases other than EDMD. In contrast, a deficiency in immunofluorescent staining of skeletal and cardiac muscle from EDMD patients was observed. A 34 kD protein is immunoreactive with the antisera - the protein is equivalent to that predicted for emerin. Together, our findings suggest the specific deficiency of emerin in the nuclear membrane of muscle cells in patients with EDMD.	NCNP,DEPT NEUROMUSCULAR RES,NATL INST NEUROSCI,KODAIRA,TOKYO 187,JAPAN; TOKYO MED COLL,DEPT INTERNAL MED 3,SHINJUKU KU,TOKYO 160,JAPAN; FUJIREBIO CENT RES INST,HACHIOJI,TOKYO 192,JAPAN; KANAZAWA MED UNIV,DEPT NEUROL,UCHINADA,ISHIKAWA 92002,JAPAN; JUNTENDO UNIV,SCH MED,RES LAB CARDIOVASC PATHOL,BUNKYO KU,TOKYO 113,JAPAN	National Center for Neurology & Psychiatry - Japan; Tokyo Medical University; H.U. Group Holdings Inc; Kanazawa Medical University; Juntendo University								ARAHATA K, 1989, P NATL ACAD SCI USA, V86, P7154, DOI 10.1073/pnas.86.18.7154; ARAHATA K, 1991, J NEUROL SCI, V101, P148, DOI 10.1016/0022-510X(91)90039-A; ARAHATA K, 1988, NATURE, V333, P861, DOI 10.1038/333861a0; ARIKAWAHIRASAWA E, 1995, NEUROMUSCULAR DISORD, V5, P429, DOI 10.1016/0960-8966(94)00087-P; BIONE S, 1993, P NATL ACAD SCI USA, V90, P10977, DOI 10.1073/pnas.90.23.10977; BIONE S, 1995, HUM MOL GENET, V4, P1859; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; COLE CG, 1992, NEUROMUSCULAR DISORD, V2, P51, DOI 10.1016/0960-8966(92)90027-4; DEDUVE C, 1981, J CELL BIOL, V91, pS293, DOI 10.1083/jcb.91.3.293s; DUBOWITZ V, 1989, COLOR ATLAS MUSCLE D; EMERY AEH, 1966, J NEUROL NEUROSUR PS, V29, P338, DOI 10.1136/jnnp.29.4.338; EMERY AEH, 1989, BRIT MED BULL, V45, P772, DOI 10.1093/oxfordjournals.bmb.a072357; HODGSON S, 1986, HUM GENET, V74, P409, DOI 10.1007/BF00280495; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; KLAUCK SM, 1995, HUM MOL GENET, V4, P1853, DOI 10.1093/hmg/4.10.1853; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOGA R, 1994, BIOCHEM BIOPH RES CO, V202, P577, DOI 10.1006/bbrc.1994.1967; KRESS W, 1992, NEUROMUSCULAR DISORD, V2, P111, DOI 10.1016/0960-8966(92)90042-5; NIGRO V, 1995, HUM MOL GENET, V4, P2003, DOI 10.1093/hmg/4.10.2003; ROMEO G, 1988, HUM GENET, V80, P59, DOI 10.1007/BF00451457; THOMAS NST, 1986, J MED GENET, V23, P596, DOI 10.1136/jmg.23.6.596; YATES JRW, 1986, J MED GENET, V23, P587, DOI 10.1136/jmg.23.6.587	22	268	269	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1996	12	3					254	259		10.1038/ng0396-254	http://dx.doi.org/10.1038/ng0396-254			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TY183	8589715				2022-12-25	WOS:A1996TY18300013
J	Haaf, T; Sirugo, G; Kidd, KK; Ward, DC				Haaf, T; Sirugo, G; Kidd, KK; Ward, DC			Chromosomal localization of long trinucleotide repeats in the human genome by fluorescence in situ hybridization	NATURE GENETICS			English	Letter									YALE UNIV,SCH MED,DEPT GENET,NEW HAVEN,CT 06520	Yale University	Haaf, T (corresponding author), MAX PLANCK INST MOLEC GENET,IHNESTR 73,D-14195 BERLIN,GERMANY.		Sirugo, Giorgio/N-9056-2019; Sirugo, Giorgio/L-1628-2016		NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH039239, R01MH050390, P50MH030929, R01MH039239, P30MH030929] Funding Source: NIH RePORTER; NIMH NIH HHS [MH-30929, MH-39239, MH-50390] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BATES G, 1994, BIOESSAYS, V16, P277, DOI 10.1002/bies.950160411; HOLMQUIST GP, 1992, AM J HUM GENET, V51, P17; LINDBLAD K, 1994, NAT GENET, V7, P124, DOI 10.1038/ng0694-124; MATERA AG, 1992, HUM MOL GENET, V1, P535, DOI 10.1093/hmg/1.7.535; RICHARDS RI, 1994, NAT GENET, V6, P114, DOI 10.1038/ng0294-114; SCHALLING M, 1993, NAT GENET, V4, P135, DOI 10.1038/ng0693-135; SIRUGO G, 1995, EPICENTRE FORUM, V2, P1; STALLINGS RL, 1994, GENOMICS, V21, P116, DOI 10.1006/geno.1994.1232; SUTHERLAND GR, 1995, P NATL ACAD SCI USA, V92, P3636, DOI 10.1073/pnas.92.9.3636; WILLEMS PJ, 1994, NAT GENET, V8, P213, DOI 10.1038/ng1194-213	10	32	33	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1996	12	2					183	185		10.1038/ng0296-183	http://dx.doi.org/10.1038/ng0296-183			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TU079	8563757				2022-12-25	WOS:A1996TU07900019
J	Wahl, AF; Donaldson, KL; Fairchild, C; Lee, FYF; Foster, SA; Demers, GW; Galloway, DA				Wahl, AF; Donaldson, KL; Fairchild, C; Lee, FYF; Foster, SA; Demers, GW; Galloway, DA			Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis	NATURE MEDICINE			English	Article							HUMAN PAPILLOMAVIRUS TYPE-16; SIMIAN VIRUS-40; DRUG SENSITIVITY; CELL-LINES; PROTEIN; GROWTH; CANCER; RESISTANCE; RADIATION; AGENTS	The anticancer agent paclitaxel (Taxol(R)) stabilizes tubulin polymerization resulting in arrest in mitosis and apoptotic cell death. Normal human fibroblasts depleted of functional p53 by SV40 T antigen or HPV-16 E6, and primary embryo fibroblasts from p53 null mice showed seven- to ninefold increased cytotoxicity by paclitaxel. Reduced levels of p53 correlated with increased G2/M phase arrest, micronucleation, and p53-independent paclitaxel-induced apoptosis. Surviving cells with intact p53 progressed through mitosis and transiently accumulated in the subsequent G1 phase, coincident with increased p53 and p21(cip1,waf1) protein levels. These results are in contrast to studies linking p53 loss with resistance to DNA damaging anticancer agents.	BRISTOL MYERS SQUIBB PHARMACEUT RES INST,PRINCETON,NJ 08543; FRED HUTCHINSON CANC RES CTR,CANC BIOL PROGRAM,SEATTLE,WA 98104	Bristol-Myers Squibb; Fred Hutchinson Cancer Center	Wahl, AF (corresponding author), BRISTOL MYERS SQUIBB PHARMACEUT RES INST,3005 1ST AVE,SEATTLE,WA 98121, USA.				NATIONAL CANCER INSTITUTE [R01CA064795] Funding Source: NIH RePORTER; NCI NIH HHS [CA 64795] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARCELLOSHOFF MH, 1990, CANCER RES, V50, P3551; BROWN R, 1993, INT J CANCER, V55, P678, DOI 10.1002/ijc.2910550428; CABANILLAS F, 1989, AM J MED, V87, P167; CHOU JY, 1978, P NATL ACAD SCI USA, V75, P1409, DOI 10.1073/pnas.75.3.1409; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; CROSS SM, 1995, SCIENCE, V267, P1353, DOI 10.1126/science.7871434; CROSSIN KL, 1981, CELL, V27, P341, DOI 10.1016/0092-8674(81)90417-7; DEMERS GW, 1994, P NATL ACAD SCI USA, V91, P4382, DOI 10.1073/pnas.91.10.4382; DING AH, 1990, SCIENCE, V248, P370, DOI 10.1126/science.1970196; DONALDSON KL, 1994, INT J CANCER, V57, P847, DOI 10.1002/ijc.2910570614; DONALDSON KL, 1994, CELL GROWTH DIFFER, V5, P1041; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; EISENHAUER EA, 1994, J CLIN ONCOL, V12, P2654, DOI 10.1200/JCO.1994.12.12.2654; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ELROUBY S, 1993, BLOOD, V82, P3452; ETTINGER DS, 1995, J CLIN ONCOL, V13, P1430, DOI 10.1200/JCO.1995.13.6.1430; FAN SJ, 1995, CANCER RES, V55, P1649; FOSTER SA, 1994, J VIROL, V68, P5698, DOI 10.1128/JVI.68.9.5698-5705.1994; GIANNI L, 1995, J CLIN ONCOL, V13, P180, DOI 10.1200/JCO.1995.13.1.180; GREGORY RE, 1993, CLIN PHARMACY, V12, P401; HALBERT CL, 1991, J VIROL, V65, P473, DOI 10.1128/JVI.65.1.473-478.1991; HARLOW E, 1981, J VIROL, V39, P861, DOI 10.1128/JVI.39.3.861-869.1981; HARTWELL L, 1992, CELL, V71, P543, DOI 10.1016/0092-8674(92)90586-2; HAWKINS DS, IN PRESS CANCER RES; HORWITZ SB, 1992, TRENDS PHARMACOL SCI, V13, P134; HORWITZ SB, 1993, MONOGR NATL CANCER I, V15, P55; KASTAN MB, 1991, CANCER RES, V51, P6304; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; LEE JM, 1993, P NATL ACAD SCI USA, V90, P5742, DOI 10.1073/pnas.90.12.5742; LONG BH, 1994, CANCER RES, V54, P4355; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; MANTHEY CL, 1992, J IMMUNOL, V149, P2459; MAXWELL SA, 1991, CELL GROWTH DIFFER, V2, P115; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; SCUDIERO DA, 1988, CANCER RES, V48, P4827; VERLHAC MH, 1993, DEV BIOL, V158, P330, DOI 10.1006/dbio.1993.1192; VOGELSTEIN B, 1990, NATURE, V348, P681, DOI 10.1038/348681a0; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; WHITE AE, 1994, GENE DEV, V8, P666, DOI 10.1101/gad.8.6.666; YOUNES A, 1995, J CLIN ONCOL, V13, P583, DOI 10.1200/JCO.1995.13.3.583; ZHAN QM, 1993, MOL CELL BIOL, V13, P4242, DOI 10.1128/MCB.13.7.4242	44	652	670	0	37	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JAN	1996	2	1					72	79		10.1038/nm0196-72	http://dx.doi.org/10.1038/nm0196-72			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TP579	8564846				2022-12-25	WOS:A1996TP57900040
J	ZHANG, L; LEEFLANG, EP; YU, J; ARNHEIM, N				ZHANG, L; LEEFLANG, EP; YU, J; ARNHEIM, N			STUDYING HUMAN MUTATIONS BY SPERM TYPING - INSTABILITY OF CAG TRINUCLEOTIDE REPEATS IN THE HUMAN ANDROGEN RECEPTOR GENE	NATURE GENETICS			English	Article							POLYMERASE CHAIN-REACTION; MYOTONIC-DYSTROPHY; DINUCLEOTIDE REPEAT; MUSCULAR-ATROPHY; HUMAN-DISEASE; EXPANSION; LOCI	Trinucleotide repeat mutations of normal alleles at the human androgen receptor locus were studied by typing similar to 4,300 sperm. Control experiments established that the mutation events were of germline origin. The mutation rate for 20-22 repeat alleles was similar to that shown by family analysis. Alleles with 28-31 repeats had a 4.4 times greater rate of mutation with contractions outnumbering expansions. Preliminary experiments on the trinucleotide repeat associated with myotonic dystrophy gave similar results although in one donor expansions were six times greater than contractions. Comparison of the sperm data to mutations of disease alleles in SBMA families suggests that expansions may have a different origin than contractions.			ZHANG, L (corresponding author), UNIV SO CALIF, PROGRAM MOLEC BIOL, LOS ANGELES, CA 90089 USA.		Yu, Jian/A-8301-2009; Zhang, Lin/A-7389-2009	Yu, Jian/0000-0002-4021-1000; Zhang, Lin/0000-0003-0018-3903; Arnheim, Norman/0000-0003-1247-1347				Biancalana V., 1992, Human Molecular Genetics, V1, P255, DOI 10.1093/hmg/1.4.255; CASKEY CT, 1992, SCIENCE, V256, P784, DOI 10.1126/science.1589758; CROW JF, 1993, ENVIRON MOL MUTAGEN, V21, P122, DOI 10.1002/em.2850210205; CUI XF, 1989, P NATL ACAD SCI USA, V86, P9389, DOI 10.1073/pnas.86.23.9389; DONNELLY A, 1994, GENOMICS, V20, P363, DOI 10.1006/geno.1994.1189; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; HUBERT R, 1992, AM J HUM GENET, V51, P985; IMBERT G, 1993, NAT GENET, V4, P72, DOI 10.1038/ng0593-72; JANSEN G, 1992, GENOMICS, V13, P509, DOI 10.1016/0888-7543(92)90118-C; JANSEN G, 1993, HUM MOL GENET, V2, P333, DOI 10.1093/hmg/2.3.333; LASPADA AR, 1992, NAT GENET, V2, P301, DOI 10.1038/ng1292-301; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LI H, 1991, Methods (Orlando), V2, P49, DOI 10.1016/S1046-2023(05)80125-2; LITT M, 1989, AM J HUM GENET, V44, P397; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MIWA S, 1994, NAT GENET, V6, P3, DOI 10.1038/ng0194-3; NEVILLE CE, 1994, HUM MOL GENET, V3, P45; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; RICHARDS RI, 1992, CELL, V70, P709, DOI 10.1016/0092-8674(92)90302-S; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123	22	105	106	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1994	7	4					531	535		10.1038/ng0894-531	http://dx.doi.org/10.1038/ng0894-531			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PA832	7951325				2022-12-25	WOS:A1994PA83200022
J	REED, PW; DAVIES, JL; COPEMAN, JB; BENNETT, ST; PALMER, SM; PRITCHARD, LE; GOUGH, SCL; KAWAGUCHI, Y; CORDELL, HJ; BALFOUR, KM; JENKINS, SC; POWELL, EE; VIGNAL, A; TODD, JA				REED, PW; DAVIES, JL; COPEMAN, JB; BENNETT, ST; PALMER, SM; PRITCHARD, LE; GOUGH, SCL; KAWAGUCHI, Y; CORDELL, HJ; BALFOUR, KM; JENKINS, SC; POWELL, EE; VIGNAL, A; TODD, JA			CHROMOSOME-SPECIFIC MICROSATELLITE SETS FOR FLUORESCENCE-BASED, SEMIAUTOMATED GENOME MAPPING	NATURE GENETICS			English	Article							MARKERS; LOCI	To facilitate large-scale genetic mapping of the human genome, we have developed chromosome-specific sets of microsatellite marker loci suitable for use with a fluorescence-based automated DNA fragment analyser. We present 254 dinucleotide repeat marker loci (80% from the Genethon genetic linkage map) arranged into 39 sets, covering all 22 autosomes and the X chromosome. The average distance between adjacent markers is 13 centiMorgans, and less than 4% of the genome lies more than 20 cM from the nearest marker. Each set of microsatellites consists of up to nine marker loci, with allele size ranges that do not overlap. We selected marker loci on the basis of their reliability in the polymerase chain reaction, polymorphism content, map position and the accuracy with which alleles can be scored automatically by the Genotyper(TM) program.	UNIV OXFORD,JOHN RADCLIFFE HOSP,NUFFIELD DEPT SURG,OXFORD OX3 9DU,ENGLAND; UNIV OXFORD,NUFFIELD ORTHOPAED CTR,WELLCOME TRUST CTR HUMAN GENET,OXFORD OX3 7LD,ENGLAND; GENETHON,F-91000 EVRY,FRANCE	University of Oxford; Nuffield Orthopaedic Centre; University of Oxford; Wellcome Centre for Human Genetics			Powell, Elizabeth/B-4455-2011; Vignal, Alain/I-6253-2017; Todd, John A/A-3542-2010	Powell, Elizabeth/0000-0001-5008-8061; Vignal, Alain/0000-0002-6797-2125; Todd, John A/0000-0003-2740-8148; Cordell, Heather/0000-0002-1879-5572	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BAIN SC, 1992, NAT GENET, V2, P212, DOI 10.1038/ng1192-212; BECKMANN JS, 1993, HUM MOL GENET, V2, P2019, DOI 10.1093/hmg/2.12.2019; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; CALLEN DF, 1993, AM J HUM GENET, V52, P922; DIEHL SR, 1990, AM J HUM GENET, V47, pA177; EDWARDS A, 1991, AM J HUM GENET, V49, P746; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; RISE ML, 1991, SCIENCE, V253, P669, DOI 10.1126/science.1871601; SCHWENGEL DA, IN PRESS GENOMICS; SMEETS HJM, 1989, HUM GENET, V83, P245, DOI 10.1007/BF00285165; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0; Weber J, 1989, AM J HUM GENET, V44, P338; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; ZIEGLE JS, 1992, GENOMICS, V14, P1026, DOI 10.1016/S0888-7543(05)80126-0	19	307	315	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1994	7	3					390	395		10.1038/ng0794-390	http://dx.doi.org/10.1038/ng0794-390			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NU306	7920657				2022-12-25	WOS:A1994NU30600013
J	GNARRA, JR; TORY, K; WENG, Y; SCHMIDT, L; WEI, MH; LI, H; LATIF, F; LIU, S; CHEN, F; DUH, FM; LUBENSKY, I; DUAN, DR; FLORENCE, C; POZZATTI, R; WALTHER, MM; BANDER, NH; GROSSMAN, HB; BRAUCH, H; POMER, S; BROOKS, JD; ISAACS, WB; LERMAN, MI; ZBAR, B; LINEHAN, WM				GNARRA, JR; TORY, K; WENG, Y; SCHMIDT, L; WEI, MH; LI, H; LATIF, F; LIU, S; CHEN, F; DUH, FM; LUBENSKY, I; DUAN, DR; FLORENCE, C; POZZATTI, R; WALTHER, MM; BANDER, NH; GROSSMAN, HB; BRAUCH, H; POMER, S; BROOKS, JD; ISAACS, WB; LERMAN, MI; ZBAR, B; LINEHAN, WM			MUTATIONS OF THE VHL TUMOR-SUPPRESSOR GENE IN RENAL-CARCINOMA	NATURE GENETICS			English	Article							VONHIPPEL-LINDAU DISEASE; CELL CARCINOMA; LINES; CANCER	Multiple, bilateral renal carcinomas are a frequent occurrence in von Hippel-Lindau (VHL) disease. To elucidate the aetiological role of the VHL gene in human kidney tumorigenesis, localized and advanced tumours from 110 patients with sporadic renal carcinoma were analysed for VHL mutations and loss of heterozygosity (LOH). VHL mutations were identified in 57% of clear cell renal carcinomas analysed and LOH was observed in 98% of those samples. Moreover, VHL was mutated and lost in a renal tumour from a patient with familial renal carcinoma carrying the constitutional translocation, t(3;8)(p14;q24). The identification of VHL mutations in a majority of localized and advanced sporadic renal carcinomas and in a second form of hereditary renal carcinoma indicates that the VHL gene plays a critical part in the origin of this malignancy.	NCI, SURG BRANCH, UROL ONCOL SECT, BETHESDA, MD 20892 USA; NCI, PATHOL LAB, BETHESDA, MD 20892 USA; NCI, FREDERICK CANC RES & DEV CTR, IMMUNOBIOL LAB, FREDERICK, MD 21702 USA; DYNCORP INC, PROGRAM RESOURCES, FREDERICK, MD 21702 USA; CORNELL UNIV, NEW YORK HOSP, CTR MED, DEPT UROL, NEW YORK, NY USA; UNIV MICHIGAN, UROL SECT, ANN ARBOR, MI 48109 USA; TECH UNIV MUNICH, MOLEC PATHOL LAB, D-81675 MUNICH, GERMANY; UNIV HEIDELBERG, SURG CLIN, HEIDELBERG, GERMANY; JOHNS HOPKINS MED INST, JAMES BUCHANAN BRADY UROL INST, BALTIMORE, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Cornell University; NewYork-Presbyterian Hospital; University of Michigan System; University of Michigan; Technical University of Munich; Ruprecht Karls University Heidelberg; Johns Hopkins University; Johns Hopkins Medicine				Gnarra, James/0000-0002-6369-3110				ANGLARD P, 1992, CANCER RES, V52, P348; ANGLARD P, 1991, CANCER RES, V51, P1071; BROOKS JD, 1993, J UROLOGY, V150, P1278, DOI 10.1016/S0022-5347(17)35760-9; COHEN AJ, 1979, NEW ENGL J MED, V301, P592, DOI 10.1056/NEJM197909133011107; DONISKELLER H, 1993, HUM MOL GENET, V2, P851, DOI 10.1093/hmg/2.7.851; EBERT T, 1990, CANCER RES, V50, P5531; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; Farrow GM, 1989, UROLOGICAL PATHOLOGY, P409; GLENN GM, 1990, PROBL UROL, V4, P312; GROSSMAN HB, 1985, J SURG ONCOL, V28, P237; HERRMANN MA, 1991, J CLIN INVEST, V88, P1596, DOI 10.1172/JCI115472; HOFSTRA RMW, 1994, NATURE, V367, P375, DOI 10.1038/367375a0; KNUDSON AG, 1985, CANCER RES, V45, P1437; KOVACS G, 1989, AM J PATHOL, V134, P27; KOVACS G, 1991, GENE CHROMOSOME CANC, V3, P249, DOI 10.1002/gcc.2870030403; LAMIELL JM, 1989, MEDICINE, V68, P1; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; LI FP, 1993, ANN INTERN MED, V118, P106, DOI 10.7326/0003-4819-118-2-199301150-00005; Linehan W M, 1993, Important Adv Oncol, P47; MAHER ER, 1991, J MED GENET, V28, P443, DOI 10.1136/jmg.28.7.443; MAKOS M, 1993, CANCER RES, V53, P2719; MULLIGAN LM, 1994, NAT GENET, V6, P70, DOI 10.1038/ng0194-70; REITER RE, 1993, CANCER RES, V53, P3092; ROBSON CJ, 1969, J UROLOGY, V101, P297, DOI 10.1016/S0022-5347(17)62331-0; ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0; SHRIVASTAV S, 1981, IN VITRO, V12, P1117; ZBAR B, 1994, J UROLOGY, V151, P561, DOI 10.1016/S0022-5347(17)35015-2; ZEIGER MA, IN PRESS GENES CHROM	28	1389	1424	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1994	7	1					85	90		10.1038/ng0594-85	http://dx.doi.org/10.1038/ng0594-85			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NJ842	7915601				2022-12-25	WOS:A1994NJ84200019
J	APPLE, RJ; ERLICH, HA; KLITZ, W; MANOS, MM; BECKER, TM; WHEELER, CM				APPLE, RJ; ERLICH, HA; KLITZ, W; MANOS, MM; BECKER, TM; WHEELER, CM			HLA DR-DQ ASSOCIATIONS WITH CERVICAL-CARCINOMA SHOW PAPILLOMAVIRUS-TYPE SPECIFICITY	NATURE GENETICS			English	Article							OLIGONUCLEOTIDE PROBES; SEVERE MALARIA; INFECTION; RISK; DNA; ANTIGENS; LINKAGE; CANCER; WOMEN	Cervical carcinoma is now known to be associated with human papillomaviruses (HPV), but the evidence for a link with specific HLA loci is controversial. The role of genetic variation at the HLA class II loci and among HPV types in cervical carcinoma was investigated by PCR DNA amplification and oligonucleotide probe typing of paraffin-embedded invasive cervical cancer tissue from Hispanic patients and of cervical swabs from Hispanic controls. Certain HLA class II haplotypes (such as DRB1(*)1501-DQB1(*)0602) were associated significantly, while DR13 haplotypes were negatively associated with cervical carcinoma. These associations are HPV16-type specific. These results suggest that specific HLA class II haplotypes may influence the immune response to specific HPV-encoded epitopes and affect the risk of cervical neoplasia.	ROCHE MOLEC SYST,DEPT HUMAN GENET,ALAMEDA,CA 94501; UNIV CALIF BERKELEY,DEPT INTEGRAT BIOL,BERKELEY,CA 94720; JOHNS HOPKINS SCH PUBL HLTH,DEPT IMMUNOL & INFECT DIS,BALTIMORE,MD; UNM,CTR CANC,NEW MEXICO TUMOR REGISTRY,ALBUQUERQUE,NM	Roche Holding; University of California System; University of California Berkeley; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of New Mexico			apple, raymond J/I-4506-2012	apple, raymond J/0000-0002-8007-0345				Amiel J.L, 1967, HISTOCOMPAT TEST, V1967, P79; APPLE RJ, 1992, TISSUE ANTIGENS, V40, P69, DOI 10.1111/j.1399-0039.1992.tb01962.x; BAUER H, 1992, DIAGNOSTIC MOL PATHO, P313; BAUER HM, 1991, JAMA-J AM MED ASSOC, V265, P472; BECKER TM, 1992, WESTERN J MED, V156, P376; BEGOVICH AB, 1992, J IMMUNOL, V148, P249; BRINTON LA, 1992, EPIDEMIOLOGY CERVICA, P3; BUGAWAN TL, 1991, IMMUNOGENETICS, V33, P163, DOI 10.1007/BF01719235; CARMICHAEL JA, 1990, AM J OBSTET GYNECOL, V162, P645; CHAN SY, 1992, J VIROL, V66, P5714, DOI 10.1128/JVI.66.10.5714-5725.1992; CHEN LP, 1991, P NATL ACAD SCI USA, V88, P110, DOI 10.1073/pnas.88.1.110; DANOS O, 1984, J INVEST DERMATOL, V83, P73; DAVID ALM, 1992, LANCET, V340, P52, DOI 10.1016/0140-6736(92)92464-Q; DEVILLIERS EM, 1989, J VIROL, V63, P4898, DOI 10.1128/JVI.63.11.4898-4903.1989; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; ERLICH HA, 1993, NAT GENET, V3, P358, DOI 10.1038/ng0493-358; GLEW SS, 1992, NATURE, V356, P22, DOI 10.1038/356022a0; GLEW SS, 1993, HUM IMMUNOL, V37, P157, DOI 10.1016/0198-8859(93)90181-Y; HAN R, 1992, NATURE, V356, P66, DOI 10.1038/356066a0; HELLAND A, 1992, NATURE, V356, P23, DOI 10.1038/356023a0; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; HILL AVS, 1992, NATURE, V360, P434, DOI 10.1038/360434a0; KIVIAT NB, 1989, J INFECT DIS, V159, P293, DOI 10.1093/infdis/159.2.293; KLITZ W, IN PRESS AM J HUM GE; KOUTSKY LA, 1992, NEW ENGL J MED, V327, P1272, DOI 10.1056/NEJM199210293271804; LORINCZ AT, 1992, OBSTET GYNECOL, V79, P328, DOI 10.1097/00006250-199203000-00002; LORINCZ AT, 1990, AM J OBSTET GYNECOL, V162, P645, DOI 10.1016/0002-9378(90)90974-C; LU SJ, 1990, NATURE, V346, P470, DOI 10.1038/346470a0; MANOS MM, 1989, CANCER CEL, V7, P209; MUNOZ N, 1992, EPIDEMIOLOGY CERVICA; NEPOM GT, 1991, ANNU REV IMMUNOL, V9, P493; PETERS RK, 1986, JNCI-J NATL CANCER I, V77, P1063; REEVES WC, 1985, INT J CANCER, V36, P55, DOI 10.1002/ijc.2910360110; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SCHARF SJ, 1991, HUM IMMUNOL, V30, P190, DOI 10.1016/0198-8859(91)90034-7; SCHIFFMAN MH, 1993, JNCI-J NATL CANCER I, V85, P958, DOI 10.1093/jnci/85.12.958; SCHIFFMAN MH, 1992, EPIDEMIOLOGY HUMAN P, P169; Sokal R.R., 1981, BIOL RES; STRANG G, 1990, J GEN VIROL, V71, P423, DOI 10.1099/0022-1317-71-2-423; VANDENVELDE C, 1993, LANCET, V341, P442, DOI 10.1016/0140-6736(93)93044-2; WANK R, 1992, NATURE, V356, P22, DOI 10.1038/356022b0; WANK R, 1991, NATURE, V352, P723, DOI 10.1038/352723a0; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; WHEELER CM, 1993, J SEX TRANS DIS, V120, P286	44	279	289	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1994	6	2					157	162		10.1038/ng0294-157	http://dx.doi.org/10.1038/ng0294-157			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU763	8162070				2022-12-25	WOS:A1994MU76300010
J	SMITH, TAG; MEHAFFEY, MG; KAYDA, DB; SAUNDERS, JM; YEI, S; TRAPNELL, BC; MCCLELLAND, A; KALEKO, M				SMITH, TAG; MEHAFFEY, MG; KAYDA, DB; SAUNDERS, JM; YEI, S; TRAPNELL, BC; MCCLELLAND, A; KALEKO, M			ADENOVIRUS-MEDIATED EXPRESSION OF THERAPEUTIC PLASMA-LEVELS OF HUMAN FACTOR-IX IN MICE	NATURE GENETICS			English	Article							GENE-TRANSFER; HEMOPHILIA-B; INVIVO; EPITHELIUM; KINETICS; ANIMALS; PROTEIN; CELLS; LIVER	Gene therapy strategies designed to combat haemophilia B, caused by defects in clotting factor IX, have so far concentrated on ex vivo approaches. We have now evaluated adenoviral vector-mediated expression of human factor IX in vivo. Injection of the vector Av1H9B, which encodes human factor IX cDNA, into the tail veins of mice resulted in efficient liver transduction and plasma levels of human factor IX that would be therapeutic for haemophilia B patients. However, levels slowly declined to baseline by nine weeks and were not re-established by a second vector injection. These results address both the advantages and obstacles to the use of adenoviral vectors for treatment of haemophilia B.	GENET THERAPY INC,GAITHERSBURG,MD 20878	Novartis				McClelland, Alan/0000-0003-2949-3542				AKLI S, 1993, NAT GENET, V3, P224, DOI 10.1038/ng0393-224; BAJOCCHI G, 1993, NAT GENET, V3, P229, DOI 10.1038/ng0393-229; BERKNER KL, 1988, BIOTECHNIQUES, V6, P616; BRIET E, 1991, BLOOD COAGUL FIBRIN, V2, P47; DAI Y, 1992, P NATL ACAD SCI USA, V89, P10892, DOI 10.1073/pnas.89.22.10892; DAVIDSON BL, 1993, NAT GENET, V3, P219, DOI 10.1038/ng0393-219; DIPERSIO CM, 1991, MOL CELL BIOL, V11, P4405, DOI 10.1128/MCB.11.9.4405; EVANS JP, 1989, BLOOD, V74, P207; GERRARD AJ, 1993, NAT GENET, V3, P180, DOI 10.1038/ng0293-180; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; HEDNER U, 1989, METABOLIC BASIS INHE, V2, P2116; HERZ J, 1993, P NATL ACAD SCI USA, V90, P2812, DOI 10.1073/pnas.90.7.2812; HORWITZ MS, 1990, VIROLOGY, V2, P1723; JAFFE HA, 1992, NAT GENET, V1, P372, DOI 10.1038/ng0892-372; JALLAT S, 1990, EMBO J, V9, P3295, DOI 10.1002/j.1460-2075.1990.tb07529.x; LI QT, 1993, HUM GENE THER, V4, P403, DOI 10.1089/hum.1993.4.4-403; MASTRANGELI A, 1993, J CLIN INVEST, V91, P225, DOI 10.1172/JCI116175; MITTAL SK, 1993, VIRUS RES, V28, P67, DOI 10.1016/0168-1702(93)90090-A; PALMER TD, 1989, BLOOD, V73, P438; RAGOT T, 1993, NATURE, V361, P647, DOI 10.1038/361647a0; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680; SCHARFMANN R, 1991, P NATL ACAD SCI USA, V88, P4626, DOI 10.1073/pnas.88.11.4626; SHENK T, 1984, CURR TOP MICROBIOL, V111, P1; SMITH KJ, 1981, BLOOD, V58, P625; STRATFORDPERRICAUDET LD, 1990, HUM GENE THER, V1, P241, DOI 10.1089/hum.1990.1.3-241; STRATFORDPERRICAUDET LD, 1992, J CLIN INVEST, V90, P626, DOI 10.1172/JCI115902; STROBER S, 1984, ANNU REV IMMUNOL, V2, P219, DOI 10.1146/annurev.iy.02.040184.001251; THOMPSON AR, 1980, BRIT J HAEMATOL, V45, P329, DOI 10.1111/j.1365-2141.1980.tb07152.x; THOMPSON AR, 1986, BLOOD, V67, P565; THOMPSON AR, 1991, CURR STUD HEMATOL BL, V58, P59; YAO SN, 1991, P NATL ACAD SCI USA, V88, P8101, DOI 10.1073/pnas.88.18.8101; 1991, B WORLD HEALTH ORGAN, V69, P17; 1993, HUM GENE THER, V4, P391	34	334	356	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1993	5	4					397	402		10.1038/ng1293-397	http://dx.doi.org/10.1038/ng1293-397			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ML145	8298650				2022-12-25	WOS:A1993ML14500018
J	KAPLAN, J; GERBER, S; LARGETPIET, D; ROZET, JM; DOLLFUS, H; DUFIER, JL; ODENT, S; POSTELVINAY, A; JANIN, N; BRIARD, ML; FREZAL, J; MUNNICH, A				KAPLAN, J; GERBER, S; LARGETPIET, D; ROZET, JM; DOLLFUS, H; DUFIER, JL; ODENT, S; POSTELVINAY, A; JANIN, N; BRIARD, ML; FREZAL, J; MUNNICH, A			A GENE FOR STARGARDTS-DISEASE (FUNDUS-FLAVIMACULATUS) MAPS TO THE SHORT ARM OF CHROMOSOME-1	NATURE GENETICS			English	Article							RETINITIS-PIGMENTOSA; MACULAR DEGENERATION; LINKAGE; DYSTROPHY	Stargardt's disease (fundus flavimaculatus) is one of the most frequent causes of macular degeneration in childhood and accounts for 7% of all retinal dystrophies. It is an autosomal recessive condition characterized by a bilateral loss of central vision occurring at age 7-12 years. Genetic linkage analysis of eight families has assigned the disease locus to chromosome 1p21-p13. Multipoint linkage analysis and haplotype analysis has allowed us to establish the best estimate for location of the gene over the locus D1S435 (maximum lod score of 12.66). Our results are consistent with the genetic homogeneity of this condition.	INST GUSTAVE ROUSSY,CONSULTAT GENET,F-94805 VILLEJUIF,FRANCE; HOP NECKER ENFANTS MALAD,INSERM,UNITE RECH HANDICAPS GENET ENFANT,U12,F-75743 PARIS 15,FRANCE; HOP NECKER ENFANTS MALAD,SERV OPHTHALMOL,F-75743 PARIS 15,FRANCE; UNIV RENNES,F-35056 RENNES,FRANCE; CHR RENNES,F-35056 RENNES,FRANCE; CTR DEPT TROUBLES AUDIT & VIS ENFANTS,F-93200 ST DENIS,FRANCE	UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Rennes; CHU Rennes	KAPLAN, J (corresponding author), HOP NECKER ENFANTS MALAD,SERV GENET,149 RUE SEVRES,F-75743 PARIS 15,FRANCE.		ROZET, Jean-Michel/E-5737-2016	ROZET, Jean-Michel/0000-0001-7951-7886; Dollfus, Helene/0000-0002-2249-895X; GERBER, Sylvie/0000-0002-6827-1769				BERSON EL, 1968, ARCH OPHTHALMOL-CHIC, V80, P68; Bither P P, 1988, J Am Optom Assoc, V59, P112; BONNIN M P, 1971, Bulletin des Societes d'Ophtalmologie de France, V71, P348; DEUTMAN AF, 1974, GENETIC METABOLIC EY, P367; EAGLE RC, 1980, OPHTHALMOLOGY, V87, P1189; Ewing CC, 1969, T OPHTHAL SOC UK, V89, P29; FERRELL RE, 1983, AM J HUM GENET, V35, P78; FISH G, 1981, BRIT J OPHTHALMOL, V65, P359, DOI 10.1136/bjo.65.5.359; FISHMAN GA, 1976, ARCH OPHTHALMOL-CHIC, V94, P2061, DOI 10.1001/archopht.1976.03910040721003; FORSIUS H, 1971, BIRTH DEFECTS, V7, P87; Franceschetti A, 1965, Arch Ophtalmol Rev Gen Ophtalmol, V25, P505; GARDINER M, 1990, GENOMICS, V8, P387, DOI 10.1016/0888-7543(90)90297-8; HADDEN OB, 1976, AM J OPHTHALMOL, V82, P527, DOI 10.1016/0002-9394(76)90539-0; HITTNER HM, 1975, DOC OPHTHALMOL, V39, P29, DOI 10.1007/BF00578758; HUMPHRIES P, 1992, SCIENCE, V256, P804, DOI 10.1126/science.1589761; JARVELA I, 1991, GENOMICS, V9, P170, DOI 10.1016/0888-7543(91)90235-7; KAPLAN J, 1990, HUM GENET, V85, P635; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Maumenee IH, 1978, 5 C EUR SOC OPHTH AP 5 C EUR SOC OPHTH AP, P80; McKusick V.A., 1992, MENDELIAN INHERITANC; MERIN S, 1970, ARCH OPHTHALMOL-CHIC, V84, P710, DOI 10.1001/archopht.1970.00990040712002; MERIN S, 1991, INHERITED EYE DISEAS, P137; NICHOLS BE, 1993, NAT GENET, V3, P202, DOI 10.1038/ng0393-202; OTT J, 1985, VARIABILITY RECOMBIN, P112; RABB MF, 1986, OPHTHALMOLOGY, V93, P1443; RIVAS F, 1986, ANN GENET-PARIS, V29, P42; RUPPS H, 1987, OPHTHALMOLOGY, V94, P1401; Stargardt K., 1909, GRAEFES ARCH CLIN EX, V71, P534, DOI DOI 10.1007/BF01961301; STONE EM, 1992, NAT GENET, V1, P246, DOI 10.1038/ng0792-246; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WILKIE TM, 1992, NAT GENET, V1, P85, DOI 10.1038/ng0592-85; ZHANG K, 1993, INVEST OPHTH VIS SCI, V34, P3749	32	140	144	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1993	5	3					308	311		10.1038/ng1193-308	http://dx.doi.org/10.1038/ng1193-308			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MF122	8275096				2022-12-25	WOS:A1993MF12200025
J	WEIFFENBACH, B; DUBOIS, J; STORVICK, D; TAWIL, R; JACOBSEN, SJ; GILBERT, J; WIJMENGA, C; MENDELL, JR; WINOKUR, S; ALTHERR, MR; SCHULTZ, P; OLANDT, S; FRANTS, RR; PERICAKVANCE, M; GRIGGS, RC				WEIFFENBACH, B; DUBOIS, J; STORVICK, D; TAWIL, R; JACOBSEN, SJ; GILBERT, J; WIJMENGA, C; MENDELL, JR; WINOKUR, S; ALTHERR, MR; SCHULTZ, P; OLANDT, S; FRANTS, RR; PERICAKVANCE, M; GRIGGS, RC			MAPPING THE FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY GENE IS COMPLICATED BY CHROMOSOME-4Q35 RECOMBINATION EVENTS	NATURE GENETICS			English	Article							DELETION; MOSAICISM; MUTATION; CLONING	A gene responsible for facioscapulohumeral muscular dystrophy (FSHD) has been linked to polymorphisms on chromosome 4q35. Multipoint linkage analyses have placed this gene distal to all reported genetic markers on the chromosome. By using as a probe a clone isolated from a cosmid containing sequences related to a homeobox domain, de novo DNA rearrangements were reported in sporadic and familial cases of FSHD. Linkage analysis of an EcoRI polymorphism detected by this clone in twenty-four multigenerational FSHD families revealed recombinants between this marker and the disease with a recombination fraction of 0.05. Two families with apparent germline mosaicism were also identified.	UNIV ROCHESTER,DEPT NEUROL,ROCHESTER,NY 14642; UNIV CALIF SAN DIEGO,LA JOLLA,CA 92093; DUKE UNIV,DEPT MED,DURHAM,NC 27710; LEIDEN UNIV,DEPT HUMAN GENET,MGC,2300 RA LEIDEN,NETHERLANDS; OHIO STATE UNIV,DEPT NEUROL,COLUMBUS,OH 43210; UNIV CALIF IRVINE,DEPT BIOL CHEM,IRVINE,CA 92717; LANL,CTR HUMAN GENOME STUDIES,LOS ALAMOS,NM 87545; UNIV CALIF SAN DIEGO,DEPT NEUROSCI,LA JOLLA,CA 92093	University of Rochester; University of California System; University of California San Diego; Duke University; Leiden University; Leiden University - Excl LUMC; University System of Ohio; Ohio State University; University of California System; University of California Irvine; United States Department of Energy (DOE); Los Alamos National Laboratory; University of California System; University of California San Diego	WEIFFENBACH, B (corresponding author), COLLABORAT RES INC,WALTHAM,MA 02154, USA.		Wijmenga, Cisca/D-2173-2009; Wijmenga, Cisca/AAE-7719-2019	Wijmenga, Cisca/0000-0002-5635-1614; Griggs, Robert/0000-0001-7988-4854	NCRR NIH HHS [MO1-RR00034, M01-RR0004] Funding Source: Medline; NIGMS NIH HHS [GM07311-18] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000034] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BAKKER E, 1987, NATURE, V329, P554, DOI 10.1038/329554a0; CARLE GF, 1986, SCIENCE, V232, P65, DOI 10.1126/science.3952500; COHN DH, 1990, AM J HUM GENET, V46, P591; DARRAS BT, 1987, NATURE, V329, P556, DOI 10.1038/329556a0; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GILBERT JR, 1992, AM J HUM GENET, V51, P424; GRIGGS RC, IN PRESS NEUROLOGY; JACOBSEN SJ, 1990, AM J HUM GENET, V47, P376; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; LANMAN JT, 1987, AM J HUM GENET, V41, P138; LUNT PW, 1989, J MED GENET, V26, P755, DOI 10.1136/jmg.26.12.755; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; MARIAT D, 1991, NUCLEIC ACIDS RES, V19, P4572, DOI 10.1093/nar/19.16.4572; MONACO AP, 1987, HUM GENET, V75, P221, DOI 10.1007/BF00281063; MURRAY EW, 1992, AM J HUM GENET, V50, P199; NICHOLLS RD, 1987, J MED GENET, V24, P39, DOI 10.1136/jmg.24.1.39; Ott J., 1991, ANAL HUMAN GENETIC L; SARFARAZI M, 1992, AM J HUM GENET, V51, P396; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; TYLER FH, 1950, ANN INTERN MED, V32, P640, DOI 10.7326/0003-4819-32-4-640; VANDILLA MA, 1986, BIO-TECHNOL, V4, P537, DOI 10.1038/nbt0686-537; WEIFFENBACH B, 1992, MAMM GENOME, V3, P143, DOI 10.1007/BF00352458; WEIFFENBACH B, 1992, AM J HUM GENET, V51, P416; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Wijmenga C, 1990, LANCET, V336, P651, DOI 10.1016/0140-6736(90)92148-B; WOOD S, 1988, HUM GENET, V78, P282, DOI 10.1007/BF00291677	28	66	66	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1993	4	2					165	169		10.1038/ng0693-165	http://dx.doi.org/10.1038/ng0693-165			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LF816	8102297				2022-12-25	WOS:A1993LF81600017
J	SULISALO, T; SISTONEN, P; HASTBACKA, J; WADELIUS, C; MAKITIE, O; DELACHAPELLE, A; KAITILA, I				SULISALO, T; SISTONEN, P; HASTBACKA, J; WADELIUS, C; MAKITIE, O; DELACHAPELLE, A; KAITILA, I			CARTILAGE-HAIR HYPOPLASIA GENE ASSIGNED TO CHROMOSOME-9 BY LINKAGE ANALYSIS	NATURE GENETICS			English	Article							FRIEDREICH ATAXIA; LOCALIZATION	Cartilage-hair hypoplasia (CHH) is an autosomal recessive skeletal dysplasia of unknown pathogenesis leading to short-limbed stature. Associated features include hypoplasia of hair, abnormal cellular immunity, deficient erythrogenesis, increased risk of malignancies, Hirschsprung disease, and Diamond-Blackfan type hypoplastic anaemia. We mapped the CHH gene by linkage analysis with 5 markers to chromosome 9. Multipoint linkage analysis gives a lod score of 9.94 for a location between D9S43 and D9S50. Based on strong linkage disequilibrium the closest marker, D9S50, is likely to be less than 1 cM from the gene. No heterogeneity was observed in 14 Finnish families, nor was there evidence of reduced penetrance. These results provide a starting point for the eventual cloning and characterization of the CHH gene.	FINNISH RED CROSS & BLOOD TRANSFUS SERV,SF-00310 HELSINKI,FINLAND; UNIV HOSP UPPSALA,DEPT CLIN GENET,S-75185 UPPSALA,SWEDEN; UNIV HELSINKI,CENT HOSP,CHILDRENS HOSP,SF-00290 HELSINKI 29,FINLAND; UNIV HELSINKI,CENT HOSP,DEPT MED GENET,SF-00290 HELSINKI 29,FINLAND	Uppsala University; Uppsala University Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital	SULISALO, T (corresponding author), UNIV HELSINKI,DEPT MED GENET,SF-00290 HELSINKI 29,FINLAND.							ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; EDWRDS JH, 1980, POPULATION STRUCTURE, P239; FOUNTAIN JW, 1992, GENOMICS, V14, P105, DOI 10.1016/S0888-7543(05)80290-3; FRANCOMANO CA, 1983, AM J HUM GENET, V35, pA89; FUJITA R, 1990, P NATL ACAD SCI USA, V87, P1796, DOI 10.1073/pnas.87.5.1796; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HASTBACKA J, 1990, P NATL ACAD SCI USA, V87, P8056, DOI 10.1073/pnas.87.20.8056; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MAKITIE O, 1992, J MED GENET, V29, P652, DOI 10.1136/jmg.29.9.652; MAKITIE O, IN PRESS EUR J PEDIA; MAKITIE O, IN PRESS ACTA PAEDIA; MAKITIE O, 1992, THESIS U HELSINKI; McKusick V. A. E., 1991, MENDELIAN INHERITANC; MCKUSICK VA, 1965, B J HOPKINS HOSP, V116, P232; OLOPADE OI, 1992, GENOMICS, V14, P437, DOI 10.1016/S0888-7543(05)80238-1; Perheentupa J, 1972, Duodecim, V88, P60; PIERCE GF, 1982, J IMMUNOL, V129, P570; POLMAR SH, 1986, CLIN IMMUNOL IMMUNOP, V40, P87, DOI 10.1016/0090-1229(86)90071-1; POVEY S, 1991, CYTOGENET CELL GENET, V58, P403, DOI 10.1159/000133169; SHAW J, 1990, CYTOGENET CELL GENET, V53, P221, DOI 10.1159/000132936; TRENT JM, 1982, P NATL ACAD SCI-BIOL, V79, P7809, DOI 10.1073/pnas.79.24.7809; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P2203; WILKIE PJ, 1992, GENOMICS, V12, P607, DOI 10.1016/0888-7543(92)90456-3	25	70	73	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1993	3	4					338	341		10.1038/ng0493-338	http://dx.doi.org/10.1038/ng0493-338			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KW257	7981754				2022-12-25	WOS:A1993KW25700016
J	MERCER, JFB; LIVINGSTON, J; HALL, B; PAYNTER, JA; BEGY, C; CHANDRASEKHARAPPA, S; LOCKHART, P; GRIMES, A; BHAVE, M; SIEMIENIAK, D; GLOVER, TW				MERCER, JFB; LIVINGSTON, J; HALL, B; PAYNTER, JA; BEGY, C; CHANDRASEKHARAPPA, S; LOCKHART, P; GRIMES, A; BHAVE, M; SIEMIENIAK, D; GLOVER, TW			ISOLATION OF A PARTIAL CANDIDATE GENE FOR MENKES DISEASE BY POSITIONAL CLONING	NATURE GENETICS			English	Article							TRANSLOCATION; RESISTANCES; COPPER; CELLS	Menkes disease is an X-linked recessive disorder of copper metabolism resulting in death in early infancy. The gene has been mapped to band Xq13 based, in part, on a translocation breakpoint in a female with the disease, which was found to lie within 300 kilobases (kb) of the PGK-1 locus, allowing the isolation of a YAC clone spanning the breakpoint. Phage subclones from the breakpoint region were isolated and used to screen cDNA libraries. cDNA clones were found which detect an 8 kb transcript from normal individuals but show diminished or absent hybridization in Menkes disease patients. Partial sequence of the cDNA shows a unique open reading frame containing putative metal binding motifs which have been found in heavy metal resistance genes in bacteria. This gene is a strong candidate for the Menkes disease gene.	UNIV MICHIGAN,HOWARD HUGHES MED INST,DEPT PEDIAT,ANN ARBOR,MI 48109; UNIV MICHIGAN,HOWARD HUGHES MED INST,DEPT HUMAN GENET,ANN ARBOR,MI 48109; UNIV MICHIGAN,CTR GENOME,ANN ARBOR,MI 48109; MURDOCH UNIV,SCOBIE & CLAIRE MACKINNON TRACE ELEMENT LAB,MURDOCH,WA 6150,AUSTRALIA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Murdoch University			Mercer, Julian/R-8583-2019; Lockhart, Paul J/E-7753-2011	Lockhart, Paul J/0000-0003-2531-8413	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P30HG000209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK044130, R01DK044130] Funding Source: NIH RePORTER; NHGRI NIH HHS [P30HGO-0209] Funding Source: Medline; NIDDK NIH HHS [R55 DK 44130, R01 DK 44130] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BROWN NL, 1991, J CELL BIOCHEM, V46, P106; CAMAKARIS J, 1980, BIOCHEM GENET, V18, P117, DOI 10.1007/BF00504364; DANKS DM, 1972, LANCET, V1, P1100; Danks DM, 1989, METABOLIC BASIS INHE, P1411; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; GONSALES GG, 1992, GENOMICS, V14, P557; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; KAPUR S, 1987, AM J MED GENET, V26, P503, DOI 10.1002/ajmg.1320260230; KEER JT, 1990, GENOMICS, V7, P566, DOI 10.1016/0888-7543(90)90200-E; KEITH DH, 1986, MOL CELL BIOL, V6, P4122, DOI 10.1128/MCB.6.11.4122; KUWANO A, 1991, CYTOGENET CELL GENET, V56, P212, DOI 10.1159/000133091; LENGAUER C, 1992, GENOMICS, V13, P826, DOI 10.1016/0888-7543(92)90160-T; MENKES JH, 1962, PEDIATRICS, V29, P764; PIECHACZYK M, 1984, NUCLEIC ACIDS RES, V12, P6951, DOI 10.1093/nar/12.18.6951; PIERETTI M, 1991, NUCLEIC ACIDS RES, V19, P2795, DOI 10.1093/nar/19.10.2795; SABURO S, 1988, J BIOL CHEM, V263, P16899; Sambrook J, 1989, MOL CLONING LABORATO; SILVER S, 1988, ANNU REV MICROBIOL, V42, P717, DOI 10.1146/annurev.mi.42.100188.003441; SILVER S, 1989, TRENDS BIOCHEM SCI, V14, P76, DOI 10.1016/0968-0004(89)90048-0; TONNESEN T, 1992, AM J HUM GENET, V50, P1012; TURNER Z, 1992, HUM MOL GENET, P483; VERGA V, 1991, AM J HUM GENET, V48, P1133	23	621	626	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1993	3	1					20	25		10.1038/ng0193-20	http://dx.doi.org/10.1038/ng0193-20			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KF372	8490647				2022-12-25	WOS:A1993KF37200007
J	Norimura, T; Nomoto, S; Katsuki, M; Gondo, Y; Kondo, S				Norimura, T; Nomoto, S; Katsuki, M; Gondo, Y; Kondo, S			p53-dependent apoptosis suppresses radiation-induced teratogenesis	NATURE MEDICINE			English	Article							MALFORMATIONS; MICE; P53	About half of human conceptions are estimated not to be implanted in the uterus, resulting in unrecognizable spontaneous abortions(1,2), and about 5% of human births have a recognizable malformation(1,3). In order to find clues to the mechanisms of malformation and abortion, we compared the incidences of radiation-induced malformations and abortions in p53 null (p53(-/-)) and wild-type (p53(+/+)) mice. After X-irradiation with 2 Cy on day 9.5 of gestation, p53(-/-) mice showed a 70% incidence of anomalies and a 7% incidence of deaths, whereas p53(+/+) mice had a 20% incidence of anomalies and a 60% incidence of deaths. Similar results were obtained after irradiation on day 3.5 of gestation. This reciprocal relationship of radiosensitivity to anomalies and to embryonic or fetal lethality supports the notion that embryonic or fetal tissues have a p53-dependent ''guardian'' of the tissue(4) that aborts cells bearing radiation-induced teratogenic DNA damage. In fact, after X-irradiation, the number of cells with apoptotic DNA fragments was greatly increased in tissues of the p53(+/+) fetuses but not in those of the p53(-/-) fetuses.	KYUSHU UNIV, MED INST BIOREGULAT, HIGASHI KU, FUKUOKA 812, JAPAN; KINKI UNIV, ATOM ENERGY RES INST, HIGASHIOSAKA, OSAKA 577, JAPAN	Kyushu University; Japan Atomic Energy Agency; Kindai University (Kinki University)	Norimura, T (corresponding author), UNIV OCCUPAT & ENVIRONM HLTH, SCH MED, DEPT RADIAT BIOL & HLTH, YAHATANISHI KU, KITAKYUSHU, FUKUOKA 807, JAPAN.		Gondo, Yoichi/A-5375-2016	Gondo, Yoichi/0000-0003-2184-6489				ARMSTRONG JF, 1995, CURR BIOL, V5, P931, DOI 10.1016/S0960-9822(95)00183-7; BOUE A, 1985, ADV HUM GENET, V14, P1; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; FUKUNAGA A, 1985, MUTAT RES, V151, P243, DOI 10.1016/0027-5107(85)90076-4; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GILBERT SF, 1991, DEV BIOL, P193; GONDO Y, 1994, BIOCHEM BIOPH RES CO, V202, P830, DOI 10.1006/bbrc.1994.2005; KONDO S, 1988, INT J RADIAT BIOL, V53, P95, DOI 10.1080/09553008814550461; KONDO S, 1993, HLTH EFFECTS LOW LEV, P73; KONDO S, 1984, PROBLEMS THRESHOLD C, P121; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; MCKEOWN T, 1976, BRIT MED BULL, V32, P1; MERRITT AJ, 1994, CANCER RES, V54, P614; MIYASHITA T, 1995, CELL, V80, P293; MOLE RH, 1992, ADV RADIAT BIOL, V15, P217; NICOL CJ, 1995, NAT GENET, V10, P181, DOI 10.1038/ng0695-181; NOMURA T, 1990, J EXP MED, V172, P1325, DOI 10.1084/jem.172.5.1325; NOMURA T, 1975, CANCER RES, V35, P264; Nomura T., 1984, CONGENIT ANOM, V24, P329; RUSSELL LB, 1954, J CELL COMPAR PHYSL, V43, pA103, DOI 10.1002/jcp.1030430407; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0	23	206	210	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	1996	2	5					577	580		10.1038/nm0596-577	http://dx.doi.org/10.1038/nm0596-577			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UJ230	8616719				2022-12-25	WOS:A1996UJ23000043
J	BenEliyahu, S; Page, GG; Yirmiya, R; Taylor, AN				BenEliyahu, S; Page, GG; Yirmiya, R; Taylor, AN			Acute alcohol intoxication suppresses natural killer cell activity and promotes tumor metastasis	NATURE MEDICINE			English	Article							MONOCLONAL-ANTIBODY; NK CELLS; RATS; CANCER; INVIVO; ETHANOL; INVOLVEMENT; IMMUNITY; DEFENSE; SPREAD	Alcohol consumption is associated with increased morbidity and mortality related to infectious diseases and malignancy(1-5), although immune mediation of these relationships is controversial. Specifically, the activity of natural killer (NK) cells, which are involved in the resistance to infections and metastasis, can be suppressed in the presence of ethanol in vitro. However, acute consumption or infusion of ethanol in vivo exerts no effects on NK activity assessed in vitro thereafter. Therefore, we have developed and used a method to study the effects of ethanol on NK activity in living rats by using an NK-sensitive metastatic process and selective depletion of NK cells in vivo. Acute ethanol intoxication caused a-marked suppression of NK activity in vivo and a tenfold increase in the number of MADB106 tumor metastases. Ethanol had no effect in rats selectively depleted of NK cells or when an NK-insensitive tumor (C4047) was used. These findings suggest that even acute ethanol intoxication markedly suppresses NK activity in the living organism. This suppression may underlie some aspects of the association between alcoholism, infectious disease and malignancies.	OHIO STATE UNIV, COLL NURSING, COLUMBUS, OH 43210 USA; HEBREW UNIV JERUSALEM, DEPT PSYCHOL, IL-91905 JERUSALEM, ISRAEL; UNIV CALIF LOS ANGELES, SCH MED, DEPT NEUROBIOL, LOS ANGELES, CA 90095 USA; W LOS ANGLES DEPT VET AFFAIRS MED CTR, LOS ANGELES, CA 90095 USA	University System of Ohio; Ohio State University; Hebrew University of Jerusalem; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	BenEliyahu, S (corresponding author), TEL AVIV UNIV, DEPT PSYCHOL, IL-69978 TEL AVIV, ISRAEL.		Ben-Eliyahu, Shamgar/AAE-5444-2020; Yirmiya, Raz/D-1090-2014	Yirmiya, Raz/0000-0002-4009-7316; Ben-Eliyahu, Shamgar/0000-0003-3832-0678	NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NCI NIH HHS [CA 16042] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARLOZZARI T, 1985, J IMMUNOL, V134, P2783; BARLOZZARI T, 1983, J IMMUNOL, V131, P1024; BENELIYAHU S, 1992, PROG NEUROENDOCRINIM, V5, P199; BLANK SE, 1993, ALCOHOL CLIN EXP RES, V17, P561, DOI 10.1111/j.1530-0277.1993.tb00800.x; CHAMBERS WH, 1989, J EXP MED, V169, P1373, DOI 10.1084/jem.169.4.1373; CHAMBERS WH, 1992, J IMMUNOL, V148, P3658; GARRO AJ, 1990, ANNU REV PHARMACOL, V30, P219, DOI 10.1146/annurev.pa.30.040190.001251; GORELIK E, 1982, INT J CANCER, V30, P107, DOI 10.1002/ijc.2910300118; HANNA N, 1984, BIOCHIM BIOPHYS ACTA, V780, P213, DOI 10.1016/0304-419X(85)90004-6; HENDERSON IC, 1980, NEW ENGL J MED, V302, P17, DOI 10.1056/NEJM198001033020104; IRWIN MR, 1993, ADV BIOSCI, V86, P69; JERRELLS TR, 1992, ALCOHOL, V9, P459, DOI 10.1016/0741-8329(92)90081-K; LESLIE I, 1993, ALCOHOL CLIN EXP RES, V17, P725; LEVY S, 1987, J CLIN ONCOL, V5, P348, DOI 10.1200/JCO.1987.5.3.348; LONG GS, 1988, TRANSPLANTATION, V46, P433, DOI 10.1097/00007890-198809000-00020; LOTZOVA E, 1993, NAT IMMUN, V12, P169; MACGREGOR RR, 1986, JAMA-J AM MED ASSOC, V256, P1474, DOI 10.1001/jama.256.11.1474; MATHER GG, 1994, IMMUNOBIOLOGY, V190, P333, DOI 10.1016/S0171-2985(11)80606-6; MEADOWS GG, 1993, ALCOHOL IMMUNITY CAN, P55; NAKACHI K, 1992, JPN J CANCER RES, V83, P798, DOI 10.1111/j.1349-7006.1992.tb01983.x; OCHSHORNADELSON M, 1994, ALCOHOL CLIN EXP RES, V18, P1361, DOI 10.1111/j.1530-0277.1994.tb01437.x; OLDHAM RK, 1990, NAT IMMUN CELL GROW, V9, P297; PAGE GG, 1994, BRAIN BEHAV IMMUN, V8, P241, DOI 10.1006/brbi.1994.1022; PAGE GG, 1993, PAIN, V54, P21, DOI 10.1016/0304-3959(93)90095-7; Roselle G, 1993, ALCOHOL IMMUNITY CAN, P3; SCHANTZ SP, 1987, CANCER IMMUNOL IMMUN, V25, P141; VANDENBRINK MRM, 1990, J EXP MED, V171, P197, DOI 10.1084/jem.171.1.197; WATSON RR, 1994, ALCOHOL ALCOHOLISM, V29, P131; WATSON RR, 1988, PROG FOOD NUTR SCI, V12, P189; WELSH RM, 1990, NAT IMMUN CELL GROW, V9, P112; WILTROUT RH, 1985, J IMMUNOL, V134, P4267; WU WJ, 1994, J PHARMACOL EXP THER, V271, P722; YEAGER MP, 1991, ARCH SURG-CHICAGO, V126, P454; YIRMIYA R, 1992, BRAIN BEHAV IMMUN, V6, P74, DOI 10.1016/0889-1591(92)90061-R; YIRMIYA R, 1993, ALCOHOL IMMUNITY CAN, P257	35	103	106	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	1996	2	4					457	460		10.1038/nm0496-457	http://dx.doi.org/10.1038/nm0496-457			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UD314	8597957				2022-12-25	WOS:A1996UD31400049
J	TAHVANAINEN, E; NORIO, R; KARILA, E; RANTA, S; WEISSENBACH, J; SISTONEN, P; DELACHAPELLE, A				TAHVANAINEN, E; NORIO, R; KARILA, E; RANTA, S; WEISSENBACH, J; SISTONEN, P; DELACHAPELLE, A			COHEN SYNDROME GENE ASSIGNED TO THE LONG ARM OF CHROMOSOME-8 BY LINKAGE ANALYSIS	NATURE GENETICS			English	Article							HOLMES-WALTON SYNDROME; HUMAN GENOME; POPULATIONS; FINLAND; MAP	Cohen syndrome is an autosomal recessive disorder characterized by mental and motor retardation, short stature, microcephaly, several dysmorphic features, major ocular symptoms and granulocytopenia. Major research challenges are the confusing nosology and the pleiotropy of the gene. We report the mapping of a locus (CHS1) by linkage analysis in as few as four two-generation pedigrees with uniform clinical features. CHS1 was assigned to an interval of approximately 10 cM between D8S270 and D8S521. Our results provide a tool to a more accurate definition of Cohen syndrome(s) and a starting point for the positional cloning of CHS1.	FINNISH FAMILY FEDERAT VAESTOLITTO,DEPT MED GENET,SF-00100 HELSINKI,FINLAND; GENETHON,F-91000 EVRY,FRANCE; FINNISH RED CROSS & BLOOD TRANSFUS SERV,SF-00310 HELSINKI,FINLAND	Family Federation of Finland	TAHVANAINEN, E (corresponding author), UNIV HELSINKI,DEPT MED GENET,HAARTMANINKATU 3,SF-00014 HELSINKI,FINLAND.		Ranta, Susanna/C-6149-2016					COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; COHEN MM, 1973, J PEDIATR-US, V83, P280; CUTICCHIA AJ, 1993, NUCLEIC ACIDS RES, V21, P3003, DOI 10.1093/nar/21.13.3003; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; GYAPAY G, 1994, IN PRESS NATURE GENE; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; KONDO I, 1990, AM J MED GENET, V37, P109, DOI 10.1002/ajmg.1320370126; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; McKusick V.A., 1992, MENDELIAN INHERITANC; MORRIS CA, 1987, P GREENWOOD GENET CT, V6, P123; NORIO R, 1984, CLIN GENET, V25, P1; NORIO R, 1986, AM J MED GENET, V25, P397, DOI 10.1002/ajmg.1320250227; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; PEARSON PL, 1991, NUCLEIC ACIDS RES, V19, P2237, DOI 10.1093/nar/19.suppl.2237; PEARSON PL, 1992, NUCLEIC ACIDS RES, V20, P2201, DOI 10.1093/nar/20.suppl.2201; RAITTA C, 1990, EYE SYSTEMIC DIS, P565; RESNICK K, 1986, OPHTHALMIC PAED GEN, V7, P1, DOI 10.3109/13816818609058036; SACK J, 1986, ISRAEL J MED SCI, V22, P766; SIERPINSKIBART J, 1981, METAB PEDIATR SYST O, V5, P225; STEINLEIN O, 1991, AM J MED GENET, V41, P196, DOI 10.1002/ajmg.1320410213; WARBURG M, 1990, OPHTHALMIC PAED GEN, V11, P7, DOI 10.3109/13816819009012943; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; Wood S, 1993, Cytogenet Cell Genet, V64, P134	26	69	69	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1994	7	2					201	204		10.1038/ng0694-201	http://dx.doi.org/10.1038/ng0694-201			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NQ037	7920642				2022-12-25	WOS:A1994NQ03700023
J	ASADA, Y; VARNUM, DS; FRANKEL, WN; NADEAU, JH				ASADA, Y; VARNUM, DS; FRANKEL, WN; NADEAU, JH			A MUTATION IN THE TER GENE CAUSING INCREASED SUSCEPTIBILITY TO TESTICULAR TERATOMAS MAPS TO MOUSE CHROMOSOME-18	NATURE GENETICS			English	Article							PRIMORDIAL GERM-CELLS; C-KIT; 129/SV-TER MICE; W LOCUS; EXPRESSION; CULTURE; LINKAGE; TERATOCARCINOMA; PROLIFERATION; FRAGMENTS	Little is known about inherited susceptibility to spontaneous germ cells tumours in humans or other species. The Ter mutation in laboratory mice is novel in that it acts codominantly to reduce germ cell numbers on many inbred strain backgrounds and to enhance dramatically inherited predisposition to spontaneous testicular teratocarcinomas in strain 129 inbred mice. We have adopted a PCR-based, DNA pooling method for mice with 'extreme' phenotypes (small testes versus normal-sized testes) to identify a candidate linkage to the Ter locus. Two independent mapping approaches confirmed this evidence for Ter linkage near D18Mit62 on mouse chromosome 18, and suggest a possible human homologue on chromosome 5q.	JACKSON LAB,BAR HARBOR,ME 04609; NIHON UNIV,SCH DENT,DEPT PEDODONT,MATSUDO,CHIBA 271,JAPAN	Jackson Laboratory; Nihon University					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD025389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031348] Funding Source: NIH RePORTER; NICHD NIH HHS [HD25389] Funding Source: Medline; NINDS NIH HHS [NS31348] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CHAGANTI RSK, 1993, UROL CLIN N AM, V20, P55; CHAMPLIN HW, 1980, JAMA-J AM MED ASSOC, V95, P96; COPELAND NG, 1993, SCIENCE, V262, P57, DOI 10.1126/science.8211130; DOUKETIS J, 1993, CAN FAM PHYSICIAN, V39, P1640; ERICSON ML, 1990, TRENDS GENET, V6, P278, DOI 10.1016/0168-9525(90)90217-T; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; HARVEY M, 1993, FASEB J, V7, P938, DOI 10.1096/fasebj.7.10.8344491; HEBERT JM, 1990, DEV BIOL, V138, P454, DOI 10.1016/0012-1606(90)90211-Z; HEERY DM, 1990, TRENDS GENET, V6, P173; Kitamura Yukihiko, 1993, P51; KLEINSMITH LJ, 1964, CANCER RES, V24, P1544; KORSMEYER SJ, 1992, IMMUNOL TODAY, V13, P285, DOI 10.1016/0167-5699(92)90037-8; LANDER ES, 1989, GENETICS, V121, P185; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LAPES M, 1977, CANCER, V39, P2317, DOI 10.1002/1097-0142(197705)39:5<2317::AID-CNCR2820390554>3.0.CO;2-Y; MANOVA K, 1991, DEV BIOL, V146, P312, DOI 10.1016/0012-1606(91)90233-S; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; MATSUI Y, 1990, NATURE, V347, P667, DOI 10.1038/347667a0; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; MINTZ B, 1957, J EXP ZOOL, V134, P207, DOI 10.1002/jez.1401340202; MOTRO B, 1991, DEVELOPMENT, V113, P1207; NADEAU JH, 1987, GENETICS, V117, P533; NOGUCHI T, 1985, JNCI-J NATL CANCER I, V75, P385; NOGUCHI T, 1982, J NATL CANCER I, V69, P907; OLIVER RTD, 1990, CANCER SURV, V9, P263; ORRURTREGER A, 1990, DEVELOPMENT, V109, P911; PELIAS TC, 1991, P NATL ACAD SCI USA, V88, P8787; PELTOMAKI P, 1990, CANCER GENET CYTOGEN, V48, P1, DOI 10.1016/0165-4608(90)90209-S; REITH AD, 1991, GENOME ANAL, V3, P105; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; RIVERS EN, 1986, AM J PATHOL, V124, P263; SILVERBERG E, 1982, CA-CANCER J CLIN, V32, P32, DOI 10.3322/canjclin.32.1.32; SKAKKEBAEK NE, 1984, INSERM, V123, P445; STEVENS LC, 1954, P NATL ACAD SCI USA, V40, P1080, DOI 10.1073/pnas.40.11.1080; STEVENS LC, 1973, J NATL CANCER I, V50, P235, DOI 10.1093/jnci/50.1.235; STEVENS LC, 1964, P NATL ACAD SCI USA, V52, P654, DOI 10.1073/pnas.52.3.654; STEVENS LC, 1967, J NATL CANCER I, V38, P549; STEVENS LC, 1959, J NATL CANCER I, V23, P1249; STEVENS LC, 1961, J NATL CANCER I, V27, P443; STEVENS LC, 1970, J NATL CANCER I, V44, P923; STEVENS LC, 1962, J NATL CANCER I, V28, P247; STEVENS LC, 1957, J NATL CANCER I, V18, P719; STEWART TA, 1982, J EXP ZOOL, V224, P465, DOI 10.1002/jez.1402240322; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; TAYLOR BA, 1989, GENOMICS, V5, P221, DOI 10.1016/0888-7543(89)90050-5; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; WATERHOUSE JAH, 1985, J ROY SOC MED, V78, P3	48	67	67	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1994	6	4					363	368		10.1038/ng0494-363	http://dx.doi.org/10.1038/ng0494-363			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ND870	8054975				2022-12-25	WOS:A1994ND87000014
J	IOANNOU, PA; AMEMIYA, CT; GARNES, J; KROISEL, PM; SHIZUYA, H; CHEN, C; BATZER, MA; DEJONG, PJ				IOANNOU, PA; AMEMIYA, CT; GARNES, J; KROISEL, PM; SHIZUYA, H; CHEN, C; BATZER, MA; DEJONG, PJ			A NEW BACTERIOPHAGE P1-DERIVED VECTOR FOR THE PROPAGATION OF LARGE HUMAN DNA FRAGMENTS	NATURE GENETICS			English	Article							YEAST ARTIFICIAL CHROMOSOMES; ESCHERICHIA-COLI; CLONING; LIBRARIES; REGION; CLONES; GENOME; INVITRO; MOUSE; HYBRIDIZATION	We have designed a P1 vector (pCYPAC-1) for the introduction of recombinant DNA into E coli using electroporation procedures. The new cloning system, P1-derived arteficial chromosomes (PACs), was used to establish an initial 15,000 clone library with an average insert size of 130-150 kilobase pairs (kb). No chimaerism has been observed in 34 clones, by fluorescence in situ hybridization. Similarly, no insert instability has been observed after extended culturing, for 20 clones. We conclude that the PAC cloning system will be useful in the mapping and detailed analysis of complex genomes.	ROSWELL PK CANC INST, DEPT HUMAN GENET, ELM & CARLTON ST, BUFFALO, NY 14263 USA; LAWRENCE LIVERMORE NATL LAB, CTR HUMAN GENOME L452, BIOL & BIOTECHNOL RES PROGRAM, LIVERMORE, CA 94550 USA; CALTECH, DIV BIOL, PASADENA, CA 91125 USA	Roswell Park Cancer Institute; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; California Institute of Technology								ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BALDINI A, 1992, GENOMICS, V14, P181, DOI 10.1016/S0888-7543(05)80303-9; BATES GP, 1992, NAT GENET, V1, P180, DOI 10.1038/ng0692-180; BELLANNECHANTELOT C, 1992, CELL, V70, P1059, DOI 10.1016/0092-8674(92)90254-A; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; BURKE DT, 1991, METHOD ENZYMOL, V194, P251; CHARTIER FL, 1992, NAT GENET, V1, P132, DOI 10.1038/ng0592-132; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; COLLINS J, 1978, P NATL ACAD SCI USA, V75, P4242, DOI 10.1073/pnas.75.9.4242; CRAIG AG, 1990, NUCLEIC ACIDS RES, V18, P2653; Dausset J, 1992, Behring Inst Mitt, P13; DEJONG PJ, 1989, CYTOGENET CELL GENET, V51, P985; DUYK GM, 1990, P NATL ACAD SCI USA, V87, P8995, DOI 10.1073/pnas.87.22.8995; FOOTE S, 1992, SCIENCE, V258, P60, DOI 10.1126/science.1359640; FUSCOE JC, 1989, CYTOGENET CELL GENET, V50, P211, DOI 10.1159/000132762; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; GREEN ED, 1991, GENOMICS, V11, P658, DOI 10.1016/0888-7543(91)90073-N; HANAHAN D, 1991, METHOD ENZYMOL, V204, P63; HARRISONLAVOIE KJ, 1989, GENOMICS, V5, P501, DOI 10.1016/0888-7543(89)90016-5; HOSODA F, 1990, NUCLEIC ACIDS RES, V11, P3863; KIM UJ, 1992, NUCLEIC ACIDS RES, V20, P1083, DOI 10.1093/nar/20.5.1083; KOPPES LJH, 1992, J BACTERIOL, V174, P2121, DOI 10.1128/JB.174.7.2121-2123.1992; KROISEL PM, 1994, CYTOGENET CELL GENET, V65, P97, DOI 10.1159/000133609; LARIN Z, 1990, GENET RES, V56, P203, DOI 10.1017/S0016672300035308; LARIN Z, 1991, P NATL ACAD SCI USA, V88, P4123, DOI 10.1073/pnas.88.10.4123; LEONARDO ED, 1990, BIO-TECHNOL, V8, P841, DOI 10.1038/nbt0990-841; MAIER E, 1992, NAT GENET, V1, P273, DOI 10.1038/ng0792-273; MORGAN JG, 1992, NUCLEIC ACIDS RES, V20, P5173, DOI 10.1093/nar/20.19.5173; NEIL DL, 1990, NUCLEIC ACIDS RES, V18, P1421, DOI 10.1093/nar/18.6.1421; NIZETIC D, 1991, P NATL ACAD SCI USA, V88, P3233, DOI 10.1073/pnas.88.8.3233; OLSEN AS, 1993, BIOTECHNIQUES, V14, P116; PARIMOO S, 1991, P NATL ACAD SCI USA, V88, P9623, DOI 10.1073/pnas.88.21.9623; PIERCE JC, 1992, MAMM GENOME, V3, P550, DOI 10.1007/BF00350620; PIERCE JC, 1992, P NATL ACAD SCI USA, V89, P2056, DOI 10.1073/pnas.89.6.2056; RAO VB, 1992, GENE, V113, P25, DOI 10.1016/0378-1119(92)90666-D; SAMBROOK J, 1979, NUCLEIC ACIDS RES, V7, P1513; SCHLESSINGER D, 1991, GENOMICS, V11, P783, DOI 10.1016/0888-7543(91)90001-U; SHEDL A, 1993, NATURE, V362, P258; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; STALLINGS RL, 1990, P NATL ACAD SCI USA, V87, P6218, DOI 10.1073/pnas.87.16.6218; STERNBERG N, 1990, New Biologist, V2, P151; STRAUSS WM, 1993, SCIENCE, V259, P1904, DOI 10.1126/science.8096090; TRASK B, 1993, GENOMICS, V15, P133, DOI 10.1006/geno.1993.1021; Vilageliu L., 1992, Techniques for the analysis of complex genomes., P93; YOKOBATA K, 1991, NUCLEIC ACIDS RES, V19, P403, DOI 10.1093/nar/19.2.403	46	722	775	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	1994	6	1					84	89						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ177	8136839				2022-12-25	WOS:A1994MQ17700019
J	LISITSYN, NA; SEGRE, JA; KUSUMI, K; LISITSYN, NM; NADEAU, JH; FRANKEL, WN; WIGLER, MH; LANDER, ES				LISITSYN, NA; SEGRE, JA; KUSUMI, K; LISITSYN, NM; NADEAU, JH; FRANKEL, WN; WIGLER, MH; LANDER, ES			DIRECT ISOLATION OF POLYMORPHIC MARKERS LINKED TO A TRAIT BY GENETICALLY DIRECTED REPRESENTATIONAL DIFFERENCE ANALYSIS	NATURE GENETICS			English	Article								We describe a technique, genetically directed representational difference analysis (GDRDA), for specifically generating genetic markers linked to a trait of interest. GDRDA is applicable, in principle, to virtually any organism, because it requires neither prior knowledge of the chromosomal location of the gene controlling the trait nor the availability of a pre-existing genetic map. Based on a subtraction technique described recently called representational difference analysis, GDRDA uses the principles of transmission genetics to create appropriate Tester and Driver samples for subtraction. We demonstrate the usefullness of GDRDA by, for example, successfully targeting three polymorphisms to an interval of less than 1 cM of the mouse nude locus of chromosome 11.	MIT,WHITEHEAD INST BIOMED RES,CAMBRIDGE,MA 02142; MIT,DEPT BIOL,CAMBRIDGE,MA 02142; COLD SPRING HARBOR LAB,COLD SPRING HARBOR,NY 11724; JACKSON LAB,BAR HARBOR,ME 04609	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Cold Spring Harbor Laboratory; Jackson Laboratory			Lisitsyn, Nikolai/AAO-7011-2021; Kusumi, Kenro/J-2626-2012	Kusumi, Kenro/0000-0002-1458-4540; Lisitsyn, Nikolai/0000-0003-4725-2662; Wigler, Michael/0000-0003-4396-1971				BROWN T, 1993, CURRENT PROTOCOLS MO; COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3; DIETRICH W, 1992, GENETICS, V131, P423; HILLYARD AL, 1993, LOCUS MAP MOUSE COMP; LISITSYN N, 1993, SCIENCE, V259, P946, DOI 10.1126/science.8438152; Lyon M., 1989, GENETIC VARIANTS STR; SNELL GD, 1958, JNCI-J NATL CANCER I, V21, P843; WILLIAMS JGK, 1993, NUCLEIC ACIDS RES, V21, P2697, DOI 10.1093/nar/21.11.2697; 1993, MOUSE GENOME PUBLIC	9	107	123	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1994	6	1					57	63		10.1038/ng0194-57	http://dx.doi.org/10.1038/ng0194-57			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ177	8136836				2022-12-25	WOS:A1994MQ17700015
J	HILAL, L; ROCHAT, A; DUQUESNOY, P; BLANCHETBARDON, C; WECHSLER, J; MARTIN, N; CHRISTIANO, AM; BARRANDON, Y; UITTO, J; GOOSSENS, M; HOVNANIAN, A				HILAL, L; ROCHAT, A; DUQUESNOY, P; BLANCHETBARDON, C; WECHSLER, J; MARTIN, N; CHRISTIANO, AM; BARRANDON, Y; UITTO, J; GOOSSENS, M; HOVNANIAN, A			A HOMOZYGOUS INSERTION-DELETION IN THE TYPE-VII COLLAGEN GENE (COL7A1) IN HALLOPEAU-SIEMENS DYSTROPHIC EPIDERMOLYSIS-BULLOSA	NATURE GENETICS			English	Article							EPIDERMAL BASEMENT-MEMBRANE; ANCHORING FIBRILS; OSTEOGENESIS IMPERFECTA; MESSENGER-RNA; LINKAGE; MUTATION; FAMILIES; CLONING; CHAIN; SKIN	The Hallopeau-Siemens type of recessive dystrophic epidermolysis bullosa (HS-RDEB) is a life-threatening autosomal disease characterized by loss of dermal-epidermal adherence with abnormal anchoring fibrils (AF). We recently linked HS-RDEB to the type VII collagen gene (COL7A1) which encodes the major component of AF. We describe a patient who is homozygous for an insertion-deletion in the FN-4A domain of the COL7A1 gene. This defect causes a frameshift mutation which leads to a premature stop codon in the FN-5A domain, resulting in a marked diminution in mutated mRNA levels, with no detectable type VII collagen polypeptide in the patient. Our data suggest strongly that this null allele prevents normal anchoring fibril formation in homozygotes and is the underlying cause of HS-RDEB in this patient.	HOP HENRI MONDOR,INSERM,U91,GENET MOLEC LAB,F-94010 CRETEIL,FRANCE; ECOLE NORMALE SUPER,DEPT BIOL,F-75231 PARIS 05,FRANCE; HOP ST LOUIS,MALAD CUTANEES CLIN,F-75010 PARIS,FRANCE; HOP HENRI MONDOR,SERV ANAT & CYTOL PATHOL,F-94010 CRETEIL,FRANCE; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,INST MOLEC MED,DEPT DERMATOL,MOLEC DERMATOL SECT,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,INST MOLEC MED,DEPT BIOCHEM & MOLEC BIOL,PHILADELPHIA,PA 19107	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Jefferson University; Jefferson University					NIAMS NIH HHS [P01-AR38923, T32-AR07561] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007561, P01AR038923] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALIMARA L, 1992, J MED GENET, V29, P381, DOI 10.1136/jmg.29.6.381; BASERGA SJ, 1988, P NATL ACAD SCI USA, V85, P2056, DOI 10.1073/pnas.85.7.2056; BONADIO J, 1990, J BIOL CHEM, V265, P2262; BONIFAS JM, 1991, SCIENCE, V254, P1202, DOI 10.1126/science.1720261; BRUCKNERTUDERMAN L, 1989, J INVEST DERMATOL, V93, P3, DOI 10.1111/1523-1747.ep12277331; BRUCKNERTUDERMAN L, 1988, DERMATOLOGICA, V176, P57, DOI 10.1159/000248673; BRUCKNERTUDERMAN L, 1990, BRIT J DERMATOL, V122, P383, DOI 10.1111/j.1365-2133.1990.tb08287.x; BURGESON RE, 1990, ANN NY ACAD SCI, V580, P32, DOI 10.1111/j.1749-6632.1990.tb17915.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRISTIANO AM, 1993, NAT GENET, V4, P62, DOI 10.1038/ng0593-62; CHRISTIANO AM, 1992, HUM MOL GENET, V1, P475, DOI 10.1093/hmg/1.7.475; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; DONG W, 1993, HUM MUTAT, V2, P94, DOI 10.1002/humu.1380020206; FINE JD, 1990, J AM ACAD DERMATOL, V22, P188, DOI 10.1016/0190-9622(90)70021-9; FINE JD, 1991, J AM ACAD DERMATOL, V24, P119, DOI 10.1016/0190-9622(91)70021-S; GAMMON WR, 1992, J INVEST DERMATOL, V99, P691, DOI 10.1111/1523-1747.ep12614080; GRUIS NA, 1992, J INVEST DERMATOL, V99, P528, DOI 10.1111/1523-1747.ep12658066; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; HASHIMOTO I, 1976, ARCH DERMATOL RES, V256, P137, DOI 10.1007/BF00567360; HEAGERTY AHM, 1986, BRIT J DERMATOL, V115, P125, DOI 10.1111/j.1365-2133.1986.tb05707.x; HOVNANIAN A, 1993, NAT GENET, V3, P327, DOI 10.1038/ng0493-327; HOVNANIAN A, 1992, J CLIN INVEST, V90, P1032, DOI 10.1172/JCI115916; JOHN SWM, 1991, NUCLEIC ACIDS RES, V19, P408, DOI 10.1093/nar/19.2.408; KONIG A, 1992, J INVEST DERMATOL, V99, P808, DOI 10.1111/1523-1747.ep12614773; LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0; LEIGH IM, 1988, J INVEST DERMATOL, V90, P639, DOI 10.1111/1523-1747.ep12560795; LERMAN LS, 1987, METHOD ENZYMOL, V155, P482; LIN AN, 1992, EPIDEMOLYSIS BULLOSA, P3; MCGRATH JA, 1993, J INVEST DERMATOL, V100, P366, DOI 10.1111/1523-1747.ep12471830; MENEGUZZI G, 1993, EXP DERMATOL, V1, P221; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; PARENTE MG, 1991, P NATL ACAD SCI USA, V88, P6931, DOI 10.1073/pnas.88.16.6931; PIHLAJANIEMI T, 1984, J BIOL CHEM, V259, P2941; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; RUSENKO KW, 1989, J INVEST DERMATOL, V92, P623, DOI 10.1111/1523-1747.ep12712167; RYYNANEN J, 1992, J CLIN INVEST, V89, P163, DOI 10.1172/JCI115557; RYYNANEN M, 1991, AM J HUM GENET, V49, P797; RYYNANEN M, 1992, J CLIN INVEST, V89, P974, DOI 10.1172/JCI115680; SAKAI LY, 1986, J CELL BIOL, V103, P1577, DOI 10.1083/jcb.103.4.1577; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SMITH LT, 1990, J INVEST DERMATOL, V94, P261, DOI 10.1111/1523-1747.ep12874614; TANAKA T, 1992, BIOCHEM BIOPH RES CO, V183, P958, DOI 10.1016/S0006-291X(05)80283-9; TIDMAN MJ, 1985, J INVEST DERMATOL, V84, P374, DOI 10.1111/1523-1747.ep12265460; TROMP G, 1988, P NATL ACAD SCI USA, V85, P5254, DOI 10.1073/pnas.85.14.5254; WILLING MC, 1992, AM J HUM GENET, V51, P508	46	113	116	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1993	5	3					287	293		10.1038/ng1193-287	http://dx.doi.org/10.1038/ng1193-287			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MF122	8275094				2022-12-25	WOS:A1993MF12200022
J	Metcalfe, JA; Parkhill, J; Campbell, L; Stacey, M; Biggs, P; Byrd, PJ; Taylor, AMR				Metcalfe, JA; Parkhill, J; Campbell, L; Stacey, M; Biggs, P; Byrd, PJ; Taylor, AMR			Accelerated telomere shortening in ataxia telangiectasia	NATURE GENETICS			English	Letter							HUMAN FIBROBLASTS; ASSOCIATION; LYMPHOCYTES; CHROMOSOMES; CARCINOMA; LEUKEMIA; PATIENT; FUSION; CELLS		UNIV BIRMINGHAM,SCH MED,CRC INST CANC STUDIES,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND	University of Birmingham			Parkhill, Julian/G-4703-2011	Parkhill, Julian/0000-0002-7069-5958; Stacey, Michael/0000-0002-3807-6233				ALEDO R, 1989, CANCER GENET CYTOGEN, V40, P95, DOI 10.1016/0165-4608(89)90150-7; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; BACCHETTI S, 1995, INT J ONCOL, V7, P423; BENN PA, 1976, AM J HUM GENET, V28, P465; BLACKBURN EH, 1984, ANNU REV BIOCHEM, V53, P163, DOI 10.1146/annurev.bi.53.070184.001115; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; FITZGERALD PH, 1984, HUM GENET, V67, P385, DOI 10.1007/BF00291396; GREENWELL PW, 1995, CELL, V82, P823, DOI 10.1016/0092-8674(95)90479-4; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HASTIE ND, 1989, TRENDS GENET, V5, P326, DOI 10.1016/0168-9525(89)90137-6; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; HAYASHI K, 1975, HUMANGENETIK, V30, P135, DOI 10.1007/BF00291946; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; KOJIS TL, 1989, HUM GENET, V83, P347, DOI 10.1007/BF00291379; MANDAHL N, 1985, HUM GENET, V71, P321, DOI 10.1007/BF00388457; MORGAN R, 1986, HUM GENET, V73, P260, DOI 10.1007/BF00401240; PANDITA TK, 1995, CYTOGENET CELL GENET, V71, P86, DOI 10.1159/000134069; PATHAK S, 1988, CYTOGENET CELL GENET, V47, P227, DOI 10.1159/000132555; SALTMAN D, 1993, CHROMOSOMA, V102, P121, DOI 10.1007/BF00356029; SALTMAN D, 1989, CYTOGENET CELL GENET, V50, P230, DOI 10.1159/000132766; Sambrook J., 2002, MOL CLONING LAB MANU; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Sedgwick R, 1991, HDB CLIN NEUROLOGY, P347; Taylor A. M. R., 1996, P138; TAYLOR AMR, 1987, J MED GENET, V24, P669, DOI 10.1136/jmg.24.11.669; TAYLOR AMR, 1981, INT J CANCER, V27, P311, DOI 10.1002/ijc.2910270309; Taylor AMR, 1996, BLOOD, V87, P423, DOI 10.1182/blood.V87.2.423.bloodjournal872423; THICK J, 1994, LEUKEMIA, V8, P564; VAZIRI H, 1993, AM J HUM GENET, V52, P661; ZAKIAN VA, 1989, ANNU REV GENET, V23, P579, DOI 10.1146/annurev.genet.23.1.579	30	278	287	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1996	13	3					350	353		10.1038/ng0796-350	http://dx.doi.org/10.1038/ng0796-350			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UU283	8673136				2022-12-25	WOS:A1996UU28300025
J	Hanis, CL; Boerwinkle, E; Chakraborty, R; Ellsworth, DL; Concannon, P; Stirling, B; Morrison, VA; Wapelhorst, B; Spielman, RS; GogolinEwens, KJ; Shephard, JM; Williams, SR; Risch, N; Hinds, D; Iwasaki, N; Ogata, M; Omori, Y; Petzold, C; Rietzsch, H; Schroder, HE; Schulze, J; Cox, NJ; Menzel, S; Boriraj, VV; Chen, X; Lim, LR; Lindner, T; Mereu, LE; Wang, YQ; Xiang, K; Yamagata, K; Yang, Y; Bell, GI				Hanis, CL; Boerwinkle, E; Chakraborty, R; Ellsworth, DL; Concannon, P; Stirling, B; Morrison, VA; Wapelhorst, B; Spielman, RS; GogolinEwens, KJ; Shephard, JM; Williams, SR; Risch, N; Hinds, D; Iwasaki, N; Ogata, M; Omori, Y; Petzold, C; Rietzsch, H; Schroder, HE; Schulze, J; Cox, NJ; Menzel, S; Boriraj, VV; Chen, X; Lim, LR; Lindner, T; Mereu, LE; Wang, YQ; Xiang, K; Yamagata, K; Yang, Y; Bell, GI			A genome-wide search for human non-insulin dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2	NATURE GENETICS			English	Article							LINKAGE ANALYSIS; MELLITUS; NIDDM; DEAFNESS; POWER	Non-insulin-dependent (type 2) diabetes mellitus (NIDDM) is a common disorder of middle-aged individuals characterized by high blood glucose levels which, if untreated, can cause serious medical complications and lead to early death. Genetic factor splay an important role in determining susceptibility to this disorder. However, the number of genes involved, their chromosomal location and the magnitude of their effect on NIDDM susceptibility are unknown. We have screened the human genome for susceptibility genes for NIDDM using non- and quasi-parametric linkage analysis methods in a group of Mexican American affected sib pairs. One marker, D2S125, showed significant evidence of linkage to NIDDM and appears to be a major factor affecting the development of diabetes mellitus in Mexican Americans. We propose that this locus be designated NIDDM1.	VIRGINIA MASON RES CTR,SEATTLE,WA 98101; UNIV WASHINGTON,DEPT IMMUNOL,SEATTLE,WA 98195; UNIV PENN,SCH MED,DEPT GENET,PHILADELPHIA,PA 19104; STANFORD UNIV,DEPT GENET,STANFORD,CA 94305; TOKYO WOMENS MED COLL,CTR DIABET,TOKYO 162,JAPAN; TECH UNIV DRESDEN,UNIV CLIN CARL GUSTAV CARUS,DEPT INTERNAL MED 3,O-8027 DRESDEN,GERMANY; UNIV CHICAGO,HOWARD HUGHES MED INST,CHICAGO,IL 60637; UNIV CHICAGO,DEPT BIOCHEM & MOLEC BIOL,CHICAGO,IL 60637; UNIV CHICAGO,DEPT MED,CHICAGO,IL 60637	Virginia Mason Medical Center; University of Washington; University of Washington Seattle; University of Pennsylvania; Stanford University; Tokyo Women's Medical University; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Howard Hughes Medical Institute; University of Chicago; University of Chicago; University of Chicago	Hanis, CL (corresponding author), UNIV TEXAS,HLTH SCI CTR,CTR HUMAN GENET,POB 20334,HOUSTON,TX 77030, USA.		Menzel, Stephan/U-6906-2019	Martin, Beth/0000-0002-9661-014X; Concannon, Patrick/0000-0002-5801-1859; Menzel, Stephan/0000-0002-1590-9108	NIDDK NIH HHS [DK-20595, DK-47481, DK-47486] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047481, P30DK020595, R01DK047486, P60DK020595] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11; BISHOP DT, 1990, AM J HUM GENET, V46, P254; BYRNE MM, 1995, DIABETES, V44, P699, DOI 10.2337/diabetes.44.6.699; CLEMENT K, 1995, NEW ENGL J MED, V333, P352, DOI 10.1056/NEJM199508103330605; CURTIS D, 1995, AM J HUM GENET, V57, P703; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FAJANS SS, 1989, DIABETES METAB REV, V5, P579, DOI 10.1002/dmr.5610050705; FASMAN KH, 1994, NUCLEIC ACIDS RES, V22, P3462, DOI 10.1093/nar/22.17.3462; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; GRUPE A, 1995, CELL, V83, P69, DOI 10.1016/0092-8674(95)90235-X; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HAGER J, 1995, NAT GENET, V9, P299, DOI 10.1038/ng0395-299; HAMMAN RF, 1992, DIABETES METAB REV, V8, P287, DOI 10.1002/dmr.5610080402; HANIS CL, 1993, DIABETES CARE, V16, P82, DOI 10.2337/diacare.16.1.82; HANIS CL, 1991, DIABETES CARE, V14, P618, DOI 10.2337/diacare.14.7.618; HARRIS MI, 1995, NIH PUBLICATION, P15; HARRIS MI, 1995, NIH PUBLICATION, P1; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; HODGE SE, 1994, GENET EPIDEMIOL, V11, P329, DOI 10.1002/gepi.1370110403; HOLMANS P, 1993, AM J HUM GENET, V52, P362; HOLMANS P, 1995, AM J HUM GENET, V57, P1221; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; IWSAKI N, 1996, DIABETES, V45, P267; KING H, 1993, DIABETES CARE, V16, P157, DOI 10.2337/diacare.16.1.157; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATHROP GM, 1985, AM J HUM GENET, V37, P482; NORMAN RA, 1995, J CLIN INVEST, V96, P158, DOI 10.1172/JCI118016; PROCHAZKA M, 1993, DIABETES, V42, P514, DOI 10.2337/diabetes.42.4.514; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1993, AM J HUM GENET, V53, pA185; ROTTER JI, 1992, GENETIC BASIS COMMON, P413; Steiner D. F., 1995, METABOLIC MOL BASES, P897; SUAREZ BK, 1979, CLIN GENET, V15, P126; Taylor S. I., 1995, METABOLIC MOL BASES, P843; THOMPSON DB, 1995, DIABETES, V44, P478, DOI 10.2337/diabetes.44.4.478; TODD JA, 1995, P NATL ACAD SCI USA, V92, P8560, DOI 10.1073/pnas.92.19.8560; TURNER RC, 1995, DIABETES, V44, P1, DOI 10.2337/diabetes.44.1.1; VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368; VAXILLAIRE M, 1995, NAT GENET, V9, P418, DOI 10.1038/ng0495-418; WALSTON J, 1995, NEW ENGL J MED, V333, P342; WIDEN E, 1995, NEW ENGL J MED, V333, P348, DOI 10.1056/NEJM199508103330604; YAMAGATA K, IN PRESS DIABETOLOGI	44	498	519	0	14	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1996	13	2					161	166		10.1038/ng0696-161	http://dx.doi.org/10.1038/ng0696-161			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UN395	8640221				2022-12-25	WOS:A1996UN39500014
J	Lei, KJ; Chen, HW; Pan, CJ; Ward, JM; Mosinger, B; Lee, EJ; Westphal, H; Mansfield, BC; Chou, JY				Lei, KJ; Chen, HW; Pan, CJ; Ward, JM; Mosinger, B; Lee, EJ; Westphal, H; Mansfield, BC; Chou, JY			Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse	NATURE GENETICS			English	Article							MICROSOMAL GLUCOSE-6-PHOSPHATASE; LIVER-TRANSPLANTATION; SYSTEM; DISRUPTION; MUTATIONS; DEFECT; GENE; MICE; IB	Glycogen storage disease type 1a (GSD-1a) is caused by a deficiency in microsomal glucose-6-phosphatase (G6Pase), the key enzyme in glucose homeostasis. A G6Pase knockout mouse which mimics the pathophysiology of human GSD-1a patients was created to understand the pathogenesis of this disorder, to delineate the mechanisms of G6Pase catalysis, and to develop future therapeutic approaches. By examining G6Pase in the liver and kidney, the primary gluconeogenic tissues, we demonstrate that glucose-6-P transport and hydrolysis are performed by separate proteins which are tightly coupled. We propose a modified translocase catalytic unit model for G6Pase catalysis.	NICHHD, HERITABLE DISORDERS BRANCH, NIH, BETHESDA, MD 20892 USA; NICHHD, LAB MAMMALIAN GENES & DEV, NIH, BETHESDA, MD 20892 USA; NCI, VET & TUMOR PATHOL SECT, OFF LAB ANIM SCI, FREDERICK, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)				Mansfield, Brian/0000-0002-8533-2789				ARION WJ, 1980, J BIOL CHEM, V255, P396; BURCHELL A, 1990, FASEB J, V4, P2978, DOI 10.1096/fasebj.4.12.2168325; BURCHELL A, 1988, CLIN CHIM ACTA, V173, P183, DOI 10.1016/0009-8981(88)90256-2; CHAYEN J, 1991, PRACTICAL HISTOCHEMI, P45; CHEN YT, 1988, NEW ENGL J MED, V318, P7, DOI 10.1056/NEJM198801073180102; CHEN YT, 1991, J INHERIT METAB DIS, V14, P80, DOI 10.1007/BF01804394; CHEN YT, 1994, METABOLIC BASIS INHE, P935; EMMETT M, 1978, JAMA-J AM MED ASSOC, V239, P1642, DOI 10.1001/jama.239.16.1642; HERS H. G., 1964, ADVAN METAB DISORDERS, V1, P1; IGARASHI Y, 1984, BIOCHEM BIOPH RES CO, V119, P593, DOI 10.1016/S0006-291X(84)80290-9; KIRSCHNER BS, 1991, GASTROENTEROLOGY, V101, P238, DOI 10.1016/0016-5085(91)90483-2; LANGE AJ, 1980, J BIOL CHEM, V255, P8381; LEI KJ, 1995, J CLIN INVEST, V95, P234, DOI 10.1172/JCI117645; LEI KJ, 1995, AM J HUM GENET, V57, P766; LEI KJ, 1993, SCIENCE, V262, P580, DOI 10.1126/science.8211187; LOVE PE, 1993, SCIENCE, V261, P918, DOI 10.1126/science.7688481; MALATACK JJ, 1983, LANCET, V1, P1073; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MCADAMS AJ, 1974, HUM PATHOL, V5, P463, DOI 10.1016/S0046-8177(74)80024-9; MOSES SW, 1990, J PEDIATR GASTR NUTR, V11, P155, DOI 10.1097/00005176-199008000-00004; NORDLIE RC, 1983, J BIOL CHEM, V258, P9739; Nordlie RC, 1985, ENZYMES BIOL MEMBRAN; SCHULZE HU, 1986, J BIOL CHEM, V261, P6571; SHELLY LL, 1993, J BIOL CHEM, V268, P21482; SINGH J, 1981, BIOCHIM BIOPHYS ACTA, V678, P477, DOI 10.1016/0304-4165(81)90129-X; STDENIS JF, 1995, J BIOL CHEM, V270, P21092, DOI 10.1074/jbc.270.36.21092; TEUTSCH HF, 1981, PROGR HISTOCHEMISTRY, V14; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; WADDELL ID, 1989, CLIN SCI, V76, P573, DOI 10.1042/cs0760573; WADDELL ID, 1991, BIOCHEM J, V275, P133, DOI 10.1042/bj2750133	30	183	188	1	16	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1996	13	2					203	209		10.1038/ng0696-203	http://dx.doi.org/10.1038/ng0696-203			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UN395	8640227	Green Published			2022-12-25	WOS:A1996UN39500020
J	Schuster, H; Wienker, TF; Bahring, S; Bilginturan, N; Toka, HR; Neitzel, H; Jeschke, E; Toka, O; Gilbert, D; Lowe, A; Ott, J; Haller, H; Luft, FC				Schuster, H; Wienker, TF; Bahring, S; Bilginturan, N; Toka, HR; Neitzel, H; Jeschke, E; Toka, O; Gilbert, D; Lowe, A; Ott, J; Haller, H; Luft, FC			Severe autosomal dominant hypertension and brachydactyly in a unique Turkish kindred maps to human chromosome 12	NATURE GENETICS			English	Letter							GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM		HUMBOLDT UNIV BERLIN,UNIV HOSP RUDOLF VIRCHOW,MAX DELBRUCK CTR MOLEC MED,FRANZ VOLHARD CLIN,BERLIN,GERMANY; HACETTEPE UNIV,SCH MED,DEPT PEDIAT,SECT PEDIAT ENDOCRINOL,ANKARA,TURKEY	Franz-Volhard Clinical Research Center; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Humboldt University of Berlin; Hacettepe University			Toka, Hakan/AAQ-2162-2021	Luft, Friedrich/0000-0002-8635-1199	NHGRI NIH HHS [HG 00008] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BILGINTURAN N, 1973, J MED GENET, V10, P253, DOI 10.1136/jmg.10.3.253; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HALLER H, 1995, CIRC RES, V76, P21, DOI 10.1161/01.RES.76.1.21; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LIFTON RP, 1993, J HYPERTENS, V11, P231, DOI 10.1097/00004872-199303000-00002; LIFTON RP, 1992, NATURE, V355, P262, DOI 10.1038/355262a0; RICH GM, 1992, ANN INTERN MED, V116, P813, DOI 10.7326/0003-4819-116-10-813; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; SPIEGEL AM, 1989, METABOLIC BASIS INHE; TAKAHASHI K, 1995, BIOCHEM BIOPH RES CO, V208, P447, DOI 10.1006/bbrc.1995.1358; ULICK S, 1990, J CLIN ENDOCR METAB, V71, P1151, DOI 10.1210/jcem-71-5-1151; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WILSON LC, 1995, AM J HUM GENET, V56, P400; ZIEGLE JS, 1992, GENOMICS, V14, P1026, DOI 10.1016/S0888-7543(05)80126-0	17	107	114	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1996	13	1					98	100		10.1038/ng0596-98	http://dx.doi.org/10.1038/ng0596-98			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH430	8673114				2022-12-25	WOS:A1996UH43000024
J	Ebersole, TA; Chen, Q; Justice, MJ; Artzt, K				Ebersole, TA; Chen, Q; Justice, MJ; Artzt, K			The quaking gene product necessary in embryogenesis and myelination combines features of RNA binding and signal transduction proteins	NATURE GENETICS			English	Article							MOLECULAR-CLONING; MESSENGER-RNA; NUCLEIC-ACID; MOUSE; BRAIN; GLYCOPROTEIN; MUTAGENESIS; MUTATIONS; FAMILY; LOCUS	The mouse quaking gene, essential for nervous system myelination and survival of the early embryo has been positionally cloned. Its sequence implies that the locus encodes a multifunctional gene used in a specific set of developing tissues to unite signal transduction with some aspect of RNA metabolism. The quaking(viable) (qk(v)) mutation has one class of messages truncated by a deletion. An independent ENU-induced mutation has a nonconservative amino acid change in one of two newly identified domains that are conserved from the C. elegans gld-1 tumour suppressor gene to the human Src-associated protein Sam68. The size and conservation of the quaking gene family implies that the pathway defined by this mutation may have broad relevance for rapid conveyance of extracellular information directly to primary gene transcripts.	UNIV TEXAS, DEPT ZOOL, AUSTIN, TX 78712 USA; KANSAS STATE UNIV, DIV BIOL, MANHATTAN, KS 66506 USA	University of Texas System; University of Texas Austin; Kansas State University					NICHD NIH HHS [HD30658, HD10668] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD030658, R01HD010668] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ASHLEY CT, 1993, NAT GENET, V4, P244, DOI 10.1038/ng0793-244; BENNETT DOROTHEA, 1956, J MORPH, V98, P199, DOI 10.1002/jmor.1050980202; BENNETT WI, 1971, BIOL REPROD, V5, P30, DOI 10.1093/biolreprod/5.1.30; BODE VC, 1984, GENETICS, V108, P457; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; CAMPAGNONI AT, 1993, J BIOL CHEM, V268, P4930; CRENSHAW EB, 1987, CELL, V49, P389, DOI 10.1016/0092-8674(87)90291-1; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DEWILLE JW, 1992, NEUROSCI LETT, V141, P195, DOI 10.1016/0304-3940(92)90893-C; EBERSOLE T, 1992, GENETICS, V131, P183; EHRICH E, 1987, GENE, V57, P229, DOI 10.1016/0378-1119(87)90126-0; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; FRIEDRIC.VL, 1974, BRAIN RES, V82, P168, DOI 10.1016/0006-8993(74)90902-0; FUJITA N, 1988, FEBS LETT, V232, P323, DOI 10.1016/0014-5793(88)80762-2; FUJITA N, 1990, J NEUROCHEM, V55, P1056, DOI 10.1111/j.1471-4159.1990.tb04596.x; FUMAGALLI S, 1994, NATURE, V368, P871, DOI 10.1038/368871a0; GIBSON TJ, 1993, FEBS LETT, V324, P361, DOI 10.1016/0014-5793(93)80152-K; HILL MA, 1994, J CELL BIOL, V126, P1221, DOI 10.1083/jcb.126.5.1221; HOBERT O, 1994, J BIOL CHEM, V269, P20225; IKENAKA K, 1992, J NEUROCHEM, V58, P2248, DOI 10.1111/j.1471-4159.1992.tb10970.x; JONES AR, 1995, GENE DEV, V9, P1491, DOI 10.1101/gad.9.12.1491; JUSTICE MJ, 1988, GENET RES, V51, P95, DOI 10.1017/S0016672300024101; JUSTICE MJ, 1986, GENET RES, V47, P187, DOI 10.1017/S0016672300023119; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; MAYEDA A, 1994, EMBO J, V13, P5483, DOI 10.1002/j.1460-2075.1994.tb06883.x; OGAWA W, 1994, J BIOL CHEM, V269, P29602; RICHARD S, 1995, MOL CELL BIOL, V15, P186, DOI 10.1128/MCB.15.1.186; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; ROSSI JM, 1992, P NATL ACAD SCI USA, V89, P2456, DOI 10.1073/pnas.89.6.2456; SHEDLOVSKY A, 1988, P NATL ACAD SCI USA, V85, P180, DOI 10.1073/pnas.85.1.180; SIDMAN RL, 1964, SCIENCE, V144, P309, DOI 10.1126/science.144.3616.309; SIOMI H, 1994, CELL, V77, P33, DOI 10.1016/0092-8674(94)90232-1; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; STEWARD O, 1994, P NATL ACAD SCI USA, V91, P10766, DOI 10.1073/pnas.91.23.10766; TAYLOR SJ, 1994, NATURE, V368, P867, DOI 10.1038/368867a0; TIMSIT S, 1995, J NEUROSCI, V15, P1012; UMEMORI H, 1994, NATURE, V367, P572, DOI 10.1038/367572a0; WENG ZG, 1994, MOL CELL BIOL, V14, P4509, DOI 10.1128/MCB.14.7.4509; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75; WONG G, 1992, CELL, V69, P551, DOI 10.1016/0092-8674(92)90455-L; YAN YM, 1993, NEURON, V11, P423, DOI 10.1016/0896-6273(93)90147-J; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0	42	281	287	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1996	12	3					260	265		10.1038/ng0396-260	http://dx.doi.org/10.1038/ng0396-260			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TY183	8589716				2022-12-25	WOS:A1996TY18300014
J	Overturf, K; AlDhalimy, M; Tanguay, R; Brantly, M; Ou, CN; Finegold, M; Grompe, M				Overturf, K; AlDhalimy, M; Tanguay, R; Brantly, M; Ou, CN; Finegold, M; Grompe, M			Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I	NATURE GENETICS			English	Article							TYROSINEMIA TYPE-I; LETHAL ALBINO MICE; FUMARYLACETOACETATE HYDROLASE; LIVER; EXPRESSION; DEFICIENT; ENZYME; TRANSPLANTATION; MOUSE; CELLS	Current strategies for hepatic gene therapy are either quantitatively inefficient or suffer from lack of permanent gene expression. We have utilized an animal model of hereditary tyrosinaemia type I (HT1), a recessive liver disease caused by deficiency of fumarylacetoacetate hydrolase (FAH), to determine whether in vivo selection of corrected hepatocytes could improve the efficiency of liver gene transfer. As few as 1,000 transplanted wild-type hepatocytes were able to repopulate mutant liver, demonstrating their strong competitive growth advantage. Mutant hepatocytes corrected in situ by retroviral gene transfer were also positively selected. In mutant animals treated by multiple retrovirus injections >90% of hepatocytes became FAH positive and liver function was restored to normal. Our results demonstrate that in vivo selection is a useful strategy for hepatic gene therapy and may lead to effective treatment of human HT1 by retroviral gene transfer.	OREGON HLTH SCI UNIV, DEPT MOLEC & MED GENET, PORTLAND, OR 97201 USA; OREGON HLTH SCI UNIV, DEPT PEDIAT, PORTLAND, OR 97201 USA; UNIV LAVAL, LAB GENET CELLULAIRE & DEV, ST FOY, PQ G1K 7P4, CANADA; NHLBI, NIH, PULM CRIT CARE MED BRANCH, BETHESDA, MD 20892 USA; TEXAS CHILDRENS HOSP, DEPT PATHOL, HOUSTON, TX 77030 USA	Oregon Health & Science University; Oregon Health & Science University; Laval University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Baylor College of Medicine			Brantly, Mark/AAH-2922-2020	Grompe, Markus/0000-0002-6616-4345	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048252] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-48252] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAIN MD, 1990, EUR J PEDIATR, V149, P637, DOI 10.1007/BF02034752; BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CEPKO CL, 1993, METHOD ENZYMOL, V225, P933; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHOWDHURY JR, 1991, SCIENCE, V254, P1802, DOI 10.1126/science.1722351; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Fausto N., 1994, LIVER BIOL PATHOBIOL; Fausto Nelson, 1994, P1501; GERBER MA, 1992, ROLE CELL TYPES HEPA, P209; GLUECKSOHNWAELSCH S, 1979, CELL, V16, P225, DOI 10.1016/0092-8674(79)90001-1; GRENIER A, 1985, METHOD ENZYMAT AN, P79; GROMPE M, 1992, BIOCHEM MED METAB B, V48, P26, DOI 10.1016/0885-4505(92)90044-Y; GROMPE M, 1993, GENE DEV, V7, P2298, DOI 10.1101/gad.7.12a.2298; GROMPE M, 1995, NAT GENET, V10, P453, DOI 10.1038/ng0895-453; GROMPE M, 1992, HUM GENE THER, V3, P35, DOI 10.1089/hum.1992.3.1-35; GROSSMAN M, 1993, CURR OPIN GENET DEV, V3, P110, DOI 10.1016/S0959-437X(05)80350-8; GROSSMAN M, 1994, NAT GENET, V6, P335, DOI 10.1038/ng0494-335; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; HIRSCHHORN R, 1994, AM J HUM GENET, V55, P59; HORWICH AL, 1991, CURR TOP MICROBIOL, V168, P185; KAY MA, 1992, P NATL ACAD SCI USA, V89, P89, DOI 10.1073/pnas.89.1.89; KAY MA, 1993, SCIENCE, V262, P117, DOI 10.1126/science.8211118; KLEBIG ML, 1992, P NATL ACAD SCI USA, V89, P1363, DOI 10.1073/pnas.89.4.1363; KNOX WE, 1955, METHOD ENZYMOL, V2, P287, DOI 10.1016/S0076-6879(55)02202-7; KVITTINGEN EA, 1994, J CLIN INVEST, V94, P1657, DOI 10.1172/JCI117509; KVITTINGEN EA, 1993, J CLIN INVEST, V91, P1816, DOI 10.1172/JCI116393; LABELLE Y, 1993, BIOCHIM BIOPHYS ACTA, V1180, P250, DOI 10.1016/0925-4439(93)90046-4; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; LI QT, 1993, HUM GENE THER, V4, P403, DOI 10.1089/hum.1993.4.4-403; LINDBLAD B, 1977, P NATL ACAD SCI USA, V74, P4641, DOI 10.1073/pnas.74.10.4641; LINDSTEDT S, 1992, LANCET, V340, P813, DOI 10.1016/0140-6736(92)92685-9; MARKOWITZ D, 1988, J VIROL, V62, P1120, DOI 10.1128/JVI.62.4.1120-1124.1988; MARKOWITZ D, 1988, VIROLOGY, V167, P400, DOI 10.1016/S0042-6822(88)90101-8; MCLACHLIN JR, 1993, VIROLOGY, V195, P1, DOI 10.1006/viro.1993.1340; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MITCHELL GA, 1994, METABOLIC MOL BASIS, P1077; PARADIS K, 1990, AM J HUM GENET, V47, P338; PEETERS MJV, IN PRESS BIOTECHNIQU; PHANEUF D, 1991, AM J HUM GENET, V48, P525; PONDER KP, 1991, P NATL ACAD SCI USA, V88, P1217, DOI 10.1073/pnas.88.4.1217; RHIM JA, 1994, SCIENCE, V263, P1149, DOI 10.1126/science.8108734; RHIM JA, 1995, P NATL ACAD SCI USA, V92, P4942, DOI 10.1073/pnas.92.11.4942; RUPPERT S, 1992, GENE DEV, V6, P1430, DOI 10.1101/gad.6.8.1430; RUPPERT S, 1990, CELL, V61, P895, DOI 10.1016/0092-8674(90)90200-X; RUSSO P, 1990, AM J HUM GENET, V47, P317; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SANDGREN EP, 1991, CELL, V66, P245, DOI 10.1016/0092-8674(91)90615-6; SCRIVER CR, 1994, METABOLIC BASIS INHE; TANGUAY RM, 1990, AM J HUM GENET, V47, P308; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407	51	464	483	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1996	12	3					266	273		10.1038/ng0396-266	http://dx.doi.org/10.1038/ng0396-266			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TY183	8589717				2022-12-25	WOS:A1996TY18300015
J	Ju, JY; Glazer, AN; Mathies, RA				Ju, JY; Glazer, AN; Mathies, RA			Energy transfer primers: A new fluorescence labeling paradigm for DNA sequencing and analysis	NATURE MEDICINE			English	Editorial Material									UNIV CALIF BERKELEY,DEPT CHEM,BERKELEY,CA 94720; UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720	University of California System; University of California Berkeley; University of California System; University of California Berkeley								BENSON SC, 1993, NUCLEIC ACIDS RES, V21, P5720, DOI 10.1093/nar/21.24.5720; CONNELL C, 1987, BIOTECHNIQUES, V5, P342; Forster T., 1965, MODERN QUANTUM CHEM, V3, P93; GLAZER AN, 1983, BIOPHYS J, V43, P383, DOI 10.1016/S0006-3495(83)84361-6; HAMMOND HA, 1994, AM J HUM GENET, V55, P175; JU J, IN PRESS NUCLEIC ACI; JU JY, 1995, ANAL BIOCHEM, V231, P131, DOI 10.1006/abio.1995.1512; JU JY, 1995, P NATL ACAD SCI USA, V92, P4347, DOI 10.1073/pnas.92.10.4347; MATHIES RA, 1992, NATURE, V359, P167, DOI 10.1038/359167a0; PEASE AC, 1994, P NATL ACAD SCI USA, V91, P5022, DOI 10.1073/pnas.91.11.5022; PROBER JM, 1987, SCIENCE, V238, P336, DOI 10.1126/science.2443975; REEVE MA, 1995, NATURE, V376, P796, DOI 10.1038/376796a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TABOR S, 1995, P NATL ACAD SCI USA, V92, P6339, DOI 10.1073/pnas.92.14.6339; WANG YW, 1995, ANAL CHEM, V67, P1197, DOI 10.1021/ac00103a010	18	85	136	0	11	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	FEB	1996	2	2					246	249		10.1038/nm0296-246	http://dx.doi.org/10.1038/nm0296-246			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TU060	8574973				2022-12-25	WOS:A1996TU06000048
J	DUHL, DMJ; VRIELING, H; MILLER, KA; WOLFF, GL; BARSH, GS				DUHL, DMJ; VRIELING, H; MILLER, KA; WOLFF, GL; BARSH, GS			NEOMORPHIC AGOUTI MUTATIONS IN OBESE YELLOW MICE	NATURE GENETICS			English	Article							A-PARTICLE GENES; COAT COLOR; MOUSE; SEQUENCES; ELEMENTS; PROTEIN	Several dominant mutations of the mouse agouti coat colour gene have pleiotropic effects that include obesity and a yellow coat. The A(y) allele is caused by a large deletion that affects the expression of several contiguous genes. We show that three other obesity-associated agouti mutations, A(iy), A(sy) and A(vy), are due to different molecular alterations that result in ubiquitous expression of a chimaeric RNA that encodes a normal agouti protein. The A(iy) and A(vy) alleles are caused by insertion of an intracisternal A particle element 1 kb or 100 kb, respectively, upstream of agouti coding sequences. These results provide a model for other genes that show allele-specific imprinting, and demonstrate that molecular mechanisms typically responsible for activation of proto-oncogenes can also lead to other disease phenotypes.	STANFORD UNIV,SCH MED,DEPT PEDIAT,STANFORD,CA 94305; STANFORD UNIV,SCH MED,HOWARD HUGHES MED INST,STANFORD,CA 94305; US FDA,NATL CTR TOXICOL RES,JEFFERSON,AR 72079	Stanford University; Howard Hughes Medical Institute; Stanford University; US Food & Drug Administration (FDA)			Vrieling, Harry/ABC-8068-2020	Vrieling, Harry/0000-0002-3034-2664	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R29HG000377] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG-00377] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ALGATE PA, 1993, ONCOGENE, V8, P1221; BARSH GS, 1990, DEVELOPMENT, V109, P683; BUITMAN SJ, 1992, CELL, V71, P1195; CHRISTY RJ, 1985, NUCLEIC ACIDS RES, V13, P289, DOI 10.1093/nar/13.1.289; CHRISTY RJ, 1988, MOL CELL BIOL, V8, P1093, DOI 10.1128/MCB.8.3.1093; CONKLIN BR, 1993, NATURE, V364, P110, DOI 10.1038/364110b0; Danforth C, 1927, J HERED, V18, P153, DOI 10.1093/oxfordjournals.jhered.a102826; DICKERSON GE, 1947, SCIENCE, V105, P496, DOI 10.1126/science.105.2732.496-a; DICKIE MM, 1969, J HERED, V60, P20, DOI 10.1093/oxfordjournals.jhered.a107920; DICKIES MM, 1962, J HERED, V53, P84, DOI 10.1093/oxfordjournals.jhered.a107129; DUHL DMJ, 1994, DEVELOPMENT, V120, P1695; FRIGERI LG, 1988, INT J OBESITY, V12, P305; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Green M. C., 1989, GENETIC VARIANTS STR, P17; HELLERSTROM C, 1963, METABOLISM, V12, P527; HESTON WE, 1961, J NATL CANCER I, V26, P969; HESTON WE, 1971, INT J CANCER, V7, P141, DOI 10.1002/ijc.2910070116; HESTON WE, 1968, J NATL CANCER I, V40, P1161; HESTON WE, 1947, J NATL CANCER I, V7, P463; HOLLIFIELD G, 1957, AM J PHYSIOL, V189, P36, DOI 10.1152/ajplegacy.1957.189.1.36; HOROWITZ M, 1984, EMBO J, V3, P2937, DOI 10.1002/j.1460-2075.1984.tb02235.x; JACKSON IJ, 1993, NATURE, V362, P587, DOI 10.1038/362587a0; JOHNSON PR, 1972, J LIPID RES, V13, P2; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KUFF EL, 1988, ADV CANCER RES, V51, P183, DOI 10.1016/S0065-230X(08)60223-7; KUFF EL, 1983, P NATL ACAD SCI-BIOL, V80, P1992, DOI 10.1073/pnas.80.7.1992; LUEDERS KK, 1993, MAMM GENOME, V4, P69, DOI 10.1007/BF00290429; MICHAUD EJ, 1993, GENE DEV, V7, P1203, DOI 10.1101/gad.7.7a.1203; MILLER MW, 1994, EMBO J, V13, P1806, DOI 10.1002/j.1460-2075.1994.tb06449.x; MILLER MW, 1993, GENE DEV, V7, P454, DOI 10.1101/gad.7.3.454; PORTER S, 1991, DEV GENET, V12, P393, DOI 10.1002/dvg.1020120604; POZNANSKI AA, 1991, DEV BIOL, V143, P271, DOI 10.1016/0012-1606(91)90077-G; SHIMIZU H, 1989, LIFE SCI, V45, P543, DOI 10.1016/0024-3205(89)90105-7; Silvers W. K., 1979, COAT COLORS MICE, P6; VLAHAKIS G, 1963, J NATL CANCER I, V31, P189; VRIELING H, 1994, P NATL ACAD SCI USA, V91, P5667, DOI 10.1073/pnas.91.12.5667; WOLFF GL, 1987, CARCINOGENESIS, V8, P1889, DOI 10.1093/carcin/8.12.1889; WOLFF GL, 1986, J HERED, V77, P151, DOI 10.1093/oxfordjournals.jhered.a110206; WOLFF GL, 1978, GENETICS, V88, P529; WOLFF GL, 1963, GENETICS, V48, P1041; YEN TT, 1994, FASEB J, V8, P479, DOI 10.1096/fasebj.8.8.8181666; YEN TT, 1984, INT J OBES S8, V1, P65	42	350	360	1	23	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1994	8	1					59	65		10.1038/ng0994-59	http://dx.doi.org/10.1038/ng0994-59			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PE157	7987393				2022-12-25	WOS:A1994PE15700016
J	COOK, GP; TOMLINSON, IM; WALTER, G; RIETHMAN, H; CARTER, NP; BULUWELA, L; WINTER, G; RABBITTS, TH				COOK, GP; TOMLINSON, IM; WALTER, G; RIETHMAN, H; CARTER, NP; BULUWELA, L; WINTER, G; RABBITTS, TH			A MAP OF THE HUMAN-IMMUNOGLOBULIN V-H LOCUS COMPLETED BY ANALYSIS OF THE TELOMERIC REGION OF CHROMOSOME 14Q	NATURE GENETICS			English	Article							HEAVY-CHAIN LOCUS; VARIABLE REGION; ANTIBODY REPERTOIRE; V(H) SEGMENTS; PHYSICAL MAP; 5' EXON; GENE; ORGANIZATION; YEAST; CLONING	Analysis of the telomeric region of chromosome 14q has enabled us to complete a map of the immunoglobulin V-H locus which accounts for almost all V-H segments known to rearrange in B-lymphocytes. The human germline V-H repertoire consists of approximately 50 functional V-H segments - the exact number depending on the haplotype - spanning 1,100 kilobases upstream of the J(H) segments. A yeast artificial chromosome used to map these segments was isolated by its ability to provide telomere activity in yeast, suggesting that the V-H locus may be located within a few kilobases of the 14q telomere. The limited structural diversity encoded by the functional V-H segments demonstrates the importance of combinatorial diversity produced by VDJ joining and the association of heavy and light chains in producing the human antibody repertoire.	MRC,MOLEC BIOL LAB,CAMBRIDGE CB2 2QH,ENGLAND; MRC,CTR PROT ENGN,CAMBRIDGE CB2 2QH,CAMBS,ENGLAND; WISTAR INST ANAT & BIOL,PHILADELPHIA,PA 19104; UNIV CAMBRIDGE,DEPT PATHOL,CAMBRIDGE CB2 1QP,ENGLAND	MRC Laboratory Molecular Biology; University of Cambridge; The Wistar Institute; University of Cambridge			; Rabbitts, Terence/D-6262-2016	Cook, Graham/0000-0003-0223-3652; Rabbitts, Terence/0000-0002-4982-2609				BAER R, 1988, J EXP MED, V167, P2011, DOI 10.1084/jem.167.6.2011; BAER R, 1985, CELL, V43, P705, DOI 10.1016/0092-8674(85)90243-0; BERMAN JE, 1988, EMBO J, V7, P727, DOI 10.1002/j.1460-2075.1988.tb02869.x; BROWN WRA, 1989, NATURE, V338, P774, DOI 10.1038/338774a0; BRUGGEMANN M, 1989, P NATL ACAD SCI USA, V86, P6709, DOI 10.1073/pnas.86.17.6709; BULUWELA L, 1988, EMBO J, V7, P2003, DOI 10.1002/j.1460-2075.1988.tb03039.x; CARTER NP, 1992, J MED GENET, V29, P299, DOI 10.1136/jmg.29.5.299; CHENG JF, 1989, NUCLEIC ACIDS RES, V17, P6109, DOI 10.1093/nar/17.15.6109; CHERIF D, 1990, GENE CHROMOSOME CANC, V2, P103, DOI 10.1002/gcc.2870020205; CHOTHIA C, 1992, J MOL BIOL, V227, P799, DOI 10.1016/0022-2836(92)90224-8; COX DW, 1982, NATURE, V297, P428, DOI 10.1038/297428a0; CROSS SH, 1989, NATURE, V338, P771, DOI 10.1038/338771a0; FISCH P, 1992, EUR J IMMUNOL, V22, P2745, DOI 10.1002/eji.1830221042; HALUSKA FG, 1987, P NATL ACAD SCI USA, V84, P6835, DOI 10.1073/pnas.84.19.6835; KODAIRA M, 1986, J MOL BIOL, V190, P529, DOI 10.1016/0022-2836(86)90239-1; MATSUDA F, 1990, EMBO J, V9, P2501, DOI 10.1002/j.1460-2075.1990.tb07429.x; MATSUDA F, 1988, EMBO J, V7, P1047, DOI 10.1002/j.1460-2075.1988.tb02912.x; MATSUDA F, 1993, NAT GENET, V3, P88, DOI 10.1038/ng0193-88; MCBRIDE OW, 1982, NUCLEIC ACIDS RES, V10, P8155, DOI 10.1093/nar/10.24.8155; MENGLEGAW L, 1988, P NATL ACAD SCI USA, V85, P9171, DOI 10.1073/pnas.85.23.9171; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; PAVAN WJ, 1990, P NATL ACAD SCI USA, V87, P1300, DOI 10.1073/pnas.87.4.1300; REEVES RH, 1992, METHOD ENZYMOL, V216, P584; RIETHMAN HC, 1989, P NATL ACAD SCI USA, V86, P6240, DOI 10.1073/pnas.86.16.6240; SANZ I, 1989, EMBO J, V8, P3741, DOI 10.1002/j.1460-2075.1989.tb08550.x; SASSO EH, 1993, J CLIN INVEST, V91, P2358, DOI 10.1172/JCI116468; SCHROEDER HW, 1987, SCIENCE, V238, P791, DOI 10.1126/science.3118465; SHIN EK, 1991, EMBO J, V10, P3641, DOI 10.1002/j.1460-2075.1991.tb04930.x; TOMLINSON IM, 1994, HUM MOL GENET, V3, P853; TOMLINSON IM, 1992, J MOL BIOL, V227, P776, DOI 10.1016/0022-2836(92)90223-7; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; VANDIJK KW, 1993, EUR J IMMUNOL, V23, P832, DOI 10.1002/eji.1830230410; VANDIJK KW, 1992, P NATL ACAD SCI USA, V89, P10430, DOI 10.1073/pnas.89.21.10430; VANES JH, 1992, J IMMUNOL, V149, P2234; WALTER G, 1993, NUCLEIC ACIDS RES, V21, P4524, DOI 10.1093/nar/21.19.4524; WALTER MA, 1990, EMBO J, V9, P3303, DOI 10.1002/j.1460-2075.1990.tb07530.x; WALTER MA, 1991, J EXP MED, V174, P335, DOI 10.1084/jem.174.2.335; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; ZELENETZ AD, 1992, J EXP MED, V176, P1137, DOI 10.1084/jem.176.4.1137	39	256	264	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1994	7	2					162	168		10.1038/ng0694-162	http://dx.doi.org/10.1038/ng0694-162			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NQ037	7920635				2022-12-25	WOS:A1994NQ03700016
J	SCHACHTER, F; FAUREDELANEF, L; GUENOT, F; ROUGER, H; FROGUEL, P; LESUEURGINOT, L; COHEN, D				SCHACHTER, F; FAUREDELANEF, L; GUENOT, F; ROUGER, H; FROGUEL, P; LESUEURGINOT, L; COHEN, D			GENETIC ASSOCIATIONS WITH HUMAN LONGEVITY AT THE APOE AND ACE LOCI	NATURE GENETICS			English	Article							ANGIOTENSIN-CONVERTING ENZYME; INSERTION DELETION POLYMORPHISM; APOLIPOPROTEIN-E POLYMORPHISM; MYOCARDIAL-INFARCTION; DNA POLYMORPHISMS; HEART-DISEASE; B GENE; LINKAGE; ATHEROSCLEROSIS; NONAGENARIANS	In an effort to dissect the genetic components of longevity, we have undertaken case-control studies of populations of centenarians (n=338) and adults aged 20-70 years at several polymorphic candidate gene loci. Here we report results on two genes, chosen for their impact on cardiovascular risk, encoding apolipoprotein E (ApoE), angiotensin-converting enzyme (ACE). We find that the epsilon4 allele of APOE, which promotes premature atherosclerosis, is significantly less frequent in centenarians than in controls (p<0.001), while the frequency of the epsilon2 allele, associated previously with type III and IV hyperlipidemia, is significantly increased (p<0.01). A variant of ACE which predisposes to coronary heart disease is surprisingly more frequent in centenarians, with a significant increase of the homozygous genotype (p<0.01). These associations provide examples of genetic influences on differential survival and may point to pleiotropic age-dependent effects on longevity.			SCHACHTER, F (corresponding author), CTR ETUD POLYMORPHISME HUMAIN,27 RUE JULIETTE DODU,F-75010 PARIS,FRANCE.		FROGUEL, Philippe/O-6799-2017	FROGUEL, Philippe/0000-0003-2972-0784				ABBOTT MH, 1974, JOHNS HOPKINS MED J, V134, P1; ANDREW S, 1992, GENOMICS, V13, P301, DOI 10.1016/0888-7543(92)90246-O; BAILLEUL S, 1993, HUM HERED, V43, P159, DOI 10.1159/000154172; BOEMI M, 1993, DIABETOLOGIA, V36, P229, DOI 10.1007/BF00399955; BOERWINKLE E, 1990, ATHEROSCLEROSIS, V81, P225, DOI 10.1016/0021-9150(90)90070-Y; CAMBIEN F, 1992, NATURE, V359, P641, DOI 10.1038/359641a0; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; COSTEROUSSE O, 1992, J CARDIOVASC PHARM, V20, pS10, DOI 10.1097/00005344-199200209-00004; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; DONALD JA, 1985, HUM GENET, V69, P39, DOI 10.1007/BF00295527; EHLERS MRW, 1989, BIOCHEMISTRY-US, V28, P5311, DOI 10.1021/bi00439a001; EISENLOHR LC, 1992, CELL, V71, P963, DOI 10.1016/0092-8674(92)90392-P; ETO M, 1989, CLIN GENET, V36, P183; FINCH CE, 1990, LONGEVITY SENESCENCE, P298; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; HATTON F, 1992, INSEE PREMIERE, V196; HIXSON JE, 1990, J LIPID RES, V31, P545; JEUNEMAITRE X, 1992, NAT GENET, V1, P72, DOI 10.1038/ng0492-72; JORGENSEN JOL, 1993, LANCET, V341, P1247; KIRKWOOD TBL, 1991, PHILOS T R SOC B, V332, P15, DOI 10.1098/rstb.1991.0028; MCGEER EG, 1992, DEMENTIA, V3, P299, DOI 10.1159/000107029; ORDOVAS JM, 1987, J LIPID RES, V28, P371; PEACOCK R, 1992, ATHEROSCLEROSIS, V92, P151, DOI 10.1016/0021-9150(92)90274-K; PROUST J, 1982, TISSUE ANTIGENS, V19, P168, DOI 10.1111/j.1399-0039.1982.tb01436.x; RIGAT B, 1992, NUCLEIC ACIDS RES, V20, P1433, DOI 10.1093/nar/20.6.1433-a; SCHACHTER F, 1993, HUM GENET, V91, P519; SCHACHTER F, 1993, LIFESPAN, V4, P1; SKOOG I, 1993, NEW ENGL J MED, V328, P153, DOI 10.1056/NEJM199301213280301; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; TAKATA H, 1987, LANCET, V2, P824; TIRET L, 1992, AM J HUM GENET, V51, P197; TIRET L, 1993, LANCET, V341, P991, DOI 10.1016/0140-6736(93)91075-W; UTERMANN G, 1982, HUM GENET, V60, P344, DOI 10.1007/BF00569216; VANBOCKXMEER FM, 1992, LANCET, V340, P879, DOI 10.1016/0140-6736(92)93288-X; WEBER JL, 1989, AM J HUM GENET, V44, P388; ZANNIS VI, 1982, J LIPID RES, V23, P911	36	885	920	2	34	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1994	6	1					29	32		10.1038/ng0194-29	http://dx.doi.org/10.1038/ng0194-29			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ177	8136829				2022-12-25	WOS:A1994MQ17700010
J	QUANE, KA; HEALY, JMS; KEATING, KE; MANNING, BM; COUCH, FJ; PALMUCCI, LM; DORIGUZZI, C; FAGERLUND, TH; BERG, K; ORDING, H; BENDIXEN, D; MORTIER, W; LINZ, U; MULLER, CR; MCCARTHY, TV				QUANE, KA; HEALY, JMS; KEATING, KE; MANNING, BM; COUCH, FJ; PALMUCCI, LM; DORIGUZZI, C; FAGERLUND, TH; BERG, K; ORDING, H; BENDIXEN, D; MORTIER, W; LINZ, U; MULLER, CR; MCCARTHY, TV			MUTATIONS IN THE RYANODINE RECEPTOR GENE IN CENTRAL CORE DISEASE AND MALIGNANT HYPERTHERMIA	NATURE GENETICS			English	Article							MUSCLE SARCOPLASMIC-RETICULUM; POLYMERASE CHAIN-REACTION; RELEASE CHANNEL; MOLECULAR-CLONING; SUSCEPTIBILITY; CHROMOSOME-19; POLYMORPHISMS; LOCUS; DNA	Central core disease (CCD) of muscle is an inherited myopathy which is closely associated with malignant hyperthermia (MH) in humans. CCD has recently been shown to be tightly linked to the ryanodine receptor gene (RYR1) and mutations in this gene are known to be present in MH. Mutation screening of RYR1 has led to the identification of two previously undescribed mutations in different CCD pedigrees. One of these mutations was also detected in an unrelated MH pedigree whose members are asymptomatic of CCD. The data suggest a model to explain how a single mutation may result in two apparently distinct clinical phenotypes.	NATL UNIV IRELAND UNIV COLL CORK,DEPT BIOCHEM,CORK,IRELAND; ULLEVAL UNIV HOSP,DEPT ANAESTHESIA,N-0407 OSLO,NORWAY; UNIV COPENHAGEN,HERLEV HOSP,DK-2730 HERLEV,DENMARK; UNIV OSLO,ULLEVAL HOSP,INST MED GENET,DEPT MED GENET,OSLO 1,NORWAY; KLINIKEN STADT WUPPERTAL,KINDERKLIN,W-5600 WUPPERTAL,GERMANY; UNIV WURZBURG,BIOCTR,DEPT HUMAN GENET,W-8700 WURZBURG,GERMANY; UNIV TURIN,CTR MALATTIE NEUROMUSCOLARI PAOLO PETROLO,NEUROL CLIN 2,I-10126 TURIN,ITALY	University College Cork; University of Oslo; University of Copenhagen; Herlev & Gentofte Hospital; University of Oslo; University of Wurzburg; University of Turin			Healy, Sandra J/D-5256-2013					BRITT BA, 1987, MALIGNANT HYPERTHERM, P325; BYRNE E, 1982, J NEUROL SCI, V53, P77, DOI 10.1016/0022-510X(82)90081-8; CARPENTER S, 1984, PATHOLOGY SKELETAL M, P434; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DENBOROUGH MA, 1973, BMJ-BRIT MED J, V1, P272, DOI 10.1136/bmj.1.5848.272; DEUFEL T, 1992, AM J HUM GENET, V50, P1153; DUBOWITZ V, 1973, MAJOR PROBLEMS NEURO, P92; DUBOWITZ V, 1970, BRAIN, V93, P138; ELLIS FR, 1985, RECENT ADV ANAESTHES, V15, P173; ENG GD, 1978, ARCH NEUROL-CHICAGO, V35, P189, DOI 10.1001/archneur.1978.00500280007002; FUJII J, 1991, SCIENCE, V253, P448, DOI 10.1126/science.1862346; GILLARD EF, 1991, GENOMICS, V11, P751, DOI 10.1016/0888-7543(91)90084-R; GILLARD EF, 1992, GENOMICS, V13, P1247, DOI 10.1016/0888-7543(92)90042-Q; GRONERT GA, 1986, MYOLOGY, V2, P1763; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; HAAN EA, 1990, HUM GENET, V86, P187; HAKAMATA Y, 1992, FEBS LETT, V312, P229, DOI 10.1016/0014-5793(92)80941-9; HAYASHI K, 1989, MUSCLE NERVE, V12, P95, DOI 10.1002/mus.880120203; ISAACS H, 1975, J NEUROL NEUROSUR PS, V38, P1177, DOI 10.1136/jnnp.38.12.1177; KRIVOSICHORBER R, 1989, PRESSE MED, V18, P828; LEVITT RC, 1991, GENOMICS, V11, P543, DOI 10.1016/0888-7543(91)90061-I; LEVITT RC, 1992, GENOMICS, V14, P562, DOI 10.1016/S0888-7543(05)80152-1; MACKENZIE AE, 1990, AM J HUM GENET, V46, P1082; MACLENNAN DH, 1992, SCIENCE, V256, P789, DOI 10.1126/science.1589759; MORGANHUGHES JA, 1973, BRAIN, V96, P527, DOI 10.1093/brain/96.3.527; MULLEY JC, 1993, AM J HUM GENET, V52, P398; Old J. M, 1983, METHODS HAEMATOLOGY, P74; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; OTSU K, 1990, J BIOL CHEM, V265, P13472; PALMUCCI L, 1978, J NEUROL, V218, P55, DOI 10.1007/BF00314719; SCHULMAN SR, 1993, ANESTHESIOLOGY, V78, P626, DOI 10.1097/00000542-199303000-00057; SHUAIB A, 1987, MEDICINE, V66, P389, DOI 10.1097/00005792-198709000-00004; SHY GM, 1956, BRAIN, V79, P610, DOI 10.1093/brain/79.4.610; ZHANG W, 1991, NUCLEIC ACIDS RES, V19, P6649, DOI 10.1093/nar/19.23.6649; ZORZATO F, 1990, J BIOL CHEM, V265, P2244; 1984, BRIT J ANAESTH, V56, P1267	36	284	291	0	11	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1993	5	1					51	55		10.1038/ng0993-51	http://dx.doi.org/10.1038/ng0993-51			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LV565	8220423				2022-12-25	WOS:A1993LV56500015
J	MOULLIER, P; BOHL, D; HEARD, JM; DANOS, O				MOULLIER, P; BOHL, D; HEARD, JM; DANOS, O			CORRECTION OF LYSOSOMAL STORAGE IN THE LIVER AND SPLEEN OF MPS-VII MICE BY IMPLANTATION OF GENETICALLY-MODIFIED SKIN FIBROBLASTS	NATURE GENETICS			English	Article							BETA-GLUCURONIDASE DEFICIENCY; MUCOPOLYSACCHARIDOSIS TYPE-VII; BONE-MARROW TRANSPLANTATION; MODEL; DIAGNOSIS; INVIVO; MOUSE; LONG	Genetic defects of lysosomal hydrolases result in severe storage diseases and treatments based on enzyme replacement have been proposed. In mice lacking beta-glucuronidase, which develop a disease homologous to human mucopolysaccharidosis type VII (Sly syndrome), we have used autologous implants of genetically-modified skin fibroblasts for the continuous in vivo production of the enzyme. The human beta-glucuronidase cDNA was introduced with a retroviral vector into mutant mice skin fibroblasts grown in primary culture. Fourteen mutant mice were implanted intraperitoneally with these modified cells embedded into collagen lattices. All animals expressed beta-glucuronidase from the vascularized neo-organs that developed after implantation and accumulated the enzyme in their tissues. A complete disappearance of the lysosomal storage lesions was observed in their liver and spleen.	INST PASTEUR,RETROVIRUS & TRANSFERT GENET LAB,25 RUE DR ROUX,F-75724 PARIS 15,FRANCE; INST PASTEUR,17K,URA 1157,F-75724 PARIS 15,FRANCE	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris			Bohl, Delphine/L-8709-2016	Bohl, Delphine/0000-0001-8262-5642				BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; BELL E, 1983, J INVEST DERMATOL, V81, P2; BIRKENMEIER EH, 1989, J CLIN INVEST, V83, P1258, DOI 10.1172/JCI114010; BIRKENMEIER EH, 1991, BLOOD, V78, P3081; DANOS O, 1988, P NATL ACAD SCI USA, V85, P6460, DOI 10.1073/pnas.85.17.6460; DANOS O, 1991, PRACTICAL MOL VIROLO, P17; GLASER JH, 1973, J LAB CLIN MED, V82, P969; HASKINS ME, 1984, PEDIATR RES, V18, P980, DOI 10.1203/00006450-198418100-00014; HAYASHI M, 1963, J HISTOCHEM CYTOCHEM, V12, P293; HOPWOOD JJ, 1990, MOL BIOL MED, V7, P381; JEZYK PF, 1977, SCIENCE, V198, P834, DOI 10.1126/science.144321; KRIVIT W, 1992, BONE MARROW TRANSPL, V10, P87; MOULLIER P, IN PRESS TRANSPLANTA; Neufeld EF, 1989, METABOLIC BASIS INHE, P1565; PALMER TD, 1991, P NATL ACAD SCI USA, V88, P1330, DOI 10.1073/pnas.88.4.1330; Pfeffer S R, 1991, Curr Top Microbiol Immunol, V170, P43; SAINTLOUIS D, 1988, P NATL ACAD SCI USA, V85, P3150; SCHARFMANN R, 1991, P NATL ACAD SCI USA, V88, P4626, DOI 10.1073/pnas.88.11.4626; SHULL RM, 1987, J CLIN INVEST, V79, P435, DOI 10.1172/JCI112830; THOMPSON JA, 1988, SCIENCE, V241, P1349, DOI 10.1126/science.2457952; VOGLER C, 1990, AM J PATHOL, V136, P207; WHITLEY CB, 1989, CLIN CHEM, V35, P374; WOLFE JH, 1992, NATURE, V360, P749, DOI 10.1038/360749a0; WOLFE JH, 1992, NAT GENET, V1, P379, DOI 10.1038/ng0892-379; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; YANAGISHITA M, 1992, J BIOL CHEM, V267, P9451	26	181	218	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1993	4	2					154	159		10.1038/ng0693-154	http://dx.doi.org/10.1038/ng0693-154			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LF816	8348154				2022-12-25	WOS:A1993LF81600015
J	ANTIGNAC, C; ARDUY, CH; BECKMANN, JS; BENESSY, F; GROS, F; MEDHIOUB, M; HILDEBRANDT, F; DUFIER, JL; KLEINKNECHT, C; BROYER, M; WEISSENBACH, J; HABIB, R; COHEN, D				ANTIGNAC, C; ARDUY, CH; BECKMANN, JS; BENESSY, F; GROS, F; MEDHIOUB, M; HILDEBRANDT, F; DUFIER, JL; KLEINKNECHT, C; BROYER, M; WEISSENBACH, J; HABIB, R; COHEN, D			A GENE FOR FAMILIAL JUVENILE NEPHRONOPHTHISIS (RECESSIVE MEDULLARY CYSTIC KIDNEY-DISEASE) MAPS TO CHROMOSOME-2P	NATURE GENETICS			English	Article							MOUSE	Familial juvenile nephronophthisis (NPH) is a chronic autosomal recessive kidney disease responsible for 15% of end stage renal failure in children. NPH is frequently (16% of cases) associated with Leber amaurosis (termed Senior-Loken syndrome, SLS). Linkage analyses, performed in 22 multiplex NPH families (18 without and 4 with ocular abnormalities), have localized the gene to a region between D2S48 and D2S51 on chromosome 2p. This was confirmed using adjacent microsatellite markers, one of which (AFM220ze3 at the D2S160 locus) gave a lod score of 4.78 at theta = 0.05 in the 18 families with isolated NPH, whereas the same marker excluded linkage with SLS. These results demonstrate linkage of the purely renal form of NPH to chromosome 2p, and suggest that there may be genetic heterogeneity between NPH and SLS.	HOP NECKER ENFANTS MALAD,INSERM,U192,F-75743 PARIS 15,FRANCE; UNIV FREIBURG,KINDERKLIN,W-7800 FREIBURG,GERMANY; HOP NECKER ENFANTS MALAD,SERV OPHTHALMOL,F-75743 PARIS 15,FRANCE; GENETHON,F-91002 EVRY,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Freiburg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	ANTIGNAC, C (corresponding author), CEPH,27 RUE JULIETTE DODU,F-75010 PARIS,FRANCE.		ANTIGNAC, Corinne/H-8945-2017; Beckmann, Jacques S/A-9772-2008	ANTIGNAC, Corinne/0000-0002-9934-4940; Beckmann, Jacques S/0000-0002-9741-1900				BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; COHEN AH, 1986, LAB INVEST, V55, P564; DAVISSON MT, 1991, GENOMICS, V9, P778, DOI 10.1016/0888-7543(91)90376-P; EDWARDS JH, 1992, J MED GENET, V24, P794; FANCONI G, 1951, Helv Paediatr Acta, V6, P1; FOXMAN SG, 1985, ARCH OPHTHALMOL-CHIC, V103, P1502; HAZAN J, 1992, GENOMICS, V12, P183, DOI 10.1016/0888-7543(92)90364-X; KLEINKNECHT C, 1992, TXB CLIN NEPHROLOGY, P2188; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LOKEN AC, 1961, ACTA PAEDIATR, V50, P177, DOI 10.1111/j.1651-2227.1961.tb08037.x; NORBY S, 1990, LANCET, V336, P323; OCONNELL P, 1989, GENOMICS, V5, P738, DOI 10.1016/0888-7543(89)90115-8; OTT J, 1991, ANAL HUMAN GENETIC L, P194; RIZZONI G, 1991, NEPHROL DIAL TRAN S4, V62, P31; SENIOR B, 1961, AM J OPHTHALMOL, V52, P625, DOI 10.1016/0002-9394(61)90147-7; SMITH CH, 1945, AM J DIS CHILD, V69, P370; SPURR NK, 1991, CYTOGENET CELL GENET, V58, P142, DOI 10.1159/000133162; STRAUSS MB, 1967, NEW ENGL J MED, V277, P863, DOI 10.1056/NEJM196710192771606; WALDHERR R, 1982, VIRCHOWS ARCH A, V394, P235, DOI 10.1007/BF00430668; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; ZERRES K, 1991, PEDIATR NEPHROL, V5, pS23	21	109	109	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1993	3	4					342	345		10.1038/ng0493-342	http://dx.doi.org/10.1038/ng0493-342			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KW257	7981755				2022-12-25	WOS:A1993KW25700017
J	Eber, SW; Gonzalez, JM; Lux, ML; Scarpa, AL; Tse, WT; Dornwell, M; Herbers, J; Kugler, W; Ozcan, R; Pekrun, A; Gallagher, PG; Schroter, W; Forget, BG; Lux, SE				Eber, SW; Gonzalez, JM; Lux, ML; Scarpa, AL; Tse, WT; Dornwell, M; Herbers, J; Kugler, W; Ozcan, R; Pekrun, A; Gallagher, PG; Schroter, W; Forget, BG; Lux, SE			Ankyrin-1 mutations are a major cause of dominant and recessive hereditary spherocytosis	NATURE GENETICS			English	Letter							POLYMORPHISM ANALYSIS; SPECTRIN DEFICIENCY; GENE; DNA; PROTEINS; SSCP		CHILDRENS HOSP,DIV HEMATOL ONCOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DEPT PEDIAT ONCOL,BOSTON,MA 02115; UNIV GOTTINGEN,KINDERKLIN,D-37075 GOTTINGEN,GERMANY; YALE UNIV,SCH MED,DEPT INTERNAL MED,SECT HEMATOL,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT GENET,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT PEDIAT,DIV PERINATAL MED,NEW HAVEN,CT 06510	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Gottingen; Yale University; Yale University; Yale University					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262, P60HL015157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034083, R01DK034083] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL32262, HL15157] Funding Source: Medline; NIDDK NIH HHS [DK34083] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AGRE P, 1986, NEW ENGL J MED, V315, P1579, DOI 10.1056/NEJM198612183152504; BEAUDET AL, 1993, HUM MUTAT, V2, P245, DOI 10.1002/humu.1380020402; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; COSTA FF, 1990, NEW ENGL J MED, V323, P1046, DOI 10.1056/NEJM199010113231507; DALBEY RE, 1990, TRENDS BIOCHEM SCI, V15, P253, DOI 10.1016/0968-0004(90)90047-F; EBER SW, 1994, BLOOD, V84, pA362; EBER SW, 1990, J PEDIATR, V177, P409; GALLAGHER PG, 1994, BLOOD, V84, pA361; GALLAGHER PG, 1992, T ASSOC AM PHYSICIAN, V105, P268; Goossens M, 1981, Methods Enzymol, V76, P805; HANSPAL M, 1991, BLOOD, V77, P165; Hassoun H., 1995, Blood, V86, p467A; HAYASHI K, 1993, HUM MUTAT, V2, P338, DOI 10.1002/humu.1380020503; JAROLIM P, 1995, J CLIN INVEST, V95, P941, DOI 10.1172/JCI117802; JAROLIM P, 1995, BLOOD, V85, P634, DOI 10.1182/blood.V85.3.634.bloodjournal853634; JAROLIM P, 1994, J CLIN INVEST, V93, P121, DOI 10.1172/JCI116935; JAROLIM P, 1995, BLOOD, V85, P3278, DOI 10.1182/blood.V85.11.3278.bloodjournal85113278; JAROLIM P, 1994, BLOOD, V84, pA362; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu Q, 1994, PCR Methods Appl, V4, P97; LUX SE, 1990, NATURE, V345, P736, DOI 10.1038/345736a0; LUX SE, 1990, NATURE, V344, P36, DOI 10.1038/344036a0; Lux SE, 1995, BLOOD PRINCIPLES PRA, P1701; LUX SE, 1989, P NATL ACAD SCI USA, V86, P9088; MCINTOSH I, 1993, NAT GENET, V4, P219, DOI 10.1038/ng0793-219; MICHAUD J, 1992, GENOMICS, V13, P389, DOI 10.1016/0888-7543(92)90258-T; Moore DD, 1995, GLOB MOB SURV; PEKRUN A, 1993, ANN HEMATOL, V67, P89, DOI 10.1007/BF01788132; Peters L. L., 1995, Blood, V86, p124A; SARKAR G, 1992, NUCLEIC ACIDS RES, V20, P871, DOI 10.1093/nar/20.4.871; SHEFFIELD VC, 1993, GENOMICS, V16, P325, DOI 10.1006/geno.1993.1193; Soto D, 1992, PCR Methods Appl, V2, P96; SVVIDES P, 1993, BLOOD, V82, P2953; Wichterle H., 1995, Blood, V86, p468A; WILMOTTE R, 1993, J CLIN INVEST, V91, P2091, DOI 10.1172/JCI116432	35	165	170	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1996	13	2					214	218		10.1038/ng0696-214	http://dx.doi.org/10.1038/ng0696-214			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UN395	8640229				2022-12-25	WOS:A1996UN39500022
J	Wong, ML; Rettori, V; AlShekhlee, A; Bongiorno, PB; Canteros, G; McCann, SM; Gold, PW; Licinio, J				Wong, ML; Rettori, V; AlShekhlee, A; Bongiorno, PB; Canteros, G; McCann, SM; Gold, PW; Licinio, J			Inducible nitric oxide synthase gene expression in the brain during systemic inflammation	NATURE MEDICINE			English	Article							CORTICOTROPIN-RELEASING HORMONE; ULCERATIVE-COLITIS; RESPONSE SYNDROME; ENCEPHALOPATHY; NEUROTOXICITY; MECHANISMS; CULTURES; DISEASE; NITRATE	Inducible nitric oxide synthase (iNOS) is a transcriptionally regulated enzyme that synthesizes nitric oxide from L-arginine(1) that has a key role in the pathophysiology of systemic inflammation and sepsis. Transgenic animals with a null mutation for the iNOS gene are resistant to hypotension and death caused by Escherichia coli lipopolysaccharide (LPS)(2,3). The regulation of peripheral iNOS has been well studied in sepsis, but little is known about iNOS regulation in the brain during systemic inflammation or sepsis. We show that at baseline there is no detectable iNOS gene expression in the brain, but a detailed neuroanatomical study reveals that early in the course of systemic inflammation there is a profound induction of iNOS messenger RNA in vascular, glial and neuronal structures of the rat brain, accompanied by the production of nitric oxide (NO) metabolites in brain parenchyma and cerebrospinal fluid (CSF). We propose that the spillover of nitrite into the CSF has the potential to be a diagnostic marker for systemic inflammation and sepsis. Pharmacological interventions aimed at regulating iNOS function in the brain might represent a new treatment strategy in sepsis. Brain iNOS may be relevant to the pathophysiology, diagnosis and treatment of systemic inflammation and sepsis.	NIMH,NIH,CLIN NEUROENDOCRINOL BRANCH,BETHESDA,MD 20892; CONSEJO NACL INVEST CIENT & TECN,CENTRO ESTUDIOS FARMACOLOG & BOTANICOS,BUENOS AIRES,DF,ARGENTINA; LOUISIANA STATE UNIV,PENNINGTON BIOMED RES CTR,BATON ROUGE,LA 70808	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center			Wong, Ma-Li/D-7903-2011; Wong, Ma-Li/ABD-5525-2020; Licinio, Julio/L-4244-2013	Wong, Ma-Li/0000-0003-1512-3073; Licinio, Julio/0000-0001-6905-5884				BARRIERE SL, 1995, CRIT CARE MED, V23, P376, DOI 10.1097/00003246-199502000-00026; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BONE RC, 1992, JAMA-J AM MED ASSOC, V268, P3452, DOI 10.1001/jama.268.24.3452; BOUGHTONSMITH NK, 1993, LANCET, V342, P338, DOI 10.1016/0140-6736(93)91476-3; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; CANTEROS G, IN PRES P NATL ACAD; COSTA A, 1993, BRAIN RES, V605, P187, DOI 10.1016/0006-8993(93)91739-F; DAWSON TM, 1994, J NEUROSCI, V14, P5147; DAWSON VL, 1993, J NEUROSCI, V13, P2651; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; Dennhardt R, 1989, Prog Clin Biol Res, V308, P751; DINARELLO CA, 1993, JAMA-J AM MED ASSOC, V269, P1829, DOI 10.1001/jama.269.14.1829; GALEA E, 1994, J NEUROSCI RES, V37, P406, DOI 10.1002/jnr.490370313; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; IALENTI A, 1992, EUR J PHARMACOL, V211, P177, DOI 10.1016/0014-2999(92)90526-A; IYENGAR R, 1987, P NATL ACAD SCI USA, V84, P6369, DOI 10.1073/pnas.84.18.6369; KUO PC, 1995, ANN SURG, V221, P220, DOI 10.1097/00000658-199503000-00003; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; LICINIO J, 1995, ENDOCRINOLOGY, V136, P4709, DOI 10.1210/en.136.10.4709; LUNDBERG JON, 1994, LANCET, V344, P1673, DOI 10.1016/S0140-6736(94)90460-X; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; MIDDLETON SJ, 1993, LANCET, V341, P465, DOI 10.1016/0140-6736(93)90211-X; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; RIVIER C, 1994, J NEUROSCI, V14, P1985; ROSSOR MN, 1996, OXFORD TXB MED, V3, P3971; SANDI C, 1995, EUR J PHARMACOL, V274, P17, DOI 10.1016/0014-2999(94)00700-H; STERNBERG EM, 1989, P NATL ACAD SCI USA, V86, P4771, DOI 10.1073/pnas.86.12.4771; WEI XQ, 1995, NATURE, V375, P408, DOI 10.1038/375408a0; WONG ML, 1993, METH NEUROSCI, V16, P81; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522; YOUNG GB, 1990, CLIN INVEST MED, V13, P297; YOUNG GB, 1992, J CLIN NEUROPHYSIOL, V9, P145, DOI 10.1097/00004691-199201000-00016	34	250	254	0	11	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAY	1996	2	5					581	584		10.1038/nm0596-581	http://dx.doi.org/10.1038/nm0596-581			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UJ230	8616720	Green Published			2022-12-25	WOS:A1996UJ23000044
J	Wajnrajch, MP; Gertner, JM; Harbison, MD; Chua, SC; Leibel, RL				Wajnrajch, MP; Gertner, JM; Harbison, MD; Chua, SC; Leibel, RL			Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse	NATURE GENETICS			English	Letter							MOLECULAR-CLONING; MICE; CHROMOSOME-6; EXPRESSION		NEW YORK HOSP,CORNELL MED CTR,CHILDRENS CLIN RES CTR,NEW YORK,NY 10021; NEW YORK HOSP,CORNELL MED CTR,DEPT PEDIAT,DIV PEDIAT ENDOCRINOL,NEW YORK,NY 10021; ROCKEFELLER UNIV,HUMAN BEHAV & METAB LAB,NEW YORK,NY 10021	Cornell University; NewYork-Presbyterian Hospital; Cornell University; NewYork-Presbyterian Hospital; Rockefeller University				Wajnrajch, Michael/0000-0002-8211-9237	NCRR NIH HHS [RR-06020] Funding Source: Medline; NICHD NIH HHS [R0-1 HD 28047] Funding Source: Medline; NIDDK NIH HHS [2PO-30 DK 22687] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028047] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BEAMER WG, 1976, J ENDOCRINOL, V71, P37, DOI 10.1677/joe.0.0710037; BICHET DG, 1994, AM J HUM GENET, V55, P278; CHOU Q, 1992, NUCLEIC ACIDS RES, V20, P1717, DOI 10.1093/nar/20.7.1717; CHUA SC, 1993, MAMM GENOME, V4, P555, DOI 10.1007/BF00361384; CLARK RG, 1985, J ENDOCRINOL, V106, P1, DOI 10.1677/joe.0.1060001; EICHER EM, 1976, J HERED, V67, P87, DOI 10.1093/oxfordjournals.jhered.a108682; FROHMAN LA, 1986, ENDOCR REV, V7, P223, DOI 10.1210/edrv-7-3-223; GAYLINN BD, 1993, MOL ENDOCRINOL, V7, P77, DOI 10.1210/me.7.1.77; GODFREY P, 1993, NAT GENET, V4, P227, DOI 10.1038/ng0793-227; LARON Z, 1993, ACTA ENDOCRINOL-COP, V129, P424, DOI 10.1530/acta.0.1290424; LAUE L, 1995, HUM MOL GENET, V4, P1429, DOI 10.1093/hmg/4.8.1429; LIN SC, 1993, NATURE, V364, P208, DOI 10.1038/364208a0; MAYO KE, 1992, MOL ENDOCRINOL, V6, P1734, DOI 10.1210/me.6.10.1734; PHILLIPS JA, 1994, J CLIN ENDOCR METAB, V78, P11, DOI 10.1210/jc.78.1.11; POLLAK MR, 1994, NAT GENET, V8, P303, DOI 10.1038/ng1194-303; ROSENFELD RG, 1995, J CLIN ENDOCR METAB, V80, P1532, DOI 10.1210/jc.80.5.1532; SARKAR G, 1992, GENOMICS, V13, P441, DOI 10.1016/0888-7543(92)90266-U; SCHIPANI E, 1995, SCIENCE, V268, P98, DOI 10.1126/science.7701349; SHENKER A, 1993, NATURE, V365, P652, DOI 10.1038/365652a0; SMITH RG, 1993, SCIENCE, V260, P1640, DOI 10.1126/science.8503009; TANNER JM, 1985, J PEDIATR-US, V107, P317, DOI 10.1016/S0022-3476(85)80501-1; TSIGOS C, 1993, J CLIN INVEST, V92, P2458, DOI 10.1172/JCI116853; WAJNRAJCH MP, 1994, MAMM GENOME, V5, P595, DOI 10.1007/BF00354940	24	217	222	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1996	12	1					88	90		10.1038/ng0196-88	http://dx.doi.org/10.1038/ng0196-88			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TM555	8528260				2022-12-25	WOS:A1996TM55500021
J	ANGRIST, M; KAUFFMAN, E; SLAUGENHAUPT, SA; MATISE, TC; PUFFENBERGER, EG; WASHINGTON, SS; LIPSON, A; CASS, DT; REYNA, T; WEEKS, DE; SIEBER, W; CHAKRAVARTI, A				ANGRIST, M; KAUFFMAN, E; SLAUGENHAUPT, SA; MATISE, TC; PUFFENBERGER, EG; WASHINGTON, SS; LIPSON, A; CASS, DT; REYNA, T; WEEKS, DE; SIEBER, W; CHAKRAVARTI, A			A GENE FOR HIRSCHSPRUNG DISEASE (MEGACOLON) IN THE PERICENTROMERIC REGION OF HUMAN CHROMOSOME-10	NATURE GENETICS			English	Article							ENDOCRINE NEOPLASIA TYPE-2A; 3-GENERATION TRANSMISSION; WAARDENBURG SYNDROME; LINKAGE ANALYSIS; IDENTIFICATION; DNA; AGANGLIONOSIS; POLYMORPHISM; CELLS; MAP	Hirschsprung disease (HSCR) is characterized by a congenital absence of enteric ganglia along a variable length of the intestine. Although long considered to be a multifactorial disease, we have identified linkage in a subset of five HSCR families to the pericentromeric region of chromosome 10, thereby proving monogenic inheritance in some families. A maximum two-point lod score of 3.37 (theta = 0.045) was observed between HSCR and D10S176, under an incompletely penetrant dominant model. Multipoint, affecteds-only and non-parametric analyses supported this finding and localize this gene to a region of almost-equal-to 7 centiMorgans, in close proximity to the locus for multiple endocrine neoplasia type 2 (MEN2). The co-occurrence of these two entities in some families might be attributable to shared pathogenetic origins.	UNIV PITTSBURGH,DEPT PSYCHIAT,PITTSBURGH,PA 15261; UNIV PITTSBURGH,DEPT HUMAN GENET,PITTSBURGH,PA 15261; ROYAL ALEXANDRA HOSP CHILDREN,BIRTH DEFECTS UNIT,CAMPERDOWN,NSW 2050,AUSTRALIA; WESTMEAD HOSP,DEPT PEDIAT SURG,WESTMEAD,AUSTRALIA; WILLIAM BEAUMONT ARMY MED CTR,DEPT SURG,PEDIAT SURG SERV,EL PASO,TX 79920; PEDIAT SURG ASSOCIATES,PITTSBURGH,PA 15213	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Sydney; William Beaumont Army Medical Center			Weeks, Daniel E/B-2995-2012	Weeks, Daniel E/0000-0001-9410-7228; Puffenberger, Erik/0000-0002-6388-9148	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028088] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-28088] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDERSON DJ, 1993, J NEUROBIOL, V24, P185, DOI 10.1002/neu.480240206; Angrist M., 1992, American Journal of Human Genetics, V51, pA359; BADNER JA, 1990, AM J HUM GENET, V46, P568; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BICKLER SW, 1992, ARCH SURG-CHICAGO, V127, P1047; BODIAN M, 1963, ANN HUM GENET, V26, P261, DOI 10.1111/j.1469-1809.1963.tb01983.x; BOLANDE RP, 1974, HUM PATHOL, V5, P409, DOI 10.1016/S0046-8177(74)80021-3; CARNAHAN JF, 1991, DEV BIOL, V148, P552, DOI 10.1016/0012-1606(91)90273-6; CASS D, 1990, J PAEDIATR CHILD H, V26, P351, DOI 10.1111/j.1440-1754.1990.tb02451.x; CHAKRAVARTI A, 1990, BANB REPORT, V33, P307; Chi D., 1992, American Journal of Human Genetics, V51, pA184; Cox Tara K., 1992, American Journal of Human Genetics, V51, pA33; DECKER RA, 1992, GENOMICS, V12, P604, DOI 10.1016/0888-7543(92)90455-2; GARVER KL, 1985, CLIN GENET, V28, P503; GUTMANN DH, 1991, P NATL ACAD SCI USA, V88, P9658, DOI 10.1073/pnas.88.21.9658; Hirschsprung H., 1888, JAHRBUCHF RKINDERHEI, V27, P1; HOWE JR, 1992, AM J HUM GENET, V51, P1430; HOWE JR, 1992, SURGERY, V112, P219; IKADAI H, 1979, Congenital Anomalies, V19, P31; KHAN AH, 1987, J PEDIATR SURG, V22, P719, DOI 10.1016/S0022-3468(87)80612-7; LAIRMORE TC, 1991, GENOMICS, V9, P181, DOI 10.1016/0888-7543(91)90237-9; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANE PW, 1984, J HERED, V75, P435, DOI 10.1093/oxfordjournals.jhered.a109980; LANE PW, 1966, J HERED, V57, P181; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEMAREC B, 1980, J GENET HUM, V28, P169; LIPSON AH, 1987, CLIN GENET, V32, P175; LIPSON AH, 1990, CLIN GENET, V37, P235; LO LC, 1991, GENE DEV, V5, P1524, DOI 10.1101/gad.5.9.1524; MAHAFFEY SM, 1990, J PEDIATR SURG, V25, P101, DOI 10.1016/S0022-3468(05)80172-1; MARTUCCIELLO G, 1992, PEDIATR SURG INT, V7, P308; MATHEW CGP, 1987, NATURE, V328, P527, DOI 10.1038/328527a0; MCDONALD H, 1992, GENOMICS, V13, P344, DOI 10.1016/0888-7543(92)90251-M; MCKUSICK VA, 1992, MENDELIAN INHERITANC, P848; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Ott J., 1991, ANAL HUMAN GENETIC L; Papi L., 1992, Human Molecular Genetics, V1, P450, DOI 10.1093/hmg/1.6.450-a; PASSARGE E, 1967, NEW ENGL J MED, V276, P138, DOI 10.1056/NEJM196701192760303; PASSARGE E, 1980, GENETICS HETEROGENEI, P441; Patterson Paul H., 1992, Current Opinion in Cell Biology, V4, P962, DOI 10.1016/0955-0674(92)90125-V; Puffenberger E. G., 1992, American Journal of Human Genetics, V51, pA106; PULITI A, 1993, CYTOGENET CELL GENET, V63, P102, DOI 10.1159/000133510; ROUSSEAUMERCK MF, 1992, GENOMICS, V13, P845, DOI 10.1016/0888-7543(92)90166-P; SHERMAN JO, 1989, J PEDIATR SURG, V24, P833, DOI 10.1016/S0022-3468(89)80548-2; SIMPSON NE, 1987, NATURE, V328, P528, DOI 10.1038/328528a0; SLAUGENHAUPT SA, 1991, THESIS U PITTSBURGH; Smith B, 1968, J Pediatr Surg, V3, P386, DOI 10.1016/0022-3468(68)90344-8; SORANT AJM, 1989, STATISTICAL ANAL GEN; SWENSON O, 1989, J PEDIATR SURG, V24, P839, DOI 10.1016/S0022-3468(89)80549-4; SWENSON O, 1982, HIRSCHSPRUNGS DISEAS, P3; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TROELSTRA C, 1992, GENOMICS, V12, P745, DOI 10.1016/0888-7543(92)90304-B; VERDY M, 1982, J PEDIATR GASTR NUTR, V1, P603, DOI 10.1097/00005176-198212000-00027; WEEKS DE, 1992, AM J HUM GENET, V50, P859; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WHITEHEAD R, 1990, MUCOSAL BIOPSY GASTR, P391; WU JS, 1989, HUM GENET, V83, P383, DOI 10.1007/BF00291386; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9	58	136	136	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1993	4	4					351	356		10.1038/ng0893-351	http://dx.doi.org/10.1038/ng0893-351			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LQ178	8401581				2022-12-25	WOS:A1993LQ17800011
J	BLUMENFELD, A; SLAUGENHAUPT, SA; AXELROD, FB; LUCENTE, DE; MAAYAN, C; LIEBERT, CB; OZELIUS, LJ; TROFATTER, JA; HAINES, JL; BREAKEFIELD, XO; GUSELLA, JF				BLUMENFELD, A; SLAUGENHAUPT, SA; AXELROD, FB; LUCENTE, DE; MAAYAN, C; LIEBERT, CB; OZELIUS, LJ; TROFATTER, JA; HAINES, JL; BREAKEFIELD, XO; GUSELLA, JF			LOCALIZATION OF THE GENE FOR FAMILIAL DYSAUTONOMIA ON CHROMOSOME-9 AND DEFINITION OF DNA MARKERS FOR GENETIC DIAGNOSIS	NATURE GENETICS			English	Article							NERVE GROWTH-FACTOR	Familial dysautonomia (DYS), the Riley-Day syndrome, is an autosomal recessive disorder characterized by developmental loss of neurons from the sensory and autonomic nervous system. It is limited to the Ashkenazi Jewish population, where the carrier frequency is 1 in 30. We have mapped the DYS gene to chromosome 9q31-q33 by linkage with ten DNA markers in 26 families. The maximum lod score of 21.1 with no recombinants was achieved with D9S58. This marker also showed strong linkage disequilibrium with DYS, with one allele present on 73% of affected chromosomes compared to 5.4% of controls (chi2=3142, 15 d.f. p<0.0001). D9S53 and D9S105 represent the closest flanking markers for the disease gene. This localization will permit prenatal diagnosis of DYS in affected families and aid the isolation of the disease gene.	MASSACHUSETTS GEN HOSP,NEUROL SERV,MOLEC NEUROGENET UNIT,BOSTON,MA 02129; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,PROGRAM NEUROSCI,BOSTON,MA 02115; HADASSAH UNIV HOSP,DEPT PEDIAT,JERUSALEM,ISRAEL; NYU,SCH MED,DEPT PEDIAT,NEW YORK,NY 10017	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Hebrew University of Jerusalem; New York University			Haines, Jonathan/C-3374-2012	Haines, Jonathan/0000-0002-4351-4728				AXELROD FB, 1984, AM J DIS CHILD, V138, P947, DOI 10.1001/archpedi.1984.02140480049016; Axelrod FB, 1984, CELL MOL BIOL NEURON, P331; BERKEMEIER LR, 1992, SOMAT CELL MOLEC GEN, V18, P233, DOI 10.1007/BF01233860; BLUMENFELD A, 1993, J MED GENET, V30, P47, DOI 10.1136/jmg.30.1.47; BREAKEFIELD XO, 1984, P NATL ACAD SCI-BIOL, V81, P4213, DOI 10.1073/pnas.81.13.4213; BREAKEFIELD XO, 1986, MOL BIOL MED, V3, P483; BRUNT PW, 1970, MEDICINE, V49, P343, DOI 10.1097/00005792-197009000-00001; CARROLL SL, 1992, NEURON, V9, P779, DOI 10.1016/0896-6273(92)90040-K; CHAO MV, 1992, NEURON, V9, P583, DOI 10.1016/0896-6273(92)90023-7; FURLONG RA, 1992, NUCLEIC ACIDS RES, V20, P925, DOI 10.1093/nar/20.4.925; GUSELLA JF, 1989, FASEB J, V3, P2036, DOI 10.1096/fasebj.3.9.2568302; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; KRAMER PL, 1990, ANN NEUROL, V27, P114, DOI 10.1002/ana.410270203; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LYALL JEW, 1992, NUCLEIC ACIDS RES, V20, P925, DOI 10.1093/nar/20.4.925-a; MAAYAN C, 1987, CLIN GENET, V32, P106; MAISONPIERRE PC, 1991, GENOMICS, V10, P558, DOI 10.1016/0888-7543(91)90436-I; MIOZZO M, 1990, ONCOGENE, V5, P1411; Ozelius L., 1992, Human Molecular Genetics, V1, P141, DOI 10.1093/hmg/1.2.141-a; OZELIUS LJ, 1992, GENOMICS, V14, P715, DOI 10.1016/S0888-7543(05)80173-9; OZELIUS LJ, 1992, AM J HUM GENET, V50, P619; POVEY S, 1992, ANN HUM GENET, V56, P167, DOI 10.1111/j.1469-1809.1992.tb01145.x; RILEY CM, 1949, PEDIATRICS, V3, P468; TANZI R E, 1988, Genomics, V3, P129, DOI 10.1016/0888-7543(88)90143-7; TROFATTER JA, 1986, AM J HUM GENET, V39, P147; VERGE VMK, 1992, J NEUROSCI, V12, P4011; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WILKIE PJ, 1992, GENOMICS, V12, P607, DOI 10.1016/0888-7543(92)90456-3; WILLIAMSON R, 1991, CYTOGENET CELL GENET, V58, P1190, DOI 10.1159/000133727	31	131	133	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1993	4	2					160	164		10.1038/ng0693-160	http://dx.doi.org/10.1038/ng0693-160			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LF816	8102296				2022-12-25	WOS:A1993LF81600016
J	SCHALLING, M; HUDSON, TJ; BUETOW, KH; HOUSMAN, DE				SCHALLING, M; HUDSON, TJ; BUETOW, KH; HOUSMAN, DE			DIRECT-DETECTION OF NOVEL EXPANDED TRINUCLEOTIDE REPEATS IN THE HUMAN GENOME	NATURE GENETICS			English	Article								Expansion of trinucleotide repeats can give rise to genetic disease. We have developed a technique, repeat expansion detection (RED), that can identify potentially pathological repeat expansion without prior knowledge of chromosomal location. Human genomic DNA is used as a template for a two-step cycling process that generates oligonucleotide multimers when expanded trinucleotide sequences are present at the level found in myotonic dystrophy and fragile-X patients. We have identified at least one new locus exhibiting trinucleotide expansion. Analysis of three families transmitting a long CTG repeat shows that the allele in these families corresponds to a locus on chromosome 18. RED constitutes a powerful tool to identify other diseases caused by this mechanism, particularly diseases associated with anticipation.	MIT,CTR CANC RES,CAMBRIDGE,MA 02139; FOX CHASE CANC CTR,PHILADELPHIA,PA 19111	Massachusetts Institute of Technology (MIT); Fox Chase Cancer Center			Schalling, Martin/F-1518-2015	Schalling, Martin/0000-0001-5011-2922	NHGRI NIH HHS [HG 00299, P50HG 00098] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000299, P50HG000098] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BARANY F, 1991, P NATL ACAD SCI USA, V88, P189, DOI 10.1073/pnas.88.1.189; BECKMANN JS, 1992, GENOMICS, V12, P627, DOI 10.1016/0888-7543(92)90285-Z; Biancalana V., 1992, Human Molecular Genetics, V1, P255, DOI 10.1093/hmg/1.4.255; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; GUSTAVSON KH, 1986, AM J MED GENET, V23, P581, DOI 10.1002/ajmg.1320230152; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; Harper P.S., 1989, MYOTONIC DYSTROPHY; HINDS HL, 1993, NAT GENET, V3, P36, DOI 10.1038/ng0193-36; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; RICHARDS RI, 1992, NAT GENET, V1, P7, DOI 10.1038/ng0492-7; RIGGINS GJ, 1992, NAT GENET, V2, P186, DOI 10.1038/ng1192-186; Sambrook J, 1989, MOL CLONING LABORATO; SCHALLING M, 1992, GENE EXPRESSION NEUR, P231; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WEBB TP, 1986, AM J MED GENET, V23, P573, DOI 10.1002/ajmg.1320230151; 1993, CELL, V72, P1	20	249	258	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1993	4	2					135	139		10.1038/ng0693-135	http://dx.doi.org/10.1038/ng0693-135			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LF816	8348150				2022-12-25	WOS:A1993LF81600011
J	DAVIDSON, BL; ALLEN, ED; KOZARSKY, KF; WILSON, JM; ROESSLER, BJ				DAVIDSON, BL; ALLEN, ED; KOZARSKY, KF; WILSON, JM; ROESSLER, BJ			A MODEL SYSTEM FOR INVIVO GENE-TRANSFER INTO THE CENTRAL-NERVOUS-SYSTEM USING AN ADENOVIRAL VECTOR	NATURE GENETICS			English	Article							EPITHELIUM; CELLS; MICE; DNA	Previous methods of in vivo gene transfer to differentiated neurons of the adult mammalian brain have been inefficient and associated with technical problems. We have therefore developed a model system of direct gene transfer using a replication-defective adenoviral vector containing a beta-galactosidase gene to transduce brain neurons. Following injection of purified high titre recombinant adenovirus into the caudate putamen of seven week old mice, lacZ activity was evident in neural components of the central nervous system (CNS) for at least 8 weeks post infection. The efficiency of adenoviral gene transfer was very high compared to other techniques, suggesting an attractive and efficient alternative for neuronal gene transfer in vivo.	UNIV MICHIGAN,MED CTR,DEPT BIOL CHEM,ANN ARBOR,MI 48109; UNIV MICHIGAN,MED CTR,HOWARD HUGHES MED INST,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	DAVIDSON, BL (corresponding author), UNIV MICHIGAN,MED CTR,DEPT INTERNAL MED,5520 MSRB I,ANN ARBOR,MI 48109, USA.		Wilson, James M/F-9220-2011	Wilson, James M/0000-0002-9630-3131	NIDDK NIH HHS [P01DK42718] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK042718] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON WF, 1984, SCIENCE, V226, P401, DOI 10.1126/science.6093246; BALL AO, 1988, J VIROL, V62, P3947, DOI 10.1128/JVI.62.11.3947-3957.1988; ENGELHARDT JF, 1991, P NATL ACAD SCI USA, V88, P11192, DOI 10.1073/pnas.88.24.11192; FINK DJ, 1992, HUM GENE THER, V3, P11, DOI 10.1089/hum.1992.3.1-11; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HURWITZ DR, 1985, P NATL ACAD SCI USA, V82, P163, DOI 10.1073/pnas.82.1.163; Ishibashi M., 1984, P497; JAFFE HA, 1992, NAT GENET, V1, P372, DOI 10.1038/ng0892-372; JIAO SS, 1992, EXP NEUROL, V115, P400, DOI 10.1016/0014-4886(92)90205-5; KAGIYAMA N, 1986, EXP ANIM TOKYO, V35, P531, DOI 10.1538/expanim1978.35.4_531; Neufeld EF, 1989, METABOLIC BASIS INHE, P1565; ONO T, 1990, NEUROSCI LETT, V117, P259, DOI 10.1016/0304-3940(90)90673-W; PALELLA TD, 1989, GENE, V80, P137, DOI 10.1016/0378-1119(89)90258-8; Peters A., 1970, FINE STRUCTURE NERVO; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; QUANTIN B, 1992, P NATL ACAD SCI USA, V89, P2581, DOI 10.1073/pnas.89.7.2581; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; WINDLE WF, 1958, BIOL NEUROGLIA; WOLFE JH, 1992, NAT GENET, V1, P379, DOI 10.1038/ng0892-379	22	531	706	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1993	3	3					219	223		10.1038/ng0393-219	http://dx.doi.org/10.1038/ng0393-219			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KP790	8387378				2022-12-25	WOS:A1993KP79000010
J	Daw, SCM; Taylor, C; Kraman, M; Call, K; Mao, JI; Schuffenhauer, S; Meitinger, T; Lipson, T; Goodship, J; Scambler, P				Daw, SCM; Taylor, C; Kraman, M; Call, K; Mao, JI; Schuffenhauer, S; Meitinger, T; Lipson, T; Goodship, J; Scambler, P			A common region of 10p deleted in DiGeorge and velocardiofacial syndromes	NATURE GENETICS			English	Letter							PARTIAL MONOSOMY 10P; GENE; HYPOPARATHYROIDISM; HYBRIDIZATION; CLONES; MOUSE		INST CHILD HLTH,MOL MED UNIT,LONDON WC1N 1EH,ENGLAND; GENOME THERAPEUT CORP,WALTHAM,MA 02154; UNIV MUNICH,ABT PADIAT GENET,D-80336 MUNICH,GERMANY; ROYAL ALEXANDRA HOSP CHILDREN,DEPT GENET,PARRAMATTA,NSW 2124,AUSTRALIA; UNIV NEWCASTLE,DIV HUMAN GENET,NEWCASTLE TYNE NE2 4AA,TYNE & WEAR,ENGLAND	University of London; University College London; University of Munich; Newcastle University - UK			Scambler, Peter J/C-4998-2008; Clelland, Catherine/AAZ-8551-2021; Scambler, Peter/AAZ-6026-2020; Meitinger, Thomas/O-1318-2015	Scambler, Peter J/0000-0002-1487-4628; Scambler, Peter/0000-0002-1487-4628; Meitinger, Thomas/0000-0002-8838-8403; Kraman, Matthew/0000-0002-5040-0067				GOODFELLOW PJ, 1989, ANN HUM GENET, V53, P15, DOI 10.1111/j.1469-1809.1989.tb01118.x; GREENBERG F, 1986, J PEDIATR-US, V109, P489, DOI 10.1016/S0022-3476(86)80124-X; HALFORD S, 1993, HUM MOL GENET, V2, P2099, DOI 10.1093/hmg/2.12.2099; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; KOSEKI H, 1993, MAMM GENOME, V4, P324, DOI 10.1007/BF00357091; LAI MMR, 1992, J MED GENET, V29, P586, DOI 10.1136/jmg.29.8.586; LARIN Z, 1991, P NATL ACAD SCI USA, V88, P4123, DOI 10.1073/pnas.88.10.4123; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; LINDSAY EA, 1995, AM J MED GENET, V56, P191, DOI 10.1002/ajmg.1320560216; LINDSAY EA, 1993, GENOMICS, V17, P403, DOI 10.1006/geno.1993.1339; LIPSON A, IN PRESS AM J MED GE; LYNCH S, 1995, J MED GENET, V32, P149; MORROW B, 1995, AM J HUM GENET, V56, P1379; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; SCHUFFENHAUER S, 1995, ANN GENET-PARIS, V38, P162; Tagle Danilo A., 1992, Human Molecular Genetics, V1, P121, DOI 10.1093/hmg/1.2.121; WADEY R, 1995, HUM MOL GENET, V4, P1027, DOI 10.1093/hmg/4.6.1027; WILSON DI, 1993, J MED GENET, V30, P852, DOI 10.1136/jmg.30.10.852	18	144	145	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1996	13	4					458	460		10.1038/ng0896-458	http://dx.doi.org/10.1038/ng0896-458			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VB620	8696341				2022-12-25	WOS:A1996VB62000027
J	Gow, A; Lazzarini, RA				Gow, A; Lazzarini, RA			A cellular mechanism governing the severity of Pelizaeus-Merzbacher disease	NATURE GENETICS			English	Article							PROTEOLIPID PROTEIN-GENE; CENTRAL-NERVOUS-SYSTEM; INTERMEDIATE COMPARTMENT; INTRACELLULAR-TRANSPORT; ENDOPLASMIC-RETICULUM; SPASTIC PARAPLEGIA; SECRETORY PATHWAY; PARALYTIC TREMOR; GOLGI-APPARATUS; TRANSGENIC MICE	Pelizaeus-Merzbacher disease (PMD) is a leukodystrophy linked to the proteolipid protein gene (PLP). We report a cellular basis for the distinction between two disease subtypes, classical and connatal, based on protein trafficking of the two PLP gene products (PLP and DM20). Classical PMD mutations correlate with accumulation of PLP in the ER of transfected COS-7 cells while the cognate DM20 traverses the secretory pathway to the cell surface. On the other hand, connatal PMD mutations lead to the accumulation of both mutant PLP and DM20 proteins in the ER of COS-7 cells with little of either isoform transported to the cell surface. Moreover, we show that transport-competent mutant DM20s facilitate trafficking of cognate PLPs and hence may influence disease severity.	CUNY MT SINAI SCH MED,BROOKDALE CTR MOL BIOL,NEW YORK,NY 10029	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai				gow, alexander/0000-0001-7446-8990	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS033165] Funding Source: NIH RePORTER; NINDS NIH HHS [3P01NS33165-01A1S1] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BILLINGSGAGLIARDI S, 1980, BRAIN RES, V194, P325, DOI 10.1016/0006-8993(80)91215-9; BOESPFLUGTANGUY O, 1994, AM J HUM GENET, V55, P461; BOISON D, 1995, J NEUROSCI, V15, P5502; BOISON D, 1994, P NATL ACAD SCI USA, V91, P11709, DOI 10.1073/pnas.91.24.11709; BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558; BONIFACINO J S, 1991, Current Opinion in Cell Biology, V3, P592, DOI 10.1016/0955-0674(91)90028-W; BOULLOCHE J, 1986, J CHILD NEUROL, V1, P223; DENTINGER P, 1982, J NEUROCYTOL, V11, P671; DOLL R, 1992, AM J HUM GENET, V51, P161; DUNCAN ID, 1983, NEUROPATH APPL NEURO, V9, P355, DOI 10.1111/j.1365-2990.1983.tb00121.x; ELLIS D, 1994, NAT GENET, V6, P333, DOI 10.1038/ng0494-333; GENCIC S, 1990, J NEUROSCI, V10, P117; GENCIC S, 1989, AM J HUM GENET, V45, P435; Gething M J, 1990, Semin Cell Biol, V1, P65; GOW A, 1994, J NEUROSCI RES, V37, P563, DOI 10.1002/jnr.490370503; GOW A, 1994, J NEUROSCI RES, V37, P574, DOI 10.1002/jnr.490370504; GRIFFITHS IR, 1990, J NEUROCYTOL, V19, P273, DOI 10.1007/BF01217305; HAMMOND C, 1994, J CELL BIOL, V126, P41, DOI 10.1083/jcb.126.1.41; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; Hodes M. E., 1995, American Journal of Human Genetics, V57, pA92; HODES ME, 1993, DEV NEUROSCI-BASEL, V15, P383, DOI 10.1159/000111361; HUDSON LD, 1989, P NATL ACAD SCI USA, V86, P8128, DOI 10.1073/pnas.86.20.8128; HUDSON LD, 1989, J CELL BIOL, V109, P717, DOI 10.1083/jcb.109.2.717; Hudson Lynn D., 1992, P677; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; KAGAWA T, 1994, NEURON, V13, P427, DOI 10.1016/0896-6273(94)90358-1; KAYE EM, 1994, ANN NEUROL, V36, P916, DOI 10.1002/ana.410360618; KOBAYASHI H, 1994, NAT GENET, V7, P351, DOI 10.1038/ng0794-351; Koeppen Arnulf H., 1992, P703; MANE SM, 1989, ARCH BIOCHEM BIOPHYS, V268, P360, DOI 10.1016/0003-9861(89)90597-3; Mckusick V.A., 1994, MENDELIAN INHERITANC; MILNER RJ, 1985, CELL, V42, P931, DOI 10.1016/0092-8674(85)90289-2; MITCHELL LS, 1992, J NEUROSCI RES, V33, P205, DOI 10.1002/jnr.490330204; NANCE MA, 1993, AM J HUM GENET, V53, P1745; NUSSBAUM JL, 1983, CELL TISSUE RES, V234, P647; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; PHAMDINH D, 1991, P NATL ACAD SCI USA, V88, P7562, DOI 10.1073/pnas.88.17.7562; POPOT JL, 1991, J MEMBRANE BIOL, V120, P233, DOI 10.1007/BF01868534; PRATT VM, 1991, AM J MED GENET, V38, P136, DOI 10.1002/ajmg.1320380129; PUCKETT C, 1987, J NEUROSCI RES, V18, P511, DOI 10.1002/jnr.490180402; RAPOSO G, 1995, J CELL BIOL, V131, P1403, DOI 10.1083/jcb.131.6.1403; RASKIND WH, 1991, AM J HUM GENET, V49, P1355; READHEAD C, 1994, NEURON, V12, P583, DOI 10.1016/0896-6273(94)90214-3; ROSE JK, 1988, ANNU REV CELL BIOL, V4, P257, DOI 10.1146/annurev.cellbio.4.1.257; ROUSSEL G, 1987, J NEUROCYTOL, V16, P195, DOI 10.1007/BF01795303; SAUGIERVEBER P, 1994, NAT GENET, V6, P257, DOI 10.1038/ng0394-257; SCHEFFER IE, 1991, NEUROPEDIATRICS, V22, P71, DOI 10.1055/s-2008-1071420; SCHNEIDER A, 1992, NATURE, V358, P758, DOI 10.1038/358758a0; Seitelberger F., 1970, HDB CLINICAL NEUROLO, V10, P150; SINOWAY MP, 1994, J NEUROSCI RES, V37, P551, DOI 10.1002/jnr.490370502; Skoff Robert P., 1992, P653; STRAUTNIEKS S, 1992, AM J HUM GENET, V51, P871; TIMSIT S, 1992, J NEUROCHEM, V58, P1936, DOI 10.1111/j.1471-4159.1992.tb10072.x; TOSIC M, 1994, J NEUROCHEM, V63, P2210; TOSIC M, 1993, BRAIN RES, V625, P307, DOI 10.1016/0006-8993(93)91073-2; Tosic M, 1996, NEUROCHEM RES, V21, P423, DOI 10.1007/BF02527706; TURNLEY AM, 1991, NATURE, V353, P566, DOI 10.1038/353566a0; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; WATANABE I, 1973, J NEUROPATH EXP NEUR, V32, P313, DOI 10.1097/00005072-197304000-00010; WEIMBS T, 1990, BIOL CHEM H-S, V371, P1175, DOI 10.1515/bchm3.1990.371.2.1175; WELMBS T, 1992, BIOCHEMISTRY-US, V31, P12289; WU Y, 1994, P NATL ACAD SCI USA, V91, P9014, DOI 10.1073/pnas.91.19.9014; YAMAMURA T, 1991, J NEUROCHEM, V57, P1671, DOI 10.1111/j.1471-4159.1991.tb06367.x; YOSHIOKA T, 1991, MOL CELL BIOL, V11, P5479, DOI 10.1128/MCB.11.11.5479	65	182	184	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1996	13	4					422	428		10.1038/ng0896-422	http://dx.doi.org/10.1038/ng0896-422			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VB620	8696336				2022-12-25	WOS:A1996VB62000022
J	Prakash, S; Chang, TMS				Prakash, S; Chang, TMS			Microencapsulated genetically engineered live E-coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats	NATURE MEDICINE			English	Article								Safety concerns about introducing genetically engineered cells into the body have prevented their use in medical treatments. To solve this problem, we prepared polymeric membrane artificial cells (semipermeable microcapsules) containing genetically engineered live cells from the bacteria Escherichia coli DH5. When given orally, the cells remain at all times in the microcapsules and are finally excreted in the stool. During their passage through the intestine, small molecules like urea diffuse rapidly into the microcapsules and are acted on by the genetically engineered cells. This lowers the high plasma urea level to normal in uremic rats with induced kidney failure, and has exciting implications for the use of this and many other types of genetically engineered cells in a number of medical applications.	MCGILL UNIV,FAC MED,ARTIFICIAL CELLS & ORGANS RES CTR,MONTREAL,PQ H3G 1Y6,CANADA; MCGILL UNIV,FAC MED,DEPT PHYSIOL,MONTREAL,PQ H3G 1Y6,CANADA; MCGILL UNIV,FAC MED,DEPT MED,MONTREAL,PQ H3G 1Y6,CANADA; MCGILL UNIV,FAC MED,DEPT BIOMED ENGN,MONTREAL,PQ H3G 1Y6,CANADA	McGill University; McGill University; McGill University; McGill University				/0000-0002-4902-2353				AGISHI T, 1980, HEMOPERFUSION KIDNEY, P255; ASABA H, 1980, MIDDLE MOL UREMIA OT, P137; CATTANEO M, 1991, J AM SOC ARTIF INTER, V37, P80; Chang T M, 1995, Biotechnol Annu Rev, V1, P267; CHANG TMS, 1964, SCIENCE, V146, P524, DOI 10.1126/science.146.3643.524; CHANG TMS, IN PRESS METHODS MOL, V63, pCH75; CHANG TMS, 1991, ENCY HUMAN BIOL, V1, P377; CHANG TMS, 1985, COMPREHENSIVE BIOTEC, P53; CHARLES S, 1990, HUMAN PHYSL FDN FRON, P526; COHEN BD, 1972, UREMIA, P1; DEMETRIOU AA, 1986, SCIENCE, V233, P1190, DOI 10.1126/science.2426782; DEMETRIOU AA, 1994, SCI AM SCI MED, V1, P58; DRUKKER W, 1983, REPLACEMENT RENAL FU; Esposito R, 1980, SORBENTS THEIR CLIN, P133; FRIEDMAN EA, 1978, STRATEGY RENAL FAILU, P521; FRIEDMAN EA, 1976, KIDNEY INT, V13, pS273; Goosen A.M., 1988, CHEM ENG EDUC, V22, P196; GRIFFIN AM, 1995, MOL BIOL CURRENT INN, P5; GU KF, 1988, BIOTECHNOL BIOENG, V32, P363, DOI 10.1002/bit.260320315; GU KF, 1991, J BIOTECH APPL BIOCH, V12, P227; KJELLSTRAND C, 1981, T AM SOC ART INT ORG, V27, P24; KOLFF WJ, 1990, INT J ARTIF ORGANS, V13, P404, DOI 10.1177/039139889001300703; LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628; MANGE AP, 1984, BIOSCIENCE, V34, P642, DOI 10.2307/1309530; MARINCS F, 1994, APPL ENVIRON MICROB, V60, P3862, DOI 10.1128/AEM.60.10.3862-3863.1994; MOBLEY HLT, 1989, MICROBIOL REV, V53, P85, DOI 10.1128/MMBR.53.1.85-108.1989; PRAKASH S, 1995, BIOTECHNOL BIOENG, V46, P621, DOI 10.1002/bit.260460615; PRAKASH S, 1993, BIOMATER ARTIF CELLS, V19, P687; SAARVEDRA MJ, 1995, LANCET, V344, P1046; Sambrook J., 2002, MOL CLONING LAB MANU; SCOOT B, 1989, J GEN MICROBIOL, V135, P1769; Setala K, 1972, Proc Eur Dial Transplant Assoc, V9, P514; SETALA K, 1973, IRCS MED SCI NEPHROL, V73, P35; SHIANSOON P, 1994, LANCET, V343, P950; SPARKS RE, 1979, CLIN NEPHROL, V11, P81; SPARKS RE, 1972, T AM SOC ART INT ORG, V18, P458; SYMMOUR AC, 1954, J BIOL CHEM, V209, P145; WALKER JM, 1977, ARTIF ORGANS, P137	38	150	166	1	11	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	AUG	1996	2	8					883	887		10.1038/nm0896-883	http://dx.doi.org/10.1038/nm0896-883			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UZ804	8705857				2022-12-25	WOS:A1996UZ80400034
J	Przylepa, KA; Paznekas, W; Zhang, MH; Golabi, M; Bias, W; Bamshad, MJ; Carey, JC; Hall, BD; Stevenson, R; Orlow, SJ; Cohen, MM; Jabs, EW				Przylepa, KA; Paznekas, W; Zhang, MH; Golabi, M; Bias, W; Bamshad, MJ; Carey, JC; Hall, BD; Stevenson, R; Orlow, SJ; Cohen, MM; Jabs, EW			Fibroblast growth factor receptor 2 mutations in Beare-Stevenson cutis gyrata syndrome	NATURE GENETICS			English	Letter							JACKSON-WEISS-SYNDROME; CROUZON-SYNDROME; ACANTHOSIS NIGRICANS; FGFR2 MUTATIONS; APERT SYNDROME; GENE		JOHNS HOPKINS UNIV, SCH MED, CTR GENET MED, DEPT PEDIAT, BALTIMORE, MD 21287 USA; JOHNS HOPKINS UNIV, SCH MED, CTR GENET MED, DEPT MED, BALTIMORE, MD 21287 USA; JOHNS HOPKINS UNIV, SCH MED, CTR GENET MED, DEPT SURG, BALTIMORE, MD 21287 USA; UNIV CALIF SAN FRANCISCO, DEPT PEDIAT, SAN FRANCISCO, CA 94143 USA; UNIV UTAH, DEPT PEDIAT, DIV MED GENET, SALT LAKE CITY, UT 84132 USA; UNIV KENTUCKY, DEPT PEDIAT, DIV GENET DYSMORPHOL, LEXINGTON, KY 40536 USA; GREENWOOD GENET CTR, JC SELF RES INST HUMAN GENET, GREENWOOD, SC 29646 USA; NYU, SCH MED, RONALD O PERELMAN DEPT DERMATOL, NEW YORK, NY 10016 USA; NYU, SCH MED, DEPT CELL BIOL, NEW YORK, NY 10016 USA; DALHOUSIE UNIV, DEPT ORAL & MAXILLOFACIAL SCI, HALIFAX, NS D3H 3J5, CANADA; DALHOUSIE UNIV, DEPT PEDIAT, HALIFAX, NS D3H 3J5, CANADA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of California System; University of California San Francisco; Utah System of Higher Education; University of Utah; University of Kentucky; Greenwood Genetic Center; New York University; New York University; Dalhousie University; Dalhousie University				Jabs, Ethylin/0000-0001-8983-5466	NCRR NIH HHS [RR00722] Funding Source: Medline; NIDCR NIH HHS [DE11441, DE11131] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE011131, R01DE011441] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ANDREWS JM, 1993, BRIT J PLAST SURG, V46, P443, DOI 10.1016/0007-1226(93)90053-E; BEARE JM, 1969, BRIT J DERMATOL, V81, P241, DOI 10.1111/j.1365-2133.1969.tb13975.x; BELLOT F, 1991, EMBO J, V10, P2849, DOI 10.1002/j.1460-2075.1991.tb07834.x; BIAS WB, 1992, MANUAL CLIN LAB IMMU, V136, P901; BRATANIC B, 1994, EUR J PEDIATR, V153, P184; Cohen M M Jr, 1988, Am J Med Genet Suppl, V4, P99; DIONNE CA, 1990, EMBO J, V9, P2685, DOI 10.1002/j.1460-2075.1990.tb07454.x; GORRY MC, 1995, HUM MOL GENET, V4, P1387, DOI 10.1093/hmg/4.8.1387; HALL BD, 1992, AM J MED GENET, V44, P82, DOI 10.1002/ajmg.1320440120; JABS EW, 1994, NAT GENET, V8, P275, DOI 10.1038/ng1194-275; JEN J, 1994, NEW ENGL J MED, V331, P213, DOI 10.1056/NEJM199407283310401; MEYERS GA, 1995, NAT GENET, V11, P462, DOI 10.1038/ng1295-462; Meyers GA, 1996, AM J HUM GENET, V58, P491; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; NEILSON KM, 1995, J BIOL CHEM, V270, P26037, DOI 10.1074/jbc.270.44.26037; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; ORNITZ DM, 1992, J BIOL CHEM, V267, P16305; ORRURTREGER A, 1993, DEV BIOL, V158, P475, DOI 10.1006/dbio.1993.1205; PARK WJ, 1995, AM J HUM GENET, V57, P321; PARK WJ, 1995, HUM MOL GENET, V4, P1229, DOI 10.1093/hmg/4.7.1229; PETERS K, 1993, DEV BIOL, V155, P423, DOI 10.1006/dbio.1993.1040; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; Rousseau F, 1996, HUM MOL GENET, V5, P509, DOI 10.1093/hmg/5.4.509; SCHELL U, 1995, HUM MOL GENET, V4, P323, DOI 10.1093/hmg/4.3.323; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; STEVENSON RE, 1978, J PEDIATR-US, V92, P950, DOI 10.1016/S0022-3476(78)80371-0; SUPERTIFURGA A, 1995, EUR J PEDIATR, V154, P215, DOI 10.1007/BF01954274; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; WERNER S, 1994, SCIENCE, V266, P819, DOI 10.1126/science.7973639; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165	30	155	159	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1996	13	4					492	494		10.1038/ng0896-492	http://dx.doi.org/10.1038/ng0896-492			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VB620	8696350				2022-12-25	WOS:A1996VB62000036
J	Mortlock, DP; Post, LC; Innis, JW				Mortlock, DP; Post, LC; Innis, JW			The molecular basis of hypodactyly (Hd): A deletion in Hoxa13 leads to arrest of digital arch formation	NATURE GENETICS			English	Article							AUG INITIATOR CODON; LIMB; GENE; MICE; TRANSLATION; CARTILAGE; HOXD-13; MODEL	Hypodactyly (Hd) is a semidominant mutation in mice that maps in a genetic interval overlapping the Hoxa cluster. The profound deficiency of digital arch structures in Hd/Hd mice is consistent with a defect in a gene activated late in limb morphogenesis. We have determined the structure of the Hoxa13 gene and describe a 50-base pair deletion in the first exon of the Hd allele that probably arose from unequal recombination or misalignment between triplet repeats. It is predicted that no Hoxa13 protein is made from Hd mRNA. The hypodactyly limb phenotype is similar to that of Hoxd13-deficient mice in sharing defects along multiple axes and alterations in cartilage maturation; however, the overall effects on digital arch formation are more severe in Hd/Hd mice. Our results confirm the critical role of AbdB-like Hox genes in the development of the autopod, and add to the spectrum of mutations involving triplet repeats.	UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,DEPT PEDIAT,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan			Mortlock, Douglas P/C-9981-2010; Morlock, Doug/C-3482-2012					Ausubel FM., 2006, ENZYMATIC MANIPULATI; BATES G, 1994, BIOESSAYS, V16, P277, DOI 10.1002/bies.950160411; COHN MJ, 1995, CELL, V80, P739, DOI 10.1016/0092-8674(95)90352-6; CONDIE BG, 1994, NATURE, V370, P304, DOI 10.1038/370304a0; COPP AJ, 1995, TRENDS GENET, V11, P87, DOI 10.1016/S0168-9525(00)89008-3; DAVIS AP, 1994, DEVELOPMENT, V120, P2187; DAVIS AP, 1995, NATURE, V375, P791, DOI 10.1038/375791a0; DOLLE P, 1991, MECH DEVELOP, V36, P3, DOI 10.1016/0925-4773(91)90067-G; DOLLE P, 1993, CELL, V75, P431, DOI 10.1016/0092-8674(93)90378-4; DOVER G, 1995, NAT GENET, V10, P254, DOI 10.1038/ng0795-254; DUBOULE D, 1992, BIOESSAYS, V14, P375, DOI 10.1002/bies.950140606; DUBOULE D, 1994, GUIDEBOOK HOMEOBOX G; FAVIER B, 1995, P NATL ACAD SCI USA, V92, P310, DOI 10.1073/pnas.92.1.310; GARDINER DM, 1995, DEVELOPMENT, V121, P1731; HAACK H, 1993, DEV BIOL, V157, P410, DOI 10.1006/dbio.1993.1145; HALAL F, 1988, AM J MED GENET, V30, P793, DOI 10.1002/ajmg.1320300312; HAN K, 1993, GENE DEV, V7, P492; HAN KY, 1993, EMBO J, V12, P2723, DOI 10.1002/j.1460-2075.1993.tb05934.x; HSIEHLI HM, 1995, DEVELOPMENT, V121, P1373; HUMMEL KP, 1970, J HERED, V61, P219, DOI 10.1093/oxfordjournals.jhered.a108088; Innis JW, 1996, MAMM GENOME, V7, P216, DOI 10.1007/s003359900058; Innis JW, 1996, MAMM GENOME, V7, P2, DOI 10.1007/s003359900002; KIMMEL CA, 1981, STAIN TECHNOL, V56, P271, DOI 10.3109/10520298109067325; KOZAK M, 1984, NATURE, V308, P241, DOI 10.1038/308241a0; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; KUNKEL TA, 1993, NATURE, V365, P207, DOI 10.1038/365207a0; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; LICHT JD, 1990, NATURE, V346, P76, DOI 10.1038/346076a0; Lupski JR, 1996, AM J HUM GENET, V58, P21; MAGLI MC, 1991, P NATL ACAD SCI USA, V88, P6348, DOI 10.1073/pnas.88.14.6348; MORGAN BA, 1994, DEVELOPMENT, P181; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; OSTER GF, 1985, J EMBRYOL EXP MORPH, V89, P93; POZNANSKI AK, 1970, RADIOLOGY, V95, P129, DOI 10.1148/95.1.129; RANCOURT DE, 1995, GENE DEV, V9, P108, DOI 10.1101/gad.9.1.108; REDLINE RW, 1994, LAB INVEST, V71, P663; REDLINE RW, 1992, LAB INVEST, V66, P659; RILI FM, 1995, P NATL ACAD SCI USA, V92, P8185; ROBERTS DJ, 1994, AM J HUM GENET, V55, P1; ROGINA B, 1993, NUCLEIC ACIDS RES, V21, P1316, DOI 10.1093/nar/21.5.1316; SATOKATA I, 1995, NATURE, V374, P460, DOI 10.1038/374460a0; SHUBIN NH, 1986, EVOL BIOL, V20, P319; SMALL KM, 1993, GENE DEV, V7, P2318, DOI 10.1101/gad.7.12a.2318; STERN AM, 1970, J PEDIATR-US, V77, P109, DOI 10.1016/S0022-3476(70)80052-X; TABIN C, 1995, CELL, V80, P671, DOI 10.1016/0092-8674(95)90343-7; TAUTZ D, 1994, CURR OPIN GENET DEV, V4, P832, DOI 10.1016/0959-437X(94)90067-1; VALDES JM, 1993, HUM MOL GENET, V2, P633, DOI 10.1093/hmg/2.6.633; VANDERHOEVEN F, 1995, X87752 GENB; YOKOUCHI Y, 1995, DEV BIOL, V169, P76, DOI 10.1006/dbio.1995.1128; YOKOUCHI Y, 1995, GENE DEV, V9, P2509, DOI 10.1101/gad.9.20.2509; YOKOUCHI Y, 1991, NATURE, V353, P443, DOI 10.1038/353443a0	52	137	141	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1996	13	3					284	289		10.1038/ng0796-284	http://dx.doi.org/10.1038/ng0796-284			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UU283	8673126				2022-12-25	WOS:A1996UU28300015
J	Teng, DHF; Bogden, R; Mitchell, J; Baumgard, M; Bell, R; Berry, S; Davis, T; Ha, PC; Kehrer, R; Jammulapati, S; Chen, QA; Offit, K; Skolnick, MH; Tavtigian, SV; Jhanwar, S; Swedlund, B; Wong, AKC; Kamb, A				Teng, DHF; Bogden, R; Mitchell, J; Baumgard, M; Bell, R; Berry, S; Davis, T; Ha, PC; Kehrer, R; Jammulapati, S; Chen, QA; Offit, K; Skolnick, MH; Tavtigian, SV; Jhanwar, S; Swedlund, B; Wong, AKC; Kamb, A			Low incidence of BRCA2 mutations in breast carcinoma and other cancers	NATURE GENETICS			English	Letter							GENE; EXPRESSION; LUNG		MYRIAD GENET INC, SALT LAKE CITY, UT 84108 USA; MEM SLOAN KETTERING CANC CTR, DEPT HUMAN GENET, NEW YORK, NY 10021 USA	Myriad Genetics, Inc; Memorial Sloan Kettering Cancer Center								CLETONJANSEN AM, 1995, BRIT J CANCER, V72, P1241, DOI 10.1038/bjc.1995.493; COLLINS N, 1995, ONCOGENE, V10, P1673; EMI M, 1993, NAT GENET, V5, P151, DOI 10.1038/ng1093-151; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; GONZALEZZULUETA M, 1995, CANCER RES, V55, P4531; HENSEL CH, 1990, CANCER RES, V50, P3067; HOSKING L, 1995, NAT GENET, V9, P343, DOI 10.1038/ng0495-343; KAMB A, 1994, SCIENCE, V265, P416, DOI 10.1126/science.265.5170.416; KNUDSON AG, 1993, NAT GENET, V5, P103, DOI 10.1038/ng1093-103; LIU Q, 1995, ONCOGENE, V10, P1061; MERAJVER SD, 1995, NAT GENET, V9, P439, DOI 10.1038/ng0495-439; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Neuhausen S, 1996, NAT GENET, V13, P126, DOI 10.1038/ng0596-126; RICHARD I, 1995, NAT GENET, V10, P259, DOI 10.1038/ng0795-259; SCHUTTE M, 1995, P NATL ACAD SCI USA, V92, P5950, DOI 10.1073/pnas.92.13.5950; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; THORLACIUS S, 1995, LANCET, V346, P544, DOI 10.1016/S0140-6736(95)91383-1; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; YOKOTA J, 1988, ONCOGENE, V3, P471	21	157	162	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1996	13	2					241	244		10.1038/ng0696-241	http://dx.doi.org/10.1038/ng0696-241			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UN395	8640236				2022-12-25	WOS:A1996UN39500029
J	Heslop, HE; Ng, CYC; Li, CF; Smith, CA; Loftin, SK; Krance, RA; Brenner, MK; Rooney, CM				Heslop, HE; Ng, CYC; Li, CF; Smith, CA; Loftin, SK; Krance, RA; Brenner, MK; Rooney, CM			Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes	NATURE MEDICINE			English	Article							MARROW TRANSPLANTATION	Adoptive transfer of antigen-specific cytotoxic T lymphocytes (CTLs) offers safe and effective therapy for certain viral infections and could prove useful in the eradication of tumor cells. Whether or not the infused T cells persist for extended periods, retaining their ability to expand in response to antigenic stimulation, is not known. We now report long-term detection of gene-marked Epstein-Barr virus (EBV)-specific CTLs in immunocompromised patients at risk for the development of EBV lymphoproliferative disease. Infusions of CTLs not only restored cellular immune responses against EBV, but also established populations of CTL precursors that could respond to in vivo or ex vivo challenge with the virus for as long as 18 months. Our findings support wider use of antigen-specific CTLs in adoptive immunotherapy.	ST JUDE CHILDRENS RES HOSP, DEPT VIROL & MOLEC BIOL, MEMPHIS, TN 38105 USA; UNIV TENNESSEE, COLL MED, DEPT PEDIAT, MEMPHIS, TN 38163 USA; UNIV TENNESSEE, COLL MED, DEPT PATHOL, MEMPHIS, TN 38163 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Heslop, HE (corresponding author), ST JUDE CHILDRENS RES HOSP, DIV BONE MARROW TRANSPLANTAT, 332 N LAUDERDALE ST, MEMPHIS, TN 38105 USA.		Heslop, Helen/AAC-9500-2020; Rooney, Cliona/ABD-5475-2021; Wilson, Matthew H/K-3193-2013; Brenner, Malcolm/Y-2509-2019		NATIONAL CANCER INSTITUTE [P30CA021765, P01CA020180, R01CA061384, U01CA061384] Funding Source: NIH RePORTER; NCI NIH HHS [CA 20180, CA 61384, P30 CA 21765] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BLAESE RM, 1995, SCIENCE, V270, P475, DOI 10.1126/science.270.5235.475; BORDIGNON C, 1995, SCIENCE, V270, P470, DOI 10.1126/science.270.5235.470; BOURGAULT I, 1991, CLIN EXP IMMUNOL, V84, P501; BOYLE MJ, 1991, BLOOD, V78, P3004; CRYSTAL RG, 1995, SCIENCE, V270, P404, DOI 10.1126/science.270.5235.404; DENHAAN JMM, 1995, SCIENCE, V268, P1476, DOI 10.1126/science.7539551; DOHERTY PC, 1994, CURR OPIN IMMUNOL, V6, P545, DOI 10.1016/0952-7915(94)90139-2; HESLOP HE, 1994, HUM GENE THER, V5, P381, DOI 10.1089/hum.1994.5.3-381; HESLOP HE, 1994, NEW ENGL J MED, V331, P679; KOLB HJ, 1995, BLOOD, V86, P2041, DOI 10.1182/blood.V86.5.2041.bloodjournal8652041; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; LUCAS K, 1994, BLOOD, V84, pA98; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; MATZINGER P, 1994, NATURE, V369, P605, DOI 10.1038/369605a0; NANDA NK, 1995, CELL, V82, P13, DOI 10.1016/0092-8674(95)90047-0; OEHEN S, 1992, J EXP MED, V176, P1273, DOI 10.1084/jem.176.5.1273; PAPADOPOULOS EB, 1994, NEW ENGL J MED, V330, P1185, DOI 10.1056/NEJM199404283301703; REITTIE JE, 1989, BLOOD, V73, P1351; RIDDELL SR, 1995, ANNU REV IMMUNOL, V13, P545; RILL DR, 1992, BLOOD, V79, P2694; ROONEY CM, 1995, BRIT J HAEMATOL, V89, P98, DOI 10.1111/j.1365-2141.1995.tb08904.x; ROONEY CM, 1995, LANCET, V345, P9, DOI 10.1016/S0140-6736(95)91150-2; Smith C A, 1995, J Hematother, V4, P73, DOI 10.1089/scd.1.1995.4.73; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603; ZIMBER U, 1986, VIROLOGY, V154, P56, DOI 10.1016/0042-6822(86)90429-0	25	660	693	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	MAY	1996	2	5					551	555		10.1038/nm0596-551	http://dx.doi.org/10.1038/nm0596-551			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UJ230	8616714				2022-12-25	WOS:A1996UJ23000038
J	Ollier, B				Ollier, B			Shock revelations about HLA-DR4 - A shortcut to rheumatoid arthritis?	NATURE MEDICINE			English	Editorial Material							SUSCEPTIBILITY				Ollier, B (corresponding author), UNIV MANCHESTER,SCH EPIDEMIOL & HLTH SCI,MANCHESTER M13 9PT,LANCS,ENGLAND.							Auger I, 1996, NAT MED, V2, P306, DOI 10.1038/nm0396-306; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; MACGREGOR A, 1995, J RHEUMATOL, V22, P1032; OLLIER W, 1992, RHEUM DIS CLIN N AM, V18, P741; ROUDIER J, 1989, P NATL ACAD SCI USA, V86, P5104, DOI 10.1073/pnas.86.13.5104; SALVAT S, 1994, J IMMUNOL, V153, P5321; SARGENT CA, 1989, P NATL ACAD SCI USA, V86, P1968, DOI 10.1073/pnas.86.6.1968; STASTNY P, 1978, NEW ENGL J MED, V298, P869, DOI 10.1056/NEJM197804202981602	8	7	7	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAR	1996	2	3					279	280		10.1038/nm0396-279	http://dx.doi.org/10.1038/nm0396-279			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TY640	8612222				2022-12-25	WOS:A1996TY64000032
J	Reiter, LT; Murakami, T; Koeuth, T; Pentao, L; Muzny, DM; Gibbs, RA; Lupski, JR				Reiter, LT; Murakami, T; Koeuth, T; Pentao, L; Muzny, DM; Gibbs, RA; Lupski, JR			A recombination hotspot responsible for two inherited peripheral neuropathies is located near a mariner transposon-like element	NATURE GENETICS			English	Article							TOOTH DISEASE TYPE-1A; HUMAN X-CHROMOSOME; DISTAL SHORT ARM; DROSOPHILA-MELANOGASTER; REPETITIVE ELEMENTS; FREQUENT DELETIONS; DNA DUPLICATION; GENE; MUTATION; FAMILIES	The Charcot-Marie Tooth disease type 1A (CMT1A) duplication and hereditary neuropathy with liability to pressure palsies (HNPP) deletion are reciprocal products of an unequal crossing-over event between misaligned flanking CMT1A-REP repeats. The molecular aetiology of this apparently homologous recombination event was examined by sequencing the crossover region. Through the detection of novel junction fragments from the recombinant CMT1A-REPs in both CMT1A and HNPP patients, a 1.7-kb recombination hotspot within the similar to 30-kb CMT1A-REPs was identified. This hotspot is 98% identical between CMT1A-REPs indicating that sequence identity is not likely the sole factor involved in promoting crossover events. Sequence analysis revealed a mariner transposon-like element (MITE) near the hotspot which we hypothesize could mediate strand exchange events via cleavage by a transposase at or near the 3' end of the element.	BAYLOR COLL MED,DEPT MOLEC & HUMAN GENET,HOUSTON,TX 77030; BAYLOR COLL MED,CELL & MOLEC BIOL PROGRAM,HOUSTON,TX 77030; BAYLOR COLL MED,DEV BIOL PROGRAM,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; BAYLOR COLL MED,CTR HUMAN GENOME,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine			Reiter, Lawrence/H-4161-2019	Reiter, Lawrence/0000-0002-4100-2630; Murakami, Tatsufumi/0000-0001-7851-6822	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027042] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00210] Funding Source: Medline; NINDS NIH HHS [NS27042] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSSON B, 1994, ANAL BIOCHEM, V218, P300, DOI 10.1006/abio.1994.1182; BALLABIO A, 1990, GENOMICS, V8, P263, DOI 10.1016/0888-7543(90)90281-X; CAPY P, 1992, GENETICA, V86, P37, DOI 10.1007/BF00133709; CHANCE PF, 1994, HUM MOL GENET, V3, P223, DOI 10.1093/hmg/3.2.223; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; DAVIES DM, 1954, LANCET, V2, P266; De Jong J, 1947, PSYCHIAT NEUROL BL A, V50, P60; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; GARZA D, 1991, GENETICS, V128, P303; HERTZ JM, 1994, CLIN GENET, V46, P291; HOOGENDIJK JE, 1992, LANCET, V339, P1081, DOI 10.1016/0140-6736(92)90668-S; IONASESCU VV, 1993, MUSCLE NERVE, V16, P1232, DOI 10.1002/mus.880161114; JACOBSON JW, 1986, P NATL ACAD SCI USA, V83, P8684, DOI 10.1073/pnas.83.22.8684; JURKA J, 1990, NUCLEIC ACIDS RES, V18, P137, DOI 10.1093/nar/18.1.137; JURKA J, IN PRESS COMP CHEM; KAKU DA, 1993, NEUROLOGY, V43, P1806, DOI 10.1212/WNL.43.9.1806; KALLIONIEMI OP, 1994, GENOMICS, V20, P125, DOI 10.1006/geno.1994.1138; KIYOSAWA H, 1995, HUM MOL GENET, V4, P2327, DOI 10.1093/hmg/4.12.2327; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; LEGUERN E, 1995, HUM MOL GENET, V4, P1673, DOI 10.1093/hmg/4.9.1673; LI XM, 1992, NUCLEIC ACIDS RES, V20, P1117, DOI 10.1093/nar/20.5.1117; LIDHOLM DA, 1993, GENETICS, V134, P859; LOHE AR, 1995, MOL BIOL EVOL, V12, P62, DOI 10.1093/oxfordjournals.molbev.a040191; LOHE AR, 1995, GENETICS, V140, P183; LORENZETTI D, 1995, AM J HUM GENET, V56, P91; LUPSKI JR, 1993, JAMA-J AM MED ASSOC, V270, P2326, DOI 10.1001/jama.270.19.2326; Lupski JR, 1996, AM J HUM GENET, V58, P21; LUPSKI JR, 1993, AM J MED GENET, V45, P92, DOI 10.1002/ajmg.1320450122; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; LUPSKI JR, 1991, CURRENT NEUROLOGY, P1; MARUYAMA K, 1991, J MOL EVOL, V33, P514, DOI 10.1007/BF02102804; MATSUNAMI N, 1992, NAT GENET, V1, P176, DOI 10.1038/ng0692-176; MAZNY DM, 1994, AUTOMATED DNA SEQUEN, P182; MCCARRON M, 1994, GENETICS, V136, P1013; Mckusick V.A., 1994, MENDELIAN INHERITANC; METZENBERG AB, 1991, GENETICS, V128, P143; NELIS E, IN PRESS EUR J HUM G; OOSUMI T, 1995, NATURE, V378, P672, DOI 10.1038/378672a0; PALAU F, 1993, HUM MOL GENET, V2, P2031, DOI 10.1093/hmg/2.12.2031; PATEL PI, 1994, TRENDS GENET, V10, P128, DOI 10.1016/0168-9525(94)90214-3; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; PENTAO L, 1992, NAT GENET, V2, P92; RAEYMAEKERS P, 1992, J MED GENET, V29, P5, DOI 10.1136/jmg.29.1.5; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; REISECKER F, 1994, NEUROLOGY, V44, P753, DOI 10.1212/WNL.44.4.753; ROA BB, 1994, ADV HUM GENET, V22, P117; ROA BB, 1993, NAT GENET, V5, P189, DOI 10.1038/ng1093-189; ROA BB, 1995, LAB MED INT, V12, P22; Robertson H.M., 1993, Insect Molecular Biology, V2, P125, DOI 10.1111/j.1365-2583.1993.tb00132.x; ROBERTSON HM, 1993, NATURE, V362, P241, DOI 10.1038/362241a0; ROSSITER JP, 1994, HUM MOL GENET, V3, P1035, DOI 10.1093/hmg/3.7.1035; Sambrook J., 2002, MOL CLONING LAB MANU; SMIT AFA, 1993, NUCLEIC ACIDS RES, V21, P1863, DOI 10.1093/nar/21.8.1863; SMIT AFA, 1995, J MOL BIOL, V246, P401, DOI 10.1006/jmbi.1994.0095; SMIT AFA, IN PRESS P NATL ACAD; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timmerman V, 1996, HUM GENET, V97, P26, DOI 10.1007/BF00218828; TIMMERMAN V, 1992, NAT GENET, V1, P171, DOI 10.1038/ng0692-171; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166; WAHLS WP, 1990, CELL, V60, P95, DOI 10.1016/0092-8674(90)90719-U; WISE CA, 1993, AM J HUM GENET, V53, P853; WORLEY KC, 1995, GENOME RES, V5, P173, DOI 10.1101/gr.5.2.173; YEN PH, 1990, CELL, V61, P603, DOI 10.1016/0092-8674(90)90472-Q	65	263	267	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1996	12	3					288	297		10.1038/ng0396-288	http://dx.doi.org/10.1038/ng0396-288			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TY183	8589720				2022-12-25	WOS:A1996TY18300018
J	Rozmahel, R; Wilschanski, M; Matin, A; Plyte, S; Oliver, M; Auerbach, W; Moore, A; Forstner, J; Durie, P; Nadeau, J; Bear, C; Tsui, LC				Rozmahel, R; Wilschanski, M; Matin, A; Plyte, S; Oliver, M; Auerbach, W; Moore, A; Forstner, J; Durie, P; Nadeau, J; Bear, C; Tsui, LC			Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor	NATURE GENETICS			English	Article							PANCREATIC FUNCTION; STEM-CELLS; MOUSE; CFTR; IDENTIFICATION; MUTAGENESIS; EPITHELIUM; MUTATIONS; PHENOTYPE; TRANSPORT	Mice that have been made deficient for the cystic fibrosis transmembrane conductance regulator (Cftr) usually die of intestinal obstruction, We have created Cftr-deficient mice and demonstrate prolonged survival among backcross and intercross progeny with different inbred strains, suggesting that modulation of disease severity is genetically determined. A genome scan showed that the major modifier locus maps near the centromere of mouse chromosome 7. Electrophysiological studies on mice with prolonged survival show that the partial rectification of Cl- and Na+ ion transport abnormalities can be explained in part by up-regulation of a calcium-activated Cl- conductance, Identification of modifier genes in our Cftr(m1HSC)/Cft(rm1HSC) mice should provide important insight into the heterogeneous disease presentation observed among CF patients.	UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO,ON,CANADA; UNIV TORONTO,DEPT PHYSIOL,TORONTO,ON,CANADA; UNIV TORONTO,DEPT BIOCHEM,TORONTO,ON,CANADA; UNIV TORONTO,DEPT PEDIAT,TORONTO,ON,CANADA; HOSP SICK CHILDREN,DEPT GENET,TORONTO,ON M56 1X8,CANADA; HOSP SICK CHILDREN,DIV GASTROENTEROL,TORONTO,ON M56 1X8,CANADA; HOSP SICK CHILDREN,DIV CELL BIOL,TORONTO,ON M56 1X8,CANADA; HOSP SICK CHILDREN,DIV BIOCHEM RES,TORONTO,ON M56 1X8,CANADA; MCGILL UNIV,DEPT HUMAN GENET,MONTREAL,PQ,CANADA	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University			Tsui, Lap-chee/A-1081-2010					ANDERSON MP, 1991, P NATL ACAD SCI USA, V88, P6003, DOI 10.1073/pnas.88.14.6003; ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; ASADA Y, 1994, NAT GENET, V6, P363, DOI 10.1038/ng0494-363; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; BJERKNES M, 1981, ANAT REC, V199, P565, DOI 10.1002/ar.1091990412; BRILLIANT MH, 1994, MAMM GENOME, V5, pS104; CHANG XB, 1993, J BIOL CHEM, V268, P11304; CLARKE LL, 1992, SCIENCE, V257, P1125, DOI 10.1126/science.257.5073.1125; CLARKE LL, 1994, P NATL ACAD SCI USA, V91, P479, DOI 10.1073/pnas.91.2.479; COREY M, 1989, J PEDIATR-US, V115, P274, DOI 10.1016/S0022-3476(89)80082-4; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; DORIN JR, 1992, NATURE, V359, P211, DOI 10.1038/359211a0; ECKMAN E, 1994, PEDIATR PULM, V10, pA62; EVANS GS, 1992, J CELL SCI, V101, P219; GRUBB BR, 1994, AM J PHYSIOL, V266, pC1478, DOI 10.1152/ajpcell.1994.266.5.C1478; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; KNOWLES MR, 1983, SCIENCE, V221, P1067, DOI 10.1126/science.6308769; KNOWLES MR, 1981, AM REV RESPIR DIS, V124, P484; KRISTIDIS P, 1992, AM J HUM GENET, V50, P1178; LISON L, 1954, STAIN TECHNOL, V29, P13; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nagy A., 1993, Gene targeting: a practical approach., P147; ONEAL WK, 1993, HUM MOL GENET, V2, P1561, DOI 10.1093/hmg/2.10.1561; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; QUINTON PM, 1983, NATURE, V301, P421, DOI 10.1038/301421a0; RATLIFF R, 1992, NAT GENET, V4, P35; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; TABCHARANI JA, 1991, NATURE, V352, P628, DOI 10.1038/352628a0; TSUI LC, 1992, TRENDS GENET, V8, P392, DOI 10.1016/0168-9525(92)90301-J; Welsh MJ, 1995, METABOLIC MOL BASES, V3, P3799; ZHOU L, 1994, SCIENCE, V266, P1705, DOI 10.1126/science.7527588	35	328	334	0	14	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1996	12	3					280	287		10.1038/ng0396-280	http://dx.doi.org/10.1038/ng0396-280			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TY183	8589719				2022-12-25	WOS:A1996TY18300017
J	Kuroiwa, Y; KanekoIshino, T; Kagitani, F; Kohda, T; Li, LL; Tada, M; Suzuki, R; Yokoyama, M; Shiroishi, T; Wakana, S; Barton, SC; Ishino, F; Surani, MA				Kuroiwa, Y; KanekoIshino, T; Kagitani, F; Kohda, T; Li, LL; Tada, M; Suzuki, R; Yokoyama, M; Shiroishi, T; Wakana, S; Barton, SC; Ishino, F; Surani, MA			Peg3 imprinted gene on proximal chromosome 7 encodes for a zinc finger protein	NATURE GENETICS			English	Letter							PRADER-WILLI SYNDROME; CRYSTAL-STRUCTURE; MOUSE CHROMOSOME-7; DNA RECOGNITION; GENOMES; COMPLEX		TOKYO INST TECHNOL,CTR GENE RES,MIDORI KU,YOKOHAMA,KANAGAWA 227,JAPAN; WELLCOME CRC INST CANC & DEV BIOL,CAMBRIDGE CB2 1QR,ENGLAND; UNIV CAMBRIDGE,PHYSIOL LAB,CAMBRIDGE,ENGLAND; MITSUBISHI KASEI INST LIFE SCI,MACHIDA,TOKYO 194,JAPAN; NATL INST GENET,DEPT MAMMALIAN,GENET LAB,MISHIMA,SHIZUOKA 411,JAPAN; CENT INST EXPTL ANIM,MIYAMAE KU,KAWASAKI,KANAGAWA 213,JAPAN	Tokyo Institute of Technology; University of Cambridge; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan			Ishino（Kaneko-Ishino）, Tomoko/AGY-0742-2022; Kohda, Takashi/C-2879-2014	Surani, Azim/0000-0002-8640-4318; Kohda, Takashi/0000-0002-6856-5601				BAIROCH A, 1994, NUCLEIC ACIDS RES, V22, P3583; BARR JA, 1995, MAMM GENOME, V6, P405, DOI 10.1007/BF00355641; BARTON SC, 1991, DEVELOPMENT, V113, P679; BROWN SDM, 1993, GENOMICS, V18, P459, DOI 10.1006/geno.1993.1502; CATTANACH BM, 1994, J INHERIT METAB DIS, V17, P403, DOI 10.1007/BF00711356; CATTANACH BM, 1992, NAT GENET, V2, P270, DOI 10.1038/ng1292-270; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; EFSTRATIADIS A, 1994, CURR OPIN GENET DEV, V4, P265, DOI 10.1016/S0959-437X(05)80054-1; FAIRALL L, 1993, NATURE, V366, P483, DOI 10.1038/366483a0; GUBBAY J, 1992, P NATL ACAD SCI USA, V89, P7953, DOI 10.1073/pnas.89.17.7953; HAYASHIZAKI Y, 1994, GENETICS, V138, P1207; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; JACOBS GH, 1992, EMBO J, V11, P4507, DOI 10.1002/j.1460-2075.1992.tb05552.x; JANSEN G, 1993, HUM MOL GENET, V8, P1221; KANEKOISHINO T, 1995, NAT GENET, V11, P52, DOI 10.1038/ng0995-52; LAWRENCE JB, 1989, CELL, V57, P493, DOI 10.1016/0092-8674(89)90924-0; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; MANDEL JL, 1993, NAT GENET, V4, P8, DOI 10.1038/ng0593-8; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; REIK W, 1989, TRENDS GENET, V5, P331, DOI 10.1016/0168-9525(89)90138-8; RUBIO MP, 1994, CANCER RES, V54, P4760; SEARLE AG, 1990, GENET RES, V56, P237, DOI 10.1017/S0016672300035333; SURANI MAH, 1986, CELL, V45, P127, DOI 10.1016/0092-8674(86)90544-1; TADA M, 1994, MAMM GENOME, V5, P655, DOI 10.1007/BF00411465; Wilkinson D. G., 1990, POSTIMPLANTATION MAM, P155; YONG WH, 1995, J NEUROPATH EXP NEUR, V54, P622, DOI 10.1097/00005072-199509000-00002	30	207	214	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1996	12	2					186	190		10.1038/ng0296-186	http://dx.doi.org/10.1038/ng0296-186			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TU079	8563758				2022-12-25	WOS:A1996TU07900020
J	Lindberg, RLP; Porcher, C; Grandchamp, B; Ledermann, B; Burki, K; Brandner, S; Aguzzi, A; Meyer, UA				Lindberg, RLP; Porcher, C; Grandchamp, B; Ledermann, B; Burki, K; Brandner, S; Aguzzi, A; Meyer, UA			Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria	NATURE GENETICS			English	Letter							DELTA-AMINOLEVULINIC-ACID; INTERMITTENT ACUTE PORPHYRIA; MOLECULAR-GENETICS		UNIV BASEL, BIOCTR, DEPT PHARMACOL, CH-4056 BASEL, SWITZERLAND; FAC XAVIER BICHAT, INSERM, U409, F-75018 PARIS, FRANCE; SANDOZ PHARMA LTD, PRECLIN RES, CH-4002 BASEL, SWITZERLAND; UNIV ZURICH HOSP, INST NEUROPATHOL, CH-8091 ZURICH, SWITZERLAND	University of Basel; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Novartis; Sandoz; University of Zurich; University Zurich Hospital			Brandner, Sebastian/J-4562-2014; Aguzzi, Adriano/A-3351-2008; Porcher, Catherine/D-7026-2016	Brandner, Sebastian/0000-0002-9821-0342; Aguzzi, Adriano/0000-0002-0344-6708				ALBERS JW, 1978, MUSCLE NERVE, V1, P292, DOI 10.1002/mus.880010405; ANDERSSON C, 1994, J INTERN MED, V236, P169, DOI 10.1111/j.1365-2796.1994.tb01279.x; BEAUMONT C, 1989, J BIOL CHEM, V264, P14829; Bielschowsky M, 1904, J PSYCHOL NEUROL, V3, P169; BONKOVSKY HL, 1993, GASTROENTEROLOGY, V105, P590, DOI 10.1016/0016-5085(93)90739-Y; Bonkowsky H L, 1982, Semin Liver Dis, V2, P108, DOI 10.1055/s-2008-1040701; BRENNAN MJW, 1979, NATURE, V280, P514, DOI 10.1038/280514a0; BROWNLIE PD, 1994, PROTEIN SCI, V3, P1644, DOI 10.1002/pro.5560031004; CAVANAGH JB, 1965, J NEUROL NEUROSUR PS, V28, P320, DOI 10.1136/jnnp.28.4.320; CHEN CH, 1994, J CLIN INVEST, V94, P1927, DOI 10.1172/JCI117543; DEMEDINACELI L, 1982, EXP NEUROL, V77, P634, DOI 10.1016/0014-4886(82)90234-5; EALES L, 1971, South African Journal of Laboratory and Clinical Medicine, V17, P89; ELDER GH, 1993, J CLIN PATHOL, V46, P977, DOI 10.1136/jcp.46.11.977; GRANDCHAMP B, 1987, EUR J BIOCHEM, V162, P105, DOI 10.1111/j.1432-1033.1987.tb10548.x; HRUSKA RE, 1979, LIFE SCI, V25, P171, DOI 10.1016/0024-3205(79)90389-8; JOHNSON P, 1990, GENE, V88, P207, DOI 10.1016/0378-1119(90)90033-N; KAPPAS A, 1989, METABOLIC BASIS INHE, P1305; LEDERMANN B, 1991, EXP CELL RES, V197, P254, DOI 10.1016/0014-4827(91)90430-3; LITMAN DA, 1983, SCIENCE, V222, P1031, DOI 10.1126/science.6648517; LOUIE GV, 1992, NATURE, V359, P33, DOI 10.1038/359033a0; MEYER UA, 1972, NEW ENGL J MED, V286, P1277, DOI 10.1056/NEJM197206152862401; MULLER WE, 1977, ANN NEUROL, V2, P340, DOI 10.1002/ana.410020415; NORDMANN Y, 1990, ANN MED, V22, P387, DOI 10.3109/07853899009147275; POLAND A, 1973, SCIENCE, V179, P476, DOI 10.1126/science.179.4072.476; TISHLER PV, 1985, AM J PSYCHIAT, V142, P1430; TOMOKUNI K, 1987, CLIN CHEM, V33, P1665	26	127	131	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1996	12	2					195	199		10.1038/ng0296-195	http://dx.doi.org/10.1038/ng0296-195			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TU079	8563760				2022-12-25	WOS:A1996TU07900022
J	Monsein, LH				Monsein, LH			New detachable coils for treating cerebral aneurysms	NATURE MEDICINE			English	Editorial Material							ENDOVASCULAR APPROACH; SACCULAR ANEURYSMS; ELECTROTHROMBOSIS; MORTALITY				Monsein, LH (corresponding author), JOHNS HOPKINS UNIV HOSP,DEPT RADIOL,600 N WOLFE ST,B112C HOUCK,BALTIMORE,MD 21287, USA.							Dandy WE, 1938, ANN SURG, V107, P654, DOI 10.1097/00000658-193805000-00003; GUGLIELMI G, 1991, J NEUROSURG, V75, P1, DOI 10.3171/jns.1991.75.1.0001; GUGLIELMI G, 1991, J NEUROSURG, V75, P8, DOI 10.3171/jns.1991.75.1.0008; HILAL SK, 1988, AM J NEURORADIOL, V9, P1030; INGALL TJ, 1989, STROKE, V20, P718, DOI 10.1161/01.STR.20.6.718; KLEIN GE, 1995, RADIOLOGY, V197, P416; NICHOLS DA, 1995, RADIOLOGY, V197, P58; ROPPER AH, 1984, J NEUROSURG, V60, P909, DOI 10.3171/jns.1984.60.5.0909; SERBINENKO FA, 1974, J NEUROSURG, V41, P125, DOI 10.3171/jns.1974.41.2.0125; VUNUELA F, 1995, SYLLABUS 1995 COURSE, P5; WEIR B, 1987, ANEURYSMS AFFECTING, P23	11	3	3	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	FEB	1996	2	2					160	161		10.1038/nm0296-160	http://dx.doi.org/10.1038/nm0296-160			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TU060	8574956				2022-12-25	WOS:A1996TU06000031
J	Brown, DM; Provoost, AP; Daly, MJ; Lander, ES; Jacob, HJ				Brown, DM; Provoost, AP; Daly, MJ; Lander, ES; Jacob, HJ			Renal disease susceptibility and hypertension are under independent genetic control in the fawn-hooded rat	NATURE GENETICS			English	Article							WISTAR-KYOTO RATS; BLOOD-PRESSURE; GLOMERULAR SCLEROSIS; FAMILIAL RISK; LINKAGE; LOCI; COSEGREGATION; PATHOGENESIS; CHROMOSOME-1; ABLATION	Hypertension, diabetes and hyperlipidemia are risk factors for life-threatening complications such as end-stage renal disease, coronary artery disease and stroke. Why some patients develop complications is unclear, but only susceptibility genes may be involved. To test this notion, we studied crosses involving the fawn-hooded rat, an animal model of hypertension that develops chronic renal failure. Here, we report the localization of two genes, Rf-1 and Rf-2, responsible for about half of the genetic variation in key indices of renal impairment. In addition, we localize a gene, Bpfh-1, responsible for about 26% of the genetic variation in blood pressure. Rf-1 strongly affects the risk of renal impairment, but has no significant effect on blood pressure. Our results show that susceptibility to a complication of hypertension is under at feast partially independent genetic control from susceptibility to hypertension itself.	HARVARD UNIV, SCH MED, MASSACHUSETTS GEN HOSP, CARDIOVASC RES CTR, BOSTON, MA 02129 USA; ERASMUS UNIV ROTTERDAM, DEPT PEDIAT SURG, ROTTERDAM, NETHERLANDS; WHITEHEAD INST BIOMED RES, MIT, CTR GENOME RES, CAMBRIDGE, MA 02142 USA; MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Erasmus University Rotterdam; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)			Daly, Mark J/B-2453-2017	Daly, Mark J/0000-0002-0949-8752; Brown, Donna/0000-0002-8805-7225				BAKER HJ, 1979, LABORATORY RAT BIOL, V1, P88; BERTY RM, 1992, AM J KIDNEY DIS, V19, P326, DOI 10.1016/S0272-6386(12)80448-3; BRANCATI FL, 1993, AM J KIDNEY DIS, V21, P15, DOI 10.1016/S0272-6386(12)80857-2; BRANDIS A, 1986, LAB INVEST, V55, P234; BRAZY PC, 1989, KIDNEY INT, V35, P670, DOI 10.1038/ki.1989.37; BRENNER BM, 1982, NEW ENGL J MED, V307, P652, DOI 10.1056/NEJM198209093071104; CHUNG O, 1993, RAT MODELS CHRONIC R, P357; CICILA GT, 1993, NAT GENET, V3, P346, DOI 10.1038/ng0493-346; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; DUBAY C, 1993, NAT GENET, V3, P354, DOI 10.1038/ng0493-354; FABINY DL, 1971, CLIN CHEM, V17, P696; FERGUSON R, 1988, J CLIN EPIDEMIOL, V41, P1189, DOI 10.1016/0895-4356(88)90023-6; FREEDMAN BI, 1993, AM J KIDNEY DIS, V21, P387, DOI 10.1016/S0272-6386(12)80266-6; FREEDMAN BI, 1995, AM J KIDNEY DIS, V25, P207, DOI 10.1016/0272-6386(95)90001-2; GAWAZ MP, 1993, HAEMOSTASIS, V23, P284; GILBOA N, 1984, LAB INVEST, V50, P72; GORDGE MP, 1988, THROMB HAEMOSTASIS, V60, P83; HARRIS EL, 1993, AM J HYPERTENS, V6, P330, DOI 10.1093/ajh/6.4.330; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; HOSTETTER TH, 1981, AM J PHYSIOL, V241, pF85, DOI 10.1681/ASN.V1261315; IWAI N, 1991, HYPERTENSION, V17, P161, DOI 10.1161/01.HYP.17.2.161; IWAI N, 1994, HYPERTENSION, V23, P375, DOI 10.1161/01.HYP.23.3.375; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; JACOB HJ, 1995, NAT GENET, V9, P63, DOI 10.1038/ng0195-63; JONES CA, 1993, AM J KIDNEY DIS, V21, pS6; KREISBERG JI, 1978, AM J PATHOL, V92, P637; KUIJPERS MHM, 1984, BRIT J EXP PATHOL, V65, P181; KUIJPERS MHM, 1987, BRIT J EXP PATHOL, V68, P179; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1989, GENETICS, V121, P185; LINCOLN SE, 1992, GENOMICS, V14, P604, DOI 10.1016/S0888-7543(05)80158-2; LINDPAINTNER K, 1993, J HYPERTENS, V11, P19, DOI 10.1097/00004872-199301000-00004; MCCLELLAN W, 1993, AM J KIDNEY DIS, V21, P25, DOI 10.1016/0272-6386(93)70072-7; MICHALAK E, 1991, THROMB HAEMOSTASIS, V65, P11; MOREL L, 1994, IMMUNITY, V1, P219, DOI 10.1016/1074-7613(94)90100-7; NABIKA T, 1993, J HYPERTENS, V11, P13, DOI 10.1097/00004872-199301000-00003; NARA Y, 1993, BIOCHEM BIOPH RES CO, V194, P1344, DOI 10.1006/bbrc.1993.1972; PERNEGER TV, 1993, JAMA-J AM MED ASSOC, V269, P1272, DOI 10.1001/jama.269.10.1272; PRIEUR DJ, 1984, J HERED, V75, P349, DOI 10.1093/oxfordjournals.jhered.a109954; Provoost Abraham P., 1993, P100; PROVOOST AP, 1994, KIDNEY INT, V45, pS2; PROVOOST AP, 1994, KIDNEY INT, V46, P1464; RAYMOND SL, 1975, THROMB DIATH HAEMOST, V33, P361, DOI 10.1055/s-0038-1647888; ROCCELLA EJ, 1991, ARCH INTERN MED, V151, P1280; SAMANI NJ, 1993, J CLIN INVEST, V92, P1099, DOI 10.1172/JCI116616; SERIKAWA T, 1992, GENETICS, V131, P701; SHULMAN N B, 1989, Hypertension (Dallas), V13, pI80; SIMONS JL, 1994, KIDNEY INT, V46, P396, DOI 10.1038/ki.1994.287; SIMONS JL, 1993, J AM SOC NEPHROL, V3, P1775; SOSLAU G, 1991, J MED SC, V300, P372; SZPIRER J, 1984, CYTOGENET CELL GENET, V38, P142, DOI 10.1159/000132047; TALKE H, 1965, KLIN WOCHENSCHR, V43, P174, DOI 10.1007/BF01484513; TSCHOPP TB, 1972, BLOOD-J HEMATOL, V40, P217, DOI 10.1182/blood.V40.2.217.217; WESTENEND PJ, 1992, J HYPERTENS, V10, P417, DOI 10.1097/00004872-199205000-00003; 1994, AM J KIDNEY DIS   S2, V24, pS48	56	236	238	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	1996	12	1					44	51		10.1038/ng0196-44	http://dx.doi.org/10.1038/ng0196-44			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TM555	8528250	Green Published			2022-12-25	WOS:A1996TM55500013
J	MOCHIZUKI, T; LEMMINK, HH; MARIYAMA, M; ANTIGNAC, C; GUBLER, MC; PIRSON, Y; VERELLENDUMOULIN, C; CHAN, B; SCHRODER, CH; SMEETS, HJ; REEDERS, ST				MOCHIZUKI, T; LEMMINK, HH; MARIYAMA, M; ANTIGNAC, C; GUBLER, MC; PIRSON, Y; VERELLENDUMOULIN, C; CHAN, B; SCHRODER, CH; SMEETS, HJ; REEDERS, ST			IDENTIFICATION OF MUTATIONS IN THE ALPHA-3(IV) AND ALPHA-4(IV) COLLAGEN GENES IN AUTOSOMAL RECESSIVE ALPORT SYNDROME	NATURE GENETICS			English	Article							GLOMERULAR-BASEMENT-MEMBRANE; IV COLLAGEN; GOODPASTURE ANTIGEN; HEREDITARY NEPHRITIS; MOLECULAR-GENETICS; CHAIN; LOCALIZATION; HETEROGENEITY; ORGANIZATION; CHROMOSOME-2	Alport syndrome (AS) is an hereditary disease of basement membranes characterized by progressive renal failure and deafness. Changes in the glomerular basement membrane (GBM) in AS suggest that the type IV collagen matrix, the major structural component of GBM, is disrupted. We recently isolated the genes for two type IV collagens, alpha 3(IV) and alpha 4(IV), that are encoded head-to-head on human chromosome 2. These chains are abundant in normal GBM but are sometimes absent in AS. We screened for mutations in families in which consanguinity suggested autosomal recessive inheritance. Homozygous mutations were found in alpha 3(IV) in two families and in alpha 4(IV) in two others, demonstrating that these chains are important in the structural integrity of the GBM and that there is an autosomal form of AS in addition to the previously-defined X-linked form.	YALE UNIV,SCH MED,HOWARD HUGHES MED INST,NEW HAVEN,CT 06536; YALE UNIV,SCH MED,DEPT GENET,NEW HAVEN,CT 06536; UNIV NIJMEGEN HOSP,DEPT HUMAN GENET,6500 HB NIJMEGEN,NETHERLANDS; UNIV NIJMEGEN HOSP,DEPT PEDIAT,6500 HB NIJMEGEN,NETHERLANDS; HOP NECKER ENFANTS MALAD,INSERM,U192,F-75743 PARIS 15,FRANCE; UNIV CATHOLIQUE LOUVAIN,SCH MED,NEPHROL UNIT,B-1200 BRUSSELS,BELGIUM; UNIV CATHOLIQUE LOUVAIN,SCH MED,CTR HUMAN GENET,B-1200 BRUSSELS,BELGIUM	Howard Hughes Medical Institute; Yale University; Yale University; Radboud University Nijmegen; Radboud University Nijmegen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Catholique Louvain; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel			ANTIGNAC, Corinne/H-8945-2017	ANTIGNAC, Corinne/0000-0002-9934-4940; Gubler, Marie-Claire/0000-0002-3526-5661				ATKIN CL, 1988, DISEASES KIDNEY, V1, P617; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; BUTKOWSKI RJ, 1987, J BIOL CHEM, V262, P7874; BUTKOWSKI RJ, 1989, KIDNEY INT, V35, P1195, DOI 10.1038/ki.1989.110; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; FEINGOLD J, 1985, KIDNEY INT, V27, P672, DOI 10.1038/ki.1985.63; GUNWAR S, 1990, J BIOL CHEM, V265, P5466; Habib R, 1982, Kidney Int Suppl, V11, pS20; HOSTIKKA SL, 1988, J BIOL CHEM, V263, P19488; HOSTIKKA SL, 1990, P NATL ACAD SCI USA, V87, P1606, DOI 10.1073/pnas.87.4.1606; HUDSON BG, 1993, KIDNEY INT, V43, P135, DOI 10.1038/ki.1993.22; HUDSON BG, 1989, LAB INVEST, V61, P256; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; JOHANSSON C, 1992, J BIOL CHEM, V267, P24533; KAMAGATA Y, 1992, J BIOL CHEM, V267, P23753; KLEPPEL MM, 1989, AM J PATHOL, V134, P813; KLEPPEL MM, 1987, J CLIN INVEST, V80, P263, DOI 10.1172/JCI113057; KLEPPEL MM, 1992, KIDNEY INT, V41, P1629, DOI 10.1038/ki.1992.235; KUIVANIEMI H, 1991, FASEB J, V5, P2052, DOI 10.1096/fasebj.5.7.2010058; MARINI JC, 1993, J BIOL CHEM, V268, P2667; MARIYAMA M, 1992, GENOMICS, V13, P809, DOI 10.1016/0888-7543(92)90157-N; MARIYAMA M, 1992, J BIOL CHEM, V267, P1253; McKusick V.A., 1992, MENDELIAN INHERITANC; MORRISON KE, 1991, J BIOL CHEM, V266, P34; MORRISON KE, 1991, AM J HUM GENET, V49, P545; OLSON DL, 1980, J PEDIATR-US, V96, P697, DOI 10.1016/S0022-3476(80)80746-3; PASSWELL JH, 1981, J PEDIATR-US, V98, P85, DOI 10.1016/S0022-3476(81)80545-8; PIHLAJANIEMI T, 1990, J BIOL CHEM, V265, P13758; QUINONES S, 1992, J BIOL CHEM, V267, P19780; REEDERS ST, 1992, KIDNEY INT, V42, P783, DOI 10.1038/ki.1992.348; RENLERI A, 1993, AM J HUM GENET S, V53, pA1219; SANES JR, 1990, J CELL BIOL, V111, P1685, DOI 10.1083/jcb.111.4.1685; SAUS J, 1988, J BIOL CHEM, V263, P13374; SUGIMOTO M, 1993, FEBS LETT, V330, P122, DOI 10.1016/0014-5793(93)80256-T; TIMPL R, 1989, EUR J BIOCHEM, V180, P487, DOI 10.1111/j.1432-1033.1989.tb14673.x; TRYGGVASON K, 1993, KIDNEY INT, V43, P38, DOI 10.1038/ki.1993.8; TURNER N, 1992, J CLIN INVEST, V89, P592, DOI 10.1172/JCI115625; VANDERHEUVEL LPWJ, 1989, PEDIATR NEPHROL, V3, P406; ZHOU J, 1993, SCIENCE, V261, P1167, DOI 10.1126/science.8356449	39	394	410	0	15	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1994	8	1					77	82		10.1038/ng0994-77	http://dx.doi.org/10.1038/ng0994-77			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PE157	7987396				2022-12-25	WOS:A1994PE15700019
J	REARDON, W; WINTER, RM; RUTLAND, P; PULLEYN, LJ; JONES, BM; MALCOLM, S				REARDON, W; WINTER, RM; RUTLAND, P; PULLEYN, LJ; JONES, BM; MALCOLM, S			MUTATIONS IN THE FIBROBLAST GROWTH-FACTOR RECEPTOR-2 GENE CAUSE CROUZON-SYNDROME	NATURE GENETICS			English	Article							SAETHRE-CHOTZEN SYNDROME; CRANIOSYNOSTOSIS; FAMILY; FORMS; RNA; LINKAGE; CLONING; CELLS; MAPS; DNA	Crouzon syndrome is an autosomal dominant condition causing premature fusion of the cranial sutures (craniosynostosis) and maps to chromosome 10q25-q26. We now present evidence that mutations in the fibroblast growth factor receptor 2 gene (FGFR2) cause Crouzon syndrome. We found SSCP variations in the B exon of FGFR2 in nine unrelated affected individuals as well as complete cosegregation between SSCP variation and disease in three unrelated multigenerational families. In four sporadic cases, the normal parents did not have SSCP variation. Finally, direct sequencing has revealed specific mutations in the B exon in all nine sporadic and familial cases, including replacement of a cysteine in an immunoglobulin-like domain in five patients.	INST CHILD HLTH, MOLEC GENET UNIT, LONDON WC1N 1EH, ENGLAND; HOSP CHILDREN, DEPT PLAST & RECONSTRUCT SURG, LONDON WC1N 3JN, ENGLAND	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	REARDON, W (corresponding author), INST CHILD HLTH, MOTHERCARE UNIT CLIN GENET & FETAL MED, 30 GUILFORD ST, LONDON WC1N 1EH, ENGLAND.							BRUETON LA, 1992, J MED GENET, V29, P681, DOI 10.1136/jmg.29.10.681; COHEN MM, 1986, CRANIOSYNOSTOSISF DI; DIONNE CA, 1990, EMBO J, V9, P2685, DOI 10.1002/j.1460-2075.1990.tb07454.x; DIONNE CA, 1992, CYTOGENET CELL GENET, V60, P34, DOI 10.1159/000133290; GILBERT E, 1993, MOL CELL BIOL, V13, P5461, DOI 10.1128/MCB.13.9.5461; HOUSSAINT E, 1990, P NATL ACAD SCI USA, V87, P8180, DOI 10.1073/pnas.87.20.8180; JABS EW, 1993, CELL, V75, P443, DOI 10.1016/0092-8674(93)90379-5; JOHNSON DE, 1990, MOL CELL BIOL, V10, P4728, DOI 10.1128/MCB.10.9.4728; JOHNSON DE, 1991, MOL CELL BIOL, V11, P4627, DOI 10.1128/MCB.11.9.4627; KEEGAN K, 1991, P NATL ACAD SCI USA, V88, P1095, DOI 10.1073/pnas.88.4.1095; KORNBLUTH S, 1988, MOL CELL BIOL, V8, P5541, DOI 10.1128/MCB.8.12.5541; Langer L O Jr, 1987, Am J Med Genet Suppl, V3, P167; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEE PL, 1989, SCIENCE, V245, P57, DOI 10.1126/science.2544996; LEWANDA AF, 1994, GENOMICS, V19, P115, DOI 10.1006/geno.1994.1020; MANSUKHANI A, 1990, P NATL ACAD SCI USA, V87, P4378, DOI 10.1073/pnas.87.11.4378; MATTEI MG, 1991, HUM GENET, V87, P84, DOI 10.1007/BF01213098; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MULLER U, 1993, HUM MOL GENET, V2, P119, DOI 10.1093/hmg/2.2.119; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; ORRURTREGER A, 1993, DEV BIOL, V158, P475, DOI 10.1006/dbio.1993.1205; ORRURTREGER A, 1991, DEVELOPMENT, V113, P1419; PARTANEN J, 1991, EMBO J, V10, P1347, DOI 10.1002/j.1460-2075.1991.tb07654.x; PASQUALE EB, 1990, P NATL ACAD SCI USA, V87, P5812, DOI 10.1073/pnas.87.15.5812; PRESTON RA, 1994, NAT GENET, V7, P149, DOI 10.1038/ng0694-149; RAZ V, 1991, ONCOGENE, V6, P753; REARDON W, 1993, AM J MED GENET, V47, P633, DOI 10.1002/ajmg.1320470510; REARDON W, 1994, J MED GENET, V31, P219, DOI 10.1136/jmg.31.3.219; REID CS, 1993, AM J MED GENET, V47, P637, DOI 10.1002/ajmg.1320470511; REID HH, 1990, P NATL ACAD SCI USA, V87, P1596, DOI 10.1073/pnas.87.4.1596; RUTA M, 1989, P NATL ACAD SCI USA, V86, P8722, DOI 10.1073/pnas.86.22.8722; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; VANHERWERDEN L, 1994, AM J HUM GENET, V54, P669; WARMAN ML, 1993, AM J MED GENET, V46, P444, DOI 10.1002/ajmg.1320460420; WINTER RM, 1994, LONDON DYSMORPHOLOGY	37	596	619	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1994	8	1					98	103		10.1038/ng0994-98	http://dx.doi.org/10.1038/ng0994-98			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PE157	7987400				2022-12-25	WOS:A1994PE15700023
J	SUTCLIFFE, JS; NAKAO, M; CHRISTIAN, S; ORSTAVIK, KH; TOMMERUP, N; LEDBETTER, DH; BEAUDET, AL				SUTCLIFFE, JS; NAKAO, M; CHRISTIAN, S; ORSTAVIK, KH; TOMMERUP, N; LEDBETTER, DH; BEAUDET, AL			DELETIONS OF A DIFFERENTIALLY METHYLATED CPG ISLAND AT THE SNRPN GENE DEFINE A PUTATIVE IMPRINTING CONTROL REGION	NATURE GENETICS			English	Article							PRADER-WILLI SYNDROME; FAMILIAL ANGELMAN SYNDROME; NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE; DNA METHYLATION; MOLECULAR DIAGNOSIS; GEL-ELECTROPHORESIS; LINKAGE ANALYSIS; PARENTAL ORIGIN; EXPRESSION; CLONING	To determine the molecular basis of Prader-Willi syndrome (PWS) and Angelman syndrome (AS), we have isolated new transcripts from chromosome 15q11-q13. Two novel transcripts located within 300 kilobases telomeric to the small nuclear ribonucleoprotein-associated polypeptide N gene (SNRPN) were paternally expressed in cultured cells, along with SNRPN, defining a large imprinted transcriptional domain. In three PWS patients (two sibs), small deletions remove a differentially methylated CpG island containing a newly described 5' exon alpha of SNRPN, and cause loss of expression for the three imprinted transcripts and altered methylation over hundreds of kilobases. The smallest PWS deletion is familial and asymptomatic with maternal transmission. Our data imply the presence of a paternal imprinting control region near exon alpha.	BAYLOR COLL MED,HOWARD HUGHES MED INST,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT MOLEC & HUMAN GENET,HOUSTON,TX 77030; ULLEVAL UNIV HOSP,DEPT MED GENET,OSLO,NORWAY; JOHN F KENNEDY INST,DANISH CTR HUMAN GENOME RES,DK-2600 GLOSTRUP,DENMARK; NIH,NATL CTR HUMAN GENOME RES,BETHESDA,MD 20892	Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; University of Oslo; Aarhus University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)			Tommerup, Niels/T-8776-2017; Sutcliffe, James/C-1348-2012	Tommerup, Niels/0000-0003-2304-0112; Sutcliffe, James/0000-0001-5200-6007	NHGRI NIH HHS [HG00210] Funding Source: Medline; NICHD NIH HHS [HD20619] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020619] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; ANAND R, 1989, NUCLEIC ACIDS RES, V17, P3425, DOI 10.1093/nar/17.9.3425; Bartolomei M.S., 1992, SEMIN DEV BIOL, V3, P107; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; CATTANACH BM, 1992, NAT GENET, V2, P270, DOI 10.1038/ng1292-270; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLAYTONSMITH J, 1992, AM J MED GENET, V44, P256, DOI 10.1002/ajmg.1320440236; DITTRICH B, 1992, HUM GENET, V90, P313; DRISCOLL DJ, 1992, GENOMICS, V13, P917, DOI 10.1016/0888-7543(92)90001-9; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GLENN CC, 1993, HUM MOL GENET, V2, P2001, DOI 10.1093/hmg/2.12.2001; GLENN CC, 1993, HUM MOL GENET, V2, P1377, DOI 10.1093/hmg/2.9.1377; HAMABE J, 1991, AM J MED GENET, V41, P64, DOI 10.1002/ajmg.1320410117; HOLM VA, 1993, PEDIATRICS, V91, P398; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; KUWANO A, 1991, AM J HUM GENET, V49, P707; Kuwano Akira, 1992, Human Molecular Genetics, V1, P417, DOI 10.1093/hmg/1.6.417; LEDBETTER DH, 1981, NEW ENGL J MED, V304, P325, DOI 10.1056/NEJM198102053040604; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; MASCARI MJ, 1992, NEW ENGL J MED, V326, P1599, DOI 10.1056/NEJM199206113262404; MCALLISTER G, 1988, P NATL ACAD SCI USA, V85, P5296, DOI 10.1073/pnas.85.14.5296; MEIJERSHEIJBOER EJ, 1992, J MED GENET, V29, P853, DOI 10.1136/jmg.29.12.853; MUTIRANGURA A, 1993, GENOMICS, V18, P546, DOI 10.1016/S0888-7543(11)80011-X; NAKAO M, 1994, HUM MOL GENET, V3, P309, DOI 10.1093/hmg/3.2.309; NICHOLLS RD, 1994, AM J HUM GENET, V54, P733; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; ORSTAVIK KH, 1992, AM J MED GENET, V44, P534; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; PETTIGREW AL, 1987, AM J MED GENET, V28, P791, DOI 10.1002/ajmg.1320280403; REED ML, 1994, NAT GENET, V6, P163, DOI 10.1038/ng0294-163; REIS A, 1994, AM J HUM GENET, V54, P741; REIS A, 1993, LANCET, V341, P122, DOI 10.1016/0140-6736(93)92606-T; ROBINSON WP, 1991, AM J HUM GENET, V49, P1219; ROKEACH LA, 1989, J BIOL CHEM, V264, P5024; SAITOH S, 1992, LANCET, V339, P366, DOI 10.1016/0140-6736(92)91686-3; SCHMAUSS C, 1989, NUCLEIC ACIDS RES, V17, P1733, DOI 10.1093/nar/17.4.1733; SCHMAUSS C, 1992, J BIOL CHEM, V267, P8521; SEALEY PG, 1985, NUCLEIC ACIDS RES, V13, P1905, DOI 10.1093/nar/13.6.1905; Smith C.L., 1988, P41; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SUTCLIFFE JS, 1992, GENOMICS, V13, P1303, DOI 10.1016/0888-7543(92)90051-S; WAGSTAFF J, 1992, NAT GENET, V1, P291, DOI 10.1038/ng0792-291; ZEMEL S, 1992, NAT GENET, V2, P61, DOI 10.1038/ng0992-61; ZOGHBI HY, 1989, AM J HUM GENET, V44, P255	48	365	370	0	14	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1994	8	1					52	58		10.1038/ng0994-52	http://dx.doi.org/10.1038/ng0994-52			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PE157	7987392				2022-12-25	WOS:A1994PE15700015
J	WEBER, BHF; VOGT, G; WOLZ, W; IVES, EJ; EWING, CC				WEBER, BHF; VOGT, G; WOLZ, W; IVES, EJ; EWING, CC			SORSBYS FUNDUS DYSTROPHY IS GENETICALLY LINKED TO CHROMOSOME 22Q13-QTER	NATURE GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; MACULAR DYSTROPHY; RETINITIS-PIGMENTOSA; RETINAL DEGENERATION; BRUCHS MEMBRANE; RDS GENE; LINKAGE; AGE; LOCUS; DISEASE	Sorsby's fundus dystrophy (SFD) is an autosomal dominant macular degeneration developing in the third or fourth decade. Patients lose central vision from subretinal neovascularization and atrophy of the choriocapillaris, pigment epithelium and retina. SFD shares some striking clinical features with age-related macular degeneration (AMD), the most common cause of blindness in western countries thereby providing a valuable genetic model for AMD. To map the SFD locus, we performed linkage analysis in a single large SFD family. After exclusion of approximately 65% of the autosomal genome, we found significant linkage to several markers from chromosome 22. Recombinant chromosomes sublocalize the SFD gene to 22q13-qter between D22S275 and D22S274.	MEM UNIV NEWFOUNDLAND,DIV COMMUNITY MED,ST JOHNS A1B 3V6,NF,CANADA; UNIV SASKATCHEWAN,DEPT OPHTHALMOL,SASKATOON S7K 0M7,SK,CANADA	Memorial University Newfoundland; University of Saskatchewan	WEBER, BHF (corresponding author), BIOZENTRUM,INST HUMANGENET,D-97074 WURZBURG,GERMANY.			Weber, Bernhard H.F./0000-0002-8808-7723				BALYEAT RM, 1987, OPHTHALMOLOGY, V94, P1140; Best, 1905, Z AUGENHEILKD, V13, P199, DOI [10.1159/000290318, DOI 10.1159/000290318]; BIRD AC, 1992, BRIT J OPHTHALMOL, V76, P166, DOI 10.1136/bjo.76.3.166; BRESSLER NM, 1988, SURV OPHTHALMOL, V32, P375, DOI 10.1016/0039-6257(88)90052-5; BREWSTER ES, 1991, NUCLEIC ACIDS RES, V19, P4022, DOI 10.1093/nar/19.14.4022; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; BURN RA, 1950, BRIT J OPHTHALMOL, V34, P393, DOI 10.1136/bjo.34.7.393; CAPON MRC, 1989, OPHTHALMOLOGY, V96, P1769; CARR RE, 1978, AM J OPHTHALMOL, V85, P318, DOI 10.1016/S0002-9394(14)77722-0; Cremers Frans P. M., 1992, Human Molecular Genetics, V1, P71, DOI 10.1093/hmg/1.2.71; DREYER RF, 1988, AM J OPHTHALMOL, V106, P154, DOI 10.1016/0002-9394(88)90827-6; EDWARDS JH, 1987, J MED GENET, V24, P539, DOI 10.1136/jmg.24.9.539; FERRELL RE, 1983, AM J HUM GENET, V35, P78; HAMILTON WK, 1989, OPHTHALMOLOGY, V96, P1755; KAPLAN J, 1993, NAT GENET, V5, P308, DOI 10.1038/ng1193-308; KAPLAN JC, 1987, J MED GENET, V24, P65, DOI 10.1136/jmg.24.2.65; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Leibowitz H M, 1980, Surv Ophthalmol, V24, P335; MARINEAU C, 1992, NUCLEIC ACIDS RES, V20, P1430, DOI 10.1093/nar/20.6.1430; NICHOLS BE, 1993, NAT GENET, V3, P202, DOI 10.1038/ng0393-202; Pagenstecher H, 1913, GRAEFES ARCH OPHTHAL, V86, P457; PAULEIKHOFF D, 1992, OPHTHALMOLOGY, V99, P1548; PAULEIKHOFF D, 1990, AM J OPHTHALMOL, V109, P211, DOI 10.1016/S0002-9394(14)75989-6; POLKINGHORNE PJ, 1989, OPHTHALMOLOGY, V96, P1763; PORTER JC, 1993, GENOMICS, V15, P57, DOI 10.1006/geno.1993.1009; RIVAS F, 1986, ANN GENET-PARIS, V29, P42; ROSEN ES, 1968, BRIT J OPHTHALMOL, V52, P828, DOI 10.1136/bjo.52.11.828; SARKS SH, 1980, AUST J OPHTHALMOL, V8, P117, DOI 10.1111/j.1442-9071.1980.tb01670.x; SHIBUYA H, 1990, NUCLEIC ACIDS RES, V18, P3697, DOI 10.1093/nar/18.13.3697; SORSBY A, 1949, BRIT J OPHTHALMOL, V33, P67, DOI 10.1136/bjo.33.2.67; STONE EM, 1992, NAT GENET, V1, P246, DOI 10.1038/ng0792-246; Trofatter J. A., 1992, Human Molecular Genetics, V1, P455, DOI 10.1093/hmg/1.6.455-a; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WELEBER RG, 1989, ARCH OPHTHALMOL-CHIC, V107, P530, DOI 10.1001/archopht.1989.01070010544028; WELLS J, 1993, NAT GENET, V3, P213, DOI 10.1038/ng0393-213; WU G, 1991, AM J OPHTHALMOL, V111, P294, DOI 10.1016/S0002-9394(14)72312-8; 1986, ARCH OPHTHALMOL-CHIC, V104, P503	38	57	61	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1994	7	2					158	161		10.1038/ng0694-158	http://dx.doi.org/10.1038/ng0694-158			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NQ037	7920634				2022-12-25	WOS:A1994NQ03700015
J	PULKKINEN, L; CHRISTIANO, AM; AIRENNE, T; HAAKANA, H; TRYGGVASON, K; UITTO, J				PULKKINEN, L; CHRISTIANO, AM; AIRENNE, T; HAAKANA, H; TRYGGVASON, K; UITTO, J			MUTATIONS IN THE GAMMA-2 CHAIN GENE (LAMC2) OF KALININ/LAMININ-5 IN THE JUNCTIONAL FORMS OF EPIDERMOLYSIS-BULLOSA	NATURE GENETICS			English	Article							BASEMENT-MEMBRANES; MOLECULAR-GENETICS; SKIN DISEASES; VII COLLAGEN; EXPRESSION; LAMININ; LINKAGE; COL7A1; FAMILIES; NIDOGEN	Junctional epidermolysis bullosa (JEB) is an autosomal recessive disorder characterized by blister formation within the dermal-epidermal basement membrane. Genes for the lamina lucida protein, kalinin/laminin 5, have been proposed as candidates for some forms of JEB, based on immunofluorescence analysis recognizing kalinin epitopes. We studied the cDNA of laminin gamma 2 chain for mutations in JEB using heteroduplex analysis. One patient showed a homozygous splice site mutation while another was heterozygous for a deletion-insertion, resulting in a premature termination codon in one allele. Our data implicate mutations in the laminin gamma 2 chain gene (LAMC2) in some forms of JEB.	THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,JEFFERSON INST MOLEC MED,DEPT DERMATOL,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,JEFFERSON INST MOLEC MED,DEPT BIOCHEM,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,JEFFERSON INST MOLEC MED,DEPT MOLEC BIOL,PHILADELPHIA,PA 19107; UNIV OULU,BIOCTR,SF-90570 OULU,FINLAND; UNIV OULU,DEPT BIOCHEM,SF-90570 OULU,FINLAND	Jefferson University; Jefferson University; Jefferson University; University of Oulu; Finland National Institute for Health & Welfare; University of Oulu								AESCHLIMANN D, 1992, J BIOL CHEM, V267, P11316; ALIMARA L, 1992, J MED GENET, V29, P381, DOI 10.1136/jmg.29.6.381; BONIFAS JM, 1991, SCIENCE, V254, P1201; BURGESON RE, IN PRESS MATRIX BIOL; CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; CHEN YQ, 1994, J INVEST DERMATOL, V102, P205, DOI 10.1111/1523-1747.ep12371763; CHRISTIANO AM, 1993, NAT GENET, V4, P62, DOI 10.1038/ng0593-62; CHRISTIANO AM, 1993, ARCH DERMATOL, V129, P1455, DOI 10.1001/archderm.129.11.1455; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; DONG W, 1993, HUM MUTAT, V2, P94, DOI 10.1002/humu.1380020206; EPSTEIN EH, 1992, SCIENCE, V256, P799, DOI 10.1126/science.1375393; FINE JD, 1991, J AM ACAD DERMATOL, V24, P119, DOI 10.1016/0190-9622(91)70021-S; FUCHS E, 1992, CELL, V69, P899, DOI 10.1016/0092-8674(92)90607-E; GREEN MR, 1991, ANNU REV CELL BIOL, V7, P559, DOI 10.1146/annurev.cellbio.7.1.559; GRUIS NA, 1992, J INVEST DERMATOL, V99, P528, DOI 10.1111/1523-1747.ep12658066; HOVNANIAN A, 1993, NAT GENET, V3, P327, DOI 10.1038/ng0493-327; HUMPHRIES MM, 1993, HUM MUTAT, V2, P37, DOI 10.1002/humu.1380020107; KALLUNKI P, 1992, J CELL BIOL, V119, P679, DOI 10.1083/jcb.119.3.679; LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0; Lin AN, 1992, EPIDERMOLYSIS BULLOS; MARINKOVICH MP, 1993, LAB INVEST, V69, P295; MARINKOVICH MP, 1992, J CELL BIOL, V119, P695, DOI 10.1083/jcb.119.3.695; MARINKOVICH MP, 1993, ARCH DERMATOL, V129, P1557, DOI 10.1001/archderm.129.12.1557; MARLNKOVICH MP, 1992, J BIOL CHEM, V267, P17900; MAYER LI, 1993, EMBO J, V12, P1879; MCINTOSH I, 1993, NAT GENET, V4, P219, DOI 10.1038/ng0793-219; Meneguzzi G, 1992, Exp Dermatol, V1, P221, DOI 10.1111/j.1600-0625.1992.tb00080.x; OLSEN D, 1989, LAB INVEST, V60, P772; OLSEN DR, 1989, J INVEST DERMATOL, V93, P127, DOI 10.1111/1523-1747.ep12277381; OLSEN DR, 1989, AM J HUM GENET, V44, P876; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; RYYNANEN M, 1991, AM J HUM GENET, V49, P797; RYYNANEN M, 1992, J CLIN INVEST, V89, P974, DOI 10.1172/JCI115680; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TIMPL R, 1986, INT REV EXP PATHOL, V29, P1; UITTO J, 1992, J CLIN INVEST, V90, P687, DOI 10.1172/JCI115938; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868; VERLINSKY Y, 1993, PREIMPLANTATION DIAG; VERRANDO P, 1988, BIOCHIM BIOPHYS ACTA, V942, P45, DOI 10.1016/0005-2736(88)90273-8; VERRANDO P, 1991, LAB INVEST, V64, P85; VERRANDO P, IN PRESS EUR J BIOCH	43	251	259	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1994	6	3					293	298		10.1038/ng0394-293	http://dx.doi.org/10.1038/ng0394-293			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ562	8012393				2022-12-25	WOS:A1994MZ56200018
J	GREEN, AJ; SMITH, M; YATES, JRW				GREEN, AJ; SMITH, M; YATES, JRW			LOSS OF HETEROZYGOSITY ON CHROMOSOME 16P13.3 IN HAMARTOMAS FROM TUBEROUS SCLEROSIS PATIENTS	NATURE GENETICS			English	Article							GENE LOCUS	Tuberous sclerosis (TSC) is an autosomal dominant condition with characteristic skin lesions, mental handicap, seizures and the development of hamartomas in the brain, heart, kidneys and other organs. Linkage studies have shown locus heterogeneity with a TSC gene mapped to chromosome 9q34 and a second, recently identified on 16p13.3. We have analysed DNA markers in eight hamartomas and one tumour from TSC patients and found allele loss on 16p13.3 in three angiomyolipomas, one cardiac rhabdomyoma, one cortical tuber and one giant cell astrocytoma. We suggest that the RSC gene on 16p13.3 functions like a tumour suppressor gene, in accordance with Knudsen's hypothesis.	ADDENBROOKES HOSP,DEPT CLIN GENET,CAMBRIDGE CB2 2QQ,CAMBS,ENGLAND; UNIV CAMBRIDGE,DEPT PATHOL,CAMBRIDGE CB2 1QP,CAMBS,ENGLAND; UNIV CALIF IRVINE,IRVINE,CA 92717	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of California System; University of California Irvine			Green, Andrew/AAJ-7592-2020	Green, Andrew/0000-0002-1077-7417				ALPER JC, 1983, PAEDIAT DERMATOLOGY, V1, P56; BURLEY MW, 1993, IN PRESS CYTOGENET C; COMINGS DE, 1980, AM J HUM GENET, V32, P285; FAHSOLD R, 1991, HUM GENET, V88, P85, DOI 10.1007/BF00204934; FRYER AE, 1987, LANCET, V1, P659; GOMEZ MR, 1991, ANN NY ACAD SCI, V615, P1; HARDING CO, 1990, AM J MED GENET, V37, P443, DOI 10.1002/ajmg.1320370402; KANDT RS, 1992, NAT GENET, V2, P37, DOI 10.1038/ng0992-37; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LEGIUS E, 1993, NAT GENET, V3, P122, DOI 10.1038/ng0293-122; Maniatis T., 1982, MOL CLONING; Neumann H. P. H., 1992, American Journal of Human Genetics, V51, pA104; ROCHA G, 1962, ARCH DERMATOL, V85, P722, DOI 10.1001/archderm.1962.01590060032006; SEIZINGER BR, 1993, NAT GENET, V3, P97, DOI 10.1038/ng0293-97; SMITH M, 1990, GENOMICS, V6, P105, DOI 10.1016/0888-7543(90)90454-3; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; WEBB DW, 1993, ARCH DIS CHILD, V68, P367, DOI 10.1136/adc.68.3.367; 1993, CELL, V75, P1	18	311	318	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1994	6	2					193	196		10.1038/ng0294-193	http://dx.doi.org/10.1038/ng0294-193			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU763	8162074	Green Published			2022-12-25	WOS:A1994MU76300016
J	SHOVLIN, CL; HUGHES, JMB; TUDDENHAM, EGD; TEMPERLEY, I; PEREMBELON, YFN; SCOTT, J; SEIDMAN, CE; SEIDMAN, JG				SHOVLIN, CL; HUGHES, JMB; TUDDENHAM, EGD; TEMPERLEY, I; PEREMBELON, YFN; SCOTT, J; SEIDMAN, CE; SEIDMAN, JG			A GENE FOR HEREDITARY HEMORRHAGIC TELANGIECTASIA MAPS TO CHROMOSOME 9Q3	NATURE GENETICS			English	Article							HEMORRHAGIC TELANGIECTASIA; ARTERIOVENOUS-MALFORMATIONS; REPEAT POLYMORPHISM; LOCUS; ULTRASTRUCTURE; ASS	Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant vascular disorder that is characterized by frequent nosebleeds, mucocutaneous telangiectases and vascular malformations that cause recurrent haemorrhage and arteriovenous shunting. Linkage analyses in one kindred identified an HHT locus on the long arm of chromosome 9 (maximum multipoint lod score = 6.20 between D9S60 and D9S61). Analyses in two other unrelated HHT families demonstrated that the disease in one was not linked to the locus on chromosome 9q3. We conclude that HHT is a genetically heterogeneous disorder. Based on its map location (9q3) and expression in vascular tissues, type V collagen is a possible candidate gene for HHT.	ROYAL POSTGRAD MED SCH,DEPT MED,LONDON W12 0HS,ENGLAND; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; HARVARD UNIV,SCH MED,HOWARD HUGHES MED INST,BOSTON,MA 02115; MRC,CLIN RES CTR,HAEMOSTASIS RES GRP,HARROW HA1 3UJ,MIDDX,ENGLAND; ST JAMES HOSP,TRINITY COLL,SCH MED,DEPT HAEMATOL,DUBLIN 8,IRELAND; HAMMERSMITH HOSP,MRC,LIPOPROT TEAM,LONDON W12 0HS,ENGLAND; HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115	Imperial College London; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Medical Research Council Clinical Trials Unit; Trinity College Dublin; Imperial College London; Harvard University; Harvard Medical School	SHOVLIN, CL (corresponding author), HAMMERSMITH HOSP,MRC,MOLEC MED GRP,LONDON W12 0HS,ENGLAND.		Tuddenham, Edward/AAS-6196-2020	Tuddenham, Edward/0000-0001-8955-2909; Shovlin, Claire/0000-0001-9007-5775	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BEIGHTON P, 1993, HERITABLE DISORDERS, P189; BRAVERMAN IM, 1990, J INVEST DERMATOL, V95, P422, DOI 10.1111/1523-1747.ep12555569; CARRITT B, 1979, CYTOGENET CELL GENET, V23, P171, DOI 10.1159/000131323; CHOU YHW, 1992, NAT GENET, V1, P295, DOI 10.1038/ng0792-295; FESSLER JH, 1987, STRUCTURE FUNCTION C, P81; GREENSPAN DS, 1992, GENOMICS, V12, P836, DOI 10.1016/0888-7543(92)90320-R; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HASHIMOTO K, 1972, ORAL SURG ORAL MED O, V34, P751, DOI 10.1016/0030-4220(72)90293-9; HUGHES JMB, 1990, CLIN RADIOL, V41, P297, DOI 10.1016/S0009-9260(05)81687-3; JAHNKE V, 1970, ARCHIV OTOLARYNGOL, V91, P262; KING CR, 1977, CLIN GENET, V12, P372; KWIATKOWSKI DJ, 1991, NUCLEIC ACIDS RES, V19, P967, DOI 10.1093/nar/19.4.967; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; KWIATKOWSKI DJ, 1993, CYTOGENET CELL GENET, V64, P94; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; McKusick V.A., 1992, MENDELIAN INHERITANC; MENEFEE MG, 1975, ARCH OTOLARYNGOL, V101, P246; Osler W, 1901, B JOHNS HOPKINS HOSP, V12, P333; OTT J, 1992, ANAL HUMAN LINKAGE; PLAUCHU H, 1989, AM J MED GENET, V32, P291, DOI 10.1002/ajmg.1320320302; RENDU H, 1896, GAZ HOP PARIS, V135, P132; TANAKA K, 1990, NATURE, V348, P73, DOI 10.1038/348073a0; WATKINS H, 1993, NAT GENET, V3, P333, DOI 10.1038/ng0493-333; WEHER FP, 1907, LANCET, V2, P160; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; YUILLE MAR, 1990, NUCLEIC ACIDS RES, V18, P7472, DOI 10.1093/nar/18.24.7472	26	155	161	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1994	6	2					205	209		10.1038/ng0294-205	http://dx.doi.org/10.1038/ng0294-205			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU763	8162076				2022-12-25	WOS:A1994MU76300018
J	WOOSTER, R; CLETONJANSEN, AM; COLLINS, N; MANGION, J; CORNELIS, RS; COOPER, CS; GUSTERSON, BA; PONDER, BAJ; VONDEIMLING, A; WIESTLER, OD; CORNELISSE, CJ; DEVILEE, P; STRATTON, MR				WOOSTER, R; CLETONJANSEN, AM; COLLINS, N; MANGION, J; CORNELIS, RS; COOPER, CS; GUSTERSON, BA; PONDER, BAJ; VONDEIMLING, A; WIESTLER, OD; CORNELISSE, CJ; DEVILEE, P; STRATTON, MR			INSTABILITY OF SHORT TANDEM REPEATS (MICROSATELLITES) IN HUMAN CANCERS	NATURE GENETICS			English	Article							MYOTONIC-DYSTROPHY; HUMAN-DISEASE; VWF GENE; POLYMORPHISM; MUTATIONS; REGION	The allele sizes of polymorphic microsatellite repeats in DNA from human cancers were compared to normal DNA from the same patients. In 16 out of 196 paired samples (8%), we found evidence of an extra allele of a different size in the tumour which was not present in the normal DNA. Sequence analysis confirmed that the extra allele originates from the appropriate locus and that the size change is attributable to alteration in the number of repeat units. This form of instability was more common in tri- and tetranucleotide repeats than in dinucleotide repeats. In any single tumour sample only one repeat in the set examined was abnormal, the remainder showing identical patterns in normal and tumour DNA or evidence of allele loss. The pattern of instability in diverse types of cancer differs from that reported in colorectal neoplasms.	INST CANC RES,HADDOW LABS,MOLEC CARCINOGENESIS SECT,SUTTON SM2 5NG,SURREY,ENGLAND; INST CANC RES,HADDOW LABS,CELL BIOL & EXPTL PATHOL SECT,SUTTON SM2 5NG,SURREY,ENGLAND; LEIDEN UNIV,DEPT HUMAN GENET,2333 AL LEIDEN,NETHERLANDS; LEIDEN UNIV,DEPT PATHOL,2333 AL LEIDEN,NETHERLANDS; UNIV CAMBRIDGE,DEPT PATHOL,CRC,HUMAN CANC GENET RES GRP,CAMBRIDGE CB2 1QP,CAMBS,ENGLAND; UNIV KINIKEN BONN,INST NEUROPATHOL,D-53105 BONN,GERMANY	University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; University of Cambridge; University of Bonn			von Deimling, Andreas/F-7774-2013; gusterson, barry a/D-3752-2009; DEVILEE, PETER/ABR-2140-2022	von Deimling, Andreas/0000-0002-5863-540X; 				AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; CASKEY CT, 1992, SCIENCE, V256, P784, DOI 10.1126/science.1589758; DEVILEE P, 1991, CANCER RES, V51, P1020; GENDLER SJ, 1990, INT J CANCER, V45, P431, DOI 10.1002/ijc.2910450309; GRODEN J, 1993, AM J HUM GENET, V52, P263; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; IMBERT G, 1993, NAT GENET, V4, P72, DOI 10.1038/ng0593-72; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; JEGO N, 1993, ONCOGENE, V8, P209; Kimpton C., 1992, Human Molecular Genetics, V1, P287, DOI 10.1093/hmg/1.4.287; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MAHTANI MM, 1993, HUM MOL GENET, V2, P431, DOI 10.1093/hmg/2.4.431; MIWA S, 1994, NAT GENET, V6, P3, DOI 10.1038/ng0194-3; OUDET C, 1993, AM J HUM GENET, V52, P297; PELTOMAKI P, 1993, SCIENCE, V260, P810, DOI 10.1126/science.8484120; RICHARDS RI, 1992, CELL, V70, P709, DOI 10.1016/0092-8674(92)90302-S; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; THOMPSON AD, 1992, GENOMICS, V13, P402, DOI 10.1016/0888-7543(92)90260-Y; VANAMSTEL HKP, 1990, NUCLEIC ACIDS RES, V18, P4957, DOI 10.1093/nar/18.16.4957-a; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WOOSTER R, 1992, NAT GENET, V2, P132; 1993, CELL, V72, P971	23	428	437	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1994	6	2					152	156		10.1038/ng0294-152	http://dx.doi.org/10.1038/ng0294-152			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU763	8162069				2022-12-25	WOS:A1994MU76300009
J	GUILFORD, P; BENARAB, S; BLANCHARD, S; LEVILLIERS, J; WEISSENBACH, J; BELKAHIA, A; PETIT, C				GUILFORD, P; BENARAB, S; BLANCHARD, S; LEVILLIERS, J; WEISSENBACH, J; BELKAHIA, A; PETIT, C			A NON-SYNDROMIC FORM OF NEUROSENSORY, RECESSIVE DEAFNESS MAPS TO THE PERICENTROMERIC REGION OF CHROMOSOME-13Q	NATURE GENETICS			English	Article							MUSCULAR-DYSTROPHY; WAARDENBURG SYNDROME; LINKAGE ANALYSIS; X-CHROMOSOME; GENE; ASSIGNMENT; MUTATIONS; DOMAIN	Non-syndromic, recessively inherited deafness is the most predominant form of severe inherited childhood deafness. Until now, no gene responsible for this type of deafness has been localized, due to extreme genetic heterogeneity and limited clinical differentiation. Linkage analyses using highly polymorphic microsatellite markers were performed on two consanguineous families from Tunisia affected by this form of deafness. The deafness was profound, fully penetrant and prelingual. A maximum two-point lod score of 9.88 (theta = 0.001) was found with a marker detecting a 13q locus (D13S175). Linkage was also observed to the pericentromeric 13q12 loci D13S115 and D13S143. These data map this neurosensory deafness gene to the same region of chromosome 13q as the gene for severe, childhood autosomal recessive muscular dystrophy.	INST PASTEUR,CNRS,URA 1445,UNITE GENET MOLEC HUMAINE,25 RUE DR ROUX,F-75724 PARIS 15,FRANCE; FAC MED TUNIS,TUNIS,TUNISIA; GENETHON,F-91002 EVRY,FRANCE; HOP RABTA,SERV OTORHINOLARYNGOL & CHIRURG MAXILLOFACIALE,TUNIS,TUNISIA	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT); Universite de Tunis-El-Manar; Hopital La Rabta				Guilford, Parry/0000-0002-7256-9576; Petit, Christine/0000-0002-9069-002X				AHN AH, 1993, NAT GENET, V3, P283, DOI 10.1038/ng0493-283; AZIBI K, 1993, HUM MOL GENET, V2, P1423; BACH I, 1992, AM J HUM GENET, V50, P38; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BENARAB S, 1990, J MED GENET, V27, P29, DOI 10.1136/jmg.27.1.29; BENOTHMANE K, 1992, NAT GENET, V2, P315, DOI 10.1038/ng1292-315; Bergstrom L, 1971, Otolaryngol Clin North Am, V4, P369; BYERS TJ, 1993, NAT GENET, V4, P77, DOI 10.1038/ng0593-77; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; DUYK G, 1992, NAT GENET, V2, P5, DOI 10.1038/ng0992-5; Fraser G. R, 1976, BIG 4 CAUSES POVERTY; HAZAN J, 1993, NAT GENET, V5, P163, DOI 10.1038/ng1093-163; HOSTIKKA SL, 1990, P NATL ACAD SCI USA, V87, P1606, DOI 10.1073/pnas.87.4.1606; HU DN, 1991, J MED GENET, V28, P79, DOI 10.1136/jmg.28.2.79; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEGOUIS R, 1993, P NATL ACAD SCI USA, V90, P2461, DOI 10.1073/pnas.90.6.2461; LEON PE, 1992, P NATL ACAD SCI USA, V89, P5181, DOI 10.1073/pnas.89.11.5181; Lyon M., 1989, GENETIC VARIANTS STR; MATSUMURA K, 1992, NATURE, V359, P320, DOI 10.1038/359320a0; McKusick V.A., 1992, MENDELIAN INHERITANC; MEINDL A, 1992, NAT GENET, V2, P139, DOI 10.1038/ng1092-139; PAPARELLA MM, 1980, OTOLARYNGOLOGY, V2; PETRUKHIN KE, 1993, GENOMICS, V15, P76, DOI 10.1006/geno.1993.1012; PILLERS DAM, 1993, NAT GENET, V4, P82, DOI 10.1038/ng0593-82; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; REARDON W, 1992, J MED GENET, V29, P521, DOI 10.1136/jmg.29.8.521; ROBINSON D, 1992, HUM GENET, V90, P316; Rose SP, 1977, CHILDHOOD DEAFNESS, P19; SPEER MC, 1992, AM J HUM GENET, V50, P1211; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	32	217	230	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1994	6	1					24	28		10.1038/ng0194-24	http://dx.doi.org/10.1038/ng0194-24			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ177	8136828				2022-12-25	WOS:A1994MQ17700009
J	HAYASHIZAKI, Y; SHIBATA, H; HIROTSUNE, S; SUGINO, H; OKAZAKI, Y; SASAKI, N; HIROSE, K; IMOTO, H; OKUIZUMI, H; MURAMATSU, M; KOMATSUBARA, H; SHIROISHI, T; MORIWAKI, K; KATSUKI, M; HATANO, N; SASAKI, H; UEDA, T; MISE, N; TAKAGI, N; PLASS, C; CHAPMAN, VM				HAYASHIZAKI, Y; SHIBATA, H; HIROTSUNE, S; SUGINO, H; OKAZAKI, Y; SASAKI, N; HIROSE, K; IMOTO, H; OKUIZUMI, H; MURAMATSU, M; KOMATSUBARA, H; SHIROISHI, T; MORIWAKI, K; KATSUKI, M; HATANO, N; SASAKI, H; UEDA, T; MISE, N; TAKAGI, N; PLASS, C; CHAPMAN, VM			IDENTIFICATION OF AN IMPRINTED U2AF BINDING-PROTEIN RELATED SEQUENCE ON MOUSE CHROMOSOME-11 USING THE RLGS METHOD	NATURE GENETICS			English	Article							PRADER-WILLI SYNDROME; GENE; DNA; REGION; SNRPN; AMPLIFICATION; METHYLATION; EXPRESSION; SHOWS; MICE	A new imprinted gene has been discovered in mice using the technique of restriction landmark genomic scanning (RGLS) with methylation sensitive enzymes. Eight out of 3,100 strain-specific NotI and BssHII spots were identified as imprinted in reciprocal F1 hybrids. Subsequently, we isolated a genomic clone for one locus on proximal chromosome 11 near the GIns locus, an imprinted region in uniparental disomic mice, and its corresponding cDNA clone. Expression of this transcript from the paternal allele was established using RT-PCR of reciprocal F1-hybrid mice. The amino-acid sequence deduced from the cDNA showed significant homology to the U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit.	NATL CARDIOVASC CTR,RES INST,DEPT BIOSCI,SUITA,OSAKA 565,JAPAN; NATL INST GENET,DEPT CELL GENET,MISHIMA,SHIZUOKA 411,JAPAN; KYUSHU UNIV,MED INST BIOREGULAT,HIGASHI KU,FUKUOKA 812,JAPAN; KYUSHU UNIV,INST GENET INFORMAT,FUKUOKA 812,JAPAN; NIIGATA UNIV,MOLEC GENET RES INST,NIIGATA 951,JAPAN; HOKKAIDO UNIV,SCH ENVIRONM EARTH SCI,DIV BIOL SCI,KITA KU,SAPPORO,HOKKAIDO 060,JAPAN; ROSWELL PK CANC INST,DEPT MOLEC & CELLULAR BIOL,BUFFALO,NY 14263	National Cerebral & Cardiovascular Center - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Kyushu University; Kyushu University; Niigata University; Hokkaido University; Roswell Park Cancer Institute	HAYASHIZAKI, Y (corresponding author), RIKEN,TSUKUBA LIFE SCI CTR,GENE BANK,3-1-1 KOYADAI,TSUKUBA,IBARAKI 305,JAPAN.		Hatano, Naoya/F-6147-2011; 名丹, 三瀬/AAD-1036-2021; Hayashizaki, Yoshihide/N-6590-2015; Sasaki, Nobuya/F-6579-2012; Plass, Christoph/H-7192-2014		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033160] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00170] Funding Source: Medline; NIGMS NIH HHS [GM33160] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BIRD A, 1985, CELL, V40, P91, DOI 10.1016/0092-8674(85)90312-5; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; BRADBURY MW, 1990, P NATL ACAD SCI USA, V87, P4053, DOI 10.1073/pnas.87.11.4053; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; CATTANACH BM, 1992, NAT GENET, V2, P270, DOI 10.1038/ng1292-270; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; HATADA I, 1991, P NATL ACAD SCI USA, V88, P9523, DOI 10.1073/pnas.88.21.9523; HAYASHIZAKI Y, 1993, ELECTROPHORESIS, V14, P251, DOI 10.1002/elps.1150140145; HAYASHIZAKI Y, 1992, GENOMICS, V14, P733, DOI 10.1016/S0888-7543(05)80176-4; HIROTSUNE S, 1992, CANCER RES, V52, P3642; HIROTSUNE S, 1993, BIOCHEM BIOPH RES CO, V194, P1406, DOI 10.1006/bbrc.1993.1981; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; LINDSAY S, 1987, NATURE, V327, P336, DOI 10.1038/327336a0; MANLY KF, 1991, MAMM GENOME, V1, P123, DOI 10.1007/BF02443789; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; REIK W, 1987, NATURE, V328, P248, DOI 10.1038/328248a0; SASAKI H, 1991, DEVELOPMENT, V111, P573; SOLTER D, 1988, ANNU REV GENET, V22, P127; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; SWAIN JL, 1987, CELL, V50, P719, DOI 10.1016/0092-8674(87)90330-8; VANYUSHIN BF, 1970, NATURE, V225, P948, DOI 10.1038/225948a0; ZHANG M, 1992, P NATL ACAD SCI USA, V89, P8769, DOI 10.1073/pnas.89.18.8769	25	205	210	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1994	6	1					33	40		10.1038/ng0194-33	http://dx.doi.org/10.1038/ng0194-33			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ177	8136831				2022-12-25	WOS:A1994MQ17700011
J	STONE, EM; MATHERS, WD; ROSENWASSER, GOD; HOLLAND, EJ; FOLBERG, R; KRACHMER, JH; NICHOLS, BE; GOREVIC, PD; TAYLOR, CM; STREB, LM; FISHBAUGH, JA; DALEY, TE; SUCHESKI, BM; SHEFFIELD, VC				STONE, EM; MATHERS, WD; ROSENWASSER, GOD; HOLLAND, EJ; FOLBERG, R; KRACHMER, JH; NICHOLS, BE; GOREVIC, PD; TAYLOR, CM; STREB, LM; FISHBAUGH, JA; DALEY, TE; SUCHESKI, BM; SHEFFIELD, VC			3 AUTOSOMAL-DOMINANT CORNEAL DYSTROPHIES MAP TO CHROMOSOME-5Q	NATURE GENETICS			English	Article							AMYLOID PRECURSOR PROTEIN; PRION PROTEIN; MUTATION; DISEASE; GENE; DNA; DEPOSITS; FIBRILS	The two most common autosomal dominant dystrophies of the corneal stroma are lattice corneal dystrophy type I and granular dystrophy. A third autosomal dominant stromal dystrophy (Avellino) has also been recognized. Chromosome linkage analysis of four families with Avellino dystrophy mapped the disease-causing gene to chromosome 5q. Subsequent linkage analysis of two families with typical lattice dystrophy and two with typical granular dystrophy also revealed significant linkage with the same markers. Thus, each of three clinically and histopathologically distinct phenotypes is independently linked to 5q. The maximum combined lod score using all 114 affected patients was 28.6 with marker D5S393. None of the 14 known human amyloid-associated genes map to chromosome 5.	UNIV IOWA, COLL MED, DEPT PATHOL, IOWA CITY, IA 52242 USA; UNIV IOWA, COLL MED, DEPT PEDIAT, IOWA CITY, IA 52242 USA; PENN STATE UNIV, MILTON S HERSHEY MED CTR, COLL MED, DEPT OPHTHALMOL, HERSHEY, PA 17033 USA; UNIV MINNESOTA, COLL MED, DEPT OPHTHALMOL, MINNEAPOLIS, MN 55455 USA; SUNY STONY BROOK, DIV RHEUMATOL & CLIN IMMUNOL, STONY BROOK, NY 11794 USA	University of Iowa; University of Iowa; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Minnesota System; University of Minnesota Twin Cities; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	STONE, EM (corresponding author), UNIV IOWA, COLL MED, DEPT OPHTHALMOL, IOWA CITY, IA 52242 USA.			Stone, Edwin M./0000-0003-3343-4414	NATIONAL EYE INSTITUTE [R29EY008426] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000457, P50HG000835] Funding Source: NIH RePORTER; NEI NIH HHS [EY08426] Funding Source: Medline; NHGRI NIH HHS [HG00457, P50HG00835] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; BENSON MD, 1993, NAT GENET, V3, P252, DOI 10.1038/ng0393-252; DELACHAPELLE A, 1992, NAT GENET, V2, P157, DOI 10.1038/ng1092-157; DWELET FE, 1984, P NATN ACAD SCI USJO, V81, P694; FOLBERG R, 1988, OPHTHALMOLOGY, V95, P46; GHISO J, 1986, BIOCHEM BIOPH RES CO, V136, P548, DOI 10.1016/0006-291X(86)90475-4; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOREVIC PD, 1986, P NATL ACAD SCI USA, V83, P7908, DOI 10.1073/pnas.83.20.7908; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; HOLLAND EJ, 1992, OPHTHALMOLOGY, V99, P1564; HSIAO K, 1991, NEW ENGL J MED, V324, P1091, DOI 10.1056/NEJM199104183241604; HSIAO K, 1992, NAT GENET, V1, P68, DOI 10.1038/ng0492-68; Jacobson D R, 1991, Adv Hum Genet, V20, P69; JOHANSSON B, 1987, BIOCHEM BIOPH RES CO, V148, P1087, DOI 10.1016/S0006-291X(87)80243-7; JOHNSON KH, 1989, NEW ENGL J MED, V321, P513; JONES ST, 1961, AM J OPHTHALMOL, V51, P394, DOI 10.1016/0002-9394(61)92085-2; KLUVEBECKERMAN B, 1986, BIOCHEM BIOPH RES CO, V137, P1196, DOI 10.1016/0006-291X(86)90352-9; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MEDORI R, 1992, NEW ENGL J MED, V326, P444, DOI 10.1056/NEJM199202133260704; MERETOJA J, 1969, Annals of Clinical Research, V1, P314; MIDURA RJ, 1990, J BIOL CHEM, V265, P15947; Nichols B. E., 1992, American Journal of Human Genetics, V51, pA369; NICHOLS WC, 1990, GENOMICS, V8, P318, DOI 10.1016/0888-7543(90)90288-6; PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P688; ROSENWASSER GOD, 1993, ARCH OPHTHALMOL-CHIC, V111, P1546, DOI 10.1001/archopht.1993.01090110112035; SIPE JD, 1992, ANNU REV BIOCHEM, V61, P947, DOI 10.1146/annurev.bi.61.070192.004503; SLETTEN K, 1990, 6 INT S AM PROG, P113; SZUBRYT SR, 1993, HUM MOL GENET, V2, P90, DOI 10.1093/hmg/2.1.90-a; TAGLIAVINI F, 1991, NEUROSCI LETT, V128, P117, DOI 10.1016/0304-3940(91)90773-M; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WOO P, 1987, LANCET, V2, P767	32	139	141	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	1994	6	1					47	51		10.1038/ng0194-47	http://dx.doi.org/10.1038/ng0194-47			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ177	8136834				2022-12-25	WOS:A1994MQ17700013
J	MELTZER, PS; GUAN, XY; TRENT, JM				MELTZER, PS; GUAN, XY; TRENT, JM			TELOMERE CAPTURE STABILIZES CHROMOSOME BREAKAGE	NATURE GENETICS			English	Article							DICENTRIC CHROMOSOMES; INSITU HYBRIDIZATION; ALPHA-THALASSEMIA; TRANSLOCATIONS; DELETIONS; (TTAGGG)N; ENDS	Terminal deletions are found frequently in both malignancies and clinically recognizable deletion syndromes in man. Little is known, particularly in cancer, of the specific mechanisms which lead to the generation of deleted chromosomes or the process by which these broken chromosomes are stabilized. We demonstrate that several examples of apparent terminal deletions are, in fact, subtelomeric translocations which were not detectable using conventional cytogenetics. The unexpectedly high frequency of this phenomenon and the diversity of partner chromosomes involved in the subtelomeric translocations is consistent with a model in which telomere capture can stabilize chromosome breakage in man.	UNIV MICHIGAN,DEPT RADIAT ONCOL,MED SCI RES BLDG 2,ROOM C560,1150 W MED CTR DR,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT PEDIAT,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan			/A-3639-2009; Guan, Xin-Yuan/A-3639-2009	/0000-0003-1874-9805; Guan, Xin-Yuan/0000-0002-4485-6017	NCI NIH HHS [R37 CA-29476] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA029476] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTHERR MR, 1991, AM J HUM GENET, V49, P1235; BLACKBURN EH, 1986, ANNU REV GENET, V20, P501; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Bridges CB, 1917, GENETICS, V2, P445; BRIDGES CB, 1923, 2ND INT C EUG, V1, P76; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; DOWDY SF, 1990, GENE CHROMOSOME CANC, V2, P318, DOI 10.1002/gcc.2870020410; GUAN XY, 1992, GENOMICS, V14, P680, DOI 10.1016/S0888-7543(05)80168-5; HABER JE, 1984, GENETICS, V106, P207; HEIM S, 1987, CANCER CYTOGENETICS; IJDO JW, 1991, NUCLEIC ACIDS RES, V19, P4780, DOI 10.1093/nar/19.17.4780; JAGER D, 1989, EMBO J, V8, P247, DOI 10.1002/j.1460-2075.1989.tb03370.x; KAMPER J, 1989, MOL CELL BIOL, V9, P3931; KUWANO A, 1991, AM J HUM GENET, V49, P707; LEDBETTER DH, 1992, AM J HUM GENET, V51, P451; McClintock B, 1938, GENETICS, V23, P315; McClintock B., 1931, U MISSOURI AGR RES S, V163, P3; MEESE EU, 1992, GENOMICS, V12, P542, DOI 10.1016/0888-7543(92)90446-Y; MELTZER PS, 1992, NAT GENET, V1, P24, DOI 10.1038/ng0492-24; MITELMAN F, 1991, CATALOG CHROMOSOME A; MORIN GB, 1991, NATURE, V353, P454, DOI 10.1038/353454a0; Muller H, 1938, COLLECTING NET, V13, P181; Muller H.J., 1938, COLLECTING NET, V13, P181; MURANE JP, 1993, MOL CELL BIOL, V13, P977; Painter TS, 1929, J HERED, V20, P287, DOI 10.1093/oxfordjournals.jhered.a103199; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; SANDBERG AA, 1990, CHROMOSOMES HUMAN CA; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; TRENT JM, 1990, SCIENCE, V247, P568, DOI 10.1126/science.2300817; WILKIE AOM, 1990, NATURE, V346, P868, DOI 10.1038/346868a0	30	149	155	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1993	4	3					252	255		10.1038/ng0793-252	http://dx.doi.org/10.1038/ng0793-252			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ842	8358433				2022-12-25	WOS:A1993LJ84200012
J	WOHRLE, D; HENNIG, I; VOGEL, W; STEINBACH, P				WOHRLE, D; HENNIG, I; VOGEL, W; STEINBACH, P			MITOTIC STABILITY OF FRAGILE-X MUTATIONS IN DIFFERENTIATED CELLS INDICATES EARLY POSTCONCEPTIONAL TRINUCLEOTIDE REPEAT EXPANSION	NATURE GENETICS			English	Article							MENTAL-RETARDATION; DNA; EXPRESSION; INSTABILITY; CHROMOSOME; PATTERN	We demonstrate here that somatic variation of CGG repeat length is based on a mosaic of cells with different but stable FMR-1 alleles and does not reflect permanent mitotic instability. The length of a particular allele in an individual cell was maintained in progeny cells establishing a clone. The mutation patterns of multiple repeats in the DNA of fetal tissues were identical and did not significantly change during proliferation in vitro. It is proposed that genotype mosaicism and expansion to full mutation are generated postconceptionally by the same molecular mechanism in a particular window of early development.	UNIV ULM,KLIN GENET ABT,PARKSTR 11,W-7900 ULM,GERMANY	Ulm University								BELL MV, 1991, CELL, V64, P861, DOI 10.1016/0092-8674(91)90514-Y; CRANE JP, 1988, PRENATAL DIAG, V8, P119, DOI 10.1002/pd.1970080206; DEVYS D, 1992, AM J MED GENET, V43, P208, DOI 10.1002/ajmg.1320430134; FONATSCH C, 1983, CLIN GENET, V23, P229; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; HEITZ D, 1992, J MED GENET, V29, P794, DOI 10.1136/jmg.29.11.794; HORI T, 1993, CLIN GENET, V43, P34, DOI 10.1111/j.1399-0004.1993.tb04423.x; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; NAKAHORI Y, 1991, NUCLEIC ACIDS RES, V19, P4355, DOI 10.1093/nar/19.16.4355; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; RICHARDS RI, 1992, TRENDS GENET, V8, P249, DOI 10.1016/0168-9525(92)90124-M; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; Smith C.L., 1988, P41; TAKAGI N, 1982, CHROMOSOMA, V85, P275, DOI 10.1007/BF00294971; TOMMERUP N, 1989, HUM GENET, V81, P377, DOI 10.1007/BF00283696; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VINCENT A, 1991, NATURE, V349, P624, DOI 10.1038/349624a0; WENGER SL, 1987, AM J MED GENET, V26, P909, DOI 10.1002/ajmg.1320260419; WILLEMS PJ, 1992, HUM MOL GENET, V1, P511, DOI 10.1093/hmg/1.7.511; WOHRLE D, 1992, HUM GENET, V89, P114, DOI 10.1007/BF00207057; WOHRLE D, 1991, HUM GENET, V87, P421; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	23	159	160	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1993	4	2					140	142		10.1038/ng0693-140	http://dx.doi.org/10.1038/ng0693-140			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LF816	8348151				2022-12-25	WOS:A1993LF81600012
J	COX, GA; PHELPS, SF; CHAPMAN, VM; CHAMBERLAIN, JS				COX, GA; PHELPS, SF; CHAPMAN, VM; CHAMBERLAIN, JS			NEW MDX MUTATION DISRUPTS EXPRESSION OF MUSCLE AND NONMUSCLE ISOFORMS OF DYSTROPHIN	NATURE GENETICS			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; MOLECULAR-BASIS; MESSENGER-RNA; GENE; MOUSE; PROTEIN; DEFICIENCY; TERMINUS; DELETION; MEMBRANE	The dystrophin gene encodes several tissue-specific protein isoforms that are generated by alternative splicing and by transcription from at least three separate promoters. We have characterized the mutation in a new strain of mdx mice that results in aberrant splicing of both the 14 and 4.8 kilobase dystrophin mRNAs and disrupts expression of the muscle and brain 427K and nonmuscle 70K isoforms of dystrophin. In contrast, we have determined that expression of the 70K isoform is normal in the original mdx mutant. We have cloned the unique 5' exon of the murine 4.8 kb mRNA and have analysed the tissue distribution and aberrant splicing of this transcript in the Mdx3Cv mutant. This new mdx mutant will provide an improved model system for functional studies of the dystrophin C-terminus in muscle and nonmuscle tissues.	UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,CTR HUMAN GENOME,ANN ARBOR,MI 48109; ROSWELL PK CANC INST,DEPT MOLEC & CELLULAR BIOL,BUFFALO,NY 14224	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Roswell Park Cancer Institute				Chamberlain, Jeffrey/0000-0001-5299-0059	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040864, R37AR040864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033160] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR40864] Funding Source: Medline; NIGMS NIH HHS [GM33160] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEGGS AH, 1991, AM J HUM GENET, V49, P54; BIES RD, 1992, NUCLEIC ACIDS RES, V20, P1725, DOI 10.1093/nar/20.7.1725; Blake Derek J., 1992, Human Molecular Genetics, V1, P103, DOI 10.1093/hmg/1.2.103; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; BUROW KL, 1991, NEUROLOGY, V41, P661; CHAMBERLAIN JS, 1988, SCIENCE, V239, P1416, DOI 10.1126/science.3347839; CHAMBERLAIN JS, 1991, J CELL BIOCHEM, V46, P255, DOI 10.1002/jcb.240460309; CHAPMAN VM, 1989, P NATL ACAD SCI USA, V86, P1292, DOI 10.1073/pnas.86.4.1292; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DANKO I, 1992, PEDIATR RES, V32, P128, DOI 10.1203/00006450-199207000-00025; EMERY AEH, 1987, OXFORD MONOGRAPHS ME, V15; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; FEENER CA, 1989, NATURE, V338, P509, DOI 10.1038/338509a0; FONG P, 1990, SCIENCE, V250, P673, DOI 10.1126/science.2173137; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; FU XY, 1988, MOL CELL BIOL, V8, P3582, DOI 10.1128/MCB.8.9.3582; GILLARD EF, 1989, AM J HUM GENET, V45, P507; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1988, NEW ENGL J MED, V318, P1363, DOI 10.1056/NEJM198805263182104; HOFFMAN EP, 1991, ANN NEUROL, V30, P605, DOI 10.1002/ana.410300414; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; JAYNES JB, 1986, MOL CELL BIOL, V6, P2855, DOI 10.1128/MCB.6.8.2855; KAATZ KW, 1992, BRAIN RES BULL, V29, P697, DOI 10.1016/0361-9230(92)90141-J; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; LEDERFEIN D, 1992, P NATL ACAD SCI USA, V89, P5346, DOI 10.1073/pnas.89.12.5346; LEE CC, 1991, NATURE, V349, P334, DOI 10.1038/349334a0; MACONOCHIE MK, 1992, MAMM GENOME, V2, P64, DOI 10.1007/BF00570441; METHERALL JE, 1986, EMBO J, V5, P2551, DOI 10.1002/j.1460-2075.1986.tb04534.x; NUDEL U, 1989, NATURE, V337, P76, DOI 10.1038/337076a0; Ochman H., 1990, PCR PROTOCOLS GUIDE, P219; OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685; ROBERTS RG, 1992, P NATL ACAD SCI USA, V89, P2331, DOI 10.1073/pnas.89.6.2331; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; SMITH CWJ, 1989, NATURE, V342, P243, DOI 10.1038/342243a0; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; TOWBIN JA, 1989, HUM GENET, V83, P122, DOI 10.1007/BF00286703	37	161	164	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1993	4	1					87	93		10.1038/ng0593-87	http://dx.doi.org/10.1038/ng0593-87			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LA337	8099842				2022-12-25	WOS:A1993LA33700020
J	HANZLIK, AJ; OSEMLAKHANZLIK, MM; HAUSER, MA; KURNIT, DM				HANZLIK, AJ; OSEMLAKHANZLIK, MM; HAUSER, MA; KURNIT, DM			A RECOMBINATION-BASED ASSAY DEMONSTRATES THAT THE FRAGILE-X SEQUENCE IS TRANSCRIBED WIDELY DURING DEVELOPMENT	NATURE GENETICS			English	Article							ESCHERICHIA-COLI; HOMOLOGOUS RECOMBINATION; BACTERIOPHAGE LIBRARIES; GENOMIC SEQUENCES; BETA-GLOBIN; DNA; SELECTION; GENE; AMPLIFICATION; EXPRESSION	To identify transcribed sequences rapidly and efficiently, we have developed a recombination-based assay to screen bacteriophage lambda libraries for sequences that share homology with a given probe. This strategy determines analytically whether a given probe is transcribed in a given tissue at a given time of development, and may also be used to isolate preparatively the transcribed sequence free of the screening probe. We illustrate this technology for the fragile X sequence, demonstrating that it is transcribed ubiquitously in an 11 week fetus, in a variety of 20 week human fetal tissues, including brain, spinal cord, eye, liver, kidney and skeletal muscle, and in adult jejunum.	UNIV MICHIGAN,SCH MED,HOWARD HUGHES MED INST,ANN ARBOR,MI 48109	Howard Hughes Medical Institute; University of Michigan System; University of Michigan								ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; DUYK GM, 1990, P NATL ACAD SCI USA, V87, P8995, DOI 10.1073/pnas.87.22.8995; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Georgopoulos C., 1971, BACTERIOPHAGE LAMBDA, P553; GUARENTE L, 1980, CELL, V20, P543, DOI 10.1016/0092-8674(80)90640-6; HENZLIK AJ, IN PRESS GENE; KING SR, 1986, MOL GEN GENET, V204, P141, DOI 10.1007/BF00330201; KURNIT DM, 1990, P NATL ACAD SCI USA, V87, P3166, DOI 10.1073/pnas.87.8.3166; LIU P, 1989, SCIENCE, V246, P813, DOI 10.1126/science.2479099; LOVETT M, 1991, P NATL ACAD SCI USA, V88, P9628, DOI 10.1073/pnas.88.21.9628; NEVE RL, 1986, GENE, V49, P361, DOI 10.1016/0378-1119(86)90372-0; Nisson P E, 1991, PCR Methods Appl, V1, P120; PARIMOO S, 1991, P NATL ACAD SCI USA, V88, P9623, DOI 10.1073/pnas.88.21.9623; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SEED B, 1983, NUCLEIC ACIDS RES, V11, P2427, DOI 10.1093/nar/11.8.2427; SHEN P, 1986, GENETICS, V112, P441; SHEN P, 1989, MOL GEN GENET, V218, P358, DOI 10.1007/BF00331291; SHORT M, 1985, NUCLEIC ACIDS RES, V16, P7583; STEWART GD, 1991, GENE, V106, P97, DOI 10.1016/0378-1119(91)90571-R; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WATT VM, 1985, P NATL ACAD SCI USA, V82, P4768, DOI 10.1073/pnas.82.14.4768	25	18	18	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1993	3	1					44	48		10.1038/ng0193-44	http://dx.doi.org/10.1038/ng0193-44			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KF372	8490653				2022-12-25	WOS:A1993KF37200011
J	Scorpio, A; Zhang, Y				Scorpio, A; Zhang, Y			Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus	NATURE MEDICINE			English	Article							NICOTINAMIDE ADENINE-DINUCLEOTIDE; PYRIDINE-NUCLEOTIDE CYCLE; MYCOBACTERIUM-TUBERCULOSIS; POINT MUTATIONS; SENSITIVITY; POLYMERASE; DNA	Naturally pyrazinamide (PZA)-resistant Mycobacterium bovis and acquired PZA-resistant M, tuberculosis strains lose pyrazinamidase (PZase). To investigate the molecular mechanism of PZA resistance, we have cloned the gene (pncA) encoding M, tuberculosis PZase. Mutations in pncA were identified in both types of PZA-resistant strains, and transformation of these strains with a functional pncA gene restored PZase activity and PZA susceptibility. These findings, besides providing the basis for understanding how PZA works, should have implications for rapid detection of PZA-resistant clinical isolates of M. tuberculosis and also for rapid differentiation of M. bovis from M. tuberculosis strains.	JOHNS HOPKINS UNIV, SCH HYG & PUBL HLTH, DEPT MOLEC MICROBIOL & IMMUNOL, BALTIMORE, MD 21205 USA	Johns Hopkins University								BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; BLOCH AB, 1994, JAMA-J AM MED ASSOC, V271, P665, DOI 10.1001/jama.271.9.665; BLOOM BR, 1992, SCIENCE, V257, P1055, DOI 10.1126/science.257.5073.1055; BONICKE R, 1959, Tuberkulosearzt, V13, P377; Centers for Disease Control (CDC), 1991, MMWR Morb Mortal Wkly Rep, V40, P585; COLLINS CH, 1985, TUBERCULOSIS BACTERI, P59; CROWLE AJ, 1991, INFECT IMMUN, V59, P1823, DOI 10.1128/IAI.59.5.1823-1831.1991; DICKINSON J M, 1970, Tubercle, V51, P389; FINKEN M, 1993, MOL MICROBIOL, V9, P1239, DOI 10.1111/j.1365-2958.1993.tb01253.x; FOSTER JW, 1980, MICROBIOL REV, V44, P83, DOI 10.1128/MMBR.44.1.83-105.1980; FOSTER JW, 1979, J BACTERIOL, V137, P1165, DOI 10.1128/JB.137.3.1165-1175.1979; GARBE TR, 1994, MICROBIOL-SGM, V140, P133, DOI 10.1099/13500872-140-1-133; HEIFETS L, 1992, AM REV RESPIR DIS, V145, P1223, DOI 10.1164/ajrccm/145.5.1223; JERLSTROM PG, 1989, GENE, V78, P37, DOI 10.1016/0378-1119(89)90312-0; Klemens SP, 1996, ANTIMICROB AGENTS CH, V40, P14, DOI 10.1128/AAC.40.1.14; KONNO K, 1967, AM REV RESPIR DIS, V95, P461; KONNO K, 1959, NATURE, V184, P1743, DOI 10.1038/1841743b0; MACKANESS GB, 1956, AM REV TUBERC PULM, V74, P718; MCCLATCHY JK, 1981, ANTIMICROB AGENTS CH, V20, P556, DOI 10.1128/AAC.20.4.556; MCCUNE RM, 1956, J EXP MED, V104, P763, DOI 10.1084/jem.104.5.763; MCDERMOTT W, 1954, AM REV TUBERC PULM, V70, P748; MITCHISON DA, 1985, TUBERCLE, V66, P219, DOI 10.1016/0041-3879(85)90040-6; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; RODRIGUEZ JG, 1995, MICROBIOL-SGM, V141, P2131, DOI 10.1099/13500872-141-9-2131; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SKINNER PS, 1994, ANTIMICROB AGENTS CH, V38, P2557, DOI 10.1128/AAC.38.11.2557; TARSHIS MS, 1953, AM REV TUBERC PULM, V67, P391; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; TRIVEDI SS, 1987, TUBERCLE, V68, P221, DOI 10.1016/0041-3879(87)90058-4; WAYNE LG, 1974, AM REV RESPIR DIS, V109, P147; YEAGER RL, 1952, AM REV TUBERC PULM, V65, P523; ZHANG Y, 1992, INFECT IMMUN, V60, P2160, DOI 10.1128/IAI.60.6.2160-2165.1992; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0; ZHANG Y, 1993, MOL MICROBIOL, V8, P521, DOI 10.1111/j.1365-2958.1993.tb01596.x; 1994, B WORLD HEALTH ORGAN, V72, P851	36	534	559	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	1996	2	6					662	667		10.1038/nm0696-662	http://dx.doi.org/10.1038/nm0696-662			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UN691	8640557				2022-12-25	WOS:A1996UN69100034
J	Kozarsky, KF; Jooss, K; Donahee, M; Strauss, JF; Wilson, JM				Kozarsky, KF; Jooss, K; Donahee, M; Strauss, JF; Wilson, JM			Effective treatment of familial hypercholesterolaemia in the mouse model using adenovirus-mediated transfer of the VLDL receptor gene	NATURE GENETICS			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; RECOMBINANT; SEQUENCE; PROTEIN	Liver directed gene transfer with adenoviral vectors is being considered for the treatment of several metabolic diseases, including familial hypercholesterolaemia (FH). Gene replacement therapy of human low density lipoprotein (LDL) receptor gene into the murine model of FH transiently corrected the dyslipidaemia; however, humoral and cellular immune responses to LDL receptor developed - possibly contributing to the associated hepatitis and extinguishing of transgene expression. We evaluated an alternative strategy of ectopic expression in the liver of the very low density lipoprotein (VLDL) receptor, which is homologous to the LDL receptor but has a different pattern of expression. Infusion of recombinant adenoviruses containing the VLDL receptor gene corrected the dyslipidaemia in the FH mouse and circumvented immune responses to the transgene leading to a more prolonged metabolic correction.	UNIV PENN,INST HUMAN GENE THERAPY,DEPT MOL & CELLULAR ENGN,PHILADELPHIA,PA 19104; UNIV PENN,INST HUMAN GENE THERAPY,DEPT OBSTET & GYNECOL,PHILADELPHIA,PA 19104; WISTAR INST ANAT & BIOL,PHILADELPHIA,PA 19104	University of Pennsylvania; University of Pennsylvania; The Wistar Institute			Wilson, James M/F-9220-2011	Wilson, James M/0000-0002-9630-3131	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029946] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-29946] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARR D, 1995, GENE THER, V2, P151; BATTEY FD, 1994, J BIOL CHEM, V269, P23268; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; CHAKRABARTI S, 1985, MOL CELL BIOL, V5, P3403, DOI 10.1128/MCB.5.12.3403; CHOWDHURY JR, 1991, SCIENCE, V254, P1802, DOI 10.1126/science.1722351; DAI Y, 1995, P NATL ACAD SCI USA, V92, P140; ENGELHARDT JF, 1994, HUM GENE THER, V5, P1217, DOI 10.1089/hum.1994.5.10-1217; ENGELHARDT JF, 1993, NAT GENET, V4, P27, DOI 10.1038/ng0593-27; FRYKMAN PK, 1995, P NATL ACAD SCI USA, V92, P8453, DOI 10.1073/pnas.92.18.8453; GAFVELS ME, 1994, ENDOCRINOLOGY, V135, P387, DOI 10.1210/en.135.1.387; GAFVELS ME, 1993, SOMAT CELL MOLEC GEN, V19, P557, DOI 10.1007/BF01233382; Goldstein J, 1995, FAMILIAL HYPERCHOLES, P1981; GROSSMAN M, 1992, HUM GENE THER, V3, P501, DOI 10.1089/hum.1992.3.5-501; GROSSMAN M, 1995, NAT MED, V1, P1148, DOI 10.1038/nm1195-1148; GROSSMAN M, 1994, NAT GENET, V6, P335, DOI 10.1038/ng0494-335; HOFFER MJV, 1993, BIOCHEM BIOPH RES CO, V191, P880, DOI 10.1006/bbrc.1993.1299; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; JOKINEN EV, 1994, J BIOL CHEM, V269, P26411; KASSEISLER A, 1994, GENE THER, V1, P395; KOZARSKY K, 1993, SOMAT CELL MOLEC GEN, V19, P449, DOI 10.1007/BF01233250; KOZARSKY KF, 1994, J BIOL CHEM, V269, P13695; LI J, 1995, J CLIN INVEST, V95, P768, DOI 10.1172/JCI117725; MOKUNO H, 1994, J BIOL CHEM, V269, P13238; OKA K, 1994, EUR J BIOCHEM, V224, P975, DOI 10.1111/j.1432-1033.1994.00975.x; POLVINO WJ, 1992, SOMAT CELL MOLEC GEN, V18, P443, DOI 10.1007/BF01233084; SHIMANO H, 1994, J CLIN INVEST, V93, P2215, DOI 10.1172/JCI117218; TAKAHASHI S, 1992, P NATL ACAD SCI USA, V89, P9252, DOI 10.1073/pnas.89.19.9252; VANGINKEL FW, 1995, HUM GENE THER, V6, P895, DOI 10.1089/hum.1995.6.7-895; WIKTOR TJ, 1984, P NATL ACAD SCI-BIOL, V81, P7194, DOI 10.1073/pnas.81.22.7194; WILLNOW TE, 1995, J MOL MED, V73, P213; YAMAMOTO T, 1993, TRENDS CARDIOVAS MED, V3, P144, DOI 10.1016/1050-1738(93)90015-X; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; YANG Y, IN PRESS GENE THERAP; YANG YP, 1995, J VIROL, V69, P2004, DOI 10.1128/JVI.69.4.2004-2015.1995; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407; YANG YP, 1994, IMMUNITY, V1, P433, DOI 10.1016/1074-7613(94)90074-4	36	143	146	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1996	13	1					54	62		10.1038/ng0596-54	http://dx.doi.org/10.1038/ng0596-54			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH430	8673104	Bronze			2022-12-25	WOS:A1996UH43000016
J	Freimer, NB; Reus, VI; Escamilla, MA; McInnes, LA; Spesny, M; Leon, P; Service, SK; Smith, LB; Silva, S; Rojas, E; Gallegos, A; Meza, L; Fournier, E; Baharloo, S; Blankenship, K; Tyler, DJ; Batki, S; Vinogradov, S; Weissenbach, J; Barondes, SH; Sandkuijl, LA				Freimer, NB; Reus, VI; Escamilla, MA; McInnes, LA; Spesny, M; Leon, P; Service, SK; Smith, LB; Silva, S; Rojas, E; Gallegos, A; Meza, L; Fournier, E; Baharloo, S; Blankenship, K; Tyler, DJ; Batki, S; Vinogradov, S; Weissenbach, J; Barondes, SH; Sandkuijl, LA			Genetic mapping using haplotype, association and linkage methods suggests a locus for severe bipolar disorder (BPI) at 18q22-q23	NATURE GENETICS			English	Letter							X-CHROMOSOME MARKERS; ILLNESS; ALLELE		UNIV CALIF SAN FRANCISCO,DEPT PSYCHIAT,CTR NEUROBIOL & PSYCHIAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,GENET PROGRAM,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,PROGRAM BIOMED SCI,SAN FRANCISCO,CA 94143; UNIV COSTA RICA,CELL & MOL BIOL RES CTR,SAN JOSE,COSTA RICA; UNIV COSTA RICA,ESCUELA MED,SAN JOSE,COSTA RICA; HOSP CALDERON GUARDIA,SAN JOSE,COSTA RICA; UNIV CALIF SAN FRANCISCO,SAN FRANCISCO GEN HOSP,DEPT PSYCHIAT,SAN FRANCISCO,CA 94110; GENETHON SA,F-91000 EVRY,FRANCE; INST PASTEUR,UNITE GENET MOL HUMAINE,CNRS,URA 1445,F-75724 PARIS,FRANCE; ERASMUS UNIV ROTTERDAM,DEPT CLIN GENET,3000 DR ROTTERDAM,NETHERLANDS; LEIDEN UNIV,DEPT HUMAN GENET,2300 RA LEIDEN,NETHERLANDS; UNIV GRONINGEN,DEPT MED GENET,9713 AW GRONINGEN,NETHERLANDS	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Universidad Costa Rica; Universidad Costa Rica; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Erasmus University Rotterdam; Leiden University; Leiden University - Excl LUMC; University of Groningen	Freimer, NB (corresponding author), UNIV CALIF SAN FRANCISCO,NEUROGENET LAB,SAN FRANCISCO,CA 94143, USA.		reus, victor i/I-7923-2015	reus, victor i/0000-0002-8193-5697	NIMH NIH HHS [MH00916, MH48695, MH49499] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K21MH000916, R01MH049499, R03MH048695] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BARON M, 1987, NATURE, V326, P289, DOI 10.1038/326289a0; BARON M, 1993, NAT GENET, V3, P49, DOI 10.1038/ng0193-49; BERRETTINI WH, 1994, P NATL ACAD SCI USA, V91, P5918, DOI 10.1073/pnas.91.13.5918; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; COPEMAN JB, 1995, NAT GENET, V9, P80, DOI 10.1038/ng0195-80; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; ESCAMILLA MA, IN PRESS NEUROPSYCHI; FARAWAY JJ, 1993, GENET EPIDEMIOL, V10, P75, DOI 10.1002/gepi.1370100108; FREIMER NB, IN PRESS NEUROPSYCHI; FRIEDMAN TB, 1995, NAT GENET, V9, P86, DOI 10.1038/ng0195-86; GARZA JC, 1995, MOL BIOL EVOL, V12, P594; Goodwin F, 1990, MANIC DEPRESSIVE ILL; GRUUIS NA, 1995, NAT GENET, V10, P351; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; KELSOE JR, 1989, NATURE, V342, P238, DOI 10.1038/342238a0; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NYSTROMLAHTI M, 1994, P NATL ACAD SCI USA, V91, P6034; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Ott J., 1991, ANAL HUMAN GENETIC L; OZELIUS LJ, 1992, AM J HUM GENET, V50, P619; PAULS DL, 1995, AM J MED GENET, V60, P290, DOI 10.1002/ajmg.1320600406; Puffenberger E. G., 1995, American Journal of Human Genetics, V57, pA42; PUFFENBERGER EG, 1994, HUM MOL GENET, V3, P1217; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; SCHELLENBERG GD, 1987, J NEUROGENET, V4, P97, DOI 10.3109/01677068709102337; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SPENCE MA, 1995, AM J MED GENET, V60, P370, DOI 10.1002/ajmg.1320600505; STINE OC, 1995, AM J HUM GENET, V57, P1384; STRAUB RE, 1994, NAT GENET, V8, P291, DOI 10.1038/ng1194-291; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; UHRHAMMER N, 1995, AM J HUM GENET, V57, P103; WEEKS DE, 1988, AM J HUM GENET, V42, P315	38	193	204	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1996	12	4					436	441		10.1038/ng0496-436	http://dx.doi.org/10.1038/ng0496-436			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UC553	8630501	Green Published			2022-12-25	WOS:A1996UC55300026
J	Zechner, U; Reule, M; Orth, A; Bonhomme, F; Strack, B; Guenet, JL; Hameister, H; Fundele, R				Zechner, U; Reule, M; Orth, A; Bonhomme, F; Strack, B; Guenet, JL; Hameister, H; Fundele, R			An X-chromosome linked locus contributes to abnormal placental development in mouse interspecific hybrids	NATURE GENETICS			English	Article							MUS-MUSCULUS; EXPRESSION; INACTIVATION; SPRETUS; TISSUES; GENE	Interspecific hybridization between closely related species is commonly associated with decreased fertility or viability of F-1 hybrids. Thus, in mouse interspecific hybrids, several different hybrid sterility genes that impair gametogenesis of the male hybrids have been described. We describe a novel effect in hybrids between different mouse species that manifests itself in abnormal growth of the placenta. Opposite phenotypes, that is, placental hypotrophy versus hypertrophy, are observed in reciprocal crosses and backcrosses. The severity of the phenotype, which is mainly caused by abnormal development of the spongiotrophoblast, is influenced by the sex of the conceptus. In general, placental hypertrophy is associated with increased fetal growth. Hypotrophy of the placenta frequently leads to growth impairment or death of the fetus. One of the major genetic determinants of placental growth maps to the proximal part of the mouse X chromosome.	UNIV FREIBURG,INST BIOL 3,D-79104 FREIBURG,GERMANY; UNIV ULM,ABT MED GENET,ALBERT EINSTEIN ALLEE 11,D-89069 ULM,GERMANY; UNIV MONTPELLIER 2,LAB GENOME & POPULAT,F-34095 MONTPELLIER,FRANCE; INST PASTEUR,UNITE GENET MAMMIFERES,F-75724 PARIS 15,FRANCE	University of Freiburg; Ulm University; Universite de Montpellier; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris			Zechner, Ulrich/G-2116-2010; Bonhomme, Francois/AAG-6558-2021; Bonhomme, Francois/C-6290-2012	Bonhomme, Francois/0000-0002-8792-9239; Bonhomme, Francois/0000-0002-8792-9239				ALLEN WR, 1993, J REPROD FERTIL, V97, P55; BIDDLE FG, 1987, GENOME, V29, P389, DOI 10.1139/g87-067; BONHOMME F, 1978, EXPERIENTIA, V34, P1140, DOI 10.1007/BF01922917; BONHOMME F, 1983, Z SAUGETIERKD, V48, P78; BONHOMME F, 1986, WILD MOUSE IMMUNOLOG, P19; BRITTON J, 1976, CR ACAD SCI D NAT, V283, P515; COPELAND NG, 1993, SCIENCE, V262, P57, DOI 10.1126/science.8211130; COYNE JA, 1992, NATURE, V355, P511, DOI 10.1038/355511a0; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; EICHER EM, 1992, P NATL ACAD SCI USA, V89, P2160, DOI 10.1073/pnas.89.6.2160; Festetics A., 1961, Z-Saugefcierk, V26, P112; GUENET JL, 1990, GENET RES, V56, P163, DOI 10.1017/S0016672300035254; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; LESCISIN KR, 1989, GENE DEV, V2, P1639; Lyon M. F., 1995, Mouse Genome, V93, P23; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MCLAREN A, 1965, J REPROD FERTIL, V9, P79, DOI 10.1530/jrf.0.0090079; MOORE T, 1995, DEV GENET, V17, P206, DOI 10.1002/dvg.1020170305; NIELSEN JT, 1977, BIOCH GENET, V21, P487; Palopoli M.F., 1994, ANNU REV GENET, V27, P283, DOI 10.1146/annurev.ge.28.120194.001435; ROGERS JF, 1970, J REPROD FERTIL, V21, P255; ROWE LB, 1994, MAMM GENOME, V5, P253, DOI 10.1007/BF00389540; RUDERT F, 1992, MAMM GENOME, V3, P262, DOI 10.1007/BF00292154; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHMID P, 1989, SCIENCE, V243, P226, DOI 10.1126/science.2911736; SOBIS H, 1991, J HISTOCHEM CYTOCHEM, V39, P569, DOI 10.1177/39.5.2016509; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; TAN SS, 1993, NAT GENET, V3, P170, DOI 10.1038/ng0293-170; WEST JD, 1977, CELL, V12, P873, DOI 10.1016/0092-8674(77)90151-9; *WHIT I MIT, 1995, GEN MAP MOUS; [No title captured]	32	101	104	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1996	12	4					398	403		10.1038/ng0496-398	http://dx.doi.org/10.1038/ng0496-398			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UC553	8630493				2022-12-25	WOS:A1996UC55300018
J	Foncin, JF				Foncin, JF			The true western diet	NATURE MEDICINE			English	Letter											Foncin, JF (corresponding author), LAB MONTYON LA SALPETRIERE,LAB NEUROHISTOL,47 BLVD HOP,F-75651 PARIS 13,FRANCE.								0	1	1	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAR	1996	2	3					255	255		10.1038/nm0396-255b	http://dx.doi.org/10.1038/nm0396-255b			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TY640	8612209	Bronze			2022-12-25	WOS:A1996TY64000005
J	Tate, P; Skarnes, W; Bird, A				Tate, P; Skarnes, W; Bird, A			The methyl-CpG binding protein MeCP2 is essential for embryonic development in the mouse	NATURE GENETICS			English	Letter							TARGETED GENE DISRUPTION; CHROMOSOMAL PROTEIN; DNA; EXPRESSION; CLONES		UNIV EDINBURGH,INST CELL & MOLEC BIOL,EDINBURGH EH9 3JR,MIDLOTHIAN,SCOTLAND; UNIV EDINBURGH,BBSRC CTR GENOME RES,EDINBURGH EH9 3JQ,MIDLOTHIAN,SCOTLAND	University of Edinburgh; University of Edinburgh				Bird, Adrian/0000-0002-8600-0372				BEDDINGTON RSP, 1989, DEVELOPMENT, V106, P37; BUSSLINGER M, 1983, CELL, V34, P107; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; HERRY DM, 1990, TRENDS GENET, V6, P173; JANG SK, 1990, GENE DEV, V4, P1560, DOI 10.1101/gad.4.9.1560; JEANNOTTE L, 1991, MOL CELL BIOL, V11, P5578, DOI 10.1128/MCB.11.11.5578; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; MEEHAN RR, 1992, NUCLEIC ACIDS RES, V20, P5085, DOI 10.1093/nar/20.19.5085; MILLER OJ, 1974, NATURE, V251, P636, DOI 10.1038/251636a0; MOUNTFORD P, 1994, P NATL ACAD SCI USA, V91, P4303, DOI 10.1073/pnas.91.10.4303; Nan XS, 1996, MOL CELL BIOL, V16, P414; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; QUADERI NA, 1994, GENOMICS, V22, P648, DOI 10.1006/geno.1994.1442; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; Runnicki M.A., 1987, TERATOCARCINOMAS EMB, P19; Sambrook J, 1989, MOL CLONING LABORATO; SCHWARTZBERG PL, 1990, P NATL ACAD SCI USA, V87, P3210, DOI 10.1073/pnas.87.8.3210; SEALEY PG, 1985, NUCLEIC ACIDS RES, V13, P1905, DOI 10.1093/nar/13.6.1905; SIMON D, 1983, NATURE, V304, P275, DOI 10.1038/304275a0; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; STEIN R, 1982, P NATL ACAD SCI USA, V79, P4418; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; ULLRICH A, 1977, SCIENCE, V196, P1313, DOI 10.1126/science.325648; URE JM, 1992, TRENDS GENET, V8, P6, DOI 10.1016/0168-9525(92)90004-N; VARDIMON L, 1982, P NATL ACAD SCI-BIOL, V79, P1073, DOI 10.1073/pnas.79.4.1073; WHITTINGHAM DG, 1969, AUST J BIOL SCI, V22, P1065, DOI 10.1071/BI9691065	28	192	199	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1996	12	2					205	208		10.1038/ng0296-205	http://dx.doi.org/10.1038/ng0296-205			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TU079	8563762				2022-12-25	WOS:A1996TU07900024
J	Brunelli, S; Faiella, A; Capra, V; Nigro, V; Simeone, A; Cama, A; Boncinelli, E				Brunelli, S; Faiella, A; Capra, V; Nigro, V; Simeone, A; Cama, A; Boncinelli, E			Germline mutations in the homeobox gene EMX2 in patients with severe schizencephaly	NATURE GENETICS			English	Letter							WAARDENBURG SYNDROME; ANIRIDIA; MR		IST SCI HS RAFFAELE,DIBIT,I-20132 MILAN,ITALY; SCI INST G GASLINI,I-14148 GENOA,ITALY; UNIV NAPLES FEDERICO II,SCH MED,IST PATOL GEN & ONCOL,I-80138 NAPLES,ITALY; CNR,INT INST GENET & BIOPHYS,I-80125 NAPLES,ITALY; CNR,CTR MOLEC & CELLULAR PHARMACOL,I-20129 MILAN,ITALY	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Consiglio Nazionale delle Ricerche (CNR)			Simeone, Antonio/ABG-5269-2020; Nigro, Vincenzo/AAB-2274-2022; Valeria, Capra/AAB-1501-2019; Brunelli, Silvia/P-3853-2019; Brunelli, Silvia/J-3248-2014; capra, valeria/N-4367-2013	Simeone, Antonio/0000-0003-2693-9836; Brunelli, Silvia/0000-0003-1753-5346; Brunelli, Silvia/0000-0003-1753-5346; capra, valeria/0000-0002-3097-0388; Nigro, Vincenzo/0000-0002-3378-5006	Telethon [E.0016] Funding Source: Medline	Telethon(Fondazione Telethon)		BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BARKOVICH AJ, 1988, AM J ROENTGENOL, V150, P1391, DOI 10.2214/ajr.150.6.1391; BARKOVICH AJ, 1987, AM J NEURORADIOL, V8, P1009; BARKOVICH AJ, 1992, AM J NEURORADIOL, V13, P85; Boncinelli E, 1995, CIBA F SYMP, V193, P100; ERICH HA, 1989, PCR TECHNOLOGY PRINC; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; GREEN S, 1988, NUCLEIC ACIDS RES, V16, P369, DOI 10.1093/nar/16.1.369; HODGSON SV, 1980, J MED GENET, V17, P478, DOI 10.1136/jmg.17.6.478; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; LI X, 1995, NAT GENET, V9, P232, DOI 10.1038/ng0395-232; MCKUSICK V, 1995, OMIM ONLINE MENDELIA; NIGRO V, 1992, HUM MOL GENET, V1, P517, DOI 10.1093/hmg/1.7.517; RICHARD I, 1995, NAT GENET, V10, P259, DOI 10.1038/ng0795-259; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; SIMEONE A, 1990, NATURE, V346, P763, DOI 10.1038/346763a0; SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x; SIMEONE A, 1992, EMBO J, V11, P2541, DOI 10.1002/j.1460-2075.1992.tb05319.x; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; TASSABEHJI M, 1994, HUM MOL GENET, V3, P1069, DOI 10.1093/hmg/3.7.1069; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TASSABEHJI M, 1993, NAT GENET, V3, P26, DOI 10.1038/ng0193-26; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; WELSH J, 1990, NUCLEIC ACIDS RES, V18, P7213, DOI 10.1093/nar/18.24.7213; WOLPERT SM, 1992, MRI PEDIATRIC NEUROR; ZLOTOGORA J, 1995, AM J HUM GENET, V56, P1173	26	226	238	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1996	12	1					94	96		10.1038/ng0196-94	http://dx.doi.org/10.1038/ng0196-94			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TM555	8528262				2022-12-25	WOS:A1996TM55500023
J	Ebstein, RP; Novick, O; Umansky, R; Priel, B; Osher, Y; Blaine, D; Bennett, ER; Nemanov, L; Katz, M; Belmaker, RH				Ebstein, RP; Novick, O; Umansky, R; Priel, B; Osher, Y; Blaine, D; Bennett, ER; Nemanov, L; Katz, M; Belmaker, RH			Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking	NATURE GENETICS			English	Letter							GENE; VARIANTS		BEN GURION UNIV NEGEV,FAC HLTH SCI,BEERSHEVA MENTAL HLTH CTR,BEER SHEVA,ISRAEL	Ben Gurion University	Ebstein, RP (corresponding author), S HERZOG MEM HOSP,RES LAB,POB 35300,IL-91351 JERUSALEM,ISRAEL.		OSHER, YAMIMA/F-1359-2012; van Lent, Laurence/G-5298-2010; Bennett, Estelle R/A-5067-2017	OSHER, YAMIMA/0000-0002-9635-7973; van Lent, Laurence/0000-0002-9354-0932; Ebstein, Richard/0000-0002-3626-541X				ASGHARI V, 1994, MOL PHARMACOL, V46, P364; Benjamin J, 1996, NAT GENET, V12, P81, DOI 10.1038/ng0196-81; CAMBIEN F, 1992, NATURE, V359, P641, DOI 10.1038/359641a0; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; GREEN SA, 1994, BIOCHEMISTRY-US, V33, P9414, DOI 10.1021/bi00198a006; KRONTIRIS TG, 1995, SCIENCE, V269, P1682, DOI 10.1126/science.7569893; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LICHTER JB, 1993, HUM MOL GENET, V2, P767, DOI 10.1093/hmg/2.6.767; MACCIARDI F, 1994, ARCH GEN PSYCHIAT, V51, P288; OWEN MJ, 1993, J MED GENET, V30, P638, DOI 10.1136/jmg.30.8.638; PLOMIN R, 1994, SCIENCE, V264, P733; SEEMAN P, 1994, TRENDS PHARMACOL SCI, V15, P264, DOI 10.1016/0165-6147(94)90323-9; SOMMER SS, 1993, AM J MED GENET, V48, P90, DOI 10.1002/ajmg.1320480207; THOMSON G, 1994, NAT GENET, V8, P108, DOI 10.1038/ng1094-108; VANBOCKXMEER FM, 1994, NAT GENET, V6, P4, DOI 10.1038/ng0194-4; VANTOL HHM, 1992, NATURE, V358, P149; VANTOL HHM, 1991, NATURE, V350, P610, DOI 10.1038/350610a0; VANYUKOV MM, 1995, AM J MED GENET, V60, P122, DOI 10.1002/ajmg.1320600207	20	1097	1129	1	85	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1996	12	1					78	80		10.1038/ng0196-78	http://dx.doi.org/10.1038/ng0196-78			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TM555	8528256				2022-12-25	WOS:A1996TM55500018
J	SupertiFurga, A; Hastbacka, J; Wilcox, WR; Cohn, DH; vanderHarten, HJ; Rossi, A; Blau, N; Rimoin, DL; Steinmann, B; Lander, ES; Gitzelmann, R				SupertiFurga, A; Hastbacka, J; Wilcox, WR; Cohn, DH; vanderHarten, HJ; Rossi, A; Blau, N; Rimoin, DL; Steinmann, B; Lander, ES; Gitzelmann, R			Achondrogenesis type IB is caused by mutations in the diastrophic dysplasia sulphate transporter gene	NATURE GENETICS			English	Letter									WHITEHEAD INST BIOMED RES,CAMBRIDGE,MA 02142; CEDARS SINAI RES INST,STEVEN SPIELBERG PEDIAT RES CTR,AHMANSON DEPT PEDIAT,LOS ANGELES,CA 90048; UNIV CALIF LOS ANGELES,SCH MED,DEPT PEDIAT,LOS ANGELES,CA 90048; FREE UNIV AMSTERDAM,ACAD HOSP,DEPT PATHOL,1007 MB AMSTERDAM,NETHERLANDS; UNIV PAVIA,DEPT BIOCHEM,I-27100 PAVIA,ITALY; UNIV ZURICH,CHILDRENS HOSP,DIV CLIN CHEM,CH-8032 ZURICH,SWITZERLAND; MIT,DEPT BIOL,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT); Whitehead Institute; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Vrije Universiteit Amsterdam; University of Pavia; University Children's Hospital Zurich; University of Zurich; Massachusetts Institute of Technology (MIT)	SupertiFurga, A (corresponding author), UNIV ZURICH,CHILDRENS HOSP,DEPT PEDIAT,DIV METAB & MOLEC DIS,STEINWIESSTR 75,CH-8032 ZURICH,SWITZERLAND.		Rossi, Antonio/E-9935-2012; superti-furga, andrea/E-9162-2015	superti-furga, andrea/0000-0002-3543-7531; Blau, Nenad/0000-0003-4347-3230	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00098] Funding Source: Medline; NICHD NIH HHS [HD 22657] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BELLUS GA, 1995, NAT GENET, V10, P357, DOI 10.1038/ng0795-357; BISSIG M, 1994, J BIOL CHEM, V269, P3017; BOROCHOWITZ Z, 1988, J PEDIATR-US, V112, P23, DOI 10.1016/S0022-3476(88)80113-6; BUDOWLE B, 1991, AM J HUM GENET, V48, P137; ESKO JD, 1986, J BIOL CHEM, V261, P5725; FILMOIN DL, 1993, HERITABLE DISORDERS, P557; FRACCARO M, 1952, FOLIA HERED PATHOL, V1, P190; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; Horton William A., 1993, P641; SHARONY R, 1993, AM J OBSTET GYNECOL, V169, P668, DOI 10.1016/0002-9378(93)90641-U; SPRANGER J, 1994, EUR J PEDIATR, V153, P56, DOI 10.1007/BF01959208; SPRANGER J, 1992, EUR J PEDIATR, V151, P407; SUPERTIFURGA A, 1994, AM J HUM GENET, V55, P1137; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; URBAN JPG, 1993, J CELL PHYSIOL, V154, P262, DOI 10.1002/jcp.1041540208; van der Harten H J, 1988, Pediatr Pathol, V8, P571; VENN M, 1977, ANN RHEUM DIS, V36, P121, DOI 10.1136/ard.36.2.121	18	166	169	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1996	12	1					100	102		10.1038/ng0196-100	http://dx.doi.org/10.1038/ng0196-100			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TM555	8528239				2022-12-25	WOS:A1996TM55500025
J	BURKE, JR; WINGFIELD, MS; LEWIS, KE; ROSES, AD; LEE, JE; HULETTE, C; PERICAKVANCE, MA; VANCE, JM				BURKE, JR; WINGFIELD, MS; LEWIS, KE; ROSES, AD; LEE, JE; HULETTE, C; PERICAKVANCE, MA; VANCE, JM			THE HAW-RIVER-SYNDROME - DENTATORUBROPALLIDOLUYSIAN ATROPHY (DRPLA) IN AN AFRICAN-AMERICAN FAMILY	NATURE GENETICS			English	Article							PALLIDO-LUYSIAN ATROPHY; HUNTINGTONS-DISEASE; REPEAT LENGTH; AGE; POLYMORPHISM; FEATURES; ONSET	Haw River Syndrome (HRS) is a dominant neurodegenerative disease that has affected five generations of an African-American family in rural North Carolina. The disorder represents a unique spectrum of multiple system degenerations resembling Huntington's disease, spinocerebellar atrophy and dentatorubropallidoluysian atrophy (DRPLA), a neurodegenerative disease that has been primarily reported in Japan. Recently, DRPLA has been shown to be due to an expanded trinucleotide repeat located on chromosome 12pter-p12. We have genotyped this family and found HRS to be tightly linked to the DRPLA region. Further examination demonstrates that, despite their distinct cultural origins and clinical and pathological differences, HRS is caused by the same expanded CTG-B37 repeat as DRPLA.	DUKE UNIV, MED CTR, DEPT PSYCHIAT, DURHAM, NC 27710 USA; DUKE UNIV, MED CTR, DEPT PATHOL, DURHAM, NC 27710 USA; JOHN UMSTEAD STATE HOSP, BUTNER, NC USA; UNIV N CAROLINA, DEPT NEUROL, CHAPEL HILL, NC USA	Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill	BURKE, JR (corresponding author), DUKE UNIV, MED CTR, DEPT MED, DIV NEUROL, DURHAM, NC 27710 USA.		Burke, James R/E-4245-2016	Burke, James R/0000-0002-3408-7787; Vance, Jeffery/0000-0003-3815-8199	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029416, K08NS001533] Funding Source: NIH RePORTER; NINDS NIH HHS [NINDS NS29416, NINDS NS01533, NINDS NS26330] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; BAKER HF, 1991, LANCET, V337, P1286, DOI 10.1016/0140-6736(91)92953-Y; BENOTHMANE K, 1992, NAT GENET, V2, P315, DOI 10.1038/ng1292-315; EDWARDS MC, 1991, NUCLEIC ACIDS RES, V19, P4791, DOI 10.1093/nar/19.17.4791-a; FARMER TW, 1989, ARCH NEUROL-CHICAGO, V46, P774, DOI 10.1001/archneur.1989.00520430068020; FARMER TW, 1992, ARCH NEUROL-CHICAGO, V49, P13, DOI 10.1001/archneur.1992.00530250017003; FARMER TW, 1991, J NEUROIMAGING, V1, P123; FARRER LA, 1993, AM J HUM GENET, V53, P125; HAYNES C, 1986, GENET EPIDEMIOL, P235; HAYNES C S, 1988, American Journal of Human Genetics, V43, pA146; IIZUKA R, 1984, J NEUROL NEUROSUR PS, V47, P1288, DOI 10.1136/jnnp.47.12.1288; Klawans HL., 1986, HDB CLIN NEUROLOGY, P437; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; LI SH, 1993, GENOMICS, V16, P572, DOI 10.1006/geno.1993.1232; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; SINGER C, 1992, ARCH NEUROL-CHICAGO, V49, P13, DOI 10.1001/archneur.1992.00530250017002; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; WARNER TT, 1994, NAT GENET, V6, P225, DOI 10.1038/ng0394-225a	18	168	172	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1994	7	4					521	524		10.1038/ng0894-521	http://dx.doi.org/10.1038/ng0894-521			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PA832	7951323				2022-12-25	WOS:A1994PA83200020
J	CRAIG, JM; BICKMORE, WA				CRAIG, JM; BICKMORE, WA			THE DISTRIBUTION OF CPG ISLANDS IN MAMMALIAN CHROMOSOMES	NATURE GENETICS			English	Article							GENOME ORGANIZATION; DNA-REPLICATION; GENE-EXPRESSION; X-CHROMOSOME; BANDS; CHROMATIN; MOUSE; NUCLEOSKELETON; NONUNIFORM; EVOLUTION	Using fluorescent in situ suppression hybridization to metaphase chromosomes, we have directly shown that CpG islands are predominantly found in the early replicating (R band) regions of the genome. Conversely, late replicating (G band) DNA is sparsely populated with islands. The very highest concentration of CpG islands is in a subset of R bands, most of which are known as T bands. We suggest that there is an interdependence between the differences in island density and the behaviour of chromosomal domains. Our findings indicate which regions of the genome will yield the highest density of coding sequence information. An awareness of local island density may influence the choice of method for identifying exons in genomic DNA.	WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND	University of Edinburgh			Craig, Jeffrey M/B-3484-2012; Bickmore, Wendy A/C-7314-2013	Craig, Jeffrey M/0000-0003-3979-7849; Bickmore, Wendy A/0000-0001-6660-7735				BERNARDI G, 1989, ANNU REV GENET, V23, P637, DOI 10.1146/annurev.genet.23.1.637; BICKMORE WA, 1992, METHOD ENZYMOL, V216, P224; BICKMORE WA, 1989, TRENDS GENET, V5, P144, DOI 10.1016/0168-9525(89)90055-3; BIRD A, 1985, CELL, V40, P91, DOI 10.1016/0092-8674(85)90312-5; BIRD AP, 1987, TRENDS GENET, V3, P342, DOI 10.1016/0168-9525(87)90294-0; CARTER KC, 1991, J CELL BIOL, V115, P1191, DOI 10.1083/jcb.115.5.1191; CHEUNG SW, 1990, PRENATAL DIAG, V10, P717, DOI 10.1002/pd.1970101105; COMINGS DE, 1978, ANNU REV GENET, V12, P25, DOI 10.1146/annurev.ge.12.120178.000325; CRAIG JM, 1993, BIOESSAYS, V15, P349, DOI 10.1002/bies.950150510; CROSS S, 1991, NUCLEIC ACIDS RES, V19, P1469, DOI 10.1093/nar/19.7.1469; DISNEY JE, 1989, J CELL BIOL, V109, P1975, DOI 10.1083/jcb.109.5.1975; DROUIN R, 1990, CHROMOSOMA, V99, P273, DOI 10.1007/BF01731703; FANTES JA, 1992, AM J HUM GENET, V51, P1286; FRANCKE U, 1994, CYTOGENET CELL GENET, V65, P206, DOI 10.1159/000133633; GLASER T, 1989, SOMAT CELL MOLEC GEN, V15, P477, DOI 10.1007/BF01534910; GRAY AJ, 1984, NUCLEIC ACIDS RES, V12, P473, DOI 10.1093/nar/12.1Part2.473; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; HOLMQUIST GP, 1989, J MOL EVOL, V28, P469, DOI 10.1007/BF02602928; HOLMQUIST GP, 1987, AM J HUM GENET, V40, P151; HOLMQUIST GP, 1992, AM J HUM GENET, V51, P17; HOZAK P, 1993, CELL, V73, P361, DOI 10.1016/0092-8674(93)90235-I; JACKSON DA, 1985, EMBO J, V4, P919, DOI 10.1002/j.1460-2075.1985.tb03719.x; JANSON M, 1991, P NATL ACAD SCI USA, V88, P10609, DOI 10.1073/pnas.88.23.10609; JEPPESEN P, 1993, CELL, V74, P281, DOI 10.1016/0092-8674(93)90419-Q; KORENBERG JR, 1988, CELL, V53, P391, DOI 10.1016/0092-8674(88)90159-6; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; MANUELIDIS L, 1990, CYTOMETRY, V11, P8, DOI 10.1002/cyto.990110104; MANUELIDIS L, 1984, CHROMOSOMA, V91, P28, DOI 10.1007/BF00286482; MITCHELL AR, 1992, EXP CELL RES, V202, P203, DOI 10.1016/0014-4827(92)90421-4; NASIR J, 1991, NUCLEIC ACIDS RES, V19, P3255, DOI 10.1093/nar/19.12.3255; OLIVER SG, 1992, NATURE, V357, P38, DOI 10.1038/357038a0; RIGGS AD, 1992, TRENDS GENET, V8, P169, DOI 10.1016/0168-9525(92)90219-T; SACCONE S, 1992, P NATL ACAD SCI USA, V89, P4913, DOI 10.1073/pnas.89.11.4913; SENTIS C, 1993, CHROMOSOMA, V102, P267, DOI 10.1007/BF00352400; SHARP PM, 1993, NUCLEIC ACIDS RES, V21, P179, DOI 10.1093/nar/21.2.179; SORIANO P, 1983, P NATL ACAD SCI-BIOL, V80, P1816, DOI 10.1073/pnas.80.7.1816; Sumner A. T, 1990, CHROMOSOME BANDING; TAZI J, 1990, CELL, V60, P909, DOI 10.1016/0092-8674(90)90339-G; WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0; WU TC, 1994, SCIENCE, V263, P515, DOI 10.1126/science.8290959; YUNIS JJ, 1965, NATURE, V205, P311, DOI 10.1038/205311a0; YUNIS JJ, 1978, CYTOGENET CELL GENET, V22, P364, DOI 10.1159/000130973	42	230	252	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1994	7	3					376	382		10.1038/ng0794-376	http://dx.doi.org/10.1038/ng0794-376			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NU306	7920655				2022-12-25	WOS:A1994NU30600011
J	PRESTON, RA; POST, JC; KEATS, BJB; ASTON, CE; FERRELL, RE; PRIEST, J; NOURI, N; LOSKEN, HW; MORRIS, CA; HURTT, MR; MULVIHILL, JJ; EHRLICH, GD				PRESTON, RA; POST, JC; KEATS, BJB; ASTON, CE; FERRELL, RE; PRIEST, J; NOURI, N; LOSKEN, HW; MORRIS, CA; HURTT, MR; MULVIHILL, JJ; EHRLICH, GD			A GENE FOR CROUZON CRANIOFACIAL DYSOSTOSIS MAPS TO THE LONG ARM OF CHROMOSOME-10	NATURE GENETICS			English	Article							REPEAT POLYMORPHISMS; PAIRED BOX; CRANIOSYNOSTOSIS; MUTATION; LINKAGE; DNA; HEAD	Crouzon craniofacial dysostosis (CFD) is an autosomal dominant craniofacial disorder characterized by premature craniosynostosis, shallow orbits and hypoplastic maxilla. To map the gene responsible, we have used a mapping strategy of testing for linkage to known developmental genes. Analysis of a large kindred established linkage between CFD and three loci (D10S190, D10S209 and D10S216) that span a 13 cM region on chromosome 10q. A maximum pairwise lod score of 4.42 (theta = 0) at D10S190 was obtained and the addition of a second kindred produced a combined pairwise lod score of 5.32 (theta = 0) at the same locus. The developmental gene, PAX2, located within this region, is an attractive candidate gene.	UNIV PITTSBURGH,DEPT OTOLARYNGOL,PITTSBURGH,PA 15261; UNIV PITTSBURGH,DEPT PATHOL,PITTSBURGH,PA 15261; UNIV PITTSBURGH,DEPT HUMAN GENET,PITTSBURGH,PA 15261; UNIV PITTSBURGH,DEPT PLAST SURG,PITTSBURGH,PA 15261; UNIV PITTSBURGH,DEPT NEUROL,PITTSBURGH,PA 15261; UNIV PITTSBURGH,DEPT INFECT DIS & MICROBIOL,PITTSBURGH,PA 15261; CHILDRENS HOSP PITTSBURGH,DEPT PEDIAT OTOLARYNGOL,PITTSBURGH,PA 15213; LOUISIANA STATE UNIV,MED CTR,DEPT BIOMETRY & GENET,NEW ORLEANS,LA 70112; UNIV NEVADA,SCH MED,DEPT PEDIAT,LAS VEGAS,NV 89102	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Louisiana State University System; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas					NCRR NIH HHS [1 P1 RR06009] Funding Source: Medline; NIDCD NIH HHS [NIDCD 1 RO1 DC02148-01] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002148] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BALLING R, 1988, CELL, V55, P531, DOI 10.1016/0092-8674(88)90039-6; BALLING R, 1989, CELL, V58, P337, DOI 10.1016/0092-8674(89)90848-9; BRUETON L, 1988, AM J MED GENET, V31, P799, DOI 10.1002/ajmg.1320310412; BRUETON LA, 1992, J MED GENET, V29, P681, DOI 10.1136/jmg.29.10.681; COHEN M M JR, 1986, P413; COHEN MM, 1992, CLIN GENET, V41, P12; Crouzon O, 1912, B MEM SOC MED HOP P, V33, P545; EHRLICH GD, 1992, CLIN MICROBIOL NEWS, V13, P149; FINKELSTEIN R, 1991, DEVELOPMENT, V112, P899; GORLIN RJ, 1990, SYNDROMES HEAD NECK, P524; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; HUNT P, 1991, CELL, V66, P1075, DOI 10.1016/0092-8674(91)90029-X; JABS EW, 1993, CELL, V75, P443, DOI 10.1016/0092-8674(93)90379-5; JONES KL, 1975, J PEDIATR-US, V86, P84, DOI 10.1016/S0022-3476(75)80709-8; Kreiborg S, 1981, Scand J Plast Reconstr Surg Suppl, V18, P1; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEWANDA AF, 1994, GENOMICS, V19, P115, DOI 10.1006/geno.1994.1020; LONAI P, 1990, FASEB J, V4, P1436, DOI 10.1096/fasebj.4.5.1968407; MCKUSICK VA, 1994, ONLINE MENDELIAN INH; MCPHERSON E, 1976, HUM GENET, V35, P117, DOI 10.1007/BF00295627; ROSENFELD MG, 1991, GENE DEV, V5, P897, DOI 10.1101/gad.5.6.897; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SIRKO DA, 1994, PCR BASED DIAGNOSTIC, P19; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; WARNICH L, 1989, NUCLEIC ACIDS RES, V17, P474, DOI 10.1093/nar/17.1.474; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4039, DOI 10.1093/nar/18.13.4039; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	28	71	73	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1994	7	2					149	153		10.1038/ng0694-149	http://dx.doi.org/10.1038/ng0694-149			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NQ037	7920632				2022-12-25	WOS:A1994NQ03700013
J	FONTAINE, B; VALESANTOS, J; JURKATROTT, K; REBOUL, J; PLASSART, E; RIME, CS; ELBAZ, A; HEINE, R; GUIMARAES, J; WEISSENBACH, J; BAUMANN, N; FARDEAU, M; LEHMANNHORN, F				FONTAINE, B; VALESANTOS, J; JURKATROTT, K; REBOUL, J; PLASSART, E; RIME, CS; ELBAZ, A; HEINE, R; GUIMARAES, J; WEISSENBACH, J; BAUMANN, N; FARDEAU, M; LEHMANNHORN, F			MAPPING OF THE HYPOKALEMIC PERIODIC PARALYSIS (HYPOPP) LOCUS TO CHROMOSOME 1Q31-32 IN 3 EUROPEAN FAMILIES	NATURE GENETICS			English	Article							CHANNEL ALPHA-SUBUNIT; PARAMYOTONIA-CONGENITA; LINKAGE ANALYSIS; GENE; POLYMORPHISMS; MUTATIONS; MAP	Hypokalaemic periodic paralysis (HypoPP) is an autosomal dominant muscle disease thought to arise from an abnormal function of ion channels. Performing a genome-wide search using polymorphic dinucleotide repeats, we have localized the HypoPP locus in three families of different geographic origin to chromosome 1q31-32, by linkage analysis. Using an intragenic microsatellite, we also demonstrate that the gene encoding the muscle DHP-sensitive calcium channel al subunit(CACNL1A3) maps to the same region, sharing a 5 centiMorgan (cM) interval with the HypoPP locus. Moreover, CACNL1A3 co-segregrates with HypoPP without recombinants in the two informative families, and is therefore a good candidate for the HypoPP gene.	HOP LA PITIE SALPETRIERE,FEDERAT NEUROL,F-75013 PARIS,FRANCE; HOP LA PITIE SALPETRIERE,SERV NEUROL,F-75013 PARIS,FRANCE; HOSP EGAZ MONIZ,SERV NEUROL,P-1300 LISBON,PORTUGAL; UNIV ULM,ANGEW PHYSIOL ABT,D-89081 ULM,GERMANY; INSERM,U153,F-75005 PARIS,FRANCE; GENETHON,F-91000 EVRY,FRANCE; INST PASTEUR,F-75015 PARIS,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Ulm University; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	FONTAINE, B (corresponding author), HOP LA PITIE SALPETRIERE,INSERM,U134,F-75013 PARIS,FRANCE.		Elbaz, Alexis/F-8952-2017	Elbaz, Alexis/0000-0001-9724-5490				BRUNS GA, 1991, CELL GENET, V9, P686; BURUMA OJS, 1979, HDB CLIN NEUROLOGY, V41, P147; CANNON SC, 1993, NEURON, V10, P317, DOI 10.1016/0896-6273(93)90321-H; CASLEY WL, 1992, GENOMICS, V14, P493, DOI 10.1016/S0888-7543(05)80249-6; CHAUDHARI N, 1992, J BIOL CHEM, V267, P25636; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; CUMMINS TR, 1993, NEURON, V10, P667, DOI 10.1016/0896-6273(93)90168-Q; DRACOPOLI NC, 1991, GENOMICS, V9, P686, DOI 10.1016/0888-7543(91)90362-I; ENGELSTEIN M, 1993, GENOMICS, V15, P251, DOI 10.1006/geno.1993.1054; FONTAINE B, 1990, SCIENCE, V250, P1000, DOI 10.1126/science.2173143; Fontaine B, 1991, Neuromuscul Disord, V1, P235, DOI 10.1016/0960-8966(91)90095-A; GEORGE AL, 1993, NAT GENET, V3, P305, DOI 10.1038/ng0493-305; GHANSHANI S, 1992, GENOMICS, V12, P190, DOI 10.1016/0888-7543(92)90365-Y; GREGG RG, 1993, GENOMICS, V15, P107, DOI 10.1006/geno.1993.1017; GUSELLA JF, 1986, ANNU REV BIOCHEM, V55, P831, DOI 10.1146/annurev.biochem.55.1.831; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HEINE R, 1993, HUM MOL GENET, V2, P1349, DOI 10.1093/hmg/2.9.1349; ILES DE, 1993, HUM MOL GENET, V2, P863; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEHMANNHORN F, IN PRESS MYOLOGY; LINKS TP, 1990, BRAIN, V113, P1873, DOI 10.1093/brain/113.6.1873; MCCLATCHEY AI, 1992, CELL, V68, P769, DOI 10.1016/0092-8674(92)90151-2; MCCLATCHEY AI, 1992, AM J HUM GENET, V50, P896; McKusick VA, 1990, MENDELIAN INHERITANC; OTSU K, 1993, GENOMICS, V17, P507, DOI 10.1006/geno.1993.1357; Ott J., 1991, ANAL HUMAN GENETIC L; PTACEK LJ, 1991, CELL, V67, P1021; PTACEK LJ, 1992, NEURON, V8, P891; ROJAS CV, 1991, NATURE, V354, P387, DOI 10.1038/354387a0; RUDEL R, 1985, TRENDS NEUROSCI, V8, P467, DOI 10.1016/0166-2236(85)90171-7; RUDEL R, 1984, MUSCLE NERVE, V7, P110, DOI 10.1002/mus.880070205; SUDBRAK R, 1993, HUM MOL GENET, V2, P857, DOI 10.1093/hmg/2.7.857; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	35	210	217	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1994	6	3					267	272		10.1038/ng0394-267	http://dx.doi.org/10.1038/ng0394-267			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ562	8012389				2022-12-25	WOS:A1994MZ56200014
J	MYERS, RH; MACDONALD, ME; KOROSHETZ, WJ; DUYAO, MP; AMBROSE, CM; TAYLOR, SAM; BARNES, G; SRINIDHI, J; LIN, CS; WHALEY, WL; LAZZARINI, AM; SCHWARZ, M; WOLFF, G; BIRD, ED; VONSATTEL, JPG; GUSELLA, JF				MYERS, RH; MACDONALD, ME; KOROSHETZ, WJ; DUYAO, MP; AMBROSE, CM; TAYLOR, SAM; BARNES, G; SRINIDHI, J; LIN, CS; WHALEY, WL; LAZZARINI, AM; SCHWARZ, M; WOLFF, G; BIRD, ED; VONSATTEL, JPG; GUSELLA, JF			DE-NOVO EXPANSION OF A (CAG)(N) REPEAT IN SPORADIC HUNTINGTONS-DISEASE	NATURE GENETICS			English	Article							MYOTONIC-DYSTROPHY; CANDIDATE REGION; FRAGILE-X; MUTATION; INSTABILITY; CHOREA; ONSET; GENE	Huntington's disease (HD) chromosomes contain an expanded unstable (CAG)n repeat in chromosome 4p16.3. We have examined nine families with potential de novo expression of the disease. With one exception, all of the affected individuals had 42 or more repeat units, well above the normal range. In four families, elderly unaffected relatives inherited the same chromosome as that containing the expanded repeat in the proband, but had repeat lengths of 34-38 units, spanning the gap between the normal and HD distributions. Thus, mutation to HD is usually associated with an expansion from an already large repeat.	HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,DEPT NEUROL,BOSTON,MA 02114; HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,DEPT GENET,BOSTON,MA 02114; HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,DEPT MOLEC,NEUROGENET UNIT,BOSTON,MA 02114; UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,DEPT NEUROL,NEW BRUNSWICK,NJ 08903; RHEIN WESTFAL TH AACHEN,NEUROL KLIN,W-5100 AACHEN,GERMANY; UNIV FREIBURG,INST HUMAN GENET & ANTHROPOL,W-7800 FREIBURG,GERMANY; MCLEAN HOSP,MAILMAN RES CTR,RALPH LOWELL LAB,CTR BRAIN TISSUE RESOURCE,BELMONT,MA 02172	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Rutgers State University New Brunswick; Rutgers State University Medical Center; RWTH Aachen University; University of Freiburg; Harvard University; McLean Hospital	MYERS, RH (corresponding author), BOSTON UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02118, USA.			Myers, Richard/0000-0002-8365-2674	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016367, P50NS016367] Funding Source: NIH RePORTER; NINDS NIH HHS [NS16367] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON MA, 1984, IN VITRO, V20; BARAITSER M, 1983, J MED GENET, V20, P459, DOI 10.1136/jmg.20.6.459; BATEMAN D, 1992, ANN NEUROL, V31, P293, DOI 10.1002/ana.410310311; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; CASKEY CT, 1992, SCIENCE, V256, P784, DOI 10.1126/science.1589758; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HARPER PS, 1992, AM J HUM GENET, V51, P10; HARPER PS, 1991, HUNTINGTON DIS MAJOR, V22, P281; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; LIN CS, 1991, SOMAT CELL MOLEC GEN, V17, P481, DOI 10.1007/BF01233172; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; MARTIN JB, 1986, NEW ENGL J MED, V315, P1267; MYERS RH, 1985, AM J HUM GENET, V37, P511; MYERS RH, 1985, J NEUROL NEUROSUR PS, V48, P530, DOI 10.1136/jnnp.48.6.530; REED TE, 1958, AM J HUM GENET, V10, P201; SHAW M, 1982, J MED GENET, V19, P161, DOI 10.1136/jmg.19.3.161; STEVENS D, 1969, J NEUROL NEUROSUR PS, V32, P140, DOI 10.1136/jnnp.32.2.140; TAYLOR SAM, 1992, HUM MOL GENET, V1, P147; VOGEL F, 1986, HUMAN GENETICS; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; WALLACE DC, 1972, MED J AUSTRALIA, V1, P299, DOI 10.5694/j.1326-5377.1972.tb46796.x; WASMUTH JJ, 1988, NATURE, V332, P734, DOI 10.1038/332734a0; WOLFF G, 1989, J MED GENET, V26, P18, DOI 10.1136/jmg.26.1.18; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179; 1993, CELL, V72, P971	28	217	219	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1993	5	2					168	173		10.1038/ng1093-168	http://dx.doi.org/10.1038/ng1093-168			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MA056	8252042				2022-12-25	WOS:A1993MA05600015
J	BHATIA, K; HUPPI, K; SPANGLER, G; SIWARSKI, D; IYER, R; MAGRATH, I				BHATIA, K; HUPPI, K; SPANGLER, G; SIWARSKI, D; IYER, R; MAGRATH, I			POINT MUTATIONS IN THE C-MYC TRANSACTIVATION DOMAIN ARE COMMON IN BURKITTS-LYMPHOMA AND MOUSE PLASMACYTOMAS	NATURE GENETICS			English	Article							EXPRESSION; GENE; TRANSLOCATION; ACTIVATION; ONCOGENES; APOPTOSIS; CELLS	We have screened the entire coding region of c-myc in a panel of Burkitt's lymphomas (BLs) and mouse plasmacytomas (PCTs). Contrary to the belief that c-myc is wild type in these tumours, we found that 65% of 57 BLs and 30% of 10 PCTs tested exhibit at least one amino acid (aa) substitution. These mutations were apparently homozygous in all BL cell lines tested and two tumour biopsies, implying that the mutations often occur before Myc/Ig translocation in BL. In PCTs, only the mutant c-myc allele was expressed indicating a functional homozygosity, but occurrence of mutations after the translocation. Many of the observed mutations are clustered in regions associated with transcriptional activation and apoptosis, and in BLs, they frequently occur at sites of phosphorylation, suggesting that the mutations have a pathogenetic role.	NCI, GENET LAB, MOLEC GENET SECT, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	BHATIA, K (corresponding author), NCI, PEDIAT BRANCH, CLIN ONCOL PROGRAM, BLDG 10, ROOM 13N240, BETHESDA, MD 20892 USA.							ASKEW DS, 1991, ONCOGENE, V6, P1915; COLE MD, 1986, ANNU REV GENET, V20, P361, DOI 10.1146/annurev.ge.20.120186.002045; CORY S, 1986, ADV CANCER RES, V47, P189, DOI 10.1016/S0065-230X(08)60200-6; DEPINHO RA, 1991, ADV CANCER RES, V57, P1; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; GU W, 1993, P NATL ACAD SCI USA, V90, P2935, DOI 10.1073/pnas.90.7.2935; GUPTA S, 1993, P NATL ACAD SCI USA, V90, P3216, DOI 10.1073/pnas.90.8.3216; LEGOUY E, 1987, EMBO J, V6, P3359, DOI 10.1002/j.1460-2075.1987.tb02657.x; Magrath I, 1992, Semin Cancer Biol, V3, P285; Magrath I, 1990, Adv Cancer Res, V55, P133, DOI 10.1016/S0065-230X(08)60470-4; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; POTTER M, 1992, CARCINOGENESIS, V13, P1681, DOI 10.1093/carcin/13.10.1681; POTTER M, 1987, SCIENCE, V235, P787, DOI 10.1126/science.3810165; PRENDERGAST GC, 1992, TRENDS GENET, V8, P91, DOI 10.1016/0168-9525(92)90196-B; RABBITTS TH, 1984, NATURE, V309, P592, DOI 10.1038/309592a0; RABBITTS TH, 1983, NATURE, V306, P760, DOI 10.1038/306760a0; SETH A, 1991, J BIOL CHEM, V266, P23521; SHI YF, 1992, SCIENCE, V257, P212, DOI 10.1126/science.1378649; SUEN TC, 1991, MOL CELL BIOL, V11, P354, DOI 10.1128/MCB.11.1.354; WYLLIE AH, 1987, BRIT J CANCER, V56, P251, DOI 10.1038/bjc.1987.186	20	228	230	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1993	5	1					56	61		10.1038/ng0993-56	http://dx.doi.org/10.1038/ng0993-56			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LV565	8220424				2022-12-25	WOS:A1993LV56500016
J	SCHAEFER, L; FERRERO, GB; GRILLO, A; BASSI, MT; ROTH, EJ; WAPENAAR, MC; VANOMMEN, GJB; MOHANDAS, TK; ROCCHI, M; ZOGHBI, HY; BALLABIO, A				SCHAEFER, L; FERRERO, GB; GRILLO, A; BASSI, MT; ROTH, EJ; WAPENAAR, MC; VANOMMEN, GJB; MOHANDAS, TK; ROCCHI, M; ZOGHBI, HY; BALLABIO, A			A HIGH-RESOLUTION DELETION MAP OF HUMAN CHROMOSOME-XP22	NATURE GENETICS			English	Article							HUMAN X-CHROMOSOME; STEROID SULFATASE DEFICIENCY; DISTAL SHORT ARM; GLYCEROL KINASE-DEFICIENCY; LINKED OCULAR ALBINISM; CONGENITAL ADRENAL HYPOPLASIA; DUCHENNE MUSCULAR-DYSTROPHY; MULTILOCUS LINKAGE ANALYSIS; CONTIGUOUS GENE SYNDROMES; CHONDRODYSPLASIA PUNCTATA	We have developed a 32-interval deletion panel for human chromosome Xp22 spanning about 30 megabases of genomic DNA. DNA samples from 50 patients with chromosomal rearrangements involving Xp22 were tested with 60 markers using a polymerase chain reaction strategy. The ensuing deletion map allowed us to confirm and refine the order of previously isolated and newly developed markers. Our mapping panel will provide the framework for mapping new sequences, for orienting chromosome walks in the region and for projects aimed at isolating genes responsible for diseases mapping to Xp22.	BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; BAYLOR COLL MED,CTR HUMAN GENOME,HOUSTON,TX 77030; LEIDEN UNIV,DEPT HUMAN GENET,2333 AL LEIDEN,NETHERLANDS; UCLA,HARBOR MED CTR,DIV MED GENET,TORRANCE,CA 90509; UNIV BARI,IST GENET,I-70126 BARI,ITALY	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Leiden University; Leiden University - Excl LUMC; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Universita degli Studi di Bari Aldo Moro			Bassi, Maria Teresa T/A-3517-2014; Ferrero, Giovanni Battista/K-5265-2018; BALLABIO, Andrea/AAL-2672-2020	Bassi, Maria Teresa T/0000-0002-8236-1197; Ferrero, Giovanni Battista/0000-0002-3793-5788; BALLABIO, Andrea/0000-0003-1381-4604; Zoghbi, Huda/0000-0002-0700-3349	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028333] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000003] Funding Source: NIH RePORTER; NHGRI NIH HHS [T32HG00003] Funding Source: Medline; NICHD NIH HHS [HD28333, HD24234] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AICARDI J, 1965, ELECTROEN CLIN NEURO, V19, P609; ALGAZALI LI, 1990, J MED GENET, V27, P59, DOI 10.1136/jmg.27.1.59; ALITALO T, 1991, HUM GENET, V86, P599, DOI 10.1007/BF00201548; BAILEY DMD, 1992, GENOMICS, V14, P203, DOI 10.1016/S0888-7543(05)80310-6; BALLABIO A, 1987, P NATL ACAD SCI USA, V84, P4519, DOI 10.1073/pnas.84.13.4519; BALLABIO A, 1989, ANN HUM GENET, V53, P9, DOI 10.1111/j.1469-1809.1989.tb01117.x; BALLABIO A, 1986, HUM GENET, V72, P237, DOI 10.1007/BF00291885; BALLABIO A, 1990, GENOMICS, V8, P263, DOI 10.1016/0888-7543(90)90281-X; BALLABIO A, 1989, P NATL ACAD SCI USA, V86, P10001, DOI 10.1073/pnas.86.24.10001; BALLABIO A, 1985, HUM GENET, V70, P315, DOI 10.1007/BF00295367; BALLABIO A, 1989, GENOMICS, V4, P36, DOI 10.1016/0888-7543(89)90311-X; BALLABIO A, 1988, CLIN GENET, V34, P31; BALLABIO A, 1991, AM J MED GENET, V41, P184, DOI 10.1002/ajmg.1320410210; Ballabio Andrea, 1992, Human Molecular Genetics, V1, P221, DOI 10.1093/hmg/1.4.221; Ballabio A, 1991, CURR OPIN GENET DEV, V1, P25, DOI 10.1016/0959-437X(91)80036-L; BARDONI B, 1988, Genomics, V3, P32, DOI 10.1016/0888-7543(88)90155-3; BARKER DF, 1989, CYTOGENET CELL GENET, V51, P958; BECKER MA, 1990, GENOMICS, V8, P555, DOI 10.1016/0888-7543(90)90043-T; BERGEN AAB, 1990, OPHTHALMIC PAED GEN, V11, P165, DOI 10.3109/13816819009020975; BERGEN AAB, 1991, HUM GENET, V88, P162, DOI 10.1007/BF00206065; BICK D, 1989, AM J MED GENET, V33, P100, DOI 10.1002/ajmg.1320330114; BREUKEL C, 1990, NUCLEIC ACIDS RES, V18, P3097, DOI 10.1093/nar/18.10.3097; BROWN CJ, 1988, HUM GENET, V80, P296, DOI 10.1007/BF01790101; CARROZZO R, 1992, GENOMICS, V12, P7, DOI 10.1016/0888-7543(92)90399-D; CHARLES SJ, 1992, J MED GENET, V29, P552, DOI 10.1136/jmg.29.8.552; COUVREUR JM, 1990, CYTOGENET CELL GENET, V53, P137, DOI 10.1159/000132914; CURRY CJR, 1984, NEW ENGL J MED, V311, P1010, DOI 10.1056/NEJM198410183111603; DAHL HHM, 1991, HUM GENET, V87, P49, DOI 10.1007/BF01213091; DAVIES KE, 1991, CYTOGENET CELL GENET, V58, P853, DOI 10.1159/000133183; DONNENFELD AE, 1990, AM J MED GENET, V37, P182, DOI 10.1002/ajmg.1320370205; DORKINS H, 1985, HUM GENET, V71, P103, DOI 10.1007/BF00283362; ELLIS NA, 1989, NATURE, V337, P81, DOI 10.1038/337081a0; ELLISON J, 1992, SOMAT CELL MOLEC GEN, V18, P259, DOI 10.1007/BF01233862; ELLISON KA, 1992, AM J HUM GENET, V50, P278; FOOTE S, 1992, SCIENCE, V258, P60, DOI 10.1126/science.1359640; FRANCKE U, 1987, AM J HUM GENET, V40, P212; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; GIBBS RA, 1989, P NATL ACAD SCI USA, V86, P1919, DOI 10.1073/pnas.86.6.1919; GILLARD EF, 1987, NUCLEIC ACIDS RES, V15, P3977, DOI 10.1093/nar/15.10.3977; GOLTZ RW, 1962, ARCH DERMATOL, V86, P708, DOI 10.1001/archderm.1962.01590120006002; GUIOLI S, 1992, NAT GENET, V1, P337, DOI 10.1038/ng0892-337; JOHNSON CL, 1991, AM J HUM GENET, V49, P261; JOHNSTON K, 1987, AM J MED GENET, V27, P603, DOI 10.1002/ajmg.1320270313; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; KERE J, 1992, GENOMICS, V14, P241, DOI 10.1016/S0888-7543(05)80212-5; KOENIG M, 1984, NUCLEIC ACIDS RES, V12, P4097, DOI 10.1093/nar/12.10.4097; KUNKEL LM, 1983, NUCLEIC ACIDS RES, V11, P7961, DOI 10.1093/nar/11.22.7961; LAGERSTROM M, 1991, GENOMICS, V10, P971, DOI 10.1016/0888-7543(91)90187-J; LAGERSTROM M, 1990, AM J HUM GENET, V46, P120; LEDBETTER DH, 1986, AM J MED GENET, V23, P429, DOI 10.1002/ajmg.1320230135; LEGOUIS R, 1991, CELL, V67, P423, DOI 10.1016/0092-8674(91)90193-3; McKusick V.A., 1992, MENDELIAN INHERITANC; METAXOTOU C, 1983, CLIN GENET, V24, P380, DOI 10.1111/j.1399-0004.1983.tb00089.x; NARITOMI K, 1992, AM J MED GENET, V43, P839, DOI 10.1002/ajmg.1320430517; NISHIMURA S, 1991, AM J MED GENET, V40, P260, DOI 10.1002/ajmg.1320400303; PETIT C, 1990, GENOMICS, V6, P651, DOI 10.1016/0888-7543(90)90500-T; PILLERS DAM, 1990, AM J MED GENET, V36, P23, DOI 10.1002/ajmg.1320360106; PIOMBO G, 1987, 2ND NAT C IT FED STU, P151; READ AP, 1986, HUM GENET, V73, P267, DOI 10.1007/BF00401242; ROPERS HH, 1985, CYTOGENET CELL GENET, V40, P736; ROPERS HH, 1982, HUM GENET, V61, P364; Sambrook J, 1989, MOL CLONING LABORATO; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; SCHNEIDERGADICKE A, 1989, NATURE, V342, P708, DOI 10.1038/342708a0; SCHNUR RE, 1991, GENOMICS, V9, P605, DOI 10.1016/0888-7543(91)90353-G; SUNOHARA N, 1986, ANN NEUROL, V19, P174, DOI 10.1002/ana.410190211; TEMPLE IK, 1990, J MED GENET, V27, P56, DOI 10.1136/jmg.27.1.56; THIES U, 1990, HUM GENET, V86, P418; TIEPOLO L, 1980, HUM GENET, V54, P205, DOI 10.1007/BF00278973; TOWBIN JA, 1989, HUM GENET, V83, P122, DOI 10.1007/BF00286703; VOLLRATH D, 1992, SCIENCE, V258, P52, DOI 10.1126/science.1439769; WANG JC, 1992, SOMAT CELL MOLEC GEN, V18, P195, DOI 10.1007/BF01233165; WAPENAAR MC, 1992, GENOMICS, V13, P167, DOI 10.1016/0888-7543(92)90217-G; WAPENAAR MC, IN PRESS HUM MOL GEN; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WIEACKER P, 1983, CYTOGENET CELL GENET, V35, P72, DOI 10.1159/000131841; WORLEY KC, 1992, GENOMICS, V13, P957, DOI 10.1016/0888-7543(92)90007-F; WULFSBERG EA, 1992, AM J MED GENET, V43, P823, DOI 10.1002/ajmg.1320430514; YEN PH, 1990, CELL, V61, P603, DOI 10.1016/0092-8674(90)90472-Q; YEN PH, 1987, CELL, V49, P443, DOI 10.1016/0092-8674(87)90447-8; YEN PH, 1984, SOMAT CELL MOLEC GEN, V10, P561, DOI 10.1007/BF01535221; YEN PH, 1991, P NATL ACAD SCI USA, V88, P8944, DOI 10.1073/pnas.88.20.8944; ZOGHBI HY, 1991, GENOMICS, V9, P713, DOI 10.1016/0888-7543(91)90365-L; ZOGHBI HY, 1989, AM J HUM GENET, V44, P255; ZOGHBI HY, IN PRESS GENERATION	85	100	101	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1993	4	3					272	279		10.1038/ng0793-272	http://dx.doi.org/10.1038/ng0793-272			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ842	8358436				2022-12-25	WOS:A1993LJ84200015
J	BAJOCCHI, G; FELDMAN, SH; CRYSTAL, RG; MASTRANGELI, A				BAJOCCHI, G; FELDMAN, SH; CRYSTAL, RG; MASTRANGELI, A			DIRECT INVIVO GENE-TRANSFER TO EPENDYMAL CELLS IN THE CENTRAL-NERVOUS-SYSTEM USING RECOMBINANT ADENOVIRUS VECTORS	NATURE GENETICS			English	Article							GENETICALLY MODIFIED CELLS; BLOOD-BRAIN-BARRIER; BETA-GALACTOSIDASE; DRUG DELIVERY; RAT	To evaluate the potential for adenovirus-mediated central nervous system (CNS) gene transfer, the replication deficient recombinant adenovirus vectors Ad.RSVbetagal (coding for beta-galactosidase) and Ad-alpha1AT (coding for human alpha1-antitrypsin) were administered to the lateral ventricle of rats. Ad.RSVbetagal transferred beta-galactosidase to ependymal cells lining the ventricles whereas Ad-alpha1AT mediated alpha1-antitrypsin secretion into the cerebral spinal fluid for 1 week. These observations, together with beta-galactosidase activity in the globus pallidus and substantia nigra following stereotactic administration of Ad.RSVbetagal to the globus pallidus, suggest that adenovirus vectors will be useful for CNS gene therapy.	NHLBI, PULM BRANCH, BETHESDA, MD 20892 USA; NHLBI, LAB ANIM MED & SURG SECT, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)			BAJOCCHI, GIANLUIGI/AAA-6565-2020; Feldman, Sanford/AAH-7070-2021	bajocchi, gianluigi/0000-0002-6430-800X				ANDERSEN JK, 1992, HUM GENE THER, V3, P487, DOI 10.1089/hum.1992.3.5-487; BALERCIA G, 1991, J NEUROCYTOL, V21, P105; BASS NH, 1973, BRAIN RES, V52, P323, DOI 10.1016/0006-8993(73)90668-9; BOWSHER D, 1957, ANAT RECORD, V128, P23, DOI 10.1002/ar.1091280104; Brumback R.A., 1989, CEREBROSPINAL FLUID, P15; CULVER KW, 1992, SCIENCE, V256, P1550, DOI 10.1126/science.1317968; DANNENBERG AM, 1981, METHODS STUDYING MON, P375; DOBSON AT, 1990, NEURON, V5, P353, DOI 10.1016/0896-6273(90)90171-B; FEDEROFF HJ, 1992, P NATL ACAD SCI USA, V89, P1636, DOI 10.1073/pnas.89.5.1636; GAGE FH, 1990, PROG BRAIN RES, V82, P1; HARBAUGH RE, 1989, NEUROBIOL AGING, V10, P623, DOI 10.1016/0197-4580(89)90155-3; HORWITZ MS, 1991, FUNDAMENTAL VIROLOGY, P1679; HUANG Q, 1992, EXP NEUROL, V115, P303, DOI 10.1016/0014-4886(92)90196-W; JAFFE HA, 1992, NAT GENET, V1, P372, DOI 10.1038/ng0892-372; Kasper M, 1992, Adv Anat Embryol Cell Biol, V126, P1; KAWAJA MD, 1992, J NEUROSCI, V12, P2849; KRIEGER DT, 1981, NEW ENGL J MED, V304, P944, DOI 10.1056/NEJM198104163041605; LEMARCHAND P, 1992, P NATL ACAD SCI USA, V89, P6482, DOI 10.1073/pnas.89.14.6482; MASTRANGELI A, 1993, J CLIN INVEST, V91, P225, DOI 10.1172/JCI116175; MIETTINEN M, 1986, AM J PATHOL, V123, P231; ONO T, 1990, NEUROSCI LETT, V117, P259, DOI 10.1016/0304-3940(90)90673-W; PARDRIDGE WM, 1988, ANNU REV PHARMACOL, V28, P25; PARDRIDGE WM, 1989, NEUROBIOL AGING, V10, P636, DOI 10.1016/0197-4580(89)90160-7; Paxinos G., 2004, J CHEM INF MODEL, V5th; ROSEMBERG MB, 1988, SCIENCE, V2, P1575; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680; ROTMAN B, 1961, P NATL ACAD SCI USA, V47, P1981, DOI 10.1073/pnas.47.12.1981; SHIMOHAMA S, 1989, MOL BRAIN RES, V5, P271, DOI 10.1016/0169-328X(89)90061-2; WOLFE JH, 1992, NAT GENET, V1, P379, DOI 10.1038/ng0892-379; [No title captured]	31	341	362	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1993	3	3					229	234		10.1038/ng0393-229	http://dx.doi.org/10.1038/ng0393-229			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KP790	8485578				2022-12-25	WOS:A1993KP79000012
J	BROWN, AG; ROSS, FM; DUNNE, EM; STEEL, CM; WEIRTHOMPSON, EM				BROWN, AG; ROSS, FM; DUNNE, EM; STEEL, CM; WEIRTHOMPSON, EM			EVIDENCE FOR A NEW TUMOR SUPPRESSOR LOCUS (DBM) IN HUMAN B-CELL NEOPLASIA TELOMERIC TO THE RETINOBLASTOMA GENE	NATURE GENETICS			English	Article							PHYSICAL MAP; ABNORMALITIES; CHROMOSOMES; LEUKEMIA; DELETION; LINE	Roughly 25% of human B-cell chronic lymphocytic leukaemias (CLL) are characterized by a chromosomal lesion involving 13q14. This region contains the retinoblastoma gene (RB1). We have used a variety of techniques to determine whether RB1 or some other locus is the critical region in 11 cases of low grade B-cell malignancy (mainly CLL), all with deletions or translocations involving 13q14. In all cases, except the one with minimal disease, there was deletion or a structural lesion in the region of D13S25, with at least 4 cases showing homozyogous disruption. We conclude that D13S25 lies close to a tumour suppressor locus whose inactivation contributes to the initiation or progression of low grade B-cell malignancy. This locus is located at least 530 kilobases telomeric to RB1.	WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,CREWE RD,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND	University of Edinburgh			Dunne, Eimear/C-6785-2012	Dunne, Eimear/0000-0001-9862-1398				ABRAMSON DH, 1984, OPHTHALMOLOGY, V91, P1351; ALHADEFF B, 1977, CYTOGENET CELL GENET, V19, P236, DOI 10.1159/000130814; BICKMORE WA, 1989, SOMAT CELL MOLEC GEN, V15, P229, DOI 10.1007/BF01534873; BOWCOCK AM, 1991, NUCLEIC ACIDS RES, V18, P7194; CHEN YC, 1990, BLOOD, V76, P2060; CHENG J, 1990, BLOOD, V75, P730; Claflin L, 1978, Curr Top Microbiol Immunol, V81, P107; FORD GM, 1990, GENOMICS, V6, P284, DOI 10.1016/0888-7543(90)90568-F; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FURUKAWA Y, 1990, BLOOD, V76, P272; GINSBERG AM, 1991, BLOOD, V77, P833; HANSEN MF, 1990, CANCER GENET CYTOGEN, V49, P15, DOI 10.1016/0165-4608(90)90159-8; HARBOUR JW, 1988, SCIENCE, V241, P353, DOI 10.1126/science.2838909; HIGGINS MJ, 1989, MOL CELL BIOL, V9, P1; HILLION J, 1991, CANCER GENET CYTOGEN, V54, P197, DOI 10.1016/0165-4608(91)90207-B; JULIUSSON G, 1990, NEW ENGL J MED, V323, P720, DOI 10.1056/NEJM199009133231105; LALANDE M, 1984, CANCER GENET CYTOGEN, V13, P283, DOI 10.1016/0165-4608(84)90073-6; LINK AJ, 1991, GENETICS, V127, P681; LIU Y, 1992, GENE CHROMOSOME CANC, V4, P250, DOI 10.1002/gcc.2870040310; LUND E, 1983, MOL CELL BIOL, V3, P2211, DOI 10.1128/MCB.3.12.2211; Maniatis T, 1989, DECONTAMINATION DILU; MARSHALL CJ, 1991, CELL, V64, P313, DOI 10.1016/0092-8674(91)90641-B; Melchers F, 1978, Curr Top Microbiol Immunol, V81, pIX; MICKLEM LR, 1987, J IMMUNOL METHODS, V104, P81, DOI 10.1016/0022-1759(87)90490-X; MORRIS CM, 1991, GENE CHROMOSOME CANC, V3, P455, DOI 10.1002/gcc.2870030607; OSCIER D, 1990, BLOOD, V76, P241; ROSS FM, 1987, CANCER GENET CYTOGEN, V25, P109, DOI 10.1016/0165-4608(87)90166-X; SALTMAN DL, 1988, BLOOD, V72, P2026, DOI 10.1182/blood.V72.6.2026.2026; TANG A, 1988, SCIENCE, V242, P263, DOI 10.1126/science.3175651; WEINBERG RA, 1992, CANCER SURV, V12, P43; WIGGS J, 1988, NEW ENGL J MED, V318, P151, DOI 10.1056/NEJM198801213180305; YUNIS JJ, 1975, HUMANGENETIK, V27, P167, DOI 10.1007/BF00278343; 1991, CYTOGENET CELL GENET, V58, P580	33	140	140	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1993	3	1					67	72		10.1038/ng0193-67	http://dx.doi.org/10.1038/ng0193-67			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KF372	8490658				2022-12-25	WOS:A1993KF37200015
J	CATTANACH, BM; BURTENSHAW, MD; RASBERRY, C; EVANS, EP				CATTANACH, BM; BURTENSHAW, MD; RASBERRY, C; EVANS, EP			LARGE DELETIONS AND OTHER GROSS FORMS OF CHROMOSOME IMBALANCE COMPATIBLE WITH VIABILITY AND FERTILITY IN THE MOUSE	NATURE GENETICS			English	Article							LOCI	Large deletions and other gross forms of chromosome imbalance are known in man but have rarely been found in the mouse. By screening progeny of spermatogonially irradiated male mice for a combination of runting and other phenotypic effects, we have identified animals that have large deletions comprising from 2.5-30 percent of the length of individual chromosomes, or other major chromosome changes, which are compatible with viability and fertility. Certain chromosome regions appear particularly susceptible to the generation of viable deletions and this has implications for radiation mutagenesis studies. Correlations with human deletions are also indicated.			CATTANACH, BM (corresponding author), MRC,DIV GENET,RADIOBIOL UNIT,DIDCOT OX11 0RD,OXON,ENGLAND.							Beechey CV, 1986, MOUSE NEWS LETT, V75, P28; CACHEIRO NLA, 1975, GENET RES, V25, P193, DOI 10.1017/S0016672300015597; CATTANACH BM, 1991, CYTOGENET CELL GENET, V56, P137, DOI 10.1159/000133070; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; CATTANACH BM, 1988, MOUSE NEWS LETT, V80, P157; CATTANACH BM, 1988, MOUSE NEWS LETT, V80, P156; CATTANACH BM, 1992, MOUSE GENOME, V90, P87; DAVISSON MT, 1991, CYTOGENET CELL GENET, V58, P1152, DOI 10.1159/000133726; DIGNAN PSJ, 1979, HUM GENET, V48, P151, DOI 10.1007/BF00286898; EVANS EP, 1990, MOUSE GENOME, V86, P230; EVANS EP, 1988, MOUSE NEWS LETT, V81, P66; FRANCO B, 1991, HUM GENET, V87, P269, DOI 10.1007/BF00200903; HOO JJ, 1986, HUM GENET, V73, P230, DOI 10.1007/BF00401233; KORENBERG JR, 1991, HUM GENET, V87, P112, DOI 10.1007/BF00204163; Lyon M. F., 1992, Mouse Genome, V90, P22; Lyon ME, 1986, MOUSE NEWS LETT, V74, P96; LYON MF, 1984, GENET RES, V44, P161, DOI 10.1017/S0016672300026367; MIKLOS GLG, 1974, CYTOGENET CELL GENET, V13, P558, DOI 10.1159/000130307; Rinchik E.M., 1990, GENOME ANAL, P121; SARDA P, 1992, J MED GENET, V29, P259, DOI 10.1136/jmg.29.4.259; SCHINZEL A, 1988, PROGR TOPICS CYTOGEN, V8, P725; SEARLE AG, 1974, ADV RAD BIOL, V4; SEARLE AG, 1989, GENETIC VARIANTS STR, P582; VAUX C, 1991, J MED GENET, V29, P256; WINKING H, 1984, GENETICS, V108, P1013; 1985, NIH852011 PUBL	26	73	73	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1993	3	1					56	61		10.1038/ng0193-56	http://dx.doi.org/10.1038/ng0193-56			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KF372	8490655				2022-12-25	WOS:A1993KF37200013
J	Dryja, TP; Hahn, LB; Reboul, T; Arnaud, B				Dryja, TP; Hahn, LB; Reboul, T; Arnaud, B			Missense mutation in the gene encoding the alpha subunit of rod transducin in the Nougaret form of congenital stationary night blindness	NATURE GENETICS			English	Letter							GS-ALPHA; RHODOPSIN GENE; ONCOGENE; ACTIVATION; ORGANIZATION; PROTEIN; CDNA		HARVARD UNIV,MASSACHUSETTS EYE & EAR INFIRM,SCH MED,TAYLOR SMITH LAB,BOSTON,MA 02114; CHU MONTPELLIER,HOP GUIDE CHAULIAC,SERV OPHTALMOL,F-34295 MONTPELLIER 5,FRANCE	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Universite de Montpellier; CHU de Montpellier	Dryja, TP (corresponding author), HARVARD UNIV,MASSACHUSETTS EYE & EAR INFIRM,SCH MED,OCULAR MOL GENET INST,243 CHARLES ST,BOSTON,MA 02114, USA.				NEI NIH HHS [EY08683] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008683] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARMINGTON JC, 1954, AMA ARCH OPHTHALMOL, V52, P725; BASCOM RA, 1993, HUM MOL GENET, V2, P385, DOI 10.1093/hmg/2.4.385; CARR R. E., 1966, INVEST OPHTHALMOL, V5, P497; CHIPPERFIELD RG, 1985, MOL CELL BIOL, V5, P1809, DOI 10.1128/MCB.5.8.1809; CUNIER F, 1838, ANN SOC MED GAND, V4, P383; Cunier F, 1838, ANN OCUL, V1, P32; DEJEAN C, 1949, B SOC OPHTALMOL FR, V1, P96; DRYJA TP, 1993, NAT GENET, V4, P280, DOI 10.1038/ng0793-280; DRYJA TP, 1995, P NATL ACAD SCI USA, V92, P10177, DOI 10.1073/pnas.92.22.10177; DRYJA TP, 1991, P NATL ACAD SCI USA, V88, P9370, DOI 10.1073/pnas.88.20.9370; FONG SL, 1992, NUCLEIC ACIDS RES, V20, P2865, DOI 10.1093/nar/20.11.2865; FRANCOIS J, 1956, OPHTHALMOLOGICA, V132, P244; GAL A, 1994, NAT GENET, V7, P64, DOI 10.1038/ng0594-64; GOODMAN G, 1957, ARCH OPHTHALMOL-CHIC, V58, P174; GRAZIANO MP, 1989, J BIOL CHEM, V264, P15475; HAHN LB, 1994, INVEST OPHTH VIS SCI, V35, P1077; HUANG SH, 1995, NAT GENET, V11, P468, DOI 10.1038/ng1295-468; KHANI SC, IN PRESS GENOMICS; KOLESNIKOV SS, 1995, NATURE, V376, P85, DOI 10.1038/376085a0; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; LEE E, 1992, J BIOL CHEM, V267, P1212; LEE YJ, 1994, NEURON, V13, P1143, DOI 10.1016/0896-6273(94)90052-3; MASTERS SB, 1989, J BIOL CHEM, V264, P15467; MCLAUGHLIN ME, 1995, P NATL ACAD SCI USA, V92, P3249, DOI 10.1073/pnas.92.8.3249; MURAKAMI A, 1992, BIOCHEM BIOPH RES CO, V187, P234, DOI 10.1016/S0006-291X(05)81483-4; Nettleship Edward, 1907, T OPHTHAL SOC UK, V27, P269; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; RAPORT CJ, 1994, INVEST OPHTH VIS SCI, V35, P2932; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; RUIZAVILA L, 1995, NATURE, V376, P80, DOI 10.1038/376080a0; SANTOS E, 1983, P NATL ACAD SCI-BIOL, V80, P4679, DOI 10.1073/pnas.80.15.4679; SCHUBERT G, 1952, OPHTHALMOLOGICA, V123, P396, DOI 10.1159/000301211; SEEBURG PH, 1984, NATURE, V312, P71, DOI 10.1038/312071a0; SLEVING PA, 1995, P NATL ACAD SCI USA, V92, P880; SUBBARAYA I, 1994, J BIOL CHEM, V269, P31080; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; TEMELES GL, 1985, NATURE, V313, P700, DOI 10.1038/313700a0; TONG L, 1989, NATURE, V337, P90, DOI 10.1038/337090a0; TRUC H, 1909, B SOC OPHTALMOL FR, V26, P285; YAMAKI K, 1990, J BIOL CHEM, V265, P20757	40	144	148	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1996	13	3					358	360		10.1038/ng0796-358	http://dx.doi.org/10.1038/ng0796-358			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UU283	8673138				2022-12-25	WOS:A1996UU28300027
J	Johnson, OL; Cleland, JL; Lee, HJ; Charnis, M; Duenas, E; Jaworowicz, W; Shepard, D; Shahzamani, A; Jones, AJS; Putney, SD				Johnson, OL; Cleland, JL; Lee, HJ; Charnis, M; Duenas, E; Jaworowicz, W; Shepard, D; Shahzamani, A; Jones, AJS; Putney, SD			A month-long effect from a single injection of microencapsulated human growth hormone	NATURE MEDICINE			English	Article							DRUG DELIVERY; PROTEINS; PITUITARY; RELEASE; ZINC; MICROSPHERES; DEGRADATION; POLYMERS; ACID)	An injectable sustained-release form of human growth hormone (hGH) was developed by stabilizing and encapsulating the protein, without altering its integrity, into biodegradable microspheres using a novel cryogenic process. A single injection of microspheres in monkeys resulted in elevated serum levels of recombinant hGH (rhGH) for more than one month. Insulin-like growth factor-I (IGF-I) and its binding protein IGFBP-3, both of which are induced by hGH, were also elevated for four weeks by the rhGH containing microspheres to a level greater than that induced by the same amount of rhGH administered by daily injections. These results show that, by using appropriate methods of stabilization and encapsulation, the advantages of sustained-release formulations previously demonstrated for low-molecular-weight drugs can now be extended to protein therapeutics.	ALKENNES INC,CAMBRIDGE,MA 02139; GENENTECH INC,S SAN FRANCISCO,CA 94080	Roche Holding; Genentech								AUSTIN PE, 1995, ANN EMERG MED, V25, P328, DOI 10.1016/S0196-0644(95)70289-X; BATTERSBY JE, 1995, ANAL CHEM, V67, P447, DOI 10.1021/ac00098a600; BATTERSBY JE, 1994, INT J PEPT PROT RES, V44, P215; BECK LR, 1980, CONTRACEPT DELIV SYS, V1, P79; CANOVADAVIS E, 1990, INT J PEPT PROT RES, V35, P17; CLELAND JL, 1995, P INT S CONTR REL BI, V22, P143; CLELAND JL, 1995, P INT S CONTR REL BI, V22, P518; COHEN S, 1990, J AM CHEM SOC, V112, P7832, DOI 10.1021/ja00177a074; COHEN S, 1991, PHARMACEUT RES, V8, P713, DOI 10.1023/A:1015841715384; COLEMAN JE, 1992, ANNU REV BIOCHEM, V61, P897, DOI 10.1146/annurev.bi.61.070192.004341; CUNNINGHAM BC, 1991, SCIENCE, V253, P545, DOI 10.1126/science.1907025; ECKHARDT BM, 1991, PHARM RES-DORDR, V8, P1360, DOI 10.1023/A:1015888704365; HARDOUIN S, 1989, J CLIN ENDOCR METAB, V69, P1291, DOI 10.1210/jcem-69-6-1291; HUTCHINSON FG, 1985, BIOCHEM SOC T, V13, P520, DOI 10.1042/bst0130520; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494; LAURSEN J, 1995, J CLIN ENDOCR METAB, V80, P2410; LI CH, 1986, ARCH BIOCHEM BIOPHYS, V245, P287, DOI 10.1016/0003-9861(86)90216-X; MATHEWS LS, 1986, P NATL ACAD SCI USA, V83, P9343, DOI 10.1073/pnas.83.24.9343; MATHIOWITZ E, 1988, J APPL POLYM SCI, V35, P755, DOI 10.1002/app.1988.070350316; MULLIGAN RC, 1993, SCIENCE, V260, P926, DOI 10.1126/science.8493530; OGAWA Y, 1988, CHEM PHARM BULL, V36, P2576; OGAWA Y, 1988, CHEM PHARM BULL, V36, P1095; Pearlman R, 1993, Pharm Biotechnol, V5, P1; PIHLAJAMAKI H, 1992, J BONE JOINT SURG BR, V74, P853, DOI 10.1302/0301-620X.74B6.1447246; PITT CG, 1990, INT J PHARMACEUT, V59, P173, DOI 10.1016/0378-5173(90)90108-G; PITT CG, 1980, CONTROLLED RELEASE B, P19; SANDERS LM, 1986, J PHARM SCI, V75, P356, DOI 10.1002/jps.2600750407; Schwendeman S.P., 1996, MICROPARTICULATE SYS, P1; SHAH SS, 1992, J CONTROL RELEASE, V18, P261, DOI 10.1016/0168-3659(92)90171-M; Steiner D., 1995, ENDOCRINOLOGY, P1296; TAUBER M, 1993, J CLIN ENDOCR METAB, V76, P1135, DOI 10.1210/jc.76.5.1135; TESHIMA G, 1992, J CHROMATOGR, V625, P207, DOI 10.1016/0021-9673(92)85204-7; TESHIMA G, 1991, J BIOL CHEM, V266, P13544; THORLACIUSUSSING O, 1987, NEUROENDOCRINOLOGY, V45, P233, DOI 10.1159/000124731; WILSON ME, 1991, J ENDOCRINOL, V130, P435, DOI 10.1677/joe.0.1300435; WINDE G, 1993, EUR J SURG, V159, P301; WISE DL, 1973, CONTRACEPTION, V8, P227; 1995, PHYSICIANS DESK REFE, P2502; [No title captured]	40	234	298	1	31	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUL	1996	2	7					795	799		10.1038/nm0796-795	http://dx.doi.org/10.1038/nm0796-795			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UU680	8673926				2022-12-25	WOS:A1996UU68000036
J	Larsson, NG; Garman, JD; Oldfors, A; Barsh, GS; Clayton, DA				Larsson, NG; Garman, JD; Oldfors, A; Barsh, GS; Clayton, DA			A single mouse gene encodes the mitochondrial transcription factor A and a testis-specific nuclear HMG-box protein	NATURE GENETICS			English	Article							RNA POLYMERASE-II; DNA; INVITRO; RECOGNITION; INITIATION; ACTIVATOR; INVIVO; GENOME	Mitochondrial transcription factor A (mtTFA) is a key regulator of mammalian mitochondrial DNA transcription. We report here that a testis-specific isoform of mouse mtTFA lacks the mitochondrial targeting sequence and is present in the nucleus of spermatocytes and elongating spermatids, thus representing the first reported mammalian gene encoding protein isoforms targeted for the mitochondria or the nucleus. The presence of the mitochondrial transcriptional activator in the nucleus raises the possibility of a role for this protein in both genetic systems. Mutations in the nuclear mtTFA gene may therefore exhibit phenotypic consequences due to altered function in either or both genetic compartments.	STANFORD UNIV,SCH MED,BECKMAN CTR MOL & GENET MED,DEPT DEV BIOL,STANFORD,CA 94305; SAHLGRENS UNIV HOSP,DEPT PATHOL,S-41345 GOTHENBURG,SWEDEN; STANFORD UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT GENET,STANFORD,CA 94305; STANFORD UNIV,SCH MED,DEPT PEDIAT,STANFORD,CA 94305	Stanford University; Sahlgrenska University Hospital; Howard Hughes Medical Institute; Stanford University; Stanford University			Larsson, Nils-Göran/GVS-5578-2022	Larsson, Nils-Göran/0000-0001-5100-996X; Oldfors, Anders/0000-0002-5758-7397	NIGMS NIH HHS [R37 GM-33088-25] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM033088] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BOISSONNEAULT G, 1993, MOL CELL BIOL, V13, P4323, DOI 10.1128/MCB.13.7.4323; CLAYTON DA, 1991, ANNU REV CELL BIOL, V7, P453, DOI 10.1146/annurev.cb.07.110191.002321; DAIRAGHI DJ, 1995, J MOL BIOL, V249, P11, DOI 10.1006/jmbi.1995.9889; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; ERICKSON RP, 1990, TRENDS GENET, V6, P264, DOI 10.1016/0168-9525(90)90209-O; FISHER RP, 1985, J BIOL CHEM, V260, P1330; FISHER RP, 1992, J BIOL CHEM, V267, P3358; FISHER RP, 1989, GENE DEV, V3, P2202, DOI 10.1101/gad.3.12b.2202; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5; HECHT NB, 1984, DEV BIOL, V102, P452, DOI 10.1016/0012-1606(84)90210-0; KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542; Kornberg A., 1991, DNA REPLICATION; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LARSSON NG, 1994, BIOCHEM BIOPH RES CO, V200, P1374, DOI 10.1006/bbrc.1994.1603; Larsson NG, 1995, ANNU REV GENET, V29, P151, DOI 10.1146/annurev.ge.29.120195.001055; MICHAEL NL, 1984, EMBO J, V3, P3165, DOI 10.1002/j.1460-2075.1984.tb02275.x; PARISI MA, 1993, MOL CELL BIOL, V13, P1951, DOI 10.1128/MCB.13.3.1951; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; POULTON J, 1994, HUM MOL GENET, V3, P1763, DOI 10.1093/hmg/3.10.1763; RYAN KR, 1995, CELL, V83, P517, DOI 10.1016/0092-8674(95)90089-6; Sambrook J., 2002, MOL CLONING LAB MANU; TAPPER DP, 1983, METHOD ENZYMOL, V97, P426; THOMPSON NE, 1989, J BIOL CHEM, V264, P11511; TIRANTI V, 1995, GENOMICS, V25, P559, DOI 10.1016/0888-7543(95)80058-T	27	118	122	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1996	13	3					296	302		10.1038/ng0796-296	http://dx.doi.org/10.1038/ng0796-296			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UU283	8673128				2022-12-25	WOS:A1996UU28300017
J	Zhao, Q; Behringer, RR; deCrombrugghe, B				Zhao, Q; Behringer, RR; deCrombrugghe, B			Prenatal folic acid treatment suppresses acrania and meroanencephaly in mice mutant for the Cart1 homeobox gene	NATURE GENETICS			English	Article							NEURAL-TUBE DEFECTS; MESENCHYMAL CELL; MOUSE EMBRYO; RAT EMBRYOS; NEURULATION; CREST; PROTOONCOGENE; DISRUPTION; CLOSURE; REGION	The paired-class homeobox-containing gene, Cart1, is expressed in forebrain mesenchyme, branchial arches, limb buds and cartilages during embryogenesis. Here, we show that Cart1-homozygous mutant mice are born alive with acrania and meroanencephaly but die soon after birth - a phenotype that strikingly resembles a corresponding human syndrome caused by a neural tube closure defect. Developmental studies suggest that Cart1 is required for forebrain mesenchyme survival and that its absence disrupts cranial neural tube morphogenesis by blocking the initiation of closure in the midbrain region that ultimately leads to the generation of lethal craniofacial defects. Prenatal treatment of Cart1 homozygous mutants with folic acid suppresses the development of the acrania/meroanencephaly phenotype.	UNIV TEXAS, MD ANDERSON CANC CTR, DEPT MOLEC GENET, HOUSTON, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center					NIAMS NIH HHS [AR42909, AR40335] Funding Source: Medline; NICHD NIH HHS [HD31155] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD031155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040335, R01AR042909] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bradley A, 1987, TERATOCARCINOMAS EMB, P113; CAMPBELL LR, 1986, TERATOLOGY, V34, P171, DOI 10.1002/tera.1420340206; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; CHEYETTE BNR, 1994, NEURON, V12, P977, DOI 10.1016/0896-6273(94)90308-5; COPP AJ, 1990, PROG NEUROBIOL, V35, P363, DOI 10.1016/0301-0082(90)90037-H; COULY GF, 1993, DEVELOPMENT, V117, P409; Edmonds L D, 1990, MMWR CDC Surveill Summ, V39, P19; GEELEN JAG, 1977, ANAT RECORD, V189, P625, DOI 10.1002/ar.1091890407; GORDON R, 1985, J EMBRYOL EXP MORPH, V89, P229; GRAHAM A, 1993, DEVELOPMENT, V119, P233; HUNTER AGW, 1993, HUMAN MALFORMATIONS, P109; JURILOFF DM, 1991, TERATOLOGY, V44, P225, DOI 10.1002/tera.1420440211; Kaufman M. H, 1990, POSTIMPLANTATION MAM, P81; KOCHHAR DM, 1973, TERATOLOGY, V7, P289, DOI 10.1002/tera.1420070310; Le Douarin N.M., 1982, NEURAL CREST; LEDOUARIN NM, 1993, DEV BIOL, V159, P24, DOI 10.1006/dbio.1993.1219; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MITCHELL PJ, 1991, GENE DEV, V5, P105, DOI 10.1101/gad.5.1.105; MORRISS GM, 1978, ZOON, V6, P33; MORRISS GM, 1978, J EMBRYOL EXP MORPH, V46, P37; MORRISSKAY GM, 1981, J EMBRYOL EXP MORPH, V65, P225; MORRISWIMAN J, 1990, ANAT REC, V226, P383, DOI 10.1002/ar.1092260316; NODEN DM, 1983, DEV BIOL, V96, P144, DOI 10.1016/0012-1606(83)90318-4; NODEN DM, 1988, DEVELOPMENT, V103, P121; OJEDA JL, 1970, STAIN TECHNOL, V45, P137; RUDNICK A, 1994, P NATL ACAD SCI USA, V91, P12203, DOI 10.1073/pnas.91.25.12203; SAKAI Y, 1989, ANAT RECORD, V223, P194, DOI 10.1002/ar.1092230212; SASSOON DA, 1988, DEVELOPMENT, V104, P155; SCHOENWOLF GC, 1990, DEVELOPMENT, V109, P243; SMITHELLS RW, 1989, LANCET, V2, P498; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; WILKINSON DG, 1987, DEVELOPMENT, V99, P493; WOLF C, 1991, DEV BIOL, V143, P363, DOI 10.1016/0012-1606(91)90086-I; XIONG WC, 1995, NEURON, V14, P581, DOI 10.1016/0896-6273(95)90314-3; ZHAO GQ, 1994, MECH DEVELOP, V48, P245, DOI 10.1016/0925-4773(94)90063-9; ZHAO GQ, 1993, P NATL ACAD SCI USA, V90, P8633, DOI 10.1073/pnas.90.18.8633	37	202	206	0	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1996	13	3					275	283		10.1038/ng0796-275	http://dx.doi.org/10.1038/ng0796-275			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UU283	8673125				2022-12-25	WOS:A1996UU28300014
J	Goudreau, G; Carpenter, S; Beaulieu, N; Jolicoeur, P				Goudreau, G; Carpenter, S; Beaulieu, N; Jolicoeur, P			Vacuolar myelopathy in transgenic mice expressing human immunodeficiency virus type 1 proteins under the regulation of the myelin basic protein gene promoter	NATURE MEDICINE			English	Article							CENTRAL-NERVOUS-SYSTEM; DEFICIENCY SYNDROME PATIENTS; SPINAL-CORD; HIV-1 INFECTION; AIDS PATIENTS; GLIAL-CELLS; OLIGODENDROCYTES; MACROPHAGES; ENCEPHALOPATHY; IDENTIFICATION	Vacuolar myelopathy is a common neurological complication in AIDS patients. The pathogenesis of this spinal cord white matter disease remains unclear and it is still debated whether infection of spinal cord with the human immunodeficiency virus type 1 (HIV-1) is causing the disease. We have generated transgenic mice expressing the entire HIV-1 genome under the regulation of an oligodendrocyte-specific promoter. These mice develop spinal cord vacuolar lesions similar to those found in AIDS patients. This animal model provides in vivo evidence linking the expression of HIV-1 proteins in oligodendrocytes to the spinal cord damage found in vacuolar myelopathy.	CLIN RES INST MONTREAL,MOLEC BIOL LAB,MONTREAL,PQ H2W 1R7,CANADA; MCGILL UNIV,MONTREAL NEUROL INST,MONTREAL,PQ H3A 2B4,CANADA; UNIV MONTREAL,DEPT MICROBIOL & IMMUNOL,MONTREAL,PQ H3C 3J7,CANADA; MCGILL UNIV,DEPT EXPTL MED,MONTREAL,PQ H3G 1A4,CANADA	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University; Universite de Montreal; McGill University								ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; ALLAN JS, 1985, SCIENCE, V230, P810, DOI 10.1126/science.2997921; ALLINQUANT B, 1991, J CELL BIOL, V113, P393, DOI 10.1083/jcb.113.2.393; ARTIGAS J, 1990, PATHOL RES PRACT, V186, P228, DOI 10.1016/S0344-0338(11)80540-6; ARYA SK, 1986, P NATL ACAD SCI USA, V83, P2209, DOI 10.1073/pnas.83.7.2209; BAGASRA O, IN PRESS AIDS; BERGMANN M, 1993, PATHOL RES PRACT, V189, P58, DOI 10.1016/S0344-0338(11)80117-2; BOUCHARD L, 1989, CELL, V57, P931, DOI 10.1016/0092-8674(89)90331-0; BUDKA H, 1988, J INFECT DIS, V157, P203, DOI 10.1093/infdis/157.1.203; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; EILBOTT DJ, 1989, P NATL ACAD SCI USA, V86, P3337, DOI 10.1073/pnas.86.9.3337; EMBRETSON J, 1993, P NATL ACAD SCI USA, V90, P357, DOI 10.1073/pnas.90.1.357; ESIRI MM, 1991, AIDS, V5, P1081, DOI 10.1097/00002030-199109000-00003; GOLDSTICK L, 1985, NEUROLOGY, V35, P103, DOI 10.1212/WNL.35.1.103; GOSZTONYI G, 1994, J NEUROPATH EXP NEUR, V53, P521, DOI 10.1097/00005072-199409000-00012; GRAFE MR, 1989, ANN NEUROL, V25, P561, DOI 10.1002/ana.410250606; GRAVEL C, 1993, J VIROL, V67, P6648, DOI 10.1128/JVI.67.11.6648-6658.1993; GREEN R, 1975, NATURE, V254, P148, DOI 10.1038/254148a0; GYORKEY F, 1987, J INFECT DIS, V155, P870, DOI 10.1093/infdis/155.5.870; HENIN D, 1992, HUM PATHOL, V23, P1106, DOI 10.1016/0046-8177(92)90028-2; JOLICOEUR P, 1992, J VIROL, V66, P3904, DOI 10.1128/JVI.66.6.3904-3908.1992; KAMIN SS, 1991, HUM PATHOL, V22, P816, DOI 10.1016/0046-8177(91)90211-7; KATSUKI M, 1988, SCIENCE, V241, P593, DOI 10.1126/science.2456614; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; KORBER BTM, 1994, J VIROL, V68, P7467, DOI 10.1128/JVI.68.11.7467-7481.1994; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; NUOVO GJ, 1994, AM J PATHOL, V144, P659; PETITO CK, 1994, J NEUROPATH EXP NEUR, V53, P86, DOI 10.1097/00005072-199401000-00011; PETITO CK, 1985, NEW ENGL J MED, V312, P874, DOI 10.1056/NEJM198504043121402; PUMAROLASUNE T, 1987, ANN NEUROL, V21, P490, DOI 10.1002/ana.410210513; RANKI A, 1995, AIDS, V9, P1001, DOI 10.1097/00002030-199509000-00004; ROSENBLUM M, 1989, NEUROLOGY, V39, P892, DOI 10.1212/WNL.39.7.892; SAITO Y, 1994, NEUROLOGY, V44, P474, DOI 10.1212/WNL.44.3_Part_1.474; Sambrook J., 2002, MOL CLONING LAB MANU; SCALABRINO G, 1995, LAB INVEST, V72, P114; SHARER LR, 1988, J INFECT DIS, V157, P204, DOI 10.1093/infdis/157.1.204; STOLER MH, 1986, JAMA-J AM MED ASSOC, V256, P2360, DOI 10.1001/jama.256.17.2360; TAKAHASHI N, 1985, CELL, V42, P139, DOI 10.1016/S0092-8674(85)80109-4; THOMAS FP, 1994, J VIROL, V68, P7099, DOI 10.1128/JVI.68.11.7099-7107.1994; TOGGAS SM, 1994, NATURE, V367, P188, DOI 10.1038/367188a0; TORNATORE C, 1994, NEUROLOGY, V44, P481, DOI 10.1212/WNL.44.3_Part_1.481; TURNLEY AM, 1991, NATURE, V353, P566, DOI 10.1038/353566a0; TYOR WR, 1993, NEUROLOGY, V43, P1002, DOI 10.1212/WNL.43.5.1002; VAZEUX R, 1987, AM J PATHOL, V126, P403; WEISER B, 1990, P NATL ACAD SCI USA, V87, P3997, DOI 10.1073/pnas.87.10.3997; WILEY CA, 1986, P NATL ACAD SCI USA, V83, P7089, DOI 10.1073/pnas.83.18.7089; YOSHIOKA T, 1991, MOL CELL BIOL, V11, P5479, DOI 10.1128/MCB.11.11.5479	47	37	37	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUN	1996	2	6					655	661		10.1038/nm0696-655	http://dx.doi.org/10.1038/nm0696-655			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UN691	8640556				2022-12-25	WOS:A1996UN69100033
J	Ginns, EI; Ott, J; Egeland, JA; Allen, CR; Fann, CSJ; Pauls, DL; Weissenbach, J; Carulli, JP; Falls, KM; Keith, TP; Paul, SM				Ginns, EI; Ott, J; Egeland, JA; Allen, CR; Fann, CSJ; Pauls, DL; Weissenbach, J; Carulli, JP; Falls, KM; Keith, TP; Paul, SM			A genome-wide search for chromosomal loci linked to bipolar affective disorder in the Old Order Amish	NATURE GENETICS			English	Letter							LINKAGE; RELIABILITY; MARKERS; GENE		COLUMBIA UNIV,NEW YORK,NY 10032; NEW YORK STATE PSYCHIAT INST & HOSP,NEW YORK,NY 10032; UNIV MIAMI,SCH MED,DEPT PSYCHIAT,MIAMI,FL 33136; YALE UNIV,SCH MED,CTR CHILD STUDY,NEW HAVEN,CT 06520; HUMAN GENOME RES CTR,EVRY,FRANCE; GENOME THERAPEUT CORP,WALTHAM,MA 02154; ELI LILLY & CO,LILLY RES LABS,INDIANAPOLIS,IN 46285; UNIV INDIANAPOLIS,SCH MED,DEPT PSYCHIAT,INDIANAPOLIS,IN 46285; UNIV INDIANAPOLIS,SCH MED,DEPT PHARMACOL,INDIANAPOLIS,IN 46285; UNIV INDIANAPOLIS,SCH MED,DEPT TOXICOL,INDIANAPOLIS,IN 46285	Columbia University; New York State Psychiatry Institute; University of Miami; Yale University; Eli Lilly	Ginns, EI (corresponding author), NIMH,CLIN NEUROSCI BRANCH,IRP,NIH,BLDG 49,RM B1EE16,49 CONVENT DR,MSC 4405,BETHESDA,MD 20892, USA.		Paul, Steve/ABE-5400-2020; Fann, Cathy SJ/F-9410-2010	Fann, Cathy SJ/0000-0001-9025-2276	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH044292, R01MH044292] Funding Source: NIH RePORTER; NIH HHS [NH28287] Funding Source: Medline; NIMH NIH HHS [MH44292] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BAILEYWILSON JE, 1989, SAGE STAT ANAL GENET; BERRETTINI WH, 1994, P NATL ACAD SCI USA, V91, P5918, DOI 10.1073/pnas.91.13.5918; COCKERHAM CC, 1973, GENETICS, V74, P701; CRADDOCK N, 1993, ANN MED, V25, P317, DOI 10.3109/07853899309147291; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; EGELAND JA, 1983, AM J PSYCHIAT, V140, P56; Egeland JA, 1994, GENETIC STUDIES AFFE, P70; EGELAND JA, 1994, NIH PUBLICATION, P408; EGELAND JA, 1972, DESCENDANTS FISHER O; Egeland Janice A., 1990, Psychiatric Genetics, V1, P5; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; Goodwin F, 1990, MANIC DEPRESSIVE ILL; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HOSTETTER AM, 1983, AM J PSYCHIAT, V140, P62; KELSOE JR, 1989, NATURE, V342, P238, DOI 10.1038/342238a0; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, IN PRESS PRINCIPLES; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; Ott J., 1991, ANAL HUMAN GENETIC L; PAULS DL, 1995, AM J MED GENET, V60, P290, DOI 10.1002/ajmg.1320600406; PAULS DL, 1995, AM J HUM GENET, V57, P636; PAULS DL, 1991, GENOMICS, V11, P730, DOI 10.1016/0888-7543(91)90081-O; PEKKARINEN P, 1995, GENOME RES, V5, P105, DOI 10.1101/gr.5.2.105; Sambrook J., 2002, MOL CLONING LAB MANU; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; STRAUB RE, 1994, NAT GENET, V8, P291, DOI 10.1038/ng1194-291; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; TERWILLIGER JD, 1994, 4 WORKSH NORD GEN IN; TERWILLIGER JD, IN PRESS AM J HUM GE; THOMSON G, 1994, GENET EPIDEMIOL, V11, P353, DOI 10.1002/gepi.1370110405; VIGNAL A, 1993, METHODS MOL GENETICS, V1, P211	37	149	151	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1996	12	4					431	435		10.1038/ng0496-431	http://dx.doi.org/10.1038/ng0496-431			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	UC553	8630500				2022-12-25	WOS:A1996UC55300025
J	Longbottom, C; Huysmans, MCDNJ; Pitts, NB; Los, P; Bruce, PG				Longbottom, C; Huysmans, MCDNJ; Pitts, NB; Los, P; Bruce, PG			Detection of dental decay and its extent using ac impedance spectroscopy	NATURE MEDICINE			English	Article							CARIES	Dental caries (decay), the most prevalent of diseases, represents a health problem of immense proportions(1). It principally affects posterior (back) teeth on occlusal (biting) and approximal (adjacent contacting) surfaces. Caries starts as a subsurface demineralization of enamel, may progress to the underlying dentine and, eventually, to cavitation of the surface. Accurate diagnosis before cavitation would permit targeted preventive treatment, thereby significantly improving dental health and reducing the need for expensive drilling and filling. Inaccessibility of caries initiation sites and recent changes in lesion morphology contribute to the relatively poor accuracy of conventional diagnostic methods(2). Among alternative techniques, measurements of electrical resistance(3-5) have shown the most promise. Here we described new experimental technique that demonstrates an outstanding 100% correlation between a.c. impedance measurements of whole teeth and the actual extent of approximal caries in vitro. Only relatively minor modifications should be required to transfer the technique to in vivo applications.	UNIV NIJMEGEN,INST DENT CLIN RES,TRIKON,DEPT CARIOL & ENDODONTOL,NIJMEGEN,NETHERLANDS; UNIV ST ANDREWS,SCH CHEM,ST ANDREWS KY16 9AJ,FIFE,SCOTLAND	Radboud University Nijmegen; University of St Andrews	Longbottom, C (corresponding author), UNIV DUNDEE,SCH DENT,DEPT DENT HLTH,PK PLACE,DUNDEE DD1 4HR,SCOTLAND.		Huysmans, Marie Charlotte/H-8052-2014; Bruce, Peter/AAB-2011-2019	Huysmans, Marie Charlotte/0000-0002-3036-7554; Bruce, Peter/0000-0001-6748-3084; Pitts, Nigel Berry/0000-0001-6184-4213				BRUCE PG, 1994, J ELECTROANAL CHEM, V367, P279, DOI 10.1016/0022-0728(94)03303-X; BRUCE PG, 1993, NATO ASI SER, P87; Bruce PG, 1987, POLYM ELECTROLYTE RE, V1, P237; JOHNSON NW, 1991, DENT CARIES MARKERS, P1; KAY EJ, 1991, THESIS U GLASGOW; LEVENKIND M, 1992, J DENT RES, V71, P426; LEVENKIND M, 1990, J DENT RES, V69, P1806; LONGBOTTOM C, 1992, THESIS U DUNDEE; LUSSI A, 1991, CARIES RES, V25, P296, DOI 10.1159/000261380; MAYUZUMI Y, 1964, J DENT RES, V43, P941; Pitts N B, 1992, Dent Update, V19, P37; PLEPER K, 1990, DTSCH ZAHNARTZI Z, V45, P721; RICKETTS DNJ, 1995, BRIT DENT J, V178, P11, DOI 10.1038/sj.bdj.4808636; RUSSELL M, 1993, CARIES RES, V27, P65, DOI 10.1159/000261518; SCHOLBERG HPF, 1984, ARCH ORAL BIOL, V29, P965, DOI 10.1016/0003-9969(84)90142-0; WHITE GE, 1978, J DENT RES, V57, P195, DOI 10.1177/00220345780570020801	16	48	48	0	14	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	FEB	1996	2	2					235	237		10.1038/nm0296-235	http://dx.doi.org/10.1038/nm0296-235			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TU060	8574971				2022-12-25	WOS:A1996TU06000046
J	Lacronique, V; Mignon, A; Fabre, M; Viollet, B; Rouquet, N; Molina, T; Porteu, A; Henrion, A; Bouscary, D; Varlet, P; Joulin, V; Kahn, A				Lacronique, V; Mignon, A; Fabre, M; Viollet, B; Rouquet, N; Molina, T; Porteu, A; Henrion, A; Bouscary, D; Varlet, P; Joulin, V; Kahn, A			Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice	NATURE MEDICINE			English	Article							HUMAN FOLLICULAR LYMPHOMA; CELL-DEATH; GENE; INVOLVEMENT; CDNA	Fas is an apoptosis-signaling cell surface antigen that has been shown to trigger cell death upon specific ligand or antibody binding. Treatment of mice with an anti-fas antibody causes fulminant hepatic failure due to massive apoptosis. To test a putative protective effect of the anti-apoptotic Bcl-2 protein, transgenic mice were generated to express the human bcl-2 gene product in hepatocytes. Early onset of massive hepatic apoptosis leading to death was observed in all nontransgenic mice treated with an anti-Fas antibody. By contrast, hepatic apoptosis was delayed and dramatically reduced in transgenic animals, yielding a 93% survival rate. These results demonstrate that Eel-2 is able to protect from in vivo Fas-mediated cytotoxicity, and could be of significance for preventing fulminant hepatic failure due to viral hepatitis in humans.	UNIV PARIS 05,INST COCHIN GENET MOLEC,U129 INSERM,F-75014 PARIS,FRANCE; CHU COCHIN PORT ROYAL,SERV REANIMAT MED,F-75014 PARIS,FRANCE; CHU BICETRE,SERC ANAT & CYTOL PATHOL,F-94270 LE KREMLIN BICETR,FRANCE; UNIV PARIS 05,INST COCHIN GENET MOLEC,U380 INSERM,F-75014 PARIS,FRANCE; UNIV PARIS 05,INST COCHIN GENET MOLEC,U363 INSERM,F-75014 PARIS,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite			Penard-Lacronique, Virginie/E-5729-2016; Viollet, Benoit/O-6927-2017; Molina, Thierry/ABA-5214-2020; Caude, Alexandra A Henrion/I-2778-2016; Viollet, Benoit/N-2397-2019; Penard-Lacronique, Virginie/R-1938-2019	Penard-Lacronique, Virginie/0000-0001-9435-7331; Viollet, Benoit/0000-0002-0121-0224; Molina, Thierry/0000-0002-3929-9754; Caude, Alexandra A Henrion/0000-0002-8170-2260; Viollet, Benoit/0000-0002-0121-0224; Penard-Lacronique, Virginie/0000-0001-9435-7331; JOULIN, Virginie/0000-0003-1091-7819; Bouscary, Didier/0000-0003-3654-5064				ANDO K, 1993, J EXP MED, V178, P1541, DOI 10.1084/jem.178.5.1541; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHIU VK, 1995, J IMMUNOL, V154, P2023; CLEVELAND JL, 1995, CELL, V81, P479, DOI 10.1016/0092-8674(95)90068-3; ENARI M, 1995, NATURE, V375, P78, DOI 10.1038/375078a0; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; GIANNINI G, 1995, J CELL BIOL, V128, P893, DOI 10.1083/jcb.128.5.893; HIRAMATSU N, 1994, HEPATOLOGY, V19, P1354, DOI 10.1002/hep.1840190606; ITOH N, 1993, J IMMUNOL, V151, P621; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; KIEFER MC, 1995, NATURE, V374, P736, DOI 10.1038/374736a0; KORSMEYER SJ, 1995, TRENDS GENET, V11, P101, DOI 10.1016/S0168-9525(00)89010-1; KRAJEWSKI S, 1994, AM J PATHOL, V145, P1323; LACRONIQUE V, 1995, J BIOL CHEM, V270, P14989, DOI 10.1074/jbc.270.25.14989; LOS M, 1995, NATURE, V375, P81, DOI 10.1038/375081a0; MIQUEROL L, 1994, J BIOL CHEM, V269, P8944; MITA E, 1994, BIOCHEM BIOPH RES CO, V204, P468, DOI 10.1006/bbrc.1994.2483; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; OLTVAI ZN, 1994, CELL, V79, P189, DOI 10.1016/0092-8674(94)90188-0; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; REHERMANN B, 1995, J EXP MED, V181, P1047, DOI 10.1084/jem.181.3.1047; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; ROUVIER E, 1993, J EXP MED, V177, P195, DOI 10.1084/jem.177.1.195; SUDA T, 1994, J EXP MED, V179, P873, DOI 10.1084/jem.179.3.873; TAKAHASHI H, 1995, P NATL ACAD SCI USA, V92, P1470, DOI 10.1073/pnas.92.5.1470; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; TSUJIMOTO Y, 1986, P NATL ACAD SCI USA, V83, P5214, DOI 10.1073/pnas.83.14.5214; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; VAUX DL, 1992, INT IMMUNOL, V4, P821, DOI 10.1093/intimm/4.7.821; WATANABE D, 1995, EMBO J, V14, P12, DOI 10.1002/j.1460-2075.1995.tb06970.x; WATANABEFUKUNAGA R, 1992, J IMMUNOL, V148, P1274; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WELLER M, 1995, J CLIN INVEST, V95, P2633, DOI 10.1172/JCI117965; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; ZHAO M, 1994, HISTOPATHOLOGY, V25, P237, DOI 10.1111/j.1365-2559.1994.tb01323.x; ZORNIG M, 1995, ONCOGENE, V10, P2397	42	351	358	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JAN	1996	2	1					80	86		10.1038/nm0196-80	http://dx.doi.org/10.1038/nm0196-80			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TP579	8564847				2022-12-25	WOS:A1996TP57900041
J	SUN, TQ; FENSTERMACHER, DA; VOS, JMH				SUN, TQ; FENSTERMACHER, DA; VOS, JMH			HUMAN ARTIFICIAL EPISOMAL CHROMOSOMES FOR CLONING LARGE DNA FRAGMENTS IN HUMAN-CELLS	NATURE GENETICS			English	Article							EPSTEIN-BARR-VIRUS; MAMMALIAN REPLICATION ORIGIN; POLYMERASE CHAIN-REACTION; STABLE REPLICATION; ESCHERICHIA-COLI; TRANSGENIC MICE; HUMAN GENOME; MOUSE CELLS; YEAST; GENE	We have developed a human artificial episomal chromosome (HAEC) system, based on the latent replication origin of the large herpes Epstein-Barr virus, for the propagation and stable maintenance of DNA as circular minichromosomes in human cells. Individual HAECs carried human genomic inserts ranging from 60-330 kb and appeared genetically stable. An HAEC library of 1,500 independent clones carrying random human genomic fragments with average sizes of 150-200 kb was established and allowed recovery of the HAEC DNA. Our autologous HAEC system, with human DNA cloned directly in human cells, provides an important tool for functional study of large mammalian DNA regions and gene therapy.	UNIV N CAROLINA, DEPT BIOCHEM & BIOPHYS, CHAPEL HILL, NC 27599 USA; UNIV N CAROLINA, CURRICULUM GENET & MOLEC BIOL, CHAPEL HILL, NC 27599 USA; UNIV N CAROLINA, LINEBERGER COMPREHENS CANC CTR, CHAPEL HILL, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill								ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0; BENTLEY DR, 1992, GENOMICS, V12, P534, DOI 10.1016/0888-7543(92)90445-X; BURKE DT, 1991, METHOD ENZYMOL, V194, P251; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; CARROLL SM, 1987, MOL CELL BIOL, V7, P1740, DOI 10.1128/MCB.7.5.1740; CHOI TK, 1993, NAT GENET, V4, P117, DOI 10.1038/ng0693-117; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; COLLINS A, 1987, J TISS CULT METHODS, V10, P209; CURIEL D, 1994, VIRUSES HUMAN GENE T, P164; DEININGER PL, 1981, J MOL BIOL, V151, P17, DOI 10.1016/0022-2836(81)90219-9; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; ECKHARDT T, 1978, PLASMID, V1, P584, DOI 10.1016/0147-619X(78)90016-1; FEATHERSTONE T, 1993, GENOMICS, V17, P267, DOI 10.1006/geno.1993.1321; FOOTE S, 1992, SCIENCE, V258, P60, DOI 10.1126/science.1359640; GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326a0; GLASER R, 1974, J VIROL, V14, P174, DOI 10.1128/JVI.14.1.174-176.1974; GREEN ED, 1991, GENOMICS, V11, P658, DOI 10.1016/0888-7543(91)90073-N; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HALL C V, 1983, Journal of Molecular and Applied Genetics, V2, P101; HAMMERSCHMIDT W, 1988, CELL, V55, P427, DOI 10.1016/0092-8674(88)90028-1; HENNESSY K, 1983, SCIENCE, V220, P1396, DOI 10.1126/science.6304878; HOSODA F, 1990, NUCLEIC ACIDS RES, V18, P3863, DOI 10.1093/nar/18.13.3863; HUXLEY C, 1991, GENOMICS, V9, P742, DOI 10.1016/0888-7543(91)90369-P; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; JANKELEVICH S, 1992, EMBO J, V11, P1165, DOI 10.1002/j.1460-2075.1992.tb05157.x; KIOUSSIS D, 1987, EMBO J, V6, P355, DOI 10.1002/j.1460-2075.1987.tb04762.x; KLAMAN LD, 1991, VIROLOGY, V185, P883, DOI 10.1016/0042-6822(91)90565-S; KRYSAN PJ, 1989, MOL CELL BIOL, V9, P1026, DOI 10.1128/MCB.9.3.1026; LAWRENCE JB, 1988, CELL, V52, P51; LIU P, 1993, CANCER GENET CYTOGEN, V65, P93, DOI 10.1016/0165-4608(93)90213-6; LUPTON S, 1985, MOL CELL BIOL, V5, P2533, DOI 10.1128/MCB.5.10.2533; MCKUSICK VA, 1989, NEW ENGL J MED, V320, P910, DOI 10.1056/NEJM198904063201406; MICKEL S, 1977, NUCLEIC ACIDS RES, V4, P1465, DOI 10.1093/nar/4.5.1465; MIDDLETON T, 1994, J VIROL, V68, P4067, DOI 10.1128/JVI.68.6.4067-4071.1994; MURRAY AW, 1983, NATURE, V305, P189, DOI 10.1038/305189a0; MURRAY AW, 1986, CELL, V45, P529, DOI 10.1016/0092-8674(86)90284-9; NELSON DL, 1989, P NATL ACAD SCI USA, V86, P6686, DOI 10.1073/pnas.86.17.6686; NONET GH, 1993, SOMAT CELL MOLEC GEN, V19, P171, DOI 10.1007/BF01233532; OCONNOR M, 1989, SCIENCE, V244, P1307, DOI 10.1126/science.2660262; PAVAN WJ, 1990, MOL CELL BIOL, V10, P4163, DOI 10.1128/MCB.10.8.4163; PIERCE JC, 1992, MAMM GENOME, V3, P550, DOI 10.1007/BF00350620; REISMAN D, 1985, MOL CELL BIOL, V5, P1822, DOI 10.1128/MCB.5.8.1822; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Rooney D E, 1986, HUMAN CYTOGENETICS P, VFirst; RUIZ JC, 1989, MOL CELL BIOL, V9, P109, DOI 10.1128/MCB.9.1.109; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; STERNBERG N, 1990, P NATL ACAD SCI USA, V87, P103, DOI 10.1073/pnas.87.1.103; STRAUSS WM, 1993, SCIENCE, V259, P1904, DOI 10.1126/science.8096090; STRAUSS WM, 1992, EMBO J, V11, P417, DOI 10.1002/j.1460-2075.1992.tb05070.x; SUN TQ, 1992, INT J GENOME RES, V1, P45; VOS JMH, 1994, VIRUSES HUMAN GENE T, P109; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WINOCOUR E, 1980, P NATL ACAD SCI-BIOL, V77, P4861, DOI 10.1073/pnas.77.8.4861; YATES J, 1984, P NATL ACAD SCI-BIOL, V81, P3806, DOI 10.1073/pnas.81.12.3806; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0	57	73	99	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1994	8	1					33	41		10.1038/ng0994-33	http://dx.doi.org/10.1038/ng0994-33			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PE157	7987390				2022-12-25	WOS:A1994PE15700013
J	STEENMAN, MJC; RAINIER, S; DOBRY, CJ; GRUNDY, P; HORON, IL; FEINBERG, AP				STEENMAN, MJC; RAINIER, S; DOBRY, CJ; GRUNDY, P; HORON, IL; FEINBERG, AP			LOSS OF IMPRINTING OF IGF2 IS LINKED TO REDUCED EXPRESSION AND ABNORMAL METHYLATION OF H19 IN WILMS-TUMOR	NATURE GENETICS			English	Article							GROWTH-FACTOR-II; SICKLE-CELL-ANEMIA; CALCITONIN GENE; GLOBIN GENES; INSULIN GENE; CHROMOSOME-11; DNA; CANCER; POLYMORPHISMS; RELAXATION	The insulin-like growth factor-II (IGF2) and H19 genes are imprinted in mouse and human, with expression of the paternal IGF2 and maternal H19 alleles. IGF2 undergoes loss of imprinting (LOI) in most Wilms' tumours (WT). We now show that: (i) LOI of IGF2 is associated with a 80-fold down regulation of H19 expression; (ii) these changes are associated with alterations in parental-origin-specific, tissue-independent sites of DNA methylation in the H19 promoter; and (iii) loss of heterozygosity is also associated with loss of H19 expression. Thus, imprinting of a large domain of the maternal chromosome results in a reversal to a paternal epigenotype. These data also suggest an epigenetic mechanism for inactivation of H19 as a tumour suppressor gene.	UNIV MICHIGAN,SCH MED,HOWARD HUGHES MED INST,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,DEPT INTERNAL MED,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48109; CROSS CANC INST,MOLEC ONCOL PROGRAM,EDMONTON T6G 1Z2,AB,CANADA; MARYLAND CTR HLTH STAT,BALTIMORE,MD 21201; JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT MOLEC BIOL & GENET,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT ONCOL,BALTIMORE,MD 21205	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Alberta; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University			Steenman, Marja/D-3618-2015; Steenman, Marja/S-8433-2019; Feinberg, Andrew/AAY-7666-2020	Steenman, Marja/0000-0003-4547-4448; Steenman, Marja/0000-0003-4547-4448; Feinberg, Andrew/0000-0002-8364-1991	NCI NIH HHS [CA54358, CA65145] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA065145, R37CA054358, R01CA054358] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARTOLOMEI M, 1994, NAT GENET, V6, P4; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; BAYLIN SB, 1987, BLOOD, V70, P412; Beckers J. M., 1990, ESO Messenger, P1; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; CATTANACH BM, 1990, DEVELOPMENT, P63; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DULL TJ, 1984, NATURE, V310, P777, DOI 10.1038/310777a0; FEDER J, 1985, AM J HUM GENET, V37, P635; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; FEINBERG AP, 1983, BIOCHEM BIOPH RES CO, V111, P47, DOI 10.1016/S0006-291X(83)80115-6; FEINBERG AP, 1993, NAT GENET, V4, P110, DOI 10.1038/ng0693-110; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; GIANNOUKAKIS N, 1993, NAT GENET, V4, P98, DOI 10.1038/ng0593-98; GLASER T, 1989, SOMAT CELL MOLEC GEN, V15, P477, DOI 10.1007/BF01534910; GOELZ SE, 1985, SCIENCE, V228, P187, DOI 10.1126/science.2579435; HAO Y, 1993, NATURE, V365, P764, DOI 10.1038/365764a0; Henry I., 1993, European Journal of Human Genetics, V1, P19; HENRY I, 1991, NATURE, V351, P665, DOI 10.1038/351665a0; HOCHBERG A, 1993, MED HYPOTHESES, V41, P355, DOI 10.1016/0306-9877(93)90083-3; KOI M, 1993, SCIENCE, V260, P361, DOI 10.1126/science.8469989; LAMBERT S, 1991, INT J CANCER, V48, P826, DOI 10.1002/ijc.2910480607; LEPPERT M, 1987, CYTOGENET CELL GENET, V46, P648; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; MANNENS M, 1988, HUM GENET, V81, P41, DOI 10.1007/BF00283727; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; NELKIN BD, 1984, BIOCHEM BIOPH RES CO, V123, P648, DOI 10.1016/0006-291X(84)90278-X; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; OGAWA O, 1993, NAT GENET, V5, P408, DOI 10.1038/ng1293-408; PHILLIPS JA, 1980, P NATL ACAD SCI-BIOL, V77, P2853, DOI 10.1073/pnas.77.5.2853; RACHMILEWITZ J, 1992, FEBS LETT, V309, P25, DOI 10.1016/0014-5793(92)80731-U; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; RAINIER S, 1994, HUM MOL GENET, V3, P386, DOI 10.1093/hmg/3.2.386; REDEKER E, 1993, HUM MOL GENET, V2, P823, DOI 10.1093/hmg/2.6.823; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SCHROEDER WT, 1987, AM J HUM GENET, V40, P413; SHAPIRO ET, 1990, J CLIN INVEST, V85, P1672, DOI 10.1172/JCI114619; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; SURANI MA, 1988, TRENDS GENET, V4, P59, DOI 10.1016/0168-9525(88)90040-6; SWAIN JL, 1987, CELL, V50, P719, DOI 10.1016/0092-8674(87)90330-8; TADOKORO K, 1991, NUCLEIC ACIDS RES, V19, P6967, DOI 10.1093/nar/19.24.6967; TANIGAMI A, 1992, AM J HUM GENET, V50, P56; TATOF KD, 1991, CELL, V65, P201; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143; WILKINS RJ, 1988, LANCET, V1, P329; WILSON JT, 1978, NUCLEIC ACIDS RES, V5, P563, DOI 10.1093/nar/5.2.563; XIANG K, 1988, NUCLEIC ACIDS RES, V16, P3599, DOI 10.1093/nar/16.8.3599; YEE D, 1988, CANCER RES, V48, P6691; ZHANG YH, 1993, AM J HUM GENET, V53, P113; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	54	421	438	0	17	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1994	7	3					433	439		10.1038/ng0794-433	http://dx.doi.org/10.1038/ng0794-433			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NU306	7920665				2022-12-25	WOS:A1994NU30600021
J	FELSENSTEIN, KM; HUNIHAN, LW; ROBERTS, SB				FELSENSTEIN, KM; HUNIHAN, LW; ROBERTS, SB			ALTERED CLEAVAGE AND SECRETION OF A RECOMBINANT BETA-APP BEARING THE SWEDISH FAMILIAL ALZHEIMERS-DISEASE MUTATION	NATURE GENETICS			English	Article							AMYLOID PRECURSOR PROTEIN; PLACENTAL ALKALINE-PHOSPHATASE; GENE-EXPRESSION; CELLS; DERIVATIVES; FRAGMENTS; REPORTER	Mutations within the beta-amyloid precursor protein gene cosegregate with the early-onset form of familial Alzheimer's Disease (FAD). It is not known how these mutations result in disease; however, one early-onset AD mutation in a Swedish kindred increases potentially amyloidogenic fragments and beta-protein production in cells expressing the mutant beta-APP. Using a novel recombinant reporter system we found a qualitative change in the secreted product, from cleavage within the beta-protein sequence to cleavage near the N-terminal region of the beta-protein, even though the total amount of secreted mutant product is similar to wild-type. The results suggest that the increased formation of potentially amyloidogenic fragments in cells expressing the Swedish FAD occurs by enzymatic cleavage in the secretory pathway. Alterations in the secretory process may predispose an individual to AD.			FELSENSTEIN, KM (corresponding author), BRISTOL MYERS SQUIBB CO,PHARMACEUT RES INST,DEPT BIOPHYS & MOLEC BIOL,CNS,5 RES PKWY,WALLINGFORD,CT 06492, USA.							ANDERSON JP, 1989, EMBO J, V8, P3627, DOI 10.1002/j.1460-2075.1989.tb08536.x; ANDERSON JP, 1992, J NEUROCHEM, V59, P2328; ANDERSON JP, 1991, NEUROSCI LETT, V128, P126, DOI 10.1016/0304-3940(91)90775-O; BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; CLEMMONS DJ, 1992, LAB ANIM SCI, V4, P307; DORNER AJ, 1990, METHOD ENZYMOL, V185, P577; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; FELSENSTEIN KM, 1993, NEUROSCI LETT, V152, P185, DOI 10.1016/0304-3940(93)90514-L; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P855; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; HAASS C, 1993, J BIOL CHEM, V268, P3021; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; HARDY J, 1991, LANCET, V337, P1342; HENTHORN P, 1988, P NATL ACAD SCI USA, V85, P6342, DOI 10.1073/pnas.85.17.6342; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; NARUSE S, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91612-X; SAHASRABUDHE SR, 1992, J BIOL CHEM, V267, P25602; SAYERS JR, 1988, NUCLEIC ACIDS RES, V16, P791, DOI 10.1093/nar/16.3.791; SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; VANDUIJN CM, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91611-W; WELDEMANN A, 1989, J BIOL CHEM, V266, P16960	36	83	85	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1994	6	3					251	256		10.1038/ng0394-251	http://dx.doi.org/10.1038/ng0394-251			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ562	8012386				2022-12-25	WOS:A1994MZ56200011
J	JEFFREYS, AJ; TAMAKI, K; MACLEOD, A; MONCKTON, DG; NEIL, DL; ARMOUR, JAL				JEFFREYS, AJ; TAMAKI, K; MACLEOD, A; MONCKTON, DG; NEIL, DL; ARMOUR, JAL			COMPLEX GENE CONVERSION EVENTS IN GERMLINE MUTATION AT HUMAN MINISATELLITES	NATURE GENETICS			English	Article							RECOMBINATION INITIATION SITE; HYPERVARIABLE MINISATELLITES; VNTR LOCI; HUMAN DNA; SEQUENCE; TANDEM; ALLELES	Mutation at the human minisatellites MS32, MS205 and MS31A has been investigated by characterizing mutant alleles in pedigrees and in the case of MS32 by direct analysis of mutant molecules in single sperm. Most mutations at all three loci are polar, involving the preferential gain of a few repeat units at one end of the tandem repeat array. Incoming repeats can be derived from the same allele or the homologous chromosome, though they are frequently rearranged during mutation. Lack of exchange of flanking markers suggests the involvement of complex conversion-like events in the generation of mutant alleles. At MS32, high frequency mutation processes in sperm appear to be largely germline specific and to occur at a constant rate irrespective of allele size. Together with mutational polarity, this implies that germline instability is controlled by elements outside the tandem repeat array.			JEFFREYS, AJ (corresponding author), UNIV LEICESTER,DEPT GENET,LEICESTER LE1 7RH,ENGLAND.		Monckton, Darren/B-4943-2013	Monckton, Darren/0000-0002-8298-8264; Neil, David/0000-0002-9994-9536; Armour, John/0000-0002-8558-8506	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ARMOUR JAL, 1993, HUM MOL GENET, V2, P1137, DOI 10.1093/hmg/2.8.1137; ARMOUR JAL, 1989, NUCLEIC ACIDS RES, V17, P4925, DOI 10.1093/nar/17.13.4925; Armour JAL, 1992, CURR OPIN GENET DEV, V2, P850, DOI 10.1016/S0959-437X(05)80106-6; CARPENTER ATC, 1987, BIOESSAYS, V6, P232, DOI 10.1002/bies.950060510; CASKEY CT, 1992, SCIENCE, V256, P784, DOI 10.1126/science.1589758; GRAY IC, 1991, P ROY SOC B-BIOL SCI, V243, P241, DOI 10.1098/rspb.1991.0038; HANSEN RS, 1993, CELL, V73, P1403, DOI 10.1016/0092-8674(93)90365-W; HARDING RM, 1992, GENETICS, V132, P847; HENKE J, 1993, INT J LEGAL MED, V105, P217, DOI 10.1007/BF01642797; JEFFREYS AJ, 1991, NATURE, V354, P204, DOI 10.1038/354204a0; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; JEFFREYS AJ, 1990, CELL, V60, P473, DOI 10.1016/0092-8674(90)90598-9; JEFFREYS AJ, 1991, AM J HUM GENET, V48, P824; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; MASSEY R, 1993, EMBO J, V12, P1459; MONCKTON DG, 1991, GENOMICS, V11, P465, DOI 10.1016/0888-7543(91)90158-B; MONCKTON DG, 1993, HUM MOL GENET, V2, P513, DOI 10.1093/hmg/2.5.513; NEIL DL, 1993, HUM MOL GENET, V2, P1129; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; RACK KA, 1993, AM J HUM GENET, V52, P987; ROYLE NJ, 1992, NUCLEIC ACIDS RES, V20, P1164, DOI 10.1093/nar/20.5.1164; ROYLE NJ, 1988, GENOMICS, V3, P352, DOI 10.1016/0888-7543(88)90127-9; SCHULTES NP, 1991, MOL CELL BIOL, V11, P322, DOI 10.1128/MCB.11.1.322; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; TAMAKI K, 1993, HUM MOL GENET, V2, P1629, DOI 10.1093/hmg/2.10.1629; VERGNAUD G, 1991, GENOMICS, V11, P135, DOI 10.1016/0888-7543(91)90110-Z; WOLFF RK, 1989, GENOMICS, V5, P382, DOI 10.1016/0888-7543(89)90076-1; WOLFF RK, 1988, GENOMICS, V3, P347, DOI 10.1016/0888-7543(88)90126-7; WONG Z, 1987, ANN HUM GENET, V51, P269, DOI 10.1111/j.1469-1809.1987.tb01062.x; 1993, CELL, V72, P971	30	451	462	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1994	6	2					136	145		10.1038/ng0294-136	http://dx.doi.org/10.1038/ng0294-136			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU763	8162067				2022-12-25	WOS:A1994MU76300007
J	RUTTLEDGE, MH; SARRAZIN, J; RANGARATNAM, S; PHELAN, CM; TWIST, E; MEREL, P; DELATTRE, O; THOMAS, G; NORDENSKJOLD, M; COLLINS, VP; DUMANSKI, JP; ROULEAU, GA				RUTTLEDGE, MH; SARRAZIN, J; RANGARATNAM, S; PHELAN, CM; TWIST, E; MEREL, P; DELATTRE, O; THOMAS, G; NORDENSKJOLD, M; COLLINS, VP; DUMANSKI, JP; ROULEAU, GA			EVIDENCE FOR THE COMPLETE INACTIVATION OF THE NF2 GENE IN THE MAJORITY OF SPORADIC MENINGIOMAS	NATURE GENETICS			English	Article							TUMOR SUPPRESSOR GENES; POINT MUTATIONS; PLASMID DNA; NEUROFIBROMATOSIS; CHROMOSOME-22; POLYMORPHISMS; ONCOGENESIS; SEQUENCE	Meningiomas are common central nervous system tumours which present usually in the 4th and 5th decades of life. Loss of constitutional heterozygosity on chromosome 22 in 60% of sporadic meningiomas has implied the involvement of a tumour suppressor gene. The neurofibromatosis type 2 gene (NF2), a prime candidate for involvement in meningioma, was screened for point mutations. After examining eight of the 16 known NF2 exons in 151 meningiomas, 24 inactivating mutations were characterized. Significantly, these aberrations were exclusively detected in tumours which lost the other chromosome 22 allele. These results provide strong evidence that the suppressor gene on chromosome 22, frequently inactivated in meningioma, is the NF2 gene, and suggest that another gene is involved in the development of 40% of meningiomas.	MONTREAL GEN HOSP,RES INST,MONTREAL H3G 1A4,PQ,CANADA; MCGILL UNIV,MONTREAL GEN HOSP,DIV MED GENET,MONTREAL H3G 1A4,PQ,CANADA; KAROLINSKA HOSP,LUDWIG INST CANC RES,S-10401 STOCKHOLM,SWEDEN; KAROLINSKA HOSP,DEPT CLIN GENET,S-10401 STOCKHOLM,SWEDEN; INST CURIE,INSERM,CJF 9201,GENET TUMEURS LAB,F-75231 PARIS,FRANCE; SAHLGRENS UNIV HOSP,DEPT PATHOL,S-41345 GOTHENBURG,SWEDEN	McGill University; McGill University; Karolinska Institutet; Karolinska University Hospital; Ludwig Institute for Cancer Research; Karolinska Institutet; Karolinska University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sahlgrenska University Hospital	RUTTLEDGE, MH (corresponding author), MCGILL UNIV,CTR RES NEUROSCI,1650 CEDAR AVE,MONTREAL H3G 1A4,PQ,CANADA.			Nordenskjold, Magnus/0000-0002-4974-425X; delattre, olivier/0000-0002-8730-2276				ALSAADI A, 1987, CANCER GENET CYTOGEN, V26, P127, DOI 10.1016/0165-4608(87)90140-3; BERGERHEIM U, 1989, CANCER RES, V49, P1390; BISHOP JM, 1991, CELL, V64, P235, DOI 10.1016/0092-8674(91)90636-D; CASALONE R, 1987, CANCER GENET CYTOGEN, V27, P145, DOI 10.1016/0165-4608(87)90269-X; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; DUMANSKI JP, 1990, CANCER RES, V50, P5863; DUMANSKI JP, 1987, P NATL ACAD SCI USA, V84, P9275, DOI 10.1073/pnas.84.24.9275; EVANS DGR, 1992, J MED GENET, V29, P847, DOI 10.1136/jmg.29.12.847; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; HOROWITZ JM, 1989, SCIENCE, V243, P937, DOI 10.1126/science.2521957; HULTMAN T, 1991, BIOTECHNIQUES, V10, P84; HULTMAN T, 1989, NUCLEIC ACIDS RES, V17, P4937, DOI 10.1093/nar/17.13.4937; KAYE FJ, 1990, P NATL ACAD SCI USA, V87, P6922, DOI 10.1073/pnas.87.17.6922; KEPES J, 1982, MENINGIOMAS BIOL PAT; KLEIN G, 1987, SCIENCE, V238, P1539, DOI 10.1126/science.3317834; LI Y, 1992, CELL, V69, P275, DOI 10.1016/0092-8674(92)90408-5; MARTUZA RL, 1988, NEW ENGL J MED, V318, P684, DOI 10.1056/NEJM198803173181106; ORITA M, 1990, GENOMICS, V8, P271, DOI 10.1016/0888-7543(90)90282-Y; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PULST SM, 1993, NEUROLOGY, V43, P2096, DOI 10.1212/WNL.43.10.2096; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; RUTTLEDGE MH, IN PRESS GENES CHROM; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1981, SCIENCE, V214, P1205, DOI 10.1126/science.7302589; SARKAR G, 1992, NUCLEIC ACIDS RES, V20, P871, DOI 10.1093/nar/20.4.871; SEIZINGER BR, 1987, P NATL ACAD SCI USA, V84, P5419, DOI 10.1073/pnas.84.15.5419; SHEFFIELD VC, 1993, GENOMICS, V16, P325, DOI 10.1006/geno.1993.1193; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; VANHEYNINGEN V, 1992, TRENDS GENET, V8, P16, DOI 10.1016/0168-9525(92)90019-Z; WEINBERG RA, 1991, SCIENCE, V254, P1138, DOI 10.1126/science.1659741; WERTELECKI W, 1988, NEW ENGL J MED, V319, P278, DOI 10.1056/NEJM198808043190505	33	449	453	0	23	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1994	6	2					180	184		10.1038/ng0294-180	http://dx.doi.org/10.1038/ng0294-180			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU763	8162072				2022-12-25	WOS:A1994MU76300014
J	OGAWA, O; BECROFT, DM; MORISON, IM; ECCLES, MR; SKEEN, JE; MAUGER, DC; REEVE, AE				OGAWA, O; BECROFT, DM; MORISON, IM; ECCLES, MR; SKEEN, JE; MAUGER, DC; REEVE, AE			CONSTITUTIONAL RELAXATION OF INSULIN-LIKE GROWTH-FACTOR-II GENE IMPRINTING ASSOCIATED WITH WILMS-TUMOR AND GIGANTISM	NATURE GENETICS			English	Article							BECKWITH-WIEDEMANN SYNDROME; CHROMOSOME-11	We have examined the imprinting of the insulin-like growth factor II gene (IGF2) in ten normal kidney samples from children with renal embryonal neoplasms. In kidney samples from nine children with normal growth profiles, IGF2 mRNA was transcribed monoallelically, consistent with normal imprinting of the gene. But in one child who had generalized somatic overgrowth, IGF2 was transcribed from both alleles in her kidney, peripheral blood leukocytes and Wilms' tumour. These findings suggest that a defect in genomic imprinting can occur constitutionally, leading to growth abnormalities and predisposition to Wilms' tumour.	UNIV OTAGO,DEPT BIOCHEM,CANC GENET LAB,DUNEDIN,NEW ZEALAND; NATL WOMENS HOSP,DEPT OBSTET & GYNAECOL,AUCKLAND,NEW ZEALAND; STARSHIP CHILDRENS HOSP,AUCKLAND,NEW ZEALAND	University of Otago; Starship Children's Hospital			Morison, Ian M/A-1236-2008	Morison, Ian M/0000-0003-3616-0025				ALECK KA, 1989, AM J MED GENET, V33, P155, DOI 10.1002/ajmg.1320330202; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BUNIN GR, 1987, CANCER RES, V47, P2972; CHAO LY, 1993, NAT GENET, V3, P127, DOI 10.1038/ng0293-127; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Dilworth D D, 1992, PCR Methods Appl, V1, P279; FERGUSONSMITH AC, 1991, NATURE, V351, P667, DOI 10.1038/351667a0; GIANNOUKAKIS N, 1993, NAT GENET, V4, P98, DOI 10.1038/ng0593-98; GRUNDY P, 1991, LANCET, V338, P1079, DOI 10.1016/0140-6736(91)91937-P; HAMILL PVV, 1977, PHS781650 US DEP HLT, P1; Henry I., 1993, European Journal of Human Genetics, V1, P19; HENRY I, 1991, NATURE, V351, P665, DOI 10.1038/351665a0; KOUFOS A, 1989, AM J HUM GENET, V44, P711; LITTLE MH, 1992, EUR J CANCER A, V28, P1879; MALDONADO V, 1984, AM J DIS CHILD, V138, P486, DOI 10.1001/archpedi.1984.02140430062016; MANNENS M, 1990, CANCER RES, V50, P3279; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; MOUTOU C, 1992, J MED GENET, V29, P217, DOI 10.1136/jmg.29.4.217; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; OHLSSON R, 1993, NAT GENET, V4, P94, DOI 10.1038/ng0593-94; PING AJ, 1989, AM J HUM GENET, V44, P720; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; REEVE AE, 1985, NATURE, V317, P258, DOI 10.1038/317258a0; REIK W, 1989, TRENDS GENET, V5, P331, DOI 10.1016/0168-9525(89)90138-8; SCOTT J, 1985, NATURE, V317, P261; TADOKORO K, 1991, NUCLEIC ACIDS RES, V19, P6961; VILJOEN D, 1992, J MED GENET, V29, P221, DOI 10.1136/jmg.29.4.221	27	108	110	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1993	5	4					408	412		10.1038/ng1293-408	http://dx.doi.org/10.1038/ng1293-408			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ML145	8298652				2022-12-25	WOS:A1993ML14500020
J	CAPEL, B; RASBERRY, C; DYSON, J; BISHOP, CE; SIMPSON, E; VIVIAN, N; LOVELLBADGE, R; RASTAN, S; CATTANACH, BM				CAPEL, B; RASBERRY, C; DYSON, J; BISHOP, CE; SIMPSON, E; VIVIAN, N; LOVELLBADGE, R; RASTAN, S; CATTANACH, BM			DELETION OF Y-CHROMOSOME SEQUENCES LOCATED OUTSIDE THE TESTIS-DETERMINING REGION CAN CAUSE XY FEMALE SEX REVERSAL	NATURE GENETICS			English	Article							DETERMINING GENE; MICE; TDY; DIFFERENTIATION; EXPRESSION; ANTIGEN; MALES; SRY	An approach designed to map and generate mutations in the region of the short arm of the mouse Y chromosome, known to be involved in sex determination and spermatogenesis, is described. This relies on homologous Yp-Sxr(a) pairing and asymmetrical exchange which can occur at meiosis in XY males carrying Sxr(a) on their X chromosome. Such exchange potentially generates deficiencies and duplications of Yp or Sxr(a). Three fertile XY females were found out of about 450 XY offspring from XSxr(a)/Y x XX crosses. In all three, despite evidence for deletion of Y chromosomal material, the Sry locus was intact. Each deletion involved a repeat sequence, Sx1, located at a distance from Sry. Since expression of Sry was affected these results suggest that long range position effects have disrupted Sry action.	MRC, DIV GENET, RADIOBIOL UNIT, DIDCOT OX11 0RD, OXON, ENGLAND; MRC, CLIN RES CTR, TRANSPLANTAT BIOL SECT, HARROW HA1 3UJ, MIDDX, ENGLAND; MRC, CLIN RES CTR, COMPARAT BIOL SECT, HARROW HA1 3UJ, MIDDX, ENGLAND; MRC, NATL INST MED RES, EUKARYOT MOLEC GENET LAB, LONDON NW7 1AA, ENGLAND; UNIV TENNESSEE, COLL MED, DEPT OBSTET & GYNAECOL, MEMPHIS, TN 38103 USA	MRC Harwell; Medical Research Council Clinical Trials Unit; Medical Research Council Clinical Trials Unit; MRC National Institute for Medical Research; University of Tennessee System; University of Tennessee Health Science Center				Lovell-Badge, Robin/0000-0001-9364-4179; Simpson, Elizabeth/0000-0002-2118-3139	Medical Research Council [MC_U117562207] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; Bishop C. E., 1991, Seminars in Developmental Biology, V2, P241; BISHOP CE, 1985, NATURE, V315, P70, DOI 10.1038/315070a0; BISHOP CE, 1988, SEX DETERMINATION MO, P119; BURGER K, 1991, STRUCT CHEM, V2, P277, DOI 10.1007/BF00672223; CATTANACH BM, 1990, GENET RES, V56, P121, DOI 10.1017/S0016672300035199; CATTANACH BM, 1971, CYTOGENETICS, V10, P318, DOI 10.1159/000130151; CATTANACH BM, 1987, ANN NY ACAD SCI, V513, P27, DOI 10.1111/j.1749-6632.1987.tb24996.x; CATTANACH BM, 1988, MOUSE NEWS LETT, V82, P94; EICHER EM, 1986, ANNU REV GENET, V20, P327, DOI 10.1146/annurev.ge.20.120186.001551; EVANS EP, 1982, NATURE, V300, P443, DOI 10.1038/300443a0; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; GUBBAY J, 1992, P NATL ACAD SCI USA, V89, P7953, DOI 10.1073/pnas.89.17.7953; HUNT PA, 1991, DEVELOPMENT, V111, P1137; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; KOOPMAN P, 1990, NATURE, V348, P450, DOI 10.1038/348450a0; LOVELLBADGE R, 1990, DEVELOPMENT, V109, P635; MAHADEVAIAH SK, 1993, J REPROD FERTIL, V97, P151, DOI 10.1530/jrf.0.0970151; MCLAREN A, 1988, P NATL ACAD SCI USA, V85, P6442, DOI 10.1073/pnas.85.17.6442; MCLAREN A, 1982, NATURE, V300, P446, DOI 10.1038/300446a0; MCLAREN A, 1984, NATURE, V312, P552, DOI 10.1038/312552a0; MCLAREN A, 1992, GENET RES, V60, P175, DOI 10.1017/S0016672300030925; MCWLEWCWY K, 1992, P NATL ACAD SCI USA, V89, P11016; MITCHELL MJ, 1992, GENOMICS, V12, P26, DOI 10.1016/0888-7543(92)90402-E; PALMER MS, 1989, NATURE, V342, P937, DOI 10.1038/342937a0; PALMER SJ, 1991, DEVELOPMENT, V113, P709; ROBERTS C, 1988, P NATL ACAD SCI USA, V85, P6446, DOI 10.1073/pnas.85.17.6446; SIMPSON EM, 1991, GENOMICS, V11, P601, DOI 10.1016/0888-7543(91)90067-O; WHITTEN WK, 1991, REPROD FERT DEVELOP, V3, P255, DOI 10.1071/RD9910255; [No title captured]	30	97	100	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1993	5	3					301	307		10.1038/ng1193-301	http://dx.doi.org/10.1038/ng1193-301			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MF122	8275095				2022-12-25	WOS:A1993MF12200024
J	POLLAK, MR; CHOU, YHW; CERDA, JJ; STEINMANN, B; LADU, BN; SEIDMAN, JG; SEIDMAN, CE				POLLAK, MR; CHOU, YHW; CERDA, JJ; STEINMANN, B; LADU, BN; SEIDMAN, JG; SEIDMAN, CE			HOMOZYGOSITY MAPPING OF THE GENE FOR ALKAPTONURIA TO CHROMOSOME-3Q2	NATURE GENETICS			English	Article							FAMILIAL HYPOCALCIURIC HYPERCALCEMIA; SEVERE PRIMARY HYPERPARATHYROIDISM; SUCRASE-ISOMALTASE; LINKAGE; MAP; SI	Alkaptonuria, the first human disorder recognized by Garrod as an inborn error of metabolism, is a rare recessive condition that darkens urine and causes a debilitating arthritis termed ochronosis. We have studied two families with consanguineous parents and four affected children in order to map the gene responsible for alkaptonuria. Coinheritance of either neonatal severe hyperparathyroidism or sucrase-isomaltase deficiency and alkaptonuria provided a candidate location for the mutated genes on chromosome 3. Homozygosity mapping with polymorphic loci identified a 16 centiMorgan region on chromosome 3q2 that contains the alkaptonuria gene. Analysis of two additional nonconsanguineous families supports linkage of alkaptonuria to this single locus (combined lod score = 4.3, theta = 0).	BRIGHAM & WOMENS HOSP,DEPT MED,DIV RENAL,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DEPT MED,DIV CARDIOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; HARVARD UNIV,SCH MED,HOWARD HUGHES MED INST,BOSTON,MA 02115; UNIV FLORIDA,DEPT MED,DIV GASTROENTEROL & NUTR,GAINESVILLE,FL 32610; UNIV ZURICH,DEPT PEDIAT,DIV METAB,CH-8006 ZURICH,SWITZERLAND; UNIV MICHIGAN,DEPT PHARMACOL,ANN ARBOR,MI 48109	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; State University System of Florida; University of Florida; University of Zurich; University of Michigan System; University of Michigan					NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046422, K11DK002138] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00082] Funding Source: Medline; NIDDK NIH HHS [DK46422, DK02138] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; APLER DH, 1970, ADV METAB DISORD, P73; Bateson W., 1902, MENDELS PRINCIPLES H, DOI 10.1017/CBO9780511694462; CHANTRET I, 1992, BIOCHEM J, V285, P915, DOI 10.1042/bj2850915; CHOU YHW, 1992, NAT GENET, V1, P295, DOI 10.1038/ng0792-295; GARNICA A D, 1981, Acta Vitaminologica et Enzymologica, V3, P157; Garrod AE, 1908, LANCET, V2, P73; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; LADU BN, 1986, METABOLIC BASIS INHE; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; MARX SJ, 1982, NEW ENGL J MED, V306, P257, DOI 10.1056/NEJM198202043060502; NAIM HY, 1988, J CLIN INVEST, V82, P667, DOI 10.1172/JCI113646; OBRIEN WM, 1963, AM J MED, V34, P813, DOI 10.1016/0002-9343(63)90089-5; RICHARDS EJ, 1992, CURRENT PROTOCOLS MO; SMITH CAB, 1953, J R STAT SOC B, V15, P153; STEINMANN B, 1984, HELV PAEDIATR ACTA, V39, P171; STENN FF, 1977, SCIENCE, V197, P466; SWALLOW DM, 1991, CYTOGENET CELL GENET, V58, P1881; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WEST LF, 1988, ANN HUM GENET, V52, P57, DOI 10.1111/j.1469-1809.1988.tb01077.x	20	101	104	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1993	5	2					201	204		10.1038/ng1093-201	http://dx.doi.org/10.1038/ng1093-201			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MA056	8252048				2022-12-25	WOS:A1993MA05600021
J	CHOI, TK; HOLLENBACH, PW; PEARSON, BE; UEDA, RM; WEDDELL, GN; KURAHARA, CG; WOODHOUSE, CS; KAY, RM; LORING, JF				CHOI, TK; HOLLENBACH, PW; PEARSON, BE; UEDA, RM; WEDDELL, GN; KURAHARA, CG; WOODHOUSE, CS; KAY, RM; LORING, JF			TRANSGENIC MICE CONTAINING A HUMAN HEAVY-CHAIN IMMUNOGLOBULIN GENE FRAGMENT CLONED IN A YEAST ARTIFICIAL CHROMOSOME	NATURE GENETICS			English	Article							MAMMALIAN-CELLS; PHYSICAL MAP; MOUSE CELLS; DNA; SEGMENTS; REGION; LOCUS; PROTOONCOGENE; ORGANIZATION; EXPRESSION	We have developed a method for the introduction of yeast artificial chromosomes (YACs) into transgenic mice. An 85 kilobase (kb) fragment of the human heavy chain immunoglobulin gene was cloned as a YAC, and embryonic stem cell lines carrying intact, integrated YACs were derived by co-lipofection of the YAC with an unlinked selectable marker. Chimaeric founder animals were produced by blastocyst injection, and offspring transgenic for the YAC were obtained. Analysis of serum from these offspring for human heavy chain antibody subunits demonstrated expression of the YAC-borne immunoglobulin gene fragment. Co-lipofection may prove to be a highly-successful means of producing transgenic mice containing large gene fragments in YACs.			CHOI, TK (corresponding author), GENPHARM INT, 297 N BERNARDO AVE, Mountain View, CA 94043 USA.		Loring, Jeanne F/A-1620-2011	Loring, Jeanne F/0000-0001-6226-9767	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI032285, R43AI032285] Funding Source: NIH RePORTER; NIAID NIH HHS [RA43 AI32285-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BERMAN JE, 1988, EMBO J, V7, P727, DOI 10.1002/j.1460-2075.1988.tb02869.x; BERMAN JE, 1991, EUR J IMMUNOL, V21, P1311, DOI 10.1002/eji.1830210532; Bradley A, 1987, TERATOCARCINOMAS EMB, P113; BRINSTER RL, 1988, P NATL ACAD SCI USA, V85, P836, DOI 10.1073/pnas.85.3.836; BROWN SDM, 1991, BIOESSAYS, V13, P607, DOI 10.1002/bies.950131112; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; CHEN J, IN PRESS INT IMMUN; DAVIES NP, 1992, NUCLEIC ACIDS RES, V20, P2693, DOI 10.1093/nar/20.11.2693; DELALUNA S, 1988, GENE, V62, P121; ELICEIRI B, 1991, P NATL ACAD SCI USA, V88, P2179, DOI 10.1073/pnas.88.6.2179; FOX T, 1991, GUIDE YEAST GENETICS; GNIRKE A, 1991, EMBO J, V10, P1629, DOI 10.1002/j.1460-2075.1991.tb07685.x; GNIRKE A, 1991, SOMAT CELL MOLEC GEN, V17, P573, DOI 10.1007/BF01233622; Guise J. W., 1989, Immunoglobulin genes., P275; HAWKINS RE, 1992, J MOL BIOL, V226, P889, DOI 10.1016/0022-2836(92)90639-2; HOFKER MH, 1989, P NATL ACAD SCI USA, V86, P5567, DOI 10.1073/pnas.86.14.5567; HUXLEY C, 1991, GENOMICS, V9, P742, DOI 10.1016/0888-7543(91)90369-P; ICHIHARA Y, 1988, EMBO J, V7, P4141, DOI 10.1002/j.1460-2075.1988.tb03309.x; JAENISCH R, 1988, SCIENCE, V240, P1468, DOI 10.1126/science.3287623; JAKOBOVITS A, 1993, NATURE, V362, P255, DOI 10.1038/362255a0; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LUBIN I, 1991, SCIENCE, V252, P427, DOI 10.1126/science.1826797; MATSUDA F, 1988, EMBO J, V7, P1047, DOI 10.1002/j.1460-2075.1988.tb02912.x; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; NEIL DL, 1990, NUCLEIC ACIDS RES, V18, P1421, DOI 10.1093/nar/18.6.1421; PACHNIS V, 1990, P NATL ACAD SCI USA, V87, P5109, DOI 10.1073/pnas.87.13.5109; PAVAN WJ, 1990, MOL CELL BIOL, V10, P4163, DOI 10.1128/MCB.10.8.4163; PAVAN WJ, 1991, P NATL ACAD SCI USA, V88, P7788, DOI 10.1073/pnas.88.17.7788; RAMIREZSOILS R, IN PRESS METHODS ENZ; RAMIREZSOLIS R, 1992, ANAL BIOCHEM, V201, P331, DOI 10.1016/0003-2697(92)90347-A; RILEY JH, 1992, NUCLEIC ACIDS RES, V20, P2971, DOI 10.1093/nar/20.12.2971; SCHEDL A, 1992, NUCLEIC ACIDS RES, V20, P3073, DOI 10.1093/nar/20.12.3073; SCHEDL A, 1993, NATURE, V362, P258, DOI 10.1038/362258a0; SHIN EK, 1991, EMBO J, V10, P3641, DOI 10.1002/j.1460-2075.1991.tb04930.x; SMITH DR, 1990, P NATL ACAD SCI USA, V87, P8242, DOI 10.1073/pnas.87.21.8242; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; STRAUSS WM, 1992, EMBO J, V11, P417, DOI 10.1002/j.1460-2075.1992.tb05070.x; STRAUSS WM, 1992, MAMM GENOME, V2, P150, DOI 10.1007/BF00302873; TRAVER CN, 1989, P NATL ACAD SCI USA, V86, P5898, DOI 10.1073/pnas.86.15.5898; TYBULEWICZ VLJ, 1991, CELL, V40, P271; Word C J, 1989, Int Immunol, V1, P296, DOI 10.1093/intimm/1.3.296	41	76	135	0	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1993	4	2					117	123		10.1038/ng0693-117	http://dx.doi.org/10.1038/ng0693-117			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LF816	8348148				2022-12-25	WOS:A1993LF81600008
J	REYNIERS, E; VITS, L; DEBOULLE, K; VANROY, B; VANVELZEN, D; DEGRAAFF, E; VERKERK, AJMH; JORENS, HZJ; DARBY, JK; OOSTRA, B; WILLEMS, PJ				REYNIERS, E; VITS, L; DEBOULLE, K; VANROY, B; VANVELZEN, D; DEGRAAFF, E; VERKERK, AJMH; JORENS, HZJ; DARBY, JK; OOSTRA, B; WILLEMS, PJ			THE FULL MUTATION IN THE FMR-1 GENE OF MALE FRAGILE-X PATIENTS IS ABSENT IN THEIR SPERM	NATURE GENETICS			English	Article							MENTAL-RETARDATION; EXPRESSION; SEQUENCE; INSTABILITY; CHROMOSOME; DIAGNOSIS	Fragile X syndrome is characterized at the molecular level by amplification of a (CGG)n repeat and hypermethylation of a CpG island preceeding the open reading frame of the fragile X gene (FMR-1) located in Xq27.3. Anticipation in this syndrome is associated with progressive amplification of the (CGG)n repeat from a premutation to a full mutation through consecutive generations. Remarkably, expansion of the premutation to the full mutation is strictly maternal. To clarify this parental influence we studied FMR-1 in sperm of four male fragile X patients. This showed that only the premutation was present in their sperm, although they had a full mutation in peripheral lymphocytes. This might suggest that expansion of the premutation to the full mutation in FMR-1 does not occur in meiosis but in a postzygotic stage.	UNIV ANTWERP,UIA,DEPT MED GENET,UNIV SPLEIN 1,B-2610 ANTWERP,BELGIUM; ERASMUS UNIV ROTTERDAM,DEPT CLIN GENET,3153 DR ROTTERDAM,NETHERLANDS; PSYCHIAT HOSP ST AMADEUS,B-2640 MORTSEL,BELGIUM	University of Antwerp; Erasmus University Rotterdam			de Graaff, Esther/D-3287-2011	Verkerk, Annemieke JMH/0000-0002-7523-3656				BELL MV, 1991, CELL, V64, P861, DOI 10.1016/0092-8674(91)90514-Y; Biancalana V., 1992, Human Molecular Genetics, V1, P255, DOI 10.1093/hmg/1.4.255; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BRUNNER HG, IN PRESS NEW ENGL J; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; DEVRIES BBA, 1993, EUR J HUM GENET, V1, P72; DEVYS D, 1992, AM J MED GENET, V43, P208, DOI 10.1002/ajmg.1320430134; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GEDEON AK, 1992, NAT GENET, V1, P341, DOI 10.1038/ng0892-341; HEITZ D, 1991, SCIENCE, V251, P1236, DOI 10.1126/science.2006411; HIETZ D, 1992, J MED GENET, V29, P794; HINDS HL, 1993, NAT GENET, V3, P36, DOI 10.1038/ng0193-36; JEFFREYS AJ, 1987, NUCLEIC ACIDS RES, V15, P2823, DOI 10.1093/nar/15.7.2823; KELLY R, 1989, GENOMICS, V5, P844, DOI 10.1016/0888-7543(89)90126-2; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LOESCH DZ, 1987, AM J MED GENET, V27, P401, DOI 10.1002/ajmg.1320270219; MORICPETROVIC S, 1983, J MED GENET, V20, P476, DOI 10.1136/jmg.20.6.476; MOY KL, 1993, SCIENCE, V259, P809; MULLEY JC, 1992, J MED GENET, V29, P368, DOI 10.1136/jmg.29.6.368; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; OOSTRA BA, 1992, CHROMOSOMA, V101, P381, DOI 10.1007/BF00582832; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; RICHARDS RI, 1992, NAT GENET, V1, P7, DOI 10.1038/ng0492-7; RICHARDS RI, 1992, CELL, V70, P709, DOI 10.1016/0092-8674(92)90302-S; ROUSSEAU F, 1991, J MED GENET, V28, P830, DOI 10.1136/jmg.28.12.830; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; SHELBOURNE P, 1992, HUM MOL GENET, V1, P467, DOI 10.1093/hmg/1.7.467; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; SHERMAN SL, 1984, ANN HUM GENET, V48, P21, DOI 10.1111/j.1469-1809.1984.tb00830.x; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; SUTHERLAND GR, 1991, NEW ENGL J MED, V325, P1720, DOI 10.1056/NEJM199112123252407; VANROY BC, 1990, AM J MED GENET, V36, P122, DOI 10.1002/ajmg.1320360124; VANROY BC, 1983, J MED GENET, V20, P286, DOI 10.1136/jmg.20.4.286; VERGNAUD G, 1991, GENOMICS, V11, P135, DOI 10.1016/0888-7543(91)90110-Z; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VINCENT A, 1991, NATURE, V349, P624, DOI 10.1038/349624a0; VOELCKEL MA, 1988, HUM GENET, V80, P375, DOI 10.1007/BF00273654; WILLEMS PJ, 1992, HUM MOL GENET, V1, P511, DOI 10.1093/hmg/1.7.511; WOHRLE D, 1992, HUM GENET, V89, P114, DOI 10.1007/BF00207057; WOHRLE D, 1992, AM J HUM GENET, V51, P299; YU S, 1992, AM J HUM GENET, V50, P968; YU WD, 1990, HUM GENET, V85, P590	44	234	237	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1993	4	2					143	146		10.1038/ng0693-143	http://dx.doi.org/10.1038/ng0693-143			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LF816	8348152				2022-12-25	WOS:A1993LF81600013
J	SHEFFIELD, VC; STONE, EM; ALWARD, WLM; DRACK, AV; JOHNSON, AT; STREB, LM; NICHOLS, BE				SHEFFIELD, VC; STONE, EM; ALWARD, WLM; DRACK, AV; JOHNSON, AT; STREB, LM; NICHOLS, BE			GENETIC-LINKAGE OF FAMILIAL OPEN-ANGLE GLAUCOMA TO CHROMOSOME-1Q21-Q31	NATURE GENETICS			English	Article							ATRIAL-NATRIURETIC-FACTOR; DINUCLEOTIDE REPEAT POLYMORPHISM; INTRAOCULAR-PRESSURE; CILIARY PROCESSES; GENOMIC DNA; RECEPTOR; EXPRESSION; SEQUENCE; CYCLASE; BLOOD	Glaucoma is a significant cause of blindness world wide. There is evidence to suggest that at least a subset of the disease is determined genetically. We studied 37 members of a family affected with an autosomal dominant form of juvenile open angle glaucoma and 22 were found to be affected. Linkage analysis using short tandem repeat markers mapped the disease-causing gene to chromosome 1q21-q31. Eight markers were significantly linked (Z(max) > 3.0) to the disease, with the highest lod score 6.5 (theta=0), provided by D1S212. The atrial natriuretic peptide (ANP)/receptor system has been proposed to have a role in glaucoma and one of the ANP receptor genes maps to chromosome 1q.	UNIV IOWA HOSP & CLIN,DEPT OPHTHALMOL,IOWA CITY,IA 52242; UNIV IOWA HOSP & CLIN,DEPT PEDIAT,IOWA CITY,IA 52242	University of Iowa; University of Iowa			Alward, Wallace/AAY-4149-2020	Drack, Arlene/0000-0002-8195-8426; Alward, Wallace/0000-0001-6368-9018; Johnson, Arlan/0000-0002-9519-2943; Stone, Edwin M./0000-0003-3343-4414	NEI NIH HHS [EY08426] Funding Source: Medline; NHGRI NIH HHS [HG00457, P50HG00835] Funding Source: Medline; NATIONAL EYE INSTITUTE [R29EY008426] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG000835, R01HG000457] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ARMALY MF, 1968, ARCH OPHTHALMOL-CHIC, V80, P354; ARMALY MF, 1967, ARCH OPHTHALMOL-CHIC, V78, P187; ARMALY MF, 1966, ARCH OPHTHALMOL-CHIC, V75, P32; ARMALY MF, 1967, ARCH OPHTHALMOL-CHIC, V78, P5; BIANCHI C, 1986, CURR EYE RES, V5, P283, DOI 10.3109/02713688609020054; BIRO I, 1951, OPHTHALMOLOGICA, V122, P228, DOI 10.1159/000301064; CHANG M, 1989, NATURE, V341, P68, DOI 10.1038/341068a0; DEBOLD AJ, 1985, SCIENCE, V230, P767, DOI 10.1126/science.2932797; DIESTELHORST M, 1989, INT OPHTHALMOL, V13, P99, DOI 10.1007/BF02028647; FERNANDEZDURANGO R, 1990, VISION RES, V30, P1305, DOI 10.1016/0042-6989(90)90004-5; FERNANDEZDURANGO R, 1991, EXP EYE RES, V53, P591, DOI 10.1016/0014-4835(91)90217-3; FRANCOIS J, 1966, AM J OPHTHALMOL, V61, P652, DOI 10.1016/0002-9394(66)91201-3; FULLER F, 1988, J BIOL CHEM, V263, P9395; GARBERS DL, 1989, J BIOL CHEM, V264, P9103; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; GUTKOWSKA J, 1989, ENDOCR REV, V10, P519, DOI 10.1210/edrv-10-4-519; HARRIS D, 1965, AM J OPHTHALMOL, V60, P91, DOI 10.1016/0002-9394(65)92398-6; HOSKINS HD, 1989, BECKER SHAFFERS DIAG, V678; INAGAMI T, 1989, J BIOL CHEM, V264, P3043; JOHNSON AT, 1993, OPHTHALMOLOGY, V100, P524; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LEIGHTON DA, 1976, T OPHTHAL SOC UK, V96, P28; LESKE MC, 1983, AM J EPIDEMIOL, V118, P166, DOI 10.1093/oxfordjournals.aje.a113626; LOWE DG, 1990, GENOMICS, V8, P304, DOI 10.1016/0888-7543(90)90286-4; LOWE DG, 1989, EMBO J, V8, P1377, DOI 10.1002/j.1460-2075.1989.tb03518.x; Miller S J, 1962, Br J Ophthalmol, V46, P513, DOI 10.1136/bjo.46.9.513; MURRAY JC, 1992, NAT GENET, V2, P46, DOI 10.1038/ng0992-46; NEEDLEMAN P, 1986, NEW ENGL J MED, V314, P828; Nichols B. E., 1992, American Journal of Human Genetics, V51, pA369; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PHELPS CD, 1974, GENETIC METABOLIC EY, P237; QUIRION R, 1984, PEPTIDES, V5, P1167, DOI 10.1016/0196-9781(84)90183-9; SHARMA V, 1991, NUCLEIC ACIDS RES, V19, P1168, DOI 10.1093/nar/19.5.1168-a; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; WAARDENBURG P. J., 1950, GENETICA, V25, P79; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P2835; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	37	351	401	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1993	4	1					47	50		10.1038/ng0593-47	http://dx.doi.org/10.1038/ng0593-47			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LA337	8513321				2022-12-25	WOS:A1993LA33700011
J	ANTONARAKIS, SE; AVRAMOPOULOS, D; BLOUIN, JL; TALBOT, CC; SCHINZEL, AA				ANTONARAKIS, SE; AVRAMOPOULOS, D; BLOUIN, JL; TALBOT, CC; SCHINZEL, AA			MITOTIC ERRORS IN SOMATIC-CELLS CAUSE TRISOMY-21 IN ABOUT 4.5-PERCENT OF CASES AND ARE NOT ASSOCIATED WITH ADVANCED MATERNAL AGE	NATURE GENETICS			English	Article							GENETIC-LINKAGE MAP; HUMAN CHROMOSOME-21; DNA POLYMORPHISMS; REDUCED RECOMBINATION; GEL-ELECTROPHORESIS; PARENTAL ORIGIN; AMPLIFICATION; SEQUENCES; MARKERS	The study of DNA polymorphisms has permitted the determination of the parental and meiotic origin of the supernumerary chromosome 21 in families with free trisomy 21. Chromosomal segregation errors in somatic cells during mitosis were recognized after analysis of DNA markers in the pericentromeric region and (in order to identify recombination events) along the long arm of chromosome 21. Mitotic errors accounted for about 4.5% (11 of 238) of free trisomy 21 cases examined. The mean maternal age of mitotic errors was 28.5 years and there was no association with advanced maternal age. There was no preference in the parental origin of the duplicated chromosome 21. The 43 maternal meiosis II errors in this study had a mean maternal age of 34.1 years - the highest mean maternal age of all categories of chromosomal segregation errors.	JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21287; JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21287; UNIV ZURICH,INST MED GENET,CH-8006 ZURICH,SWITZERLAND	Johns Hopkins University; Johns Hopkins University; University of Zurich	ANTONARAKIS, SE (corresponding author), JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,CMSC1004,BALTIMORE,MD 21287, USA.		Antonarakis, Stylianos E/N-8866-2014; Avramopoulos, Dimitrios/J-4392-2012	Antonarakis, Stylianos E/0000-0001-8907-5823; 				ANTONARAKIS SE, 1991, NEW ENGL J MED, V324, P872, DOI 10.1056/NEJM199103283241302; ANTONARAKIS SE, 1992, AM J HUM GENET, V50, P544; ARNHEIM N, 1980, P NATL ACAD SCI USA, V77, P7373; BURMEISTER M, 1991, GENOMICS, V9, P19, DOI 10.1016/0888-7543(91)90216-2; CAROTHERS AD, 1987, AM J HUM GENET, V40, P639; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; COX DR, 1991, CYTOGENET CELL GENET, V58, P800, DOI 10.1159/000133181; DAGNABRICARELLI F, 1989, HUM GENET, V82, P20; DAVIES KE, 1984, HUM GENET, V66, P54, DOI 10.1007/BF00275186; GARDINER K, 1990, EMBO J, V9, P25, DOI 10.1002/j.1460-2075.1990.tb08076.x; HASSOLD T, 1985, HUM GENET, V70, P11, DOI 10.1007/BF00389450; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; HENSON V, 1991, P NATL ACAD SCI USA, V88, P6486, DOI 10.1073/pnas.88.15.6486; HOOK EB, 1981, TRISOMY, V21, P11; ICHIKAWA H, 1992, P NATL ACAD SCI USA, V89, P23, DOI 10.1073/pnas.89.1.23; JABS EW, 1991, GENOMICS, V9, P141, DOI 10.1016/0888-7543(91)90231-3; Kalousek D K, 1989, Prog Clin Biol Res, V311, P153; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721; PENROSE LS, 1933, J GENET, V44, P17; PETERSEN MB, 1991, AM J HUM GENET, V48, P65; PETERSEN MB, 1991, GENOMICS, V9, P407, DOI 10.1016/0888-7543(91)90406-5; PETERSEN MB, IN PRESS AM J HUM GE; ROEDER GS, 1988, TRENDS GENET, V4, P263; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SHARMA V, 1992, HUM MOL GENET, V1, P289; SHERMAN SL, 1991, AM J HUM GENET, V49, P608; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TANZI RE, 1992, AM J HUM GENET, V50, P551; VANHUL W, 1992, 3RD INT WORKSH CHROM; WANG D, 1992, P NATL ACAD SCI USA, V89, P3222, DOI 10.1073/pnas.89.8.3222; WARRBURTON D, 1989, PROG CLIN BIOL RES, V311, P165; WARREN AC, 1987, SCIENCE, V237, P652, DOI 10.1126/science.2955519; WARREN AC, 1989, GENOMICS, V4, P579, DOI 10.1016/0888-7543(89)90282-6; WARREN AC, IN PRESS GENOMICS; WERNERT A, IN PRESS HUM MOL GEN	36	120	127	1	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1993	3	2					146	150		10.1038/ng0293-146	http://dx.doi.org/10.1038/ng0293-146			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KL010	8499948				2022-12-25	WOS:A1993KL01000012
J	Fuchs, E				Fuchs, E			Clues to B-cell memory	NATURE MEDICINE			English	Editorial Material											Fuchs, E (corresponding author), JOHNS HOPKINS ONCOL CTR,BALTIMORE,MD 21287, USA.							Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; ALLSOPP TE, 1993, CELL, V73, P295, DOI 10.1016/0092-8674(93)90230-N; ALOE L, 1994, AUTOIMMUNITY, V19, P141, DOI 10.3109/08916939409009542; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Barde Y A, 1994, Prog Clin Biol Res, V390, P45; GRAY D, 1988, NATURE, V336, P70, DOI 10.1038/336070a0; HEFTI F, 1994, J NEUROBIOL, V25, P1418, DOI 10.1002/neu.480251109; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; SCHITTEK B, 1990, NATURE, V346, P749, DOI 10.1038/346749a0; Torcia M, 1996, CELL, V85, P345, DOI 10.1016/S0092-8674(00)81113-7; VERRALL M, 1994, NATURE, V370, P6, DOI 10.1038/370006a0; VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324	13	1	1	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUL	1996	2	7					743	744		10.1038/nm0796-743	http://dx.doi.org/10.1038/nm0796-743			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UU680	8673914				2022-12-25	WOS:A1996UU68000024
J	David, K; Ollert, MW; Juhl, H; Vollmert, C; Erttmann, R; Vogel, CW; Bredehorst, R				David, K; Ollert, MW; Juhl, H; Vollmert, C; Erttmann, R; Vogel, CW; Bredehorst, R			Growth arrest of solid human neuroblastoma xenografts in nude rats by natural IgM from healthy humans	NATURE MEDICINE			English	Article							ANTIGANGLIOSIDE GD2 ANTIBODY; NEURO-BLASTOMA; MEDIATED LYSIS; CELLS	Neuroblastoma (NB) is the most common extracranial solid neoplasm of infancy and is associated with very poor prognosis in patients with advanced disease(1,2). Current therapeutic regimens of advanced NE which combine surgical resection with radiation therapy and/or chemotherapy brought some improvements, but in a significant number of patients, a cure remains elusive(3). Normal human serum of healthy adults contains natural IgM antibodies that are cytotoxic for human NE cells. In this study, we evaluated the anti-NB activity of these natural IgM antibodies in nude rats bearing solid human NE tumors. A single intravenous (i.v.) injection of purified cytotoxic IgM led to uptake of IgM into the tumors with massive perivascular complement activation and accumulation of neutrophil granulocytes after 24 hours. Five consecutive i.v. injections of purified cytotoxic IgM into NB-bearing animals resulted in complete growth arrest of even large and established solid tumors which lasted for several weeks after discontinuation of the injections, whereas tumors of control animals continued to grow exponentially during the observation period. These studies suggest that natural anti-NB IgM may have a potential as a novel therapeutic modality in the treatment of human NE.	CHRISTIAN ALBRECHTS UNIV KIEL,DEPT SURG,D-24105 KIEL,GERMANY; UNIV HAMBURG,HOSP EPPENDORF,DEPT PEDIAT ONCOL,D-20246 HAMBURG,GERMANY	University of Kiel; University of Hamburg	David, K (corresponding author), UNIV HAMBURG,DEPT BIOCHEM & MOLEC BIOL,MARTIN LUTHER KING PL 6,D-20146 HAMBURG,GERMANY.			Ollert, Markus W./0000-0002-8055-0103				BARKER E, 1993, CANCER RES, V53, P362; BARKER E, 1991, CANCER RES, V51, P144; BRUCHELT G, 1989, J BIOLUM CHEMILUM, V3, P93, DOI 10.1002/bio.1170030212; BURCK HC, 1988, HISTOLOGISCHE TECHNI, P104; DIXON FJ, 1958, ARCH PATHOL, V65, P18; HANDGRETINGER R, 1993, HUMAN NEUROBLASTOMA, P24; JUHL H, 1995, CANCER RES, V55, pS5749; KUSHNER BH, 1989, BLOOD, V73, P1936; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MUJOO K, 1989, CANCER RES, V49, P2857; OLLERT MW, IN PRESS P NATL ACAD; Ouchterlony O., 1978, HDB EXPT IMMUNOLOGY; Philip T, 1989, NEW DIRECTIONS CANCE, P605; PINKERTON CR, 1993, HUMAN NEUROBLASTOMA, P3; SAVILL J, 1993, IMMUNOL TODAY, V14, P131, DOI 10.1016/0167-5699(93)90215-7; SIEGEL SE, 1986, ONCOLOGY, P1211; VOGEL CW, 1984, J IMMUNOL METHODS, V73, P203, DOI 10.1016/0022-1759(84)90045-0	17	27	30	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUN	1996	2	6					686	689		10.1038/nm0696-686	http://dx.doi.org/10.1038/nm0696-686			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UN691	8640561				2022-12-25	WOS:A1996UN69100038
J	Breton, S; Smith, PJS; Lui, B; Brown, D				Breton, S; Smith, PJS; Lui, B; Brown, D			Acidification of the male reproductive tract by a proton pumping (H+)-ATPase	NATURE MEDICINE			English	Article							ANHYDRASE-II DEFICIENCY; CARBONIC-ANHYDRASE; HISTOCHEMICAL-LOCALIZATION; SPERM MOTILITY; RAT EPIDIDYMIS; H+-ATPASE; PH; TESTIS; KIDNEY; CELLS	An acidic luminal pH (ref. 1-3) is involved in sperm maturation, and in maintaining sperm in an immotile state in the epididymis and vas deferens(2,4-6). Neutralization by prostatic fluid is one of a complex series of events that triggers sperm motility(2,7,8). Failure of the acidification mechanism might, therefore, result in poor sperm maturation, premature motility and infertility. We have shown that a vacuolar (H+)-ATPase is expressed at high levels on the luminal plasma membrane of specialized cells in the epididymis(9), which closely resemble acid-secreting kidney intercalated cells(10.11). We now show that similar cells are also present in the vas deferens, and that a bafilomycin-sensitive proton flux can be detected using a noninvasive proton-selective vibrating probe. Up to 80% of the net proton secretion in the vas deferens is inhibited by bafilomycin, consistent with a major role of a vacuolar-type (H+)-ATPase in this process. This acidification mechanism is a potential target for novel strategies aimed at modulating the acidification capacity of parts of the male reproductive tract and, therefore, in regulating male fertility.	HARVARD UNIV, SCH MED, BOSTON, MA 02129 USA; MASSACHUSETTS GEN HOSP, RENAL UNIT, BOSTON, MA 02129 USA; MASSACHUSETTS GEN HOSP, DEPT PATHOL, BOSTON, MA 02129 USA; MARINE BIOL LAB, NATL VIBRATING PROBE FACIL, WOODS HOLE, MA 02543 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Marine Biological Laboratory - Woods Hole				Smith, Peter/0000-0003-4400-6853	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042956] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 42956] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ACOTT TS, 1984, BIOL REPROD, V30, P926, DOI 10.1095/biolreprod30.4.926; ALAWQATI Q, 1989, METHOD ENZYMOL, V172, P49; AU CL, 1980, J PHYSIOL-LONDON, V309, P419, DOI 10.1113/jphysiol.1980.sp013517; BROWN D, 1988, NATURE, V331, P622, DOI 10.1038/331622a0; BROWN D, 1988, J CLIN INVEST, V82, P2114, DOI 10.1172/JCI113833; BROWN D, 1992, AM J PHYSIOL, V263, pC913, DOI 10.1152/ajpcell.1992.263.4.C913; CALFISCH CR, 1990, AM J PHYSIOL, V258, pE143; CARR DW, 1989, BIOL REPROD, V41, P907, DOI 10.1095/biolreprod41.5.907; CARR DW, 1985, BIOL REPROD, V33, P588, DOI 10.1095/biolreprod33.3.588; COHEN EP, 1992, J AM SOC NEPHROL, V3, P264; COHEN JP, 1976, BIOL REPROD, V14, P339, DOI 10.1095/biolreprod14.3.339; EKSTEDT E, 1991, ACTA ANAT, V141, P257, DOI 10.1159/000147131; EKSTEDT E, 1992, ACTA ANAT, V143, P258, DOI 10.1159/000147258; HINTON BT, 1995, MICROSC RES TECHNIQ, V30, P67, DOI 10.1002/jemt.1070300106; KAUNISTO K, 1995, BIOL REPROD, V52, P1350, DOI 10.1095/biolreprod52.6.1350; LEVINE N, 1978, J REPROD FERTIL, V52, P333, DOI 10.1530/jrf.0.0520333; LEWIS SE, 1988, P NATL ACAD SCI USA, V85, P1962, DOI 10.1073/pnas.85.6.1962; SCHUSTER VL, 1993, ANNU REV PHYSIOL, V55, P267, DOI 10.1146/annurev.ph.55.030193.001411; SLY WS, 1985, PEDIATR RES, V19, P1033, DOI 10.1203/00006450-198510000-00017; SMITH PJS, 1994, METHOD CELL BIOL, V40, P115; STEINMETZ PR, 1986, AM J PHYSIOL, V251, pF173, DOI 10.1152/ajprenal.1986.251.2.F173; USSELMAN MC, 1983, BIOL REPROD, V29, P1241, DOI 10.1095/biolreprod29.5.1241; WONG PYD, 1980, PFLUG ARCH EUR J PHY, V387, P61, DOI 10.1007/BF00580845	23	215	219	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	1996	2	4					470	472		10.1038/nm0496-470	http://dx.doi.org/10.1038/nm0496-470			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UD314	8597961				2022-12-25	WOS:A1996UD31400053
J	Maas, R				Maas, R			Keeping an eye on eye development	NATURE GENETICS			English	Editorial Material							RETINA; DIFFERENTIATION		BRIGHAM & WOMENS HOSP, DEPT MED, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Maas, R (corresponding author), BRIGHAM & WOMENS HOSP, HOWARD HUGHES MED INST, 20 SHATTUCK ST, BOSTON, MA 02115 USA.							ADLER R, 1989, SCIENCE, V243, P391, DOI 10.1126/science.2911751; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; FUJIWARA M, 1994, DIFFERENTIATION, V57, P31, DOI 10.1046/j.1432-0436.1994.5710031.x; GAN L, IN PRESS P NATL ACAD; Glaser T., 1995, MOL GENETICS OCULAR, P51; KONYUKHOV BV, 1971, EXPERIENTIA, V27, P970, DOI 10.1007/BF02135780; KONYUKHOV BV, 1975, DEV BIOL, V45, P1, DOI 10.1016/0012-1606(75)90235-3; LEVINE EM, 1994, J COMP NEUROL, V348, P596, DOI 10.1002/cne.903480409; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; Quinn JC, 1996, GENE DEV, V10, P435, DOI 10.1101/gad.10.4.435; ROBB RM, 1978, INVEST OPHTH VIS SCI, V5, P468; SILVER J, 1979, DEV BIOL, V68, P175, DOI 10.1016/0012-1606(79)90252-5; THEILER K, 1976, ANAT EMBRYOL, V150, P85; TRUSLOVE GM, 1962, J EMBRYOL EXP MORPH, V10, P652; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; WILSON D, 1993, GENE DEV, V7, P2120, DOI 10.1101/gad.7.11.2120; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	18	3	3	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1996	12	4					346	347		10.1038/ng0496-346	http://dx.doi.org/10.1038/ng0496-346			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UC553	8630480				2022-12-25	WOS:A1996UC55300004
J	Manenti, G; Gariboldi, M; Elango, R; Fiorino, A; DeGregorio, L; Falvella, FS; Hunter, K; Housman, D; Pierotti, MA; Dragani, TA				Manenti, G; Gariboldi, M; Elango, R; Fiorino, A; DeGregorio, L; Falvella, FS; Hunter, K; Housman, D; Pierotti, MA; Dragani, TA			Genetic mapping of a pulmonary adenoma resistance locus (Par1) in mouse	NATURE GENETICS			English	Letter							LUNG-CANCER; LINKAGE MAPS; SUSCEPTIBILITY; PREDISPOSITION; CARCINOGENESIS; NEOPLASIA; SMOKING; MICE		IST NAZL TUMORI, DIV EXPTL ONCOL A, I-20133 MILAN, ITALY; MIT, CTR CANC RES, CAMBRIDGE, MA 02139 USA	Fondazione IRCCS Istituto Nazionale Tumori Milan; Massachusetts Institute of Technology (MIT)			Pierotti, Marco Alessandro/AAC-4728-2022; Elango, Ramu/C-7684-2014; Dragani, Tommaso A./K-4493-2016; Elango, Ramu/I-7812-2013; Fiorino, Antonio/D-5828-2017; Manenti, Giacomo/J-3339-2017; Gariboldi, Manuela/K-4744-2016	Pierotti, Marco Alessandro/0000-0002-7431-8332; Elango, Ramu/0000-0003-4264-2135; Dragani, Tommaso A./0000-0001-5915-4598; Fiorino, Antonio/0000-0002-2621-9276; Manenti, Giacomo/0000-0002-4887-4482; Gariboldi, Manuela/0000-0001-8406-165X				AMOS CI, 1992, CANCER EPIDEM BIOMAR, V1, P505; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; DE LUCA LM, 1991, FASEB J, V5, P2924; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; Dragani TA, 1995, ADV CANCER RES, V67, P83, DOI 10.1016/S0065-230X(08)60711-3; DRAGANI TA, 1991, CANCER RES, V51, P6299; GARIBOLDI M, 1993, NAT GENET, V3, P132, DOI 10.1038/ng0293-132; GILLILAND FD, 1994, CANCER SURV, V20, P175; HSU LC, 1994, CANCER RES, V54, P2765; International Agency for Research on Cancer, 1986, IARC MON EV CARC RIS, P83; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANDER ES, 1989, GENETICS, V121, P185; LAW MR, 1990, BRIT J CANCER, V61, P195, DOI 10.1038/bjc.1990.37; LEE GH, 1995, GENETICS, V139, P387; LINCOLN S, 1992, MAPPING GENES CONTRO; Lincoln S, 1992, CONSTRUCING GENETIC, V3rd; LOEB LA, 1984, CANCER RES, V44, P5940; LOSSIE AC, 1994, MAMM GENOME, V5, pS164; MACPHEE M, 1995, CELL, V81, P957, DOI 10.1016/0092-8674(95)90015-2; MALKINSON AM, 1989, TOXICOLOGY, V54, P241, DOI 10.1016/0300-483X(89)90062-0; MANENTI G, 1995, GENOMICS, V29, P438, DOI 10.1006/geno.1995.9984; MCCARTHY L, 1995, P NATL ACAD SCI USA, V92, P5302, DOI 10.1073/pnas.92.12.5302; Moon R C, 1992, J Natl Cancer Inst Monogr, P45; NAGASE H, 1995, NAT GENET, V10, P424, DOI 10.1038/ng0895-424; PASTORINO U, 1993, J CLIN ONCOL, V11, P1216, DOI 10.1200/JCO.1993.11.7.1216; *SAS I, 1988, SAS US GUID; SELLERS TA, 1992, CANCER RES, V52, pS2694; TOMA S, 1995, EUR J CANCER PREV, V4, P213, DOI 10.1097/00008469-199506000-00002	29	68	68	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1996	12	4					455	457		10.1038/ng0496-455	http://dx.doi.org/10.1038/ng0496-455			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UC553	8630506				2022-12-25	WOS:A1996UC55300031
J	Romer, J; Bugge, TH; Pyke, C; Lund, LR; Flick, MJ; Degen, JL; Dano, K				Romer, J; Bugge, TH; Pyke, C; Lund, LR; Flick, MJ; Degen, JL; Dano, K			Impaired wound healing in mice with a disrupted plasminogen gene	NATURE MEDICINE			English	Article							UROKINASE-TYPE; EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; ACTIVATOR; RECEPTOR; TISSUE; EXPRESSION; CANCER; KERATINOCYTES; LOCALIZATION	Activation of plasminogen (Plg) has been proposed to play a role in proteolytic degradation of extracellular matrices in tissue remodeling events, including wound healing. However, there has been no definitive proof of involvement of Plg in such processes. We now report that healing of skin wounds is severely impaired in mice made deficient in plg by targeted gene disruption. The results demonstrate that plg is required for normal repair of skin wounds in mice and support the assumption that it also plays a central role in other disease processes involving extracellular matrix degradation, such as cancer invasion.	CHILDRENS HOSP RES FDN,DIV DEV BIOL,CINCINNATI,OH 45229; UNIV CALIF SAN FRANCISCO,RADIOBIOL & ENVIRONM HLTH LAB,SAN FRANCISCO,CA 94143	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University of California System; University of California San Francisco	Romer, J (corresponding author), RIGSHOSP,FINSEN LAB,STRANDBOULEVARDEN 49,DK-2100 COPENHAGEN O,DENMARK.							BEERS WH, 1975, CELL, V6, P387, DOI 10.1016/0092-8674(75)90188-9; BLASI F, 1987, J CELL BIOL, V104, P801, DOI 10.1083/jcb.104.4.801; BUGGE TH, 1995, GENE DEV, V9, P794, DOI 10.1101/gad.9.7.794; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; Clark R. A. F., 1988, MOL CELLULAR BIOL WO; COLLEN D, 1993, LANCET, V342, P34, DOI 10.1016/0140-6736(93)91888-S; CROWLEY CW, 1993, P NATL ACAD SCI USA, V90, P5021, DOI 10.1073/pnas.90.11.5021; DANO K, 1994, FIBRINOLYSIS, V8, P189, DOI 10.1016/0268-9499(94)90717-X; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; DONALDSON DJ, 1988, J INVEST DERMATOL, V90, P623, DOI 10.1111/1523-1747.ep12560762; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; GRAINGER DJ, 1994, NATURE, V370, P460, DOI 10.1038/370460a0; GRONDAHLHANSEN J, 1988, J INVEST DERMATOL, V90, P790, DOI 10.1111/1523-1747.ep12461511; HEIPLE JM, 1986, J EXP MED, V164, P826, DOI 10.1084/jem.164.3.826; HEISS MM, 1995, NAT MED, V1, P1035, DOI 10.1038/nm1095-1035; INOUE M, 1995, J INVEST DERMATOL, V104, P479, DOI 10.1111/1523-1747.ep12605917; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; MIGNATTI P, 1993, PHYSIOL REV, V73, P161, DOI 10.1152/physrev.1993.73.1.161; MORIOKA S, 1987, J INVEST DERMATOL, V88, P418, DOI 10.1111/1523-1747.ep12469754; NY T, 1985, ENDOCRINOLOGY, V116, P1666, DOI 10.1210/endo-116-4-1666; OSSOWSKI L, 1979, CELL, V16, P929, DOI 10.1016/0092-8674(79)90108-9; OSSOWSKI L, 1988, CELL, V52, P321, DOI 10.1016/S0092-8674(88)80025-4; PEPPER MS, 1993, J CELL BIOL, V122, P673, DOI 10.1083/jcb.122.3.673; PEPPER MS, 1987, J CELL BIOL, V105, P2535, DOI 10.1083/jcb.105.6.2535; POLLANEN J, 1988, J CELL BIOL, V106, P87, DOI 10.1083/jcb.106.1.87; PRENDERGAST GC, 1990, MOL CELL BIOL, V10, P1265, DOI 10.1128/MCB.10.3.1265; PYKE C, 1991, AM J PATHOL, V138, P1059; ROMER J, 1994, J INVEST DERMATOL, V102, P519, DOI 10.1111/1523-1747.ep12373187; ROMER J, 1991, J INVEST DERMATOL, V97, P803, DOI 10.1111/1523-1747.ep12486833; SAARIALHOKERE UK, 1995, J INVEST DERMATOL, V104, P982, DOI 10.1111/1523-1747.ep12606231; SAKSELA O, 1988, ANNU REV CELL BIOL, V4, P93, DOI 10.1146/annurev.cb.04.110188.000521; SALO T, 1994, LAB INVEST, V70, P176; SAPPINO AP, 1989, J CELL BIOL, V109, P2471, DOI 10.1083/jcb.109.5.2471; SCHAFER BM, 1994, AM J PATHOL, V144, P1269; SUH TT, 1995, GENE DEV, V9, P2020, DOI 10.1101/gad.9.16.2020; TALHOUK RS, 1992, J CELL BIOL, V118, P1271, DOI 10.1083/jcb.118.5.1271; UNKELESS JC, 1974, J EXP MED, V139, P834, DOI 10.1084/jem.139.4.834; Vassalli J D, 1992, Curr Top Microbiol Immunol, V181, P65; VASSALLI JD, 1991, J CLIN INVEST, V88, P1067, DOI 10.1172/JCI115405; WERB Z, 1977, NEW ENGL J MED, V296, P1017, DOI 10.1056/NEJM197705052961801	40	475	488	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAR	1996	2	3					287	292		10.1038/nm0396-287	http://dx.doi.org/10.1038/nm0396-287			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TY640	8612226				2022-12-25	WOS:A1996TY64000036
J	Saam, BT				Saam, BT			Magnetic resonance imaging with laser-polarized noble gases	NATURE MEDICINE			English	Editorial Material							NUCLEAR-SPIN RELAXATION; XE-129; EXCHANGE				Saam, BT (corresponding author), PRINCETON UNIV,DEPT PHYS,JADWIN HALL,POB 708,PRINCETON,NJ 08544, USA.							ALBERT MS, 1994, NATURE, V370, P199, DOI 10.1038/370199a0; BHASKAR ND, 1982, PHYS REV LETT, V49, P25, DOI 10.1103/PhysRevLett.49.25; BLACK RD, IN PRESS RADIOLOGY; CATES GD, 1992, PHYS REV A, V45, P4631, DOI 10.1103/PhysRevA.45.4631; CHUPP TE, 1987, PHYS REV C, V36, P2244, DOI 10.1103/PhysRevC.36.2244; DIXON WT, 1984, RADIOLOGY, V153, P189, DOI 10.1148/radiology.153.1.6089263; GATZKE M, 1993, PHYS REV LETT, V70, P690, DOI 10.1103/PhysRevLett.70.690; HAPPER W, 1984, PHYS REV A, V29, P3092, DOI 10.1103/PhysRevA.29.3092; HOULT DI, 1979, J MAGN RESON, V34, P425, DOI 10.1016/0022-2364(79)90019-2; JAMESON CJ, 1988, J CHEM PHYS, V89, P4074, DOI 10.1063/1.454842; MIDDLETON H, 1995, MAGNET RESON MED, V33, P271, DOI 10.1002/mrm.1910330219; MILLER KW, 1981, P NATL ACAD SCI-BIOL, V78, P4946, DOI 10.1073/pnas.78.8.4946; SAAM B, 1995, PHYS REV A, V52, P862, DOI 10.1103/PhysRevA.52.862; WAGSHUL ME, IN PRESS MAGN RESON; WEATHERSBY PK, 1980, UNDERSEA BIOMED RES, V7, P277	15	11	11	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAR	1996	2	3					358	359		10.1038/nm0396-358	http://dx.doi.org/10.1038/nm0396-358			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TY640	8612239				2022-12-25	WOS:A1996TY64000049
J	CLARK, J; ROCQUES, PJ; CREW, AJ; GILL, S; SHIPLEY, J; CHAN, AML; GUSTERSON, BA; COOPER, CS				CLARK, J; ROCQUES, PJ; CREW, AJ; GILL, S; SHIPLEY, J; CHAN, AML; GUSTERSON, BA; COOPER, CS			IDENTIFICATION OF NOVEL GENES, SYT AND SSX, INVOLVED IN THE T(X18)(P11.2Q11.2) TRANSLOCATION FOUND IN HUMAN SYNOVIAL SARCOMA	NATURE GENETICS			English	Article							SOFT-TISSUE TUMORS; CHROMOSOME-TRANSLOCATION; CELL-LINE; PROTEIN; FUSION; CHOP; HYBRIDIZATION; LIPOSARCOMA; EXPRESSION; REGULATOR	Human synovial sarcomas contain a recurrent and specific chromosomal translocation t(X;18)(p11.2;q11.2). By screening a synovial sarcoma cDNA library with a yeast artificial chromosome spanning the X chromosome breakpoint, we have indentified a hybrid transcript that contains 5' sequences (designated SYT) mapping to chromosome 18 and 3' sequences (designated SSX) mapping to chromosome X. An SM probe detected genomic rearrangements in 10/13 synovial sarcomas. Sequencing of cDNA clones shows that the normal SM gene encodes a protein rich in glutamine, proline and glycine, and indicates that in synovial sarcoma rearrangement of the SYT gene results in the formation of an STT-SSX fusion protein. Both SYT and SSX failed to exhibit significant homology to known gene sequences.	INST CANC RES, HADDOW LABS, DEPT MOLEC CARCINOGENESIS, SUTTON SM2 5NG, SURREY, ENGLAND; ROCKEFELLER UNIV, MT SINAI SCH MED, RUTTENBERG CANC CTR, NEW YORK, NY 10021 USA	University of London; Institute of Cancer Research - UK			gusterson, barry a/D-3752-2009; Chan, Andrew Man-Lok/J-9497-2013; Chan, Andrew/AAC-1145-2020	Chan, Andrew Man-Lok/0000-0001-9923-5464; Chan, Andrew/0000-0001-9923-5464; Shipley, Janet/0000-0001-6748-8678				AMAN P, 1992, GENE CHROMOSOME CANC, V5, P278, DOI 10.1002/gcc.2870050403; BUETTNER R, 1991, MOL CELL BIOL, V11, P3573, DOI 10.1128/MCB.11.7.3573; COOPER CS, 1984, NATURE, V311, P29, DOI 10.1038/311029a0; COOPER CS, 1993, ADV CANCER RES, V60, P75; COOPER CS, 1991, CARCINOGENESIS, V12, P155, DOI 10.1093/carcin/12.2.155; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Enzinger RM., 2011, SOFT TISSUE TUMORS, P1178; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FISHER C, 1994, CURR DIAGN PATHOL, V1, P13; FRY MJ, 1993, PROTEIN SCI, V2, P1785, DOI 10.1002/pro.5560021102; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; GROSS SJ, 1975, NATURE, V255, P68; KNIGHT JC, 1992, HUM MOL GENET, V1, P633, DOI 10.1093/hmg/1.8.633; KNIGHT JC, 1992, INT J ONCOL, V1, P747; LAFRENIERE RG, 1991, GENOMICS, V10, P276, DOI 10.1016/0888-7543(91)90512-D; LIMON J, 1991, GENE CHROMOSOME CANC, V3, P338, DOI 10.1002/gcc.2870030504; MIKI T, 1991, P NATL ACAD SCI USA, V88, P5167, DOI 10.1073/pnas.88.12.5167; MITCHELL PJ, 1992, ONCOGENE, V7, P383; MITCHELL PJ, 1992, ONCOGENE, V7, P2329; MYLIN LM, 1991, NUCLEIC ACIDS RES, V19, P5345, DOI 10.1093/nar/19.19.5345; RABBITTS TH, 1993, NAT GENET, V4, P175, DOI 10.1038/ng0693-175; REEVES BR, 1989, CANCER CEL, V7, P69; REEVES BR, 1989, ONCOGENE, V4, P373; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHENG WW, 1987, CANCER GENET CYTOGEN, V29, P179, DOI 10.1016/0165-4608(87)90048-3; SHIPLEY JM, 1994, ONCOGENE, V9, P1447; SMITH S, 1987, CANCER GENET CYTOGEN, V26, P179, DOI 10.1016/0165-4608(87)90147-6; SNELL RG, 1993, HUM MOL GENET, V2, P305, DOI 10.1093/hmg/2.3.305; SONOBE H, 1992, LAB INVEST, V67, P498; STROEHER VL, 1986, MOL CELL BIOL, V6, P4667, DOI 10.1128/MCB.6.12.4667; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; TURCCAREL C, 1987, P NATL ACAD SCI USA, V84, P1981, DOI 10.1073/pnas.84.7.1981; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0	34	598	630	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1994	7	4					502	508		10.1038/ng0894-502	http://dx.doi.org/10.1038/ng0894-502			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PA832	7951320				2022-12-25	WOS:A1994PA83200017
J	HUBERT, R; MACDONALD, M; GUSELLA, J; ARNHEIM, N				HUBERT, R; MACDONALD, M; GUSELLA, J; ARNHEIM, N			HIGH-RESOLUTION LOCALIZATION OF RECOMBINATION HOT-SPOTS USING SPERM TYPING	NATURE GENETICS			English	Article							POLYMERASE CHAIN-REACTION; HUNTINGTONS-DISEASE GENE; PHYSICAL MAP; HUMAN GENOME; LINKAGE MAP; SHORT ARM; REGION; AMPLIFICATION; POLYMORPHISMS; CHROMOSOMES	We have applied sperm DNA typing to determine the distribution of crossover events within a one megabase region of the short arm of human chromosome 4 near the locus for Huntington disease. A total of 29 recombinants were detected among 602 sperm typed after whole genome amplification. These recombinants were typed for seven polymorphic markers. The 280 kilobase D4S10-D4S126 interval was found to undergo recombination at a 6-9-fold greater rate per unit of physical distance than the adjacent 720 kb D4S126-D4S127 interval. Sperm typing has the potential to dissect mammalian recombination hot spots to the point where DNA sequence analysis may reveal the molecular basis for hyperrecombination.	UNIV SO CALIF,PROGRAM MOLEC BIOL,LOS ANGELES,CA 90089; MASSACHUSETTS GEN HOSP,NEUROGENET PROGRAM,BOSTON,MA 02114	University of Southern California; Harvard University; Massachusetts General Hospital				Arnheim, Norman/0000-0003-1247-1347				ALLITTO BA, 1991, GENOMICS, V9, P104, DOI 10.1016/0888-7543(91)90226-5; BATES GP, 1992, NAT GENET, V1, P180, DOI 10.1038/ng0692-180; BAXENDALE S, 1993, NAT GENET, V4, P181, DOI 10.1038/ng0693-181; BENGER JC, 1991, GENOMICS, V9, P614, DOI 10.1016/0888-7543(91)90354-H; BOWCOCK AM, 1988, P NATL ACAD SCI USA, V85, P2701, DOI 10.1073/pnas.85.8.2701; BRYDA EC, 1992, MAMM GENOME, V2, P123, DOI 10.1007/BF00353860; CUI XF, 1989, P NATL ACAD SCI USA, V86, P9389, DOI 10.1073/pnas.86.23.9389; CUI XF, 1992, GENOMICS, V13, P713, DOI 10.1016/0888-7543(92)90146-J; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HENKE A, 1993, GENOMICS, V18, P478, DOI 10.1016/S0888-7543(11)80003-0; HUBERT R, 1992, AM J HUM GENET, V51, P985; HUBERT R, 1992, GENOMICS, V12, P683, DOI 10.1016/0888-7543(92)90294-3; JANSON M, 1991, P NATL ACAD SCI USA, V88, P10609, DOI 10.1073/pnas.88.23.10609; LAURIE DA, 1985, ANN HUM GENET, V49, P203, DOI 10.1111/j.1469-1809.1985.tb01694.x; LI H, 1991, Methods (Orlando), V2, P49, DOI 10.1016/S1046-2023(05)80125-2; LI HH, 1988, NATURE, V335, P414, DOI 10.1038/335414a0; LITT M, 1989, AM J HUM GENET, V44, P397; LOCKE PA, 1993, SOMAT CELL MOLEC GEN, V19, P95, DOI 10.1007/BF01233958; MCCOMBIE WR, 1992, NAT GENET, V1, P348, DOI 10.1038/ng0892-348; OUDET C, 1992, HUM MOL GENET, V1, P599, DOI 10.1093/hmg/1.8.599; PAGE D C, 1987, Genomics, V1, P243, DOI 10.1016/0888-7543(87)90051-6; Petes T. D., 1991, MOL CELLULAR BIOL YE, P407; ROUYER F, 1986, COLD SPRING HARB SYM, V51, P221, DOI 10.1101/SQB.1986.051.01.027; SEFTON L, 1990, GENOMICS, V7, P382, DOI 10.1016/0888-7543(90)90172-Q; SHUTLER GG, 1994, AM J HUM GENET, V54, P104; STAPLETON PM, 1988, NUCLEIC ACIDS RES, V16, P2735, DOI 10.1093/nar/16.6.2735; WEBER JL, 1989, AM J HUM GENET, V44, P388; WESTPHAL E-M, 1987, Genomics, V1, P313, DOI 10.1016/0888-7543(87)90030-9; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847; ZUO J, 1992, HUM MOL GENET, V1, P149, DOI 10.1093/hmg/1.3.149	32	70	71	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1994	7	3					420	424		10.1038/ng0794-420	http://dx.doi.org/10.1038/ng0794-420			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NU306	7920662				2022-12-25	WOS:A1994NU30600018
J	ROBISON, K; GILBERT, W; CHURCH, GM				ROBISON, K; GILBERT, W; CHURCH, GM			LARGE-SCALE BACTERIAL GENE DISCOVERY BY SIMILARITY SEARCH	NATURE GENETICS			English	Article							COENZYME-M REDUCTASE; ACID SUBSTITUTION MATRICES; PROTEIN CODING REGIONS; NUCLEOTIDE-SEQUENCE; METHANOCOCCUS-VANNIELII; PHOSPHATE DIKINASE; RIBOSOMAL-PROTEINS; ESCHERICHIA-COLI; IDENTIFICATION; ORGANIZATION	DNA sequencing efforts frequently uncover genes other than the targeted ones. We have used rapid database scanning methods to search for undescribed eubacterial and archean protein coding frames in regions flanking known genes. By searching all prokaryotic DNA sequences not marked as coding for proteins or stable RNAs against the protein databases, we have identified more than 450 new examples of bacterial proteins, as well as a smaller number of possible revisions to known proteins, at a surprisingly high rate of one new protein or revision for every 24 initial DNA sequences or 8,300 nucleotides examined. Seven proteins are members of families which have not been described in prokaryotic sequences. We also describe 49 re-interpretations of existing sequence data of particular biological significance.	HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; HOWARD HUGHES MED INST,BOSTON,MA 02115	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	ROBISON, K (corresponding author), HARVARD UNIV,DEPT CELLULAR & MOLEC BIOL,16 DIVIN AVE,CAMBRIDGE,MA 02138, USA.			church, george/0000-0001-6232-9969				ALKSNE LE, 1993, J BIOL CHEM, V268, P10813; ALTSCHUL SF, 1991, J MOL BIOL, V219, P555, DOI 10.1016/0022-2836(91)90193-A; ALTSCHUL SF, 1990, J MOL BIOL, V214, P1; AUER J, 1991, SYST APPL MICROBIOL, V14, P14, DOI 10.1016/S0723-2020(11)80356-5; BAIROCH A, 1991, NUCLEIC ACIDS RES, V19, P2247, DOI 10.1093/nar/19.suppl.2247; BARKER WC, 1991, NUCLEIC ACIDS RES, V19, P2231, DOI 10.1093/nar/19.suppl.2231; BELUNIS CJ, 1992, J BIOL CHEM, V267, P18702; BENSON D, 1993, NUCLEIC ACIDS RES, V21, P2963, DOI 10.1093/nar/21.13.2963; BOKRANZ M, 1987, NUCLEIC ACIDS RES, V15, P4350, DOI 10.1093/nar/15.10.4350; BOKRANZ M, 1988, J BACTERIOL, V170, P568, DOI 10.1128/jb.170.2.568-577.1988; CARLISLE SM, 1990, J BIOL CHEM, V265, P18366; CECH TR, 1991, CELL, V64, P667, DOI 10.1016/0092-8674(91)90494-J; CLAVERIE JM, 1992, GENOMICS, V12, P838, DOI 10.1016/0888-7543(92)90321-I; CRAM DS, 1987, P NATL ACAD SCI USA, V84, P3992, DOI 10.1073/pnas.84.12.3992; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; FICKETT JW, 1992, NUCLEIC ACIDS RES, V20, P6441, DOI 10.1093/nar/20.24.6441; GESTELAND RF, 1992, SCIENCE, V257, P1640, DOI 10.1126/science.1529352; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HIGGINS DG, 1992, COMPUT APPL BIOL SCI, V8, P181; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; KLENIN A, 1988, MOL GEN GENET, V213, P409; KLENK HP, 1991, NUCLEIC ACIDS RES, V19, P6047, DOI 10.1093/nar/19.21.6047; KOEPLIN R, 1992, Journal of Bacteriology, V174, P191; KRAWETZ SA, 1989, NUCLEIC ACIDS RES, V17, P3951, DOI 10.1093/nar/17.10.3951; Kristensen T, 1992, DNA Seq, V2, P343, DOI 10.3109/10425179209020815; KUWANO Y, 1992, J BIOL CHEM, V267, P25304; LARSEN N, 1993, NUCLEIC ACIDS RES, V21, P3021, DOI 10.1093/nar/21.13.3021; LECHNER K, 1989, J MOL EVOL, V29, P20, DOI 10.1007/BF02106178; LEE SJ, 1992, J GEN MICROBIOL, V138, P1843, DOI 10.1099/00221287-138-9-1843; LEFFERS H, 1989, J MOL BIOL, V206, P1, DOI 10.1016/0022-2836(89)90519-6; MATSUOKA M, 1988, J BIOL CHEM, V263, P11080; NIELSEN H, 1986, EMBO J, V5, P2711, DOI 10.1002/j.1460-2075.1986.tb04555.x; OSAWA S, 1992, MICROBIOL REV, V56, P229, DOI 10.1128/MMBR.56.1.229-264.1992; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; POCALYKO DJ, 1990, BIOCHEMISTRY-US, V29, P10757, DOI 10.1021/bi00500a006; POSFAI J, 1992, P NATL ACAD SCI USA, V89, P4698, DOI 10.1073/pnas.89.10.4698; PUEHLER G, 1987, NUCLEIC ACIDS RES, V17, P4517; ROTH JR, 1993, J BACTERIOL, V175, P3303, DOI 10.1128/jb.175.11.3303-3316.1993; STATES DJ, 1991, P NATL ACAD SCI USA, V88, P5518, DOI 10.1073/pnas.88.13.5518; STORMO GD, 1982, NUCLEIC ACIDS RES, V10, P2997, DOI 10.1093/nar/10.9.2997; STROEHER UH, 1992, P NATL ACAD SCI USA, V89, P2566, DOI 10.1073/pnas.89.7.2566; ZIELINSKI NA, 1991, J BIOL CHEM, V266, P9754	43	39	56	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1994	7	2					205	214		10.1038/ng0694-205	http://dx.doi.org/10.1038/ng0694-205			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NQ037	7920643				2022-12-25	WOS:A1994NQ03700024
J	MATISE, TC; PERLIN, M; CHAKRAVARTI, A				MATISE, TC; PERLIN, M; CHAKRAVARTI, A			AUTOMATED CONSTRUCTION OF GENETIC-LINKAGE MAPS USING AN EXPERT-SYSTEM (MULTIMAP) - A HUMAN GENOME LINKAGE MAP	NATURE GENETICS			English	Article								High-resolution genetic linkage maps are indispensable for positional cloning of disease genes. Current procedures for map construction, although aided considerably by many existing computer programs, require extensive user-intervention at each of many repetitive steps. This is time consuming, labour intensive and increases the chance of error. We have developed an expert system computer program, MultiMap, which automates this step-by- step procedure. MultiMap is based on a novel map construction algorithm and allows investigator control of marker locus characteristics, such as informativeness, scorability or distance to nearest neighbours. We used MultiMap to construct a human genetic map at an average resolution of 6 cM, using published genotypes at 1266 microsatellite markers, and further extended this map by adding 397 VNTR and polymorphic gene markers.	UNIV PITTSBURGH,DEPT HUMAN GENET,PITTSBURGH,PA 15261; UNIV PITTSBURGH,DEPT PSYCHIAT,PITTSBURGH,PA 15261; CARNEGIE MELLON UNIV,SCH COMP SCI,PITTSBURGH,PA 15213	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University					NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000344] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00344] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BARKER D, 1987, P NATL ACAD SCI USA, V84, P8006, DOI 10.1073/pnas.84.22.8006; BUCHANAN BG, 1988, ANNU REV COMPUT SCI, V3, P23, DOI 10.1146/annurev.cs.03.060188.000323; BUETOW KH, 1991, AM J HUM GENET, V48, P911; CHAKRAVARTI A, 1991, BANBURY REPORT, V33, P307; COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3; Cox Tara K., 1992, American Journal of Human Genetics, V51, pA33; COX TK, THESIS; DAUSSET J, 1986, PRESSE MED, V15, P1801; DIETRICH W, 1992, GENETICS, V131, P423; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; KEATS BJB, 1991, GENOMICS, V9, P557, DOI 10.1016/0888-7543(91)90426-F; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LITT M, 1989, AM J HUM GENET, V44, P397; O'CONNELL P, 1987, Genomics, V1, P93, DOI 10.1016/0888-7543(87)90110-8; OTT J, 1974, AM J HUM GENET, V26, P588; VIGNAL A, 1993, METHODS MOL GENETICS, V1, P211; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEEKS D E, 1991, P297; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; ZIEGLE JS, 1992, GENOMICS, V14, P1026, DOI 10.1016/S0888-7543(05)80126-0	24	399	405	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1994	6	4					384	390		10.1038/ng0494-384	http://dx.doi.org/10.1038/ng0494-384			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ND870	8054979				2022-12-25	WOS:A1994ND87000018
J	CASEY, B; DEVOTO, M; JONES, KL; BALLABIO, A				CASEY, B; DEVOTO, M; JONES, KL; BALLABIO, A			MAPPING A GENE FOR FAMILIAL SITUS ABNORMALITIES TO HUMAN-CHROMOSOME XQ24-Q27.1	NATURE GENETICS			English	Article							INVERSUS-VISCERUM IV; LEFT RIGHT ASYMMETRY; LINKAGE ANALYSIS; SPECTRUM; HOMOLOGS; HEART; MOUSE; MICE	Ambiguous abdominal situs, asplenia/polysplenia and severe cardiac malformations characterize heterotaxy in humans. These anomalies result from the inability of the developing embryo to establish normal left-right asymmetry. We have studied an interesting family in which the heterotaxy phenotype segregates as an X-linked recessive trait. In order to map the heterotaxy locus (HTX), we have analysed 39 family members using highly-polymorphic microsatellite markers from the X chromosome. One of these markers, DXS994, shows no recombination with the disease locus in 20 informative meioses. Linkage analysis results in a maximum lod score of 6.37. Current genetic and physical mapping data assign the order of loci in Xq24-q27.1 as cen-DXS1001-(DXS994, HTX)-DXS984-tel. These results establish the first mapping assignment of situs abnormalities in humans.	BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PATHOL,HOUSTON,TX 77030; BAYLOR COLL MED,CTR HUMAN GENOME,HOUSTON,TX 77030; COLUMBIA UNIV,DEPT PSYCHIAT,NEW YORK,NY 10032; UCSD,SCH MED,DEPT PEDIAT,SAN DIEGO,CA 92103	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Columbia University; University of California System; University of California San Diego			Devoto, Marcella/AAP-7595-2021; BALLABIO, Andrea/AAL-2672-2020	BALLABIO, Andrea/0000-0003-1381-4604; DEVOTO, MARCELLA/0000-0002-4431-5114	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046970] Funding Source: NIH RePORTER; NHGRI NIH HHS [NCHGR HG00008] Funding Source: Medline; NIGMS NIH HHS [NIGMS GM46970] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AFZELIUS BA, 1989, METABOLIC BASIS INHE, P2739; BROWN NA, 1989, DEVELOPMENT, V107, P637; BRUECKNER M, 1989, P NATL ACAD SCI USA, V86, P5035, DOI 10.1073/pnas.86.13.5035; BURN J, 1991, BIOL ASYMMETRY HANDE, P282; HANZLIK AJ, 1990, GENOMICS, V7, P389, DOI 10.1016/0888-7543(90)90173-R; ICARDO JM, 1991, CIRCULATION, V84, P2547, DOI 10.1161/01.CIR.84.6.2547; JONES KL, 1988, SMITHS RECOGNIZABLE, P543; KOKEN MHM, 1992, GENOMICS, V12, P447, DOI 10.1016/0888-7543(92)90433-S; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LAYTON WM, 1978, MORPHOGENESIS MALFOR, P277; MATHIAS RS, 1987, AM J MED GENET, V28, P111, DOI 10.1002/ajmg.1320280116; MCGRATH J, 1992, GENOMICS, V14, P643, DOI 10.1016/S0888-7543(05)80163-6; McKusick V.A., 1992, MENDELIAN INHERITANC; MORENO A, 1981, AM J MED GENET, V8, P305, DOI 10.1002/ajmg.1320080309; NIIKAWA N, 1983, AM J MED GENET, V16, P43, DOI 10.1002/ajmg.1320160108; OKABE I, 1992, NUCLEIC ACIDS RES, V20, P4649, DOI 10.1093/nar/20.17.4649; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; SCHLESSINGER D, IN PRESS CYTOGENET C; SKARE J, 1993, GENOMICS, V16, P254, DOI 10.1006/geno.1993.1169; STURGESS JM, 1986, AM J MED GENET, V25, P149, DOI 10.1002/ajmg.1320250117; VANPRAAGH R, 1992, NADAS PEDIATRIC CARD, P1; VILLA A, 1992, GENOMICS, V13, P1231, DOI 10.1016/0888-7543(92)90040-Y; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WINERMURAM HT, 1989, RADIOL CLIN N AM, V27, P1147; WRIGHT DK, 1990, PCR PROTOCOLS GUIDE, P153; WYANDT HE, 1989, AM J MED GENET, V33, P426, DOI 10.1002/ajmg.1320330331; YOKOYAMA T, 1993, SCIENCE, V260, P679, DOI 10.1126/science.8480178	28	115	117	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1993	5	4					403	407		10.1038/ng1293-403	http://dx.doi.org/10.1038/ng1293-403			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ML145	8298651				2022-12-25	WOS:A1993ML14500019
J	DEVYS, D; LUTZ, Y; ROUYER, N; BELLOCQ, JP; MANDEL, JL				DEVYS, D; LUTZ, Y; ROUYER, N; BELLOCQ, JP; MANDEL, JL			THE FMR-1 PROTEIN IS CYTOPLASMIC, MOST ABUNDANT IN NEURONS AND APPEARS NORMAL IN CARRIERS OF A FRAGILE X PREMUTATION	NATURE GENETICS			English	Article							GENE; DNA; INSTABILITY; METHYLATION; TRANSCRIPTION; EXPRESSION; SEQUENCE; REPEAT; SITES	Fragile X mental retardation syndrome is caused by the unstable expansion of a CGG repeat in the FMR-1 gene. In patients with a full mutation, abnormal methylation results in suppression of FMR-1 transcription. FMR-1 is expressed in many tissues but its function is unknown. We have raised monoclonal antibodies specific for the FMR-1 protein. They detect 4-5 protein bands which appear identical in cells of normal males and of males carrying a premutation, but are absent in affected males with a full mutation. Immunohistochemistry shows a cytoplasmic localization of FMR-1. The highest levels were observed in neurons, while glial cells contain very low levels. In epithelial tissues, levels of FMR-1 were higher in dividing layers. In adult testis, FMR-1 was detected only in spermatogonia. FMR-1 was not detected in dermis and cardiac muscle except under pathological conditions.	FAC MED STRASBOURG,CNRS,INSERM,UNITE 184,GENET MOLEC EUCARYOTES LAB,11 RUE HUMANN,F-67085 STRASBOURG,FRANCE; CHRU,F-67085 STRASBOURG,FRANCE; CHU,HOSP HAUTEPIERRE,SERV ANAT PATHOL GEN,F-67089 STRASBOURG,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; CHU Strasbourg				Devys, Didier/0000-0001-9655-3512				ABITBOL M, 1993, NAT GENET, V4, P148; ASHLEY CT, 1993, NAT GENET, V4, P244, DOI 10.1038/ng0793-244; BERRYKRAVIS E, 1992, ANN NEUROL, V31, P22, DOI 10.1002/ana.410310105; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROU C, 1993, EMBO J, V12, P489, DOI 10.1002/j.1460-2075.1993.tb05681.x; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; DIECKMANN CL, 1985, J BIOL CHEM, V260, P1513; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GEDEON AK, 1992, NAT GENET, V1, P341, DOI 10.1038/ng0892-341; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; HAGERMANN, 1991, FRAGILE X SYNDROME D, P3; HANSEN RS, 1992, HUM MOL GENET, V1, P571, DOI 10.1093/hmg/1.8.571; HARLOW E, 1988, ANTIBODIES LABORATOR; HEITZ D, 1992, J MED GENET, V29, P794, DOI 10.1136/jmg.29.11.794; HINDS HL, 1993, NAT GENET, V3, P36, DOI 10.1038/ng0193-36; JOHANNISSON R, 1988, HUM GENET, V79, P231, DOI 10.1007/BF00366242; JOHANNISSON R, 1987, HUM GENET, V76, P141, DOI 10.1007/BF00284911; KASTNER P, 1992, EMBO J, V11, P629, DOI 10.1002/j.1460-2075.1992.tb05095.x; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; MANTOVANI R, 1992, EMBO J, V11, P3315, DOI 10.1002/j.1460-2075.1992.tb05410.x; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; REISS AL, 1991, ANN NEUROL, V29, P26, DOI 10.1002/ana.410290107; REYNIERS E, 1993, NAT GENET, V4, P143, DOI 10.1038/ng0693-143; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; Sherman S., 1991, FRAGILE X SYNDROME D, P69; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; STGROTH FS, 1986, J IMMUNOL METHODS, V35, P1; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; SUTHERLAND GR, 1977, SCIENCE, V197, P265, DOI 10.1126/science.877551; VERKERK AJMH, 1993, HUM MOL GENET, V2, P399, DOI 10.1093/hmg/2.4.399; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WOHRLE D, 1992, AM J HUM GENET, V51, P299; YU S, 1992, AM J HUM GENET, V50, P968; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	36	601	612	0	23	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1993	4	4					335	340		10.1038/ng0893-335	http://dx.doi.org/10.1038/ng0893-335			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LQ178	8401578				2022-12-25	WOS:A1993LQ17800008
J	Kozal, MJ; Shah, N; Shen, NP; Yang, R; Fucini, R; Merigan, TC; Richman, DD; Morris, D; Hubbell, ER; Chee, M; Gingeras, TR				Kozal, MJ; Shah, N; Shen, NP; Yang, R; Fucini, R; Merigan, TC; Richman, DD; Morris, D; Hubbell, ER; Chee, M; Gingeras, TR			Extensive polymorphisms observed in HIV-1 clade B protease gene using high-density oligonucleotide arrays	NATURE MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NUCLEOTIDE-SEQUENCE; VIRAL INFECTIVITY; AIDS VIRUS	Naturally occurring mutations in HIV-1-infected patients have important implications for therapy and the outcome of clinical studies. However, little is known about the prevalence of mutations that confer resistance to HIV-1 protease inhibitors in isolates derived from patients naive for such inhibitors. In the first clinical application of high-density oligonucleotide array sequencing, the sequences of 167 viral isolates from 102 patients have been determined, The DNA sequence of USA HIV-1 clade B proteases was found to be extremely variable and 47.5% of the 99 amino acid positions varied. This level of amino acid diversity is greater than that previously known for all worldwide HIV-1 clades combined (40%). Many of the amino acid changes that are known to contribute to drug resistance occurred as natural polymorphisms in isolates from patients who had never received protease inhibitors.	AFFYMETRIX,DEPT BIOL MOLEC,SANTA CLARA,CA 95051; STANFORD UNIV,DIV INFECT DIS,STANFORD,CA 94305; UNIV CALIF SAN DIEGO,DEPT PATHOL,LA JOLLA,CA 92093; UNIV CALIF SAN DIEGO,DEPT MED,LA JOLLA,CA 92093; VET AFFAIRS MED CTR,SAN DIEGO,CA 92161	Affymetrix; Stanford University; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA)			Merigan, Thomas/AGQ-7464-2022	, Michael/0000-0002-7719-7396; Kozal, Michael/0000-0002-3100-8254; Gingeras, Thomas/0000-0001-9106-3573; Hubbell, Earl/0000-0001-7301-3759	NIAID NIH HHS [1R43-AI 36809, 1U01-AI 30457, R44-AI/GM 36809-02] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI036809, U01AI030457, R44AI036809] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; CONDRA JH, 1995, NATURE, V374, P569, DOI 10.1038/374569a0; DELWART EL, 1993, SCIENCE, V262, P1257, DOI 10.1126/science.8235655; Eckert K A, 1991, PCR Methods Appl, V1, P17; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; GINGERAS TR, 1991, J INFECT DIS, V164, P1066, DOI 10.1093/infdis/164.6.1066; HO DD, 1994, J VIROL, V68, P2016, DOI 10.1128/JVI.68.3.2016-2020.1994; JACOBSEN H, 1994, HIV DRUG RES 3 INT W, P16; KAPLAN AH, 1994, P NATL ACAD SCI USA, V91, P5022; KOHL NE, 1988, P NATL ACAD SCI USA, V85, P4686, DOI 10.1073/pnas.85.13.4686; LEGRICE SFJ, 1988, EMBO J, V7, P2547, DOI 10.1002/j.1460-2075.1988.tb03103.x; LIPSHUTZ RJ, 1994, CURR OPIN STRUC BIOL, V4, P376, DOI 10.1016/S0959-440X(94)90106-6; LIPSHUTZ RJ, 1995, BIOTECHNIQUES, V19, P442; Mellors J. W., 1995, International Antiviral News, V3, P8; MEYERS G, 1994, HUMAN RETROVIRUSES A, V3, P97; MEYERS G, 1994, HUMAN RETROVIRUSES A, V1, P79; MILLER M, 1989, NATURE, V337, P576, DOI 10.1038/337576a0; PEASE AC, 1994, P NATL ACAD SCI USA, V91, P5022, DOI 10.1073/pnas.91.11.5022; PENG C, 1989, J VIROL, V63, P2550, DOI 10.1128/JVI.63.6.2550-2556.1989; PILLAY D, 1995, REV MED VIROL, V5, P23, DOI 10.1002/rmv.1980050104; POTTS KE, 1994, HIV DRUG RES 3 INT W, P4; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; ROSE B, 1994, HIV DRUG RES 3 INT W, P17; SANCHEZPESCADOR R, 1985, SCIENCE, V227, P484, DOI 10.1126/science.2578227; Tabor S., 1995, P NATL ACAD SCI USA, V92, P6639; THEODORE T, 1990, HUMAN RETROVIRUSES A, P162; TISDALE M, 1994, 3RD INT WORKSH HIV D, P14; TOH H, 1985, NATURE, V315, P691, DOI 10.1038/315691a0	28	422	574	0	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUL	1996	2	7					753	759		10.1038/nm0796-753	http://dx.doi.org/10.1038/nm0796-753			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UU680	8673920				2022-12-25	WOS:A1996UU68000030
J	Shimomura, I; Funahashi, T; Takahashi, M; Maeda, K; Kotani, K; Nakamura, T; Yamashita, S; Miura, M; Fukuda, Y; Takemura, K; Tokunaga, K; Matsuzawa, Y				Shimomura, I; Funahashi, T; Takahashi, M; Maeda, K; Kotani, K; Nakamura, T; Yamashita, S; Miura, M; Fukuda, Y; Takemura, K; Tokunaga, K; Matsuzawa, Y			Enhanced expression of PAI-1 in visceral fat: Possible contributor to vascular disease in obesity	NATURE MEDICINE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR; CARDIOVASCULAR-DISEASE; INSULIN RESISTANCE; RAPID INHIBITOR; ADIPOSE-TISSUE; MESSENGER-RNA; BODY-FAT; PLASMA; LEVEL; RISK	The presence of obesity increases the risk of thrombotic vascular diseases. The role of fat accumulation and its effect on plasminogen activator inhibitor-1 (PAI-1) levels was investigated in humans and animals. Plasma PAI-1 levels were closely correlated with visceral fat area but not with subcutaneous fat area in human subjects. PAI-1 mRNA was detected in both types of fat tissue in obese rats but increased only in visceral fat during the development of obesity. These data suggest that an enhanced expression of the PAI-7 gene in visceral fat may increase plasma levels and may have a role in the development of vascular disease in visceral obesity.	OSAKA UNIV,SCH MED,DEPT INTERNAL MED 2,SUITA,OSAKA 565,JAPAN; MITSUBISHI KAGAKU BIOCLIN LABS,ITABASHI KU,TOKYO 174,JAPAN; OTSUKA ASSAY LABS,HIRAI,TOKUSHIMA,JAPAN	Osaka University; Mitsubishi Kagaku Bio-Clinical Laboratories								ALLHAUD G, 1992, ANNU REV NUTR, V12, P207; AUWERX J, 1988, ARTERIOSCLEROSIS, V8, P68, DOI 10.1161/01.ATV.8.1.68; BJORNTORP P, 1990, ARTERIOSCLEROSIS, V10, P493, DOI 10.1161/01.ATV.10.4.493; DEPRES JP, 1989, DIABETES, V38, P304; FUJIOKA S, 1987, METABOLISM, V36, P54, DOI 10.1016/0026-0495(87)90063-1; FUNAHASHI T, 1995, BIOCHEM BIOPH RES CO, V211, P469, DOI 10.1006/bbrc.1995.1837; HAMSTEN A, 1985, NEW ENGL J MED, V313, P1557, DOI 10.1056/NEJM198512193132501; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; KISSEBAH AH, 1982, J CLIN ENDOCR METAB, V54, P254, DOI 10.1210/jcem-54-2-254; KOOISTRA T, 1989, THROMB HAEMOSTASIS, V62, P723; LARSSON B, 1984, BRIT MED J, V288, P1401, DOI 10.1136/bmj.288.6428.1401; LUCORE CL, 1988, J BIOL CHEM, V263, P15845; MATSUZAWA Y, 1990, PROGR OBESITY RES, P309; NAKAMURA T, 1994, ATHEROSCLEROSIS, V107, P239, DOI 10.1016/0021-9150(94)90025-6; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; SHIMOMURA I, 1993, AM J PHYSIOL, V265, pE44, DOI 10.1152/ajpendo.1993.265.1.E44; SPIEGELMAN BM, 1993, J BIOL CHEM, V268, P6823; TOKUNAGA K, 1986, AM J PHYSIOL, V251, pR1221, DOI 10.1152/ajpregu.1986.251.6.R1221; TOKUNAGA K, 1983, INT J OBESITY, V7, P437; VAGUE P, 1986, METABOLISM, V35, P250, DOI 10.1016/0026-0495(86)90209-X; WIMAN B, 1984, J BIOL CHEM, V259, P3644; WIMAN B, 1990, SEMIN THROMB HEMOST, V16, P207, DOI 10.1055/s-2007-1002671	23	719	746	0	23	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUL	1996	2	7					800	803		10.1038/nm0796-800	http://dx.doi.org/10.1038/nm0796-800			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UU680	8673927				2022-12-25	WOS:A1996UU68000037
J	Naski, MC; Wang, Q; Xu, JS; Ornitz, DM				Naski, MC; Wang, Q; Xu, JS; Ornitz, DM			Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia	NATURE GENETICS			English	Letter							FEATURES; HEPARIN; PROTEIN; DOMAIN		WASHINGTON UNIV, SCH MED, DEPT MOLEC BIOL & PHARMACOL, ST LOUIS, MO 63110 USA	Washington University (WUSTL)				Ornitz, David/0000-0003-1592-7629	NCI NIH HHS [CA-60673] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA060673] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BLECHMAN JM, 1995, CELL, V80, P103, DOI 10.1016/0092-8674(95)90455-7; BRINER J, 1991, PATHOL RES PRACT, V187, P271; CHELLAIAH AT, 1994, J BIOL CHEM, V269, P11620; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; FORMISANO P, 1993, J BIOL CHEM, V268, P5241; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANNEKEN A, 1994, P NATL ACAD SCI USA, V91, P9170, DOI 10.1073/pnas.91.19.9170; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; KEEGAN K, 1991, ONCOGENE, V6, P2229; Mohammadi M, 1996, MOL CELL BIOL, V16, P977; MUENKE M, 1995, TRENDS GENET, V11, P308, DOI 10.1016/S0168-9525(00)89088-5; NEILSON KM, 1995, J BIOL CHEM, V270, P26037, DOI 10.1074/jbc.270.44.26037; OBERKLAID F, 1979, J MED GENET, V16, P140, DOI 10.1136/jmg.16.2.140; OLWIN BB, 1990, J CELL BIOL, V110, P503, DOI 10.1083/jcb.110.2.503; ORNITZ DM, 1992, J BIOL CHEM, V267, P16305; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; RIMOIN DL, 1993, MCKUSICKS HERITABLE, P557; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; SANTORO M, 1995, SCIENCE, V267, P381, DOI 10.1126/science.7824936; SHAH K, 1973, J MED GENET, V10, P243, DOI 10.1136/jmg.10.3.243; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; SOROKIN A, 1994, J BIOL CHEM, V269, P9752; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; WATOWICH SS, 1994, MOL CELL BIOL, V14, P3535, DOI 10.1128/MCB.14.6.3535; Webster MK, 1996, EMBO J, V15, P520, DOI 10.1002/j.1460-2075.1996.tb00384.x; WILKIE AOM, 1995, CURR BIOL, V5, P500	30	403	422	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1996	13	2					233	237		10.1038/ng0696-233	http://dx.doi.org/10.1038/ng0696-233			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UN395	8640234				2022-12-25	WOS:A1996UN39500027
J	Scholander, C; Treutiger, CJ; Hultenby, K; Wahlgren, M				Scholander, C; Treutiger, CJ; Hultenby, K; Wahlgren, M			Novel fibrillar structure confers adhesive property to malaria-infected erythrocytes	NATURE MEDICINE			English	Article							HUMAN CEREBRAL MALARIA; PLASMODIUM-FALCIPARUM; CYTOADHERENCE; RECEPTOR; MOLECULE-1; CD36	Infections with the malaria parasite Plasmodium falciparum are characterized by sequestration of erythrocytes infected by mature forms of the parasite. Sequestration seems critical for the survival of the parasite, but may lead to excessive binding in the microvasculature and death of the human host. We report here that a novel electron-dense fibrillar structure, containing immunoglobulins M or M and G, is found at the surface of infected erythrocytes that adhere to host cells. In cases of cerebral malaria, fibrillar strands are also seen in the microvasculature at autopsy. Our findings may explain the adhesive mechanism by which malaria-infected erythrocytes cause the vascular obstruction seen in complicated malaria infections.	KAROLINSKA INST,CTR MICROBIOL & TUMOR BIOL,S-17177 STOCKHOLM,SWEDEN; SWEDISH INST INFECT DIS CONTROL,S-17177 STOCKHOLM,SWEDEN; HUDDINGE HOSP,KAROLINSKA INST,CLIN RES CTR,S-14186 HUDDINGE,SWEDEN	Karolinska Institutet; Swedish Institute for Infectious Disease Control; Karolinska Institutet								AIKAWA M, 1988, AM J TROP MED HYG, V39, P3, DOI 10.4269/ajtmh.1988.39.3; BARNWELL JW, 1989, J CLIN INVEST, V84, P765, DOI 10.1172/JCI114234; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; CARLSON J, 1990, LANCET, V336, P1457, DOI 10.1016/0140-6736(90)93174-N; FUJIOKA H, 1994, EXP PARASITOL, V78, P371, DOI 10.1006/expr.1994.1040; HANDUNNETTI SM, 1992, BLOOD, V80, P2097; HIDAYAT AA, 1993, OPHTHALMOLOGY, V100, P1183, DOI 10.1016/S0161-6420(93)31508-3; HOWARD RJ, 1989, BLOOD, V74, P2603; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; MILLER LH, 1994, SCIENCE, V264, P1878, DOI 10.1126/science.8009217; MILLER LH, 1972, T ROY SOC TROP MED H, V66, P459, DOI 10.1016/0035-9203(72)90277-5; NAGATAKE T, 1992, AM J TROP MED HYG, V47, P359; OCKENHOUSE CF, 1992, J EXP MED, V176, P1183, DOI 10.1084/jem.176.4.1183; RIGANTI M, 1990, IMMUNOL LETT, V25, P199, DOI 10.1016/0165-2478(90)90115-7; RINGWALD P, 1993, INFECT IMMUN, V61, P5198, DOI 10.1128/IAI.61.12.5198-5204.1993; ROBERTS DD, 1985, NATURE, V318, P64, DOI 10.1038/318064a0; ROWE A, 1995, INFECT IMMUN, V63, P2323, DOI 10.1128/IAI.63.6.2323-2326.1995; RUANGJIRACHUPORN W, 1991, PARASITOLOGY, V102, P325, DOI 10.1017/S003118200006426X; TRAGER W, 1966, B WORLD HEALTH ORGAN, V35, P883; TREUTIGER CJ, 1992, AM J TROP MED HYG, V46, P503, DOI 10.4269/ajtmh.1992.46.503	20	90	91	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	FEB	1996	2	2					204	208		10.1038/nm0296-204	http://dx.doi.org/10.1038/nm0296-204			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TU060	8574966				2022-12-25	WOS:A1996TU06000041
J	Levanat, S; Gorlin, RJ; Fallet, S; Johnson, DR; Fantasia, JE; Bale, AE				Levanat, S; Gorlin, RJ; Fallet, S; Johnson, DR; Fantasia, JE; Bale, AE			A two-hit model for developmental defects in Gorlin syndrome	NATURE GENETICS			English	Letter							MUTATION; TUMOR		YALE UNIV,SCH MED,DEPT GENET,NEW HAVEN,CT 06520; UNIV MINNESOTA,SCH DENT,DEPT ORAL PATHOL,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,SCH DENT,DEPT GENET,MINNEAPOLIS,MN 55455; ALBERT EINSTEIN COLL MED,LONG ISL JEWISH MED CTR,SCHNEIDER CHILDRENS HOSP,DEPT DENT MED,NEW HYDE PK,NY 11042	Yale University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; Yeshiva University					NATIONAL CANCER INSTITUTE [R01CA057605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007439] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA57605] Funding Source: Medline; NIGMS NIH HHS [5T32 GM07439] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHLFORS E, 1984, J ORAL MAXIL SURG, V42, P10, DOI 10.1016/0278-2391(84)90390-2; BALE SJ, 1991, AM J MED GENET, V40, P206, DOI 10.1002/ajmg.1320400217; BROWNE R M, 1975, Journal of Oral Pathology, V4, P31, DOI 10.1111/j.1600-0714.1975.tb01738.x; CROSBY JL, 1993, AM J HUM GENET, V52, P866; FRASER FC, 1980, AM J HUM GENET, V32, P796; GAILANI MR, 1992, CELL, V69, P111, DOI 10.1016/0092-8674(92)90122-S; GALE AE, 1994, J INVEST DERMATOL, V103, pS126; GORLIN RJ, 1995, DERMATOL CLIN, V13, P113, DOI 10.1016/S0733-8635(18)30114-1; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; JOHNSON DR, 1995, BIOTECHNIQUES, V19, P190; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KURNIT DM, 1987, AM J HUM GENET, V41, P979; LAIRD PW, 1995, CELL, V81, P197, DOI 10.1016/0092-8674(95)90329-1; LI CC, 1987, AM J HUM GENET, V41, P517; LYALL JEW, 1992, NUCLEIC ACIDS RES, V20, P925, DOI 10.1093/nar/20.4.925-a; Moore KL, 1993, DEV HUMAN, V5thed.; PANDERS AK, 1969, J ORAL SURG, V27, P931; PERICAKVANCE MA, IN PRESS ANN HUM GEN; REGEZI JA, 1981, HEAD NECK SURG, V4, P48, DOI 10.1002/hed.2890040110; Sambrook J, 1989, MOL CLONING LABORATO; Soskolne W A, 1967, Br Dent J, V123, P321; STOELINGA PJW, 1975, J ORAL SURG, V33, P659; TOLLER PAUL, 1967, ANN ROY COLL SURG ENGL, V40, P306; TOVELL KE, 1972, J CAN DENT ASSOC, V4, P145; VANHEYNINGEN V, 1994, NATURE, V367, P319, DOI 10.1038/367319a0; VEDTOFTE P, 1982, SCAND J DENT RES, V90, P306	26	148	155	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1996	12	1					85	87		10.1038/ng0196-85	http://dx.doi.org/10.1038/ng0196-85			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TM555	8528259				2022-12-25	WOS:A1996TM55500020
J	RISINGER, JI; BERCHUCK, A; KOHLER, MF; BOYD, J				RISINGER, JI; BERCHUCK, A; KOHLER, MF; BOYD, J			MUTATIONS OF THE E-CADHERIN GENE IN HUMAN GYNECOLOGIC CANCERS	NATURE GENETICS			English	Article							CELL-ADHESION MOLECULE; TUMOR SUPPRESSOR GENE; PROSTATE-CANCER; EXPRESSION; CARCINOMA; CHROMOSOME-16; UVOMORULIN; ADENOCARCINOMA; PROGRESSION; ALLELOTYPE	Expression of the E-cadherin cell adhesion molecule is reduced in several types of human carcinomas, and the protein serves as an invasion suppressor in vitro. To determine if mutations of the E-cadherin gene (on chromosome 16q22) contribute to epithelial tumorigenesis, 135 carcinomas of the endometrium and ovary were examined for alterations in the E-cadherin coding region. Four mutations were identified: one somatic nonsense and one somatic missense mutation, both with retention of the wildtype alleles, and two missense mutations with somatic loss of heterozygosity in the tumour tissue. These data support the classification of E-cadherin as a human tumour suppressor gene.	NIEHS,GYNECOL PATHOBIOL GRP,MOLEC CARCINOGENESIS LAB,RES TRIANGLE PK,NC 27709; DUKE UNIV,MED CTR,DEPT OBSTET & GYNECOL,DURHAM,NC 27710	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University				Boyd, Jeff/0000-0002-3517-7637				BEHRENS J, 1989, J CELL BIOL, V108, P2435, DOI 10.1083/jcb.108.6.2435; BERGERHEIM USR, 1991, GENE CHROMOSOME CANC, V3, P215, DOI 10.1002/gcc.2870030308; BRABANT G, 1993, CANCER RES, V53, P4987; BRINGUIER PP, 1993, CANCER RES, V53, P3241; BUSSEMAKERS MJG, 1993, MOL BIOL REP, V17, P123, DOI 10.1007/BF00996219; BUSSEMAKERS MJG, 1992, CANCER RES, V52, P2916; CARTER BS, 1990, P NATL ACAD SCI USA, V87, P8751, DOI 10.1073/pnas.87.22.8751; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DEVILEE P, 1991, ONCOGENE, V6, P1705; DOHERTY P, 1990, NATURE, V343, P464, DOI 10.1038/343464a0; EDELMAN GM, 1988, BIOCHEMISTRY-US, V27, P3533, DOI 10.1021/bi00410a001; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; GAO X, 1993, CANCER RES, V53, P2723; HOFFMAN S, 1983, P NATL ACAD SCI-BIOL, V80, P5762, DOI 10.1073/pnas.80.18.5762; HOHNE MW, 1992, CANCER RES, V52, P2616; INOUE M, 1992, AM J CLIN PATHOL, V98, P76, DOI 10.1093/ajcp/98.1.76; KUNIMI K, 1991, GENOMICS, V11, P530, DOI 10.1016/0888-7543(91)90059-N; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; MANSOURI A, 1988, DIFFERENTIATION, V38, P67, DOI 10.1111/j.1432-0436.1988.tb00593.x; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; NATT E, 1989, CYTOGENET CELL GENET, V50, P145, DOI 10.1159/000132745; ODA T, 1994, P NATL ACAD SCI USA, V91, P1858, DOI 10.1073/pnas.91.5.1858; SASAKI H, 1993, CANCER RES, V53, P1906; SATO T, 1991, CANCER RES, V51, P5118; SHIMOYAMA Y, 1989, CANCER RES, V49, P2128; SHIMOYAMA Y, 1991, CANCER RES, V51, P2185; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; TSUDA H, 1990, P NATL ACAD SCI USA, V87, P6791, DOI 10.1073/pnas.87.17.6791; UMBAS R, 1992, CANCER RES, V52, P5104; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M	31	264	270	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1994	7	1					98	102		10.1038/ng0594-98	http://dx.doi.org/10.1038/ng0594-98			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NJ842	8075649				2022-12-25	WOS:A1994NJ84200021
J	MONTGOMERY, GW; CRAWFORD, AM; PENTY, JM; DODDS, KG; EDE, AJ; HENRY, HM; PIERSON, CA; LORD, EA; GALLOWAY, SM; SCHMACK, AE; SISE, JA; SWARBRICK, PA; HANRAHAN, V; BUCHANAN, FC; HILL, DF				MONTGOMERY, GW; CRAWFORD, AM; PENTY, JM; DODDS, KG; EDE, AJ; HENRY, HM; PIERSON, CA; LORD, EA; GALLOWAY, SM; SCHMACK, AE; SISE, JA; SWARBRICK, PA; HANRAHAN, V; BUCHANAN, FC; HILL, DF			THE OVINE BOOROOLA FECUNDITY GENE (FECB) IS LINKED TO MARKERS FROM A REGION OF HUMAN CHROMOSOME-4Q	NATURE GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; OVULATION RATE; MAJOR GENE; ROMNEY EWES; SHEEP; GROWTH; LOCUS; FEC(B); EXPRESSION; NUCLEOTIDE	The autosomal Booroola fecundity gene (FecB) mutation in sheep increases ovulation rate and litter size, with associated effects on ovarian physiology and hormone profiles. Analysis of segregation in twelve families (379 female progeny) identified linkage between the mutation, two microsatellite markers (OarAE101 and OarHH55, Z(max) >9.0) and epidermal growth factor (EGF) from human chromosome 4q25 (Z(max) >3.0). The marker OarAE101 was linked to secreted phosphoprotein 1 (SPP1, which maps to chromosome 4q21-23 in man) in the test pedigrees and independent families (Z(max) >9.7). The identification of linkage between the FecB mutation and markers from human chromosome 4q is an important step towards further understanding the control of ovulation rates in mammals.	UNIV OTAGO, CTR GENE RES, DUNEDIN, NEW ZEALAND	University of Otago	MONTGOMERY, GW (corresponding author), UNIV OTAGO, DEPT BIOCHEM, AGRES MOLEC BIOL UNIT, DUNEDIN, NEW ZEALAND.		Montgomery, Grant W/B-7148-2008; Lumsden, Joanne M/B-6475-2009	Montgomery, Grant W/0000-0002-4140-8139; Dodds, Ken/0000-0002-9347-6379; Lumsden, Joanne/0000-0002-0730-9946				ANSARI A, IN PRESS 10TH P EUR; BENDELL JJ, 1990, ENDOCRINOLOGY, V127, P533, DOI 10.1210/endo-127-2-533; BINDON BM, 1986, OXFORD REV REPROD B, V8, P414; BRADFORD GE, 1991, COLLOQ INRA, V57, P67; BROWN WM, 1989, NUCLEIC ACIDS RES, V17, P10495, DOI 10.1093/nar/17.24.10495; BUCHANAN FC, 1991, ANIM GENET, V22, P373, DOI 10.1111/j.1365-2052.1991.tb00694.x; CHARBOT B, 1988, NATURE, V335, P88; CRAWFORD AM, 1990, ANIM GENET, V21, P433, DOI 10.1111/j.1365-2052.1990.tb01990.x; CRAWFORD AM, 1991, PROC NEW ZEAL SOC AN, V51, P79; Davis G. H., 1983, Proceedings of the New Zealand Society of Animal Production, V43, P197; DAVIS GH, 1982, NEW ZEAL J AGR RES, V25, P525, DOI 10.1080/00288233.1982.10425216; DAVIS GH, 1991, BIOL REPROD, V44, P620, DOI 10.1095/biolreprod44.4.620; DODDS KG, 1993, J HERED, V84, P43, DOI 10.1093/oxfordjournals.jhered.a111275; EYTHORSDOTTIR E, 1991, COLLOQ INRA, V57, P75; FLEMING JS, 1992, J MOL ENDOCRINOL, V8, P265, DOI 10.1677/jme.0.0080265; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GOLDBERGER G, 1987, J BIOL CHEM, V262, P10065; HENDERSON KM, 1988, J REPROD FERTIL, V84, P187, DOI 10.1530/jrf.0.0840187; HENDERSON KM, 1987, P ASIAN AUSTRALASIAN, V4, P130; KELLY JD, 1991, J BIOL CHEM, V266, P8987; KERR JM, 1991, GENE, V108, P237, DOI 10.1016/0378-1119(91)90439-I; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LORD EA, 1991, PROC NEW ZEAL SOC AN, V51, P91; MARTIN NG, 1984, FERTIL STERIL, V41, P878; MARTYNIUK E, 1991, COLLOQ INRA, V57, P85; MCNATTY KP, 1987, J STEROID BIOCHEM, V27, P365, DOI 10.1016/0022-4731(87)90329-3; MCNATTY KP, 1985, J REPROD FERTIL, V75, P121, DOI 10.1530/jrf.0.0750121; MONTGOMERY GW, 1992, ANIM GENET, V23, P411, DOI 10.1111/j.1365-2052.1992.tb02159.x; MONTGOMERY GW, 1992, ENDOCR REV, V13, P309, DOI 10.1210/er.13.2.309; MONTGOMERY GW, 1987, J REPROD FERTIL, V79, P207, DOI 10.1530/jrf.0.0790207; MONTGOMERY GW, 1990, NEW ZEAL J AGR RES, V33, P437, DOI 10.1080/00288233.1990.10428440; MONTGOMERY GW, 1992, J REPROD FERTIL, V95, P895, DOI 10.1530/jrf.0.0950895; MONTGOMERY GW, 1990, J MOL ENDOCRINOL, V5, P167, DOI 10.1677/jme.0.0050167; MONTGOMERY GW, 1991, COLLOQ INRA, V57, P269; MONTGOMERY GW, 1990, P AUST ASS ANIM BREE, V8, P191; MULSANT P, 1991, COLLOQ INRA, V57, P259; MURRAY JC, 1986, NUCLEIC ACIDS RES, V14, P5117, DOI 10.1093/nar/14.12.5117; NOCKA K, 1989, GENE DEV, V3, P816, DOI 10.1101/gad.3.6.816; PARISI P, 1983, NATURE, V304, P626, DOI 10.1038/304626a0; PHILIPPE P, 1985, AM J MED GENET, V20, P97, DOI 10.1002/ajmg.1320200112; Piper L. R., 1982, The Booroola Merino. Proceedings of a workshop held at Armidale, N.S.W. 24 August 1980, P9; Piper L. R., 1985, Genetics of reproduction in sheep., P115; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; Silvers WK., 1979, COAT COLORS MICE, DOI [10.1007/978-1-4612-6164-3, DOI 10.1007/978-1-4612-6164-3]; STEWART AF, 1984, NUCLEIC ACIDS RES, V12, P3895, DOI 10.1093/nar/12.9.3895; SWARBRICK PA, 1991, ANIM GENET, V22, P191, DOI 10.1111/j.1365-2052.1991.tb00663.x; TATE ML, 1992, ANIM GENET, V23, P417, DOI 10.1111/j.1365-2052.1992.tb02160.x; THREADGILL DW, 1990, NUCLEIC ACIDS RES, V18, P6935, DOI 10.1093/nar/18.23.6935; Webb R., 1985, Genetics of reproduction in sheep., P261; WYSHAK G, 1965, AM J PUBLIC HEALTH N, V55, P1586, DOI 10.2105/AJPH.55.10.1586; 1989, STANDARDISED GENETIC	53	159	195	0	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1993	4	4					410	414		10.1038/ng0893-410	http://dx.doi.org/10.1038/ng0893-410			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LQ178	8401591				2022-12-25	WOS:A1993LQ17800021
J	GOUDIE, DR; YUILLE, MAR; LEVERSHA, MA; FURLONG, RA; CARTER, NP; LUSH, MJ; AFFARA, NA; FERGUSONSMITH, MA				GOUDIE, DR; YUILLE, MAR; LEVERSHA, MA; FURLONG, RA; CARTER, NP; LUSH, MJ; AFFARA, NA; FERGUSONSMITH, MA			MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMATA (ESS1) MAPPED TO CHROMOSOME 9Q22-Q31 IN FAMILIES WITH COMMON ANCESTRY	NATURE GENETICS			English	Article							INSITU HYBRIDIZATION; DNA-SEQUENCES; HUMAN GENOME; POLYMORPHISMS; PROGRAM; PROBES; CDNA	A gene (ESS1) predisposing to the development of multiple invasive but self-healing skin tumours (squamous cell epitheliomata) is tightly linked to the polymorphic DNA marker D9S53 (9q31) with a maximum lod score of 9.02 at a recombination fraction of 0.03. Multipoint linkage analysis demonstrates that the disease locus is most likely to lie between D9S58 (9q22.3-31) and ASSP3 (9q11-q22). Comparison of markers associated with ESS1 in independently ascertained families suggests a common origin of the disease and defines the location of ESS1. Haplotype studies indicate that the disease locus is most likely to lie between D9S29 (9q31) and D9S1 (9q22.1-q22.2).			GOUDIE, DR (corresponding author), UNIV CAMBRIDGE,IMPERIAL CANC RES FUND,GENET & TUMOUR VIRUS PATHOL UNIT,CAMBRIDGE CB2 1QP,ENGLAND.							ANAND R, 1989, NUCLEIC ACIDS RES, V17, P3425, DOI 10.1093/nar/17.9.3425; BOARD PG, 1986, GENE, V44, P127, DOI 10.1016/0378-1119(86)90051-X; CARTER NP, 1991, T ROY MICROSCOP SOC, V1, P511; COTTER F, 1989, GENOMICS, V5, P470, DOI 10.1016/0888-7543(89)90011-6; DAIGER SP, 1984, AM J HUM GENET, V36, P736; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; FAN YS, 1990, P NATL ACAD SCI USA, V87, P6223, DOI 10.1073/pnas.87.16.6223; FARNDON PA, 1992, LANCET, V339, P581, DOI 10.1016/0140-6736(92)90868-4; Ferguson-Smith J., 1934, BRIT J DERMATOL, V46, P267, DOI 10.1111/j.1365-2133.1934.tb09778.x; FERGUSON-SMITH M A, 1971, Birth Defects Original Article Series, V7, P157; FERGUSONSMITH J, 1948, BRIT J DERMATOL, V60, P315; FURLONG RA, 1992, NUCLEIC ACIDS RES, V20, P925, DOI 10.1093/nar/20.4.925; GAILANI MR, 1992, CELL, V69, P111, DOI 10.1016/0092-8674(92)90122-S; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; KIEVITS T, 1990, CYTOMETRY, V11, P105, DOI 10.1002/cyto.990110112; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANGER PR, 1981, P NATL ACAD SCI-BIOL, V78, P6633, DOI 10.1073/pnas.78.11.6633; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1988, GENOMICS, V3, P361; LYALL JEW, 1992, NUCLEIC ACIDS RES, V20, P925, DOI 10.1093/nar/20.4.925-a; NAYLOR SL, 1984, P NATL ACAD SCI-BIOL, V81, P2447, DOI 10.1073/pnas.81.8.2447; OTT J, 1976, AM J HUM GENET, V28, P528; PANDOLFO M, 1988, NUCLEIC ACIDS RES, V16, P7213, DOI 10.1093/nar/16.14.7213; POVEY S, IN PRESS ANN HUM GEN; REIS, 1992, LANCET, V339, P617; Sambrook J., 1989, MOL CLONING; VIEGASPEQUIGNOT E, 1989, P NATL ACAD SCI USA, V86, P582, DOI 10.1073/pnas.86.2.582; WEBER JL, 1989, AM J HUM GENET, V44, P388; WILKIE PJ, 1992, GENOMICS, V12, P607, DOI 10.1016/0888-7543(92)90456-3; Yuille M. A. R., 1992, Human Molecular Genetics, V1, P351, DOI 10.1093/hmg/1.5.351-a; YUILLE MAR, 1991, NUCLEIC ACIDS RES, V19, P5097, DOI 10.1093/nar/19.18.5097-a; YUILLE MAR, 1992, ANN HUM GENET, V56, P213	34	86	86	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1993	3	2					165	169		10.1038/ng0293-165	http://dx.doi.org/10.1038/ng0293-165			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KL010	8499949				2022-12-25	WOS:A1993KL01000015
J	Momose, A; Takeda, T				Momose, A; Takeda, T			Seeing how we hear	NATURE MEDICINE			English	Editorial Material							RAY TOMOGRAPHIC MICROSCOPY; SYNCHROTRON-RADIATION; RESOLUTION		UNIV TSUKUBA,INST CLIN MED,TSUKUBA,IBARAKI 305,JAPAN	University of Tsukuba	Momose, A (corresponding author), HITACHI LTD,ADV RES LAB,HATOYAMA,SAITAMA 35003,JAPAN.		Momose, Atsushi/T-4873-2019					BONSE U, 1994, BONE MINER, V25, P25, DOI 10.1016/S0169-6009(08)80205-X; BONSE U, 1991, J MATER SCI, V26, P4076, DOI 10.1007/BF02402949; FLANNERY BP, 1987, SCIENCE, V237, P1439, DOI 10.1126/science.237.4821.1439; KINNEY JH, 1992, ANNU REV MATER SCI, V22, P121, DOI 10.1146/annurev.ms.22.080192.001005; MOMOSE A, 1995, MED PHYS, V22, P375, DOI 10.1118/1.597472; Momose A, 1996, NAT MED, V2, P473, DOI 10.1038/nm0496-473; Pateyron M, 1996, P SOC PHOTO-OPT INS, V2708, P417, DOI 10.1117/12.237803; Shibata T, 1996, NAT MED, V2, P933, DOI 10.1038/nm0896-933; TAKEDA T, 1994, J COMPUT ASSIST TOMO, V18, P98, DOI 10.1097/00004728-199401000-00021	9	1	1	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	AUG	1996	2	8					852	853		10.1038/nm0896-852	http://dx.doi.org/10.1038/nm0896-852			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UZ804	8705847				2022-12-25	WOS:A1996UZ80400024
J	Tascon, RE; Colston, MJ; Ragno, S; Stavropoulos, E; Gregory, D; Lowrie, DB				Tascon, RE; Colston, MJ; Ragno, S; Stavropoulos, E; Gregory, D; Lowrie, DB			Vaccination against tuberculosis by DNA injection	NATURE MEDICINE			English	Article							HEAT-SHOCK PROTEIN; PLASMID DNA; T-CELLS; PROTECTIVE IMMUNITY; GENE-EXPRESSION; ANTIGEN; INFECTION; MICE; INVIVO; IMMUNIZATION	There are 3 million deaths per annum worldwide due to tuberculosis, and AIDS is compounding the problem. A better vaccine than the live mycobacterium currently in use, bacillus Calmette-Guerin (BCG), is needed. When mice were injected with plasmid DNA encoding a single mycobacterial antigen (65-kDa heat shock protein, hsp65) they made specific cellular and humoral responses to the protein and became immune to subsequent challenge with Mycobacterium tuberculosis. Protection was equivalent to that obtained by vaccinating with live BCG, whereas immunizing with the protein was ineffective. Protection was also obtained with DNA encoding another mycobacterial antigen (36-kDa proline-rich antigen). These results suggest that DNA vaccination might yield improved vaccines to replace BCG.	NATL INST MED RES,DIV MYCOBACTERIAL RES,LONDON NW7 1AA,ENGLAND	MRC National Institute for Medical Research			Lowrie, Douglas/B-8151-2013	Lowrie, Douglas/0000-0003-2689-9627				ANDERSEN P, 1994, INFECT IMMUN, V62, P2536, DOI 10.1128/IAI.62.6.2536-2544.1994; ANDERSON DC, 1988, J IMMUNOL, V141, P607; BILLINGHAM MEJ, 1990, J EXP MED, V171, P339, DOI 10.1084/jem.171.1.339; BLANCHARD DK, 1995, BLOOD, V85, P3173, DOI 10.1182/blood.V85.11.3173.bloodjournal85113173; BOTHAMLEY GH, 1992, LANCET, V339, P315, DOI 10.1016/0140-6736(92)91397-Q; COX GJM, 1993, J VIROL, V67, P5664, DOI 10.1128/JVI.67.9.5664-5667.1993; DELIBERO G, 1988, EUR J IMMUNOL, V18, P59, DOI 10.1002/eji.1830180110; DONNELLY JJ, 1995, NAT MED, V1, P583, DOI 10.1038/nm0695-583; ELIAS D, 1990, P NATL ACAD SCI USA, V87, P1576, DOI 10.1073/pnas.87.4.1576; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; FYNAN EF, 1995, INT J IMMUNOPHARMACO, V17, P79, DOI 10.1016/0192-0561(94)00090-B; GAUTIER C, 1989, NUCLEIC ACIDS RES, V17, P8389, DOI 10.1093/nar/17.20.8389; JIAO SS, 1992, HUM GENE THER, V3, P21, DOI 10.1089/hum.1992.3.1-21; JONES RF, 1995, J IMMUNOL METHODS, V179, P137, DOI 10.1016/0022-1759(94)00324-P; KOGA T, 1989, SCIENCE, V245, P1112, DOI 10.1126/science.2788923; MEHRA V, 1986, P NATL ACAD SCI USA, V83, P7013, DOI 10.1073/pnas.83.18.7013; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; MULLER I, 1987, INFECT IMMUN, V55, P2037; Orme I M, 1993, Trends Microbiol, V1, P77, DOI 10.1016/0966-842X(93)90109-5; OTTENHOFF THM, 1995, EUR J CLIN INVEST, V25, P371, DOI 10.1111/j.1365-2362.1995.tb01716.x; ROBERTSON JS, 1994, VACCINE, V12, P1526, DOI 10.1016/0264-410X(94)90077-9; SEDEGAH M, 1994, P NATL ACAD SCI USA, V91, P9866, DOI 10.1073/pnas.91.21.9866; SILVA CL, 1994, IMMUNOLOGY, V82, P244; Silva CL, 1996, INFECT IMMUN, V64, P2400, DOI 10.1128/IAI.64.7.2400-2407.1996; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; THOLE JER, 1990, INFECT IMMUN, V58, P80, DOI 10.1128/IAI.58.1.80-87.1990; THOLE JER, 1990, MOL BIOL MYCOBACTERI, P37; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WALKER KB, 1992, J IMMUNOL, V184, P1885; WILTROUT RH, 1982, INT J CANCER, V30, P335, DOI 10.1002/ijc.2910300313; Wolff Jon A., 1992, Human Molecular Genetics, V1, P363, DOI 10.1093/hmg/1.6.363; XIANG ZQ, 1994, VIROLOGY, V199, P132, DOI 10.1006/viro.1994.1105; XU D, 1994, VACCINE, V12, P1534, DOI 10.1016/0264-410X(94)90079-5; XU QB, 1993, LANCET, V341, P255, DOI 10.1016/0140-6736(93)92613-X; YANG NS, 1992, CRIT REV BIOTECHNOL, V12, P335, DOI 10.3109/07388559209040627; YEWDELL JW, 1992, ADV IMMUNOL, V52, P1, DOI 10.1016/S0065-2776(08)60875-5; YOUNG D, 1990, MOL BIOL MYCOBACTERI, P1; ZHU N, 1993, SCIENCE, V261, P209, DOI 10.1126/science.7687073	38	453	477	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	AUG	1996	2	8					888	892		10.1038/nm0896-888	http://dx.doi.org/10.1038/nm0896-888			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UZ804	8705858				2022-12-25	WOS:A1996UZ80400035
J	Harris, E				Harris, E			Developing essential scientific capability in countries with limited resources	NATURE MEDICINE			English	Editorial Material							MOLECULAR-BIOLOGY; DENGUE				Harris, E (corresponding author), UNIV CALIF SAN FRANCISCO,PROGRAM MOL PATHOGENESIS,APPL MOL BIOL APPROPR TECHNOL TRANSFER PROGRAM,SAN FRANCISCO,CA 94143, USA.							[Anonymous], 1994, SCI PUBL PAN AM HLTH; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Harris E, 1996, BIOCHEM EDUC, V24, P3, DOI 10.1016/0307-4412(95)00154-9; HARRIS E, 1993, BIOCHEM EDUC, V21, P16, DOI 10.1016/0307-4412(93)90004-J; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; MORENS DM, 1994, CLIN INFECT DIS, V19, P500, DOI 10.1093/clinids/19.3.500; 1995, MMWR-MORBID MORTAL W, V44, P839	7	9	9	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUL	1996	2	7					737	739		10.1038/nm0796-737	http://dx.doi.org/10.1038/nm0796-737			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UU680	8673911				2022-12-25	WOS:A1996UU68000021
J	Ikeda, H; Yamaguchi, M; Sugai, S; Aze, Y; Narumiya, S; Kakizuka, A				Ikeda, H; Yamaguchi, M; Sugai, S; Aze, Y; Narumiya, S; Kakizuka, A			Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo	NATURE GENETICS			English	Article							ALZHEIMERS-DISEASE; TRANSGENE EXPRESSION; KININOGEN GENES; SEQUENCES; RECEPTOR; LOCALIZATION; APOPTOSIS; ALPHA; CDNA; ACID	Recently, we identified a novel gene, MJD1, which contains an expanded CAG triplet repeat in Machado-Joseph disease. Here we report the induction of apoptosis in cultured cells expressing a portion of the MJD1 gene that includes the expanded CAG repeats. Cell death occurs only when the CAG repeat is translated into polyglutamine residues, which apparently precipitate in large covalently modified forms. We also created ataxic transgenic mice by expressing the expanded polyglutamine stretch in Purkinje cells. Our results demonstrate the potential involvement of the expanded polyglutamine as the common aetiological agent for inherited neurodegenerative diseases with CAG expansions.	KYOTO UNIV, FAC MED, DEPT PHARMACOL, KYOTO 60601, JAPAN; ONO PHARMACEUT, FUKUI INST SAFETY RES, MIKUNI, FUKUI 913, JAPAN	Kyoto University; Ono Pharmaceutical Co Ltd				Ikeda, Hanako/0000-0001-9572-8659				Alzheimer A., 1907, Z GESAMTE NEUROL PSY, V18, P177; BINGHAM PM, 1995, NAT GENET, V9, P191, DOI 10.1038/ng0295-191; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; CITRON M, 1995, NEURON, V14, P661, DOI 10.1016/0896-6273(95)90323-2; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; EADIE MJ, 1975, HDB CLIN NEUROLOGY, V20, P403; FLEID J, 1988, MOL CELL BIOL, V8, P2159; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; GORDON JW, 1993, METHOD ENZYMOL, V225, P747; GREEN H, 1993, CELL, V74, P955, DOI 10.1016/0092-8674(93)90718-6; HOUSMAN D, 1995, NAT GENET, V10, P3, DOI 10.1038/ng0595-3; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; KAKIZUKA A, 1992, GENE DEV, V6, P578, DOI 10.1101/gad.6.4.578; KAKIZUKA A, 1988, J BIOL CHEM, V263, P3884; KAKIZUKA A, 1990, J BIOL CHEM, V265, P10102; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KAWAKAMI H, 1995, NAT GENET, V9, P344, DOI 10.1038/ng0495-344; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MARUYAMA H, 1995, HUM MOL GENET, V4, P807, DOI 10.1093/hmg/4.5.807; MAYEUX R, 1995, MERRITTS TXB NEUROLO; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; OBERDICK J, 1988, NEURON, V1, P367, DOI 10.1016/0896-6273(88)90186-9; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; PRUSINER SB, 1994, ANN NEUROL, V35, P385, DOI 10.1002/ana.410350404; ROSL F, 1992, NUCLEIC ACIDS RES, V20, P5243, DOI 10.1093/nar/20.19.5243; ROSS CA, 1995, NEURON, V15, P493, DOI 10.1016/0896-6273(95)90138-8; SAITOU M, 1995, NATURE, V374, P159, DOI 10.1038/374159a0; SAITOU M, 1994, J BIOL CHEM, V269, P19101; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; SMEYNE RJ, 1991, SCIENCE, V254, P719, DOI 10.1126/science.1948052; TAKIYAMA Y, 1995, HUM MOL GENET, V4, P1137, DOI 10.1093/hmg/4.7.1137; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; VANDAELE S, 1991, GENE DEV, V5, P1136, DOI 10.1101/gad.5.7.1136; WILLEMS PJ, 1994, NAT GENET, V8, P213, DOI 10.1038/ng1194-213; YAMAGUCHI M, 1992, J BIOL CHEM, V267, P22035; YAZAWA I, 1995, NAT GENET, V10, P99, DOI 10.1038/ng0595-99; YONEHARA S, 1989, J EXP MED, V169, P1747, DOI 10.1084/jem.169.5.1747	52	472	484	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1996	13	2					196	202		10.1038/ng0696-196	http://dx.doi.org/10.1038/ng0696-196			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UN395	8640226				2022-12-25	WOS:A1996UN39500019
J	Strautnieks, SS; Thompson, RJ; Gardiner, RM; Chung, E				Strautnieks, SS; Thompson, RJ; Gardiner, RM; Chung, E			A novel splice-site mutation in the gamma subunit of the epithelial sodium channel gene in three pseudohypoaldosteronism type 1 families	NATURE GENETICS			English	Letter							EXPRESSION		UNIV LONDON UNIV COLL,SCH MED,RAYNE INST,DEPT PAEDIAT,LONDON WC1E 6JJ,ENGLAND	University of London; King's College London; University College London; UCL Medical School			Thompson, Richard J/B-7954-2009	Thompson, Richard J/0000-0001-5652-0150				CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; FULLER CM, 1995, AM J PHYSIOL-CELL PH, V269, pC641, DOI 10.1152/ajpcell.1995.269.3.C641; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; HONG K, 1994, NATURE, V367, P412; KOMESAROFF PA, 1994, BAILLIERE CLIN ENDOC, V8, P333, DOI 10.1016/S0950-351X(05)80256-3; LINGUEGLIA E, 1993, FEBS LETT, V318, P95, DOI 10.1016/0014-5793(93)81336-X; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; MEISLER MH, 1994, GENOMICS, V24, P185, DOI 10.1006/geno.1994.1599; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Strautnieks SS, 1996, HUM MOL GENET, V5, P293, DOI 10.1093/hmg/5.2.293; VOILLEY N, 1995, GENOMICS, V28, P560, DOI 10.1006/geno.1995.1188	15	197	201	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1996	13	2					248	250		10.1038/ng0696-248	http://dx.doi.org/10.1038/ng0696-248			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UN395	8640238				2022-12-25	WOS:A1996UN39500031
J	Bollag, G; Clapp, DW; Shih, S; Adler, F; Zhang, YY; Thompson, P; Lange, BJ; Freedman, MH; McCormick, F; Jacks, T; Shannon, K				Bollag, G; Clapp, DW; Shih, S; Adler, F; Zhang, YY; Thompson, P; Lange, BJ; Freedman, MH; McCormick, F; Jacks, T; Shannon, K			Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells	NATURE GENETICS			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; COLONY-STIMULATING FACTOR; VONRECKLINGHAUSEN NEUROFIBROMATOSIS; TYPE-1 NEUROFIBROMATOSIS; SARCOMA-VIRUSES; GM-CSF; GENE; MUTATIONS; TRANSFORMATION; ONCOGENES	Individuals with neurofibromatosis type 1 (NF1) are predisposed to certain cancers including juvenile chronic myelogenous leukaemia (JCML). The NF1 tumour-suppressor gene encodes a protein (neurofibromin) that accelerates GTP hydrolysis on Pas proteins. Here we show that primary leukaemic cells from children with NF1 show a selective decrease in NF1-like GTPase activating protein (GAP) activity for Pas but retain normal cellular GAP activity. Leukaemic cells also show an elevated percentage of Pas in the GTP-bound conformation. JCML cells are hypersensitive to granulocyte-macrophage colony stimulating factor (GM-CSF), and we observed a similar pattern of aberrant growth in haematopoietic cells from Nf1(-/-) mouse embryos. These data define a specific role for neurofibromin in negatively regulating GM-CSF signaling through Pas in haematopoietic cells and they suggest that hypersensitivity to GM-CSF may be a primary event in the development of JCML.	INDIANA UNIV,JAMES WHITCOMB RILEY HOSP CHILDREN,MED CTR,HERMAN B WELLS RES CTR,INDIANAPOLIS,IN 46202; MIT,HOWARD HUGHES MED INST,CAMBRIDGE,MA 02139; MIT,CTR CANC RES,CAMBRIDGE,MA 02139; UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,SAN FRANCISCO,CA 94143; CHILDRENS HOSP PHILADELPHIA,DIV HEMATOL ONCOL,PHILADELPHIA,PA 19104; HOSP SICK CHILDREN,DIV HEMATOL ONCOL,TORONTO,ON M5G 1X8,CANADA	Indiana University System; Indiana University-Purdue University Indianapolis; James Whitcomb Riley Hospital Children; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of California System; University of California San Francisco; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Bollag, G (corresponding author), ONYX PHARMACEUT,3031 RES DR,RICHMOND,CA 94806, USA.				NCRR NIH HHS [3M01 RR01271-13S1] Funding Source: Medline; NHLBI NIH HHS [HLO-2721] Funding Source: Medline; NIDDK NIH HHS [DK 07636] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001271] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL002721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007636] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSEN LB, 1993, NAT GENET, V3, P118, DOI 10.1038/ng0293-118; BADER JL, 1978, J PEDIATR-US, V92, P925, DOI 10.1016/S0022-3476(78)80362-X; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BASU TN, 1992, NATURE, V356, P713, DOI 10.1038/356713a0; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOLLAG G, 1991, NATURE, V351, P576, DOI 10.1038/351576a0; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019; BURGERING BMT, 1993, MOL CELL BIOL, V13, P7248, DOI 10.1128/MCB.13.12.7248; DECLUE JE, 1992, CELL, V69, P265, DOI 10.1016/0092-8674(92)90407-4; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; EMANUEL PD, 1991, BLOOD, V77, P925; FREEDMAN MH, 1992, BRIT J HAEMATOL, V80, P40, DOI 10.1111/j.1365-2141.1992.tb06398.x; GADNER H, 1992, HEMATOL ONCOL CLIN N, V6, P655, DOI 10.1016/S0889-8588(18)30334-4; GIBBS JB, 1994, CELL, V77, P175, DOI 10.1016/0092-8674(94)90308-5; GLOVER TW, 1991, GENE CHROMOSOME CANC, V3, P62, DOI 10.1002/gcc.2870030111; HALL A, 1992, CELL, V69, P389, DOI 10.1016/0092-8674(92)90441-E; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; JOHNSON GR, 1989, EMBO J, V8, P441, DOI 10.1002/j.1460-2075.1989.tb03396.x; JOHNSON MR, 1993, P NATL ACAD SCI USA, V90, P5539, DOI 10.1073/pnas.90.12.5539; JOHNSON MR, 1994, MOL CELL BIOL, V14, P641, DOI 10.1128/MCB.14.1.641; KAHN P, 1986, CELL, V45, P349, DOI 10.1016/0092-8674(86)90320-X; KALRA R, 1994, BLOOD, V84, P3435; KANEKO Y, 1989, LEUKEMIA, V3, P36; LANFRANCONE L, 1995, ONCOGENE, V10, P907; LANG RA, 1987, CELL, V51, P675, DOI 10.1016/0092-8674(87)90136-X; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MENON AG, 1990, P NATL ACAD SCI USA, V87, P5435, DOI 10.1073/pnas.87.14.5435; MIYAUCHI J, 1994, BLOOD, V83, P2248; MUI ALF, 1994, P SOC EXP BIOL MED, V206, P284; NEUBAUER A, 1991, BLOOD, V77, P594; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; PIERCE JH, 1985, MOL CELL BIOL, V5, P667, DOI 10.1128/MCB.5.4.667; RICCARDI VM, 1986, NEUROFIBROMATOSIS; RIDLEY AJ, 1988, EMBO J, V7, P1635, DOI 10.1002/j.1460-2075.1988.tb02990.x; Rodenhuis S, 1992, Semin Cancer Biol, V3, P241; SATOH T, 1990, P NATL ACAD SCI USA, V87, P7926, DOI 10.1073/pnas.87.20.7926; SHANNON KM, 1992, BLOOD, V79, P1311; SHANNON KM, 1994, NEW ENGL J MED, V330, P597, DOI 10.1056/NEJM199403033300903; SKUSE GR, 1989, GENE CHROMOSOME CANC, V1, P36, DOI 10.1002/gcc.2870010107; THE I, 1993, NAT GENET, V3, P62, DOI 10.1038/ng0193-62; VOGEL KS, 1995, CELL, V82, P733, DOI 10.1016/0092-8674(95)90470-0; XU W, 1992, GENE CHROMOSOME CANC, V4, P337, DOI 10.1002/gcc.2870040411	44	440	451	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1996	12	2					144	148		10.1038/ng0296-144	http://dx.doi.org/10.1038/ng0296-144			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TU079	8563751				2022-12-25	WOS:A1996TU07900013
J	Teller, JK; Russo, C; DeBusk, LM; Angelini, G; Zaccheo, D; DagnaBricarelli, F; Scartezzini, P; Bertolini, S; Mann, DMA; Tabaton, M; Gambetti, P				Teller, JK; Russo, C; DeBusk, LM; Angelini, G; Zaccheo, D; DagnaBricarelli, F; Scartezzini, P; Bertolini, S; Mann, DMA; Tabaton, M; Gambetti, P			Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome	NATURE MEDICINE			English	Article							ALZHEIMERS-DISEASE; PROTEIN; PRECURSOR	Abnormal and excessive accumulation of the amyloid beta-peptide (A beta) in the brain is a major and common characteristic of all Alzheimer's disease (AD) forms irrespective of their genetic background. Insoluble aggregates of A beta are identified as amyloid plaques. These deposits are thought to form when the amount of A beta is. increased in the brain parenchyma as a result of either overexpression or altered processing of the amyloid precursor protein (APP)(1-3). Soluble A beta ending at carboxyl-terminal residue 40 (A beta(40)) and, in lesser amount, the form ending at residue 42 (A beta(42)) are normal products of the APP metabolism in cell cultures. Increased secretion of soluble A beta(42) has been observed in cells transfected with constructs modeling APP gene mutations of familial forms of AD (refs 4, 5). On the basis of these in vitro data it has been hypothesized that the presence of soluble AP, plays a role in the formation of amyloid plaques. Subjects affected by Down's syndrome (DS) have an increased APP gene dosage and overexpress APP. Apparently because of this overexpression, they almost invariably develop amyloid deposits after the age of 30 years, although they are free of them at earlier ages(6,7). Moreover, it has been observed that A beta(42) precedes A beta(40) in the course of amyloid deposition in DS brains. Thus, DS subjects provide the opportunity to investigate in the human brain the metabolic conditions that precede the formation of the amyloid deposits. Here we report that soluble A beta(42) is present in the brains of DS-affected subjects aged from 21 gestational weeks to 61 years but it is undetectable in age-matched controls. It is argued that overexpression of APP leads specifically to A beta(42) increase and that the presence of the soluble A beta(42) is causally related to plaque formation in DS and, likely, in AD brains.	ADV BIOTECHNOL CTR,I-16132 GENOA,ITALY; UNIV GENOA,INST ANAT,I-16132 GENOA,ITALY; GALLIERA HOSP,CTR HUMAN GENET,I-16128 GENOA,ITALY; GALLIERA HOSP,DIV PEDIAT,I-16128 GENOA,ITALY; UNIV GENOA,DEPT INTERNAL MED,I-16132 GENOA,ITALY; UNIV MANCHESTER,DEPT PATHOL SCI,MANCHESTER M13 9PT,LANCS,ENGLAND	University of Genoa; Ente Ospedaliero Ospedali Galliera; Ente Ospedaliero Ospedali Galliera; University of Genoa; University of Manchester	Teller, JK (corresponding author), CASE WESTERN RESERVE UNIV,INST PATHOL,DIV NEUROPATHOL,CLEVELAND,OH 44106, USA.		Russo, Claudio/AIA-1429-2022; /V-4899-2019; Angelini, Giovanna/C-8476-2013	ANGELINI, giovanna/0000-0003-1474-5452; russo, claudio/0000-0002-2520-2958				ASAMIODAKA A, 1995, BIOCHEMISTRY-US, V34, P10272, DOI 10.1021/bi00032a022; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; HILBICH C, 1991, J MOL BIOL, V218, P149, DOI 10.1016/0022-2836(91)90881-6; IWATSUBO T, 1995, ANN NEUROL, V37, P294, DOI 10.1002/ana.410370305; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; KIM KS, 1990, NEUROSCI RES COMMUN, V7, P113; MANN DMA, 1992, NEURODEGENERATION, V1, P201; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; RUMBLE B, 1989, NEW ENGL J MED, V320, P1446, DOI 10.1056/NEJM198906013202203; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SELKOE DJ, 1994, ANNU REV CELL BIOL, V10, P373, DOI 10.1146/annurev.cb.10.110194.002105; SELKOE DJ, 1994, ANNU REV NEUROSCI, V17, P489, DOI 10.1146/annurev.neuro.17.1.489; STERNBERGER LA, 1986, IMMUNOCYTOCHEMISTRY; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; TABATON M, 1994, BIOCHEM BIOPH RES CO, V200, P1598, DOI 10.1006/bbrc.1994.1634; TAMAOKA A, 1994, BIOCHEM BIOPH RES CO, V205, P834, DOI 10.1006/bbrc.1994.2740; TAMAOKA A, 1995, BRAIN RES, V679, P151, DOI 10.1016/0006-8993(95)00162-J; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310; YAMAGUCHI H, 1995, AMYLOID, V2, P7, DOI 10.3109/13506129509031882	23	306	337	0	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JAN	1996	2	1					93	95		10.1038/nm0196-93	http://dx.doi.org/10.1038/nm0196-93			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TP579	8564851				2022-12-25	WOS:A1996TP57900044
J	HEMMINKI, A; PELTOMAKI, P; MECKLIN, JP; JARVINEN, H; SALOVAARA, R; NYSTROMLAHTI, M; DELACHAPELLE, A; AALTONEN, LA				HEMMINKI, A; PELTOMAKI, P; MECKLIN, JP; JARVINEN, H; SALOVAARA, R; NYSTROMLAHTI, M; DELACHAPELLE, A; AALTONEN, LA			LOSS OF THE WILD-TYPE MLH1 GENE IS A FEATURE OF HEREDITARY NONPOLYPOSIS COLORECTAL-CANCER	NATURE GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; COLON-CANCER; DCC GENE; APC GENE; CARCINOMA; LOCUS; INSTABILITY; FAMILY; SUSCEPTIBILITY; MUTATIONS	The mechanism by which germline mutations of DNA mismatch repair genes cause susceptibility to tumour formation is not yet understood. Studies in vitro indicate that heterozygosity for these mutations, unlike homozygosity, does not affect mismatch repair. Surprisingly, no loss of heterozygosity at the predisposing loci has so far been described in hereditary nonpolyposis colorectal cancers. Here, we show that loss of heterozygosity (LOH) of markers within or adjacent to the MLH1 gene on chromosome 3p occurs nonrandomly in tumours from members of families in which the disease phenotype cosegregates with MLH1. In every informative case, the loss affects the wild type allele. These results suggest that DNA mismatch repair genes resemble tumour suppressor genes in that two hits are required to cause a phenotypic effect.	UNIV HELSINKI, DEPT MED GENET, SF-00014 HELSINKI, FINLAND; JYVASKYLA CENT HOSP, DEPT SURG, SF-40620 JYVASKYLA, FINLAND; UNIV HELSINKI, CENT HOSP, DEPT SURG, SF-00290 HELSINKI, FINLAND; UNIV HELSINKI, DEPT PATHOL, SF-00014 HELSINKI, FINLAND	University of Helsinki; Central Finland Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki			Aaltonen, Lauri/A-5375-2010; Mecklin, Jukka-Pekka/AAB-5378-2020; Mecklin, Jukka-Pekka/AAC-9650-2019	Aaltonen, Lauri/0000-0001-6839-4286; Mecklin, Jukka-Pekka/0000-0003-4895-2249; Peltomaki, Paivi/0000-0001-8819-2980; Nystrom, Minna/0000-0003-0827-0243				AALTONEN LA, 1994, CANCER RES, V54, P1645; AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; BODMER W, 1994, NAT GENET, V6, P217, DOI 10.1038/ng0394-217; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; GANLY PS, 1992, GENOMICS, V12, P221, DOI 10.1016/0888-7543(92)90369-4; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; ISOLA J, 1994, IN PRESS AM J PATHOL; JIRLCNY J, 1994, TRENDS GENET, V10, P164; JONES MH, 1992, GENE CHROMOSOME CANC, V5, P89, DOI 10.1002/gcc.2870050113; Jones Michael H., 1992, Human Molecular Genetics, V1, P131, DOI 10.1093/hmg/1.2.131; KNUDSON AG, 1993, NAT GENET, V5, P103, DOI 10.1038/ng1093-103; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KOURI M, 1990, CANCER, V65, P1825, DOI 10.1002/1097-0142(19900415)65:8<1825::AID-CNCR2820650827>3.0.CO;2-H; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LINDBLOM A, 1993, NAT GENET, V5, P279, DOI 10.1038/ng1193-279; LIU B, 1994, CANCER RES, V54, P4590; LOTHE RA, 1993, CANCER RES, V53, P5849; LYNCH HT, 1993, GASTROENTEROLOGY, V104, P1535, DOI 10.1016/0016-5085(93)90368-M; MECKLIN JP, 1987, GASTROENTEROLOGY, V93, P1021, DOI 10.1016/0016-5085(87)90565-8; MECKLIN JP, 1986, GASTROENTEROLOGY, V90, P328, DOI 10.1016/0016-5085(86)90928-5; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; NYSTROMLAHTI M, 1994, P NATL ACAD SCI USA, V91, P6054, DOI 10.1073/pnas.91.13.6054; NYSTROMLAHTI M, 1994, AM J HUM GENET, V55, P659; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; PELTOMAKI P, 1993, SCIENCE, V260, P810, DOI 10.1126/science.8484120; PELTOMAKI P, 1991, CANCER RES, V51, P4135; PELTOMAKI P, 1992, CANCER RES, V52, P4530; RISINGER JI, 1993, CANCER RES, V53, P5100; RISINGER JI, 1992, HUM MOL GENET, V1, P657, DOI 10.1093/hmg/1.8.657-a; Sambrook J, 1989, MOL CLONING LABORATO; SPIRIO L, 1991, NUCLEIC ACIDS RES, V19, P6348, DOI 10.1093/nar/19.22.6348; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WU C, 1994, ONCOGENE, V9, P991	38	294	297	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1994	8	4					405	410		10.1038/ng1294-405	http://dx.doi.org/10.1038/ng1294-405			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PV682	7894494				2022-12-25	WOS:A1994PV68200024
J	ALBERTSEN, HM; SMITH, SA; MAZOYER, S; FUJIMOTO, E; STEVENS, J; WILLIAMS, B; RODRIGUEZ, P; CROPP, CS; SLIJEPCEVIC, P; CARLSON, M; ROBERTSON, M; BRADLEY, P; LAWRENCE, E; HARRINGTON, T; SHENG, ZM; HOOPES, R; STERNBERG, N; BROTHMAN, A; CALLAHAN, R; PONDER, BAJ; WHITE, R				ALBERTSEN, HM; SMITH, SA; MAZOYER, S; FUJIMOTO, E; STEVENS, J; WILLIAMS, B; RODRIGUEZ, P; CROPP, CS; SLIJEPCEVIC, P; CARLSON, M; ROBERTSON, M; BRADLEY, P; LAWRENCE, E; HARRINGTON, T; SHENG, ZM; HOOPES, R; STERNBERG, N; BROTHMAN, A; CALLAHAN, R; PONDER, BAJ; WHITE, R			A PHYSICAL MAP AND CANDIDATE GENES IN THE BRCA1 REGION ON CHROMOSOME 17Q12-21	NATURE GENETICS			English	Article							BREAST-OVARIAN-CANCER; POLYMERASE CHAIN-REACTION; FAMILIAL BREAST; YEAST; DNA; CLONING; SEQUENCES; LIBRARY; CDNA; PCR	We have constructed a physical map of a 4 cM region on chromosome 17q12-21 that contains the hereditary breast and ovarian cancer gene BRCA1. The map comprises a contig of 137 overlapping yeast artificial chromosomes and P1 clones, onto which we have placed 112 PCR markers. We have localized more than 20 genes on this map, ten of which had not been mapped to the region previously, and have isolated 30 cDNA clones representing partial sequences of as yet unidentified genes. Two genes that lie within a narrow region defined by meiotic breakpoints in BRCA1 patients have been sequenced in breast cancer patients without revealing any deleterious mutations. These new reagents should facilitate the identification of BRCA1.	UNIV UTAH,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112; UNIV CAMBRIDGE,DEPT PATHOL,CRC,HUMAN CANC GENET RES GRP,CAMBRIDGE CB2 1QP,ENGLAND; NCI,TUMOR IMMUNOL & BIOL LAB,BETHESDA,MD 20892; DUPONT MERCK PHARMACEUT CO,WILMINGTON,DE 19880	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); DuPont	ALBERTSEN, HM (corresponding author), UNIV UTAH,ECCLES INST HUMAN GENET,SALT LAKE CITY,UT 84112, USA.		Mazoyer, Sylvie/N-7559-2017	Mazoyer, Sylvie/0000-0002-2135-0160	NHGRI NIH HHS [R01-HG00367-04, R01-HG00339] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000367, R01HG000339] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ABEL KJ, 1993, GENOMICS, V17, P632, DOI 10.1006/geno.1993.1383; ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; ALBERTSEN LA, 1994, AM J HUM GENET, V54, P516; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANAND R, 1990, NUCLEIC ACIDS RES, V18, P1951, DOI 10.1093/nar/18.8.1951; ANDERSON LA, 1993, GENOMICS, V17, P618, DOI 10.1006/geno.1993.1381; BOWCOCK AM, 1993, AM J HUM GENET, V52, P718; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; CAMPBELL IG, 1994, HUM MOL GENET, V3, P589, DOI 10.1093/hmg/3.4.589; CHAMBERLAIN JS, 1993, AM J HUM GENET, V52, P792; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; CHUMAKOV IM, 1992, NAT GENET, V1, P222, DOI 10.1038/ng0692-222; CROPP CS, 1994, CANCER RES, V54, P2548; EASTON DF, 1993, AM J HUM GENET, V52, P678; EISHOUBAGY N, 1992, EUR J BIOCHEM, V204, P491; ERNI M, 1993, NAT GENET, V5, P151; FLEJTER WL, 1993, GENOMICS, V17, P624, DOI 10.1006/geno.1993.1382; GEORGAKOPOULOS T, 1992, EMBO J, V11, P4145, DOI 10.1002/j.1460-2075.1992.tb05507.x; GOLDGAR DE, 1994, J NATL CANCER I, V86, P200, DOI 10.1093/jnci/86.3.200; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; KEISELL DP, 1993, HUM MOL GENET, V2, P1823; KOHRI K, 1993, BIOCHIM BIOPHYS ACTA, V1173, P345, DOI 10.1016/0167-4781(93)90136-2; LEMONS RS, 1990, GENE CHROMOSOME CANC, V2, P79, DOI 10.1002/gcc.2870020202; NELSON DL, 1989, P NATL ACAD SCI USA, V86, P6686, DOI 10.1073/pnas.86.17.6686; NIKAIDO T, 1990, CLIN EXP IMMUNOL, V79, P209; OCONNELL P, 1994, AM J HUM GENET, V54, P526; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; SHEPHERD NS, 1994, P NATL ACAD SCI USA, V91, P2629, DOI 10.1073/pnas.91.7.2629; SIMARD J, 1993, HUM MOL GENET, V2, P1193, DOI 10.1093/hmg/2.8.1193; SMITH SA, 1994, GENE CHROMOSOME CANC, V10, P71, DOI 10.1002/gcc.2870100112; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; SPRINKLE TJ, 1993, GENOMICS, V16, P542, DOI 10.1006/geno.1993.1227; Tagle Danilo A., 1992, Human Molecular Genetics, V1, P121, DOI 10.1093/hmg/1.2.121; TONIN P, 1993, GENOMICS, V18, P414, DOI 10.1006/geno.1993.1487; TRASK BJ, 1991, AM J HUM GENET, V48, P1; TSAIPFLUGFELDER M, 1988, P NATL ACAD SCI USA, V85, P7177, DOI 10.1073/pnas.85.19.7177; XU W, 1989, CYTOGENET CELL GENET, V51, P1111; [No title captured]	40	92	113	0	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1994	7	4					472	479		10.1038/ng0894-472	http://dx.doi.org/10.1038/ng0894-472			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PA832	7951316				2022-12-25	WOS:A1994PA83200012
J	LI, L; BALES, ES; PETERSON, CA; LEGERSKI, RJ				LI, L; BALES, ES; PETERSON, CA; LEGERSKI, RJ			CHARACTERIZATION OF MOLECULAR DEFECTS IN XERODERMA-PIGMENTOSUM GROUP-C	NATURE GENETICS			English	Article							DNA-REPAIR GENE; BIOLOGICAL CHARACTERIZATION; MYOTONIC-DYSTROPHY; CTG REPEAT; FRAGILE-X; CLONING; INSTABILITY	Xeroderma pigmentosum (XP) is a rare autosomal recessive disease of humans characterized by an accelerated chronic degeneration of sun-exposed areas of the body, including an elevated risk of developing cancers of the skin. We recently reported the isolation of a gene XPCC that complements the repair deficiency of cultured XP-C cells. Here we report the results of a characterization of XPCC at the nucleotide level in five XP-C cell lines. Each cell line exhibited a unique mutation that correlated well with the cellular DNA repair deficiency and the clinical severity of the disease. These results extend our previous observations and indicate that defects in XPCC cause Xeroderma pigmentosum group C.			LI, L (corresponding author), UNIV TEXAS,MD ANDERSON CANC CTR,DEPT MOLEC GENET,1515 HOLCOMBE BLVD,HOUSTON,TX 77030, USA.							ANDREWS AD, 1978, P NATL ACAD SCI USA, V75, P1984, DOI 10.1073/pnas.75.4.1984; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; CLEAVER JE, 1968, NATURE, V218, P652, DOI 10.1038/218652a0; Cleaver JE, 1989, METABOLIC BASIS INHE, V6th, P2949; DAYAGROSJEAN L, 1987, MUTAT RES, V183, P185, DOI 10.1016/0167-8817(87)90061-7; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; LEGERSKI R, 1992, NATURE, V359, P70, DOI 10.1038/359070a0; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MASHIMA Y, 1992, AM J HUM GENET, V51, P81; PETERSON C, 1991, GENE, V107, P279, DOI 10.1016/0378-1119(91)90328-9; ROBBINS JH, 1974, ANN INTERN MED, V80, P221, DOI 10.7326/0003-4819-80-2-221; ROBBINS JH, 1978, JNCI-J NATL CANCER I, V61, P645; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; TANAKA K, 1989, P NATL ACAD SCI USA, V86, P5512, DOI 10.1073/pnas.86.14.5512; WALLACE MR, 1991, NATURE, V353, P864, DOI 10.1038/353864a0; WEBER CA, 1988, MOL CELL BIOL, V8, P1137, DOI 10.1128/MCB.8.3.1137; WEEDA G, 1990, MOL CELL BIOL, V10, P2570, DOI 10.1128/MCB.10.6.2570	20	101	106	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1993	5	4					413	417		10.1038/ng1293-413	http://dx.doi.org/10.1038/ng1293-413			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ML145	8298653				2022-12-25	WOS:A1993ML14500021
J	FRIEDMAN, E; GEJMAN, PV; MARTIN, GA; MCCORMICK, F				FRIEDMAN, E; GEJMAN, PV; MARTIN, GA; MCCORMICK, F			NONSENSE MUTATIONS IN THE C-TERMINAL SH2 REGION OF THE GTPASE-ACTIVATING PROTEIN (GAP) GENE IN HUMAN TUMORS	NATURE GENETICS			English	Article							GRADIENT GEL-ELECTROPHORESIS; POLYMERASE CHAIN-REACTION; CYTOPLASMIC SIGNALING PROTEINS; SINGLE-BASE CHANGES; SACCHAROMYCES-CEREVISIAE; TYROSINE KINASES; MAMMALIAN GAP; DNA FRAGMENTS; RAS PROTEINS; SKIN CANCERS	GTPase Activating Protein (GAP) is involved in down-regulating normal ras proteins and in the signal transduction pathway of some growth factors. We have screened 188 human tumours for mutations in the catalytic domain and at the C terminal SH2 region GAP. Three nonsense mutations in basal cell carcinomas were detected in the SH2 region and no mutations could be demonstrated in the catalytic domain. We conclude that mutations in the SH2 region of GAP may play a role in tumorigenesis and that inactivating mutations of the GAP catalytic domain do not contribute to tumour development.	NIMH,CLIN NEUROGENET BRANCH,BETHESDA,MD 20892; ONYX PHARMACEUT,RICHMOND,CA 94806	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	FRIEDMAN, E (corresponding author), KAROLINSKA HOSP,DEPT CLIN GENET,POB 60500,S-10401 STOCKHOLM 60,SWEDEN.							ADARI H, 1988, SCIENCE, V240, P518, DOI 10.1126/science.2833817; ANANTHASWAMY HN, 1989, MOL CARCINOGEN, V2, P298, DOI 10.1002/mc.2940020510; ANDERSON D, 1990, SCIENCE, V250, P979, DOI 10.1126/science.2173144; BACKER JM, 1992, EMBO J, V11, P3469, DOI 10.1002/j.1460-2075.1992.tb05426.x; BALLESTER R, 1989, CELL, V59, P681, DOI 10.1016/0092-8674(89)90014-7; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BARBETTI F, 1992, DIABETES, V41, P408, DOI 10.2337/diabetes.41.4.408; BOOKER GW, 1992, NATURE, V358, P684, DOI 10.1038/358684a0; BROTT BK, 1991, P NATL ACAD SCI USA, V88, P755, DOI 10.1073/pnas.88.3.755; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; DUCHESNE M, 1993, SCIENCE, V259, P525, DOI 10.1126/science.7678707; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; ERLICH HA, 1991, SCIENCE, V252, P1643, DOI 10.1126/science.2047872; FANTL WJ, 1992, CELL, V69, P413, DOI 10.1016/0092-8674(92)90444-H; FIELD J, 1987, MOL CELL BIOL, V7, P2128, DOI 10.1128/MCB.7.6.2128; GIBBS JB, 1984, P NATL ACAD SCI-BIOL, V81, P5704, DOI 10.1073/pnas.81.18.5704; GREER CE, 1991, AM J CLIN PATHOL, V95, P117, DOI 10.1093/ajcp/95.2.117; GROSS-BELLARD MM, 1973, EUR J BIOCHEM, V36, P32, DOI 10.1111/j.1432-1033.1973.tb02881.x; HIRAI H, 1990, MOL CELL BIOL, V10, P1307, DOI 10.1128/MCB.10.4.1307; JEANPIERRE M, 1987, NUCLEIC ACIDS RES, V15, P9611, DOI 10.1093/nar/15.22.9611; KLEIN G, 1987, SCIENCE, V238, P1539, DOI 10.1126/science.3317834; KOCH CA, 1989, MOL CELL BIOL, V9, P4131, DOI 10.1128/MCB.9.10.4131; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; LERMAN LS, 1984, ANNU REV BIOPHYS BIO, V13, P399; LI Y, 1992, CELL, V69, P275, DOI 10.1016/0092-8674(92)90408-5; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MARSHALL MS, 1989, EMBO J, V8, P1105, DOI 10.1002/j.1460-2075.1989.tb03480.x; MARTIN GA, 1992, SCIENCE, V255, P192, DOI 10.1126/science.1553544; Mayer Bruce J., 1993, Trends in Cell Biology, V3, P8, DOI 10.1016/0962-8924(93)90194-6; MCCORMICK F, 1990, ONCOGENE, V5, P1281; MEDEMA RH, 1992, MOL CELL BIOL, V12, P3425, DOI 10.1128/MCB.12.8.3425; MERTENS F, 1991, CANCER RES, V51, P954; MILLER SJ, 1991, J AM ACAD DERMATOL, V24, P1, DOI 10.1016/0190-9622(91)70001-I; MYERS RM, 1985, NUCLEIC ACIDS RES, V13, P3131, DOI 10.1093/nar/13.9.3131; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; NAZAMI MN, 1990, BRIT J DERMATOL, V123, P153; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PATTERSON H, 1987, CELL, V51, P803; PIERCEALL WE, 1991, MOL CARCINOGEN, V4, P196, DOI 10.1002/mc.2940040306; QUAIFE CJ, 1987, CELL, V48, P1023, DOI 10.1016/0092-8674(87)90710-0; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; SYVANEN AC, 1989, FEBS LETT, V258, P71, DOI 10.1016/0014-5793(89)81618-7; TANAKA K, 1990, CELL, V60, P803, DOI 10.1016/0092-8674(90)90094-U; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; TRAHEY M, 1988, SCIENCE, V242, P1697, DOI 10.1126/science.3201259; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; TRAHEY M, 1987, MOL CELL BIOL, V7, P541, DOI 10.1128/MCB.7.1.541; WAKSMAN G, 1992, NATURE, V358, P646, DOI 10.1038/358646a0; WAXMAN G, 1993, CELL, V72, P779; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9	52	52	57	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1993	5	3					242	247		10.1038/ng1193-242	http://dx.doi.org/10.1038/ng1193-242			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MF122	8275088				2022-12-25	WOS:A1993MF12200013
J	CARRIER, L; HENGSTENBERG, C; BECKMANN, JS; GUICHENEY, P; DUFOUR, C; BERCOVICI, J; DAUSSE, E; BEREBBIBERTRAND, I; WISNEWSKY, C; PULVENIS, D; FETLER, L; VIGNAL, A; WEISSENBACH, J; HILLAIRE, D; FEINGOLD, J; BOUHOUR, JB; HAGEGE, A; DESNOS, M; ISNARD, R; DUBOURG, O; KOMAJDA, M; SCHWARTZ, K				CARRIER, L; HENGSTENBERG, C; BECKMANN, JS; GUICHENEY, P; DUFOUR, C; BERCOVICI, J; DAUSSE, E; BEREBBIBERTRAND, I; WISNEWSKY, C; PULVENIS, D; FETLER, L; VIGNAL, A; WEISSENBACH, J; HILLAIRE, D; FEINGOLD, J; BOUHOUR, JB; HAGEGE, A; DESNOS, M; ISNARD, R; DUBOURG, O; KOMAJDA, M; SCHWARTZ, K			MAPPING OF A NOVEL GENE FOR FAMILIAL HYPERTROPHIC CARDIOMYOPATHY TO CHROMOSOME-11	NATURE GENETICS			English	Article							MOLECULAR-BASIS	Familial hypertrophic cardiomyopathy (FHC) is a cardiac disorder transmitted as an autosomal dominant trait. FHC has been shown to be genetically heterogeneous with less than 50% of published pedigrees being associated with mutations in the beta myosin heavy chain (beta-MHC) gene on chromosome 14q11-q12. A second locus has recently been reported on chromosome 1. We examined the segregation of microsatellite markers in a French pedigree for which the disease is not linked to beta-MHC gene. We found significant linkage of the disease locus to several (CA)n repeats located on chromosome 11 (lod scores between +3.3 and +4.98). The data suggest the localization of the novel FHC gene in a region spanning 17 centiMorgans.	CEPH,PARIS,FRANCE; HOP PITRE SALPETRIERE,SOC FRANCAISE CARDIOL,MYOCARDIOPATHIES GRP,F-75013 PARIS,FRANCE; AFM,GENETHON,EVRY,FRANCE; INST PASTEUR,CNRS,URA 1445,F-75724 PARIS 15,FRANCE; INSERM,U155,F-75005 PARIS,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	CARRIER, L (corresponding author), HOP LARIBOISIERE,INSERM,41 BVD CHAPELLE,F-75475 PARIS 10,FRANCE.		Guicheney, Pascale/D-1034-2017; Vignal, Alain/I-6253-2017; Beckmann, Jacques S/A-9772-2008; Hengstenberg, Christian/U-5485-2019; Fetler, luc/M-9034-2018	Guicheney, Pascale/0000-0002-7663-2050; Vignal, Alain/0000-0002-6797-2125; Beckmann, Jacques S/0000-0002-9741-1900; HAGEGE, Albert/0000-0003-4685-6077				CUDA G, 1992, CIRCULATION, V86, P229; DUFOUR C, IN PRESS CR ACAD SCI, V316; EPSTEIN ND, 1992, CIRCULATION, V86, P345, DOI 10.1161/01.CIR.86.2.345; EPSTEIN ND, 1992, CIRCULATION, V85, P635, DOI 10.1161/01.CIR.85.2.635; FNANAPAZIR L, 1992, CIRCULATION, V86, P229; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; HARADA H, 1992, CIRCULATION, V86, P591; HEJTMANCIK JF, 1991, CIRCULATION, V83, P1592, DOI 10.1161/01.CIR.83.5.1592; HIRSCHFIELD W, 1992, European Heart Journal, V13, P32; JARCHO JA, 1989, NEW ENGL J MED, V321, P1372, DOI 10.1056/NEJM198911163212005; KO YL, 1992, HUM GENET, V89, P597; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MARES A, 1992, CIRCULATION, V86, P228; MARIAN AJ, 1992, J CLIN INVEST, V90, P2156, DOI 10.1172/JCI116101; MARON BJ, 1978, PROG CARDIOVASC DIS, V21, P207, DOI 10.1016/0033-0620(78)90026-9; MARON BJ, 1984, AM J CARDIOL, V53, P1087, DOI 10.1016/0002-9149(84)90643-X; NISHI H, 1992, BIOCHEM BIOPH RES CO, V188, P379, DOI 10.1016/0006-291X(92)92396-F; RICHARDS EJ, 1987, CURRENT PROTOCOL MOL, V1; SCHWARTZ K, 1992, CIRC RES, V71, P3, DOI 10.1161/01.RES.71.1.3; SOLOMON SD, 1990, J CLIN INVEST, V86, P993, DOI 10.1172/JCI114802; SOLOMON SD, 1990, AM J HUM GENET, V47, P389; TANIGAWA G, 1990, CELL, V62, P991, DOI 10.1016/0092-8674(90)90273-H; VIGNAL A, 1993, METHODS MOL GENETICS, V1, P211; WATKINS H, 1993, NAT GENET, V3, P333, DOI 10.1038/ng0493-333; WATKINS H, 1992, NEW ENGL J MED, V326, P1106; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; 1992, SCIENC E, V258, P67	27	176	179	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1993	4	3					311	313		10.1038/ng0793-311	http://dx.doi.org/10.1038/ng0793-311			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ842	8358441				2022-12-25	WOS:A1993LJ84200022
J	PICKETTS, DJ; LILLICRAP, DP; MUELLER, CR				PICKETTS, DJ; LILLICRAP, DP; MUELLER, CR			SYNERGY BETWEEN TRANSCRIPTION FACTORS DBP AND C/EBP COMPENSATES FOR A HEMOPHILIA-B LEYDEN FACTOR-IX MUTATION	NATURE GENETICS			English	Article							HEMOPHILIA-B; DEVELOPMENTAL REGULATION; ALBUMIN PROMOTER; POINT MUTATIONS; GENE; EXPRESSION; RECOGNITION; ACTIVATOR; SEQUENCE; PROTEIN	Haemophilia B Leyden is characterized by low childhood levels of factor IX which gradually increase after puberty, eventually resulting in a return to health. The disease is the result of single nucleotide substitutions within a 40 bp region encompassing the major transcriptional start site. We have characterized transcription factor binding sites within the factor IX promoter. Five sites were identified and a Leyden mutation at nucleotide -5 was shown to interfere with the binding of proteins to one of three newly identified sites. The correlation between the post-pubertal recovery of these mutants and the induction of the transcription factor DBP led us to the discovery of a synergistic interaction between DBP and C/EBP responsible for the recovery of normal transcriptional activity of the -5 mutant promoter and may play a role in the resolution of other Leyden mutants.	QUEENS UNIV, DEPT PATHOL, KINGSTON K7L 3N6, ONTARIO, CANADA; QUEENS UNIV, CANC RES LABS, KINGSTON K7L 3N6, ONTARIO, CANADA	Queens University - Canada; Queens University - Canada								ANSON DS, 1984, EMBO J, V3, P1053, DOI 10.1002/j.1460-2075.1984.tb01926.x; BABISS LE, 1987, GENE DEV, V1, P256, DOI 10.1101/gad.1.3.256; BIRKENMEIER EH, 1989, GENE DEV, V3, P1146, DOI 10.1101/gad.3.8.1146; BRIET E, 1982, NEW ENGL J MED, V306, P788, DOI 10.1056/NEJM198204013061306; CROSSLEY M, 1990, NUCLEIC ACIDS RES, V18, P4633, DOI 10.1093/nar/18.15.4633; CROSSLEY M, 1990, NATURE, V345, P444, DOI 10.1038/345444a0; CROSSLEY M, 1992, SCIENCE, V257, P377, DOI 10.1126/science.1631558; CROSSLEY M, 1992, NATURE, V257, P377; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; DROLET DW, 1991, GENE DEV, V5, P1739, DOI 10.1101/gad.5.10.1739; FREEDENBERG DL, 1991, THROMB HAEMOSTASIS, V65, P964; GIANNELLI F, 1991, NUCLEIC ACIDS RES, V19, P2193, DOI 10.1093/nar/19.suppl.2193; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; GRAVES BJ, 1986, CELL, V44, P565, DOI 10.1016/0092-8674(86)90266-7; HARRISON SC, 1991, NATURE, V353, P715, DOI 10.1038/353715a0; HEDNER U, 1987, HEMOSTASIS THROMBOSI, P39; HIROSAWA S, 1990, P NATL ACAD SCI USA, V87, P4421, DOI 10.1073/pnas.87.12.4421; HUANG MN, 1989, THROMB HAEMOSTASIS, V62, P81; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; LICHTSTEINER S, 1987, CELL, V51, P963, DOI 10.1016/0092-8674(87)90583-6; LILLICRAP DP, 1986, BRIT J HAEMATOL, V62, P557, DOI 10.1111/j.1365-2141.1986.tb02968.x; MAIRE P, 1989, SCIENCE, V244, P343, DOI 10.1126/science.2711183; MINTY A, 1986, MOL CELL BIOL, V6, P2125, DOI 10.1128/MCB.6.6.2125; MUELLER CR, 1990, CELL, V61, P279, DOI 10.1016/0092-8674(90)90808-R; PICKETTS DJ, 1992, GENOMICS, V12, P161, DOI 10.1016/0888-7543(92)90421-N; RAMJI DP, 1991, NUCLEIC ACIDS RES, V19, P1139, DOI 10.1093/nar/19.5.1139; REIJNEN MJ, 1992, P NATL ACAD SCI USA, V89, P6300, DOI 10.1073/pnas.89.14.6300; REITSMA PH, 1989, BLOOD, V73, P743; REITSMA PH, 1988, BLOOD, V72, P1074; ROYLE G, 1991, BRIT J HAEMATOL, V77, P191, DOI 10.1111/j.1365-2141.1991.tb07976.x; SALIER JP, 1990, J BIOL CHEM, V265, P7062; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; YOSHITAKE S, 1985, BIOCHEMISTRY-US, V24, P3736, DOI 10.1021/bi00335a049	34	52	52	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1993	3	2					175	179		10.1038/ng0293-175	http://dx.doi.org/10.1038/ng0293-175			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KL010	8499951				2022-12-25	WOS:A1993KL01000017
J	Huygen, K; Content, J; Denis, O; Montgomery, DL; Yawman, AM; Deck, RR; DeWitt, CM; Orme, IM; Baldwin, S; DSouza, C; Drowart, A; Lozes, E; Vandenbussche, P; VanVooren, JP; Liu, MA; Ulmer, JB				Huygen, K; Content, J; Denis, O; Montgomery, DL; Yawman, AM; Deck, RR; DeWitt, CM; Orme, IM; Baldwin, S; DSouza, C; Drowart, A; Lozes, E; Vandenbussche, P; VanVooren, JP; Liu, MA; Ulmer, JB			Immunogenicity and protective efficacy of a tuberculosis DNA vaccine	NATURE MEDICINE			English	Article							MYCOBACTERIUM-BOVIS BCG; MAJOR HISTOCOMPATIBILITY COMPLEX; INTERFERON-GAMMA; T-CELLS; MICE; INFECTION; ANTIGEN; LEPROSY; IDENTIFICATION; IMMUNIZATION	Tuberculosis is the most widespread and lethal infectious disease affecting humans. Immunization of mice with plasmid DNA constructs encoding one of the secreted components of Mycobacterium tuberculosis, antigen 85 (Ag85), induced substantial humoral and cell-mediated immune responses and conferred significant protection against challenge with live M. tuberculosis and M. bovis bacille Calmette-Guerin (BCG). These results indicate that immunization with DNA encoding a mycobacterial antigen provides an efficient and simple method for generating protective immunity and that this technique may be useful for defining the protective antigens of M. tuberculosis, leading to the development of a more effective vaccine.	INST PASTEUR, DEPT VIROL, B-1180 BRUSSELS, BELGIUM; COLORADO STATE UNIV, DEPT MICROBIOL, FT COLLINS, CO 80523 USA; FREE UNIV BRUSSELS, HOP ERASME, B-1070 BRUSSELS, BELGIUM	Colorado State University; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Huygen, K (corresponding author), MERCK RES LABS, DEPT VIRUS & CELL BIOL, WP16-10, W POINT, PA 19486 USA.			Huygen, Kris/0000-0001-7808-0512	NIAID NIH HHS [AI 35182] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035182] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSEN P, 1994, INFECT IMMUN, V62, P2536, DOI 10.1128/IAI.62.6.2536-2544.1994; APPELBERG R, 1993, IMMUNOLOGY, V80, P352; BARRY MA, 1995, NATURE, V377, P632, DOI 10.1038/377632a0; BORREMANS ML, 1989, INFECT IMMUN, V57, P3122; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; DEBRUYN J, 1987, MICROB PATHOGENESIS, V2, P351, DOI 10.1016/0882-4010(87)90077-5; DENIS M, 1990, IMMUNOL LETT, V24, P203, DOI 10.1016/0165-2478(90)90049-V; DENIS O, 1993, INT IMMUNOL, V5, P71, DOI 10.1093/intimm/5.1.71; DONNELLY JJ, 1994, J IMMUNOL METHODS, V176, P145, DOI 10.1016/0022-1759(94)90308-5; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; FLYNN JL, 1992, P NATL ACAD SCI USA, V89, P12013, DOI 10.1073/pnas.89.24.12013; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; GRIFFIN JP, 1994, INFECT IMMUN, V62, P1683, DOI 10.1128/IAI.62.5.1683-1690.1994; HAANEN JBAG, 1991, J EXP MED, V174, P583, DOI 10.1084/jem.174.3.583; HORWITZ MA, 1995, P NATL ACAD SCI USA, V92, P1530, DOI 10.1073/pnas.92.5.1530; HUYGEN K, 1993, INFECT IMMUN, V61, P2687, DOI 10.1128/IAI.61.6.2687-2693.1993; HUYGEN K, 1992, INFECT IMMUN, V60, P2880, DOI 10.1128/IAI.60.7.2880-2886.1992; HUYGEN K, 1994, INFECT IMMUN, V62, P363, DOI 10.1128/IAI.62.2.363-370.1994; KAUFMANN SHE, 1993, ANNU REV IMMUNOL, V11, P129, DOI 10.1146/annurev.iy.11.040193.001021; LAUNOIS P, 1994, INFECT IMMUN, V62, P3679, DOI 10.1128/IAI.62.9.3679-3687.1994; LAUNOIS P, 1993, J INFECT DIS, V167, P1160, DOI 10.1093/infdis/167.5.1160; MONTGOMERY DL, 1993, DNA CELL BIOL, V12, P777, DOI 10.1089/dna.1993.12.777; NATHAN CF, 1983, J EXP MED, V158, P670, DOI 10.1084/jem.158.3.670; PARISH CR, 1983, J IMMUNOL METHODS, V58, P225, DOI 10.1016/0022-1759(83)90277-6; SHIVER JW, 1995, VACCINES, P95; Silva CL, 1995, IMMUNOLOGY, V86, P519; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; WIKER HG, 1992, MICROBIOL REV, V56, P648, DOI 10.1128/MMBR.56.4.648-661.1992; YAMAMURA M, 1991, SCIENCE, V254, P277, DOI 10.1126/science.1925582	30	562	614	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	1996	2	8					893	898		10.1038/nm0896-893	http://dx.doi.org/10.1038/nm0896-893			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UZ804	8705859				2022-12-25	WOS:A1996UZ80400036
J	Alonso, AD; GrundkeIqbal, I; Iqbal, K				Alonso, AD; GrundkeIqbal, I; Iqbal, K			Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules	NATURE MEDICINE			English	Article							PAIRED HELICAL FILAMENTS; PROTEIN-TAU; NEUROFIBRILLARY TANGLES; ABNORMAL PHOSPHORYLATION; BRAIN; ASSAY	Microtubule-associated protein tau becomes abnormally hyperphosphorylated in Alzheimer's disease (AD) and accumulates as tangles of paired helical filaments in neurons undergoing degeneration. We now show that in solution normal tau associates with the AD hyperphosphorylated tau (AD P-tau) in a nonsaturable fashion, forming large tangles of filaments 3.3 +/- 0.7 nm in diameter. These tangles, which are not detected in identically treated normal tau or AD P-tau alone, are made up of filaments several microns in length and are labeled with tau antibodies. Dephosphorylation with alkaline phosphatase abolishes the ability of AD P-tau to aggregate with normal tau and prevents tangle formation. AD P-tau disassembles microtubules assembled from normal tau and tubulin. These data provide insight into how the hyperphosphorylation of tau might lead to the formation of the neurofibrillary tangles and the degeneration of the affected neurons in AD.			Alonso, AD (corresponding author), NEW YORK STATE INST BASIC RES DEV DISABIL,1050 FOREST HILL RD,STATEN ISL,NY 10314, USA.				FOGARTY INTERNATIONAL CENTER [R03TW000507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG008076, R01AG005892] Funding Source: NIH RePORTER; FIC NIH HHS [TW 00507] Funding Source: Medline; NIA NIH HHS [AG 08076, AG 05892] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALAFUZOFF I, 1987, ACTA NEUROPATHOL, V74, P209, DOI 10.1007/BF00688184; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; ALONSO AD, 1995, BRAIN RES MOL BRAIN, V31, P194; BANCHER C, 1989, BRAIN RES, V477, P90, DOI 10.1016/0006-8993(89)91396-6; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; CROWTHER RA, 1992, FEBS LETT, V309, P199, DOI 10.1016/0014-5793(92)81094-3; CROWTHER RA, 1994, FEBS LETT, V337, P135, DOI 10.1016/0014-5793(94)80260-2; GONG CX, 1995, J NEUROCHEM, V65, P732, DOI 10.1046/j.1471-4159.1995.65020732.x; GONG CX, 1993, J NEUROCHEM, V61, P921, DOI 10.1111/j.1471-4159.1993.tb03603.x; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; GRUNDKEIQBAL I, 1988, MOL BRAIN RES, V4, P43, DOI 10.1016/0169-328X(88)90017-4; IQBAL K, 1986, LANCET, V2, P421; IQBAL K, 1994, FEBS LETT, V349, P104, DOI 10.1016/0014-5793(94)00650-4; KHATOON S, 1992, J NEUROCHEM, V59, P750, DOI 10.1111/j.1471-4159.1992.tb09432.x; KOPKE E, 1993, J BIOL CHEM, V268, P24374; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; RUBEN GC, 1988, J BIOL CHEM, V263, P2861; RUBEN GC, 1992, BRAIN RES, V590, P164, DOI 10.1016/0006-8993(92)91092-S; RUBEN GC, 1991, J BIOL CHEM, V266, P22019; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; SLOBODA RD, 1979, BIOCHEMISTRY-US, V18, P48, DOI 10.1021/bi00568a008; TOMLINSON BE, 1970, J NEUROL SCI, V11, P205, DOI 10.1016/0022-510X(70)90063-8; WANG JZ, 1995, J BIOL CHEM, V270, P4854, DOI 10.1074/jbc.270.9.4854; WANG JZ, UNPUB NATURE MED; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; WRZOLEK MA, 1992, AM J PATHOL, V141, P343	30	655	678	3	73	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUL	1996	2	7					783	787		10.1038/nm0796-783	http://dx.doi.org/10.1038/nm0796-783			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UU680	8673924				2022-12-25	WOS:A1996UU68000034
J	GeorgesLabouesse, E; Messaddeq, N; Yehia, G; Cadalbert, L; Dierich, A; LeMeur, M				GeorgesLabouesse, E; Messaddeq, N; Yehia, G; Cadalbert, L; Dierich, A; LeMeur, M			Absence of integrin alpha 6 leads to epidermolysis bullosa and neonatal death in mice	NATURE GENETICS			English	Letter							BASEMENT-MEMBRANE ADHESION; MONOCLONAL-ANTIBODY; CELL-ADHESION; HEMIDESMOSOMES; SUBUNIT; PROTEIN; DISRUPTION; COMPONENT; COMPLEX; KALININ				GeorgesLabouesse, E (corresponding author), ULP, INSERM,CNRS,INST GENET & BIOL MOL & CELLULAIRE, BP 163, CU STRASBOURG, F-67404 ILLKIRCH GRAFFENSTADEN, FRANCE.			Cadalbert, Laurence/0000-0003-1333-2146				ABERDAM D, 1994, NAT GENET, V6, P299, DOI 10.1038/ng0394-299; CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLLO G, 1995, CELL ADHES COMMUN, V3, P101, DOI 10.3109/15419069509081280; DAMSKY C, 1993, FASEB J, V7, P1320, DOI 10.1096/fasebj.7.14.8224605; DECURTIS I, 1993, DEVELOPMENT, V118, P377; DELWEL GO, 1996, ADHESION RECEPTORS T, P9; FINE JD, 1991, J AM ACAD DERMATOL, V24, P119, DOI 10.1016/0190-9622(91)70021-S; GUO LF, 1995, CELL, V81, P233, DOI 10.1016/0092-8674(95)90333-X; HEMLER ME, 1989, J BIOL CHEM, V264, P6529; HIERCK BP, 1993, CELL ADHES COMMUN, V1, P33, DOI 10.3109/15419069309095680; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; JONES JCR, 1991, CELL REGUL, V2, P427, DOI 10.1091/mbc.2.6.427; KENNEL SJ, 1986, CANCER RES, V46, P707; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LUFKIN T, 1991, CELL, V66, P1105, DOI 10.1016/0092-8674(91)90034-V; MARINKOVICH MP, 1992, J BIOL CHEM, V267, P17900; MARK M, 1993, DEVELOPMENT, V119, P319; MASIAKOWSKI P, 1982, NUCLEIC ACIDS RES, V10, P7895, DOI 10.1093/nar/10.24.7895; PULKKINEN L, 1994, NAT GENET, V6, P293, DOI 10.1038/ng0394-293; PULKKINEN L, 1994, GENOMICS, V24, P357, DOI 10.1006/geno.1994.1627; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; SIMONASSMANN P, 1994, DEV DYNAM, V201, P71, DOI 10.1002/aja.1002010108; SONNENBERG A, 1990, J CELL SCI, V96, P207; SONNENBERG A, 1987, J BIOL CHEM, V262, P10376; SONNENBERG A, 1991, J CELL BIOL, V113, P907, DOI 10.1083/jcb.113.4.907; SOROKIN L, 1990, J CELL BIOL, V111, P1265, DOI 10.1083/jcb.111.3.1265; SPINARDI L, 1993, MOL BIOL CELL, V4, P871, DOI 10.1091/mbc.4.9.871; STEPP MA, 1990, P NATL ACAD SCI USA, V87, P8970, DOI 10.1073/pnas.87.22.8970; SUTHERLAND AE, 1993, DEVELOPMENT, V119, P1175; THORSTEINSDOTTIR S, 1995, DEV DYNAM, V204, P240, DOI 10.1002/aja.1002040304; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; VERRANDO P, 1987, EXP CELL RES, V170, P116, DOI 10.1016/0014-4827(87)90121-2; VIDAL F, 1995, NAT GENET, V10, P229, DOI 10.1038/ng0695-229	35	446	454	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1996	13	3					370	373		10.1038/ng0796-370	http://dx.doi.org/10.1038/ng0796-370			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UU283	8673141				2022-12-25	WOS:A1996UU28300030
J	Perou, CM; Moore, KJ; Nagle, DL; Misumi, DJ; Woolf, EA; McGrail, SH; Holmgren, L; Brody, TH; Dussault, BJ; Monroe, CA; Duyk, GM; Pryor, RJ; Li, LT; Justice, MJ; Kaplan, J				Perou, CM; Moore, KJ; Nagle, DL; Misumi, DJ; Woolf, EA; McGrail, SH; Holmgren, L; Brody, TH; Dussault, BJ; Monroe, CA; Duyk, GM; Pryor, RJ; Li, LT; Justice, MJ; Kaplan, J			Identification of the murine beige gene by YAC complementation and positional cloning	NATURE GENETICS			English	Article							CHEDIAK-HIGASHI-SYNDROME; SEARCH	The beige mutation is a murine autosomal recessive disorder, resulting in hypopigmentation, bleeding and immune cell dysfunction. The gene defective in beige is thought to be a homologue of the gene for the human disorder Chediak-Higashi syndrome. We have identified the murine beige gene by in vitro complementation and positional cloning, and confirmed its identification by defining mutations in two independent mutant alleles. The sequence of the beige gene message shows strong nucleotide homology to multiple human ESTs, one or more of which may be associated with the Chediak-Higashi syndrome gene. The amino acid sequence of the Beige protein revealed a novel protein with significant amino acid homology to orphan proteins identified in Saccharomyces cerevisiae, Caenorhabditis elegans and humans.	UNIV UTAH, SCH MED, DEPT PATHOL, DIV CELL BIOL & IMMUNOL, SALT LAKE CITY, UT 84132 USA; MILLENNIUM PHARMACEUT INC, CAMBRIDGE, MA 02139 USA; OAK RIDGE NATL LAB, DIV BIOL, OAK RIDGE, TN 37831 USA	Utah System of Higher Education; University of Utah; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; United States Department of Energy (DOE); Oak Ridge National Laboratory			Perou, Charles M/H-9934-2014	Perou, Charles M/0000-0001-9827-2247	NHLBI NIH HHS [HL26922] Funding Source: Medline; NIGMS NIH HHS [2T32GM07464] Funding Source: Medline; PHS HHS [ERKP057] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL026922, R37HL026922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007464] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BALCH WE, 1990, TRENDS BIOCHEM SCI, V15, P473, DOI 10.1016/0968-0004(90)90301-Q; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; COLOMBO MI, 1994, J BIOL CHEM, V269, P14919; DURONIO RJ, 1992, PROTEINS, V13, P41, DOI 10.1002/prot.340130105; ELAZAR Z, 1994, J CELL BIOL, V124, P415, DOI 10.1083/jcb.124.4.415; FEUCHTER AE, 1992, GENOMICS, V13, P1237, DOI 10.1016/0888-7543(92)90041-P; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; GNIRKE A, 1991, GENOMICS, V9, P742; HAAK RA, 1979, J CLIN INVEST, V64, P138, DOI 10.1172/JCI109432; JENKINS NA, 1982, J VIROL, V43, P26, DOI 10.1128/JVI.43.1.26-36.1982; Kelley E. M, 1957, MOUSE NEWS LETT, V16, P36; KRAMER JW, 1977, LAB INVEST, V36, P554; LUTZNER MA, 1965, LAB INVEST, V14, P2063; NOVAK EK, 1984, BLOOD, V63, P536; OLIVER JM, 1975, NATURE, V253, P471, DOI 10.1038/253471a0; OLIVER JM, 1976, J CELL BIOL, V69, P205, DOI 10.1083/jcb.69.1.205; PADGETT GA, 1964, GENETICS, V49, P505; Perou CM, 1996, P NATL ACAD SCI USA, V93, P5905, DOI 10.1073/pnas.93.12.5905; PEROU CM, 1993, SOMAT CELL MOLEC GEN, V19, P459, DOI 10.1007/BF01233251; PEROU CM, 1993, J CELL SCI, V106, P99; RODRIGUEZ F, 1991, YEAST, V7, P631, DOI 10.1002/yea.320070612; SPICER SS, 1981, FED PROC, V40, P1451; TAYLOR RF, 1973, FED PROC, V32, P822; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANDERVOORN L, 1992, FEBS LETT, V307, P131, DOI 10.1016/0014-5793(92)80751-2; WANG DS, 1994, BIOCHEM BIOPH RES CO, V203, P29, DOI 10.1006/bbrc.1994.2144; WHITE RA, 1992, NAT GENET, V2, P80, DOI 10.1038/ng0992-80; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; Zerial M, 1993, CURR OPIN CELL BIOL, V5, P613, DOI 10.1016/0955-0674(93)90130-I	30	158	164	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1996	13	3					303	308		10.1038/ng0796-303	http://dx.doi.org/10.1038/ng0796-303			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UU283	8673129				2022-12-25	WOS:A1996UU28300018
J	Armour, JAL; Anttinen, T; May, CA; Vega, EE; Sajantila, A; Kidd, JR; Kidd, KK; Bertranpetit, J; Paabo, S; Jeffreys, AJ				Armour, JAL; Anttinen, T; May, CA; Vega, EE; Sajantila, A; Kidd, JR; Kidd, KK; Bertranpetit, J; Paabo, S; Jeffreys, AJ			Minisatellite diversity supports a recent African origin for modern humans	NATURE GENETICS			English	Article							HYPERVARIABLE LOCUS; MITOCHONDRIAL-DNA; MUTATION; SEQUENCE; D16S309	In a study of human diversity at a highly variable locus, we have mapped the internal structures of tandem-repetitive alleles from different populations at the minisatellite MS205 (D16S309). The results give an unusually detailed view of the different allelic structures represented on modern human chromosomes, and of the ancestral relationships between them. There was a clear difference in allelic diversity between African and non-African populations. A restricted set of allele families was found in non-African populations, and formed a subset of the much greater diversity seen on African chromosomes. The data strongly support a recent African origin for modern human diversity at this locus.	UNIV LEICESTER,DEPT GENET,LEICESTER LE1 7RH,LEICS,ENGLAND; UNIV MUNICH,INST ZOOL,D-80021 MUNICH,GERMANY; YALE UNIV,SCH MED,DEPT GENET,NEW HAVEN,CT 06520; UNIV BARCELONA,FAC BIOL,LAB ANTROPOL,E-08028 BARCELONA,SPAIN	University of Leicester; University of Munich; Yale University; University of Barcelona			Sajantila, Antti/AAY-9084-2021; Bertranpetit, Jaume/F-8550-2012	Bertranpetit, Jaume/0000-0003-0100-0590; Armour, John/0000-0002-8558-8506; Sajantila, Antti/0000-0003-4117-5248; May, Celia/0000-0001-8541-2458	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ARMOUR JAL, 1993, HUM MOL GENET, V2, P1137, DOI 10.1093/hmg/2.8.1137; Armour JAL, 1996, ANN HUM GENET, V60, P11, DOI 10.1111/j.1469-1809.1996.tb01167.x; Armour JAL, 1992, CURR OPIN GENET DEV, V2, P850, DOI 10.1016/S0959-437X(05)80106-6; BATZER MA, 1994, P NATL ACAD SCI USA, V91, P12288, DOI 10.1073/pnas.91.25.12288; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; BUARD J, 1994, EMBO J, V13, P3203, DOI 10.1002/j.1460-2075.1994.tb06619.x; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CASTIGLIONE CM, 1995, AM J HUM GENET, V57, P1445; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; FLINT J, 1989, HUM GENET, V83, P257, DOI 10.1007/BF00285167; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; JEFFREYS AJ, 1991, NATURE, V354, P204, DOI 10.1038/354204a0; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; JEFFREYS AJ, 1990, CELL, V60, P473, DOI 10.1016/0092-8674(90)90598-9; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; KIDD KK, CAMBRIDGE S MOL BIOL; MONCKTON DG, 1994, NAT GENET, V8, P162, DOI 10.1038/ng1094-162; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NEIL DL, 1993, HUM MOL GENET, V2, P1129; ROYLE NJ, 1992, NUCLEIC ACIDS RES, V20, P1164, DOI 10.1093/nar/20.5.1164; SAJANTILA A, 1995, GENOME RES, V5, P42, DOI 10.1101/gr.5.1.42; TEMPLETON AR, 1995, GENETICS, V140, P767; TEMPLETON AR, 1994, AM ANTHROPOL, V96, P141, DOI 10.1525/aa.1994.96.1.02a00080; TEMPLETON AR, 1992, SCIENCE, V255, P737, DOI 10.1126/science.1590849; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; VERGNAUD G, 1991, GENOMICS, V11, P135, DOI 10.1016/0888-7543(91)90110-Z; WAINSCOAT JS, 1986, NATURE, V319, P491, DOI 10.1038/319491a0; ZISCHLER H, 1995, NATURE, V378, P489, DOI 10.1038/378489a0	29	143	144	0	11	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1996	13	2					154	160		10.1038/ng0696-154	http://dx.doi.org/10.1038/ng0696-154			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UN395	8640220				2022-12-25	WOS:A1996UN39500013
J	Perucho, M				Perucho, M			Microsatellite instability: The mutator that mutates the other mutator	NATURE MEDICINE			English	Editorial Material							CARCINOGENESIS				Perucho, M (corresponding author), BURNHAM INST,10901 N TORREY PINES RD,LA JOLLA,CA 92037, USA.			Perucho, Manuel/0000-0002-2169-2662				Casares S, 1995, ONCOGENE, V11, P2303; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; KNUDSON AG, 1985, CANCER RES, V45, P1437; LOEB LA, 1991, CANCER RES, V51, P3075; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; MARRA G, 1995, J NATL CANCER I, V87, P1114, DOI 10.1093/jnci/87.15.1114; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; PERUCHO M, 1994, COLD SPRING HARB SYM, V59, P339, DOI 10.1101/SQB.1994.059.01.038; Shibata D, 1996, NAT MED, V2, P676, DOI 10.1038/nm0696-676; SHIBATA D, 1994, NAT GENET, V6, P273, DOI 10.1038/ng0394-273; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014	13	165	173	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUN	1996	2	6					630	631		10.1038/nm0696-630	http://dx.doi.org/10.1038/nm0696-630			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UN691	8640546				2022-12-25	WOS:A1996UN69100023
J	Karalis, K; Goodwin, G; Majzoub, JA				Karalis, K; Goodwin, G; Majzoub, JA			Cortisol blockade of progesterone: A possible molecular mechanism involved in the initiation of human labor	NATURE MEDICINE			English	Article							CORTICOTROPIN-RELEASING HORMONE; GLUCOCORTICOID RECEPTOR; MESSENGER-RNA; PREGNANCY; ANTIPROGESTERONE; EXPRESSION; PLACENTA; PEPTIDE; PLASMA; PARTURITION	In most mammals, labor is heralded by progesterone withdrawal, which is believed to be related to the activation of multiple pathways leading to parturition. In humans, despite no decrease in placental progesterone production, activation of similar pathways preceding labor suggests the presence of an endogenous antiprogestin, which we reasoned might: be cortisol, whose secretion from the fetal adrenal rises markedly at the end of human gestation. We report that in primary cultures of human placenta, cortisol is able to compete with the action of progesterone in the regulation of the corticotropin-releasing hormone (CRH) gene. CRH is a peptide highly expressed in human placenta at the end of gestation, which has been suggested to be involved in regulating the timing of parturition. These findings provide a model for functional progesterone withdrawal at the end of human pregnancy, which may be involved in the initiation of labor.			Karalis, K (corresponding author), CHILDRENS HOSP, DIV ENDOCRINOL, 300 LONGWOOD AVE, BOSTON, MA 02115 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD024704] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002172] Funding Source: NIH RePORTER; NCRR NIH HHS [2MO1 RR 02172] Funding Source: Medline; NICHD NIH HHS [R01 HD 24704-05] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDERSON ABM, 1975, J ENDOCRINOL, V66, P61, DOI 10.1677/joe.0.0660061; BAULIEU EE, 1989, SCIENCE, V245, P1351, DOI 10.1126/science.2781282; BERGHORN KA, 1991, ENDOCRINOLOGY, V129, P1424, DOI 10.1210/endo-129-3-1424; BLOCH K, 1945, J BIOL CHEM, V157, P661; CASEY ML, 1993, SEMIN REPROD ENDOCR, V11, P272, DOI 10.1055/s-2007-1018840; CASEY ML, 1988, CLIN OBSTET GYNECOL, V31, P533, DOI 10.1097/00003081-198809000-00005; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CIDLOWSKI JA, 1990, MOL ENDOCRINOL, V4, P1427, DOI 10.1210/mend-4-10-1427; Csapo A I, 1977, Ciba Found Symp, P159; EMANUEL RL, 1994, CLIN ENDOCRINOL, V40, P257, DOI 10.1111/j.1365-2265.1994.tb02477.x; FENCL MDM, 1980, NATURE, V287, P225, DOI 10.1038/287225a0; FRIM DM, 1988, J CLIN INVEST, V82, P287, DOI 10.1172/JCI113585; GASPARONI A, 1991, EUR J PEDIATR, V150, P481, DOI 10.1007/BF01958427; GOLAND RS, 1988, AM J OBSTET GYNECOL, V159, P884, DOI 10.1016/S0002-9378(88)80162-5; JAHN GA, 1987, J STEROID BIOCHEM, V28, P371, DOI 10.1016/0022-4731(87)91053-3; JONES SA, 1989, J CLIN ENDOCR METAB, V68, P825, DOI 10.1210/jcem-68-4-825; KHANDAWOOD FS, 1984, AM J OBSTET GYNECOL, V150, P501, DOI 10.1016/S0002-9378(84)90428-9; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; LELAIDIER C, 1994, BRIT J OBSTET GYNAEC, V101, P501, DOI 10.1111/j.1471-0528.1994.tb13150.x; LIGGINS GC, 1994, AUST NZ J OBSTET GYN, V34, P338, DOI 10.1111/j.1479-828X.1994.tb01085.x; LIGGINS GC, 1981, FETAL ENDOCRINOLOGY, P211; LIPPMAN M, 1977, ANN NY ACAD SCI, V286, P101, DOI 10.1111/j.1749-6632.1977.tb29409.x; MAJZOUB JA, 1988, METHODS NEUROSCI, V52, P1160; MCLEAN M, 1995, NAT MED, V1, P460, DOI 10.1038/nm0595-460; NORDEEN SK, 1989, MOL ENDOCRINOL, V3, P1270, DOI 10.1210/mend-3-8-1270; OJASOO T, 1988, J MED CHEM, V31, P1160, DOI 10.1021/jm00401a015; OKAMOTO E, 1989, HORM METAB RES, V21, P566, DOI 10.1055/s-2007-1009289; PHILIBERT D, 1991, FRONT HORM RES, V19, P1; PRESS MF, 1988, AM J PATHOL, V131, P112; ROBINSON BG, 1988, P NATL ACAD SCI USA, V85, P5244, DOI 10.1073/pnas.85.14.5244; ROBINSON BG, 1989, MOL CELL ENDOCRINOL, V62, P337, DOI 10.1016/0303-7207(89)90022-1; RYAN KJ, 1980, MATERNAL FETAL ENDOC, P297; SAWCHENKO PE, 1987, J NEUROSCI, V7, P1093; SCHWARZ BE, 1977, ANN NY ACAD SCI, V286, P304, DOI 10.1111/j.1749-6632.1977.tb29425.x; SIITERI PK, 1963, STEROIDS, V2, P713, DOI 10.1016/0039-128X(63)90044-8; SIITERI PK, 1981, FETAL ENDOCRINOLOGY, V5, P1; SLATER EP, 1988, MOL ENDOCRINOL, V2, P485, DOI 10.1210/mend-2-6-485; SPEEG KV, 1979, ENDOCRINOLOGY, V104, P1364, DOI 10.1210/endo-104-5-1364; STALLA GK, 1989, GYNECOL ENDOCRINOL, V3, P1, DOI 10.3109/09513598909152447; STRAHLE U, 1989, NATURE, V339, P629, DOI 10.1038/339629a0; TULCHINSKY D, 1972, AM J OBSTET GYNECOL, V112, P1095, DOI 10.1016/0002-9378(72)90185-8; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; VONDERAHE D, 1985, NATURE, V313, P706, DOI 10.1038/313706a0; WESTPHAL U, 1977, ANN NY ACAD SCI, V286, P10, DOI 10.1111/j.1749-6632.1977.tb29402.x	44	186	188	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	1996	2	5					556	560		10.1038/nm0596-556	http://dx.doi.org/10.1038/nm0596-556			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UJ230	8616715				2022-12-25	WOS:A1996UJ23000039
J	Rade, JJ; Schulick, AH; Virmani, R; Dichek, DA				Rade, JJ; Schulick, AH; Virmani, R; Dichek, DA			Local adenoviral-mediated expression of recombinant hirudin reduces neointima formation after arterial injury	NATURE MEDICINE			English	Article							MUSCLE CELL-PROLIFERATION; THROMBIN; RECEPTOR; HEPARIN; ANGIOPLASTY; RESTENOSIS; INHIBITOR	Catalytically active thrombin, acting locally, is thought to mediate neointima formation after arterial injury. We constructed an adenovirus vector, AdHV-1.2, containing a complementary DNA for the thrombin inhibitor hirudin. AdHV-1.2 directed the synthesis and secretion of biologically active hirudin from vascular cells in vitro. In vivo gene transfer of hirudin into smooth muscle cells of injured rat carotid arteries resulted in peak secretion of at least 34 +/- 23 pg hirudin per vessel per 24 hours, and resulted in a significant (P < 0.05) 35% reduction in neointima formation. Systemic partial thromboplastin times were not affected by local hirudin expression. These results support the hypothesis that local thrombin activity contributes to neointima formation after arterial injury and suggest that local delivery of a highly specific antithrombin may constitute an effective intervention for arterial proliferative disease.	UNIV CALIF SAN FRANCISCO,GLADSTONE INST CARDIOVASC DIS,SAN FRANCISCO,CA 94141; NHLBI,MOLEC HEMATOL BRANCH,BETHESDA,MD 20892; ARMED FORCES INST PATHOL,DIV CARDIOVASC,WASHINGTON,DC 20307; JOHNS HOPKINS SCH MED,DIV CARDIOL,BALTIMORE,MD 21205	University of California System; University of California San Francisco; The J David Gladstone Institutes; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); United States Department of Defense; Johns Hopkins University; Johns Hopkins Medicine				Dichek, David/0000-0002-5224-2736				BENEZRA M, 1993, BLOOD, V81, P3324; BLOMBACK B, 1958, ARK KEMI, V12, P321; CHANG MW, 1995, SCIENCE, V267, P518, DOI 10.1126/science.7824950; CLOWES AW, 1977, NATURE, V265, P625, DOI 10.1038/265625a0; DANIEL WW, 1991, BIOSTATISTICS F ANAL; DAVEY MG, 1967, NATURE, V216, P857, DOI 10.1038/216857a0; DILLON PJ, 1990, BIOTECHNIQUES, V9, P298; Eccleston E., 1977, Comparative clinical haematology,, P611; FORTKAMP E, 1986, DNA-J MOLEC CELL BIO, V5, P511, DOI 10.1089/dna.1.1986.5.511; FUSTER V, 1992, NEW ENGL J MED, V326, P310; Graham F L, 1991, Methods Mol Biol, V7, P109, DOI 10.1385/0-89603-178-0:109; GUYTON JR, 1980, CIRC RES, V46, P625, DOI 10.1161/01.RES.46.5.625; GUZMAN RJ, 1994, P NATL ACAD SCI USA, V91, P10732, DOI 10.1073/pnas.91.22.10732; HATTON MWC, 1994, THROMB HAEMOSTASIS, V71, P499; INDOLFI C, 1995, NAT MED, V1, P541, DOI 10.1038/nm0695-541; JOHNSON PH, 1991, HAEMOSTASIS, V21, P41; JUST M, 1991, HAEMOSTASIS, V21, P80; LEE SW, 1993, CIRC RES, V73, P797, DOI 10.1161/01.RES.73.5.797; Markwardt F., 1970, METHOD ENZYMOL, V19, P924, DOI [10.1016/0076-6879(70)19082-3, DOI 10.1016/0076-6879(70)19082-3]; MCNAMARA CA, 1993, J CLIN INVEST, V91, P94, DOI 10.1172/JCI116206; NELKEN NA, 1992, J CLIN INVEST, V90, P1614, DOI 10.1172/JCI116031; Newman KD, 1995, J CLIN INVEST, V96, P2955, DOI 10.1172/JCI118367; OHNO T, 1994, SCIENCE, V265, P781, DOI 10.1126/science.8047883; OKAZAKI H, 1992, CIRC RES, V71, P1285, DOI 10.1161/01.RES.71.6.1285; SAREMBOCK IJ, 1991, CIRCULATION, V84, P232, DOI 10.1161/01.CIR.84.1.232; SCHULICK AH, 1995, CIRC RES, V77, P475, DOI 10.1161/01.RES.77.3.475; SCHULICK AH, 1995, CIRCULATION, V91, P2407, DOI 10.1161/01.CIR.91.9.2407; SERRUYS PW, 1995, NEW ENGL J MED, V333, P757, DOI 10.1056/NEJM199509213331203; SPANNAGL M, 1991, HAEMOSTASIS, V21, P36; STRAUSS BH, 1992, CIRCULATION, V85, P1952, DOI 10.1161/circ.85.5.1533354; TOPOL EJ, 1994, CIRCULATION, V89, P1557, DOI 10.1161/01.CIR.89.4.1557; VANDENBOS AA, 1993, CIRCULATION, V88, P2058, DOI 10.1161/01.CIR.88.5.2058; VONDERLEYEN HE, 1995, P NATL ACAD SCI USA, V92, P1137, DOI 10.1073/pnas.92.4.1137; WALLACE A, 1989, BIOCHEMISTRY-US, V28, P10079, DOI 10.1021/bi00452a030; WALSMANN P, 1991, SEMIN THROMB HEMOST, V17, P83, DOI 10.1055/s-2007-1002593; YANG YP, 1995, J VIROL, V69, P2004, DOI 10.1128/JVI.69.4.2004-2015.1995; 1994, CIRCULATION, V90, P1631; 1992, CIRCULATION, V86, P100	38	135	139	1	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAR	1996	2	3					293	298		10.1038/nm0396-293	http://dx.doi.org/10.1038/nm0396-293			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TY640	8612227				2022-12-25	WOS:A1996TY64000037
J	Abkowitz, JL; Catlin, SN; Guttorp, P				Abkowitz, JL; Catlin, SN; Guttorp, P			Evidence that hematopoiesis may be a stochastic process in vivo	NATURE MEDICINE			English	Article							BONE-MARROW TRANSPLANTATION; STEM-CELL CLONES; PROGENITOR CELLS; W/WV MICE; DIFFERENTIATION; GENE; RECONSTITUTION; SEPARATION; NUMBERS; SYSTEM	To study the behavior of hematopoietic stem cells in vivo, hematopoiesis was simulated by assuming that all stem cell decisions (that is, replication, apoptosis, initiation of a differentiation/maturation program) were determined by chance. Predicted outcomes from simulated experiments were compared with data obtained in autologous marrow transplantation studies of glucose 6-phosphate dehydrogenase (G6PD) heterozygous female Safari cats. With this approach, we prove that stochastic differentiation can result in the wide spectrum of discrete outcomes observed in vivo, and that clonal dominance can occur by chance. As the analyses also suggest that the frequency of feline hematopoietic stem cells is only 6 per 10(7) nucleated marrow cells, and that stem cells do not replicate on average more frequently than once every three weeks, these large-animal data challenge clinical strategies for marrow transplantation and gene therapy.	UNIV WASHINGTON, DEPT STAT, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle	Abkowitz, JL (corresponding author), UNIV WASHINGTON, DEPT MED, DIV HEMATOL, BOX 357710, SEATTLE, WA 98195 USA.				NHLBI NIH HHS [R01 HL 46598] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046598] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABKOWITZ JL, 1985, J CLIN INVEST, V75, P133, DOI 10.1172/JCI111665; ABKOWITZ JL, 1995, P NATL ACAD SCI USA, V92, P2031, DOI 10.1073/pnas.92.6.2031; ABKOWITZ JL, 1990, P NATL ACAD SCI USA, V87, P9062, DOI 10.1073/pnas.87.22.9062; Arley N., 1943, THEORY STOCHASTIC PR; BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804; BERARDI AC, 1995, SCIENCE, V267, P104, DOI 10.1126/science.7528940; BLACKETT NM, 1987, CELL TISSUE KINET, V20, P393, DOI 10.1111/j.1365-2184.1987.tb01324.x; BODINE NM, 1993, BLOOD, V82, P1875; CAPEL B, 1990, BLOOD, V75, P2267; CAPEL B, 1989, P NATL ACAD SCI USA, V86, P4564, DOI 10.1073/pnas.86.12.4564; Coffin J. M., 1990, VIROLOGY, P1437; DICK JE, 1985, CELL, V42, P71, DOI 10.1016/S0092-8674(85)80102-1; FAIRBAIRN LJ, 1993, CELL, V74, P823, DOI 10.1016/0092-8674(93)90462-Y; GORDON MY, 1994, STEM CELLS, V12, P175, DOI 10.1002/stem.5530120205; GUTTORP P, 1990, IMA J MATH APPL MED, V7, P125; Guttorp P, 1995, STOCHASTIC MODELING; HARRISON DE, 1988, P NATL ACAD SCI USA, V85, P822, DOI 10.1073/pnas.85.3.822; HARRISON DE, 1992, P NATL ACAD SCI USA, V89, P10134, DOI 10.1073/pnas.89.21.10134; HELLINGA HW, 1994, P NATL ACAD SCI USA, V91, P5803, DOI 10.1073/pnas.91.13.5803; HOGGE DE, 1994, BAILLIERE CLIN HAEM, V7, P49, DOI 10.1016/S0950-3536(05)80006-X; JONES RJ, 1990, NATURE, V347, P188, DOI 10.1038/347188a0; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; JORDAN CT, 1990, CELL, V61, P953, DOI 10.1016/0092-8674(90)90061-I; KARLSSON S, 1991, BLOOD, V78, P2481; KELLER G, 1990, J EXP MED, V171, P1407, DOI 10.1084/jem.171.5.1407; KIEFER F, 1991, BLOOD, V78, P2577; KIEM HP, 1994, BLOOD, V83, P1467; KURNIT DM, 1985, J CELL PHYSIOL, V123, P55, DOI 10.1002/jcp.1041230110; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; LOTHROP CD, 1991, BLOOD, V78, P237; METCALF D, 1993, BLOOD, V82, P3515; MICKLEM HS, 1987, EXP HEMATOL, V15, P251; NASH R, 1988, BLOOD, V72, P2031; NEWTON M, IN PRESS J AM STAT A; OBRIEN SJ, 1986, TRENDS GENET, V2, P137, DOI 10.1016/0168-9525(86)90204-0; OGATA H, 1992, BLOOD, V80, P91; OGAWA M, 1983, BLOOD, V61, P823; ONISHI M, 1993, BLOOD, V81, P3217; ORLIC D, 1994, BLOOD, V84, P3991, DOI 10.1182/blood.V84.12.3991.bloodjournal84123991; POSAKONY JW, 1994, CELL, V76, P415, DOI 10.1016/0092-8674(94)90105-8; SNODGRASS R, 1987, EMBO J, V6, P3955, DOI 10.1002/j.1460-2075.1987.tb02737.x; SPAIN LM, 1992, P NATL ACAD SCI USA, V89, P3790, DOI 10.1073/pnas.89.9.3790; STEWART FM, 1993, BLOOD, V81, P2566; TERSTAPPEN LWMM, 1991, BLOOD, V77, P1218; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; TURHAN AG, 1989, NEW ENGL J MED, V320, P1655, DOI 10.1056/NEJM198906223202504; UCHIDA N, 1994, BLOOD, V83, P3758; UCHIDA N, 1992, J EXP MED, V175, P175, DOI 10.1084/jem.175.1.175; UCHIDA N, 1993, CURR OPIN IMMUNOL, V5, P177, DOI 10.1016/0952-7915(93)90002-A; VOGEL H, 1969, J THEOR BIOL, V22, P249, DOI 10.1016/0022-5193(69)90004-6; WICHMANN HE, 1988, BLOOD CELLS, V14, P411; WOLF NS, 1993, EXP HEMATOL, V21, P614	52	195	201	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	1996	2	2					190	197		10.1038/nm0296-190	http://dx.doi.org/10.1038/nm0296-190			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TU060	8574964				2022-12-25	WOS:A1996TU06000039
J	Martin, MG; Turk, E; Lostao, MP; Kerner, C; Wright, EM				Martin, MG; Turk, E; Lostao, MP; Kerner, C; Wright, EM			Defects in Na+ glucose cotransporter (SGLT1) trafficking and function cause glucose-galactose malabsorption	NATURE GENETICS			English	Letter									UNIV CALIF LOS ANGELES,SCH MED,DEPT PEDIAT,LOS ANGELES,CA 90095	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Martin, MG (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,DEPT PHYSIOL,LOS ANGELES,CA 90095, USA.		Lostao, M. Pilar/AAW-4238-2021; Alshali, Rasha A/K-8051-2012; Martín, María/HDL-9512-2022; Lostao, M. Pilar/ABH-4714-2020	Lostao, M. Pilar/0000-0002-7319-3451; Lostao, M. Pilar/0000-0002-7319-3451	NIDDK NIH HHS [DK-4458] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		DESJEUX JF, 1995, METABOLIC BASIS INHE, V3, P3563; HEDIGER MA, 1987, NATURE, V330, P379, DOI 10.1038/330379a0; HIGUCHI RB, 1986, NUCLEIC ACIDS RES, V16, P7351; HIRAYAMA BA, 1992, BIOCHIM BIOPHYS ACTA, V1103, P37, DOI 10.1016/0005-2736(92)90054-P; IKEDA TS, 1989, J MEMBRANE BIOL, V110, P87, DOI 10.1007/BF01870995; KRAWCZAK M, 1992, HUM GENET, V90, P41; KWON HM, 1992, J BIOL CHEM, V267, P6297; LAPLANE R, 1962, ARCH FR PEDIATR, V19, P895; LINDQUIST B, 1962, ACTA PAEDIATR SCAND, V51, P674, DOI 10.1111/j.1651-2227.1962.tb06600.x; LOD DDF, 1993, P NATL ACAD SCI USA, V90, P5767; Lostao MP, 1995, FEBS LETT, V377, P181, DOI 10.1016/0014-5793(95)01339-3; MACKENZIE B, 1994, J BIOL CHEM, V269, P22488; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PANAYOTOVAHEIERMANN M, 1994, J BIOL CHEM, V269, P21016; PARENT L, 1992, J MEMBRANE BIOL, V125, P49; STIRLING CE, 1972, J CLIN INVEST, V51, P438, DOI 10.1172/JCI106830; TURK E, 1994, J BIOL CHEM, V269, P15204; Turk E, 1996, J BIOL CHEM, V271, P1925, DOI 10.1074/jbc.271.4.1925; TURK E, 1991, NATURE, V350, P354, DOI 10.1038/350354a0; Wright Ernest M., 1994, P1751; ZAMPIGHI GA, 1995, J MEMBRANE BIOL, V148, P65	22	196	204	0	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1996	12	2					216	220		10.1038/ng0296-216	http://dx.doi.org/10.1038/ng0296-216			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TU079	8563765				2022-12-25	WOS:A1996TU07900027
J	Accili, D; Drago, J; Lee, EJ; Johnson, MD; Cool, MH; Salvatore, P; Asico, LD; Jose, PA; Taylor, SI; Westphal, H				Accili, D; Drago, J; Lee, EJ; Johnson, MD; Cool, MH; Salvatore, P; Asico, LD; Jose, PA; Taylor, SI; Westphal, H			Early neonatal death in mice homozygous for a null allele of the insulin receptor gene	NATURE GENETICS			English	Letter							GROWTH FACTOR-I; SUBSTRATE PHOSPHORYLATION; TYROSINE KINASE; BETA-SUBUNIT; AUTOPHOSPHORYLATION; MUTATION; LEPRECHAUNISM; EXPRESSION; BINDING; IGF-1		NICHHD, MAMMALIAN GENES & DEV LAB, BETHESDA, MD 20892 USA; GEORGETOWN UNIV, MED CTR, DEPT PEDIAT, WASHINGTON, DC 20007 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Georgetown University	Accili, D (corresponding author), NIDDKD, DIABET BRANCH, BETHESDA, MD 20892 USA.			SALVATORE, Paola/0000-0002-7294-9253				ACCILI D, 1995, DIABETES METAB REV, V11, P47, DOI 10.1002/dmr.5610110105; ACCILI D, 1991, P NATL ACAD SCI USA, V88, P4708, DOI 10.1073/pnas.88.11.4708; ACCILI D, 1991, J BIOL CHEM, V266, P434; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; CARO JF, 1988, J CLIN INVEST, V81, P976, DOI 10.1172/JCI113451; CHIN JE, 1991, J BIOL CHEM, V266, P15587; DRAGO J, 1994, P NATL ACAD SCI USA, V91, P12564, DOI 10.1073/pnas.91.26.12564; FLORESRIVEROS JR, 1989, J BIOL CHEM, V264, P21557; FRATTALI AL, 1992, J BIOL CHEM, V267, P19521; GAROFALO RS, 1989, MOL CELL BIOL, V9, P2806, DOI 10.1128/MCB.9.7.2806; HEDO JA, 1981, BIOCHEMISTRY-US, V20, P3385, DOI 10.1021/bi00515a013; HONE J, 1995, HUM MUTAT, V6, P17, DOI 10.1002/humu.1380060105; JOSPE N, 1993, 75TH ANN M END SOC, P453; KAHN CR, 1994, DIABETES, V43, P1066, DOI 10.2337/diab.43.8.1066; KAKU K, 1988, DIABETES, V37, P707, DOI 10.2337/diabetes.37.6.707; KROOK A, 1993, LANCET, V342, P277, DOI 10.1016/0140-6736(93)91820-C; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; MAEGAWA H, 1988, J BIOL CHEM, V263, P12629; MORGAN DO, 1986, BIOCHEMISTRY-US, V25, P5560, DOI 10.1021/bi00367a032; MOSES AC, 1991, INSULIN LIKE GROWTH, P245; SCHULTZ GA, 1992, REPROD FERT DEVELOP, V4, P361, DOI 10.1071/RD9920361; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; TAYLOR SI, 1992, DIABETES, V41, P1473, DOI 10.2337/diabetes.41.11.1473; TOBE K, 1995, J BIOL CHEM, V270, P5698, DOI 10.1074/jbc.270.11.5698; WADA J, 1993, P NATL ACAD SCI USA, V90, P10360, DOI 10.1073/pnas.90.21.10360; WERTHEIMER E, 1993, NAT GENET, V5, P71, DOI 10.1038/ng0993-71	29	421	436	0	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	1996	12	1					106	109		10.1038/ng0196-106	http://dx.doi.org/10.1038/ng0196-106			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TM555	8528241				2022-12-25	WOS:A1996TM55500027
J	DURHAMPIERRE, D; GARDNER, JM; NAKATSU, Y; KING, RA; FRANCKE, U; CHING, A; AQUARON, R; DELMARMOL, V; BRILLIANT, MH				DURHAMPIERRE, D; GARDNER, JM; NAKATSU, Y; KING, RA; FRANCKE, U; CHING, A; AQUARON, R; DELMARMOL, V; BRILLIANT, MH			AFRICAN ORIGIN OF AN INTRAGENIC DELETION OF THE HUMAN-P GENE IN TYROSINASE POSITIVE OCULOCUTANEOUS ALBINISM	NATURE GENETICS			English	Article							MOUSE; LOCUS	Oculocutaneous albinism (OCA) is a genetically heterogeneous hypopigmentation disorder. One of the two major autosomal recessive forms involves the tyrosinase gene (OCA1), while the other form (OCA2) has recently been associated with alterations of the P gene on chromosome 15. OCA2 is about twice as common as OCA1 in African and African-American populations. We now describe an interstitial deletion that removes a single exon of the P gene. Tn a large family from an inbred population of tri-racial origin, all individuals with OCA2 were found to be homozygous for this allele. Moreover, the same mutant P allele was detected in several unrelated African American individuals with OCA2, but not in Caucasians with OCA2. The detection of the same allele in two unrelated Africans with OCA2 indicates an African origin for this allele.	FOX CHASE CANC CTR,INST CANC RES,PHILADELPHIA,PA 19111; UNIV MINNESOTA,DEPT MED,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,DEPT PEDIAT,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,INST HUMAN GENET,MINNEAPOLIS,MN 55455; STANFORD UNIV,MED CTR,DEPT GENET,STANFORD,CA 94305; STANFORD UNIV,MED CTR,DEPT PEDIAT,STANFORD,CA 94305; STANFORD UNIV,MED CTR,HOWARD HUGHES MED INST,STANFORD,CA 94305; CHILDRENS HOSP,BIOL LAB,MARSEILLE,FRANCE; INST JULES BORDET,LOCE,B-1000 BRUSSELS,BELGIUM	Fox Chase Cancer Center; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut Jules Bordet			del marmol, veronique/AAZ-8117-2020	Nakatsu, Yoshimichi/0000-0001-7408-7071	NCI NIH HHS [CA06927] Funding Source: Medline; NIGMS NIH HHS [GM43840, GM22167] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM022167, R01GM043840] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AQUARON R, 1990, OPHTHALMIC PAEDIAT G, V4, P255; BRILLIANT MH, 1991, SCIENCE, V252, P566, DOI 10.1126/science.1673574; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; GARDNER JM, 1992, SCIENCE, V257, P1121, DOI 10.1126/science.257.5073.1121; HEARING VJ, 1973, J ULTRA MOL STRUCT R, V43, P88, DOI 10.1016/S0022-5320(73)90072-5; KROMBERG JGR, 1982, S AFR MED J, V61, P383; LEE ST, 1994, NEW ENGL J MED, V330, P529, DOI 10.1056/NEJM199402243300803; OKORO AN, 1975, BRIT J DERMATOL, V92, P485; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; RAMSAY M, 1992, AM J HUM GENET, V51, P879; RINCHIK EM, 1993, NATURE, V361, P72, DOI 10.1038/361072a0; RUSSELL ES, 1949, GENETICS, V34, P146; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Silvers WK., 1979, COAT COLORS MICE, DOI [10.1007/978-1-4612-6164-3, DOI 10.1007/978-1-4612-6164-3]; WITKOP CJ, 1972, AM J PHYS ANTHROPOL, V36, P397, DOI 10.1002/ajpa.1330360311; WITKOP CJ, 1973, J INVEST DERMATOL, V60, P443, DOI 10.1111/1523-1747.ep12702920; WITKOP CJ, 1970, AM J HUM GENET, V22, P55; [No title captured]	18	91	92	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1994	7	2					176	179		10.1038/ng0694-176	http://dx.doi.org/10.1038/ng0694-176			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NQ037	7920637				2022-12-25	WOS:A1994NQ03700018
J	GOYETTE, P; SUMNER, JS; MILOS, R; DUNCAN, AMV; ROSENBLATT, DS; MATTHEWS, RG; ROZEN, R				GOYETTE, P; SUMNER, JS; MILOS, R; DUNCAN, AMV; ROSENBLATT, DS; MATTHEWS, RG; ROZEN, R			HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE - ISOLATION OF CDNA, MAPPING AND MUTATION IDENTIFICATION	NATURE GENETICS			English	Article							NUCLEOTIDE-SEQUENCE; INSITU HYBRIDIZATION; ESCHERICHIA-COLI; RISK FACTOR; GENE; DISEASE; HYPERHOMOCYSTEINEMIA; HETEROZYGOSITY; PURIFICATION; LOCALIZATION	Methylenetetrahydrofolate reductase (MTHFR) catalyses the reduction of methylenetetrahydrofolate to methyltetrahydrofolate, a cofactor for homocysteine methylation to methionine. MTHFR deficiency, an autosomal recessive disorder, results in homocysteinemia. Using degenerate oligonucleotides based on porcine peptide sequence data, we isolated a 90-bp cDNA by PCR from pig liver RNA. This cDNA was used to isolate a human cDNA, the predicted amino acid sequence of which shows strong homology to porcine MTHFR and to bacterial metF genes. The human gene has been localized to chromosome 1 p36.3. Two mutations were identified in MTHFR-deficient patients: a missense mutation (Arg to Gln), in a residue conserved in bacterial enzymes, and a nonsense mutation (Arg to Ter).	MCGILL UNIV,MONTREAL CHILDRENS HOSP,RES INST,DEPT PEDIAT,MONTREAL H3H 1P3,PQ,CANADA; MCGILL UNIV,MONTREAL CHILDRENS HOSP,RES INST,DEPT HUMAN GENET,MONTREAL H3H 1P3,PQ,CANADA; MCGILL UNIV,MONTREAL CHILDRENS HOSP,RES INST,DEPT BIOL,MONTREAL H3H 1P3,PQ,CANADA; UNIV MICHIGAN,DIV BIOPHYS RES,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT BIOL CHEM,ANN ARBOR,MI 48109; QUEENS UNIV,KINGSTON K7L 2V7,ON,CANADA; KINGSTON GEN HOSP,KINGSTON K7L 2V7,ON,CANADA; MCGILL UNIV,DEPT MED,MONTREAL H3A 1A1,PQ,CANADA	McGill University; McGill University; McGill University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Queens University - Canada; Queens University - Canada; McGill University					NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024908] Funding Source: NIH RePORTER; NCI NIH HHS [P30CA46952] Funding Source: Medline; NCRR NIH HHS [MO1 RR00042] Funding Source: Medline; NIGMS NIH HHS [R37 GM24908] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOERS GHJ, 1985, NEW ENGL J MED, V313, P709, DOI 10.1056/NEJM198509193131201; BrõndÚn CI., 1991, INTRO PROTEIN STRUCT; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; DAUBNER SC, 1982, J BIOL CHEM, V257, P140; DOCKHORNDWORNICZAK B, 1991, NUCLEIC ACIDS RES, V19, P2500, DOI 10.1093/nar/19.9.2500; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HAWORTH JC, 1993, AM J MED GENET, V45, P572, DOI 10.1002/ajmg.1320450510; KANG SS, 1991, AM J HUM GENET, V48, P536; KANG SS, 1991, AM J HUM GENET, V48, P546; KATZEN HM, 1965, J BIOL CHEM, V240, P825; KUTZBACH C, 1971, BIOCHIM BIOPHYS ACTA, V250, P459, DOI 10.1016/0005-2744(71)90247-6; LIN CC, 1985, CYTOGENET CELL GENET, V39, P269, DOI 10.1159/000132156; MATTHEWS RG, 1984, J BIOL CHEM, V259, P1647; MATTHEWS RG, 1986, METHOD ENZYMOL, V122, P372; ORITA M, 1989, GENOMICS, V5, P8874; ROSENBLATT DS, 1992, BIOCHEM MED METAB B, V47, P221, DOI 10.1016/0885-4505(92)90029-X; ROSENBLATT DS, 1989, METABOLIC BASIS INHE, P2049; ROZEN R, 1985, NATURE, V313, P815, DOI 10.1038/313815a0; SAINTGIRONS I, 1983, NUCLEIC ACIDS RES, V11, P6723, DOI 10.1093/nar/11.19.6723; SOM S, 1990, J BIOL CHEM, V265, P4278; STAUFFER GV, 1988, MOL GEN GENET, V212, P246, DOI 10.1007/BF00334692; SUMNER J, 1986, J BIOL CHEM, V261, P7697; YANG E, 1984, MOL CELL BIOL, V4, P2161, DOI 10.1128/MCB.4.10.2161; ZHOU JM, 1990, BIOCHEM MED METAB B, V43, P234, DOI 10.1016/0885-4505(90)90029-Z	24	587	641	0	17	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1994	7	2					195	200		10.1038/ng0694-195	http://dx.doi.org/10.1038/ng0694-195			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NQ037	7920641				2022-12-25	WOS:A1994NQ03700022
J	GREENMAN, L				GREENMAN, L			GREENMAN,LEON, HOLOCAUST SURVIVOR - INFLUENCES	NEW STATESMAN & SOCIETY			English	Editorial Material														Noguchi, Masato/0000-0002-3092-0946				GRAY, THOSE I LOVED; LEVI P, THIS IS MAN; WIESEL E, NIGHT	3	242	677	0	25	STATESMAN & NATION PUBL CO LTD	LONDON	FOUNDATION HOUSE 38 KINGSLAND ROAD, LONDON, ENGLAND E2 8DQ	0954-2361			NEW STATESMAN SOC		MAY 13	1994	7	302					13	13		10.1038/ng0594-13	http://dx.doi.org/10.1038/ng0594-13			1	Social Issues; Social Sciences, Interdisciplinary	Social Science Citation Index (SSCI)	Social Issues; Social Sciences - Other Topics	NL157	8075633				2022-12-25	WOS:A1994NL15700010
J	WALTER, MA; SPILLETT, DJ; THOMAS, P; WEISSENBACH, J; GOODFELLOW, PN				WALTER, MA; SPILLETT, DJ; THOMAS, P; WEISSENBACH, J; GOODFELLOW, PN			A METHOD FOR CONSTRUCTING RADIATION HYBRID MAPS OF WHOLE GENOMES	NATURE GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; SOMATIC-CELL HYBRIDS; HUMAN X-CHROMOSOME; DNA-SEQUENCE; GENE; IRRADIATION; REGION; FUSION; LOCUS; LOCALIZATION	In radiation hybrid mapping, chromosomes in human-rodent hybrid cells are fragmented by X-rays and fragments rescued by fusion of the donor cell to a recipient rodent cell. The co-retention frequencies of markers in 100-200 hybrids are used to map individual chromosomes, but mapping the whole genome in this way is impractical. We have reverted to the original protocols of Goss and Harris and have produced a panel of 44 hybrids using irradiated human fibroblasts as donors. This panel has been used to make a map of human chromosome 14 containing 40 ordered markers. The map integrates previously published maps and localizes nine new markers. We suggest that the construction of a high resolution map of the whole human genome is feasible with a single panel of 100-200 hybrids.	UNIV CAMBRIDGE,DEPT GENET,CAMBRIDGE CB2 3EH,ENGLAND; SOC LAB GENETHON,F-91000 EVRY,FRANCE	University of Cambridge					Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARRETT JH, 1992, GENOMICS, V13, P95, DOI 10.1016/0888-7543(92)90207-9; BENHAM F, 1989, GENOMICS, V4, P509, DOI 10.1016/0888-7543(89)90274-7; BOEHNKE M, 1991, AM J HUM GENET, V49, P1174; BYTH BC, 1993, HUM MOL GENET, V2, P1752, DOI 10.1093/hmg/2.10.1752-a; CECCHERINI I, 1992, P NATL ACAD SCI USA, V89, P104, DOI 10.1073/pnas.89.1.104; COTTER FE, 1990, GENOMICS, V7, P257, DOI 10.1016/0888-7543(90)90548-9; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; COX DW, 1994, CYTOGENET CELL GENET, V66, P2; GOODFELLOW PJ, 1990, SOMAT CELL MOLEC GEN, V16, P163, DOI 10.1007/BF01233046; GORSKI JL, 1992, GENOMICS, V14, P657, DOI 10.1016/S0888-7543(05)80165-X; GOSS SJ, 1975, NATURE, V255, P680, DOI 10.1038/255680a0; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HUGSON TJ, 1992, GENOMICS, V13, P622; JORDAN SA, 1991, NUCLEIC ACIDS RES, V19, P1171, DOI 10.1093/nar/19.5.1171; LAWRENCE S, 1991, P NATL ACAD SCI USA, V88, P7477, DOI 10.1073/pnas.88.17.7477; LUTY JA, 1991, NUCLEIC ACIDS RES, V19, P4308, DOI 10.1093/nar/19.15.4308; ORITA M, 1990, GENOMICS, V8, P271, DOI 10.1016/0888-7543(90)90282-Y; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P4019, DOI 10.1093/nar/19.14.4019-a; POLYMEROPOULOS MH, 1993, HUM MOL GENET, V2, P490, DOI 10.1093/hmg/2.4.490; POWELL SJ, 1993, GENOMICS, V15, P435, DOI 10.1006/geno.1993.1084; SEFTON L, 1992, MAMM GENOME, V2, P21, DOI 10.1007/BF00570437; SHARMA V, 1991, NUCLEIC ACIDS RES, V19, P1722, DOI 10.1093/nar/19.7.1722; SIDEN TS, 1992, SOMAT CELL MOLEC GEN, V18, P33, DOI 10.1007/BF01233447; WALTER MA, 1993, TRENDS GENET, V9, P352, DOI 10.1016/0168-9525(93)90040-O; WANG ZY, 1992, GENOMICS, V13, P532, DOI 10.1016/0888-7543(92)90121-8; WARRINGTON JA, 1992, GENOMICS, V13, P803, DOI 10.1016/0888-7543(92)90156-M; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4638, DOI 10.1093/nar/18.15.4638-a; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WESTERVELD A, 1971, NATURE-NEW BIOL, V234, P20, DOI 10.1038/newbio234020a0; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; WILLARD HF, 1985, HUM GENET, V71, P138; YAMADA Y, 1993, GENOMICS, V15, P449, DOI 10.1006/geno.1993.1088; ZHAO B, 1992, NUCLEIC ACIDS RES, V20, P4097, DOI 10.1093/nar/20.15.4097	33	352	370	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1994	7	1					22	28		10.1038/ng0594-22	http://dx.doi.org/10.1038/ng0594-22			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NJ842	8075634				2022-12-25	WOS:A1994NJ84200008
J	TERRETT, JA; NEWBURYECOB, R; CROSS, GS; FENTON, I; RAEBURN, JA; YOUNG, ID; BROOK, JD				TERRETT, JA; NEWBURYECOB, R; CROSS, GS; FENTON, I; RAEBURN, JA; YOUNG, ID; BROOK, JD			HOLT-GRAM SYNDROME IS A GENETICALLY HETEROGENEOUS DISEASE WITH ONE LOCUS MAPPING TO HUMAN-CHROMOSOME 12Q	NATURE GENETICS			English	Article							ORAM SYNDROME; LINKAGE	Holt-Gram syndrome (HOS) is an autosomal dominant condition affecting the heart and upper limbs. We have sought to identify the location of this gene using microsatellite DNA markers in a linkage study. Of seven families analysed, five show linkage between HOS and markers on chromosome 12q. But the two remaining families, phenotypically indistinguishable from the others, do not show this linkage. Analysis with the computer program HOMOG indicates that HOS is a heterogeneous disease. Our analysis places one HOS locus in a 21cM interval in the distal region of chromosome 12q. The localization of a gene for HOS, reported here, represents an important step towards a better understanding of limb and cardiac development.	UNIV WALES COLL CARDIFF,COLL MED,INST MED GENET,CARDIFF CF4 4XN,WALES	Cardiff University	TERRETT, JA (corresponding author), CITY HOSP NOTTINGHAM,CTR MED GENET,HUCKNALL RD,NOTTINGHAM NG5 1PB,ENGLAND.			Brook, John David/0000-0002-5946-6740				CRAIG IW, 1991, CYTOGENET CELL GENET, V58, P555, DOI 10.1159/000133172; HAHN GV, 1992, GENOMICS, V14, P759, DOI 10.1016/S0888-7543(05)80181-8; HAMILTON WJ, 1972, HUMAN EMBRYOLOGY PRE, P182; HOLT M, 1960, BRIT HEART J, V22, P236; HURST JA, 1991, J MED GENET, V28, P406, DOI 10.1136/jmg.28.6.406; JONES CM, 1991, DEVELOPMENT, V111, P531; LATHROP GM, 1985, AM J HUM GENET, V37, P482; NEWBURYECOB R, 1993, CARDIOLOGY YOUNG, V3, P84; OCKEY CH, 1967, ARCH DIS CHILD, V42, P428, DOI 10.1136/adc.42.224.428; OTT J, 1985, ANAL HUMAN GENETIC L, P112; RYBAK M, 1971, AM J DIS CHILD, V121, P490, DOI 10.1001/archpedi.1971.02100170072008; SMITH AT, 1979, J PEDIATR-US, V95, P538, DOI 10.1016/S0022-3476(79)80758-1; TURLEAU C, 1984, ANN GENET-PARIS, V27, P237; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; YANG S, 1990, PEDIATR RES, V27, pA137	15	65	70	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1994	6	4					401	404		10.1038/ng0494-401	http://dx.doi.org/10.1038/ng0494-401			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ND870	8054982				2022-12-25	WOS:A1994ND87000021
J	MCDONALD, MT; PAPENBERG, KA; GHOSH, S; GLATFELTER, AA; BIESECKER, BB; HELMBOLD, EA; MARKEL, DS; ZOLOTOR, A; MCKINNON, WC; VANDERSTOEP, JL; JACKSON, CE; IANNUZZI, M; COLLINS, FS; BOEHNKE, M; PORTEOUS, ME; GUTTMACHER, AE; MARCHUK, DA				MCDONALD, MT; PAPENBERG, KA; GHOSH, S; GLATFELTER, AA; BIESECKER, BB; HELMBOLD, EA; MARKEL, DS; ZOLOTOR, A; MCKINNON, WC; VANDERSTOEP, JL; JACKSON, CE; IANNUZZI, M; COLLINS, FS; BOEHNKE, M; PORTEOUS, ME; GUTTMACHER, AE; MARCHUK, DA			A DISEASE LOCUS FOR HEREDITARY HEMORRHAGIC TELANGIECTASIA MAPS TO CHROMOSOME 9Q33-34	NATURE GENETICS			English	Article							HEMORRHAGIC TELANGIECTASIA; IDENTIFICATION; POLYMORPHISMS; EXPRESSION; LINKAGE; 9Q32-34; FAMILY; CHAIN; DNA	Hereditary haemorrhagic telangiectasia (HHT), or Osler-Weber-Rendu disease, is an autosomal dominant vascular dysplasia of unknown pathogenesis reading to 'widespread' dermal, mucosal and visceral telangiectases and recurrent haemorrhage. We have mapped the HHT gene, by linkage analysis, to markers on 9q33-34 in two large multi-generation families. Haplotype analysis and mapping of recombination breakpoints gives a 4 cM interval between D9S61 and D9S63 as the most likely location of the gene. The closest marker, D9S65, is estimated to be within 1 cM of the gene and shows a combined lod score of 11.41. Two potential candidate genes, COL5A1 and ZNF79, are also located within 9q33-34. These results provide a starting point for the eventual cloning of the HHT gene.	UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT PEDIAT & COMMUNICABLE DIS,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT BIOSTAT,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT RADIAT ONCOL,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT INTERNAL MED,ANN ARBOR,MI 48109; UNIV MICHIGAN,CTR HUMAN GENOME,ANN ARBOR,MI 48109; UNIV VERMONT,COLL MED,DEPT PEDIAT,BURLINGTON,VT 05405; HENRY FORD HOSP,DIV CLIN & MOLEC GENET,DETROIT,MI 48202; HENRY FORD HOSP,DIV PULM MED,DETROIT,MI 48202; NATL CTR HUMAN GENOME RES,BETHESDA,MD 20892; UNIV NEWCASTLE UPON TYNE,DEPT HUMAN GENET,NEWCASTLE TYNE NE2 4AA,TYNE & WEAR,ENGLAND; WESTERN GEN HOSP,CLIN GENET SERV,EDINBURGH EH4 2XY,MIDLOTHIAN,SCOTLAND; DUKE UNIV,MED CTR,DEPT GENET,DURHAM,NC 27710	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Vermont; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Newcastle University - UK; University of Edinburgh; Duke University				Markel, Dorene/0000-0002-3382-6779; Marchuk, Douglas/0000-0002-3110-6671; Biesecker, Barbara/0000-0001-9665-8963	NHLBI NIH HHS [HL49171] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049171] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AHR DJ, 1977, AM J MED, V62, P452, DOI 10.1016/0002-9343(77)90846-4; BIRD RM, 1957, NEW ENGL J MED, V257, P105, DOI 10.1056/NEJM195707182570303; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; BRAVERMAN IM, 1990, J INVEST DERMATOL, V95, P422, DOI 10.1111/1523-1747.ep12555569; CARDI G, 1992, HUM GENET, V90, P174; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; GREENSPAN DS, 1991, J BIOL CHEM, V266, P24727; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HASHIMOTO K, 1972, ORAL SURG ORAL MED O, V34, P751, DOI 10.1016/0030-4220(72)90293-9; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; HUEBNER K, 1993, HUM GENET, V91, P217, DOI 10.1007/BF00218259; IANNUZZI MC, 1991, AM J HUM GENET, V48, P757; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; KWIATKOWSKI DJ, 1991, AM J HUM GENET, V48, P121; KWIATKOWSKI DJ, 1991, NUCLEIC ACIDS RES, V19, P967, DOI 10.1093/nar/19.4.967; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEIBOWITZ D, 1985, BLOOD, V65, P526; MAHMIAS J, 1992, HUM MOL GENET, V1, P286; McKusick V.A., 1992, MENDELIAN INHERITANC; MULLER JY, 1978, NOUV PRESSE MED, V7, P1723; PLAUCHU H, 1989, AM J MED GENET, V32, P291, DOI 10.1002/ajmg.1320320302; PLOUGHMAN LM, 1989, AM J HUM GENET, V44, P543; PORTEOUS MEM, 1992, J MED GENET, V29, P527, DOI 10.1136/jmg.29.8.527; ROMAN G, 1978, ANN NEUROL, V4, P130, DOI 10.1002/ana.410040207; SENSI A, 1986, TISSUE ANTIGENS, V28, P275; Snyder LH, 1944, J LAB CLIN MED, V29, P1211; STEEL D, 1988, AM J CLIN PATHOL, V90, P274, DOI 10.1093/ajcp/90.3.274; VASE P, 1985, ACTA MED SCAND, V218, P105; WEBER JL, 1989, AM J HUM GENET, V44, P388	31	134	143	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1994	6	2					197	204		10.1038/ng0294-197	http://dx.doi.org/10.1038/ng0294-197			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU763	8162075				2022-12-25	WOS:A1994MU76300017
J	ORR, HT; CHUNG, MY; BANFI, S; KWIATKOWSKI, TJ; SERVADIO, A; BEAUDET, AL; MCCALL, AE; DUVICK, LA; RANUM, LPW; ZOGHBI, HY				ORR, HT; CHUNG, MY; BANFI, S; KWIATKOWSKI, TJ; SERVADIO, A; BEAUDET, AL; MCCALL, AE; DUVICK, LA; RANUM, LPW; ZOGHBI, HY			EXPANSION OF AN UNSTABLE TRINUCLEOTIDE CAG REPEAT IN SPINOCEREBELLAR ATAXIA TYPE-1	NATURE GENETICS			English	Article							ANDROGEN RECEPTOR GENE; HEREDITARY ATAXIA; LINKAGE; LOCUS; HLA; PROTEIN; ONSET; LOCALIZATION; DROSOPHILA; SEQUENCE	Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant disorder characterized by neurodegeneration of the cerebellum, spinal cord and brainstem. A 1.2-Megabase stretch of DNA from the short arm of chromosome 6 containing the SCA1 locus was isolated in a yeast artificial chromosome contig and subcloned into cosmids. A highly polymorphic CAG repeat was identified in this region and was found to be unstable and expanded in individuals with SCA1. There is a direct correlation between the size of the (CAG)n repeat expansion and the age-of-onset of SCA1, with larger alleles occurring in juvenile cases. We also show that the repeat is present in a 10 kilobase mRNA transcript. SCA1 is therefore the fifth genetic disorder to display a mutational mechanism involving an unstable trinucleotide repeat.	UNIV MINNESOTA,INST DEMOG & POPULAT GENET,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,DEPT LAB MED & PATHOL,MINNEAPOLIS,MN 55455; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030; BAYLOR COLL MED,HOWARD HUGHES MED INST,HOUSTON,TX 77030	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute			Banfi, Sandro/K-3963-2018	Banfi, Sandro/0000-0002-6541-8833; Chung, Ming-yi/0000-0003-2198-6860; Zoghbi, Huda/0000-0002-0700-3349; Orr, Harry/0000-0001-6118-741X				ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; BELLEN HJ, 1992, GENE DEV, V6, P2125, DOI 10.1101/gad.6.11.2125; BENSON M, 1988, EMBO J, V7, P3907, DOI 10.1002/j.1460-2075.1988.tb03277.x; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BROWNSTEIN BH, 1989, SCIENCE, V244, P1348, DOI 10.1126/science.2544027; BRUNNER HG, 1993, NEW ENGL J MED, V328, P476, DOI 10.1056/NEJM199302183280705; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; COUREY AJ, 1989, CELL, V59, P827, DOI 10.1016/0092-8674(89)90606-5; COUTINHO P, 1978, NEUROLOGY, V28, P706; CURRIER RD, 1972, NEUROLOGY, V22, P1040, DOI 10.1212/WNL.22.9.1040; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; Greenfield JG., 1954, SPINO CEREBELLAR DEG; HAINES JL, 1984, NEUROLOGY, V34, P1542, DOI 10.1212/WNL.34.12.1542; HARDING AE, 1981, J MED GENET, V18, P436, DOI 10.1136/jmg.18.6.436; HARLEY HG, 1991, AM J HUM GENET, V49, P68; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; HARLEY HG, 1992, LANCET, V339, P1125, DOI 10.1016/0140-6736(92)90729-M; JACKSON JF, 1977, NEW ENGL J MED, V296, P1138, DOI 10.1056/NEJM197705192962003; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; KWIATKOWSKI TJ, IN PRESS AM J HUM GE; LASPADA AR, 1992, NAT GENET, V2, P301, DOI 10.1038/ng1292-301; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; NINO HE, 1980, NEUROLOGY, V30, P12, DOI 10.1212/WNL.30.1.12; OROZCO G, 1989, J NEUROL SCI, V93, P27; QUIGLEY CA, 1992, J CLIN ENDOCR METAB, V74, P927, DOI 10.1210/jc.74.4.927; RANUM LPW, 1991, AM J HUM GENET, V49, P31; RICH SS, 1987, AM J HUM GENET, V41, P524; RICHARDS RI, 1992, NAT GENET, V1, P257, DOI 10.1038/ng0792-257; Sambrook J, 1989, MOL CLONING LABORATO; SCHUT JW, 1954, ARCH NEUROL PSYCHIAT, V63, P535; TAKIYAMA Y, 1993, NAT GENET, V4, P300, DOI 10.1038/ng0793-300; TRIFIRO M, 1991, MOL CELL ENDOCRINOL, V75, P37, DOI 10.1016/0303-7207(91)90243-L; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; YAKURA H, 1974, NEW ENGL J MED, V291, P154; ZOGHBI HY, 1988, AM J HUM GENET, V42, P877; ZOGHBI HY, 1988, ANN NEUROL, V23, P580, DOI 10.1002/ana.410230609; 1993, CELL, V72, P971	43	1476	1520	1	33	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1993	4	3					221	226		10.1038/ng0793-221	http://dx.doi.org/10.1038/ng0793-221			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ842	8358429				2022-12-25	WOS:A1993LJ84200007
J	Chresta, CM; Hickman, JA				Chresta, CM; Hickman, JA			Oddball p53 in testicular tumors	NATURE MEDICINE			English	Editorial Material											Chresta, CM (corresponding author), UNIV MANCHESTER,SCH BIOL SCI,MANCHESTER M13 9PT,LANCS,ENGLAND.							BARAK Y, 1994, GENE DEV, V8, P1739, DOI 10.1101/gad.8.15.1739; BARTKOVA J, 1991, INT J CANCER, V49, P196, DOI 10.1002/ijc.2910490209; CANMAN CE, 1995, GENE DEV, V9, P600, DOI 10.1101/gad.9.5.600; Chresta CM, 1996, CANCER RES, V56, P1834; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; CORDONCARDO C, 1994, CANCER RES, V54, P794; FRY AM, 1991, CANCER RES, V51, P6592; Hall SR, 1996, NUCLEIC ACIDS RES, V24, P1119, DOI 10.1093/nar/24.6.1119; Hawkins DS, 1996, CANCER RES, V56, P892; Hecker D, 1996, ONCOGENE, V12, P953; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; HUPP TR, 1995, CELL, V83, P237, DOI 10.1016/0092-8674(95)90165-5; Lutzker SG, 1996, NAT MED, V2, P804, DOI 10.1038/nm0796-804; MONTES DOL, 1995, NATURE, V378, P203; PECKHAM MJ, 1985, BRIT J CANCER, V52, P7, DOI 10.1038/bjc.1985.141; RIOU G, 1995, MOL CARCINOGEN, V12, P124, DOI 10.1002/mc.2940120303	16	18	23	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUL	1996	2	7					745	746		10.1038/nm0796-745	http://dx.doi.org/10.1038/nm0796-745			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UU680	8673915				2022-12-25	WOS:A1996UU68000025
J	Rothwell, NJ; Luheshi, GN				Rothwell, NJ; Luheshi, GN			Brain TNF damage limitation or damaged reputation?	NATURE MEDICINE			English	Editorial Material											Rothwell, NJ (corresponding author), UNIV MANCHESTER,SCH BIOL SCI,1124 STOPFORD BLDG,MANCHESTER M13 9PT,LANCS,ENGLAND.							Bruce AJ, 1996, NAT MED, V2, P788, DOI 10.1038/nm0796-788; Chao CC, 1995, BRAIN BEHAV IMMUN, V9, P355, DOI 10.1006/brbi.1995.1033; CHAO CC, 1995, J LEUKOCYTE BIOL, V58, P65, DOI 10.1002/jlb.58.1.65; CHENG B, 1994, NEURON, V12, P139, DOI 10.1016/0896-6273(94)90159-7; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Mitcham JL, 1996, J BIOL CHEM, V271, P5777, DOI 10.1074/jbc.271.10.5777; ROTHWELL NJ, 1995, INT J DEV NEUROSCI, V13, P179, DOI 10.1016/0736-5748(95)00018-C; ROTHWELL NJ, 1995, TRENDS NEUROSCI, V18, P130, DOI 10.1016/0166-2236(95)93890-A; VANDENABEELE P, 1995, TRENDS CELL BIOL, V5, P392, DOI 10.1016/S0962-8924(00)89088-1; WONG GHW, 1995, BBA-MOL BASIS DIS, V1271, P205, DOI 10.1016/0925-4439(95)00029-4	10	37	38	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUL	1996	2	7					746	747		10.1038/nm0796-746	http://dx.doi.org/10.1038/nm0796-746			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UU680	8673916				2022-12-25	WOS:A1996UU68000026
J	Dimitrov, DS				Dimitrov, DS			Fusin - A place for HIV-1 and T4 cells to meet	NATURE MEDICINE			English	Editorial Material							AIDS				Dimitrov, DS (corresponding author), NCI,NIH,BETHESDA,MD 20892, USA.							BLUMENTHAL R, 1996, HDB PHYSL, V1, pCH14; BURKLY L, 1995, J VIROL, V69, P4267, DOI 10.1128/JVI.69.7.4267-4273.1995; CAPON DJ, 1989, NATURE, V337, P525, DOI 10.1038/337525a0; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; REIMANN KA, 1993, AIDS RES HUM RETROV, V9, P199, DOI 10.1089/aid.1993.9.199; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770	8	29	42	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUN	1996	2	6					640	641		10.1038/nm0696-640	http://dx.doi.org/10.1038/nm0696-640			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UN691	8640552	Bronze			2022-12-25	WOS:A1996UN69100029
J	Melo, JA; Shendure, J; Pociask, K; Silver, LM				Melo, JA; Shendure, J; Pociask, K; Silver, LM			Identification of sex specific quantitative trait loci controlling alcohol preference in C57BL/6 mice	NATURE GENETICS			English	Article							MOUSE; POLYMORPHISMS; STRAINS; MEN	Mice from various inbred strains consume alcoholic beverages at highly reproducible and strain-specific levels. While most mice consume alcohol in moderate amounts, C57BL/6J animals exhibit sustained oral ingestion of high levels of alcohol in the presence of competing water and food. We now report a genetic investigation of this phenotype as one potential model for alcoholism. An intercross-backcross breeding protocol was used to identify two recessive alcohol preference quantitative trait loci (QTLs) that are both sex-restricted in expression. A comparison of our results with those of an earlier morphine preference study argues against the hypothesis of a single unified phenotype defined by a preference for all euphoria-producing drugs.	PRINCETON UNIV,DEPT MOLEC BIOL,PRINCETON,NJ 08544	Princeton University			Shendure, Jay/AAU-3684-2021; Melo, Justine/AAH-4339-2021	Melo, Justine/0000-0002-7476-0470; Shendure, Jay/0000-0002-1516-1865				ALEXANDER RC, 1993, PSYCHIAT GENET, V3, P33; Begleiter H, 1995, GENETICS ALCOHOLISM; BERRETTINI WH, 1994, NAT GENET, V7, P54, DOI 10.1038/ng0594-54; BOHMAN M, 1981, ARCH GEN PSYCHIAT, V38, P965; BOND SL, 1991, ALCOHOL CLIN EXP RES, V15, P304, DOI 10.1111/j.1530-0277.1991.tb01874.x; CATTANACH BM, 1985, NATURE, V315, P469; CRABBE JC, 1989, ALCOHOL CLIN EXP RES, V13, P120, DOI 10.1111/j.1530-0277.1989.tb00296.x; CRABBE JC, 1994, SCIENCE, V264, P1715, DOI 10.1126/science.8209252; DESANCTIS GT, 1995, NAT GENET, V11, P150, DOI 10.1038/ng1095-150; DEVOR EJ, 1989, ANNU REV GENET, V23, P19, DOI 10.1146/annurev.ge.23.120189.000315; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; GREGOR P, 1993, MAMM GENOME, V4, P283, DOI 10.1007/BF00417438; HARADA S, 1982, LANCET, V2, P827, DOI 10.1016/s0140-6736(82)92722-2; Hesselbrock M. N., 1995, GENETICS ALCOHOLISM, P40; Hesselbrock V. M., 1995, GENETICS ALCOHOLISM, P17; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; JACOBY RF, 1994, GENOMICS, V22, P381, DOI 10.1006/geno.1994.1399; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LEE GH, 1995, GENETICS, V139, P387; LUMENG L, 1995, GENETICS ALCOHOLISM, P165; MARTINEZ O, 1992, THEOR APPL GENET, V85, P480, DOI 10.1007/BF00222330; MCCLEARN GE, 1959, Q J STUD ALCOHOL, V20, P691; MCCLEARN GE, 1961, J COMP PHYSIOL PSYCH, V54, P116, DOI 10.1037/h0042530; MCMAHON FJ, 1995, AM J HUM GENET, V56, P1277; MOCK BA, 1993, P NATL ACAD SCI USA, V90, P9499, DOI 10.1073/pnas.90.20.9499; NAGASE H, 1995, NAT GENET, V10, P424, DOI 10.1038/ng0895-424; PHILLIPS TJ, 1994, ALCOHOL CLIN EXP RES, V18, P931, DOI 10.1111/j.1530-0277.1994.tb00062.x; PLOMIN R, 1991, BEHAV GENET, V21, P99, DOI 10.1007/BF01066330; PLOMIN R, 1993, BEHAV GENET, V23, P197, DOI 10.1007/BF01067425; RAUSCH JL, 1991, NEUROPSYCHOPHARMACOL, V4, P83; RODGERS DA, 1962, Q J STUD ALCOHOL, V23, P26; RODRIGUEZ LA, 1994, ALCOHOL CLIN EXP RES, V18, P1416, DOI 10.1111/j.1530-0277.1994.tb01444.x; RODRIGUEZ LA, 1995, ALCOHOL CLIN EXP RES, V19, P367, DOI 10.1111/j.1530-0277.1995.tb01517.x; SCHUCKIT MA, 1994, J STUD ALCOHOL, V55, P5, DOI 10.15288/jsa.1994.55.5; Silver L.M., 1995, MOUSE GENETICS CONCE; SOLLER M, 1976, THEOR APPL GENET, V47, P35, DOI 10.1007/BF00277402; THOMASSON HR, 1993, BEHAV GENET, V23, P131, DOI 10.1007/BF01067417; THOMASSON HR, 1991, AM J HUM GENET, V48, P677; XU SH, 1995, GENETICS, V141, P1657	41	164	167	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1996	13	2					147	153		10.1038/ng0696-147	http://dx.doi.org/10.1038/ng0696-147			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UN395	8640219				2022-12-25	WOS:A1996UN39500012
J	Isaka, Y; Brees, DK; Ikegaya, K; Kaneda, Y; Imai, E; Noble, NA; Border, WA				Isaka, Y; Brees, DK; Ikegaya, K; Kaneda, Y; Imai, E; Noble, NA; Border, WA			Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney	NATURE MEDICINE			English	Article							GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX; PROTEOGLYCAN; LIVER; PROTEIN; DNA	There are currently no effective therapies for progressive fibrotic diseases. Recent evidence has implicated overproduction of transforming growth factor-beta 1 (TGF-beta 1) as a major cause of tissue fibrosis. Furthermore, this evidence implies that inhibitors of TGF-beta 1 may be clinically useful as antifibrotic agents. The proteoglycan decorin is a known inhibitor of TGF-beta 1. In a rat model of glomerulonephritis we have shown that fibrosis is mediated by TGF-beta 1. We report here that transfer of decorin cDNA into rat skeletal muscle increases the amount of decorin messenger RNA and protein present in skeletal muscle and decorin protein present in kidney, where it has a marked therapeutic effect on fibrosis induced by glomerulonephritis. Transfected glomerulonephritic rats showed a significant reduction in levels of glomerular TGF-beta 1 mRNA and TGF-beta 1 protein, extracellular matrix accumulation and proteinuria. These results demonstrate the potential of gene therapy as a novel treatment for fibrotic diseases caused by TGF-beta 1.	UNIV UTAH,SCH MED,SALT LAKE CITY,UT 84132; OSAKA UNIV,INST MOLEC & CELLULAR BIOL,SUITA,OSAKA 565,JAPAN; OSAKA UNIV,SCH MED,DEPT MED 1,SUITA,OSAKA 565,JAPAN	Utah System of Higher Education; University of Utah; Osaka University; Osaka University					NIDDK NIH HHS [DK 49374, DK 49342, DK 43609] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049342, R37DK043609, R01DK049374, R01DK043609] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASUNDI VK, 1992, EUR J CELL BIOL, V59, P314; BLAU HM, 1995, NEW ENGL J MED, V333, P1294; BORDER WA, 1990, NATURE, V346, P371, DOI 10.1038/346371a0; BORDER WA, 1995, NAT MED, V1, P1000, DOI 10.1038/nm1095-1000; BORDER WA, 1992, NATURE, V360, P361, DOI 10.1038/360361a0; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; BORDER WA, 1995, J CLIN INVEST, V6, P665; DANKO I, 1994, VACCINE, V12, P1499, DOI 10.1016/0264-410X(94)90072-8; DERYNCK R, 1986, J BIOL CHEM, V261, P4377; DREHER KL, 1990, EUR J CELL BIOL, V53, P296; FELGNER PL, 1993, LAB INVEST, V68, P1; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; ISAKA Y, 1993, J CLIN INVEST, V92, P2597, DOI 10.1172/JCI116874; KAHARI VM, 1991, J BIOL CHEM, V266, P10608; KANEDA Y, 1989, SCIENCE, V243, P375, DOI 10.1126/science.2911748; KANEDA Y, 1989, J BIOL CHEM, V264, P12126; KATO K, 1991, J BIOL CHEM, V266, P22071; MARSHALL E, 1995, SCIENCE, V269, P1050, DOI 10.1126/science.7652552; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Noble Nancy A., 1992, Progress in Growth Factor Research, V4, P369, DOI 10.1016/0955-2235(92)90017-C; OKUDA S, 1990, J CLIN INVEST, V86, P453, DOI 10.1172/JCI114731; RAZ E, 1993, P NATL ACAD SCI USA, V90, P4523, DOI 10.1073/pnas.90.10.4523; RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L; SPORN MB, 1992, J CELL BIOL, V119, P1017, DOI 10.1083/jcb.119.5.1017; TAKESHITA S, 1994, J CLIN INVEST, V93, P652, DOI 10.1172/JCI117017; Touchette N, 1996, NAT MED, V2, P7, DOI 10.1038/nm0196-7; TRIPATHY SK, 1994, P NATL ACAD SCI USA, V91, P11557, DOI 10.1073/pnas.91.24.11557; VANDENBORN J, 1994, J HISTOCHEM CYTOCHEM, V42, P89, DOI 10.1177/42.1.8263327; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; YAMAMOTO T, 1994, KIDNEY INT, V45, P916, DOI 10.1038/ki.1994.122; Yamamoto T, 1996, KIDNEY INT, V49, P461, DOI 10.1038/ki.1996.65	32	436	457	0	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	APR	1996	2	4					418	423		10.1038/nm0496-418	http://dx.doi.org/10.1038/nm0496-418			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UD314	8597951				2022-12-25	WOS:A1996UD31400043
J	McQueen, HA; Fantes, J; Cross, SH; Clark, VH; Archibald, AL; Bird, AP				McQueen, HA; Fantes, J; Cross, SH; Clark, VH; Archibald, AL; Bird, AP			CpG islands of chicken are concentrated on microchromosomes	NATURE GENETICS			English	Letter							GENE; DNA; ASSIGNMENT; DOMAINS		WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND; ROSLIN INST,EDINBURGH EH25 9PS,MIDLOTHIAN,SCOTLAND	University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute	McQueen, HA (corresponding author), UNIV EDINBURGH,INST CELL & MOLEC BIOL,DARWIN BLDG,MAYFIELD RD,EDINBURGH EH9 3JR,MIDLOTHIAN,SCOTLAND.		McQueen, Heather/AAS-3294-2020	McQueen, Heather/0000-0002-4228-6081; Archibald, Alan/0000-0001-9213-1830; Bird, Adrian/0000-0002-8600-0372; Cross, Sally/0000-0001-6518-6449				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; BLOOM SE, 1985, J HERED, V76, P146; BLOOM SE, 1993, MANIPULATION OF THE AVIAN GENOME, P39; BRENNER S, 1993, NATURE, V366, P265, DOI 10.1038/366265a0; BUMSTEAD N, 1994, ANIM GENET, V25, P337, DOI 10.1111/j.1365-2052.1994.tb00368.x; BURT DW, 1995, TRENDS GENET, V11, P190, DOI 10.1016/S0168-9525(00)89042-3; COOPER DN, 1983, NUCLEIC ACIDS RES, V11, P647, DOI 10.1093/nar/11.3.647; CRAIG JM, 1994, NAT GENET, V7, P376, DOI 10.1038/ng0794-376; CROSS SH, 1994, NAT GENET, V6, P236, DOI 10.1038/ng0394-236; DOMINGUEZSTEGLICH M, 1992, CYTOGENET CELL GENET, V61, P155, DOI 10.1159/000133396; DOMINGUEZSTEGLICH M, 1992, GENOMICS, V12, P829, DOI 10.1016/0888-7543(92)90318-M; DOMINGUEZSTEGLICH M, 1990, GENOMICS, V8, P536, DOI 10.1016/0888-7543(90)90041-R; DOMINGUEZSTEGLICH M, 1993, J EXP ZOOL, V265, P295, DOI 10.1002/jez.1402650310; HUGHES AL, 1995, NATURE, V377, P391, DOI 10.1038/377391a0; HUGHES SH, 1979, P NATL ACAD SCI USA, V76, P1348, DOI 10.1073/pnas.76.3.1348; MATSUO K, 1993, SOMAT CELL MOLEC GEN, V19, P543, DOI 10.1007/BF01233381; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; SCHMID M, 1989, CYTOGENET CELL GENET, V52, P139, DOI 10.1159/000132864; WANSINK DG, 1993, J CELL BIOL, V122, P283, DOI 10.1083/jcb.122.2.283; WEINTRAUB H, 1981, CELL, V24, P333, DOI 10.1016/0092-8674(81)90323-8	21	101	106	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1996	12	3					321	324		10.1038/ng0396-321	http://dx.doi.org/10.1038/ng0396-321			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TY183	8589727				2022-12-25	WOS:A1996TY18300025
J	Renne, R; Zhong, WD; Herndier, B; McGrath, M; Abbey, N; Kedes, D; Ganem, D				Renne, R; Zhong, WD; Herndier, B; McGrath, M; Abbey, N; Kedes, D; Ganem, D			Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture	NATURE MEDICINE			English	Article							EPSTEIN-BARR VIRUS; INFECTION; GENOME; LINES; AIDS	Kaposi's sarcoma (KS) is the leading neoplasm of AIDS patients, and HIV infection is known to be a major risk factor for its development(1,2). However, KS can occur in the absence of HIV infection(3-5) and the risk of KS development varies widely even among HIV-infected patients, with homosexual men with AIDS being 20 times more likely to develop KS than AIDS-afflicted children or hemophiliacs(6). These and other data strongly suggest that a sexually transmitted agent or co-factor may be involved in KS pathogenesis(7). Recently, DNA sequences corresponding to the genome of a novel member of the herpesvirus family have been identified within AIDS-KS biopsies(8), and several reports indicate that these sequences are also present in all forms of HIV-negative KS (ref. 9-13). These and other findings(14) suggest this new agent, referred to as KS-associated herpesvirus (KSHV) or human herpesvirus 8 (HHV8), as a candidate for the putative etiologic cofactor. However, the role of this agent in KS remains hotly debated(15). Further progress in understanding its biology has been severely hampered by the lack of a cell culture system for virus growth. Here we report the development of a system for the lytic growth of this virus in a latently infected B cell line and present the first ultrastructural visualization of the virus. This system will facilitate the detailed study of the molecular biology of viral replication, the testing of antiviral drugs and the development of diagnostic tests for viral infection.	UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MICROBIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PATHOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT LAB MED,SAN FRANCISCO,CA 94143	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco					NCI NIH HHS [CA 67381] Funding Source: Medline; NIAID NIH HHS [AI 27763] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA067381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMBROZIAK JA, 1995, SCIENCE, V268, P582, DOI 10.1126/science.7725108; BENSASSON SA, 1981, INT J CANCER, V28, P131, DOI 10.1002/ijc.2910280204; BERAL V, 1990, LANCET, V335, P123, DOI 10.1016/0140-6736(90)90001-L; BERAL V, 1991, CANCER SURV, V10, P5; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chuck S, 1996, J INFECT DIS, V173, P248, DOI 10.1093/infdis/173.1.248; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COHEN J, 1995, SCIENCE, V268, P1847, DOI 10.1126/science.7604255; COUNTRYMAN J, 1987, J VIROL, V61, P3672, DOI 10.1128/JVI.61.12.3672-3679.1987; ENSOLI B, 1991, HEMATOL ONCOL CLIN N, V5, P281, DOI 10.1016/S0889-8588(18)30441-6; FREIDMANKIEN AE, 1990, LANCET, V335, P168; GANEM D, 1995, CURR BIOL, V5, P469, DOI 10.1016/S0960-9822(95)00093-5; HUANG YQ, 1995, LANCET, V345, P759, DOI 10.1016/S0140-6736(95)90641-X; HUMMEL M, 1982, P NATL ACAD SCI-BIOL, V79, P5698, DOI 10.1073/pnas.79.18.5698; KIEFF E, 1990, VIROLOGY, P1902; LENHOFF RJ, 1994, J VIROL, V68, P4565, DOI 10.1128/JVI.68.7.4565-4571.1994; LUKA J, 1979, VIROLOGY, V94, P228, DOI 10.1016/0042-6822(79)90455-0; Moore PS, 1996, J VIROL, V70, P549, DOI 10.1128/JVI.70.1.549-558.1996; MOORE PS, 1995, NEW ENGL J MED, V332, P1181, DOI 10.1056/NEJM199505043321801; PENN I, 1979, TRANSPLANTATION, V27, P8, DOI 10.1097/00007890-197901000-00003; ROIZMAN B, 1990, VIROLOGY, P1787; SCHALLING M, 1995, NAT MED, V1, P707, DOI 10.1038/nm0795-707; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; TAKADA K, 1984, INT J CANCER, V33, P27, DOI 10.1002/ijc.2910330106; WHITBY D, 1995, LANCET, V346, P799, DOI 10.1016/S0140-6736(95)91619-9; ZIEGLER JL, 1984, SEMIN ONCOL, V11, P47; ZURHAUSEN H, 1978, NATURE, V272, P373	28	860	884	1	25	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAR	1996	2	3					342	346		10.1038/nm0396-342	http://dx.doi.org/10.1038/nm0396-342			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TY640	8612236				2022-12-25	WOS:A1996TY64000046
J	Russell, S				Russell, S			Peptide-displaying phages for targeted gene delivery?	NATURE MEDICINE			English	Editorial Material											Russell, S (corresponding author), MRC CTR,CAMBRIDGE CTR PROT ENGN,HILLS RD,CAMBRIDGE CB2 2QH,ENGLAND.							Barry MA, 1996, NAT MED, V2, P299, DOI 10.1038/nm0396-299; COSSET FL, 1995, J VIROL, V69, P6314, DOI 10.1128/JVI.69.10.6314-6322.1995; DEKRUIF J, 1995, P NATL ACAD SCI USA, V92, P3938, DOI 10.1073/pnas.92.9.3938; HART SL, 1995, GENE THER, V2, P552; KASAHARA N, 1994, SCIENCE, V266, P1373, DOI 10.1126/science.7973726; ROSENBERG SA, 1990, NEW ENGL J MED, V323, P570, DOI 10.1056/NEJM199008303230904; VALSESIAWITTMANN S, 1994, J VIROL, V68, P4609, DOI 10.1128/JVI.68.7.4609-4619.1994; WADMAN M, 1995, NATURE, V378, P655, DOI 10.1038/378655a0	8	8	13	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAR	1996	2	3					276	277		10.1038/nm0396-276	http://dx.doi.org/10.1038/nm0396-276			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TY640	8612220				2022-12-25	WOS:A1996TY64000030
J	Schwartz, O; Marechal, V; LeGall, S; Lemonnier, F; Heard, JM				Schwartz, O; Marechal, V; LeGall, S; Lemonnier, F; Heard, JM			Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein	NATURE MEDICINE			English	Article							DOWN-REGULATION; COATED PITS; HLA; EXPRESSION; ANTIGENS; CHAINS; ASSOCIATION; HEAVY; GENE	Like other pathogenic viruses, HIV-1 down-modulates surface expression of major histocompatibility complex class I (MHC-I) molecules in infected cells, thus impairing lysis by cytotoxic T lymphocytes(1,2). We have observed that this phenomenon depends on the expression of Nef. nef is an early gene of primate lentiviruses(3), which is necessary for maintaining high virus loads and inducing AIDS (ref. 4). Nef is not necessary for viral replication in vitro and stimulates the endocytosis of CD4 (ref. 5-8). We show that the expression of MHC-I at the surface of lymphoid, monocytic and epithelial cells was reduced in the presence of Nef protein from various HIV-1 strains. Whereas MHC-I protein synthesis and transport through the endoplasmic reticulum and cis Golgi apparatus occurred normally in Nef(+) cells, surface MHC-I molecules were rapidly internalized, accumulated in endosomal vesicles and were degraded. The stimulation of MHC-I endocytosis by Nef represents a previously undocumented viral mechanism for evading the immune response.	INST PASTEUR,UNITE IMMUNITE CELLULAIRE ANTIVIRALE,F-75724 PARIS 15,FRANCE	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Schwartz, O (corresponding author), INST PASTEUR,LAB RETROVIRUS & TRANSFERT GENET,URA CNRS 1157,25 RUE DR ROUX,F-75724 PARIS 15,FRANCE.		Schwartz, Olivier/AAZ-3765-2021	Schwartz, Olivier/0000-0002-0729-1475; Le Gall, Sylvie/0000-0003-0385-926X				AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; BACHELERIE F, 1990, J VIROL, V64, P3059, DOI 10.1128/JVI.64.6.3059-3062.1990; BEERSMA MFC, 1993, J IMMUNOL, V151, P4455; BEVAN MJ, 1995, P NATL ACAD SCI USA, V92, P5765, DOI 10.1073/pnas.92.13.5765; BOSKHOV LK, 1992, J IMMUNOL, V148, P881; CLAVEL F, 1994, J VIROL, V68, P1179, DOI 10.1128/JVI.68.2.1179-1185.1994; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; CULLEN BR, 1994, VIROLOGY, V205, P1, DOI 10.1006/viro.1994.1613; DASGUPTA JD, 1988, J IMMUNOL, V141, P2577; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; FERRIER P, 1985, J IMMUNOL, V135, P1281; FRUH K, 1995, NATURE, V375, P415, DOI 10.1038/375415a0; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; GUILD BC, 1984, J BIOL CHEM, V259, P9235; HILL A, 1995, NATURE, V375, P411, DOI 10.1038/375411a0; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; KERKAU T, 1989, AIDS RES HUM RETROV, V5, P613, DOI 10.1089/aid.1989.5.613; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; MACHY P, 1987, NATURE, V328, P724, DOI 10.1038/328724a0; Miller Michael D., 1994, Trends in Microbiology, V2, P294, DOI 10.1016/0966-842X(94)90007-8; MOSS PAH, 1995, P NATL ACAD SCI USA, V92, P5773, DOI 10.1073/pnas.92.13.5773; NOWAK MA, 1995, NATURE, V375, P606, DOI 10.1038/375606a0; RINALDO CR, 1994, AM J PATHOL, V144, P637; SCHEPPLER JA, 1989, J IMMUNOL, V143, P2858; SCHWARTZ O, 1995, J VIROL, V69, P528, DOI 10.1128/JVI.69.1.528-533.1995; SCHWARTZ O, 1995, J VIROL, V69, P4053, DOI 10.1128/JVI.69.7.4053-4059.1995; SCHWARTZ O, 1993, J VIROL, V67, P3274, DOI 10.1128/JVI.67.6.3274-3280.1993; SKOWRONSKI J, 1993, EMBO J, V12, P703, DOI 10.1002/j.1460-2075.1993.tb05704.x; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; VEGA MA, 1989, P NATL ACAD SCI USA, V86, P2688, DOI 10.1073/pnas.86.8.2688; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0	31	845	856	0	27	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAR	1996	2	3					338	342		10.1038/nm0396-338	http://dx.doi.org/10.1038/nm0396-338			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TY640	8612235				2022-12-25	WOS:A1996TY64000045
J	Grandis, JR; Zeng, Q; Tweardy, DJ				Grandis, JR; Zeng, Q; Tweardy, DJ			Retinoic acid normalizes the increased gene transcription rate of TGF-alpha and EGFR in head and neck cancer cell lines	NATURE MEDICINE			English	Article							SQUAMOUS CARCINOMA; GROWTH; RECEPTOR; DIFFERENTIATION; EXPRESSION; MODULATION; MARKERS; CLONING	Retinoic acid (RA) has been shown to be effective in eradicating premalignant lesions(1) and preventing second primary malignancies in patients cured of squamous cell carcinoma of the head and neck (SCCHN) in clinical trials(2). The basis for this effect is unclear. We have previously demonstrated that messenger RNA from tumor growth factor-alpha (TCF-alpha) and its receptor, the epidermal growth factor (EGFR), is upregulated in tumors and histologically normal mucosal samples from patients with SCCHN compared with control normal mucosa from patients without cancer, implicating this ligand-receptor pair in an autocrine growth pathway early in the molecular pathogenesis of this disease(3). In this report, we examined the hypothesis that the action of RA on the mucosa of the upper aerodigestive tract is mediated via downregulation of steady-state TGF-alpha and/or EGFR mRNA levels. Following exposure to all-trans-RA, a series of SCCHN cell lines demonstrated a 35.4% reduction in TCF-alpha mRNA expression (P = 0.022) and 58.5% reduction in EGFR mRNA (P = 0.0027). Nuclear run-on analysis indicated that the RA-mediated reduction of TCF-alpha and EGFR steady-state mRNA levels was a result of decreased gene transcription. These results suggest that the clinical effects of RA in SCCHN patients may be due to a downmodulation of TCF-alpha and EGFR mRNA production.	UNIV PITTSBURGH,DEPT MED,PITTSBURGH,PA 15213; UNIV PITTSBURGH,DEPT MOLEC GENET & BIOCHEM,PITTSBURGH,PA 15213; UNIV PITTSBURGH,INST CANC,PITTSBURGH,PA 15213	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Grandis, JR (corresponding author), UNIV PITTSBURGH,DEPT OTOLARYNGOL,200 LOTHROP ST,SUITE 500,PITTSBURGH,PA 15213, USA.		Tweardy, David/L-3929-2019					BOYLE JO, 1993, CANCER RES, V53, P4477; CALLENDER T, 1994, CANCER-AM CANCER SOC, V74, P152, DOI 10.1002/1097-0142(19940701)74:1<152::AID-CNCR2820740124>3.0.CO;2-K; DMITROVSKY E, 1990, ONCOGENE RES, V5, P233; FIELD JK, 1989, ONCOGENE, V4, P1463; GAREWAL HS, 1990, J CLIN ONCOL, V8, P1715, DOI 10.1200/JCO.1990.8.10.1715; GRANDIS JR, 1993, CANCER RES, V53, P3579; HONG WK, 1990, NEW ENGL J MED, V323, P795, DOI 10.1056/NEJM199009203231205; JETTEN AM, 1990, INT J CANCER, V45, P195, DOI 10.1002/ijc.2910450135; KIM JS, 1992, J NCI MONOGR, V13, P101; LOTAN R, 1995, NEW ENGL J MED, V332, P1405, DOI 10.1056/NEJM199505253322103; MAESTRO R, 1993, CANCER RES, V53, P5775; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; NAWROZ H, 1994, CANCER RES, V54, P1152; SACKS PG, 1989, INT J CANCER, V44, P926, DOI 10.1002/ijc.2910440530; SCHUURING E, 1992, ONCOGENE, V7, P355; STELLMACH V, 1991, P NATL ACAD SCI USA, V88, P4582, DOI 10.1073/pnas.88.11.4582; TODD R, 1989, CARCINOGENESIS, V10, P1553, DOI 10.1093/carcin/10.8.1553; WARRELL RP, 1993, NEW ENGL J MED, V329, P177, DOI 10.1056/NEJM199307153290307; WILLIAMS ME, 1993, ARCH OTOLARYNGOL, V119, P1238; ZHENG ZS, 1990, CANCER RES, V50, P1201	20	109	109	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	FEB	1996	2	2					237	240		10.1038/nm0296-237	http://dx.doi.org/10.1038/nm0296-237			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TU060	8574972				2022-12-25	WOS:A1996TU06000047
J	Taniguchi, H; Toyoshima, T; Fukao, K; Nakauchi, H				Taniguchi, H; Toyoshima, T; Fukao, K; Nakauchi, H			Presence of hematopoietic stem cells in the adult liver	NATURE MEDICINE			English	Article							MONOCLONAL-ANTIBODY; MARROW-CELLS; BONE-MARROW; TRANSPLANTATION; CHIMERISM; MICE; PROGENITORS; EXPRESSION; ANTIGENS	Recently, cases have been reported in which a mixed chimeric state of blood cells is established after liver transplantation. Because the established chimerism may have aided in the induction of donor-specific tolerance, the mechanism responsible for this chimerism is of clinical importance. To establish this, we examined cells in adult mouse liver and identified the presence of c-kit(+) Sca-1(+) Lin(lo/-) cells. These cells were capable of forming in vivo as well as in vitro colonies. Furthermore, the cells could reconstitute bone marrow of lethally irradiated recipient mice for at least 12 months. These data obtained from the mouse study strongly suggest that hematopoietic stem cells residing in the donor liver are responsible for mixed chimerism and maintenance of tolerance after liver transplantation.	UNIV TSUKUBA,INST BASIC MED SCI,DEPT IMMUNOL,TSUKUBA,IBARAKI 305,JAPAN; UNIV TSUKUBA,CTR TSUKUBA ADV RES ALLIANCE,TSUKUBA,IBARAKI 305,JAPAN; UNIV TSUKUBA,INST CLIN MED,DEPT SURG,TSUKUBA,IBARAKI 305,JAPAN	University of Tsukuba; University of Tsukuba; University of Tsukuba								BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; BRECHER G, 1982, P NATL ACAD SCI-BIOL, V79, P5085, DOI 10.1073/pnas.79.16.5085; CALNE R, 1994, LANCET, V343, P67, DOI 10.1016/S0140-6736(94)90809-5; Coffman R L, 1982, Immunol Rev, V69, P5; DEMETRIS AJ, 1993, TRANSPL P, V25, P3337; DIALYNAS DP, 1983, IMMUNOL REV, V74, P29, DOI 10.1111/j.1600-065X.1983.tb01083.x; DUNBAR CE, 1995, BLOOD, V85, P3048, DOI 10.1182/blood.V85.11.3048.bloodjournal85113048; EMA H, 1990, BLOOD, V75, P1941; HARDY RR, 1986, HDB EXPT IMMUNOLOGY, pCH31; HOLMES KL, 1986, J IMMUNOL, V137, P679; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; KAMADA N, 1981, NATURE, V292, P840, DOI 10.1038/292840a0; KAMADA N, 1980, TRANSPLANTATION, V29, P429, DOI 10.1097/00007890-198005000-00021; KORBLING M, 1979, EXP HEMATOL, V7, P277; LEDBETTER JA, 1980, J EXP MED, V152, P280, DOI 10.1084/jem.152.2.280; LU L, 1993, BLOOD, V81, P41; MARKUS BH, 1988, TRANSPLANTATION, V46, P372; MORCE HC, 1987, IMMUNOGENETICS, V23, P71; NISHIKAWA S, 1991, EMBO J, V10, P2111, DOI 10.1002/j.1460-2075.1991.tb07744.x; OKADA S, 1992, BLOOD, V80, P3044; PHILIP AL, 1991, EXP HEMATOL, V19, P994; PHILIP AL, 1992, BLOOD, V80, P663; QIAN SW, 1994, HEPATOLOGY, V19, P916, DOI 10.1002/hep.1840190418; RASMUSSEN A, 1993, 6TH C EUR SOC ORG TR; SAXE DF, 1984, EXP HEMATOL, V12, P277; SCHEID MP, 1979, IMMUNOGENETICS, V9, P423, DOI 10.1007/BF01570435; SCHMITZ N, 1995, BLOOD, V85, P1666, DOI 10.1182/blood.V85.6.1666.bloodjournal8561666; SHEN FW, 1981, MONOCLONAL ANTIBODIE, P25; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SPRINGER T, 1979, EUR J IMMUNOL, V9, P301, DOI 10.1002/eji.1830090410; STARZL TE, 1993, NEW ENGL J MED, V328, P745, DOI 10.1056/NEJM199303183281101; STARZL TE, 1982, HEPATOLOGY, V2, P614; STARZL TE, 1992, LANCET, V339, P1579, DOI 10.1016/0140-6736(92)91840-5; STARZL TE, 1993, IMMUNOL TODAY, V14, P326, DOI 10.1016/0167-5699(93)90054-O; STEWART FM, 1993, BLOOD, V81, P2566; TANIGUCHI H, 1995, J IMMUNOL, V155, P5631; TANIGUCHI H, 1995, TRANSPLANT P, V27, P196; TANIGUCHI H, 1994, TRANSPLANT P, V26, P1966; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892	39	260	265	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	FEB	1996	2	2					198	203		10.1038/nm0296-198	http://dx.doi.org/10.1038/nm0296-198			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TU060	8574965				2022-12-25	WOS:A1996TU06000040
J	KEMP, CJ; WHELDON, T; BALMAIN, A				KEMP, CJ; WHELDON, T; BALMAIN, A			P53-DEFICIENT MICE ARE EXTREMELY SUSCEPTIBLE TO RADIATION-INDUCED TUMORIGENESIS	NATURE GENETICS			English	Article							WILD-TYPE P53; CHROMOSOMAL INSTABILITY; IONIZING-RADIATION; SKIN TUMORS; DNA-DAMAGE; CANCER; APOPTOSIS; GENE; TRANSMISSION; DEFICIENT	Mice constitutively lacking alleles of the p53 tumour suppressor gene spontaneously develop lymphomas and sarcomas. We report here that a single dose of 4 Gy radiation dramatically decreases the latency for tumour development in p53 heterozygous mice. The pattern of genetic alterations at the remaining wild type allele in these tumours differs substantially from spontaneous tumours from similar mice indicating that p53 itself may have been a target for radiation-induced alterations. Lower dose irradiation (1 Gy) of preweanling p53 null mice also significantly decreases tumour latency, suggesting that there are additional genetic targets involved in radiation-induced malignancy. Thus p53-deficient mice provide a sensitive model system for studies of the consequences of radiation exposure.	BEATSON INST CANC RES,CRC,BEATSON LABS,GLASGOW G61 1BD,SCOTLAND; DEPT MED ONCOL,GLASGOW G61 1BD,LANARK,SCOTLAND; DEPT RADIAT ONCOL & CLIN PHYS,GLASGOW G61 1BD,LANARK,SCOTLAND	Beatson Institute								BREIMER LH, 1988, BRIT J CANCER, V57, P6, DOI 10.1038/bjc.1988.2; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; HARVEY M, 1993, ONCOGENE, V8, P2457; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; KADHIM MA, 1992, NATURE, V355, P738, DOI 10.1038/355738a0; KEMP CJ, 1993, CELL, V74, P813, DOI 10.1016/0092-8674(93)90461-X; KEMP CJ, 1993, CANCER RES, V53, P6022; KENNEDY AR, 1980, P NATL ACAD SCI-BIOL, V77, P7262, DOI 10.1073/pnas.77.12.7262; KEURBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; LEE JM, 1993, P NATL ACAD SCI USA, V90, P5742, DOI 10.1073/pnas.90.12.5742; LI FP, 1988, CANCER RES, V48, P5358; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; LOTEM J, 1993, BLOOD, V82, P1092, DOI 10.1182/blood.V82.4.1092.bloodjournal8241092; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MARDER BA, 1993, MOL CELL BIOL, V13, P6667, DOI 10.1128/MCB.13.11.6667; MERRITT AJ, 1994, CANCER RES, V54, P614; NELSON WG, 1994, MOL CELL BIOL, V14, P1815, DOI 10.1128/MCB.14.3.1815; PURDIE CA, 1994, ONCOGENE, V9, P603; SEARLE AG, 1989, LOW DOSE RAD BIOL BA, P123; SLICHENMYER WJ, 1993, CANCER RES, V53, P4164; SRIVASTAVA S, 1990, NATURE, V348, P747, DOI 10.1038/348747a0; WISEMAN RW, 1994, P NATL ACAD SCI USA, V91, P3759, DOI 10.1073/pnas.91.9.3759; YI CH, 1992, MOL CARCINOG, V5, P270; 1988, UNSCEAR UN SCI COMMI	28	323	331	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1994	8	1					66	69		10.1038/ng0994-66	http://dx.doi.org/10.1038/ng0994-66			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PE157	7987394				2022-12-25	WOS:A1994PE15700017
J	DIETRICH, WF; MILLER, JC; STEEN, RG; MERCHANT, M; DAMRON, D; NAHF, R; GROSS, A; JOYCE, DC; WESSEL, M; DREDGE, RD; MARQUIS, A; STEIN, LD; GOODMAN, N; PAGE, DC; LANDER, ES				DIETRICH, WF; MILLER, JC; STEEN, RG; MERCHANT, M; DAMRON, D; NAHF, R; GROSS, A; JOYCE, DC; WESSEL, M; DREDGE, RD; MARQUIS, A; STEIN, LD; GOODMAN, N; PAGE, DC; LANDER, ES			A GENETIC-MAP OF THE MOUSE WITH 4,006 SIMPLE SEQUENCE LENGTH POLYMORPHISMS	NATURE GENETICS			English	Article							LINKAGE MAP; HUMAN DNA; GENOME; CONSTRUCTION; MARKERS; SEX	We have constructed a genetic map of the mouse genome containing 4,006 simple sequence length polymorphims (SSLPs). The map provides an average spacing of 0.35 centiMorgans (cM) between markers, corresponding to about 750 kb. Approximately 90% of the genome lies within 1.1 cM of a marker and 99% lies within 2.2 cM. The markers have an average polymorphism rate of 50% in crosses between laboratory strains. The markers are distributed in a relatively uniform fashion across the genome, although some deviations from randomness can be detected. In particular, there is a significant underrepresentation of markers on the X chromosome. This map represents the two-thirds point toward our goal of developing a mouse genetic map containing 6,000 SSLPs.			DIETRICH, WF (corresponding author), MIT, WHITEHEAD INST BIOMED RES, CTR GENOME RES, 9 CAMBRIDGE CTR, CAMBRIDGE, MA 02142 USA.			Merchant, Mark/0000-0003-0690-8581				Arratia R., 1990, STAT SCI, P403, DOI [10.1214/ss/1177012015, DOI 10.1214/SS/1177012015]; BRUFORD MW, 1993, CURR OPIN GENET DEV, V3, P939, DOI 10.1016/0959-437X(93)90017-J; BRYDA EC, 1992, MAMM GENOME, V2, P123, DOI 10.1007/BF00353860; COPELAND NG, 1993, SCIENCE, V262, P57, DOI 10.1126/science.8211130; DIETRICH W, 1992, GENETICS, V131, P423; DIETRICH WF, 1992, GENETIC MAPS 1992; EICHER EM, 1993, MAMM GENOME, V4, P226, DOI 10.1007/BF00417568; EVANS EP, 1989, GENETIC VARIANTS STR, P576; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Hawkins T., 1992, DNA Sequence, V3, P65, DOI 10.3109/10425179209033998; HOFKER MH, 1986, AM J HUM GENET, V39, P438; KUSUMI K, 1993, MAMM GENOME, V4, P391, DOI 10.1007/BF00360591; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1989, GENETICS, V121, P185; LARIN Z, 1991, P NATL ACAD SCI USA, V88, P4123, DOI 10.1073/pnas.88.10.4123; LINCOLN SE, 1992, GENOMICS, V14, P604, DOI 10.1016/S0888-7543(05)80158-2; LOVE JM, 1990, NUCLEIC ACIDS RES, V18, P4123, DOI 10.1093/nar/18.14.4123; MARDON G, 1990, MOL CELL BIOL, V10, P681, DOI 10.1128/MCB.10.2.681; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; MILLER JC, IN PRESS GENETIC VAR; Sambrook J, 1989, MOL CLONING LABORATO; TANZI RE, 1992, AM J HUM GENET, V50, P551; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; YOKOYAMA T, 1993, SCIENCE, V260, P679, DOI 10.1126/science.8480178	25	590	596	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1994	7	2			SI		220	245		10.1038/ng0694supp-220	http://dx.doi.org/10.1038/ng0694supp-220			26	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NQ898	7920646				2022-12-25	WOS:A1994NQ89800003
J	NEUMANN, PE; FRANKEL, WN; LETTS, VA; COFFIN, JM; COPP, AJ; BERNFIELD, M				NEUMANN, PE; FRANKEL, WN; LETTS, VA; COFFIN, JM; COPP, AJ; BERNFIELD, M			MULTIFACTORIAL INHERITANCE OF NEURAL-TUBE DEFECTS - LOCALIZATION OF THE MAJOR GENE AND RECOGNITION OF MODIFIERS IN CT MUTANT MICE	NATURE GENETICS			English	Article							CURLY-TAIL MOUSE; POSTERIOR NEUROPORE CLOSURE; WAARDENBURG SYNDROME; VALPROIC ACID; EMBRYOS; SUSCEPTIBILITY; PREVENTION; REGION; GENOME; PROTOONCOGENE	Neural tube defects (NTD) in humans have been considered to have a multifactorial aetiology, however the participating genes have not been identified. The curly-tail (ct) mutant mouse develops NTD that resemble the human malformations in location, pathology and associated abnormalities. Moreover, there appears to be multifactorial influence on the incidence of NTD in offspring of curly-tail mice. We now describe a linkage analysis that localizes the ct gene to distal chromosome 4 in mice. Further analysis using recombinant inbred strains demonstrates the presence of at least three modifier loci that influence the incidence of NTD. This study provides definitive evidence for multifactorial inheritance in a mouse model of human NTD.	HARVARD UNIV,CHILDRENS HOSP,SCH MED,DEPT NEUROL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,JOINT PROGRAM NEONATOL,BOSTON,MA 02115; TUFTS UNIV,SCH MED,DEPT MOLEC BIOL,BOSTON,MA 02111; JACKSON LAB,BAR HARBOR,ME 04609; UNIV LONDON,INST CHILD HLTH,LONDON WC1N 1EH,ENGLAND	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Tufts University; Jackson Laboratory; University of London; University College London			Copp, Andrew/C-4174-2008	Copp, Andrew/0000-0002-2544-9117; Neumann, Paul/0000-0002-8480-4799	NCI NIH HHS [CA28735] Funding Source: Medline; NICHD NIH HHS [HD06763, HD28882] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD006763, R01HD006763, U01HD028882] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA028735] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADINOLFI M, 1976, J MED GENET, V13, P511, DOI 10.1136/jmg.13.6.511; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BEIER DR, 1992, P NATL ACAD SCI USA, V89, P9102, DOI 10.1073/pnas.89.19.9102; Bernfield M., 1984, ROLE EXTRACELLULAR M, P545; BROOK FA, 1991, DEVELOPMENT, V113, P671; CAREY DJ, 1992, J CELL BIOL, V117, P191, DOI 10.1083/jcb.117.1.191; CHERNOUSOV MA, 1993, J BIOL CHEM, V268, P16810; COCKROFT DL, 1992, TERATOLOGY, V45, P223, DOI 10.1002/tera.1420450216; COPP AJ, 1982, J EMBRYOL EXP MORPH, V69, P151; COPP AJ, 1985, J EMBRYOL EXP MORPH, V88, P39; COPP AJ, 1988, DEVELOPMENT, V104, P297; COPP AJ, 1989, J MED GENET, V26, P160, DOI 10.1136/jmg.26.3.160; COPP AJ, 1988, DEVELOPMENT, V104, P285; COPP AJ, 1988, DEV BIOL, V130, P583, DOI 10.1016/0012-1606(88)90353-3; CORNALL RJ, 1991, GENOMICS, V10, P874, DOI 10.1016/0888-7543(91)90175-E; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; DIETRICH W, 1992, GENETICS, V131, P423; EIPERS PG, 1991, GENOMICS, V11, P621, DOI 10.1016/0888-7543(91)90069-Q; EMBURY S, 1979, PROC R SOC SER B-BIO, V206, P85, DOI 10.1098/rspb.1979.0092; EMERY AEH, 1986, METHODOLOGY MED GENE, P58; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; ESSIEN FB, 1993, J NUTR, V123, P27, DOI 10.1093/jn/123.1.27; ESTIBEIRO JP, 1993, DEVELOPMENT, V119, P113; FINNELL RH, 1988, TERATOLOGY, V38, P313, DOI 10.1002/tera.1420380403; FINNELL RH, 1986, TERATOLOGY, V33, P247, DOI 10.1002/tera.1420330213; FRANKEL WN, 1990, GENETICS, V124, P221; GRUNEBERG H, 1954, J GENET, V52, P52, DOI 10.1007/BF02981490; HEARNE CM, 1991, MAMM GENOME, V1, P273, DOI 10.1007/BF00352339; HOBBINS JC, 1991, NEW ENGL J MED, V324, P690, DOI 10.1056/NEJM199103073241009; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; JOSTES B, 1991, MECH DEVELOP, V33, P27; KING TR, 1989, P NATL ACAD SCI USA, V86, P222, DOI 10.1073/pnas.86.1.222; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; LAMMER EJ, 1987, TERATOLOGY, V35, P465, DOI 10.1002/tera.1420350319; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Laurence KM, 1990, PRINCIPLES PRACTICE, P323; Lyon ML, 1989, GENETIC VARIANTS STR, P773; MESSER A, 1992, GENOMICS, V13, P797, DOI 10.1016/0888-7543(92)90155-L; NEUMANN PE, 1992, BEHAV GENET, V22, P665, DOI 10.1007/BF01066637; NEUMANN PE, 1991, P NATL ACAD SCI USA, V88, P5408, DOI 10.1073/pnas.88.12.5408; NOONAN DM, 1993, MOL CELLULAR ASPECTS, P189; SARTOR O, 1992, J BIOL CHEM, V267, P3460; SELLER MJ, 1979, PROC R SOC SER B-BIO, V206, P95, DOI 10.1098/rspb.1979.0093; SELLER MJ, 1983, J CRAN GENET DEV BIO, V3, P11; SELLER MJ, 1986, TERATOLOGY, V33, P305, DOI 10.1002/tera.1420330308; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TAYLOR BA, 1976, GENETICS, V83, P373; THOMAS KR, 1991, CELL, V67, P969, DOI 10.1016/0092-8674(91)90369-A; VANSTRAATEN HWM, 1992, ANAT EMBRYOL, V185, P169; VANSTRAATEN HWM, 1993, DEVELOPMENT, V117, P1163; WALD N, 1991, LANCET, V338, P131	51	105	107	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1994	6	4					357	362		10.1038/ng0494-357	http://dx.doi.org/10.1038/ng0494-357			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ND870	8054974				2022-12-25	WOS:A1994ND87000013
J	MULLIGAN, LM; ENG, C; HEALEY, CS; CLAYTON, D; KWOK, JBJ; GARDNER, E; PONDER, MA; FRILLING, A; JACKSON, CE; LEHNERT, H; NEUMANN, HPH; THIBODEAU, SN; PONDER, BAJ				MULLIGAN, LM; ENG, C; HEALEY, CS; CLAYTON, D; KWOK, JBJ; GARDNER, E; PONDER, MA; FRILLING, A; JACKSON, CE; LEHNERT, H; NEUMANN, HPH; THIBODEAU, SN; PONDER, BAJ			SPECIFIC MUTATIONS OF THE RET PROTOONCOGENE ARE RELATED TO DISEASE PHENOTYPE IN MEN 2A AND FMTC	NATURE GENETICS			English	Article							MULTIPLE ENDOCRINE NEOPLASIA; MEDULLARY-THYROID CARCINOMA; CYSTIC-FIBROSIS; CHROMOSOME-10; PROTOONCOGENE; TYPE-2A; REGION	We have analysed 118 families with inherited medullary thyroid carcinoma (MTC) for mutations of the RET proto-oncogene. These included cases of multiple endocrine neoplasia types 2A (MEN 2A) and 2B (MEN 2B) and familial MTC (FMTC). Mutations at one of 5 cysteines in the extracellular domain were found in 97% of patients with MEN 2A and 86% with FMTC but not in MEN 2B patients or normal controls. 84% of the MEN2A mutations affected codon 634. MEN 2A patients with a Cys634 to Arg substitution had a greater risk of developing parathyroid disease than those with other codon 634 mutations. Our data show a strong correlation between disease phenotype and the nature and position of the RET mutation, suggesting that a simple, constitutive activation of the RET tyrosine kinase is unlikely to explain the events leading to MEN 2A and FMTC.	UNIV CAMBRIDGE,DEPT PATHOL,CANC RES CAMPAIGN,HUMAN CANC GENET RES GRP,CAMBRIDGE CB2 1QP,ENGLAND; UNIV CAMBRIDGE,INST PUBL HLTH,MRC,BIOSTAT UNIT,CAMBRIDGE CB2 2SR,ENGLAND; UNIV HAMBURG KRANKENHAUS,CHIRURG KLIN,W-2000 HAMBURG 20,GERMANY; HENRY FORD HOSP,DEPT MED,DETROIT,MI 48202; UNIV MAINZ,MED KLIN & POLIKLIN,INNERE MED ABT,W-6500 MAINZ,GERMANY; UNIV FREIBURG,INNERE MED ABT 4,D-79106 FREIBURG,GERMANY; MAYO CLIN & MAYO FDN,DEPT LAB MED,ROCHESTER,MN 55905	CRUK Cambridge Institute; University of Cambridge; MRC Biostatistics Unit; University of Cambridge; University of Hamburg; University Medical Center Hamburg-Eppendorf; Henry Ford Health System; Henry Ford Hospital; Johannes Gutenberg University of Mainz; University of Freiburg; Mayo Clinic				Kwok, John/0000-0001-9574-6195; Eng, Charis/0000-0002-3693-5145				ANGUIANO A, 1992, JAMA-J AM MED ASSOC, V267, P1794, DOI 10.1001/jama.267.13.1794; DONISKELLER H, 1993, HUM MOL GENET, V2, P851, DOI 10.1093/hmg/2.7.851; FARNDON JR, 1986, BRIT J SURG, V73, P278, DOI 10.1002/bjs.1800730411; GAGEL RF, 1988, NEW ENGL J MED, V318, P478, DOI 10.1056/NEJM198802253180804; GARDNER E, 1993, HUM MOL GENET, V2, P241, DOI 10.1093/hmg/2.3.241; ITOH F, 1992, ONCOGENE, V7, P1201; IWAMOTO T, 1993, ONCOGENE, V8, P1087; KWOK JBJ, 1993, ONCOGENE, V8, P2575; LAIRMORE TC, 1993, P NATL ACAD SCI USA, V90, P492, DOI 10.1073/pnas.90.2.492; LAIRMORE TC, 1991, GENOMICS, V9, P181, DOI 10.1016/0888-7543(91)90237-9; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MATHEW CGP, 1987, NATURE, V328, P524, DOI 10.1038/328524a0; Miya A, 1992, Henry Ford Hosp Med J, V40, P215; MOLE SE, 1993, HUM MOL GENET, V2, P247, DOI 10.1093/hmg/2.3.247; MULLIGAN LM, 1993, NATURE, V363, P458, DOI 10.1038/363458a0; NORUM RA, 1990, GENOMICS, V8, P313, DOI 10.1016/0888-7543(90)90287-5; SANTORO M, 1990, ONCOGENE, V5, P1595; SCHIMKE RN, 1984, ANNU REV MED, V35, P25, DOI 10.1146/annurev.me.35.020184.000325; TAKAHASHI M, 1989, ONCOGENE, V4, P805; TAKAHASHI M, 1988, ONCOGENE, V3, P571; THAKKER RV, 1988, BAILLIERE CLIN ENDOC, V2, P1031, DOI 10.1016/S0950-351X(88)80029-6; TSUI LC, 1992, TRENDS GENET, V8, P392, DOI 10.1016/0168-9525(92)90301-J	22	541	552	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1994	6	1					70	74		10.1038/ng0194-70	http://dx.doi.org/10.1038/ng0194-70			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ177	7907913				2022-12-25	WOS:A1994MQ17700017
J	BENHAMIDA, C; DOERFLINGER, N; BELAL, S; LINDER, C; REUTENAUER, L; DIB, C; GYAPAY, G; VIGNAL, A; LEPASLIER, D; COHEN, D; PANDOLFO, M; MOKINI, V; NOVELLI, G; HENTATI, F; BENHAMIDA, M; MANDEL, JL; KOENIG, M				BENHAMIDA, C; DOERFLINGER, N; BELAL, S; LINDER, C; REUTENAUER, L; DIB, C; GYAPAY, G; VIGNAL, A; LEPASLIER, D; COHEN, D; PANDOLFO, M; MOKINI, V; NOVELLI, G; HENTATI, F; BENHAMIDA, M; MANDEL, JL; KOENIG, M			LOCALIZATION OF FRIEDREICH ATAXIA PHENOTYPE WITH SELECTIVE VITAMIN-E-DEFICIENCY TO CHROMOSOME-8Q BY HOMOZYGOSITY MAPPING	NATURE GENETICS			English	Article							LINKAGE MAP; ALPHA-TOCOPHEROL; HUMAN GENOME; DISEQUILIBRIUM; POLYMORPHISMS; FAMILIES; GENE	Friedreich ataxia and ataxia with selective vitamin E deficiency (AVED) share very similar clinical phenotypes. We have mapped the AVED locus to proximal 8q with only three large consanguinous Tunisian families, representing to our knowledge the first use of homozygosity mapping for primary linkage analysis. Subsequently, three additional families showed linkage with the same markers. A maximum lod score of 17.9 was obtained at theta = 0 for the haplotype D8S260-D8S510, consisting of the two closest markers. With only 6 families, the AVED locus is therefore mapped precisely as illustrated by the lod-1 confidence interval of 2.4 cM on either side of D8S260-D8S510. Isolation of a yeast artificial chromosome contig >800 kilobases (kb) showed that D8S260 and D8S510 are less than 400 kb apart.	INST NATL NEUROL, NEUROBIOL MOLEC & NEUROPATHOL LAB, RABTA, TUNISIA; FAC MED STRASBOURG, GENET MOLEC LAB,CNRS,U 184,INSERM, STRASBOURG, FRANCE; CTR HOSP REG & UNIV STRASBOURG, STRASBOURG, FRANCE; GENETHON, EVRY, FRANCE; CTR ETUD POLYMORPHISME HUMAIN, PARIS, FRANCE; IST NEUROCHIRURG C BESTA, I-20133 MILAN, ITALY; UNIV TIRANA, DEPT PEDIAT, Tirana, ALBANIA; UNIV CATTOLICA SACRO CUORE, CHAIR HUMAN GENET, I-00168 ROME, ITALY	Universite de Tunis-El-Manar; Institut National de Neurologie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Tirana (UT); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli			Novelli, Giuseppe/T-8822-2019; Novelli, Giuseppe/GQB-3329-2022; Novelli, Giuseppe/A-5195-2013; Pandolfo, Massimo/B-2853-2010; Vignal, Alain/I-6253-2017	Novelli, Giuseppe/0000-0002-7781-602X; Novelli, Giuseppe/0000-0002-7781-602X; Vignal, Alain/0000-0002-6797-2125; Le Paslier, Denis/0000-0003-4335-9956	Fondazione Telethon Funding Source: Custom; Telethon [148] Funding Source: Medline	Fondazione Telethon(Fondazione Telethon); Telethon(Fondazione Telethon)		ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; BEHRENS WA, 1982, NUTR RES, V2, P611, DOI 10.1016/S0271-5317(82)80073-0; BELLANNECHANTELOT C, 1992, CELL, V70, P1059, DOI 10.1016/0092-8674(92)90254-A; BENHAMIDA M, 1991, REV NEUROL, V147, P798; BENHAMIDA M, IN PRESS NEUROLOGY; BENOTHMANE K, 1992, NAT GENET, V2, P315, DOI 10.1038/ng1292-315; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; BURCK U, 1981, NEUROPEDIATRICS, V12, P267, DOI 10.1055/s-2008-1059657; DI MASCIO P, 1991, AM J CLIN NUTR, V53, pS194, DOI 10.1093/ajcn/53.1.194S; ELVIN P, 1990, NUCLEIC ACIDS RES, V18, P3913, DOI 10.1093/nar/18.13.3913; FUJITA R, 1992, HUM GENET, V89, P531, DOI 10.1007/BF00219179; FUJITA R, 1990, P NATL ACAD SCI USA, V87, P1796, DOI 10.1073/pnas.87.5.1796; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; HARDING AE, 1985, NEW ENGL J MED, V313, P32, DOI 10.1056/NEJM198507043130107; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HAZAN J, 1992, GENOMICS, V12, P183, DOI 10.1016/0888-7543(92)90364-X; KERE J, 1992, GENOMICS, V14, P241, DOI 10.1016/S0888-7543(05)80212-5; KRENDEL DA, 1987, NEUROLOGY, V37, P538, DOI 10.1212/WNL.37.3.538; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MULLER DPR, 1983, LANCET, V1, P225; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SCHELLENBERG GD, 1992, LANCET, V339, P1002, DOI 10.1016/0140-6736(92)91590-5; SIRUGO G, 1992, AM J HUM GENET, V50, P559; SOKOL RJ, 1988, J LAB CLIN MED, V111, P548; STUMPF DA, 1987, NEUROLOGY, V37, P68, DOI 10.1212/WNL.37.1.68; TAGLE DA, 1993, NATURE, V361, P751, DOI 10.1038/361751a0; TOMFOHRDE J, 1992, GENOMICS, V14, P144, DOI 10.1016/S0888-7543(05)80297-6; TRABER MG, 1990, J CLIN INVEST, V85, P397, DOI 10.1172/JCI114452; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WILKIE PJ, 1992, GENOMICS, V12, P607, DOI 10.1016/0888-7543(92)90456-3; YOKOTA T, 1987, ANN NEUROL, V22, P84, DOI 10.1002/ana.410220119	33	172	174	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1993	5	2					195	200		10.1038/ng1093-195	http://dx.doi.org/10.1038/ng1093-195			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MA056	8252047				2022-12-25	WOS:A1993MA05600020
J	GISPERT, S; TWELLS, R; OROZCO, G; BRICE, A; WEBER, J; HEREDERO, L; SCHEUFLER, K; RILEY, B; ALLOTEY, R; NOTHERS, C; HILLERMANN, R; LUNKES, A; KHATI, C; STEVANIN, G; HERNANDEZ, A; MAGARINO, C; KLOCKGETHER, T; DURR, A; CHNEIWEISS, H; ENCZMANN, J; FARRALL, M; BECKMANN, J; MULLAN, M; WERNET, P; AGID, Y; FREUND, HJ; WILLIAMSON, R; AUBURGER, G; CHAMBERLAIN, S				GISPERT, S; TWELLS, R; OROZCO, G; BRICE, A; WEBER, J; HEREDERO, L; SCHEUFLER, K; RILEY, B; ALLOTEY, R; NOTHERS, C; HILLERMANN, R; LUNKES, A; KHATI, C; STEVANIN, G; HERNANDEZ, A; MAGARINO, C; KLOCKGETHER, T; DURR, A; CHNEIWEISS, H; ENCZMANN, J; FARRALL, M; BECKMANN, J; MULLAN, M; WERNET, P; AGID, Y; FREUND, HJ; WILLIAMSON, R; AUBURGER, G; CHAMBERLAIN, S			CHROMOSOMAL ASSIGNMENT OF THE 2ND LOCUS FOR AUTOSOMAL-DOMINANT CEREBELLAR-ATAXIA (SCA2) TO CHROMOSOME 12Q23-24.1	NATURE GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; LINKAGE; SYSTEM	The autosomal dominant cerebellar ataxias (ADCA) are a group of neurodegenerative disorders characterized by onset with gait ataxia, dysarthria, dysmetria and dysdiadochokinesia. We have demonstrated previously genetic heterogeneity within these disorders by excluding the disease locus from the documented spinocerebellar ataxia locus (SCA1) on chromosome 6p in a large Cuban founder population. We now report the assignment of a second locus for ADCA (SCA2) to chromosome 12q23-24.1 following linkage analyses carried out for the Cuban pedigrees, with probable flanking markers D12S58 and phospholipase A2. Investigation of linkage to the interval containing SCA2 for seven French ADCA families, previously excluded from linkage to SCA1, provides preliminary data suggesting the existence of a third ADCA locus (SCA3).	UNIV HOSP DUESSELDORF, DEPT NEUROL, MOORENSTR 5, W-4000 DUSSELDORF, GERMANY; UNIV LONDON IMPERIAL COLL SCI & TECHNOL, ST MARYS HOSP, SCH MED, DEPT BIOCHEM & MOLEC GENET, LONDON W2 1PG, ENGLAND; NATL CTR MED GENET, HAVANA, CUBA; LENIN HOSP, DEPT NEUROL, HOLGUIN, CUBA; MARSHFIELD MED RES FDN, MARSHFIELD, WI 54449 USA; INST HAEMATOL & IMMUNOL, HAVANA, CUBA; UNIV HOSP TUEBINGEN, DEPT NEUROL, TUBINGEN, GERMANY; UNIV HOSP DUESSELDORF, INST TRANSFUS MED, IMMUNOL LAB, DUSSELDORF, GERMANY; CTR ETUD POLYMORPHISME HUMAIN, F-75010 PARIS, FRANCE; UNIV S FLORIDA, SUNCOAST GERONTOL CTR, TAMPA, FL 33612 USA; ROYAL POSTGRAD MED SCH, DEPT MED, MRC, MOLEC MED GRP, LONDON W12 0HS, ENGLAND; COLL FRANCE, INSERM, U114, F-75231 PARIS 05, FRANCE; HOP LA PITIE SALPETRIERE, INSERM, U289, F-75651 PARIS 13, FRANCE; HOP LA PITIE SALPETRIERE, SERV NEUROL & NEUROPSYCHOL, F-75651 PARIS 13, FRANCE	Imperial College London; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; State University System of Florida; University of South Florida; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite			brice, alexis/AAE-8275-2019; Brice, Alexis/A-2170-2009; Stevanin, Giovanni/E-5038-2016; herve, chneiweiss/Q-6818-2019; Beckmann, Jacques S/A-9772-2008	brice, alexis/0000-0002-0941-3990; Stevanin, Giovanni/0000-0001-9368-8657; herve, chneiweiss/0000-0001-7675-5061; Beckmann, Jacques S/0000-0002-9741-1900				AUBURGER G, 1990, AM J HUM GENET, V46, P1163; Brown S., 1892, BRAIN, V15, P250; COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3; COUTINHO P, 1978, NEUROLOGY, V28, P703, DOI 10.1212/WNL.28.7.703; DIAZ GO, 1990, NEUROLOGY, V40, P1369, DOI 10.1212/WNL.40.9.1369; GIPSERT S, 1993, HUM HERED, V43, P12; HOPPENER JWM, 1985, HUM GENET, V69, P157, DOI 10.1007/BF00293288; JACKSON JF, 1977, NEW ENGL J MED, V296, P1138, DOI 10.1056/NEJM197705192962003; KEATS BJB, 1991, GENOMICS, V9, P557, DOI 10.1016/0888-7543(91)90426-F; KHATI C, IN PRESS NEUROLOGY; KONIGSMARK BW, 1971, BRITH DEFECTS ORIG A, V1, P178; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LITT M, 1990, NUCLEIC ACIDS RES, V18, P4301, DOI 10.1093/nar/18.14.4301; OTT J, 1979, TRANSPLANT P, V11, P1689; POGACAR S, 1978, ARCH NEUROL-CHICAGO, V35, P156, DOI 10.1001/archneur.1978.00500270038008; POLYMEROPOULOS MH, 1990, NUCLEIC ACIDS RES, V18, P7468, DOI 10.1093/nar/18.24.7468-a; RANUM LPW, 1991, NUCLEIC ACIDS RES, V19, P1171, DOI 10.1093/nar/19.5.1171-a; ROMANUL FCA, 1977, NEW ENGL J MED, V296, P1505, DOI 10.1056/NEJM197706302962606; WEATHERALL DJ, 1984, NEW GENETICS CLIN PR; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEBER JL, 1991, CYTOGENET CELL GENET, V58, P1864; WEINER LP, 1967, ARCH NEUROL-CHICAGO, V16, P364, DOI 10.1001/archneur.1967.00470220028004; YAKURA H, 1974, NEW ENGL J MED, V291, P154	23	314	321	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1993	4	3					295	299		10.1038/ng0793-295	http://dx.doi.org/10.1038/ng0793-295			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ842	8358438				2022-12-25	WOS:A1993LJ84200019
J	WU, CL; MELTON, DW				WU, CL; MELTON, DW			PRODUCTION OF A MODEL FOR LESCH-NYHAN SYNDROME IN HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE-DEFICIENT MICE	NATURE GENETICS			English	Article							MOUSE MODEL; MUSCULAR-DYSTROPHY; DOPAMINE AGONISTS; BRAIN; IDENTIFICATION; AMPHETAMINE; MUTATIONS; RATS; INVOLVEMENT; CLONIDINE	The inherited disease Lesch-Nyhan syndrome, which is caused by a deficiency of the enzyme hypoxanthine phosphoribosyltransferase (HPRT), is characterized by behavioural alterations, including self-injurious behaviour and mental retardation. Although HPRT-deficient mice have been generated using the embryonic stem cell system, no spontaneous behavioural abnormalities had been reported. We examined whether mice were more tolerant of HPRT deficiency because they were more reliant on adenine phosphoribosyltransferase (APRT) than HPRT for their purine salvage. The administration of an APRT inhibitor to HPRT-deficient mice induced persistent self-injurious behaviour. This combined genetic and biochemical model will facilitate the study of Lesch-Nyhan syndrome and the evaluation of novel therapies.	UNIV EDINBURGH,INST CELL & MOLEC BIOL,MAYFIELD RD,EDINBURGH EH9 3JR,MIDLOTHIAN,SCOTLAND	University of Edinburgh			Wu, Chao-Liang/K-5272-2013	Wu, Chao-Liang/0000-0001-7821-9406				BREESE GR, 1984, J PHARMACOL EXP THER, V231, P343; BREESE GR, 1990, BRAIN RES BULL, V25, P477, DOI 10.1016/0361-9230(90)90240-Z; BROSH S, 1990, J NEUROCHEM, V54, P1776, DOI 10.1111/j.1471-4159.1990.tb01233.x; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; DAVIDSON BL, 1991, AM J HUM GENET, V48, P951; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DORIN JR, 1992, NATURE, V359, P211, DOI 10.1038/359211a0; DUNNETT SB, 1989, BRAIN RES, V501, P401, DOI 10.1016/0006-8993(89)90659-8; FINGER S, 1988, J NEUROL SCI, V86, P203, DOI 10.1016/0022-510X(88)90099-8; FRAY PJ, 1980, PSYCHOPHARMACOLOGY, V69, P253, DOI 10.1007/BF00433091; FUJIMORI S, 1989, J CLIN INVEST, V83, P11, DOI 10.1172/JCI113846; GIBBS RA, 1989, P NATL ACAD SCI USA, V86, P1919, DOI 10.1073/pnas.86.6.1919; GOLDSTEIN M, 1989, PSYCHOPHARMACOL BULL, V25, P349; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; JINNAH HA, 1990, BRAIN RES BULL, V25, P467, DOI 10.1016/0361-9230(90)90239-V; JINNAH HA, 1991, BEHAV NEUROSCI, V105, P1004, DOI 10.1037/0735-7044.105.6.1004; KEOUGH DT, 1988, J INHERIT METAB DIS, V11, P229, DOI 10.1007/BF01800364; KUEHN MR, 1987, NATURE, V326, P295, DOI 10.1038/326295a0; LAKE CR, 1977, SCIENCE, V196, P905, DOI 10.1126/science.860124; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; LEESE HJ, 1991, J REPROD FERTIL, V91, P197; LESCH M, 1964, AM J MED, V36, P561, DOI 10.1016/0002-9343(64)90104-4; LEWIS MH, 1985, PSYCHOPHARMACOLOGY, V85, P204, DOI 10.1007/BF00428415; LLOYD HGE, 1981, PHARMACOL BIOCHEM BE, V14, P827, DOI 10.1016/0091-3057(81)90368-3; LLOYD KG, 1981, NEW ENGL J MED, V305, P1106, DOI 10.1056/NEJM198111053051902; MINANA MD, 1984, J NEUROCHEM, V43, P1556, DOI 10.1111/j.1471-4159.1984.tb06078.x; MOORE TF, 1992, DEVELOPMENT, V1152, P1011; MOYER JD, 1983, CAN J BIOCHEM CELL B, V61, P1153, DOI 10.1139/o83-148; MUELLER K, 1982, PHARMACOL BIOCHEM BE, V17, P613, DOI 10.1016/0091-3057(82)90332-X; PETERS JM, 1967, ARCH INT PHARMACOD T, V169, P139; RAZZAK A, 1977, JPN J PHARMACOL, V27, P145, DOI 10.1254/jjp.27.145; ROSENBLOOM FM, 1967, J AMER MED ASSOC, V202, P175, DOI 10.1001/jama.202.3.175; SIMMONDS HA, 1986, CLIN CHIM ACTA, V160, P1003; SINNETT D, 1988, HUM GENET, V81, P4, DOI 10.1007/BF00283719; Smith AG., 1991, J TISSUE CULT METHOD, V13, P89, DOI [10.1007/BF01666137, DOI 10.1007/BF01666137, 10.1007/bf01666137]; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; SZYBALSKA EH, 1962, P NATL ACAD SCI USA, V48, P2026, DOI 10.1073/pnas.48.12.2026; TYBULEWICZ VLJ, 1992, NATURE, V357, P407, DOI 10.1038/357407a0; USHIJIMA I, 1984, PSYCHOPHARMACOLOGY, V83, P335, DOI 10.1007/BF00428541; WILLIAMSON DJ, 1992, J INHERIT METAB DIS, V15, P665, DOI 10.1007/BF01799622; WILLIAMSON DJ, 1991, ADV EXP MED BIOL, V309, P269	44	75	83	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1993	3	3					235	240		10.1038/ng0393-235	http://dx.doi.org/10.1038/ng0393-235			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KP790	8485579				2022-12-25	WOS:A1993KP79000013
J	Okazaki, Y; Okuizumi, H; Ohsumi, T; Nomura, O; Takada, S; Kamiya, M; Sasaki, N; Matsuda, Y; Nishimura, M; Tagaya, O; Muramatsu, M; Hayashizaki, Y				Okazaki, Y; Okuizumi, H; Ohsumi, T; Nomura, O; Takada, S; Kamiya, M; Sasaki, N; Matsuda, Y; Nishimura, M; Tagaya, O; Muramatsu, M; Hayashizaki, Y			Genetic linkage map of the Syrian hamster and localization of cardiomyopathy locus on chromosome 9qa2.1-b1 using RLGS spot-mapping	NATURE GENETICS			English	Letter									NATL INST RADIOL SCI HOSP, GENOME RES GRP, INAGE KU, CHIBA 263, JAPAN; HAMAMATSU UNIV SCH MED, INST EXPT ANIM, HAMAMATSU, SHIZUOKA 43131, JAPAN; EISAI & CO LTD, DIV RES, DEPT PLANNING & RESOURCES, BUNKYO KU, TOKYO 11288, JAPAN	National Institutes for Quantum Science & Technology; Hamamatsu University School of Medicine; Eisai Co Ltd	Okazaki, Y (corresponding author), RIKEN, INST PHYS & CHEM RES, TSUKUBA LIFE SCI CTR, GENOME SCI LAB, 3-1-1 KOYADAI, TSUKUBA, IBARAKI 305, JAPAN.		Hayashizaki, Yoshihide/N-6590-2015; Sasaki, Nobuya/F-6579-2012	Takada, Shuji/0000-0002-9406-4683				BAJUSZ E, 1966, SCIENCE, V152, P1112, DOI 10.1126/science.152.3725.1112; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; HATADA I, 1991, P NATL ACAD SCI USA, V88, P9523, DOI 10.1073/pnas.88.21.9523; HAYASHIZAKI Y, 1994, GENETICS, V138, P1207; HIROTSUNE S, 1995, NAT GENET, V10, P77, DOI 10.1038/ng0595-77; HIROTSUNE S, 1993, BIOCHEM BIOPH RES CO, V194, P1406, DOI 10.1006/bbrc.1993.1981; HOMBURGER F, 1970, J AMER MED ASSOC, V212, P604, DOI 10.1001/jama.212.4.604; HOMBURGER F, 1962, MED EXP, V6, P339; LI S, 1982, CYTOGENET CELL GENET, V33, P295, DOI 10.1159/000131775; MANLY KF, 1993, MAMM GENOME, V4, P303, DOI 10.1007/BF00357089; MATSUDA Y, 1992, CYTOGENET CELL GENET, V61, P282, DOI 10.1159/000133423; OHSUMI T, 1995, ELECTROPHORESIS, V16, P203, DOI 10.1002/elps.1150160135; OKAZAKI Y, 1994, BIOCHEM BIOPH RES CO, V205, P1922, DOI 10.1006/bbrc.1994.2895; OKAZAKI Y, 1995, P NATL ACAD SCI USA, V92, P5610, DOI 10.1073/pnas.92.12.5610; OKUIZUMI H, 1995, ELECTROPHORESIS, V16, P233, DOI 10.1002/elps.1150160139; ROBERDS SL, 1993, J BIOL CHEM, V268, P11496; ROBINSON R, 1993, GENETICS MAPS LOCUS; Sambrook J., 2002, MOL CLONING LAB MANU; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; WAGNER JA, 1986, SCIENCE, V232, P515, DOI 10.1126/science.3008330	20	34	42	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	1996	13	1					87	90		10.1038/ng0596-87	http://dx.doi.org/10.1038/ng0596-87			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH430	8673110				2022-12-25	WOS:A1996UH43000021
J	Murray, GI; Duncan, ME; ONeil, P; Melvin, WT; Fothergill, JE				Murray, GI; Duncan, ME; ONeil, P; Melvin, WT; Fothergill, JE			Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer	NATURE MEDICINE			English	Article							COLLAGENOLYTIC ACTIVITY; MONOCLONAL-ANTIBODIES; COLLAGENASE; METASTASIS; EXPRESSION; NEOPLASIA; ENOLASE; TUMORS	Colorectal cancer is one of the commonest malignant tumors and has a relatively poor prognosis. The outcome depends on the extent of local and particularly metastatic tumor spread. The matrix metalloproteinases (MMPs) are a family of closely related enzymes that degrade the extracellular matrix and are considered to be important in facilitating tumor invasion and spread(1-3). Using immunohistochemistry we have investigated the occurrence in colorectal cancer of MMP-1 (interstitial collagenase). Our monoclonal antibody was prepared against a synthetic peptide corresponding to an amino acid sequence specific for MMP-1 and was selected to react in formalin-fixed wax-embedded sections, thus allowing use in diagnostic histopathology and also enabling access to archival material. We found that the presence of MMP-1 in colorectal cancer is associated with a poor prognosis (P = 0.006) and has prognostic value independent of Dukes stage. One MMP inhibitor that strongly inhibits MMP-1 has already been shown to inhibit growth of human colon cancer xenografts in nude mice(4). Our results suggest that treatment of those individuals whose colon tumors produce MMP-1 with MMP inhibitors is a therapeutic strategy worth pursuing.	UNIV ABERDEEN,DEPT MOLEC & CELL BIOL,ABERDEEN AB9 2ZD,SCOTLAND	University of Aberdeen	Murray, GI (corresponding author), UNIV ABERDEEN,DEPT PATHOL,ABERDEEN AB9 2ZD,SCOTLAND.							BROWN PD, 1993, CURR OPIN INVEST DR, V2, P617; DUNCAN ME, 1992, J IMMUNOL METHODS, V151, P227, DOI 10.1016/0022-1759(92)90121-9; FENOGLIOPREISER CM, 1995, GASTROINTESTINAL OES, P833; GRAY ST, 1993, AM J PATHOL, V143, P663; HART IR, 1992, LANCET, V339, P1453, DOI 10.1016/0140-6736(92)92039-I; HEWITT RE, 1991, INT J CANCER, V49, P666, DOI 10.1002/ijc.2910490507; IRIMURA T, 1987, INT J CANCER, V40, P24, DOI 10.1002/ijc.2910400106; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; MURRAY GI, 1993, J CLIN PATHOL, V46, P993, DOI 10.1136/jcp.46.11.993; STETLERSTEVENSO.WG, 1992, FASEB J, V7, P1434; URBANSKI SJ, 1993, DIAGN MOL PATHOL, V2, P81; VANDERSTAPPEN JWJ, 1990, INT J CANCER, V45, P1071; WANG X, 1994, CANCER RES, V54, P4726	13	421	430	1	17	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	APR	1996	2	4					461	462		10.1038/nm0496461	http://dx.doi.org/10.1038/nm0496461			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UD314	8597958				2022-12-25	WOS:A1996UD31400050
J	Benjamin, J; Li, L; Patterson, C; Greenberg, BD; Murphy, DL; Hamer, DH				Benjamin, J; Li, L; Patterson, C; Greenberg, BD; Murphy, DL; Hamer, DH			Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking	NATURE GENETICS			English	Letter							VARIANTS; TRAITS		NCI,BIOCHEM LAB,BETHESDA,MD 20892; NIMH,CLIN SCI LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)			Hamer, Dean H/L-1248-2015	Hamer, Dean H/0000-0002-6211-5781				[Anonymous], 1990, PERSONALITY ADULTHOO; ASGHARI V, 1994, MOL PHARMACOL, V46, P364; BOUCHARD TJ, 1994, SCIENCE, V264, P1700, DOI 10.1126/science.8209250; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; CLONINGER CR, 1991, PSYCHOL REP, V69, P1047, DOI 10.2466/PR0.69.7.1047-1057; COHEN J, 1988, STATISTICAL POWER AN; Costa P.T., 1992, NEO FFI PERSONALITY; COSTA PT, IN PRESS REVISED NEO; COSTA PTJ, IN PRESS DEV STRUCTU, P139; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; ELSTON RC, 1994, TRAIT MARKER ASS PRO; FINK JS, 1980, NEUROSCI LETT, V17, P61, DOI 10.1016/0304-3940(80)90062-2; FINK JS, 1981, BRAIN RES, V222, P335, DOI 10.1016/0006-8993(81)91037-4; GEORGE VT, 1987, GENET EPIDEMIOL, V4, P193, DOI 10.1002/gepi.1370040304; Hamer D., 1994, SCI DESIRE; HEATH AC, 1994, J PERS SOC PSYCHOL, V66, P762, DOI 10.1037/0022-3514.66.4.762; HOOKS MS, 1994, J PHARMACOL EXP THER, V269, P976; KALIVAS PW, 1988, ANN NY ACAD SCI, P537; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LICHTER JB, 1993, HUM MOL GENET, V2, P767, DOI 10.1093/hmg/2.6.767; MEADORWOODRUFF JH, 1994, NEUROPSYCHOPHARMACOL, V10, P239, DOI 10.1038/npp.1994.27; MENZA MA, 1993, NEUROLOGY, V43, P505, DOI 10.1212/WNL.43.3_Part_1.505; NICK TG, 1995, GENET EPIDEMIOL, V12, P145, DOI 10.1002/gepi.1370120204; PLOMIN R, 1994, SCIENCE, V264, P1733, DOI 10.1126/science.8209254; RITZ MC, 1993, BIOCHEM SOC SYMP, P51; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stellar J. R., 1985, NEUROBIOLOGY MOTIVAT; VANTOL HHM, 1992, NATURE, V358, P149; VANTOL HHM, 1991, NATURE, V350, P610, DOI 10.1038/350610a0	29	901	931	0	73	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1996	12	1					81	84		10.1038/ng0196-81	http://dx.doi.org/10.1038/ng0196-81			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TM555	8528258	Green Published			2022-12-25	WOS:A1996TM55500019
J	Gabizon, R; Telling, G; Meiner, Z; Halimi, H; Kahana, I; Prusiner, SB				Gabizon, R; Telling, G; Meiner, Z; Halimi, H; Kahana, I; Prusiner, SB			Insoluble wild-type and protease-resistant mutant prion protein in brains of patients with inherited prion disease	NATURE MEDICINE			English	Article							CREUTZFELDT-JAKOB DISEASE; GERSTMANN-STRAUSSLER SYNDROME; AMYLOID PRECURSOR GENE; LIBYAN JEWS; MISSENSE VARIANT; PRP ACCUMULATION; SCRAPIE; MUTATION; CODON-200; REPLICATION	We studied prion proteins (PrP) in skin and brains of Libyan Jews carrying the E200K mutation who died of familial Creutzfeldt-Jakob disease (CJD). Unexpectedly, studies with brain showed that PrP molecules encoded both by the wild-type (wt) and mutant alleles exhibit altered properties characteristic of the prion protein associated with prion diseases (PrPSc). Using monospecific antisera, we found that wtPrP was insoluble in the brains of three patients who were heterozygous for the E200K mutation, whereas mutant PrP was both insoluble and protease-resistant. Our results argue that both wild-type and mutant PrP undergo conformational changes and are particularly intriguing, because the normal isoform PrPC is soluble in nondenaturing detergents and is readily digested by proteases, whereas PrPSc is insoluble and resistant to proteolytic digestion. Our findings indicate that insoluble wtPrP represents a conformational intermediate, the first to be identified, within a pathway in which PrPC is converted to PrPSc.	UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT NEUROL,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gabizon, R (corresponding author), HADASSAH UNIV HOSP,DEPT NEUROL,IL-91120 JERUSALEM,ISRAEL.		Telling, Glenn C/G-1217-2019	Telling, Glenn C/0000-0002-6294-1805				BERTONI J M, 1992, Neurology, V42, P350; BROWN P, 1992, J NEUROL SCI, V112, P65, DOI 10.1016/0022-510X(92)90133-6; CAUGHEY B, 1992, J NEUROCHEM, V59, P768, DOI 10.1111/j.1471-4159.1992.tb09437.x; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; CHAPMAN J, 1994, NEUROLOGY, V44, P1683, DOI 10.1212/WNL.44.9.1683; COLLINGE J, 1993, BRIT MED J, V306, P391; COME JH, 1993, P NATL ACAD SCI USA, V90, P5959, DOI 10.1073/pnas.90.13.5959; DIRINGER H, 1991, J GEN VIROL, V72, P457, DOI 10.1099/0022-1317-72-2-457; EHLERS B, 1984, J GEN VIROL, V65, P1325, DOI 10.1099/0022-1317-65-8-1325; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; GABIZON R, 1988, J BIOL CHEM, V263, P4950; GABIZON R, 1993, AM J HUM GENET, V33, P828; GABIZON R, 1993, J CELL PHYSL, V157; GASSET M, 1993, P NATL ACAD SCI USA, V90, P1, DOI 10.1073/pnas.90.1.1; GASSET M, 1992, P NATL ACAD SCI USA, V89, P10940, DOI 10.1073/pnas.89.22.10940; GOLDFARB LG, 1993, P NATL ACAD SCI USA, V90, P4451, DOI 10.1073/pnas.90.10.4451; GOLDFARB LG, 1991, LANCET, V337, P425, DOI 10.1016/0140-6736(91)91198-4; GOLDFARB LG, 1990, LANCET, V336, P514, DOI 10.1016/0140-6736(90)92073-Q; GOLDFARB LG, 1990, LANCET, V336, P637, DOI 10.1016/0140-6736(90)93443-S; GOLDFARB LG, 1992, SCIENCE, V258, P806, DOI 10.1126/science.1439789; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; HSIAO K, 1991, NEW ENGL J MED, V324, P1091, DOI 10.1056/NEJM199104183241604; HSIAO K, 1992, NAT GENET, V1, P68, DOI 10.1038/ng0492-68; HUANG ZW, 1994, P NATL ACAD SCI USA, V91, P7139, DOI 10.1073/pnas.91.15.7139; INGROSSO L, 1995, J VIROL, V69, P506, DOI 10.1128/JVI.69.1.506-508.1995; KAHANA E, 1974, SCIENCE, V183, P90, DOI 10.1126/science.183.4120.90; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; KIMBERLIN RH, 1983, ARCH VIROL, V78, P9, DOI 10.1007/BF01310854; KITAMOTO T, 1991, NEUROLOGY, V41, P306, DOI 10.1212/WNL.41.2_Part_1.306; KITAMOTO T, 1993, BIOCHEM BIOPH RES CO, V192, P525, DOI 10.1006/bbrc.1993.1447; LADOGANA A, 1992, J GEN VIROL, V73, P661, DOI 10.1099/0022-1317-73-3-661; MASTERS CL, 1981, BRAIN, V104, P559, DOI 10.1093/brain/104.3.559; MEINER Z, 1992, NEUROLOGY, V42, P1355, DOI 10.1212/WNL.42.7.1355; MEYER RK, 1986, P NATL ACAD SCI USA, V83, P2310, DOI 10.1073/pnas.83.8.2310; MONARI L, 1994, P NATL ACAD SCI USA, V91, P2839, DOI 10.1073/pnas.91.7.2839; NGUYEN J, 1995, BIOCHEMISTRY-US, V34, P4186, DOI 10.1021/bi00013a006; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; PRUSINER SB, 1994, P NATL ACAD SCI USA, V91, P4611, DOI 10.1073/pnas.91.11.4611; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; ROGERS M, 1990, Glycobiology, V1, P101, DOI 10.1093/glycob/1.1.101; SAFAR J, 1993, J BIOL CHEM, V268, P20276; SPUDICH S, 1995, MOL MED, V1, P607, DOI 10.1007/BF03401601; TAGLIAVINI F, 1994, CELL, V79, P695, DOI 10.1016/0092-8674(94)90554-1; TARABOULOS A, 1990, P NATL ACAD SCI USA, V87, P8262, DOI 10.1073/pnas.87.21.8262; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; TELLING GC, 1994, P NATL ACAD SCI USA, V91, P9936, DOI 10.1073/pnas.91.21.9936	47	82	82	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JAN	1996	2	1					59	64		10.1038/nm0196-59	http://dx.doi.org/10.1038/nm0196-59			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TP579	8564843				2022-12-25	WOS:A1996TP57900038
J	JINNO, Y; YUN, KK; NISHIWAKI, K; KUBOTA, T; OGAWA, O; REEVE, AE; NIIKAWA, N				JINNO, Y; YUN, KK; NISHIWAKI, K; KUBOTA, T; OGAWA, O; REEVE, AE; NIIKAWA, N			MOSAIC AND POLYMORPHIC IMPRINTING OF THE WT1 GENE IN HUMANS	NATURE GENETICS			English	Article							FACTOR-II GENE; WILMS-TUMOR; UROGENITAL DEVELOPMENT; DRASH SYNDROME; EXPRESSION; MUTATIONS; RECEPTOR	We have examined the imprinting of the Wilms' tumour suppressor gene (WT1) in human tissues. We confirm that WT1 is biallelically expressed in the kidney, however, in five of nine preterm placentae WT1 was expressed largely or exclusively from the maternal allele. Monoallelic expression of WT1 was also found in two fetal brains. These data demonstrate that WT1 can undergo tissue specific imprinting. Furthermore, because monoallelic expression of WT1 was not found in all placentae examined, WT1 imprinting may be genetically polymorphic within the human population.	UNIV OTAGO,SCH MED,DEPT PATHOL,DUNEDIN,NEW ZEALAND; ASAHIKAWA MED COLL,DEPT OBSTET & GYNECOL,ASAHIKAWA 078,JAPAN; UNIV OTAGO,DEPT BIOCHEM,CANC GENET LAB,DUNEDIN,NEW ZEALAND	University of Otago; Asahikawa Medical College; University of Otago	JINNO, Y (corresponding author), NAGASAKI UNIV,SCH MED,DEPT HUMAN GENET,NAGASAKI 852,JAPAN.							BARLOW DP, 1993, SCIENCE, V260, P309, DOI 10.1126/science.8469984; BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BRUENING W, 1992, NAT GENET, V1, P144, DOI 10.1038/ng0592-144; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DRUMMOND IA, 1992, SCIENCE, V257, P674, DOI 10.1126/science.1323141; GESSLER M, 1992, GENOMICS, V12, P807, DOI 10.1016/0888-7543(92)90313-H; GIANNOUKAKIS N, 1993, NAT GENET, V4, P98, DOI 10.1038/ng0593-98; HAIG D, 1991, CELL, V64, P1045; HALL JG, 1990, AM J HUM GENET, V46, P857; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HOBAN PR, 1991, NUCLEIC ACIDS RES, V19, P1164, DOI 10.1093/nar/19.5.1164-a; HUFF V, 1990, AM J HUM GENET, V47, P155; JADRESIC L, 1990, J PEDIATR-US, V117, P717, DOI 10.1016/S0022-3476(05)83327-X; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; LITTLE MH, 1993, HUM MOL GENET, V2, P259, DOI 10.1093/hmg/2.3.259; LITTLE MH, 1992, ONCOGENE, V7, P635; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; OGAWA O, 1993, NAT GENET, V5, P408, DOI 10.1038/ng1293-408; OHLSSON R, 1993, NAT GENET, V4, P94, DOI 10.1038/ng0593-94; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; PELLETIER J, 1991, CELL, V67, P437, DOI 10.1016/0092-8674(91)90194-4; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; RICCARDI VM, 1982, J PEDIATR-US, V100, P574, DOI 10.1016/S0022-3476(82)80755-5; RICCARDI VM, 1980, CANCER GENET CYTOGEN, V2, P131, DOI 10.1016/0165-4608(80)90056-4; SAPIENZA C, 1990, MOL CARCINOGEN, V3, P118, DOI 10.1002/mc.2940030303; VANHEYNINGEN V, 1992, TRENDS GENET, V8, P16, DOI 10.1016/0168-9525(92)90019-Z; WAGSTAFF J, 1992, NAT GENET, V1, P291, DOI 10.1038/ng0792-291; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	29	174	175	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1994	6	3					305	309		10.1038/ng0394-305	http://dx.doi.org/10.1038/ng0394-305			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ562	8012395				2022-12-25	WOS:A1994MZ56200020
J	ARBONES, ML; AUSTIN, HA; CAPON, DJ; GREENBURG, G				ARBONES, ML; AUSTIN, HA; CAPON, DJ; GREENBURG, G			GENE TARGETING IN NORMAL SOMATIC-CELLS - INACTIVATION OF THE INTERFERON-GAMMA RECEPTOR IN MYOBLASTS	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; HOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS; SYSTEMIC DELIVERY; DISRUPTION; EXPRESSION; FIBROBLASTS; SELECTION; ANTIBODY; FIDELITY	Gene targeting in somatic cells represents a potentially powerful method for gene therapy, yet with the exception of pluripotent mouse embryonic stem (ES) cells, homologous recombination has not been reported for a well characterized, non-transformed mammalian cell. Applying a highly efficient strategy for targeting an integral membrane protein - the interferon gamma receptor - in ES cells, we have used homologous recombination to target a non-transformed somatic cell, the mouse myoblast, and to compare targeting efficiencies in these two cell types. Gene-targeted myoblasts display the properties of normal cells including normal morphology, ability to differentiate in vitro, stable diploid karyotype, inability to form colonies in soft agar and lack of tumorigenicity in nude mice.	CELL GENESYS INC,322 LAKESIDE DR,FOSTER CITY,CA 94404	Cell Genesys Inc			Arbones, Maria/D-4668-2016	Arbones, Maria/0000-0002-6035-0235				ACCILI D, 1991, P NATL ACAD SCI USA, V88, P4708, DOI 10.1073/pnas.88.11.4708; AGUET M, 1988, CELL, V55, P273, DOI 10.1016/0092-8674(88)90050-5; AUSTIN HA, 1993, IN VITRO, V29, pA105; BAO S, 1990, IMMUNOL CELL BIOL, V68, P235, DOI 10.1038/icb.1990.33; BARR E, 1991, SCIENCE, V254, P1507, DOI 10.1126/science.1962212; BASU M, 1989, J INTERFERON RES, V9, P551, DOI 10.1089/jir.1989.9.551; BRADLEY A, 1992, BIO-TECHNOL, V10, P534, DOI 10.1038/nbt0592-534; CAMERINI-OTERO R D, 1990, New Biologist, V2, P337; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CHARRON J, 1990, MOL CELL BIOL, V10, P1799, DOI 10.1128/MCB.10.4.1799; DHAWAN J, 1991, SCIENCE, V254, P1509, DOI 10.1126/science.1962213; DOETSCHMAN T, 1988, P NATL ACAD SCI USA, V85, P8583, DOI 10.1073/pnas.85.22.8583; FARRAR MA, 1991, J BIOL CHEM, V266, P19626; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; FELL HP, 1989, P NATL ACAD SCI USA, V86, P8507, DOI 10.1073/pnas.86.21.8507; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; GUSSONI E, 1992, NATURE, V356, P435, DOI 10.1038/356435a0; HEMMI S, 1989, P NATL ACAD SCI USA, V86, P9901, DOI 10.1073/pnas.86.24.9901; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; JAKOBOVITS A, 1993, P NATL ACAD SCI USA, V90, P2551, DOI 10.1073/pnas.90.6.2551; JASIN M, 1988, GENE DEV, V2, P1353, DOI 10.1101/gad.2.11.1353; JEANNOTTE L, 1991, MOL CELL BIOL, V11, P5578, DOI 10.1128/MCB.11.11.5578; KOLLER BH, 1992, ANNU REV IMMUNOL, V10, P705, DOI 10.1146/annurev.iy.10.040192.003421; KOLLER BH, 1989, P NATL ACAD SCI USA, V86, P8932, DOI 10.1073/pnas.86.22.8932; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; MACPHERSON I, 1964, VIROLOGY, V23, P291, DOI 10.1016/0042-6822(64)90301-0; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; NESBITT MN, 1973, CHROMOSOMA, V41, P145, DOI 10.1007/BF00319691; PARTRIDGE TA, 1978, NATURE, V273, P306, DOI 10.1038/273306a0; PARTRIDGE TA, 1991, MUSCLE NERVE, V14, P197, DOI 10.1002/mus.880140302; PATRUSKY B, 1990, MOSAIC, V21, P44; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; RASTINEJAD F, 1993, CELL, V72, P903, DOI 10.1016/0092-8674(93)90579-F; RIELE HT, 1990, NATURE, V348, P649, DOI 10.1038/348649a0; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; ROSA F, 1984, IMMUNOL TODAY, V5, P261, DOI 10.1016/0167-5699(84)90135-X; Roth D., 1988, GENETIC RECOMBINATIO, P621; SCHWARTZBERG PL, 1990, P NATL ACAD SCI USA, V87, P3210, DOI 10.1073/pnas.87.8.3210; SEDIVY JM, 1989, P NATL ACAD SCI USA, V86, P227, DOI 10.1073/pnas.86.1.227; STEEG CM, 1990, P NATL ACAD SCI USA, V87, P4680, DOI 10.1073/pnas.87.12.4680; THOMAS KR, 1992, MOL CELL BIOL, V12, P2919, DOI 10.1128/MCB.12.7.2919; TRINCHIERI G, 1985, IMMUNOL TODAY, V6, P131, DOI 10.1016/0167-5699(85)90080-5; TROWSDALE J, 1990, NATURE, V348, P741, DOI 10.1038/348741a0; VALANCIUS V, 1991, MOL CELL BIOL, V11, P1402, DOI 10.1128/MCB.11.3.1402; Verma R. S, 1989, HUMAN CHROMOSOMES MA, P45; WALDMAN AS, 1992, CRIT REV ONCOL HEMAT, V12, P49, DOI 10.1016/1040-8428(92)90064-W; Worton R G, 1979, Methods Enzymol, V58, P322; ZHENG H, 1991, P NATL ACAD SCI USA, V88, P8067, DOI 10.1073/pnas.88.18.8067	49	47	54	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1994	6	1					90	97		10.1038/ng0194-90	http://dx.doi.org/10.1038/ng0194-90			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ177	8136841				2022-12-25	WOS:A1994MQ17700020
J	DUBAY, C; VINCENT, M; SAMANI, NJ; HILBERT, P; KAISER, MA; BERESSI, JP; KOTELEVTSEV, Y; BECKMANN, JS; SOUBRIER, F; SASSARD, J; LATHROP, GM				DUBAY, C; VINCENT, M; SAMANI, NJ; HILBERT, P; KAISER, MA; BERESSI, JP; KOTELEVTSEV, Y; BECKMANN, JS; SOUBRIER, F; SASSARD, J; LATHROP, GM			GENETIC-DETERMINANTS OF DIASTOLIC AND PULSE PRESSURE MAP TO DIFFERENT LOCI IN LYON HYPERTENSIVE RATS	NATURE GENETICS			English	Article							BLOOD-PRESSURE; RENIN GENE; ANGIOTENSIN; STRAIN	Several genetic loci involved in blood pressure regulation have recently been localized in experimental models of hypertension, but the manner in which they influence blood pressure remains unknown. Here, we report a study of the Lyon hypertensive rat strain showing that different loci are involved in the regulation of steady-state (diastolic pressure) and pulsatile (systolic - diastolic, or pulse pressure) components of blood pressure. Significant linkage was established between diastolic blood pressure and a microsatellite marker of the renin gene (REN) on rat chromosome 13, and between pulse pressure and the carboxypeptidase B gene (CPB) on chromosome 2. These findings show that two independent loci influence different haemodynamic components of blood pressure, and that pulse pressure has a specific genetic determination.	CTR ETUD POLYMORPHISME HUMAIN,INSERM,U358,F-75010 PARIS,FRANCE; FAC PHARM LYON,DEPT PHYSIOL & PHARMACOL CLIN,CNRS,URA 1483,F-69373 LYON,FRANCE; UNIV LEICESTER,ROYAL INFIRM,DEPT MED,LEICESTER LE2 7LX,ENGLAND; IRIBNH,B-1070 BRUSSELS,BELGIUM; COLL FRANCE,INSERM,U36,F-75005 PARIS,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Leicester; Universite Libre de Bruxelles; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France			Beckmann, Jacques S/A-9772-2008; Kotelevtsev, Yuri V/R-1772-2016	Beckmann, Jacques S/0000-0002-9741-1900; Kotelevtsev, Yuri/0000-0002-7255-7794	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ADAMS M, 1984, BIOCHEM GENET, V22, P611, DOI 10.1007/BF00485848; CANESSA M, 1980, NEW ENGL J MED, V302, P772, DOI 10.1056/NEJM198004033021403; DENG YL, 1992, NAT GENET, V1, P267, DOI 10.1038/ng0792-267; DIXON WJ, 1988, BMDP STATISTICAL SOF; GUSTIN MP, 1990, COMPUT BIOL MED, V20, P205, DOI 10.1016/0010-4825(90)90006-B; HALL JE, 1980, AM J PHYSIOL, V239, pF271, DOI 10.1152/ajprenal.1980.239.3.F271; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; HOLLENBERG NK, 1986, AM J MED, V81, P412, DOI 10.1016/0002-9343(86)90291-3; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; KURTZ TW, 1990, J CLIN INVEST, V85, P1328, DOI 10.1172/JCI114572; LARAGH JH, 1982, FED PROC, V41, P2415; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LINDPAINTENER K, 1991, HYPERTENSION, V8, P763; NICOLS WW, 1990, MCDONALD BLOOD FLOW, P216; PRAVENEC M, 1991, GENOMICS, V9, P466, DOI 10.1016/0888-7543(91)90412-8; RAPP JP, 1989, SCIENCE, V243, P542, DOI 10.1126/science.2563177; SAFAR ME, 1989, J HYPERTENS, V7, P769, DOI 10.1097/00004872-198910000-00001; SERIKAWA, 1992, GENETICS, V131, P703; SOUBRIER F, 1991, GENETIC APPROACHES C, P27; SU DF, 1986, AM J PHYSIOL, V251, pH1111, DOI 10.1152/ajpheart.1986.251.6.H1111; VINCENT M, 1979, JAP HEART J, V20, P135; WARD R, 1990, HYPERTENSION PATHOPH, P81; ZINNER SH, 1976, AM J EPIDEMIOL, V104, P124, DOI 10.1093/oxfordjournals.aje.a112282	23	128	130	1	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1993	3	4					354	357		10.1038/ng0493-354	http://dx.doi.org/10.1038/ng0493-354			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KW257	7981757				2022-12-25	WOS:A1993KW25700019
J	GURRIERI, F; TRASK, BJ; VANDENENGH, G; KRAUSS, CM; SCHINZEL, A; PETTENATI, MJ; SCHINDLER, D; DIETZBAND, J; VERGNAUD, G; SCHERER, SW; TSUI, LC; MUENKE, M				GURRIERI, F; TRASK, BJ; VANDENENGH, G; KRAUSS, CM; SCHINZEL, A; PETTENATI, MJ; SCHINDLER, D; DIETZBAND, J; VERGNAUD, G; SCHERER, SW; TSUI, LC; MUENKE, M			PHYSICAL MAPPING OF THE HOLOPROSENCEPHALY CRITICAL REGION ON CHROMOSOME-7Q36	NATURE GENETICS			English	Article							UNBALANCED SEGREGATION; FAMILIAL TRANSLOCATION; POLYMORPHIC LOCI; DNA FRAGMENTS; LINKAGE MAP; CLONING; GENE; CYCLOPIA; MARKERS; PERSPECTIVES	Holoprosencephaly (HPE) is a developmental field defect involving the brain and face. Cytogenetic deletions in patients with HPE have localized one of the HPE genes to chromosomal region 7q36. We have characterized the 7q deletions in thirteen HPE patients. The result is the construction of a high resolution physical map of 7q32-qter. As a first step towards cloning an HPE gene crucial for normal brain development, we have defined the HPE minimal critical region in 7q36 between D7S292 and D7S392.	CHILDRENS HOSP PHILADELPHIA,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT PEDIAT,DIV HUMAN GENET & MOLEC BIOL,PHILADELPHIA,PA 19104; LAWRENCE LIVERMORE NATL LAB,DIV BIOMED SCI,LIVERMORE,CA 94550; HARVARD COMMUNITY HLTH PLAN,BOSTON,MA 02116; INST MED GENET,ZURICH,SWITZERLAND; WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT PEDIAT,DIV MED GENET,WINSTON SALEM,NC 27103; INST HUMAN GENET & ANTHROPOL,WURZBURG,GERMANY; ONCOR INC,GAITHERSBURG,MD 20884; CTR ETUD BOUCHET,F-91710 VERT LE PETIT,FRANCE; HOSP SICK CHILDREN,DEPT GENET,TORONTO M5G 1X8,ONTARIO,CANADA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Wake Forest University; Wake Forest Baptist Medical Center; University of Wurzburg; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)			Gurrieri, Fiorella/K-3214-2016; Tsui, Lap-chee/A-1081-2010; Vergnaud, Gilles/AAC-1162-2020; Scherer, Stephen W./B-3785-2013; Vergnaud, Gilles/P-1304-2015	Gurrieri, Fiorella/0000-0002-6775-5972; Vergnaud, Gilles/0000-0003-0913-194X; Scherer, Stephen W./0000-0002-8326-1999; Vergnaud, Gilles/0000-0003-0913-194X; Muenke, Maximilian/0000-0002-7719-6545				BARKER D, 1987, P NATL ACAD SCI USA, V84, P8006, DOI 10.1073/pnas.84.22.8006; BELL GI, 1982, NATURE, V295, P31, DOI 10.1038/295031a0; COHEN MM, 1989, TERATOLOGY, V40, P211, DOI 10.1002/tera.1420400304; COHEN MM, 1989, AM J MED GENET, V34, P271, DOI 10.1002/ajmg.1320340232; COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3; DIETZBAND J, 1990, GENOMICS, V8, P168, DOI 10.1016/0888-7543(90)90240-U; ECKERT RL, 1986, CELL, V46, P583, DOI 10.1016/0092-8674(86)90884-6; FREZAL J, 1991, CYTOGENET CELL GENET, V58, P986, DOI 10.1159/000133716; HATZIIOANNOU AG, 1991, AM J MED GENET, V40, P201, DOI 10.1002/ajmg.1320400216; ISOBE M, 1985, SCIENCE, V228, P580, DOI 10.1126/science.3983641; JEFFREYS AJ, 1988, NUCLEIC ACIDS RES, V16, P10953, DOI 10.1093/nar/16.23.10953; KRAUSS CM, 1989, AM J MED GENET, V34, P514, DOI 10.1002/ajmg.1320340412; KURTZMAN DN, 1987, AM J MED GENET, V27, P33, DOI 10.1002/ajmg.1320270105; LATHROP GM, 1989, GENOMICS, V5, P866, DOI 10.1016/0888-7543(89)90128-6; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LAUTHIER V, 1992, HUM MOL GENET, V1, P64, DOI 10.1093/hmg/1.1.64; LOGAN C, 1989, GENOMICS, V4, P206, DOI 10.1016/0888-7543(89)90301-7; MCKUSICK VA, 1992, MENDELIAN INHERITANC, P544; MUNKE M, 1988, AM J MED GENET, V30, P929, DOI 10.1002/ajmg.1320300409; MUNKE M, 1989, AM J MED GENET, V34, P237, DOI 10.1002/ajmg.1320340222; PUNNETT HH, 1979, CYTOGENET CELL GENET, V24, P126, DOI 10.1159/000131366; RIETHMAN HC, 1989, P NATL ACAD SCI USA, V86, P6240, DOI 10.1073/pnas.86.16.6240; ROMMENS JM, 1988, AM J HUM GENET, V43, P645; SCHINZEL A, 1984, AM J MED GENET, V18, P153, DOI 10.1002/ajmg.1320180119; SCHINZEL A, 1986, AM J MED GENET, V24, P205, DOI 10.1002/ajmg.1320240128; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STEWART EA, 1990, AM J HUM GENET, V46, P795; TAYSI K, 1982, ANN GENET-PARIS, V25, P159; TRASK B, 1989, AM J HUM GENET, V45, P739; TRASK B, 1990, CYTOMETRY, V11, P184, DOI 10.1002/cyto.990110121; VERGNAUD G, 1989, NUCLEIC ACIDS RES, V17, P7623, DOI 10.1093/nar/17.19.7623; VERGNAUD G, 1991, GENOMICS, V11, P135, DOI 10.1016/0888-7543(91)90110-Z; WONG Z, 1986, NUCLEIC ACIDS RES, V14, P4605, DOI 10.1093/nar/14.11.4605; YUNIS JJ, 1984, SCIENCE, V226, P1199, DOI 10.1126/science.6239375; ZACKOWSKI JL, 1990, ANN GENET-PARIS, V33, P113; SCIENCE, V258, P67	36	80	81	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1993	3	3					247	251		10.1038/ng0393-247	http://dx.doi.org/10.1038/ng0393-247			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KP790	8485580				2022-12-25	WOS:A1993KP79000015
J	TASSABEHJI, M; READ, AP; NEWTON, VE; PATTON, M; GRUSS, P; HARRIS, R; STRACHAN, T				TASSABEHJI, M; READ, AP; NEWTON, VE; PATTON, M; GRUSS, P; HARRIS, R; STRACHAN, T			MUTATIONS IN THE PAX3 GENE CAUSING WAARDENBURG SYNDROME TYPE-1 AND TYPE-2	NATURE GENETICS			English	Article							POINT MUTATION; PAIRED BOX; MOUSE; DNA	Waardenburg syndrome (WS) is a combination of deafness and pigmentary disturbances, normally inherited as an autosomal dominant trait. The pathology involves neural crest derivatives, but WS is heterogeneous clinically and genetically. Some type I WS families show linkage with markers on distal 2q and in three cases the disease has been attributed to mutations in the PAX3 gene. PAX3 encodes a paired domain, a highly conserved octapeptide and probably also a paired-type homeodomain. Here we describe a further three PAX3 mutations which cause WS; one alters the octapeptide motif plus the presumed homeodomain; a second alters all three elements and the third alters the paired box alone. The latter occurs in a family with probable type 2 WS, a clinical variant usually considered not to be allelic with type 1 WS.	UNIV MANCHESTER,ST MARYS HOSP,DEPT MED GENET,MANCHESTER M13 0JH,LANCS,ENGLAND; UNIV MANCHESTER,CTR AUDIOL,MANCHESTER M13 9PL,LANCS,ENGLAND; ST GEORGE HOSP,SCH MED,DEPT CLIN GENET,LONDON SW17 0RE,ENGLAND; MAX PLANCK INST BIOPHYS CHEM,W-3400 GOTTINGEN,GERMANY	University of Manchester; University of Manchester; St Georges University London; Max Planck Society					Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BALLING R, 1988, CELL, V55, P531, DOI 10.1016/0092-8674(88)90039-6; BURRI M, 1989, EMBO J, V8, P1183, DOI 10.1002/j.1460-2075.1989.tb03490.x; CHALEPAKIS G, 1991, CELL, V66, P873, DOI 10.1016/0092-8674(91)90434-Z; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; FARRER LA, 1992, AM J HUM GENET, V50, P902; FOY C, 1990, AM J HUM GENET, V46, P1017; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; GRUSS P, 1992, CELL, V69, P719, DOI 10.1016/0092-8674(92)90281-G; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; McKusick V. A. E., 1991, MENDELIAN INHERITANC; MOASE CE, 1992, J MED GENET, V29, P145, DOI 10.1136/jmg.29.3.145; Morell Robert, 1992, Human Molecular Genetics, V1, P243, DOI 10.1093/hmg/1.4.243; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; NEWTON VE, 1989, SCAND AUDIOL, V18, P221, DOI 10.3109/01050398909042198; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; WALTHER C, 1991, GENOMICS, V11, P424, DOI 10.1016/0888-7543(91)90151-4; WILCOX ER, 1992, HUM MOL GENET, V1, P215, DOI 10.1093/hmg/1.3.215-a	21	176	180	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1993	3	1					26	30		10.1038/ng0193-26	http://dx.doi.org/10.1038/ng0193-26			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KF372	8490648				2022-12-25	WOS:A1993KF37200008
J	Scheuner, D; Eckman, C; Jensen, M; Song, X; Citron, M; Suzuki, N; Bird, TD; Hardy, J; Hutton, M; Kukull, W; Larson, E; LevyLahad, E; Viitanen, M; Peskind, E; Poorkaj, P; Schellenberg, G; Tanzi, R; Wasco, W; Lannfelt, L; Selkoe, D; Younkin, S				Scheuner, D; Eckman, C; Jensen, M; Song, X; Citron, M; Suzuki, N; Bird, TD; Hardy, J; Hutton, M; Kukull, W; Larson, E; LevyLahad, E; Viitanen, M; Peskind, E; Poorkaj, P; Schellenberg, G; Tanzi, R; Wasco, W; Lannfelt, L; Selkoe, D; Younkin, S			Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease	NATURE MEDICINE			English	Article							PRECURSOR PROTEIN; APOLIPOPROTEIN-E; MISSENSE MUTATIONS; A-BETA; GENE; PEPTIDE; CELLS; CHROMOSOME-1; A-BETA-42(43); PATHOGENESIS	To determine whether the presenilin 1 (PS1), presenilin 2 (PS2) and amyloid beta-protein precursor (APP) mutations linked to familial Alzheimer's disease (FAD) increase the extracellular concentration of amyloid beta-protein (A beta) ending at A beta 42(43) in vivo, we performed a blinded comparison of plasma A beta levels in carriers of these mutations and controls. A beta 1-42(43) was elevated in plasma from subjects with FAD-linked PS1 (P < 0.0007), PS2(N141I) (P = 0.009), APP(K670N,M671L) (P < 0.0001), and APP(Y717I) (one subject) mutations. A beta ending at A beta 42(43) was also significantly elevated in fibroblast media from subjects with PS1 (P < 0.0001) or PS2 (P = 0.03) mutations. These findings indicate that the FAD-linked mutations may all cause Alzheimer's disease by increasing the extracellular concentration of A beta 42(43), thereby fostering cerebral deposition of this highly amyloidogenic peptide.	CASE WESTERN RESERVE UNIV,DEPT NEUROSCI,CLEVELAND,OH 44106; MAYO CLIN JACKSONVILLE,JACKSONVILLE,FL 32224; HUDDINGE UNIV HOSP,KAROLINSKA INST,DEPT CLIN NEUROSCI & FAMILY MED,NOVUM KFC,S-14186 HUDDINGE,SWEDEN; CASE WESTERN RESERVE UNIV,DEPT PATHOL,CLEVELAND,OH 44106; HARVARD UNIV,SCH MED,CTR NEUROL DIS,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,BOSTON,MA 02115; TAKEDA CHEM IND LTD,DIV DISCOVERY RES,TSUKUBA,IBARAKI 30042,JAPAN; UNIV WASHINGTON,DEPT NEUROL,SEATTLE,WA 98185; UNIV WASHINGTON,DEPT EPIDEMIOL,SEATTLE,WA 98185; UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98185; UNIV WASHINGTON,DEPT PSYCHIAT & BEHAV SCI,SEATTLE,WA 98185; UNIV WASHINGTON,DEPT PHARMACOL,SEATTLE,WA 98185; VET AFFAIRS PUGET SOUND HLTH CARE SYST,NEUROL SERV,SEATTLE,WA 98108; VET AFFAIRS PUGET SOUND HLTH CARE SYST,CTR GERIATR RES EDUC & CLIN,SEATTLE,WA 98108; UNIV S FLORIDA,DEPT PSYCHIAT,SUNCOAST ALZHEIMERS DIS LABS,TAMPA,FL 33613; HARVARD UNIV,SCH MED,MASSACHUSETTS GEN HOSP,DEPT NEUROL,GENET & AGING UNIT,CHARLESTOWN,MA 02129	Case Western Reserve University; Mayo Clinic; Karolinska Institutet; Case Western Reserve University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Takeda Chemical Industries; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; State University System of Florida; University of South Florida; Harvard University; Massachusetts General Hospital			Tanzi, Rudolph/AAE-9622-2019; Hardy, John/C-2451-2009; Levy-Lahad, Ephrat/F-2186-2018	Tanzi, Rudolph/0000-0002-7032-1454; Hardy, John/0000-0002-3122-0423; Levy-Lahad, Ephrat/0000-0002-2637-1921; Kukull, Walter/0000-0001-8761-9014				BURDICK D, 1992, J BIOL CHEM, V267, P546; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CASTANO EM, 1995, BIOCHEM J, V306, P599, DOI 10.1042/bj3060599; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; CITRON M, 1994, P NATL ACAD SCI USA, V91, P11993, DOI 10.1073/pnas.91.25.11993; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; DOVEY HF, 1993, NEUROREPORT, V4, P1039, DOI 10.1097/00001756-199308000-00011; EVANS KC, 1995, P NATL ACAD SCI USA, V92, P763, DOI 10.1073/pnas.92.3.763; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; GRUBB A, 1984, NEW ENGL J MED, V311, P1547, DOI 10.1056/NEJM198412133112406; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HARDY J, 1991, LANCET, V337, P1342; HILBICH C, 1991, J MOL BIOL, V218, P149, DOI 10.1016/0022-2836(91)90881-6; IWATSUBO T, 1995, ANN NEUROL, V37, P294, DOI 10.1002/ana.410370305; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; KUKULL WA, 1995, AM J EPIDEMIOL, V141, P1059, DOI 10.1093/oxfordjournals.aje.a117370; KUKULL WA, 1996, AM J EPIDEMIOL, V142, P450; Larson E B, 1990, Aging (Milano), V2, P404; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MILLER DL, 1993, ARCH BIOCHEM BIOPHYS, V301, P41, DOI 10.1006/abbi.1993.1112; MOTTER R, 1995, ANN NEUROL, V38, P643, DOI 10.1002/ana.410380413; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; NARUSE S, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91612-X; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; ROHER AE, 1993, J BIOL CHEM, V268, P3072; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; TAMAOKA A, 1994, J BIOL CHEM, V269, P32721; VIGOPELFREY C, 1993, J NEUROCHEM, V61, P19965; WISNIEWSKI T, 1994, AM J PATHOL, V145, P1030; YOSHIOKA K, 1991, BIOCHEM BIOPH RES CO, V178, P1141, DOI 10.1016/0006-291X(91)91011-Z	40	2174	2302	1	256	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	AUG	1996	2	8					864	870		10.1038/nm0896-864	http://dx.doi.org/10.1038/nm0896-864			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UZ804	8705854				2022-12-25	WOS:A1996UZ80400031
J	Jansen, G; Groenen, PJTA; Bachner, D; Jap, PHK; Coerwinkel, M; Oerlemans, F; vandenBroek, W; Gohlsch, B; Pette, D; Plomp, JJ; Molenaar, PC; Nederhoff, MGJ; vanEchteld, CJA; Dekker, M; Berns, A; Hameister, H; Wieringa, B				Jansen, G; Groenen, PJTA; Bachner, D; Jap, PHK; Coerwinkel, M; Oerlemans, F; vandenBroek, W; Gohlsch, B; Pette, D; Plomp, JJ; Molenaar, PC; Nederhoff, MGJ; vanEchteld, CJA; Dekker, M; Berns, A; Hameister, H; Wieringa, B			Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice	NATURE GENETICS			English	Article							UNSTABLE CTG REPEAT; CARDIAC INVOLVEMENT; MUSCULAR-DYSTROPHY; SKELETAL-MUSCLES; GENE; EXPRESSION; REGION; TRANSCRIPT; EXPANSION; SEQUENCE	Myotonic dystrophy (DM) is commonly associated with CTG repeat expansions within the gene for DM-protein kinase (DMPK). The effect of altered expression levels of DMPK, which is ubiquitously expressed in all muscle cell lineages during development, was examined by disrupting the endogenous Dmpk gene and overexpressing a normal human DMPK transgene in mice. Nullizygous (-/-) mice showed only inconsistent and minor size changes in head and neck muscle fibres at older age, animals with the highest DMPK transgene expression showed hypertrophic cardiomyopathy and enhanced neonatal mortality. However, both models lack other frequent DM symptoms including the fibre-type dependent atrophy, myotonia, cataract and male-infertility. These results strengthen the contention that simple loss- or gain-of-expression of DMPK is not the only crucial requirement for development of the disease.	UNIV NIJMEGEN, FAC MED, DEPT HISTOL & CELL BIOL, 6500 HB NIJMEGEN, NETHERLANDS; UNIV ULM KLINIKUM, D-89069 ULM, GERMANY; UNIV KONSTANZ, FAC BIOL, D-78434 CONSTANCE, GERMANY; LEIDEN UNIV, DEPT PHYSIOL, 2300 RC LEIDEN, NETHERLANDS; UNIV UTRECHT HOSP, DEPT CARDIOL, 3584 CX UTRECHT, NETHERLANDS; NETHERLANDS CANC INST, DEPT MOLEC GENET, AMSTERDAM, NETHERLANDS	Radboud University Nijmegen; Ulm University; University of Konstanz; Leiden University; Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center; Netherlands Cancer Institute			Wieringa, Berend/A-5346-2011; Jansen, Gert/HCI-8852-2022; Groenen, Patricia/L-4336-2015	Wieringa, Berend/0000-0001-9192-8020; Groenen, Patricia/0000-0003-4314-228X; Jansen, Gert/0000-0002-7524-171X				ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BACHNER D, 1993, HUM MOL GENET, V2, P2043, DOI 10.1093/hmg/2.12.2043; BEILHARZ MW, 1992, MOL CELL NEUROSCI, V3, P326, DOI 10.1016/1044-7431(92)90029-2; BIANCHI G, 1983, GASTROENTEROLOGY, V85, P852; BOUCHER CA, 1995, HUM MOL GENET, V4, P1919, DOI 10.1093/hmg/4.10.1919; Bradley A, 1987, TERATOCARCINOMAS EMB, P113; BREWSTER BS, 1993, BIOCHEM BIOPH RES CO, V194, P1256, DOI 10.1006/bbrc.1993.1958; BRILLIANT MH, 1994, MAMM GENOME, V5, pS104; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BRUNNER HG, 1993, AM J HUM GENET, V53, P1016; BRUNNER HG, 1992, J MED GENET, V29, P791, DOI 10.1136/jmg.29.11.791; DANGAIN J, 1984, MUSCLE NERVE, V7, P700, DOI 10.1002/mus.880070903; DUNNE PW, 1994, BIOCHEMISTRY-US, V33, P10809, DOI 10.1021/bi00201a031; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1993, SCIENCE, V260, P235, DOI 10.1126/science.8469976; HAMALAINEN N, 1993, J HISTOCHEM CYTOCHEM, V41, P733, DOI 10.1177/41.5.8468455; HARLEY HG, 1993, AM J HUM GENET, V52, P1164; Harper P.S., 1989, MYOTONIC DYSTROPHY; HOFMANNRADVANYI H, 1993, HUM MOL GENET, V2, P1263, DOI 10.1093/hmg/2.8.1263; HUNTER A, 1992, J MED GENET, V29, P774, DOI 10.1136/jmg.29.11.774; JANSEN G, 1992, NAT GENET, V1, P261, DOI 10.1038/ng0792-261; JANSEN G, 1994, AM J HUM GENET, V54, P575; JANSEN G, 1995, HUM MOL GENET, V4, P843, DOI 10.1093/hmg/4.5.843; JASPERT A, 1995, J NEUROL, V242, P99, DOI 10.1007/BF00887824; KOGA R, 1994, BIOCHEM BIOPH RES CO, V202, P577, DOI 10.1006/bbrc.1994.1967; KRAHE R, 1995, GENOMICS, V28, P1, DOI 10.1006/geno.1995.1099; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LEM J, 1992, P NATL ACAD SCI USA, V89, P4422, DOI 10.1073/pnas.89.10.4422; MAEDA M, 1995, J BIOL CHEM, V270, P20246, DOI 10.1074/jbc.270.35.20246; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MAHADEVAN MS, 1993, HUM MOL GENET, V2, P299, DOI 10.1093/hmg/2.3.299; MELACINI P, 1988, CLIN CARDIOL, V11, P231, DOI 10.1002/clc.4960110407; MONCKTON DG, 1995, HUM MOL GENET, V4, P1; MOORMAN JR, 1985, MEDICINE, V64, P371, DOI 10.1097/00005792-198511000-00002; NGUYEN HH, 1988, J AM COLL CARDIOL, V11, P662, DOI 10.1016/0735-1097(88)91547-1; PLOMP JJ, 1994, J PHYSIOL-LONDON, V478, P125, DOI 10.1113/jphysiol.1994.sp020236; ROSEN B, 1993, TRENDS GENET, V9, P162, DOI 10.1016/0168-9525(93)90162-B; SABOURI LA, 1993, NAT GENET, V4, P233, DOI 10.1038/ng0793-233; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; SHAW DJ, 1993, GENOMICS, V18, P673, DOI 10.1016/S0888-7543(05)80372-6; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; VANDERVEN PFM, 1993, HUM MOL GENET, V2, P1889; VANDERVEN PFM, 1995, THESIS U NIJMEGEN ME; VANDEURSEN J, 1992, NUCLEIC ACIDS RES, V20, P3815, DOI 10.1093/nar/20.15.3815; VANDEURSEN J, 1993, CELL, V74, P621, DOI 10.1016/0092-8674(93)90510-W; VANECHTELD CJA, 1991, J MOL CELL CARDIOL, V23, P297, DOI 10.1016/0022-2828(91)90066-U; WANG YH, 1994, SCIENCE, V265, P669, DOI 10.1126/science.8036515; WEISS LM, 1991, AM J PATHOL, V138, P497; WHITING EJ, 1995, HUM MOL GENET, V4, P1063, DOI 10.1093/hmg/4.6.1063; WIERINGA B, 1994, HUM MOL GENET, V3, P1, DOI 10.1093/hmg/3.1.1-a	51	245	250	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1996	13	3					316	324		10.1038/ng0796-316	http://dx.doi.org/10.1038/ng0796-316			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UU283	8673131				2022-12-25	WOS:A1996UU28300020
J	Avarbock, MR; Brinster, CJ; Brinster, RL				Avarbock, MR; Brinster, CJ; Brinster, RL			Reconstitution of spermatogenesis from frozen spermatogonial stem cells	NATURE MEDICINE			English	Article							MOUSE	Spermatozoa from a number of species can be cryopreserved and then subsequently used to fertilize eggs'. However, this technique has several limitations. First, the freezing protocol varies for each species and must be determined empirically, and for some species appropriate methods have not yet been identified(1,2). Second, because these cells are fully differentiated, they will not undergo replication when thawed, and recombination of genetic information cannot occur. We now demonstrate, by using the recently developed spermatogonial transplantation technique(3,4), that male germline stem cells can be successfully cryopreserved. Donor testis cells isolated from prepubertal or adult mice and frozen from 4 to 156 days at -196 degrees C were able to generate spermatogenesis in recipient seminiferous tubules. Relatively standard preservation techniques were used, suggesting that male germ cells from other species can also be stored for long periods. Because transplanted testis stem cells will ultimately undergo replication and meiotic recombination during spermatogenesis, one might consider these preserved male germ lines as biologically immortal.	UNIV PENN,SCH VET MED,REPROD PHYSIOL LAB,PHILADELPHIA,PA 19104	University of Pennsylvania				Brinster, Ralph/0000-0003-1408-7656	NICHD NIH HHS [R01 HD036504] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036504] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aitken RJ, 1996, NATURE, V379, P493, DOI 10.1038/379493a0; Baker TG., 1972, REPROD BIOL, P398; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; BELLVE AR, 1993, METHOD ENZYMOL, V225, P84; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; BUCCI LR, 1987, MUTAT RES, V176, P259, DOI 10.1016/0027-5107(87)90057-1; Clermont Y., 1993, FRONT ENDOCRINOL, P332; CLOUTHIER DE, IN PRESS NATURE, P381; De Rooij DG, 1992, ANN NY ACAD SCI, V364, P140; DEANESLY R, 1954, J ENDOCRINOL, V11, P201, DOI 10.1677/joe.0.0110201; DYM M, 1993, HISTOLOGY CELL TISSU, P1000; EWING LL, 1980, INT REV PHYSL, P41; FISHEL S, 1995, LANCET, V345, P1641, DOI 10.1016/S0140-6736(95)90149-3; Freshney R.I., 1994, CULTURE ANIMAL CELLS, P253; GOSDEN RG, 1992, FETAL TISSUE TRANSPL, P253; Hafez E. S. E., 1993, P503; KIMURA Y, 1995, DEVELOPMENT, V121, P2397; Meistrich ML, 1993, MOL BIOL MALE REPROD, P67; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; Russell LD, 1990, HISTOLOGICAL HISTOPA, P1; Setchell B.P., 1982, P63; TADA N, 1990, J REPROD FERTIL, V89, P511, DOI 10.1530/jrf.0.0890511; TESARIK JN, 1995, NEW ENGL J MED, V333, P525, DOI 10.1056/NEJM199508243330819; ZAMBROWICZ BP, 1994, DEVELOPMENT, V120, P1549	25	236	266	0	19	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUN	1996	2	6					693	696		10.1038/nm0696-693	http://dx.doi.org/10.1038/nm0696-693			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UN691	8640563	Green Accepted			2022-12-25	WOS:A1996UN69100040
J	Monia, BP; Johnston, JF; Geiger, T; Muller, M; Fabbro, D				Monia, BP; Johnston, JF; Geiger, T; Muller, M; Fabbro, D			Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase	NATURE MEDICINE			English	Article							TRANSFORMING SEQUENCE; BIOLOGICAL-ACTIVITY; MESSENGER-RNA; V-RAF; OLIGONUCLEOTIDES; ACTIVATION; EXPRESSION; ONCOGENE; HYBRIDIZATION; MECHANISMS	Substantial evidence exists supporting a direct role for raf kinases in the development and maintenance of certain human malignancies. Here we test the potential of phosphorothioate antisense oligodeoxynucleotides targeted against human C-raf-l kinase to specifically inhibit C-raf-l kinase gene expression and tumor progression in cell culture and in vivo, using human tumor xenograft mouse models. Treatment of human tumor cells with appropriate phosphorothioate antisense oligodeoxynucleotides led to specific inhibition of C-raf kinase gene expression in cell culture and in vivo at well-tolerated doses. Moreover, oligodeoxynucleotide treatment resulted in potent antiproliferative effects in cell culture and potent antitumor effects in vivo against a variety of tumor types that were highly consistent with an antisense mechanism of action for these compounds. These studies strongly suggest that antisense inhibitors targeted against C-raf-l kinase may be of considerable value as antineoplastic agents that display activity against a wide spectrum of tumor types at well-tolerated doses.	CIBA GEIGY AG,DEPT ONCOL,CH-4002 BASEL,SWITZERLAND	Novartis	Monia, BP (corresponding author), ISIS PHARMACEUT,DEPT MOLEC PHARMACOL,2280 FARADAY AVE,CARLSBAD,CA 92008, USA.							Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BACON TA, 1991, ONCOGENE RES, V6, P13; BENNETT CF, 1992, MOL PHARMACOL, V41, P1023; BENNETT CF, IN PRESS J PHARM EXP; BLUMER KJ, 1994, TRENDS BIOCHEM SCI, V19, P236, DOI 10.1016/0968-0004(94)90147-3; BOS JL, 1988, MUTAT RES, V195, P255, DOI 10.1016/0165-1110(88)90004-8; BOS JL, 1989, CANCER RES, V49, P4682; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; CHIANG MY, 1991, J BIOL CHEM, V266, P18162; CROOKE RM, 1995, J PHARMACOL EXP THER, V275, P462; CROOKE ST, 1992, ANNU REV PHARMACOL, V32, P329; CROOKE ST, IN PRESS J PHARM EXP; DAUM G, 1994, TRENDS BIOCHEM SCI, V19, P474, DOI 10.1016/0968-0004(94)90133-3; DEAN NM, 1994, P NATL ACAD SCI USA, V91, P11762, DOI 10.1073/pnas.91.24.11762; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; FABLAN JR, 1984, P NATL ACAD SCI USA, V91, P5982; FREIER SM, 1975, BIOCHEMISTRY-US, V14, P3310, DOI 10.1021/bi00686a004; FUKUI M, 1985, P NATL ACAD SCI USA, V81, P5954; HEIDECKER G, 1990, MOL CELL BIOL, V10, P2503, DOI 10.1128/MCB.10.6.2503; HERSCHLAG D, 1990, BIOCHEMISTRY-US, V29, P10172, DOI 10.1021/bi00496a004; HOKE GD, 1991, NUCLEIC ACIDS RES, V19, P5743, DOI 10.1093/nar/19.20.5743; INDOLFI C, 1995, NAT MED, V1, P541, DOI 10.1038/nm0695-541; KURAMOTO E, 1992, JPN J CANCER RES, V83, P1128, DOI 10.1111/j.1349-7006.1992.tb02734.x; LIMA WF, 1992, BIOCHEMISTRY-US, V31, P12055, DOI 10.1021/bi00163a013; MEYER T, 1989, INT J CANCER, V43, P851, DOI 10.1002/ijc.2910430519; MONIA BP, 1992, J BIOL CHEM, V267, P19954; MONIA BP, 1993, J BIOL CHEM, V268, P14514; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; PORRAS A, 1994, J BIOL CHEM, V269, P12741; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; RAPP UR, 1988, HDB ONCOGENES, P213; RAPP UR, 1987, P MODERN TRENDS LEUK, V7, P69; RAPP UR, 1987, P INT C HORM GROWTH, P122; REDDY EP, 1983, SCIENCE, V220, P1061, DOI 10.1126/science.6844927; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; SHIMIZU K, 1985, P NATL ACAD SCI USA, V82, P5641, DOI 10.1073/pnas.82.17.5641; STANTON VP, 1987, MOL CELL BIOL, V7, P1171, DOI 10.1128/MCB.7.3.1171; STEIN CA, 1995, NAT MED, V1, P1119, DOI 10.1038/nm1195-1119; STEPKOWSKI SM, 1994, J IMMUNOL, V153, P5336; UHLENBECK OC, 1972, J MOL BIOL, V65, P25, DOI 10.1016/0022-2836(72)90489-5; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; VALENZUELA DM, 1986, NUCLEIC ACIDS RES, V14, P844; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WAGNER RW, 1995, NAT MED, V1, P1116, DOI 10.1038/nm1195-1116; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; YAMAMOTO S, 1992, MICROBIOL IMMUNOL, V36, P983, DOI 10.1111/j.1348-0421.1992.tb02102.x; YAMAMOTO T, 1994, MICROBIOL IMMUNOL, V38, P831, DOI 10.1111/j.1348-0421.1994.tb01867.x; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	48	421	504	1	22	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUN	1996	2	6					668	675		10.1038/nm0696-668	http://dx.doi.org/10.1038/nm0696-668			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UN691	8640558				2022-12-25	WOS:A1996UN69100035
J	Druker, BJ; Tamura, S; Buchdunger, E; Ohno, S; Segal, GM; Fanning, S; Zimmermann, J; Lydon, NB				Druker, BJ; Tamura, S; Buchdunger, E; Ohno, S; Segal, GM; Fanning, S; Zimmermann, J; Lydon, NB			Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells	NATURE MEDICINE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; CHRONIC MYELOCYTIC-LEUKEMIA; PHILADELPHIA-CHROMOSOME; SIGNAL-TRANSDUCTION; V-ABL; ONCOGENE; EXPRESSION; INDUCTION; MICE; LINE	The bcr-abl oncogene, present in 95% of patients with chronic myelogenous leukemia (CML), has been implicated as the cause of this disease. A compound, designed to inhibit the Abl protein tyrosine kinase, was evaluated for its effects on cells containing the Bcr-Abl fusion protein. Cellular proliferation and tumor formation by Bcr-Abl-expressing cells were specifically inhibited by this compound. In colony-forming assays of peripheral blood or bone marrow from patients with CML, there was a 92-98% decrease in the number of bcr-abl colonies formed but no inhibition of normal colony formation. This compound may be useful in the treatment of bcr-abl-positive leukemias.	CIBA GEIGY AG, ONCOL RES DEPT, CIBA PHARMACEUT DIV, CH-4002 BASEL, SWITZERLAND	Novartis	Druker, BJ (corresponding author), OREGON HLTH SCI UNIV, DIV HEMATOL & MED ONCOL, 3181 S W SAN JACKSON PK RD, PORTLAND, OR 97201 USA.		Califano, Andrea/F-7239-2012	Druker, Brian/0000-0001-8331-8206	NATIONAL CANCER INSTITUTE [K08CA001422] Funding Source: NIH RePORTER; NCI NIH HHS [CA 01422] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLAN NC, 1994, BLOOD, V84, pA382; ANAFI M, 1993, BLOOD, V82, P3524; ARION D, 1988, CELL, V55, P371, DOI 10.1016/0092-8674(88)90060-8; AVANZI GC, 1988, BRIT J HAEMATOL, V69, P359, DOI 10.1111/j.1365-2141.1988.tb02374.x; BARTRAM CR, 1983, NATURE, V306, P277, DOI 10.1038/306277a0; BEDI A, 1994, BLOOD, V83, P2038; BUCHDUNGER E, 1994, P NATL ACAD SCI USA, V91, P2334, DOI 10.1073/pnas.91.6.2334; BUCHDUNGER E, 1995, P NATL ACAD SCI USA, V92, P2558, DOI 10.1073/pnas.92.7.2558; CARACCIOLO D, 1989, SCIENCE, V245, P1107, DOI 10.1126/science.2672339; CLARK SS, 1988, SCIENCE, V239, P775, DOI 10.1126/science.3422516; DALEY GQ, 1988, P NATL ACAD SCI USA, V85, P9312, DOI 10.1073/pnas.85.23.9312; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; ERWIN JL, 1992, ONCOGENE, V7, P1101; EVANS BD, 1982, BRIT J CANCER, V45, P466, DOI 10.1038/bjc.1982.75; EVANS CA, 1993, CANCER RES, V53, P1735; Furet P, 1995, J COMPUT AID MOL DES, V9, P465, DOI 10.1007/BF00124317; GREENBERGER JS, 1983, P NATL ACAD SCI USA, V80, P2391; HEISTERKAMP N, 1983, NATURE, V306, P239, DOI 10.1038/306239a0; HELDIN CH, 1990, CELL REGUL, V1, P555, DOI 10.1091/mbc.1.8.555; HERNANDEZ A, 1990, EXP HEMATOL, V18, P1142; HONMA Y, 1989, CANCER RES, V49, P331; KANAKURA Y, 1990, BLOOD, V76, P706; KANTARJIAN HM, 1993, BLOOD, V82, P691; KAUR G, 1994, ANTI-CANCER DRUG, V5, P213, DOI 10.1097/00001813-199404000-00013; KELLIHER MA, 1990, P NATL ACAD SCI USA, V87, P6649, DOI 10.1073/pnas.87.17.6649; KHARBANDA S, 1995, NATURE, V376, P785, DOI 10.1038/376785a0; LANEUVILLE P, 1991, ONCOGENE, V6, P275; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; MARTIAT P, 1993, BLOOD, V81, P502; MATSUGUCHI T, 1994, J BIOL CHEM, V269, P5016; MATULONIS U, 1993, EXP HEMATOL, V21, P1460; MCGLAVE PB, 1994, LANCET, V343, P1486, DOI 10.1016/S0140-6736(94)92589-5; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NOWELL PC, 1960, SCIENCE, V132, P1497; OBRIEN SG, 1994, BLOOD REV, V8, P63, DOI 10.1016/S0268-960X(05)80009-8; OBRIEN SG, 1995, J CLIN ONCOL, V13, P541, DOI 10.1200/JCO.1995.13.3.541; ODA T, 1994, J BIOL CHEM, V269, P22925; ODA T, 1995, LEUKEMIA, V9, P295; ORKIN SH, 1975, P NATL ACAD SCI USA, V72, P98, DOI 10.1073/pnas.72.1.98; OZER H, 1993, BLOOD, V82, P2975; PENDERGAST AM, 1991, P NATL ACAD SCI USA, V88, P5927, DOI 10.1073/pnas.88.13.5927; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; SAWYERS CL, 1994, CELL, V77, P121, DOI 10.1016/0092-8674(94)90240-2; SCHWARTZBERG PL, 1991, CELL, V65, P1165, DOI 10.1016/0092-8674(91)90012-N; SCOTT ML, 1991, P NATL ACAD SCI USA, V88, P6506, DOI 10.1073/pnas.88.15.6506; SEGAL GM, 1994, J CLIN INVEST, V94, P846, DOI 10.1172/JCI117405; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; SILVENNOINEN O, 1993, P NATL ACAD SCI USA, V90, P8429, DOI 10.1073/pnas.90.18.8429; TURA S, 1994, NEW ENGL J MED, V330, P820; YAISH P, 1988, SCIENCE, V242, P933, DOI 10.1126/science.3263702	52	2821	2965	3	194	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	1996	2	5					561	566		10.1038/nm0596-561	http://dx.doi.org/10.1038/nm0596-561			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UJ230	8616716				2022-12-25	WOS:A1996UJ23000040
J	Giordano, FJ; Ping, PP; McKirnan, MD; Nozaki, S; DeMaria, AN; Dillmann, WH; MathieuCostello, O; Hammond, HK				Giordano, FJ; Ping, PP; McKirnan, MD; Nozaki, S; DeMaria, AN; Dillmann, WH; MathieuCostello, O; Hammond, HK			Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart	NATURE MEDICINE			English	Article							CORONARY COLLATERAL DEVELOPMENT; SKELETAL-MUSCLES; ARTERY OCCLUSION; DOWN-REGULATION; MYOCARDIUM; LOCALIZATION; CIRCULATION; EXPRESSION; EXERCISE; MODEL	Increased coronary blood vessel development could potentially benefit patients with ischemic heart disease. In a model of stress-induced myocardial ischemia, intracoronary injection of a recombinant adenovirus expressing human fibroblast growth factor-5 (FGF-5) resulted in messenger RNA and protein expression of the transferred gene. Two weeks after gene transfer, regional abnormalities in stress-induced function and blood flow were improved, effects that persisted for 12 weeks. Improved blood flow and function were associated with evidence of angiogenesis. This report documents, for the first time, successful amelioration of abnormalities in myocardial blood flow and function following in vivo gene transfer.	VET AFFAIRS MED CTR,DEPT MED,SAN DIEGO,CA 92161; UNIV CALIF SAN DIEGO,SAN DIEGO,CA 92161	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Diego								BANAI S, 1994, CIRCULATION, V89, P2183, DOI 10.1161/01.CIR.89.5.2183; BARR E, 1994, GENE THER, V1, P51; BENHARROCH D, 1990, ISRAEL J MED SCI, V26, P212; BERNOTATDANIELOWSKI S, 1993, CARDIOVASC RES, V27, P1220, DOI 10.1093/cvr/27.7.1220; CASSCELLS W, 1990, J CLIN INVEST, V85, P433, DOI 10.1172/JCI114456; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; FRENCH BA, 1994, CIRCULATION, V90, P2414, DOI 10.1161/01.CIR.90.5.2414; GOLDFARB M, 1991, ANN NY ACAD SCI, V638, P38, DOI 10.1111/j.1749-6632.1991.tb49016.x; GOTO F, 1993, LAB INVEST, V69, P508; GUZMAN RJ, 1993, CIRC RES, V73, P1202, DOI 10.1161/01.RES.73.6.1202; HAMMOND HK, 1993, J CLIN INVEST, V92, P2644, DOI 10.1172/JCI116880; HAMMOND HK, 1994, J AM COLL CARDIOL, V23, P475, DOI 10.1016/0735-1097(94)90436-7; HARADA K, 1994, J CLIN INVEST, V94, P623, DOI 10.1172/JCI117378; KAJSTURA J, 1994, CIRC RES, V74, P383, DOI 10.1161/01.RES.74.3.383; KASSEISLER A, 1993, P NATL ACAD SCI USA, V90, P11498, DOI 10.1073/pnas.90.24.11498; KITAOKA T, 1994, INVEST OPHTH VIS SCI, V35, P3189; MATHIEUCOSTELLO O, 1987, MICROVASC RES, V33, P98, DOI 10.1016/0026-2862(87)90010-0; MCGRORY WJ, 1988, VIROLOGY, V163, P614, DOI 10.1016/0042-6822(88)90302-9; MORROW NG, 1990, J CLIN INVEST, V85, P1816, DOI 10.1172/JCI114640; MOULLIER P, 1994, KIDNEY INT, V45, P1220, DOI 10.1038/ki.1994.162; NIENABER CA, 1990, AM J CARDIOL, V65, P991, DOI 10.1016/0002-9149(90)91002-N; OHNO T, 1994, SCIENCE, V265, P781, DOI 10.1126/science.8047883; PING PP, 1994, AM J PHYSIOL-HEART C, V267, pH2079, DOI 10.1152/ajpheart.1994.267.5.H2079; POOLE DC, 1990, AM J PHYSIOL, V259, pH204, DOI 10.1152/ajpheart.1990.259.1.H204; ROTH DA, 1993, J CLIN INVEST, V91, P939, DOI 10.1172/JCI116315; ROTH DM, 1990, CIRCULATION, V82, P1778, DOI 10.1161/01.CIR.82.5.1778; ROTH DM, 1987, AM J PHYSIOL, V253, pH1279, DOI 10.1152/ajpheart.1987.253.5.H1279; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; SKYBA DM, 1994, CIRCULATION, V90, P1513, DOI 10.1161/01.CIR.90.3.1513; STRATFORDPERRICAUDET LD, 1992, J CLIN INVEST, V90, P626, DOI 10.1172/JCI115902; THOMPSON JA, 1989, P NATL ACAD SCI USA, V86, P7928, DOI 10.1073/pnas.86.20.7928; TSAI PS, 1995, ENDOCRINOLOGY, V136, P3831, DOI 10.1210/en.136.9.3831; UNGER EF, 1994, AM J PHYSIOL, V266, pH1588, DOI 10.1152/ajpheart.1994.266.4.H1588; WHITE FC, 1992, CIRC RES, V71, P1490, DOI 10.1161/01.RES.71.6.1490; YANAGISAWAMIWA A, 1992, SCIENCE, V257, P1401, DOI 10.1126/science.1382313; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407	36	364	449	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAY	1996	2	5					534	539		10.1038/nm0596-534	http://dx.doi.org/10.1038/nm0596-534			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UJ230	8616711				2022-12-25	WOS:A1996UJ23000035
J	Ross, R				Ross, R			Genetically modified mice as models of transplant atherosclerosis	NATURE MEDICINE			English	Editorial Material							REJECTION; ARTERIOSCLEROSIS; PATHOGENESIS; ALLOGRAFTS				Ross, R (corresponding author), UNIV WASHINGTON,SCH MED,DEPT PATHOL,BOX 357470,SEATTLE,WA 98195, USA.							ALONSO DR, 1977, AM J PATHOL, V87, P415; HANSSON GK, 1996, ATHEROSCLEROSIS CORO, P557; HAYRY P, 1993, IMMUNOL REV, V134, P33, DOI 10.1111/j.1600-065X.1993.tb00639.x; ISIK FF, 1992, AM J PATHOL, V141, P1139; PAUL LC, 1993, TRANSPLANT P, V25, P2024; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; SHI CW, 1994, CIRC RES, V75, P199, DOI 10.1161/01.RES.75.2.199; Shi CW, 1996, P NATL ACAD SCI USA, V93, P4051, DOI 10.1073/pnas.93.9.4051	8	32	34	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAY	1996	2	5					527	528		10.1038/nm0596-527	http://dx.doi.org/10.1038/nm0596-527			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UJ230	8616709				2022-12-25	WOS:A1996UJ23000033
J	Walsh, GP; Tan, EV; delaCruz, EC; Abalos, RM; Villahermosa, LG; Young, LJ; Cellona, RV; Nazareno, JB; Horwitz, MA				Walsh, GP; Tan, EV; delaCruz, EC; Abalos, RM; Villahermosa, LG; Young, LJ; Cellona, RV; Nazareno, JB; Horwitz, MA			The Philippine cynomolgus monkey (Macaca fascicularis) provides a new nonhuman primate model of tuberculosis that resembles human disease	NATURE MEDICINE			English	Article							PULMONARY TUBERCULOSIS	A nonhuman primate model of tuberculosis that closely resembles human disease is urgently needed. We have evaluated the Philippine cynomolgus monkey, Macaca fasicularis, as a model of TB. Cynomolgus monkeys challenged intratracheally with extremely high doses of Mycobocterium tuberculosis (10(5) or 10(4) CFU) developed an acute, rapidly progressive, highly fatal multilobar pneumonia. However, monkeys challenged with moderate or low doses of M. tuberculosis (less than or equal to 10(3) CFU) developed a chronic, slowly progressive, localized form of pulmonary TB, akin to the disease in humans, that was frequently accompanied by such clinical syndromes as ocular tuberculosis, meningitis and tuberculous spondylitis. A significant proportion of monkeys challenged with 10(2) or 10(1) CFU contained the infection in a subclinical state. The Philippine cynomolgus monkey model is an excellent model of chronic TB and provides an opportunity to study subclinical and potentially latent disease in an animal model.	UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,LOS ANGELES,CA 90095; LEONARD WOOD MEM RES CTR,CEBU,PHILIPPINES; SIMIAN CONSERVAT & BREEDING CORP,TANAY,PHILIPPINES	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035189] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 35189] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AUERBACH O, 1951, AM REV TUBERC PULM, V64, P419; BARRETTC.E, 1967, SOUTH MED J, V60, P1061, DOI 10.1097/00007611-196710000-00008; BOYUM A, 1964, NATURE, V204, P793, DOI 10.1038/204793a0; CHAPARAS SD, 1975, AM REV RESPIR DIS, V112, P43; CHAPARAS SD, 1970, AM J VET RES, V31, P1437; CORCORAN KD, 1991, LAB ANIM SCI, V41, P57; DONAHUE HC, 1967, AM J OPHTHALMOL, V64, P742, DOI 10.1016/0002-9394(67)92860-7; FARER LS, 1979, AM J EPIDEMIOL, V109, P205, DOI 10.1093/oxfordjournals.aje.a112675; GOOD RC, 1968, ANN NY ACAD SCI, V154, P200, DOI 10.1111/j.1749-6632.1968.tb16710.x; Good RC., 1984, MYCOBACTERIA SOURCEB, P903; GOOD RC, 1978, NONHUMAN PRIMATES ME, P39; HORWITZ MA, 1995, P NATL ACAD SCI USA, V92, P1530, DOI 10.1073/pnas.92.5.1530; MUSCOPLAT CC, 1975, AM J VET RES, V36, P699; PAL PG, 1992, INFECT IMMUN, V60, P4781, DOI 10.1128/IAI.60.11.4781-4792.1992; SCHMIDT LH, 1956, AM REV TUBERC PULM, V74, P138; SCHMIDT LH, 1972, AM REV RESPIR DIS, V105, P183; SCHMIDT LH, 1962, B INT UNION TUBERC, V32, P487; TRIBE G W, 1976, Laboratory Animals (London), V10, P39, DOI 10.1258/002367776780948970; WARD GS, 1985, LAB ANIM SCI, V35, P395; WURTZ R, 1993, CLIN INFECT DIS, V16, P806, DOI 10.1093/clind/16.6.806	20	172	179	1	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	APR	1996	2	4					430	436		10.1038/nm0496-430	http://dx.doi.org/10.1038/nm0496-430			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UD314	8597953				2022-12-25	WOS:A1996UD31400045
J	Zhang, W; Lee, WH; Triarhou, LC				Zhang, W; Lee, WH; Triarhou, LC			Grafted cerebellar cells in a mouse model of hereditary ataxia express IGF-I system genes and partially restore behavioral function	NATURE MEDICINE			English	Article							GROWTH FACTOR-I; DEGENERATION MUTANT MICE; PURKINJE-CELLS; RAT-BRAIN; INSULIN; SUSPENSIONS; NEURONS; PCD; DIFFERENTIATION; TRANSPLANTATION	Fetal grafts of normal cerebellar tissue were implanted into the cerebellum of Purkinje cell degeneration mutant mice (pcd/pcd), a model of adult-onset recessively inherited cerebello-olivary atrophy, in an attempt at correcting their cellular and motor impairment. Donor cerebellar cells engrafted in the appropriate sites, as evidenced by the pattern of expression of insulin-like growth factor-I (ICF-I) system genes. Bilateral cerebellar grafts led to an improvement of motor behaviors in balance rod tests and in the open field, providing evidence for functional integration into the atrophic mouse cerebellum and underscoring the potential of neural transplantation for counteracting the human cerebellar ataxias.	INDIANA UNIV, SCH MED, DEPT PATHOL & LAB MED, INDIANAPOLIS, IN 46202 USA; INDIANA UNIV, SCH MED, DEPT ANAT, INDIANAPOLIS, IN 46202 USA; INDIANA UNIV, SCH MED, DEPT PEDIAT, INDIANAPOLIS, IN 46202 USA; INDIANA UNIV, SCH MED, HERMAN B WELLS CTR PEDIAT RES, INDIANAPOLIS, IN 46202 USA; INDIANA UNIV, SCH MED, PROGRAM MED NEUROBIOL, INDIANAPOLIS, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis			Triarhou, Lazaros/ABE-4651-2020		NINDS NIH HHS [R29-NS29283] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS029283] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALVARADOMALLART RM, 1982, J COMP NEUROL, V212, P247, DOI 10.1002/cne.902120304; BONDY C, 1992, NEUROSCIENCE, V46, P909, DOI 10.1016/0306-4522(92)90193-6; BONDY C, 1993, J NEUROSCI, V13, P5092, DOI 10.1523/JNEUROSCI.13-12-05092.1993; Bondy C.A., 1992, NEUROPROTOCOLS, V1, P240, DOI 10.1016/1058-6741(92)90034-U; BONDY CA, 1991, J NEUROSCI, V11, P3442; BONDY CA, 1993, ANN NY ACAD SCI, V692, P33; Bures J., 1976, TECHNIQUES BASIC EXP, P37; CADDY KWT, 1979, PHILOS T ROY SOC B, V287, P167, DOI 10.1098/rstb.1979.0055; CASTROALAMANCOS MA, 1993, P NATL ACAD SCI USA, V90, P7386, DOI 10.1073/pnas.90.15.7386; DAS GD, 1971, SCIENCE, V173, P637, DOI 10.1126/science.173.3997.637; DUNNETT SB, 1994, FUNCTIONAL NEURAL TR; GARDETTE R, 1988, NEUROSCIENCE, V24, P777, DOI 10.1016/0306-4522(88)90066-8; Ghetti B., 1992, CEREBELLAR DEGENERAT, P159; GREER CA, 1982, BRAIN RES, V235, P156, DOI 10.1016/0006-8993(82)90206-2; HARDING AE, 1993, ADV NEUROL, V61, P1; HEPLER JE, 1990, MOL NEUROBIOL, V4, P93, DOI 10.1007/BF02935586; HOLMES G, 1907, BRAIN, V30, P467; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; LANDIS SC, 1978, J COMP NEUROL, V177, P125, DOI 10.1002/cne.901770109; LEE PDK, 1993, P SOC EXP BIOL MED, V204, P4; LEE WH, 1992, J NEUROSCI, V12, P4737; LEE WH, 1993, NEUROSCIENCE, V53, P251, DOI 10.1016/0306-4522(93)90303-W; LEROITH D, 1993, NEUROTROPHIC FACTORS, P391; MULLEN RJ, 1975, NATURE, V258, P528, DOI 10.1038/258528a0; MULLEN RJ, 1976, P NATL ACAD SCI USA, V73, P208, DOI 10.1073/pnas.73.1.208; NIETOBONA MP, 1993, J NEUROSCI RES, V36, P520, DOI 10.1002/jnr.490360504; OBATA K, 1969, EXPERIENTIA, V25, P1285; OGORMAN S, 1985, J COMP NEUROL, V234, P277, DOI 10.1002/cne.902340302; POIRIER J, 1990, MANUAL BASIC NEUROPA, P151; Sokal R. R, 1981, BIOMETRY; SOTELO C, 1987, NEUROSCIENCE, V20, P1, DOI 10.1016/0306-4522(87)90002-9; SOTELO C, 1986, P NATL ACAD SCI USA, V83, P1135, DOI 10.1073/pnas.83.4.1135; Thach WT, 1992, CEREBELLUM REVISITED, P283; TORRESALEMAN I, 1994, J NEUROSCI RES, V39, P117, DOI 10.1002/jnr.490390202; TRIARHOU LC, 1992, ANAT EMBRYOL, V185, P409; TRIARHOU LC, 1987, ANAT EMBRYOL, V176, P145, DOI 10.1007/BF00310047; TRIARHOU LC, 1992, NEUROCHEM RES, V17, P475, DOI 10.1007/BF00969895; WELLS J, 1982, DEV BRAIN RES, V4, P167, DOI 10.1016/0165-3806(82)90040-2; WETTS R, 1985, Society for Neuroscience Abstracts, V11, P1037; YUASA S, 1991, ANAT EMBRYOL, V184, P195, DOI 10.1007/BF01673256	40	46	47	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	1996	2	1					65	71		10.1038/nm0196-65	http://dx.doi.org/10.1038/nm0196-65			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TP579	8564845				2022-12-25	WOS:A1996TP57900039
J	EICHLER, EE; HOLDEN, JJA; POPOVICH, BW; REISS, AL; SNOW, K; THIBODEAU, SN; RICHARDS, CS; WARD, PA; NELSON, DL				EICHLER, EE; HOLDEN, JJA; POPOVICH, BW; REISS, AL; SNOW, K; THIBODEAU, SN; RICHARDS, CS; WARD, PA; NELSON, DL			LENGTH OF UNINTERRUPTED CGG REPEATS DETERMINES INSTABILITY IN THE FMR1 GENE	NATURE GENETICS			English	Article							FRAGILE-X-SYNDROME; FOUNDER CHROMOSOMES; MISMATCH REPAIR; FULL MUTATION; DNA; REPLICATION; POPULATION; SEQUENCE; SITE	Analysis of 84 human X chromosomes for the presence of interrupting AGG trinucleotides within the CGG repeat tract of the FMR1 gene revealed that most alleles possess two interspersed AGGs and that the longest tract of uninterrupted CGG repeats is usually found at the 3' end. Variation in the length of the repeat appears polar. Alleles containing between 34 and 55 repeats, with documented unstable transmissions, were shown to have lost one or both AGG interruptions. These comparisons define an instability threshold of 34-38 uninterrupted CGG repeats. Analysis of premutation alleles in Fragile X syndrome carriers reveals that 70% of these alleles contain a single AGG interruption. These data suggest that the loss of an AGG is an important mutational event in the generation of unstable alleles predisposed to the Fragile X syndrome.	BAYLOR COLL MED,CTR HUMAN GENOME,DEPT MOLEC & HUMAN GENET,HOUSTON,TX 77030; QUEENS UNIV,DEPT PSYCHIAT,KINGSTON K7L 3N6,ON,CANADA; ONGWANADA RESOURCE CTR,CYTOGENET & DNA RES LAB,KINGSTON K7L 3N6,ON,CANADA; OREGON HLTH SCI UNIV,DEPT MED & MOLEC GENET,PORTLAND,OR 97201; JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; MAYO CLIN & MAYO FDN,GENET LAB,ROCHESTER,MN 55905; JOHNS HOPKINS UNIV,SCH MED,KENNEDY KRIEGER INST,BALTIMORE,MD 21205	Baylor College of Medicine; Queens University - Canada; Oregon Health & Science University; Johns Hopkins University; Johns Hopkins University; Mayo Clinic; Johns Hopkins University; Kennedy Krieger Institute					NICHD NIH HHS [HD29256] Funding Source: Medline; NIMH NIH HHS [MH50047, MH01142] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH050047, K02MH001142] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALEXIOU M, 1992, DEVELOPMENT, V114, P185; ARMOUR JAL, 1993, HUM MOL GENET, V2, P1137, DOI 10.1093/hmg/2.8.1137; ASHLEY CT, 1993, NAT GENET, V4, P244, DOI 10.1038/ng0793-244; BROWN WT, 1993, JAMA-J AM MED ASSOC, V270, P1569, DOI 10.1001/jama.270.13.1569; BUYLE S, 1993, HUM GENET, V92, P269, DOI 10.1007/BF00244471; CHONG SS, 1994, AM J MED GENET, V51, P522, DOI 10.1002/ajmg.1320510447; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GIBBS M, 1993, GENOMICS, V17, P121, DOI 10.1006/geno.1993.1292; GOSTOUT B, 1993, AM J HUM GENET, V52, P1182; HEITZ D, 1992, J MED GENET, V29, P794, DOI 10.1136/jmg.29.11.794; HIRST MC, 1993, J MED GENET, V30, P647, DOI 10.1136/jmg.30.8.647; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; KREMER EJ, 1991, AM J HUM GENET, V49, P656; LEVINSON G, 1986, A REV BIOCH, P203; MACPHERSON JN, 1994, HUM MOL GENET, V3, P399, DOI 10.1093/hmg/3.3.399; NELSON DL, 1993, NAT GENET, V4, P107, DOI 10.1038/ng0693-107; NELSON DL, 1992, AM J HUM GENET, V51, pA186; NETHANEL T, 1992, J VIROL, V66, P6634, DOI 10.1128/JVI.66.11.6634-6640.1992; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; OUDET C, 1993, AM J HUM GENET, V52, P297; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; PERGOLIZZI RG, 1992, LANCET, V339, P271, DOI 10.1016/0140-6736(92)91334-5; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; REISS AL, 1994, HUM MOL GENET, V3, P393, DOI 10.1093/hmg/3.3.393; REYNIERS E, 1993, NAT GENET, V4, P143, DOI 10.1038/ng0693-143; RICHARDS RI, 1991, J MED GENET, V28, P818, DOI 10.1136/jmg.28.12.818; RICHARDS RI, 1994, NAT GENET, V6, P114, DOI 10.1038/ng0294-114; RICHARDS RI, 1992, NAT GENET, V1, P257, DOI 10.1038/ng0792-257; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; SNOW K, 1993, AM J HUM GENET, V53, P1217; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; THOMMES P, 1990, EUR J BIOCHEM, V194, P699, DOI 10.1111/j.1432-1033.1990.tb19460.x; TRINH TQ, 1991, NATURE, V352, P544, DOI 10.1038/352544a0; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WARREN ST, 1994, JAMA-J AM MED ASSOC, V271, P536, DOI 10.1001/jama.271.7.536; WELLS RD, 1993, GENOME ANAL GENOME R, P107; WOOSTER R, 1994, NAT GENET, V6, P152, DOI 10.1038/ng0294-152; YU S, 1992, AM J HUM GENET, V50, P968; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	41	414	444	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1994	8	1					88	94		10.1038/ng0994-88	http://dx.doi.org/10.1038/ng0994-88			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PE157	7987398				2022-12-25	WOS:A1994PE15700021
J	ISSA, JPJ; OTTAVIANO, YL; CELANO, P; HAMILTON, SR; DAVIDSON, NE; BAYLIN, SB				ISSA, JPJ; OTTAVIANO, YL; CELANO, P; HAMILTON, SR; DAVIDSON, NE; BAYLIN, SB			METHYLATION OF THE ESTROGEN-RECEPTOR CPG ISLAND LINKS AGING AND NEOPLASIA IN HUMAN COLON	NATURE GENETICS			English	Article							HUMAN ESTROGEN-RECEPTOR; DNA METHYLATION; CELL-LINE; DENOVO METHYLATION; EPITHELIAL-CELLS; GENE; CANCER; HYPERMETHYLATION; GROWTH; PROLIFERATION	We report that CpG island methylation, an epigenetic modification of DNA known to correlate closely with silencing of gene transcription, appears in the oestrogen receptor (ER) gene in a subpopulation of cells which increases as a direct function of age in human colonic mucosa. This same methylation change characterizes virtually all cells in art 45 colorectal tumours examined, including the earliest stages of tumour formation. ER gene expression is diminished or absent in colorectal tumours, and introduction of an exogenous ER gene in cultured colon carcinoma cells resulted in marked growth suppression. Our data suggest that methylation associated inactivation of the ER gene in ageing cotorectal mucosa could be one of the earliest events that predispose to sporadic cotorectal tumorigenesis.	JOHNS HOPKINS UNIV,INST MED,DEPT PATHOL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,INST MED,DEPT MED,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University	ISSA, JPJ (corresponding author), JOHNS HOPKINS UNIV,INST MED,CTR ONCOL,BALTIMORE,MD 21205, USA.		jia, xu/A-8386-2016	Issa, Jean-Pierre/0000-0003-2258-5030	NATIONAL CANCER INSTITUTE [R01CA043318] Funding Source: NIH RePORTER; NCI NIH HHS [CA4396-03, CA43318] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANTEQUERA F, 1990, CELL, V62, P503, DOI 10.1016/0092-8674(90)90015-7; ARJANDI BH, 1993, BONE MINER, V21, P63; ATILLASOY E, 1993, J GERONTOL, V48, pB43, DOI 10.1093/geronj/48.2.B43; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BROMMAGE R, 1993, BIOL REPROD, V49, P544, DOI 10.1095/biolreprod49.3.544; CHUTE CG, 1991, EPIDEMIOLOGY, V2, P201; COLBY WW, 1983, NATURE, V301, P722, DOI 10.1038/301722a0; CORRADINO RA, 1993, ENDOCRINOLOGY, V132, P193, DOI 10.1210/en.132.1.193; DAWSON PM, 1990, J CLIN PATHOL, V43, P149, DOI 10.1136/jcp.43.2.149; DEBUSTROS A, 1988, P NATL ACAD SCI USA, V85, P5693; DEVERDIER MG, 1992, CANCER CAUSE CONTROL, V3, P355, DOI 10.1007/BF00146889; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; FURNER SE, 1989, CANCER RES, V49, P4936; GARCIA M, 1992, P NATL ACAD SCI USA, V89, P11538, DOI 10.1073/pnas.89.23.11538; GHAZI H, 1992, GENE, V114, P203, DOI 10.1016/0378-1119(92)90575-A; GREEN S, 1992, NATURE, V320, P996; GREENE GL, 1986, SCIENCE, V231, P1150, DOI 10.1126/science.3753802; HANSEN RS, 1992, HUM MOL GENET, V1, P571, DOI 10.1093/hmg/1.8.571; HAYASHIZAKI Y, 1994, NAT GENET, V6, P33, DOI 10.1038/ng0194-33; HOLLIDAY R, 1987, SCIENCE, V238, P1763; JIANG SY, 1992, JNCI-J NATL CANCER I, V84, P580, DOI 10.1093/jnci/84.8.580; JONES PA, 1990, P NATL ACAD SCI USA, V87, P6117, DOI 10.1073/pnas.87.16.6117; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; MA ZQ, 1993, P NATL ACAD SCI USA, V90, P3740, DOI 10.1073/pnas.90.8.3740; MAKOS M, 1992, P NATL ACAD SCI USA, V89, P1929, DOI 10.1073/pnas.89.5.1929; MAMINTA MLD, 1991, MOL CELL ENDOCRINOL, V78, P61, DOI 10.1016/0303-7207(91)90186-V; MEGGOUH F, 1991, CANCER RES, V51, P1227; MIGEON BR, 1990, GENET RES, V56, P91, DOI 10.1017/S0016672300035151; NEUGUT AI, 1993, CANCER EPIDEM BIOMAR, V2, P159; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; OTTAVIANO YL, 1994, CANCER RES, V54, P2552; PIVA R, 1992, BIOCHEM BIOPH RES CO, V183, P996, DOI 10.1016/S0006-291X(05)80289-X; SAKAI T, 1991, AM J HUM GENET, V48, P880; SAPOLSKY RM, 1993, J GERONTOL, V48, P196; Singer-Sam J., 1993, Experientia Supplementum (Basel), V64, P358; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; TATA JR, 1993, J STEROID BIOCHEM, V46, P105, DOI 10.1016/0960-0760(93)90286-6; THOMAS ML, 1993, ENDOCRINOLOGY, V132, P426, DOI 10.1210/en.132.1.426; UEHARA Y, 1989, ONCOGENE, V4, P1023; WATTS CKW, 1989, J STEROID BIOCHEM, V34, P483, DOI 10.1016/0022-4731(89)90132-5; WEIGEL RJ, 1993, CANCER RES, V53, P3472; ZAJCHOWSKI DA, 1993, CANCER RES, V53, P5004	43	990	1043	0	28	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1994	7	4					536	540		10.1038/ng0894-536	http://dx.doi.org/10.1038/ng0894-536			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PA832	7951326				2022-12-25	WOS:A1994PA83200023
J	MOULTON, T; CRENSHAW, T; HAO, Y; MOOSIKASUWAN, J; LIN, N; DEMBITZER, F; HENSLE, T; WEISS, L; MCMORROW, L; LOEW, T; KRAUS, W; GERALD, W; TYCKO, B				MOULTON, T; CRENSHAW, T; HAO, Y; MOOSIKASUWAN, J; LIN, N; DEMBITZER, F; HENSLE, T; WEISS, L; MCMORROW, L; LOEW, T; KRAUS, W; GERALD, W; TYCKO, B			EPIGENETIC LESIONS AT THE H19 LOCUS IN WILMS-TUMOR PATIENTS	NATURE GENETICS			English	Article							GROWTH FACTOR-II; BECKWITH-WIEDEMANN SYNDROME; REPEAT POLYMORPHISM; HUMAN CANCERS; GENE; EXPRESSION; MOUSE; RNA; CELLS; HYPOMETHYLATION	To test the potential role of H19 as a tumour suppressor gene we have examined its expression and DNA methylation in Wilms' tumours (WTs). In most WTs (18/25), H19 RNA was reduced at least 20-fold from fetal kidney levels. Of the expression-negative tumours ten retained 11p15.5 heterozygosity: in nine of these, H19 DNA was biallelically hypermethylated and in two cases hypermethylation locally restricted to H19 sequences was also present in the non-neoplastic kidney parenchyma. IGF2 mRNA was expressed in most but not all WTs and expression patterns were consistent with IGF2/H19 enhancer competition without obligate inverse coupling. These observations implicate genetic and epigenetic inactivation of H19 in Wilms' tumorigenesis.	COLUMBIA UNIV,COLL PHYS & SURG,DEPT PATHOL,DIV ONCOL,NEW YORK,NY 10032; COLUMBIA UNIV,COLL PHYS & SURG,DEPT PEDIAT,DIV PEDIAT HEMATOL ONCOL,NEW YORK,NY 10032; COLUMBIA UNIV,COLL PHYS & SURG,DEPT PATHOL,DIV NEUROPATHOL,NEW YORK,NY 10032; COLUMBIA UNIV,COLL PHYS & SURG,DEPT SURG,DIV PEDIAT SURG,NEW YORK,NY 10032; CITY HOPE NATL MED CTR,DEPT PATHOL,DUARTE,CA 91010; UNIV MED & DENT NEW JERSEY,COOPER HOSP,MED CTR,DEPT PEDIAT,DIV HEMATOL ONCOL,CAMDEN,NJ 08103; SO ILLINOIS UNIV,SCH MED,DEPT PEDIAT,DIV PEDIAT HEMATOL ONCOL,SPRINGFIELD,IL 62702; SCOTTISH RITE CHILDRENS HOSP,DEPT PEDIAT,DIV GENET,ATLANTA,GA 30342; MEM SLOAN KETTERING CANC CTR,DEPT PATHOL,NEW YORK,NY 10021	Columbia University; Columbia University; Columbia University; Columbia University; City of Hope; Rutgers State University New Brunswick; Rutgers State University Medical Center; Southern Illinois University System; Southern Illinois University; Memorial Sloan Kettering Cancer Center								BACCARINI P, 1993, AM J PATHOL, V143, P1535; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BRUNKOW ME, 1991, GENE DEV, V5, P1092, DOI 10.1101/gad.5.6.1092; CHAO LY, 1993, NAT GENET, V3, P127, DOI 10.1038/ng0293-127; COPPES MJ, 1992, GENE CHROMOSOME CANC, V5, P326, DOI 10.1002/gcc.2870050408; DULL TJ, 1984, NATURE, V310, P777, DOI 10.1038/310777a0; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; FEINBERG AP, 1983, BIOCHEM BIOPH RES CO, V111, P47, DOI 10.1016/S0006-291X(83)80115-6; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; FIDLER AE, 1992, LANCET, V339, P243, DOI 10.1016/0140-6736(92)90042-2; GOSHEN R, 1993, MOL REPROD DEV, V34, P374, DOI 10.1002/mrd.1080340405; HAN DKM, 1992, CIRC RES, V71, P711, DOI 10.1161/01.RES.71.3.711; HAO Y, 1993, NATURE, V365, P764, DOI 10.1038/365764a0; HASELBACHER GK, 1987, P NATL ACAD SCI USA, V84, P1104, DOI 10.1073/pnas.84.4.1104; HENRY I, 1989, HUM GENET, V81, P273, DOI 10.1007/BF00279003; KLINEDINST DK, 1991, MUTAT RES, V250, P365, DOI 10.1016/0027-5107(91)90193-R; LITTLE MH, 1992, EUR J CANCER, V28A, P1876, DOI 10.1016/0959-8049(92)90027-Y; LUSTIG O, IN PRESS MOL REP DEV; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; PACHNIS V, 1988, EMBO J, V7, P673, DOI 10.1002/j.1460-2075.1988.tb02862.x; POIRIER F, 1991, DEVELOPMENT, V113, P1105; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P3753, DOI 10.1093/nar/19.13.3753; RACHMILEWITZ J, 1992, MOL REPROD DEV, V32, P196, DOI 10.1002/mrd.1080320303; RACHMILEWITZ J, 1992, FEBS LETT, V309, P25, DOI 10.1016/0014-5793(92)80731-U; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; RASTINEJAD F, 1993, CELL, V75, P1107, DOI 10.1016/0092-8674(93)90320-P; REEVE AE, 1985, NATURE, V317, P258, DOI 10.1038/317258a0; Riggins Gregory J., 1992, Human Molecular Genetics, V1, P775, DOI 10.1093/hmg/1.9.775; SCOTT J, 1985, NATURE, V317, P260, DOI 10.1038/317260a0; TADOKORO K, 1991, NUCLEIC ACIDS RES, V19, P6967, DOI 10.1093/nar/19.24.6967; TARTOF KD, 1991, CELL, V65, P201, DOI 10.1016/0092-8674(91)90153-P; TYCKO B, 1994, AM J PATHOL, V144, P431; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143; WILES MV, 1988, DEVELOPMENT, V104, P403; YANDELL DW, 1986, SOMAT CELL MOLEC GEN, V12, P255, DOI 10.1007/BF01570784; ZHANG YH, 1993, AM J HUM GENET, V53, P113; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	40	314	321	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1994	7	3					440	447		10.1038/ng0794-440	http://dx.doi.org/10.1038/ng0794-440			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NU306	7920666				2022-12-25	WOS:A1994NU30600022
J	SCHNEIDER, A; DAVIDSON, JJ; WULLRICH, A; KILIMANN, MW				SCHNEIDER, A; DAVIDSON, JJ; WULLRICH, A; KILIMANN, MW			PHOSPHORYLASE-KINASE DEFICIENCY IN I-STRAIN MICE IS ASSOCIATED WITH A FRAMESHIFT MUTATION IN THE ALPHA-SUBUNIT MUSCLE ISOFORM	NATURE GENETICS			English	Article							GLYCOGEN-STORAGE DISEASE; CATALYTIC GAMMA-SUBUNIT; MESSENGER-RNA; CDNA CLONING; LIVER GLYCOGENOSIS; BETA-SUBUNITS; X-CHROMOSOME; GENE; EXPRESSION; ENZYMES	Heritable phosphorylase kinase (Phk) deficiency underlies a group of glycogenoses in humans, mice and rats that differ in mode of inheritance and tissue-specificity. It is assumed that this heterogeneity is caused by mutations affecting different subunits and isoforms of Phk. As the first Phk deficiency mutation to be identified, we report a single-nucleotide insertion in the coding sequence of the Phk alpha subunit muscle isoform of the I-strain mouse. This mutation accounts for the virtually complete enzymatic deficiency, the tissue specificity and the X-linked mode of inheritance in this mutant.	RUHR UNIV BOCHUM,FAK MED,INST PHYSIOL CHEM,D-44780 BOCHUM,GERMANY	Ruhr University Bochum								ABARBANEL JM, 1986, NEUROLOGY, V36, P560, DOI 10.1212/WNL.36.4.560; ALVARADO LJF, 1988, J PEDIATR-US, V113, P865, DOI 10.1016/S0022-3476(88)80020-9; BAKKER HD, 1991, J INHERIT METAB DIS, V14, P269, DOI 10.1007/BF01800604; BARNARD PJ, 1990, CYTOGENET CELL GENET, V53, P91, DOI 10.1159/000132902; BENDER PK, 1989, P NATL ACAD SCI USA, V86, P9996, DOI 10.1073/pnas.86.24.9996; CALALB MB, 1992, J BIOL CHEM, V267, P1455; CHAMBERLAIN JS, 1987, P NATL ACAD SCI USA, V84, P2886, DOI 10.1073/pnas.84.9.2886; CLEMENS PR, 1990, ANN NEUROL, V28, P529, DOI 10.1002/ana.410280410; COHEN PTW, 1981, CARBOHYD METABOL, V3, P119; DAVIDSON JJ, 1992, P NATL ACAD SCI USA, V89, P2096, DOI 10.1073/pnas.89.6.2096; DEBRUIJN WC, 1975, PATHOL EUR, V10, P3; EISHI Y, 1985, HUM PATHOL, V16, P193, DOI 10.1016/S0046-8177(85)80071-X; FRANCKE U, 1989, AM J HUM GENET, V45, P276; HARMANN B, 1991, J BIOL CHEM, V266, P15631; HUG G, 1966, SCIENCE, V153, P1534, DOI 10.1126/science.153.3743.1534; HUIJING F, 1969, AM J HUM GENET, V21, P275; HUIJING F, 1973, BIOCHEM GENET, V9, P193, DOI 10.1007/BF00487449; JONES TA, 1990, BIOCHIM BIOPHYS ACTA, V1048, P24, DOI 10.1016/0167-4781(90)90017-V; KEE SM, 1986, J BIOL CHEM, V261, P4732; KILIMANN MW, 1988, P NATL ACAD SCI USA, V85, P9381, DOI 10.1073/pnas.85.24.9381; LEDERER B, 1980, BIOCHEM BIOPH RES CO, V92, P169, DOI 10.1016/0006-291X(80)91535-1; LEDERER B, 1975, BIOCHEM J, V147, P23, DOI 10.1042/bj1470023; LERNER A, 1982, AM J DIS CHILD, V136, P406, DOI 10.1001/archpedi.1982.03970410024004; LYON JB, 1970, BIOCHEM GENET, V4, P169, DOI 10.1007/BF00484028; LYON JB, 1957, AM J PHYSIOL, V190, P434, DOI 10.1152/ajplegacy.1957.190.3.434; MADLOM M, 1989, EUR J PEDIATR, V149, P52, DOI 10.1007/BF02024335; MALTHUS R, 1980, BIOCHEM J, V188, P99, DOI 10.1042/bj1880099; MASHIMA Y, 1992, AM J HUM GENET, V51, P81; OHTANI Y, 1982, NEUROLOGY, V32, P833, DOI 10.1212/WNL.32.8.833; Pickett-Gies CA., 1986, ENZYMES, V17, P395; SCHIMKE RN, 1973, J PEDIATR-US, V83, P1031, DOI 10.1016/S0022-3476(73)80544-X; SERVIDEI S, 1988, J PEDIATR-US, V113, P82, DOI 10.1016/S0022-3476(88)80535-3; SHIN YS, 1990, J INHERIT METAB DIS, V13, P19; VARSANYI M, 1980, BIOCHEM GENET, V18, P247, DOI 10.1007/BF00484240; WEXLER ID, 1988, P NATL ACAD SCI USA, V85, P7336, DOI 10.1073/pnas.85.19.7336; WULLRICH A, 1993, J BIOL CHEM, V268, P23208; ZANDER NF, 1988, P NATL ACAD SCI USA, V85, P2929, DOI 10.1073/pnas.85.9.2929	37	22	26	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1993	5	4					381	385		10.1038/ng1293-381	http://dx.doi.org/10.1038/ng1293-381			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ML145	8298647				2022-12-25	WOS:A1993ML14500015
J	TANZI, RE; PETRUKHIN, K; CHERNOV, I; PELLEQUER, JL; WASCO, W; ROSS, B; ROMANO, DM; PARANO, E; PAVONE, L; BRZUSTOWICZ, LM; DEVOTO, M; PEPPERCORN, J; BUSH, AI; STERNLIEB, I; PIRASTU, M; GUSELLA, JF; EVGRAFOV, O; PENCHASZADEH, GK; HONIG, B; EDELMAN, IS; SOARES, MB; SCHEINBERG, IH; GILLIAM, TC				TANZI, RE; PETRUKHIN, K; CHERNOV, I; PELLEQUER, JL; WASCO, W; ROSS, B; ROMANO, DM; PARANO, E; PAVONE, L; BRZUSTOWICZ, LM; DEVOTO, M; PEPPERCORN, J; BUSH, AI; STERNLIEB, I; PIRASTU, M; GUSELLA, JF; EVGRAFOV, O; PENCHASZADEH, GK; HONIG, B; EDELMAN, IS; SOARES, MB; SCHEINBERG, IH; GILLIAM, TC			THE WILSON DISEASE GENE IS A COPPER TRANSPORTING ATPASE WITH HOMOLOGY TO THE MENKES DISEASE GENE	NATURE GENETICS			English	Article							ESTERASE-D; PROTEIN; LINKAGE; HYDROPHOBICITY; CHROMOSOME-13; RESISTANCE; MARKERS; LOCUS	Wilson disease (WD) is an autosomal recessive disorder characterized by the toxic accumulation of copper in a number of organs, particularly the liver and brain. As shown in the accompanying paper, linkage disequilibrium & haplotype analysis confirmed the disease locus to a single marker interval at 13q14.3. Here we describe a partial cDNA clone (pWD) which maps to this region and shows a particular 76% amino acid homology to th Menkes disease gene, Mc1. The predicted functional properties of the pWD gene together with its strong homology to Mc1, genetic mapping data and identification of four independent disease-specific mutations, provide convincing evidence that pWD is the Wilson disease gene.	COLUMBIA UNIV,DEPT GENET & DEV,NEW YORK,NY 10032; COLUMBIA UNIV,DEPT PSYCHIAT,NEW YORK,NY 10032; COLUMBIA UNIV,DEPT BIOCHEM & MOLEC BIOPHYS,NEW YORK,NY 10032; COLUMBIA UNIV,DEPT MED,NEW YORK,NY 10032; COLUMBIA UNIV,CTR REPROD SCI,NEW YORK,NY 10032; HARVARD UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02115; MASSACHUSETTS GEN HOSP,BOSTON,MA 02114; UNIV CATANIA,PEDIAT CLIN,CATANIA,ITALY; NATL CTR STUDY WILSONS DIS,NEW YORK,NY 10019; ST LUKES ROOSEVELT HOSP,NEW YORK,NY 10019; CNR,INST RIC TALASSEMIE & ANEMIE MEDITERRANEE,CAGLIARI,ITALY; MOSCOW MED GENET RES CTR,MOSCOW,RUSSIA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Catania; Mount Sinai St. Luke's; Mount Sinai West; Consiglio Nazionale delle Ricerche (CNR); Research Centre for Medical Genetics			Devoto, Marcella/AAP-7595-2021; Pellequer, Jean-Luc/L-6855-2013; Bush, Ashley I/A-1186-2007; Bush, Ashley/Y-2457-2019; Tanzi, Rudolph/AAE-9622-2019; Peppercorn, Jeffrey/GPX-3100-2022; PARANO, ENRICO/AAX-8784-2020; PARANO, ENRICO/AAV-9143-2020	Pellequer, Jean-Luc/0000-0002-8944-2715; Bush, Ashley I/0000-0001-8259-9069; Bush, Ashley/0000-0001-8259-9069; Tanzi, Rudolph/0000-0002-7032-1454; PARANO, ENRICO/0000-0002-0713-7339; Chernov, Igor/0000-0002-8879-1964; Petrukhin, Konstantin/0000-0002-5545-6924; DEVOTO, MARCELLA/0000-0002-4431-5114	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028877] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00462] Funding Source: Medline; NIDDK NIH HHS [DK34668] Funding Source: Medline; NINDS NIH HHS [NS28877] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS MD, 1993, NAT GENET, V4, P373, DOI 10.1038/ng0893-373; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BONNETAMIR B, 1986, GENET EPIDEMIOL, V3, P201, DOI 10.1002/gepi.1370030307; BOWCOCK AM, 1987, AM J HUM GENET, V41, P27; BOWCOCK AM, 1991, GENOMICS, V11, P517, DOI 10.1016/0888-7543(91)90058-M; BrõndÚn CI., 1991, INTRO PROTEIN STRUCT; Bush A. J., 1993, Society for Neuroscience Abstracts, V19, P19; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Compston A., 1912, BRAIN, V34, P295, DOI DOI 10.1093/BRAIN/34.4.295; CORNETTE JL, 1987, J MOL BIOL, V195, P659, DOI 10.1016/0022-2836(87)90189-6; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; FARRER LA, 1991, NEUROLOGY, V41, P992, DOI 10.1212/WNL.41.7.992; FRYDMAN M, 1985, P NATL ACAD SCI USA, V82, P1819, DOI 10.1073/pnas.82.6.1819; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GIBBS K, 1979, Q J MED, V48, P447; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; IVY DM, 1992, J BACTERIOL, V174, P4878; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MANIATIS T, 1989, J MOL CLONING LABORA; MENKES JH, 1962, PEDIATRICS, V29, P764; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; NUCIFORA G, 1989, P NATL ACAD SCI USA, V86, P3544, DOI 10.1073/pnas.86.10.3544; OEDERMATT A, 1993, J BIOL CHEM, V268, P12775; PELLEQUER JL, 1993, IMMUNOL LETT, V36, P83, DOI 10.1016/0165-2478(93)90072-A; PETRUKHIN K, 1993, NAT GENET, V5, P338, DOI 10.1038/ng1293-338; SASSKORTSAK A, 1978, METABOLIC BASIS INHE, P1098; SCHEINBERG IH, 1984, WILSONS DISEASE, V22; SILVER S, 1989, TRENDS BIOCHEM SCI, V14, P76, DOI 10.1016/0968-0004(89)90048-0; SILVER S, 1992, MICROBIOL REV, V56, P195, DOI 10.1128/MMBR.56.1.195-228.1992; SOARES MB, IN PRESS AUTOMATED D; STEWART EA, 1993, AM J HUM GENET, V53, P864; THOMAS GR, 1993, HUM MOL GENET, V2, P1401, DOI 10.1093/hmg/2.9.1401; VILSEN B, 1989, J BIOL CHEM, V264, P21024; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7	37	1077	1109	1	42	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1993	5	4					344	350		10.1038/ng1293-344	http://dx.doi.org/10.1038/ng1293-344			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ML145	8298641				2022-12-25	WOS:A1993ML14500009
J	Rubattu, S; Volpe, M; Kreutz, R; Ganten, U; Ganten, D; Lindpaintner, K				Rubattu, S; Volpe, M; Kreutz, R; Ganten, U; Ganten, D; Lindpaintner, K			Chromosomal mapping of quantitative trait loci contributing to stroke in a rat model of complex human disease	NATURE GENETICS			English	Article							SPONTANEOUSLY HYPERTENSIVE RATS; BLOOD-PRESSURE; RISK-FACTORS; LINKAGE; GENE; MEN; HEMORRHAGE; PROTECTION; DISSECTION; MORTALITY	Stroke is a complex disorder with a poorly understood multifactorial and polygenic aetiology. We used the stroke-prone spontaneously hypertensive rat (SHRSP) as a model organism, mated it with the stroke-resistant spontaneously hypertensive rat (SHR) and performed a genome-wide screen in the resultant F2 cohort where latency until stroke, but not hypertension (a major confounder) segregated. We identified three major quantitative trait loci, STR1-3, with lod scores of 7.4, 4.7 and 3.0, respectively, that account for 28% of the overall phenotypic variance. STR2 colocalizes with the genes encoding atrial and brain natriuretic factor, peptides with important vasoactive properties. Our results demonstrate the existence of primary, blood pressure-independent genetic factors predisposing to a complex form of stroke.	BRIGHAM & WOMENS HOSP, DIV CARDIOVASC, BOSTON, MA 02115 USA; UNIV NAPLES FEDERICO II, DEPT INTERNAL MED, I-80131 NAPLES, ITALY; IST NEUROL MEDITERRANEO NEUROMED, I-86067 POZZILLI, ITALY; UNIV ROMA LA SAPIENZA, DEPT EXPT MED & PATHOL, I-00100 ROME, ITALY; MAX DELBRUCK CTR MOLEC MED, D-13122 BERLIN, GERMANY	Harvard University; Brigham & Women's Hospital; University of Naples Federico II; IRCCS Neuromed; Sapienza University Rome; Helmholtz Association; Max Delbruck Center for Molecular Medicine			Kreutz, Reinhold/AEV-0507-2022; Volpe, Massimo/K-5240-2016; Rubattu, S./K-4036-2016	Volpe, Massimo/0000-0002-9642-8380; RUBATTU, Speranza Donatella/0000-0001-5921-7368; Rubattu, Speranza/0000-0002-9808-7970; Kreutz, Reinhold/0000-0002-4818-211X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056411, K04HL003138] Funding Source: NIH RePORTER; NHLBI NIH HHS [K04-HL03138-01, R01-HL56411-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1970, JAMA, V213, P1143; BOERS GHJ, 1985, NEW ENGL J MED, V313, P709, DOI 10.1056/NEJM198509193131201; BRASS LM, 1992, STROKE, V23, P221, DOI 10.1161/01.STR.23.2.221; DEFAIRE U, 1975, PREV MED, V4, P509, DOI 10.1016/0091-7435(75)90036-5; DIAZ JF, 1986, STROKE, V17, P1239, DOI 10.1161/01.STR.17.6.1239; Ducros A, 1996, AM J HUM GENET, V58, P171; GIFFORD AJ, 1966, AM J PUBLIC HEALTH N, V56, P452, DOI 10.2105/AJPH.56.3.452; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; HUBNER N, 1994, HYPERTENSION, V23, P797, DOI 10.1161/01.HYP.23.6.797; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; JACOB HJ, 1995, NAT GENET, V9, P63, DOI 10.1038/ng0195-63; KAGAN A, 1980, STROKE, V11, P14, DOI 10.1161/01.STR.11.1.14; KANNEL WB, 1970, J AMER MED ASSOC, V214, P301, DOI 10.1001/jama.214.2.301; KANNEL WB, 1976, EPIDEMIOLOGY CONTROL, P553; KREUTZ R, 1995, P NATL ACAD SCI USA, V92, P8778, DOI 10.1073/pnas.92.19.8778; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; MARSHALL J, 1971, J MED GENET, V8, P84, DOI 10.1136/jmg.8.1.84; NAGAOKA A, 1976, AM J PHYSIOL, V230, P1354, DOI 10.1152/ajplegacy.1976.230.5.1354; NEEDLEMAN P, 1989, ANNU REV PHARMACOL, V29, P23, DOI 10.1146/annurev.pa.29.040189.000323; OKAMOTO K, 1974, CIRC RES, V34, pI143; OSTFELD AM, 1974, AM J PUBLIC HEALTH, V64, P450, DOI 10.2105/AJPH.64.5.450; PALSDOTTIR A, 1988, LANCET, V2, P603; SADOSHIMA S, 1983, AM J PHYSIOL, V244, pH406, DOI 10.1152/ajpheart.1983.244.3.H406; SLIVKA A, 1991, STROKE, V22, P884, DOI 10.1161/01.STR.22.7.884; TAGAMI M, 1981, STROKE, V12, P852, DOI 10.1161/01.STR.12.6.852; TAGAMI M, 1987, STROKE, V18, P733, DOI 10.1161/01.STR.18.4.733; TOURNIERLASSERVE E, 1993, NAT GENET, V3, P256, DOI 10.1038/ng0393-256; VOLPE M, 1990, HYPERTENSION, V15, P318, DOI 10.1161/01.HYP.15.3.318; VOLPE M, IN PRESS J CLIN INVE; WELIN L, 1987, NEW ENGL J MED, V317, P521, DOI 10.1056/NEJM198708273170901; Witte JS, 1996, NAT GENET, V12, P355, DOI 10.1038/ng0496-355; YAMORI Y, 1984, HYPERTENSION, V6, P49, DOI 10.1161/01.HYP.6.1.49; YAMORI Y, 1982, JPN CIRC J, V46, P933, DOI 10.1253/jcj.46.933; YAMORI Y, 1976, STROKE, V7, P46, DOI 10.1161/01.STR.7.1.46; YAMORI Y, 1982, JPN CIRC J, V46, P274, DOI 10.1253/jcj.46.274	39	215	219	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1996	13	4					429	434		10.1038/ng0896-429	http://dx.doi.org/10.1038/ng0896-429			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VB620	8696337				2022-12-25	WOS:A1996VB62000023
J	Forrest, D; Erway, LC; Ng, L; Altschuler, R; Curran, T				Forrest, D; Erway, LC; Ng, L; Altschuler, R; Curran, T			Thyroid hormone receptor beta is essential for development of auditory function	NATURE GENETICS			English	Letter							PROTEIN; RESISTANCE; GENE; RATS		UNIV CINCINNATI, DEPT BIOL SCI, CINCINNATI, OH 45221 USA; UNIV MICHIGAN, KRESGE HEARING RES INST, ANN ARBOR, MI 48109 USA; ST JUDE CHILDRENS RES HOSP, DEPT DEV NEUROBIOL, MEMPHIS, TN 38105 USA	University System of Ohio; University of Cincinnati; University of Michigan System; University of Michigan; St Jude Children's Research Hospital	Forrest, D (corresponding author), MT SINAI SCH MED, DEPT HUMAN GENET, 5TH AVE 100TH ST, NEW YORK, NY 10029 USA.		Curran, Tom/C-1164-2008; Curran, Tom/D-7515-2011; Curran, Tom/F-5234-2018; Curran, Thomas/AAE-7631-2019	Curran, Tom/0000-0003-1444-7551; Curran, Tom/0000-0003-1444-7551; Curran, Thomas/0000-0003-1444-7551	NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA21765] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANAND VT, 1989, ACTA OTO-LARYNGOL, V108, P83, DOI 10.3109/00016488909107396; BRADLEY DJ, 1994, P NATL ACAD SCI USA, V91, P439, DOI 10.1073/pnas.91.2.439; BRUCKERDAVIS F, 1995, ANN INTERN MED, V123, P572, DOI 10.7326/0003-4819-123-8-199510150-00002; BURROW GN, 1994, NEW ENGL J MED, V331, P1072; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; COREY DP, 1994, P NATL ACAD SCI USA, V91, P433, DOI 10.1073/pnas.91.2.433; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; DEESCOBAR GM, 1991, ADV EXP MED BIOL, V299, P133; Delong G. Robeert, 1993, American Journal of Clinical Nutrition, V57, p286S, DOI 10.1093/ajcn/57.2.286S; DEOL MS, 1976, ACTA OTO-LARYNGOL, V81, P429; DEOL MS, 1973, J MED GENET, V10, P235, DOI 10.1136/jmg.10.3.235; ERWAY LC, 1993, HEARING RES, V65, P125, DOI 10.1016/0378-5955(93)90207-H; FORREST D, 1994, SEMIN CANCER BIOL, V5, P167; FORREST D, 1990, EMBO J, V9, P1519, DOI 10.1002/j.1460-2075.1990.tb08270.x; FORREST D, IN PRESS EMBO J; FREEMAN S, 1993, HEARING RES, V69, P229, DOI 10.1016/0378-5955(93)90112-E; HEBERT R, 1986, PEDIATR RES, V20, P570, DOI 10.1203/00006450-198606000-00020; HEBERT R, 1995, DEV BRAIN RES, V23, P161; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; McCarrison R, 1908, LANCET, V2, P1275; MEYERHOFF WL, 1979, LARYNGOSCOPE, V89, P1; OMALLEY BW, 1995, HEARING RES, V88, P181, DOI 10.1016/0378-5955(95)00111-G; Pendred V, 1896, LANCET, V148, P532, DOI [DOI 10.1016/S0140-6736(01)74403-0, 10.1016/S0140-6736(01)74403-0]; REFETOFF S, 1993, ENDOCR REV, V14, P348, DOI 10.1210/er.14.3.348; REFETOFF S, 1967, J CLIN ENDOCR METAB, V27, P279, DOI 10.1210/jcem-27-2-279; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SJOBERG M, 1995, MOL CELL BIOL, V15, P4718; STANBURY JB, 1984, J ENDOCRINOL INVEST, V7, P409, DOI 10.1007/BF03351027; STEEL KP, 1994, TRENDS GENET, V10, P428, DOI 10.1016/0168-9525(94)90113-9; STRAIT KA, 1990, J BIOL CHEM, V265, P10514; TAKEDA K, 1992, J CLIN ENDOCR METAB, V74, P49, DOI 10.1210/jc.74.1.49; UZIEL A, 1986, ACTA OTO-LARYNGOL, P23; UZIEL A, 1981, ACTA OTO-LARYNGOL, V92, P469, DOI 10.3109/00016488109133286; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0	34	274	281	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	1996	13	3					354	357		10.1038/ng0796-354	http://dx.doi.org/10.1038/ng0796-354			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UU283	8673137				2022-12-25	WOS:A1996UU28300026
J	Paulson, RF; Vesely, S; Siminovitch, KA; Bernstein, A				Paulson, RF; Vesely, S; Siminovitch, KA; Bernstein, A			Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1	NATURE GENETICS			English	Article							STEM-CELL FACTOR; MOTH-EATEN MICE; C-KIT RECEPTOR; HEMATOPOIETIC-CELLS; PROGENITOR CELLS; MOTHEATEN MICE; GROWTH-FACTOR; MUTANT MICE; MAST-CELLS; W-LOCUS	Protein tyrosine phosphorylation plays a key role in regulating eukaryotic cell proliferation and differentiation. Genetic analysis in invertebrates has been invaluable for dissecting the signalling events downstream of receptor tyrosine kinases (RTKs). We have used this approach in mammals to analyse the interactions between the Kit RTK encoded by the murine Dominant white spotting (W) locus and the Shp1 protein tyrosine phosphatase, the product of the murine motheaten (me) gene. Homozygosity for mutations in both W and me ameliorates aspects of both the me and W phenotypes, including the lethal lung disease associated with me and the embryonic lethality and mast cell deficiency associated with W, demonstrating that the Kit receptor plays a role in the pathology of the me phenotype and conversely that Shp1 negatively regulates Kit signalling in vivo.	MT SINAI HOSP, SAMUEL LUNENFELD RES INST, PROGRAM MOL BIOL & CANC, TORONTO, ON M5G 1X5, CANADA; UNIV TORONTO, DEPT MED, TORONTO, ON, CANADA; UNIV TORONTO, DEPT MED & MOLEC GENET, TORONTO, ON, CANADA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto			Siminovitch, Katherine/K-1475-2013					ABRAHAMSON JLA, 1995, MOL CELL BIOL, V15, P6953; ADACHI S, 1992, BLOOD, V79, P650; ALAI M, 1992, J BIOL CHEM, V267, P18021; ALESSI DR, 1995, CURR BIOL, V5, P283, DOI 10.1016/S0960-9822(95)00059-5; BLOUIN R, 1993, CLIN DISORDERS EXPT, P157; BROXMEYER HE, 1991, CANCER CELL-MON REV, V3, P480; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; CUTLER RL, 1993, J BIOL CHEM, V268, P21463; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; DAMBROSIO D, 1995, SCIENCE, V268, P293, DOI 10.1126/science.7716523; DAVID M, 1995, MOL CELL BIOL, V15, P7050; DENBURG JA, 1992, BLOOD, V79, P846; DOLCI S, 1991, NATURE, V352, P809, DOI 10.1038/352809a0; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; FUJITA J, 1988, J CELL PHYSIOL, V134, P78, DOI 10.1002/jcp.1041340109; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GREEN MC, 1975, J HERED, V66, P250, DOI 10.1093/oxfordjournals.jhered.a108625; HUIZINGA JD, 1995, NATURE, V373, P347, DOI 10.1038/373347a0; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; KAYNE PS, 1995, CURR OPIN GENET DEV, V5, P38, DOI 10.1016/S0959-437X(95)90051-9; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; KOO GC, 1993, J IMMUNOL, V151, P6733; KOZLOWSKI M, 1993, J EXP MED, V178, P2157, DOI 10.1084/jem.178.6.2157; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; Little CC, 1937, P NATL ACAD SCI USA, V23, P535, DOI 10.1073/pnas.23.10.535; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MATSUI Y, 1991, NATURE, V353, P750, DOI 10.1038/353750a0; MCNIECE IK, 1991, J IMMUNOL, V146, P3785; MCNIECE IK, 1991, EXP HEMATOL, V19, P226; MEININGER CJ, 1992, BLOOD, V79, P958; MUTA K, 1995, BLOOD, V86, P572, DOI 10.1182/blood.V86.2.572.bloodjournal862572; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63; PANI G, 1995, J EXP MED, V181, P2077, DOI 10.1084/jem.181.6.2077; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; REITH AD, 1990, GENE DEV, V4, P390, DOI 10.1101/gad.4.3.390; ROSSI GA, 1985, AM REV RESPIR DIS, V131, P150; ROTTAPEL R, 1991, MOL CELL BIOL, V11, P3043, DOI 10.1128/MCB.11.6.3043; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SHULTZ LD, 1983, EXP HEMATOL, V11, P667; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; SHULTZ LD, 1988, CURR TOP MICROBIOL, V137, P216; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; SUN H, 1994, TRENDS BIOCHEM SCI, V19, P480, DOI 10.1016/0968-0004(94)90134-1; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; VANZANT G, 1989, EXP HEMATOL, V17, P81; Wang Y., 1993, PROTEIN PHOSPHORYLAT, P121; WARD SM, 1994, J PHYSIOL-LONDON, V480, P91, DOI 10.1113/jphysiol.1994.sp020343; YEUNG YG, 1992, J BIOL CHEM, V267, P23447; YI TL, 1992, MOL CELL BIOL, V12, P836, DOI 10.1128/MCB.12.2.836; YI TL, 1993, MOL CELL BIOL, V13, P7577, DOI 10.1128/MCB.13.12.7577; YI TL, 1993, MOL CELL BIOL, V13, P3350, DOI 10.1128/MCB.13.6.3350	57	135	136	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1996	13	3					309	315		10.1038/ng0796-309	http://dx.doi.org/10.1038/ng0796-309			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UU283	8673130				2022-12-25	WOS:A1996UU28300019
J	Riggins, GJ; Thiagalingam, S; Rozenblum, E; Weinstein, CL; Kern, SE; Hamilton, SR; Willson, JKV; Markowitz, SD; Kinzler, KW; Vogelstein, B				Riggins, GJ; Thiagalingam, S; Rozenblum, E; Weinstein, CL; Kern, SE; Hamilton, SR; Willson, JKV; Markowitz, SD; Kinzler, KW; Vogelstein, B			Mad-related genes in the human	NATURE GENETICS			English	Letter							GROWTH-FACTOR-BETA		JOHNS HOPKINS ONCOL CTR,BALTIMORE,MD 21231; JOHNS HOPKINS UNIV,SCH MED,DEPT PATHOL,BALTIMORE,MD 21205; CASE WESTERN RESERVE UNIV HOSP,DEPT MED,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV HOSP,IRELAND CANC CTR,CLEVELAND,OH 44106; JOHNS HOPKINS ONCOL CTR,HOWARD HUGHES MED INST,BALTIMORE,MD 21231	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University Hospital; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine				Thiagalingam, Sam/0000-0001-5211-266X	NCI NIH HHS [CA35494, CA 43460, CA 09243] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA035494, R01CA043460, R37CA043460, T32CA009243, R37CA035494] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Brattain Michael G., 1994, Current Opinion in Oncology, V6, P77, DOI 10.1097/00001622-199401000-00011; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FYNAN TM, 1993, CRIT REV ONCOGENESIS, V4, P493; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; HILLIER L, IN PRESS NATURE; HOULGATTE R, 1995, GENOME RES, V5, P272, DOI 10.1101/gr.5.3.272; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; HURSH DA, 1993, DEVELOPMENT, V117, P1211; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; KORENBERG JR, 1995, GENOMICS, V29, P364, DOI 10.1006/geno.1995.9993; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; MASSAGUE J, 1995, CURR OPIN GENET DEV, V5, P91, DOI 10.1016/S0959-437X(95)90059-4; Ogasawara S, 1996, GASTROENTEROLOGY, V110, P52, DOI 10.1053/gast.1996.v110.pm8536888; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; POWELL SM, 1993, NEW ENGL J MED, V329, P1982, DOI 10.1056/NEJM199312303292702; ROBERTS AB, 1993, GROWTH FACTORS, V8, P1; ROJAS K, 1995, GENOMICS, V25, P329, DOI 10.1016/0888-7543(95)80153-D; SATTERWHITE DJ, 1994, INVAS METAST, V14, P309; Savage C, 1996, P NATL ACAD SCI USA, V93, P790, DOI 10.1073/pnas.93.2.790; SCHULER GD, 1991, PROTEINS, V9, P180, DOI 10.1002/prot.340090304; Schutte M, 1996, CANCER RES, V56, P2527; SEKELSKY JJ, 1995, GENETICS, V139, P1347; TNIAGALINGAM S, 1996, NAT GENET, V13, P343; Wick W, 1996, ONCOGENE, V12, P973; Wieland I, 1996, ONCOGENE, V12, P97	26	352	371	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1996	13	3					347	349		10.1038/ng0796-347	http://dx.doi.org/10.1038/ng0796-347			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UU283	8673135				2022-12-25	WOS:A1996UU28300024
J	vanderNeut, R; Krimpenfort, P; Calafat, J; Niessen, CM; Sonnenberg, A				vanderNeut, R; Krimpenfort, P; Calafat, J; Niessen, CM; Sonnenberg, A			Epithelial detachment due to absence of hemidesmosomes in integrin beta 4 null mice	NATURE GENETICS			English	Letter							BASEMENT-MEMBRANE ADHESION; CELL-ADHESION; COMPONENT; SEQUENCE; GENE; ALPHA-6-BETA-4; IDENTIFICATION; AUTOANTIGEN; EXPRESSION; RECEPTORS		NETHERLANDS CANC INST, DIV CELL BIOL, 1066 CX AMSTERDAM, NETHERLANDS; NETHERLANDS CANC INST, DIV MOLEC GENET, 1066 CX AMSTERDAM, NETHERLANDS	Netherlands Cancer Institute; Netherlands Cancer Institute				Niessen, Carien M./0000-0002-4892-9391				ADRA CN, 1987, GENE, V60, P65, DOI 10.1016/0378-1119(87)90214-9; BAUDOIN C, IN PRESS CELL ADH CO; BONIFAS JM, 1991, SCIENCE, V254, P1202, DOI 10.1126/science.1720261; CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; CHAN YM, 1994, GENE DEV, V8, P2574, DOI 10.1101/gad.8.21.2574; DIAZ LA, 1990, J CLIN INVEST, V86, P1088, DOI 10.1172/JCI114812; DIPERSIO CM, 1995, J CELL SCI, V108, P2321; GIUDICE GJ, 1991, J CLIN INVEST, V87, P734, DOI 10.1172/JCI115054; GRITZ L, 1983, GENE, V25, P179, DOI 10.1016/0378-1119(83)90223-8; GUO LF, 1995, CELL, V81, P233, DOI 10.1016/0092-8674(95)90333-X; HASHIMOTO T, 1993, J INVEST DERMATOL, V100, P310, DOI 10.1111/1523-1747.ep12469916; HIEDA Y, 1992, J CELL BIOL, V116, P1497, DOI 10.1083/jcb.116.6.1497; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; HOPKINSON SB, 1992, J INVEST DERMATOL, V99, P264, DOI 10.1111/1523-1747.ep12616615; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; JONES JCR, 1994, EXP CELL RES, V213, P1, DOI 10.1006/excr.1994.1166; KAJIJI S, 1989, EMBO J, V8, P673, DOI 10.1002/j.1460-2075.1989.tb03425.x; KENNEL SJ, 1992, J CELL SCI, V101, P145; KENNEL SJ, 1989, J BIOL CHEM, V264, P15515; KENNEL SJ, 1993, GENE, V130, P209, DOI 10.1016/0378-1119(93)90421-X; LANGHOFER M, 1993, CELL SCI, P753; MAANDAG ECR, 1994, EMBO J, V13, P4260, DOI 10.1002/j.1460-2075.1994.tb06746.x; MAINIERO F, 1995, EMBO J, V14, P4470, DOI 10.1002/j.1460-2075.1995.tb00126.x; NIESSEN CM, 1994, J CELL SCI, V107, P543; NIESSEN CM, 1994, EXP CELL RES, V211, P360, DOI 10.1006/excr.1994.1099; NIESSEN CM, IN PRESS J CELL SCI; RIELE HT, 1992, P NATL ACAD SCI USA, V89, P5128, DOI 10.1073/pnas.89.11.5128; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SONNENBERG A, 1993, J CELL SCI, V106, P1083; SONNENBERG A, 1987, J BIOL CHEM, V262, P10376; SONNENBERG A, 1991, J CELL BIOL, V113, P907, DOI 10.1083/jcb.113.4.907; STEPP MA, 1990, P NATL ACAD SCI USA, V87, P8970, DOI 10.1073/pnas.87.22.8970; VIDAL F, 1995, NAT GENET, V10, P229, DOI 10.1038/ng0695-229; WATT SM, 1992, EXP HEMATOL, V20, P1101	35	341	345	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1996	13	3					366	369		10.1038/ng0796-366	http://dx.doi.org/10.1038/ng0796-366			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UU283	8673140				2022-12-25	WOS:A1996UU28300029
J	Chen, HL; Gabrilovich, D; Tampe, R; Girgis, KR; Nadaf, S; Carbone, DP				Chen, HL; Gabrilovich, D; Tampe, R; Girgis, KR; Nadaf, S; Carbone, DP			A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer	NATURE GENETICS			English	Letter							TRANSPORTER; EXPRESSION		UNIV TEXAS, SW MED CTR, HARMON CTR THERAPEUT ONCOL RES, DALLAS, TX 75235 USA; MAX PLANCK INST BIOCHEM, W-8033 MARTINSRIED, GERMANY	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Max Planck Society			Gabrilovich, Dmitry/ABE-7122-2020; Tampé, Robert/H-2953-2015	Tampé, Robert/0000-0002-0403-2160				BHARDWAJ N, 1994, J CLIN INVEST, V94, P797, DOI 10.1172/JCI117399; BODMER H, 1989, NATURE, V342, P443, DOI 10.1038/342443a0; DELASALLE H, 1994, SCIENCE, V265, P237, DOI 10.1126/science.7517574; DOYLE A, 1985, J EXP MED, V161, P1135, DOI 10.1084/jem.161.5.1135; GABATHULER R, 1994, J EXP MED, V180, P1415, DOI 10.1084/jem.180.4.1415; KAKLAMANIS L, 1995, CANCER RES, V55, P5191; KELLY A, 1992, NATURE, V355, P641, DOI 10.1038/355641a0; MEYER TH, 1994, FEBS LETT, V351, P443, DOI 10.1016/0014-5793(94)00908-2; MOTAL UMA, 1993, SCAND J IMMUNOL, V38, P395, DOI 10.1111/j.1365-3083.1993.tb01743.x; POWIS SH, 1993, IMMUNOGENETICS, V37, P373, DOI 10.1007/BF00216802; RESTIFO NP, 1993, J EXP MED, V177, P265, DOI 10.1084/jem.177.2.265; Sambrook J, 1989, MOL CLONIG LAB MANUA; SANDA MG, 1995, J NATL CANCER I, V87, P280, DOI 10.1093/jnci/87.4.280; SPIES T, 1991, NATURE, V351, P323, DOI 10.1038/351323a0; SUZUKI Y, 1990, ONCOGENE, V5, P1037; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x	16	154	158	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1996	13	2					210	213		10.1038/ng0696-210	http://dx.doi.org/10.1038/ng0696-210			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UN395	8640228				2022-12-25	WOS:A1996UN39500021
J	Laporte, J; Hu, LJ; Kretz, C; Mandel, JL; Kioschis, P; Coy, JF; Klauck, SM; Poustka, A; Dahl, N				Laporte, J; Hu, LJ; Kretz, C; Mandel, JL; Kioschis, P; Coy, JF; Klauck, SM; Poustka, A; Dahl, N			A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast	NATURE GENETICS			English	Article							CENTRONUCLEAR MYOPATHY; MENTAL-RETARDATION; DNA; LINKAGE; XQ28; LOCALIZATION; SEQUENCES; HOMOLOGY; PROTEINS; RNA	X-linked recessive myotubular myopathy (MTM1) is characterized by severe hypotonia and generalized muscle weakness, with impaired maturation of muscle fibres. We have restricted the candidate region to 280 kb and characterized two candidate genes using positional cloning strategies. The presence of frameshift or missense mutations (of which two are new mutations) in seven patients proved that one of these genes is indeed implicated in MTM1. The protein encoded by the MTM1 gene is highly conserved in yeast, which is surprising for a muscle specific disease. The protein contains the consensus sequence for the active site of tyrosine phosphatases, a wide class of proteins involved in signal transduction. At least three other genes, one located within 100 kb distal from the MTM1 gene, encode proteins with very high sequence similarities and define, together with the MTM1 gene, a new family of putative tyrosine phosphatases in man.	UNIV STRASBOURG 1,CNRS,INSERM,INST GENET & BIOL MOL & CELLULAIRE,F-67404 ILLKIRCH GRAFFENS,FRANCE; DEUTSCH KREBSFORSCHUNGSZENTRUM,ABT MOL GENOMANAL,D-69120 HEIDELBERG,GERMANY; UNIV UPPSALA,CHILDRENS HOSP,DEPT CLIN GENET,S-75185 UPPSALA,SWEDEN	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Helmholtz Association; German Cancer Research Center (DKFZ); Uppsala University			laporte, jocelyn/O-4888-2019; laporte, jocelyn/J-7008-2012; Laporte, Jocelyn/H-6801-2016					ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSSON B, 1995, DNA SEQUENCE, V5, P219, DOI 10.3109/10425179509030969; BERRY R, 1995, NAT GENET, V10, P415, DOI 10.1038/ng0895-415; BIANCALANA V, 1991, HUM GENET, V88, P228, DOI 10.1007/BF00206078; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; DAHL N, 1994, J MED GENET, V31, P922, DOI 10.1136/jmg.31.12.922; DAHL N, 1995, AM J HUM GENET, V56, P1108; DARNFORS C, 1990, CLIN GENET, V37, P335; DONOGHUE MJ, 1994, TRENDS GENET, V10, P396, DOI 10.1016/0168-9525(94)90056-6; FARDEAU M, 1992, SKELETAL MUSCLE PATH; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; FLORINI JR, 1991, ANNU REV PHYSIOL, V53, P201, DOI 10.1146/annurev.ph.53.030191.001221; GEDEON A, 1991, J MED GENET, V28, P372, DOI 10.1136/jmg.28.6.372; GREGG RG, 1991, GENOMICS, V9, P701, DOI 10.1016/0888-7543(91)90363-J; GRIBSKOV M, 1986, NUCLEIC ACIDS RES, V14, P6745, DOI 10.1093/nar/14.16.6745; HECKMATT JZ, 1985, BRAIN, V108, P941, DOI 10.1093/brain/108.4.941; Hu LJ, 1996, HUM MOL GENET, V5, P139, DOI 10.1093/hmg/5.1.139; HU LJ, IN PRESS HUM GENET; JANSSEN EAM, 1994, NEUROMUSCULAR DISORD, V4, P455, DOI 10.1016/0960-8966(94)90084-1; KIOSCHIS P, IN PRESS GENOMICS; Korn Bernhard, 1992, Human Molecular Genetics, V1, P235, DOI 10.1093/hmg/1.4.235; LAN MS, 1994, DNA CELL BIOL, V13, P505, DOI 10.1089/dna.1994.13.505; LANFRANCHI G, IN PRESS GENOME RES; LEHESJOKI AE, 1990, J MED GENET, V27, P288, DOI 10.1136/jmg.27.5.288; LIECHTIGALLATI S, 1991, NEUROMUSCULAR DISORD, V4, P239; MAURO LJ, 1994, J BIOL CHEM, V269, P30659; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; MOUREY RJ, 1994, CURR OPIN GENET DEV, V4, P31, DOI 10.1016/0959-437X(94)90088-4; OBERLE I, 1986, HUM GENET, V72, P43, DOI 10.1007/BF00278816; PALMIERI G, 1994, GENOMICS, V24, P149, DOI 10.1006/geno.1994.1592; RASTINEJAD F, 1993, CELL, V75, P1107, DOI 10.1016/0092-8674(93)90320-P; SAMSON F, 1995, AM J HUM GENET, V57, P120; SARNAT HB, 1990, CAN J NEUROL SCI, V17, P109, DOI 10.1017/S0317167100030304; SAWCHAK JA, 1991, NEUROLOGY, V41, P135, DOI 10.1212/WNL.41.1.135; SEDLACEK Z, 1993, HUM MOL GENET, V2, P1865; SOLOVYEV VV, 1994, NUCLEIC ACIDS RES, V22, P5156, DOI 10.1093/nar/22.24.5156; STARR J, 1990, J MED GENET, V27, P281, DOI 10.1136/jmg.27.5.281; STREULI M, 1989, P NATL ACAD SCI USA, V86, P8698, DOI 10.1073/pnas.86.22.8698; THOMAS NST, 1990, J MED GENET, V27, P284, DOI 10.1136/jmg.27.5.284; Tonks N K, 1993, Semin Cell Biol, V4, P373, DOI 10.1006/scel.1993.1044; TUGENDREICH S, 1994, HUM MOL GENET, V3, P1509, DOI 10.1093/hmg/3.suppl_1.1509; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; WALLGRENPETTERSSON C, 1994, NEUROMUSCULAR DISORD, V4, P71, DOI 10.1016/0960-8966(94)90050-7; WALLGRENPETTERSSON C, 1995, J MED GENET, V32, P673, DOI 10.1136/jmg.32.9.673; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; Xu Y, 1994, Genet Eng (N Y), V16, P241; YANG Q, 1991, P NATL ACAD SCI USA, V88, P5949, DOI 10.1073/pnas.88.14.5949	52	473	491	1	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1996	13	2					175	182		10.1038/ng0696-175	http://dx.doi.org/10.1038/ng0696-175			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UN395	8640223				2022-12-25	WOS:A1996UN39500016
J	Couch, FJ; Farid, LM; DeShano, ML; Tavtigian, SV; Calzone, K; Campeau, L; Peng, Y; Bogden, B; Chen, Q; Neuhausen, S; ShattuckEidens, D; Godwin, AK; Daly, M; Radford, DM; Sedlacek, S; Rommens, J; Simard, J; Garber, J; Merajver, S; Weber, BL				Couch, FJ; Farid, LM; DeShano, ML; Tavtigian, SV; Calzone, K; Campeau, L; Peng, Y; Bogden, B; Chen, Q; Neuhausen, S; ShattuckEidens, D; Godwin, AK; Daly, M; Radford, DM; Sedlacek, S; Rommens, J; Simard, J; Garber, J; Merajver, S; Weber, BL			BRCA2 germline mutations in male breast cancer cases and breast cancer families	NATURE GENETICS			English	Letter									UNIV PENN,DEPT MED,STELLAR CHANCE LABS 1010,PHILADELPHIA,PA 19104; UNIV PENN,DEPT PATHOL,PHILADELPHIA,PA 19104; MYRIAD GENET INC,SALT LAKE CITY,UT 84108; UNIV UTAH,DEPT GENET EPIDEMIOL,SALT LAKE CITY,UT 84108; FOX CHASE CANC CTR,DEPT MED ONCOL,PHILADELPHIA,PA 19111; WASHINGTON UNIV,SCH MED,DEPT SURG,ST LOUIS,MO 63110; UNIV COLORADO,DEPT MED,DENVER,CO 80220; HOSP SICK CHILDREN,DEPT GENET,TORONTO,ON M5G 1X8,CANADA; UNIV LAVAL,QUEBEC CITY,PQ G1V 4G2,CANADA; CHU LAVAL,RES CTR,DEPT MOLEC ENDOCRINOL,QUEBEC CITY,PQ G1V 4G2,CANADA; DANA FARBER CANC INST,DIV CANC EPIDEMIOL & CONTROL,BOSTON,MA 02115; UNIV MICHIGAN,DEPT INTERNAL MED,ANN ARBOR,MI 48109; UNIV PENN,DEPT GENET,PHILADELPHIA,PA 19104	University of Pennsylvania; University of Pennsylvania; Myriad Genetics, Inc; Utah System of Higher Education; University of Utah; Fox Chase Cancer Center; Washington University (WUSTL); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Laval University; Laval University; Harvard University; Dana-Farber Cancer Institute; University of Michigan System; University of Michigan; University of Pennsylvania				Calzone, Kathleen/0000-0002-2354-6810; Simard, Jacques/0000-0001-6906-3390	NATIONAL CANCER INSTITUTE [F32CA067403, R01CA057601, T32CA009615] Funding Source: NIH RePORTER; NCI NIH HHS [CA09615, CA67403, R01 CA57601] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		GANGULY A, 1989, P NATL ACAD SCI USA, V86, P2766; Neuhausen S, 1996, NAT GENET, V13, P126, DOI 10.1038/ng0596-126; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	5	285	290	1	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1996	13	1					123	125		10.1038/ng0596-123	http://dx.doi.org/10.1038/ng0596-123			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH430	8673091				2022-12-25	WOS:A1996UH43000031
J	Ernfors, P; Duan, ML; ElShamy, WM; Canlon, B				Ernfors, P; Duan, ML; ElShamy, WM; Canlon, B			Protection of auditory neurons from aminoglycoside toxicity by neurotrophin-3	NATURE MEDICINE			English	Article							INNER-EAR; COCHLEOVESTIBULAR GANGLION; SENSORY NEURONS; MESSENGER-RNAS; GUINEA-PIG; OTOTOXICITY; RAT; DEGENERATION; EXPRESSION; GENTAMICIN	Hearing is conveyed from the auditory receptors, the hair cells in the organ of Corti, to the brain via the spiral ganglion neurons. Damage or loss of either spiral ganglion neurons or hair cells causes hearing impairment. Such hearing disorders are often permanent and can be caused by therapeutic agents, such as aminoglycoside antibiotics and cisplatin, or by aging, loud sounds, infections and mechanical injury(1). Brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3), members of the neurotrophin family of neurotrophic factors that also include nerve growth factor (NGF) and neurotrophin-4/5 (NT-4), are important in development of the neuronal components of the inner ear. We report here that the loss of target innervation and the degeneration of approximately 90% of the adult spiral ganglion neurons caused by aminoglycoside toxicity can be prevented by infusion of the neurotrophic factor, neurotrophin-3 (NT-3) in the membranous labyrinth in guinea pigs. The potency of NT-3 in protecting spiral ganglion neurons from degenerating suggests that neurotrophins may be useful for the treatment of hearing disorders.	KAROLINSKA INST,DEPT PHYSIOL & PHARMACOL,S-17177 STOCKHOLM,SWEDEN	Karolinska Institutet	Ernfors, P (corresponding author), KAROLINSKA INST,DEPT MED BIOCHEM & BIOPHYS,MOLEC NEUROBIOL LAB,DOKTORSRINGEN 12A,S-17177 STOCKHOLM,SWEDEN.		ElShamy, Wael M./L-1090-2018; ElShamy, Wael/AAF-2867-2019	Ernfors, Patrik/0000-0002-1140-3986				ARVIDSSON J, 1995, SOC NEUR ABSTR; AVILA MA, 1993, DEV BIOL, V159, P266, DOI 10.1006/dbio.1993.1239; AXDORPH U, 1993, J INTERN MED, V233, P401, DOI 10.1111/j.1365-2796.1993.tb00691.x; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; BICHLER E, 1983, ARCH OTO-RHINO-LARYN, V237, P201, DOI 10.1007/BF00453725; CANLON B, 1992, J ACOUST SOC AM, V94, P1140; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; DAVIES AM, 1986, J NEUROSCI, V6, P1897; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; ERNFORS P, 1992, EUR J NEUROSCI, V4, P1140, DOI 10.1111/j.1460-9568.1992.tb00141.x; ERNFORS P, 1995, NEURON, V14, P1153, DOI 10.1016/0896-6273(95)90263-5; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; ESTREM SA, 1981, OTOLARYNG HEAD NECK, V89, P638, DOI 10.1177/019459988108900424; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; FLEISCHMAN RW, 1975, TOXICOL APPL PHARM, V33, P320, DOI 10.1016/0041-008X(75)90098-8; GAO WQ, 1995, ANN NEUROL, V38, P30, DOI 10.1002/ana.410380108; HENLEY CM, 1993, OTOLARYNG CLIN N AM, V26, P857; HINOJOSA R, 1987, J INFECT DIS, V156, P449, DOI 10.1093/infdis/156.3.449; HORYLEE F, 1993, P NATL ACAD SCI USA, V90, P2613, DOI 10.1073/pnas.90.7.2613; HUY PTB, 1981, J INFECT DIS, V143, P476; HUY PTB, 1986, J CLIN INVEST, V77, P1492, DOI 10.1172/JCI112463; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; KOITCHEV K, 1982, ACTA OTO-LARYNGOL, V94, P431, DOI 10.3109/00016488209128931; KONISHI T, 1983, AM J OTOLARYNG, V4, P18, DOI 10.1016/S0196-0709(83)80003-9; KUMANA CR, 1994, DRUGS, V47, P902, DOI 10.2165/00003495-199447060-00004; LEFEBVRE PP, 1994, NEUROREPORT, V5, P865, DOI 10.1097/00001756-199404000-00003; LEWIN GR, 1993, TRENDS NEUROSCI, V16, P353, DOI 10.1016/0166-2236(93)90092-Z; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LUO L, 1993, HEARING RES, V69, P182; MATZ GJ, 1993, OTOLARYNGOL CLIN N A, V26, P706; NAKAI Y, 1982, ACTA OTO-LARYNGOL, V93, P227, DOI 10.3109/00016488209130876; OAKLEY RA, 1995, DEVELOPMENT, V121, P1341; PAPARELLA MM, 1980, OTOLARYNGOLOGY, P1817; PIRVOLA U, 1992, P NATL ACAD SCI USA, V89, P9915, DOI 10.1073/pnas.89.20.9915; PIRVOLA U, 1995, P NATL ACAD SCI USA, V92, P9269, DOI 10.1073/pnas.92.20.9269; REPRESA J, 1993, DEV BIOL, V159, P257, DOI 10.1006/dbio.1993.1238; THOMPSON SW, 1984, CANCER, V54, P1269, DOI 10.1002/1097-0142(19841001)54:7<1269::AID-CNCR2820540707>3.0.CO;2-9; VAZQUEZ E, 1994, ANAT EMBRYOL, V189, P157; YLIKOSKI J, 1993, HEARING RES, V65, P69, DOI 10.1016/0378-5955(93)90202-C; ZHENG JL, 1995, J NEUROSCI, V15, P5079	40	204	214	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	APR	1996	2	4					463	467		10.1038/nm0496-463	http://dx.doi.org/10.1038/nm0496-463			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UD314	8597959				2022-12-25	WOS:A1996UD31400051
J	Kennedy, D; Ramsdale, T; Mattick, JS; Little, M				Kennedy, D; Ramsdale, T; Mattick, JS; Little, M			An RNA recognition motif in Wilms' tumour protein (WT1) revealed by structural modelling	NATURE GENETICS			English	Letter							TRANSCRIPTION FACTOR; CRYSTAL-STRUCTURE; BINDING DOMAIN; FINGER PROTEIN; GENE-PRODUCT; DNA-BINDING; SEQUENCE		UNIV QUEENSLAND, CTR CELLULAR & MOLEC BIOL, BRISBANE, QLD 4072, AUSTRALIA; UNIV QUEENSLAND, DEPT BIOCHEM, ST LUCIA, QLD 4072, AUSTRALIA; UNIV QUEENSLAND, CTR DRUG DESIGN & DEV, ST LUCIA, QLD 4072, AUSTRALIA	University of Queensland; University of Queensland; University of Queensland			Little, Melissa H/A-6170-2010; Mattick, John S/I-7789-2012; Mattick, John/ABH-6130-2020; Kennedy, Hendrick/A-7635-2010	Little, Melissa H/0000-0003-0380-2263; Mattick, John S/0000-0002-7680-7527; Mattick, John/0000-0002-7680-7527; Kennedy, Hendrick/0000-0001-7937-3069				AMIT AG, 1986, SCIENCE, V233, P747, DOI 10.1126/science.2426778; BICKMORE WA, 1992, SCIENCE, V257, P235, DOI 10.1126/science.1321494; BIRNEY E, 1993, NUCLEIC ACIDS RES, V21, P5803, DOI 10.1093/nar/21.25.5803; BLUNDELL TL, 1987, NATURE, V326, P347, DOI 10.1038/326347a0; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CARICASOLE A, IN PRESS P NATL ACAD; CHOTHIA C, 1986, SCIENCE, V233, P755, DOI 10.1126/science.3090684; COPPES MJ, 1993, FASEB J, V7, P886, DOI 10.1096/fasebj.7.10.8393819; DRIESSEN HPC, 1985, MOL REPLACEMENT, P27; EISENBERG D, 1989, CHEM SCRIPTA, V29A, P217; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; HABER DA, 1991, P NATL ACAD SCI USA, V88, P9618, DOI 10.1073/pnas.88.21.9618; JOHO KE, 1990, CELL, V61, P293, DOI 10.1016/0092-8674(90)90809-S; KENAN DJ, 1991, TRENDS BIOCHEM SCI, V16, P214, DOI 10.1016/0968-0004(91)90088-D; KENT J, IN PRESS ONCOGENE; KIM YJ, 1993, MOL CELL BIOL, V13, P174, DOI 10.1128/MCB.13.1.174; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5; LUTHY R, 1991, PROTEINS, V10, P229, DOI 10.1002/prot.340100307; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; NAGAI K, 1990, NATURE, V348, P515, DOI 10.1038/348515a0; NAKAGAMA H, 1995, MOL CELL BIOL, V15, P1489; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; RAUSCHER FJ, 1990, SCIENCE, V250, P1259, DOI 10.1126/science.2244209; RAUSCHER FJ, 1993, FASEB J, V7, P896, DOI 10.1096/fasebj.7.10.8393820; REDDY JC, 1995, J BIOL CHEM, V270, P10878, DOI 10.1074/jbc.270.18.10878; SMITH CWJ, 1989, ANNU REV GENET, V23, P527, DOI 10.1146/annurev.genet.23.1.527; WANG ZY, 1993, J BIOL CHEM, V268, P9172	29	97	97	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1996	12	3					329	332		10.1038/ng0396-329	http://dx.doi.org/10.1038/ng0396-329			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TY183	8589729				2022-12-25	WOS:A1996TY18300027
J	Phelan, CM; Rebbeck, TR; Weber, BL; Devilee, P; Ruttledge, MH; Lynch, HT; Lenoir, GM; Stratton, MR; Easton, DF; Ponder, BAJ; CannonAlbright, L; Larsson, C; Goldgar, DE; Narod, SA				Phelan, CM; Rebbeck, TR; Weber, BL; Devilee, P; Ruttledge, MH; Lynch, HT; Lenoir, GM; Stratton, MR; Easton, DF; Ponder, BAJ; CannonAlbright, L; Larsson, C; Goldgar, DE; Narod, SA			Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus	NATURE GENETICS			English	Letter							BREAST-CANCER; DNA-SEQUENCE; MINISATELLITE; FREQUENCY; ONCOGENE; GENE		MONTREAL GEN HOSP,DIV MED GENET,MONTREAL,PQ H3G 1A4,CANADA; KAROLINSKA HOSP,DEPT MOLEC MED,ENDOCRINE UNIT,S-10401 STOCKHOLM,SWEDEN; UNIV PENN,SCH MED,PHILADELPHIA,PA 19104; SYLVIUS LABS,DEPT HUMAN GENET,LEIDEN,NETHERLANDS; CREIGHTON UNIV,OMAHA,NE 68178; INT AGCY RES CANC,F-69372 LYON,FRANCE; INST CANC RES,HADDOW LABS,SUTTON,SURREY,ENGLAND; UNIV CAMBRIDGE,CANC RES CAMPAIGN,HUMAN CANC GENET RES GRP,CAMBRIDGE,ENGLAND; UNIV CAMBRIDGE,DEPT COMMUNITY MED,CAMBRIDGE,ENGLAND; UNIV UTAH,SCH MED,DEPT INTERNAL MED,SALT LAKE CITY,UT; UNIV UTAH,DEPT MED INFORMAT,SALT LAKE CITY,UT 84112	McGill University; Karolinska Institutet; Karolinska University Hospital; University of Pennsylvania; Creighton University; World Health Organization; International Agency for Research on Cancer (IARC); University of London; Institute of Cancer Research - UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah			DEVILEE, PETER/ABR-2140-2022; Rebbeck, Timothy/GLU-8348-2022; Narod, Steven A/AAA-6112-2022	Rebbeck, Timothy/0000-0002-4799-1900; albright, lisa/0000-0003-2602-3668	NCI NIH HHS [CA55914] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA055914] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARDERN JC, 1993, LEUKEMIA, V7, P258; CAPON DJ, 1983, NATURE, V302, P33, DOI 10.1038/302033a0; CASTILLA LH, 1995, NAT GENET, V8, P387; COX DR, 1972, J R STAT SOC B, V34, P187; DECORTE R, 1990, DNA CELL BIOL, V9, P461, DOI 10.1089/dna.1990.9.461; EASTON DF, 1995, AM J HUM GENET, V56, P265; GARRETT PA, 1993, CANCER EPIDEM BIOMAR, V2, P131; GREEN M, 1993, GENOMICS, V17, P429, DOI 10.1006/geno.1993.1343; HOGERVORST FBL, 1995, NAT GENET, V10, P208, DOI 10.1038/ng0695-208; KRONTIRIS TG, 1993, NEW ENGL J MED, V329, P517, DOI 10.1056/NEJM199308193290801; LIDEREAU R, 1986, JNCI-J NATL CANCER I, V77, P697, DOI 10.1093/jnci/77.3.697; Narod SA, 1995, INT J CANCER, V64, P394, DOI 10.1002/ijc.2910640608; NAROD SA, 1995, AM J HUM GENET, V56, P254; RYBERG D, 1995, CANCER RES, V55, P3996; Serova O, 1996, AM J HUM GENET, V58, P42; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; SPANDIDOS DA, 1987, FEBS LETT, V218, P41, DOI 10.1016/0014-5793(87)81014-1; TREPICCHIO WL, 1992, NUCLEIC ACIDS RES, V20, P2427, DOI 10.1093/nar/20.10.2427	19	180	183	1	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1996	12	3					309	311		10.1038/ng0396-309	http://dx.doi.org/10.1038/ng0396-309			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TY183	8589723				2022-12-25	WOS:A1996TY18300021
J	Golino, P; Ragni, M; Cirillo, P; Avvedimento, VE; Feliciello, A; Esposito, N; Scognamiglio, A; Trimarco, B; Iaccarino, G; Condorelli, M; Chiariello, M; Ambrosio, G				Golino, P; Ragni, M; Cirillo, P; Avvedimento, VE; Feliciello, A; Esposito, N; Scognamiglio, A; Trimarco, B; Iaccarino, G; Condorelli, M; Chiariello, M; Ambrosio, G			Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion	NATURE MEDICINE			English	Article							HUMAN-ENDOTHELIAL-CELLS; FACTOR MESSENGER-RNA; PLATELET-AGGREGATION; BLOOD-FLOW; PROSTAGLANDIN ENDOPEROXIDES; ARTERY OCCLUSION; PROCOAGULANT; RABBIT; GENERATION; INJURY	Tissue factor is a transmembrane protein that activates the extrinsic coagulation pathway by binding factor VII. Endothelial cells, being in contact with circulating blood, do not normally express tissue factor. Here we provide evidence that oxygen free radicals induce tissue factor messenger RNA transcription and expression of tissue factor procoagulant activity in endothelial cells in culture. Isolated, perfused rabbit hearts exposed to exogenous oxygen free radicals also showed a marked increase in tissue factor activity within the coronary circulation. Furthermore, in ex vivo and in vivo hearts subjected to ischemia and reperfusion, a condition associated with a production of oxygen free radicals in large amounts, a marked increase in tissue factor activity occurred. This phenomenon could be abolished by oxygen radical scavengers. This increase in tissue factor activity during postischemic reperfusion was accompanied by a significant decrease in coronary flow, suggesting that increase in tissue factor activity with the consequent activation of the coagulation cascade might impair coronary flow during reperfusion and possibly contribute to the occurrence of reperfusion injury.	UNIV NAPLES,SCH MED 2,CNR,CTR ENDOCRINOL & ONCOL SPERIMENTALE,I-80138 NAPLES,ITALY; UNIV REGGIO CALABRIA,SCH MED CATANZARO,DEPT EXPTL MED,CALABRIA,ITALY; UNIV PERUGIA,SCH MED,DIV CARDIOL,I-06100 PERUGIA,ITALY	Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II; Universita Mediterranea di Reggio Calabria; University of Perugia	Golino, P (corresponding author), UNIV NAPLES,SCH MED 2,CNR,CTR ENDOCRINOL & ONCOL SPERIMENTALE,DEPT INTERNAL MED,DIV CARDIOL,I-80138 NAPLES,ITALY.		IACCARINO, Guido/A-7702-2010; Iaccarino, Guido/D-4540-2009; Ambrosio, Giuseppe/C-6596-2013; Trimarco, Bruno BT/K-7851-2016; CIRILLO, Plinio/K-9263-2016	IACCARINO, Guido/0000-0002-8997-835X; Iaccarino, Guido/0000-0002-8997-835X; Ambrosio, Giuseppe/0000-0002-9677-980X; Trimarco, Bruno BT/0000-0002-0701-6449; CIRILLO, Plinio/0000-0001-7818-4952; GOLINO, Paolo/0000-0002-3590-6983				AMBROSIO G, 1994, AM J PHYSIOL, V267, pH308, DOI 10.1152/ajpheart.1994.267.1.H308; AMBROSIO G, 1994, J CLIN INVEST, V93, P2408, DOI 10.1172/JCI117248; AMBROSIO G, 1989, CIRCULATION, V80, P1846, DOI 10.1161/01.CIR.80.6.1846; AMBROSIO G, 1987, J MOL CELL CARDIOL, V19, P953, DOI 10.1016/S0022-2828(87)80568-0; AMBROSIO G, 1991, J CLIN INVEST, V87, P2056, DOI 10.1172/JCI115236; BAJAJ MS, 1990, P NATL ACAD SCI USA, V87, P8869, DOI 10.1073/pnas.87.22.8869; BLOEM LJ, 1989, J CELL PHYSIOL, V139, P418, DOI 10.1002/jcp.1041390226; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLAUSS M, 1990, J BIOL CHEM, V265, P7078; COLUCCI M, 1983, J CLIN INVEST, V71, P1893, DOI 10.1172/JCI110945; CONNELLY C, 1982, AM J PHYSIOL, V243, pH682, DOI 10.1152/ajpheart.1982.243.5.H682; CROSSMAN DC, 1990, J BIOL CHEM, V265, P9782; ESMON CT, 1981, P NATL ACAD SCI-BIOL, V78, P2249, DOI 10.1073/pnas.78.4.2249; GOLINO P, 1992, CIRC RES, V71, P1447, DOI 10.1161/01.RES.71.6.1447; GOLINO P, 1993, J AM COLL CARDIOL, V21, P493, DOI 10.1016/0735-1097(93)90694-V; HALLIWELL B, 1987, FASEB J, V1, P358, DOI 10.1096/fasebj.1.5.2824268; HARTZELL S, 1989, MOL CELL BIOL, V9, P2567, DOI 10.1128/MCB.9.6.2567; JAFFE EA, 1991, HEMATOLOGY BASIC PRI, P1198; KAO J, 1992, J BIOL CHEM, V267, P20239; KOWALLIK P, 1991, CIRCULATION, V83, P974, DOI 10.1161/01.CIR.83.3.974; MARMUR JD, 1993, J CLIN INVEST, V91, P2253, DOI 10.1172/JCI116452; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0; NAWROTH PP, 1986, P NATL ACAD SCI USA, V83, P3460, DOI 10.1073/pnas.83.10.3460; NEMERSON Y, 1988, BLOOD, V71, P1; OGAWA S, 1990, J CLIN INVEST, V85, P1090, DOI 10.1172/JCI114540; PAWASHE A, 1991, THROMB HAEMOSTASIS, V66, P315; PAWASHE AB, 1994, CIRC RES, V74, P56, DOI 10.1161/01.RES.74.1.56; SCHOSSER R, 1979, COMPUT PROG BIOMED, V9, P19, DOI 10.1016/0010-468X(79)90014-X; SIES H, 1985, PHILOS T ROY SOC B, V311, P617, DOI 10.1098/rstb.1985.0168; YAO SK, 1993, CIRC RES, V73, P952, DOI 10.1161/01.RES.73.5.952; YUZAWA Y, 1993, J IMMUNOL, V150, P5633; ZWEIER JL, 1987, P NATL ACAD SCI USA, V84, P1404, DOI 10.1073/pnas.84.5.1404; ZWEIER JL, 1994, J BIOL CHEM, V269, P24156; ZWEIER JL, 1988, P NATL ACAD SCI USA, V85, P4046, DOI 10.1073/pnas.85.11.4046; ZWEIER JL, 1989, J BIOL CHEM, V264, P18890	36	157	161	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JAN	1996	2	1					35	40		10.1038/nm0196-35	http://dx.doi.org/10.1038/nm0196-35			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TP579	8564835				2022-12-25	WOS:A1996TP57900034
J	Simon, DB; NelsonWilliams, C; Bia, MJ; Ellison, D; Karet, FE; Molina, AM; Vaara, I; Iwata, F; Cushner, HM; Koolen, M; Gainza, FJ; Gitelman, HJ; Lifton, RP				Simon, DB; NelsonWilliams, C; Bia, MJ; Ellison, D; Karet, FE; Molina, AM; Vaara, I; Iwata, F; Cushner, HM; Koolen, M; Gainza, FJ; Gitelman, HJ; Lifton, RP			Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter	NATURE GENETICS			English	Article							DNA; HYPOKALEMIA; RESISTANCE; GENE	Maintenance of fluid and electrolyte homeostasis is critical for normal neuromuscular function. Bartter's syndrome is an autosomal recessive disease characterized by diverse abnormalities in electrolyte homeostasis including hypokalaemic metabolic alkalosis; Gitelman's syndrome represents the predominant subset of Bartter's patients having hypomagnesemia and hypocalciuria. We now demonstrate complete linkage of Gitelman's syndrome to the locus encoding the renal thiazide-sensitive Na-Cl cotransporter, and identify a wide variety of non-conservative mutations, consistent with loss of function alleles, in affected subjects. These findings demonstrate the molecular basis of Gitelman's syndrome. We speculate that these mutant alleles lead to reduced sodium chloride reabsorption in the more common heterozygotes, potentially protecting against development of hypertension.	YALE UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT GENET,BOYER CTR MOLEC MED,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,W HAVEN VET ADM HOSP,NEW HAVEN,CT 06510; HOSP SON DURETA,SERV NEFROL,E-07014 PALMA DE MALLORCA,SPAIN; CTY HOSP VAXJO,DEPT CLIN CHEM,S-35185 VAXJO,SWEDEN; NIHON UNIV,SCH MED,DEPT PEDIAT,ITABASHI KU,TOKYO 173,JAPAN; MADIGAN ARMY MED CTR,DEPT MED,TACOMA,WA 98431; LOCATIE GROOF ZIEKENGASTHIUS,BOSCH MEDICENTRUM,5200 ME SHERTOGENBOSCH,NETHERLANDS; HOSP CRUCES,SERV NEFROL,E-48903 VIZCAYA,SPAIN; UNIV N CAROLINA,SCH MED,DIV NEPHROL,CHAPEL HILL,NC 27599	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Hospital Universitari Son Espases; Hospital Universitari Son Dureta; Nihon University; Madigan Army Medical Center; Hospital Universitario Cruces; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine			, David/X-5730-2019; Gainza, Francisco Javier/B-5385-2008	Karet, Fiona/0000-0002-2457-2869; Ellison, David/0000-0003-2915-265X; Gainza, Francisco Javier/0000-0002-6695-6270				BARTTER FC, 1962, AM J MED, V33, P811, DOI 10.1016/0002-9343(62)90214-0; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BETTINELLI A, 1992, J PEDIATR-US, V120, P38, DOI 10.1016/S0022-3476(05)80594-3; CLIVE DM, 1995, AM J KIDNEY DIS, V25, P813, DOI 10.1016/0272-6386(95)90562-6; CUSHNER HM, 1990, AM J KIDNEY DIS, V16, P495, DOI 10.1016/S0272-6386(12)80067-9; DUNN MJ, 1981, KIDNEY INT, V19, P86, DOI 10.1038/ki.1981.12; ELLISON DH, 1991, ANN INTERN MED, V114, P886, DOI 10.7326/0003-4819-114-10-886; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GAMBA G, 1993, P NATL ACAD SCI USA, V90, P2749, DOI 10.1073/pnas.90.7.2749; GAMBA G, 1994, J BIOL CHEM, V269, P17713; Gitelman H J, 1966, Trans Assoc Am Physicians, V79, P221; GOODMAN AD, 1969, NEW ENGL J MED, V281, P1435, DOI 10.1056/NEJM196912252812601; GRAHAM RM, 1986, HYPERTENSION, V8, P549, DOI 10.1161/01.HYP.8.6.549; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; IMAI M, 1969, J PEDIATR, V74, P738, DOI 10.1016/S0022-3476(69)80136-8; Iwata Fujihiko, 1993, Acta Paediatrica Japonica, V35, P252; LARRONDO SZ, 1992, NEPHRON, V62, P340; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LIFTON RP, 1995, P NATL ACAD SCI USA, V92, P8545, DOI 10.1073/pnas.92.19.8545; MARCOFRANCO JE, 1994, CLIN NEPHROL, V42, P33; OBERMULLER N, IN PRESS AM J PHYSL; OKUSA MD, 1987, HORMONE RESISTANCE O, P231; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PEREIRA RR, 1983, AM J MED GENET, V15, P79, DOI 10.1002/ajmg.1320150110; RUDIN A, 1988, SCAND J UROL NEPHROL, V22, P35, DOI 10.1080/00365599.1988.11690381; RUDIN A, 1988, ACTA MED SCAND, V224, P165; SCOBLE JE, 1990, NEPHROL DIAL TRANSPL, V5, P388, DOI 10.1093/ndt/5.5.388; SHEN Y, 1994, GENOMICS, V22, P68, DOI 10.1006/geno.1994.1346; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; SILVERBERG AB, 1978, AM J MED, V64, P231, DOI 10.1016/0002-9343(78)90050-5; SIMOPOULOS AP, 1979, NEPHRON, V23, P130, DOI 10.1159/000181622; SMILDE TJ, 1994, J RHEUMATOL, V21, P1515; STAHL MMS, 1993, EUR J CLIN INVEST, V23, P80, DOI 10.1111/j.1365-2362.1993.tb00744.x; SUTTON RAL, 1992, MINER ELECTROL METAB, V18, P43; WARD R, 1990, HYPERTENSION PATHOPH, P81; YOSHIDA H, 1994, KIDNEY INT, V46, P1505, DOI 10.1038/ki.1994.431	36	941	986	2	29	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1996	12	1					24	30		10.1038/ng0196-24	http://dx.doi.org/10.1038/ng0196-24			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TM555	8528245				2022-12-25	WOS:A1996TM55500010
J	AALTONEN, J; BJORSES, P; SANDKUIJL, L; PERHEENTUPA, J; PELTONEN, L				AALTONEN, J; BJORSES, P; SANDKUIJL, L; PERHEENTUPA, J; PELTONEN, L			AN AUTOSOMAL LOCUS CAUSING AUTOIMMUNE-DISEASE - AUTOIMMUNE POLYGLANDULAR DISEASE TYPE-I ASSIGNED TO CHROMOSOME-21	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; LOCALIZATION; GENE	Autoimmune polyglandular disease type I (APECED) is an autosomal recessive autoimmune disease characterized by a variable combination of the failure of the endocrine glands. The pathogenesis of this unique autoimmune disease is unknown; unlike many other autoimmune diseases, APECED does not show association to specific HLA haplotypes. Unravelling the APECED locus will identify a novel gene outside the HLA loci influencing the outcome of autoimmune diseases. We have assigned the disease locus to chromosome 21q22.3 by linkage analyses in 14 Finnish families. Linkage disequilibrium studies have significantly increased the informativeness of the analyses and helped to locate the critical DNA region for the APECED locus to just 500 kilobases, a much more precise definition than linkage analyses alone could achieve.	NATL PUBL HLTH INST,DEPT HUMAN MOLEC GENET,SF-00300 HELSINKI,FINLAND; CHILDRENS HOSP,SF-00290 HELSINKI,FINLAND; ERASMUS UNIV ROTTERDAM,INST CLIN GENET,3000 DR ROTTERDAM,NETHERLANDS; SYLVIUS LABS,DEPT HUMAN GENET,2333 AL LEIDEN,NETHERLANDS	Finland National Institute for Health & Welfare; Erasmus University Rotterdam								Aaltonen J., 1993, European Journal of Human Genetics, V1, P164; AHONEN P, 1985, CLIN GENET, V27, P535, DOI 10.1111/j.1399-0004.1985.tb02037.x; AHONEN P, 1990, NEW ENGL J MED, V322, P1829, DOI 10.1056/NEJM199006283222601; AHONEN P, 1988, J CLIN ENDOCR METAB, V66, P1152, DOI 10.1210/jcem-66-6-1152; ANTONARAKIS SE, 1993, TRENDS GENET, V9, P142, DOI 10.1016/0168-9525(93)90210-9; ARNAOUT MA, 1990, J CLIN INVEST, V85, P977, DOI 10.1172/JCI114529; CARSON DA, 1992, FASEB J, V6, P2800, DOI 10.1096/fasebj.6.10.1634042; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; GU Z, 1991, AM J HUM GENET, V49, pA406; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HAWKINS JW, 1987, HUM GENET, V76, P375, DOI 10.1007/BF00272448; HELLSTEN E, 1993, GENOMICS, V16, P720, DOI 10.1006/geno.1993.1253; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LAWRENCE S, 1993, P NATL ACAD SCI USA, V90, P7210, DOI 10.1073/pnas.90.15.7210; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; LEVANON D, 1986, BIOCHEM BIOPH RES CO, V141, P374, DOI 10.1016/S0006-291X(86)80379-5; Luria SE, 1943, GENETICS, V28, P491; McKusick V.A., 1992, MENDELIAN INHERITANC; MULLIS KB, 1987, METHOD ENZYMOL, V155, P355; Norio R., 1981, BIOCULTURAL ASPECTS, P359; SYVANEN AC, 1991, GENOMICS, V12, P1; TODD JA, 1992, CURR OPIN IMMUNOL, V4, P699, DOI 10.1016/0952-7915(92)90048-J; VANDENPLAS S, 1984, J MED GENET, V21, P164, DOI 10.1136/jmg.21.3.164; YETMAN N, 1992, IMMUNOL TODAY, V13, P239; ZLOTOGORA J, 1992, J MED GENET, V29, P824, DOI 10.1136/jmg.29.11.824	25	274	281	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1994	8	1					83	87		10.1038/ng0994-83	http://dx.doi.org/10.1038/ng0994-83			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PE157	7987397	Green Published			2022-12-25	WOS:A1994PE15700020
J	RUBINSZTEIN, DC; AMOS, W; LEGGO, J; GOODBURN, S; RAMESAR, RS; OLD, J; BONTROP, R; MCMAHON, R; BARTON, DE; FERGUSONSMITH, MA				RUBINSZTEIN, DC; AMOS, W; LEGGO, J; GOODBURN, S; RAMESAR, RS; OLD, J; BONTROP, R; MCMAHON, R; BARTON, DE; FERGUSONSMITH, MA			MUTATIONAL BIAS PROVIDES A MODEL FOR THE EVOLUTION OF HUNTINGTONS-DISEASE AND PREDICTS A GENERAL INCREASE IN DISEASE PREVALENCE	NATURE GENETICS			English	Article							AGE-OF-ONSET; TRINUCLEOTIDE REPEAT; POLYMORPHISM; LENGTH; EXPANSION	Huntington's disease (HD) correlates with abnormal expansion in a block of GAG repeats in the Huntington's disease gene. We have investigated HD evolution by typing GAG alleles in several human populations and in a variety of primates. We find that human alleles have expanded from a shorter ancestral state and exhibit unusual asymmetric length distributions. Computer simulations are used to show that the human state can be derived readily from a primate ancestor, without the need to invoke natural selection. The key element is a simple length-dependent mutational bias towards longer alleles. Our model can explain a number of empirical observations, and predicts an ever-increasing incidence of HD.	ADDENBROOKES NHS TRUST, DEPT CLIN GENET, CAMBRIDGE CB2 2QQ, CAMBS, ENGLAND; UNIV CAMBRIDGE, DEPT GENET, CAMBRIDGE CB2 3EH, CAMBS, ENGLAND; UNIV CAPE TOWN, DEPT HUMAN GENET, CAPE TOWN, SOUTH AFRICA; JOHN RADCLIFFE HOSP, INST MOLEC MED, OXFORD OX3 9DU, ENGLAND; TNO, MED BIOL LAB, 2280 RIJSWIJK, NETHERLANDS; UNIV CAMBRIDGE, DEPT PATHOL, CAMBRIDGE CB2 1QP, CAMBS, ENGLAND	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cape Town; University of Oxford; Netherlands Organization Applied Science Research; University of Cambridge	RUBINSZTEIN, DC (corresponding author), ADDENBROOKES NHS TRUST, E ANGLIAN REG GENET SERV, GENET MOLEC LAB, BOX 158, CAMBRIDGE CB2 2QQ, CAMBS, ENGLAND.		Rubinsztein, David C/C-3472-2011; Barton, David E/B-9460-2008; Ramesar, Rajkumar/I-6941-2015; Bontrop, Ronald/J-3628-2012	Barton, David E/0000-0002-2031-9719; Ramesar, Rajkumar/0000-0001-5688-1634; Bontrop, Ronald/0000-0003-0874-6467				ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; BARRON LH, 1993, J MED GENET, V30, P1003, DOI 10.1136/jmg.30.12.1003; CAREY N, 1994, NAT GENET, V6, P117, DOI 10.1038/ng0294-117; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; GOLDBERG YP, 1993, NAT GENET, V5, P174, DOI 10.1038/ng1093-174; HARPER PS, 1991, HUNTINGTONS DISEASE, P251; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MADDOX J, 1994, NATURE, V368, P685, DOI 10.1038/368685a0; MAHADEVAN MS, 1993, GENOMICS, V15, P446, DOI 10.1006/geno.1993.1087; MYERS RH, 1993, NAT GENET, V5, P168, DOI 10.1038/ng1093-168; RIESS O, 1993, HUM MOL GENET, V2, P637, DOI 10.1093/hmg/2.6.637; ROUSE I, 1986, MIGRATIONS PREHISTOR, P67; RUBINSZTEIN DC, 1993, NAT GENET, V5, P214, DOI 10.1038/ng1193-214; RUBINSZTEIN DC, 1993, HUM MOL GENET, V2, P1713, DOI 10.1093/hmg/2.10.1713; SLIERENDREGT BL, 1993, TISSUE ANTIGENS, V42, P55, DOI 10.1111/j.1399-0039.1993.tb02167.x; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; VERGNAUD G, 1991, GENOMICS, V11, P135, DOI 10.1016/0888-7543(91)90110-Z; WARNER JP, 1993, MOL CELL PROBE, V7, P235, DOI 10.1006/mcpr.1993.1034; ZUHLKE C, 1993, HUM MOL GENET, V2, P2063, DOI 10.1093/hmg/2.12.2063	19	122	122	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1994	7	4					525	530		10.1038/ng0894-525	http://dx.doi.org/10.1038/ng0894-525			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PA832	7951324				2022-12-25	WOS:A1994PA83200021
J	STRATTON, MR; FORD, D; NEUHASEN, S; SEAL, S; WOOSTER, R; FRIEDMAN, LS; KING, MC; EGILSSON, V; DEVILEE, P; MCMANUS, R; DALY, PA; SMYTH, E; PONDER, BAJ; PETO, J; CANNONALBRIGHT, L; EASTON, DF; GOLDGAR, DE				STRATTON, MR; FORD, D; NEUHASEN, S; SEAL, S; WOOSTER, R; FRIEDMAN, LS; KING, MC; EGILSSON, V; DEVILEE, P; MCMANUS, R; DALY, PA; SMYTH, E; PONDER, BAJ; PETO, J; CANNONALBRIGHT, L; EASTON, DF; GOLDGAR, DE			FAMILIAL MALE BREAST-CANCER IS NOT LINKED TO THE BRCA1 LOCUS ON CHROMOSOME 17Q	NATURE GENETICS			English	Article							RISK-FACTORS; LINKAGE; ONSET; GENE; MEN	Breast cancer in men is about a hundredfold less common than in women and this has hindered research into its genetic basis. We have examined 22 families with at least one case of male breast cancer for linkage to the hereditary breast and ovarian cancer locus, BRCA1, on chromosome 17q. We found strong evidence against linkage to BRCA1 (led score - 16.63) and the best estimate of the proportion of linked families was 0% (95% Cl 0-18%). Our results indicate that there is a gene(s) other than BRCA1 which predisposes to early-onset breast cancer in women and which confers a higher risk of male breast cancer. Identification of additional pedigrees that include cases of male breast cancer may therefore facilitate the mapping and isolation of this gene.	INST CANC RES, CRC, EPIDEMIOL SECT, SUTTON SM2 5NG, SURREY, ENGLAND; UNIV UTAH, DEPT MED INFORMAT, SALT LAKE CITY, UT 84108 USA; UNIV UTAH, DEPT INTERNAL MED, SALT LAKE CITY, UT 84108 USA; UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, BERKELEY, CA 94720 USA; UNIV CALIF BERKELEY, SCH PUBL HLTH, BERKELEY, CA 94720 USA; UNIV HOSP ICELAND, CELL BIOL LAB, IS-121 REYKJAVIK, ICELAND; LEIDEN STATE UNIV, DEPT PATHOL, 2333 AL LEIDEN, NETHERLANDS; UNIV DUBLIN TRINITY COLL, ST JAMES HOSP, SCH MED, DEPT MED, DUBLIN 8, IRELAND; WESTERN GEN HOSP, MRC, HUMAN GENET UNIT, EDINBURGH EH4 2XU, MIDLOTHIAN, SCOTLAND; UNIV CAMBRIDGE, DEPT PATHOL, CRC, HUMAN CANC GENET GRP, CAMBRIDGE CB2 1QP, ENGLAND	University of London; Institute of Cancer Research - UK; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Landspitali National University Hospital; Leiden University; Leiden University - Excl LUMC; Trinity College Dublin; University of Edinburgh; University of Cambridge	STRATTON, MR (corresponding author), INST CANC RES, MOLEC CARCINOGENESIS SECT, SUTTON SM2 5NG, SURREY, ENGLAND.		McManus, Ross/AAE-9236-2020; DEVILEE, PETER/ABR-2140-2022	King, Mary-Claire/0000-0001-9426-1743; McManus, Ross/0000-0002-0529-9617; albright, lisa/0000-0003-2602-3668	NCI NIH HHS [CA-54936, CA-48711] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R03CA054936, P01CA048711] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABEL KJ, 1993, GENOMICS, V17, P632, DOI 10.1006/geno.1993.1383; ANDERSON DE, 1992, J NATL CANCER I, V84, P1114, DOI 10.1093/jnci/84.14.1114; ANDERSON LA, 1993, GENOMICS, V17, P618, DOI 10.1006/geno.1993.1381; ARASON A, 1993, AM J HUM GENET, V52, P711; BOWCOCK AM, 1993, AM J HUM GENET, V52, P718; CLAUS EB, 1991, AM J HUM GENET, V48, P232; CLAUS EB, 1990, AM J EPIDEMIOL, V131, P961, DOI 10.1093/oxfordjournals.aje.a115616; COHEN BB, 1993, AM J HUM GENET, V52, P723; DEMETER JG, 1990, CANCER, V65, P2342, DOI 10.1002/1097-0142(19900515)65:10<2342::AID-CNCR2820651029>3.0.CO;2-Y; EASTON DF, 1993, AM J HUM GENET, V52, P678; EASTON DF, IN PRESS CANCER SURV; EVERSON RB, 1976, LANCET, V1, P9; FLEJTER WL, 1993, GENOMICS, V17, P624, DOI 10.1006/geno.1993.1382; HALL JM, 1992, AM J HUM GENET, V50, P1235; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; KOZAK FK, 1986, CANCER, V58, P2736, DOI 10.1002/1097-0142(19861215)58:12<2736::AID-CNCR2820581230>3.0.CO;2-A; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LAURENCE DJ, 1991, OXFORD REV REPROD B, V13, P149; LENFANTPEJOVIC MH, 1990, INT J CANCER, V45, P661, DOI 10.1002/ijc.2910450415; LOBACCARO JM, 1993, NAT GENET, V5, P109, DOI 10.1038/ng1093-109; MARGER D, 1975, CANCER-AM CANCER SOC, V36, P458, DOI 10.1002/1097-0142(197508)36:2<458::AID-CNCR2820360222>3.0.CO;2-V; NAROD SA, 1991, LANCET, V338, P82; PAGE RCL, 1995, DIABETIC MED, V12, P209, DOI 10.1111/j.1464-5491.1995.tb00460.x; ROSENBLATT KA, 1991, JNCI-J NATL CANCER I, V83, P849, DOI 10.1093/jnci/83.12.849; SMITH CAB, 1961, 2ND P INT C HUM GEN, V1, P212; SMITH SA, 1993, AM J HUM GENET, V52, P767; TEASDALE C, 1976, LANCET, V1, P360; THOMAS DB, 1993, EPIDEMIOL REV, V15, P220, DOI 10.1093/oxfordjournals.epirev.a036108; THOMAS DB, 1992, AM J EPIDEMIOL, V135, P734, DOI 10.1093/oxfordjournals.aje.a116360; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4640, DOI 10.1093/nar/18.15.4640-a; WILSON JD, 1987, HARRISONS PRINCIPLES, P1387; WOOSTER R, 1992, NAT GENET, V2, P132, DOI 10.1038/ng1092-132	32	124	125	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1994	7	1					103	107		10.1038/ng0594-103	http://dx.doi.org/10.1038/ng0594-103			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NJ842	8075631				2022-12-25	WOS:A1994NJ84200022
J	TAKAHASHI, R; YOKOJI, H; MISAWA, H; HAYASHI, M; HU, JG; DEGUCHI, T				TAKAHASHI, R; YOKOJI, H; MISAWA, H; HAYASHI, M; HU, JG; DEGUCHI, T			A NULL MUTATION IN THE HUMAN CNTF GENE IS NOT CAUSALLY RELATED TO NEUROLOGICAL DISEASES	NATURE GENETICS			English	Article							CILIARY NEUROTROPHIC FACTOR; FACTOR PREVENTS; CHOLINERGIC DIFFERENTIATION; EMBRYONIC MOTONEURONS; NEURONOTROPHIC FACTOR; REGIONAL DISTRIBUTION; RECOMBINANT HUMAN; ESCHERICHIA-COLI; MOTOR NEURONS; RAT-BRAIN	We report a null mutation in the human ciliary neurotrophic factor gene (CNTF). The mutated allele shows a G to A transition producing a new splice acceptor site and the resulting mRNA species codes for an aberrant protein. Analysis of tissue samples and transfection of CNTF minigenes into cultured cells demonstrates that the mutated allele expresses only the mutated mRNA species. In 391 Japanese people tested, 61.9% were normal homozygotes, 35.8% heterozygotes and 2.3% mutant homozygotes. The distribution of the three genotypes is similar in health and neurological disease subjects, indicating that human CNTF-deficiency is not causally related to neurological diseases.	TOKYO METROPOLITAN NEUROL HOSP,DEPT NEUROL,FUCHU,TOKYO 183,JAPAN; BML INC,CTR RES & DEV,KAWAGOE,SAITAMA 350,JAPAN	Tokyo Metropolitan Institute for Neuroscience; BML, Inc.	TAKAHASHI, R (corresponding author), TOKYO METROPOLITAN INST NEUROSCI,DEPT NEUROL,2-6 MUSASHIDAI,FUCHU,TOKYO 183,JAPAN.							ADLER R, 1979, SCIENCE, V204, P1434, DOI 10.1126/science.451576; ARAKAWA Y, 1990, J NEUROSCI, V10, P3507; BARBIN G, 1984, J NEUROCHEM, V43, P1468, DOI 10.1111/j.1471-4159.1984.tb05410.x; BAZAN JF, 1991, NEURON, V7, P197, DOI 10.1016/0896-6273(91)90258-2; BLOTTNER D, 1989, NEUROSCI LETT, V105, P316, DOI 10.1016/0304-3940(89)90640-X; DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265; DEGUCHI T, 1990, J BIOL CHEM, V265, P12757; DOBREA GM, 1992, DEV BRAIN RES, V66, P209, DOI 10.1016/0165-3806(92)90082-8; FRIEDMAN B, 1992, NEURON, V9, P295, DOI 10.1016/0896-6273(92)90168-D; HAGG T, 1992, NEURON, V8, P145, DOI 10.1016/0896-6273(92)90116-U; HUGHES SM, 1988, NATURE, V335, P70, DOI 10.1038/335070a0; IP NY, 1991, J NEUROSCI, V11, P3124; IP NY, 1992, CELL, V69, P1121, DOI 10.1016/0092-8674(92)90634-O; IP NY, 1993, NEURON, V10, P89, DOI 10.1016/0896-6273(93)90245-M; KIM DW, 1990, GENE, V91, P217, DOI 10.1016/0378-1119(90)90091-5; LAM A, 1991, GENE, V102, P271, DOI 10.1016/0378-1119(91)90089-T; LEUNG DW, 1992, NEURON, V8, P1045, DOI 10.1016/0896-6273(92)90126-X; LILLIEN LE, 1988, NEURON, V1, P485, DOI 10.1016/0896-6273(88)90179-1; LIN LFH, 1989, SCIENCE, V246, P1023, DOI 10.1126/science.2587985; MARTINOU JC, 1992, NEURON, V8, P737, DOI 10.1016/0896-6273(92)90094-T; MASIAKOWSKI P, 1991, J NEUROCHEM, V57, P1003, DOI 10.1111/j.1471-4159.1991.tb08250.x; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; MCDONALD JR, 1991, BIOCHIM BIOPHYS ACTA, V1090, P70, DOI 10.1016/0167-4781(91)90038-N; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; NEGRO A, 1991, EUR J BIOCHEM, V201, P289, DOI 10.1111/j.1432-1033.1991.tb16286.x; NICOLOSO M, 1989, BIOCHEM BIOPH RES CO, V159, P1233, DOI 10.1016/0006-291X(89)92242-0; OPPENHEIM RW, 1991, SCIENCE, V251, P1616, DOI 10.1126/science.2011743; RAO MS, 1993, J NEUROBIOL, V24, P215, DOI 10.1002/neu.480240208; RENDE M, 1992, GLIA, V5, P25, DOI 10.1002/glia.440050105; SAADAT S, 1989, J CELL BIOL, V108, P1807, DOI 10.1083/jcb.108.5.1807; Sambrook J, 1989, MOL CLONING LABORATO; SENDTNER M, 1992, NATURE, V358, P502, DOI 10.1038/358502a0; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; SENDTNER M, 1992, J CELL BIOL, V265, P12757; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; STOCKLI KA, 1991, J CELL BIOL, V115, P447, DOI 10.1083/jcb.115.2.447; TAGA T, 1992, P NATL ACAD SCI USA, V89, P10998, DOI 10.1073/pnas.89.22.10998	38	185	194	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1994	7	1					79	84		10.1038/ng0594-79	http://dx.doi.org/10.1038/ng0594-79			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NJ842	8075647	Green Submitted			2022-12-25	WOS:A1994NJ84200018
J	ABERDAM, D; GALLIANO, MF; VAILLY, J; PULKKINEN, L; BONIFAS, J; CHRISTIANO, AM; TRYGGVASON, K; UITTO, J; EPSTEIN, EH; ORTONNE, JP; MENEGUZZI, G				ABERDAM, D; GALLIANO, MF; VAILLY, J; PULKKINEN, L; BONIFAS, J; CHRISTIANO, AM; TRYGGVASON, K; UITTO, J; EPSTEIN, EH; ORTONNE, JP; MENEGUZZI, G			HERLITZS JUNCTIONAL EPIDERMOLYSIS-BULLOSA IS LINKED TO MUTATIONS IN THE GENE (LAMC2) FOR THE GAMMA-2 SUBUNIT OF NICEIN/KALININ (LAMININ-5)	NATURE GENETICS			English	Article							MONOCLONAL-ANTIBODY; BASEMENT-MEMBRANES; PROTEINS; PROBE	We have linked Herlitz's junctional epidermolysis bullosa (H-JEB) to the gene (LAMC2) encoding the gamma 2 subunit of nicein/kalinin, an isolaminin (laminin-5) expressed by basal keratinocytes. In four H-JEB kindreds, a maximum two-point lod score of 5.33 at theta=0 was observed between a microsatellite near LAMC2 at 1q25-31 and the disease. In one family, a homozygous point mutation leading to a premature stop codon (CGA to TGA) was identified in exon 3 of the gene. The segregation of the mutated allele implicates the mutation in the pathology of the disorder and corroborates the linkage results.	FAC MED NICE,INSERM,U385,F-06107 NICE 2,FRANCE; THOMAS JEFFERSON UNIV,DEPT DERMATOL,PHILADELPHIA,PA 19107; UNIV CALIF SAN FRANCISCO,SAN FRANCISCO GEN HOSP,DEPT DERMATOL,SAN FRANCISCO,CA 94110; UNIV OULU,BIOCTR,SF-90570 OULU,FINLAND; UNIV OULU,DEPT BIOCHEM,SF-90570 OULU,FINLAND	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Jefferson University; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of Oulu; Finland National Institute for Health & Welfare; University of Oulu			Aberdam, Daniel/G-3299-2013	Aberdam, Daniel/0000-0002-4019-5418	NIAMS NIH HHS [R01-AR 41120, P01-AR38923] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041120, P01AR038923] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ABERDAM D, IN PRESS MAMM GENOME; BARE JW, 1992, CANCER RES, V52, P1494; BAUDOIN C, IN PRESS J INVEST DE; BROWN DL, 1992, NUCLEIC ACIDS RES, V200, P141; BURGESON RE, 1993, J INVEST DERMATOL, V101, P252, DOI 10.1111/1523-1747.ep12365129; BURGESON RE, IN PRESS J CLIN INVE; CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRISTIANO AM, 1993, NAT GENET, V4, P62, DOI 10.1038/ng0593-62; ENGEL J, 1992, BIOCHEMISTRY-US, V31, P10643, DOI 10.1021/bi00159a001; EPSTEIN EH, 1992, SCIENCE, V256, P799, DOI 10.1126/science.1375393; FINE JD, 1991, J AM ACAD DERMATOL, V24, P119, DOI 10.1016/0190-9622(91)70021-S; FINE JD, 1986, INT J DERMATOL, V25, P143, DOI 10.1111/j.1365-4362.1986.tb02206.x; FINE JD, 1990, ARCH DERMATOL, V126, P1187, DOI 10.1001/archderm.126.9.1187; GERECKE D, IN PRESS J BIOL CHEM; GROUP NCC, 1992, SCIENCE, V258, P148; KALLUNKI P, 1992, J CELL BIOL, V119, P679, DOI 10.1083/jcb.119.3.679; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MARINKOVICH MP, 1992, J CELL BIOL, V119, P695, DOI 10.1083/jcb.119.3.695; Meneguzzi G, 1992, Exp Dermatol, V1, P221, DOI 10.1111/j.1600-0625.1992.tb00080.x; ORTONNE JP, 1990, J INVEST DERMATOL, V94, P400; PULKKINEN L, 1994, NAT GENET, V6, P293, DOI 10.1038/ng0394-293; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; SAKAI LI, 1986, J CELL BIOL, V114, P1567; Sambrook J, 1989, MOL CLONING LABORATO; SIMON M, 1985, CELL, V40, P677, DOI 10.1016/0092-8674(85)90216-8; UITTO J, 1993, SEMIN DERMATOL, V12, P191; VAILLY J, 1994, EUR J BIOCHEM, V219, P209, DOI 10.1111/j.1432-1033.1994.tb19932.x; VAILLY J, IN PRESS GENOMICS; VERRANDO P, 1987, EXP CELL RES, V170, P116, DOI 10.1016/0014-4827(87)90121-2; VERRANDO P, 1993, J INVEST DERMATOL, V101, P738, DOI 10.1111/1523-1747.ep12371685; VERRANDO P, 1991, LAB INVEST, V64, P85; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WOODLEY DT, 1992, EPIDERMOLYSIS BULLOS, P19	35	300	308	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1994	6	3					299	304		10.1038/ng0394-299	http://dx.doi.org/10.1038/ng0394-299			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ562	8012394				2022-12-25	WOS:A1994MZ56200019
J	MEITINGER, T; MEINDL, A; BORK, P; ROST, B; SANDER, C; HAASEMANN, M; MURKEN, J				MEITINGER, T; MEINDL, A; BORK, P; ROST, B; SANDER, C; HAASEMANN, M; MURKEN, J			MOLECULAR MODELING OF THE NORRIE DISEASE PROTEIN PREDICTS A CYSTINE KNOT GROWTH-FACTOR TERTIARY STRUCTURE	NATURE GENETICS			English	Article							CRYSTAL-STRUCTURE; TRANSFORMING GROWTH-FACTOR-BETA-2; EXTRACELLULAR PROTEIN; CANDIDATE GENE; VONWILLEBRAND-FACTOR; SEQUENCE; RESOLUTION; MUTATIONS; CYTOKINES; PROGRAM	The X-lined gene for Norrie disease, which is characterized by blindness, deafness and mental retardation has been cloned recently. This gene has been thought to code for a putative extracellular factor; its predicted amino acid sequence is homologous to the C-terminal domain of diverse extracellular proteins. Sequence pattern searches and three-dimensional modelling now suggest that the Norrie disease protein (NDP) has a tertiary structure similar to that of transforming growth factor beta (TGF beta). Our model identifies NDP as a member of an emerging family of growth factors containing a cystine knot motif, with direct implications for the physiological role of NDP. The model also sheds light on sequence related domains such as the C-terminal domain of mucins and of von Willebrand factor.	EUROPEAN MOLEC BIOL LAB,D-69012 HEIDELBERG,GERMANY; MAX DELBRUCK CTR MOLEC MED,D-13122 BERLIN,GERMANY; INST JACQUES MONOD,F-75251 PARIS,FRANCE	European Molecular Biology Laboratory (EMBL); Helmholtz Association; Max Delbruck Center for Molecular Medicine; UDICE-French Research Universities; Universite Paris Cite	MEITINGER, T (corresponding author), LUDWIG MAXIMILIANS UNIV MUNCHEN,KINDERPOLIKLIN,PADIATR GENET ABT,GOETHESTR 29,D-80336 MUNICH,GERMANY.		Rost, Burkhard/A-1908-2016; Sander, Chris/H-1452-2011; Meitinger, Thomas/O-1318-2015; Bork, Peer/F-1813-2013	Rost, Burkhard/0000-0003-0179-8424; Sander, Chris/0000-0001-6059-6270; Bork, Peer/0000-0002-2627-833X; Meitinger, Thomas/0000-0002-8838-8403				ANGELETT.RH, 1971, P NATL ACAD SCI USA, V68, P2417, DOI 10.1073/pnas.68.10.2417; APPLE DJ, 1974, AM J OPHTHALMOL, V78, P196, DOI 10.1016/0002-9394(74)90076-2; AREND WP, 1990, ARTHRITIS RHEUM-US, V33, P305, DOI 10.1002/art.1780330302; ARGOS P, 1987, J MOL BIOL, V193, P385, DOI 10.1016/0022-2836(87)90226-9; BERGER W, 1992, NAT GENET, V1, P199, DOI 10.1038/ng0692-199; BERGER W, 1992, HUM MOL GENET, V1, P461, DOI 10.1093/hmg/1.7.461; BERNSTEIN SC, 1978, J MOL BIOL, V112, P535; Bork P, 1992, CURR OPIN STRUC BIOL, V2, P413; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; CHEN ZY, 1992, NAT GENET, V1, P204, DOI 10.1038/ng0692-204; DAOPIN S, 1992, SCIENCE, V257, P369, DOI 10.1126/science.1631557; GUM JR, 1992, J BIOL CHEM, V267, P21375; KOUSSEFF BG, 1992, AM J MED GENET, V42, P751, DOI 10.1002/ajmg.1320420526; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; MANCUSO DJ, 1989, J BIOL CHEM, V264, P19514; MCDONALD NQ, 1993, CELL, V73, P421, DOI 10.1016/0092-8674(93)90127-C; MCDONALD NQ, 1991, NATURE, V354, P411, DOI 10.1038/354411a0; MEINDL A, 1992, NAT GENET, V2, P139, DOI 10.1038/ng1092-139; MUDGE AW, 1993, NATURE, V363, P213, DOI 10.1038/363213a0; OEFNER C, 1992, EMBO J, V11, P3921, DOI 10.1002/j.1460-2075.1992.tb05485.x; PARSONS MA, 1992, GRAEF ARCH CLIN EXP, V230, P248, DOI 10.1007/BF00176299; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; QIAN SW, 1992, P NATL ACAD SCI USA, V89, P6290, DOI 10.1073/pnas.89.14.6290; ROHDE K, 1993, CABIOS, V6, P183; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; ROST B, 1993, TRENDS BIOCHEM SCI, V18, P120, DOI 10.1016/0968-0004(93)90017-H; ROTHBERG JM, 1992, J MOL BIOL, V227, P367, DOI 10.1016/0022-2836(92)90891-M; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; SCHLUNEGGER MP, 1992, NATURE, V358, P430, DOI 10.1038/358430a0; SKEVAS A, 1992, LARYNGO RHINO OTOL, V71, P534, DOI 10.1055/s-2007-997349; Sporn M. B., 1990, PEPTIDE GROWTH FACTO; STEEL CM, 1989, PEPTIDE REGULATORY F, P121; SWINDELLS MB, 1992, SCIENCE, V258, P1160, DOI 10.1126/science.1439827; TAMAOKI H, 1991, PROTEIN ENG, V4, P509, DOI 10.1093/protein/4.5.509; VOORBERG J, 1991, J CELL BIOL, V113, P195, DOI 10.1083/jcb.113.1.195; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Warburg M., 1966, ACTA OPHTHALMOL SCAN, V89, P1; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; XU GQ, 1992, J BIOL CHEM, V267, P5401	42	150	162	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1993	5	4					376	380		10.1038/ng1293-376	http://dx.doi.org/10.1038/ng1293-376			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ML145	8298646				2022-12-25	WOS:A1993ML14500014
J	ANDERSEN, LB; FOUNTAIN, JW; GUTMANN, DH; TARLE, SA; GLOVER, TW; DRACOPOLI, NC; HOUSMAN, DE; COLLINS, FS				ANDERSEN, LB; FOUNTAIN, JW; GUTMANN, DH; TARLE, SA; GLOVER, TW; DRACOPOLI, NC; HOUSMAN, DE; COLLINS, FS			MUTATIONS IN THE NEUROFIBROMATOSIS-1 GENE IN SPORADIC MALIGNANT-MELANOMA CELL-LINES	NATURE GENETICS			English	Article							TYPE-1 GENE; TUMOR PROGRESSION; POINT MUTATIONS; PRODUCT; IDENTIFICATION; LOCUS; GAP; HETEROZYGOSITY; RETINOBLASTOMA; HETEROGENEITY	Neurofibromatosis type 1 (NF1) is a common autosomal dominant disorder characterized by progressive and variable involvement of tissues predominantly derived from the neural crest and a predisposition toward malignancies. The NF1 gene encodes neurofibromin, a GTPase-activating protein containing a GAP-related domain (NF1-GRD) that is capable of down-regulating ras by stimulating its intrinsic GTPase activity. We report a homozygous deletion of most of NF1 in one of eight malignant melanoma cell lines leading to loss of detectable mRNA and protein, as well as the apparent absence of protein and mRNA in another melanoma. This data suggests that NF1 can function as a tumour suppressor gene in the development or progression of malignant melanoma.	UNIV MICHIGAN,HOWARD HUGHES MED INST,MSRB 2,1150 W MED CTR DR,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT INTERNAL MED,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT PEDIAT,ANN ARBOR,MI 48109; MIT,CTR CANC RES,CAMBRIDGE,MA 02139; MIT,CTR GENOME RES,DEPT BIOL,CAMBRIDGE,MA 02139	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)				Dracopoli, Nicholas/0000-0003-3962-4059; Gutmann, David/0000-0002-3127-5045	NCI NIH HHS [1-F32-CA08985-01] Funding Source: Medline; NINDS NIH HHS [NS01590, NS23410] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA008985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001590, R01NS023410] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBINO AP, 1989, ONCOGENE, V4, P1363; ALBINO AP, 1984, NATURE, V308, P69, DOI 10.1038/308069a0; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; BASU TN, 1992, NATURE, V356, P713, DOI 10.1038/356713a0; BEAN MA, 1975, CANCER RES, V35, P2902; BECHER R, 1983, CANCER RES, V43, P5010; Bolande R P, 1981, Adv Neurol, V29, P67; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CAREY TE, 1976, P NATL ACAD SCI USA, V73, P3278, DOI 10.1073/pnas.73.9.3278; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; Crowe FW, 1956, CLIN PATHOLOGICAL GE; DASTON MM, 1992, NEURON, V8, P415, DOI 10.1016/0896-6273(92)90270-N; DECLUE JE, 1991, P NATL ACAD SCI USA, V88, P9914, DOI 10.1073/pnas.88.22.9914; DRACOPOLI NC, 1987, CANCER RES, V47, P3995; DRACOPOLI NC, 1989, P NATL ACAD SCI USA, V86, P4614, DOI 10.1073/pnas.86.12.4614; DRACOPOLI NC, 1985, P NATL ACAD SCI USA, V82, P1470, DOI 10.1073/pnas.82.5.1470; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; FOUNTAIN JW, 1992, P NATL ACAD SCI USA, V89, P10557, DOI 10.1073/pnas.89.21.10557; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; GUTMANN DH, 1991, P NATL ACAD SCI USA, V88, P9658, DOI 10.1073/pnas.88.21.9658; HARLOW E, 1988, ANTIBODIES LABORATOR, P421; HERLYN M, 1987, LAB INVEST, V56, P461; LI Y, 1992, CELL, V69, P275, DOI 10.1016/0092-8674(92)90408-5; MARCHUK DA, 1991, GENOMICS, V11, P931, DOI 10.1016/0888-7543(91)90017-9; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; MARTUZA RL, 1985, J INVEST DERMATOL, V85, P347, DOI 10.1111/1523-1747.ep12276952; MILLIKIN D, 1991, CANCER RES, V51, P5449; Riccardi VM., 1993, PLASTIC RECONST SURG, V91, P561, DOI [10.1097/00006534-199303000-00029, DOI 10.1097/00006534-199303000-00029]; SAMBROOJ J, 1989, MOL CLONING LABORATO; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; TANG A, 1988, SCIENCE, V242, P263, DOI 10.1126/science.3175651; UPADHYAYA M, 1990, J MED GENET, V27, P738, DOI 10.1136/jmg.27.12.738; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; WALLACE MR, 1989, NUCLEIC ACIDS RES, V17, P1665, DOI 10.1093/nar/17.4.1665; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WALLACE MR, 1991, NATURE, V353, P864, DOI 10.1038/353864a0; WHITE R, 1987, Genomics, V1, P364, DOI 10.1016/0888-7543(87)90040-1; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9	39	141	144	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1993	3	2					118	121		10.1038/ng0293-118	http://dx.doi.org/10.1038/ng0293-118			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KL010	8499944				2022-12-25	WOS:A1993KL01000007
J	Bentley, DJ; Selfridge, J; Millar, JK; Samuel, K; Hole, N; Ansell, JD; Melton, DW				Bentley, DJ; Selfridge, J; Millar, JK; Samuel, K; Hole, N; Ansell, JD; Melton, DW			DNA ligase I is required for fetal liver erythropoiesis but is not essential for mammalian cell viability	NATURE GENETICS			English	Letter							EMBRYONIC STEM-CELLS; BLOOMS-SYNDROME; STRAIN 46BR; GENE; REPLICATION; EXPRESSION; REPAIR; PATIENT; HYPERSENSITIVITY; INDUCTION		UNIV EDINBURGH,INST CELL & MOL BIOL,EDINBURGH EH9 3JR,MIDLOTHIAN,SCOTLAND; UNIV EDINBURGH,INST CELL ANIM & POPULAT BIOL,EDINBURGH EH9 3JT,MIDLOTHIAN,SCOTLAND	University of Edinburgh; University of Edinburgh				SELFRIDGE, JIM/0000-0003-2473-4386; Bentley, Darren/0000-0003-2136-9264				ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; APPLEGREN N, 1995, J CELL BIOCHEM, V59, P91, DOI 10.1002/jcb.240590111; BARNES DE, 1990, P NATL ACAD SCI USA, V87, P6679, DOI 10.1073/pnas.87.17.6679; BARNES DE, 1992, CELL, V69, P495, DOI 10.1016/0092-8674(92)90450-Q; CHAN JYH, 1985, CARCINOGENESIS, V6, P1275, DOI 10.1093/carcin/6.9.1275; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Freshney M. G., 1994, P265; GARIBOLDI M, 1995, MOL CARCINOGEN, V14, P71, DOI 10.1002/mc.2940140202; HENDERSON LM, 1985, P NATL ACAD SCI USA, V82, P2044, DOI 10.1073/pnas.82.7.2044; JESSOP JK, 1995, GENE, V160, P307, DOI 10.1016/0378-1119(95)00222-R; LEHMANN AR, 1988, CANCER RES, V48, P6343; LONN U, 1989, CARCINOGENESIS, V10, P981, DOI 10.1093/carcin/10.6.981; LORIMORE SA, 1990, LEUKEMIA RES, V14, P481, DOI 10.1016/0145-2126(90)90036-9; MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217; METCALF D, 1971, HEMOPOIETIC COLONIES; MONTECUCCO A, 1992, NUCLEIC ACIDS RES, V20, P6209, DOI 10.1093/nar/20.23.6209; MONTECUCCO A, 1995, NUCLEIC ACIDS RES, V23, P962, DOI 10.1093/nar/23.6.962; NOGUIEZ P, 1992, NUCLEIC ACIDS RES, V20, P3845, DOI 10.1093/nar/20.15.3845; PETRINI JHJ, 1995, MOL CELL BIOL, V15, P4303; PRIGENT C, 1994, MOL CELL BIOL, V14, P310, DOI 10.1128/MCB.14.1.310; SELFRIDGE J, 1992, SOMAT CELL MOLEC GEN, V18, P325, DOI 10.1007/BF01235756; STACEY A, 1994, MOL CELL BIOL, V14, P1009, DOI 10.1128/MCB.14.2.1009; TEO IA, 1983, MUTAT RES, V107, P371, DOI 10.1016/0027-5107(83)90177-X; THOMPSON S, 1989, CELL, V56, P313, DOI 10.1016/0092-8674(89)90905-7; TOMKINSON AE, 1991, J BIOL CHEM, V266, P21728; TOMKINSON AE, 1990, J BIOL CHEM, V265, P12611; TURCHI JJ, 1994, P NATL ACAD SCI USA, V91, P9803, DOI 10.1073/pnas.91.21.9803; WAGA S, 1994, J BIOL CHEM, V269, P10923; WEBSTER ADB, 1992, LANCET, V339, P1508, DOI 10.1016/0140-6736(92)91266-B; WEI YF, 1995, MOL CELL BIOL, V15, P3206; WU W, 1994, J BIOL CHEM, V54, P32	31	90	91	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1996	13	4					489	491		10.1038/ng0896-489	http://dx.doi.org/10.1038/ng0896-489			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VB620	8696349				2022-12-25	WOS:A1996VB62000035
J	Hanenberg, H; Xiao, XL; Dilloo, D; Hashino, K; Kato, I; Williams, DA				Hanenberg, H; Xiao, XL; Dilloo, D; Hashino, K; Kato, I; Williams, DA			Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells	NATURE MEDICINE			English	Article							HEMATOPOIETIC STEM-CELLS; CORD-BLOOD-CELLS; BONE-MARROW; PERIPHERAL-BLOOD; RECEPTOR; EXPRESSION; PROGENITORS; THERAPY; BINDING; ALPHA-4-BETA-1	Hematopoietic cells are important targets for genetic modification with retroviral vectors. Attempts at human gene therapy of stem cells have achieved limited success partly because of low gene transfer efficiency. Chymotryptic fragments of the extracellular matrix molecule fibronectin used during infection have been shown to increase transduction of human hematopoietic progenitor cells. Here, we demonstrate that this enhanced gene transfer into mammalian target cells is due to direct binding of retroviral particles to sequences within the fibronectin molecule. Transduction of mammalian cells, including murine long-term repopulating hematopoietic cells, is greatly enhanced when cells are adherent to chimeric fragments containing these retroviral binding sequences. In addition, colocalization of retrovirus and target cells on fibronectin peptides allows targeted transduction of specific cell types by exploiting unique ligand/receptor interactions.	INDIANA UNIV, SCH MED, SECT PEDIAT HEMATOL ONCOL, JAMES WHITCOMB RILEY HOSP CHILDREN, INDIANAPOLIS, IN 46202 USA; ST JUDE CHILDRENS RES HOSP, MEMPHIS, TN 38101 USA; TAKARA SHUZO CO LTD, BIOTECHNOL RES LABS, OTSU, SHIGA 52021, JAPAN; INDIANA UNIV, SCH MED, HOWARD HUGHES MED INST, INDIANAPOLIS, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; James Whitcomb Riley Hospital Children; St Jude Children's Research Hospital; Takara Holdings Inc.; Howard Hughes Medical Institute; Indiana University System; Indiana University-Purdue University Indianapolis					NATIONAL CANCER INSTITUTE [P01CA059348] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL053586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK049218] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA 59348] Funding Source: Medline; NHLBI NIH HHS [P01 HL 53586] Funding Source: Medline; NIDDK NIH HHS [P50 DK 49218] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 1996, B MED ETHICS; BLAESE RM, 1995, SCIENCE, V270, P475, DOI 10.1126/science.270.5235.475; BODINE DM, 1991, EXP HEMATOL, V19, P206; BORDIGNON C, 1995, SCIENCE, V270, P470, DOI 10.1126/science.270.5235.470; BORK P, 1993, PROTEIN SCI, V2, P1185, DOI 10.1002/pro.5560020714; BRADLEY TR, 1979, BLOOD, V54, P1446; BRENNER MK, 1993, LANCET, V342, P1134, DOI 10.1016/0140-6736(93)92122-A; CLAPP DW, 1995, EXP HEMATOL, V23, P630; DALTON SL, 1992, J BIOL CHEM, V267, P8186; DEISSEROTH AB, 1994, BLOOD, V83, P3068, DOI 10.1182/blood.V83.10.3068.3068; DHAWAN S, 1993, VIROLOGY, V197, P778, DOI 10.1006/viro.1993.1656; DICK JE, 1985, CELL, V42, P71, DOI 10.1016/S0092-8674(85)80102-1; DUNBAR CE, 1995, BLOOD, V85, P3048, DOI 10.1182/blood.V85.11.3048.bloodjournal85113048; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; KELLER G, 1985, NATURE, V318, P149, DOI 10.1038/318149a0; KIMIZUKA F, 1991, J BIOCH, V110, P281; KOHN DB, 1995, NAT MED, V1, P1017, DOI 10.1038/nm1095-1017; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; LIM B, 1987, MOL CELL BIOL, V7, P3549; MARKOWITZ D, 1988, J VIROL, V62, P1120, DOI 10.1128/JVI.62.4.1120-1124.1988; MARKOWITZ D, 1988, VIROLOGY, V167, P400, DOI 10.1016/S0042-6822(88)90101-8; MILLER AD, 1990, HUM GENE THER, V1, P5, DOI 10.1089/hum.1990.1.1-5; MORITZ T, 1994, J CLIN INVEST, V93, P1451, DOI 10.1172/JCI117122; MORITZ T, 1993, J EXP MED, V178, P529, DOI 10.1084/jem.178.2.529; MORITZ T, 1996, IN PRESS BLOOD; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; MULLIGAN RC, 1993, SCIENCE, V260, P926, DOI 10.1126/science.8493530; PATEL VP, 1986, J CELL BIOL, V102, P449, DOI 10.1083/jcb.102.2.449; PELES E, 1995, CELL, V82, P251, DOI 10.1016/0092-8674(95)90312-7; RIDER CC, 1994, BIOCHEMISTRY-US, V33, P6974, DOI 10.1021/bi00188a029; RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111; TSAI S, 1987, BLOOD, V69, P1587; VERFAILLIE CM, 1994, BLOOD, V84, P1802; VERFAILLIE CM, 1991, J EXP MED, V174, P693, DOI 10.1084/jem.174.3.693; WILLIAMS DA, 1984, NATURE, V310, P476, DOI 10.1038/310476a0; WILLIAMS DA, 1991, NATURE, V352, P438, DOI 10.1038/352438a0; WILLIAMS DA, 1986, P NATL ACAD SCI USA, V83, P2566, DOI 10.1073/pnas.83.8.2566; YODER MC, 1995, EXP HEMATOL, V23, P961	39	468	504	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	1996	2	8					876	882		10.1038/nm0896-876	http://dx.doi.org/10.1038/nm0896-876			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UZ804	8705856				2022-12-25	WOS:A1996UZ80400033
J	Baker, SM; Plug, AW; Prolla, TA; Bronner, CE; Harris, AC; Yao, X; Christie, DM; Monell, C; Arnheim, N; Bradley, A; Ashley, T; Liskay, RM				Baker, SM; Plug, AW; Prolla, TA; Bronner, CE; Harris, AC; Yao, X; Christie, DM; Monell, C; Arnheim, N; Bradley, A; Ashley, T; Liskay, RM			Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; PSEUDOAUTOSOMAL REGION; SYNAPTONEMAL COMPLEX; GENE CONVERSION; RECOMBINATION; SPERMATOCYTES; INITIATION; CHROMOSOME; HOMOLOGS; SEQUENCE	Mice that are deficient in either the Pms2 or Msh2 DNA mismatch repair genes have microsatellite instability and a predisposition to tumours. Interestingly, Pms2-deficient males display sterility associated with abnormal chromosome pairing in meiosis. Here mice deficient in another mismatch repair gene, MIh1, possess not only microsatellite instability but are also infertile (both males and females). MIh1-deficient spermatocytes exhibit high levels of prematurely separated chromosomes and arrest in first division meiosis. We also show that MIh1 appears to localize to sites of crossing over on meiotic chromosomes. Together these findings suggest that MIh1 is involved in DNA mismatch repair and meiotic crossing over.	OREGON HLTH SCI UNIV,DEPT MED & MOLEC GENET,PORTLAND,OR 97201; YALE UNIV,SCH MED,DEPT GENET,NEW HAVEN,CT 06510; BAYLOR COLL MED,HOWARD HUGHES MED INST,DEPT MOL & HUMAN GENET,HOUSTON,TX 77030; UNIV SO CALIF,PROGRAM MOLEC BIOL,LOS ANGELES,CA 90089; PHARMINGEN,SAN DIEGO,CA 92121	Oregon Health & Science University; Yale University; Baylor College of Medicine; Howard Hughes Medical Institute; University of Southern California				Arnheim, Norman/0000-0003-1247-1347; Bradley, Allan/0000-0002-2349-8839	NIGMS NIH HHS [GM49779, GM32741, GM45413] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM032741, R01GM045413, R01GM049779, R01GM032741] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALANI E, 1994, GENETICS, V137, P19; ASHLEY T, 1995, CHROMOSOMA, V104, P19, DOI 10.1007/BF00352222; ASHLEY T, 1994, HUM GENET, V94, P587, DOI 10.1007/BF00206950; AU KG, 1992, J BIOL CHEM, V267, P12142; BAKER SM, 1995, CELL, V82, P309, DOI 10.1016/0092-8674(95)90318-6; BISHOP DK, 1989, P NATL ACAD SCI USA, V86, P3713, DOI 10.1073/pnas.86.10.3713; Bradley A, 1987, TERATOCARCINOMAS EMB, P113; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; BURGOYNE PS, 1982, HUM GENET, V61, P85, DOI 10.1007/BF00274192; CARPENTER ATC, 1987, BIOESSAYS, V6, P232, DOI 10.1002/bies.950060510; Darlington C. D., 1937, RECENT ADV CYTOLOGY; Datta A, 1996, MOL CELL BIOL, V16, P1085; DESTGROTH SF, 1980, TRANSPLANT P, V12, P447; DETLOFF P, 1992, GENETICS, V132, P113; DEWIND N, 1995, CELL, V82, P321, DOI 10.1016/0092-8674(95)90319-4; DIETRICH AJJ, 1983, CHROMOSOMA, V88, P377, DOI 10.1007/BF00285860; DIETRICH AJJ, 1981, CHROMOSOMA, V83, P409, DOI 10.1007/BF00327362; FISHEL R, 1994, CANCER RES, V54, P5539; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; GALIRE G, 1977, NATURE, V266, P550; GOETZ P, 1984, J CELL SCI, V65, P249; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; HAWLEY RS, 1987, MEIOSIS, P497; HILLINGSWORTH NM, 1995, GENE DEV, V9, P1728; Hunter N, 1996, EMBO J, V15, P1726, DOI 10.1002/j.1460-2075.1996.tb00518.x; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; KRAMER W, 1989, J BACTERIOL, V171, P5339, DOI 10.1128/jb.171.10.5339-5346.1989; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LEEFLANG PE, 1994, CURRENT PROTOCOLS HU, V1; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; MASISCHKY GT, 1996, GENE DEV, V10, P407; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MODRICH P, 1991, ANNU REV GENET, V25, P229, DOI 10.1146/annurev.ge.25.120191.001305; MOENS PB, 1987, J CELL BIOL, V105, P93, DOI 10.1083/jcb.105.1.93; Moses M J, 1984, Symp Soc Exp Biol, V38, P245; MOSES MJ, 1977, CHROMOSOMA, V60, P127, DOI 10.1007/BF00288460; MOSES MJ, 1984, CHROMOSOMES TODAY, V8, P90; NEW L, 1993, MOL GEN GENET, V239, P97, DOI 10.1007/BF00281607; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; PETES TD, 1991, MOL CELLULAR BIOL YE, V1, P407; PETIT C, 1988, EMBO J, V7, P2369, DOI 10.1002/j.1460-2075.1988.tb03081.x; PETIT MA, 1991, GENETICS, V129, P327; POLANI PE, 1976, CYTOGENET CELL GENET, V16, P505, DOI 10.1159/000130668; PROLLA TA, 1994, SCIENCE, V265, P1091, DOI 10.1126/science.8066446; PROLLA TA, 1994, MOL CELL BIOL, V14, P407, DOI 10.1128/MCB.14.1.407; RAMIREZSOLIS R, 1993, GUIDE TECHNIQUES MOU, P855; RAPPOLD GA, 1988, NUCLEIC ACIDS RES, V16, P5361, DOI 10.1093/nar/16.12.5361; REENAN RAG, 1992, GENETICS, V132, P963; REITMAIR AH, 1995, NAT GENET, V11, P64, DOI 10.1038/ng0995-64; ROEDER GS, 1990, TRENDS GENET, V6, P385, DOI 10.1016/0168-9525(90)90297-J; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; ROUYER F, 1986, NATURE, V319, P291, DOI 10.1038/319291a0; SELVA EM, 1995, GENETICS, V139, P1175; Solari A.J., 1989, P77; SORIANO P, 1987, P NATL ACAD SCI USA, V84, P7218, DOI 10.1073/pnas.84.20.7218; SPEED RM, 1982, CHROMOSOMA, V85, P427, DOI 10.1007/BF00330366; WEST SC, 1992, ANNU REV BIOCHEM, V61, P603, DOI 10.1146/annurev.bi.61.070192.003131; WILLIAMSON MS, 1985, GENETICS, V110, P609; WORTH L, 1994, P NATL ACAD SCI USA, V91, P3238, DOI 10.1073/pnas.91.8.3238	60	659	675	0	24	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1996	13	3					336	342		10.1038/ng0796-336	http://dx.doi.org/10.1038/ng0796-336			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UU283	8673133				2022-12-25	WOS:A1996UU28300022
J	Miller, CJ; McGhee, JR				Miller, CJ; McGhee, JR			Progress towards a vaccine to prevent sexual transmission of HIV	NATURE MEDICINE			English	Editorial Material							MACAQUES		UNIV ALABAMA,DEPT MICROBIOL,MUCOSAL IMMUNIZAT RES GRP,BIRMINGHAM,AL 35294	University of Alabama System; University of Alabama Birmingham	Miller, CJ (corresponding author), UNIV CALIF DAVIS,CALIF REG PRIMATE RES CTR,DAVIS,CA 95616, USA.							BRINCHMANN JE, 1990, J IMMUNOL, V144, P2961; CLERICI M, 1994, AIDS, V8, P1391, DOI 10.1097/00002030-199410000-00004; COPELAND KFT, 1995, AIDS RES HUM RETROV, V11, P1321, DOI 10.1089/aid.1995.11.1321; CRANAGE MP, 1992, LANCET, V339, P273, DOI 10.1016/0140-6736(92)91335-6; Lehner T, 1996, NAT MED, V2, P767, DOI 10.1038/nm0796-767; LOHMAN BL, 1995, J IMMUNOL, V155, P5855; MARTHAS ML, 1992, VACCINES 92 : MODERN APPROACHES TO NEW VACCINES INCLUDING PREVENTION OF AIDS, P117; Miller C. J., 1992, Laboratory Investigation, V68, P129; MILLER CJ, 1992, J MED PRIMATOL, V21, P64; Moore JP, 1996, J VIROL, V70, P427, DOI 10.1128/JVI.70.1.427-444.1996; OTSYULA MG, IN PRESS VIROLOGY; THAPAR MA, 1990, IMMUNOLOGY, V70, P121	12	13	13	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUL	1996	2	7					751	752		10.1038/nm0796-751	http://dx.doi.org/10.1038/nm0796-751			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UU680	8673919	Bronze			2022-12-25	WOS:A1996UU68000029
J	Jones, JT; Lee, SW; Sullenger, BA				Jones, JT; Lee, SW; Sullenger, BA			Tagging ribozyme reaction sites to follow trans-splicing in mammalian cells	NATURE MEDICINE			English	Article							TETRAHYMENA RIBOZYME; BINDING-SITE; RNA; SEQUENCE; SPECIFICITY; EXPRESSION; CLEAVAGE	In mammalian cells, genetic instructions are usually revised by RNA splicing before they are translated to proteins. Here we demonstrate that a trans-splicing group I ribozyme can be employed to intentionally modify the sequence of targeted transcripts in tissue culture cells. By analyzing the ribozyme reaction products, we demonstrate that targeted trans-splicing can proceed in murine fibroblasts with high fidelity, providing direct evidence that ribozymes function as anticipated in a therapeutically relevant setting. Trans-splicing is not very specific however, and the ribozyme reacted with and tagged a variety of cellular transcripts with its 3' exon sequence. RNA tagging provides a unique approach to study RNA catalysis in mammalian cells. Such analysis should facilitate the logical development of safe, therapeutic ribozymes that can repair mutant RNAs associated with a variety of inherited diseases.	DUKE UNIV,MED CTR,DEPT GENET,PROGRAM MOL THERAPEUT,DURHAM,NC 27710	Duke University	Jones, JT (corresponding author), DUKE UNIV,MED CTR,DEPT EXPTL SURG,BOX 2601,DURHAM,NC 27710, USA.			Lee, Seong-Wook/0000-0003-1718-7601	NIGMS NIH HHS [1 RO1 GM 53525-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053525] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARMATANO D, 1987, J VIROL, V61, P1647; BEEN MD, 1986, CELL, V47, P207, DOI 10.1016/0092-8674(86)90443-5; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; CECH TR, 1988, JAMA-J AM MED ASSOC, V260, P3030; CHOWRIRA BM, 1991, BIOCHEMISTRY-US, V30, P8518, DOI 10.1021/bi00099a003; CULLEN BR, 1986, CELL, V46, P973, DOI 10.1016/0092-8674(86)90696-3; ELROYSTEIN O, 1990, P NATL ACAD SCI USA, V87, P6743, DOI 10.1073/pnas.87.17.6743; FELDSTEIN PA, 1989, GENE, V82, P53, DOI 10.1016/0378-1119(89)90029-2; FERAMISCO JR, 1982, J BIOL CHEM, V257, P1024; FORESTER AC, 1990, SCIENCE, V249, P783; Frohman M.A., 1990, PCR PROTOCOLS GUIDE, P28; HAMPEL A, 1990, NUCLEIC ACIDS RES, V18, P299, DOI 10.1093/nar/18.2.299; HANTZOPOULOS PA, 1989, P NATL ACAD SCI USA, V86, P3519, DOI 10.1073/pnas.86.10.3519; HASSELOFF J, 1988, NATURE, V334, pS85; INOUE T, 1985, CELL, V43, P431, DOI 10.1016/0092-8674(85)90173-4; KRAMER A, 1995, RNA, V1, P260; MURPHY FL, 1989, P NATL ACAD SCI USA, V86, P9218, DOI 10.1073/pnas.86.23.9218; PERROTTA AT, 1992, BIOCHEMISTRY-US, V31, P16, DOI 10.1021/bi00116a004; PYLE AM, 1992, NATURE, V358, P123, DOI 10.1038/358123a0; ROSSI J J, 1992, Current Opinion in Biotechnology, V3, P3, DOI 10.1016/0958-1669(92)90117-2; SIMONSEN CC, 1983, P NATL ACAD SCI-BIOL, V80, P2495, DOI 10.1073/pnas.80.9.2495; SULLENGER BA, 1995, CHEM BIOL, V2, P249, DOI 10.1016/1074-5521(95)90043-8; SULLENGER BA, 1994, NATURE, V371, P619, DOI 10.1038/371619a0; SULLENGER BA, 1990, MOL CELL BIOL, V10, P6512, DOI 10.1128/MCB.10.12.6512; SULLENGER BA, 1993, SCIENCE, V262, P1566, DOI 10.1126/science.8248806; UHLENBECK OC, 1987, NATURE, V328, P596, DOI 10.1038/328596a0; YARUS M, 1988, SCIENCE, V240, P1751, DOI 10.1126/science.3381099; YARUS M, 1989, BIOCHEMISTRY-US, V28, P980, DOI 10.1021/bi00429a010; YOUNG B, 1991, CELL, V67, P1007, DOI 10.1016/0092-8674(91)90373-7; YU M, 1994, GENE THER, V1, P13; ZAUG AJ, 1986, NATURE, V324, P429, DOI 10.1038/324429a0; ZAUG AJ, 1988, BIOCHEMISTRY-US, V27, P8924, DOI 10.1021/bi00425a008	32	110	126	1	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUN	1996	2	6					643	648		10.1038/nm0696-643	http://dx.doi.org/10.1038/nm0696-643			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UN691	8640554				2022-12-25	WOS:A1996UN69100031
J	Lancaster, JM; Wooster, R; Mangion, J; Phelan, CM; Cochran, C; Gumbs, C; Seal, S; Barfoot, R; Collins, N; Bignell, G; Patel, S; Hamoudi, R; Larsson, C; Wiseman, RW; Berchuck, A; Iglehart, JD; Marks, JR; Ashworth, A; Stratton, MR; Futreal, PA				Lancaster, JM; Wooster, R; Mangion, J; Phelan, CM; Cochran, C; Gumbs, C; Seal, S; Barfoot, R; Collins, N; Bignell, G; Patel, S; Hamoudi, R; Larsson, C; Wiseman, RW; Berchuck, A; Iglehart, JD; Marks, JR; Ashworth, A; Stratton, MR; Futreal, PA			BRCA2 mutations in primary breast and ovarian cancers	NATURE GENETICS			English	Letter									DUKE UNIV, MED CTR, DEPT SURG, DURHAM, NC 27710 USA; NIEHS, MOLEC CARCINOGENESIS LAB, NIH, RES TRIANGLE PK, NC 27709 USA; INST CANC RES, HADDOW LABS, SECT MOL CARCINOGENESIS, SURREY, ENGLAND; INST CANC RES, CHESTER BEATTY LABS, LONDON SW3 6JB, ENGLAND; KAROLINSKA HOSP, DEPT MOLEC MED, ENDOCRINE TUMOR UNIT, S-10401 STOCKHOLM, SWEDEN; MCGILL UNIV, MONTREAL GEN HOSP, DEPT HUMAN GENET & MED, MONTREAL, PQ H3G 1A4, CANADA; INST CANC RES, HADDOW LABS, CRC, CTR BIOL MOLEC, SURREY, ENGLAND; DUKE UNIV, MED CTR, DEPT OBSTET & GYNECOL, DIV GYNECOL ONCOL, DURHAM, NC 27710 USA; DUKE UNIV, MED CTR, DEPT GENET, DURHAM, NC USA	Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Karolinska Institutet; Karolinska University Hospital; McGill University; University of London; Institute of Cancer Research - UK; Duke University; Duke University				Hamoudi, Rifat/0000-0002-1402-0868	NATIONAL CANCER INSTITUTE [R21CA066228, P50CA068438] Funding Source: NIH RePORTER; NCI NIH HHS [R21-CA68348, P50-CA68438, 1R21-CA66228] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CHEN YM, 1995, SCIENCE, V270, P789, DOI 10.1126/science.270.5237.789; CLETONJANSEN AM, 1995, BRIT J CANCER, V72, P1241, DOI 10.1038/bjc.1995.493; COLLINS N, 1995, ONCOGENE, V10, P1673; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; HOSKING L, 1995, NAT GENET, V9, P343, DOI 10.1038/ng0495-343; KERANGUEVEN F, 1995, GENE CHROMOSOME CANC, V13, P291, DOI 10.1002/gcc.2870130410; KIM TM, 1994, CANCER RES, V54, P605; LUNDBERG C, 1987, P NATL ACAD SCI USA, V84, P2372, DOI 10.1073/pnas.84.8.2372; MERAJVER SD, 1995, NAT GENET, V9, P439, DOI 10.1038/ng0495-439; Phelan CM, 1996, NAT GENET, V13, P120, DOI 10.1038/ng0596-120; TAKAHASHI H, 1995, CANCER RES, V55, P2998; THOMPSON ME, 1995, NAT GENET, V9, P444, DOI 10.1038/ng0495-444; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	13	277	281	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1996	13	2					238	240		10.1038/ng0696-238	http://dx.doi.org/10.1038/ng0696-238			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UN395	8640235				2022-12-25	WOS:A1996UN39500028
J	Jamison, KR; McInnis, MG				Jamison, KR; McInnis, MG			Genetic studies of manic-depressive illness	NATURE MEDICINE			English	Editorial Material							DISORDERS				Jamison, KR (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT,BALTIMORE,MD 21287, USA.		McInnis, Melvin G/F-6963-2012	McInnis, Melvin G/0000-0002-0375-6247				ANGST J, 1986, NEW RESULTS DEPRESSI; BAXTER LR, 1985, ARCH GEN PSYCHIAT, V42, P441; BERRETTINI WH, 1994, P NATL ACAD SCI USA, V91, P5918, DOI 10.1073/pnas.91.13.5918; Blackwood DHR, 1996, NAT GENET, V12, P427, DOI 10.1038/ng0496-427; Freimer NB, 1996, NAT GENET, V12, P436, DOI 10.1038/ng0496-436; Ginns EI, 1996, NAT GENET, V12, P431, DOI 10.1038/ng0496-431; Goodwin F, 1990, MANIC DEPRESSIVE ILL; Jamison K.R., 1993, TOUCHED FIRE MANIC D; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; POE EA, 1986, FALL OF HOUSE OF USH; REGIER DA, 1988, ARCH GEN PSYCHIAT, V45, P977; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; RICHARDS RL, 1981, GENET PSYCHOL MONOGR, V103, P261; ROYBYRNE P, 1985, ACTA PSYCHIAT SCAND, V71, P1, DOI 10.1111/j.1600-0447.1985.tb10510.x; STINE OC, 1995, AM J HUM GENET, V57, P1384; WYATT RJ, 1995, SOC PSYCH PSYCH EPID, V30, P213	16	6	6	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAY	1996	2	5					521	522		10.1038/nm0596-521	http://dx.doi.org/10.1038/nm0596-521			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UJ230	8616706				2022-12-25	WOS:A1996UJ23000030
J	Paxton, WA; Martin, SR; Tse, D; OBrien, TR; Skurnick, J; VanDevanter, NL; Padian, N; Braun, JF; Kotler, DP; Wolinsky, SM; Koup, RA				Paxton, WA; Martin, SR; Tse, D; OBrien, TR; Skurnick, J; VanDevanter, NL; Padian, N; Braun, JF; Kotler, DP; Wolinsky, SM; Koup, RA			Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures	NATURE MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; IMMUNE-RESPONSE; REPLICATION; ANTIGEN; ENTRY; DECLINE; CELLS	Some individuals remain uninfected with human immunodeficiency virus type-1 (HIV-1) despite multiple high-risk sexual exposures. We studied a cohort of 25 subjects with histories of multiple high-risk sexual exposures to HIV-1 and found that their CD8(+) lymphocytes had greater anti-HIV-1 activity than did CD8(+) lymphocytes from nonexposed controls. further studies indicated that their purified CD4(+) lymphocytes were less susceptible to infection with multiple primary isolates of HIV-1 than were CD4(+) lymphocytes from the nonexposed controls. This relative resistance to HIV-1 infection did not extend to T-cell line-adapted strains, was restricted by the envelope glycoprotein, was not explained by the cell surface density of CD4 molecules, but was associated with the activity of the C-C chemokines RANTES, MIP-1 alpha, and MIP-1 beta. This relative resistance of CD4(+) lymphocytes may contribute to protection from HIV-1 in multiply exposed persons.	AARON DIAMOND AIDS RES CTR, NEW YORK, NY 10016 USA; NYU, SCH MED, NEW YORK, NY 10016 USA; NCI, VIRAL EPIDEMIOL BRANCH, NIH, ROCKVILLE, MD 20852 USA; UNIV MED & DENT NEW JERSEY, NEW JERSEY MED SCH, DEPT PREVENT MED & COMMUNITY HLTH, NEWARK, NJ 07103 USA; COLUMBIA UNIV, SCH PUBL HLTH, DIV SOCIOMED SCI, NEW YORK, NY 10032 USA; UNIV CALIF SAN FRANCISCO, DEPT OBSTET GYNECOL & REPROD SCI, SAN FRANCISCO, CA 94110 USA; ST LUKES ROOSEVELT HOSP, GASTROINTESTINAL IMMUNOL DIV, NEW YORK, NY 10025 USA; NORTHWESTERN UNIV, DIV INFECT DIS, CHICAGO, IL 60611 USA	New York University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rutgers State University New Brunswick; Rutgers State University Medical Center; Columbia University; University of California System; University of California San Francisco; Mount Sinai St. Luke's; Mount Sinai West; Northwestern University			paxton, william/R-9747-2019; Wolinsky, Steven/B-2893-2012	Paxton, William/0000-0002-2654-5186; Wolinsky, Steven/0000-0002-9625-6697; Paxton, William/0000-0001-5200-0801	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035522, R01AI030358, R37AI035522] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 35522, AI 45218, AI 30358] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; BHAT S, 1991, P NATL ACAD SCI USA, V88, P7131, DOI 10.1073/pnas.88.16.7131; BRAND D, 1995, J VIROL, V69, P166, DOI 10.1128/JVI.69.1.166-171.1995; CALLEBAUT C, 1993, SCIENCE, V262, P2045, DOI 10.1126/science.7903479; CAO YZ, 1995, NEW ENGL J MED, V332, P201, DOI 10.1056/NEJM199501263320401; CLERICI M, 1992, J INFECT DIS, V165, P1012, DOI 10.1093/infdis/165.6.1012; CLOYD MW, 1990, VIROLOGY, V174, P103, DOI 10.1016/0042-6822(90)90059-Z; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; CONNOR RI, 1993, J VIROL, V67, P1772, DOI 10.1128/JVI.67.4.1772-1777.1993; DEGRUTTOLA V, 1989, J CLIN EPIDEMIOL, V42, P849, DOI 10.1016/0895-4356(89)90098-X; DETELS R, 1994, J ACQ IMMUN DEF SYND, V7, P1263; GHABANBASANI MZ, 1994, CLIN EXP IMMUNOL, V97, P517; HARROWE G, 1995, VIROLOGY, V210, P490, DOI 10.1006/viro.1995.1367; HODGE TW, 1991, HUM IMMUNOL, V30, P99, DOI 10.1016/0198-8859(91)90077-M; Just J, 1992, Paediatr Perinat Epidemiol, V6, P215, DOI 10.1111/j.1365-3016.1992.tb00762.x; KABAT D, 1994, J VIROL, V68, P2570, DOI 10.1128/JVI.68.4.2570-2577.1994; KASLOW RA, 1990, LANCET, V335, P927, DOI 10.1016/0140-6736(90)90995-H; KILPATRICK DC, 1991, DIS MARKERS, V9, P21; KLEIN MR, 1994, J INFECT DIS, V169, P1244, DOI 10.1093/infdis/169.6.1244; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; KOUP RA, 1990, TECHNIQUES HIV RES, P107; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; LANGLADEDEMOYEN P, 1994, J CLIN INVEST, V93, P1293, DOI 10.1172/JCI117085; LEDERMAN MM, 1995, J INFECT DIS, V172, P228, DOI 10.1093/infdis/172.1.228; MACKEWICZ C, 1992, AIDS RES HUM RETROV, V8, P1039, DOI 10.1089/aid.1992.8.1039; MAGGI E, 1994, SCIENCE, V265, P244, DOI 10.1126/science.8023142; MOORE JP, 1994, J VIROL, V68, P8350, DOI 10.1128/JVI.68.12.8350-8364.1994; MORI K, 1993, J VIROL, V67, P2807, DOI 10.1128/JVI.67.5.2807-2814.1993; OBRIEN TR, 1994, J ACQ IMMUN DEF SYND, V7, P705; OMETTO L, 1995, AIDS, V9, P427, DOI 10.1097/00002030-199509050-00003; PATEL M, 1993, AIDS RES HUM RETROV, V9, P167, DOI 10.1089/aid.1993.9.167; PREVOTS DR, 1994, AIDS S1, V8, pS109; REED L. J., 1938, AMER JOUR HYG, V27, P493; RODERIQUEZ G, 1995, J VIROL, V69, P2233, DOI 10.1128/JVI.69.4.2233-2239.1995; ROOS MTL, 1992, J INFECT DIS, V165, P427, DOI 10.1093/infdis/165.3.427; ROWLANDJONES S, 1995, NAT MED, V1, P59, DOI 10.1038/nm0195-59; ROWLANDJONES SL, 1993, LANCET, V341, P860, DOI 10.1016/0140-6736(93)93063-7; SPIRA AI, 1995, J VIROL, V69, P422, DOI 10.1128/JVI.69.1.422-429.1995; Spira AI, 1996, J EXP MED, V183, P215, DOI 10.1084/jem.183.1.215; STEEL CM, 1988, LANCET, V1, P1185; STEFANO KA, 1993, J VIROL, V67, P6707, DOI 10.1128/JVI.67.11.6707-6715.1993; TAYLOR R, 1994, J NIH RES, V6, P29; VYAKARNAM A, 1995, IMMUNOLOGY, V86, P85; WAINBERG MA, 1987, CLIN EXP IMMUNOL, V70, P136; WHETSELL AJ, 1992, J CLIN MICROBIOL, V30, P845, DOI 10.1128/JCM.30.4.845-853.1992; WILLIAMS LM, 1991, VIROLOGY, V184, P723, DOI 10.1016/0042-6822(91)90442-E; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453; [No title captured]	48	581	602	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	1996	2	4					412	417		10.1038/nm0496-412	http://dx.doi.org/10.1038/nm0496-412			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UD314	8597950				2022-12-25	WOS:A1996UD31400042
J	Hummler, E; Barker, P; Gatzy, J; Beermann, F; Verdumo, C; Schmidt, A; Boucher, R; Rossier, BC				Hummler, E; Barker, P; Gatzy, J; Beermann, F; Verdumo, C; Schmidt, A; Boucher, R; Rossier, BC			Early death due to defective neonatal lung liquid clearance in alpha ENaC-deficient mice	NATURE GENETICS			English	Letter							EPITHELIAL NA+ CHANNEL; FETAL-RAT; GENE; EXPRESSION; SECRETION; EXPLANTS; MUTATION; SUBUNIT		UNIV LAUSANNE, INST PHARMACOL & TOXICOL, CH-1005 LAUSANNE, SWITZERLAND; UNIV N CAROLINA, SCH MED, CHAPEL HILL, NC 27599 USA; SWISS INST EXPTL CANC RES, CH-1066 EPALINGES, SWITZERLAND	University of Lausanne; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Swiss Institute Experimental Cancer Research								ADRA CN, 1987, GENE, V60, P65, DOI 10.1016/0378-1119(87)90214-9; BARKER PM, 1993, AM J PHYSIOL, V265, pL512, DOI 10.1152/ajplung.1993.265.5.L512; BEERMANN F, 1993, MECH DEVELOP, V42, P59, DOI 10.1016/0925-4773(93)90098-I; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; CHEEK DB, 1958, ARCH DIS CHILD, V33, P252, DOI 10.1136/adc.33.169.252; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; HANUKOGLU A, 1991, J CLIN ENDOCR METAB, V73, P936, DOI 10.1210/jcem-73-5-936; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; JOBE AH, 1993, NEW ENGL J MED, V328, P861; KROCHMALMOKRZAN EM, 1993, J PHYSIOL-LONDON, V463, P647, DOI 10.1113/jphysiol.1993.sp019615; MATALON S, 1993, AM J PHYSIOL, V264, pL357, DOI 10.1152/ajplung.1993.264.4.L357; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; OBRODOVICH H, 1990, J APPL PHYSIOL, V68, P1758, DOI 10.1152/jappl.1990.68.4.1758; OBRODOVICH H, 1993, AM J PHYSIOL, V265, pC491, DOI 10.1152/ajpcell.1993.265.2.C491; OLVER RE, 1986, J PHYSIOL-LONDON, V376, P321, DOI 10.1113/jphysiol.1986.sp016156; SCHILD L, 1995, P NATL ACAD SCI USA, V92, P5699, DOI 10.1073/pnas.92.12.5699; SCHMIDT A, 1994, P NATL ACAD SCI USA, V91, P4756, DOI 10.1073/pnas.91.11.4756; SELFRIDGE J, 1992, SOMAT CELL MOLEC GEN, V18, P325, DOI 10.1007/BF01235756; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; STRANG LB, 1991, PHYSIOL REV, V71, P991, DOI 10.1152/physrev.1991.71.4.991; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; TCHEPICHEV S, 1995, AM J PHYSIOL-CELL PH, V269, pC805, DOI 10.1152/ajpcell.1995.269.3.C805; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; VOILLEY N, 1994, P NATL ACAD SCI USA, V91, P247, DOI 10.1073/pnas.91.1.247; WEGMAN ME, 1993, PEDIATRICS, V92, P743	27	732	753	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1996	12	3					325	328		10.1038/ng0396-325	http://dx.doi.org/10.1038/ng0396-325			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TY183	8589728				2022-12-25	WOS:A1996TY18300026
J	Axelrod, N				Axelrod, N			Of telomeres and tumors	NATURE MEDICINE			English	Editorial Material							CHROMOSOME											BIESSMANN H, 1992, MOL CELL BIOL, V12, P3910, DOI 10.1128/MCB.12.9.3910; BLASCO MA, 1995, SCIENCE, V269, P1267, DOI 10.1126/science.7544492; BLASCO MA, 1996, NAT GENET, V12, P1; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; COUNTER CM, 1994, P NATL ACAD SCI USA, V91, P2900, DOI 10.1073/pnas.91.8.2900; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; DELANGE T, 1995, TELOMERES, P265; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARLEY CB, 1995, TELOMERES, P247; HIYAMA E, 1995, NAT MED, V1, P249, DOI 10.1038/nm0395-249; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H	15	22	23	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	FEB	1996	2	2					158	159		10.1038/nm0296-158	http://dx.doi.org/10.1038/nm0296-158			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TU060	8574955				2022-12-25	WOS:A1996TU06000030
J	Neurath, AR; Jiang, SB; Strick, N; Lin, K; Li, YY; Debnath, AK				Neurath, AR; Jiang, SB; Strick, N; Lin, K; Li, YY; Debnath, AK			Bovine beta-lactoglobulin modified by 3-hydroxyphthalic anhydride blocks the CD4 cell receptor for HIV	NATURE MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEIN; BINDING; INFECTION; COMPLEX; DOCKING	Sexual transmission is the most frequent (86%) route of adult HIV-1 transmission worldwide(1). In the absence of a prophylactic anti-HIV vaccine, other methods of preventing infection should be implemented. Virucidal spermicides have been considered for this purpose, but their application is contraindicated by adverse effects(2). Anti-HIV drugs(3) or virus-neutralizing monoclonal antibodies(4) are expensive, suggesting that their wide use in topical chemoprophylaxis is unlikely. This emphasizes the importance of developing other methods for preventing HIV transmission. The target cells for sexual and mucosal HIV transmission include T lymphocytes, monocytes/macrophages and dendritic cells(5). Therefore, compounds blocking HIV-CD4 binding are expected to inhibit virus transmission. In exploring the possibility that chemical modification of food proteins might lead to compounds with anti-HIV-1 activity, we found that bovine beta-lactoglobulin (P-LG) modified by 3-hydroxyphthalic anhydride (3HP-beta-LG) (1) blocked at nanomolar concentrations the binding to CD4 of human (HIV) and simian (SIV) immunodeficiency virus surface glycoproteins and monoclonal antibodies specific for the HIV binding site on CD4 and (2) inhibited infection by HIV-1, including primary virus isolates, by HIV-2 and by SIV. The inexpensive and widely available source (whey) for production of 3HP-beta-LG suggests its potential application (nonparenteral) for diminishing the frequency of HIV transmission.			Neurath, AR (corresponding author), NEW YORK BLOOD CTR,LINDSLEY F KIMBALL RES INST,LAB BIOCHEM VIROL,NEW YORK,NY 10021, USA.		Jiang, Shibo/L-4500-2014	Jiang, Shibo/0000-0001-8283-7135	NATIONAL CANCER INSTITUTE [R01CA043315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029373] Funding Source: NIH RePORTER; NCI NIH HHS [CA 43315] Funding Source: Medline; NIAID NIH HHS [AI 29373] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLAWAY GP, 1995, AIDS RES HUM RETROV, V11, P533, DOI 10.1089/aid.1995.11.533; [Anonymous], 1992, AIDS WORLD; BIRD KD, 1991, AIDS, V5, P791, DOI 10.1097/00002030-199107000-00001; DAAR ES, 1990, P NATL ACAD SCI USA, V87, P6574, DOI 10.1073/pnas.87.17.6574; FORTHAL DN, 1995, AIDS RES HUM RETROV, V11, P1095, DOI 10.1089/aid.1995.11.1095; GARRETT TPJ, 1993, J MOL BIOL, V234, P763, DOI 10.1006/jmbi.1993.1625; GARTNER S, 1990, TECHNIQUES HIV RES, P53; GOODSELL DS, 1990, PROTEINS, V8, P195, DOI 10.1002/prot.340080302; HEALEY D, 1990, J EXP MED, V172, P1233, DOI 10.1084/jem.172.4.1233; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Miller C. J., 1992, Laboratory Investigation, V68, P129; MONACO HL, 1987, J MOL BIOL, V197, P695, DOI 10.1016/0022-2836(87)90476-1; MORR CV, 1993, CRIT REV FOOD SCI, V33, P431, DOI 10.1080/10408399309527643; MULLER R, 1983, METHOD ENZYMOL, V92, P589; NEURATH AR, 1992, ANTIVIR CHEM CHEMOTH, V3, P55, DOI 10.1177/095632029200300108; NEURATH AR, 1992, J EXP MED, V175, P461, DOI 10.1084/jem.175.2.461; SATO H, 1992, VIROLOGY, V186, P712, DOI 10.1016/0042-6822(92)90038-Q; SATTENTAU QJ, 1988, AIDS, V2, P101, DOI 10.1097/00002030-198804000-00005; SATTENTAU QJ, 1989, J EXP MED, V170, P1319, DOI 10.1084/jem.170.4.1319; STEELE F, 1995, NAT MED, V1, P285, DOI 10.1038/nm0495-285; STODDARD BL, 1992, NATURE, V358, P774, DOI 10.1038/358774a0	23	72	80	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	FEB	1996	2	2					230	234		10.1038/nm0296-230	http://dx.doi.org/10.1038/nm0296-230			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TU060	8574970				2022-12-25	WOS:A1996TU06000045
J	Shimizu, N; Kanda, T; Wahl, GM				Shimizu, N; Kanda, T; Wahl, GM			Selective capture of acentric fragments by micronuclei provides a rapid method for purifying extrachromosomally amplified DNA	NATURE GENETICS			English	Article							HOMOGENEOUSLY STAINING REGIONS; DOUBLE MINUTE CHROMOSOMES; CHINESE-HAMSTER CELLS; HUMAN-COLON CARCINOMA; WILD-TYPE P53; C-MYC GENE; CYTOGENETIC ANALYSIS; TUMOR-CELLS; MOUSE CELLS; AMPLIFICATION	The amplification and overexpression of a number of oncogenes is strongly associated with the progression of a variety of different cancers. We now present a strategy to purify amplified DNA on double minute chromosomes (DMs) to enable analysis of their prevalence and contribution to tumourigenesis, Using cell lines derived from four different tumour types, we have developed a general and rapid method to purify micronuclei that are known to entrap extrachromosomal elements. The isolated DNA is highly enriched in DM sequences and can be used to prepare probes to localize the progenitor single copy chromosomal regions. The capture of DMs by micronuclei appears to be dependent on their lack of a centromere rather than their small size.	SALK INST BIOL STUDIES,GENE EXPRESS LAB,LA JOLLA,CA 92037; HIROSHIMA UNIV,FAC INTEGRATED ARTS & SCI,HIGASHIHIROSHIMA 724,JAPAN	Salk Institute; Hiroshima University			Kanda, Teru/J-7313-2019	Kanda, Teru/0000-0002-1391-3349				ALITALO K, 1983, P NATL ACAD SCI-BIOL, V80, P1707, DOI 10.1073/pnas.80.6.1707; BECKER P, 1990, GENE CHROMOSOME CANC, V2, P59, DOI 10.1002/gcc.2870020111; BENNER SE, 1991, ANTI-CANCER DRUG, V2, P11, DOI 10.1097/00001813-199102000-00002; BIEDLER JL, 1976, J NATL CANCER I, V57, P683, DOI 10.1093/jnci/57.3.683; BIGNER SH, 1990, CANCER RES, V50, P2347; BRISON O, 1993, BIOCHIM BIOPHYS ACTA, V1155, P25, DOI 10.1016/0304-419X(93)90020-D; CARINE K, 1986, SOMAT CELL MOLEC GEN, V12, P479, DOI 10.1007/BF01539919; CARINE K, 1989, SOMAT CELL MOLEC GEN, V15, P445, DOI 10.1007/BF01534895; COLLINS SJ, 1987, BLOOD, V70, P1233; COWELL JK, 1982, ANNU REV GENET, V16, P21, DOI 10.1146/annurev.ge.16.120182.000321; DHAR V, 1984, SOMAT CELL MOLEC GEN, V10, P547, DOI 10.1007/BF01535220; ECKHARDT SG, 1994, P NATL ACAD SCI USA, V91, P6674, DOI 10.1073/pnas.91.14.6674; EKI T, 1987, CANCER RES, V47, P5162; FENECH M, 1985, MUTAT RES, V147, P29, DOI 10.1016/0165-1161(85)90015-9; FORD JH, 1988, AM J HUM GENET, V43, P733; FORSTER E, 1994, BIOTECHNIQUES, V16, P1006; GUAN XY, 1994, NAT GENET, V8, P155, DOI 10.1038/ng1094-155; HARTZER MK, 1985, J MOL BIOL, V183, P365; HEDDLE JA, 1977, MUTAT RES, V44, P63, DOI 10.1016/0027-5107(77)90115-4; HEDDLE JA, 1983, MUTAT RES, V123, P61, DOI 10.1016/0165-1110(83)90047-7; HOLT JT, 1988, MOL CELL BIOL, V8, P963, DOI 10.1128/MCB.8.2.963; KALLIONIEMI A, 1994, P NATL ACAD SCI USA, V91, P2156, DOI 10.1073/pnas.91.6.2156; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; LI JC, 1984, P NATL ACAD SCI-BIOL, V81, P5694, DOI 10.1073/pnas.81.18.5694; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; MA C, 1993, GENE DEV, V7, P605, DOI 10.1101/gad.7.4.605; McGill J. R., 1995, Proceedings of the American Association for Cancer Research Annual Meeting, V36, P540; MCGILL JR, 1993, CANCER GENET CYTOGEN, V71, P125, DOI 10.1016/0165-4608(93)90017-G; MEITZER PS, 1992, NAT GENET, V1, P24; NEEL BG, 1982, P NATL ACAD SCI-BIOL, V79, P7842, DOI 10.1073/pnas.79.24.7842; NIELSEN JL, 1993, CANCER GENET CYTOGEN, V65, P120, DOI 10.1016/0165-4608(93)90219-C; NUSSE M, 1984, CYTOMETRY, V5, P20, DOI 10.1002/cyto.990050105; PATHAK S, 1986, CANCER GENET CYTOGEN, V8, P125; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; PINKEL D, 1994, NAT GENET, V8, P107, DOI 10.1038/ng1094-107; QUINN LA, 1979, CANCER RES, V39, P4914; RASHEED BKA, 1994, CANCER RES, V54, P1324; SHIMIZU N, 1994, CANCER RES, V54, P3561; SIEBERT PD, 1993, BIOTECHNIQUES, V14, P244; SMITH KA, 1992, P NATL ACAD SCI USA, V89, P5427, DOI 10.1073/pnas.89.12.5427; SNAPKA RM, 1983, P NATL ACAD SCI-BIOL, V80, P7533, DOI 10.1073/pnas.80.24.7533; STARK GR, 1984, ANNU REV BIOCHEM, V53, P447, DOI 10.1146/annurev.bi.53.070184.002311; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; TELENIUS H, 1992, GENE CHROMOSOME CANC, V4, P257, DOI 10.1002/gcc.2870040311; TLSTY TD, 1990, P NATL ACAD SCI USA, V87, P3132, DOI 10.1073/pnas.87.8.3132; VONHOFF DD, 1991, CANCER RES, V51, P6273; VONHOFF DD, 1992, P NATL ACAD SCI USA, V89, P8165, DOI 10.1073/pnas.89.17.8165; WAHL GM, 1989, CANCER RES, V49, P1333; WINDLE B, 1991, GENE DEV, V5, P160, DOI 10.1101/gad.5.2.160; WRIGHT JA, 1990, P NATL ACAD SCI USA, V87, P1791, DOI 10.1073/pnas.87.5.1791; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7	51	58	62	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1996	12	1					65	71		10.1038/ng0196-65	http://dx.doi.org/10.1038/ng0196-65			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TM555	8528254				2022-12-25	WOS:A1996TM55500016
J	HANSON, IM; FLETCHER, JM; JORDAN, T; BROWN, A; TAYLOR, D; ADAMS, RJ; PUNNETT, HH; VANHEYNINGEN, V				HANSON, IM; FLETCHER, JM; JORDAN, T; BROWN, A; TAYLOR, D; ADAMS, RJ; PUNNETT, HH; VANHEYNINGEN, V			MUTATIONS AT THE PAX6 LOCUS ARE FOUND IN HETEROGENEOUS ANTERIOR SEGMENT MALFORMATIONS INCLUDING PETERS ANOMALY	NATURE GENETICS			English	Article							HOMEOBOX-CONTAINING GENE; WILMS-TUMOR; VARIABLE EXPRESSIVITY; INSITU HYBRIDIZATION; ANIRIDIA; MOUSE; CONSERVATION; DOMAIN; DELETION; PROTEIN	Mutation or deletion of the PAX6 gene underlies many cases of aniridia. Three lines of evidence now converge to implicate PAX6 more widely in anterior segment malformations including Peters' anomaly. First, a child with Peters' anomaly is deleted for one copy of PAX6. Second, affected members of a family with dominantly inherited anterior segment malformations, including Peters' anomaly are heterozygous for an R26G mutation in the PAX6 paired box. Third, a proportion of Sey/+ Smalleye mice, heterozygous for a nonsense mutation in murine Pax-6, have an ocular phenotype resembling Peters' anomaly. We therefore propose that a variety of anterior segment anomalies may be associated with PAX6 mutations.	WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND; HOSP SICK CHILDREN,DEPT OPHTHALMOL,LONDON WC1N 3JH,ENGLAND; ST CHRISTOPHERS HOSP CHILDREN,PHILADELPHIA,PA 19134	University of Edinburgh; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust			van Heyningen, Veronica/B-8039-2008; fletcher, jack/Q-5975-2019; Fletcher, Jack/AAX-2931-2020; VAN HEYNINGEN, Veronica/GYE-0531-2022	van Heyningen, Veronica/0000-0003-0359-0141; Hanson, Isabel/0000-0002-1878-0530	Medical Research Council [MC_U127527199] Funding Source: Medline; NCI NIH HHS [CA8659] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F33CA008659] Funding Source: NIH RePORTER; MRC [MC_U127527199] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ASHER JH, 1991, AM J HUM GENET, V48, P43; BEATTIE PH, 1947, BRIT J OPHTHALMOL, V31, P649, DOI 10.1136/bjo.31.11.649; BEAUCHAMP GR, 1978, J PEDIATR OPHTHALMOL, V17, P55; BOPP D, 1986, CELL, V47, P1033, DOI 10.1016/0092-8674(86)90818-4; BURRI M, 1989, EMBO J, V8, P1183, DOI 10.1002/j.1460-2075.1989.tb03490.x; CHALEPAKIS G, 1992, J CELL SCI S, V16, P61; CLAYTON R, 1985, OCULAR LENS, P61; EIFERMAN RA, 1984, ANN OPHTHALMOL, V16, P933; FANTES JA, 1992, AM J HUM GENET, V51, P1286; GLASER T, 1990, SCIENCE, V250, P823, DOI 10.1126/science.2173141; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; Green MC., 1989, GENETIC VARIANTS STR, P12; HANSON IM, 1993, HUM MOL GENET, V2, P915; HEON E, 1992, OPHTHALMIC PAED GEN, V13, P137, DOI 10.3109/13816819209087614; HILL R, 1992, TRENDS GENET, V8, P119, DOI 10.1016/0168-9525(92)90359-C; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HITTNER HM, 1980, AM J OPHTHALMOL, V89, P531, DOI 10.1016/0002-9394(80)90062-8; HITTNER HM, 1982, AM J OPHTHALMOL, V93, P57, DOI 10.1016/0002-9394(82)90700-0; HOGAN BLM, 1988, DEVELOPMENT, V103, P115; HOGAN BLM, 1986, J EMBRYOL EXP MORPH, V97, P95; HOLMSTROM GE, 1991, BRIT J OPHTHALMOL, V75, P591, DOI 10.1136/bjo.75.10.591; HOTH CF, 1993, AM J HUM GENET, V52, P455; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; JOTTERAND V, 1990, BRIT J OPHTHALMOL, V74, P568, DOI 10.1136/bjo.74.9.568; KENYON KR, 1975, EXP EYE RES, V21, P125, DOI 10.1016/0014-4835(75)90077-9; KRAUSS S, 1991, EMBO J, V10, P3609, DOI 10.1002/j.1460-2075.1991.tb04927.x; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; MARTIN P, 1992, ONCOGENE, V7, P1721; MURRAY JC, 1992, NAT GENET, V2, P46, DOI 10.1038/ng0992-46; Peters A., 1906, KLIN MONATSBL AUGENH, V44; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; STONE DL, 1976, AM J OPHTHALMOL, V81, P173, DOI 10.1016/0002-9394(76)90729-7; TASSABEHJI M, 1993, NAT GENET, V3, P26, DOI 10.1038/ng0193-26; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; TREISMAN J, 1991, GENE DEV, V5, P594, DOI 10.1101/gad.5.4.594; VANHEYNINGEN V, 1990, P NATL ACAD SCI USA, V87, P5383, DOI 10.1073/pnas.87.14.5383; WALTER MA, 1992, NATURE, V355, P590, DOI 10.1038/355590a0; WALTHER C, 1991, GENOMICS, V11, P424, DOI 10.1016/0888-7543(91)90151-4; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Waring G O 3rd, 1975, Surv Ophthalmol, V20, P3, DOI 10.1016/0039-6257(75)90034-X	40	405	415	0	17	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1994	6	2					168	173		10.1038/ng0294-168	http://dx.doi.org/10.1038/ng0294-168			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU763	8162071				2022-12-25	WOS:A1994MU76300012
J	ROA, BB; DYCK, PJ; MARKS, HG; CHANCE, PF; LUPSKI, JR				ROA, BB; DYCK, PJ; MARKS, HG; CHANCE, PF; LUPSKI, JR			DEJERINE-SOTTAS SYNDROME-ASSOCIATED WITH POINT MUTATION IN THE PERIPHERAL MYELIN PROTEIN 22 (PMP22) GENE	NATURE GENETICS			English	Article							TOOTH DISEASE TYPE-1A; TREMBLER-J MOUSE; DUPLICATION; NEUROPATHY; MECHANISM; PMP-22; DOSAGE	Dejerine-Sottas syndrome is a hypertrophic, demyelinating neuropathy which appears to demonstrate autosomal recessive inheritance in most pedigrees. Clinical symptoms are similar but more severe than Charcot-Marie-Tooth disease type 1 (CMT1), of which the major subtype, CMT1A, results either from duplication of a 1.5-megabase DNA region in chromosome 17p11.2-p12 containing the myelin gene PMP22, or from PMP22 point mutation. Mutational analysis of the PMP22 coding region in two unrelated Dejerine-Sottas patients identified individual missense point mutations present in the heterozygous state. These findings suggest that Dejerine-Sottas syndrome can result from dominant point mutation alleles of PMP22.	BAYLOR COLL MED,INST MOLEC GENET,1 BAYLOR PLAZA,HOUSTON,TX 77030; MAYO CLIN & MAYO FDN,DEPT NEUROL,ROCHESTER,MN 55905; ALFRED I DUPONT INST,DIV NEUROL,WILMINGTON,DE 19899; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; UNIV UTAH,MED CTR,DIV MED GENET,SALT LAKE CITY,UT 84132; BAYLOR COLL MED,CTR HUMAN GENOME,HOUSTON,TX 77030	Baylor College of Medicine; Mayo Clinic; Nemours Alfred I. duPont Hospital for Children; Baylor College of Medicine; Utah System of Higher Education; University of Utah; Baylor College of Medicine			Chance, Phillip/AAX-5826-2020					BEIGHTON P, 1986, MAN SYNDROME, P26; BORDO D, 1991, J MOL BIOL, V217, P721, DOI 10.1016/0022-2836(91)90528-E; BYERS PH, 1989, METABOLIC BASIS INHE, P2805; CHANCE PF, 1992, NEUROLOGY, V42, P2295, DOI 10.1212/WNL.42.12.2295; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; Charcot JM, 1886, REV MED-PARIS, V6, P97; COHN DH, 1990, AM J HUM GENET, V46, P591; Dejerine J J, 1893, COMPTES RENDUS SOC B, V45, P63; Dyck P.J, 1993, PNP, P1094; DYCK PJ, 1968, MAYO CLIN PROC, V43, P280; DYCK PJ, 1968, ARCH NEUROL-CHICAGO, V18, P603, DOI 10.1001/archneur.1968.00470360025002; DYCK PJ, 1971, MAYO CLIN PROC, V46, P432; DYCK PJ, 1966, P MAYO CLIN, V41, P742; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; EDWARDS A, 1991, AM J HUM GENET, V49, P746; HOOGENDIJK JE, 1993, NEUROLOGY, V43, P1010, DOI 10.1212/WNL.43.5.1010; KAKU DA, 1993, NEUROLOGY, V43, P1806, DOI 10.1212/WNL.43.9.1806; KILLIAN JM, 1979, ANN NEUROL, V5, P515, DOI 10.1002/ana.410050604; LUPSKI JR, 1992, NAT GENET, V1, P29, DOI 10.1038/ng0492-29; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; LUPSKI JR, 1992, BRAIN PATHOL, V2, P337, DOI 10.1111/j.1750-3639.1992.tb00710.x; LUPSKI JR, 1991, CURRENT NEUROLOGY, P1; MATSUNAMI N, 1992, NAT GENET, V1, P176, DOI 10.1038/ng0692-176; McKusick V.A., 1992, MENDELIAN INHERITANC; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; RAO BB, 1993, NAT GENET, V5, P189; SNIPES GJ, 1992, J CELL BIOL, V117, P225, DOI 10.1083/jcb.117.1.225; SUTER U, 1992, P NATL ACAD SCI USA, V89, P4382, DOI 10.1073/pnas.89.10.4382; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; TIMMERMAN V, 1992, NAT GENET, V1, P171, DOI 10.1038/ng0692-171; TOOTH HH, 1886, PERSONEAL TYPE PROGR; UPADHYAYA M, 1993, HUM GENET, V91, P392; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166; WISE CA, 1993, AM J HUM GENET, V53, P853	37	241	247	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1993	5	3					269	273		10.1038/ng1193-269	http://dx.doi.org/10.1038/ng1193-269			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MF122	8275092				2022-12-25	WOS:A1993MF12200018
J	KERCKAERT, JP; DEWEINDT, C; TILLY, H; QUIEF, S; LECOCQ, G; BASTARD, C				KERCKAERT, JP; DEWEINDT, C; TILLY, H; QUIEF, S; LECOCQ, G; BASTARD, C			LAZ3, A NOVEL ZINC-FINGER ENCODING GENE, IS DISRUPTED BY RECURRING CHROMOSOME-3Q27 TRANSLOCATIONS IN HUMAN LYMPHOMAS	NATURE GENETICS			English	Article							TRANSCRIPTION FACTORS; ACUTE LEUKEMIAS; ONCOGENIC CONVERSION; DROSOPHILA-TRITHORAX; BURKITTS-LYMPHOMA; RAR-ALPHA; PROTEIN; EXPRESSION; FAMILY; T(15-17)	We have shown previously that chromosomal translocations involving chromosome 3q27 and immunoglobulin gene regions are the third most common specific translocations in non-Hodgkin's lymphoma (NHL). We now report the isolation of a gene that is disrupted in two cases by t(3;14) and t(3;4) translocations. The gene (LAZ3) encodes a 79 kDa protein containing six zinc-finger motifs and sharing amino-terminal homology with several transcription factors including the Drosophila tramtrack and Broad-complex genes, both of which are developmental transcription regulators. LAZ3 is transcribed as a 3.8 kb message predominantly in normal adult skeletal muscle and in several NHL carrying 3q27 chromosomal defects. We suggest that it may act as a transcription regulator and play an important role in lymphomagenesis.	CTR HENRI BECQUEREL,F-76038 ROUEN,FRANCE; CTR REG TRANSFUS SANGUINE,DEPT CYTOGENET,F-76232 BOISE GUILLAUME,FRANCE	UNICANCER; Centre Henri Becquerel	KERCKAERT, JP (corresponding author), INST RECH CANC LILLE,INSERM,U124,PL VERDUN,F-59045 LILLE,FRANCE.							ADAMS MD, 1993, NAT GENET, V4, P256, DOI 10.1038/ng0793-256; BARON BW, 1993, P NATL ACAD SCI USA, V90, P5262, DOI 10.1073/pnas.90.11.5262; BASTARD C, 1992, BLOOD, V79, P2527; CHARDIN P, 1991, NUCLEIC ACIDS RES, V19, P1431, DOI 10.1093/nar/19.7.1431; CLEARY ML, 1991, CELL, V66, P619, DOI 10.1016/0092-8674(91)90105-8; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; DEWEINDT C, IN PRESS CANCER; DIBELLO PR, 1991, GENETICS, V129, P385; DJABALI M, 1992, NAT GENET, V2, P113, DOI 10.1038/ng1092-113; EVANS RM, 1988, CELL, V52, P1, DOI 10.1016/0092-8674(88)90522-3; FICHELSON S, 1992, LEUKEMIA, V6, P93; FUKUHARA S, 1979, CANCER RES, V39, P3119; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; HARRISON SD, 1990, EMBO J, V9, P207, DOI 10.1002/j.1460-2075.1990.tb08097.x; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; KOONIN EV, 1992, TRENDS BIOCHEM SCI, V17, P213, DOI 10.1016/0968-0004(92)90379-N; LEDER P, 1983, SCIENCE, V222, P765, DOI 10.1126/science.6356357; LENOIR GM, 1982, NATURE, V298, P474, DOI 10.1038/298474a0; LEWIN B, 1991, CELL, V64, P303, DOI 10.1016/0092-8674(91)90640-K; LICHTER P, 1992, GENOMICS, V13, P999, DOI 10.1016/0888-7543(92)90013-I; MANOLOVA Y, 1979, HEREDITAS, V90, P5; MCGUIRE EA, 1989, MOL CELL BIOL, V9, P2124, DOI 10.1128/MCB.9.5.2124; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; NICHOLS J, 1992, BLOOD, V80, P2953; OLSON EN, 1990, GENE DEV, V4, P1454, DOI 10.1101/gad.4.9.1454; RABBITTS TH, 1991, CELL, V67, P641, DOI 10.1016/0092-8674(91)90057-6; READ D, 1992, EMBO J, V11, P1035, DOI 10.1002/j.1460-2075.1992.tb05142.x; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; XIONG WC, 1993, GENE DEV, V7, P1085, DOI 10.1101/gad.7.6.1085; YE BHH, 1993, CANCER RES, V53, P2732	30	398	403	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1993	5	1					66	70		10.1038/ng0993-66	http://dx.doi.org/10.1038/ng0993-66			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LV565	8220427				2022-12-25	WOS:A1993LV56500018
J	LAMB, BT; SISODIA, SS; LAWLER, AM; SLUNT, HH; KITT, CA; KEARNS, WG; PEARSON, PL; PRICE, DL; GEARHART, JD				LAMB, BT; SISODIA, SS; LAWLER, AM; SLUNT, HH; KITT, CA; KEARNS, WG; PEARSON, PL; PRICE, DL; GEARHART, JD			INTRODUCTION AND EXPRESSION OF THE 400 KILOBASE PRECURSOR AMYLOID PROTEIN GENE IN TRANSGENIC MICE	NATURE GENETICS			English	Article							HEREDITARY CEREBRAL-HEMORRHAGE; FAMILIAL ALZHEIMERS-DISEASE; AGE-ASSOCIATED INCLUSIONS; BETA-PROTEIN; NEUROFIBRILLARY TANGLES; GEL-ELECTROPHORESIS; TERMINAL FRAGMENT; DOWNS-SYNDROME; CLEAVAGE SITE; MOUSE-BRAIN	Overexpression of the gene encoding the beta-amyloid precursor protein (APP) may have a key role in the pathogenesis of both Alzheimer's disease (AD) and Down Syndrome (DS). We have therefore introduced a 650 kilobase (kb) yeast artificial chromosome (YAC) that contains the entire, unrearranged 400 kb human APP gene into mouse embryonic stem (ES) cells by lipid-mediated transfection. ES lines were generated that contain a stably integrated, unrearranged human APP gene. Moreover, we demonstrate germ line transmission of the APP YAC in transgenic mice and expression of human APP mRNA and protein at levels comparable to endogenous APP. This transgenic strategy may prove invaluable for the development of mouse models for AD and DS.	JOHNS HOPKINS UNIV, SCH MED,DEPT GYNECOL & OBSTET,DEV GENET LAB, 205 PHYSIOL BLDG,725 N WOLFE ST, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT PATHOL, NEUROPATHOL LAB, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, CTR MED GENET, DEPT MED, BALTIMORE, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University			Kearns, William/AAE-7699-2020					ANAND R, 1989, NUCLEIC ACIDS RES, V17, P3425, DOI 10.1093/nar/17.9.3425; ANDERSON JP, 1991, NEUROSCI LETT, V128, P126, DOI 10.1016/0304-3940(91)90775-O; Bradley A, 1987, TERATOCARCINOMAS EMB, P113; BRINSTER RL, 1988, P NATL ACAD SCI USA, V85, P836, DOI 10.1073/pnas.85.3.836; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; CHOI TK, 1993, NAT GENET, V4, P117, DOI 10.1038/ng0693-117; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; CONNELLY C, 1991, GENOMICS, V10, P10, DOI 10.1016/0888-7543(91)90477-V; Davis R W, 1980, Methods Enzymol, V65, P404; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GARDINER K, 1986, SOMAT CELL MOLEC GEN, V12, P185, DOI 10.1007/BF01560665; GIACCONE G, 1989, NEUROSCI LETT, V97, P232, DOI 10.1016/0304-3940(89)90169-9; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOLDE TE, 1990, NEURON, V4, P253, DOI 10.1016/0896-6273(90)90100-T; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; HIETER P, 1990, GENOME ANAL, V1, P83; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JAKOBOVITS A, 1993, NATURE, V362, P255, DOI 10.1038/362255a0; JUCKER M, 1992, SCIENCE, V255, P1443, DOI 10.1126/science.1542796; KAMMESHEIDT A, 1992, P NATL ACAD SCI USA, V89, P10857, DOI 10.1073/pnas.89.22.10857; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KAWABATA S, 1991, NATURE, V354, P476, DOI 10.1038/354476a0; KAWABATA S, 1992, NATURE, V356, P23, DOI 10.1038/356023b0; Kemper T., 1984, CLIN NEUROLOGY AGING, P9; Lamb Bruce T., 1991, Gene Expression, V1, P185; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; LINNEY E, 1983, CELL, V35, P693, DOI 10.1016/0092-8674(83)90102-2; MANN DMA, 1989, J NEUROL SCI, V89, P169, DOI 10.1016/0022-510X(89)90019-1; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; NARUSE S, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91612-X; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; PRICE DL, 1992, AM J PATHOL, V141, P767; QUON D, 1991, NATURE, V352, P239, DOI 10.1038/352239a0; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; RUMBLE B, 1989, NEW ENGL J MED, V320, P1446, DOI 10.1056/NEJM198906013202203; SCHEDL A, 1993, NATURE, V362, P258, DOI 10.1038/362258a0; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; SELKOE DJ, 1987, SCIENCE, V235, P873, DOI 10.1126/science.3544219; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Sisodia S S, 1992, Curr Opin Neurobiol, V2, P648, DOI 10.1016/0959-4388(92)90033-H; SISODIA SS, 1987, MOL CELL BIOL, V7, P3602, DOI 10.1128/MCB.7.10.3602; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; STRAUSS WM, 1993, SCIENCE, V259, P1904, DOI 10.1126/science.8096090; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; TASSONE F, 1992, AM J HUM GENET, V51, P1251; VAN BROECKHOVEN C, 1990, SCIENCE, V248, P1120, DOI 10.1126/science.1971458; WANG R, 1991, J BIOL CHEM, V266, P16960; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; WIRAK D, 1992, SCIENCE, V255, P1445, DOI 10.1126/science.255.5050.1445; WIRAK DO, 1991, EMBO J, V10, P289, DOI 10.1002/j.1460-2075.1991.tb07949.x; WIRAK DO, 1991, SCIENCE, V253, P323, DOI 10.1126/science.1857970; YOSHIKAI S, 1990, GENE, V87, P257, DOI 10.1016/0378-1119(90)90310-N; YOSHIKAI S, 1991, GENE, V102, P291, DOI 10.1016/0378-1119(91)90093-Q	67	266	311	0	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1993	5	1					22	29		10.1038/ng0993-22	http://dx.doi.org/10.1038/ng0993-22			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LV565	8220418				2022-12-25	WOS:A1993LV56500010
J	BARON, M; FREIMER, NF; RISCH, N; LERER, B; ALEXANDER, JR; STRAUB, RE; ASOKAN, S; DAS, K; PETERSON, A; AMOS, J; ENDICOTT, J; OTT, J; GILLIAM, TC				BARON, M; FREIMER, NF; RISCH, N; LERER, B; ALEXANDER, JR; STRAUB, RE; ASOKAN, S; DAS, K; PETERSON, A; AMOS, J; ENDICOTT, J; OTT, J; GILLIAM, TC			DIMINISHED SUPPORT FOR LINKAGE BETWEEN MANIC-DEPRESSIVE ILLNESS AND X-CHROMOSOME MARKERS IN 3 ISRAELI PEDIGREES	NATURE GENETICS			English	Article							DIAGNOSTIC CRITERIA; AFFECTIVE-DISORDERS; BIPOLAR PEDIGREES; GENETIC-LINKAGE; HUMAN XQ28; RELIABILITY; REGION	The hypothesis that chromosomal region Xq27-28 harbours a gene for manic-depression has been a focus of interest in human genetics. X-linked inheritance of manic depressive illness has been re-examined in 3 multigeneration Israeli kindreds. Extension and re-evaluation of pedigree data, including new individuals, diagnostic follow-up, and analysis with DNA markers, shows greatly diminished support for linkage to Xq28. The peak lod scores in two of the pedigrees have dropped several lod units to clearly negative values at the RCP-F8-G6PD gene cluster. On the other hand, positive lod scores (Z(max) = 2.09) are sustained in another pedigree at the same map location. None of the pedigrees show linkage to more proximal markers, including the Xq27 locus DXS98. Our analysis underscores the uncertainties in studying complex disorders.	COLUMBIA UNIV COLL PHYS & SURG,DEPT PSYCHIAT,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT GENET & DEV,NEW YORK,NY 10032; YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT GENET,NEW HAVEN,CT 06510; HEBREW UNIV JERUSALEM,HADASSAH MED CTR,DEPT PSYCHIAT,IL-91120 JERUSALEM,ISRAEL; BOSTON UNIV,MED CTR,CTR HUMAN GENET,BOSTON,MA 02118	Columbia University; Columbia University; Yale University; Yale University; Hebrew University of Jerusalem; Hadassah University Medical Center; Boston University	BARON, M (corresponding author), NEW YORK STATE PSYCHIAT INST & HOSP,NEW YORK,NY 10032, USA.							ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229; BARON M, 1987, NATURE, V326, P289, DOI 10.1038/326289a0; BARON M, 1991, ARCH GEN PSYCHIAT, V48, P671; BARON M, 1990, BRIT J PSYCHIAT, V157, P645, DOI 10.1192/bjp.157.5.645; BARON M, 1991, SOC BIOL, V38, P179; BELL MV, 1989, AM J HUM GENET, V45, P883; BERNSTEIN RE, 1962, NATURE, V194, P192, DOI 10.1038/194192a0; BERRETTINI WH, 1990, ARCH GEN PSYCHIAT, V47, P366; BUCKLE VJ, 1989, NEURON, V3, P645; DAVIES KE, 1991, CYTOGENET CELL GENET, V58, P853, DOI 10.1159/000133183; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; FEIL R, 1990, GENOMICS, V6, P367, DOI 10.1016/0888-7543(90)90578-I; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FELDMAN E, 1991, ARCH GEN PSYCHIAT, V48, P671; GEJMAN PV, 1990, GENOMICS, V8, P648, DOI 10.1016/0888-7543(90)90251-O; GILL M, 1992, BRIT J PSYCHIAT, V160, P112, DOI 10.1192/bjp.160.1.112; GILLIAM TC, 1987, NUCLEIC ACIDS RES, V15, P1445, DOI 10.1093/nar/15.4.1445; HEBEBRAND J, 1992, BRIT J PSYCHIAT, V160, P7, DOI 10.1192/bjp.160.1.7; HICKS AA, 1991, NUCLEIC ACIDS RES, V19, P4016, DOI 10.1093/nar/19.14.4016; HODGE SE, 1992, AM J HUM GENET, V50, P1053; KELSOE JR, 1989, NATURE, V342, P238, DOI 10.1038/342238a0; KURDIHAIDAR B, 1990, AM J HUM GENET, V47, P1013; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Lohr G. W., 1974, METHODS ENZYMATIC AN, V2, P636, DOI [DOI 10.1016/B978-0-12-091302-2.50026-8, 10.1016/B978-0-12-091302-2.50026-8]; MENDLEWICZ J, 1987, LANCET, V1, P1230; Moses Robert A., 1981, ADLERS PHYSL EYE; Ott J., 1991, ANAL HUMAN GENETIC L; POKOMY J, 1987, COLOR RES, V7, P483; POUSTKA A, 1991, P NATL ACAD SCI USA, V88, P8302, DOI 10.1073/pnas.88.19.8302; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; RISCH N, 1991, AM J HUM GENET, V48, P1058; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; VANBROECKHOVEN C, 1991, AM J HUM GENET, V49, P362; VULLIAMY TJ, 1988, P NATL ACAD SCI USA, V85, P5171, DOI 10.1073/pnas.85.14.5171; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WINDERICKX J, 1992, NAT GENET, V1, P251, DOI 10.1038/ng0792-251; WINOKUR G, 1991, ARCH GEN PSYCHIAT, V48, P671	39	157	165	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1993	3	1					49	55		10.1038/ng0193-49	http://dx.doi.org/10.1038/ng0193-49			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	KF372	8490654				2022-12-25	WOS:A1993KF37200012
J	Goldberg, YP; Nicholson, DW; Rasper, DM; Kalchman, MA; Koide, HB; Graham, RK; Bromm, M; KazemiEsfarjani, P; Thornberry, NA; Vaillancourt, JP; Hayden, MR				Goldberg, YP; Nicholson, DW; Rasper, DM; Kalchman, MA; Koide, HB; Graham, RK; Bromm, M; KazemiEsfarjani, P; Thornberry, NA; Vaillancourt, JP; Hayden, MR			Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract	NATURE GENETICS			English	Article							DISEASE GENE; CELL-DEATH; POLY(ADP-RIBOSE) POLYMERASE; EMBRYONIC LETHALITY; C-ELEGANS; APOPTOSIS; INHIBITION; REPEAT; CED-3; IDENTIFICATION	Apoptosis has recently been recognized as a mode of cell death in Huntington disease (HD). Apopain, a human counterpart of the nematode cysteine protease death-gene product, CED-3, has a key role in proteolytic events leading to apoptosis. Here we show that apoptotic extracts and apopain itself specifically cleave the HD gene product, huntingtin. The rate of cleavage increases with the length of the huntingtin polyglutamine tract, providing an explanation for the gain-of-function associated with CAG expansion. Our results show that huntingtin is cleaved by cysteine proteases and suggest that HD might be a disorder of inappropriate apoptosis.	UNIV BRITISH COLUMBIA,DEPT MED GENET,VANCOUVER,BC,CANADA; MERCK FROSST CTR THERAPEUT RES,DEPT BIOCHEM & MOL BIOL,MONTREAL,PQ,CANADA; MERCK & CO INC,MERCK SHARP & DOHME RES LABS,DEPT ENZYMOL,RAHWAY,NJ 07065	University of British Columbia; Merck & Company; Merck & Company			Hayden, Michael R/D-8581-2011; Graham, Rona K/R-7358-2018	Hayden, Michael R/0000-0001-5159-1419; Graham, Rona K/0000-0003-3722-6241				BUMP NJ, 1995, SCIENCE, V269, P1885, DOI 10.1126/science.7569933; Burke JR, 1996, NAT MED, V2, P347, DOI 10.1038/nm0396-347; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; CASCIOLAROSEN LA, 1994, J BIOL CHEM, V269, P30757; CASCIOLAROSEN LA, 1995, J EXP MED, V182, P1625, DOI 10.1084/jem.182.6.1625; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; DRAGUNOW M, 1995, CLIN NEUROSCI NEUROP, V6, P1053; DUYAO MP, 1995, HDH SCI, V269, P407; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; FERNANDESALNEMR.T, 1994, J BIOL CHEM, V270, P15870; FERNANDESALNEMRI T, 1995, CANCER RES, V55, P6045; Goldberg YP, 1996, HUM MOL GENET, V5, P177, DOI 10.1093/hmg/5.2.177; GUTEKUNST CA, 1995, P NATL ACAD SCI USA, V92, P8710, DOI 10.1073/pnas.92.19.8710; Harper PS, 1991, HUNTINGTONS DIS; Hayden MR., 1981, HUNTINGTONS CHOREA, P45; JOU YS, 1995, HUM MOL GENET, V4, P465, DOI 10.1093/hmg/4.3.465; KAUFMANN SH, 1993, CANCER RES, V53, P3976; KREMER HPH, 1994, NEW ENGL J MED, V330, P1401; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; MARTIN SJ, 1995, CELL, V82, P349, DOI 10.1016/0092-8674(95)90422-0; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nicholson DW, 1996, NAT BIOTECHNOL, V14, P297, DOI 10.1038/nbt0396-297; PROTERACAILLIAU C, 1995, J NEUROSCI, V15, P3775; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; TELENIUS H, 1993, HUM MOL GENET, V2, P1535, DOI 10.1093/hmg/2.10.1535; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; THOMAS LB, 1995, EXP NEUROL, V133, P265, DOI 10.1006/exnr.1995.1029; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; THORNBERRY NA, 1994, METHOD ENZYMOL, V244, P615; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Wang XD, 1996, EMBO J, V15, P1012, DOI 10.1002/j.1460-2075.1996.tb00438.x; XUE D, 1995, NATURE, V377, P248, DOI 10.1038/377248a0; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155; 1993, CELL, V72, P971	37	477	497	0	14	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1996	13	4					442	449		10.1038/ng0896-442	http://dx.doi.org/10.1038/ng0896-442			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VB620	8696339				2022-12-25	WOS:A1996VB62000025
J	Putnam, AJ; Mooney, DJ				Putnam, AJ; Mooney, DJ			Tissue engineering using synthetic extracellular matrices	NATURE MEDICINE			English	Editorial Material									UNIV MICHIGAN,DEPT CHEM ENGN,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT BIOL & MAT SCI,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan			Putnam, Andrew J./E-8643-2010	Putnam, Andrew J./0000-0002-1262-4377; Mooney, David/0000-0001-6299-1194				Alberts B., 1994, MOL BIOL CELL, P971; ATALA A, 1994, J UROLOGY, V152, P641, DOI 10.1016/S0022-5347(17)32671-X; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; GILDING DK, 1981, BIOCOMPATIBILITY CLI, V2, P209; HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565; KIM WS, 1994, PLAST RECONSTR SURG, V94, P233, DOI 10.1097/00006534-199408000-00001; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lo H, 1995, Tissue Eng, V1, P15, DOI 10.1089/ten.1995.1.15; MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9; Mooney D J, 1995, Tissue Eng, V1, P107, DOI 10.1089/ten.1995.1.107; Mooney DJ, 1996, BIOTECHNOL BIOENG, V50, P422, DOI 10.1002/(SICI)1097-0290(19960520)50:4<422::AID-BIT9>3.0.CO;2-N; MOONEY DJ, 1995, J BIOMED MATER RES, V29, P959, DOI 10.1002/jbm.820290807; MOONEY DJ, 1994, CELL TRANSPLANT, V3, P203, DOI 10.1177/096368979400300209; MOONEY DJ, IN PRESS BIOMATERIAL; Mooney DT, 1996, BIOMATERIALS, V17, P115, DOI 10.1016/0142-9612(96)85756-5; Nerem R M, 1995, Tissue Eng, V1, P3, DOI 10.1089/ten.1995.1.3; ORGAN GM, 1992, TRANSPLANT P, V24, P3008; PUELACHER WC, 1994, BIOMATERIALS, V15, P774, DOI 10.1016/0142-9612(94)90031-0; PUELACHER WC, 1994, INT J ORAL MAX SURG, V23, P49, DOI 10.1016/S0901-5027(05)80328-5	19	180	193	0	18	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUL	1996	2	7					824	826		10.1038/nm0796-824	http://dx.doi.org/10.1038/nm0796-824			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UU680	8673932				2022-12-25	WOS:A1996UU68000044
J	Roberts, RG; Freeman, TC; Kendall, E; Vetrie, DLP; Dixon, AK; ShawSmith, C; Bone, Q; Bobrow, M				Roberts, RG; Freeman, TC; Kendall, E; Vetrie, DLP; Dixon, AK; ShawSmith, C; Bone, Q; Bobrow, M			Characterization of DRP2, a novel human dystrophin homologue	NATURE GENETICS			English	Letter							PROTEIN; GENE; TRANSCRIPT		UMDS,DIV MED & MOLEC GENET,LONDON,ENGLAND; ADDENBROOKES HOSP,DEPT MED GENET,CAMBRIDGE,ENGLAND; SANGER CTR,HUMAN GENET GRP,HINXTON,ENGLAND; HAMMERSMITH HOSP,GASTROENTEROL UNIT,LONDON,ENGLAND; MARINE BIOL LAB,PLYMOUTH,DEVON,ENGLAND	University of London; King's College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; Imperial College London; Marine Biological Association United Kingdom			Roberts, Roland G/C-3596-2009	Roberts, Roland/0000-0001-6636-1579; Vetrie, David/0000-0003-2075-4662; Freeman, Thomas/0000-0001-5235-8483				BYERS TJ, 1993, NAT GENET, V4, P77, DOI 10.1038/ng0593-77; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; FEENER CA, 1989, NATURE, V338, P509, DOI 10.1038/338509a0; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GREEN PM, 1989, EMBO J, V8, P1067, DOI 10.1002/j.1460-2075.1989.tb03474.x; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; LOVE DR, 1989, NATURE, V339, P55, DOI 10.1038/339055a0; MARUYAMA IN, 1995, NUCLEIC ACIDS RES, V23, P3796, DOI 10.1093/nar/23.18.3796; NAYLOR J, 1993, HUM MOL GENET, V2, P1773, DOI 10.1093/hmg/2.11.1773; PHILIPPE C, GENOMICS, V27, P539; PONTING CP, IN PRESS TRENDS BIOC; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; ROBERTS RG, 1992, GENOMICS, V13, P942, DOI 10.1016/0888-7543(92)90005-D; ROBERTS RG, 1991, AM J HUM GENET, V49, P298; SCHOFIELD JN, 1994, HUM MOL GENET, V3, P1309; SLEGTENHORSTEEGDEMAN KE, 1995, MOL CELL ENDOCRINOL, V108, P115, DOI 10.1016/0303-7207(94)03468-9; SUDOL M, 1995, J BIOL CHEM, V270, P14733, DOI 10.1074/jbc.270.24.14733; SUZUKI A, 1992, FEBS LETT, V308, P154, DOI 10.1016/0014-5793(92)81265-N; SUZUKI A, 1995, J CELL BIOL, V128, P373, DOI 10.1083/jcb.128.3.373; VETRIE D, 1994, GENOMICS, V19, P42, DOI 10.1006/geno.1994.1010; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; WAGNER KR, 1993, NEURON, V10, P511, DOI 10.1016/0896-6273(93)90338-R; WINDER SJ, 1995, FEBS LETT, V369, P27, DOI 10.1016/0014-5793(95)00398-S; WORTON R, 1995, SCIENCE, V270, P7555	24	68	71	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1996	13	2					223	226		10.1038/ng0696-223	http://dx.doi.org/10.1038/ng0696-223			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UN395	8640231				2022-12-25	WOS:A1996UN39500024
J	Bione, S; DAdamo, P; Maestrini, E; Gedeon, AK; Bolhuis, PA; Toniolo, D				Bione, S; DAdamo, P; Maestrini, E; Gedeon, AK; Bolhuis, PA; Toniolo, D			A novel X-linked gene, G4.5. is responsible for Barth syndrome	NATURE GENETICS			English	Article							XQ28; MITOCHONDRIA	Barth Syndrome is a severe inherited disorder, often fatal in childhood, characterized by cardiac and skeletal myopathy, short stature and neutropenia. The disease has been mapped to a very gene-rich region in distal portion of Xq28. We now report the identification of unique mutations in one of the genes in this region, termed G4.5, expressed at high level in cardiac and skeletal muscle, Different mRNAs can be produced by alternative splicing of the primary G4.5 transcript, encoding novel proteins that differ at the N terminus and in the central region. The mutations introduce stop codons in the open reading frame interrupting translation of most of the putative proteins (which we term 'tafazzins'), Our results suggest that G4.5 is the genetic locus responsible for the Barth syndrome.	CNR,INST GENET BIOCHEM & EVOLUT,I-27100 PAVIA,ITALY; WOMENS & CHILDRENS HOSP,DEPT CYTOGENET & MOLEC GENET,ADELAIDE,SA 5006,AUSTRALIA; UNIV AMSTERDAM,ACAD MED CTR,LAB NEUROL,1105 AZ AMSTERDAM,NETHERLANDS	Consiglio Nazionale delle Ricerche (CNR); Womens & Childrens Hospital Australia; University of Amsterdam; Academic Medical Center Amsterdam			D'Adamo, Patrizia/AAN-3919-2020; Maestrini, Elena/K-7508-2012; Gedeon, Agi/G-7890-2011; Toniolo, Daniela/AAE-2969-2019	D'Adamo, Patrizia/0000-0002-0312-5541; Maestrini, Elena/0000-0001-5924-3179; Toniolo, Daniela/0000-0001-9545-6032; Bione, Silvia/0000-0002-3924-4606	Telethon [E.0297] Funding Source: Medline	Telethon(Fondazione Telethon)		ADES LC, 1993, AM J MED GENET, V45, P327, DOI 10.1002/ajmg.1320450309; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; BIONE S, 1993, P NATL ACAD SCI USA, V90, P10977, DOI 10.1073/pnas.90.23.10977; BIONE S, 1995, HUM MOL GENET, V4, P1859; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; BOLHUIS PA, 1991, AM J HUM GENET, V48, P481; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; GEDEON AK, 1995, J MED GENET, V32, P383, DOI 10.1136/jmg.32.5.383; HURT EC, 1986, TRENDS BIOCHEM SCI, V11, P204, DOI 10.1016/0968-0004(86)90007-1; KELLEY DP, NEW ENGL J MED, V330, P913; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; McKusick VA, 1990, MENDELIAN INHERITANC; NELSON DL, 1995, IN PRESS CYTOGENET C; Sambrook J., 2002, MOL CLONING LAB MANU; WICKNER WT, 1985, SCIENCE, V230, P400, DOI 10.1126/science.4048938	15	537	562	1	20	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1996	12	4					385	389		10.1038/ng0496-385	http://dx.doi.org/10.1038/ng0496-385			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UC553	8630491				2022-12-25	WOS:A1996UC55300016
J	GarciaZepeda, EA; Rothenberg, ME; Ownbey, RT; Celestin, J; Leder, P; Luster, AD				GarciaZepeda, EA; Rothenberg, ME; Ownbey, RT; Celestin, J; Leder, P; Luster, AD			Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia	NATURE MEDICINE			English	Article							COLONY-STIMULATING FACTOR; FUNCTIONAL-PROPERTIES; BLOOD EOSINOPHILS; CROHNS-DISEASE; LEUKOCYTE; INTERLEUKIN-3; SURVIVAL; RELEASE; BOWEL	Eotaxin is an eosinophil-specific chemoattractant that has been recently identified in rodent models of asthma and host response against tumors. To determine whether a similar molecule might play a role in human inflammatory diseases characterized by eosinophilia, we isolated the human eotaxin gene. We demonstrate that human eotaxin is an early response gene of cytokine-stimulated epithelial and endothelial cells, and is induced in peripheral blood eosinophils by interleukin-3. Eotaxin is directly chemotactic for eosinophils, but not mononuclear cells or neutrophils. Eotaxin messenger RNA accumulates markedly in the lesions of patients with inflammatory bowel disease (ulcerative colitis and Crohn's disease), but not in the lesions of patients with diverticulitis. These results now provide a mechanism involving eotaxin to explain the eosinophil infiltration seen in a variety of human diseases; as such, an eotaxin antagonist may be a novel therapy for certain human diseases characterized by tissue eosinophilia.	HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02129 USA; HOWARD HUGHES MED INST, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT GENET, BOSTON, MA 02115 USA; CHILDRENS HOSP, DIV IMMUNOL, BOSTON, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital			Luster, Andrew/ABE-6504-2020	Luster, Andrew/0000-0001-9679-7912	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 43351] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; BIRNSTIEL ML, 1985, CELL, V41, P349, DOI 10.1016/S0092-8674(85)80007-6; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; BUCKLEY MG, 1995, IMMUNOLOGY, V84, P410; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; COLLINS PD, 1995, J EXP MED, V182, P1169, DOI 10.1084/jem.182.4.1169; CROMWELL O, 1992, IMMUNOLOGY, V77, P330; CYBULSKY MI, 1991, AM J PATHOL, V138, P815; DUBUCQUOI S, 1995, GUT, V37, P242, DOI 10.1136/gut.37.2.242; DVORAK AM, 1980, J IMMUNOL, V125, P460; FALK W, 1980, J IMMUNOL METHODS, V33, P239, DOI 10.1016/S0022-1759(80)80014-7; FUGGLE WJ, 1984, J CLIN PATHOL, V37, P267, DOI 10.1136/jcp.37.3.267; GLEICH GJ, 1986, ADV IMMUNOL, V39, P177; GONG JH, 1995, J EXP MED, V181, P631, DOI 10.1084/jem.181.2.631; GRIFFITHSJOHNSON DA, 1993, BIOCHEM BIOPH RES CO, V197, P1167, DOI 10.1006/bbrc.1993.2599; HALLGREN R, 1989, AM J MED, V86, P56, DOI 10.1016/0002-9343(89)90230-1; HANSEL TT, 1991, J IMMUNOL METHODS, V145, P105, DOI 10.1016/0022-1759(91)90315-7; JIANG YL, 1990, J BIOL CHEM, V265, P18318; JOSE PJ, 1994, BIOCHEM BIOPH RES CO, V205, P788, DOI 10.1006/bbrc.1994.2734; JOSE PJ, 1994, J EXP MED, V179, P881, DOI 10.1084/jem.179.3.881; KITA H, 1991, J EXP MED, V174, P745, DOI 10.1084/jem.174.3.745; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; POWRIE F, 1995, IMMUNITY, V3, P171, DOI 10.1016/1074-7613(95)90086-1; ROTHENBERG ME, 1987, SCIENCE, V237, P645, DOI 10.1126/science.3110954; ROTHENBERG ME, 1988, J CLIN INVEST, V81, P1986, DOI 10.1172/JCI113547; ROTHENBERG ME, 1995, J EXP MED, V181, P1211, DOI 10.1084/jem.181.3.1211; ROTHENBERG ME, 1995, P NATL ACAD SCI USA, V92, P8960, DOI 10.1073/pnas.92.19.8960; SARIN SK, 1987, DIGEST DIS SCI, V32, P363, DOI 10.1007/BF01296289; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SPRY CJF, 1971, CELL TISSUE KINET, V4, P351, DOI 10.1111/j.1365-2184.1971.tb01545.x; TOMONAGA M, 1986, BLOOD, V67, P1433; WALSH RE, 1991, SCAND J GASTROENTERO, V26, P1217, DOI 10.3109/00365529108998617; WELLER PF, 1991, NEW ENGL J MED, V324, P1110; WILLOUGHBY CP, 1979, SCAND J GASTROENTERO, V14, P394; ZHANG YJ, 1994, J BIOL CHEM, V269, P15918	38	589	608	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	1996	2	4					449	456		10.1038/nm0496-449	http://dx.doi.org/10.1038/nm0496-449			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UD314	8597956				2022-12-25	WOS:A1996UD31400048
J	Momose, A; Takeda, T; Itai, Y; Hirano, K				Momose, A; Takeda, T; Itai, Y; Hirano, K			Phase-contrast X-ray computed tomography for observing biological soft tissues	NATURE MEDICINE			English	Article								Biological soft tissues are almost transparent to hard X rays and therefore cannot be investigated without enhancement with a contrast medium, such as iodine. On the other hand, phase-contrast X-ray imaging is sensitive to light elements(1-8). This is because the X-ray phase shift cross section is almost a thousand times larger than the X-ray absorption cross section for light elements such as hydrogen, carbon, nitrogen and oxygen(4,5). Hence, phase-contrast X-ray imaging is a promising technique for observing the structure inside biological soft tissues without the need for staining and without serious radiation exposure. We have devised a means of observing biological tissues in three dimensions using a novel X-ray computed tomography (CT) by modifying the phase-contrast technique. To generate appropriate CT input data, we used phase-mapping images obtained using an X-ray interferometer(6) and computer analysis of interference patterns(9). Now, we present a three-dimensional observation result of a nonstained sample of a cancerous rabbit liver, using a synchrotron X-ray source. Phase-contrast X-ray CT was able to clearly differentiate the cancer lesion from the normal tissue. Moreover, fine structures corresponding to cancerous degeneration and fibrous tissues were clearly depicted.	UNIV TSUKUBA, INST CLIN MED, TSUKUBA, IBARAKI 305, JAPAN; NATL LAB HIGH ENERGY PHYS, PHOTON FACTORY, TSUKUBA, IBARAKI 305, JAPAN	University of Tsukuba; High Energy Accelerator Research Organization (KEK)	Momose, A (corresponding author), HITACHI LTD, ADV RES LAB, HATOYAMA, SAITAMA 35003, JAPAN.		Momose, Atsushi/T-4873-2019	Hirano, Keiichi/0000-0001-9105-3746				ANDO M, 1972, 6TH P INT C XRAY OPT, P63; BECKER P, 1981, PHYS REV LETT, V46, P1540, DOI 10.1103/PhysRevLett.46.1540; BONSE U, 1965, APPL PHYS LETT, V7, P99, DOI 10.1063/1.1754330; BONSE U, 1965, APPL PHYS LETT, V6, P155, DOI 10.1063/1.1754212; BRUNING JH, 1974, APPL OPTICS, V13, P2693, DOI 10.1364/AO.13.002693; DESLATTES RD, 1973, PHYS REV LETT, V31, P972, DOI 10.1103/PhysRevLett.31.972; HART M, 1975, P ROY SOC LOND A MAT, V346, P1, DOI 10.1098/rspa.1975.0163; MCNULTY I, 1994, NUCL INSTRUM METH A, V347, P170, DOI 10.1016/0168-9002(94)91874-0; MOMOSE A, 1995, ACAD RADIOL, V2, P883, DOI 10.1016/S1076-6332(05)80067-4; MOMOSE A, 1995, MED PHYS, V22, P375, DOI 10.1118/1.597472; MOMOSE A, 1995, NUCL INSTRUM METH A, V352, P622, DOI 10.1016/0168-9002(95)90017-9; MOMOSE A, 1995, REV SCI INSTRUM, V66, P1434, DOI 10.1063/1.1145931; SUZUKI Y, 1989, REV SCI INSTRUM, V60, P2299, DOI 10.1063/1.1140798; TAKEDA T, 1995, ACAD RADIOL, V2, P799, DOI 10.1016/S1076-6332(05)80490-8	14	716	744	6	129	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	1996	2	4					473	475		10.1038/nm0496-473	http://dx.doi.org/10.1038/nm0496-473			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UD314	8597962				2022-12-25	WOS:A1996UD31400054
J	Longley, BJ; Tyrrell, L; Lu, SZ; Ma, YS; Langley, K; Ding, TG; Duffy, T; Jacobs, P; Tang, LH; Modlin, I				Longley, BJ; Tyrrell, L; Lu, SZ; Ma, YS; Langley, K; Ding, TG; Duffy, T; Jacobs, P; Tang, LH; Modlin, I			Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: Establishment of clonality in a human mast cell neoplasm	NATURE GENETICS			English	Letter							CONNECTIVE-TISSUE-TYPE; PROTO-ONCOGENE; GROWTH-FACTOR; HUMAN MELANOCYTES; TYROSINE KINASE; W-LOCUS; LIGAND; RECEPTOR; LEUKEMIA; INVIVO		YALE UNIV,SCH MED,DEPT HEMATOL,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,YALE SKIN DIS RES CTR,NEW HAVEN,CT 06510; AMGEN INC,THOUSAND OAKS,CA 91320; WYNBERG HOSP,CAPE TOWN,SOUTH AFRICA; VET ADM MED CTR,GASTR PATHOBIOL SURG RES GRP,W HAVEN,CT 06516	Yale University; Yale University; Amgen; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Longley, BJ (corresponding author), YALE UNIV,SCH MED,DEPT DERMATOL,NEW HAVEN,CT 06510, USA.							ANDERSON DM, 1990, CELL, V63, P235, DOI 10.1016/0092-8674(90)90304-W; BUTTERFIELD JH, 1988, LEUKEMIA RES, V12, P345, DOI 10.1016/0145-2126(88)90050-1; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; COLUMBO M, 1992, J IMMUNOL, V149, P599; FUNASAKA Y, 1992, MOL BIOL CELL, V3, P197, DOI 10.1091/mbc.3.2.197; FURITSU T, 1993, J CLIN INVEST, V92, P1736, DOI 10.1172/JCI116761; GALLI SJ, 1993, J CLIN INVEST, V91, P148, DOI 10.1172/JCI116164; GALLI SJ, 1993, NEW ENGL J MED, V328, P257; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; HALABAN R, 1993, ANN NY ACAD SCI, V680, P290, DOI 10.1111/j.1749-6632.1993.tb19691.x; HARRIST TJ, 1995, LAB INVEST, V72, pA48; LONGLEY BJ, 1993, NEW ENGL J MED, V328, P1302, DOI 10.1056/NEJM199305063281803; LONGLEY BJ, 1995, J AM ACAD DERMATOL, V32, P545; LONGLEY J, 1991, J INVEST DERMATOL, V97, P974, DOI 10.1111/1523-1747.ep12491890; LONGLEY J, 1994, ANN MED, V26, P115, DOI 10.3109/07853899409147338; METCALFE DD, 1991, J INVEST DERMATOL, V96, pS2, DOI 10.1111/1523-1747.ep12468882; NAGATA H, 1995, P NATL ACAD SCI USA, V92, P10560, DOI 10.1073/pnas.92.23.10560; QIU F, 1988, EMBO J, V7, P1003, DOI 10.1002/j.1460-2075.1988.tb02907.x; SPERR WR, 1993, INT ARCH ALLERGY IMM, V102, P170, DOI 10.1159/000236568; TAKAGI M, 1992, J IMMUNOL, V148, P3446; TRAVIS WD, 1988, MEDICINE, V67, P345, DOI 10.1097/00005792-198811000-00001; TRAVIS WD, 1986, MAYO CLIN PROC, V61, P957, DOI 10.1016/S0025-6196(12)62636-6; TSAI M, 1995, AM J PATHOL, V146, P335; TSAI M, 1991, J EXP MED, V174, P125, DOI 10.1084/jem.174.1.125; TYRRELL L, 1995, AM J DERMATOPATH, V17, P476, DOI 10.1097/00000372-199510000-00008; YARDEN Y, 1987, EMBO J, V6, P3341, DOI 10.1002/j.1460-2075.1987.tb02655.x	26	512	562	1	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1996	12	3					312	314		10.1038/ng0396-312	http://dx.doi.org/10.1038/ng0396-312			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TY183	8589724				2022-12-25	WOS:A1996TY18300022
J	Shiels, A; Bassnett, S				Shiels, A; Bassnett, S			Mutations in the founder of the MIP gene family underlie cataract development in the mouse	NATURE GENETICS			English	Letter							MAJOR INTRINSIC PROTEIN; FIBER CELL-MEMBRANES; EYE-LENS; CRYSTALLIN GENE; INSITU HYBRIDIZATION; HEREDITARY CATARACTS; CONGENITAL CATARACT; CHANNEL PROTEINS; BETA-CRYSTALLIN; SEQUENCE		UNIFORMED SERV UNIV HLTH SCI, DEPT ANAT & CELL BIOL, BETHESDA, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	Shiels, A (corresponding author), UCL, DEPT MOLEC GENET, INST OPHTHALMOL, 11-43 BATH ST, LONDON EC1V 9EL, ENGLAND.			Bassnett, Steven/0000-0002-8337-2760	NATIONAL EYE INSTITUTE [R01EY009179, R01EY009852] Funding Source: NIH RePORTER; NEI NIH HHS [EY09179, EY09852] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BASSNETT S, 1995, INVEST OPHTH VIS SCI, V36, P1793; BRAKENHOFF RH, 1994, HUM MOL GENET, V3, P279, DOI 10.1093/hmg/3.2.279; BREEN M, 1994, HUM MOL GENET, V3, P621, DOI 10.1093/hmg/3.4.621; CARTIER M, 1992, NAT GENET, V2, P42, DOI 10.1038/ng0992-42; CHAMBERS C, 1991, J BIOL CHEM, V266, P6742; CHRISPEELS MJ, 1994, TRENDS BIOCHEM SCI, V19, P421, DOI 10.1016/0968-0004(94)90091-4; FRASER FC, 1962, GENET RES, V3, P383, DOI 10.1017/S0016672300003220; GRIFFIN CS, 1992, CYTOGENET CELL GENET, V59, P300, DOI 10.1159/000133274; GRIFFIN CS, 1992, CYTOGENET CELL GENET, V61, P8, DOI 10.1159/000133360; KAGHAD M, 1985, EMBO J, V4, P2911, DOI 10.1002/j.1460-2075.1985.tb04022.x; KENT NA, 1990, NUCLEIC ACIDS RES, V18, P4256, DOI 10.1093/nar/18.14.4256; KUSHMERICK C, 1995, EXP EYE RES, V61, P351, DOI 10.1016/S0014-4835(05)80129-0; LYON MF, 1981, GENET RES, V38, P337, DOI 10.1017/S0016672300020668; MICHEA LF, 1995, EXP EYE RES, V61, P293, DOI 10.1016/S0014-4835(05)80124-1; MUGGLETONHARRIS AL, 1987, EXP EYE RES, V44, P805, DOI 10.1016/S0014-4835(87)80043-X; MUGGLETONHARRIS AL, 1987, GENET RES, V49, P235, DOI 10.1017/S0016672300027129; MUGGLETONHARRIS AL, 1987, DEVELOPMENT, V99, P473; MULDERS SM, 1995, J BIOL CHEM, V270, P9010, DOI 10.1074/jbc.270.15.9010; PISANO MM, 1991, GENOMICS, V11, P981; PRESTON GM, 1994, SCIENCE, V265, P1585, DOI 10.1126/science.7521540; RAO Y, 1990, NATURE, V345, P163, DOI 10.1038/345163a0; REIZER J, 1993, CRIT REV BIOCHEM MOL, V28, P235, DOI 10.3109/10409239309086796; RODRIGUEZ IR, 1992, BIOCHIM BIOPHYS ACTA, V1180, P44, DOI 10.1016/0925-4439(92)90025-I; SAITO F, 1995, CYTOGENET CELL GENET, V68, P45, DOI 10.1159/000133885; SHIELS A, 1991, BIOCHIM BIOPHYS ACTA, V1097, P318, DOI 10.1016/0925-4439(91)90087-P; SHIELS A, 1991, BIOCHIM BIOPHYS ACTA, V1097, P81, DOI 10.1016/0925-4439(91)90028-8; SHIELS A, 1993, CURR EYE RES, V12, P913, DOI 10.3109/02713689309020398; VANLIEBURG AF, 1994, AM J HUM GENET, V55, P648; VAUX D, 1990, NATURE, V345, P495, DOI 10.1038/345495a0; YANCEY SB, 1988, J CELL BIOL, V106, P705, DOI 10.1083/jcb.106.3.705; ZAMPIGHI GA, 1992, INT REV CYTOL, V136, P185, DOI 10.1016/S0074-7696(08)62053-7	31	215	221	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1996	12	2					212	215		10.1038/ng0296-212	http://dx.doi.org/10.1038/ng0296-212			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TU079	8563764				2022-12-25	WOS:A1996TU07900026
J	Craig, JE; Rochette, J; Fisher, CA; Weatherall, DJ; Marc, S; Lathrop, GM; Demenais, F; Thein, SL				Craig, JE; Rochette, J; Fisher, CA; Weatherall, DJ; Marc, S; Lathrop, GM; Demenais, F; Thein, SL			Dissecting the loci controlling fetal haemoglobin production on chromosomes 11p and 6q by the regressive approach	NATURE GENETICS			English	Article							BETA-GLOBIN GENE; HEREDITARY PERSISTENCE; HEMOGLOBIN EXPRESSION; NORMAL INDIVIDUALS; F-CELLS; CLUSTER; LINKAGE; ADULTS; MODELS; ASSOCIATION	The changes in the type of haemoglobin (Hb) produced during embryonic, fetal and adult life, have served as a paradigm for understanding the developmental regulation of human genes. A genetically determined persistence of fetal Hb synthesis has an ameliorating effect on beta thalassaemia and sickle cell anaemia, globally the commonest single gene disorders. The search for the putative gene(s) controlling the level of fetal Hb production has been extremely difficult because this trait may be influenced by several factors. We have studied a large kindred with hereditary persistence of fetal haemoglobin (HPFH). Using a genetic mapping strategy and statistical methods that account simultaneously for the effects of several genetic factors, we have demonstrated that in addition to the two factors (beta thalassaemia and Xmn I-(G) gamma site) on chromosome 11p, there is a third major genetic determinant for fetal Hb production localized on chromosome 6q.	JOHN RADCLIFFE HOSP, INST MOLEC MED, MRC, MOLEC HAEMATOL UNIT, OXFORD OX3 9DU, ENGLAND; GENETHON, F-91000 EVRY, FRANCE; WELLCOME TRUST CTR HUMAN GENET, OXFORD, ENGLAND; HOP ST LOUIS, INSERM, U358, F-75010 PARIS, FRANCE	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite			Demenais, Florence/G-3298-2013	Demenais, Florence/0000-0001-8361-0936; Craig, Jamie/0000-0001-9955-9696	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BONNEY GE, 1988, AM J HUM GENET, V43, P29; BONNEY GE, 1984, AM J MED GENET, V18, P731, DOI 10.1002/ajmg.1320180420; CAPPELLINI MD, 1981, BRIT J HAEMATOL, V48, P561, DOI 10.1111/j.1365-2141.1981.tb02753.x; CHANG YC, 1995, BLOOD, V85, P1111, DOI 10.1182/blood.V85.4.1111.bloodjournal8541111; COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3; CROSSLEY M, 1993, CURR OPIN GENET DEV, V3, P232, DOI 10.1016/0959-437X(93)90028-N; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DEMENAIS F, 1994, GENET EPIDEMIOL, V11, P291; DEMENAIS FM, 1990, GENET EPIDEMIOL, V7, P319, DOI 10.1002/gepi.1370070503; DESIMONE J, 1981, BRIT J HAEMATOL, V49, P175, DOI 10.1111/j.1365-2141.1981.tb07213.x; DOVER GJ, 1992, BLOOD, V80, P816; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; GIAMPAOLO A, 1984, HUM GENET, V66, P151, DOI 10.1007/BF00286590; GIANNI AM, 1983, EMBO J, V2, P921, DOI 10.1002/j.1460-2075.1983.tb01522.x; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; GILMAN JG, 1985, BLOOD, V66, P783; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; GROSVELD F, 1993, BAILLIERE CLIN HAEM, V6, P31, DOI 10.1016/S0950-3536(05)80065-4; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; HIGGS DR, 1993, BAILLIERE CLIN HAEM, V6, P117, DOI 10.1016/S0950-3536(05)80068-X; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; MARTINEZ G, 1989, HUM GENET, V82, P335, DOI 10.1007/BF00273993; MARTINEZ M, IN PRESS GENET EPIDE; MELONI R, 1993, NUCLEIC ACIDS RES, V20, P1166; MIYOSHI K, 1988, BLOOD, V72, P1854; MORTON NE, 1956, AM J HUM GENET, V8, P80; Ott J., 1991, ANAL HUMAN GENETIC L; PERRINE RP, 1972, LANCET, V2, P1163; ROCHETTE J, 1990, AM J HEMATOL, V34, P223, DOI 10.1002/ajh.2830340313; RUTLAND PC, 1983, BRIT J HAEMATOL, V53, P673, DOI 10.1111/j.1365-2141.1983.tb07319.x; SAMPIETRO M, 1992, BLOOD, V79, P832; SPARKES RS, 1986, AM J HUM GENET, V39, P186; Stamatoyannopolous G., 1994, MOL BASIS BLOOD DIS, P107; STAMATOYANNOPOULOS G, 1975, BLOOD, V46, P683; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; THEIN SL, 1993, BLOOD, V82, P961; THEIN SL, 1994, AM J HUM GENET, V54, P214; Thein SL, 1989, HEMOGLOBIN SWITCHI B, P97; VOLZ A, 1994, GENOMICS, V21, P464, DOI 10.1006/geno.1994.1302; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; ZAGO MA, 1979, BLOOD, V53, P977	44	139	141	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	1996	12	1					58	64		10.1038/ng0196-58	http://dx.doi.org/10.1038/ng0196-58			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TM555	8528252				2022-12-25	WOS:A1996TM55500015
J	POLYMEROPOULOS, MH; SWIFT, RG; SWIFT, M				POLYMEROPOULOS, MH; SWIFT, RG; SWIFT, M			LINKAGE OF THE GENE FOR WOLFRAM-SYNDROME TO MARKERS ON THE SHORT ARM OF CHROMOSOME-4	NATURE GENETICS			English	Article								Wolfram syndrome is an autosomal recessive disorder defined by the occurrence of diabetes mellitus and progressive bilateral optic atrophy. Wolfram syndrome homozygotes develop widespread nervous system abnormalities; in particular, they exhibit severe behavioural difficulties that often lead to suicide attempts or psychiatric hospitalizations. The Wolfram syndrome gene also predisposes heterozygous carriers to psychiatric disorders, and may contribute significantly to the overall burden of psychiatric illness. Based on a linkage analysis of 11 families segregating for this syndrome using microsatellite repeat polymorphisms throughout the human genome, we found the Wolfram syndrome gene to be linked to markers on the short arm of human chromosome 4, with Z(max) = 6.46 at theta = 0.02 for marker D4S431.	NEW YORK MED COLL, INST GENET ANAL COMMON DIS, DEPT PEDIAT, DIV PSYCHIAT GENET, HAWTHORNE, NY 10532 USA; NEW YORK MED COLL, INST GENET ANAL COMMON DIS, DEPT PEDIAT, DIV HUMAN MOLEC GENET, HAWTHORNE, NY 10532 USA	New York Medical College; New York Medical College	POLYMEROPOULOS, MH (corresponding author), NIH, NATL CTR HUMAN GENOME RES, GENET DIS RES LAB, BETHESDA, MD 20892 USA.							BORGNAPIGNATTI C, 1989, J PEDIATR-US, V114, P405, DOI 10.1016/S0022-3476(89)80558-X; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; IKKOS DG, 1970, ACTA ENDOCRINOL-COP, V65, P95, DOI 10.1530/acta.0.0650095; PAGE MM, 1976, Q J MED, V45, P505; POLYMEROPOULOS MH, 1993, PSYCHIAT RES, V48, P27, DOI 10.1016/0165-1781(93)90110-3; RORSMAN G, 1967, ACTA MED SCAND, V182, P419; ROSE FC, 1966, Q J MED, V35, P385; ROTIG A, 1993, J CLIN INVEST, V91, P1095, DOI 10.1172/JCI116267; SHAW DA, 1958, J NEUROL NEUROSUR PS, V21, P47, DOI 10.1136/jnnp.21.1.47; SWIFT M, 1990, AM J HUM GENET, V47, P266; SWIFT RG, 1990, LANCET, V336, P667, DOI 10.1016/0140-6736(90)92157-D; SWIFT RG, 1991, AM J PSYCHIAT, V148, P775; TAGLE DA, 1992, HUM MOL GENET, V1, P215, DOI 10.1093/hmg/1.3.215; WOLFRAM DJ, 1986, MAYO CLIN P, V13, P715	14	115	120	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1994	8	1					95	97		10.1038/ng0994-95	http://dx.doi.org/10.1038/ng0994-95			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PE157	7987399				2022-12-25	WOS:A1994PE15700022
J	BULL, PC; THOMAS, GR; ROMMENS, JM; FORBES, JR; COX, DW				BULL, PC; THOMAS, GR; ROMMENS, JM; FORBES, JR; COX, DW			THE WILSON DISEASE GENE IS A PUTATIVE COPPER TRANSPORTING P-TYPE ATPASE SIMILAR TO THE MENKES GENE	NATURE GENETICS			English	Article							HUMAN CERULOPLASMIN; LOCUS; CHROMOSOME-13; POLYMORPHISMS; BIOSYNTHESIS; RESISTANCE; MECHANISMS; SEQUENCE; MARKERS	Wilson disease (WD) is an autosomal recessive disorder of copper transport, resulting in copper accumulation and toxicity to the liver and brain. The gene (WD) has been mapped to chromosome 13 q14.3. On yeast artificial chromosomes from this region we have identified a sequence, similar to that coding for the proposed copper binding regions of the putative ATPase gene (MNK) defective in Menkes disease. We show that this sequence forms part of aP-type ATPase gene (referred to here as Wc1) that is very similar to MNK, with six putative metal binding regions similar to those found in prokaryotic heavy metal transporters. The gene, expressed in liver and kidney, lies within a 300 kb region likely to include the WD locus. Two WD patients were found to be homozygous for a seven base deletion within the. coding region of Wc1. Wc1 is proposed as the gene for WD.	HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ON,CANADA; UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO,ON,CANADA; UNIV TORONTO,DEPT PAEDIAT,TORONTO,ON,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto			Rommens, Johanna/AAT-7465-2021	Bull, Peter/0000-0002-7674-6752				BOWCOCK AM, 1987, AM J HUM GENET, V41, P27; BOWCOCK AM, 1988, AM J HUM GENET, V43, P664; BREWER GJ, 1992, MEDICINE, V71, P139, DOI 10.1097/00005792-199205000-00004; BULL PC, 1993, CYTOGENET CELL GENET, V64, P12, DOI 10.1159/000133550; BULL PC, 1993, GENOMICS, V16, P593, DOI 10.1006/geno.1993.1235; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; Danks DM, 1989, METABOLIC BASIS INHE, P1411; DARWISH HM, 1983, J BIOL CHEM, V258, P3621; FARRER LA, 1991, NEUROLOGY, V41, P992, DOI 10.1212/WNL.41.7.992; FRYDMAN M, 1985, P NATL ACAD SCI USA, V82, P1819, DOI 10.1073/pnas.82.6.1819; GITLIN JD, 1992, BIOCHEM J, V282, P835, DOI 10.1042/bj2820835; Goldberg Y. P., 1992, Human Molecular Genetics, V1, P669, DOI 10.1093/hmg/1.9.669; GREEN NM, 1992, ACTA PHYSIOL SCAND, V146, P59; GRIFFIN HG, 1987, P NATL ACAD SCI USA, V84, P3112, DOI 10.1073/pnas.84.10.3112; HOUWEN R H J, 1992, Journal of Hepatology, V16, pS15; KAGL JHR, 1988, BIOCHEMISTRY-US, V27, P8509; KAHN D, 1989, J BACTERIOL, V171, P929, DOI 10.1128/jb.171.2.929-939.1989; MACLENNAN DH, 1992, ACTA PHYSIOL SCAND, V146, P141; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; NUCIFORA G, 1989, P NATL ACAD SCI USA, V86, P3544, DOI 10.1073/pnas.86.10.3544; ODERMATT A, 1993, J BIOL CHEM, V268, P12775; OHALLORAN TV, 1993, SCIENCE, V261, P715, DOI 10.1126/science.8342038; ORENA SJ, 1986, BIOCHEM BIOPH RES CO, V139, P822, DOI 10.1016/S0006-291X(86)80064-X; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; OWEN CA, 1965, AM J PHYSIOL, V209, P900, DOI 10.1152/ajplegacy.1965.209.5.900; ROMMENS JM, 1993, HUM MOL GENET, V2, P901, DOI 10.1093/hmg/2.7.901; Sambrook J, 1989, MOL CLONING LABORATO; SARKAR B, 1981, MET IONS BIOL SYST, P233; Sass-Kortsak A, 1965, Adv Clin Chem, V8, P1; SATO M, 1991, J BIOL CHEM, V266, P5128; SCHERER S, 1991, P33; SILVER S, 1993, MOL MICROBIOL, V10, P7, DOI 10.1111/j.1365-2958.1993.tb00898.x; STERNLIEB I, 1990, HEPATOLOGY, V12, P1234, DOI 10.1002/hep.1840120526; STEWART EA, 1993, AM J HUM GENET, V53, P864; THOMAS GR, IN PRESS AM J HUM GE; THOMAS GR, 1993, HUM MOLEC GENET, V2, P1404; TRIGLIA T, 1988, NUCLEIC ACIDS RES, V16, P8186, DOI 10.1093/nar/16.16.8186; VULPE C, 1993, NAT GENET, V3, P273, DOI 10.1038/ng0393-273a; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; WHITE MB, 1992, GENOMICS, V12, P301, DOI 10.1016/0888-7543(92)90377-5; YANG F, 1986, P NATL ACAD SCI USA, V83, P3257, DOI 10.1073/pnas.83.10.3257; YARZE JC, 1992, AM J MED, V92, P643, DOI 10.1016/0002-9343(92)90783-8; YUZBASIYANGURKAN V, 1988, AM J HUM GENET, V42, P825	43	1594	1656	3	92	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1993	5	4					327	337		10.1038/ng1293-327	http://dx.doi.org/10.1038/ng1293-327			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ML145	8298639				2022-12-25	WOS:A1993ML14500007
J	CHUNG, MY; RANUM, LPW; DUVICK, LA; SERVADIO, A; ZOGHBI, HY; ORR, HT				CHUNG, MY; RANUM, LPW; DUVICK, LA; SERVADIO, A; ZOGHBI, HY; ORR, HT			EVIDENCE FOR A MECHANISM PREDISPOSING TO INTERGENERATIONAL CAG REPEAT INSTABILITY IN SPINOCEREBELLAR ATAXIA TYPE-I	NATURE GENETICS			English	Article							BULBAR MUSCULAR-ATROPHY; TRINUCLEOTIDE REPEAT; FRAGILE-X; HEREDITARY ATAXIA; LINKAGE; HLA; GENE; MUTATIONS; KINDREDS; FAMILY	Spinocerebellar ataxia type I (SCAI) is an autosomal dominant neurodegenerative disease caused by the expansion of a CAG trinucleotide repeat on chromosome 6p. Normal alleles range from 19-36 repeats while SCA1 alleles contain 43-81 repeats. We now show that in 63% of paternal transmissions, an increase in repeat number is observed, whereas 69% of maternal transmissions showed no change or a decrease in repeat number. Sequence analysis of the repeat from 126 chromosomes reveals an interrupted repeat configuration in 98% of the unexpanded alleles but a contiguous repeat (CAG)n configuration in 30 expanded alleles from seven SCA1 families. This indicates that the repeat instability in SCA1 is more complex than a simple variation in repeat number and that the loss of an interruption predisposes the SCA1 (CAG)n to expansion.	UNIV MINNESOTA, DEPT LAB MED & PATHOL, MINNEAPOLIS, MN 55455 USA; BAYLOR COLL MED, DEPT PEDIAT, HOUSTON, TX 77030 USA; BAYLOR COLL MED, INST MOLEC GENET, HOUSTON, TX 77030 USA; UNIV MINNESOTA, INST HUMAN GENET, MINNEAPOLIS, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; Baylor College of Medicine; Baylor College of Medicine; University of Minnesota System; University of Minnesota Twin Cities				Orr, Harry/0000-0001-6118-741X; Chung, Ming-yi/0000-0003-2198-6860; Zoghbi, Huda/0000-0002-0700-3349	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027699, R37NS022920, R01NS022920] Funding Source: NIH RePORTER; NINDS NIH HHS [NS27699, NS22920] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANFI S, IN PRESS MAPPING CLO; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; CURRIER RD, 1972, NEUROLOGY, V22, P1040, DOI 10.1212/WNL.22.9.1040; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GOSTOUT B, 1993, AM J HUM GENET, V52, P1182; HAINES JL, 1984, NEUROLOGY, V34, P1542, DOI 10.1212/WNL.34.12.1542; KONIGSMARK BW, 1970, MEDICINE, V49, P227, DOI 10.1097/00005792-197005000-00003; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; KWIATKOWSKI TJ, 1993, AM J HUM GENET, V53, P391; LASPADA AR, 1992, NAT GENET, V2, P301, DOI 10.1038/ng1292-301; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MORTON NE, 1980, AM J MED GENET, V6, P251, DOI 10.1002/ajmg.1320060309; NINO HE, 1980, NEUROLOGY, V30, P12, DOI 10.1212/WNL.30.1.12; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PEDERSEN L, 1980, HUM GENET, V54, P371, DOI 10.1007/BF00291585; RANUM LPW, 1991, AM J HUM GENET, V49, P31; RICHARDS RI, 1992, CELL, V70, P709, DOI 10.1016/0092-8674(92)90302-S; SCHUT JW, 1950, ARCH NEURO PSYCHIATR, V63, P535, DOI 10.1001/archneurpsyc.1950.02310220002001; SLEDDENS HFBM, 1992, NUCLEIC ACIDS RES, V20, P1427; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WHITTINGTON JE, 1980, CYTOGENET CELL GENET, V28, P145, DOI 10.1159/000131524; YAKURA H, 1974, NEW ENGL J MED, V291, P154; ZOGHBI HY, 1988, ANN NEUROL, V23, P580, DOI 10.1002/ana.410230609; ZOGHBI HY, 1991, AM J HUM GENET, V49, P23	26	442	455	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1993	5	3					254	258		10.1038/ng1193-254	http://dx.doi.org/10.1038/ng1193-254			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MF122	8275090				2022-12-25	WOS:A1993MF12200015
J	WEKSBERG, R; SHEN, DR; FEI, YL; SONG, QL; SQUIRE, J				WEKSBERG, R; SHEN, DR; FEI, YL; SONG, QL; SQUIRE, J			DISRUPTION OF INSULIN-LIKE GROWTH FACTOR-II IMPRINTING IN BECKWITH-WIEDEMANN SYNDROME	NATURE GENETICS			English	Article							FACTOR-II GENE; AUTOSOMAL-DOMINANT INHERITANCE; WILMS-TUMOR; MATERNAL ALLELE; CHROMOSOME-11; HETEROZYGOSITY; EXPRESSION; REGION; POLYMORPHISM; DUPLICATION	To study insulin-like growth factor 2 (IGF2) imprinting in BWS (Beckwith-Wiedemann syndrome, an overgrowth syndrome associated with Wilms and other embryonal tumours), we examined allele-specific expression using an ApaI polymorphism in the 3' untranslated region of IGF2. Four of six BWS fibroblast strains demonstrated biallelic expression, as did the tongue tissue from one of these patients. Paternal heterodisomy was excluded for all BWS patients with biallelic expression, suggesting strongly that the BWS phenotype in some patients involves disruption of IGF2 imprinting. Constitutional loss of IGF2 imprinting in a subgroup of our BWS patients, and recent reports of loss of imprinting in sporadic Wilms tumour, further strengthens the view that IGF2 overexpression plays an important role in somatic overgrowth and the development of embryonal tumours.	HOSP SICK CHILDREN,DEPT PATHOL,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,TORONTO M5S 1A1,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	WEKSBERG, R (corresponding author), HOSP SICK CHILDREN,DEPT GENET,TORONTO M5G 1X8,ONTARIO,CANADA.		Squire, Jeremy A/A-9352-2012	Squire, Jeremy A/0000-0002-9863-468X				BELL GI, 1985, P NATL ACAD SCI USA, V82, P6450, DOI 10.1073/pnas.82.19.6450; BEST LG, 1981, AM J MED GENET, V9, P291, DOI 10.1002/ajmg.1320090405; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COPPES MJ, 1992, GENE CHROMOSOME CANC, V5, P326, DOI 10.1002/gcc.2870050408; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; EDWARDS A, 1991, AM J HUM GENET, V49, P746; FERGUSONSMITH AC, 1991, NATURE, V351, P667, DOI 10.1038/351667a0; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GLANNOUKAKIS N, 1993, NAT GENET, V4, P96; GRAY A, 1987, DNA-J MOLEC CELL BIO, V6, P283, DOI 10.1089/dna.1987.6.283; HENRY I, 1989, HUM GENET, V81, P273, DOI 10.1007/BF00279003; HENRY I, 1991, NATURE, V351, P665, DOI 10.1038/351665a0; HENRY I, 1993, NATURE, V1, P19; HOBAN PR, 1991, NUCLEIC ACIDS RES, V19, P4576, DOI 10.1093/nar/19.16.4576-a; HUMBEL RE, 1990, EUR J BIOCHEM, V190, P445, DOI 10.1111/j.1432-1033.1990.tb15595.x; Junien C, 1992, CURR OPIN GENET DEV, V2, P431, DOI 10.1016/S0959-437X(05)80154-6; KOUFOS A, 1989, AM J HUM GENET, V44, P711; LITTLE M, 1991, NATURE, V351, P609, DOI 10.1038/351609a0; MANNENS M, 1988, HUM GENET, V81, P41, DOI 10.1007/BF00283727; MANNENS M, IN PRESS EUR J HUM G; MOUTOU C, 1992, J MED GENET, V29, P217, DOI 10.1136/jmg.29.4.217; NIIKAWA N, 1986, AM J MED GENET, V24, P41, DOI 10.1002/ajmg.1320240107; NORMAN AM, 1992, AM J MED GENET, V42, P638, DOI 10.1002/ajmg.1320420441; NYSTROM A, 1992, EUR J PEDIATR, V151, P511, DOI 10.1007/BF01957756; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; OHLSSON R, 1993, NAT GENET, V4, P94, DOI 10.1038/ng0593-94; OKANO Y, 1986, JPN J HUM GENET, V31, P365, DOI 10.1007/BF01907937; PETTENATI MJ, 1986, HUM GENET, V124, P140; PING AJ, 1989, AM J HUM GENET, V44, P720; PUESCHEL SM, 1984, J PEDIATR-US, V104, P484, DOI 10.1016/S0022-3476(84)81127-0; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; REEVE AE, 1985, NATURE, V317, P258, DOI 10.1038/317258a0; SASAKI H, 1992, GENE DEV, V6, P1843, DOI 10.1101/gad.6.10.1843; SCHNEID H, 1991, GROWTH REGULAT, V1, P168; SCOTT J, 1985, NATURE, V317, P260, DOI 10.1038/317260a0; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; TADOKORO K, 1991, NUCLEIC ACIDS RES, V19, P6967, DOI 10.1093/nar/19.24.6967; TURLEAU C, 1984, HUM GENET, V67, P219, DOI 10.1007/BF00273006; WAZIRI M, 1983, J PEDIATR-US, V102, P873, DOI 10.1016/S0022-3476(83)80014-6; WEKSBERG R, 1990, GENOMICS, V8, P693, DOI 10.1016/0888-7543(90)90256-T; WEKSBERG R, 1993, HUM MOL GENET, V2, P549, DOI 10.1093/hmg/2.5.549; WIEDEMANN HR, 1983, EUR J PEDIATR, V141, P129, DOI 10.1007/BF00496807; WILLIAMS JC, 1989, LANCET, V1, P283; ZEMEL S, 1992, NAT GENET, V2, P61, DOI 10.1038/ng0992-61; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	46	359	365	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1993	5	2					143	150		10.1038/ng1093-143	http://dx.doi.org/10.1038/ng1093-143			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MA056	8252039				2022-12-25	WOS:A1993MA05600011
J	PARRA, I; WINDLE, B				PARRA, I; WINDLE, B			HIGH-RESOLUTION VISUAL MAPPING OF STRETCHED DNA BY FLUORESCENT HYBRIDIZATION	NATURE GENETICS			English	Article							INTERPHASE CELL-NUCLEI; INSITU HYBRIDIZATION; GENOMIC DISTANCE; GENE; CHROMOSOMES; SEQUENCES; CHROMATIN; MODEL	We describe a method for stretching DNA, which, when combined with fluorescent hybridization procedures, forms a new mapping technology that produces a high resolution, vivid, multi-colour image and map. Restriction fragments and cosmid probes were successfully mapped by this procedure with validation by standard restriction mapping. A long range map of a >200 kilobase region containing five copies of the amplified dihydrofolate reductase gene was easily generated within two days. This DNA mapping procedure offers a significant and rapid alternative to a variety of standard mapping procedures.	CANC THERAPY & RES CTR S TEXAS,8122 DATAPOINT DR,SAN ANTONIO,TX 78229	Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio								AMLER LC, 1989, MOL CELL BIOL, V9, P4903, DOI 10.1128/MCB.9.11.4903; BALLANNECHANTEL.B, 1992, CELL, V70, P1059; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; EVANS GA, 1987, METHOD ENZYMOL, V152, P604; GREEN ED, 1990, SCIENCE, V250, P94, DOI 10.1126/science.2218515; HENG HHQ, 1992, P NATL ACAD SCI USA, V89, P9509, DOI 10.1073/pnas.89.20.9509; LAWRENCE JB, 1992, NAT GENET, V2, P171, DOI 10.1038/ng1192-171; LAWRENCE JB, 1990, SCIENCE, V249, P928, DOI 10.1126/science.2203143; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; MA C, 1988, MOL CELL BIOL, V8, P2316, DOI 10.1128/MCB.8.6.2316; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; TRASK B, 1989, GENOMICS, V5, P710, DOI 10.1016/0888-7543(89)90112-2; TRASK BJ, 1991, AM J HUM GENET, V48, P1; URLAUB G, 1986, SOMAT CELL MOLEC GEN, V12, P555, DOI 10.1007/BF01671941; VANDENENGH G, 1992, SCIENCE, V257, P1410, DOI 10.1126/science.1388286; WIEGANT J, 1992, HUM MOL GENET, V1, P587, DOI 10.1093/hmg/1.8.587; WINDLE B, 1991, GENE DEV, V5, P160, DOI 10.1101/gad.5.2.160	17	242	266	0	19	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1993	5	1					17	21		10.1038/ng0993-17	http://dx.doi.org/10.1038/ng0993-17			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LV565	8106079				2022-12-25	WOS:A1993LV56500009
J	TARONI, F; VERDERIO, E; DWORZAK, F; WILLEMS, PJ; CAVADINI, P; DIDONATO, S				TARONI, F; VERDERIO, E; DWORZAK, F; WILLEMS, PJ; CAVADINI, P; DIDONATO, S			IDENTIFICATION OF A COMMON MUTATION IN THE CARNITINE PALMITOYLTRANSFERASE II GENE IN FAMILIAL RECURRENT MYOGLOBINURIA PATIENTS	NATURE GENETICS			English	Article								Carnitine palmitoyltransferase (CPT) II deficiency is the most common inherited disorder of lipid metabolism affecting skeletal muscle. We have identified a missense mutation (Ser113Leu) in one patient with the classical muscular symptomatology. Transfection experiments in COS cells demonstrate that the mutation drastically depresses the catalytic activity of CPT II. The mutation results in normal synthesis but a markedly reduced steady-state level of the protein, indicating decreased stability of mutant CPT II. The Ser113Leu mutation is the most frequent cause of CPT II deficiency. The mutation can be detected easily by restriction analysis enabling molecular diagnosis of most patients and identification of heterozygous carriers.	IST NAZL NEUROL CARLO BESTA,DIV STUDIO MALATTIE NEUROMUSCOLARI,I-20133 MILAN,ITALY; UNIV INSTELLING ANTWERP,DEPT MED GENET,B-2610 WILRIJK,BELGIUM	IRCCS Istituto Neurologico Besta; University of Antwerp	TARONI, F (corresponding author), IST NAZL NEUROL CARLO BESTA,DIV BIOCHIM & GENET,VIA CELORIA 11,I-20133 MILAN,ITALY.		Verderio, Elisabetta/H-2789-2016; Di Donato, Stefano/B-9717-2012; Taroni, Franco/N-3879-2013	Verderio, Elisabetta/0000-0001-9153-8997; Taroni, Franco/0000-0002-2420-5233; cavadini, patrizia/0000-0002-1774-5290	Telethon [149] Funding Source: Medline	Telethon(Fondazione Telethon)			0	169	171	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1993	4	3					314	319		10.1038/ng0793-314	http://dx.doi.org/10.1038/ng0793-314			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ842	8358442				2022-12-25	WOS:A1993LJ84200023
J	PILLERS, DAM; BULMAN, DE; WELEBER, RG; SIGESMUND, DA; MUSARELLA, MA; POWELL, BR; MURPHEY, WH; WESTALL, C; PANTON, C; BECKER, LE; WORTON, RG; RAY, PN				PILLERS, DAM; BULMAN, DE; WELEBER, RG; SIGESMUND, DA; MUSARELLA, MA; POWELL, BR; MURPHEY, WH; WESTALL, C; PANTON, C; BECKER, LE; WORTON, RG; RAY, PN			DYSTROPHIN EXPRESSION IN THE HUMAN RETINA IS REQUIRED FOR NORMAL FUNCTION AS DEFINED BY ELECTRORETINOGRAPHY	NATURE GENETICS			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; STATIONARY NIGHT BLINDNESS; ISLAND EYE DISEASE; B-WAVE; MUDPUPPY RETINA; MESSENGER-RNA; X-CHROMOSOME; GLIAL-CELLS; MUSCLE; GENE	We have studied retinal function by electroretinography in five Becker and six Duchenne muscular dystrophy patients. All had abnormal electroretinograms with a markedly reduced amplitude for the b-wave in the dark-adapted state. Using three antisera raised to different domains of dystrophin, we identified dystrophin in the outer plexiform layer of human retina. The retinal dystrophin is present in multiple isoforms as the result of alternative splicing. The localization of dystrophin to the outer plexiform layer coincident with the abnormal b-wave suggests that dystrophin is required for normal retinal electrophysiology.	UNIV TORONTO, HOSP SICK CHILDREN, DEPT GENET, TORONTO M5G 1X8, ONTARIO, CANADA; OREGON HLTH SCI UNIV, DEPT PEDIAT, PORTLAND, OR 97201 USA; OREGON HLTH SCI UNIV, DEPT MOLEC & MED GENET, PORTLAND, OR 97201 USA; UNIV TORONTO, HOSP SICK CHILDREN, RES INST, TORONTO M5G 1X8, ONTARIO, CANADA; UNIV TORONTO, DEPT MED & MOLEC GENET, TORONTO M5G 1X8, ON, CANADA; OREGON HLTH SCI UNIV, DEPT OPHTHALMOL, PORTLAND, OR 97201 USA; HOSP SICK CHILDREN, DEPT OPHTHALMOL, TORONTO M5G 1X8, ONTARIO, CANADA; HOSP SICK CHILDREN, DEPT NEUROPATHOL, TORONTO M5G 1X8, ONTARIO, CANADA; HOSP SICK CHILDREN, RES INST, TORONTO M5G 1X8, ONTARIO, CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Oregon Health & Science University; Oregon Health & Science University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Oregon Health & Science University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)			Westall, Carol A/M-9646-2013					ALITALO T, 1991, AM J HUM GENET, V48, P31; BECHHANSEN NT, 1990, HUM GENET, V84, P406; BIES RD, 1992, NUCLEIC ACIDS RES, V20, P1725, DOI 10.1093/nar/20.7.1725; BOYCE FM, 1991, P NATL ACAD SCI USA, V88, P1276, DOI 10.1073/pnas.88.4.1276; BULMAN DE, 1991, AM J HUM GENET, V48, P295; BURROW KL, 1991, NEUROLOGY, V41, P661, DOI 10.1212/WNL.41.5.661; CARPENTER S, 1979, BRAIN, V102, P147, DOI 10.1093/brain/102.1.147; CHAMBERLAIN JS, 1988, SCIENCE, V239, P1416, DOI 10.1126/science.3347839; CHELLY J, 1990, EUR J BIOCHEM, V187, P691, DOI 10.1111/j.1432-1033.1990.tb15355.x; CHELLY J, 1990, NATURE, V344, P64, DOI 10.1038/344064a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DAVIES KE, 1991, CYTOGENET CELL GENET, V58, P853, DOI 10.1159/000133183; DICK E, 1978, BRAIN RES, V154, P388; EMORY AEH, 1988, DUCHENNE MUSCULAR DY; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; FABER DS, 1969, THESIS U NEW YORK BU; FEENER CA, 1989, NATURE, V338, P509, DOI 10.1038/338509a0; GAL A, 1989, HUM GENET, V81, P315, DOI 10.1007/BF00283682; GORECKI DC, 1992, HUM MOL GENET, V1, P505, DOI 10.1093/hmg/1.7.505; HEERY DM, 1990, TRENDS GENET, V6, P173; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1988, NEURON, V1, P411, DOI 10.1016/0896-6273(88)90191-2; KLINE RP, 1978, P NATL ACAD SCI USA, V75, P5727, DOI 10.1073/pnas.75.11.5727; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANSMAN JB, 1991, J MUSCLE RES CELL M, V12, P409, DOI 10.1007/BF01738325; LEDERFEIN D, 1992, P NATL ACAD SCI USA, V89, P5346, DOI 10.1073/pnas.89.12.5346; LIDOV HGW, 1990, NATURE, V348, P725, DOI 10.1038/348725a0; MEHLER MF, 1992, P NATL ACAD SCI USA, V89, P2461, DOI 10.1073/pnas.89.6.2461; MIIKE T, 1989, BRAIN DEV-JPN, V11, P344, DOI 10.1016/S0387-7604(89)80067-1; MILLER RF, 1970, J NEUROPHYSIOL, V33, P323, DOI 10.1152/jn.1970.33.3.323; MUSARELLA MA, 1989, GENOMICS, V5, P727, DOI 10.1016/0888-7543(89)90114-6; NUDEL U, 1989, NATURE, V337, P76, DOI 10.1038/337076a0; PILLERS DAM, 1990, AM J MED GENET, V36, P23, DOI 10.1002/ajmg.1320360106; PILLERS DAM, 1990, AM J HUM GENET, V47, P795; ROBERTS RG, 1992, GENOMICS, V13, P942, DOI 10.1016/0888-7543(92)90005-D; RONG W, 1990, P NATL ACAD SCI USA, V87, P2117, DOI 10.1073/pnas.87.6.2117; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TURNER PR, 1991, J CELL BIOL, V115, P1701, DOI 10.1083/jcb.115.6.1701; WELEBER RG, 1989, ARCH OPHTHALMOL-CHIC, V107, P1170, DOI 10.1001/archopht.1989.01070020236032; YEADON JE, 1991, J CELL BIOL, V115, P1069, DOI 10.1083/jcb.115.4.1069; ZHAO JE, 1991, BRAIN DEV-JPN, V13, P135, DOI 10.1016/S0387-7604(12)80123-9; ZUBRZYCKAGAARN EE, 1991, EXP CELL RES, V192, P278, DOI 10.1016/0014-4827(91)90187-Y; ZUBRZYCKAGAARN EF, 1988, NATURE, V333, P466, DOI 10.1038/333466a0	45	138	142	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1993	4	1					82	86		10.1038/ng0593-82	http://dx.doi.org/10.1038/ng0593-82			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LA337	8513332				2022-12-25	WOS:A1993LA33700019
J	AKLI, S; CAILLAUD, C; VIGNE, E; STRATFORDPERRICAUDET, LD; POENARU, L; PERRICAUDET, M; KAHN, A; PESCHANSKI, MR				AKLI, S; CAILLAUD, C; VIGNE, E; STRATFORDPERRICAUDET, LD; POENARU, L; PERRICAUDET, M; KAHN, A; PESCHANSKI, MR			TRANSFER OF A FOREIGN GENE INTO THE BRAIN USING ADENOVIRUS VECTORS	NATURE GENETICS			English	Article							RECOMBINANT	The ability of a replication-deficient adenovirus vector to transfer a foreign gene into neural cells of adult rats in vivo has been analysed. A large number of neural cells (including neurons, astrocytes and ependymal cells) expressed an E coli lacZ transgene for at least 45 days after inoculation of various brain areas. Injecting up to 3 x 10(5) pfu in 10 mul did not result in any detectable cytopathic effects - these were only observed for very high titres of infection (>10(7) pfu 10 mul-1). Adenovirus vectors therefore appear to be a promising means for in vivo transfer of therapeutic genes into the central nervous system.	FAC MED CRETEIL,INSERM,CJF 91-02,8 RUE GEN SARRAIL,F-94010 CRETEIL,FRANCE; INST COCHIN GENET MOLEC,INSERM,U129,F-75014 PARIS,FRANCE; INST GUSTAVE ROUSSY,CNRS,URA 1301,F-94805 VILLEJUIF,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy			Peschanski, Marc/N-5769-2017					CHANOCK RM, 1966, J AMER MED ASSOC, V195, P445, DOI 10.1001/jama.195.6.445; CULVER WC, 1992, SCIENCE, V256, P1550; FINK JD, 1992, HUM GENE THER, V3, P11; JAFFE HA, 1992, NAT GENET, V1, P372, DOI 10.1038/ng0892-372; JOHNSON PA, 1992, J VIROL, V66, P2952, DOI 10.1128/JVI.66.5.2952-2965.1992; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; QUANTIN B, 1992, P NATL ACAD SCI USA, V89, P2581, DOI 10.1073/pnas.89.7.2581; RAGOT T, IN PRESS NATURE; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; STRATFORDPERRICAUDET LD, 1990, HUM GENE THER, V1, P241, DOI 10.1089/hum.1990.1.3-241; STRATFORDPERRICAUDET LD, 1992, J CLIN INVEST, V90, P626, DOI 10.1172/JCI115902; STRAUS SE, 1984, ADENOVIRUSES; WOLFE JH, 1992, NAT GENET, V1, P379, DOI 10.1038/ng0892-379	15	486	510	0	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1993	3	3					224	228		10.1038/ng0393-224	http://dx.doi.org/10.1038/ng0393-224			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KP790	8485577				2022-12-25	WOS:A1993KP79000011
J	Lutzker, SG; Levine, AJ				Lutzker, SG; Levine, AJ			A functionally inactive p53 protein in teratocarcinoma cells is activated by either DNA damage or cellular differentiation	NATURE MEDICINE			English	Article							WILD-TYPE P53; TESTICULAR CANCER; MDM-2 ONCOGENE; TUMOR-ANTIGEN; C-MYC; APOPTOSIS; GENE; EXPRESSION; TRANSFORMATION; MUTATIONS	Testicular teratocarcinomas never contain p53 gene mutations even though these tumors express high levels of nuclear p53 protein. We have characterized two murine teratocarcinoma cell lines and find no evidence that endogenous p53-regulated genes are correspondingly upregulated. Differentiation of these teratocarcinoma cells with retinoic acid results in a marked decrease in p53 protein levels but is accompanied by a marked increase in p53-mediated transcriptional activity. Together these results support the hypothesis that the p53 protein in undifferentiated teratocarcinoma cells is transcriptionally inactive and accounts for the lack of selection for p53 gene mutations in this tumor type. These teratocarcinoma cells undergo p53-mediated apoptosis in response to DNA damage, which may explain the routine cures of human testicular tumors with combination chemotherapy.	UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,CANC INST NEW JERSEY,NEW BRUNSWICK,NJ 08901	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Lutzker, SG (corresponding author), PRINCETON UNIV,DEPT MOLEC BIOL,PRINCETON,NJ 08540, USA.				PHS HHS [P01 41086] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; BARTKOVA J, 1991, INT J CANCER, V49, P196, DOI 10.1002/ijc.2910490209; CAMPISI J, 1984, CELL, V36, P241, DOI 10.1016/0092-8674(84)90217-4; CANMAN CE, 1995, GENE DEV, V9, P600, DOI 10.1101/gad.9.5.600; CHAMPLIN R, 1987, BLOOD, V69, P1551; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; DEBBAS M, 1993, GENE DEV, V7, P546, DOI 10.1101/gad.7.4.546; ELDEIRY WS, 1994, CANCER RES, V54, P1169; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; FAKHARZADEH SS, 1991, EMBO J, V10, P1565, DOI 10.1002/j.1460-2075.1991.tb07676.x; FINLAY CA, 1993, MOL CELL BIOL, V13, P301, DOI 10.1128/MCB.13.1.301; GANNON JV, 1990, EMBO J, V9, P1595, DOI 10.1002/j.1460-2075.1990.tb08279.x; HAINES DS, 1994, MOL CELL BIOL, V14, P1171, DOI 10.1128/MCB.14.2.1171; HARRIS CC, 1993, NEW ENGL J MED, V329, P1318, DOI 10.1056/NEJM199310283291807; HARVEY M, 1993, FASEB J, V7, P938, DOI 10.1096/fasebj.7.10.8344491; HEIMDAL K, 1993, GENE CHROMOSOME CANC, V6, P92, DOI 10.1002/gcc.2870060205; HEN R, 1986, NATURE, V321, P249, DOI 10.1038/321249a0; HERMEKING H, 1994, SCIENCE, V265, P2091, DOI 10.1126/science.8091232; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; IMPERIALE MJ, 1984, MOL CELL BIOL, V4, P867, DOI 10.1128/MCB.4.5.867; KASTAN MB, 1991, CANCER RES, V51, P6304; LANGLEY RE, 1994, INT J RADIAT BIOL, V65, P605, DOI 10.1080/09553009414550691; LEVINE AJ, 1994, BRIT J CANCER, V69, P409, DOI 10.1038/bjc.1994.76; LEWIS DJ, 1994, J UROLOGY, V152, P418, DOI 10.1016/S0022-5347(17)32753-2; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; LOTEM J, 1993, BLOOD, V82, P1092, DOI 10.1182/blood.V82.4.1092.bloodjournal8241092; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; LU H, 1995, P NATL ACAD SCI USA, V92, P5154, DOI 10.1073/pnas.92.11.5154; LUCJEHUHLE C, 1991, INT J CANCER, V47, P461; MARECHAL V, 1994, MOL CELL BIOL, V14, P7414, DOI 10.1128/MCB.14.11.7414; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; MORA PT, 1980, NATURE, V288, P722, DOI 10.1038/288722a0; MURTY VVVS, 1994, ONCOGENE, V9, P2245; NICOL CJ, 1995, NAT GENET, V10, P181, DOI 10.1038/ng0695-181; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; OLSON DC, 1993, ONCOGENE, V8, P2353; OREN M, 1982, MOL CELL BIOL, V2, P443, DOI 10.1128/MCB.2.4.443; PENG HQ, 1993, CANCER RES, V53, P3574; PENNICA D, 1984, VIROLOGY, V134, P477, DOI 10.1016/0042-6822(84)90316-7; PERRY ME, 1993, P NATL ACAD SCI USA, V90, P11623, DOI 10.1073/pnas.90.24.11623; POTTERN LM, 1986, PRINCIPLES MANAGEMEN, P108; RAO L, 1992, P NATL ACAD SCI USA, V89, P7742, DOI 10.1073/pnas.89.16.7742; REICH NC, 1983, MOL CELL BIOL, V3, P2143, DOI 10.1128/MCB.3.12.2143; RIOU G, 1995, MOL CARCINOGEN, V12, P124, DOI 10.1002/mc.2940120303; ROTTER V, 1993, P NATL ACAD SCI USA, V90, P9075, DOI 10.1073/pnas.90.19.9075; SCHENKMAN NS, 1995, J UROLOGY, V154, P617, DOI 10.1016/S0022-5347(01)67122-2; SCHMID P, 1991, DEVELOPMENT, V113, P857; SHAW P, 1992, P NATL ACAD SCI USA, V89, P4495, DOI 10.1073/pnas.89.10.4495; SLACK RS, 1995, J CELL BIOL, V129, P779, DOI 10.1083/jcb.129.3.779; STRICKLAND S, 1980, CELL, V21; STROHMEYER T, 1991, P NATL ACAD SCI USA, V88, P6662, DOI 10.1073/pnas.88.15.6662; THUT CJ, 1995, SCIENCE, V267, P100, DOI 10.1126/science.7809597; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; YONISHROUACH E, 1991, NATURE, V352, P345, DOI 10.1038/352345a0	57	194	199	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUL	1996	2	7					804	810		10.1038/nm0796-804	http://dx.doi.org/10.1038/nm0796-804			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UU680	8673928				2022-12-25	WOS:A1996UU68000038
J	Miki, Y; Katagiri, T; Kasumi, F; Yoshimoto, T; Nakamura, Y				Miki, Y; Katagiri, T; Kasumi, F; Yoshimoto, T; Nakamura, Y			Mutation analysis in the BRCA2 gene in primary breast cancers	NATURE GENETICS			English	Letter							ALU INSERTION; SEQUENCE; SUBFAMILY; DNA		JAPANESE FDN CANC RES,DEPT SURG,TOSHIMA KU,TOKYO 170,JAPAN; UNIV TOKYO,INST MED SCI,MOLEC MED LAB,MINATO KU,TOKYO 108,JAPAN	Japanese Foundation for Cancer Research; University of Tokyo	Miki, Y (corresponding author), JAPANESE FDN CANC RES,CTR CANC CHEMOTHERAPY,DEPT HUMAN GENOME ANAL,TOSHIMA KU,37-1 KAMIIKEBUKURO,TOKYO 170,JAPAN.							BATZER MA, 1991, GENOMICS, V9, P481, DOI 10.1016/0888-7543(91)90414-A; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; DEININGER PL, 1981, J MOL BIOL, V151, P17, DOI 10.1016/0022-2836(81)90219-9; Deininger PL, 1989, MOBILE DNA, P619; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; Holt JT, 1996, NAT GENET, V12, P298, DOI 10.1038/ng0396-298; Jensen RA, 1996, NAT GENET, V12, P303, DOI 10.1038/ng0396-303; KOYAMA K, 1995, GENOMICS, V26, P245, DOI 10.1016/0888-7543(95)80207-3; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MATERA AG, 1990, MOL CELL BIOL, V10, P5424, DOI 10.1128/MCB.10.10.5424; MIKI Y, 1992, CANCER RES, V52, P643; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MITCHELL GA, 1991, P NATL ACAD SCI USA, V88, P815, DOI 10.1073/pnas.88.3.815; MURATANI K, 1991, P NATL ACAD SCI USA, V88, P11315, DOI 10.1073/pnas.88.24.11315; ROGERS J, 1983, NATURE, V301, P460, DOI 10.1038/301460e0; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; THOMPSON ME, 1995, NAT GENET, V9, P444, DOI 10.1038/ng0495-444; Vidaud Dominique, 1993, European Journal of Human Genetics, V1, P30; WALLACE MR, 1991, NATURE, V353, P864, DOI 10.1038/353864a0; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	22	251	258	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1996	13	2					245	247		10.1038/ng0696-245	http://dx.doi.org/10.1038/ng0696-245			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UN395	8640237				2022-12-25	WOS:A1996UN39500030
J	Rubin, H				Rubin, H			Serine protease inhibitors (serpins): Where mechanism meets medicine	NATURE MEDICINE			English	Editorial Material											Rubin, H (corresponding author), UNIV PENN,MED CTR,PHILADELPHIA,PA 19104, USA.							CARRELL RW, 1994, STRUCTURE, V2, P257, DOI 10.1016/S0969-2126(00)00028-9; Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396; Enari M, 1996, NATURE, V380, P723, DOI 10.1038/380723a0; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; KUMAR S, 1995, FEBS LETT, V375, P169, DOI 10.1016/0014-5793(95)01186-I; LAWRENCE DA, 1995, J BIOL CHEM, V270, P25309, DOI 10.1074/jbc.270.43.25309; MIGNATTI P, 1993, PHYSIOL REV, V73, P161, DOI 10.1152/physrev.1993.73.1.161; PLOTNICK MI, IN PRESS BIOCH; Romer J, 1996, NAT MED, V2, P287, DOI 10.1038/nm0396-287; SCHREUDER HA, 1994, NAT STRUCT BIOL, V1, P48, DOI 10.1038/nsb0194-48; Tanaka M, 1996, NAT MED, V2, P317, DOI 10.1038/nm0396-317; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; WEI AZ, 1994, NAT STRUCT BIOL, V1, P251, DOI 10.1038/nsb0494-251; WILCZYNSKA M, 1995, J BIOL CHEM, V270, P29652	14	47	49	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUN	1996	2	6					632	633		10.1038/nm0696-632	http://dx.doi.org/10.1038/nm0696-632			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UN691	8640547				2022-12-25	WOS:A1996UN69100024
J	Shibata, D; Navidi, W; Salovaara, R; Li, ZH; Aaltonen, LA				Shibata, D; Navidi, W; Salovaara, R; Li, ZH; Aaltonen, LA			Somatic microsatellite mutations as molecular tumor clocks	NATURE MEDICINE			English	Article							CARCINOGENESIS; CANCER; MODEL	Microsatellite (MS) mutations can potentially unravel the past of mutator phenotype tumors, with greater genetic diversity expected in older regions. Rapid clonal expansions of xenografts were characterized by relatively homogenous MS alleles, whereas greater diversity was observed in a colorectal cancer with the greatest variation in its adjacent adenoma. A subcutaneous lung cancer metastasis demonstrated diversity consistent with its one-month clinical duration and evidence of active mitosis during dormancy. The genetic legacy inherent to multistep tumorigenesis provides direct estimates of tumor ages, with up to thousands of cell divisions and high death rates necessary to yield the observed diversities. MS molecular tumor clocks have the unique potential to systematically reconstruct the early and occult evolution of individual human mutator phenotype tumors.	UNIV SO CALIF,DEPT PREVENT MED,LOS ANGELES,CA 90033; HAARTMAN INST,DEPT PATHOL,FIN-00014 HELSINKI,FINLAND; HAARTMAN INST,DEPT MED GENET,FIN-00014 HELSINKI,FINLAND	University of Southern California	Shibata, D (corresponding author), UNIV SO CALIF,SCH MED,DEPT PATHOL,1200 N STATE ST,LOS ANGELES,CA 90033, USA.		Aaltonen, Lauri/A-5375-2010	Aaltonen, Lauri/0000-0001-6839-4286	NATIONAL CANCER INSTITUTE [R01CA058704, P30CA014089] Funding Source: NIH RePORTER; NCI NIH HHS [CA58704, 5 P30 CA14089-20] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; BHATTACHARYYA NP, 1994, P NATL ACAD SCI USA, V91, P6319, DOI 10.1073/pnas.91.14.6319; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; GOLDSTEIN DB, 1995, GENETICS, V139, P463; HAUGE XY, 1993, HUM MOL GENET, V2, P411, DOI 10.1093/hmg/2.4.411; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; LEVINSON G, 1987, NUCLEIC ACIDS RES, V15, P5322; LOEB LA, 1991, CANCER RES, V51, P3075; MANOUKIAN EB, 1986, MODERN CONCEPTS THEO, P126; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; NYSTROMLAHTI M, 1995, NAT MED, V1, P1203, DOI 10.1038/nm1195-1203; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; SHIBATA D, 1992, AM J PATHOL, V141, P539; SHIBATA D, 1994, NAT GENET, V6, P273, DOI 10.1038/ng0394-273; SLATKIN M, 1995, GENETICS, V139, P457; STEEL G. G., 1967, EUR J CANCER, V3, P381, DOI 10.1016/0014-2964(67)90022-9; STEEL GG, 1977, GROWTH KINETICS TUMO, P185; STRAUSS M, 1995, NAT MED, V1, P1245, DOI 10.1038/nm1295-1245; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; UMAR A, 1994, J BIOL CHEM, V269, P14367; VALDES AM, 1993, GENETICS, V133, P737; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WELIN S, 1963, AMER J ROENTGENOL RA, V90, P673; Wheelock E F, 1981, Adv Cancer Res, V34, P107; ZUCKERKANDL EMILE, 1965, P97	30	89	90	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUN	1996	2	6					676	681		10.1038/nm0696-676	http://dx.doi.org/10.1038/nm0696-676			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UN691	8640559				2022-12-25	WOS:A1996UN69100036
J	Simon, DB; Karet, FE; Hamdan, JM; DiPietro, A; Sanjad, SA; Lifton, RP				Simon, DB; Karet, FE; Hamdan, JM; DiPietro, A; Sanjad, SA; Lifton, RP			Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2	NATURE GENETICS			English	Article							DNA; PROSTAGLANDINS; INDOMETHACIN; GENE; LOOP	Inherited hypokalaemic alkalosis with low blood pressure can be divided into two groups - Gitelman's syndrome, featuring hypocalciuria, hypomagnesaemia and milder clinical manifestations, and Bartter's syndrome, featuring hypercalciuria and early presentation with severe volume depletion. Mutations in the renal Na-Cl cotransporter have been shown to cause Gitelman's syndrome. We demonstrate linkage of Bartter's syndrome to the renal Na-K-2Cl cotransporter gene NKCC2, and identify frameshift or non-conservative missense mutations for this gene that co-segregate with the disease. These findings demonstrate the molecular basis of Bartter's syndrome, provide the basis for molecular classification of patients with inherited hypokalaemic alkalosis, and suggest potential phenotypes in heterozygous carriers of NKCC2 mutations.	YALE UNIV,SCH MED,BOYER CTR MOLEC MED,HOWARD HUGES MED INST,DEPT MED,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,BOYER CTR MOLEC MED,DEPT GENET,NEW HAVEN,CT 06510; DHARAN HLTH CTR,SPECIALTY PEDIAT SERV DIV,DHAHRAN 31311,SAUDI ARABIA; OSPED ANTONIO CARDARELLI,DIV PEDIAT 28,I-80131 NAPLES,ITALY; KING FAISAL SPECIALIST HOSP & RES CTR,DEPT PEDIAT,RIYADH 11211,SAUDI ARABIA	Yale University; Yale University; Antonio Cardarelli Hospital; King Faisal Specialist Hospital & Research Center				Karet, Fiona/0000-0002-2457-2869				BARTTER FC, 1962, AM J MED, V33, P811, DOI 10.1016/0002-9343(62)90214-0; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BETTINELLI A, 1992, J PEDIATR-US, V120, P38, DOI 10.1016/S0022-3476(05)80594-3; BIANCHETTI MG, 1992, CLIN NEPHROL, V38, P338; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; CLIVE DM, 1995, AM J KIDNEY DIS, V25, P813, DOI 10.1016/0272-6386(95)90562-6; COOPER DN, 1989, HUM GENET, V83, P181, DOI 10.1007/BF00286715; Di Pietro A, 1991, Pediatr Med Chir, V13, P279; DUNN MJ, 1981, KIDNEY INT, V19, P86, DOI 10.1038/ki.1981.12; GAMBA G, 1994, J BIOL CHEM, V269, P17713; GILL JR, 1978, AM J MED, V65, P766, DOI 10.1016/0002-9343(78)90794-5; GILL JR, 1976, AM J MED, V61, P43, DOI 10.1016/0002-9343(76)90029-2; Gitelman H J, 1966, Trans Assoc Am Physicians, V79, P221; GLADZIWA U, 1995, NEPHROL DIAL TRANSPL, V10, P1607; GOODMAN AD, 1969, NEW ENGL J MED, V281, P1435, DOI 10.1056/NEJM196912252812601; GREGER R, 1985, PHYSIOL REV, V65, P760, DOI 10.1152/physrev.1985.65.3.760; GREGER R, 1983, KLIN WOCHENSCHR, V61, P1019, DOI 10.1007/BF01537500; GULLNER HG, 1981, AM J MED, V71, P578, DOI 10.1016/0002-9343(81)90209-6; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; HETZEL W, 1991, NERVENARZT, V62, P500; IGARASHI P, 1995, AM J PHYSIOL-RENAL, V269, pF405, DOI 10.1152/ajprenal.1995.269.3.F405; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; Iwata Fujihiko, 1993, Acta Paediatrica Japonica, V35, P252; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LARRONDO SZ, 1992, NEPHRON, V62, P340; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LIFTON RP, 1992, NATURE, V355, P262, DOI 10.1038/355262a0; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; MARCOFRANCO JE, 1994, CLIN NEPHROL, V42, P33; MATSUMOTO J, 1989, AM J ROENTGENOL, V152, P1251, DOI 10.2214/ajr.152.6.1251; MCCREDIE DA, 1974, AUST PAEDIATR J, V10, P286; MUNE T, 1995, NAT GENET, V10, P394, DOI 10.1038/ng0895-394; OHLSSON A, 1984, ACTA PAEDIATR SCAND, V73, P868, DOI 10.1111/j.1651-2227.1984.tb17793.x; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PAYNE JA, 1995, J BIOL CHEM, V270, P17977, DOI 10.1074/jbc.270.30.17977; PAYNE JA, 1994, P NATL ACAD SCI USA, V91, P4544, DOI 10.1073/pnas.91.10.4544; QUAGGIN SE, 1995, MAMM GENOME, V6, P557, DOI 10.1007/BF00356178; SEYBERTH HW, 1987, PEDIATR NEPHROL, V1, P491, DOI 10.1007/BF00849259; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; SILVERBERG AB, 1978, AM J MED, V64, P231, DOI 10.1016/0002-9343(78)90050-5; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; SIMOPOULOS AP, 1979, NEPHRON, V23, P130, DOI 10.1159/000181622; SMILDE TJ, 1994, J RHEUMATOL, V21, P1515; SUTTON RAL, 1981, KIDNEY, P551; XU JC, 1994, P NATL ACAD SCI USA, V91, P2201, DOI 10.1073/pnas.91.6.2201	46	705	729	0	21	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1996	13	2					183	188		10.1038/ng0696-183	http://dx.doi.org/10.1038/ng0696-183			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UN395	8640224				2022-12-25	WOS:A1996UN39500017
J	Manome, Y; Wen, PY; Dong, YH; Tanaka, T; Mitchell, BS; Kufe, DW; Fine, HA				Manome, Y; Wen, PY; Dong, YH; Tanaka, T; Mitchell, BS; Kufe, DW; Fine, HA			Viral vector transduction of the human deoxycytidine kinase cDNA sensitizes glioma cells to the cytotoxic effects of cytosine arabinoside in vitro and in vivo	NATURE MEDICINE			English	Article							HIGH-DOSE 1-BETA-D-ARABINOFURANOSYLCYTOSINE; ACUTE MYELOCYTIC-LEUKEMIA; HUMAN ADENOVIRUS TYPE-5; DNA POLYMERASE; GENE-TRANSFER; RAT MODEL; ARA-C; ADRIAMYCIN; TRANSPORT; TOXICITY	Cytosine arabinoside (ara-C) is a cytidine analog that incorporates into replicating DNA and induces lethal DNA strand breaks. Although ara-C is a potent antitumor agent for hematologic malignancies, it has only minimal activity against most solid tumors. The rate-limiting step in intracellular ara-C activation is phosphorylation of the prodrug by deoxycytidine kinase (dCK). The present results demonstrate that both retroviral and adenoviral vector-mediated transduction of the dCK cDNA results in marked sensitization of glioma cell lines to the cytotoxic effects of ara-C in vitro. We also demonstrate that ara-C treatment of established intradermal and intracerebral gliomas transduced with dCK results in significant antitumor effects in vivo. These data suggest that viral vector transduction of the dCK gene followed by treatment with ara-C represents a new chemosensitization strategy for cancer gene therapy.	DANA FARBER CANC INST,DIV CANC PHARMACOL,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DIV NEUROL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,BOSTON,MA 02115; UNIV N CAROLINA,SCH MED,CHAPEL HILL,NC 27599	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine			Wen, Patrick/AAE-3776-2022	Manome, Yoshinobu/0000-0002-8755-8976				ANDERSON WF, 1992, SCIENCE, V256, P808, DOI 10.1126/science.1589762; CADMAN E, 1977, CANCER TREAT REP, V61, P1109; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOTTINER EG, 1991, P NATL ACAD SCI USA, V88, P1531, DOI 10.1073/pnas.88.4.1531; COLLY LP, 1984, LEUKEMIA RES, V8, P945, DOI 10.1016/0145-2126(84)90048-1; COLLY LP, 1986, CANCER RES, V46, P3825; COLLY LP, 1982, MED PEDIAT ONCOL S1, V209, P209; CULVER KW, 1992, SCIENCE, V256, P1550, DOI 10.1126/science.1317968; EARLY AP, 1982, CANCER RES, V42, P1587; ELLISON RR, 1968, BLOOD, V32, P507, DOI 10.1182/blood.V32.4.507.507; ENGELHARDT JF, 1994, P NATL ACAD SCI USA, V91, P6196, DOI 10.1073/pnas.91.13.6196; ENGELHARDT JF, 1993, NAT GENET, V4, P27, DOI 10.1038/ng0593-27; FRAM RJ, 1983, LEUKEMIA RES, V7, P243, DOI 10.1016/0145-2126(83)90014-0; FREEMAN SM, 1993, CANCER RES, V53, P5274; GRAHAM FL, 1970, CANCER RES, V30, P2636; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Graham FL, 1991, METHOD MOL BIOL, P109; HOUSEY GM, 1988, CELL, V52, P343, DOI 10.1016/S0092-8674(88)80027-8; KOBAYASHI N, 1980, J NEUROSURG, V53, P808, DOI 10.3171/jns.1980.53.6.0808; KUFE D, 1984, BLOOD, V64, P54; KUFE DW, 1984, MOL PHARMACOL, V26, P128; KUFE DW, 1980, J BIOL CHEM, V255, P8997; MAJOR PP, 1981, P NATL ACAD SCI-BIOL, V78, P3235, DOI 10.1073/pnas.78.5.3235; MAJOR PP, 1982, BIOCHEM PHARMACOL, V31, P2937, DOI 10.1016/0006-2952(82)90266-0; MANOME Y, 1994, CANCER RES, V54, P5408; MANOME Y, 1993, BIOCHEM PHARMACOL, V45, P1677, DOI 10.1016/0006-2952(93)90309-K; MCGRORY WJ, 1988, VIROLOGY, V163, P614, DOI 10.1016/0042-6822(88)90302-9; MIKITA T, 1988, BIOCHEMISTRY-US, V27, P4698, DOI 10.1021/bi00413a018; MOOLTEN FL, 1986, CANCER RES, V46, P5276; MULLEN CA, 1992, P NATL ACAD SCI USA, V89, P33, DOI 10.1073/pnas.89.1.33; OHNO Y, 1988, CANCER RES, V48, P1494; PLAGEMANN PGW, 1978, CANCER RES, V38, P978; TAPSCOTT SJ, 1994, P NATL ACAD SCI USA, V91, P8185, DOI 10.1073/pnas.91.17.8185; VAUGHAN WP, 1983, CANCER RES, V43, P2005; WILEY JS, 1982, J CLIN INVEST, V69, P479, DOI 10.1172/JCI110472	35	102	108	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAY	1996	2	5					567	573		10.1038/nm0596-567	http://dx.doi.org/10.1038/nm0596-567			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UJ230	8616717				2022-12-25	WOS:A1996UJ23000041
J	Gupta, S; Maiden, MCJ; Feavers, IM; Nee, S; May, RM; Anderson, RM				Gupta, S; Maiden, MCJ; Feavers, IM; Nee, S; May, RM; Anderson, RM			The maintenance of strain structure in populations of recombining infectious agents	NATURE MEDICINE			English	Article							HORIZONTAL GENETIC EXCHANGE; OUTER-MEMBRANE PROTEINS; PLASMODIUM-FALCIPARUM; TRANSMISSION DYNAMICS; NEISSERIA-MENINGITIDIS; ANTIGENIC DIVERSITY; ESCHERICHIA-COLI; IMMUNE-RESPONSE; SURFACE; MALARIA	Using mathematical models that combine population genetic and epidemiological processes, we resolve the paradox that many important pathogens appear to persist as discrete strains despite the constant exchange of genetic material. We show that dominant polymorphic determinants (that is, those that elicit the most effective immune responses) will be organized into nonoverlapping combinations as a result of selection by the host immune system, thereby defining a set of discrete independently transmitted strains. By analysing 222 isolates of Neisseria meningitidis, we show that two highly polymorphic epitopes of the outer membrane protein PorA exist in nonoverlapping combinations as predicted by this general framework. The model indicates that dominant polymorphic determinants will be in linkage disequilibrium, despite frequent genetic exchange, even though they may be encoded by several unlinked genes. This suggests that the detection of nonrandom associations between epitope regions can be employed as a novel strategem for identifying dominant polymorphic antigens.	NATL INST BIOL STAND & CONTROLS, DIV BACTERIOL, POTTERS BAR EN6 3QG, HERTS, ENGLAND	National Institute for Biological Standards & Control	Gupta, S (corresponding author), UNIV OXFORD, DEPT ZOOL, WELLCOME CTR EPIDEMIOL INFECT DIC, S PARKS RD, OXFORD OX1 3PS, ENGLAND.		Maiden, Martin/N-6805-2019; Maiden, Martin C J/C-5055-2014	Maiden, Martin/0000-0001-6321-5138; Maiden, Martin C J/0000-0001-6321-5138; Anderson, Roy/0000-0002-9528-3175	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDERSON R M, 1991; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; BOLLYKY PL, IN PRESS J MOL EVOL; CARMAN WF, 1993, VIRAL HEPATITIS SCI, P115; CARTWRIGHT KAV, 1987, EPIDEMIOL INFECT, V99, P591, DOI 10.1017/S0950268800066449; CRAVEN DE, 1980, J INFECT DIS, V142, P556, DOI 10.1093/infdis/142.4.556; DALY TM, 1993, INFECT IMMUN, V61, P2462, DOI 10.1128/IAI.61.6.2462-2467.1993; DESJARDINS P, 1995, J MOL EVOL, V41, P440, DOI 10.1007/BF00160315; FEAVERS IM, 1992, MOL MICROBIOL, V6, P489, DOI 10.1111/j.1365-2958.1992.tb01493.x; FEAVERS IM, IN PRESS CLIN DIAGN; GOTSCHLICH EC, 1969, J EXP MED, V129, P1367, DOI 10.1084/jem.129.6.1367; GUPTA S, 1994, PARASITOL TODAY, V10, P476, DOI 10.1016/0169-4758(94)90160-0; GUPTA S, 1994, P ROY SOC B-BIOL SCI, V256, P231, DOI 10.1098/rspb.1994.0075; GUPTA S, 1994, PARASITE IMMUNOL, V16, P361, DOI 10.1111/j.1365-3024.1994.tb00361.x; GUPTA S, 1994, SCIENCE, V263, P961, DOI 10.1126/science.8310293; Hartl D., 1989, PRINCIPLES POPULATIO; HAYES LJ, 1995, J INFECT DIS, V172, P268, DOI 10.1093/infdis/172.1.268; HILL AVS, 1992, NATURE, V360, P434, DOI 10.1038/360434a0; HOFFMAN SL, 1987, SCIENCE, V237, P639, DOI 10.1126/science.3299709; HUGHES AL, 1992, MOL BIOL EVOL, V9, P381; Jones T R, 1993, Prog Clin Parasitol, V3, P103; LEVIN BR, 1981, GENETICS, V99, P1; LOUWAGIE J, 1993, AIDS, V7, P769, DOI 10.1097/00002030-199306000-00003; MAIDEN MCJ, 1991, MOL MICROBIOL, V5, P727, DOI 10.1111/j.1365-2958.1991.tb00743.x; MAIDEN MCJ, 1993, FEMS MICROBIOL LETT, V112, P243, DOI 10.1111/j.1574-6968.1993.tb06457.x; MAIDEN MCJ, 1995, SYMP SOC GEN MICROBI, V52, P269; MANDRELL RE, 1989, INFECT IMMUN, V57, P1590, DOI 10.1128/IAI.57.5.1590-1598.1989; NORDER H, 1993, J GEN VIROL, V74, P1341, DOI 10.1099/0022-1317-74-7-1341; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; ROBERTSON DL, 1995, NATURE, V374, P124, DOI 10.1038/374124b0; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; SMITH JM, 1991, NATURE, V349, P29, DOI 10.1038/349029a0; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; SPRATT BG, 1995, SYMP SOC GEN MICROBI, V52, P143; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; SUKER J, 1994, MOL MICROBIOL, V12, P253, DOI 10.1111/j.1365-2958.1994.tb01014.x; TIBAYRENC M, 1994, PARASITOL TODAY, V10, P456, DOI 10.1016/0169-4758(94)90152-X; TIBAYRENC M, 1990, P NATL ACAD SCI USA, V87, P2414, DOI 10.1073/pnas.87.7.2414; WALLIKER D, 1989, EXP PARASITOL, V69, P303, DOI 10.1016/0014-4894(89)90078-7; WIERTZ EJHJ, 1991, J IMMUNOL, V147, P2012; WYLE FA, 1972, J INFECT DIS, V126, P514, DOI 10.1093/infdis/126.5.514	41	213	214	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	1996	2	4					437	442		10.1038/nm0496-437	http://dx.doi.org/10.1038/nm0496-437			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UD314	8597954				2022-12-25	WOS:A1996UD31400046
J	Chang, SS; Grunder, S; Hanukoglu, A; Rosler, A; Mathew, PM; Hanukoglu, I; Schild, L; Lu, Y; Shimkets, RA; NelsonWilliams, C; Rossier, BC; Lifton, RP				Chang, SS; Grunder, S; Hanukoglu, A; Rosler, A; Mathew, PM; Hanukoglu, I; Schild, L; Lu, Y; Shimkets, RA; NelsonWilliams, C; Rossier, BC; Lifton, RP			Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1	NATURE GENETICS			English	Article							NEURODEGENERATION; INHERITANCE; DEFECTS; DNA	Autosomal recessive pseudohypoaldosteronism type I is a rave life-threatening disease characterized by severe neonatal salt wasting, hyperkalaemia, metabolic acidosis, and unresponsiveness to mineralocorticoid hormones. Investigation of affected offspring of consanguineous union reveals mutations in either the alpha or beta subunits of the amiloride-sensitive epithelial sodium channel in five kindreds. These mutations are homozygous in affected subjects, co-segregate with the disease, and introduce frameshift, premature termination or missense mutations that result in loss of channel activity. These findings demonstrate the molecular basis and explain the pathophysiology of this disease.	YALE UNIV, SCH MED,HOWARD HUGHES MED INST,DEPT GENET, BOYER CTR MOLEC MED, NEW HAVEN, CT 06510 USA; YALE UNIV, SCH MED, DEPT MED, NEPHROL SECT, NEW HAVEN, CT 06510 USA; UNIV LAUSANNE, INST PHARMACOL & TOXICOL, CH-1005 LAUSANNE, SWITZERLAND; E WOLFSON HOSP, DEPT PEDIAT, HOLON, ISRAEL; TEL AVIV UNIV, SACKLER SCH MED, IL-69978 TEL AVIV, ISRAEL; HEBREW UNIV JERUSALEM, HADASSAH MED CTR, DEPT ENDOCRINOL & METAB, JERUSALEM, ISRAEL; DHAHRAN HLTH CTR, DEPT PEDIAT, DHAHRAN, SAUDI ARABIA; COLL JUDEA & SAMARIA, RES INST, ARIEL, ISRAEL; SOURASKY MED CTR, INST ENDOCRINOL, TEL AVIV, ISRAEL	Howard Hughes Medical Institute; Yale University; Yale University; University of Lausanne; Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem; Hadassah University Medical Center; Ariel University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center			Gründer, Stefan/I-2495-2019; Hanukoglu, Aaron/L-4892-2016; Hanukoglu, Israel/B-9694-2008	Gründer, Stefan/0000-0002-7635-9883; Hanukoglu, Aaron/0000-0003-1486-6641; Hanukoglu, Israel/0000-0003-3889-0320				ARMANINI D, 1985, NEW ENGL J MED, V313, P1178, DOI 10.1056/NEJM198511073131902; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BOSSON D, 1986, ACTA ENDOCRINOL-COP, V113, P376, DOI 10.1530/acta.0.112S376; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1994, AM J PHYSIOL-CELL PH, V267, pC1682, DOI 10.1152/ajpcell.1994.267.6.C1682; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; CHALFIE M, 1990, NATURE, V345, P410, DOI 10.1038/345410a0; CHEEK DB, 1958, ARCH DIS CHILD, V33, P252, DOI 10.1136/adc.33.169.252; DILLON MJ, 1980, ARCH DIS CHILD, V55, P427, DOI 10.1136/adc.55.6.427; DONNELL GN, 1959, AMA J DIS CHILD, V97, P813, DOI 10.1001/archpedi.1959.02070010815008; DUC C, 1994, J CELL BIOL, V127, P1907, DOI 10.1083/jcb.127.6.1907; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HANSSON JH, 1995, P NATL ACAD SCI USA, V92, P11495, DOI 10.1073/pnas.92.25.11495; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; HANUKOGLU A, 1994, J PEDIATR-US, V125, P752, DOI 10.1016/S0022-3476(94)70071-0; HANUKOGLU A, 1991, J CLIN ENDOCR METAB, V73, P936, DOI 10.1210/jcem-73-5-936; HANUKOGLU A, 1978, LANCET, V1, P1359; HOGG RJ, 1991, PEDIATR NEPHROL, V5, P205, DOI 10.1007/BF01095953; HORISBERGER JD, 1993, CELL PHYSIOL BIOCHEM, V3, P283, DOI 10.1159/000154694; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; Hummler E, 1996, NAT GENET, V12, P325, DOI 10.1038/ng0396-325; KOMESAROFF PA, 1994, J CLIN ENDOCR METAB, V79, P27, DOI 10.1210/jc.79.1.27; KUHNLE U, 1990, J CLIN ENDOCR METAB, V70, P638, DOI 10.1210/jcem-70-3-638; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LI XJ, 1995, MOL PHARMACOL, V47, P1133; LIMAL JM, 1978, LANCET, V1, P51; MATHEW PM, 1993, CLIN PEDIATR, V32, P58, DOI 10.1177/000992289303200112; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; POPOW C, 1988, ACTA PAEDIATR SCAND, V77, P136, DOI 10.1111/j.1651-2227.1988.tb10612.x; PUOTI A, 1995, AM J PHYSIOL-CELL PH, V269, pC188, DOI 10.1152/ajpcell.1995.269.1.C188; ROSLER A, 1984, J CLIN ENDOCR METAB, V59, P689; Rossier BC, 1992, KIDNEY PHYSL PATHOPH, P1373; SCHILD L, 1995, P NATL ACAD SCI USA, V92, P5699, DOI 10.1073/pnas.92.12.5699; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; SPEISER PW, 1986, MECHANISMS CLIN ASPE, P173; STRANG LB, 1991, PHYSIOL REV, V71, P991, DOI 10.1152/physrev.1991.71.4.991; WALDMANN R, 1995, J BIOL CHEM, V270, P27411, DOI 10.1074/jbc.270.46.27411; ZENNARO MC, 1994, J CLIN ENDOCR METAB, V79, P32, DOI 10.1210/jc.79.1.32	40	622	635	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1996	12	3					248	253		10.1038/ng0396-248	http://dx.doi.org/10.1038/ng0396-248			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TY183	8589714				2022-12-25	WOS:A1996TY18300012
J	Hamilton, BS				Hamilton, BS			A new role for a fat actor	NATURE MEDICINE			English	Editorial Material											Hamilton, BS (corresponding author), SUNNYBROOK HLTH SCI CTR,N YORK,ON M4N 3M5,CANADA.							BARINAGA M, 1995, SCIENCE, V269, P475, DOI 10.1126/science.7624769; Chehab FE, 1996, NAT GENET, V12, P318, DOI 10.1038/ng0396-318; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; MCLACHLAN RI, 1987, ENDOCRINOL METAB, P957; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; SALADIN R, 1995, NATURE, V377, P527, DOI 10.1038/377527a0; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	13	6	8	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAR	1996	2	3					272	273		10.1038/nm0396-272	http://dx.doi.org/10.1038/nm0396-272			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TY640	8612218				2022-12-25	WOS:A1996TY64000028
J	Kovacs, DM; Fausett, HJ; Page, KJ; Kim, TW; Moir, RD; Merriam, DE; Hollister, RD; Hallmark, OG; Mancini, R; Felsenstein, KM; Hyman, BT; Tanzi, RE; Wasco, W				Kovacs, DM; Fausett, HJ; Page, KJ; Kim, TW; Moir, RD; Merriam, DE; Hollister, RD; Hallmark, OG; Mancini, R; Felsenstein, KM; Hyman, BT; Tanzi, RE; Wasco, W			Alzheimer-associated presenilins 1 and 2: Neuronal expression in brain and localization to intracellular membranes in mammalian cells	NATURE MEDICINE			English	Article							BETA-PROTEIN PRECURSOR; DISEASE	Mutations in two recently identified genes appear to cause the majority of early-onset familial Alzheimer's disease (FAD). These two novel genes, presenilin 1 (PS1) and presenilin 2 (PS2) are members of an evolutionarily conserved gene family. The normal biological role(s) of the presenilins and the mechanism(s) by which the FAD-associated mutations exert their effect remain unknown. Employing in situ hybridization, we demonstrate that the expression patterns of PS1 and PS2 in the brain are extremely similar to each other and that messages for both are primarily detectable in neuronal populations. Immunochemical analyses indicate that PS1 and PS2 are similar in size and localized to similar intracellular compartments (endoplasmic reticulum and Golgi complex). FAD-associated mutations in PS1 and PS2 do not significantly modify either their migration patterns on SDS-polyacrylamide gel electrophoresis or their overall subcellular localization, although subtle differences in perinuclear staining were noted for mutant PS1.	HARVARD UNIV,MASSACHUSETTS GEN HOSP EAST,SCH MED,GENET & AGING UNIT,BOSTON,MA 02129; HARVARD UNIV,MASSACHUSETTS GEN HOSP EAST,SCH MED,DEPT NEUROL,BOSTON,MA 02129; BRISTOL MYERS SQUIBB CO,DEPT 405,WALLINGFORD,CT 06492	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Bristol-Myers Squibb			Tanzi, Rudolph/AAE-9622-2019; Moir, Robert D./M-7612-2017	Tanzi, Rudolph/0000-0002-7032-1454; Moir, Robert D./0000-0001-5431-3553				CAMPION D, 1995, HUM MOL GENET, V4, P2373, DOI 10.1093/hmg/4.12.2373; CRUTS M, 1995, HUM MOL GENET, V4, P2363, DOI 10.1093/hmg/4.12.2363; ESCHENFELDT WH, 1987, METHOD ENZYMOL, V152, P337; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HYMAN BT, 1993, MOL BRAIN RES, V18, P253, DOI 10.1016/0169-328X(93)90197-W; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; LHERNAULT SW, 1992, J CELL BIOL, V119, P55, DOI 10.1083/jcb.119.1.55; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Scheuner D., 1995, Society for Neuroscience Abstracts, V21, P1500; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SIRINATHSINGHJI DS, 1993, MOL IMAGING NEUROSCI; SLUNT HH, 1994, J BIOL CHEM, V269, P2637; SORBI S, 1995, LANCET, V346, P439, DOI 10.1016/S0140-6736(95)92809-X; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; TANAHASHI H, 1995, LANCET, V346, P440, DOI 10.1016/S0140-6736(95)92810-3; TANZI RE, 1993, MOL BRAIN RES, V18, P246, DOI 10.1016/0169-328X(93)90196-V; Van Broeckhoven C, 1995, NAT GENET, V11, P230; VONSATTEL JPG, 1995, J NEUROPATH EXP NEUR, V54, P42; WASCO W, 1995, NAT MED, V1, P848, DOI 10.1038/nm0995-848a; Wasco W., 1995, NEUROBIOLOGY ALZHEIM, P51; WISDEN W, 1991, MOL NEUROBIOLOGY PRA; 1995, NAT GENET, V11, P219	24	517	534	0	19	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	FEB	1996	2	2					224	229		10.1038/nm0296-224	http://dx.doi.org/10.1038/nm0296-224			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TU060	8574969				2022-12-25	WOS:A1996TU06000044
J	HUSSUSSIAN, CJ; STRUEWING, JP; GOLDSTEIN, AM; HIGGINS, PAT; ALLY, DS; SHEAHAN, MD; CLARK, WH; TUCKER, MA; DRACOPOLI, NC				HUSSUSSIAN, CJ; STRUEWING, JP; GOLDSTEIN, AM; HIGGINS, PAT; ALLY, DS; SHEAHAN, MD; CLARK, WH; TUCKER, MA; DRACOPOLI, NC			GERMLINE P16 MUTATIONS IN FAMILIAL MELANOMA	NATURE GENETICS			English	Article							DYSPLASTIC NEVUS; LINKAGE; LOCUS	The p16 gene is located in chromosome 9p21, a region that is linked to familial melanoma and homozygously deleted in many tumour cell lines. We describe eight p16 germline substitutions (one nonsense, one splice donor site and six missense) in 13/18 familiar melanoma kindreds. Six of these mutations were identified in 33/36 melanoma cases in nine families, whereas two were detected in normal controls and are not disease-related. The melanoma-specific mutations were detected in 9p21-linked, but not in 1p36-linked, families, thereby confirming previous reports of genetic heterogeneity. Functional analyses of these mutations will confirm those causally related to the development of familial melanoma.	WASHINGTON UNIV,SCH MED,DEPT SURG,ST LOUIS,MO 63110; NCI,GENET EPIDEMIOL BRANCH,BETHESDA,MD 20892; HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,DEPT PATHOL,BOSTON,MA 02115; NIH,NATL CTR HUMAN GENOME RES,GENET DIS RES LAB,BETHESDA,MD 20892	Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)			Tucker, Margaret A/B-4297-2015; Struewing, Jeffery P/I-7502-2013; Struewing, Jeffery P/C-3221-2008	Struewing, Jeffery P/0000-0002-4848-3334; Dracopoli, Nicholas/0000-0003-3962-4059; Higgins, Paul/0000-0002-1604-2091				BALE SJ, 1989, NEW ENGL J MED, V320, P1367, DOI 10.1056/NEJM198905253202102; CAIRNS P, 1994, SCIENCE, V265, P415, DOI 10.1126/science.8023167; CANNONALBRIGHT LA, 1992, SCIENCE, V258, P1148, DOI 10.1126/science.1439824; CLARK WH, 1990, PATHOLOGY SKIN, P684; COWAN JM, 1988, J NATL CANCER I, V80, P1159, DOI 10.1093/jnci/80.14.1159; FOUNTAIN JW, 1992, P NATL ACAD SCI USA, V89, P10557, DOI 10.1073/pnas.89.21.10557; FOUNTAIN JW, 1993, HUM MOL GENET, V2, P823, DOI 10.1093/hmg/2.6.823-a; GOLDSTEIN AM, 1994, AM J HUM GENET, V54, P489; GOLDSTEIN AM, 1993, AM J HUM GENET, V52, P537; Greene MH., 1979, HEREDITARY VARIANT M; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; KWLATKOWSKI DJ, 1992, HUM MOL GENET, V1, P658; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MACKIE RM, 1989, LANCET, V2, P487; NANCARROW DJ, 1993, AM J HUM GENET, V53, P936; NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; Ott J., 1991, ANAL HUMAN GENETIC L; OTT J, 1992, HOMOG PROGRAMS; PETTY EM, 1993, AM J HUM GENET, V53, P96; RAVNIKGLAVAC M, 1994, HUM MOL GENET, V3, P801, DOI 10.1093/hmg/3.5.801; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; SHUBER AP, 1993, HUM MOL GENET, V2, P159; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; TUCKER MA, 1983, J PEDIATR-US, V103, P65, DOI 10.1016/S0022-3476(83)80777-X; TUCKER MA, 1993, J INVEST DERMATOL, V100, pS350, DOI 10.1111/1523-1747.ep12470264; TUCKER MA, 1988, PIGMENT CELL, V9, P95	27	1127	1156	0	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1994	8	1					15	21		10.1038/ng0994-15	http://dx.doi.org/10.1038/ng0994-15			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PE157	7987387				2022-12-25	WOS:A1994PE15700010
J	NYGAARD, TG; WILHELMSEN, KC; RISCH, NJ; BROWN, DL; TRUGMAN, JM; GILLIAM, TC; FAHN, S; WEEKS, DE				NYGAARD, TG; WILHELMSEN, KC; RISCH, NJ; BROWN, DL; TRUGMAN, JM; GILLIAM, TC; FAHN, S; WEEKS, DE			LINKAGE MAPPING OF DOPA-RESPONSIVE DYSTONIA (DRD) TO CHROMOSOME 14Q	NATURE GENETICS			English	Article							TERM TREATMENT RESPONSE; DIURNAL-VARIATION; GENE; POLYMORPHISM; MAP; TETRAHYDROBIOPTERIN; IDENTIFICATION; PARKINSONISM; CONSTRUCTION; HYDROXYLASE	Dopa-responsive dystonia (DRD) is an autosomal-dominant neurological disorder which appears to result from a genetically determined deficiency of striatal dopamine. Pathological evidence suggests that this may be due to the establishment of a reduced number of dopaminergic nerve terminals in the striatum, or to an excessive reduction (pruning) of these terminals in early development. We have mapped the DRD gene to chromosome 14 by linkage analysis in 3 families with a maximum 2-point lod score of 4.67 at 8.6 centiMorgans from D14S63; maximum multipoint lod scores >6 were obtained for the intervals D14S47-D14S52 and D14S52-D14S63. The flanking loci D14S47 and D14S63 define a region of about 22 cM as containing the DRD gene.	YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT GENET,NEW HAVEN,CT 06510; UNIV PITTSBURGH,DEPT HUMAN GENET,PITTSBURGH,PA 15261; UNIV VIRGINIA,HLTH SCI CTR,DEPT NEUROL,CHARLOTTESVILLE,VA 22908; COLUMBIA PRESBYTERIAN MED CTR,DEPT PSYCHIAT,NEW YORK,NY 10032; COLUMBIA PRESBYTERIAN MED CTR,DEPT GENET & DEV,NEW YORK,NY 10032	Yale University; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Virginia; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital	NYGAARD, TG (corresponding author), COLUMBIA PRESBYTERIAN MED CTR,DEPT NEUROL,NEW YORK,NY 10032, USA.		Weeks, Daniel E/B-2995-2012	Weeks, Daniel E/0000-0001-9410-7228	NHGRI NIH HHS [HG00648] Funding Source: Medline; NICHD NIH HHS [HD00914] Funding Source: Medline; NINDS NIH HHS [NS30024] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD000914] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS030024] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTROCCHI PH, 1983, NEUROLOGY, V33, P802, DOI 10.1212/WNL.33.6.802; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; BRAVERMAN MS, 1985, COMPUT BIOMED RES, V8, P24; BRESSMAN SB, 1989, ANN NEUROL, V26, P612, DOI 10.1002/ana.410260505; Cox Tara K., 1992, American Journal of Human Genetics, V51, pA33; DAUSSET J, 1986, PRESSE MED, V15, P1801; FAHN S, 1989, J NEUROL NEUROSUR PS, P96; FAHN S, 1987, MOVEMENT DISORD, V2, P332; FINK JK, 1988, NEUROLOGY, V38, P707, DOI 10.1212/WNL.38.5.707; FINK JK, 1989, NEUROLOGY, V39, P1393, DOI 10.1212/WNL.39.10.1393; FLETCHER NA, 1989, J NEUROL NEUROSUR PS, V52, P112, DOI 10.1136/jnnp.52.1.112; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HAZAN J, 1993, NAT GENET, V5, P163, DOI 10.1038/ng1093-163; Hornykiewicz O, 1988, Adv Neurol, V50, P157; KRAMER PL, 1990, ANN NEUROL, V27, P114, DOI 10.1002/ana.410270203; KUPKE KG, 1990, NEUROLOGY, V40, P1438, DOI 10.1212/WNL.40.9.1438; KWIATKOWSKI DJ, 1991, AM J HUM GENET, V48, P121; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEWITT PA, 1986, NEUROLOGY, V36, P760, DOI 10.1212/WNL.36.6.760; MCGEER PL, 1977, ARCH NEUROL-CHICAGO, V34, P33, DOI 10.1001/archneur.1977.00500130053010; Nygaard T, 1993, HEREDITARY PROGR DYS, P97; Nygaard T G, 1988, Adv Neurol, V50, P377; NYGAARD TG, 1992, ANN NEUROL, V32, P603, DOI 10.1002/ana.410320502; NYGAARD TG, 1993, ADV NEUROL, V60, P577; NYGAARD TG, 1991, NEUROLOGY, V41, P174, DOI 10.1212/WNL.41.2_Part_1.174; NYGAARD TG, 1990, NEUROLOGY, V40, P66, DOI 10.1212/WNL.40.1.66; OZELIUS L, 1989, NEURON, V2, P1427, DOI 10.1016/0896-6273(89)90188-8; RAJPUT AH, 1992, MOV DISORD S1, V7, P124; SCHUBACK D, 1991, HUM GENET, V87, P311, DOI 10.1007/BF00200910; SHARMA V, 1991, NUCLEIC ACIDS RES, V19, P1722, DOI 10.1093/nar/19.7.1722; STRAUB RE, 1993, GENOMICS, V15, P48, DOI 10.1006/geno.1993.1008; WANG ZY, 1992, GENOMICS, V13, P532, DOI 10.1016/0888-7543(92)90121-8; WATERS CH, 1993, MOVEMENT DISORD, V8, P387, DOI 10.1002/mds.870080328; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WILHELMSEN KC, 1991, ANN NEUROL, V29, P124, DOI 10.1002/ana.410290203; ZEMAN W, 1970, NEUROLOGY, V20, P79, DOI 10.1212/WNL.20.11_Part_2.79	39	156	170	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1993	5	4					386	391		10.1038/ng1293-386	http://dx.doi.org/10.1038/ng1293-386			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ML145	8298648				2022-12-25	WOS:A1993ML14500016
J	SHIANG, R; RYAN, SG; ZHU, YZ; HAHN, AF; OCONNELL, P; WASMUTH, JJ				SHIANG, R; RYAN, SG; ZHU, YZ; HAHN, AF; OCONNELL, P; WASMUTH, JJ			MUTATIONS IN THE ALPHA-1 SUBUNIT OF THE INHIBITORY GLYCINE RECEPTOR CAUSE THE DOMINANT NEUROLOGIC DISORDER, HYPEREKPLEXIA	NATURE GENETICS			English	Article							GRADIENT GEL-ELECTROPHORESIS; SINGLE-BASE CHANGES; CHROMOSOMAL LOCALIZATION; STARTLE DISEASE; FUNCTIONAL EXPRESSION; GENES; MOUSE; HYPEREXPLEXIA; ASSIGNMENT; FRAGMENTS	Hereditary hyperekplexia, or familiar startle disease (STHE), is an autosomal dominant neurologic disorder characterized by marked muscle rigidity of central nervous system origin and an exaggerated startle response to unexpected acoustic or tactile stimuli. Linkage analyses in several large families provided evidence for locus homogeneity and showed the disease gene was linked to DNA markers on the long arm of chromosome 5. Here we describe the identification of point mutations in the gene encoding the alpha(1) subunit of the glycine receptor (GLRA1) in STHE patients from four different families. All mutations occur in the same base pair of exon 6 and result in the substitution of an uncharged amino acid (leucine or glutamine) for Arg271 in the mature protein.	UNIV CALIF IRVINE,DEPT BIOL CHEM,IRVINE,CA 92717; UNIV TEXAS,HLTH SCI CTR,DEPT PEDIAT,SAN ANTONIO,TX 78284; UNIV TEXAS,HLTH SCI CTR,DEPT PATHOL,SAN ANTONIO,TX 78284; UNIV WESTERN ONTARIO,DEPT CLIN NEUROL STUDIES,LONDON,ON,CANADA	University of California System; University of California Irvine; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Western University (University of Western Ontario)								ANDERMANN F, 1980, BRAIN, V103, P985, DOI 10.1093/brain/103.4.985; BECKER CM, 1992, NEURON, V8, P283, DOI 10.1016/0896-6273(92)90295-O; BECKER CM, 1988, EMBO J, V7, P3717, DOI 10.1002/j.1460-2075.1988.tb03255.x; BROWN P, 1991, BRAIN, V114, P1903, DOI 10.1093/brain/114.4.1903; BUCKLE VJ, 1989, NEURON, V3, P647, DOI 10.1016/0896-6273(89)90275-4; BUCKWALTER MS, 1993, GENOMICS, V17, P279, DOI 10.1006/geno.1993.1322; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; DANA S, 1982, SOMAT CELL GENET, V8, P245, DOI 10.1007/BF01538680; DAVIS M, 1982, J NEUROSCI, V2, P791; DAVIS M, 1976, PSYCHOPHARMACOLOGY, V47, P217, DOI 10.1007/BF00427605; EICHER EM, 1980, J HERED, V71, P315, DOI 10.1093/oxfordjournals.jhered.a109378; GIACOLA GP, IN PRESS AM J DIS CH; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; GRENNINGLOH G, 1990, EMBO J, V9, P771, DOI 10.1002/j.1460-2075.1990.tb08172.x; HELLER AH, 1982, BRAIN RES, V234, P299, DOI 10.1016/0006-8993(82)90870-8; KIRSTEIN L, 1958, ACTA PSYCH NEUROL, V33, P471, DOI 10.1111/j.1600-0447.1958.tb03533.x; KRNJEVIC K, 1981, HDB PHYSL, P107; LANE PW, 1987, J HERED, V78, P353, DOI 10.1093/oxfordjournals.jhered.a110414; LANGOSCH D, 1990, EUR J BIOCHEM, V194, P1, DOI 10.1111/j.1432-1033.1990.tb19419.x; LERMAN LS, 1987, METHOD ENZYMOL, V155, P482; MALOSIO ML, 1991, J BIOL CHEM, V266, P2048; MARKAND ON, 1984, ARCH NEUROL-CHICAGO, V41, P71, DOI 10.1001/archneur.1984.04050130077028; MATSUMOTO J, 1992, ANN NEUROL, V32, P41, DOI 10.1002/ana.410320108; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; NIGRO MA, 1992, PEDIATR NEUROL, V8, P221, DOI 10.1016/0887-8994(92)90073-8; OVERHAUSER J, 1987, NUCLEIC ACIDS RES, V15, P4617, DOI 10.1093/nar/15.11.4617; PUCKETT C, 1991, P NATL ACAD SCI USA, V88, P7557, DOI 10.1073/pnas.88.17.7557; RYAN SG, 1992, ANN NEUROL, V31, P663, DOI 10.1002/ana.410310615; RYAN SG, 1992, AM J HUM GENET, V51, P1334; SCHMIEDEN V, 1989, EMBO J, V8, P695, DOI 10.1002/j.1460-2075.1989.tb03428.x; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; SUHREN O, 1966, J NEUROL SCI, V3, P577, DOI 10.1016/0022-510X(66)90047-5; TEBECIS AK, 1972, BRAIN RES, V40, P373, DOI 10.1016/0006-8993(72)90140-0; Warrington J. A., 1992, American Journal of Human Genetics, V51, pA248; WARRINGTON JA, 1992, GENOMICS, V13, P803, DOI 10.1016/0888-7543(92)90156-M; WASMUTH JJ, 1991, CYTOGENET CELL GENET, V58, P261, DOI 10.1159/000133165	36	407	420	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1993	5	4					351	358		10.1038/ng1293-351	http://dx.doi.org/10.1038/ng1293-351			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ML145	8298642				2022-12-25	WOS:A1993ML14500010
J	TODA, T; SEGAWA, M; NOMURA, Y; NONAKA, I; MASUDA, K; ISHIHARA, T; SUZUKI, M; TOMITA, I; ORIGUCHI, Y; OHNO, K; MISUGI, N; SASAKI, Y; TAKADA, K; KAWAI, M; OTANI, K; MURAKAMI, T; SAITO, K; FUKUYAMA, Y; SHIMIZU, T; KANAZAWA, I; NAKAMURA, Y				TODA, T; SEGAWA, M; NOMURA, Y; NONAKA, I; MASUDA, K; ISHIHARA, T; SUZUKI, M; TOMITA, I; ORIGUCHI, Y; OHNO, K; MISUGI, N; SASAKI, Y; TAKADA, K; KAWAI, M; OTANI, K; MURAKAMI, T; SAITO, K; FUKUYAMA, Y; SHIMIZU, T; KANAZAWA, I; NAKAMURA, Y			LOCALIZATION OF A GENE FOR FUKUYAMA TYPE CONGENITAL MUSCULAR-DYSTROPHY TO CHROMOSOME 9Q31-33	NATURE GENETICS			English	Article							NERVOUS-SYSTEM INVOLVEMENT; LINKAGE MAP; DNA; ABNORMALITIES; POLYMORPHISM	Fukuyama type congenital muscular dystrophy (FCMD) is an autosomal recessive severe muscular dystrophy associated with an anomaly of the brain. Twenty-one FCMD families, 13 of them with consanguineous marriages, were analysed by genetic linkage analyses with polymorphic microsatellite markers to map the FCMD gene. Significant lod scores were obtained with the markers D9S58 (Z(max)=5.81 at theta=0.06), D9S59 (Z(max)=4.33 at theta=0.02), and HXB (Z(max)=3.28 at theta=0.09) on chromosome 9q31-33. Multipoint analysis placed FCMD between D9S58 and D9S59, with a maximum lod score of 16.93. These markers will be useful for presymptomatic, prenatal and carrier diagnosis of family members carrying FCMD, and they represent important resources for the identification of a gene responsible for FCMD.	UNIV TOKYO, DEPT NEUROL, TOKYO 113, JAPAN; NATL HARA HOSP, DEPT NEUROL & PSYCHIAT, HIROSHIMA, JAPAN; NATL SUZUKA HOSP, DEPT NEUROL, MIE, JAPAN; NATL KAWATANA HOSP, DEPT NEUROL, NAGASAKI, JAPAN; NATL NISHIBEPPU HOSP, DEPT PAEDIAT, OHITO, JAPAN; TOTTORI UNIV, SCH MED, DEPT CHILD NEUROL, TOTTORI 680, JAPAN; KANAGAWA CHILDRENS MED CTR, DEPT PATHOL, KANAGAWA, JAPAN; OSAKA MED CTR, DEPT PAEDIAT NEUROL, OSAKA, JAPAN; RES INST MATERNAL & CHILD HLTH, OSAKA, JAPAN; TOKYO WOMENS MED COLL, DEPT PAEDIAT, TOKYO 162, JAPAN; TEIKYO UNIV, DEPT NEUROL, TOKYO 173, JAPAN; SEGAWA NEUROL CLIN CHILDREN, TOKYO, JAPAN; NATL INST NEUROSCI, NATL CTR NEUROL & PSYCHIAT, TOKYO, JAPAN; NATL HIGASHISAITAMA HOSP, DEPT INTERNAL MED, SAITAMA, JAPAN; KANAGAWA CHILDRENS MED CTR, DEPT ORTHOPAED SURG, KANAGAWA, JAPAN; TOKYO METROPOLITAN INST NEUROSCI, DEPT CLIN NEUROPATHOL, TOKYO, JAPAN; NATL SHIMOSHIZU HOSP, DEPT NEUROL, CHIBA, JAPAN; TOKYO UNIV BRANCH HOSP, DEPT PATHOL, TOKYO, JAPAN	University of Tokyo; Tottori University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Tokyo Women's Medical University; Teikyo University; National Center for Neurology & Psychiatry - Japan; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science	TODA, T (corresponding author), JAPANESE FDN CANC RES, INST CANC, DEPT BIOCHEM, TOKYO 170, JAPAN.			Saito, Kayoko/0000-0003-2632-0873; Toda, Tatsushi/0000-0002-0717-1123				ARAHATA K, 1989, P NATL ACAD SCI USA, V86, P7154, DOI 10.1073/pnas.86.18.7154; ARIKAWA E, 1991, J NEUROL SCI, V105, P79, DOI 10.1016/0022-510X(91)90122-N; BEGGS AH, 1992, P NATL ACAD SCI USA, V89, P623, DOI 10.1073/pnas.89.2.623; BENHAMIDA C, 1993, NAT GENET, V5, P195, DOI 10.1038/ng1093-195; BENOTHMANE K, 1992, NAT GENET, V2, P315, DOI 10.1038/ng1292-315; BLUMENFELD A, 1993, NAT GENET, V4, P160, DOI 10.1038/ng0693-160; DOBYNS WB, 1989, AM J MED GENET, V32, P195, DOI 10.1002/ajmg.1320320213; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; FARRALL M, 1993, NAT GENET, V5, P107, DOI 10.1038/ng1093-107; FUKUYAMA Y, 1981, BRAIN DEV-JPN, V3, P1; Fukuyama Y, 1960, PAEDIAT U TOKYO, V4, P5; GOELZ SE, 1985, BIOCHEM BIOPH RES CO, V130, P118, DOI 10.1016/0006-291X(85)90390-0; GOTO M, 1992, NATURE, V355, P735, DOI 10.1038/355735a0; GUYER M, 1992, SCIENCE, V258, P67; Ibraghimov-Beskrovnaya O., 1992, American Journal of Human Genetics, V51, pA130; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MATSUMURA K, 1993, LANCET, V341, P521, DOI 10.1016/0140-6736(93)90279-P; NONAKA I, 1982, MUSCLE NERVE, V5, P102, DOI 10.1002/mus.880050204; OSAWA M, 1978, J TOKYO WOMENS MED C, V48, P112; Ozelius L., 1992, Human Molecular Genetics, V1, P141, DOI 10.1093/hmg/1.2.141-a; OZELIUS LJ, 1992, GENOMICS, V14, P715, DOI 10.1016/S0888-7543(05)80173-9; POLLAK MR, 1993, NAT GENET, V5, P201, DOI 10.1038/ng1093-201; PRAS E, 1992, NEW ENGL J MED, V326, P1509, DOI 10.1056/NEJM199206043262301; Sambrook J, 1989, MOL CLONING; SANTAVUORI P, 1980, POPULATION STRUCTURE, P647; TAKADA K, 1984, J NEUROPATH EXP NEUR, V43, P395, DOI 10.1097/00005072-198407000-00005; TAKESHITA K, 1977, JPN J HUM GENET, V22, P43, DOI 10.1007/BF01908284; TANAKA K, 1990, NATURE, V348, P73, DOI 10.1038/348073a0; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	32	249	257	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1993	5	3					283	286		10.1038/ng1193-283	http://dx.doi.org/10.1038/ng1193-283			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MF122	8275093				2022-12-25	WOS:A1993MF12200021
J	HAZAN, J; LAMY, C; MELKI, J; MUNNICH, A; DERECONDO, J; WEISSENBACH, J				HAZAN, J; LAMY, C; MELKI, J; MUNNICH, A; DERECONDO, J; WEISSENBACH, J			AUTOSOMAL-DOMINANT FAMILIAL SPASTIC PARAPLEGIA IS GENETICALLY HETEROGENEOUS AND ONE LOCUS MAPS TO CHROMOSOME-14Q	NATURE GENETICS			English	Article							LINKAGE ANALYSIS	Autosomal dominant familial spastic paraplegia (FSP) is a degenerative disorder of unknown aetiology characterized by a progressive spasticity of the legs. Three families with autosomal dominant FSP of early onset were analysed in linkage studies using highly polymorphic microsatellite markers. Close linkage to a group of markers on chromosome 14q (maximum multipoint lodscore z=10) was observed in one family. This chromosome 14q candidate region was entirely excluded in the two other families, providing evidence of genetic heterogeneity within a homogeneous clinical form of FSP.	INST PASTEUR,CNRS,UNITE GENET MOLEC HUMAINE,URA 1445,25 DOCTEUR ROUX,F-75724 PARIS 15,FRANCE; HOP ST ANNE,CTR RAYMOND GARCIN,SERV NEUROL,F-75674 PARIS 14,FRANCE; HOP NECKER ENFANTS MALAD,UNITE RECH HANDICAPS GENET ENFANT,INSERM,U12,F-75743 PARIS 15,FRANCE	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite				Hazan, Jamile/0000-0001-8119-0325				BOUSTANY RMN, 1987, NEUROLOGY, V37, P910, DOI 10.1212/WNL.37.6.910; CHURCH GM, 1988, SCIENCE, V240, P185, DOI 10.1126/science.3353714; Claudio J. O., 1992, American Journal of Human Genetics, V51, pA361; HARDING AE, 1983, LANCET, V1, P1151; HARDING AE, 1981, J NEUROL NEUROSUR PS, V44, P871, DOI 10.1136/jnnp.44.10.871; HAZAN J, 1992, GENOMICS, V12, P183, DOI 10.1016/0888-7543(92)90364-X; HOLMES GL, 1977, J NEUROL NEUROSUR PS, V40, P1003, DOI 10.1136/jnnp.40.10.1003; KENWRICK S, 1986, HUM GENET, V73, P264, DOI 10.1007/BF00401241; KEPPEN LD, 1987, AM J HUM GENET, V41, P933; LATHROP GM, 1985, AM J HUM GENET, V37, P482; McKusick VA, 1990, MENDELIAN INHERITANC; POLO JM, 1993, J NEUROL NEUROSUR PS, V56, P175, DOI 10.1136/jnnp.56.2.175; SCHADY W, 1990, BRAIN, V113, P709, DOI 10.1093/brain/113.3.709; Seeligmuller A, 1876, DEUT MED WOCHENSCHR, V2, P185; Struampell A., 1880, ARCH PSYCHIAT NERVEN, V10, P676, DOI [10.1007/BF02224539, DOI 10.1007/BF02224539, 10.1007/bf02054821]; SUTHERLAND JM, 1975, HDB CLIN NEUROLOGY, V22, P421; SUTHERS GK, 1992, AM J HUM GENET, V50, P887; VANCE JM, 1991, J MED GENET, V28, P1, DOI 10.1136/jmg.28.1.1; VANDEUTEKORM J, 1992, AM J HUM GENET, V52, pA375; VIGNAL A, 1993, IN PRESS METHODS MOL, V1; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	21	160	163	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1993	5	2					163	167		10.1038/ng1093-163	http://dx.doi.org/10.1038/ng1093-163			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MA056	8252041				2022-12-25	WOS:A1993MA05600014
J	SNELL, RG; MACMILLAN, JC; CHEADLE, JP; FENTON, I; LAZAROU, LP; DAVIES, P; MACDONALD, ME; GUSELLA, JF; HARPER, PS; SHAW, DJ				SNELL, RG; MACMILLAN, JC; CHEADLE, JP; FENTON, I; LAZAROU, LP; DAVIES, P; MACDONALD, ME; GUSELLA, JF; HARPER, PS; SHAW, DJ			RELATIONSHIP BETWEEN TRINUCLEOTIDE REPEAT EXPANSION AND PHENOTYPIC VARIATION IN HUNTINGTONS-DISEASE	NATURE GENETICS			English	Article							MYOTONIC-DYSTROPHY; TRANSMISSION; PATTERNS; REGION; ONSET; GENE; AGE	The molecular analysis of a specific CAG repeat sequence in the Huntington's disease gene in 440 Huntington's disease patients and 360 normal controls reveals a range of 30-70 repeats in affected individuals and 9-34 in normals. We find significant negative correlations between the number of repeats on the HD chromosome and age at onset, regardless of sex of the transmitting parent, and between the number of repeats on the normal paternal allele and age at onset in individuals with maternally transmitted disease. This effect of the normal paternal allele may account for the weaker age at onset correlation between affected sib pairs with disease of maternal as opposed to paternal origin and suggests that normal gene function varies because of the size of the repeat in the normal range and a sex-specific modifying effect.	UNIV WALES COLL MED,INST MED GENET,HEATH PK,CARDIFF CF4 4XN,S GLAM,WALES; MASSACHUSETTS GEN HOSP,MOLEC NEUROGENET UNIT,BOSTON,MA 02114; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115	Cardiff University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School			MacMillan, John C/C-9591-2011	Snell, Russell/0000-0002-8166-4014	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; FARRER LA, 1984, AM J MED GENET, V18, P115, DOI 10.1002/ajmg.1320180115; FARRER LA, 1985, AM J HUM GENET, V37, P350; FARRER LA, IN PRESS AM J HUM GE; FENTON I, 1992, 2ND INT WORKSH PKD, P70; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; HARPER PS, 1992, AM J HUM GENET, V51, P10; Harper PS, 1991, HUNTINGTONS DISEASE; KRAWCZAK M, 1991, AM J HUM GENET, V49, P735; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MACDONALD ME, 1991, AM J HUM GENET, V49, P723; MERRITT AD, 1969, PROGR NEUROGENETICS, P645; MYERS RH, 1983, LANCET, V1, P208; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; RIDLEY RM, 1991, J MED GENET, V28, P224, DOI 10.1136/jmg.28.4.224; SNELL RG, 1989, J MED GENET, V26, P273; THEILMANN J, 1989, J MED GENET, V26, P676, DOI 10.1136/jmg.26.11.676; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WENT LN, 1983, ANN HUM GENET, V47, P205, DOI 10.1111/j.1469-1809.1983.tb00989.x; WENT LN, 1984, LANCET, V1, P1100; 1993, CELL, V72, P971	22	612	623	1	30	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1993	4	4					393	397		10.1038/ng0893-393	http://dx.doi.org/10.1038/ng0893-393			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LQ178	8401588				2022-12-25	WOS:A1993LQ17800018
J	SABOURI, LA; MAHADEVAN, MS; NARANG, M; LEE, DSC; SURH, LC; KORNELUK, RG				SABOURI, LA; MAHADEVAN, MS; NARANG, M; LEE, DSC; SURH, LC; KORNELUK, RG			EFFECT OF THE MYOTONIC-DYSTROPHY (DM) MUTATION ON MESSENGER-RNA LEVELS OF THE DM GENE	NATURE GENETICS			English	Article							FRAGILE-X SYNDROME; EXPRESSION; EXTRACTION; STABILITY; FRAGMENTS; ARREST; MUSCLE	Myotonic dystrophy (DM) results from the amplification of an unstable CTG repeat in the 3' untranslated region of a transcript encoding a putative serine/threonine kinase. We have analysed the amplification of the repeat and the steady state levels of the DM kinase (DMK) mRNA in tissues and cell lines from normal and congenital DM individuals. Southern blot analysis of DNA samples from a severely affected neonate shows somatic heterogeneity of the repeat in all tissues studied. RNA analyses on these tissues show a marked increase in DMK steady state mRNA levels. We demonstrate that the mutant DMK allele is expressed regardless of the number of CTG repeats and that the increase in DMK mRNA levels is due to elevated mutant mRNA levels. We postulate that elevated DMK levels explains the dominant inheritance pattern of DM.	UNIV OTTAWA,DEPT MICROBIOL & IMMUNOL,OTTAWA K1H 8M5,ONTARIO,CANADA; CHILDRENS HOSP EASTERN ONTARIO,DIV GENET,OTTAWA K1H 8L1,ON,CANADA; UNIV WESTERN ONTARIO,ST JOSEPHS HLTH CTR,LONDON NGA 6V2,ON,CANADA	University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; Western University (University of Western Ontario)								ANNEMIEKE J, 1991, CELL, V65, P905; ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BARCELONA JM, IN PRESS HUM MOL GEN; BELL MV, 1991, CELL, V64, P861, DOI 10.1016/0092-8674(91)90514-Y; BERNSTEIN PL, 1992, GENE DEV, V6, P642, DOI 10.1101/gad.6.4.642; BIRNBOIM HC, 1988, NUCLEIC ACIDS RES, V16, P1487, DOI 10.1093/nar/16.4.1487; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; CASKEY CT, 1992, SCIENCE, V256, P784, DOI 10.1126/science.1589758; DIX DJ, 1992, BIOCHEMISTRY-US, V31, P2818, DOI 10.1021/bi00125a024; DRETZEN G, 1981, ANAL BIOCHEM, V112, P295, DOI 10.1016/0003-2697(81)90296-7; FARKASBARGETON E, 1988, J NEUROL SCI, V83, P145, DOI 10.1016/0022-510X(88)90064-0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1993, SCIENCE, V260, P235, DOI 10.1126/science.8469976; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GILILAND G, 1990, P NATL ACAD SCI USA, V87, P2725; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; Harper P.S., 1989, MYOTONIC DYSTROPHY; HOWELER CJ, 1989, BRAIN, V112, P779, DOI 10.1093/brain/112.3.779; JANSEN G, 1992, NAT GENET, V1, P261, DOI 10.1038/ng0792-261; KASPAR RL, 1992, J BIOL CHEM, V267, P508; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LI L, 1992, CELL, V71, P1181, DOI 10.1016/S0092-8674(05)80066-2; LI L, 1992, MOL CELL BIOL, V12, P4478, DOI 10.1128/MCB.12.10.4478; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MAHADEVAN M, IN PRESS HUM MOL GEN; MCALLISTER RM, 1969, CANCER-AM CANCER SOC, V24, P520, DOI 10.1002/1097-0142(196909)24:3<520::AID-CNCR2820240313>3.0.CO;2-M; MCCORMACK SJ, 1992, VIROLOGY, V188, P47, DOI 10.1016/0042-6822(92)90733-6; MULLNER EW, 1989, CELL, V58, P373, DOI 10.1016/0092-8674(89)90851-9; MULLNER EW, 1988, CELL, V53, P815, DOI 10.1016/0092-8674(88)90098-0; PELTZ S W, 1991, Critical Reviews in Eukaryotic Gene Expression, V1, P99; PIECHACZYK M, 1984, NUCLEIC ACIDS RES, V12, P6951, DOI 10.1093/nar/12.18.6951; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; PUISSANT C, 1990, BIOTECHNIQUES, V8, P148; RICHARDS RI, 1992, CELL, V70, P709, DOI 10.1016/0092-8674(92)90302-S; SABOURIN LA, 1990, J CELL PHYSIOL, V145, P564, DOI 10.1002/jcp.1041450325; Sambrook J, 1989, MOL CLONING LABORATO; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P466, DOI 10.1001/archneur.1976.00500070008002; SENGUPTA DN, 1990, P NATL ACAD SCI USA, V87, P7492, DOI 10.1073/pnas.87.19.7492; SOUSSIYANICOSTA.N, 1992, NEUROMUSCULAR DISORD, V1, P103; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; TSLIFIDIS C, 1992, NAT GENET, V1, P192; VANIER TM, 1960, BRIT MED J, V2, P1285; WISDOM R, 1990, J BIOL CHEM, V265, P19015; ZUCKER M, 1981, NUCLEIC ACIDS RES, V9, P133; 1993, CELL, V72, P971	48	147	149	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1993	4	3					233	238		10.1038/ng0793-233	http://dx.doi.org/10.1038/ng0793-233			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ842	8358430				2022-12-25	WOS:A1993LJ84200009
J	GEORGES, M; DRINKWATER, R; KING, T; MISHRA, A; MOORE, SS; NIELSEN, D; SARGEANT, LS; SORENSEN, A; STEELE, MR; ZHAO, XY; WOMACK, JE; HETZEL, J				GEORGES, M; DRINKWATER, R; KING, T; MISHRA, A; MOORE, SS; NIELSEN, D; SARGEANT, LS; SORENSEN, A; STEELE, MR; ZHAO, XY; WOMACK, JE; HETZEL, J			MICROSATELLITE MAPPING OF A GENE AFFECTING HORN DEVELOPMENT IN BOS-TAURUS	NATURE GENETICS			English	Article							MARKERS	The presence or absence of horns in Bos taurus is thought to be under the genetic control of the autosomal polled locus, characterized by two alleles: P dominant over p, and causing the polled or hornless phenotype. We have demonstrated genetic linkage between the polled locus and two microsatellite markers, GMPOLL-1 and GMPOLL-2, and have assigned the corresponding linkage group to bovine chromosome 1. This confirms the existence of the postulated polled locus and the hypothesized inheritance pattern. It will allow marker assisted selection for the polledness trait in breeding programs and is a first step towards positional cloning and molecular study of a gene that has been subjected to both natural and artificial selection.	UNIV QUEENSLAND,CSIRO,CTR MOLEC ANIM GENET,DIV TROP ANIM PRODUCT,BRISBANE,QLD 4072,AUSTRALIA; TEXAS A&M UNIV SYST,COLL VET MED,DEPT PATHOBIOL,COLL STN,TX 77843	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; Texas A&M University System; Texas A&M University College Station	GEORGES, M (corresponding author), GENMARK INC,421 WAKARA WAY,SALT LAKE CITY,UT 84108, USA.		Moore, Stephen S/F-5285-2013	Moore, Stephen/0000-0002-9758-166X; Georges, Michel/0000-0003-4124-2375; Nielsen, Dahlia/0000-0003-0123-6085				BATESON W, 1902, REPORTS EVOLUTIONARY, V1; BRICKER RA, 1991, 36TH ANN M GEN SOC C; BURGOYNE PS, 1982, HUM GENET, V61, P85, DOI 10.1007/BF00274192; CHEVALET C, 1986, CYTOGENET CELL GENET, V43, P132, DOI 10.1159/000132311; DIETZ AB, 1992, MAMM GENOME, V3, P106, DOI 10.1007/BF00431254; Dove WF, 1935, J EXP ZOOL, V69, P347, DOI 10.1002/jez.1400690302; FRISCH JE, 1980, ANIM PROD, V31, P119, DOI 10.1017/S000335610002434X; GEORGES M, 1993, P NATL ACAD SCI USA, V90, P1058, DOI 10.1073/pnas.90.3.1058; GEORGES M, 1991, GENOMICS, V11, P24, DOI 10.1016/0888-7543(91)90098-Y; GEORGES M, 1992, Patent No. 13102; JOHANSSON I, 1968, GENETICS ANIMAL BREE, P180; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LONG CR, 1978, J HERED, V69, P395, DOI 10.1093/oxfordjournals.jhered.a108980; MEISCHKE HR, 1974, AUST VET J, V50, P432, DOI 10.1111/j.1751-0813.1974.tb06864.x; O'Brien S.J., 1991, Current Opinion in Genetics & Development, V1, P105, DOI 10.1016/0959-437X(91)80050-V; OBRIEN SJ, 1991, CYTOGENET CELL GENET, V58, P1124, DOI 10.1159/000133725; Smith ADB, 1927, J GENET, V18, P365, DOI 10.1007/BF02983113; SOLLER M, 1969, CYTOGENETICS, V8, P51, DOI 10.1159/000130022; STEELE MR, 1991, GENOMICS, V10, P889, DOI 10.1016/0888-7543(91)90177-G; White WT, 1936, J GENET, V32, P33, DOI 10.1007/BF02982500; WOMACK JE, 1986, J HERED, V77, P2, DOI 10.1093/oxfordjournals.jhered.a110160; [No title captured]	23	124	133	1	19	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1993	4	2					206	210		10.1038/ng0693-206	http://dx.doi.org/10.1038/ng0693-206			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LF816	8348158				2022-12-25	WOS:A1993LF81600025
J	NELSON, SF; MCCUSKER, JH; SANDER, MA; KEE, Y; MODRICH, P; BROWN, PO				NELSON, SF; MCCUSKER, JH; SANDER, MA; KEE, Y; MODRICH, P; BROWN, PO			GENOMIC MISMATCH SCANNING - A NEW APPROACH TO GENETIC-LINKAGE MAPPING	NATURE GENETICS			English	Article							AFFECTED RELATIVE PAIRS; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; COMPLEX TRAITS; DNA; MAP; HYBRIDIZATION; STRATEGIES; PRODUCT; SYSTEM	Genomic mismatch scanning (GMS) is a new method of genetic linkage analysis that does not require conventional polymorphic markers or gel electrophoresis. GMS is ideally suited to affected-relative-pair mapping. DNA fragments from all regions of identity-by-descent between two relatives are isolated based on their ability to form extensive mismatch-free hybrid molecules. The genomic origin of this selected pool of DNA fragments is then mapped in a single hybridization step. Here we demonstrate the practicality of GMS in a model organism, Saccharomyces cerevisiae. GMS is likely to be applicable to other organisms, including humans, and may be of particular value in mapping complex genetic traits.	STANFORD UNIV, MED CTR, DEPT PEDIAT, STANFORD, CA 94305 USA; STANFORD UNIV, MED CTR, DEPT BIOCHEM, STANFORD, CA 94305 USA; STANFORD UNIV, MED CTR, HOWARD HUGHES MED INST, STANFORD, CA 94305 USA; DUKE UNIV, MED CTR, DEPT BIOCHEM, DURHAM, NC 27710 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Duke University			Nelson, Stanley F/D-4771-2009	Nelson, Stanley F/0000-0002-2082-3114; Modrich, Paul/0000-0001-8708-9885; McCusker, John/0000-0002-8803-9131				AU KG, 1992, J BIOL CHEM, V267, P12142; BELLANNECHANTELOT C, 1992, CELL, V70, P1059, DOI 10.1016/0092-8674(92)90254-A; BISHOP DT, 1990, AM J HUM GENET, V46, P254; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; CASNA NJ, 1986, NUCLEIC ACIDS RES, V14, P7285, DOI 10.1093/nar/14.18.7285; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; COOPER DN, 1985, HUM GENET, V69, P201, DOI 10.1007/BF00293024; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P266; FEINGOLD E, IN PRESS AM J HUM GE; FOOTE S, 1992, SCIENCE, V258, P60, DOI 10.1126/science.1359640; GRILLEY M, 1989, J BIOL CHEM, V264, P1000; GUYER M, 1992, SCIENCE, V258, P67; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; KOHNE DE, 1977, BIOCHEMISTRY-US, V16, P5329, DOI 10.1021/bi00643a026; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; LANDER ES, 1986, COLD SPRING HARB SYM, V51, P49, DOI 10.1101/SQB.1986.051.01.007; LEARN BA, 1989, J BACTERIOL, V171, P6473, DOI 10.1128/jb.171.12.6473-6481.1989; MELTZER PS, 1992, NAT GENET, V1, P24, DOI 10.1038/ng0492-24; MORTIMER RK, 1989, YEAST, V5, P321, DOI 10.1002/yea.320050503; OLIVER SG, 1992, NATURE, V357, P38, DOI 10.1038/357038a0; PHILIPPSEN P, 1991, METHOD ENZYMOL, V194, P169; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; RILES L, IN PRESS GENETICS; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P242; SANDA AI, 1986, NUCLEIC ACIDS RES, V14, P1765; SEDAT JW, 1967, J MOL BIOL, V26, P537, DOI 10.1016/0022-2836(67)90321-X; SIKORSKI RS, 1989, GENETICS, V122, P19; SU SS, 1986, P NATL ACAD SCI USA, V83, P5057, DOI 10.1073/pnas.83.14.5057; SU SS, 1988, J BIOL CHEM, V263, P6829; WELSH KM, 1987, J BIOL CHEM, V262, P15624	31	100	130	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1993	4	1					11	18		10.1038/ng0593-11	http://dx.doi.org/10.1038/ng0593-11			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LA337	8513319				2022-12-25	WOS:A1993LA33700006
J	TAN, SS; WILLIAMS, EA; TAM, PPL				TAN, SS; WILLIAMS, EA; TAM, PPL			X-CHROMOSOME INACTIVATION OCCURS AT DIFFERENT TIMES IN DIFFERENT TISSUES OF THE POSTIMPLANTATION MOUSE EMBRYO	NATURE GENETICS			English	Article							FEMALE MOUSE; EXPRESSION; MEMBRANES; LINE	During mammalian development, one of the two X chromosomes in female embryos is randomly inactivated in the somatic cell in order to achieve gene dosage compensation. But is X inactivation established simultaneously or is it accomplished over time in a lineage-dependent fashion? We have examined this question in mouse embryos carrying an X-linked lacZ transgene. This transgene is subject to inactivation and the loss of beta-galactosidase activity provides a direct indication of X inactivation in individual cells. We find that X inactivation proceeds with different schedules in different somatic tissues, and the notochord, the heart, cranial mesoderm and the hindgut are among the last tissues to undergo X inactivation.	CHILDRENS MED RES INST,EMBRYOL UNIT,WENTWORTHVILLE,NSW 2145,AUSTRALIA	Children's Medical Research Institute - Australia	TAN, SS (corresponding author), UNIV MELBOURNE,DEPT ANAT,EMBRYOL LAB,PARKVILLE,VIC 3052,AUSTRALIA.							ADLER DA, 1977, NATURE, V267, P838, DOI 10.1038/267838a0; CATTANACH BM, 1975, ANNU REV GENET, V9, P1, DOI 10.1146/annurev.ge.09.120175.000245; COLLICK A, 1988, DEVELOPMENT, V104, P235; EPSTEIN CJ, 1978, NATURE, V274, P500, DOI 10.1038/274500a0; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; GAUTIER C, 1989, NUCLEIC ACIDS RES, V20, P8398; GOLDMAN MA, 1987, SCIENCE, V536, P593; GRANT M, 1992, NAT GENET, V2, P161, DOI 10.1038/ng1092-161; GRANT SG, 1988, ANNU REV GENET, V22, P199, DOI 10.1146/annurev.ge.22.120188.001215; GRIFFITHS DFR, 1988, NATURE, V333, P461, DOI 10.1038/333461a0; KRATZER PG, 1978, NATURE, V274, P503, DOI 10.1038/274503a0; KRUMLAUF R, 1986, NATURE, V319, P224, DOI 10.1038/319224a0; LAWSON KA, 1991, DEVELOPMENT, V113, P891; LOCK LF, 1987, CELL, V48, P39, DOI 10.1016/0092-8674(87)90353-9; LYON MF, 1964, CYTOGENETICS, V3, P306, DOI 10.1159/000129820; MONK M, 1981, DIFFERENTIATION, V19, P71, DOI 10.1111/j.1432-0436.1981.tb01131.x; MONK M, 1978, J EMBRYOL EXP MORPH, V46, P53; MONK M, 1979, NATURE, V281, P311, DOI 10.1038/281311a0; OHNO S, 1965, CHROMOSOMA, V16, P90, DOI 10.1007/BF00320564; PONDER BAJ, 1985, NATURE, V313, P689, DOI 10.1038/313689a0; RASTAN S, 1980, NATURE, V288, P172, DOI 10.1038/288172a0; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; TAKAGI N, 1982, CHROMOSOMA, V85, P275, DOI 10.1007/BF00294971; TAKAGI N, 1974, EXP CELL RES, V86, P127, DOI 10.1016/0014-4827(74)90657-0; TAKAGI N, 1990, DEVELOPMENT, V109, P189; TAM PPL, 1992, DEVELOPMENT, V115, P703; TAM PPL, 1992, CIBA F SYMP, V165, P27; WEST JD, 1977, CELL, V12, P873, DOI 10.1016/0092-8674(77)90151-9; WEST JD, 1978, GENET RES, V32, P91, DOI 10.1017/S0016672300018565	29	227	229	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1993	3	2					170	174		10.1038/ng0293-170	http://dx.doi.org/10.1038/ng0293-170			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KL010	8499950				2022-12-25	WOS:A1993KL01000016
J	Waisman, A; Ruiz, PJ; Hirschberg, DL; Gelman, A; Oksenberg, JR; Brocke, S; Mor, F; Cohen, IR; Steinman, L				Waisman, A; Ruiz, PJ; Hirschberg, DL; Gelman, A; Oksenberg, JR; Brocke, S; Mor, F; Cohen, IR; Steinman, L			Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity	NATURE MEDICINE			English	Article							MYELIN-BASIC-PROTEIN; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; V-BETA-6.1 CDR2 PEPTIDES; MULTIPLE-SCLEROSIS; LYMPHOCYTE-T; TCR PEPTIDES; IMMUNIZATION; DISEASE; ANTIBODY; THERAPY	A variable region gene of the T-cell receptor, V beta 8.2, is rearranged, and its product is expressed on pathogenic T cells that induce experimental autoimmune encephalomyelitis (EAE) in H-2(u) mice after immunization with myelin basic protein (MBP). Vaccination of these mice with naked DNA encoding V beta 8.2 protected mice from EAE. Analysis of T cells reacting to the pathogenic portion of the MBP molecule indicated that in the vaccinated mice there was a reduction in the Th1 cytokines interleukin-2 (IL-2) and interferon-gamma. In parallel, there was an elevation in the production of IL-4, a Th2 cytokine associated with suppression of disease. A novel feature of DNA immunization for autoimmune disease, reversal of the autoimmune response from Th1 to Th2, may make this approach attractive for treatment of Th1-mediated diseases like multiple sclerosis, juvenile diabetes and rheumatoid arthritis.	WEIZMANN INST SCI,DEPT IMMUNOL,IL-76100 REHOVOT,ISRAEL; WEIZMANN INST SCI,DEPT NEUROBIOL,IL-76100 REHOVOT,ISRAEL; STANFORD UNIV,DEPT NEUROL,STANFORD,CA 94305; STANFORD UNIV,DEPT NEUROL SCI,STANFORD,CA 94305; UNIV CALIF SAN FRANCISCO,DEPT NEUROL,SAN FRANCISCO,CA 94143	Weizmann Institute of Science; Weizmann Institute of Science; Stanford University; Stanford University; University of California System; University of California San Francisco			Waisman, Ari/C-7383-2015; Cohen, Irun R/B-3542-2009; Mor, Felix/K-1093-2012	Waisman, Ari/0000-0003-4304-8234; Steinman, Lawrence/0000-0002-2437-2250	NINDS NIH HHS [NS 18235] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018235] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABBAS AK, 1991, IMMUNOL REV, V123, P5, DOI 10.1111/j.1600-065X.1991.tb00603.x; ACHAORBEA H, 1988, CELL, V54, P263, DOI 10.1016/0092-8674(88)90558-2; BENNUN A, 1981, NATURE, V292, P60, DOI 10.1038/292060a0; BOURDETTE DN, 1994, J IMMUNOL, V152, P2510; Brocke S, 1996, NATURE, V379, P343, DOI 10.1038/379343a0; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; CHOU YK, 1994, J IMMUNOL, V152, P2520; DAVIS HL, 1993, HUM MOL GENET, V2, P1847, DOI 10.1093/hmg/2.11.1847; DAVIS HL, 1993, FEBS LETT, V333, P146, DOI 10.1016/0014-5793(93)80393-9; HOWELL MD, 1989, SCIENCE, V246, P668, DOI 10.1126/science.2814489; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; LEHMANN PV, 1992, NATURE, V358, P155, DOI 10.1038/358155a0; LIDER O, 1988, SCIENCE, V239, P181, DOI 10.1126/science.2447648; MEDAER R, 1995, LANCET, V346, P807, DOI 10.1016/S0140-6736(95)91622-9; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; OKSENBERG JR, 1993, NATURE, V362, P68, DOI 10.1038/362068a0; PARDOLL DM, 1995, IMMUNITY, V3, P165, DOI 10.1016/1074-7613(95)90085-3; POWELL MB, 1990, INT IMMUNOL, V2, P539, DOI 10.1093/intimm/2.6.539; RACKE MK, 1994, J EXP MED, V180, P1961, DOI 10.1084/jem.180.5.1961; SAKAI K, 1988, J NEUROIMMUNOL, V19, P21, DOI 10.1016/0165-5728(88)90032-X; SAKAI K, 1988, P NATL ACAD SCI USA, V85, P8608, DOI 10.1073/pnas.85.22.8608; Sambrook J., 2002, MOL CLONING LAB MANU; STEINMAN L, 1995, CELL, V80, P7, DOI 10.1016/0092-8674(95)90443-3; STEINMAN L, 1995, MOL MED TODAY, V1, P79, DOI 10.1016/S1357-4310(95)92366-7; STEINMAN L, 1995, NATURE, V375, P739, DOI 10.1038/375739b0; TANG DC, 1992, NATURE, V356, P152, DOI 10.1038/356152a0; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; URBAN JL, 1988, CELL, V54, P577, DOI 10.1016/0092-8674(88)90079-7; VANDENBARK AA, 1989, NATURE, V341, P541, DOI 10.1038/341541a0; WARREN KG, 1995, P NATL ACAD SCI USA, V92, P11061, DOI 10.1073/pnas.92.24.11061; WRAITH DC, 1989, CELL, V57, P709, DOI 10.1016/0092-8674(89)90786-1; WUCHERPFENNIG KW, 1990, SCIENCE, V248, P1016, DOI 10.1126/science.1693015; XU D, 1995, IMMUNOLOGY, V84, P173; ZAMVIL SS, 1988, J EXP MED, V167, P1586, DOI 10.1084/jem.167.5.1586; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051; ZAMVIL SS, 1988, J EXP MED, V168, P1181, DOI 10.1084/jem.168.3.1181; ZHANG JW, 1993, SCIENCE, V261, P1451, DOI 10.1126/science.7690157	37	225	241	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	AUG	1996	2	8					899	905		10.1038/nm0896-899	http://dx.doi.org/10.1038/nm0896-899			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UZ804	8705860				2022-12-25	WOS:A1996UZ80400037
J	Thiagalingam, S; Lengauer, C; Leach, FS; Schutte, M; Hahn, SA; Overhauser, J; Willson, JKV; Markowitz, S; Hamilton, SR; Kern, SE; Kinzler, KW; Vogelstein, B				Thiagalingam, S; Lengauer, C; Leach, FS; Schutte, M; Hahn, SA; Overhauser, J; Willson, JKV; Markowitz, S; Hamilton, SR; Kern, SE; Kinzler, KW; Vogelstein, B			Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers	NATURE GENETICS			English	Letter							CARCINOGENESIS; MUTATIONS; COLON		JOHNS HOPKINS ONCOL CTR,BALTIMORE,MD 21231; JOHNS HOPKINS UNIV,SCH MED,DEPT PATHOL,BALTIMORE,MD 21205; THOMAS JEFFERSON UNIV,DEPT BIOCHEM & MOLEC BIOL,PHILADELPHIA,PA 19107; CASE WESTERN RESERVE UNIV HOSP,DEPT MED,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV HOSP,IRELAND CANC CTR,CLEVELAND,OH 44106; JOHNS HOPKINS ONCOL CTR,HOWARD HUGHES MED INST,BALTIMORE,MD 21231	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Jefferson University; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University Hospital; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine			Hahn, Stephan A./AAV-6062-2021; Hahn, Stephan/E-3880-2010	Hahn, Stephan A./0000-0003-0855-9741; Hahn, Stephan/0000-0003-0855-9741; Thiagalingam, Sam/0000-0001-5211-266X	NATIONAL CANCER INSTITUTE [T32CA009243, R37CA035494, R01CA035494, R37CA043460, R01CA043460] Funding Source: NIH RePORTER; NCI NIH HHS [CA43460, CA35494, CA09243] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; AKIYAMA M, 1995, MUTAT RES-DNAGING G, V338, P141, DOI 10.1016/0921-8734(95)00019-3; CAVENEE WK, 1995, SCI AM, V272, P72, DOI 10.1038/scientificamerican0395-72; CHO KR, 1994, GENOMICS, V19, P525, DOI 10.1006/geno.1994.1102; CHO KR, 1995, CURR OPIN GENET DEV, V5, P72, DOI 10.1016/S0959-437X(95)90056-X; HACKMAN P, 1995, GENE CHROMOSOME CANC, V14, P215, DOI 10.1002/gcc.2870140310; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; JEN J, 1994, NEW ENGL J MED, V331, P213, DOI 10.1056/NEJM199407283310401; KNUDSON AG, 1993, P NATL ACAD SCI USA, V90, P10914, DOI 10.1073/pnas.90.23.10914; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LENGAUER C, 1994, GENET ANAL-BIOMOL E, V11, P140, DOI 10.1016/1050-3862(94)90034-5; LICHTER P, 1992, HUMAN CYTOGENETICS P, P157; LOEB LA, 1991, CANCER RES, V51, P3075; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; MARRA G, 1995, J NATL CANCER I, V87, P1114, DOI 10.1093/jnci/87.15.1114; Martin GM, 1996, HUM MOL GENET, V5, P215, DOI 10.1093/hmg/5.2.215; MITELMAN F, 1991, CATALOG CHROMOSOME A; MULERIS M, 1985, Annales de Genetique, V28, P206; OLOPADE OI, 1993, CANC MED, P99; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; PIETENPOL JA, 1994, CANCER RES, V54, P3714; POWELL SM, 1993, NEW ENGL J MED, V329, P1982, DOI 10.1056/NEJM199312303292702; RIED T, 1992, GENE CHROMOSOME CANC, V4, P69, DOI 10.1002/gcc.2870040109; Riggins GJ, 1996, NAT GENET, V13, P347, DOI 10.1038/ng0796-347; ROJAS K, 1995, GENOMICS, V25, P329, DOI 10.1016/0888-7543(95)80153-D; Sandberg A A, 1994, In Vivo, V8, P807; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; VANDENENGH G, 1992, SCIENCE, V257, P1410, DOI 10.1126/science.1388286; VANDERLUIJT R, 1994, GENOMICS, V20, P1, DOI 10.1006/geno.1994.1119; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; WILLSON JKV, 1987, CANCER RES, V47, P2704	32	523	537	1	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1996	13	3					343	346		10.1038/ng0796-343	http://dx.doi.org/10.1038/ng0796-343			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UU283	8673134				2022-12-25	WOS:A1996UU28300023
J	Johnson, DW; Berg, JN; Baldwin, MA; Gallione, CJ; Marondel, I; Yoon, SJ; Stenzel, TT; Speer, M; PericakVance, MA; Diamond, A; Guttmacher, AE; Jackson, CE; Attisano, L; Kucherlapati, R; Porteous, MEM; Marchuk, DA				Johnson, DW; Berg, JN; Baldwin, MA; Gallione, CJ; Marondel, I; Yoon, SJ; Stenzel, TT; Speer, M; PericakVance, MA; Diamond, A; Guttmacher, AE; Jackson, CE; Attisano, L; Kucherlapati, R; Porteous, MEM; Marchuk, DA			Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2	NATURE GENETICS			English	Article							HUMAN ENDOTHELIAL-CELLS; BETA; ENDOGLIN	Hereditary haemorrhagic telangiectasia, or Osler-Rendu-Weber (ORW) syndrome, is an autosomal dominant vascular dysplasia. So far, two loci have been demonstrated for ORW. Linkage studies established an ORW locus at chromosome 9q3; endoglin was subsequently identified as the ORW1 gene. A second locus, designated ORW2, was mapped to chromosome 12. Here we report a new 4 cM interval for ORW2 that does not overlap with any previously defined. A 1.38-Mb YAC contig spans the entire interval. It includes the activin receptor like kinase 1 gene (ACVRLK1 or ALK1), a member of the serine-threonine kinase receptor family expressed in endothelium. We report three mutations in the coding sequence of the ALK1 gene in those families which show linkage of the ORW phenotype to chromosome 12. Our data suggest a critical role for ALK1 in the control of blood vessel development or repair.	DUKE UNIV,MED CTR,DEPT GENET,DURHAM,NC 27710; WESTERN GEN HOSP,DEPT HUMAN GENET,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT MOLEC GENET,BRONX,NY 10461; DUKE UNIV,MED CTR,DEPT PATHOL,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT MED,DIV NEUROL,DURHAM,NC 27710; UNIV NEWCASTLE UPON TYNE,DEPT IMMUNOL,NEWCASTLE TYNE NE2 4AA,TYNE & WEAR,ENGLAND; UNIV VERMONT,DEPT PEDIAT,BURLINGTON,VT 05401; HENRY FORD HOSP,DEPT MED,DIV CLIN & MOL GENET,DETROIT,MI 48202; UNIV TORONTO,DEPT ANAT & CELL BIOL,TORONTO,ON M5S 1A8,CANADA	Duke University; University of Edinburgh; Yeshiva University; Albert Einstein College of Medicine; Duke University; Duke University; Newcastle University - UK; University of Vermont; Henry Ford Health System; Henry Ford Hospital; University of Toronto			Kucherlapati, Raju/ABC-8807-2021	Marchuk, Douglas/0000-0002-3110-6671	NHLBI NIH HHS [1F32 HL09394, 1F32 HL09349, HL 49171] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049171, F32HL009394, F32HL009349] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; Berg JN, 1996, J MED GENET, V33, P256, DOI 10.1136/jmg.33.3.256; BRUMMEL TJ, 1994, CELL, V78, P251, DOI 10.1016/0092-8674(94)90295-X; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; CHOI ME, 1995, J BIOL CHEM, V270, P21144, DOI 10.1074/jbc.270.36.21144; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; GOUGOS A, 1990, J BIOL CHEM, V265, P8361; GUTTMACHER AE, 1994, AM J MED GENET, V52, P252, DOI 10.1002/ajmg.1320520232; GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HEUTINK P, 1994, J MED GENET, V31, P933, DOI 10.1136/jmg.31.12.933; JOHNSON DW, 1995, GENOME RES, V5, P21, DOI 10.1101/gr.5.1.21; KRAUTER K, 1995, NATURE, V377, P321; KUCHERLAPATI R, 1994, CYTOGENET CELL GENET, V67, P246; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; LUSCINSKAS FW, 1994, FASEB J, V8, P929, DOI 10.1096/fasebj.8.12.7522194; MADRI JA, 1992, ENDOTHELIAL CELL DYS; MATHEWS LS, 1994, ENDOCR REV, V15, P310, DOI 10.1210/er.15.3.310; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; MCALLISTER KA, 1994, J MED GENET, V31, P927, DOI 10.1136/jmg.31.12.927; MCALLISTER KA, 1995, HUM MOL GENET, V4, P1983, DOI 10.1093/hmg/4.10.1983; MCDONALD MT, 1994, NAT GENET, V6, P197, DOI 10.1038/ng0294-197; Miyazono Kohei, 1994, Seminars in Cell Biology, V5, P389, DOI 10.1006/scel.1994.1046; PORTEOUS MEM, 1994, J MED GENET, V31, P925, DOI 10.1136/jmg.31.12.925; SHOVLIN CL, 1994, NAT GENET, V6, P205, DOI 10.1038/ng0294-205; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; Ten Dijke Peter, 1994, Progress in Growth Factor Research, V5, P55, DOI 10.1016/0955-2235(94)90017-5; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; TENDIJKE P, 1993, ONCOGENE, V8, P2879; VINCENT P, 1995, HUM MOL GENET, V4, P945, DOI 10.1093/hmg/4.5.945; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; WRANA JL, 1994, MOL CELL BIOL, V14, P944, DOI 10.1128/MCB.14.2.944; XIE T, 1994, SCIENCE, V263, P1756, DOI 10.1126/science.8134837	35	759	793	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1996	13	2					189	195		10.1038/ng0696-189	http://dx.doi.org/10.1038/ng0696-189			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UN395	8640225				2022-12-25	WOS:A1996UN39500018
J	Mao, L; Lee, JS; Fan, YH; Ro, JY; Batsakis, JG; Lippman, S; Hittelman, W; Hong, WK				Mao, L; Lee, JS; Fan, YH; Ro, JY; Batsakis, JG; Lippman, S; Hittelman, W; Hong, WK			Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment	NATURE MEDICINE			English	Article							LEUKOPLAKIA	To better understand genetic alterations in oral premalignant lesions, we examined 84 oral leukoplakia samples from 37 patients who had been enrolled in a chemoprevention trial. The samples were analyzed for two microsatellite markers located at chromosomes 9p21 and 3p14. Loss of heterozygosity (LOH) at either or both loci was identified in 19 of the 37 (51%) patients. Of these 19 patients, seven (37%) have developed head and neck squamous cell carcinoma (HNSCC) while only one of 18 (6%) of patients without LOH developed HNSCC. Our data suggest that clonal genetic alterations are common in oral premalignant lesions; that multiple genetic alterations have already occurred in oral premalignant lesions, allowing at least a focal clonal expansion; and that losses of the 9p21 and 3p14 regions may be related to early processes of tumorigenesis in HNSCC. These genetic alterations in premalignant tissues may serve as markers for cancer risk assessment.	UNIV TEXAS,MD ANDERSON CANCER CTR,DEPT PATHOL,HOUSTON,TX 77030; UNIV TEXAS,MD ANDERSON CANCER CTR,DEPT CLIN INVEST,HOUSTON,TX 77030	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Mao, L (corresponding author), UNIV TEXAS,MD ANDERSON CANCER CTR,DEPT THORAC HEAD & NECK MED ONCOL,1515 HOLCOMBE BLVD,HOUSTON,TX 77030, USA.		Mao, Li/C-7570-2011	Mao, Li/0000-0001-7263-3358	NCI NIH HHS [P01 CA 52051] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA052051] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BANOCZY J, 1972, CANCER, V29, P1230, DOI 10.1002/1097-0142(197205)29:5<1230::AID-CNCR2820290515>3.0.CO;2-3; CAIRNS P, 1995, NAT GENET, V11, P210, DOI 10.1038/ng1095-210; FIELD JK, 1995, BRIT J CANCER, V72, P1180, DOI 10.1038/bjc.1995.483; HONG WK, 1986, NEW ENGL J MED, V315, P1501, DOI 10.1056/NEJM198612113152401; HUNG J, 1995, JAMA-J AM MED ASSOC, V273, P558, DOI 10.1001/jama.273.7.558; KISHIMOTO Y, 1995, JNCI-J NATL CANCER I, V87, P1224, DOI 10.1093/jnci/87.16.1224; LIPPMAN SM, 1993, NEW ENGL J MED, V328, P15, DOI 10.1056/NEJM199301073280103; MAESTRO R, 1993, CANCER RES, V53, P5775; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; NAWROZ H, 1994, CANCER RES, V54, P1152; NAYLOR SL, 1987, NATURE, V329, P451, DOI 10.1038/329451a0; NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0; Ohta M, 1996, CELL, V84, P587, DOI 10.1016/S0092-8674(00)81034-X; Sidransky David, 1995, Current Opinion in Oncology, V7, P229, DOI 10.1097/00001622-199505000-00007; SILVERMAN S, 1984, CANCER, V53, P563; VANDERRIET P, 1994, CANCER RES, V54, P1156; ZHANG S, 1994, CANCER RES, V54, P5060	17	411	414	0	16	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUN	1996	2	6					682	685		10.1038/nm0696-682	http://dx.doi.org/10.1038/nm0696-682			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UN691	8640560				2022-12-25	WOS:A1996UN69100037
J	Dimitroulakos, J; Yeger, H				Dimitroulakos, J; Yeger, H			HMG-CoA reductase mediates the biological effects of retinoic acid on human neuroblastoma cells: Lovastatin specifically targets P-glycoprotein-expressing cells	NATURE MEDICINE			English	Article							HUMAN NEURO-BLASTOMA; COENZYME-A REDUCTASE; MOLECULAR CHARACTERIZATION; COMPETITIVE INHIBITOR; MULTIDRUG-RESISTANCE; MESSENGER-RNA; GROWTH; LINE; DIFFERENTIATION; MORPHOLOGY	The enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, involved in de novo cholesterol synthesis and cell-cycle progression, was identified as a potential mediator of the growth inhibitory effects of retinoic acid on human neuroblastoma. a nonreversible inhibitor of HMG-CoA reductase, induced extensive that was restricted to drug-resistant P-glycoprotein-expressing neuroblastoma cell lines. This response was potentiated by dibutyryl cyclic AMP but not retinoic acid. Patients with advanced-stage metastatic neuroblastoma often display an acquired chemoresistant phenotype, which may in part be mediated by P-glycoprotein. Our studies support the application or use of HMG-CoA reductase inhibitors as potential therapeutic agents in the treatment of these patients who are refractory to chemotherapy.	HOSP SICK CHILDREN,DEPT PATHOL,TORONTO,ON M5G 1X8,CANADA; UNIV TORONTO,TORONTO,ON M5G 1X8,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto			Dimitroulakos, Jim/AAK-3398-2020					ABERMAYOR E, 1992, LARYNGOSCOPE, V102, P1133; ADAM A, 1983, CANCER, V47, P373; AREY JB, 1975, J CLIN LAB SCI, V5, P475; BARDOW SB, 1994, CANCER RES, V54, P5036; BIEDLER JL, 1973, CANCER RES, V33, P2643; BOLANDE RP, 1985, SURV SYN PATHOL RES, V4, P296; BOURHIS J, 1989, J NATL CANCER I, V81, P1401, DOI 10.1093/jnci/81.18.1401; Britton G, 1995, FASEB J, V9, P1551, DOI 10.1096/fasebj.9.15.8529834; CHAN HSL, 1991, NEW ENGL J MED, V325, P1608, DOI 10.1056/NEJM199112053252304; CHERVINSKY DS, 1993, ANTICANCER RES, V13, P93; COHN SL, 1991, PROG CLIN BIOL RES, V366, P21; CORSINI A, 1995, PHARMACOL RES, V31, P9, DOI 10.1016/1043-6618(95)80042-5; DE LUCA LM, 1991, FASEB J, V5, P2924; DIMITROULAKOS J, 1994, CELL GROWTH DIFFER, V5, P373; Evans A E, 1976, Natl Cancer Inst Monogr, V44, P49; GAETANO C, 1992, CANCER RES, V52, P4402; GIBBS JB, 1991, CELL, V65, P1, DOI 10.1016/0092-8674(91)90352-Y; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; GOLDSTEIN LJ, 1990, J CLIN ONCOL, V8, P128, DOI 10.1200/JCO.1990.8.1.128; GOTTESMAN MM, 1986, CANCER SURV, V5, P291; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; HELSON L, 1976, J NATL CANCER I, V57, P727, DOI 10.1093/jnci/57.3.727; HOLMBERG M, 1994, ANTI-CANCER DRUG, V5, P598, DOI 10.1097/00001813-199410000-00012; IMASHUKU S, 1973, J CLIN ENDOCR METAB, V36, P931, DOI 10.1210/jcem-36-5-931; KARP JE, 1995, NAT MED, V1, P309, DOI 10.1038/nm0495-309; KERR JFR, 1994, CANCER-AM CANCER SOC, V73, P2013, DOI 10.1002/1097-0142(19940415)73:8<2013::AID-CNCR2820730802>3.0.CO;2-J; KEYOMARSI K, 1991, CANCER RES, V51, P3602; KLEINERT R, 1991, ACTA NEUROPATHOL, V82, P502, DOI 10.1007/BF00293385; KOHL NE, 1995, NAT MED, V1, P792, DOI 10.1038/nm0895-792; LANGE Y, 1994, J BIOL CHEM, V269, P29371; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; MALTESE WA, 1985, J CLIN INVEST, V76, P1748, DOI 10.1172/JCI112165; MALTESE WA, 1983, NEUROLOGY, V33, P1294, DOI 10.1212/WNL.33.10.1294; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MURAKAMI T, 1991, PROG CLIN BIOL RES, V366, P65; ODORISIO MS, 1992, REGUL PEPTIDES, V37, P231; PIACENTINI M, 1993, FEBS LETT, V320, P150, DOI 10.1016/0014-5793(93)80081-5; RAMANI P, 1995, J PATHOL, V175, P13, DOI 10.1002/path.1711750104; RAMHARACK R, 1990, DNA CELL BIOL, V9, P677, DOI 10.1089/dna.1990.9.677; ROCCHI P, 1992, ANTICANCER RES, V12, P917; SEEGER RC, 1977, CANCER RES, V37, P1364; SEKIGUCHI M, 1979, JPN J EXP MED, V49, P67; SHIMADA H, 1984, J NATL CANCER I, V73, P405, DOI 10.1093/jnci/73.2.405; THIELE CJ, 1985, NATURE, V313, P404, DOI 10.1038/313404a0; TSOKOS M, 1987, AM J PATHOL, V128, P484; TSUJITA Y, 1986, BIOCHIM BIOPHYS ACTA, V877, P50, DOI 10.1016/0005-2760(86)90117-7; TUMILOWICZ JJ, 1970, CANCER RES, V30, P2110; WIRNALASENA J, 1991, GYNECOL ONCOL, V41, P56; WOODS WG, 1992, PEDIATRICS, V89, P114; YEGER H, 1990, CANCER RES, V50, P2794; YEGER H, 1988, DIFFERENTIATION, V39, P216, DOI 10.1111/j.1432-0436.1988.tb00095.x	51	106	108	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAR	1996	2	3					326	333		10.1038/nm0396-326	http://dx.doi.org/10.1038/nm0396-326			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TY640	8612233				2022-12-25	WOS:A1996TY64000043
J	Thomas, JT; Lin, KM; Nandedkar, M; Camargo, M; Cervenka, A; Luyten, FP				Thomas, JT; Lin, KM; Nandedkar, M; Camargo, M; Cervenka, A; Luyten, FP			A human chondrodysplasia due to a mutation in a TGF-beta superfamily member	NATURE GENETICS			English	Letter							BONE-INDUCTIVE PROTEIN; FAMILY; PURIFICATION; OSTEOGENIN; MOUSE; GENE		UNIV ANTIOQUIA,DEPT BIOL,MEDELLIN,COLOMBIA; UNIV MINNESOTA,SCH DENT,DEPT ORAL SCI,MINNEAPOLIS,MN 55455	Universidad de Antioquia; University of Minnesota System; University of Minnesota Twin Cities	Thomas, JT (corresponding author), NIDR,NIH,BONE RES BRANCH,BETHESDA,MD 20892, USA.		Luyten, Frank/GPS-7793-2022					AMATAYAKULCHANTLER S, 1994, J BIOL CHEM, V269, P27687; BRUNNER AM, 1992, MOL ENDOCRINOL, V6, P1691, DOI 10.1210/me.6.10.1691; CELESTE AJ, 1990, P NATL ACAD SCI USA, V87, P9843, DOI 10.1073/pnas.87.24.9843; CHANG SC, 1994, J BIOL CHEM, V269, P28227; GREULICH WW, 1983, RADIOGRAPHIC ATLAS S, P108; GRIFFITH DL, IN PRESS P NATL ACAD; GRUNEBERG H, 1973, J EMBRYOL EXP MORPH, V30, P119; HUNTER AGW, 1976, HUM GENET, V34, P107; KINGSLEY DM, 1994, TRENDS GENET, V10, P16, DOI 10.1016/0168-9525(94)90014-0; KINGSLEY DM, 1992, CELL, V71, P399, DOI 10.1016/0092-8674(92)90510-J; LANGER LO, 1989, HUM GENET, V81, P323, DOI 10.1007/BF00283684; LUYTEN FP, 1989, J BIOL CHEM, V264, P13377; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; Mckusick V.A., 1994, MENDELIAN INHERITANC; OZKAYNAK E, 1990, EMBO J, V9, P2085, DOI 10.1002/j.1460-2075.1990.tb07376.x; PADGETT RW, 1987, NATURE, V325, P81, DOI 10.1038/325081a0; SAMPATH TK, 1987, P NATL ACAD SCI USA, V84, P7109, DOI 10.1073/pnas.84.20.7109; SPANGER J, 1992, EUR J PADIATR, V151, P407; STENZEL P, 1994, DEV BIOL, V166, P149, DOI 10.1006/dbio.1994.1303; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; VENKATARAMAN G, 1995, P NATL ACAD SCI USA, V92, P5406, DOI 10.1073/pnas.92.12.5406; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WANG EA, 1988, P NATL ACAD SCI USA, V85, P9484, DOI 10.1073/pnas.85.24.9484; WHARTON KA, 1991, P NATL ACAD SCI USA, V88, P9214, DOI 10.1073/pnas.88.20.9214; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241	26	331	351	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1996	12	3					315	317		10.1038/ng0396-315	http://dx.doi.org/10.1038/ng0396-315			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TY183	8589725	Green Published			2022-12-25	WOS:A1996TY18300023
J	Nakamura, T; Largaespada, DA; Shaughnessy, JD; Jenkins, NA; Copeland, NG				Nakamura, T; Largaespada, DA; Shaughnessy, JD; Jenkins, NA; Copeland, NG			Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias	NATURE GENETICS			English	Article							LEUKEMIA-VIRUS DNA; T-CELL LEUKEMIA; HOMEOBOX GENE; CHROMOSOMAL TRANSLOCATION; LINKAGE MAP; PRE-B; MICE; TRANSCRIPTION; PROTEIN; MOUSE	Retroviruses induce myeloid leukaemia in BXH-2 mice by the insertional mutation of cellular proto-oncogenes or tumour suppressor genes. Disease genes can thus be identified by proviral tagging through the identification of common viral integration sites in BXH-2 leukaemia. Here, we describe a new approach for proviral tagging that greatly facilitates the identification of BXH-2 leukaemia genes. Using this approach, we identify three genes whose expression is activated by proviral integration in BXH-2 leukaemias; Hoxa7, Hoxa9, and a Pbx1-related homeobox gene, Meis1. Proviral activation of Hoxa7 or Hoxa9 is strongly correlated with proviral activation of Meis1 implying that Hoxa7 and Hoxa9 cooperate with Meis1 in leukaemia formation. These studies provide the first genetic evidence that Pbx1-related genes cooperate with Hox genes in leukaemia formation and identify a number of new murine myeloid leukaemia genes.	NCI,FREDERICK CANC RES & DEV CTR,ABL BASIC RES PROGRAM,MAMMALIAN GENET LAB,FREDERICK,MD 21702	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick			Largaespada, David/C-9832-2014					BADER JL, 1978, J PEDIATR-US, V92, P925, DOI 10.1016/S0022-3476(78)80362-X; Bickmore W., 1992, Techniques for the analysis of complex genomes., P19; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BUCHBERG AM, 1990, MOL CELL BIOL, V10, P4658, DOI 10.1128/MCB.10.9.4658; CAWTHON RM, 1991, GENOMICS, V9, P446, DOI 10.1016/0888-7543(91)90410-G; CHAN SK, 1994, CELL, V78, P603, DOI 10.1016/0092-8674(94)90525-8; CHANG CP, 1995, GENE DEV, V9, P663, DOI 10.1101/gad.9.6.663; CHATTOPADHYAY SK, 1980, P NATL ACAD SCI-BIOL, V77, P5774, DOI 10.1073/pnas.77.10.5774; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COPELAND NG, 1991, TRENDS GENET, V7, P113, DOI 10.1016/0168-9525(91)90455-Y; COPELAND NG, 1993, SCIENCE, V262, P57, DOI 10.1126/science.8211130; DEDERA DA, 1993, CELL, V74, P833, DOI 10.1016/0092-8674(93)90463-Z; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DUBE ID, 1991, BLOOD, V78, P2996; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; HATANO M, 1991, SCIENCE, V253, P79, DOI 10.1126/science.1676542; HENTHORN P, 1990, SCIENCE, V247, P467, DOI 10.1126/science.2105528; HERR W, 1983, J VIROL, V46, P70, DOI 10.1128/JVI.46.1.70-82.1983; HUNGER SP, 1991, BLOOD, V77, P687; ICHIKAWA Y, 1969, J CELL PHYSIOL, V74, P223, DOI 10.1002/jcp.1040740303; JENKINS NA, 1982, J VIROL, V42, P379, DOI 10.1128/JVI.42.2.379-388.1982; KAMPS MP, 1993, MOL CELL BIOL, V13, P351, DOI 10.1128/MCB.13.1.351; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; KAMPS MP, 1994, ONCOGENE, V9, P3159; KENNEDY MA, 1991, P NATL ACAD SCI USA, V88, P8900, DOI 10.1073/pnas.88.20.8900; KONGSUWAN K, 1989, NUCLEIC ACIDS RES, V17, P1881, DOI 10.1093/nar/17.5.1881; LARGAESPADA DA, 1995, J VIROL, V69, P5095, DOI 10.1128/JVI.69.8.5095-5102.1995; Largaespada DA, 1996, NAT GENET, V12, P137, DOI 10.1038/ng0296-137; LU M, 1991, EMBO J, V10, P2905, DOI 10.1002/j.1460-2075.1991.tb07840.x; LU QA, 1995, MOL CELL BIOL, V15, P3786; MONICA K, 1991, MOL CELL BIOL, V11, P6149, DOI 10.1128/MCB.11.12.6149; MOSCOW JJ, 1995, MOL CELL BIOL, V15, P5434; MOUNTZ JD, 1984, SCIENCE, V226, P1087, DOI 10.1126/science.6494925; NOURSE J, 1990, CELL, V60, P535, DOI 10.1016/0092-8674(90)90657-Z; PHELAN ML, 1995, MOL CELL BIOL, V15, P3989; POPPERL H, 1995, CELL, V81, P1031, DOI 10.1016/S0092-8674(05)80008-X; PRIVITERA E, 1992, BLOOD, V79, P1781; RAUSKOLB C, 1994, EMBO J, V13, P3561, DOI 10.1002/j.1460-2075.1994.tb06663.x; Sambrook J, 1989, MOL CLONING LABORATO; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; VANDIJK MA, 1994, CELL, V78, P617, DOI 10.1016/0092-8674(94)90526-6; VANLOHUIZEN M, 1990, BIOCHIM BIOPHYS ACTA, V1032, P213, DOI 10.1016/0304-419X(90)90005-L	42	275	281	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1996	12	2					149	153		10.1038/ng0296-149	http://dx.doi.org/10.1038/ng0296-149			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TU079	8563752				2022-12-25	WOS:A1996TU07900014
J	Zuo, L; Weger, J; Yang, QB; Goldstein, AM; Tucker, MA; Walker, GJ; Hayward, N; Dracopoli, NC				Zuo, L; Weger, J; Yang, QB; Goldstein, AM; Tucker, MA; Walker, GJ; Hayward, N; Dracopoli, NC			Germline mutations in the p16(INK4a) binding domain of CDK4 in familial melanoma	NATURE GENETICS			English	Letter							RET PROTOONCOGENE		SEQUANA THERAPEUT INC,LA JOLLA,CA 92037; NCI,GENET EPIDEMIOL BRANCH,BETHESDA,MD 20892; QUEENSLAND INST MED RES,HERSTON,QLD 4029,AUSTRALIA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); QIMR Berghofer Medical Research Institute			hayward, nick/AAV-8802-2020; hayward, nicholas k/C-1367-2015; Tucker, Margaret A/B-4297-2015	hayward, nicholas k/0000-0003-4760-1033; Dracopoli, Nicholas/0000-0003-3962-4059				DEMETRICK DJ, 1994, CYTOGENET CELL GENET, V66, P72, DOI 10.1159/000133669; DONISKELLER H, 1993, HUM MOL GENET, V2, P851, DOI 10.1093/hmg/2.7.851; FOUNTAIN JW, 1990, CANCER SURV, V9, P645; GOLDSTEIN AM, 1994, AM J HUM GENET, V54, P489; GOLDSTEIN AM, 1993, AM J HUM GENET, V52, P537; GRUIS NA, 1995, NAT GENET, V10, P351, DOI 10.1038/ng0795-351; GUAN KL, 1994, GENE DEV, V8, P2939, DOI 10.1101/gad.8.24.2939; HANKS SK, 1987, P NATL ACAD SCI USA, V84, P388, DOI 10.1073/pnas.84.2.388; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; HE J, 1994, CANCER RES, V54, P5804; HOFSTRA RMW, 1994, NATURE, V367, P375, DOI 10.1038/367375a0; HUSSUSSIAN CJ, 1994, NAT GENET, V8, P15, DOI 10.1038/ng0994-15; KAMB A, 1994, NAT GENET, V8, P22, DOI 10.1038/ng0994-22; KHATIB ZA, 1993, CANCER RES, V53, P5535; LADANYI M, 1995, J PATHOL, V175, P211, DOI 10.1002/path.1711750209; LAIRD PW, 1994, HUM MOL GENET, V3, P1487, DOI 10.1093/hmg/3.suppl_1.1487; LIU L, 1995, ONCOGENE, V11, P405; MACGEOCH C, 1994, HUM MOL GENET, V3, P2195, DOI 10.1093/hmg/3.12.2195; MULLIGAN LM, 1993, NATURE, V363, P458, DOI 10.1038/363458a0; NANCARROW DJ, 1993, AM J HUM GENET, V53, P936; OHTA M, 1994, CANCER RES, V54, P5269; OTTERSON GA, 1994, ONCOGENE, V9, P3375; RANADE K, 1995, NAT GENET, V10, P114, DOI 10.1038/ng0595-114; SCHMIDT EE, 1994, CANCER RES, V54, P6321; SERRANO M, 1995, SCIENCE, V267, P249, DOI 10.1126/science.7809631; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; WALKER GJ, 1995, HUM MOL GENET, V4, P1845, DOI 10.1093/hmg/4.10.1845; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577; 1995, PCR SSCP ANAL	30	608	627	1	16	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1996	12	1					97	99		10.1038/ng0196-97	http://dx.doi.org/10.1038/ng0196-97			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TM555	8528263				2022-12-25	WOS:A1996TM55500024
J	GLASER, T; JEPEAL, L; EDWARDS, JG; YOUNG, SR; FAVOR, J; MAAS, RL				GLASER, T; JEPEAL, L; EDWARDS, JG; YOUNG, SR; FAVOR, J; MAAS, RL			PAX6 GENE DOSAGE EFFECT IN A FAMILY WITH CONGENITAL CATARACTS, ANIRIDIA, ANOPHTHALMIA AND CENTRAL-NERVOUS-SYSTEM DEFECTS	NATURE GENETICS			English	Article							HOMEOBOX-CONTAINING GENE; PAIRED BOX GENE; SMALL EYE SEY; CORTICAL MALFORMATIONS; NEURONAL MIGRATION; MUTATION; TRANSCRIPTION; MOUSE; PROTEIN; DOMAIN	The human eye malformation aniridia results from haploinsufficiency of PAX6, a paired box DNA-binding protein. To study this dosage effect, we characterized two PAX6 mutations in a family segregating aniridia and a milder syndrome consisting of congenital cataracts and late onset corneal dystrophy. The nonsense mutations, at codons 103 and 353, truncate PAX6 within the N-terminal paired and C-terminal PST domains, respectively. The wild-type PST domain activates transcription autonomously and the mutant form has partial activity. A compound heterozygote had severe craniofacial and central nervous system defects and no eyes. The pattern of malformations is similar to that in homozygous Sey mice and suggests a critical role for PAX6 in controlling the migration and differentiation of specific neuronal progenitor cells in the brain.	HARVARD UNIV, BRIGHAM & WOMENS HOSP,SCH MED,DEPT MED,DIV GENET, BOSTON, MA 02115 USA; HARVARD UNIV, BRIGHAM & WOMENS HOSP, SCH MED, HOWARD HUGHES MED INST, BOSTON, MA 02115 USA; UNIV S CAROLINA, SCH MED, DEPT OBSTET & GYNECOL, DIV MED GENET, COLUMBIA, SC 29203 USA; GSF FORSCHUNGSZENTRUM UNWELT & GESUNDHEIT, INST SAUGETIERGENET, D-85758 OBERSCHLEISSHEIM, GERMANY	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health					NEI NIH HHS [EY10123] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010123] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADAMS B, 1992, GENE DEV, V6, P1589, DOI 10.1101/gad.6.9.1589; ALTMAN J, 1990, EXP NEUROL, V107, P36, DOI 10.1016/0014-4886(90)90061-V; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; CARRIERE C, 1993, MOL CELL BIOL, V13, P7257, DOI 10.1128/MCB.13.12.7257; CHALEPAKIS G, 1991, CELL, V66, P873, DOI 10.1016/0092-8674(91)90434-Z; CHALEPAKIS G, 1993, J NEUROBIOL, V24, P1367, DOI 10.1002/neu.480241009; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; CZERNY T, 1993, GENE DEV, V7, P2048, DOI 10.1101/gad.7.10.2048; DAMBLYCHAUDIERE C, 1992, CELL, V69, P159, DOI 10.1016/0092-8674(92)90127-X; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; DUKEELDER S, 1964, SYSTEM OPHTHALMOLO 2, V3, P415; EDWARDS JG, 1984, J CLIN DYSMORPH, V2, P8; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; FICKENSCHER HR, 1993, DNA CELL BIOL, V12, P381, DOI 10.1089/dna.1993.12.381; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; GLASER T, IN PRESS MOL GENETIC; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HANSON IM, 1993, HUM MOL GENET, V2, P915; HILL RE, 1992, NATURE, V355, P750, DOI 10.1038/355750a0; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HITTNER HM, 1980, AM J OPHTHALMOL, V89, P531, DOI 10.1016/0002-9394(80)90062-8; HODGSON SV, 1980, J MED GENET, V17, P478, DOI 10.1136/jmg.17.6.478; HOGAN BLM, 1986, J EMBRYOL EXP MORPH, V97, P95; JIANG J, 1993, CELL, V72, P741, DOI 10.1016/0092-8674(93)90402-C; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; KELLER SA, IN PRESS GENOMICS; KOSEKI H, 1993, DEVELOPMENT, V119, P649; KOZMIK Z, 1993, MOL CELL BIOL, V13, P6024, DOI 10.1128/MCB.13.10.6024; KRAUSS S, 1992, NATURE, V360, P87, DOI 10.1038/360087a0; LI XL, 1994, NATURE, V367, P83, DOI 10.1038/367083a0; LILLIE JW, 1989, NATURE, V338, P39, DOI 10.1038/338039a0; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; MACKMAN G, 1979, AM J OPHTHALMOL, V87, P497, DOI 10.1016/0002-9394(79)90238-1; Margo C E, 1983, J Pediatr Ophthalmol Strabismus, V20, P192; MATSUO T, 1993, NAT GENET, V3, P299, DOI 10.1038/ng0493-299; MCCONNELL SK, 1991, ANNU REV NEUROSCI, V14, P269, DOI 10.1146/annurev.ne.14.030191.001413; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; NELSON LB, 1984, SURV OPHTHALMOL, V28, P621, DOI 10.1016/0039-6257(84)90184-X; NOLL M, 1993, CURR OPIN GENET DEV, V3, P595, DOI 10.1016/0959-437X(93)90095-7; PLAZA S, 1993, CELL GROWTH DIFFER, V4, P1041; RAKIC P, 1988, PROG BRAIN RES, V73, P15; SCHMAHL W, 1993, ACTA NEUROPATHOL, V86, P126, DOI 10.1007/BF00334879; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; THEILL LE, 1989, NATURE, V342, P945, DOI 10.1038/342945a0; TON CCT, 1992, GENOMICS, V13, P251, DOI 10.1016/0888-7543(92)90239-O; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; WALTHER C, 1991, DEVELOPMENT, V113, P1435; WRIGHT DK, 1990, PCR PROTOCOLS GUIDE, P153; ZANNINI M, 1992, MOL CELL BIOL, V12, P4230, DOI 10.1128/MCB.12.9.4230	51	563	575	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1994	7	4					463	471		10.1038/ng0894-463	http://dx.doi.org/10.1038/ng0894-463			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PA832	7951315				2022-12-25	WOS:A1994PA83200011
J	HENTATI, A; BEJAOUI, K; PERICAKVANCE, MA; HENTATI, F; SPEER, MC; HUNG, WY; FIGLEWICZ, DA; HAINES, J; RIMMLER, J; BENHAMIDA, C; BENHAMIDA, M; BROWN, RH; SIDDIQUE, T				HENTATI, A; BEJAOUI, K; PERICAKVANCE, MA; HENTATI, F; SPEER, MC; HUNG, WY; FIGLEWICZ, DA; HAINES, J; RIMMLER, J; BENHAMIDA, C; BENHAMIDA, M; BROWN, RH; SIDDIQUE, T			LINKAGE OF RECESSIVE FAMILIAL AMYOTROPHIC-LATERAL-SCLEROSIS TO CHROMOSOME 2Q33-Q35	NATURE GENETICS			English	Article							GENETIC-LOCUS HETEROGENEITY; SUPEROXIDE-DISMUTASE; MAP	Amyotrophic lateral sclerosis (ALS) usually presents as a sporadic disorder of motor neurons. However, familial forms of ALS have been described - autosomal dominant forms (ALS1, ALS3), clinically indistinguishable from the sporadic form, and autosomal recessive forms with early onset and slower progression of symptoms (ALS2). To localize the gene for one of the autosomal recessive forms of ALS, we applied linkage analysis to a large inbred family from Tunisia. A lod score maximum of Z(max) = 8.2 at theta=0.00 was obtained with marker D2S72 located on chromosome 2q33-q35. The fine mapping of this region suggested that the ALS2 locus lies in the 8 cM segment flanked by D2S155 and D2S115.	NORTHWESTERN UNIV, SCH MED, DEPT NEUROL, CHICAGO, IL 60611 USA; NORTHWESTERN UNIV, SCH MED, DEPT CELL MOLEC & STRUCT BIOL, CHICAGO, IL 60611 USA; NORTHWESTERN UNIV, SCH MED, NORTHWESTERN INST NEUROSCI, CHICAGO, IL 60611 USA; INST NATL NEUROL, TUNIS 1006, TUNISIA; MASSACHUSETTS GEN HOSP, DEPT NEUROL, HILLSBOROUGH 02129, NORTH IRELAND; DUKE UNIV, MED CTR, DIV NEUROL, DURHAM, NC 27710 USA; UNIV ROCHESTER, MED CTR, CTR NEUROMUSCULAR DIS, ROCHESTER, NY 14642 USA	Northwestern University; Northwestern University; Northwestern University; Universite de Tunis-El-Manar; Institut National de Neurologie; Duke University; University of Rochester			Siddique, Teepu/AAT-8166-2021; Haines, Jonathan/C-3374-2012	Haines, Jonathan/0000-0002-4351-4728; Siddique, Teepu/0000-0001-7293-9146				BENHAMIDA M, 1990, BRAIN, V113, P347; BENHAMIDA M, 1987, J NEUROL SCI, V78, P313; BENHAMIDA M, 1986, GENET HUM, V34, P267; BENOTHMANE K, 1992, NAT GENET, V2, P315, DOI 10.1038/ng1292-315; DARIAVACH P, 1988, EUR J IMMUNOL, V18, P1901, DOI 10.1002/eji.1830181206; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; HAMIDA MB, 1984, REV NEUROL-FRANCE, V140, P202; HENTATI A, 1993, AM J HUM GENET, V53, P1014; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; MELKI J, 1990, NATURE, V344, P767, DOI 10.1038/344767a0; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SCHWARTZ MS, 1991, CLIN NEUROLOGY, P1356; SELDIN MF, 1991, MAMM GENOME, V1, P51; SIDDIQUE T, 1989, NEUROLOGY, V39, P919, DOI 10.1212/WNL.39.7.919; SIDDIQUE T, 1991, NEW ENGL J MED, V324, P1381, DOI 10.1056/NEJM199105163242001; SIES H, 1991, AM J MED, V91, pS31, DOI 10.1016/0002-9343(91)90281-2; STRAUB RE, 1993, GENOMICS, V15, P48, DOI 10.1006/geno.1993.1008; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P2200; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	20	188	189	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1994	7	3					425	428		10.1038/ng0794-425	http://dx.doi.org/10.1038/ng0794-425			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NU306	7920663				2022-12-25	WOS:A1994NU30600019
J	VANDUIJN, CM; DEKNIJFF, P; CRUTS, M; WEHNERT, A; HAVEKES, LM; HOFMAN, A; VAN BROECKHOVEN, C				VANDUIJN, CM; DEKNIJFF, P; CRUTS, M; WEHNERT, A; HAVEKES, LM; HOFMAN, A; VAN BROECKHOVEN, C			APOLIPOPROTEIN E4 ALLELE IN A POPULATION-BASED STUDY OF EARLY-ONSET ALZHEIMERS-DISEASE	NATURE GENETICS			English	Article							PRECURSOR PROTEIN GENE; HEREDITARY CEREBRAL-HEMORRHAGE; DUTCH TYPE; MUTATION; LOCUS; CHROMOSOME-19; DIAGNOSIS; DEMENTIA; LINKAGE; EXON-17	Several studies have reported an association of the apolipoprotein E allele epsilon 4 (APOE*4) to familial and sporadic late-onset Alzheimer's disease (LOAD). Here we report on the relationship between APOE*4 and early-onset Alzheimer's disease (EOAD) in a Dutch population-based study. The frequency of the APOE*4 allele was 2.3 times higher among EOAD cases compared to controls. Among patients, the allele frequency was 1.6 times higher in those with a positive family history than in those without. A significant increase in risk of EOAD was found for subjects homozygous for APOE*4 regardless of family history of dementia, but an increase in EOAD risk for APOE*4 heterozygotes could only be shown in subjects with a positive family history. Our study demonstrates a significant association between APOE*4 and EOAD which is modified by family history of dementia.	UNIV ANTWERP, DEPT BIOCHEM, BORN BUNGE FDN, NEUROGENET LAB, B-2610 ANTWERP, BELGIUM; ERASMUS UNIV ROTTERDAM, SCH MED, DEPT EPIDEMIOL & BIOSTAT, 3000 DR ROTTERDAM, NETHERLANDS; TNO, INST AGEING & VASC RES, GAUBIUS LAB, 2300 AK LEIDEN, NETHERLANDS; INNOGENET, B-9052 GHENT, BELGIUM	University of Antwerp; Erasmus University Rotterdam; Netherlands Organization Applied Science Research; Innogenetics NV			Van Broeckhoven, Christine/G-8362-2017; de Knijff, Peter/Y-2519-2018	Van Broeckhoven, Christine/0000-0003-0183-7665; de Knijff, Peter/0000-0002-0899-771X				ADROER R, 1992, NEUROSCI LETT, V141, P69, DOI 10.1016/0304-3940(92)90336-6; BAKKER E, 1991, AM J HUM GENET, V49, P518; BORGAONKAR DS, 1993, LANCET, V342, P625, DOI 10.1016/0140-6736(93)91458-X; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DAS HK, 1985, J BIOL CHEM, V260, P6240; Elston RC, 1987, ESSENTIALS BIOSTATIS; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HAVEKES LM, 1987, J LIPID RES, V28, P445; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; HOFMAN A, 1989, NEUROLOGY, V39, P1589, DOI 10.1212/WNL.39.12.1589; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; MAHLEY RW, 1989, METABOLIC BASIS INHE, V1, P1195; MAYEUX R, 1993, ANN NEUROL, V34, P752, DOI 10.1002/ana.410340527; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MULLAN M, 1992, NAT GENET, V2, P340, DOI 10.1038/ng1292-340; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; NARUSE S, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91612-X; NOGUCHI S, 1993, LANCET, V342, P737, DOI 10.1016/0140-6736(93)91728-5; OLAISEN B, 1982, HUM GENET, V62, P233, DOI 10.1007/BF00333526; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PAYAMI H, 1993, LANCET, V342, P738; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; SAUNDERS AM, 1993, LANCET, V342, P710, DOI 10.1016/0140-6736(93)91709-U; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; Schlesselman JJ, 1982, CASE CONTROL STUDIES; STGEORGEHYSLOP P, 1992, NAT GENET, V2, P330, DOI 10.1038/ng1292-330; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; VAN BROECKHOVEN C, 1992, NAT GENET, V2, P335, DOI 10.1038/ng1292-335; VANBROECKHOVEN C, IN PRESS NEUROSCI LE; VANDUIJN CM, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91611-W; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; 1993, LANCET, V342, P737	38	418	424	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1994	7	1					74	78		10.1038/ng0594-74	http://dx.doi.org/10.1038/ng0594-74			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NJ842	8075646	Green Published			2022-12-25	WOS:A1994NJ84200017
J	CROSS, SH; CHARLTON, JA; NAN, XS; BIRD, AP				CROSS, SH; CHARLTON, JA; NAN, XS; BIRD, AP			PURIFICATION OF CPG ISLANDS USING A METHYLATED DNA-BINDING COLUMN	NATURE GENETICS			English	Article							VERTEBRATE DNA; GENE MARKERS; SEQUENCE; PROTEIN; LONG; EVOLUTION; FRAGMENTS; PATTERNS; GENOMES; CLUSTER	CpG islands are short stretches of DNA containing a high density of non-methylated CpG dinucleotides, predominantly associated with coding regions. We have constructed an affinity matrix that contains the methyl-CpG binding domain from the rat chromosomal protein MeCP2, attached to a solid support. A column containing the matrix fractionates DNA according to its degree of CpG methylation, strongly retaining those sequences that are highly methylated. Using this column, we have developed a procedure for bulk isolation of CpG islands from human genomic DNA. As CpG islands overlap with approximately 60% of human genes, the resulting CpG island library can be used to isolate full-length cDNAs and to place genes on genomic maps.			CROSS, SH (corresponding author), UNIV EDINBURGH,INST CELL & MOLEC BIOL,KINGS BLDG,EDINBURGH EH9 3JR,SCOTLAND.			Nan, Xinsheng/0000-0002-0865-7934; Cross, Sally/0000-0001-6518-6449; Bird, Adrian/0000-0002-8600-0372	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ABBOTT C, 1991, GENOMICS, V9, P73, DOI 10.1016/0888-7543(91)90222-Z; ADAMS MD, 1993, NAT GENET, V4, P373, DOI 10.1038/ng0893-373; ANTEQUERA F, 1993, DNA METHYLATION MOL, P169; ANTEQUERA P, IN PRESS P NATN ACAD; BAENS M, 1993, GENOMICS, V16, P214, DOI 10.1006/geno.1993.1161; BIRD A, 1985, CELL, V40, P91, DOI 10.1016/0092-8674(85)90312-5; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1485, DOI 10.1093/nar/8.7.1485; BIRD AP, 1987, EMBO J, V6, P999, DOI 10.1002/j.1460-2075.1987.tb04851.x; BIRD AP, 1987, TRENDS GENET, V3, P342, DOI 10.1016/0168-9525(87)90294-0; BRITTEN RJ, 1988, P NATL ACAD SCI USA, V85, P4770, DOI 10.1073/pnas.85.13.4770; BROWN WRA, 1986, NATURE, V322, P477, DOI 10.1038/322477a0; COOKE HJ, 1986, COLD SPRING HARB SYM, V51, P213, DOI 10.1101/SQB.1986.051.01.026; COOPER DN, 1983, NUCLEIC ACIDS RES, V11, P647, DOI 10.1093/nar/11.3.647; CROSS S, 1991, NUCLEIC ACIDS RES, V19, P1469, DOI 10.1093/nar/19.7.1469; DAWID IB, 1974, SCIENCE, V184, P80, DOI 10.1126/science.184.4132.80; DEININGER PL, 1981, J MOL BIOL, V151, P17, DOI 10.1016/0022-2836(81)90219-9; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FEARNLEY IM, 1991, BIOCHEM J, V278, P821, DOI 10.1042/bj2780821; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; HENDRIKS RW, 1992, GENET, V1, P187; HOCHULI E, 1987, J CHROMATOGR, V411, P177, DOI 10.1016/S0021-9673(00)93969-4; KENWRICK S, 1992, HUM MOL GENET, V1, P179, DOI 10.1093/hmg/1.3.179; LARSEN F, 1993, HUM MOL GENET, V2, P1589, DOI 10.1093/hmg/2.10.1589; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; LAVIA P, 1987, EMBO J, V6, P2773, DOI 10.1002/j.1460-2075.1987.tb02572.x; LAWN RM, 1981, SCIENCE, V212, P1159, DOI 10.1126/science.6165082; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; LINDSAY S, 1987, NATURE, V327, P336, DOI 10.1038/327336a0; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; MCCOMBIE WR, 1992, NAT GENET, V1, P348, DOI 10.1038/ng0892-348; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; MEEHAN RR, 1992, NUCLEIC ACIDS RES, V20, P5085, DOI 10.1093/nar/20.19.5085; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; PFEIFER GP, 1990, GENE DEV, V4, P1277, DOI 10.1101/gad.4.8.1277; PONCE MR, 1992, NUCLEIC ACIDS RES, V20, P623, DOI 10.1093/nar/20.3.623; SHAFITZAGARDO B, 1982, GENE, V20, P397, DOI 10.1016/0378-1119(82)90208-6; SHEMER R, 1991, J BIOL CHEM, V266, P23676; STATES D J, 1991, Methods (Orlando), V3, P66, DOI 10.1016/S1046-2023(05)80165-3; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TOLAN DR, 1986, MOL BIOL MED, V3, P245; VANSPRONSEN A, 1993, EUR J BIOCHEM, V213, P1117, DOI 10.1111/j.1432-1033.1993.tb17861.x	42	375	455	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1994	6	3					236	244		10.1038/ng0394-236	http://dx.doi.org/10.1038/ng0394-236			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ562	8012384				2022-12-25	WOS:A1994MZ56200009
J	HEUTINK, P; ZGURICAS, J; VANOOSTERHOUT, L; BREEDVELD, GJ; TESTERS, L; SANDKUIJL, LA; SNIJDERS, PJLM; WEISSENBACH, J; LINDHOUT, D; HOVIUS, SER; OOSTRA, BA				HEUTINK, P; ZGURICAS, J; VANOOSTERHOUT, L; BREEDVELD, GJ; TESTERS, L; SANDKUIJL, LA; SNIJDERS, PJLM; WEISSENBACH, J; LINDHOUT, D; HOVIUS, SER; OOSTRA, BA			THE GENE FOR TRIPHALANGEAL THUMB MAPS TO THE SUBTELOMERIC REGION OF CHROMOSOME 7Q	NATURE GENETICS			English	Article							PATTERN-FORMATION; LINKAGE; EXPRESSION; MOUSE; EN-2; LOCALIZATION	Triphalangeal thumb is a developmental anomaly, sometimes dominantly transmitted, characterized by a long, finger-like thumb with three phalanges instead of two. The underlying genetic defect is unknown, but presumably involves genes that regulate the differentiation of the developing forelimb. In two large kindreds with triphalangeal thumb, evidence for linkage to the long arm of chromosome 7 was obtained with a maximum lod score of 12.61. Multipoint linkage and haplotype analysis placed the gene close to the telomere of the long arm. To our knowledge this is the first time that a human gene involved solely in the pathologic morphogenesis of the hand and feet has been localized.	ACAD HOSP ROTTERDAM DIJKZIGT,DEPT PLAST & RECONSTRUCT SURG,ROTTERDAM,NETHERLANDS; REG HLTH CARE CTR,ST WILLEBRORD,NETHERLANDS; GENETHON,HUMAN GENOME RES CTR,EVRY,FRANCE	Erasmus University Rotterdam; Erasmus MC	HEUTINK, P (corresponding author), ERASMUS UNIV ROTTERDAM,DEPT CLIN GENET,POB 1738,3000 DR ROTTERDAM,NETHERLANDS.		Lindhout, Dick/AAH-5765-2019	Lindhout, Dick/0000-0001-9580-624X; Heutink, Peter/0000-0001-5218-1737				BROOK JD, IN PRESS NATURE GENE; DAVIS CA, 1991, DEVELOPMENT, V111, P287; DOLLE P, 1991, MECH DEVELOP, V36, P3, DOI 10.1016/0925-4773(91)90067-G; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; Green MC, 1964, MOUSE NEWS LETT, V31, P27; HAN KY, 1993, EMBO J, V12, P2723, DOI 10.1002/j.1460-2075.1993.tb05934.x; HING AV, 1993, AM J HUM GENET, V53, P509; JOYNER AL, 1987, GENE DEV, V1, P29, DOI 10.1101/gad.1.1.29; KNUDSEN TB, 1981, J EMBRYOL EXP MORPH, V65, P289; Lapidus PW., 1943, SURG GYNECOL OBSTET, V77, P178; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LOGAN C, 1989, GENOMICS, V4, P206, DOI 10.1016/0888-7543(89)90301-7; MANN WR, 1991, GENOMICS, V9, P329, DOI 10.1016/0888-7543(91)90261-C; MARTIN GR, 1990, GENOMICS, V6, P302, DOI 10.1016/0888-7543(90)90570-K; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MORGAN BA, 1992, NATURE, V358, P236, DOI 10.1038/358236a0; NICOLAI JPA, 1988, J HAND SURG A, V13, P417; POOLE SJ, 1989, GENOMICS, V4, P225, DOI 10.1016/0888-7543(89)90324-8; QAZI Q, 1988, J MED GENET, V25, P505, DOI 10.1136/jmg.25.8.505; RADHAKRISHNA U, 1993, J MED GENET, V30, P296, DOI 10.1136/jmg.30.4.296; ROSEN DR, 1993, HUM MOL GENET, V2, P617, DOI 10.1093/hmg/2.5.617; SWEET HO, 1982, MOUSE NEWS LETT, V66, P66; TABIN CJ, 1992, DEVELOPMENT, V116, P289; TABIN CJ, 1991, CELL, V66, P199, DOI 10.1016/0092-8674(91)90612-3; TENTAMY S, 1978, BIRTH DEFECTS, V14, P3; TURLEAU C, 1984, ANN GENET-PARIS, V27, P237; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; WARM A, 1988, J MED GENET, V25, P337, DOI 10.1136/jmg.25.5.337; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; Winter Robin M., 1993, European Journal of Human Genetics, V1, P96; YOKOUCHI Y, 1991, NATURE, V353, P443, DOI 10.1038/353443a0	32	89	91	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1994	6	3					287	292		10.1038/ng0394-287	http://dx.doi.org/10.1038/ng0394-287			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ562	8012392	Green Published			2022-12-25	WOS:A1994MZ56200017
J	KOIDE, R; IKEUCHI, T; ONODERA, O; TANAKA, H; IGARASHI, S; ENDO, K; TAKAHASHI, H; KONDO, R; ISHIKAWA, A; HAYASHI, T; SAITO, M; TOMODA, A; MIIKE, T; NAITO, H; IKUTA, F; TSUJI, S				KOIDE, R; IKEUCHI, T; ONODERA, O; TANAKA, H; IGARASHI, S; ENDO, K; TAKAHASHI, H; KONDO, R; ISHIKAWA, A; HAYASHI, T; SAITO, M; TOMODA, A; MIIKE, T; NAITO, H; IKUTA, F; TSUJI, S			UNSTABLE EXPANSION OF CAG REPEAT IN HEREDITARY DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY (DRPLA)	NATURE GENETICS			English	Article							MYOTONIC-DYSTROPHY; MYOCLONUS EPILEPSY; LUYSIAN ATROPHY; CTG REPEAT; GENE; DNA; REGION	Hereditary dentatorubral-pallidoluysian atrophy (DRPLA) is an autosomal dominant neurologic disorder characterized by variable combinations of myoclonus, epilepsy, cerebellar ataxia, choreoathetosis and dementia. By specifically searching published brain cDNA sequences for the presence of CAG repeats we identified unstable expansion of a CAG in a gene on chromosome 12 in all the 22 DRPLA patients examined. A good correlation between the size of the CAG repeat expansion and the ages of disease onset is found in this group. Patients with earlier onset tended to have a phenotype of progressive myoclonus epilepsy and larger expansions. We propose that the wide variety of clinical manifestations of DRPLA can now be explained by the variable unstable expansion of the CAG repeat.	NIIGATA UNIV,BRAIN RES INST,DEPT NEUROL,1-757 ASAHIMACHI,NIIGATA 951,JAPAN; NIIGATA UNIV,BRAIN RES INST,DEPT PATHOL,NIIGATA 951,JAPAN; SHIRONE KENSEI HOSP,DEPT NEUROL,SHIRONE 95012,JAPAN; NISHI OJIYA HOSP,NATL SANAT,DEPT NEUROL,OJIYA 947,JAPAN; KUMAMOTO UNIV,SCH MED,DEPT CHILD DEV,KUMAMOTO 860,JAPAN; MATSUHAMA HOSP,NIIGATA 95031,JAPAN	Niigata University; Niigata University; Kumamoto University			Onodera, Osamu/K-7327-2013; naito, hiroyoshi/E-7083-2011	Onodera, Osamu/0000-0003-3354-5472; naito, hiroyoshi/0000-0002-8138-6077				AKASHI T, 1987, RINSHO SEISHINIGAKU, V16, P1163; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; IIZUKA R, 1984, J NEUROL NEUROSUR PS, V47, P1288, DOI 10.1136/jnnp.47.12.1288; IIZUKA R, 1986, HDB CLIN NEUROLOGY, V49, P437; Iwabuchi K., 1993, SHINKEI KENKYU NO SH, V37, P678; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; KONDO I, 1990, J MED GENET, V27, P105, DOI 10.1136/jmg.27.2.105; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LI SH, 1993, GENOMICS, V16, P572, DOI 10.1006/geno.1993.1232; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Maniatis T, 1989, DECONTAMINATION DILU; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; McKusick V.A., 1992, MENDELIAN INHERITANC; MIYASHITA K, 1992, Brain and Nerve (Tokyo), V44, P279; MORIOKA E, 1987, Brain and Nerve (Tokyo), V39, P769; NAITO H, 1982, NEUROLOGY, V32, P798, DOI 10.1212/WNL.32.8.798; Naito H, 1987, PSYCHIAT NEUROL JPN, V74, P871; NAITO H, 1987, PSYCHIATR NEUROL JPN, V89, P144; NAITO H, 1990, SHINKEI KENKYU SHINP, V34, P56; NAKANO T, 1985, Brain and Nerve (Tokyo), V37, P767; NECHIPORUK SMP, 1993, NAT GENET, V5, P8; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; RIGGINS GJ, 1992, NAT GENET, V2, P186, DOI 10.1038/ng1192-186; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SMITH JK, 1958, NEUROLOGY, V8, P205, DOI 10.1212/WNL.8.3.205; Smith JK, 1975, HDB CLIN NEUROLOGY, V21, P519; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; TAKAHASHI H, 1988, NEUROLOGY, V38, P1065, DOI 10.1212/WNL.38.7.1065; TAKIYAMA Y, 1993, NAT GENET, V4, P300, DOI 10.1038/ng0793-300; TOMODA A, 1991, BRAIN DEV-JPN, V13, P266, DOI 10.1016/S0387-7604(12)80061-1; 1993, CELL, V72, P971	39	1004	1035	0	24	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1994	6	1					9	13		10.1038/ng0194-9	http://dx.doi.org/10.1038/ng0194-9			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ177	8136840				2022-12-25	WOS:A1994MQ17700006
J	LAKICH, D; KAZAZIAN, HH; ANTONARAKIS, SE; GITSCHIER, J				LAKICH, D; KAZAZIAN, HH; ANTONARAKIS, SE; GITSCHIER, J			INVERSIONS DISRUPTING THE FACTOR-VIII GENE ARE A COMMON-CAUSE OF SEVERE HEMOPHILIA-A	NATURE GENETICS			English	Article							HEMOPHILIA-A; MOLECULAR CHARACTERIZATION; DELETIONS; CLUSTER; LOCUS; DNA; RECOMBINATION; REARRANGEMENT; REGIONS; YEAST	Mutations in the factor VIII gene have been discovered for barely more than half of the examined cases of severe haemophilia A. To account for the unidentified mutations, we propose a model based on the possibility of recombination between homologous sequences located in intron 22 and upstream of the factor VIII gene. Such a recombination would lead to an inversion of all intervening DNA and a disruption of the gene. We present evidence to support this model and describe a Southern blot assay that detects the inversion. These findings should be valuable for genetic prediction of haemophilia A in approximately 45% of families with severe disease.	UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21287; JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,BALTIMORE,MD 21287; UNIV GENEVA,SCH MED,DEPT GENET,CH-1211 GENEVA 4,SWITZERLAND	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins University; University of Geneva			Antonarakis, Stylianos E/N-8866-2014	Antonarakis, Stylianos E/0000-0001-8907-5823				CARLE GF, 1985, P NATL ACAD SCI USA, V82, P3756, DOI 10.1073/pnas.82.11.3756; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; EFREMOV GD, 1978, HEMOGLOBIN, V2, P197, DOI 10.3109/03630267809007068; FREIJE D, 1992, AM J HUM GENET, V51, P66; GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326a0; HIGUCHI M, 1991, P NATL ACAD SCI USA, V88, P8307, DOI 10.1073/pnas.88.19.8307; HIGUCHI M, 1991, P NATL ACAD SCI USA, V88, P7405, DOI 10.1073/pnas.88.16.7405; JONES RW, 1981, NATURE, V291, P39, DOI 10.1038/291039a0; KARATHANASIS SK, 1987, P NATL ACAD SCI USA, V84, P7198, DOI 10.1073/pnas.84.20.7198; KATZ BZ, 1989, J INFECT DIS, V160, P589, DOI 10.1093/infdis/160.4.589; KENWRICK S, 1989, AM J HUM GENET, V45, P873; KULOZIK AE, 1992, BLOOD, V79, P2455; KUNKEL LM, 1986, NATURE, V322, P73, DOI 10.1038/322073a0; LEVINSON B, 1990, GENOMICS, V7, P1, DOI 10.1016/0888-7543(90)90512-S; LEVINSON B, 1992, GENOMICS, V14, P585, DOI 10.1016/S0888-7543(05)80155-7; NAYLOR JA, 1993, HUM MOL GENET, V2, P11, DOI 10.1093/hmg/2.1.11; PATTERSON M, 1989, AM J HUM GENET, V44, P679; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; RIZZA CR, 1983, BRIT MED J, V286, P929, DOI 10.1136/bmj.286.6369.929; SMITHIES O, 1964, COLD SPRING HARB SYM, V29, P309, DOI 10.1101/SQB.1964.029.01.033; TUDDENHAM EGD, 1991, NUCLEIC ACIDS RES, V19, P4821, DOI 10.1093/nar/19.18.4821; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; YEN PH, 1990, CELL, V61, P603, DOI 10.1016/0092-8674(90)90472-Q	23	662	694	1	45	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1993	5	3					236	241		10.1038/ng1193-236	http://dx.doi.org/10.1038/ng1193-236			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MF122	8275087				2022-12-25	WOS:A1993MF12200012
J	MHATRE, AN; TRIFIRO, MA; KAUFMAN, M; KAZEMIESFARJANI, P; FIGLEWICZ, D; ROULEAU, G; PINSKY, L				MHATRE, AN; TRIFIRO, MA; KAUFMAN, M; KAZEMIESFARJANI, P; FIGLEWICZ, D; ROULEAU, G; PINSKY, L			REDUCED TRANSCRIPTIONAL REGULATORY COMPETENCE OF THE ANDROGEN RECEPTOR IN X-LINKED SPINAL AND BULBAR MUSCULAR-ATROPHY	NATURE GENETICS			English	Article							GLUCOCORTICOID RECEPTOR; TRINUCLEOTIDE REPEAT; MOLECULAR-BASIS; GENE; ACTIVATION; EXPRESSION; BINDING; LOCALIZATION; TESTOSTERONE; PROTEIN	Expansion of the long (CAG; glutamine)n repeat in the first exon of the X-linked human androgen receptor gene (hAR) causes spinal and bulbar muscular atrophy, frequently in association with mild androgen insensitivity. The relevant normal motor neurons are preferentially stimulated by androgen, however no motor neuron disorder occurs with any other known AR mutation, including those that cause complete androgen insensitivity. We have found that a polyglutamine (Gln) expanded AR transactivates an androgen-responsive reporter gene subnormally. Other groups have reported that a poly Gln-deleted AR transactivates normally. A parsimonious interpretation of all these facts is that poly Gln expansion causes the AR to lose a function that is necessary for full androgen sensitivity and to gain a function that is selectively motor neuronotoxic.	SIR MORTIMER B DAVIS JEWISH HOSP,LADY DAVIS INST MED RES,3755 COTE ST,MONTREAL H3T 1E2,QUEBEC,CANADA; MONTREAL GEN HOSP,CTR RES NEUROSCI,MONTREAL H3G 1A4,QUEBEC,CANADA; MCGILL UNIV,DEPT BIOL,MONTREAL H3A 1B1,QUEBEC,CANADA; MCGILL UNIV,DEPT MED,MONTREAL H3A 1B1,QUEBEC,CANADA; MCGILL UNIV,DEPT PEDIAT,MONTREAL H3A 1B1,QUEBEC,CANADA; MCGILL UNIV,DEPT NEUROSCI,MONTREAL H3A 1B1,QUEBEC,CANADA	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University; McGill University; McGill University								ARAKI I, 1991, J NEUROSCI, V11, P3025; ARBIZU T, 1983, J NEUROL SCI, V59, P371, DOI 10.1016/0022-510X(83)90022-9; Biancalana V., 1992, Human Molecular Genetics, V1, P255, DOI 10.1093/hmg/1.4.255; BLOCHLINGER K, 1988, NATURE, V333, P629, DOI 10.1038/333629a0; BREEDLOVE SM, 1986, J NEUROBIOL, V17, P157, DOI 10.1002/neu.480170304; BRINKMANN AO, 1989, J STEROID BIOCHEM, V34, P307, DOI 10.1016/0022-4731(89)90098-8; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BROWN CJ, 1989, AM J HUM GENET, V44, P264; CHANG CS, 1988, P NATL ACAD SCI USA, V85, P7211, DOI 10.1073/pnas.85.19.7211; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; DANIELSEN M, 1986, EMBO J, V5, P2513, DOI 10.1002/j.1460-2075.1986.tb04529.x; DOYU M, 1992, ANN NEUROL, V32, P707, DOI 10.1002/ana.410320517; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; FABER PW, 1989, MOL CELL ENDOCRINOL, V61, P257, DOI 10.1016/0303-7207(89)90137-8; FABER PW, 1991, BIOCHEM J, V278, P269, DOI 10.1042/bj2780269; FISCHBECK KH, 1986, NEUROLOGY, V36, P1595, DOI 10.1212/WNL.36.12.1595; FRANKEL AD, 1991, CELL, V65, P717, DOI 10.1016/0092-8674(91)90378-C; GOLDSTEIN LA, 1992, J COMP NEUROL, V326, P147, DOI 10.1002/cne.903260113; GOTTLIEB B, 1987, J STEROID BIOCHEM, V28, P279, DOI 10.1016/0022-4731(87)91019-3; HAUSER KF, 1987, BRAIN RES, V406, P62, DOI 10.1016/0006-8993(87)90769-4; HIGUCHI R, 1989, SIMPLE RAPID PREPARA; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; ING NH, 1992, J BIOL CHEM, V267, P17617; JENSTER G, 1991, MOL ENDOCRINOL, V5, P1396, DOI 10.1210/mend-5-10-1396; KAO CC, 1990, SCIENCE, V248, P1646, DOI 10.1126/science.2194289; KAZEMIESFARJANI P, 1993, MOL ENDOCRINOL, V7, P37, DOI 10.1210/me.7.1.37; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; KUJAWA KA, 1989, EXP NEUROL, V105, P80, DOI 10.1016/0014-4886(89)90174-X; LASPADA AR, 1992, NAT GENET, V2, P301, DOI 10.1038/ng1292-301; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LEVINE M, 1989, CELL, V59, P405, DOI 10.1016/0092-8674(89)90024-X; MACGREGOR GR, 1989, NUCLEIC ACIDS RES, V17, P2365, DOI 10.1093/nar/17.6.2365; MATSUURA T, 1992, NEUROLOGY, V42, P1724, DOI 10.1212/WNL.42.9.1724; MCPHAUL MJ, 1991, J CLIN INVEST, V87, P1413, DOI 10.1172/JCI115147; MHATRE A, 1992, AM J HUM GENET, V51; MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8; OLNEY RK, 1990, NEUROLOGY, V47, P1111; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PIROTTA V, 1987, EMBO J, V6, P791; RIGGINS GJ, 1992, NAT GENET, V2, P186, DOI 10.1038/ng1192-186; SAR M, 1977, SCIENCE, V197, P77, DOI 10.1126/science.867053; SHERIDAN PJ, 1982, BRAIN RES, V235, P225, DOI 10.1016/0006-8993(82)91002-2; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; STRAHLE U, 1988, COLD SPRING HARB SYM, V53, P835, DOI 10.1101/SQB.1988.053.01.095; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; TORA L, 1988, NATURE, V333, P185, DOI 10.1038/333185a0; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WARNER CL, 1992, NEUROLOGY, V42, P2181, DOI 10.1212/WNL.42.11.2181; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; YU WHA, 1989, J NEUROSCI, V9, P3908; YU WHA, 1986, J NEUROSCI, V6, P1302; YU WHA, 1983, EXP NEUROL, V80, P349, DOI 10.1016/0014-4886(83)90288-1; 1993, CELL, V72, P971	53	310	317	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1993	5	2					184	188		10.1038/ng1093-184	http://dx.doi.org/10.1038/ng1093-184			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MA056	8252045				2022-12-25	WOS:A1993MA05600018
J	INGLEHEARN, CF; CARTER, SA; KEEN, TJ; LINDSEY, J; STEPHENSON, AM; BASHIR, R; ALMAGHTHEH, M; MOORE, AT; JAY, M; BIRD, AC; BHATTACHARYA, SS				INGLEHEARN, CF; CARTER, SA; KEEN, TJ; LINDSEY, J; STEPHENSON, AM; BASHIR, R; ALMAGHTHEH, M; MOORE, AT; JAY, M; BIRD, AC; BHATTACHARYA, SS			A NEW LOCUS FOR AUTOSOMAL-DOMINANT RETINITIS-PIGMENTOSA ON CHROMOSOME-7P	NATURE GENETICS			English	Article							LINKAGE ANALYSIS; GENE; MUTATIONS	Autosomal dominant retinitis pigmentosa (adRP) is known to result from mutations in two different retinal genes-rhodopsin and peripherin-while a third locus has been implicated by linkage data. However, families have been reported in which all three known loci have been excluded. We report linkage of adRP in one such family to two microsatellite markers on chromosome 7p. D7S435 has previously been localized to 7p13-15.1; D7S460, previously only localized to chromosome 7, maps to within 2 cM of D7S435 with a lod score of 12.15. Two point linkage analysis between these markers and adRP gave lod scores of 5.65 (theta = 0) and 4.19 (theta = 0.046) for D7S460 and D7S435, respectively. Multipoint analysis gave a maximum lod score of 8.22. These data strongly suggest a new adRP locus on chromosome 7p.	NEWCASTLE UNIV,DEPT HUMAN GENET,NEWCASTLE TYNE NE4 2AJ,ENGLAND; INST OPHTHALMOL,DEPT CLIN OPHTHALMOL,LONDON EC1V 2PD,ENGLAND; MOORFIELDS EYE HOSP,LONDON EC1V 2PD,ENGLAND	Newcastle University - UK; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	INGLEHEARN, CF (corresponding author), INST OPHTHALMOL,DEPT MOLEC GENET,BATH ST,LONDON EC1V 9EL,ENGLAND.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ATTWOOD J, 1988, ANN HUM GENET, V52, P259, DOI 10.1111/j.1469-1809.1988.tb01103.x; BASHIR R, 1992, GENOMICS, V14, P191, DOI 10.1016/S0888-7543(05)80306-4; BERSON EL, 1979, ARCH OPHTHALMOL-CHIC, V97, P1286, DOI 10.1001/archopht.1979.01020020028006; BERSON EL, 1969, ARCH OPHTHALMOL-CHIC, V81, P226; BIRD AC, 1988, AUST NZ J OPHTHALMOL, V16, P189, DOI 10.1111/j.1442-9071.1988.tb01209.x; BLANTON SH, 1991, GENOMICS, V11, P857, DOI 10.1016/0888-7543(91)90008-3; DRYJA TP, 1991, P NATL ACAD SCI USA, V88, P9370, DOI 10.1073/pnas.88.20.9370; FARRAR GJ, 1991, NATURE, V354, P478, DOI 10.1038/354478a0; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; INGLEHEARN CF, 1992, HUM MOL GENET, V1, P41, DOI 10.1093/hmg/1.1.41; JAY M, 1992, J MED GENET, V29, P906, DOI 10.1136/jmg.29.12.906; JORDAN SA, 1993, NAT GENET, V4, P54, DOI 10.1038/ng0593-54; KAJIWARA K, 1991, NATURE, V354, P480, DOI 10.1038/354480a0; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LESTER DH, 1990, AM J HUM GENET, V47, P536; LYNESS AL, 1985, BRIT J OPHTHALMOL, V69, P326, DOI 10.1136/bjo.69.5.326; MASSOF RW, 1981, DOC OPHTHALMOL, V51, P289, DOI 10.1007/BF00143336; MISHRA SK, 1992, GENOMICS, V12, P326, DOI 10.1016/0888-7543(92)90381-2; MOORE AT, 1992, BRIT J OPHTHALMOL, V76, P465, DOI 10.1136/bjo.76.8.465; MOORE AT, 1987, OPHTHAL S, V28, P3; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4039, DOI 10.1093/nar/18.13.4039; WELLS J, 1993, NAT GENET, V3, P213, DOI 10.1038/ng0393-213; ZHENG K, 1992, AM J HUM GENET S, V51, P986	25	87	88	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1993	4	1					51	53		10.1038/ng0593-51	http://dx.doi.org/10.1038/ng0593-51			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LA337	8513323				2022-12-25	WOS:A1993LA33700012
J	GERRARD, AJ; HUDSON, DL; BROWNLEE, GG; WATT, FM				GERRARD, AJ; HUDSON, DL; BROWNLEE, GG; WATT, FM			TOWARDS GENE-THERAPY FOR HEMOPHILIA-B USING PRIMARY HUMAN KERATINOCYTES	NATURE GENETICS			English	Article							HUMAN FACTOR-IX; MODIFIED SKIN FIBROBLASTS; HUMAN EPIDERMAL-CELLS; HEMOPHILIA-B; MONOCLONAL-ANTIBODIES; ENDOTHELIAL-CELLS; GROWTH-HORMONE; EXPRESSION; TRANSPLANTATION; IMMUNOASSAYS	Haemophilia B might be permanently cured by gene therapy - the introduction of a correct copy of the factor IX gene into the somatic cells of a patient. Here, we have introduced a recombinant human factor IX cDNA into primary human keratinocytes by means of a defective retroviral vector. In tissue culture, transduced keratinocytes were found to secrete biologically active factor IX and after transplantation of these cells into nude mice, human factor IX was detected in the bloodstream in small quantities for one week. This is the first demonstration of a therapeutic protein reaching the bloodstream from transduced primary keratinocytes. This may have implications for the treatment of haemophilia B and other disorders.	UNIV OXFORD SIR WILLIAM DUNN SCH PATHOL,CHEM PATHOL UNIT,S PARKS RD,OXFORD OX1 3RE,ENGLAND; IMPERIAL CANC RES FUND,KERATINOCYTE LAB,LONDON WC2A 3PX,ENGLAND	University of Oxford; Cancer Research UK			Watt, Fiona/AHB-0226-2022	Watt, Fiona/0000-0001-9151-5154				ANSON DS, 1987, MOL BIOL MED, V4, P11; ANSON DS, 1984, EMBO J, V3, P1053, DOI 10.1002/j.1460-2075.1984.tb01926.x; ANSON DS, 1985, NATURE, V315, P683, DOI 10.1038/315683a0; ARMENTANO D, 1990, P NATL ACAD SCI USA, V87, P6141, DOI 10.1073/pnas.87.16.6141; AUSTEN DEG, 1975, LABORATORY MANUAL BL; AXELROD JH, 1990, P NATL ACAD SCI USA, V87, P5173, DOI 10.1073/pnas.87.13.5173; BARRANDON Y, 1988, J INVEST DERMATOL, V91, P315, DOI 10.1111/1523-1747.ep12475646; BIGGS R, 1963, BRIT J HAEMATOL, V9, P532, DOI 10.1111/j.1365-2141.1963.tb05478.x; CORUH G, 1980, BRIT J DERMATOL, V102, P497, DOI 10.1111/j.1365-2133.1980.tb07646.x; FENJVES ES, 1989, P NATL ACAD SCI USA, V86, P8803, DOI 10.1073/pnas.86.22.8803; FENJVES ES, 1990, DNA DAMAGE REPAIR HU, P215; FLOWERS MED, 1990, P NATL ACAD SCI USA, V87, P2349, DOI 10.1073/pnas.87.6.2349; FUCHS HE, 1984, J CLIN INVEST, V73, P1696, DOI 10.1172/JCI111377; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; GERRARD AJ, 1992, BRIT J HAEMATOL, V81, P610, DOI 10.1111/j.1365-2141.1992.tb03001.x; HANDFORD PA, 1991, PROTEIN ENG, V4, P319, DOI 10.1093/protein/4.3.319; HEDNER U, 1989, METABOLIC BASIS INHE, P2107; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; LIN SW, 1990, J BIOL CHEM, V265, P144; MILLER AD, 1986, SOMAT CELL MOLEC GEN, V12, P175, DOI 10.1007/BF01560664; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; MILLER AD, 1986, MOL CELL BIOL, V6, P2895, DOI 10.1128/MCB.6.8.2895; MORGAN JR, 1987, SCIENCE, V237, P1476; PALMER TD, 1989, BLOOD, V73, P438; PALMER TD, 1991, P NATL ACAD SCI USA, V88, P1330, DOI 10.1073/pnas.88.4.1330; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; SCHARFMANN R, 1991, P NATL ACAD SCI USA, V88, P4626, DOI 10.1073/pnas.88.11.4626; SMITH KJ, 1984, THROMB RES, V33, P211, DOI 10.1016/0049-3848(84)90182-8; STERN DM, 1983, P NATL ACAD SCI-BIOL, V80, P4119, DOI 10.1073/pnas.80.13.4119; STLOUIS D, 1988, P NATL ACAD SCI USA, V85, P3150; TEUMER J, 1990, FASEB J, V4, P3245, DOI 10.1096/fasebj.4.14.2227214; WU SM, 1991, SCIENCE, V254, P1634, DOI 10.1126/science.1749935; YAO SN, 1992, P NATL ACAD SCI USA, V89, P3357, DOI 10.1073/pnas.89.8.3357; YAO SN, 1991, P NATL ACAD SCI USA, V88, P8101, DOI 10.1073/pnas.88.18.8101; YOSHIOKA A, 1985, BRIT J HAEMATOL, V59, P265, DOI 10.1111/j.1365-2141.1985.tb02993.x	35	171	181	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1993	3	2					180	183		10.1038/ng0293-180	http://dx.doi.org/10.1038/ng0293-180			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KL010	8499952				2022-12-25	WOS:A1993KL01000018
J	Rahman, N; Arbour, L; Tonin, P; Renshaw, J; Pelletier, J; Baruchel, S; PritchardJones, K; Stratton, MR; Narod, SA				Rahman, N; Arbour, L; Tonin, P; Renshaw, J; Pelletier, J; Baruchel, S; PritchardJones, K; Stratton, MR; Narod, SA			Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21	NATURE GENETICS			English	Letter							OVARIAN-CANCER; WT1 MUTATIONS; LINKAGE MAP; PREDISPOSITION; LOCUS; BREAST		INST CANC RES, SECT MOL CARCINOGENESIS, SUTTON SM2 5NG, SURREY, ENGLAND; INST CANC RES, PAEDIAT SECT, SUTTON SM2 5NG, SURREY, ENGLAND; MCGILL UNIV, MONTREAL GEN HOSP, DEPT MED, DIV MED GENET, MONTREAL, PQ H3G 1A4, CANADA; MCGILL UNIV, MONTREAL GEN HOSP, DEPT HUMAN GENET, MONTREAL, PQ H3G 1A4, CANADA; MCGILL UNIV, MONTREAL GEN HOSP, DEPT BIOCHEM, MONTREAL, PQ H3G 1A4, CANADA; MCGILL UNIV, MONTREAL GEN HOSP, DEPT PAEDIAT ONCOL, MONTREAL, PQ H3G 1A4, CANADA; MONTREAL CHILDRENS HOSP, RES INST, MONTREAL, PQ H3H 1P3, CANADA; WOMENS COLL HOSP, TORONTO, ON M5S 1B2, CANADA	University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; McGill University; McGill University; McGill University; McGill University; McGill University; University of Toronto; University Toronto Affiliates; Womens College Hospital			Rahman, Nazneen/B-8890-2012; Pritchard-Jones, Kathy/F-4286-2014; Narod, Steven A/AAA-6112-2022; Rahman, Nazneen/D-2802-2013	Pritchard-Jones, Kathy/0000-0002-2384-9475; Arbour, Laura/0000-0002-9589-0880; Rahman, Nazneen/0000-0003-4376-0440				BAIRD PN, 1992, ONCOGENE, V7, P2141; BRESLOW NE, 1982, JNCI-J NATL CANCER I, V68, P429; CAIRNEY A, 1990, J PEDIATR, V11, P414; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; GEISER CF, 1969, PEDIATRICS, V44, P111; GRUNDY P, 1988, NATURE, V336, P374, DOI 10.1038/336374a0; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARTLEY AL, 1993, CANCER GENET CYTOGEN, V67, P133, DOI 10.1016/0165-4608(93)90166-J; HUFF V, 1992, CANCER RES, V52, P6117; HUFF V, 1988, NATURE, V336, P377, DOI 10.1038/336377a0; KOUFOS A, 1989, AM J HUM GENET, V44, P711; LITTLE MH, 1993, HUM MOL GENET, V2, P259, DOI 10.1093/hmg/2.3.259; MAW MA, 1992, CANCER RES, V52, P3094; Moutou C., 1993, European Journal of Human Genetics, V1, P190; NAROD SA, 1994, BRIT MED BULL, V50, P656, DOI 10.1093/oxfordjournals.bmb.a072915; NERI G, 1984, AM J MED GENET, V19, P195, DOI 10.1002/ajmg.1320190120; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; PELLETIER J, 1991, NATURE, V353, P431, DOI 10.1038/353431a0; Pilia G, 1996, NAT GENET, V12, P241, DOI 10.1038/ng0396-241; SCHWARTZ CE, 1991, GENOMICS, V10, P927, DOI 10.1016/0888-7543(91)90181-D; STAY EJ, 1977, CANCER, V39, P2550, DOI 10.1002/1097-0142(197706)39:6<2550::AID-CNCR2820390636>3.0.CO;2-Y; SZABO J, 1995, AM J HUM GENET, V56, P944; TONIN P, 1993, GENOMICS, V18, P414, DOI 10.1006/geno.1993.1487; VARANASI R, 1994, P NATL ACAD SCI USA, V91, P3554, DOI 10.1073/pnas.91.9.3554; WADEY RB, 1990, ONCOGENE, V5, P901; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	28	107	107	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1996	13	4					461	463		10.1038/ng0896-461	http://dx.doi.org/10.1038/ng0896-461			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VB620	8696342				2022-12-25	WOS:A1996VB62000028
J	Fox, AJ; Lalloo, UG; Belvisi, MG; Bernareggi, M; Chung, KF; Barnes, PJ				Fox, AJ; Lalloo, UG; Belvisi, MG; Bernareggi, M; Chung, KF; Barnes, PJ			Bradykinin-evoked sensitization of airway sensory nerves: A mechanism for ACE-inhibitor cough	NATURE MEDICINE			English	Article							BRONCHIAL HYPERREACTIVITY; GUINEA-PIG; REFLEX	Cough accompanied by an increased sensitivity of the cough reflex is the most common symptom of inflammatory airway disease(1,5). This symptom is also frequently reported in patients receiving angiotensin-converting converting enzyme (ACE) inhibitors as therapy for heart failure or hypertension(2-4), although the underlying mechanism is unknown. We have investigated the possibility that the inflammatory peptide bradykinin, normally degraded by ACE, causes sensitization of airway sensory nerves and an enhancement of the cough reflex in conscious guinea pigs. Treatment of guinea pigs for two weeks with captopril led to an increased cough response to inhaled citric acid, which was prevented by concomitant treatment with the bradykinin receptor antagonist icatibant. A similar icatibant-sensitive enhancement of citric acid-evoked cough was seen in untreated animals after prior inhalation of bradykinin, although cough evoked by hypertonic saline was unaffected. In electrophysiological studies performed in vitro, responses of single vagal C fibers to capsaicin, applied to receptive fields of single-fiber units in the trachea, were also markedly increased after perfusion with bradykinin, whereas A delta fiber responses to hypertonic saline were unaffected. These results indicate that bradykinin-evoked sensitization of airway sensory nerves may underlie the pathogenesis of ACE-inhibitor cough. Bradykinin receptor antagonists may be of benefit in treating chronic cough seen with this and other inflammatory conditions.	NATL HEART & LUNG INST,DEPT THORAC MED,LONDON SW3 6LY,ENGLAND	Imperial College London			Belvisi, Maria G/A-3055-2009; Chung, Kian Fan/B-1872-2012; Chung, Kian Fan/I-8456-2019	Chung, Kian Fan/0000-0001-7101-1426; Chung, Kian Fan/0000-0001-7101-1426; Barnes, Peter/0000-0002-5122-4018	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BUCKNALL CE, 1988, BRIT MED J, V296, P86, DOI 10.1136/bmj.296.6615.86; CHOUDRY NB, 1992, EUR RESPIR J, V5, P296; COLERIDGE JCG, 1984, REV PHYSIOL BIOCH P, V99, P1, DOI 10.1007/BFb0027715; DRAY A, 1994, TRENDS PHARMACOL SCI, V15, P190, DOI 10.1016/0165-6147(94)90147-3; EMPEY DW, 1976, AM REV RESPIR DIS, V113, P131; Forsberg K, 1988, Pulm Pharmacol, V1, P33, DOI 10.1016/0952-0600(88)90008-7; FOX AJ, 1995, NEUROSCIENCE, V67, P741, DOI 10.1016/0306-4522(95)00115-Y; FOX AJ, 1995, J PHYSIOL-LONDON, V482, P179, DOI 10.1113/jphysiol.1995.sp020508; FOX AJ, 1993, J PHYSIOL-LONDON, V469, P21, DOI 10.1113/jphysiol.1993.sp019802; HARGREAVES MR, 1995, LANCET, V345, P13, DOI 10.1016/S0140-6736(95)91151-0; HOLZER P, 1991, PHARMACOL REV, V43, P143; ISRAILI ZH, 1992, ANN INTERN MED, V117, P234, DOI 10.7326/0003-4819-117-3-234; KARLSSON JA, 1988, J APPL PHYSIOL, V65, P1007, DOI 10.1152/jappl.1988.65.3.1007; LALLOO UG, 1995, J APPL PHYSIOL, V79, P1082, DOI 10.1152/jappl.1995.79.4.1082; MCEWAN JR, 1989, BMJ-BRIT MED J, V299, P13, DOI 10.1136/bmj.299.6690.13; MOHAMMED SP, 1993, J PHYSIOL-LONDON, V469, P51, DOI 10.1113/jphysiol.1993.sp019804; OCONNELL F, 1995, AM J RESP CRIT CARE, V152, P2068, DOI 10.1164/ajrccm.152.6.8520777; OCONNELL F, 1994, AM J RESP CRIT CARE, V150, P374, DOI 10.1164/ajrccm.150.2.8049818; TSUBONE H, 1991, RESP PHYSIOL, V86, P215, DOI 10.1016/0034-5687(91)90082-T; WIDDICOMBE JG, 1995, EUR RESPIR J, V8, P1193, DOI 10.1183/09031936.95.08071193	20	197	210	0	16	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUL	1996	2	7					814	817		10.1038/nm0796-814	http://dx.doi.org/10.1038/nm0796-814			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UU680	8673930				2022-12-25	WOS:A1996UU68000040
J	Jonsen, AR; Durfy, SJ; Burke, W; Motulsky, AG				Jonsen, AR; Durfy, SJ; Burke, W; Motulsky, AG			The advent of the 'unpatients'	NATURE MEDICINE			English	Editorial Material							HUNTINGTON DISEASE; CANADA; RISK		UNIV WASHINGTON,WOMENS HLTH CARE CTR,DEPT MED,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT GENET,SEATTLE,WA 98195	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Jonsen, AR (corresponding author), UNIV WASHINGTON,SCH MED,DEPT MED HIST & ETH,BOX 357120,SEATTLE,WA 98195, USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000477] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG 00477] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BLOCH M, 1992, AM J MED GENET, V42, P499, DOI 10.1002/ajmg.1320420416; Cook-Deegan R M, 1991, Mol Genet Med, V1, P1; Dunlop M G, 1992, Semin Cancer Biol, V3, P131; FANOS JH, 1995, AM J HUM GENET, V57, P431; GROOP LC, 1993, NEW ENGL J MED, V328, P10, DOI 10.1056/NEJM199301073280102; HIPPOCRATES, 1923, ART, P204; HUGGINS M, 1992, AM J MED GENET, V42, P508, DOI 10.1002/ajmg.1320420417; Jones WH, 1923, EPIDEMICS, V1, P165; Kevles 8Daniel, 1985, NAME EUGENICS GENETI; MARSHALL E, 1993, SCIENCE, V262, P23, DOI 10.1126/science.8211123; MEHLMAN MJ, 1994, AM J HUM GENET, V55, P1054; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MOSELEY R, 1993, ETHICAL LEGAL SOCIAL; MOTULSKY AG, 1992, GENETIC BASIS COMMON, P150; MYERS MF, 1994, AM J HUM GENET, V54, P719; Proctor Robert N., 1988, RACIAL HYGIENE MED N; ROTTER JI, 1992, GENETIC BASIS COMMON, P413; TAMBOR ES, 1994, AM J HUM GENET, V55, P626; WIGGINS S, 1992, NEW ENGL J MED, V327, P1401, DOI 10.1056/NEJM199211123272001; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; YESLEY MS, 1993, ELSI BIBLIO ETHICAL; 1993, GENETIC INFORMATION	22	67	67	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUN	1996	2	6					622	624		10.1038/nm0696-622	http://dx.doi.org/10.1038/nm0696-622			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UN691	8640544				2022-12-25	WOS:A1996UN69100021
J	Meissner, PN; Dailey, TA; Hift, R; Ziman, M; Corrigall, AV; Roberts, AG; Meissner, DM; Kirsch, RE; Dailey, HA				Meissner, PN; Dailey, TA; Hift, R; Ziman, M; Corrigall, AV; Roberts, AG; Meissner, DM; Kirsch, RE; Dailey, HA			A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria	NATURE GENETICS			English	Letter							PORPHOBILINOGEN DEAMINASE		UNIV GEORGIA,CTR METALLOENZYME STUDIES,ATHENS,GA 30602; UNIV GEORGIA,DEPT MICROBIOL,ATHENS,GA 30602; UNIV WALES COLL MED,DEPT MED BIOCHEM,CARDIFF CF4 4XN,S GLAM,WALES	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Cardiff University	Meissner, PN (corresponding author), UNIV CAPE TOWN,DEPT MED,MRC UCT LIVER RES CTR,LENNOX EALES PORPHYRIA LAB,OBSERV 7925,CAPE TOWN 7925,SOUTH AFRICA.		Ziman, Mel/A-2272-2008	Ziman, Mel/0000-0001-7527-3538	NIDDK NIH HHS [R56 DK032303, DK32303, DK35898] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035898, R01DK032303] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BLOCH KD, 1994, CURRENT PROTOCOLS MO; BRENNER DA, 1980, NEW ENGL J MED, V302, P732; Dailey TA, 1996, PROTEIN SCI, V5, P98; DAILEY TA, 1994, J BIOL CHEM, V269, P813; Dailey TA, 1995, ARCH BIOCHEM BIOPHYS, V324, P379, DOI 10.1006/abbi.1995.0051; DAILEY TA, IN PRESS J BIOL CHEM, V271; DAY RS, 1986, SEMIN DERMATOL, V5, P138; DAY RS, 1978, INT J BIOCHEM, V9, P897, DOI 10.1016/0020-711X(78)90067-8; DEAN G, 1971, PORPHYRIAS; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; DEYBACH JC, 1981, HUM GENET, V58, P425, DOI 10.1007/BF00282829; EALES L, 1980, INT J BIOCHEM, V12, P837; HIFT RJ, 1993, POSTGRAD MED J, V69, P781, DOI 10.1136/pgmj.69.816.781; MEISSNER P, 1993, J CLIN INVEST, V91, P1436, DOI 10.1172/JCI116348; MEISSNER PN, 1986, EUR J CLIN INVEST, V16, P257, DOI 10.1111/j.1365-2362.1986.tb01339.x; MEISSNER PN, 1987, S AFR MED J, V72, P755; NISHIMURA K, 1995, J BIOL CHEM, V270, P8076, DOI 10.1074/jbc.270.14.8076; ROBERTS AG, 1995, HUM MOL GENET, V4, P2387, DOI 10.1093/hmg/4.12.2387; VILJOEN DJ, 1979, AM J HEMATOL, V6, P185, DOI 10.1002/ajh.2830060302	19	165	169	0	11	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1996	13	1					95	97		10.1038/ng0596-95	http://dx.doi.org/10.1038/ng0596-95			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH430	8673113				2022-12-25	WOS:A1996UH43000023
J	Thorlacius, S; Olafsdottir, G; Tryggvadottir, L; Neuhausen, S; Jonasson, JG; Tavtigian, SV; Tulinius, H; Ogmundsdottir, HM; Eyfjord, JE				Thorlacius, S; Olafsdottir, G; Tryggvadottir, L; Neuhausen, S; Jonasson, JG; Tavtigian, SV; Tulinius, H; Ogmundsdottir, HM; Eyfjord, JE			A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes	NATURE GENETICS			English	Letter									ICELAND CANC SOC,MOL & CELL BIOL RES LAB,IS-125 REYKJAVIK,ICELAND; UNIV UTAH,SCH MED,DEPT MED INFORMAT,SALT LAKE CITY,UT; ICELAND CANC SOC,CANC REGISTRY,IS-125 REYKJAVIK,ICELAND; UNIV ICELAND,DEPT PATHOL,IS-121 REYKJAVIK,ICELAND	Utah System of Higher Education; University of Utah; University of Iceland			Ögmundsdóttir, Helga M/L-6970-2015	Tryggvadottir, Laufey/0000-0001-8067-9030; Jonasson, Jon G./0000-0002-2635-5032				BARDARDOTTIR RB, 1995, ACTA ONCOL, V34, P657; Jonasson JG, 1996, INT J CANCER, V65, P446, DOI 10.1002/(SICI)1097-0215(19960208)65:4<446::AID-IJC9>3.0.CO;2-X; LATHROP GM, 1984, AM J HUM GENET, V36, P460; PARKIN DM, 1992, CANC INCIDENCE 5 CON, V6, P618; SCHUTTE M, 1995, P NATL ACAD SCI USA, V92, P5950, DOI 10.1073/pnas.92.13.5950; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; THORLACIUS S, 1993, CANCER RES, V53, P1637; THORLACIUS S, 1995, LANCET, V346, P544, DOI 10.1016/S0140-6736(95)91383-1; TONIN P, 1995, J MED GENET, V32, P982, DOI 10.1136/jmg.32.12.982; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; WRIGHT DK, 1990, PCR PROTOCOLS GUIDE, P153	12	428	434	0	20	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1996	13	1					117	119		10.1038/ng0596-117	http://dx.doi.org/10.1038/ng0596-117			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH430	8673089				2022-12-25	WOS:A1996UH43000029
J	Wolff, G; Mastrangeli, A; Heinflink, M; FalckPedersen, E; Gershengorn, MC; Crystal, RG				Wolff, G; Mastrangeli, A; Heinflink, M; FalckPedersen, E; Gershengorn, MC; Crystal, RG			Ectopic expression of thyrotropin releasing hormone (TRH) receptors in liver modulates organ function to regulate blood glucose by TRH	NATURE GENETICS			English	Article							ADENOVIRUS-MEDIATED TRANSFER; SIGNAL-TRANSDUCTION; GENE; INVIVO; RAT; VASOPRESSIN; EPITHELIUM; GLUCAGON; DISEASE; CELLS	Maintenance of blood glucose by the liver is normally initiated by extracellular regulatory molecules such as glucagon and vasopressin triggering specific hepatocyte receptors to activate the cAMP or phosphoinositide signal transduction pathways, respectively. We now show that the normal ligand-receptor regulators of blood glucose in the liver can be bypassed using an adenovirus vector expressing the mouse pituitary thyrotropin releasing hormone receptor (TRHR) cDNA ectopically in rat liver in vivo. The ectopically expressed TRHR links to the phosphoinositide pathway, providing a means to regulate liver function with TRH, an extracellular ligand that does not normally affect hepatic function. Administration of TRH to these animals activates the phosphoinositide pathway, resulting in a sustained rise in blood glucose. It should be possible to use this general strategy to modulate the differentiated functions of target organs in a wide variety of pathologic states.	CORNELL UNIV,COLL MED,DIV PULM & CRIT CARE MED,NEW YORK,NY 10021; CORNELL UNIV,COLL MED,DIV MOLEC MED,NEW YORK,NY 10021; CORNELL UNIV,COLL MED,DEPT MICROBIOL,NEW YORK,NY 10021; NEW YORK HOSP,NEW YORK,NY 10021	Cornell University; Cornell University; Cornell University; NewYork-Presbyterian Hospital				Wolff MD|PhD, Gerhard/0000-0002-4458-0700	NIDDK NIH HHS [R01 DK43036] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043036] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BIRNBAUMER L, 1990, CRIT REV BIOCHEM MOL, V25, P225, DOI 10.3109/10409239009090610; BOND RA, 1995, NATURE, V374, P272, DOI 10.1038/374272a0; BRINGHURST FR, 1993, ENDOCRINOLOGY, V132, P2090, DOI 10.1210/en.132.5.2090; BUWALDA B, 1993, PHYSIOL BEHAV, V54, P947, DOI 10.1016/0031-9384(93)90307-2; EXTON J H, 1987, Diabetes Metabolism Reviews, V3, P163; FALCKPEDERSEN E, 1994, MOL PHARMACOL, V45, P684; GAMMELTOFT S, 1995, ENDOCRINOLOGY, P17; GERSHENGORN MC, 1993, RECENT PROG HORM RES, V48, P341; GERSHENGORN MC, 1994, J BIOL CHEM, V269, P6779; GERSHENGORN MC, 1978, J CLIN INVEST, V62, P937, DOI 10.1172/JCI109222; GERSHENGORN MC, 1995, ENDOCRINOLOGY, P66; GROSSMAN M, 1994, NAT GENET, V6, P335, DOI 10.1038/ng0494-335; HABENER JF, 1995, ENDOCRINOLOGY, P77; HEINFLINK M, 1994, J CLIN ENDOCR METAB, V79, P650, DOI 10.1210/jc.79.2.650; HEMS DA, 1975, BIOCHIM BIOPHYS ACTA, V411, P155, DOI 10.1016/0304-4165(75)90294-9; HERSH J, 1995, GENE THER, V2, P124; HERZ J, 1993, P NATL ACAD SCI USA, V90, P2812, DOI 10.1073/pnas.90.7.2812; IMAI A, 1987, METHOD ENZYMOL, V141, P100; JAFFE HA, 1992, NAT GENET, V1, P372, DOI 10.1038/ng0892-372; KANEKO KJ, 1993, BIOCHEMISTRY-US, V32, P8348, DOI 10.1021/bi00083a039; KOZARSKY KF, 1994, J BIOL CHEM, V269, P13695; LEFKOWITZ RJ, 1993, J CLIN INVEST, V92, P2089, DOI 10.1172/JCI116806; LI QT, 1993, HUM GENE THER, V4, P403, DOI 10.1089/hum.1993.4.4-403; MILANO CA, 1994, SCIENCE, V264, P582, DOI 10.1126/science.8160017; MILANO CA, 1994, P NATL ACAD SCI USA, V91, P10109, DOI 10.1073/pnas.91.21.10109; NAPARSTEK Y, 1993, ANNU REV IMMUNOL, V11, P79, DOI 10.1146/annurev.iy.11.040193.000455; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Rawnsley HM, 1977, CLIN BIOCH HEMATOLOG, P117; RAYMOND JR, 1994, AM J PHYSIOL, V266, pF163, DOI 10.1152/ajprenal.1994.266.2.F163; ROGERS SW, 1994, SCIENCE, V265, P648, DOI 10.1126/science.8036512; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680; SCANLON MF, 1995, ENDOCRINOLOGY, P192; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; SPIEGEL AM, 1993, J CLIN INVEST, V92, P1119, DOI 10.1172/JCI116680; TSUNODA Y, 1993, BIOCHIM BIOPHYS ACTA, V1154, P105, DOI 10.1016/0304-4157(93)90008-C; VALE W, 1971, ENDOCRINOLOGY, V89, P1485, DOI 10.1210/endo-89-6-1485; WALSH DA, 1994, FASEB J, V8, P1227, DOI 10.1096/fasebj.8.15.8001734; WILKIN TJ, 1990, NEW ENGL J MED, V323, P1318; YOUNG AA, 1993, AM J PHYSIOL, V264, pE943, DOI 10.1152/ajpendo.1993.264.6.E943	40	8	9	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1996	12	3					274	279		10.1038/ng0396-274	http://dx.doi.org/10.1038/ng0396-274			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TY183	8589718				2022-12-25	WOS:A1996TY18300016
J	Borrow, J; Shearman, AM; Stanton, VP; Becher, R; Collins, T; Williams, AJ; Dube, I; Katz, F; Kwong, YL; Morris, C; Ohyashiki, K; Toyama, K; Rowley, J; Housman, DE				Borrow, J; Shearman, AM; Stanton, VP; Becher, R; Collins, T; Williams, AJ; Dube, I; Katz, F; Kwong, YL; Morris, C; Ohyashiki, K; Toyama, K; Rowley, J; Housman, DE			The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9	NATURE GENETICS			English	Article							HUMAN HEMATOPOIETIC-CELLS; HOMEOBOX GENE; MESSENGER-RNA; LEUKEMIA; EXPRESSION; FUSION; ACID; DNA; TRANSCRIPTION; BREAKPOINT	The t(7;11)(p15;p15) translocation is a recurrent chromosomal abnormality associated primarily with acute myeloid leukaemia (FAB M2 and M4). We present here the molecular definition of this translocation. On chromosome 7 positional cloning revealed the consistent rearrangement of the HOXA9 gene, which encodes a class I homeodomain protein potentially involved in myeloid differentiation. On chromosome 11 the translocation targets the human homologue of NUP98, a member of the GLFG nucleoporin family. Chimaeric messages spliced over the breakpoint fuse the GLFG Massachusetts repeat domains of NUP98 in-frame to the HOXA9 homeobox. The predicted NUP98-HOXA9 fusion protein may promote leukaemogenesis through inhibition of HOXA9-mediated terminal differentiation and/or aberrant nucleocytoplasmic transport.	W GERMAN CANC CTR, D-45122 ESSEN 1, GERMANY; BRIGHAM & WOMENS HOSP, DEPT PATHOL, BOSTON, MA 02115 USA; UNIV TORONTO, TORONTO, ON M5G 1L5, CANADA; GREAT ORMOND ST HOSP SICK CHILDREN, LONDON WC1N 1EH, ENGLAND; UNIV HONG KONG, QUEEN MARY HOSP, DEPT MED, HONG KONG, HONG KONG; CHRISTCHURCH SCH MED, CHRISTCHURCH, NEW ZEALAND; TOKYO MED COLL, SHINJUKU KU, TOKYO 160, JAPAN; UNIV CHICAGO, MED CTR, CHICAGO, IL 60637 USA	Harvard University; Brigham & Women's Hospital; University of Toronto; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Hong Kong; University of Otago; Tokyo Medical University; University of Chicago; University of Chicago Medical Center	Borrow, J (corresponding author), MIT, CTR CANC RES, 77 MASSACHUSETTS AVE, CAMBRIDGE, MA 02139 USA.		Kwong, Yok Lam/C-4296-2009; Morris, Christine/G-1690-2011	Stanton, Vincent/0000-0002-2205-6000	NATIONAL CANCER INSTITUTE [R01CA017575, R37CA017575] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000299] Funding Source: NIH RePORTER; NCI NIH HHS [CA17575] Funding Source: Medline; NHGRI NIH HHS [HG00299] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BENSON GV, 1995, MOL CELL BIOL, V15, P1591; BEPLER G, 1994, P NATL ACAD SCI USA, V91, P5513, DOI 10.1073/pnas.91.12.5513; BILL J, 1986, SOMAT CELL MOLEC GEN, V12, P409, DOI 10.1007/BF01570736; BLOBEL G, 1985, P NATL ACAD SCI USA, V82, P8527, DOI 10.1073/pnas.82.24.8527; BORROW J, 1990, SCIENCE, V249, P1577, DOI 10.1126/science.2218500; CHAN SK, 1994, CELL, V78, P603, DOI 10.1016/0092-8674(94)90525-8; CHANG CP, 1995, GENE DEV, V9, P663, DOI 10.1101/gad.9.6.663; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; COLLINS SJ, 1990, MOL CELL BIOL, V10, P2154, DOI 10.1128/MCB.10.5.2154; DAVIS LI, 1995, ANNU REV BIOCHEM, V64, P865, DOI 10.1146/annurev.bi.64.070195.004245; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; DUBE ID, 1991, BLOOD, V78, P2996; FABRE E, 1994, CELL, V78, P275, DOI 10.1016/0092-8674(94)90297-6; FORNEROD M, 1995, ONCOGENE, V10, P1739; FUJIMURA T, 1993, CANCER GENET CYTOGEN, V68, P143, DOI 10.1016/0165-4608(93)90012-B; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; GARDINER DM, 1995, DEVELOPMENT, V121, P1731; GLASER T, 1989, SOMAT CELL MOLEC GEN, V15, P477, DOI 10.1007/BF01534910; GLASER T, 1990, GENOMICS, V6, P48, DOI 10.1016/0888-7543(90)90447-3; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HATANO M, 1991, SCIENCE, V253, P79, DOI 10.1126/science.1676542; HEISTERKAMP N, 1990, NATURE, V344, P251, DOI 10.1038/344251a0; HOLTON TA, 1991, NUCLEIC ACIDS RES, V19, P1156, DOI 10.1093/nar/19.5.1156; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; KENNEDY MA, 1991, P NATL ACAD SCI USA, V88, P8900, DOI 10.1073/pnas.88.20.8900; KONGSUWAN K, 1988, EMBO J, V7, P2131, DOI 10.1002/j.1460-2075.1988.tb03052.x; KONGSUWAN K, 1989, NUCLEIC ACIDS RES, V17, P1881, DOI 10.1093/nar/17.5.1881; KRAEMER D, 1994, P NATL ACAD SCI USA, V91, P1519, DOI 10.1073/pnas.91.4.1519; KWONG YL, 1992, LEUKEMIA, V6, P232; KWONG YL, 1994, AM J HEMATOL, V47, P62, DOI 10.1002/ajh.2830470117; LANGSTON AW, 1992, MECH DEVELOP, V38, P217, DOI 10.1016/0925-4773(92)90055-O; LIU J, 1995, GENOMICS, V26, P178, DOI 10.1016/0888-7543(95)80199-V; LOWNEY P, 1991, NUCLEIC ACIDS RES, V19, P3443, DOI 10.1093/nar/19.12.3443; MAGLI MC, 1991, P NATL ACAD SCI USA, V88, P6348, DOI 10.1073/pnas.88.14.6348; MOROIANU J, 1995, P NATL ACAD SCI USA, V92, P6532, DOI 10.1073/pnas.92.14.6532; MORRIS CM, 1989, BRIT J HAEMATOL, V71, P481, DOI 10.1111/j.1365-2141.1989.tb06306.x; NOURSE J, 1990, CELL, V60, P535, DOI 10.1016/0092-8674(90)90657-Z; POWERS MA, 1995, J CELL BIOL, V128, P721, DOI 10.1083/jcb.128.5.721; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; Rubin M R, 1990, DNA Seq, V1, P115, DOI 10.3109/10425179009016039; RUBIN MR, 1987, MOL CELL BIOL, V7, P3836, DOI 10.1128/MCB.7.10.3836; Sambrook J, 1989, MOL CLONING LABORATO; SATO Y, 1987, BLOOD, V70, P1654; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; SHEN WF, 1989, P NATL ACAD SCI USA, V86, P8536, DOI 10.1073/pnas.86.21.8536; SUKEGAWA J, 1993, CELL, V72, P29, DOI 10.1016/0092-8674(93)90047-T; TOMIYASU T, 1982, JPN J HUM GENET, V27, P243, DOI 10.1007/BF01901320; VANDIJK MA, 1994, CELL, V78, P617, DOI 10.1016/0092-8674(94)90526-6; VIEILLEGROSJEAN I, 1992, BIOCHEM BIOPH RES CO, V183, P1124, DOI 10.1016/S0006-291X(05)80307-9; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; VONLINDERN M, 1990, MOL CELL BIOL, V10, P4016, DOI 10.1128/MCB.10.8.4016; VONLINDERN M, 1992, MOL CELL BIOL, V12, P1687, DOI 10.1128/MCB.12.4.1687; WINQVIST R, 1993, CANCER RES, V53, P4486; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; ZAVORTINK M, 1989, GENE DEV, V3, P1969, DOI 10.1101/gad.3.12a.1969	59	373	384	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1996	12	2					159	167		10.1038/ng0296-159	http://dx.doi.org/10.1038/ng0296-159			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TU079	8563754				2022-12-25	WOS:A1996TU07900016
J	Gauguier, D; Froguel, P; Parent, V; Bernard, C; Bihoreau, MT; Portha, B; James, MR; Penicaud, L; Lathrop, M; Ktorza, A				Gauguier, D; Froguel, P; Parent, V; Bernard, C; Bihoreau, MT; Portha, B; James, MR; Penicaud, L; Lathrop, M; Ktorza, A			Chromosomal mapping of genetic loci associated with non-insulin dependent diabetes in the GK rat	NATURE GENETICS			English	Article							SPONTANEOUSLY HYPERTENSIVE RAT; BLOOD-PRESSURE; MELLITUS; ENDOCRINE; ETIOLOGY; LINKAGE; TWINS; MAP	Goto-Kakizaki (GK) rats are a well characterized model for non-insulin dependent diabetes mellitus (NIDDM). We have used a combination of physiological and genetic studies to identify quantitative trait loci (QTLs) responsible for the control of glucose homeostasis and insulin secretion in a F-2 cohort bred from spontaneously diabetic GK rats. The genetic dissection of NIDDM allowed us to map up to six independently segregating loci predisposing to hyperglycaemia, glucose intolerance or altered insulin secretion, and a seventh locus implicated in body weight. QTLs implicated in glucose tolerance and adiposity map to the same region of rat chromosome 1, and may indicate the influence of a single locus. Our study demonstrates that distinct combinations of genetic loci are responsible for different physiological characteristics associated with the diabetic phenotype in the GK rat, and it constitutes an important step for directing the search for the genetic factors involved in human NIDDM.	ST LOUIS HOSP,INSERM,U358,F-75010 PARIS,FRANCE; INST PASTEUR,CNRS,EP 10,F-59019 LILLE,FRANCE; UNIV PARIS 07,PHYSIOPATHOL NUTR LAB,CNRS,URA 307,F-75005 PARIS,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Gauguier, D (corresponding author), WELLCOME TRUST CTR HUMAN GENET,WINDMILL RD,OXFORD OX3 7BN,ENGLAND.		FROGUEL, Philippe/O-6799-2017; Gauguier, Dominique/G-2190-2016; Portha, Bernard/AAW-3021-2021	FROGUEL, Philippe/0000-0003-2972-0784; Gauguier, Dominique/0000-0001-6156-9530; 	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ABDELHALIM SM, 1994, DIABETES, V43, P2811; AKABAYASHI A, 1994, MOL BRAIN RES, V21, P55, DOI 10.1016/0169-328X(94)90377-8; ANDERSSON L, 1994, SCIENCE, V263, P1771, DOI 10.1126/science.8134840; BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11; BARNETT AH, 1981, DIABETOLOGIA, V20, P87, DOI 10.1007/BF00262007; COOK DL, 1992, INT TXB DIABETES MEL, P89; DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68; DENG YL, 1992, NAT GENET, V1, P267, DOI 10.1038/ng0792-267; DUBAY C, 1993, NAT GENET, V3, P354, DOI 10.1038/ng0493-354; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; GAUGUIER D, 1994, DIABETES, V43, P220, DOI 10.2337/diabetes.43.2.220; GHOSH S, 1993, NAT GENET, V4, P404, DOI 10.1038/ng0893-404; GLASER B, 1994, NAT GENET, V7, P185, DOI 10.1038/ng0694-185; GOTO Y, 1975, P JPN ACAD, V51, P80, DOI 10.2183/pjab1945.51.80; GOTO Y, 1988, LESSONS ANIMAL DIABE, V2, P490; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; JACOB HJ, 1992, NAT GENET, V2, P56, DOI 10.1038/ng0992-56; KING H, 1988, BAILLIERE CLIN ENDOC, V2, P291, DOI 10.1016/S0950-351X(88)80033-8; LEIBOWITZ SF, 1991, BRAIN RES BULL, V27, P333, DOI 10.1016/0361-9230(91)90121-Y; LINDPAINTNER K, 1993, J HYPERTENS, V11, P19, DOI 10.1097/00004872-199301000-00004; NEWMAN B, 1987, DIABETOLOGIA, V30, P763; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; PORTHA B, 1991, DIABETES, V40, P486, DOI 10.2337/diabetes.40.4.486; RICH SS, 1990, DIABETES, V39, P1315, DOI 10.2337/diabetes.39.11.1315; ROSEN KM, 1993, ENDOCRINOLOGY, V133, P168; SAMANI NJ, 1993, J CLIN INVEST, V92, P1099, DOI 10.1172/JCI116616; SERIKAWA T, 1992, GENETICS, V131, P701; SHEIKH SP, 1988, AM J PHYSIOL, V255, pG46, DOI 10.1152/ajpgi.1988.255.1.G46; STEINER DF, 1990, DIABETES CARE, V13, P600, DOI 10.2337/diacare.13.6.600; TAYLOR R, 1989, BRIT MED BULL, V45, P73, DOI 10.1093/oxfordjournals.bmb.a072322; TAYLOR SI, 1991, J CLIN ENDOCR METAB, V73, P1158, DOI 10.1210/jcem-73-6-1158; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; Wallum BJ, 1992, INT TXB DIABETES MEL, P285; WEST DB, 1994, J CLIN INVEST, V94, P1410, DOI 10.1172/JCI117477	35	261	266	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1996	12	1					38	43		10.1038/ng0196-38	http://dx.doi.org/10.1038/ng0196-38			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TM555	8528248				2022-12-25	WOS:A1996TM55500012
J	Khandjian, EW; Corbin, F; Woerly, S; Rousseau, F				Khandjian, EW; Corbin, F; Woerly, S; Rousseau, F			The fragile X mental retardation protein is associated with ribosomes	NATURE GENETICS			English	Letter							NERVOUS-SYSTEM; RNA-BINDING; FMR-1 GENE; EXPRESSION; INSTABILITY; METHYLATION; PRODUCT		UNIV LAVAL,FAC MED,DEPT BIOCHIM,QUEBEC CITY,PQ,CANADA; ORGANOGEL CANADA LTEE,QUEBEC CITY,PQ,CANADA	Laval University	Khandjian, EW (corresponding author), HOP ST FRANCOIS ASSISE,UNITE RECH GENET HUMAINE & MOLEC,QUEBEC CITY,PQ G1L 3L5,CANADA.							ABITBOL M, 1993, NAT GENET, V4, P147, DOI 10.1038/ng0693-147; [Anonymous], 1994, CELL, V78, P23; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; BLOBEL G, 1971, P NATL ACAD SCI USA, V68, P390, DOI 10.1073/pnas.68.2.390; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; ELKON K, 1990, NEUROCHEM RES, V15, P401, DOI 10.1007/BF00969925; Fawcett DW, 1986, HISTOLOGY, P579; GOODWIN GH, 1982, GEL ELECTROPHORESIS, P199; HERGERSBERG M, 1995, HUM MOL GENET, V4, P359, DOI 10.1093/hmg/4.3.359; HINDS HL, 1993, NAT GENET, V3, P36, DOI 10.1038/ng0193-36; KHANDJIAN EW, 1995, HUM MOL GENET, V4, P783, DOI 10.1093/hmg/4.5.783; KOZAK M, 1992, ANNU REV CELL BIOL, V8, P197, DOI 10.1146/annurev.cb.08.110192.001213; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; LAJTHA A, 1981, LIFE SCI, V29, P755, DOI 10.1016/0024-3205(81)90030-8; LERNER EA, 1981, P NATL ACAD SCI-BIOL, V78, P2737, DOI 10.1073/pnas.78.5.2737; MOLDAVE K, 1985, ANNU REV BIOCHEM, V54, P1109, DOI 10.1146/annurev.biochem.54.1.1109; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; OGATA K, 1981, RNA PROTEIN SYNTHESI, P598; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Ross M. H., 1989, HISTOLOGY TEXT ATLAS; SCHWARTZ JH, 1992, PRINCIPLES NEURONAL; SIEGMANN M, 1987, METHOD ENZYMOL, V146, P362; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; SIOMI H, 1994, CELL, V77, P33, DOI 10.1016/0092-8674(94)90232-1; SIOMI MC, 1995, EMBO J, V14, P2401, DOI 10.1002/j.1460-2075.1995.tb07237.x; SITTIER A, IN PRESS HUM MOL GEN; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; VERHEIJ C, 1995, HUM MOL GENET, V4, P895, DOI 10.1093/hmg/4.5.895; VERHEIJ C, 1993, NATURE, V363, P722, DOI 10.1038/363722a0; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; ZIEMIECKI A, 1990, EMBO J, V9, P191, DOI 10.1002/j.1460-2075.1990.tb08095.x	31	195	197	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1996	12	1					91	93		10.1038/ng0196-91	http://dx.doi.org/10.1038/ng0196-91			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TM555	8528261				2022-12-25	WOS:A1996TM55500022
J	BROUGHTON, BC; STEINGRIMSDOTTIR, H; WEBER, CA; LEHMANN, AR				BROUGHTON, BC; STEINGRIMSDOTTIR, H; WEBER, CA; LEHMANN, AR			MUTATIONS IN THE XERODERMA-PIGMENTOSUM GROUP-D DNA REPAIR/TRANSCRIPTION GENE IN PATIENTS WITH TRICHOTHIODYSTROPHY	NATURE GENETICS			English	Article							NUCLEOTIDE-EXCISION-REPAIR; SACCHAROMYCES-CEREVISIAE; RAD3 PROTEIN; YEAST RAD3; HELICASE; CLONING; ERCC2; HETEROGENEITY; RECOMBINATION; DISORDER	DNA repair defects in the xeroderma pigmentosum (XP) group D complementation group can be associated with the clinical features of two quite different disorders; XP, a sun-sensitive and cancer-prone disorder, or trichothiodystrophy (TTD) which is characterized by sulphur-deficient brittle hair and a variety of other associated abnormalities, but no skin cancer. The XPD gene product, a DNA helicase, is required for nucleotide excision repair and recent evidence has demonstrated a role in transcription. We have now identified causative mutations in XPD in four TTD patients. The patients are all compound heterozygotes and the locations of the mutations enable us to suggest relationships between different domains in the gene and its roles in excision repair and transcription.	UNIV SUSSEX, MRC, CELL MUTAT UNIT, BRIGHTON BN1 9RR, ENGLAND; LAWRENCE LIVERMORE NATL LAB, DIV BIOMED SCI, BIOL & BIOTECHNOL RES PROGRAM, LIVERMORE, CA 94551 USA	University of Sussex; United States Department of Energy (DOE); Lawrence Livermore National Laboratory								BAILLY V, 1991, P NATL ACAD SCI USA, V88, P9712, DOI 10.1073/pnas.88.21.9712; BROUGHTON BC, 1990, MUTAT RES, V235, P33, DOI 10.1016/0921-8777(90)90020-6; COOPER DN, 1990, HUM GENET, V85, P55; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; FEAVER WJ, 1993, CELL, V75, P1379, DOI 10.1016/0092-8674(93)90624-Y; FLEJTER WL, 1992, P NATL ACAD SCI USA, V89, P261, DOI 10.1073/pnas.89.1.261; FRIEDBERG EC, 1988, MICROBIOL REV, V52, P70, DOI 10.1128/MMBR.52.1.70-102.1988; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; HAROSH I, 1991, NUCLEIC ACIDS RES, V19, P6331, DOI 10.1093/nar/19.22.6331; HOEIJMAKERS JHJ, 1993, TRENDS GENET, V9, P211, DOI 10.1016/0168-9525(93)90121-W; ITIN PH, 1990, J AM ACAD DERMATOL, V22, P705, DOI 10.1016/0190-9622(90)70096-Z; KING MD, 1984, J MED GENET, V21, P286, DOI 10.1136/jmg.21.4.286; KOVALIC D, 1991, NUCLEIC ACIDS RES, V19, P4560, DOI 10.1093/nar/19.16.4560; LEHMANN AR, 1988, CANCER RES, V48, P6090; LEHMANN AR, 1989, CARCINOGENESIS, V10, P1353, DOI 10.1093/carcin/10.8.1353; LEHMANN AR, 1992, MUTAT RES, V273, P1, DOI 10.1016/0921-8777(92)90046-6; MURRAY JM, 1992, NUCLEIC ACIDS RES, V20, P2673, DOI 10.1093/nar/20.11.2673; NAEGELI H, 1992, J BIOL CHEM, V267, P7839; NAUMOVSKI L, 1986, MOL CELL BIOL, V6, P1218, DOI 10.1128/MCB.6.4.1218; REYNOLDS PR, 1992, NUCLEIC ACIDS RES, V20, P2327, DOI 10.1093/nar/20.9.2327; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SONG JM, 1990, J BACTERIOL, V172, P6620, DOI 10.1128/jb.172.12.6620-6630.1990; STEFANINI M, 1986, HUM GENET, V74, P107, DOI 10.1007/BF00282072; STEFANINI M, 1992, MUTAT RES, V273, P119, DOI 10.1016/0921-8777(92)90073-C; STEFANINI M, 1993, CARCINOGENESIS, V14, P1101, DOI 10.1093/carcin/14.6.1101; STEFANINI M, 1993, AM J HUM GENET, V53, P817; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; SUNG P, 1987, P NATL ACAD SCI USA, V84, P8951, DOI 10.1073/pnas.84.24.8951; SUNG P, 1993, NATURE, V365, P852, DOI 10.1038/365852a0; SUNG P, 1988, EMBO J, V7, P3263, DOI 10.1002/j.1460-2075.1988.tb03193.x; Tolmie J L, 1994, Clin Dysmorphol, V3, P1; WEBER CA, 1988, MOL CELL BIOL, V8, P1137, DOI 10.1128/MCB.8.3.1137; WEBER CA, 1990, EMBO J, V9, P1437, DOI 10.1002/j.1460-2075.1990.tb08260.x	33	124	126	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1994	7	2					189	194		10.1038/ng0694-189	http://dx.doi.org/10.1038/ng0694-189			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NQ037	7920640				2022-12-25	WOS:A1994NQ03700021
J	MORRAL, N; BERTRANPETIT, J; ESTIVILL, X; NUNES, V; CASALS, T; GIMENEZ, J; REIS, A; VARONMATEEVA, R; MACEK, M; KALAYDJIEVA, L; ANGELICHEVA, D; DANCHEVA, R; ROMEO, G; RUSSO, MP; GARNERONE, S; RESTAGNO, G; FERRARI, M; MAGNANI, C; CLAUSTRES, M; DESGEORGES, M; SCHWARTZ, M; SCHWARZ, M; DALLAPICCOLA, B; NOVELLI, G; FEREC, C; DEARCE, M; NEMETI, M; KERE, T; ANVRET, M; DAHL, N; KADASI, L				MORRAL, N; BERTRANPETIT, J; ESTIVILL, X; NUNES, V; CASALS, T; GIMENEZ, J; REIS, A; VARONMATEEVA, R; MACEK, M; KALAYDJIEVA, L; ANGELICHEVA, D; DANCHEVA, R; ROMEO, G; RUSSO, MP; GARNERONE, S; RESTAGNO, G; FERRARI, M; MAGNANI, C; CLAUSTRES, M; DESGEORGES, M; SCHWARTZ, M; SCHWARZ, M; DALLAPICCOLA, B; NOVELLI, G; FEREC, C; DEARCE, M; NEMETI, M; KERE, T; ANVRET, M; DAHL, N; KADASI, L			THE ORIGIN OF THE MAJOR CYSTIC-FIBROSIS MUTATION (DELTA-F508) IN EUROPEAN POPULATIONS	NATURE GENETICS			English	Article							REGULATOR CFTR GENE; MICROSATELLITE ALLELES; REPEAT POLYMORPHISM; MULTIPLEX PCR; IDENTIFICATION; HAPLOTYPES; INTRON-17B; LOCUS; DNA	Delta F508 is the most frequent cystic fibrosis (CF) mutation and accounts for approximately 70% of CF chromosomes worldwide. Three highly polymorphic microsatellite markers have been used to study the origin and evolution of Delta F508 chromosomes in Europe. Haplotype data demonstrate that Delta F508 occurred more than 52,000 years ago, in a population genetically distinct from any present European group, and spread throughout Europe in chronologically distinct expansions, which are responsible for the different frequencies of Delta F508 in Europe.	HOSP DURAN & REYNALS,INST RECERCA ONCOL,E-08907 BARCELONA,SPAIN; UNIV BARCELONA,BARCELONA,SPAIN; FREE UNIV BERLIN,W-1000 BERLIN,GERMANY; CHARLES UNIV,PRAGUE,CZECH REPUBLIC; UNIV SOFIA,HOSP OBSTET,BU-1126 SOFIA,BULGARIA; IST GIANNINA GASLINI,I-16148 GENOA,ITALY; UNIV TURIN,TURIN,ITALY; IST SCI HS RAFFAELE,MILAN,ITALY; INST BIOL,MONTPELLIER,FRANCE; RIGSHOSP,DK-2100 COPENHAGEN,DENMARK; ROYAL MANCHESTER CHILDRENS HOSP,MANCHESTER,LANCS,ENGLAND; UNIV ROME,ROME,ITALY; CTR BIOGENET,BREST,FRANCE; UNIV DUBLIN,DUBLIN,IRELAND; SEMMELWEIS UNIV MED,SCH MED,BUDAPEST,HUNGARY; CHILDRENS HOSP,OAKLAND,CA 94609; UNIV HELSINKI,HELSINKI,FINLAND; KAROLINSKA HOSP,S-10401 STOCKHOLM,SWEDEN; UNIV UPPSALA,UPPSALA,SWEDEN; UNIV BRATISLAVA,BRATISLAVA,SLOVAKIA	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; University of Barcelona; Free University of Berlin; Charles University Prague; University of Sofia; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Turin; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Rigshospitalet; University of Copenhagen; Royal Manchester Children's Hospital; Sapienza University Rome; Semmelweis University; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of Helsinki; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Comenius University Bratislava			Morral, Nuria/AAC-7149-2020; Estivill, Xavier/A-3125-2013; Reis, André/D-2309-2009; Novelli, Giuseppe/T-8822-2019; Novelli, Giuseppe/GQB-3329-2022; Ferec, Claude/ABG-9699-2020; Nunes, Virginia/AAD-1014-2019; Kadasi, Ludevit/A-4677-2013; Novelli, Giuseppe/A-5195-2013; Ferrari, Maurizio/D-9107-2013; Bertranpetit, Jaume/F-8550-2012; Dallapiccola, Bruno/K-8692-2016	Estivill, Xavier/0000-0002-0723-2256; Reis, André/0000-0002-6301-6363; Novelli, Giuseppe/0000-0002-7781-602X; Ferec, Claude/0000-0002-2325-0710; Nunes, Virginia/0000-0002-5747-9310; Novelli, Giuseppe/0000-0002-7781-602X; Bertranpetit, Jaume/0000-0003-0100-0590; Dallapiccola, Bruno/0000-0002-5031-1013; Morral, Nuria/0000-0002-8932-2887				AMMERMAN AJ, 1984, NEOLITHIC TRANSITION; BANCHS I, IN PRESS HUMAN MUT; BERTRANPETIT J, 1991, ANN HUM GENET, V55, P51, DOI 10.1111/j.1469-1809.1991.tb00398.x; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; CASALS T, 1992, AM J HUM GENET, V50, P404; CHEHAB EF, 1991, AM J HUM GENET, V48, P223; Cystic Fibrosis Genetic Anal Consortium, 1990, AM J HUM GENET, V47, P354; DORK T, 1992, HUM GENET, V88, P417, DOI 10.1007/BF00215676; ESTIVILL X, 1989, LANCET, V2, P1404; ESTIVILL X, 1987, Genomics, V1, P257, DOI 10.1016/0888-7543(87)90052-8; ESTIVILL X, 1991, LANCET, V338, P458, DOI 10.1016/0140-6736(91)91092-9; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; GASPARINI P, 1991, HUM GENET, V86, P625; Gimbutas M., 1991, CIVILISATION GODDESS; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Laughlin W.S., 1968, MAN HUNTER, P304; MORRAL N, 1992, GENOMICS, V13, P1362, DOI 10.1016/0888-7543(92)90071-Y; MORRAL N, 1992, HUM GENET, V88, P356; MORRAL N, 1993, HUM MOL GENET, V2, P1015, DOI 10.1093/hmg/2.7.1015; MORRAL N, 1991, GENOMICS, V10, P692, DOI 10.1016/0888-7543(91)90454-M; NUNES V, 1990, NUCLEIC ACIDS RES, V18, P1318, DOI 10.1093/nar/18.5.1318-a; RAMSAY M, 1993, HUM MOL GENET, V2, P1007, DOI 10.1093/hmg/2.7.1007; REYNOLDS J, 1983, GENETICS, V105, P767; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMEO G, 1989, HUM GENET, V84, P1, DOI 10.1007/BF00210660; ROMMENS J, 1990, AM J HUM GENET, V46, P395; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SERRE JL, 1990, HUM GENET, V84, P449; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; STRINGER CB, 1990, SCI AM, V263, P98, DOI 10.1038/scientificamerican1290-98; Tsui Lap-Chee, 1992, Human Mutation, V1, P197, DOI 10.1002/humu.1380010304; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WEBER JL, 1990, GENOME ANAL, V1, P159; ZIELENSKI J, 1991, AM J HUM GENET, V49, P1256; 1990, HUM GENET, V85, P436	36	281	291	1	48	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1994	7	2					169	175		10.1038/ng0694-169	http://dx.doi.org/10.1038/ng0694-169			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NQ037	7920636				2022-12-25	WOS:A1994NQ03700017
J	BIANCHI, AB; HARA, T; RAMESH, V; GAO, JZ; KLEINSZANTO, AJP; MORIN, F; MENON, AG; TROFATTER, JA; GUSELLA, JF; SEIZINGER, BR; KLEY, N				BIANCHI, AB; HARA, T; RAMESH, V; GAO, JZ; KLEINSZANTO, AJP; MORIN, F; MENON, AG; TROFATTER, JA; GUSELLA, JF; SEIZINGER, BR; KLEY, N			MUTATIONS IN TRANSCRIPT ISOFORMS OF THE NEUROFIBROMATOSIS-2 GENE IN MULTIPLE HUMAN TUMOR TYPES	NATURE GENETICS			English	Article							BILATERAL ACOUSTIC NEUROFIBROMATOSIS; BREAST-CANCER; CHROMOSOME-22; NF2; RETINOBLASTOMA; HETEROZYGOSITY; HETEROGENEITY; EXPRESSION; CARCINOMA; POLYPOSIS	The neurofibromatosis 2 gene (NF2) has recently been isolated and predicted to encode a novel protein related to the moesin-ezrin-radixin family of cytoskeleton-associated proteins. Here we describe a novel isoform of the NF2 transcript that shows differential tissue expression and encodes a modified C terminus of the predicted protein. Mutations affecting both isoforms of the NF2 transcript were detected in multiple tumour types including melanoma and breast carcinoma. These findings provide evidence that alterations in the NF2 transcript occur not only in the hereditary brain neoplasms typically associated with NF2, but also as somatic mutations in their sporadic counterparts and in seemingly unrelated tumour types. The NF2 gene may thus constitute a tumour suppressor gene of more general importance in tumorigenesis.	MASSACHUSETTS GEN HOSP,MOLEC NEUROGENET UNIT,BOSTON,MA 02129; HARVARD UNIV,SCH MED,BOSTON,MA 02129; FOX CHASE CANC CTR,PHILADELPHIA,PA 19111; UNIV CINCINNATI,MED CTR,DEPT MOLEC GENET,CINCINNATI,OH 45267	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Fox Chase Cancer Center; University System of Ohio; University of Cincinnati	BIANCHI, AB (corresponding author), BRISTOL MYERS SQUIBB PHARMACEUT RES INST,DEPT MOLEC GENET & CELL BIOL,ONCOL DRUG DISCOVERY,PRINCETON,NJ 08543, USA.		Klein-Szanto, A./E-6218-2010		NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS024279] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00016, HG00317] Funding Source: Medline; NINDS NIH HHS [NS24279] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSEN LB, 1993, NAT GENET, V3, P118, DOI 10.1038/ng0293-118; CHEN LC, 1992, J NATL CANCER I, V84, P506, DOI 10.1093/jnci/84.7.506; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DISCHER D, 1993, J BIOL CHEM, V268, P7186; ELDRIDGE R, 1991, AM J HUM GENET, V49, P133; FONTAINE B, 1991, GENOMICS, V10, P280, DOI 10.1016/0888-7543(91)90513-E; HABER DA, 1991, CELL, V64, P5, DOI 10.1016/0092-8674(91)90200-I; JENKINS RB, 1989, CANCER GENET CYTOGEN, V39, P253, DOI 10.1016/0165-4608(89)90192-1; KAISERKUPFER MI, 1989, ARCH OPHTHALMOL-CHIC, V107, P541, DOI 10.1001/archopht.1989.01070010555030; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LARSSON C, 1990, GENE CHROMOSOME CANC, V2, P191, DOI 10.1002/gcc.2870020305; LUNA EJ, 1992, SCIENCE, V258, P955, DOI 10.1126/science.1439807; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MARTUZA RL, 1988, NEW ENGL J MED, V318, P684, DOI 10.1056/NEJM198803173181106; MIYAKI M, 1990, CANCER RES, V50, P7166; OKAMOTO M, 1988, NATURE, V331, P273, DOI 10.1038/331273a0; ROULEAU GA, 1990, AM J HUM GENET, V46, P323; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; ROULEAU GA, 1987, NATURE, V329, P246, DOI 10.1038/329246a0; Rubinstein LJ, 1972, ATLAS TUMOR PATHOLOG, V2; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATO T, 1990, CANCER RES, V50, P7184; SEIZINGER BR, 1987, P NATL ACAD SCI USA, V84, P5419, DOI 10.1073/pnas.84.15.5419; SEIZINGER BR, 1991, CYTOGENET CELL GENET, V58, P1080, DOI 10.1159/000133722; SELZINGER BR, 1986, NATURE, V322, P644; SELZINGER BR, 1987, SCIENCE, V236, P317; SMITH CWJ, 1989, ANNU REV GENET, V23, P527, DOI 10.1146/annurev.genet.23.1.527; TANAKA N, 1992, GENE CHROMOSOME CANC, V5, P399, DOI 10.1002/gcc.2870050416; THE I, 1993, NAT GENET, V3, P62, DOI 10.1038/ng0193-62; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; WERTELECKI W, 1988, NEW ENGL J MED, V319, P278, DOI 10.1056/NEJM198808043190505; WOLFF RK, 1992, AM J HUM GENET, V51, P478; YOKOTA J, 1988, ONCOGENE, V3, P471	34	214	226	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1994	6	2					185	192		10.1038/ng0294-185	http://dx.doi.org/10.1038/ng0294-185			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU763	8162073				2022-12-25	WOS:A1994MU76300015
J	KRISTJANSSON, K; CHONG, SS; VANDENVEYVER, IB; SUBRAMANIAN, S; SNABES, MC; HUGHES, MR				KRISTJANSSON, K; CHONG, SS; VANDENVEYVER, IB; SUBRAMANIAN, S; SNABES, MC; HUGHES, MR			PREIMPLANTATION SINGLE-CELL ANALYSES OF DYSTROPHIN GENE DELETIONS USING WHOLE GENOME AMPLIFICATION	NATURE GENETICS			English	Article							POLYMERASE CHAIN-REACTION; X-CHROMOSOME; Y-CHROMOSOME; DNA; SPERM; GLOBIN; PCR	Primer extension preamplification (PEP) increases the scope and capacity of single cell genetic diagnosis by generating sufficient template to perform multiple subsequent DNA analyses using the polymerase chain reaction. We report the simultaneous analysis of single cells at five commonly deleted dystrophin exons and at the ZFX/ZFY loci. Ninety three percent of PEP reactions with single amniocytes, chorionic villus cells and blastomeres were successful, and a blinded analysis of single lymphoblasts from affected males resulted in 93% diagnostic accuracy, demonstrating its applicability in preimplantation prevention of Duchenne muscular dystrophy. Transfer of unaffected male embryos and improved diagnostic reliability are achieved with the ability to perform replicate multilocus analyses from the same blastomere.	BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT OBSTET & GYNECOL,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine			Van den Veyver, Ignatia B/AAF-4510-2021; Chong, Samuel S./D-8098-2015	Van den Veyver, Ignatia B/0000-0002-0651-5924; Chong, Samuel S./0000-0002-1872-5937				BEGGS AH, 1990, HUM GENET, V86, P45; BOEHNKE M, 1989, AM J HUM GENET, V45, P21; CHAMBERLAIN JS, 1991, METHOD MOL BIOL, V9, P299; Chamberlain JS, 1990, CURRENT NEUROLOGY, V10, P65; CHONG SS, 1993, HUM MOL GENET, V2, P1187, DOI 10.1093/hmg/2.8.1187; CUI XF, 1989, P NATL ACAD SCI USA, V86, P9389, DOI 10.1073/pnas.86.23.9389; GRIFFIN DK, 1992, HUM GENET, V89, P18, DOI 10.1007/BF00207035; GRIFO JA, 1992, JAMA-J AM MED ASSOC, V268, P727, DOI 10.1001/jama.268.6.727; HANDYSIDE AH, 1990, NATURE, V344, P768, DOI 10.1038/344768a0; HANDYSIDE AH, 1992, NEW ENGL J MED, V327, P905, DOI 10.1056/NEJM199209243271301; HUBERT R, 1992, AM J HUM GENET, V51, P985; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KONTOGIANNI EH, 1991, 1ST P S PREIMPL GEN, P139; LI A, 1988, NATURE, V335, P414; NAVIDI W, 1992, AM J HUM GENET, V50, P347; NAVIDI W, 1991, HUM REPROD, V6, P836, DOI 10.1093/oxfordjournals.humrep.a137438; PICKERING SJ, 1992, HUM REPROD, V7, P630, DOI 10.1093/oxfordjournals.humrep.a137710; WITKOWSKI J, 1990, J CHILD NEUROL, V4, P251; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847; 1992, JAMA-J AM MED ASSOC, V267, P2609	20	81	88	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1994	6	1					19	23		10.1038/ng0194-19	http://dx.doi.org/10.1038/ng0194-19			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ177	8136827				2022-12-25	WOS:A1994MQ17700008
J	EMI, M; KATAGIRI, T; HARADA, Y; SAITO, H; INAZAWA, J; ITO, I; KASUMI, F; NAKAMURA, Y				EMI, M; KATAGIRI, T; HARADA, Y; SAITO, H; INAZAWA, J; ITO, I; KASUMI, F; NAKAMURA, Y			A NOVEL METALLOPROTEASE DISINTEGRIN-LIKE GENE AT 17Q21.3 IS SOMATICALLY REARRANGED IN 2 PRIMARY BREAST CANCERS	NATURE GENETICS			English	Article							PLATELET-AGGREGATION INHIBITOR; AMINO-ACID-SEQUENCE; FAMILIAL BREAST; OVARIAN-CANCER; HEMORRHAGIC PROTEIN; ALLELE LOSSES; VENOM; CHROMOSOME-17; CARCINOMA; LINKAGE	From chromosomal region 17q21.3, where a tumour suppressor gene(s) for breast and ovarian cancers is thought to be present, we have isolated a novel gene from a cosmid clone that revealed somatic rearrangements in two breast cancers. The gene (MDC) encodes a 524-amino acid metalloprotease-like, disintegrin-like and cysteine-rich protein with sequence similarity to members of the snake-venom metalloprotease/disintegrin family and guinea-pig sperm-surface protein PH-30. These proteins have been implicated in cell-cell or cell-extracellular matrix interactions. Rearrangements in both tumours involve multiple exons and disrupt the coding region of the new MDC.	JAPANESE FDN CANC RES,INST CANC,DEPT BIOCHEM,1-37-1 KAMI KEBUKURO,TOSHIMA KU,TOKYO 170,JAPAN; JAPANESE FDN CANC RES,INST CANC,DEPT SURG,TOKYO 170,JAPAN	Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research								AU LC, 1991, BIOCHEM BIOPH RES CO, V181, P585, DOI 10.1016/0006-291X(91)91230-A; BISHOP DT, 1988, GENET EPIDEMIOL, V5, P151, DOI 10.1002/gepi.1370050303; Blobel Carl P., 1992, Current Opinion in Cell Biology, V4, P760; BLOBEL CP, 1992, NATURE, V356, P248, DOI 10.1038/356248a0; BOWCOCK AM, 1993, AM J HUM GENET, V52, P718; CHAO BH, 1989, P NATL ACAD SCI USA, V86, P8050, DOI 10.1073/pnas.86.20.8050; CLAUS EB, 1991, AM J HUM GENET, V48, P232; EASTON DF, 1993, AM J HUM GENET, V52, P678; ECCLES DM, 1990, ONCOGENE, V5, P1599; EMI M, 1992, CANCER RES, V52, P5368; FAIN PR, 1992, CYTOGENET CELL GENET, V60, P178; GOULD RJ, 1990, P SOC EXP BIOL MED, V195, P168, DOI 10.3181/00379727-195-43129B; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; INAZAWA J, 1992, JPN J CANCER RES, V83, P1248, DOI 10.1111/j.1349-7006.1992.tb02753.x; INAZAWA J, IN PRESS GENOMICS; INAZAWA J, IN PRESS CYTOGENET C; LYNCH HT, 1991, ANN MED, V23, P475, DOI 10.3109/07853899109150505; NAROD SA, 1991, LANCET, V338, P82; NEEPER MP, 1990, NUCLEIC ACIDS RES, V18, P4255, DOI 10.1093/nar/18.14.4255; RANDOLPH A, 1992, PROTEIN SCI, V1, P590, DOI 10.1002/pro.5560010505; SAITO H, IN PRESS CANCER RES; Sambrook J., 1989, MOL CLONING; SANCHEZ EF, 1991, FEBS LETT, V282, P178, DOI 10.1016/0014-5793(91)80472-F; SATO T, 1991, CANCER RES, V51, P5794; SATO T, 1991, CANCER RES, V51, P5118; SCARBOROUGH RM, 1991, J BIOL CHEM, V266, P9359; SHEBUSKI RJ, 1989, J BIOL CHEM, V264, P2155; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; TAKEYA H, 1990, J BIOL CHEM, V265, P16068; TANIGAMI A, 1992, GENOMICS, V13, P16, DOI 10.1016/0888-7543(92)90195-X	30	98	103	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1993	5	2					151	157		10.1038/ng1093-151	http://dx.doi.org/10.1038/ng1093-151			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MA056	8252040				2022-12-25	WOS:A1993MA05600012
J	ISHIOKA, C; FREBOURG, T; YAN, YX; VIDAL, M; FRIEND, SH; SCHMIDT, S; IGGO, R				ISHIOKA, C; FREBOURG, T; YAN, YX; VIDAL, M; FRIEND, SH; SCHMIDT, S; IGGO, R			SCREENING PATIENTS FOR HETEROZYGOUS-P53 MUTATIONS USING A FUNCTIONAL ASSAY IN YEAST	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR GENE; LINE P53 MUTATIONS; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; GERMLINE MUTATIONS; BINDING PROTEIN; BREAST-CANCER; TYPE-1 GENE; IDENTIFICATION; LOCUS	Inherited mutations of the p53 gene significantly increase the risk of developing diverse malignancies, and germline p53 mutations can be detected by assaying the transcriptional activity of the p53 protein in mammalian cells. Here we describe a method starting with lymphocytes that allows detection of germline p53 mutations by 'functional' analysis of p53 protein expressed in Saccharomyces cerevisiae. The p53 PCR products are directly cloned into yeast expression vectors in vivo and subsequently tested for transcriptional activity in a simple growth assay. This technique, functional analysis of separated alleles in yeast (FASAY), requires only a few steps, can be automated readily and should permit screening for germline or somatic heterozygous mutations in any gene whose function can be monitored in yeast.	MASSACHUSETTS GEN HOSP,CTR CANC,BOSTON,MA 02129; TOHOKU UNIV,INST DEV AGING & CANC,DEPT CLIN ONCOL,SENDAI,MIYAGI 980,JAPAN; HARVARD UNIV,CHILDRENS HOSP,SCH MED,DANA FARBER INST,DEPT PEDIAT,DW HEMATOL ONCOL,BOSTON,MA 02114; SWISS INST EXPTL CANC RES,CH-1066 EPALINGES,SWITZERLAND	Harvard University; Massachusetts General Hospital; Tohoku University; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Swiss Institute Experimental Cancer Research			Iggo, Richard/G-3546-2014; Frebourg, Thierry/AAK-8390-2020					AMMERER G, 1983, METHOD ENZYMOL, V101, P192; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CANNONALBRIGHT LA, 1992, SCIENCE, V258, P1148, DOI 10.1126/science.1439824; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; FARMER G, 1992, NATURE, V358, P83, DOI 10.1038/358083a0; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FLICK JS, 1990, MOL CELL BIOL, V10, P4757, DOI 10.1128/MCB.10.9.4757; FOUNTAIN JW, 1992, P NATL ACAD SCI USA, V89, P1055; FREBOURG T, 1992, CANCER RES, V52, P6976; FREBOURG T, 1992, J CLIN INVEST, V90, P1637, DOI 10.1172/JCI116034; FREBOURG T, 1992, P NATL ACAD SCI USA, V89, P6413, DOI 10.1073/pnas.89.14.6413; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Guthrie C, 1991, METHODS ENZYMOLOGY, V194; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HELIN K, 1992, CELL, V70, P337, DOI 10.1016/0092-8674(92)90107-N; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; KING CR, 1987, CANCER GENET CYTOGEN, V27, P345, DOI 10.1016/0165-4608(87)90017-3; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; LARSSON C, 1988, NATURE, V332, P85, DOI 10.1038/332085a0; LI FP, 1988, CANCER RES, V48, P5358; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MALKIN D, 1992, NEW ENGL J MED, V326, P1309, DOI 10.1056/NEJM199205143262002; METZGER AK, 1991, P NATL ACAD SCI USA, V88, P7825, DOI 10.1073/pnas.88.17.7825; NAROD SA, 1991, LANCET, V338, P82; NIGRO JM, 1992, MOL CELL BIOL, V12, P1357, DOI 10.1128/MCB.12.3.1357; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; ORRWEAVER TL, 1983, METHOD ENZYMOL, V101, P202; PRIVES C, 1993, GENE DEV, V7, P529, DOI 10.1101/gad.7.4.529; SCHARER E, 1992, NUCLEIC ACIDS RES, V20, P1539, DOI 10.1093/nar/20.7.1539; SIKORSKI RS, 1989, GENETICS, V122, P19; THIERRY A, 1990, YEAST, V6, P521, DOI 10.1002/yea.320060609; TOGUCHIDA J, 1992, NEW ENGL J MED, V326, P1301, DOI 10.1056/NEJM199205143262001; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541	43	235	241	1	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1993	5	2					124	129		10.1038/ng1093-124	http://dx.doi.org/10.1038/ng1093-124			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MA056	8252037				2022-12-25	WOS:A1993MA05600008
J	LYONNET, S; BOLINO, A; PELET, A; ABEL, L; NIHOULFEKETE, C; BRIARD, ML; MOKSIU, V; KAARIAINEN, H; MARTUCCIELLO, G; LERONE, M; PULITI, A; LUO, Y; WEISSENBACH, J; DEVOTO, M; MUNNICH, A; ROMEO, G				LYONNET, S; BOLINO, A; PELET, A; ABEL, L; NIHOULFEKETE, C; BRIARD, ML; MOKSIU, V; KAARIAINEN, H; MARTUCCIELLO, G; LERONE, M; PULITI, A; LUO, Y; WEISSENBACH, J; DEVOTO, M; MUNNICH, A; ROMEO, G			A GENE FOR HIRSCHSPRUNG DISEASE MAPS TO THE PROXIMAL LONG ARM OF CHROMOSOME-10	NATURE GENETICS			English	Article							INTERSTITIAL DELETION; WAARDENBURG SYNDROME; AGANGLIONOSIS; ASSOCIATION; MEGACOLON	Hirschsprung disease (HSCR) is a frequent congenital disorder (1 in 5,000 newborns) of unknown origin characterized by the absence of parasympathetic intrinsic ganglion cells of the hindgut. Taking advantage of a proximal deletion of chromosome 10q (del 10q11.2-q21.2) in a patient with total colonic aganglionosis, and of a high-density genetic map of microsatellite DNA markers, we performed genetic linkage analysis in 15 non-syndromic long-segment and short-segment HSCR families. Multipoint linkage analysis indicated that the most likely location for a HSCR locus is between loci D10S208 and D10S196, suggesting that a dominant gene for HSCR maps to 10q11.2, a region to which other neural crest defects have been mapped.	IST GIANNINA GASLINI,SERV GENET MOLEC,I-16148 GENOA,ITALY; IST GIANNINA GASLINI,SERV ORGAN CHEM,I-16148 GENOA,ITALY; HOP LA PITIE SALPETRIERE,INSERM,U194,PARIS,FRANCE; CHILDRENS HOSP WESTERN ONTARIO,CTR REG MED GENET,LONDON,ON,CANADA; DEPT MED GENET,HELSINKI,FINLAND; INST PASTEUR,CNRS,URA 1445,F-75724 PARIS 15,FRANCE; GENETHUN,EVRY,FRANCE; HOP ENFANTS MALAD,DEPT PEDIAT,INSERM,U12,F-75743 PARIS,FRANCE; HOP ENFANTS MALAD,INSERM,UNITE RECH HANDICAPS GENE T ENFANT 12,F-75743 PARIS,FRANCE	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Western University (University of Western Ontario); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)			Puliti, Aldamaria/AAF-5400-2021; Devoto, Marcella/AAP-7595-2021; Bolino, Alessandra/AAN-5442-2020; Bolino, Alessandra/O-2933-2013; Puliti, Aldamaria/K-7866-2016; Abel, Laurent/H-8888-2017; Lyonnet, Stanislas/H-5483-2017; Martucciello, Giuseppe/J-6543-2018; lerone, margherita/AAC-1583-2021	Bolino, Alessandra/0000-0002-8980-4878; Puliti, Aldamaria/0000-0001-9310-6514; Abel, Laurent/0000-0001-7016-6493; Lyonnet, Stanislas/0000-0001-5426-9417; Martucciello, Giuseppe/0000-0002-7709-8937; lerone, margherita/0000-0003-0666-4740; DEVOTO, MARCELLA/0000-0002-4431-5114; PELET, Anastella/0000-0002-8353-1725				Angrist M., 1992, American Journal of Human Genetics, V51, pA359; BADNER JA, 1990, AM J HUM GENET, V46, P568; BADNER JA, 1990, AM J MED GENET, V35, P100, DOI 10.1002/ajmg.1320350119; BODIAN M, 1963, ANN HUM GENET, V26, P261, DOI 10.1111/j.1469-1809.1963.tb01983.x; BOLANDE RP, 1974, HUM PATHOL, V5, P409, DOI 10.1016/S0046-8177(74)80021-3; BOTTANI A, 1991, HUM GENET, V87, P748; CARMI R, 1982, BIRTH DEFECTS-ORIG, V18, P187; CASS DT, 1992, J PEDIATR SURG, V27, P351, DOI 10.1016/0022-3468(92)90860-A; COHEN IT, 1982, J PEDIATR SURG, V17, P632, DOI 10.1016/S0022-3468(82)80124-3; DODERO P, 1988, PEDIAT SURG INT, V4, P269; EMANUEL B, 1965, J PEDIATR-US, V66, P437, DOI 10.1016/S0022-3476(65)80201-3; GARVER KL, 1985, CLIN GENET, V28, P503; GOLDBERG EL, 1984, INT J EPIDEMIOL, V13, P479, DOI 10.1093/ije/13.4.479; Hirschsprung H., 1888, JAHRBUCHF RKINDERHEI, V27, P1; LAIRMORE TC, 1991, GENOMICS, V9, P181, DOI 10.1016/0888-7543(91)90237-9; LAKE BD, 1978, ARCH PATHOL LAB MED, V102, P244; LAMONT MA, 1989, J MED GENET, V26, P100, DOI 10.1136/jmg.26.2.100; LANE PW, 1984, J HERED, V75, P435, DOI 10.1093/oxfordjournals.jhered.a109980; LANE PW, 1966, J HERED, V57, P29, DOI 10.1093/oxfordjournals.jhered.a107457; Larsson L T, 1990, Acta Histochem Suppl, V38, P115; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1988, GENOMICS, V2, P157; LESSER PB, 1979, JAMA-J AM MED ASSOC, V242, P747, DOI 10.1001/jama.242.8.747; LIPSON AH, 1987, CLIN GENET, V32, P175; MAHAFFEY SM, 1990, J PEDIATR SURG, V25, P101, DOI 10.1016/S0022-3468(05)80172-1; Mallory S B, 1986, Pediatr Dermatol, V3, P119, DOI 10.1111/j.1525-1470.1986.tb00501.x; MARTUCCIELLO G, 1992, PEDIATR SURG INT, V7, P308; MEIERRUGE W, 1988, PEDIATR SURG INT, V1, P37; MICHNA BA, 1988, J PEDIATR SURG, V23, P57, DOI 10.1016/S0022-3468(88)80541-4; MOORE SW, 1991, EUR J PEDIATR SURG, V1, P97, DOI 10.1055/s-2008-1042468; NIHOULFEKETE C, 1986, J PEDIATR SURG, V21, P251; ODELL K, 1987, J PEDIATR SURG, V22, P1019, DOI 10.1016/S0022-3468(87)80504-3; Okamoto E, 1967, J PEDIATR SURG, V2, P437; OMENN GS, 1979, AM J MED GENET, V3, P217, DOI 10.1002/ajmg.1320030302; PARIKH DH, 1992, J PEDIATR SURG, V27, P991, DOI 10.1016/0022-3468(92)90545-I; PASSARGE E, 1967, NEW ENGL J MED, V276, P138, DOI 10.1056/NEJM196701192760303; PATTERSON K, 1983, J PEDIATR-US, V103, P425, DOI 10.1016/S0022-3476(83)80422-3; POLEEY TZ, 1986, PEDIATR SURG INT, V1, P80; PULITI A, 1993, CYTOGENET CELL GENET, V63, P102, DOI 10.1159/000133510; SIMPSON NE, 1991, CYTOGENET CELL GENET, V58, P428, DOI 10.1159/000133170; SPONGE D, 1985, TERATOLOGY, V32, P171; VERDY M, 1982, J PEDIATR GASTR NUTR, V1, P603, DOI 10.1097/00005176-198212000-00027; VIEGASPEQUIGNOT E, 1991, GENOMICS, V9, P210, DOI 10.1016/0888-7543(91)90242-7; VIGNAL A, IN PRESS METHODS MOL, V1, P211; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WINTER HS, 1991, NEW ENGL J MED, V325, P1870	47	164	165	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1993	4	4					346	350		10.1038/ng0893-346	http://dx.doi.org/10.1038/ng0893-346			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LQ178	8401580				2022-12-25	WOS:A1993LQ17800010
J	GODFREY, P; RAHAL, JO; BEAMER, WG; COPELAND, NG; JENKINS, NA; MAYO, KE				GODFREY, P; RAHAL, JO; BEAMER, WG; COPELAND, NG; JENKINS, NA; MAYO, KE			GHRH RECEPTOR OF LITTLE MICE CONTAINS A MISSENSE MUTATION IN THE EXTRACELLULAR DOMAIN THAT DISRUPTS RECEPTOR FUNCTION	NATURE GENETICS			English	Article							HORMONE-RELEASING HORMONE; MESSENGER-RIBONUCLEIC-ACID; PANCREATIC-ISLET TUMOR; MOUSE GENOME; RAT PLACENTA; GROWTH; GENE; EXPRESSION; SEQUENCES; DWARF	The growth hormone-releasing hormone receptor (GHRHR) is a member of the family of G protein-coupled receptors that is expressed on pituitary somatotrope cells and mediates the actions of GHRH in stimulating growth hormone (GH) synthesis and secretion. We report that the Ghrhr gene is located in the middle of mouse chromosome 6 in the same region as the little mutation. Mice homozygous for this mutation have reduced GH secretion and a dwarf phenotype. A missense mutation was identified in the extracellular domain of the little GHRHR that disrupts receptor function, suggesting that the growth deficit in these mice results from a defect in the GHRHR. Similar alterations in GHRHR might explain some isolated GH deficiencies in humans.	NORTHWESTERN UNIV, DEPT BIOCHEM, EVANSTON, IL 60208 USA; NORTHWESTERN UNIV, DEPT MOLEC BIOL, EVANSTON, IL 60208 USA; NORTHWESTERN UNIV, DEPT CELL BIOL, EVANSTON, IL 60208 USA; NCI, FREDERICK CANC RES & DEV CTR, MAMMALIAN GENET LAB, ABL BASIC RES PROGRAM, FREDERICK, MD 21702 USA; JACKSON LAB, BAR HARBOR, ME 04609 USA	Northwestern University; Northwestern University; Northwestern University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Jackson Laboratory					NATIONAL CANCER INSTITUTE [R03CA054889] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NCI [N01CO074101] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-74101, CA-54889] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARRUFO A, 1987, P NATL ACAD SCI USA, V84, P8573; ASA SL, 1992, ENDOCRINOLOGY, V131, P2083, DOI 10.1210/en.131.5.2083; BAGNATO A, 1992, ENDOCRINOLOGY, V130, P1097, DOI 10.1210/en.130.3.1097; BEAMER WG, 1976, J ENDOCRINOL, V71, P37, DOI 10.1677/joe.0.0710037; BERRY SA, 1990, ENDOCRINOLOGY, V127, P1404, DOI 10.1210/endo-127-3-1404; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; CAMP TA, 1991, MOL ENDOCRINOL, V5, P1405, DOI 10.1210/mend-5-10-1405; CHENG TC, 1983, ENDOCRINOLOGY, V113, P1669, DOI 10.1210/endo-113-5-1669; CHIAMPANI T, 1992, ENDOCRINOLOGY, V131, P2785; COPELAND NG, 1991, TRENDS GENET, V7, P113, DOI 10.1016/0168-9525(91)90455-Y; DONAHUE LR, 1993, J ENDOCRINOL, V136, P91, DOI 10.1677/joe.0.1360091; DRYJA TP, 1991, P NATL ACAD SCI USA, V88, P9370, DOI 10.1073/pnas.88.20.9370; EICHER EM, 1976, J HERED, V67, P87, DOI 10.1093/oxfordjournals.jhered.a108682; GAYLINN BD, 1993, MOL ENDOCRINOL, V7, P77, DOI 10.1210/me.7.1.77; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Green EL, 1981, GENETICS PROBABILITY, P77; GUILLEMIN R, 1982, SCIENCE, V218, P585, DOI 10.1126/science.6812220; HAMMER RE, 1984, NATURE, V311, P65, DOI 10.1038/311065a0; HARPOLD MM, 1979, CELL, V17, P1025, DOI 10.1016/0092-8674(79)90341-6; HELLER DL, 1988, MOL CELL BIOL, V8, P2797, DOI 10.1128/MCB.8.7.2797; HORVATH S, 1989, BRAIN RES, V481, P8, DOI 10.1016/0006-8993(89)90479-4; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; ISHAHARA T, 1991, EMBO J, V10, P1635; ISHIHARA T, 1992, NEURON, V8, P811, DOI 10.1016/0896-6273(92)90101-I; JANSSON JO, 1986, SCIENCE, V232, P511, DOI 10.1126/science.3008329; JELINEK LJ, 1993, SCIENCE, V259, P1614, DOI 10.1126/science.8384375; JENKINS NA, 1982, J VIROL, V43, P26, DOI 10.1128/JVI.43.1.26-36.1982; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; LIN CJ, 1992, NATURE, V360, P765, DOI 10.1038/360765a0; LIN HY, 1991, SCIENCE, V254, P1022, DOI 10.1126/science.1658940; MACGILLIVRAY MH, 1987, ENDOCRINOL METAB, P1581; MARGIORIS AN, 1990, ENDOCRINOLOGY, V126, P151, DOI 10.1210/endo-126-1-151; MAYO KE, 1992, MOL ENDOCRINOL, V6, P1734, DOI 10.1210/me.6.10.1734; MAYO KE, 1988, MOL ENDOCRINOL, V2, P606, DOI 10.1210/mend-2-7-606; MCCORMICK A, 1990, NATURE, V345, P829, DOI 10.1038/345829a0; MEIGAN G, 1988, ENDOCRINOLOGY, V123, P1098, DOI 10.1210/endo-123-2-1098; MORETTI C, 1990, ENDOCRINOLOGY, V127, P2117, DOI 10.1210/endo-127-5-2117; PAN Y, 1992, NAT GENET, V2, P103, DOI 10.1038/ng1092-103; PHELPS CJ, 1987, PEPTIDES, V8, P1127, DOI 10.1016/0196-9781(87)90146-X; RIVIER J, 1982, NATURE, V300, P276, DOI 10.1038/300276a0; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; ROSENTHAL W, 1992, NATURE, V359, P233, DOI 10.1038/359233a0; SANO T, 1988, ENDOCR REV, V9, P357, DOI 10.1210/edrv-9-3-357; Schaible R., 1961, Genetics, V46, P896; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SIRACUSA LD, 1991, GENOMICS, V10, P313, DOI 10.1016/0888-7543(91)90314-5; Sneil GD, 1929, P NATL ACAD SCI USA, V15, P733, DOI 10.1073/pnas.15.9.733; SPATOLA E, 1991, ENDOCRINOLOGY, V129, P1193, DOI 10.1210/endo-129-3-1193; STRUTHERS RS, 1991, NATURE, V350, P622, DOI 10.1038/350622a0; SUHR ST, 1989, MOL ENDOCRINOL, V3, P1693, DOI 10.1210/mend-3-11-1693; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; THORNER MO, 1982, J CLIN INVEST, V70, P965, DOI 10.1172/JCI110708; UNDERWOOD L E, 1985, P155; WILSON DB, 1988, ACTA ANAT, V131, P150	56	325	328	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1993	4	3					227	232		10.1038/ng0793-227	http://dx.doi.org/10.1038/ng0793-227			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ842	8395283				2022-12-25	WOS:A1993LJ84200008
J	WHELAN, J; PHEAR, G; YAMAUCHI, M; MEUTH, M				WHELAN, J; PHEAR, G; YAMAUCHI, M; MEUTH, M			CLUSTERED BASE SUBSTITUTIONS IN CTP SYNTHETASE CONFERRING DRUG-RESISTANCE IN CHINESE-HAMSTER OVARY CELLS	NATURE GENETICS			English	Article							HIGH-FREQUENCY; APRT LOCUS; MULTIDRUG RESISTANCE; MAMMALIAN-CELLS; MOLECULAR-BASIS; GENE; MUTATIONS; TRIPHOSPHATE; P53; CHROMOSOME	Dominantly acting mutations that eliminate the allosteric regulation of CTP synthetase confer a form of multidrug resistance and a mutator phenotype to cultured Chinese hamster ovary cells. Mutations responsible for this phenotype have been identified in 23 independent strains selected for resistance to arabinosyl cytosine and 5-fluorouracil. All these mutations were due to base substitutions at seven sites within a highly conserved region of the ctps gene. This clustering should make it feasible to assess the role of such mutations in the development of drug resistance encountered in the treatment of malignant disease.	IMPERIAL CANC RES FUND,CLARE HALL LABS,BLANCHE LANE,S MIMMS EN6 3LD,HERTS,ENGLAND; ST BARTHOLOMEWS HOSP,DEPT MED ONCOL,IMPERIAL CANC RES FUND,LONDON EC1A 7BE,ENGLAND	Cancer Research UK; University of London; Queen Mary University London								ADAIR GM, 1989, SOMAT CELL MOLEC GEN, V15, P535, DOI 10.1007/BF01534914; ARONOW B, 1984, J BIOL CHEM, V259, P9035; BRADLEY G, 1988, BIOCHIM BIOPHYS ACTA, V948, P87, DOI 10.1016/0304-419X(88)90006-6; BRADLEY WEC, 1982, SOMAT CELL GENET, V8, P51, DOI 10.1007/BF01538650; CHU EHY, 1984, BIOCHEM GENET, V22, P701, DOI 10.1007/BF00485854; DEWYSE P, 1989, SOMAT CELL MOLEC GEN, V15, P19, DOI 10.1007/BF01534666; DROBETSKY EA, 1987, P NATL ACAD SCI USA, V84, P9103, DOI 10.1073/pnas.84.24.9103; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; KANG GJ, 1989, J BIOL CHEM, V264, P713; KAUFMAN ER, 1986, MUTAT RES, V161, P19, DOI 10.1016/0027-5107(86)90096-5; KELSALL A, 1988, SOMAT CELL MOLEC GEN, V14, P149, DOI 10.1007/BF01534400; LANE DP, 1990, GENE DEV, V4, P1, DOI 10.1101/gad.4.1.1; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; MCPARTLAND RP, 1979, J BIOL CHEM, V254, P1394; MEUTH M, 1979, P NATL ACAD SCI USA, V76, P6505, DOI 10.1073/pnas.76.12.6505; MEUTH M, 1989, EXP CELL RES, V181, P305, DOI 10.1016/0014-4827(89)90090-6; MEUTH M, 1981, SOMAT CELL GENET, V7, P89, DOI 10.1007/BF01544750; MOMPARLER RL, 1989, RESISTANCE ANTINEOPL, P354; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; OZIERKALOGEROPOULOS O, 1991, MOL GEN GENET, V231, P7, DOI 10.1007/BF00293815; PASTAN I, 1991, ANNU REV MED, V42, P277, DOI 10.1146/annurev.me.42.020191.001425; PHEAR G, 1989, J MOL BIOL, V209, P577, DOI 10.1016/0022-2836(89)90595-0; TRACH K, 1988, J BACTERIOL, V170, P4194, DOI 10.1128/jb.170.9.4194-4208.1988; WENG M, 1986, J BIOL CHEM, V261, P5568; YAMAUCHI M, 1990, EMBO J, V9, P2095, DOI 10.1002/j.1460-2075.1990.tb07377.x; YAMAUCHI M, 1991, GENOMICS, V11, P1088, DOI 10.1016/0888-7543(91)90036-E; ZHANG LH, 1992, J MOL BIOL, V223, P627, DOI 10.1016/0022-2836(92)90979-T	28	43	44	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1993	3	4					317	322		10.1038/ng0493-317	http://dx.doi.org/10.1038/ng0493-317			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KW257	7981751				2022-12-25	WOS:A1993KW25700012
J	Kere, J; Srivastava, AK; Montonen, O; Zonana, J; Thomas, N; Ferguson, B; Munoz, F; Morgan, D; Clarke, A; Baybayan, P; Chen, EY; Ezer, S; SaarialhoKere, U; delaChapelle, A; Schlessinger, D				Kere, J; Srivastava, AK; Montonen, O; Zonana, J; Thomas, N; Ferguson, B; Munoz, F; Morgan, D; Clarke, A; Baybayan, P; Chen, EY; Ezer, S; SaarialhoKere, U; delaChapelle, A; Schlessinger, D			X-linked anhidrotic (hypohidrotic) ectodermal dysplasia is caused by mutation in a novel transmembrane protein	NATURE GENETICS			English	Article							EPIDERMAL GROWTH-FACTOR; GENE LOCALIZATION; LINKAGE ANALYSIS; HAIR FOLLICLE; SWEAT GLANDS; HMG DOMAIN; DNA; EXPRESSION; DELETION; RECEPTOR	Ectodermal dysplasias comprise over 150 syndromes of unknown pathogenesis. X-linked anhidrotic ectodermal dysplasia (EDA) is characterized by abnormal hair, teeth and sweat glands. We now describe the positional cloning of the gene mutated in EDA. Two exons, separated by a 200-kilobase intron, encode a predicted 135-residue transmembrane protein. The gene is disrupted in six patients with X;autosome translocations or submicroscopic deletions; nine patients had point mutations. The gene is expressed in keratinocytes, hair follicles, and sweat glands, and in other adult and fetal tissues. The predicted EDA protein may belong to a novel class with a role in epithelial-mesenchymal signalling.	WASHINGTON UNIV,SCH MED,DEPT MOL MICROBIOL,ST LOUIS,MO 63110; OREGON HLTH SCI UNIV,DEPT MED & MOL GENET,PORTLAND,OR 97201; UNIV WALES COLL MED,INST MED GENET,CARDIFF CF4 4XN,S GLAM,WALES; ADV CTR GENET TECHNOL,APPL BIOSYST DIV,FOSTER CITY,CA 94404; UNIV HELSINKI,CENT HOSP,DEPT DERMATOL,HELSINKI 00250,FINLAND	Washington University (WUSTL); Oregon Health & Science University; Cardiff University; Thermo Fisher Scientific; Applied Biosystems; University of Helsinki; Helsinki University Central Hospital	Kere, J (corresponding author), UNIV HELSINKI,DEPT MED GENET,HAARTMAN INST,POB 21,HELSINKI 00014,FINLAND.		Kere, Juha/A-9179-2008; Kere, Juha/AAX-9117-2021	Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BASERGA SJ, 1988, P NATL ACAD SCI USA, V85, P2056, DOI 10.1073/pnas.85.7.2056; BLECHER SR, 1990, NATURE, V345, P542, DOI 10.1038/345542a0; BLECHER SR, 1986, J INVEST DERMATOL, V87, P720, DOI 10.1111/1523-1747.ep12456718; BROCKDORFF N, 1991, MAMM GENOME, V1, P152, DOI 10.1007/BF00351061; Chromczynski P, 1987, ANAL BIOCHEM, V162, P156; CLARKE A, 1987, HUM GENET, V75, P378, DOI 10.1007/BF00284112; Darwin C., 1875, VARIATION ANIMALS PL, V2, P319; ELOMAA O, 1995, CELL, V80, P603, DOI 10.1016/0092-8674(95)90514-6; FALCONER DS, 1952, NATURE, V169, P664, DOI 10.1038/169664b0; Freire-Maia N, 1984, ECTODERMAL DYSPLASIA; FREIREMAIA N, 1994, AM J MED GENET, V53, P153; Genetic Computer Group, 1994, PROGR MAN WISC PACK; GIESE K, 1992, CELL, V69, P185, DOI 10.1016/0092-8674(92)90129-Z; HANAUER A, 1988, HUM GENET, V80, P177, DOI 10.1007/BF00702863; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; KERE J, 1993, GENOMICS, V16, P305, DOI 10.1006/geno.1993.1189; KERR C. B., 1966, J MED GENET, V3, P169, DOI 10.1136/jmg.3.3.169; KINNIBURGH AJ, 1982, NUCLEIC ACIDS RES, V10, P5421, DOI 10.1093/nar/10.18.5421; KOLVRAA S, 1986, HUM GENET, V74, P284; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LIMON J, 1991, HUM GENET, V87, P338; MACDERMOT KD, 1986, HUM GENET, V74, P172, DOI 10.1007/BF00282084; Mckusick V.A., 1994, MENDELIAN INHERITANC; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; PEISSEL B, 1993, HUM GENET, V92, P417; PIHLAJANIEMI T, 1995, PROG NUCLEIC ACID RE, V50, P225, DOI 10.1016/S0079-6603(08)60816-8; PROSSER IW, 1989, AM J PATHOL, V135, P1073; REED WB, 1970, ARCH DERMATOL, V102, P134, DOI 10.1001/archderm.102.2.134; ROGERS GE, 1993, J INVEST DERMATOL, V101, pS50, DOI 10.1111/1523-1747.ep12362626; SAARIALHOKERE UK, 1993, J CLIN INVEST, V92, P2858, DOI 10.1172/JCI116906; Sambrook J., 2002, MOL CLONING LAB MANU; SINGER SJ, 1990, ANNU REV CELL BIOL, V6, P247, DOI 10.1146/annurev.cb.06.110190.001335; Srivastava AK, 1996, AM J HUM GENET, V58, P126; THOMAS NST, 1993, HUM MOL GENET, V10, P1679; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; TURLEAU C, 1989, CLIN GENET, V35, P462; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; ZHOU P, 1995, GENE DEV, V9, P570; ZONANA J, 1992, AM J HUM GENET, V51, P1036; ZONANA J, 1988, AM J HUM GENET, V43, P75; ZONANA J, 1994, J MED GENET, V31, P287, DOI 10.1136/jmg.31.4.287; ZONANA J, 1993, SEMIN DERMATOL, V12, P241; ZONANA J, 1993, AM J HUM GENET, V52, P78	46	529	568	0	25	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1996	13	4					409	416		10.1038/ng0895-409	http://dx.doi.org/10.1038/ng0895-409			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VB620	8696334				2022-12-25	WOS:A1996VB62000020
J	Lee, SW				Lee, SW			H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer	NATURE MEDICINE			English	Article							CELL-ADHESION MOLECULES; TUMOR-SUPPRESSOR GENES; ASSOCIATION; METASTASIS; CARCINOMAS; MUTATIONS; SURVIVAL; INVASION	A newly identified gene, H-cadherin, is reported. H-cadherin encodes a protein related to the cadherin superfamily of cell adhesion molecules, and its expression is shown to be significantly reduced in human breast carcinoma cell lines and breast cancer specimens. H-cadherin was localized to chromosome 16q24 and is highly expressed in the heart. Introduction of H-cadherin cDNA markedly diminished tumor cell growth and resulted in a significant change from invasive morphology to a normal cell-like morphology in the Matrigel outgrowth assay. These studies indicate that downregulation of H-cadherin may be frequent in the breast malignant progression and suggest that it may have prognostic value as a marker for breast cancer development.	HARVARD UNIV,SCH MED,DIV AGING,BOSTON,MA 02215; HARVARD UNIV,INST MED,BOSTON,MA 02215	Harvard University; Harvard Medical School; Harvard University	Lee, SW (corresponding author), BETH ISRAEL HOSP,DEPT MED,ROOM 921,77 AVE LOUIS PASTEUR,BOSTON,MA 02215, USA.				NCI NIH HHS [1R01 CA 66271-01] Funding Source: Medline; NIA NIH HHS [AG 08812] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA066271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P60AG008812, P30AG008812] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BAND V, 1989, P NATL ACAD SCI USA, V86, P1249, DOI 10.1073/pnas.86.4.1249; BEHRENS J, 1993, BREAST CANCER RES TR, V24, P175, DOI 10.1007/BF01833258; BERNDORFF D, 1994, J CELL BIOL, V125, P1353, DOI 10.1083/jcb.125.6.1353; BONGIORNO PF, 1995, BRIT J CANCER, V71, P166, DOI 10.1038/bjc.1995.34; BRINGUIER PP, 1993, CANCER RES, V53, P3241; CARTER BS, 1990, P NATL ACAD SCI USA, V87, P8751, DOI 10.1073/pnas.87.22.8751; DANTZIG AH, 1994, SCIENCE, V264, P430, DOI 10.1126/science.8153632; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; GISHOP JM, 1995, GENE DEV, V9, P1309; HENDRIX MJC, 1987, CANCER LETT, V38, P137, DOI 10.1016/0304-3835(87)90209-6; HERMISTON ML, 1995, SCIENCE, V270, P1203, DOI 10.1126/science.270.5239.1203; Holt JT, 1996, NAT GENET, V12, P298, DOI 10.1038/ng0396-298; Jensen RA, 1996, NAT GENET, V12, P303, DOI 10.1038/ng0396-303; KATSUMATA M, 1995, NAT MED, V1, P644, DOI 10.1038/nm0795-644; KINSELLA AR, 1992, BRIT J CANCER, V67, P804; LEE SW, 1991, P NATL ACAD SCI USA, V88, P2825, DOI 10.1073/pnas.88.7.2825; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; LINDBLOM A, 1993, CANCER RES, V53, P3707; Liotta L A, 1991, Important Adv Oncol, P85; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MATSUZAKI F, 1990, J CELL BIOL, V110, P1239, DOI 10.1083/jcb.110.4.1239; MAYER B, 1993, CANCER RES, V53, P1690; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Nagafuchi A, 1993, Semin Cell Biol, V4, P175, DOI 10.1006/scel.1993.1021; NAVARRO P, 1993, J CELL SCI, V105, P923; OKA H, 1993, CANCER RES, V53, P1696; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; PRITCHARDJONES K, 1990, NATURE, V346, P194, DOI 10.1038/346194a0; RANSCHT B, 1991, NEURON, V7, P391, DOI 10.1016/0896-6273(91)90291-7; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; SAINSBURY JRC, 1987, LANCET, V1, P1398; SATO T, 1991, CANCER RES, V51, P5794; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Simcha I, 1996, J CELL BIOL, V133, P199, DOI 10.1083/jcb.133.1.199; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SOLOMON E, 1991, SCIENCE, V254, P1153, DOI 10.1126/science.1957167; SOMMERS CL, 1994, CANCER RES, V54, P3544; Stappert J, 1993, Curr Opin Neurobiol, V3, P60, DOI 10.1016/0959-4388(93)90036-X; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; THOMSON RB, 1995, J BIOL CHEM, V270, P17594, DOI 10.1074/jbc.270.29.17594; TSUDA H, 1992, CANCER RES, V52, P1504; TSUDA H, 1995, CANCER RES, V55, P3395; TSUDA H, 1994, CANCER RES, V54, P513; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; WATABE M, 1994, J CELL BIOL, V127, P247, DOI 10.1083/jcb.127.1.247; WEINBERG RA, 1991, SCIENCE, V254, P1138, DOI 10.1126/science.1659741	51	185	197	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUL	1996	2	7					776	782		10.1038/nm0796-776	http://dx.doi.org/10.1038/nm0796-776			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UU680	8673923				2022-12-25	WOS:A1996UU68000033
J	Reddy, S; Smith, DBJ; Rich, MM; Leferovich, JM; Reilly, P; Davis, BM; Tran, K; Rayburn, H; Bronson, R; Cros, D; BaliceGordon, RJ; Housman, D				Reddy, S; Smith, DBJ; Rich, MM; Leferovich, JM; Reilly, P; Davis, BM; Tran, K; Rayburn, H; Bronson, R; Cros, D; BaliceGordon, RJ; Housman, D			Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy	NATURE GENETICS			English	Article							UNSTABLE CTG REPEAT; MYOSIN HEAVY-CHAIN; FRAGILE-X SYNDROME; MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; MDX MOUSE; MESSENGER-RNA; CONTRACTILE PROPERTIES; TRIPLET REPEAT; GENE	Myotonic dystrophy (DM) is an autosomal dominant disorder resulting from the expansion of a CTG repeat in the 3' untranslated region of a putative protein kinase (DMPK). To elucidate the role of DMPK in DM pathogenesis we have developed Dmpk deficient (Dmpk-/-) mice. Dmpk-/- mice develop a late-onset, progressive skeletal myopathy that shares some pathological features with DM. Muscles from mature mice show variation in fibre size, increased fibre degeneration and fibrosis. Adult Dmpk-/- mice show ultrastructural changes in muscle and a 50% decrease in force generation compared to young mice. Our results indicate that DMPK may be necessary for the maintenance of skeletal muscle structure and function and suggest that a decrease in DMPK levels may contribute to DM pathology.	MIT,CTR CANC RES,CAMBRIDGE,MA 02138; UNIV PENN,SCH MED,DEPT NEUROSCI,PHILADELPHIA,PA 19104; TUFTS UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02111; TUFTS UNIV,SCH VET MED,BOSTON,MA 02111; MASSACHUSETTS GEN HOSP,DEPT NEUROL,BOSTON,MA 02214	Massachusetts Institute of Technology (MIT); University of Pennsylvania; Tufts University; Tufts University; Harvard University; Massachusetts General Hospital				Balice-Gordon, Rita/0000-0002-9950-7965	NATIONAL INSTITUTE ON AGING [P01AG013329] Funding Source: NIH RePORTER; NIA NIH HHS [P0IAG 1332901] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALEU FP, 1964, AM J PATHOL, V45, P221; ANDERSON JE, 1987, ANAT REC, V219, P243, DOI 10.1002/ar.1092190305; BALICEGORDON RJ, 1990, J NEUROSCI, V10, P894; Bancroft JD, 1990, THEORY PRACTICE HIST; BEILHARZ MW, 1992, MOL CELL NEUROSCI, V3, P326, DOI 10.1016/1044-7431(92)90029-2; BELANGER AY, 1983, J NEUROL NEUROSUR PS, V46, P625, DOI 10.1136/jnnp.46.7.625; BOUCHER CA, 1995, HUM MOL GENET, V4, P1919, DOI 10.1093/hmg/4.10.1919; BRAUN T, 1989, EMBO J, V8, P3617, DOI 10.1002/j.1460-2075.1989.tb08535.x; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; BURKE JR, 1994, NAT GENET, V7, P521, DOI 10.1038/ng0894-521; BURKE RE, 1994, MYOLOGY, V1, P464; CAMPION DR, 1984, INT REV CYTOL, V87, P225, DOI 10.1016/S0074-7696(08)62444-4; CARANGO P, 1993, GENOMICS, V18, P340, DOI 10.1006/geno.1993.1474; CARNWATH JW, 1987, J NEUROL SCI, V80, P39, DOI 10.1016/0022-510X(87)90219-X; CASANOVA G, 1979, ACTA NEUROPATHOL, V45, P231, DOI 10.1007/BF00702675; CLOSE RI, 1972, PHYSIOL REV, V52, P129, DOI 10.1152/physrev.1972.52.1.129; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DUBOWITZ V, 1985, MUSLCE BIOPSY; DUNNE PW, 1995, CELL MOTILITY CYTOSK, V33; FARDEAU M, 1970, MUSCLE DISEASES, P98; FENG Y, 1995, SCIENCE, V268, P731, DOI 10.1126/science.7732383; FITZSIMONS RB, 1981, J NEUROL SCI, V52, P367, DOI 10.1016/0022-510X(81)90018-6; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1993, SCIENCE, V260, P235, DOI 10.1126/science.8469976; GAMBKE B, 1984, J BIOL CHEM, V259, P2092; GROUNDS MD, 1992, CELL TISSUE RES, V267, P99, DOI 10.1007/BF00318695; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HARLEY HG, 1993, AM J HUM GENET, V52, P1164; Harper P.S., 1989, MYOTONIC DYSTROPHY; HOFMANNRADVANYI H, 1993, HUM MOL GENET, V2, P1263, DOI 10.1093/hmg/2.8.1263; HOGAN B, 1986, MANIPULATING MOUSE E; HOUSMAN D, 1995, NAT GENET, V10, P3, DOI 10.1038/ng0595-3; HOWELER CJ, 1989, BRAIN, V112, P779, DOI 10.1093/brain/112.3.779; JANSEN G, 1992, NAT GENET, V1, P261, DOI 10.1038/ng0792-261; JOHNSON AG, 1969, ACTA NEUROPATHOL, V12, P218, DOI 10.1007/BF00687646; JOHNSON AG, 1969, ACTA NEUROPATHOL, V12, P183, DOI 10.1007/BF00692505; KAMPS MP, 1984, NATURE, V310, P589, DOI 10.1038/310589a0; KARSCHMIZRACHI I, 1989, NUCLEIC ACIDS RES, V17, P6167, DOI 10.1093/nar/17.15.6167; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; KOGA R, 1994, BIOCHEM BIOPH RES CO, V202, P577, DOI 10.1006/bbrc.1994.1967; KOIDE R, 1994, NATURE GENET, V6; KOLSHI K, 1995, DEV DYNAMICS, V202, P244; KRAHE R, 1995, GENOMICS, V28; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MAEDA M, 1995, J BIOL CHEM, V270, P20246, DOI 10.1074/jbc.270.35.20246; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MAHADEVAN MS, 1993, HUM MOL GENET, V2, P299, DOI 10.1093/hmg/2.3.299; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MCCOMAS AJ, 1971, J NEUROL NEUROSUR PS, V34, P132, DOI 10.1136/jnnp.34.2.132; MORGANHUGHES JA, 1994, MYOLOGY, P1610; MOSS FP, 1971, ANAT REC, V170, P421, DOI 10.1002/ar.1091700405; NANCARROW JK, 1994, SCIENCE, V264, P1938, DOI 10.1126/science.8009225; NOVELLI G, 1993, BIOCHEM MED METAB B, V50, P85, DOI 10.1006/bmmb.1993.1049; OBRIEN TA, 1984, DEV MED CHILD NEUROL, V26, P62; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; RASTINEJAD F, 1993, CELL, V72, P903, DOI 10.1016/0092-8674(93)90579-F; RHODES SJ, 1989, GENE DEV, V3, P2050, DOI 10.1101/gad.3.12b.2050; SABOURI LA, 1993, NAT GENET, V4, P233, DOI 10.1038/ng0793-233; SACCO P, 1992, CLIN SCI, V82, P227, DOI 10.1042/cs0820227; SALVATORI S, 1994, BIOCHEM BIOPH RES CO, V203, P1365, DOI 10.1006/bbrc.1994.2335; SCHIAFFINO S, 1986, MUSCLE NERVE, V9, P51, DOI 10.1002/mus.880090108; SCHOTLAND DL, 1970, J NEUROPATH EXP NEUR, V29, P241; SHACKLEFORD GM, 1987, CELL, V50, P89, DOI 10.1016/0092-8674(87)90665-9; SHAW DJ, 1993, GENOMICS, V18, P673, DOI 10.1016/S0888-7543(05)80372-6; TAYLOR RG, 1992, ARCH PHYS MED REHAB, V73, P233; TIMCHENKO L, 1995, P NATL ACAD SCI USA, V92, P5366, DOI 10.1073/pnas.92.12.5366; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WANG JZ, 1995, HUM MOL GENET, V4, P599, DOI 10.1093/hmg/4.4.599; WANG YH, 1995, GENOMICS, V25, P570, DOI 10.1016/0888-7543(95)80061-P; WANG YH, 1994, SCIENCE, V265, P1709; WERNIG A, 1986, PROG NEUROBIOL, V27, P251, DOI 10.1016/0301-0082(86)90023-7; 1993, CELL, V72, P971	78	255	264	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1996	13	3					325	335		10.1038/ng0796-325	http://dx.doi.org/10.1038/ng0796-325			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UU283	8673132				2022-12-25	WOS:A1996UU28300021
J	Hammes, HP; Brownlee, M; Jonczyk, A; Sutter, A; Preissner, KT				Hammes, HP; Brownlee, M; Jonczyk, A; Sutter, A; Preissner, KT			Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization	NATURE MEDICINE			English	Article							ENDOTHELIAL-CELLS	Retinal neovascularization is a major cause of blindness in such disorders as retinopathy of prematurity, proliferative diabetic retinopathy and senile macular degeneration. Because ligation of vitronectin receptor-type integrins appears to be required for the survival and maturation of newly formed but not quiescent blood vessels in several vascular beds including the retina, blockade of this downstream adhesion receptor system was investigated. In a mouse model of hypoxia-induced retinal neovascularization twice daily administration of 1 to 20 mg cyclic alpha(nu)-integrin antagonist peptide per kilogram of body weight reduced capillary proliferation in a dose-dependent fashion - maximum 76% - without obvious side effects. A cyclic control peptide displayed no inhibitory effect on neovascularization. These findings indicate that systemic application of vitronectin receptor antagonists appears to be clinically feasible and is efficient in preventing retinal neovascularization and superior to cytokine-blocking strategies.	YESHIVA UNIV ALBERT EINSTEIN COLL MED, DIABET RES CTR, BRONX, NY 10461 USA; MERCK KGAA, D-64293 DARMSTADT, GERMANY; KERCKHOFF KLIN, MPI, HAEMOSTASIS RES UNIT, D-61231 BAD NAUHEIM, GERMANY	Yeshiva University; Albert Einstein College of Medicine; Merck KGaA; Kerckhoff Clinic; Max Planck Society	Hammes, HP (corresponding author), UNIV GIESSEN, MED KLIN & POLIKLIN, DEPT INTERNAL MED 3, RODTHOHL 6, D-35385 GIESSEN, GERMANY.		Hammes, Hans-Peter/S-3719-2019		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033861] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-33861] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; [Anonymous], 1981, OPHTHALMOLOGY, V88, P583; AUMAILLEY M, 1991, FEBS LETT, V291, P50, DOI 10.1016/0014-5793(91)81101-D; BACHARACH E, 1992, P NATL ACAD SCI USA, V89, P10686, DOI 10.1073/pnas.89.22.10686; BERKA JL, 1995, INVEST OPHTH VIS SCI, V36, P1450; BISCHOFF J, 1995, TRENDS CELL BIOL, V5, P69, DOI 10.1016/S0962-8924(00)88949-7; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; BROWN GC, 1987, INT OPHTHALMOL, V11, P41, DOI 10.1007/BF02027896; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; Habermann BF, 1993, CURR OPIN CELL BIOL, V5, P864, DOI 10.1016/0955-0674(93)90036-P; IRUELAARISPE ML, 1991, P NATL ACAD SCI USA, V88, P5026, DOI 10.1073/pnas.88.11.5026; JOHNSON MD, 1994, J CELL PHYSIOL, V160, P194, DOI 10.1002/jcp.1041600122; JONCZYK A, 1993, Patent No. 632053; LEAVESLEY DI, 1992, J CELL BIOL, V117, P1101, DOI 10.1083/jcb.117.5.1101; MARANO RPC, 1995, EXP EYE RES, V60, P5, DOI 10.1016/S0014-4835(05)80079-X; MARANO RPC, 1994, INVEST OPHTH VIS SCI, V35, P2791; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; MOSES MA, 1990, SCIENCE, V248, P1408, DOI 10.1126/science.1694043; MOSS SE, 1994, OPHTHALMOLOGY, V101, P1061; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; PEER J, 1995, LAB INVEST, V72, P638; PFEIFFER A, 1995, EXP CLIN ENDOCR DIAB, V103, P7, DOI 10.1055/s-0029-1211323; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; PREISSNER KT, 1988, BLOOD, V71, P1581; PROST M, 1988, BRIT J OPHTHALMOL, V72, P363, DOI 10.1136/bjo.72.5.363; ROBBINS SG, 1994, INVEST OPHTH VIS SCI, V35, P3649; SASISEKHARAN R, 1994, P NATL ACAD SCI USA, V91, P1524, DOI 10.1073/pnas.91.4.1524; SCHULTZ G S, 1991, Eye (London), V5, P170; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; SPRANGER J, 1995, MED KLIN, V90, P134; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115	34	290	331	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	1996	2	5					529	533		10.1038/nm0596-529	http://dx.doi.org/10.1038/nm0596-529			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UJ230	8616710				2022-12-25	WOS:A1996UJ23000034
J	Auger, I; Escola, JM; Gorvel, JP; Roudier, J				Auger, I; Escola, JM; Gorvel, JP; Roudier, J			HLA-DR4 and HLA-DR10 motifs that carry susceptibility to rheumatoid arthritis bind 70-kD heat shock proteins	NATURE MEDICINE			English	Article							SHARED-EPITOPE HYPOTHESIS; NUCLEOTIDE-SEQUENCE; CELL; GENE; DISEASE; ASSOCIATION; PEPTIDE; CHAIN; DNAK	Most patients with rheumatoid arthritis express particular HLA-DR alleles. The DR beta 1 chains of these alleles share a highly homologous amino acid motif, in their third hypervariable (HV3) region, and this motif seems to help the development of rheumatoid arthritis via unknown mechanisms. In an attempt to identify a ligand of this motif, we screened bacterial proteins. HV3 peptides from HLA-DRB1 alleles containing a QKRAA or RRRAA motif bound the 70-kD heat shock protein (HSP) from Escherichia coli, dnaK. In lymphoblastoid cells homozygous for these same HLA-DRB1 alleles the constitutive 70-kD HSP, HSP73, that targets selected proteins to lysosomes coprecipitated with HLA-DR. Thus, the QKRAA and RRRAA amino acid motifs of HLA-DR mediate binding of HLA-DR to HSP73. This property may influence the intracellular route, processing or peptide associations of the HLA-DR beta 1 chain in these two rheumatoid arthritis-associated alleles.	CTR IMMUNOL,INSERM,CNRS MARSEILLE LUMINY,F-13288 MARSEILLE 9,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Auger, I (corresponding author), FAC MED MARSEILLE,LAB IMMUNORHUMATOL,F-13005 MARSEILLE,FRANCE.		AUGER, ISABELLE/P-6294-2016; roudier, jean/A-8654-2011; Gorvel, Jean-Pierre/O-1332-2018	AUGER, ISABELLE/0000-0002-1414-8095; roudier, jean/0000-0001-5435-8567; Gorvel, Jean-Pierre/0000-0002-2829-9804				ALBANI, 1995, NATURE MED, V1, P448; BARDWELL JCA, 1986, J BIOL CHEM, V261, P1782; BARDWELL JCA, 1984, P NATL ACAD SCI-BIOL, V81, P848, DOI 10.1073/pnas.81.3.848; BOKI KA, 1992, ARTHRITIS RHEUM, V35, P749, DOI 10.1002/art.1780350706; CELLIER MF, 1992, J BACTERIOL, V174, P8032; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; ESCOLA JM, 1995, J CELL SCI, V108, P2337; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; GOMES SL, 1990, J BACTERIOL, V172, P3051, DOI 10.1128/jb.172.6.3051-3059.1990; GOYERT SM, 1983, P NATL ACAD SCI-BIOL, V80, P5719, DOI 10.1073/pnas.80.18.5719; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; HOUGHTEN RA, 1980, INT J PEPT PROT RES, V16, P311; KRISHNAN HB, 1991, MOL MICROBIOL, V3, P737; OLLIER W, 1992, RHEUM DIS CLIN N AM, V18, P761; ROUDIER J, 1989, P NATL ACAD SCI USA, V86, P5104, DOI 10.1073/pnas.86.13.5104; ROUDIER J, 1991, EUR J IMMUNOL, V21, P2063, DOI 10.1002/eji.1830210914; SALVAT S, 1994, J IMMUNOL, V153, P5321; SILVER PA, 1993, CELL, V74, P5, DOI 10.1016/0092-8674(93)90287-Z; STASTNY P, 1978, NEW ENGL J MED, V298, P869, DOI 10.1056/NEJM197804202981602; TERLECKY SR, 1992, J BIOL CHEM, V267, P9202; VANASSELDONK M, 1993, J BACTERIOL, V175, P1637, DOI 10.1128/JB.175.6.1637-1644.1993; WEYAND CM, 1995, J CLIN INVEST, V95, P2120, DOI 10.1172/JCI117900; WEYAND CM, 1992, ARTHRITIS RHEUM-US, V35, P990, DOI 10.1002/art.1780350903; WILLKENS RF, 1991, ARTHRITIS RHEUM, V34, P43, DOI 10.1002/art.1780340107; WUCHERPFENNIG KW, 1995, J EXP MED, V181, P1597, DOI 10.1084/jem.181.5.1597	25	88	101	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAR	1996	2	3					306	310		10.1038/nm0396-306	http://dx.doi.org/10.1038/nm0396-306			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TY640	8612229				2022-12-25	WOS:A1996TY64000039
J	Contrino, J; Hair, G; Kreutzer, DL; Rickles, FR				Contrino, J; Hair, G; Kreutzer, DL; Rickles, FR			In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease	NATURE MEDICINE			English	Article							TUMOR-DERIVED POLYPEPTIDE; FACTOR MESSENGER-RNA; PERMEABILITY FACTOR; PROCOAGULANT ACTIVITY; MONOCLONAL-ANTIBODY; GROWTH-FACTOR; EXPRESSION; IDENTIFICATION; CARCINOMA; CANCER	Expression of tissue factor (TF) in the endothelium has been observed only rarely in human disease and has been thought to be elaborated on the surface of vascular endothelial cells (VECs) in vitro as an artifact of tissue culture. Using monoclonal antibodies and a novel probe for functional TF, we have localized TF to the VECs (and tumor cells) within the tumors of seven patients with invasive breast cancer but not in the VECs (or tumor cells) of benign tumors from ten patients with fibrocystic disease of the breast. The potent procoagulant TF was shown to be a marker of the initiation of angiogenesis in human breast cancer. Further evidence that the TF was the demonstration of a similar distribution of cross-linked fibrin only in the VECs of the malignant tumors. We interpret these data as further support for the concept that tumor cells can activate nearby VECs and regulate blood vessel growth in vivo. Large clinical-pathologic studies will be necessary to determine whether TF is a useful marker for the ''switch to the angiogenic phenotype'' in human breast disease and/or correlates with the thromboembolic complications of breast cancer.	CTR DIS CONTROL & PREVENT,NATL CTR INFECT DIS MSD02,ATLANTA,GA 30333; UNIV CONNECTICUT,SCH MED,DEPT MED,FARMINGTON,CT 06032; UNIV CONNECTICUT,SCH MED,DEPT SURG,FARMINGTON,CT 06032; UNIV CONNECTICUT,SCH MED,DEPT PATHOL,FARMINGTON,CT 06032; EMORY UNIV,SCH MED,DEPT MED,ATLANTA,GA 30322; VET ADM MED CTR,NEWINGTON,CT 06111	Centers for Disease Control & Prevention - USA; University of Connecticut; University of Connecticut; University of Connecticut; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System					NCI NIH HHS [CA 22202] Funding Source: Medline; NEI NIH HHS [EYE 04131] Funding Source: Medline; NHLBI NIH HHS [HL 25015] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA022202] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY004131] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL025015] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BERSE B, 1992, MOL BIOL CELL, V3, P211, DOI 10.1091/mbc.3.2.211; BEVILACQUA MP, 1984, J EXP MED, V160, P618, DOI 10.1084/jem.160.2.618; BRETT J, 1989, J EXP MED, V169, P1977, DOI 10.1084/jem.169.6.1977; BROWN LF, 1993, CANCER RES, V53, P4727; BROZE GJ, 1982, J CLIN INVEST, V70, P526, DOI 10.1172/JCI110644; CALLANDER NS, 1992, CANCER-AM CANCER SOC, V70, P1194, DOI 10.1002/1097-0142(19920901)70:5<1194::AID-CNCR2820700528>3.0.CO;2-E; CLAUSS M, 1990, J EXP MED, V172, P1535, DOI 10.1084/jem.172.6.1535; COLUCCI M, 1983, J CLIN INVEST, V71, P1893, DOI 10.1172/JCI110945; CONTRINO J, 1994, AM J PATHOL, V145, P1315; CONWAY EM, 1989, THROMB RES, V53, P231, DOI 10.1016/0049-3848(89)90098-4; COSTANTINI V, 1991, CANCER RES, V51, P349; CROSSMAN DC, 1990, J BIOL CHEM, V265, P9782; DRAKE TA, 1993, AM J PATHOL, V142, P1458; DRAKE TA, 1989, AM J PATHOL, V134, P1087; DVORAK HF, 1981, J NATL CANCER I, V67, P335; Dvorak HF, 1994, HEMOSTASIS THROMBOSI, P1238; FAULK WP, 1990, BLOOD, V76, P86; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FOLKMAN J, 1994, J CLIN ONCOL, V12, P441, DOI 10.1200/JCO.1994.12.3.441; GASPARINI G, 1994, J CLIN ONCOL, V12, P454, DOI 10.1200/JCO.1994.12.3.454; GUESDON JL, 1979, J HISTOCHEM CYTOCHEM, V27, P1131, DOI 10.1177/27.8.90074; HOFFMAN M, 1994, BLOOD, V83, P38; JANICKE F, 1993, BREAST CANCER RES TR, V24, P195, DOI 10.1007/BF01833260; KAO J, 1992, J BIOL CHEM, V267, P20239; KIRCHHOFER D, 1993, BLOOD, V81, P2050; KUDRYK B, 1984, MOL IMMUNOL, V21, P89, DOI 10.1016/0161-5890(84)90093-2; KUDRYK B, 1988, FIBRINOGEN, V3, P129; LI VW, 1994, LANCET, V344, P82, DOI 10.1016/S0140-6736(94)91280-7; LYBERG T, 1983, BRIT J HAEMATOL, V53, P85, DOI 10.1111/j.1365-2141.1983.tb01989.x; MAYNARD JR, 1977, BLOOD, V50, P387; MCKEVER RP, 1991, THROMB HAEMOSTASIS, V66, P80; MIYAUCHI S, 1988, IN VITRO CELL DEV B, V24, P753; MORRISSEY JH, 1988, THROMB RES, V52, P247, DOI 10.1016/0049-3848(88)90084-9; MUSS HB, 1994, NEW ENGL J MED, V330, P1260, DOI 10.1056/NEJM199405053301802; NEMERSON Y, 1988, BLOOD, V71, P1; NOGUCHI M, 1989, BIOCHEM BIOPH RES CO, V160, P222, DOI 10.1016/0006-291X(89)91644-6; RICKLES FR, 1988, SEMIN THROMB HEMOST, V14, P126, DOI 10.1055/s-2007-1002765; RICKLES FR, 1992, CANCER METAST REV, V11, P237, DOI 10.1007/BF01307180; RICKLES FR, 1994, HEMOSTASIS THROMBOSI, P1164; RUENING U, 1993, THROMB HAEMOSTASIS, V69, P197; RUF W, 1991, THROMB HAEMOSTASIS, V66, P529; RUF W, 1991, BIOCHEM J, V278, P729, DOI 10.1042/bj2780729; SATO Y, 1986, AM J PATHOL, V125, P431; STERN DM, 1982, P NATL ACAD SCI USA, V82, P2523; TANNENBAUM SH, 1986, J IMMUNOL, V137, P1532; Trousseau A, 1865, CLIN MED HOTEL DIEU, P654; VANHOEF MEHM, 1993, EUR J CANCER, V29A, P1141; WEIDNER N, 1992, JNCI-J NATL CANCER I, V84, P1875, DOI 10.1093/jnci/84.24.1875; WEIDNER N, 1993, AM J PATHOL, V143, P401; WILCOX JN, 1989, P NATL ACAD SCI USA, V86, P2839, DOI 10.1073/pnas.86.8.2839; WILLIAMS EB, 1989, J BIOL CHEM, V264, P7536; ZHANG YM, 1994, J CLIN INVEST, V94, P1320, DOI 10.1172/JCI117451	52	511	538	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	FEB	1996	2	2					209	215		10.1038/nm0296-209	http://dx.doi.org/10.1038/nm0296-209			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TU060	8574967				2022-12-25	WOS:A1996TU06000042
J	Nakamura, T; Largaespada, DA; Lee, MP; Johnson, LA; Ohyashiki, K; Toyama, K; Chen, SJ; Willman, CL; Chen, IM; Feinberg, AP; Jenkins, NA; Copeland, NG; Shaughnessy, JD				Nakamura, T; Largaespada, DA; Lee, MP; Johnson, LA; Ohyashiki, K; Toyama, K; Chen, SJ; Willman, CL; Chen, IM; Feinberg, AP; Jenkins, NA; Copeland, NG; Shaughnessy, JD			Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia	NATURE GENETICS			English	Article							LEUKEMIA; IDENTIFICATION; EXPRESSION; CLONING; FAMILY; SET	Expression of Hoxa7 and Hoxa9 is activated by proviral integration in BXH2 murine myeloid leukaemias. This result, combined with the mapping of the HOXA, locus to human chromosome 7p15, suggested that one of the HOXA genes might be involved in the t(7;11)(p15;p15) translocation found in some human myeloid leukaemia patients. Here we show that in three patients with t(7;11), the chromosome rearrangement creates a genomic fusion between the HOXA9 gene and the nucleoporin gene NUP98 on chromosome 11p15. The translocation produces an invariant chimaeric NUP98/HOXA9 transcript containing the amino terminal half of NUP98 fused in frame to HOXA9. These studies identify HOXA9 as an important human myeloid leukaemia gene and suggest an important role for nucleoporins in human myeloid leukaemia given that a second nucleoporin, NUP214, has also been implicated in human myeloid leukaemia.	NCI, FREDERICK CANC RES & DEV CTR, ABL BASIC RES PROGRAM, MAMMALIAN GENET LAB, FREDERICK, MD 21702 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT MED, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT ONCOL, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT MOLEC BIOL, BALTIMORE, MD 21205 USA; TOKYO MED COLL, DEPT INTERNAL MED 1, TOKYO 160, JAPAN; SHANGHAI MED UNIV 2, RUI JIN HOSP, INST HEMATOL, SHANGHAI, PEOPLES R CHINA; UNIV NEW MEXICO, CTR CANC, DEPT CELL BIOL, ALBUQUERQUE, NM 87131 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Tokyo Medical University; Shanghai Jiao Tong University; University of New Mexico			Feinberg, Andrew/AAY-7666-2020; Largaespada, David/C-9832-2014	Feinberg, Andrew/0000-0002-8364-1991	NATIONAL CANCER INSTITUTE [R37CA054358, R01CA054358] Funding Source: NIH RePORTER; NCI NIH HHS [CA54358, R01 CA054358] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; ADACHI Y, 1994, J BIOL CHEM, V269, P2258; BARKER D, 1984, AM J HUM GENET, V36, P1159; BENSON GV, 1995, MOL CELL BIOL, V15, P1591; BEPLER G, 1994, P NATL ACAD SCI USA, V91, P5513, DOI 10.1073/pnas.91.12.5513; BURD CG, 1994, SCIENCE, V154, P1662; CHAN SK, 1994, CELL, V78, P603, DOI 10.1016/0092-8674(94)90525-8; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FABRE E, 1994, CELL, V78, P275, DOI 10.1016/0092-8674(94)90297-6; FORNEROD M, 1995, ONCOGENE, V10, P1739; FUJIMURA T, 1993, CANCER GENET CYTOGEN, V68, P143, DOI 10.1016/0165-4608(93)90012-B; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; GLASER T, 1989, SOMAT CELL MOLEC GEN, V15, P477, DOI 10.1007/BF01534910; HOOVERS JMN, IN PRESS P NATL ACAD; IRIS FJM, 1993, NAT GENET, V3, P137, DOI 10.1038/ng0293-137; ISHIMI Y, 1991, J BIOL CHEM, V266, P7025; JENKINS NA, 1982, J VIROL, V42, P379, DOI 10.1128/JVI.42.2.379-388.1982; KOI M, 1993, SCIENCE, V260, P361, DOI 10.1126/science.8469989; KRAEMER D, 1994, P NATL ACAD SCI USA, V91, P1519, DOI 10.1073/pnas.91.4.1519; KWONG YL, 1994, AM J HEMATOL, V47, P62, DOI 10.1002/ajh.2830470117; MORRIS CM, 1989, BRIT J HAEMATOL, V71, P481, DOI 10.1111/j.1365-2141.1989.tb06306.x; Nakamura T, 1996, NAT GENET, V12, P149, DOI 10.1038/ng0296-149; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; REDEKER E, 1994, GENOMICS, V21, P538, DOI 10.1006/geno.1994.1312; RUBIN MR, 1987, MOL CELL BIOL, V7, P3836, DOI 10.1128/MCB.7.10.3836; Sambrook J, 1989, MOL CLONING LABORATO; SANDBERG AA, 1990, CHROMOSOMES HUMAN CA; SHIMAMOTO T, 1995, LEUKEMIA, V9, P640; SILVER PA, 1991, CELL, V64, P489, DOI 10.1016/0092-8674(91)90233-O; TANIGAMI A, 1992, AM J HUM GENET, V50, P56; VANDIJK MA, 1994, CELL, V78, P617, DOI 10.1016/0092-8674(94)90526-6; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; VONLINDERN M, 1992, MOL CELL BIOL, V12, P1687, DOI 10.1128/MCB.12.4.1687; WINQVIST R, 1995, CANCER RES, V55, P2660	35	415	425	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1996	12	2					154	158		10.1038/ng0296-154	http://dx.doi.org/10.1038/ng0296-154			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TU079	8563753				2022-12-25	WOS:A1996TU07900015
J	KINGSMORE, SF; GIROS, B; SUH, D; BIENIARZ, M; CARON, MG; SELDIN, MF				KINGSMORE, SF; GIROS, B; SUH, D; BIENIARZ, M; CARON, MG; SELDIN, MF			GLYCINE RECEPTOR BETA-SUBUNIT GENE MUTATION IN SPASTIC MOUSE ASSOCIATED WITH LINE-1 ELEMENT INSERTION	NATURE GENETICS			English	Article							CONSERVED LINKAGE GROUP; POLL HEREFORD CALVES; MUTANT MOUSE; INHERITED MYOCLONUS; SPINAL-CORD; HUMAN CHROMOSOME-1; BINDING SUBUNIT; LPR MICE; EXPRESSION; IDENTIFICATION	Congenital myoclonus is a widespread neurologic disorder characterized by hyperexcitability, muscular spasticity and myoclonus associated with marked reduction in neural glycine binding sites. The recessive mouse mutation spastic (spa) is a prototype of inherited myoclonus. Here we show that defects in the gene encoding the beta-subunit of the glycine receptor (Glrb) underlie spa: Glrb maps to the same region of mouse chromosome 3 as spa, and Glrb mRNA is markedly reduced throughout brains of spa mice, most likely as a result of an insertional mutation of a 7.1 kilobase LINE-1 element within intron 6 of Glrb. These results provide evidence that Glrb is necessary for postsynaptic expression of glycine receptor complexes, and suggest Glrb as a candidate gene for inherited myoclonus in other species.	DUKE UNIV,MED CTR,DEPT MED,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT CELL BIOL,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT MICROBIOL,DURHAM,NC 27710; DUKE UNIV,MED CTR,HOWARD HUGHES MED INST LABS,DURHAM,NC 27710	Duke University; Duke University; Duke University; Duke University			GIROS, Bruno/ABD-5790-2021	GIROS, Bruno/0000-0001-5876-9822; kingsmore, stephen/0000-0002-3758-4631; Kingsmore, Stephen/0000-0001-7180-2527	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000734] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00101, HG00734] Funding Source: Medline; NINDS NIH HHS [NS15976] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADACHI M, 1993, P NATL ACAD SCI USA, V90, P1756, DOI 10.1073/pnas.90.5.1756; BECKER CM, 1992, NEURON, V8, P283, DOI 10.1016/0896-6273(92)90295-O; BECKER CM, 1986, J NEUROSCI, V6, P1358; BETZ H, 1990, NEURON, V5, P383, DOI 10.1016/0896-6273(90)90077-S; BETZ H, 1992, Q REV BIOPHYS, V25, P381, DOI 10.1017/S0033583500004340; BETZ H, 1991, TRENDS NEUROSCI, V14, P458, DOI 10.1016/0166-2236(91)90045-V; BISCOE TJ, 1984, ACTIONS INTERACTIONS, P217; BISCOE TJ, 1981, J PHYSL, V317, P32; BISHOP D T, 1985, Genetic Epidemiology, V2, P349, DOI 10.1002/gepi.1370020404; CHAI CK, 1962, P SOC EXP BIOL MED, V109, P491; CHAI CK, 1961, J HERED, V52, P241, DOI 10.1093/oxfordjournals.jhered.a107083; EICHER EM, 1980, J HERED, V71, P315, DOI 10.1093/oxfordjournals.jhered.a109378; EICKBUSH TH, 1992, NEW BIOL, V4, P430; ELMESTIKAWY S, 1994, J NEUROCHEM, V62, P445; FANNING TG, 1983, NUCLEIC ACIDS RES, V11, P5073, DOI 10.1093/nar/11.15.5073; GIROS B, 1991, FEBS LETT, V295, P149, DOI 10.1016/0014-5793(91)81406-X; Green EL, 1981, GENETICS PROBABILITY, P77; GREGOR P, 1993, P NATL ACAD SCI USA, V90, P3053, DOI 10.1073/pnas.90.7.3053; GRENNINGLOH G, 1990, NEURON, V4, P963, DOI 10.1016/0896-6273(90)90149-A; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; GUNDLACH AL, 1990, FASEB J, V4, P2761, DOI 10.1096/fasebj.4.10.2165010; GUNDLACH AL, 1993, BRAIN RES, V628, P263, DOI 10.1016/0006-8993(93)90963-N; GUNDLACH AL, 1988, SCIENCE, V241, P1807, DOI 10.1126/science.2845573; HELLER AH, 1982, BRAIN RES, V234, P299, DOI 10.1016/0006-8993(82)90870-8; HOCH W, 1989, NEURON, V3, P339, DOI 10.1016/0896-6273(89)90258-4; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; KIRKNESS EF, 1991, GENOMICS, V10, P985, DOI 10.1016/0888-7543(91)90189-L; KOBAYASHI S, 1993, BIOCHEM BIOPH RES CO, V191, P617, DOI 10.1006/bbrc.1993.1262; KUHSE J, 1990, NEURON, V5, P867, DOI 10.1016/0896-6273(90)90346-H; KUHSE J, 1993, NEURON, V11, P1049, DOI 10.1016/0896-6273(93)90218-G; KUHSE J, 1990, J BIOL CHEM, V265, P22317; LANE PW, 1972, J HERED, V63, P135, DOI 10.1093/oxfordjournals.jhered.a108252; LASHAM A, 1991, J NEUROCHEM, V57, P352, DOI 10.1111/j.1471-4159.1991.tb02135.x; LOEB DD, 1986, MOL CELL BIOL, V6, P168, DOI 10.1128/MCB.6.1.168; MALOSIO ML, 1991, EMBO J, V10, P2401, DOI 10.1002/j.1460-2075.1991.tb07779.x; MEIER H, 1970, EXP MED SURG, V28, P24; MORSE B, 1988, NATURE, V333, P87, DOI 10.1038/333087a0; MOSELEY WS, 1989, GENOMICS, V5, P899, DOI 10.1016/0888-7543(89)90132-8; NARITA N, 1993, J CLIN INVEST, V91, P1862, DOI 10.1172/JCI116402; PRIBILLA I, 1992, EMBO J, V11, P4305, DOI 10.1002/j.1460-2075.1992.tb05529.x; RYAN SG, 1994, NAT GENET, V7, P131, DOI 10.1038/ng0694-131; Sambrook J, 1989, MOL CLONING LABORATO; SCHMIEDEN V, 1989, EMBO J, V8, P695, DOI 10.1002/j.1460-2075.1989.tb03428.x; SCHMIEDEN V, 1992, EMBO J, V11, P2025, DOI 10.1002/j.1460-2075.1992.tb05259.x; SELDIN MF, 1988, J EXP MED, V167, P688, DOI 10.1084/jem.167.2.688; SELDIN MF, 1993, MAMM GENOME, V4, pS47, DOI 10.1007/BF00360829; SHIANG R, 1993, NAT GENET, V5, P351, DOI 10.1038/ng1293-351; SOMMER B, 1990, DNA CELL BIOL, V9, P561, DOI 10.1089/dna.1990.9.561; SONTHEIMER H, 1989, NEURON, V2, P1491, DOI 10.1016/0896-6273(89)90195-5; STEINMEYER K, 1991, NATURE, V354, P304, DOI 10.1038/354304a0; WHITE WF, 1982, NATURE, V298, P655, DOI 10.1038/298655a0; WHITE WF, 1985, BRAIN RES, V329, P1; WHITE WF, 1982, SOC NEUR ABSTR, V8, P575; ZIV I, 1984, DEV MED CHILD NEUROL, V26, P94	54	190	196	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1994	7	2					136	142		10.1038/ng0694-136	http://dx.doi.org/10.1038/ng0694-136			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NQ037	7920630				2022-12-25	WOS:A1994NQ03700011
J	GREEN, LL; HARDY, MC; MAYNARDCURRIE, CE; TSUDA, H; LOUIE, DM; MENDEZ, MJ; ABDERRAHIM, H; NOGUCHI, M; SMITH, DH; ZENG, Y; DAVID, NE; SASAI, H; GARZA, D; BRENNER, DG; HALES, JF; MCGUINNESS, RP; CAPON, DJ; KLAPHOLZ, S; JAKOBOVITS, A				GREEN, LL; HARDY, MC; MAYNARDCURRIE, CE; TSUDA, H; LOUIE, DM; MENDEZ, MJ; ABDERRAHIM, H; NOGUCHI, M; SMITH, DH; ZENG, Y; DAVID, NE; SASAI, H; GARZA, D; BRENNER, DG; HALES, JF; MCGUINNESS, RP; CAPON, DJ; KLAPHOLZ, S; JAKOBOVITS, A			ANTIGEN-SPECIFIC HUMAN MONOCLONAL-ANTIBODIES FROM MICE ENGINEERED WITH HUMAN IG HEAVY AND LIGHT-CHAIN YACS	NATURE GENETICS			English	Article							PREFERENTIAL UTILIZATION; PHYSICAL MAP; K-LOCUS; REGION; GENE; SEGMENTS; ORGANIZATION; EXPRESSION; DIVERSITY; SEQUENCE	We describe a strategy for producing human monoclonal antibodies in mice by introducing large segments of the human heavy and K light chain loci contained on yeast artificial chromosomes into the mouse germline. Such mice produce a diverse repertoire of human heavy and light chains, and upon immunization with tetanus toxin have been used to derive antigen-specific, fully human monoclonal antibodies. Breeding such animals with mice engineered by gene targeting to be deficient in mouse immunoglobulin (Ig) production has led to a mouse strain in which high levels of antibodies are produced, mostly comprised of both human heavy and light chains. These strains should provide insight into the adoptive human antibody response and permit the development of fully human monoclonal antibodies with therapeutic potential.	CELL GENESYS INC,FOSTER CITY,CA 94404	Cell Genesys Inc				Noguchi, Masato/0000-0002-3092-0946				ABNEY ER, 1978, J IMMUNOL, V120, P2041; BERMAN JE, 1988, EMBO J, V7, P727, DOI 10.1002/j.1460-2075.1988.tb02869.x; BRUGGEMANN M, 1989, P NATL ACAD SCI USA, V86, P6709, DOI 10.1073/pnas.86.17.6709; BRUGGERMANN M, 1991, EUR J IMMUNOL, V27, P1323; CHOI TK, 1993, NAT GENET, V4, P117, DOI 10.1038/ng0693-117; CUISINIER AM, 1989, SCAND J IMMUNOL, V30, P493, DOI 10.1111/j.1365-3083.1989.tb02455.x; DAVIES NP, 1993, BIO-TECHNOL, V11, P911, DOI 10.1038/nbt0893-911; FEENEY AJ, 1990, J EXP MED, V172, P1377, DOI 10.1084/jem.172.5.1377; FLANAGAN JG, 1982, EMBO J, V1, P655, DOI 10.1002/j.1460-2075.1982.tb01223.x; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HIETER PA, 1982, J BIOL CHEM, V257, P1516; ICHIHARA Y, 1988, EMBO J, V7, P4141, DOI 10.1002/j.1460-2075.1988.tb03309.x; JAKOBOVITS A, 1993, P NATL ACAD SCI USA, V90, P2551, DOI 10.1073/pnas.90.6.2551; JAKOBOVITS A, 1993, NATURE, V362, P255, DOI 10.1038/362255a0; Kabat E, 1991, US DEPT HLTH HUMAN S, V91, P3242; KLOBECK HG, 1989, BIOL CHEM H-S, V370, P1007, DOI 10.1515/bchm3.1989.370.2.1007; LORENZ W, 1988, MOL IMMUNOL, V25, P479, DOI 10.1016/0161-5890(88)90168-X; LORENZ W, 1987, NUCLEIC ACIDS RES, V15, P9667, DOI 10.1093/nar/15.23.9667; MARKS JD, 1991, EUR J IMMUNOL, V21, P985, DOI 10.1002/eji.1830210419; MATSUDA F, 1993, NAT GENET, V3, P88, DOI 10.1038/ng0193-88; NEUMAIER PS, 1983, NUCLEIC ACIDS RES, V11, P3631, DOI 10.1093/nar/11.11.3631; RAVETCH JV, 1981, CELL, V27, P583, DOI 10.1016/0092-8674(81)90400-1; REID LH, 1990, P NATL ACAD SCI USA, V87, P4299, DOI 10.1073/pnas.87.11.4299; Sambrook J, 1989, MOL CLONING LABORATO; SCHROEDER HW, 1990, P NATL ACAD SCI USA, V87, P6146, DOI 10.1073/pnas.87.16.6146; SHIN EK, 1991, EMBO J, V10, P3641, DOI 10.1002/j.1460-2075.1991.tb04930.x; TAKAHASHI N, 1984, P NATL ACAD SCI-BIOL, V81, P5194, DOI 10.1073/pnas.81.16.5194; TAYLOR LD, 1992, NUCLEIC ACIDS RES, V20, P6287, DOI 10.1093/nar/20.23.6287; TUAILLON N, 1993, P NATL ACAD SCI USA, V90, P3720, DOI 10.1073/pnas.90.8.3720; WEICHHOLD GM, 1993, GENOMICS, V16, P503, DOI 10.1006/geno.1993.1217; YAMADA M, 1991, J EXP MED, V173, P395, DOI 10.1084/jem.173.2.395	31	242	677	0	25	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1994	7	1					13	21		10.1038/ng0594-13	http://dx.doi.org/10.1038/ng0594-13			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NJ842	8075633				2022-12-25	WOS:A1994NJ84200007
J	TSUKUROV, O; BOEHMER, A; FLYNN, J; NICOLAI, JP; HAMEL, BCJ; TRAILL, S; ZALESKE, D; MANKIN, HJ; YEON, H; HO, C; TABIN, C; SEIDMAN, JG; SEIDMAN, C				TSUKUROV, O; BOEHMER, A; FLYNN, J; NICOLAI, JP; HAMEL, BCJ; TRAILL, S; ZALESKE, D; MANKIN, HJ; YEON, H; HO, C; TABIN, C; SEIDMAN, JG; SEIDMAN, C			A COMPLEX BILATERAL POLYSYNDACTYLY DISEASE LOCUS MAPS TO CHROMOSOME 7Q36	NATURE GENETICS			English	Article							GENE; FAMILIES; LINKAGE; EN-2	We demonstrate that the gene responsible for a congenital limb deformity (polysyndactyly) maps to chromosome 7q36 in a large family. Pre- and postaxial anomalies of the extremities are inherited in this family as an autosomal dominant trait. The disease locus is closely linked to D7S550 (maximum lod score = 6.85, theta = 0). This region is homologous to a segment of mouse chromosome 5, where the mutations hammer toe (HM) and hemimelic extra toes (HX) have been mapped. These data suggest that human chromosome 7q36 and the homologous region of mouse chromosome 5 contain genes involved in limb pattern formation.	HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; HARVARD UNIV,SCH MED,HOWARD HUGHES MED INST,BOSTON,MA 02115; MASSACHUSETTS GEN HOSP,PEDIAT ORTHOPED UNIT,BOSTON,MA; MASSACHUSETTS GEN HOSP,DEPT ORTHOPED,BOSTON,MA 02114; ERASMUS UNIV ROTTERDAM,DEPT ENDOCRINOL & REPROD,3000 DR ROTTERDAM,NETHERLANDS; CHILDRENS HOSP,DEPT PEDIAT,ROTTERDAM,NETHERLANDS; REG CTR PLAST RECONSTRUCT & HAND SURG,ARNHEM,NETHERLANDS; UNIV HOSP NIJMEGEN,DEPT HUMAN GENET,6500 HB NIJMEGEN,NETHERLANDS; BRIGHAM & WOMENS HOSP,DEPT MED,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Erasmus University Rotterdam; Radboud University Nijmegen; Harvard University; Brigham & Women's Hospital								ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; BAILER MG, 1987, AM J HUM GENET, V28, P723; BERRY R, 1989, AM J MED GENET, V34, P358, DOI 10.1002/ajmg.1320340312; CHOU YHW, 1992, NAT GENET, V1, P295, DOI 10.1038/ng0792-295; DICKIE MM, 1968, MOUSE NEWS LETT, V38, P24; DOLYLY G, 1817, HOLY BIBLE; Green MC, 1964, MOUSE NEWS LETT, V31, P27; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HELMS C, 1992, GENOMICS, V14, P1041, DOI 10.1016/S0888-7543(05)80128-4; HING AV, 1993, AM J HUM GENET, V53, P509; KNUDSEN TB, 1981, J EMBRYOL EXP MORPH, V65, P289; KORNBERG T, 1981, P NATL ACAD SCI-BIOL, V78, P1095, DOI 10.1073/pnas.78.2.1095; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LEWANDOWSKI RC, 1977, NEW CHROMOSOMAL SYND, P375; MARTIN GR, 1990, GENOMICS, V6, P302, DOI 10.1016/0888-7543(90)90570-K; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; McKusick V.A., 1992, MENDELIAN INHERITANC; MORGAN BA, 1992, NATURE, V358, P236, DOI 10.1038/358236a0; NICOLAI JPA, 1988, J HAND SURG-AM, V13A, P405, DOI 10.1016/S0363-5023(88)80019-4; NICOLAI JPA, 1986, J HAND SURG-AM, V11A, P293, DOI 10.1016/S0363-5023(86)80075-2; POOLE SJ, 1989, GENOMICS, V4, P225, DOI 10.1016/0888-7543(89)90324-8; RICHARDS EJ, 1992, CURRENT PROTOCOLS MO; SCOTTEMUAKPOR AB, 1976, HUM HERED, V26, P198, DOI 10.1159/000152803; SWEET HO, 1982, MOUSE NEWS LETT, V66, P66; Temtamy SA, 1978, GENETICS HAND MALFOR; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; [No title captured]	28	84	93	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1994	6	3					282	286		10.1038/ng0394-282	http://dx.doi.org/10.1038/ng0394-282			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ562	8012391				2022-12-25	WOS:A1994MZ56200016
J	HINDS, HL; ASHLEY, CT; SUTCLIFFE, JS; NELSON, DL; WARREN, ST; HOUSMAN, DE; SCHALLING, M				HINDS, HL; ASHLEY, CT; SUTCLIFFE, JS; NELSON, DL; WARREN, ST; HOUSMAN, DE; SCHALLING, M			TISSUE SPECIFIC EXPRESSION OF FMR-1 PROVIDES EVIDENCE FOR A FUNCTIONAL-ROLE IN FRAGILE-X SYNDROME	NATURE GENETICS			English	Article							LINKED MENTAL-RETARDATION; DNA; PREVALENCE	We have performed mRNA in situ hybridization studies and northern blot analysis in the mouse and human, respectively, to determine the normal gene expression patterns of FMR-1. Expression in the adult mouse was localized to several regions of the brain and the tubules of the testes, which are two of the major organs affected in fragile X syndrome. Universal and very strong expression was observed in early mouse embryos, with differentially decreasing expression during subsequent stages of embryonic development. The early embryonic onset and tissue specificity of FMR-1 gene expression is consistent with involvement in the fragile X phenotype, and also suggests additional organ systems in which clinical manifestations of reduced FMR-1 gene expression may occur.	MIT,CTR CANC RES,CAMBRIDGE,MA 02139; BAYLOR COLL MED,HOUSTON,TX 77030; HOWARD HUGHES MED INST,CTR HUMAN GENOME,INST MOLEC GENET,HOUSTON,TX; EMORY UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT BIOCHEM,ATLANTA,GA 30322; EMORY UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT PEDIAT,ATLANTA,GA 30322	Massachusetts Institute of Technology (MIT); Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Emory University; Howard Hughes Medical Institute; Emory University; Howard Hughes Medical Institute			Warren, Stephen T/A-2498-2012; Sutcliffe, James S/C-1348-2012	Sutcliffe, James S/0000-0001-5200-6007	NHLBI NIH HHS [5P01-HL41484] Funding Source: Medline; NICHD NIH HHS [HD20521, 1R01-HD29256] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029256, R37HD020521, R01HD020521] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL041484] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BELL MV, 1991, CELL, V64, P861, DOI 10.1016/0092-8674(91)90514-Y; BENNETT DOROTHEA, 1956, J MORPH, V98, P199, DOI 10.1002/jmor.1050980202; Davies KE, 1989, FRAGILE X SYNDROME; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GEDEON AK, 1992, NAT GENET, V1, P341, DOI 10.1038/ng0892-341; GUSTAVSON KH, 1986, AM J MED GENET, V23, P581, DOI 10.1002/ajmg.1320230152; HARRISON CJ, 1983, J MED GENET, V20, P280, DOI 10.1136/jmg.20.4.280; HEITZ D, 1991, SCIENCE, V251, P1236, DOI 10.1126/science.2006411; KAHKONEN M, 1987, HUM GENET, V77, P85; LUBS HA, 1969, AM J HUM GENET, V21, P231; Maino D M, 1990, J Am Optom Assoc, V61, P316; MANDEL JL, AM J MED GENET, V43, P5; MINTZ B, 1957, J EXP ZOOL, V134, P207, DOI 10.1002/jez.1401340202; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; PEMBREY ME, 1986, TRENDS NEUROSCI, V9, P58, DOI 10.1016/0166-2236(86)90021-4; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; REISS AL, 1990, J AM ACAD CHILD PSY, V29, P885, DOI 10.1097/00004583-199011000-00007; REISS AL, 1991, ANN NEUROL, V29, P26, DOI 10.1002/ana.410290107; REISS AL, 1990, BIOL PSYCHIAT, V27, P223, DOI 10.1016/0006-3223(90)90652-I; ROUSSEAU F, 1991, J MED GENET, V28, P830, DOI 10.1136/jmg.28.12.830; Sambrook J, 1989, MOL CLONING LABORATO; SCHALLING M, 1992, GENE EXPRESSION NEUR, P231; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; SHERMAN SL, 1984, ANN HUM GENET, V48, P21, DOI 10.1111/j.1469-1809.1984.tb00830.x; SUTHERLAND GR, 1991, NEW ENGL J MED, V325, P1720, DOI 10.1056/NEJM199112123252407; TURNER G, 1980, AM J MED GENET, V7, P407, DOI 10.1002/ajmg.1320070403; TURNER G, 1980, J PEDIATR-US, V96, P837, DOI 10.1016/S0022-3476(80)80552-X; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VINCENT A, 1991, NATURE, V349, P624, DOI 10.1038/349624a0; WEBB TP, 1986, AM J MED GENET, V23, P573, DOI 10.1002/ajmg.1320230151; WILLEMS PJ, 1993, NATURE GENET, V3, P31; WOHRLE D, 1992, AM J HUM GENET, V51, P299; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	33	314	323	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1993	3	1					36	43		10.1038/ng0193-36	http://dx.doi.org/10.1038/ng0193-36			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KF372	8490651				2022-12-25	WOS:A1993KF37200010
J	THE, I; MURTHY, AE; HANNIGAN, GE; JACOBY, LB; MENON, AG; GUSELLA, JF; BERNARDS, A				THE, I; MURTHY, AE; HANNIGAN, GE; JACOBY, LB; MENON, AG; GUSELLA, JF; BERNARDS, A			NEUROFIBROMATOSIS TYPE-1 GENE-MUTATIONS IN NEUROBLASTOMA	NATURE GENETICS			English	Article							RAS GENE; VONRECKLINGHAUSEN NEUROFIBROMATOSIS; NEURO-BLASTOMA; N-MYC; PROTEIN; CHROMOSOME-17; TRANSLOCATION; AMPLIFICATION; ACTIVATION; SEQUENCE	The introduction of human chromosome 17 suppresses the tumourigenicity of a neuroblastoma cell line in the absence of any effects on in vitro growth and the neurofibromatosis type 1 (NF1) gene may be responsible. Here we report that 4 out of 10 human neuroblastoma lines express little or no neurofibromin and that two of these lines show evidence of NF1 mutations, providing further proof that NF1 mutations occur in tumours that are not commonly found in NF1 patients. We also show that NF1 deficient neuroblastomas show only moderately elevated ras-GTP levels, in contrast to NF1 tumour cells, indicating that neurofibromin contributes differently to the negative regulation of ras in different cell types.	MASSACHUSETTS GEN HOSP,MOLEC NEUROGENET UNIT,MGH E,BLDG 149,13TH ST,BOSTON,MA 02129; MASSACHUSETTS GEN HOSP,CTR CANC,BOSTON,MA 02129	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital			The, Inge/B-8884-2011; Hannigan, Greg/A-5092-2009		NCI NIH HHS [CA51410] Funding Source: Medline; NINDS NIH HHS [NS22224] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA051410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022224] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BADER SA, 1991, CELL GROWTH DIFFER, V2, P245; BARKER D, 1987, SCIENCE, V236, P1100, DOI 10.1126/science.3107130; BASU TN, 1992, NATURE, V356, P713, DOI 10.1038/356713a0; BERNARDS A, 1990, EMBO J, V9, P2279, DOI 10.1002/j.1460-2075.1990.tb07399.x; BERNARDS A, 1987, MOL CELL BIOL, V7, P3231, DOI 10.1128/MCB.7.9.3231; BERNARDS A, IN PRESS DNA CELL BI; BOS JL, 1989, CANCER RES, V49, P4682; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; BUCHBERG AM, 1990, NATURE, V347, P291, DOI 10.1038/347291a0; BURGERING BMT, 1991, EMBO J, V10, P1103, DOI 10.1002/j.1460-2075.1991.tb08050.x; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; CLAUSEN N, 1989, ACTA PAEDIATR SCAND, V78, P736, DOI 10.1111/j.1651-2227.1989.tb11135.x; DASTON MM, 1992, NEURON, V8, P1; DECLUE JE, 1992, CELL, V69, P265, DOI 10.1016/0092-8674(92)90407-4; FONG CT, 1989, P NATL ACAD SCI USA, V86, P3753, DOI 10.1073/pnas.86.10.3753; FURTH ME, 1982, J VIROL, V43, P294, DOI 10.1128/JVI.43.1.294-304.1982; GIBBS JB, 1988, P NATL ACAD SCI USA, V85, P5026, DOI 10.1073/pnas.85.14.5026; GILBERT F, 1984, CANCER RES, V44, P5444; HARLOW E, 1988, ANTIBODIES LABORATOR; KUSHNER BH, 1985, J CLIN ONCOL, V3, P117, DOI 10.1200/JCO.1985.3.1.117; LI Y, 1992, CELL, V69, P275, DOI 10.1016/0092-8674(92)90408-5; MOLEY JF, 1991, CANCER RES, V51, P1596; NISHI T, 1991, ONCOGENE, V6, P1555; RICCARDI VM, 1981, NEW ENGL J MED, V305, P1617, DOI 10.1056/NEJM198112313052704; SEIZINGER BR, 1987, CELL, V49, P589, DOI 10.1016/0092-8674(87)90534-4; SHIMADA H, 1984, J NATL CANCER I, V73, P405, DOI 10.1093/jnci/73.2.405; SOLOMON E, 1976, SOMAT CELL GENET, V2, P125, DOI 10.1007/BF01542626; TAPAROWSKY E, 1983, CELL, V34, P581, DOI 10.1016/0092-8674(83)90390-2; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9	34	141	144	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1993	3	1					62	66		10.1038/ng0193-62	http://dx.doi.org/10.1038/ng0193-62			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KF372	8490657				2022-12-25	WOS:A1993KF37200014
J	McCarthy, PM				McCarthy, PM			Ventricular remodeling: Hype or hope?	NATURE MEDICINE			English	Editorial Material											McCarthy, PM (corresponding author), CLEVELAND CLIN FDN,DEPT THORAC & CARDIOVASC SURG,9500 EUCLID AVE,F-25,CLEVELAND,OH 44195, USA.								0	18	18	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	AUG	1996	2	8					859	860		10.1038/nm0896-859	http://dx.doi.org/10.1038/nm0896-859			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UZ804	8705851				2022-12-25	WOS:A1996UZ80400028
J	Chen, M; Tomkins, DJ; Auerbach, W; McKerlie, C; Youssoufian, H; Liu, L; Gan, O; Carreau, M; Auerbach, A; Groves, T; Guidos, CJ; Freedman, MH; Cross, J; Percy, DH; Dick, JE; Joyner, AL; Buchwald, M				Chen, M; Tomkins, DJ; Auerbach, W; McKerlie, C; Youssoufian, H; Liu, L; Gan, O; Carreau, M; Auerbach, A; Groves, T; Guidos, CJ; Freedman, MH; Cross, J; Percy, DH; Dick, JE; Joyner, AL; Buchwald, M			Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia	NATURE GENETICS			English	Letter							ANEMIA; CLONING; GENE; SUSCEPTIBILITY; BREAKAGE; AGENTS		HOSP SICK CHILDREN,DEPT GENET,RES INST,TORONTO,ON M5G 1X8,CANADA; MCMASTER UNIV,HAMILTON,ON,CANADA; NYU,SKIRBALL INST BIOMOL MED,NEW YORK,NY 10016; UNIV GUELPH,ONTARIO VET COLL,DEPT PATHOL,GUELPH,ON N1G 2W1,CANADA; BRIGHAM & WOMENS HOSP,BOSTON,MA 02115; HARVARD UNIV,SCH MED,BOSTON,MA 02115; UNIV TORONTO,DEPT IMMUNOL,TORONTO,ON,CANADA; UNIV TORONTO,DEPT PEDIAT,TORONTO,ON,CANADA; MT SINAI HOSP,TORONTO,ON M5G 1X5,CANADA; UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO,ON,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; New York University; University of Guelph; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto			Cross, James/AAU-2973-2020; Cross, James/F-4814-2011	Cross, James/0000-0003-0956-9378; Cross, James/0000-0003-0956-9378; Carreau, Madeleine/0000-0002-0582-6114; McKerlie, Colin/0000-0002-2232-0967	NHLBI NIH HHS [HL52138] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052138] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTER BP, 1991, BRIT J HAEMATOL, V77, P410, DOI 10.1111/j.1365-2141.1991.tb08593.x; AUERBACH AD, 1981, PEDIATRICS, V67, P128; BAKER SM, 1995, CELL, V82, P309, DOI 10.1016/0092-8674(95)90318-6; BARGMAN GJ, 1977, EUR J PEDIATR, V125, P163, DOI 10.1007/BF00480592; Beamer WG, 1983, MOUSE BIOMEDICAL RES, VIII, P166; BRADY G, 1995, CURR BIOL, V5, P909, DOI 10.1016/S0960-9822(95)00181-3; CERVENKA J, 1981, PEDIATRICS, V67, P119; DANSKA JS, 1994, SCIENCE, V266, P450, DOI 10.1126/science.7524150; FANCONI G., 1967, SEMINARS HAMATOL, V4, P233; GIBSON RA, 1993, HUM MOL GENET, V2, P35, DOI 10.1093/hmg/2.1.35; ISHIDA R, 1982, CANCER RES, V42, P4000; JOENJE H, 1995, BLOOD, V86, P2156, DOI 10.1182/blood.V86.6.2156.bloodjournal8662156; Krasnoshtein F, 1996, HUM MOL GENET, V5, P85, DOI 10.1093/hmg/5.1.85; MEAD DA, 1991, BIO-TECHNOL, V9, P657, DOI 10.1038/nbt0791-657; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; ROSENDORFF J, 1988, CANCER GENET CYTOGEN, V33, P175, DOI 10.1016/0165-4608(88)90027-1; Sambrook J., 2002, MOL CLONING LAB MANU; SASAKI MS, 1973, CANCER RES, V33, P1829; Speed R.M., 1989, FERTILITY CHROMOSOME, P1; STRATHDEE CA, 1992, NAT GENET, V1, P196, DOI 10.1038/ng0692-196; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; TILL JE, 1961, RADIAT RES, V4, P214; VERLANDER PC, 1994, AM J HUM GENET, V54, P595; WEVRICK R, 1993, HUM MOL GENET, V2, P655, DOI 10.1093/hmg/2.6.655; WHITNEY MA, 1993, NAT GENET, V4, P202, DOI 10.1038/ng0693-202; WURST W, 1983, GENE TARGETING, P33; YAMASHITA T, 1994, P NATL ACAD SCI USA, V91, P6712, DOI 10.1073/pnas.91.14.6712; Young N. S., 1994, APLASTIC ANEMIA ACQU; YOUSSOUFIAN H, 1994, P NATL ACAD SCI USA, V91, P7975, DOI 10.1073/pnas.91.17.7975; YOUSSOUFIAN H, 1990, AM J HUM GENET, V47, P62	30	204	206	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1996	12	4					448	451		10.1038/ng0496-448	http://dx.doi.org/10.1038/ng0496-448			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UC553	8630504				2022-12-25	WOS:A1996UC55300029
J	Howard, M; Frizzell, DM; Bedwell, DM				Howard, M; Frizzell, DM; Bedwell, DM			Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations	NATURE MEDICINE			English	Article							CYSTIC-FIBROSIS; PHENOTYPIC SUPPRESSION; ESCHERICHIA-COLI; CODONS; CELLS; UAG	Cystic fibrosis (CF) is caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR). A single recessive mutation, the deletion of phenylalanine 508 (Delta F508), causes severe CF and resides on 70% of mutant chromosomes. Severe CF is also caused by premature stop mutations, which are found on 5% of CF chromosomes. Here we report that two common, disease-associated stop mutations can be suppressed by treating cells with low doses of the aminoglycoside antibiotic G-418. Aminoglycoside treatment resulted in the expression of full-length CFTR and restored its cyclic AMP-activated chloride channel activity. Another aminoglycoside, gentamicin, also promoted the expression of full-length CFTR. These results suggest that treatment with aminoglycosides may provide a means of restoring CFTR function in CF patients with this class of mutation.	UNIV ALABAMA,DEPT MICROBIOL,BIRMINGHAM,AL 35294; UNIV ALABAMA,DEPT PHYSIOL,BIRMINGHAM,AL 35294; UNIV ALABAMA,DEPT BIOPHYS,BIRMINGHAM,AL 35294	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham				Bedwell, David/0000-0002-6605-818X				BONETTI B, 1995, J MOL BIOL, V251, P334, DOI 10.1006/jmbi.1995.0438; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; CUTTING GR, 1993, J BIOENERG BIOMEMBR, V25, P7, DOI 10.1007/BF00768062; DAVIES J, 1965, MOL PHARMACOL, V1, P93; EGGERTSSON G, 1988, MICROBIOL REV, V52, P354, DOI 10.1128/MMBR.52.3.354-374.1988; FEARON K, 1994, J BIOL CHEM, V269, P17802; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; HATFIELD DL, 1990, CRIT REV BIOCHEM MOL, V25, P71, DOI 10.3109/10409239009090606; HOWARD M, 1995, AM J PHYSIOL, V38, pC1565; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; MARTIN R, 1989, MOL GEN GENET, V217, P411, DOI 10.1007/BF02464911; MCCAUGHAN KK, 1995, P NATL ACAD SCI USA, V92, P5431, DOI 10.1073/pnas.92.12.5431; PALMER E, 1979, NATURE, V277, P148, DOI 10.1038/277148a0; POOLE ES, 1995, EMBO J, V14, P151, DOI 10.1002/j.1460-2075.1995.tb06985.x; SHERMAN F, 1982, MOL BIOL YEAST SACCH, P463; SHOSHANI T, 1992, AM J HUM GENET, V50, P222; SINGH A, 1979, NATURE, V277, P146, DOI 10.1038/277146a0; SKUZESKI JM, 1991, J MOL BIOL, V218, P365, DOI 10.1016/0022-2836(91)90718-L; YANG YP, 1993, HUM MOL GENET, V2, P1253, DOI 10.1093/hmg/2.8.1253; 1994, HUM MUTAT, V4, P167	20	363	381	1	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	APR	1996	2	4					467	469		10.1038/nm0496-467	http://dx.doi.org/10.1038/nm0496-467			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UD314	8597960				2022-12-25	WOS:A1996UD31400052
J	Speicher, MR; Ballard, SG; Ward, DC				Speicher, MR; Ballard, SG; Ward, DC			Karyotyping human chromosomes by combinatorial multi-fluor FISH	NATURE GENETICS			English	Article							FLUORESCENCE INSITU HYBRIDIZATION; DIGITAL IMAGING MICROSCOPY; DYE LABELING REAGENTS; PAINTING PROBES; DNA PROBES; GENERATION; SEQUENCES	We have developed epifluorescence filter sets and computer software for the detection and discrimination of 27 different DNA probes hybridized simultaneously. For karyotype analysis, a pool of human chromosome painting probes, each labelled with a different fluor combination, was hybridized to metaphase chromosomes prepared from normal cells, clinical specimens, and neoplastic cell lines. Both simple and complex chromosomal rearrangements could be detected rapidly and unequivocally; many of the move complex chromosomal abnormalities could not be delineated by conventional cytogenetic banding techniques. Our data suggest that multiplex-fluorescence in situ hybridization (M-FISH) could have wide clinical utility and complement standard cytogenetics, particularly for the characterization of complex karyotypes.	YALE UNIV, SCH MED, DEPT BIOCHEM, NEW HAVEN, CT 06510 USA	Yale University	Speicher, MR (corresponding author), YALE UNIV, SCH MED, DEPT GENET & MOL BIOPHYS, 333 CEDAR ST, NEW HAVEN, CT 06510 USA.		Speicher, Michael R/B-5362-2013	Speicher, Michael R/0000-0003-0105-955X				BALDINI A, 1991, GENOMICS, V9, P770, DOI 10.1016/0888-7543(91)90374-N; BRAYWARD P, IN PRESS GENOMICS; CHUMAKOV IM, 1995, NATURE, V377, P175; DAUWERSE JG, 1992, HUM MOL GENET, V1, P593, DOI 10.1093/hmg/1.8.593; DUMANOIR S, 1993, HUM GENET, V90, P590, DOI 10.1007/BF00202476; DUMANOIR S, 1995, CYTOMETRY, V19, P27, DOI 10.1002/cyto.990190105; ERNST LA, 1989, CYTOMETRY, V10, P3, DOI 10.1002/cyto.990100103; FRANCKE U, 1994, CYTOGENET CELL GENET, V65, P206, DOI 10.1159/000133633; Gray Joe W., 1992, Current Opinion in Biotechnology, V3, P623, DOI 10.1016/0958-1669(92)90006-5; GUAN XY, 1995, HUM GENET, V95, P637; GUAN XY, 1993, HUM MOL GENET, V2, P1117, DOI 10.1093/hmg/2.8.1117; GUAN XY, 1994, GENOMICS, V22, P101, DOI 10.1006/geno.1994.1350; Guan XY, 1996, NAT GENET, V12, P10, DOI 10.1038/ng0196-10; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; Ledbetter David H., 1992, Human Molecular Genetics, V1, P297, DOI 10.1093/hmg/1.5.297; LENGAUER C, 1993, HUM MOL GENET, V2, P505, DOI 10.1093/hmg/2.5.505; MATERA AG, 1992, HUM MOL GENET, V1, P535, DOI 10.1093/hmg/1.7.535; MELTZER PS, 1992, NAT GENET, V1, P24, DOI 10.1038/ng0492-24; MUJUMDAR RB, 1989, CYTOMETRY, V10, P11, DOI 10.1002/cyto.990100104; NEDERLOF PM, 1989, CYTOMETRY, V10, P20, DOI 10.1002/cyto.990100105; NEDERLOF PM, 1992, CYTOMETRY, V13, P839, DOI 10.1002/cyto.990130806; NEDERLOF PM, 1990, CYTOMETRY, V11, P126, DOI 10.1002/cyto.990110115; POPP S, 1993, HUM GENET, V92, P527, DOI 10.1007/BF00420933; RIED T, 1992, P NATL ACAD SCI USA, V89, P1388, DOI 10.1073/pnas.89.4.1388; Ried Thomas, 1992, Human Molecular Genetics, V1, P307, DOI 10.1093/hmg/1.5.307; SMITH TG, 1988, J NEUROSCI METH, V26, P75, DOI 10.1016/0165-0270(88)90130-6; WAGGONER A, 1989, METHOD CELL BIOL, V30, P449; WAGGONER A, 1995, METHOD ENZYMOL, V246, P362; WIEGANT J, 1993, CYTOGENET CELL GENET, V63, P73, DOI 10.1159/000133507; XING Y, 1993, CAUSES CONSEQUENCES, P3; YU H, 1994, NUCLEIC ACIDS RES, V22, P3226, DOI 10.1093/nar/22.15.3226	31	938	1042	1	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1996	12	4					368	375		10.1038/ng0496-368	http://dx.doi.org/10.1038/ng0496-368			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UC553	8630489				2022-12-25	WOS:A1996UC55300014
J	Tanaka, M; Suda, T; Haze, K; Nakamura, N; Sato, K; Kimura, F; Motoyoshi, K; Mizuki, M; Tagawa, S; Ohga, S; Hatake, K; Drummond, AH; Nagata, S				Tanaka, M; Suda, T; Haze, K; Nakamura, N; Sato, K; Kimura, F; Motoyoshi, K; Mizuki, M; Tagawa, S; Ohga, S; Hatake, K; Drummond, AH; Nagata, S			Fas ligand in human serum	NATURE MEDICINE			English	Article							TUMOR-NECROSIS-FACTOR; GRANULAR LYMPHOCYTIC-LEUKEMIA; GROWTH-FACTOR; EXPRESSION; CELLS; ANTIGEN; APO-1; RECEPTOR; MEMBER; LEVEL	The Fas ligand (FasL), a member of the tumor necrosis factor family, induces apoptosis in Fas-bearing cells. The membrane-bound human Fast was found to be converted to a soluble form (sFasL) by the action of a matrix metalloproteinase-like enzyme. Two neutralizing monoclonal anti-human Fast antibodies were identified, and an enzyme-linked immunosorbent assay (ELISA) for sFasL in human sera was established. Sera from healthy persons did not contain a detectable level of sFasL, whereas those from patients with large granular lymphocytic (LGL) leukemia and natural killer (NK) cell lymphoma did. These malignant cells constitutively expressed Fast, whereas peripheral NK cells from healthy persons expressed Fast only on activation. These results suggested that the systemic tissue damage seen in most patients with LGL leukemia and NK-type lymphoma is due to sFasL produced by these malignant cells. Neutralizing anti-Fast antibodies or matrix metalloproteinase inhibitors may be of use in modulating such tissue damage.	OSAKA BIOSCI INST,SUITA,OSAKA 565,JAPAN; OSAKA UNIV,SCH MED,DEPT GENET,SUITA,OSAKA 565,JAPAN; OSAKA UNIV,SCH MED,DEPT CLIN RES,SUITA,OSAKA 565,JAPAN; MOCHIDA PHARMACEUT CO,BIOSCI RES LAB,TOKYO 115,JAPAN; NATL DEF MED COLL,DEPT INTERNAL MED 3,TOKOROZAWA,SAITAMA 359,JAPAN; OSAKA CITY UNIV,SCH MED,DEPT CLIN HEMATOL,ABENO,OSAKA 545,JAPAN; TENRI HOSP,DIV HEMATOL,TENRI,NARA 632,JAPAN; JICHI MED SCH,DEPT MED,DIV HEMATOL,MINAMI KAWACHI,TOCHIGI 32904,JAPAN; BRITISH BIOTECH PHARMACEUT,OXFORD OX4 5LY,ENGLAND	Osaka University; Osaka University; Mochida Pharmaceutical Co Ltd; National Defense Medical College - Japan; Osaka Metropolitan University; Tenri Hospital; Jichi Medical University			Nagata, Shigekazu/AAG-3203-2019	Nagata, Shigekazu/0000-0001-9758-8426				ADACHI M, 1995, NAT GENET, V11, P294, DOI 10.1038/ng1195-294; ADACHI M, IN PRESS P NATL ACAD; AMEISEN JC, 1995, CELL DEATH DIFFER, V2, P9; ARASE H, 1995, J EXP MED, V181, P1235, DOI 10.1084/jem.181.3.1235; BELLGRAU D, 1995, NATURE, V377, P630, DOI 10.1038/377630a0; BEUTLER B, 1986, NATURE, V320, P584, DOI 10.1038/320584a0; CHEHIMI J, 1992, J EXP MED, V175, P789, DOI 10.1084/jem.175.3.789; CLARE JJ, 1991, GENE, V105, P205, DOI 10.1016/0378-1119(91)90152-2; DEBATIN KM, 1994, BLOOD, V83, P3101, DOI 10.1182/blood.V83.10.3101a.3101a; ENARI M, 1995, NATURE, V375, P78, DOI 10.1038/375078a0; FALK MH, 1992, BLOOD, V79, P3300; FIERS W, 1991, FEBS LETT, V285, P199, DOI 10.1016/0014-5793(91)80803-B; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; Gougeon M L, 1995, Cell Death Differ, V2, P1; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; GRUSS HJ, 1995, BLOOD, V85, P3378, DOI 10.1182/blood.V85.12.3378.bloodjournal85123378; GUMPERZ JE, 1995, NATURE, V378, P245, DOI 10.1038/378245a0; HIRAMATSU N, 1994, HEPATOLOGY, V19, P1354, DOI 10.1002/hep.1840190606; IWAI K, 1994, BLOOD, V84, P1201; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; KATAOKA T, 1994, J IMMUNOL, V153, P3938; KATSIKIS PD, 1995, J EXP MED, V181, P2029, DOI 10.1084/jem.181.6.2029; KOJIMA H, 1994, IMMUNITY, V1, P357, DOI 10.1016/1074-7613(94)90066-3; LEITHAUSER F, 1993, LAB INVEST, V69, P415; LOUGHRAN TP, 1993, BLOOD, V82, P1; LOWIN B, 1994, NATURE, V370, P650, DOI 10.1038/370650a0; MCGEEHAN GM, 1994, NATURE, V370, P558, DOI 10.1038/370558a0; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; MOHLER KM, 1994, NATURE, V370, P218, DOI 10.1038/370218a0; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; OWENSCHAUB LB, 1993, J IMMUNOTHER, V14, P234, DOI 10.1097/00002371-199310000-00011; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; SUDA T, 1995, J IMMUNOL, V154, P3806; SUDA T, 1994, J EXP MED, V179, P873, DOI 10.1084/jem.179.3.873; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; TAGAWA S, 1988, BLOOD, V71, P1161; TAGAWA S, 1992, LEUKEMIA, V6, P465; TAKAHASHI T, 1994, INT IMMUNOL, V6, P1567, DOI 10.1093/intimm/6.10.1567; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; TANAKA M, 1995, EMBO J, V14, P1129, DOI 10.1002/j.1460-2075.1995.tb07096.x; VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211; VIGNAUX F, 1995, J EXP MED, V181, P781, DOI 10.1084/jem.181.2.781; WATANABEFUKUNAGA R, 1992, J IMMUNOL, V148, P1274; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; YOKOYAMA WM, 1995, P NATL ACAD SCI USA, V92, P3081, DOI 10.1073/pnas.92.8.3081	50	638	654	0	15	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAR	1996	2	3					317	322		10.1038/nm0396-317	http://dx.doi.org/10.1038/nm0396-317			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TY640	8612231				2022-12-25	WOS:A1996TY64000041
J	Noishiki, Y; Tomizawa, Y; Yamane, Y; Matsumoto, A				Noishiki, Y; Tomizawa, Y; Yamane, Y; Matsumoto, A			Autocrine angiogenic vascular prosthesis with bone marrow transplantation	NATURE MEDICINE			English	Article							VENOUS TISSUE FRAGMENTS; GRAFT; INVITRO	Synthetic vascular prostheses are foreign bodies, so that blood coagulation can occur on their luminal surfaces, causing graft occlusion very frequently in prostheses of small diameter. A vascular prosthesis needs angiogenesis for endothelialization of the luminal surface, as endothelial cells have natural and permanent antithrombogenic properties'. To induce capillary growth into the graft, we developed a method of transplanting bone marrow cells, which are primitive, strong enough to survive, and create blood cells, resulting in the inducement of,capillary growth. In an animal experiment, marrow cells were infiltrated into the walls of long-fibril expanded polytetrafluoroethylene (ePTFE) vascular grafts. The grafts were implanted in the abdominal aortic position of 24 dogs autologously. Marrow cells survived and continued exogenous hemopoiesis for up to six months and were immunohistochemically reactive to basic fibroblast growth factor (bFGF). All the grafts older than three weeks had complete endothelialization and maintained their patency. Twenty grafts without bone marrow were implanted as controls. Endothelialization was present at anastomotic sites, but other areas were covered with fresh thrombi. Four out of seven control grafts were patent with endothelial cell lining at six months, but three were occluded and one of the four grafts was still covered with a thrombus layer. Bone marrow with its unique native properties produced autocrine angiogenicity in the graft.	TOKYO WOMENS MED COLL,DEPT CARDIOVASC SURG,SHINJUKU KU,TOKYO 162,JAPAN; TOKYO UNIV AGR & TECHNOL,FAC AGR SCI,DEPT VET MED,FUCHU,TOKYO 183,JAPAN	Tokyo Women's Medical University; Tokyo University of Agriculture & Technology	Noishiki, Y (corresponding author), YOKOHAMA CITY UNIV,SCH MED,DEPT SURG 1,KANAZAWA KU,3-9 FUKUURA,YOKOHAMA,KANAGAWA 236,JAPAN.							BELL E, 1981, SCIENCE, V211, P1052, DOI 10.1126/science.7008197; BIKFALVI A, 1994, LEUKEMIA, V8, P523; BURGER K, 1972, ANN SURG, V175, P118; CLOWES AW, 1986, AM J PATHOL, V123, P220; FU YM, 1991, J CELL BIOL, V114, P1261, DOI 10.1083/jcb.114.6.1261; GOLDEN PB, 1983, IN VITRO CELL DEV, V19, P661; HARKESS JW, 1991, ROCKWOOD GREENS FRAC, P145; MIWA AY, 1992, SCIENCE, V267, P1401; NOISHIKI Y, 1993, J THORAC CARDIOV SUR, V105, P796; NOISHIKI Y, 1992, J THORAC CARDIOV SUR, V104, P770; NOISHIKI Y, 1994, J VASC SURG, V20, P279, DOI 10.1016/0741-5214(94)90017-5; NOISHIKI Y, 1995, ARTIF ORGANS, V19, P17, DOI 10.1111/j.1525-1594.1995.tb02239.x; NOISHIKI Y, 1995, ARTIF ORGANS, V19, P7, DOI 10.1111/j.1525-1594.1995.tb02238.x; PARK PK, 1990, J VASC SURG, V11, P468, DOI 10.1067/mva.1990.17242; RADOMSKI JS, 1989, J SURG RES, V47, P173, DOI 10.1016/0022-4804(89)90084-X; Rudolph R, 1990, PLAST SURG-CHIR PLAS, V1, P221; SAUVAGE LR, 1969, SURGERY, V65, P78; TILG H, 1994, BLOOD, V83, P113; WANG CL, 1978, BIOCHIM BIOPHYS ACTA, V68, P544; 1985, NIH8023 PUBL	20	115	135	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JAN	1996	2	1					90	93		10.1038/nm0196-90	http://dx.doi.org/10.1038/nm0196-90			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TP579	8564850				2022-12-25	WOS:A1996TP57900043
J	WILLIAMS, BO; REMINGTON, L; ALBERT, DM; MUKAI, S; BRONSON, RT; JACKS, T				WILLIAMS, BO; REMINGTON, L; ALBERT, DM; MUKAI, S; BRONSON, RT; JACKS, T			COOPERATIVE TUMORIGENIC EFFECTS OF GERMLINE MUTATIONS IN RB AND P53	NATURE GENETICS			English	Article							WILD-TYPE P53; CELL LUNG-CANCER; RETINOBLASTOMA SUSCEPTIBILITY GENE; TUMOR-SUPPRESSOR GENE; LARGE T-ANTIGEN; TRANSGENIC MICE; BREAST-CANCER; CYCLE CONTROL; PINEAL ORGAN; APOPTOSIS	The tumour suppressor genes Rb and p53 are mutated in several types of human cancer, and many tumour types carry mutations in both genes. To study how these genes normally function, we and others have created mouse strains with Rb and p53 mutations. Here we describe the phenotypic effects of combined germline mutations in these two tumour suppressor genes. Mice mutant for both genes have reduced viability and exhibit novel pathology including pinealoblastomas, islet cell tumours, bronchial epithelial hyperplasia and retinal dysplasia. These data indicate that mutations in Rb and p53 can cooperate in the transformation of certain cell types in the mouse.	MIT,CTR CANC RES,DEPT BIOL,CAMBRIDGE,MA 02139; UNIV WISCONSIN,DEPT OPHTHALMOL,MADISON,WI 53792; HARVARD UNIV,SCH MED,MASSACHUSETTS EYE & EAR INFIRM,DEPT OPHTHALMOL,BOSTON,MA 02114; TUFTS UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02111; TUFTS UNIV,SCH VET MED,DEPT PATHOL,BOSTON,MA 02111	Massachusetts Institute of Technology (MIT); University of Wisconsin System; University of Wisconsin Madison; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Tufts University; Tufts University			Williams, Bart/A-3539-2013	Williams, Bart/0000-0002-5261-5301				AGUAYO SM, 1992, NEW ENGL J MED, V327, P1285, DOI 10.1056/NEJM199210293271806; ALUBAIDI MR, 1992, J CELL BIOL, V119, P1681, DOI 10.1083/jcb.119.6.1681; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; CROOK T, 1991, ONCOGENE, V6, P873; DAVIDOFF AM, 1991, P NATL ACAD SCI USA, V88, P5006, DOI 10.1073/pnas.88.11.5006; DEBBAS M, 1993, GENE DEV, V7, P546, DOI 10.1101/gad.7.4.546; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DYSON N, 1989, CELL, V58, P249, DOI 10.1016/0092-8674(89)90839-8; EWEN ME, 1989, CELL, V58, P257, DOI 10.1016/0092-8674(89)90840-4; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; HANAHAN D, 1989, SCIENCE, V246, P1265, DOI 10.1126/science.2686032; HARRIS CC, 1993, NEW ENGL J MED, V329, P1318, DOI 10.1056/NEJM199310283291807; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; HENSEL CH, 1991, ONCOGENE, V6, P1067; HENSEL CH, 1990, CANCER RES, V50, P3067; HOLLINGSWORTH J, 1993, CURR OPIN CELL BIOL, V5, P194; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; JAKOBIEC FA, 1977, CANCER-AM CANCER SOC, V39, P2048, DOI 10.1002/1097-0142(197705)39:5<2048::AID-CNCR2820390522>3.0.CO;2-9; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KASTAN MB, 1991, CANCER RES, V51, P6304; KNUDSON AG, 1993, P NATL ACAD SCI USA, V90, P10914, DOI 10.1073/pnas.90.23.10914; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; LOWE SW, 1994, P NATL ACAD SCI USA, V91, P2026, DOI 10.1073/pnas.91.6.2026; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MALKIN D, 1993, CANCER GENET CYTOGEN, V66, P83, DOI 10.1016/0165-4608(93)90233-C; MARTINEZ J, 1991, GENE DEV, V5, P151, DOI 10.1101/gad.5.2.151; MERCER WE, 1990, P NATL ACAD SCI USA, V87, P6166, DOI 10.1073/pnas.87.16.6166; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; PESIN SR, 1989, AM J OPHTHALMOL, V107, P121, DOI 10.1016/0002-9394(89)90209-2; PROSSER J, 1990, ONCOGENE, V5, P1573; RUGGERI B, 1992, ONCOGENE, V7, P1503; RYGAARD K, 1990, CANCER RES, V50, P5312; SCHEFFNER M, 1991, P NATL ACAD SCI USA, V88, P5523, DOI 10.1073/pnas.88.13.5523; SHAW P, 1992, P NATL ACAD SCI USA, V89, P4495, DOI 10.1073/pnas.89.10.4495; Shew J.-Y., 1989, ONCOGENE RES, V1, P205; STANNARD C, 1985, BRIT J OPHTHALMOL, V69, P749, DOI 10.1136/bjo.69.10.749; STRATTON MR, 1990, ONCOGENE, V5, P1297; TANG A, 1988, SCIENCE, V241, P1797; VANDYKE TA, 1994, SEMIN CANCER BIOL, V5, P47; VARLEY JM, 1989, ONCOGENE, V4, P725; VARLEY JM, 1991, ONCOGENE, V6, P413; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; WEINBERG RA, 1992, CANCER SURV, V12, P43; WINDLE JJ, 1990, NATURE, V343, P665, DOI 10.1038/343665a0; WURTMAN RJ, 1977, NEW ENGL J MED, V296, P1383, DOI 10.1056/NEJM197706162962405; WURTMAN RJ, 1977, NEW ENGL J MED, V296, P1329, DOI 10.1056/NEJM197706092962307; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7; YONISHROUACH E, 1991, NATURE, V352, P345, DOI 10.1038/352345a0	58	333	340	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1994	7	4					480	484		10.1038/ng0894-480	http://dx.doi.org/10.1038/ng0894-480			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PA832	7951317				2022-12-25	WOS:A1994PA83200013
J	FERRIN, LJ; CAMERINIOTERO, RD				FERRIN, LJ; CAMERINIOTERO, RD			LONG-RANGE MAPPING OF GAPS AND TELOMERES WITH RECA-ASSISTED RESTRICTION-ENDONUCLEASE (RARE) CLEAVAGE	NATURE GENETICS			English	Article							HUNTINGTON DISEASE GENE; CANDIDATE REGION; DNA; SEQUENCE; CLONES; CHROMOSOME-4; LOCATION; 4P16.3; MAPS	RecA-assisted restriction endonuclease (RARE) cleavage is a method to perform sequence-specific cleavage of genomic DNA, and is useful in physical mapping studies. After making two modifications, we have applied this method to mapping targe regions of DNA in several cell types, including a notorious gap near the Huntington disease (HD) locus on chromosome 4. RARE cleavage fragments were analysed by pulsed field gel electrophoresis and Southern blotting and the distances between cleavage sites determined with accuracy. Using RARE cleavage, the gap measured was less than 60 kilobases in length. RARE cleavage is also a straightforward technique to map the distance from a marker to a telomere. The terminal 1.7 megabases of several HD and control cell lines were mapped with no large differences between cell lines in this region.	NIDDKD,GENET & BIOCHEM BRANCH,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)								ALTHERR MR, 1992, GENOMICS, V13, P1040, DOI 10.1016/0888-7543(92)90017-M; BATES GP, 1990, AM J HUM GENET, V46, P762; BATES GP, 1991, AM J HUM GENET, V49, P7; BUCAN M, 1990, GENOMICS, V6, P1; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FERRIN LJ, 1991, SCIENCE, V254, P1494, DOI 10.1126/science.1962209; FERRIN LJ, 1993, METH MOL G, V2, P57; FOOTE S, 1992, SCIENCE, V258, P60, DOI 10.1126/science.1359640; GANDELMAN KY, 1992, AM J HUM GENET, V51, P571; GUSELLA JF, 1992, GENOMICS, V13, P75, DOI 10.1016/0888-7543(92)90204-6; HERRMANN BG, 1987, METHOD ENZYMOL, V152, P180; ICHIKAWA H, 1993, NAT GENET, V4, P361, DOI 10.1038/ng0893-361; MCCOMBIE WR, 1992, NAT GENET, V1, P348, DOI 10.1038/ng0892-348; PATTERSON D, 1993, NAT GENET, V4, P323, DOI 10.1038/ng0893-323; RIETHMAN HC, 1993, GENOMICS, V17, P25, DOI 10.1006/geno.1993.1278; SCHWARTZ DC, 1993, SCIENCE, V262, P110, DOI 10.1126/science.8211116; SCOTT HS, 1992, GENOMICS, V14, P1118, DOI 10.1016/S0888-7543(05)80145-4; VANDENENGH G, 1992, SCIENCE, V257, P1410, DOI 10.1126/science.1388286; WANG YK, 1993, NUCLEIC ACIDS RES, V21, P2528, DOI 10.1093/nar/21.10.2528; WEBER B, 1991, NUCLEIC ACIDS RES, V19, P6263, DOI 10.1093/nar/19.22.6263; WHALEY WL, 1991, SOMAT CELL MOLEC GEN, V17, P83, DOI 10.1007/BF01233207; 1993, CELL, V72, P971	25	29	33	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1994	6	4					379	383		10.1038/ng0494-379	http://dx.doi.org/10.1038/ng0494-379			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ND870	8054978				2022-12-25	WOS:A1994ND87000017
J	PRAS, E; ARBER, N; AKSENTIJEVICH, I; KATZ, G; SCHAPIRO, JM; PROSEN, L; GRUBERG, L; HAREL, D; LIBERMAN, U; WEISSENBACH, T; PRAS, M; KASTNER, DL				PRAS, E; ARBER, N; AKSENTIJEVICH, I; KATZ, G; SCHAPIRO, JM; PROSEN, L; GRUBERG, L; HAREL, D; LIBERMAN, U; WEISSENBACH, T; PRAS, M; KASTNER, DL			LOCALIZATION OF A GENE CAUSING CYSTINURIA TO CHROMOSOME 2P	NATURE GENETICS			English	Article							EXPRESSION CLONING; RAT-KIDNEY; LINKAGE; TRANSPORT; CDNA; MAP	Cystinuria is an autosomal recessive disorder of amino acid transport. It is a common hereditary cause of kidney stones worldwide, and is associated with significant morbidity. in 17 affected families, we found linkage between cystinuria and three chromosome 2p markers. Maximal two-point rod scores between cystinuria and D2S119, D2S391 and D2S288 were 8.23 (theta=0.07), 3.73 (theta=0.15) and 3.03 (theta=0.12), respectively. Analysis of recombinants and multipoint linkage data indicated that the most likely order is cen-D2S391-D2S119-cystinuria-D2S177-tel. We also observed high rates of homozygosity for markers in this chromosomal region among 11 affected offspring of consanguineous marriages. Based on its map position and function, the recently cloned SLC3A1 amino acid transporter gene is a primary candidate gene for this disease.	NIAMSD,ARTHRITIS & RHEUMATISM BRANCH,BETHESDA,MD 20892; BEILINSON MED CTR,DEPT MED D,PETAH TIQWA,ISRAEL; BEILINSON MED CTR,DEPT METAB,PETAH TIQWA,ISRAEL; BEILINSON MED CTR,CLIN LABS,PETAH TIQWA,ISRAEL; HADASSAH MED CTR,DEPT UROL,JERUSALEM,ISRAEL; CHAIM SHEBA MED CTR,DEPT MED F,IL-52621 TEL HASHOMER,ISRAEL; CHAIM SHEBA MED CTR,HELLER INST MED RES,IL-52621 TEL HASHOMER,ISRAEL; INST PASTEUR,UNITE GENET MOLEC HUMAINE,CNRS,URA 1445,F-75724 PARIS 15,FRANCE	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Rabin Medical Center; Rabin Medical Center; Rabin Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris			Aksentijevich, Ivona/AAF-1335-2019	Arber, Nadir/0000-0001-5283-6991				ANTIGNAC C, 1993, NAT GENET, V3, P342, DOI 10.1038/ng0493-342; BENHAMIDA C, 1993, NAT GENET, V5, P195; BENOTHMANE K, 1992, NAT GENET, V2, P315, DOI 10.1038/ng1292-315; BERTRAN J, 1993, J BIOL CHEM, V268, P14842; BERTRAN J, 1992, P NATL ACAD SCI USA, V89, P5601, DOI 10.1073/pnas.89.12.5601; DAHLBERG PJ, 1977, MAYO CLIN PROC, V52, P533; DENT CE, 1951, Q J MED, V20, P205; Ellis N. A., 1992, American Journal of Human Genetics, V51, pA187; FRYDMAN M, 1985, P NATL ACAD SCI USA, V82, P1819, DOI 10.1073/pnas.82.6.1819; Garrod AE, 1908, LANCET, V2, P1; GILLIAM TC, 1990, NATURE, V345, P823, DOI 10.1038/345823a0; GOODYER PR, 1993, J PEDIATR-US, V122, P568, DOI 10.1016/S0022-3476(05)83537-1; GOTO M, 1992, NATURE, V355, P735, DOI 10.1038/355735a0; HILDEBRANDT F, 1993, AM J HUM GENET, V53, P1256; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEE WS, 1993, J CLIN INVEST, V91, P1959, DOI 10.1172/JCI116415; LEVY HL, 1972, PEDIATRICS, V49, P825; McKusick VA, 1990, MENDELIAN INHERITANC; Ott J., 1991, ANAL HUMAN GENETIC L; POLINSKY MS, 1987, PEDIATR CLIN N AM, V34, P683; POLLAK MR, NAT GENET, V5, P2013; PRAS E, 1992, NEW ENGL J MED, V326, P1509, DOI 10.1056/NEJM199206043262301; ROSENBERG LE, 1966, J CLIN INVEST, V45, P365, DOI 10.1172/JCI105351; SMITH CAB, 1953, J R STAT SOC B, V15, P153; STEPHENS AD, 1989, J INHERIT METAB DIS, V12, P197, DOI 10.1007/BF01800726; TATE SS, 1992, P NATL ACAD SCI USA, V89, P1, DOI 10.1073/pnas.89.1.1; WALSH PC, 1992, CAMBELLS UROLOGY; WEINBERGER A, 1974, HUM HERED, V24, P568, DOI 10.1159/000152696; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WELLS RG, 1992, P NATL ACAD SCI USA, V89, P5596, DOI 10.1073/pnas.89.12.5596; Wollaston W., 1810, PHILOS T R SOC LOND, V100, P223, DOI [10.1080/14786441108563237, DOI 10.1080/14786441108563237]	33	103	103	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1994	6	4					415	419		10.1038/ng0494-415	http://dx.doi.org/10.1038/ng0494-415			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ND870	8054985				2022-12-25	WOS:A1994ND87000024
J	EVANS, K; FRYER, A; INGLEHEARN, C; DUVALLYOUNG, J; WHITTAKER, JL; GREGORY, CY; BUTLER, R; EBENEZER, N; HUNT, DM; BHATTACHARYA, S				EVANS, K; FRYER, A; INGLEHEARN, C; DUVALLYOUNG, J; WHITTAKER, JL; GREGORY, CY; BUTLER, R; EBENEZER, N; HUNT, DM; BHATTACHARYA, S			GENETIC-LINKAGE OF CONE-ROD RETINAL DYSTROPHY TO CHROMOSOME 19Q AND EVIDENCE FOR SEGREGATION DISTORTION	NATURE GENETICS			English	Article								Inherited retinal dystrophies are the most common cause of childhood blindness in the developed world. Cone-rod retinal dystrophies are severe examples of this group of disorders. Analysis of a large cone-rod dystrophy pedigree suggested that inheritance within the family was influenced by meiotic drive (p=0.008), a rare segregation distortion in human genetics. Two-point linkage analysis showed significant linkage with three markers mapping to chromosome 19q. Multipoint analysis gave a maximum rod score of 10.08 (theta=0.05) distal to D19S47. Cone-rod dystrophy is therefore assigned to 19q13.1-q13.2 and a new candidate locus for other retinal dystrophies is identified.	INST CHILD HLTH,DEPT MOLEC GENET,LIVERPOOL L12 2AP,ENGLAND; WALTON HOSP,LIVERPOOL L9 1AE,ENGLAND	University of Liverpool; Walton Centre	EVANS, K (corresponding author), INST OPHTHALMOL,DEPT MOLEC GENET,BATH ST,LONDON EC1V 9EL,ENGLAND.		Gregory-Evans, Cheryl Y/G-9550-2011; Hunt, David M/K-6024-2012; Gregory-Evans, Kevin/G-9551-2011	Hunt, David M/0000-0002-9264-3948; 				ALMAGHTHEH M, 1993, HUM MUTAT, V2, P249, DOI 10.1002/humu.1380020403; ATTWOOD J, 1988, ANN HUM GENET, V52, P259, DOI 10.1111/j.1469-1809.1988.tb01103.x; BENNETT D, 1971, P S IMMUNOGENETICS H, P90; BERSON EL, 1968, ARCH OPHTHALMOL-CHIC, V80, P68; BJORK A, 1956, J NEUROL NEUROSUR PS, V19, P186, DOI 10.1136/jnnp.19.3.186; BURIAN HM, 1967, AM J OPHTHALMOL, V63, P22, DOI 10.1016/0002-9394(67)90577-6; ELSTON J, 1992, PAEDIAT OPHTHALMOLOG, P3; FERRELL RE, 1981, AM J MED GENET, V8, P363, DOI 10.1002/ajmg.1320080316; GASS JDM, 1987, STEREOSCOPIC ATLAS M, P60; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HECKENLIVELY JR, 1988, DOC OPHTHALMOL, V68, P257, DOI 10.1007/BF00156432; HECKENLIVELY JR, 1981, ARCH OPHTHALMOL-CHIC, V99, P1983; HIRAIZUMI Y, 1979, GENETICS, V93, P423; JALILI IK, 1989, J MED GENET, V26, P504, DOI 10.1136/jmg.26.8.504; JALILI IK, 1988, J MED GENET, V25, P738, DOI 10.1136/jmg.25.11.738; JANSEN G, 1992, GENOMICS, V13, P509, DOI 10.1016/0888-7543(92)90118-C; KRILL AE, 1973, DOC OPHTHALMOL, V35, P1; KYISTRA JA, 1993, CAN J OPHTHALMOL, V28, P79; LANG GE, 1988, RETINAL DYSTROPHIES, P331; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LYTTLE TW, 1991, ANNU REV GENET, V25, P511, DOI 10.1146/annurev.ge.25.120191.002455; MAGENIS RE, 1990, AM J MED GENET, V35, P333, DOI 10.1002/ajmg.1320350307; MANTYJARVI M, 1989, ACTA OPHTHALMOL, V67, P234; MOORE AT, 1992, J MED GENET, V29, P289, DOI 10.1136/jmg.29.5.289; RICHARDS RI, 1992, NAT GENET, V1, P257, DOI 10.1038/ng0792-257; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Samra D, 1988, Metab Pediatr Syst Ophthalmol (1985), V11, P83; SMALL KW, 1993, INVEST OPHTH VIS SCI, V34, P1305; STONE EM, 1992, NAT GENET, V1, P246, DOI 10.1038/ng0792-246; TRAVIS GH, 1993, NAT GENET, V3, P191, DOI 10.1038/ng0393-191; WARBURG M, 1991, AM J MED GENET, V39, P288, DOI 10.1002/ajmg.1320390309; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WELLS J, 1993, NAT GENET, V3, P213, DOI 10.1038/ng0393-213; YAGASAKI K, 1989, ARCH OPHTHALMOL-CHIC, V107, P701, DOI 10.1001/archopht.1989.01070010719034	34	99	100	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1994	6	2					210	213		10.1038/ng0294-210	http://dx.doi.org/10.1038/ng0294-210			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU763	8162077				2022-12-25	WOS:A1994MU76300019
J	MCWHIR, J; SELFRIDGE, J; HARRISON, DJ; SQUIRES, S; MELTON, DW				MCWHIR, J; SELFRIDGE, J; HARRISON, DJ; SQUIRES, S; MELTON, DW			MICE WITH DNA-REPAIR GENE (ERCC-1) DEFICIENCY HAVE ELEVATED LEVELS OF P53, LIVER NUCLEAR ABNORMALITIES AND DIE BEFORE WEANING	NATURE GENETICS			English	Article							XERODERMA-PIGMENTOSUM; ESCHERICHIA-COLI; EXCISION; EXPRESSION; CELLS; MUTANTS; CLONING; INVITRO; PROTEIN	Defects in nucleotide excision repair are associated with the human condition xeroderma pigmentosum which predisposes to skin cancer. Mice with defective DNA repair were generated by targeting the excision repair cross complementing gene (ERCC-1) in the embryonic stem cell line, HM-1. Homozygous ERCC-1 mutants were runted at birth and died before weaning with liver failure. Examination of organs revealed polyploidy in perinatal liver, progressing to severe aneuploidy by 3 weeks of age. Elevated p53 levels were detected in liver, brain and kidney, supporting the hypothesised role for p53 as a monitor of DNA damage.	UNIV EDINBURGH,INST CELL & MOLEC BIOL,MAYFIELD RD,EDINBURGH EH9 3JR,MIDLOTHIAN,SCOTLAND; UNIV EDINBURGH,DEPT PATHOL,EDINBURGH EH8 9AG,MIDLOTHIAN,SCOTLAND; UNIV CAMBRIDGE,DEPT ZOOL,CANCER RES CAMPAIGN MAMMALIAN CELL DNA REPAIR RES GRP,CAMBRIDGE CB2 3EJ,ENGLAND	University of Edinburgh; University of Edinburgh; University of Cambridge				SELFRIDGE, JIM/0000-0003-2473-4386				[Anonymous], 1985, DNA REPAIR; BELT PBGM, 1991, NUCLEIC ACIDS RES, V19, P5633, DOI 10.1093/nar/19.20.5633; BIGGERSTAFF M, 1993, EMBO J, V12, P3685, DOI 10.1002/j.1460-2075.1993.tb06043.x; BIGGERSTAFF M, 1992, J BIOL CHEM, V267, P6879; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; BRUGAL G, 1992, CYTOMETRY, V13, P109, DOI 10.1002/cyto.990130202; BUSCH D, 1989, MUTAGENESIS, V4, P349, DOI 10.1093/mutage/4.5.349; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; Cleaver J. E., 1989, METABOLIC BASIS INHE, V2, P2949; COLLINS AR, 1993, MUTAT RES, V293, P99, DOI 10.1016/0921-8777(93)90062-L; EPSTEIN CJ, 1967, NATURE, V214, P1050, DOI 10.1038/2141050a0; FLEJTER WL, 1992, P NATL ACAD SCI USA, V89, P261, DOI 10.1073/pnas.89.1.261; GULYAS KD, 1992, CELL, V69, P1031, DOI 10.1016/0092-8674(92)90621-I; HARRISON DJ, 1989, J CLIN PATHOL, V42, P624, DOI 10.1136/jcp.42.6.624; JENKINS JR, 1984, NUCLEIC ACIDS RES, V12, P5609, DOI 10.1093/nar/12.14.5609; KASTAN MB, 1991, CANCER RES, V51, P6304; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; MIDGLEY CA, 1992, J CELL SCI, V101, P183; MINTY AJ, 1981, J BIOL CHEM, V256, P1008; MITCHELL DL, 1990, BIOESSAYS, V12, P74, DOI 10.1002/bies.950120205; ODONOVAN A, 1993, NATURE, V363, P185, DOI 10.1038/363185a0; OLANOW CW, 1992, ANN NEUROL, V32, pS2, DOI 10.1002/ana.410320703; Ormerod M.G., 1990, FLOW CYTOMETRY PRACT, P69; PINKUS R, 1993, BIOCHEM J, V290, P637, DOI 10.1042/bj2900637; REGAN JD, 1990, MUTAT RES, V235, P157, DOI 10.1016/0921-8777(90)90069-H; SANCAR A, 1988, ANNU REV BIOCHEM, V57, P29, DOI 10.1146/annurev.bi.57.070188.000333; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SCHIESTL RH, 1990, MOL CELL BIOL, V10, P2485, DOI 10.1128/MCB.10.6.2485; SELFRIDGE J, 1992, SOMAT CELL MOLEC GEN, V18, P325, DOI 10.1007/BF01235756; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; SQUIRES S, 1982, MUTAT RES, V95, P389, DOI 10.1016/0027-5107(82)90273-1; THOMPSON S, 1989, CELL, V56, P313, DOI 10.1016/0092-8674(89)90905-7; TOMKINSON AE, 1993, NATURE, V362, P860, DOI 10.1038/362860a0; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; VANDUIN M, 1987, NUCLEIC ACIDS RES, V15, P9195, DOI 10.1093/nar/15.22.9195; VANDUIN M, 1988, NUCLEIC ACIDS RES, V16, P5305, DOI 10.1093/nar/16.12.5305; VANDUIN M, 1989, MUTAT RES, V217, P83, DOI 10.1016/0921-8777(89)90059-1; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; VOIGT JM, 1989, J BIOL CHEM, V264, P5172; WEEDA G, 1993, BIOESSAYS, V15, P249, DOI 10.1002/bies.950150405; WEEDA G, 1990, CELL, V62, P777, DOI 10.1016/0092-8674(90)90122-U; WESTERVELD A, 1984, NATURE, V310, P425, DOI 10.1038/310425a0; YOKE WK, 1990, MUTAT RES, V235, P147	44	286	294	1	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1993	5	3					217	224		10.1038/ng1193-217	http://dx.doi.org/10.1038/ng1193-217			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MF122	8275084				2022-12-25	WOS:A1993MF12200009
J	CHEN, ZY; BATTINELLI, EM; FIELDER, A; BUNDEY, S; SIMS, K; BREAKEFIELD, XO; CRAIG, IW				CHEN, ZY; BATTINELLI, EM; FIELDER, A; BUNDEY, S; SIMS, K; BREAKEFIELD, XO; CRAIG, IW			A MUTATION IN THE NORRIE DISEASE GENE (NDP) ASSOCIATED WITH X-LINKED FAMILIAL EXUDATIVE VITREORETINOPATHY	NATURE GENETICS			English	Article							CANDIDATE GENE; CHROMOSOME; DELETION; MAPS; DNA	Familial exudative vitreoretinopathy (FEVR) is a hereditary disorder characterized by an abnormality of the peripheral retina. Both autosomal dominant (adFEVR) and X-linked (XLFEVR) forms have been described, but the biochemical defect(s) underlying the symptoms are unknown. Molecular analysis of the Norrie gene locus (NDP) in a four generation FEVR family (shown previously to exhibit linkage to the X-chromosome markers DXS228 and MAOA (Xp11.4-p11.3)) reveals a missense mutation in the highly conserved region of the NDP gene, which caused a neutral amino acid substitution (Leu124Phe), was detected in all of the affected males, but not in the unaffected family members, nor in normal controls. The observations suggest that phenotypes of both XLFEVR and Norrie disease can result from mutations in the same gene.	BIRMINGHAM & MIDLAND EYE HOSP,DEPT OPHTHALMOL,BIRMINGHAM B3 2NS,ENGLAND; UNIV BIRMINGHAM,MATERN HOSP,DEPT CLIN GENET,BIRMINGHAM B15 2TA,ENGLAND; UNIV OXFORD,DEPT BIOCHEM,GENET LAB,OXFORD OX1 3QU,ENGLAND	University of Birmingham; University of Oxford	CHEN, ZY (corresponding author), MASSACHUSETTS GEN HOSP E,CTR NEUROSCI,MOLEC NEUROGENET LAB,BLDG 149,13TH ST,BOSTON,MA 02129, USA.		Craig, Ian/AAF-9167-2019	Craig, Ian/0000-0002-4063-1005	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021921] Funding Source: NIH RePORTER; NINDS NIH HHS [2 RO1NS21 921-10] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission)		BERGER W, 1992, NAT GENET, V1, P199, DOI 10.1038/ng0692-199; BERGER W, 1992, HUM MOL GENET, V1, P461, DOI 10.1093/hmg/1.7.461; BLEEKERWAGEMAKERS EM, 1988, OPHTHALMIC PAED GEN, V9, P137, DOI 10.3109/13816818809031489; CHEN ZY, 1992, NAT GENET, V1, P204, DOI 10.1038/ng0692-204; CHEN ZY, 1992, GENOMICS, V14, P75, DOI 10.1016/S0888-7543(05)80286-1; CHEN ZY, 1993, GENOMICS, V16, P533, DOI 10.1006/geno.1993.1224; CHEN ZY, 1992, HUM MOL GENET, V3, P161; CRISWICK VG, 1969, AM J OPHTHALMOL, V68, P578, DOI 10.1016/0002-9394(69)91237-9; DONNAI D, 1988, J MED GENET, V25, P73, DOI 10.1136/jmg.25.2.73; DUDGEON J, 1979, T OPHTHAL SOC UK, V99, P45; FELDMAN EL, 1983, ARCH OPHTHALMOL-CHIC, V101, P1532; FULLWOOD P, 1993, BRIT J OPHTHALMOL, V77, P168, DOI 10.1136/bjo.77.3.168; GODEL V, 1978, AM J OPHTHALMOL, V86, P221, DOI 10.1016/S0002-9394(14)76816-3; GOW J, 1971, ARCH OPHTHALMOL-CHIC, V86, P150, DOI 10.1001/archopht.1971.01000010152007; HITTNER MH, 1986, RETINOPATHY PREMATUR, P53; KAJIWARA K, 1993, NAT GENET, V3, P208, DOI 10.1038/ng0393-208; LAQUA H, 1980, A GRAEF ARCH KLIN EX, V213, P121, DOI 10.1007/BF00413539; LaRussa F, 1992, J Am Optom Assoc, V63, P404; LI Y, 1992, AM J HUM GENET, V51, P749; McKusick VA, 1990, MENDELIAN INHERITANC; MEINDL A, 1992, NAT GENET, V2, P139, DOI 10.1038/ng1092-139; NICHOLS BE, 1993, NAT GENET, V3, P202, DOI 10.1038/ng0393-202; NORRIE GORDON, 1927, ACTA OPHTHALMOLOGICA, V5, P357; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PARSONS MA, 1992, GRAEF ARCH CLIN EXP, V230, P248, DOI 10.1007/BF00176299; PLAGER DA, 1992, AM J OPHTHALMOL, V114, P145, DOI 10.1016/S0002-9394(14)73977-7; POLOMENO RC, 1987, CAN J OPHTHALMOL, V22, P21; Sims K. B., 1992, Human Molecular Genetics, V1, P83, DOI 10.1093/hmg/1.2.83; SIMS KB, 1989, NEURON, V2, P1069, DOI 10.1016/0896-6273(89)90231-6; TRAVIS GH, 1993, NAT GENET, V3, P191, DOI 10.1038/ng0393-191; TRESE MT, 1991, INVEST OPHTH VIS SCI, V32, P692; VANNOUHUYS CE, 1982, DOC OPHTHALMOL, V54, P1; VOORBERG J, 1991, J CELL BIOL, V113, P195, DOI 10.1083/jcb.113.1.195; WARBURG M, 1961, ACTA OPHTHALMOL, V39, P757; WELLS J, 1993, NAT GENET, V3, P213, DOI 10.1038/ng0393-213; ZHU DP, 1989, AM J MED GENET, V33, P485, DOI 10.1002/ajmg.1320330415	36	246	263	0	11	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1993	5	2					180	183		10.1038/ng1093-180	http://dx.doi.org/10.1038/ng1093-180			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MA056	8252044				2022-12-25	WOS:A1993MA05600017
J	GHOSH, S; PALMER, SM; RODRIGUES, NR; CORDELL, HJ; HEARNE, CM; CORNALL, RJ; PRINS, JB; MCSHANE, P; LATHROP, GM; PETERSON, LB; WICKER, LS; TODD, JA				GHOSH, S; PALMER, SM; RODRIGUES, NR; CORDELL, HJ; HEARNE, CM; CORNALL, RJ; PRINS, JB; MCSHANE, P; LATHROP, GM; PETERSON, LB; WICKER, LS; TODD, JA			POLYGENIC CONTROL OF AUTOIMMUNE DIABETES IN NONOBESE DIABETIC MICE	NATURE GENETICS			English	Article							MOUSE GENOME; MICROSATELLITE MARKERS; MURINE INTERLEUKIN-2; LINKAGE ANALYSIS; GENE; SUSCEPTIBILITY; RAT; MAP; CHROMOSOME-1; RESOLUTION	Partial exclusion mapping of the nonobese (NOD) diabetic mouse genome has shown linkage of diabetes to at least five different chromosomes. We have now excluded almost all of the genome for the presence of susceptibility genes with fully recessive effects and have obtained evidence of linkage of ten distinct loci to diabetes or the prediabetic lesion, insulitis, indicative of a polygenic mode of inheritance. The relative importance of these loci and their interactions have been assessed using a new application of multiple polychotomous regression methods. A candidate disease gene, interleukin-2 (Il-2), which is closely linked to insulitis and diabetes, is shown to have a different sequence in NOD, including an insertion and a deletion of tandem repeat sequences which encode amino acid repeats in the mature protein.	UNIV OXFORD, JOHN RADCLIFFE HOSP, NUFFIELD DEPT SURG, OXFORD OX3 9DU, ENGLAND; INSERM, F-75010 PARIS, FRANCE; MERCK RES LABS, DEPT CELLULAR & MOLEC PHARMACOL, RAHWAY, NJ 07065 USA; MERCK RES LABS, DEPT AUTOIMMUNE DIS RES, RAHWAY, NJ USA	University of Oxford; Institut National de la Sante et de la Recherche Medicale (Inserm); Merck & Company; Merck & Company			Wicker, Linda S/F-7384-2010; Todd, John A/A-3542-2010	Todd, John A/0000-0003-2740-8148; Cordell, Heather/0000-0002-1879-5572; Prins, Jan-Bas/0000-0002-1831-8522	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AITMAN TJ, 1991, MAMM GENOME, V1, P206, DOI 10.1007/BF00352326; BAIN SC, 1992, NAT GENET, V2, P212, DOI 10.1038/ng1192-212; CASTANO L, 1990, ANNU REV IMMUNOL, V8, P647, DOI 10.1146/annurev.iy.08.040190.003243; CORNALL RJ, 1991, GENOMICS, V10, P874, DOI 10.1016/0888-7543(91)90175-E; CORNALL RJ, 1991, NATURE, V353, P262, DOI 10.1038/353262a0; CORNALL RJ, 1992, MAMM GENOME, V3, P620, DOI 10.1007/BF00352478; Crow J., 1986, BASIC CONCEPTS POPUL; DEGOUYON B, 1993, P NATL ACAD SCI USA, V90, P1877, DOI 10.1073/pnas.90.5.1877; DEGRAVE W, 1986, MOL BIOL REP, V11, P57, DOI 10.1007/BF00417597; DIETRICH W, 1992, GENETICS, V131, P423; DIETRICH W, 1993, GENETIC MAPS LOCUS M; Dixon W. J., 1990, BMDP STATISTICAL SOF; FLEMMING CL, 1993, EUR J IMMUNOL, V23, P917, DOI 10.1002/eji.1830230423; GARCHON HJ, 1991, NATURE, V353, P260, DOI 10.1038/353260a0; HEARNE CM, 1991, MAMM GENOME, V1, P273, DOI 10.1007/BF00352339; HEARNE CM, 1992, TRENDS GENET, V8, P288, DOI 10.1016/0168-9525(92)90256-4; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; JACOB HJ, 1992, NAT GENET, V2, P56, DOI 10.1038/ng0992-56; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; KASHIMA N, 1985, NATURE, V313, P402, DOI 10.1038/313402a0; KROEMER G, 1991, ADV IMMUNOL, V50, P147; LOVE JM, 1990, NUCLEIC ACIDS RES, V18, P4123, DOI 10.1093/nar/18.14.4123; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MATESANZ F, 1992, BIOCHIM BIOPHYS ACTA, V1132, P335, DOI 10.1016/0167-4781(92)90174-X; MATESANZ F, IN PRESS IMMUNOGENET; MCALEER MA, 1992, MAMM GENOME, V3, P457, DOI 10.1007/BF00356156; MORTON NE, 1991, ANN HUM GENET, V55, P301, DOI 10.1111/j.1469-1809.1991.tb00857.x; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; POUSTKA A, 1984, P NATL ACAD SCI-BIOL, V81, P4129, DOI 10.1073/pnas.81.13.4129; PRINS JB, 1993, SCIENCE, V260, P695, DOI 10.1126/science.8480181; RIGGINS GJ, 1992, NAT GENET, V2, P186, DOI 10.1038/ng1192-186; RISCH N, IN PRESS AM J HUM GE; RISE ML, 1991, SCIENCE, V253, P669, DOI 10.1126/science.1871601; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; WICKER LS, 1992, J EXP MED, V176, P67, DOI 10.1084/jem.176.1.67; ZURAWSKI SM, 1986, J IMMUNOL, V137, P3354	38	296	298	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1993	4	4					404	409		10.1038/ng0893-404	http://dx.doi.org/10.1038/ng0893-404			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LQ178	8401590				2022-12-25	WOS:A1993LQ17800020
J	ZUCMAN, J; DELATTRE, O; DESMAZE, C; EPSTEIN, AL; STENMAN, G; SPELEMAN, F; FLETCHERS, CDM; AURIAS, A; THOMAS, G				ZUCMAN, J; DELATTRE, O; DESMAZE, C; EPSTEIN, AL; STENMAN, G; SPELEMAN, F; FLETCHERS, CDM; AURIAS, A; THOMAS, G			EWS AND ATF-1 GENE FUSION INDUCED BY T(12-22) TRANSLOCATION IN MALIGNANT-MELANOMA OF SOFT PARTS	NATURE GENETICS			English	Article							CLEAR-CELL-SARCOMA; EWINGS-SARCOMA; PERIPHERAL NEUROEPITHELIOMA; CHROMOSOME-TRANSLOCATION; CDNA CLONES; PROTEINS; LEUKEMIA; APONEUROSES; TENDONS; DOMAIN	The genes involved in the t(12;22)(q13;q12) translocation found recurrently in malignant melanoma of soft parts have been characterized and shown to form, in four cases studied, hybrid transcripts. The deduced chimaeric protein encoded by the der(22) chromosome consists of the N-terminal domain of EWS linked to the bZIP domain of ATF-1, a transcription factor which may normally be regulated by cAMP. ATF-1 has not previously been implicated in oncogenesis. EWS was first identified as forming a hybrid transcript in Ewing's sarcoma, which links its N-terminal domain to the DNA binding domain of the FLI-1 gene. Thus the oncogenic conversion of EWS follows a common scheme of activation, exchanging its putative RNA binding domain with different DNA binding domains that appear to be tumour-specific.	INST CURIE, INSERM, TUMOUR GENET LAB, CJF 9201, 26 RUE ULM, F-75231 PARIS 05, FRANCE; UNIV SO CALIF, MED CTR, DEPT PATHOL, LOS ANGELES, CA 90033 USA; GOTHENBURG UNIV, DEPT ODONTOL, S-400330 GOTEBOTG, SWEDEN; STATE UNIV GHENT HOSP, DEPT MED GENET, B-9000 GHENT, BELGIUM; ST THOMAS HOSP, DEPT HISTOPATHOL, LONDON SE1 7EH, ENGLAND	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Southern California; University of Gothenburg; Ghent University; Ghent University Hospital; Guy's & St Thomas' NHS Foundation Trust			zucman-rossi, Jessica/B-5098-2009; speleman, frank/AAR-5184-2020; j, zucman-rossi/AAV-3594-2021	zucman-rossi, Jessica/0000-0002-5687-0334; speleman, frank/0000-0002-6628-8559; j, zucman-rossi/0000-0002-5687-0334; Desmaze, Chantal/0000-0003-0777-8854; delattre, olivier/0000-0002-8730-2276				BRIDGE JA, 1991, CANCER GENET CYTOGEN, V52, P101, DOI 10.1016/0165-4608(91)90059-4; BRIDGE JA, 1990, AM J CLIN PATHOL, V93, P26, DOI 10.1093/ajcp/93.1.26; CHUNG EB, 1983, AM J SURG PATHOL, V7, P405, DOI 10.1097/00000478-198307000-00003; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; DESMAZE C, 1992, GENE CHROMOSOME CANC, V5, P30, DOI 10.1002/gcc.2870050105; DOUGLASS EC, 1986, J NATL CANCER I, V77, P1211; EDWARDS JBDM, 1991, NUCLEIC ACIDS RES, V19, P5227, DOI 10.1093/nar/19.19.5227; EPSTEIN AL, 1984, CANCER RES, V44, P1265; FLETCHER JA, 1992, GENE CHROMOSOME CANC, V5, P184, DOI 10.1002/gcc.2870050214; FLINT KJ, 1991, ONCOGENE, V6, P2019; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GODDARD AD, 1991, SCIENCE, V254, P1371, DOI 10.1126/science.1720570; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; HUNGER SP, 1992, GENE DEV, V6, P1608, DOI 10.1101/gad.6.9.1608; INABA T, 1992, SCIENCE, V257, P531, DOI 10.1126/science.1386162; Maniatis T, 1989, MOL CLONING; Mitelman F., 1988, CATALOG CHROMOSOME A; PEULVE P, 1991, GENE CHROMOSOME CANC, V3, P400, DOI 10.1002/gcc.2870030512; SPELEMAN F, 1992, CANCER GENET CYTOGEN, V60, P176, DOI 10.1016/0165-4608(92)90012-W; STENMAN G, 1992, GENE CHROMOSOME CANC, V4, P122, DOI 10.1002/gcc.2870040204; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; TURCCAREL C, 1988, CANCER GENET CYTOGEN, V32, P229, DOI 10.1016/0165-4608(88)90285-3; YOSHIMURA T, 1990, EMBO J, V9, P2537, DOI 10.1002/j.1460-2075.1990.tb07434.x; ZUCMAN J, 1992, GENE CHROMOSOME CANC, V5, P271, DOI 10.1002/gcc.2870050402	25	417	426	0	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1993	4	4					341	345		10.1038/ng0893-341	http://dx.doi.org/10.1038/ng0893-341			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LQ178	8401579				2022-12-25	WOS:A1993LQ17800009
J	Aas, T; Borresen, AL; Geisler, S; SmithSorensen, B; Johnsen, H; Varhaug, JE; Akslen, LA; Lonning, PE				Aas, T; Borresen, AL; Geisler, S; SmithSorensen, B; Johnsen, H; Varhaug, JE; Akslen, LA; Lonning, PE			Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients	NATURE MEDICINE			English	Article							EXPRESSION	The mechanisms causing resistance to chemotherapeutic drugs in cancer patients are poorly understood. Recent evidence suggests that different forms of chemotherapy may exert their cytotoxic effects by inducing apoptosis(1). The tumor suppressor gene P53 has a pivotal role inducing apoptosis in response to cellular damage. In vitro investigations have shown intact p53 to play a critical role executing cell death in response to treatment with cytotoxic drugs like 5-fluorouracil, etoposide and doxorubicin(2). Recently, mutations in the P53 gene were found to confer resistance to anthracyclines in a mouse sarcoma tumor model(3) and overexpression of the p53 protein (which, in most cases, is due to a mutated gene) was found to be associated with lack of response to cisplatin-based chemotherapy in non-small cell lung cancer(4). Previous studies have shown mutations in the P53 gene or overexpression of the p53 protein to predict a poor prognosis(5-7), but also a beneficial effect of adjuvant radiotherapy(8) or chemotherapy(9) in breast cancer. In this study we present data linking specific mutations in the P53 gene to primary resistance to doxorubicin therapy and early relapse in breast cancer patients.	NORWEGIAN RADIUMHOSP,DEPT GENET,N-0310 MONTEBELLO,OSLO,NORWAY; HAUKELAND UNIV HOSP,DEPT ONCOL,N-5021 BERGEN,NORWAY; GADE INST,DEPT SURG,N-5021 BERGEN,NORWAY; GADE INST,DEPT PATHOL,N-5021 BERGEN,NORWAY	University of Bergen; Haukeland University Hospital			Akslen, Lars A./AAG-6097-2021; Akslen, Lars A/C-1202-2017	Akslen, Lars A./0000-0003-2710-9543; Akslen, Lars A/0000-0003-2710-9543; Lonning, Per Eystein/0000-0002-8890-6303				ALLRED DC, 1993, J NATL CANCER I, V85, P200, DOI 10.1093/jnci/85.3.200; ANDERSEN TI, 1995, DIAGN MOL PATHOL, V4, P203, DOI 10.1097/00019606-199509000-00008; BERGH J, 1995, NAT MED, V1, P1029, DOI 10.1038/nm1095-1029; BORRESEN AL, 1995, GENE CHROMOSOME CANC, V14, P71, DOI 10.1002/gcc.2870140113; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; CLAVEL M, 1993, EUR J CANCER, V29A, P598, DOI 10.1016/S0959-8049(05)80161-3; DIXON WJ, 1995, BMDP STATISTICAL SOF; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; GUNDERSEN S, 1994, EUR J CANCER, V30A, P1775, DOI 10.1016/0959-8049(94)00213-O; HAYWARD JL, 1977, BRIT J CANCER, V35, P292, DOI 10.1038/bjc.1977.42; JANSSON T, 1995, J CLIN ONCOL, V13, P2745, DOI 10.1200/JCO.1995.13.11.2745; KERR JFR, 1994, CANCER-AM CANCER SOC, V73, P2013, DOI 10.1002/1097-0142(19940415)73:8<2013::AID-CNCR2820730802>3.0.CO;2-J; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Pocard M, 1996, ONCOGENE, V12, P875; PREUDHOMME C, 1993, LEUKEMIA, V7, P1888; RUSCH V, 1995, CANCER RES, V55, P5038; STAL O, 1995, ACTA ONCOL, V34, P767, DOI 10.3109/02841869509127184	18	654	667	0	46	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUL	1996	2	7					811	814		10.1038/nm0796-811	http://dx.doi.org/10.1038/nm0796-811			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UU680	8673929				2022-12-25	WOS:A1996UU68000039
J	Kono, T; Obata, Y; Yoshimzu, T; Nakahara, T; Carroll, J				Kono, T; Obata, Y; Yoshimzu, T; Nakahara, T; Carroll, J			Epigenetic modifications during oocyte growth correlates with extended parthenogenetic development in the mouse	NATURE GENETICS			English	Letter							DNA METHYLATION; EMBRYOS; EMBRYOGENESIS; GAMETOGENESIS; GENOMES; GENES; EGGS		ST GEORGE HOSP, SCH MED, MRC, EMBRYOL & TERATOL UNIT, LONDON SW17 0RE, ENGLAND	St Georges University London	Kono, T (corresponding author), TOKYO UNIV AGR, NODAI RES INST, SETAGAYA KU, TOKYO 156, JAPAN.			Carroll, John/0000-0001-9644-5861				BALKIER H, 1980, EXP CELL RES, V128, P79; BARTON SC, 1985, J EMBRYOL EXP MORPH, V90, P267; BOSMIKICH A, 1995, MOL REPROD DEV, V41, P84, DOI 10.1002/mrd.1080410113; BRANDEIS M, 1993, EMBO J, V12, P3669, DOI 10.1002/j.1460-2075.1993.tb06041.x; CHAILLET JR, 1991, CELL, V66, P77, DOI 10.1016/0092-8674(91)90140-T; DRISCOLL DJ, 1990, SOMAT CELL MOLEC GEN, V16, P267, DOI 10.1007/BF01233363; EPIG JJ, 1993, ISOLATION CULTURE OO, P77; GUILLEMOT F, 1995, NAT GENET, V9, P235, DOI 10.1038/ng0395-235; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; KONO T, 1993, MOL REPROD DEV, V34, P43, DOI 10.1002/mrd.1080340107; LATHAM KE, 1991, DEVELOPMENT, V113, P561; LAU MMH, 1994, GENE DEV, V8, P2953, DOI 10.1101/gad.8.24.2953; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; MCGRATH J, 1983, SCIENCE, V220, P1330; MONK M, 1988, GENE DEV, V2, P921, DOI 10.1101/gad.2.8.921; NEUMANN B, 1995, NAT GENET, V9, P12, DOI 10.1038/ng0195-12; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; SURANI MA, 1990, DEVELOPMENT, P89; SURANI MAH, 1986, CELL, V45, P127, DOI 10.1016/0092-8674(86)90544-1; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; SURANI MAH, 1987, NATURE, V326, P395, DOI 10.1038/326395a0; SURANI MAH, 1983, SCIENCE, V222, P1034, DOI 10.1126/science.6648518; SZABO PE, IN PRESS DEV; SZABO PE, 1995, GENE DEV, V9, P857; THEILER K, 1989, HOUSE MOUSE; UEDA T, 1992, DEVELOPMENT, V116, P834; Whittingham D G, 1971, J Reprod Fertil Suppl, V14, P7	28	199	209	0	20	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1996	13	1					91	94		10.1038/ng0596-91	http://dx.doi.org/10.1038/ng0596-91			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH430	8673112				2022-12-25	WOS:A1996UH43000022
J	Burke, JR; Enghild, JJ; Martin, ME; Jou, YS; Myers, RM; Roses, AD; Vance, JM; Strittmatter, WJ				Burke, JR; Enghild, JJ; Martin, ME; Jou, YS; Myers, RM; Roses, AD; Vance, JM; Strittmatter, WJ			Huntington and DRPLA proteins selectively interact with the enzyme GAPDH	NATURE MEDICINE			English	Article							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; GLYCOLYTIC-ENZYMES; BINDING PROTEINS; IDENTIFICATION; CELLS	At least five adult-onset neurodegenerative diseases, including Huntington disease (HD), and dentatorubral-pallidoluysian atrophy (DRPLA) are produced by genes containing a variably increased CAG repeat within the coding region(1-4). The size range of the repeats is similar in all diseases; unaffected individuals have fewer than 30 CAG repeats, whereas affected patients usually have more than 40 repeats. The size of the inherited CAG repeat correlates with the severity and age of disease onset(1,5-7). The CAG triplet repeat produces a polyglutamine domain in the expressed proteins(3,8-10). All of these diseases are inherited in a dominant fashion, and a pathologic gain of function in gene carriers has been proposed. We sought to identify proteins in the brain that selectively interact with polyglutamine domain proteins, hypothesizing that the polyglutamine domain may determine protein-protein interactions.	DUKE UNIV, MED CTR, DEPT PATHOL, DURHAM, NC 27710 USA; DUKE UNIV, MED CTR, DEPT NEUROBIOL, DURHAM, NC 27710 USA; DUKE UNIV, MED CTR, DEPT GENET, DURHAM, NC 27710 USA; DUKE UNIV, MED CTR, DEANE LAB, DURHAM, NC 27710 USA; STANFORD UNIV, SCH MED, DEPT GENET, STANFORD, CA 94305 USA	Duke University; Duke University; Duke University; Duke University; Stanford University	Burke, JR (corresponding author), DUKE UNIV, MED CTR, DEPT MED NEUROL, DURHAM, NC 27710 USA.		Jou, Yuh-Shan/O-5921-2018; Burke, James R/E-4245-2016	Jou, Yuh-Shan/0000-0001-5090-3732; Burke, James R/0000-0002-3408-7787; Vance, Jeffery/0000-0003-3815-8199; Enghild, Jan Johannes/0000-0001-9292-9172	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001533, P01NS026630] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 01533, NS 26630] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; BEAL MF, 1992, ANN NEUROL, V31, P119, DOI 10.1002/ana.410310202; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; HOOGEVEEN AT, 1993, HUM MOL GENET, V2, P2069, DOI 10.1093/hmg/2.12.2069; JOU YS, 1995, HUM MOL GENET, V4, P465, DOI 10.1093/hmg/4.3.465; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KNULL HR, 1985, COMP BIOCHEM PHYS B, V81, P349, DOI 10.1016/0305-0491(85)90324-4; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MEJEAN C, 1989, BIOCHEM J, V264, P671, DOI 10.1042/bj2640671; MEYERSIEGLER K, 1991, P NATL ACAD SCI USA, V88, P8460, DOI 10.1073/pnas.88.19.8460; MINASCHEK G, 1992, EUR J CELL BIOL, V58, P418; MORGENEGG G, 1986, J NEUROCHEM, V47, P54; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; NAGAFUCHI S, 1994, NAT GENET, V8, P177, DOI 10.1038/ng1094-177; NAGY E, 1995, J BIOL CHEM, V270, P2755, DOI 10.1074/jbc.270.6.2755; NAKAI A, 1991, BIOCHEM BIOPH RES CO, V176, P59, DOI 10.1016/0006-291X(91)90889-F; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; RANUM LPW, 1994, AM J HUM GENET, V55, P244; RONAI Z, 1993, INT J BIOCHEM, V25, P1073, DOI 10.1016/0020-711X(93)90123-V; SCHULZE H, 1993, J NEUROCHEM, V60, P1915, DOI 10.1111/j.1471-4159.1993.tb13420.x; SERVADIO A, 1995, NAT GENET, V10, P94, DOI 10.1038/ng0595-94; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; SOMERS M, 1990, EUR J BIOCHEM, V193, P437, DOI 10.1111/j.1432-1033.1990.tb19357.x; STOTT K, 1995, P NATL ACAD SCI USA, V92, P6509, DOI 10.1073/pnas.92.14.6509; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; VANTUINEN E, 1987, J HISTOCHEM CYTOCHEM, V35, P327, DOI 10.1177/35.3.3546482; WILLEMS PJ, 1994, NAT GENET, V8, P213, DOI 10.1038/ng1194-213; YAZAWA I, 1995, NAT GENET, V10, P99, DOI 10.1038/ng0595-99; ZENG FY, 1993, INT J BIOCHEM, V25, P1019, DOI 10.1016/0020-711X(93)90116-V; [No title captured]	32	380	394	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	1996	2	3					347	350		10.1038/nm0396-347	http://dx.doi.org/10.1038/nm0396-347			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TY640	8612237				2022-12-25	WOS:A1996TY64000047
J	Dieken, ES; Epner, EM; Fiering, S; Fournier, REK; Groudine, M				Dieken, ES; Epner, EM; Fiering, S; Fournier, REK; Groudine, M			Efficient modification of human chromosomal alleles using recombination-proficient chicken human microcell hybrids	NATURE GENETICS			English	Article							BETA-GLOBIN LOCUS; B-CELL LINES; HOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS; GENE-EXPRESSION; CONTROL REGION; DNA-SEQUENCES; HYBRIDIZATION; ACTIVATION; MUTATIONS	Targeted modification of human chromosomal alleles by homologous recombination is a powerful approach to study gene function, but gene targeting in mammalian cells is an inefficient process. In contrast, gene targeting in a chicken pre-B cell line, DT40, is highly efficient. We have transferred human chromosome 11 into DT40 cells by microcell fusion, and find that the resulting hybrids are recombination-proficient. In these cells, targeting efficiencies into the chicken ovalbumin locus were >90% and into the human beta-globin and Ha-ras loci were 10-15%. These modified human chromosomes can be transferred subsequently to mammalian cells for functional tests. This chromosome shuttle system allows for the efficient homologous modification of human chromosomal genes, and for subsequent phenotypic analyses of the modified alleles in different mammalian cell types.	FRED HUTCHINSON CANC RES CTR, DIV MOLEC MED, SEATTLE, WA 98104 USA; FRED HUTCHINSON CANC RES CTR, DIV BASIC SCI, SEATTLE, WA 98104 USA; UNIV WASHINGTON, SCH MED, DEPT MOLEC BIOTECHNOL, SEATTLE, WA 98195 USA; UNIV WASHINGTON, SCH MED, DEPT RADIAT ONCOL, SEATTLE, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle				Fiering, Steven/0000-0003-0624-974X	NATIONAL CANCER INSTITUTE [R01CA054337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044746, R37DK044746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026449] Funding Source: NIH RePORTER; NCI NIH HHS [CA54337] Funding Source: Medline; NIDDK NIH HHS [DK44746] Funding Source: Medline; NIGMS NIH HHS [GM26449] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALADJEM MI, 1995, SCIENCE, V270, P815, DOI 10.1126/science.270.5237.815; BABA TW, 1985, VIROLOGY, V144, P139, DOI 10.1016/0042-6822(85)90312-5; BARON MH, 1986, CELL, V46, P591, DOI 10.1016/0092-8674(86)90885-8; BAUTISTA D, 1993, J IMMUNOL, V151, P1950; BRANDRIFF B, 1991, GENOMICS, V10, P75, DOI 10.1016/0888-7543(91)90486-X; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CHARRON J, 1990, MOL CELL BIOL, V10, P1799, DOI 10.1128/MCB.10.4.1799; CHEN TR, 1977, EXP CELL RES, V104, P255, DOI 10.1016/0014-4827(77)90089-1; CHOI ORB, 1988, CELL, V55, P17, DOI 10.1016/0092-8674(88)90005-0; DEISSEROTH A, 1978, CELL, V15, P55, DOI 10.1016/0092-8674(78)90082-X; EPNER E, 1992, Current Biology, V2, P262, DOI 10.1016/0960-9822(92)90379-O; FIERING S, 1993, P NATL ACAD SCI USA, V90, P8469, DOI 10.1073/pnas.90.18.8469; FIERING S, IN PRESS GENES DEV; FORRESTER WC, 1990, GENE DEV, V4, P1637, DOI 10.1101/gad.4.10.1637; GEBHARD W, 1983, J MOL BIOL, V170, P567, DOI 10.1016/S0022-2836(83)80161-2; GOURDEAU H, 1990, ANNU REV CELL BIOL, V6, P69, DOI 10.1146/annurev.cb.06.110190.000441; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; KAO FT, 1973, P NATL ACAD SCI USA, V70, P2893, DOI 10.1073/pnas.70.10.2893; KIM CG, 1992, GENE DEV, V6, P928, DOI 10.1101/gad.6.6.928; LAI EC, 1980, P NATL ACAD SCI-BIOL, V77, P244, DOI 10.1073/pnas.77.1.244; LANGSTON AA, 1993, METHODS MOL GENET, V1, P115; LEACH RJ, 1989, GENOMICS, V5, P167, DOI 10.1016/0888-7543(89)90043-8; LI YK, 1992, POULTRY SCI, V71, P151, DOI 10.3382/ps.0710151; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; PAPAYANNOPOULOU T, 1988, SCIENCE, V242, P1056, DOI 10.1126/science.2461587; RAICH N, 1989, J BIOL CHEM, V264, P10186; Ringertz N R, 1974, Int Rev Exp Pathol, V13, P83; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; SAUER B, 1990, New Biologist, V2, P441; SHAPERO MH, 1994, SOMAT CELL MOLEC GEN, V20, P215, DOI 10.1007/BF02254761; SHESELY EG, 1991, P NATL ACAD SCI USA, V88, P4294, DOI 10.1073/pnas.88.10.4294; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STUBBLEFIELD E, 1992, SOMAT CELL MOLEC GEN, V18, P485, DOI 10.1007/BF01232645; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; TAKEDA S, 1992, P NATL ACAD SCI USA, V89, P4023, DOI 10.1073/pnas.89.9.4023; TEREILE H, 1990, NATURE, V348, P649; THEUNE S, 1991, GENOMICS, V9, P511, DOI 10.1016/0888-7543(91)90418-E; TRASK BJ, 1991, AM J HUM GENET, V48, P1; XU LX, 1993, P NATL ACAD SCI USA, V90, P3705, DOI 10.1073/pnas.90.8.3705; YUASA Y, 1983, NATURE, V303, P775, DOI 10.1038/303775a0; ZHEN L, 1993, P NATL ACAD SCI USA, V90, P9832, DOI 10.1073/pnas.90.21.9832	42	80	85	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1996	12	2					174	182		10.1038/ng0296-174	http://dx.doi.org/10.1038/ng0296-174			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TU079	8563756				2022-12-25	WOS:A1996TU07900018
J	Largaespada, DA; Brannan, CI; Jenkins, NA; Copeland, NG				Largaespada, DA; Brannan, CI; Jenkins, NA; Copeland, NG			Nf1 deficiency causes Ras-mediated granulocyte macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia	NATURE GENETICS			English	Article							NEUROFIBROMATOSIS TYPE-1 GENE; BONE-MARROW CELLS; LEUKEMIA; MICE; PROTEIN; GROWTH; NEUROBLASTOMA; INTERLEUKIN-3; ONCOGENES; MUTATIONS	The Ras signal transduction pathway is often deregulated in human myeloid leukaemia. For example, activating point mutations in RAS genes are found in some patients with juvenile chronic myelogenous leukaemia (JCML), while other patients with JCML show loss of the neurofibromatosis type 1 (NF1) gene, a Ras GTPase activating protein. By generating mice whose haematopoietic system is reconsituted with Nf1 deficient haematopoietic stem cells we show that Nf1 gene loss, by itself, is sufficient to produce the myeloproliferative symptoms associated with human JCML. We also provide evidence to indicate that Nf1 gene loss induces myeloproliferative disease through a Ras-mediated hypersensitivity to granulocyte/macrophage-colony stimulating factor (GM-CSF). Finally, we describe a genetic screen for identifying genes that cooperate with Nf1 gene loss during progression to acute myeloid leukaemia.	NCI,FREDERICK CANC RES & DEV CTR,MAMMALIAN GENET LAB,ABL BASIC RES PROGRAM,FREDERICK,MD 21702	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick			Largaespada, David/C-9832-2014					BADER JL, 1978, J PEDIATR-US, V92, P925, DOI 10.1016/S0022-3476(78)80362-X; BADER JL, 1986, ANN NY ACAD SCI, V486, P56; BARBACID M, 1990, EUR J CLIN INVEST, V20, P225, DOI 10.1111/j.1365-2362.1990.tb01848.x; BASU TN, 1992, NATURE, V356, P713, DOI 10.1038/356713a0; BEDIGIAN HG, 1984, J VIROL, V51, P586, DOI 10.1128/JVI.51.3.586-594.1984; BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019; BUCHBERG AM, 1990, MOL CELL BIOL, V10, P4658, DOI 10.1128/MCB.10.9.4658; CASTROMALASPINA H, 1984, CANCER, V54, P675, DOI 10.1002/1097-0142(1984)54:4<675::AID-CNCR2820540415>3.0.CO;2-Q; DECLUE JE, 1992, CELL, V69, P265, DOI 10.1016/0092-8674(92)90407-4; DUNN AR, 1985, BIOL CHARACTERIZATIO; EMANUEL PD, 1991, BLOOD, V77, P925; GONDA TJ, 1993, BLOOD, V82, P2813; GONDA TJ, 1991, SEMINARS VIROLOGY, V2, P351; GUTMANN DH, 1993, NEURON, V10, P335, DOI 10.1016/0896-6273(93)90324-K; HESTDAL K, 1991, J IMMUNOL, V147, P22; Hope D G, 1981, Adv Neurol, V29, P33; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; JANSSEN JWG, 1987, P NATL ACAD SCI USA, V84, P9228, DOI 10.1073/pnas.84.24.9228; JENKINS NA, 1982, J VIROL, V42, P379, DOI 10.1128/JVI.42.2.379-388.1982; JOHNSON GR, 1989, EMBO J, V8, P441, DOI 10.1002/j.1460-2075.1989.tb03396.x; JOHNSON MR, 1993, P NATL ACAD SCI USA, V90, P5539, DOI 10.1073/pnas.90.12.5539; JOHNSON MR, 1994, MOL CELL BIOL, V14, P641, DOI 10.1128/MCB.14.1.641; KAIRA R, 1994, BLOOD, V84, P3435; LANG RA, 1987, CELL, V51, P675, DOI 10.1016/0092-8674(87)90136-X; LARGAESPADA DA, 1995, J VIROL, V69, P5095, DOI 10.1128/JVI.69.8.5095-5102.1995; MIYAJIMA A, 1993, BLOOD, V82, P1960; MOORE MAS, 1970, J CELL PHYSIOL, V75, P181, DOI 10.1002/jcp.1040750207; PENDERGAST AM, 1993, CELL, V75, P175, DOI 10.1016/S0092-8674(05)80094-7; PETERS G, 1990, CELL GROWTH DIFFER, V1, P503; PUIL L, 1994, EMBO J, V13, P764, DOI 10.1002/j.1460-2075.1994.tb06319.x; Riccardi V. M., 1992, NEUROFIBROMATOSIS PH; SATOH T, 1991, P NATL ACAD SCI USA, V88, P3314, DOI 10.1073/pnas.88.8.3314; SHANNON KM, 1994, NEW ENGL J MED, V330, P597, DOI 10.1056/NEJM199403033300903; THE I, 1993, NAT GENET, V3, P62, DOI 10.1038/ng0193-62; VONLOHUIZEN M, 1990, BIOCHIM BIOPHYS ACTA, V1032, P213	35	245	249	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1996	12	2					137	143		10.1038/ng0296-137	http://dx.doi.org/10.1038/ng0296-137			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TU079	8563750				2022-12-25	WOS:A1996TU07900012
J	Galli, J; Li, LS; Glaser, A; Ostenson, CG; Jiao, H; FakhraiRad, H; Jacob, HJ; Lander, ES; Luthman, H				Galli, J; Li, LS; Glaser, A; Ostenson, CG; Jiao, H; FakhraiRad, H; Jacob, HJ; Lander, ES; Luthman, H			Genetic analysis of non-insulin dependent diabetes mellitus in the GK rat	NATURE GENETICS			English	Article							IMPAIRED GLUCOSE-TOLERANCE; EXPRESSION; HISTORY; REGION; CELLS	Non-insulin dependent diabetes mellitus (NIDDM) is a major public health problem, but its aetiology remains poorly understood. We have performed a comprehensive study of the genetic basis of diabetes in the Goto-Kakizaki (GK) rat, the most widely used animal model of non-obese NIDDM. The genetic dissection of NIDDM using this model has allowed us to map three independent loci involved in the disease. In addition, we identify a major factor affecting body weight, but not glucose tolerance, on chromosome 7 and map a further 10 regions that are suggestive for linkage. We conclude that NIDDM is polygenic and fasting hyperglycaemia and postprandial hyperglycaemia clearly have distinct genetic bases.	KAROLINSKA HOSP,DEPT MOLEC MED,ROLF LUFT CTR DIABET RES,S-17176 STOCKHOLM,SWEDEN; MASSACHUSETTS GEN HOSP,CARDIOVASC RES CTR,BOSTON,MA 02129; WHITEHEAD INST BIOMED RES,CAMBRIDGE,MA 02142; MIT,DEPT BIOL,CAMBRIDGE,MA 02139	Karolinska Institutet; Karolinska University Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)								ABDELHALIM SM, 1994, DIABETES, V43, P281, DOI 10.2337/diabetes.43.2.281; ALCOLADO JC, 1991, BRIT MED J, V302, P1178, DOI 10.1136/bmj.302.6786.1178; ALPERT S, 1988, CELL, V53, P295, DOI 10.1016/0092-8674(88)90391-1; BENNETT PH, 1990, DIABETES MELLITUS TH, P357; BISBIS S, 1993, AM J PHYSIOL, V265, pE807, DOI 10.1152/ajpendo.1993.265.5.E807; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DORNER G, 1987, EXP CLIN ENDOCRINOL, V89, P84; GAUGUIER D, 1994, DIABETES, V43, P220, DOI 10.2337/diabetes.43.2.220; GERMAN MS, 1994, MOL CELL BIOL, V14, P4067, DOI 10.1128/MCB.14.6.4067; GOTO Y, 1975, P JPN ACAD, V51, P80, DOI 10.2183/pjab1945.51.80; HARLAN LC, 1987, AM J EPIDEMIOL, V126, P674, DOI 10.1093/oxfordjournals.aje.a114707; HUGHES SJ, 1994, DIABETOLOGIA, V37, P863, DOI 10.1007/s001250050189; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; JACOB HJ, 1995, NAT GENET, V9, P63, DOI 10.1038/ng0195-63; KARLSSON O, 1987, P NATL ACAD SCI USA, V84, P8819, DOI 10.1073/pnas.84.24.8819; LAKSHMIKUMARAN MS, 1985, MOL CELL BIOL, V5, P2197, DOI 10.1128/MCB.5.9.2197; LANDER ES, 1989, GENETICS, V121, P185; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LILLIOJA S, 1988, NEW ENGL J MED, V318, P1217, DOI 10.1056/NEJM198805123181901; MARTIN AO, 1985, AM J OBSTET GYNECOL, V151, P471, DOI 10.1016/0002-9378(85)90272-8; MITCHELL BD, 1995, DIABETOLOGIA, V38, P314, DOI 10.1007/BF00400636; MITCHELL BD, 1993, DIABETES CARE, V16, P1262, DOI 10.2337/diacare.16.9.1262; MITRAKOU A, 1992, NEW ENGL J MED, V326, P22, DOI 10.1056/NEJM199201023260104; NORGREN S, 1994, P NATL ACAD SCI USA, V91, P1465, DOI 10.1073/pnas.91.4.1465; OSTENSON CG, 1993, DIABETOLOGIA, V36, P3, DOI 10.1007/BF00399086; PORTHA B, 1991, DIABETES, V40, P486, DOI 10.2337/diabetes.40.4.486; ROSSETTI L, 1990, DIABETES CARE, V13, P610, DOI 10.2337/diacare.13.6.610; SUZUKI KI, 1992, LESSONS ANIMAL DIABE, P107; THOMAS F, 1994, DIABETES, V43, P63, DOI 10.2337/diabetes.43.1.63; VILLARPALASI C, 1994, DIABETOLOGIA, V37, P885; WALKER MD, 1983, NATURE, V306, P557, DOI 10.1038/306557a0; WEDELL A, 1992, P NATL ACAD SCI USA, V89, P7232, DOI 10.1073/pnas.89.15.7232; Wright S., 1968, EVOLUTION GENETICS P, V1; 1994, WHO TECH REP SER, V844	34	232	234	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1996	12	1					31	37		10.1038/ng0196-31	http://dx.doi.org/10.1038/ng0196-31			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TM555	8528247				2022-12-25	WOS:A1996TM55500011
J	BANFI, S; SERVADIO, A; CHUNG, MY; KWIATKOWSKI, TJ; MCCALL, AE; DUVICK, LA; SHEN, Y; ROTH, EJ; ORR, HT; ZOGHBI, HY				BANFI, S; SERVADIO, A; CHUNG, MY; KWIATKOWSKI, TJ; MCCALL, AE; DUVICK, LA; SHEN, Y; ROTH, EJ; ORR, HT; ZOGHBI, HY			IDENTIFICATION AND CHARACTERIZATION OF THE GENE CAUSING TYPE-1 SPINOCEREBELLAR ATAXIA	NATURE GENETICS			English	Article							ANDROGEN RECEPTOR GENE; MESSENGER-RNA; UNTRANSLATED REGION; MYOTONIC-DYSTROPHY; EXPRESSION; LINKAGE; HLA; TRANSCRIPTS; MUTATIONS; KINDREDS	Spinocerebellar ataxia type 1 (SCA1) is a neurodegenerative disorder caused by expansion of a CAG trinucleotide repeat. In this study, we describe the identification and characterization of the gene harbouring this repeat. The SCA1 transcript is 10,660 bases and is transcribed from both the wild type and SCA1 alleles. The CAG repeat, coding for a polyglutamine tract, lies within the coding region. The gene spans 450 kb of genomic DNA and is organized in nine exons. The first seven fall in the 5' untranslated region and the last two contain the coding region, and a 7,277 basepairs 3' untranslated region. The first four non-coding exons undergo alternative splicing in several tissues. These features suggest that the transcriptional and translational regulation of ataxin-1, the SCA1 encoded protein, may be complex.	BAYLOR COLL MED, DEPT PEDIAT, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT HUMAN GENET, HOUSTON, TX 77030 USA; UNIV MINNESOTA, INST HUMAN GENET, DEPT LAB MED & PATHOL, MINNEAPOLIS, MN 55455 USA; UNIV MINNESOTA, INST HUMAN GENET, DEPT BIOCHEM, MINNEAPOLIS, MN 55455 USA	Baylor College of Medicine; Baylor College of Medicine; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities			Banfi, Sandro/K-3963-2018	Banfi, Sandro/0000-0002-6541-8833; Chung, Ming-yi/0000-0003-2198-6860; Zoghbi, Huda/0000-0002-0700-3349; Orr, Harry/0000-0001-6118-741X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027699, R01NS022920, R37NS022920] Funding Source: NIH RePORTER; NINDS NIH HHS [NS27699, NS22920] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS MD, 1993, NAT GENET, V4, P256, DOI 10.1038/ng0793-256; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BANFI S, 1993, GENOMICS, V18, P627, DOI 10.1016/S0888-7543(05)80365-9; BANKIER AT, 1987, METHOD ENZYMOL, V155, P51; CRIPE LD, 1992, BIOCHEMISTRY-US, V31, P3777, DOI 10.1021/bi00130a007; CURRIER RD, 1972, NEUROLOGY, V22, P1040, DOI 10.1212/WNL.22.9.1040; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; Frohman MA, 1990, PCR PROTOCOLS GUIDE; FU YH, 1993, SCIENCE, V260, P235, DOI 10.1126/science.8469976; GIBBS RA, 1989, P NATL ACAD SCI USA, V86, P1919, DOI 10.1073/pnas.86.6.1919; Greenfield JG, 1954, SPINOCEREBELLAR DEGE; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; HAINES JL, 1984, NEUROLOGY, V34, P1542, DOI 10.1212/WNL.34.12.1542; JACKSON JF, 1977, NEW ENGL J MED, V296, P1138, DOI 10.1056/NEJM197705192962003; JODICE C, 1994, AM J HUM GENET, V54, P959; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KWIATKOWSKI TJ, 1993, AM J HUM GENET, V53, P391; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LIN BY, 1993, HUM MOL GENET, V2, P1541, DOI 10.1093/hmg/2.10.1541; LINK DC, 1992, ONCOGENE, V7, P877; LUDWIG EH, 1987, DNA-J MOLEC CELL BIO, V6, P363, DOI 10.1089/dna.1987.6.363; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; MATILLA T, 1993, HUM MOL GENET, V2, P2123, DOI 10.1093/hmg/2.12.2123; MYERS RL, 1993, ONCOGENE, V8, P341; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; QUIGLEY CA, 1992, J CLIN ENDOCR METAB, V74, P927, DOI 10.1210/jc.74.4.927; RANUM LPW, 1994, AM J HUM GENET, V55, P244; RANUM LPW, 1991, AM J HUM GENET, V49, P31; RASTINEJAD F, 1993, CELL, V75, P1107, DOI 10.1016/0092-8674(93)90320-P; SABOURI LA, 1993, NAT GENET, V4, P233, DOI 10.1038/ng0793-233; SCHUT JW, 1950, ARCH NEURO PSYCHIATR, V63, P535, DOI 10.1001/archneurpsyc.1950.02310220002001; SEALEY PG, 1985, NUCLEIC ACIDS RES, V13, P1905, DOI 10.1093/nar/13.6.1905; TILLEY WD, 1990, J BIOL CHEM, V265, P13776; TRIFIRO M, 1991, MOL CELL ENDOCRINOL, V75, P37, DOI 10.1016/0303-7207(91)90243-L; WAPENAAR MC, 1993, HUM MOL GENET, V2, P947, DOI 10.1093/hmg/2.7.947; ZOGHBI HY, 1988, AM J HUM GENET, V42, P877; ZOGHBI HY, 1988, ANN NEUROL, V23, P580, DOI 10.1002/ana.410230609; ZOGHBI HY, 1991, AM J HUM GENET, V49, P23; ZOGHBI HY, 1991, CURRENT NEUROLOGY, P121	43	300	311	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1994	7	4					513	520		10.1038/ng0894-513	http://dx.doi.org/10.1038/ng0894-513			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PA832	7951322				2022-12-25	WOS:A1994PA83200019
J	GLASER, B; CHIU, KC; ANKER, R; NESTOROWICZ, A; LANDAU, H; BENBASSAT, H; SHLOMAI, Z; KAISER, N; THORNTON, PS; STANLEY, CA; SPIELMAN, RS; GOGOLINEWENS, K; CERASI, E; BAKER, L; RICE, J; DONISKELLER, H; PERMUTT, MA				GLASER, B; CHIU, KC; ANKER, R; NESTOROWICZ, A; LANDAU, H; BENBASSAT, H; SHLOMAI, Z; KAISER, N; THORNTON, PS; STANLEY, CA; SPIELMAN, RS; GOGOLINEWENS, K; CERASI, E; BAKER, L; RICE, J; DONISKELLER, H; PERMUTT, MA			FAMILIAL HYPERINSULINISM MAPS TO CHROMOSOME-11P14-15.1, 30 CM CENTROMERIC TO THE INSULIN GENE	NATURE GENETICS			English	Article							BECKWITH-WIEDEMANN SYNDROME; PERSISTENT NEONATAL HYPOGLYCEMIA; AUTOSOMAL RECESSIVE INHERITANCE; DEPENDENT DIABETES-MELLITUS; REPEAT POLYMORPHISMS; DNA POLYMORPHISM; NESIDIOBLASTOSIS; LOCALIZATION; INFANCY; LINKAGE	Familial hyperinsulinism (HI) is the most common cause of persistent neonatal hyperinsulinaemic hypoglycemia. Linkage analysis in 15 families (12 Ashkenazi Jewish, 2 consanguineous Arab, 1 non-Jewish Caucasian) mapped HI to chromosome 11p-1415.1 (lod score = 9.5, theta = 0 at D11S921). Recombinants localized the disease locus to the 6.6 cM interval between D11S926 and D11S928. In Jewish families, association (p=0.003) with specific D11S921/D11S419 haplotypes suggested a founder effect. This locus, which is important for normal glucose-regulated insulin secretion, represents a candidate gene for studies of other diseases of beta-cell dysfunction including non-insulin-dependent diabetes mellitus (NIDDM).	WASHINGTON UNIV,SCH MED,DEPT INTERNAL MED,DIV ENDOCRINOL DIABET & METAB,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT PSYCHIAT,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT SURG,DIV HUMAN MOLEC GENET,ST LOUIS,MO 63110; HEBREW UNIV JERUSALEM,HADASSAH MED SCH,DEPT ENDOCRINOL & METAB,IL-91010 JERUSALEM,ISRAEL; HEBREW UNIV JERUSALEM,HADASSAH MED SCH,DEPT PEDIAT,IL-91010 JERUSALEM,ISRAEL; HEBREW UNIV JERUSALEM,HADASSAH MED SCH,DEPT EXPTL SURG,IL-91010 JERUSALEM,ISRAEL; CHILDRENS HOSP PHILADELPHIA,DIV ENDOCRINOL DIABET,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT GENET,PHILADELPHIA,PA 19104	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania			Glaser, Benjamin/F-8411-2017	Glaser, Benjamin/0000-0003-4711-5000; STANLEY, CHARLES/0000-0003-4881-9392	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK016746, R01DK016746, T32DK007120, R01DK046618] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK07120, DK16746, DK 46618] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BELL GI, 1991, P NATL ACAD SCI USA, V88, P1484, DOI 10.1073/pnas.88.4.1484; BIANCHI C, 1992, ACTA PAEDIATR, V81, P853, DOI 10.1111/j.1651-2227.1992.tb12121.x; BRUINING G J, 1990, Current Opinion in Pediatrics, V2, P758, DOI 10.1097/00008480-199008000-00024; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; DEVIJLDER JJM, 1988, CYTOGENET CELL GENET, V47, P170, DOI 10.1159/000132538; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; GAENSLER KML, 1991, GENOMICS, V10, P976, DOI 10.1016/0888-7543(91)90188-K; GLASER B, 1990, AM J MED GENET, V37, P511, DOI 10.1002/ajmg.1320370416; GLASER B, 1993, J PEDIATR-US, V123, P644, DOI 10.1016/S0022-3476(05)80970-9; GREEN AA, 1981, ARCH DIS CHILD, V56, P496; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; KAISER N, 1990, DIABETOLOGIA, V33, P482, DOI 10.1007/BF00405110; KEITH TP, 1992, SCIENCE, V258, P67; KOUFOS A, 1989, AM J HUM GENET, V44, P711; LANDAU H, 1982, PEDIATRICS, V70, P440; LANDAU H, 1991, PEDIATRIC SURGERY LI, P187; LITT M, 1993, HUM MOL GENET, V2, P909, DOI 10.1093/hmg/2.7.909; MATHEW PM, 1988, CLIN PEDIATR, V27, P148, DOI 10.1177/000992288802700307; MATSUTANI A, 1992, GENOMICS, V12, P319, DOI 10.1016/0888-7543(92)90380-B; MATSUTANI A, 1992, GENOMICS, V13, P495, DOI 10.1016/0888-7543(92)90116-A; MORRIS CM, 1989, BLOOD, V74, P1768; ORAHILLY S, 1988, DIABETOLOGIA, V31, P407, DOI 10.1007/BF00271584; PING AJ, 1989, AM J HUM GENET, V44, P720; RAHIER J, 1984, DIABETOLOGIA, V26, P282; Stanley C A, 1976, Adv Pediatr, V23, P315; STOFFEL M, 1993, DIABETES, V42, P1215, DOI 10.2337/diabetes.42.8.1215; TANIGAMI A, 1992, AM J HUM GENET, V50, P56; TANIZAWA Y, IN PRESS DIABETES; THORNTON PS, 1991, J PEDIATR-US, V119, P721, DOI 10.1016/S0022-3476(05)80286-0; THORNTON PS, 1993, J PEDIATR-US, V123, P637, DOI 10.1016/S0022-3476(05)80969-2; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4036, DOI 10.1093/nar/18.13.4036; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143; WEKSBERG R, 1990, GENOMICS, V8, P693, DOI 10.1016/0888-7543(90)90256-T; WOOLF DA, 1991, ARCH DIS CHILD, V66, P529, DOI 10.1136/adc.66.4.529	34	111	114	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1994	7	2					185	188		10.1038/ng0694-185	http://dx.doi.org/10.1038/ng0694-185			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NQ037	7920639				2022-12-25	WOS:A1994NQ03700020
J	WATANABE, H; KIMATA, K; LINE, S; STRONG, D; GAO, LY; KOZAK, CA; YAMADA, Y				WATANABE, H; KIMATA, K; LINE, S; STRONG, D; GAO, LY; KOZAK, CA; YAMADA, Y			MOUSE CARTILAGE MATRIX DEFICIENCY (CMD) CAUSED BY A 7 BP DELETION IN THE AGGRECAN GENE	NATURE GENETICS			English	Article							PROTEOGLYCAN CORE PROTEIN; STICKLER SYNDROME ARTHROOPHTHALMOPATHY; STOP CODON; CHONDROCYTES; NANOMELIA; IDENTIFICATION; SYNTHESIZE; MUTATION; RECEPTOR; ABSENCE	Mouse cartilage matrix deficiency (cmd) is an autosomal recessive mutation characterized by cleft palate, short limbs, tail and snout. Heterozygous mice show normal size and phenotype, while homozygous mice die just after birth due to respiratory failure. Biochemical and immunohistochemical characterization of cmd cartilage reveals normal levels of type II collagen and link protein, but an absence of the large cartilage proteoglycan, aggrecan. Here, we have mapped the aggrecan gene to a region of mouse chromosome 7 near the cmd locus. DNA sequencing of the aggrecan gene identified a 7 bp deletion in exon 5 resulting in a severely truncated molecule. The finding of an aggrecan mutation in the cmd mouse confirms the critical role of aggrecan in cartilage formation.	NIAID,MOLEC MICROBIOL LAB,BETHESDA,MD 20892; AICHI MED UNIV,INST MOLEC SCI MED,NAGAKUTE,AICHI 48011,JAPAN	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Aichi Medical University	WATANABE, H (corresponding author), NIDR,DEV BIOL LAB,BETHESDA,MD 20892, USA.		Line, Sergio/H-5272-2012	Line, Sergio/0000-0002-6574-9464				ADAMSON MC, 1991, VIROLOGY, V183, P778, DOI 10.1016/0042-6822(91)91010-E; AHMAD NN, 1991, P NATL ACAD SCI USA, V88, P6624, DOI 10.1073/pnas.88.15.6624; AHMAD NN, 1993, AM J HUM GENET, V52, P39; ARGRAVES WS, 1981, FEBS LETT, V131, P265, DOI 10.1016/0014-5793(81)80381-X; DANCIGER M, 1993, GENOMICS, V16, P361, DOI 10.1006/geno.1993.1198; DOEGE K, 1987, J BIOL CHEM, V262, P17757; DOEGE K, 1990, EXTRACELLULAR MATRIX, P137; DOEGE KJ, 1991, J BIOL CHEM, V266, P894; FINKELSTEIN JE, 1991, AM J HUM GENET, V48, P97; FRANCOMANO C A, 1987, Genomics, V1, P293, DOI 10.1016/0888-7543(87)90027-9; Green EL, 1981, GENETICS PROBABILITY, P77; HARDINGHAM TE, 1992, FASEB J, V6, P861, DOI 10.1096/fasebj.6.3.1740236; KIMATA K, 1981, J BIOL CHEM, V256, P6961; KIMATA K, 1983, ARCH BIOCHEM BIOPHYS, V226, P506, DOI 10.1016/0003-9861(83)90320-X; KOCHHAR DM, 1985, PREVENTION PHYSICAL, P131; KOZAK CA, 1990, GENOMICS, V8, P519, DOI 10.1016/0888-7543(90)90039-W; LEE B, 1989, SCIENCE, V244, P978, DOI 10.1126/science.2543071; LI H, 1993, J BIOL CHEM, V268, P23504; MCKUSIK VA, 1992, MENDELIAN INHERITANC, P1176; ODONNELL CM, 1988, J BIOL CHEM, V263, P17749; PAROTIE A, 1989, LANCET, V1, P924; RITTENHOUSE E, 1978, J EMBRYOL EXP MORPH, V43, P71; Sambrook J, 1989, MOL CLONING LABORATO; STIRPE NS, 1987, DEV BIOL, V124, P77, DOI 10.1016/0012-1606(87)90461-1; STOLL J, 1990, GENOMICS, V7, P88, DOI 10.1016/0888-7543(90)90522-V; TAKEDA M, 1986, J CELL BIOL, V103, P1605, DOI 10.1083/jcb.103.4.1605; VANDENBERG P, 1993, BIOCHEM MED METAB B, V49, P1, DOI 10.1006/bmmb.1993.1001	27	198	205	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1994	7	2					154	157		10.1038/ng0694-154	http://dx.doi.org/10.1038/ng0694-154			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NQ037	7920633				2022-12-25	WOS:A1994NQ03700014
J	GEISSLER, WM; DAVIS, DL; WU, L; BRADSHAW, KD; PATEL, S; MENDONCA, BB; ELLISTON, KO; WILSON, JD; RUSSELL, DW; ANDERSSON, S				GEISSLER, WM; DAVIS, DL; WU, L; BRADSHAW, KD; PATEL, S; MENDONCA, BB; ELLISTON, KO; WILSON, JD; RUSSELL, DW; ANDERSSON, S			MALE PSEUDOHERMAPHRODITISM CAUSED BY MUTATIONS OF TESTICULAR 17-BETA-HYDROXYSTEROID DEHYDROGENASE-3	NATURE GENETICS			English	Article							HUMAN-PLACENTA; DIFFERENTIATION; DEFICIENCY; SEQUENCE	Defects in the conversion of androstenedione to testosterone in the fetal testes by the enzyme 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD) give rise to genetic males with female external genitalia. We have used expression cloning to isolate cDNAs encoding a microsomal 17 beta-HSD type 3 isozyme that shares 23% sequence identity with other 17 beta-HSD enzymes, uses NADPH as a cofactor, and is expressed predominantly in the testes. The 17 beta HSD3 gene on chromosome 9q22 contains 11 exons. Four substitution and two splice junction mutations were identified in the 17 beta HSD3 genes of five unrelated male pseudohermaphrodites. The substitution mutations severely compromised the activity of the 17 beta-HSD type 3 isozyme.	UNIV TEXAS,SW MED CTR,DEPT MOLEC GENET,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT OBSTET & GYNECOL,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT INTERNAL MED,DALLAS,TX 75235; MERCK & CO INC,MERCK SHARP & DOHME RES LABS,DEPT BIOCHEM,RAHWAY,NJ 07065; MERCK & CO INC,MERCK SHARP & DOHME RES LABS,DEPT BIOL DATA,RAHWAY,NJ 07065; UNIV SAO PAULO,DEPT MED,SAO PAULO,SP,BRAZIL	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Merck & Company; Merck & Company; Universidade de Sao Paulo			Mendonca, Berenice B/J-6917-2015; Mendonca, Berenice B/C-2827-2012; Mendonca, Berenice/AAS-3742-2021	Mendonca, Berenice B/0000-0003-1762-1084; Mendonca, Berenice/0000-0003-1762-1084; Elliston, Keith/0000-0002-9110-9233; Russell, David/0000-0002-0277-403X				AKESODE FA, 1977, CLIN ENDOCRINOL, V7, P443, DOI 10.1111/j.1365-2265.1977.tb01336.x; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; ANDERSSON S, 1991, NATURE, V354, P159, DOI 10.1038/354159a0; BAIROCH A, 1992, NUCLEIC ACIDS RES, V20, P2013, DOI 10.1093/nar/20.suppl.2013; ECKSTEIN B, 1989, J CLIN ENDOCR METAB, V68, P477, DOI 10.1210/jcem-68-2-477; GRIFFIN JE, IN PRESS METABOLIC B; Grumbach M. M., 1992, WILLIAMS TXB ENDOCRI, P853; INANO H, 1977, J STEROID BIOCHEM, V8, P787; INANO H, 1980, STEROID BIOCH, V13, P287; JOST A, 1970, PHILOS T ROY SOC B, V259, P119, DOI 10.1098/rstb.1970.0052; KOHN G, 1985, J PEDIATR ENDOCRINOL, V1, P30; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KROZOWSKI Z, 1992, MOL CELL ENDOCRINOL, V84, pC25, DOI 10.1016/0303-7207(92)90064-D; LEE MM, 1993, ENDOCR REV, V14, P152, DOI 10.1210/er.14.2.152; LIN SX, 1992, J BIOL CHEM, V267, P16182; LUU-THE V, 1990, Molecular Endocrinology, V4, P268; MARTEL C, 1992, J STEROID BIOCHEM, V41, P597, DOI 10.1016/0960-0760(92)90390-5; NEW MI, 1989, METABOLIC BASIS INHE, P1881; PELTOKETO H, 1988, FEBS LETT, V239, P73, DOI 10.1016/0014-5793(88)80548-9; POUTANEN M, 1993, ENDOCRINOLOGY, V133, P2639, DOI 10.1210/en.133.6.2639; Sambrook J, 1989, MOL CLONING LABORATO; THE VL, 1989, MOL ENDOCRINOL, V3, P1301, DOI 10.1210/mend-3-8-1301; THIGPEN AE, 1992, J CLIN INVEST, V90, P799, DOI 10.1172/JCI115954; TIGHPEN AE, 1993, J CLIN INVEST, V92, P903; WILSON JD, 1993, ENDOCR REV, V14, P577, DOI 10.1210/er.14.5.577; WILSON JD, 1978, ANNU REV PHYSIOL, V40, P279, DOI 10.1146/annurev.ph.40.030178.001431; WU L, 1993, J BIOL CHEM, V268, P12964	27	466	499	0	11	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1994	7	1					34	39		10.1038/ng0594-34	http://dx.doi.org/10.1038/ng0594-34			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NJ842	8075637				2022-12-25	WOS:A1994NJ84200010
J	NAGAFUCHI, S; YANAGISAWA, H; SATO, K; SHIRAYAMA, T; OHSAKI, E; BUNDO, M; TAKEDA, T; TADOKORO, K; KONDO, I; MURAYAMA, N; TANAKA, Y; KIKUSHIMA, H; UMINO, K; KUROSAWA, H; FURUKAWA, T; NIHEI, K; INOUE, T; SANO, A; KOMURE, O; TAKAHASHI, M; YOSHIZAWA, T; KANAZAWA, I; YAMADA, M				NAGAFUCHI, S; YANAGISAWA, H; SATO, K; SHIRAYAMA, T; OHSAKI, E; BUNDO, M; TAKEDA, T; TADOKORO, K; KONDO, I; MURAYAMA, N; TANAKA, Y; KIKUSHIMA, H; UMINO, K; KUROSAWA, H; FURUKAWA, T; NIHEI, K; INOUE, T; SANO, A; KOMURE, O; TAKAHASHI, M; YOSHIZAWA, T; KANAZAWA, I; YAMADA, M			DENTATORUBRAL AND PALLIDOLUYSIAN ATROPHY EXPANSION OF AN UNSTABLE CAG TRINUCLEOTIDE ON CHROMOSOME-12P	NATURE GENETICS			English	Article							BULBAR MUSCULAR-ATROPHY; MYOTONIC-DYSTROPHY; CTG REPEAT; GENE; REGION; DNA; FRAGMENT	Dentatorubral and pallidoluysian atrophy (DRPLA) is an autosomal dominant neurodegenerative disorder characterized by combined systemic degeneration of the dentatofugal and pallidofugal pathways. We investigated a candidate gene and found that DRPLA patients had an expanded CAG trinucleotide repeat in a gene on the short arm of chromosome 12. The repeat size varied from 7-23 in normal individuals. In patients one allele was expanded to between 49-75 repeats or occasionally even more. Expansion was usually associated with paternal transmission and only occasionally with maternal transmission. Repeat size showed a close correlation with age of onset of symptoms and disease severity. We conclude that DRPLA is the seventh genetic disorder known to be associated with expansion of an unstable trinucleotide repeat.	NATL CHILDRENS MED RES CTR,3-35-31 TAISHIDO,SETAGAYA KU,TOKYO 154,JAPAN; NIHON UNIV,NUCLE ACID SCI LAB,FUHISAWA 252,JAPAN; EHIME UNIV,SCH MED,DEPT HYG,SHIGENOBU,EHIME 79102,JAPAN; EHIME UNIV,SCH MED,DEPT NEUROPSYCHIAT,SHIGENOBU,EHIME 79102,JAPAN; DOKKYO UNIV,SCH MED,DEPT PEDIAT 2,MIBU,TOCHIGI 32102,JAPAN; NATL CHILDRENS HOSP,TOKYO 154,JAPAN; KOBE UNIV,SCH MED,DEPT NEUROL & PSYCHIAT,KOBE 650,JAPAN; KOCHI UNIV,DEPT NEUROPSYCHIAT,NANKOKU,KOCHI 783,JAPAN; UNIV TSUKUBA,INST CLIN MED,DEPT NEUROL,TSUKUBA,IBARAKI 305,JAPAN; UNIV TOKYO,INST BRAIN RES,TOKYO 113,JAPAN	National Center for Child Health & Development - Japan; Nihon University; Ehime University; Ehime University; Dokkyo Medical University; National Center for Child Health & Development - Japan; Kobe University; Kochi University; University of Tsukuba; University of Tokyo				Bundo, Miki/0000-0002-5786-0509; Sano, Akira/0000-0001-5843-9786; Yanagisawa, Hiroko/0000-0002-6917-5218				ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; KONDO I, 1990, J MED GENET, V27, P105, DOI 10.1136/jmg.27.2.105; KUROSAWA H, 1987, ONCOGENE, V2, P85; LASPADA AR, 1992, NAT GENET, V2, P301, DOI 10.1038/ng1292-301; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LI SH, 1993, GENOMICS, V16, P572, DOI 10.1006/geno.1993.1232; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; NAITO H, 1982, NEUROLOGY, V32, P798, DOI 10.1212/WNL.32.8.798; NEUMANN MA, 1959, NEUROLOGY, V9, P430, DOI 10.1212/WNL.9.6.430; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PHILLIPS SC, 1992, GENE, V116, P181, DOI 10.1016/0378-1119(92)90514-P; RIGGINS GJ, 1992, NAT GENET, V2, P186, DOI 10.1038/ng1192-186; Sambrook J, 1989, MOL CLONING LABORATO; SMITH JK, 1958, NEUROLOGY, V8, P205, DOI 10.1212/WNL.8.3.205; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; TADOKORO K, 1992, ONCOGENE, V7, P1215; TADOKORO K, 1991, NUCLEIC ACIDS RES, V19, P6967, DOI 10.1093/nar/19.24.6967; TAKAHASHI H, 1988, NEUROLOGY, V38, P1065, DOI 10.1212/WNL.38.7.1065; TAKIGUCHI Y, 1992, DOKKYO MED J, V7, P283; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179; 1993, CELL, V72, P971	31	682	692	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1994	6	1					14	18		10.1038/ng0194-14	http://dx.doi.org/10.1038/ng0194-14			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ177	8136826				2022-12-25	WOS:A1994MQ17700007
J	WATANABE, M; ZINN, AR; PAGE, DC; NISHIMOTO, T				WATANABE, M; ZINN, AR; PAGE, DC; NISHIMOTO, T			FUNCTIONAL EQUIVALENCE OF HUMAN X-ENCODED AND Y-ENCODED ISOFORMS OF RIBOSOMAL PROTEIN-S4 CONSISTENT WITH A ROLE IN TURNER SYNDROME	NATURE GENETICS			English	Article							UBIQUITIN-ACTIVATING ENZYME-E1; TEMPERATURE-SENSITIVE MUTANTS; BHK-CELLS; GENE; CHROMOSOME; INACTIVATION; EXPRESSION; CLONING; REGION	Several genes are found on both the human X and Y chromosomes in regions that do not recombine during male meiosis. In each case, nucleotide sequence analysis suggests that these X-Y gene pairs encode similar but nonidentical proteins. Here we show that the human Y- and X-encoded ribosomal proteins, RPS4Y and RPS4X, are interchangeable and provide an essential function: either protein rescued a mutant hamster cell line that was otherwise incapable of growth at modestly elevated temperatures. These findings are consistent with the hypothesis that RPS4 deficiency has a role in Turner syndrome, a complex human phenotype associated with monosomy X.	WHITEHEAD INST,HOWARD HUGHES RES LABS,CAMBRIDGE,MA 02142; MIT,DEPT BIOL,CAMBRIDGE,MA 02142	HRL Laboratories; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	WATANABE, M (corresponding author), KYUSHU UNIV,GRAD SCH MED SCI,DEPT MOLEC BIOL,FUKUOKA 812,JAPAN.			Zinn, Andrew/0000-0002-4935-3291				ASHWORTH A, 1991, NATURE, V351, P406, DOI 10.1038/351406a0; BALLABIO A, 1989, P NATL ACAD SCI USA, V86, P10001, DOI 10.1073/pnas.86.24.10001; ELLISON J, 1992, SOMAT CELL MOLEC GEN, V18, P259, DOI 10.1007/BF01233862; FERGUSON-SMITH M A, 1965, J Med Genet, V2, P142, DOI 10.1136/jmg.2.2.142; FISHER EMC, 1990, CELL, V63, P1205, DOI 10.1016/0092-8674(90)90416-C; FORD CE, 1959, LANCET, V1, P711; GOODFELLOW PJ, 1986, SCIENCE, V234, P740, DOI 10.1126/science.2877492; GOUGH NM, 1990, NATURE, V345, P734, DOI 10.1038/345734a0; HAMVAS RMJ, 1992, GENOMICS, V12, P363, DOI 10.1016/0888-7543(92)90386-7; HAYAKAWA H, 1990, J MOL BIOL, V213, P739, DOI 10.1016/S0022-2836(05)80260-8; JUST W, 1992, HUM GENET, V89, P240; KAY GF, 1991, NATURE, V354, P486, DOI 10.1038/354486a0; LEVILLIERS J, 1989, P NATL ACAD SCI USA, V86, P2296, DOI 10.1073/pnas.86.7.2296; LIPPE B, 1991, ENDOCRIN METAB CLIN, V20, P121, DOI 10.1016/S0889-8529(18)30284-6; MITCHELL MJ, 1991, NATURE, V354, P483, DOI 10.1038/354483a0; NISHIMOTO T, 1982, SOMAT CELL GENET, V8, P811, DOI 10.1007/BF01543021; NISHIMOTO T, 1978, SOMAT CELL GENET, V4, P323, DOI 10.1007/BF01542846; Ohno S., 1967, SEX CHROMOSOMES SEX; PAGE DC, 1990, NATURE, V346, P279, DOI 10.1038/346279a0; SALIDO EC, 1992, AM J HUM GENET, V50, P303; SCHIEBEL K, 1993, NAT GENET, V3, P82, DOI 10.1038/ng0193-82; SCHNEIDERGADICKE A, 1989, CELL, V57, P1247, DOI 10.1016/0092-8674(89)90061-5; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; SYNETOS D, 1992, J BIOL CHEM, V267, P3008; SZEWCZYK B, 1985, ANAL BIOCHEM, V150, P403, DOI 10.1016/0003-2697(85)90528-7; WATANABE M, 1991, J CELL SCI, V100, P35; WOOL IG, 1990, BIOCHIM BIOPHYS ACTA, V1050, P69, DOI 10.1016/0167-4781(90)90143-P; WOOLFORD JL, 1991, ADV GENET, V29, P63, DOI 10.1016/S0065-2660(08)60107-8; ZINN AR, 1991, GENOMICS, V11, P1097, DOI 10.1016/0888-7543(91)90037-F	29	107	111	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1993	4	3					268	271		10.1038/ng0793-268	http://dx.doi.org/10.1038/ng0793-268			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ842	8358435				2022-12-25	WOS:A1993LJ84200014
J	MCLAUGHLIN, ME; SANDBERG, MA; BERSON, EL; DRYJA, TP				MCLAUGHLIN, ME; SANDBERG, MA; BERSON, EL; DRYJA, TP			RECESSIVE MUTATIONS IN THE GENE ENCODING THE BETA-SUBUNIT OF ROD PHOSPHODIESTERASE IN PATIENTS WITH RETINITIS-PIGMENTOSA	NATURE GENETICS			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; HUMAN RETINAL DEGENERATION; CGMP-PHOSPHODIESTERASE; PHOTORECEPTOR CELLS; GUANOSINE MONOPHOSPHATE; REVEALS SIMILARITIES; RHODOPSIN MUTATIONS; GMP ACCUMULATION; ALPHA-TRANSDUCIN; GAMMA-SUBUNIT	We have found four mutations in the human gene encoding the beta-subunit of rod cGMP phosphodiesterase (PDE beta) that cosegregate with autosomal recessive retinitis pigmentosa, a degenerative disease of photoreceptors. In one family two affected siblings both carry allelic nonsense mutations at codons 298 and 531. Affected individuals have abnormal rod and cone electroretinograms. PDE beta is the second member of the phototransduction cascade besides rhodopsin that is absent or altered as a cause of retinitis pigmentosa, suggesting that other members of this pathway may be defective in other forms of this disease.	HARVARD UNIV,MASSACHUSETTS EYE & EAR INFIRM,SCH MED,BERMAN GUND LAB STUDY RETINAL DEGENERAT,BOSTON,MA 02114; HARVARD UNIV,MASSACHUSETTS EYE & EAR INFIRM,SCH MED,HOWE LAB OPHTHALMOL,BOSTON,MA 02114	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary					NEI NIH HHS [EY00169, EY08683] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008683, R37EY000169, R01EY000169] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANDREASSON SOL, 1988, AM J OPHTHALMOL, V105, P500, DOI 10.1016/0002-9394(88)90241-3; BERSON EL, 1968, ARCH OPHTHALMOL-CHIC, V80, P58; BERSON EL, 1985, AM J OPHTHALMOL, V99, P240, DOI 10.1016/0002-9394(85)90351-4; BOUGHMAN JA, 1980, AM J HUM GENET, V32, P223; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; BUNKER CH, 1984, AM J OPHTHALMOL, V97, P357, DOI 10.1016/0002-9394(84)90636-6; CHARBONNEAU H, 1986, P NATL ACAD SCI USA, V83, P9308, DOI 10.1073/pnas.83.24.9308; CHARBONNEAU H, 1990, P NATL ACAD SCI USA, V87, P288, DOI 10.1073/pnas.87.1.288; COLLINS C, 1992, GENOMICS, V13, P698, DOI 10.1016/0888-7543(92)90144-H; COTRAN PR, 1991, EXP EYE RES, V53, P557, DOI 10.1016/0014-4835(91)90213-X; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; DOSHI M, 1985, EXP EYE RES, V41, P61, DOI 10.1016/0014-4835(85)90094-6; DRYJA TP, 1991, P NATL ACAD SCI USA, V88, P9370, DOI 10.1073/pnas.88.20.9370; FARBER DB, 1976, J CYCLIC NUCL PROT, V2, P139; FARBER DB, 1974, SCIENCE, V186, P449, DOI 10.1126/science.186.4162.449; FARRAR GJ, 1991, NATURE, V354, P478, DOI 10.1038/354478a0; FERRENDELLI JA, 1976, BIOCHEM BIOPH RES CO, V73, P421, DOI 10.1016/0006-291X(76)90724-5; INGLEHEARN CF, 1992, HUM MOL GENET, V1, P41, DOI 10.1093/hmg/1.1.41; KAJIWARA K, 1991, NATURE, V354, P480, DOI 10.1038/354480a0; KAJIWARA K, 1993, NAT GENET, V3, P208, DOI 10.1038/ng0393-208; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KEELER C, 1966, J HERED, V57, P47, DOI 10.1093/oxfordjournals.jhered.a107462; Keeler CE, 1924, P NATL ACAD SCI USA, V10, P329, DOI 10.1073/pnas.10.7.329; Keeler CE, 1926, P NATL ACAD SCI USA, V12, P255, DOI 10.1073/pnas.12.4.255; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LEREA CL, 1989, NEURON, V3, P367, DOI 10.1016/0896-6273(89)90261-4; LI T, 1990, P NATL ACAD SCI USA, V87, P293, DOI 10.1073/pnas.87.1.293; LOLLEY RN, 1977, SCIENCE, V196, P664, DOI 10.1126/science.193183; LORENZ W, 1991, P NATL ACAD SCI USA, V88, P8715, DOI 10.1073/pnas.88.19.8715; NICHOLS BE, 1993, NAT GENET, V3, P202, DOI 10.1038/ng0393-202; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PITTLER SJ, 1990, GENOMICS, V6, P272, DOI 10.1016/0888-7543(90)90567-E; PITTLER SJ, 1992, J BIOL CHEM, V267, P6257; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; RIESS O, 1992, AM J HUM GENET, V51, P755; RIESS O, 1992, NAT GENET, V1, P104, DOI 10.1038/ng0592-104; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; SANDBERG MA, 1990, INVEST OPHTH VIS SCI, V31, P2283; SHEFFIELD VC, 1991, AM J HUM GENET, V49, P699; SHYJAN AW, 1992, NEURON, V9, P727, DOI 10.1016/0896-6273(92)90035-C; SUBER ML, 1993, P NATL ACAD SCI USA, V90, P3968, DOI 10.1073/pnas.90.9.3968; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; TUTEJA N, 1990, GENE, V88, P227, DOI 10.1016/0378-1119(90)90035-P; ULSHAFER RJ, 1980, INVEST OPHTH VIS SCI, V19, P1236; WEBER B, 1991, NUCLEIC ACIDS RES, V19, P6263, DOI 10.1093/nar/19.22.6263; WELLS J, 1993, NAT GENET, V3, P213, DOI 10.1038/ng0393-213; YAMAKI K, 1988, FEBS LETT, V234, P39, DOI 10.1016/0014-5793(88)81298-5; YANDELL DW, 1989, CANCER CEL, V7, P223	48	479	492	0	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1993	4	2					130	134		10.1038/ng0693-130	http://dx.doi.org/10.1038/ng0693-130			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LF816	8394174				2022-12-25	WOS:A1993LF81600010
J	HUI, CC; JOYNER, AL				HUI, CC; JOYNER, AL			A MOUSE MODEL OF GREIG CEPHALOPOLYSYNDACTYLY SYNDROME - THE EXTRA-TOES(J) MUTATION CONTAINS AN INTRAGENIC DELETION OF THE GLI3 GENE	NATURE GENETICS			English	Article							CRANIOFACIAL ANOMALIES; KRUPPEL FAMILY; EXTRA-TOES; TRANSLOCATION; LOCALIZATION; DROSOPHILA; DOMINANT; 7P13; XT	Greig cephalopolysyndactyly syndrome (GCPS) is an autosomal dominant disorder affecting limb and craniofacial development. Recently, the human GLl3 gene has been proposed to be a candidate gene for GCPS. Here we describe the molecular characterization of extra-toes (Xt), which is a mouse model of GCPS. The Xt heterozygotes show craniofacial defects and a polydactyly phenotype similar to GCPS. We show that a deficiency of Gli3 expression in the Xt(J) mutant is due to a deletion within the 3' end of the gene. Furthermore, structures affected in the mouse mutant and human syndrome were found to correlate with expression domains of Gli3 in mouse. These results strongly suggest that the deficiency of GLl3 function leads to GCPS.	UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA	University of Toronto	HUI, CC (corresponding author), MT SINAI HOSP,SAMUEL LUNENFELD RES INST,DIV MOLEC & DEV BIOL,TORONTO M5G 1X5,ONTARIO,CANADA.							Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BARAITSER M, 1983, CLIN GENET, V24, P257; BRUETON L, 1988, AM J MED GENET, V31, P799, DOI 10.1002/ajmg.1320310412; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DRABKIN H, 1989, GENOMICS, V4, P518, DOI 10.1016/0888-7543(89)90275-9; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; FRYNS JP, 1977, EUR J PEDIATR, V126, P283, DOI 10.1007/BF00477055; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; GOLLOP TR, 1985, AM J MED GENET, V22, P59, DOI 10.1002/ajmg.1320220106; GREIG DAVID M., 1926, EDINBURGH MED JOUR, V33, P189; GRUSS P, 1992, CELL, V69, P719, DOI 10.1016/0092-8674(92)90281-G; HAYASAKA I, 1980, EXP ANIM, V29, P391; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Hinchliffe J. R., 1980, DEV VERTEBRATE LIMB; HOOTNICK D, 1972, CLIN GENET, V3, P128; HUNTER CP, 1990, CELL, V63, P1193, DOI 10.1016/0092-8674(90)90415-B; JOHNSON DR, 1969, GENET RES, V13, P275, DOI 10.1017/S0016672300002962; JOHNSON DR, 1967, J EMBRYOL EXP MORPH, V3, P543; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; JOYNER AL, 1985, CELL, V43, P29, DOI 10.1016/0092-8674(85)90009-1; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; KINZLER KW, 1988, NATURE, V332, P371, DOI 10.1038/332371a0; KRUGER G, 1989, AM J MED GENET, V32, P411, DOI 10.1002/ajmg.1320320329; Lyon M. F., 1992, Mouse Genome, V90, P22; LYON MF, 1967, GENET RES, V9, P383, DOI 10.1017/S0016672300010673; McKusick VA, 1990, MENDELIAN INHERITANC; MERLOB P, 1981, ACTA PAEDIATR SCAND, V70, P275, DOI 10.1111/j.1651-2227.1981.tb05557.x; Morell Robert, 1992, Human Molecular Genetics, V1, P243, DOI 10.1093/hmg/1.4.243; NARUSE I, 1989, Environmental Medicine (Nagoya), V33, P27; NARUSE I, 1984, ENV MED, V28, P89; ORENIC TV, 1990, GENE DEV, V4, P1053, DOI 10.1101/gad.4.6.1053; PETTIGREW AL, 1991, HUM GENET, V87, P452; POHL TM, 1990, DEVELOPMENT, V110, P1153; RUPPERT JM, 1990, MOL CELL BIOL, V10, P5408, DOI 10.1128/MCB.10.10.5408; RUPPERT JM, 1988, MOL CELL BIOL, V8, P3104, DOI 10.1128/MCB.8.8.3104; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TASSABEHJI M, 1993, NAT GENET, V3, P26, DOI 10.1038/ng0193-26; TOMMERUP N, 1983, AM J MED GENET, V16, P313, DOI 10.1002/ajmg.1320160304; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; WAGNER K, 1990, GENOMICS, V8, P487, DOI 10.1016/0888-7543(90)90035-S; WINTER RM, 1988, AM J MED GENET, V31, P793, DOI 10.1002/ajmg.1320310411; ZARKOWER D, 1992, CELL, V70, P237, DOI 10.1016/0092-8674(92)90099-X; [No title captured]	45	594	602	0	16	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1993	3	3					241	246		10.1038/ng0393-241	http://dx.doi.org/10.1038/ng0393-241			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KP790	8387379				2022-12-25	WOS:A1993KP79000014
J	SCHIEBEL, K; WEISS, B; WOHRLE, D; RAPPOLD, G				SCHIEBEL, K; WEISS, B; WOHRLE, D; RAPPOLD, G			A HUMAN PSEUDOAUTOSOMAL GENE, ADP ATP TRANSLOCASE, ESCAPES X-INACTIVATION WHEREAS A HOMOLOG ON XQ IS SUBJECT TO X-INACTIVATION	NATURE GENETICS			English	Article							ADENINE-NUCLEOTIDE TRANSLOCATOR; RANGE RESTRICTION MAP; HUMAN Y-CHROMOSOME; SHORT ARM; MOLECULAR-CLONING; STEROID SULFATASE; ADP/ATP CARRIER; DNA-SEQUENCES; MESSENGER-RNA; LINKAGE MAP	We report the cloning of a highly conserved pseudoautosomal gene on the human sex chromosomes. A cDNA clone was selected by crosshybridization with a microdissected clone from the chromosomal subregion Xp22.3. It encodes a previously characterized member of the ADP/ATP translocase family and plays a fundamental role in cellular energy metabolism. This gene, ANT3, is located approximately 1,300 kilobases from the telomere, proximal to the pseudoautosomal gene CSF2RA, and escapes X-inactivation. Interestingly, a homologue of ANT3, ANT2, maps to Xq and is subject to X-inactivation. These genes provide the first evidence of two closely related X-chromosomal genes, which show striking differences in their X-inactivation behaviour.	UNIV ULM,DEPT CLIN GENET,W-7900 ULM,GERMANY	Ulm University	SCHIEBEL, K (corresponding author), UNIV HEIDELBERG,INST HUMAN GENET,W-6900 HEIDELBERG,GERMANY.							BATHGATE B, 1989, EUR J BIOCHEM, V183, P303, DOI 10.1111/j.1432-1033.1989.tb14929.x; BATTINI R, 1987, J BIOL CHEM, V262, P4355; BISACCIA F, 1988, BIOCHIM BIOPHYS ACTA, V933, P229, DOI 10.1016/0005-2728(88)90030-8; BROWN CJ, 1991, NATURE, V349, P82, DOI 10.1038/349082a0; BROWN CJ, 1989, AM J HUM GENET, V45, P592; BROWN CJ, 1990, NUCLEIC ACIDS RES, V18, P4191, DOI 10.1093/nar/18.14.4191; BROWN WRA, 1988, EMBO J, V7, P2377, DOI 10.1002/j.1460-2075.1988.tb03082.x; BURK RD, 1985, MOL CELL BIOL, V5, P576, DOI 10.1128/MCB.5.3.576; CHEN ST, 1990, SOMAT CELL MOLEC GEN, V16, P143, DOI 10.1007/BF01233044; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COZENS AL, 1989, J MOL BIOL, V206, P261, DOI 10.1016/0022-2836(89)90477-4; DOCHERTY AJP, 1985, NATURE, V318, P66, DOI 10.1038/318066a0; FAN YS, 1992, CYTOGENET CELL GENET, V60, P29, DOI 10.1159/000133288; FERGUSON-SMITH M A, 1965, J Med Genet, V2, P142, DOI 10.1136/jmg.2.2.142; FISHER EMC, 1990, CELL, V63, P1205, DOI 10.1016/0092-8674(90)90416-C; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; FRASER N, 1987, DEVELOPMENT, V101, P127; GEARING DP, 1989, EMBO J, V8, P3667, DOI 10.1002/j.1460-2075.1989.tb08541.x; GOODFELLOW P, 1984, AM J HUM GENET, V36, P777; GOODFELLOW PJ, 1986, SCIENCE, V234, P740, DOI 10.1126/science.2877492; GOUGH NM, 1990, NATURE, V345, P734, DOI 10.1038/345734a0; HASTIE ND, 1976, CELL, V9, P761, DOI 10.1016/0092-8674(76)90139-2; HENKE A, 1991, AM J HUM GENET, V49, P811; HERRMANN BG, 1987, CELL, V48, P813, DOI 10.1016/0092-8674(87)90078-X; HOULDSWORTH J, 1988, P NATL ACAD SCI USA, V85, P377, DOI 10.1073/pnas.85.2.377; KLINGEBERG M, 1990, TRENDS BIOCHEM SCI, V5, P18; KU DH, 1990, J BIOL CHEM, V265, P16060; LAWSON JE, 1988, J BIOL CHEM, V263, P14812; LEGOUIS R, 1991, CELL, V67, P423, DOI 10.1016/0092-8674(91)90193-3; LEVILLIERS J, 1989, P NATL ACAD SCI USA, V86, P2296, DOI 10.1073/pnas.86.7.2296; LI K, 1989, J BIOL CHEM, V264, P13998; LUDECKE HJ, 1989, NATURE, V338, P348, DOI 10.1038/338348a0; MACKINNON RN, 1990, AM J HUM GENET, V47, P181; MONDELLO C, 1987, ANN HUM GENET, V51, P137, DOI 10.1111/j.1469-1809.1987.tb01055.x; PETIT C, 1988, EMBO J, V7, P2369, DOI 10.1002/j.1460-2075.1988.tb03081.x; PETIT C, 1990, P NATL ACAD SCI USA, V87, P3680, DOI 10.1073/pnas.87.10.3680; POWELL SJ, 1989, BIOCHEMISTRY-US, V28, P866, DOI 10.1021/bi00428a069; RAPPOLD G, 1992, GENOMICS, V14, P455, DOI 10.1016/S0888-7543(05)80241-1; RAPPOLD GA, 1988, NUCLEIC ACIDS RES, V16, P5361, DOI 10.1093/nar/16.12.5361; ROPERS HH, 1985, CYTOGENET CELL GENET, V40, P736; RUNSWICK MJ, 1987, EMBO J, V6, P1367, DOI 10.1002/j.1460-2075.1987.tb02377.x; SALIDO EC, 1992, AM J HUM GENET, V50, P303; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNEIDERGADICKE A, 1989, CELL, V57, P1247, DOI 10.1016/0092-8674(89)90061-5; SCHULTHEISS HP, 1985, ARCH BIOCHEM BIOPHYS, V239, P273, DOI 10.1016/0003-9861(85)90836-7; SPENCER JA, 1991, GENOMICS, V11, P339, DOI 10.1016/0888-7543(91)90141-Z; STEPIEN G, 1992, J BIOL CHEM, V267, P14592; WAPENAAR MC, 1992, GENOMICS, V13, P167, DOI 10.1016/0888-7543(92)90217-G; WATSON JM, 1990, P NATL ACAD SCI USA, V87, P7125, DOI 10.1073/pnas.87.18.7125; WIEACKER P, 1984, AM J HUM GENET, V36, P265; WOHRLE D, 1990, HUM GENET, V85, P659; YEN PH, 1988, CELL, V55, P1123, DOI 10.1016/0092-8674(88)90257-7; YEN PH, 1992, HUM MOL GENET, V1, P47	53	73	76	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1993	3	1					82	87		10.1038/ng0193-82	http://dx.doi.org/10.1038/ng0193-82			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KF372	8490661				2022-12-25	WOS:A1993KF37200018
J	DEsposito, M; Ciccodicola, A; Gianfrancesco, F; Esposito, T; Flagiello, L; Mazzarella, R; Schlessinger, D; DUrso, M				DEsposito, M; Ciccodicola, A; Gianfrancesco, F; Esposito, T; Flagiello, L; Mazzarella, R; Schlessinger, D; DUrso, M			A synaptobrevin-like gene in the Xq28 pseudoautosomal region undergoes X inactivation	NATURE GENETICS			English	Letter							POSITION-EFFECT VARIEGATION; CHROMOSOME INACTIVATION; Y-CHROMOSOME; TELOMERES; SEQUENCES; PROBES		CNR,INT INST GENET & BIOPHYS,I-80125 NAPLES,ITALY; UNIV MODENA,SEZ ISTOL EMBRIOL & GENET,DIPARTIMENTO SCI MORFOL & MEDICOLEGALI,I-41100 MODENA,ITALY; WASHINGTON UNIV,SCH MED,DEPT MOLEC MICROBIOL,ST LOUIS,MO 63110	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Universita di Modena e Reggio Emilia; Washington University (WUSTL)			D'Esposito, Maurizio/AAY-6376-2020; Esposito, Teresa/AAA-5488-2019; Gianfrancesco, Fernando/P-6853-2014	Esposito, Teresa/0000-0002-7879-8441; Ciccodicola, Alfredo/0000-0002-9924-1482; Gianfrancesco, Fernando/0000-0002-3812-2471	Telethon [E.0344] Funding Source: Medline	Telethon(Fondazione Telethon)		BICKMORE WA, 1987, NUCLEIC ACIDS RES, V15, P6261, DOI 10.1093/nar/15.15.6261; BROWN CJ, 1990, NUCLEIC ACIDS RES, V18, P4191, DOI 10.1093/nar/18.14.4191; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; CATTANACH BM, 1974, GENET RES, V23, P291, DOI 10.1017/S0016672300014932; CHANDLEY AC, 1984, CYTOGENET CELL GENET, V38, P241, DOI 10.1159/000132070; COOKE HJ, 1984, NATURE, V311, P259, DOI 10.1038/311259a0; DESPOSITO M, 1994, NUCLEIC ACIDS RES, V22, P4806, DOI 10.1093/nar/22.22.4806; FREIJE D, 1992, SCIENCE, V258, P1784, DOI 10.1126/science.1465614; FREIJE D, 1992, AM J HUM GENET, V51, P66; GOODFELLOW PJ, 1986, SCIENCE, V234, P740, DOI 10.1126/science.2877492; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; GRAUSZ JD, 1993, GENOMICS, V17, P530, DOI 10.1006/geno.1993.1366; GRAVES JAM, 1995, BIOESSAYS, V17, P311, DOI 10.1002/bies.950170407; HAMER DH, 1993, SCIENCE, V261, P321, DOI 10.1126/science.8332896; HENDRICH BD, 1995, HUM MOL GENET, V4, P1765, DOI 10.1093/hmg/4.suppl_1.1765; HENIKOFF S, 1990, TRENDS GENET, V6, P422, DOI 10.1016/0168-9525(90)90304-O; INCERTI B, 1992, NAT GENET, V2, P311, DOI 10.1038/ng1292-311; KERMOUNI A, 1995, GENOMICS, V29, P371, DOI 10.1006/geno.1995.9992; KOZAK M, 1983, MICROBIOL REV, V47, P1; KUTAY U, 1995, EMBO J, V14, P217, DOI 10.1002/j.1460-2075.1995.tb06994.x; KVALOY K, 1994, HUM MOL GENET, V3, P771, DOI 10.1093/hmg/3.5.771; LI L, 1995, HUM MOL GENET, V4, P2013, DOI 10.1093/hmg/4.11.2013; LYON MF, 1988, AM J HUM GENET, V42, P8; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MOHANDAS TK, 1992, AM J HUM GENET, V51, P526; PALMIERI G, 1994, GENOMICS, V24, P149, DOI 10.1006/geno.1994.1592; PROTOPOPOV V, 1993, CELL, V74, P855, DOI 10.1016/0092-8674(93)90465-3; RAPPOLD GA, 1993, HUM GENET, V92, P315, DOI 10.1007/BF01247327; ROUYER F, 1986, NATURE, V319, P291, DOI 10.1038/319291a0; SKOWRONSKI J, 1988, MOL CELL BIOL, V8, P1385, DOI 10.1128/MCB.8.4.1385	30	80	81	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1996	13	2					227	229		10.1038/ng0696-227	http://dx.doi.org/10.1038/ng0696-227			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UN395	8640232				2022-12-25	WOS:A1996UN39500025
J	Kelly, EJ; Palmiter, RD				Kelly, EJ; Palmiter, RD			A murine model of Menkes disease reveals a physiological function of metallothionein	NATURE GENETICS			English	Letter							X-CHROMOSOME; CANDIDATE GENE; MOTTLED MUTANTS; MOUSE; EXPRESSION; ENCODES; BINDING; MICE		UNIV WASHINGTON,DEPT BIOCHEM,SEATTLE,WA 98195; UNIV WASHINGTON,HOWARD HUGHES MED INST,SEATTLE,WA 98195	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle					NCI NIH HHS [CA-61268] Funding Source: Medline; NIGMS NIH HHS [T32 GM07270] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA061268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDREWS GK, 1984, DEV BIOL, V103, P294, DOI 10.1016/0012-1606(84)90317-8; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; CUTHBERT JA, 1995, J INVEST MED, V43, P323; Freshney R. I., 1987, CULTURE ANIMAL CELLS, P107; HARRISON KB, 1989, CYTOGENET CELL GENET, V52, P37, DOI 10.1159/000132835; HUNT DM, 1979, LIFE SCI, V24, P1453, DOI 10.1016/0024-3205(79)90028-6; HUNT DM, 1974, NATURE, V249, P852, DOI 10.1038/249852a0; ISZARD MB, 1995, TOXICOL APPL PHARM, V133, P305, DOI 10.1006/taap.1995.1155; Kagi JHR, 1993, METALLOTHIONEIN, P29; KELLY EJ, IN PRESS J NUTR; LEVINSON B, 1994, NAT GENET, V6, P369, DOI 10.1038/ng0494-369; MASTERS BA, 1994, P NATL ACAD SCI USA, V91, P584, DOI 10.1073/pnas.91.2.584; MCARDLE HJ, 1991, J NUTR, V121, P208, DOI 10.1093/jn/121.2.208; MERCER JFB, 1994, NAT GENET, V6, P374, DOI 10.1038/ng0494-374; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; MICHALSKA AE, 1993, P NATL ACAD SCI USA, V90, P8088, DOI 10.1073/pnas.90.17.8088; MIGEON BR, 1985, P NATL ACAD SCI USA, V82, P3390, DOI 10.1073/pnas.82.10.3390; Mossmann T., 1983, J IMMUNOL METHODS, V65, P55; *MOUS GEN DAT, 1995, MOUS GEN INF PROJ; PALMITER RD, 1993, MOL CELL BIOL, V13, P5266, DOI 10.1128/MCB.13.9.5266; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; PALMITER RD, 1992, P NATL ACAD SCI USA, V89, P63333; PHILLIPS M, 1986, BIOCHEM J, V238, P177, DOI 10.1042/bj2380177; SHAO CS, 1990, DEVELOPMENT, V110, P969; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; WEST JD, 1977, CELL, V12, P873, DOI 10.1016/0092-8674(77)90151-9	26	106	111	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1996	13	2					219	222		10.1038/ng0696-219	http://dx.doi.org/10.1038/ng0696-219			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UN395	8640230				2022-12-25	WOS:A1996UN39500023
J	Friesen, C; Herr, I; Krammer, PH; Debatin, KM				Friesen, C; Herr, I; Krammer, PH; Debatin, KM			Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells	NATURE MEDICINE			English	Article							MONOCLONAL-ANTIBODY; CONTINUOUS-INFUSION; MOLECULAR-CLONING; DEATH APOPTOSIS; SURFACE ANTIGEN; FAS; PHARMACOKINETICS; DOXORUBICIN; ACTIVATION; ADRIAMYCIN	Cytotoxic drugs used in chemotherapy of leukemias and solid tumors cause apoptosis in target cells(1,2). In lymphoid cells the CD95 (APO-1/Fas)/CD95 ligand (CD95-L) system is a key regulator of apoptosis(3-6). Here we describe that doxorbicin induces apoptosis via the CD95/CD95-L system in human leukemia T-cell lines. Doxorubicin-induced apoptosis was completely blocked by inhibition of gene expression and protein synthesis. Also, doxorbicin strongly stimulated CD95-L messenger RNA expression in vitro at concentrations relevant for therapy in vivo. CEM and jurkat cells resistant to CD95-mediated apoptosis were also resistant to doxorbicin-induced apoptosis. Furthermore, doxorbicin-induced apoptosis was inhibited by blocking F(ab')(2)anti-APO-1 (anti-CD95) antibody fragments; Expression of CD95-L mRNA and protein in vitro was also stimulated by other cytotoxic drugs such as methotrexate. The finding that apoptosis caused by anticancer drugs may be mediated via the CD95 system provides a new molecular insight into resistance and sensitivity toward chemotherapy in malignancies.	UNIV HEIDELBERG,CHILDRENS HOSP,W-6900 HEIDELBERG,GERMANY; GERMAN CANC RES CTR,DIV MOLEC ONCOL,D-69120 HEIDELBERG,GERMANY; GERMAN CANC RES CTR,TUMOR IMMUNOL PROGRAM,DIV IMMUNOGENET,D-69120 HEIDELBERG,GERMANY	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)			Debatin, Klaus-Michael/J-9704-2014	Debatin, Klaus-Michael/0000-0002-8397-1886				BARRY MA, 1990, BIOCHEM PHARMACOL, V40, P2353, DOI 10.1016/0006-2952(90)90733-2; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; CARBONARI M, 1994, BLOOD, V83, P1268; CIFONE MG, 1994, J EXP MED, V180, P1547, DOI 10.1084/jem.180.4.1547; CUSACK BJ, 1993, CANCER CHEMOTH PHARM, V32, P53, DOI 10.1007/BF00685876; DEBATIN KM, 1995, LEUKEMIA, V9, P815; DEBATIN KM, 1993, BLOOD, V81, P2972; DEBATIN KM, 1990, LANCET, V335, P497, DOI 10.1016/0140-6736(90)90735-N; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; HERR I, IN PRESS CELL DEATH; HICKMAN JA, 1994, PHILOS T ROY SOC B, V345, P319, DOI 10.1098/rstb.1994.0112; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; KISCHKEL FC, IN PRESS EMBO J; KLAS C, 1993, INT IMMUNOL, V5, P625, DOI 10.1093/intimm/5.6.625; KRAMMER PH, 1994, IMMUNOL REV, V142, P175, DOI 10.1111/j.1600-065X.1994.tb00889.x; MARIANI SM, 1995, EUR J IMMUNOL, V25, P2303, DOI 10.1002/eji.1830250828; MULLER C, 1993, CANCER CHEMOTH PHARM, V32, P379, DOI 10.1007/BF00735923; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; OEHM A, 1992, J BIOL CHEM, V267, P10709; SKLADANOWSKI A, 1993, BIOCHEM PHARMACOL, V46, P375, DOI 10.1016/0006-2952(93)90512-U; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; TANAKA M, 1995, EMBO J, V14, P1129, DOI 10.1002/j.1460-2075.1995.tb07096.x; THAKKAR NS, 1992, BIOCHEM PHARMACOL, V43, P1683, DOI 10.1016/0006-2952(92)90697-H; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530	25	932	957	0	21	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAY	1996	2	5					574	577		10.1038/nm0596-574	http://dx.doi.org/10.1038/nm0596-574			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UJ230	8616718				2022-12-25	WOS:A1996UJ23000042
J	Mecenas, CA; Giussani, DA; Owiny, JR; Jenkins, SL; Wu, WX; Honnebier, MBOM; Lockwood, CJ; Kong, L; Guller, S; Nathanielsz, PW				Mecenas, CA; Giussani, DA; Owiny, JR; Jenkins, SL; Wu, WX; Honnebier, MBOM; Lockwood, CJ; Kong, L; Guller, S; Nathanielsz, PW			Production of premature delivery in pregnant rhesus monkeys by androstenedione infusion	NATURE MEDICINE			English	Article							FIBRONECTIN EXPRESSION; PLASMA-CONCENTRATIONS; OXYTOCIN ANTAGONIST; PERIPHERAL PLASMA; AMNIOTIC-FLUID; LATE GESTATION; FETAL SHEEP; LAST 3RD; PARTURITION; ESTRADIOL	The endocrine mechanisms involved in term and preterm delivery in primates, including pregnant women, are poorly understood. In the term monkey, fetal plasma androgen concentration rises to two hundred times the maternal concentration which remains unchanged. Placental conversion of androgen to estrogen results in increased maternal plasma estrogen concentration at term in both pregnant nonhuman primates and women. In the present study, continuous infusion of androstenedione to 0.8 gestation monkeys resulted in the premature occurrence of labor-type myometrial activity and increases in maternal plasma estrogen, oxytocin and amnion fibronectin concentrations similar to those measured at normal-term labor. Androstenedione induction of these normal-term biochemical and endocrine changes accompanied by fetal membrane rupture, cervical dilatation and live delivery provides a rich opportunity to study the molecular and physiological mechanisms of both term and preterm labor in primates.	CORNELL UNIV,COLL VET MED,DEPT PHYSIOL,LAB PREGNANCY & NEWBORN RES,ITHACA,NY 14853; MT SINAI SCH MED,DEPT OBSTET & GYNECOL,NEW YORK,NY 10029	Cornell University; Icahn School of Medicine at Mount Sinai				Nathanielsz, Peter/0000-0001-8410-6280; Giussani, Dino/0000-0002-1308-1204	NICHD NIH HHS [HD 21350] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD021350] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALBRECHT ED, 1989, AM J OBSTET GYNECOL, V160, P237, DOI 10.1016/0002-9378(89)90128-2; AMICO JA, 1990, NEUROENDOCRINOLOGY, V51, P437, DOI 10.1159/000125371; ANDERSON ABM, 1975, J ENDOCRINOL, V66, P61, DOI 10.1677/joe.0.0660061; BINIENDA Z, 1989, J CLIN ENDOCR METAB, V68, P1184, DOI 10.1210/jcem-68-6-1184; BUSTER JE, 1979, J CLIN ENDOCR METAB, V48, P139, DOI 10.1210/jcem-48-1-139; CHALLIS JRG, 1974, ENDOCRINOLOGY, V95, P547, DOI 10.1210/endo-95-2-547; CHALLIS JRG, 1975, ENDOCRINOLOGY, V96, P185, DOI 10.1210/endo-96-1-185; CHALLIS JRG, 1977, J ENDOCRINOL, V73, P355, DOI 10.1677/joe.0.0730355; CHALLIS JRG, 1971, NATURE, V229, P208, DOI 10.1038/229208a0; CHALLIS JRG, 1974, ENDOCRINOLOGY, V95, P1300, DOI 10.1210/endo-95-5-1300; CHALLIS JRG, 1977, CIBA F S, V47, P211; ELSNER CW, 1979, J CLIN ENDOCR METAB, V49, P30, DOI 10.1210/jcem-49-1-30; FIGUEROA JP, 1989, AM J OBSTET GYNECOL, V161, P481, DOI 10.1016/0002-9378(89)90545-0; FUCHS AR, 1983, ENDOCRINOLOGY, V113, P742, DOI 10.1210/endo-113-2-742; GARFIELD RE, 1980, AM J PHYSIOL, V238, P81; GULLER S, 1993, ENDOCRINOLOGY, V133, P1139, DOI 10.1210/en.133.3.1139; GULLER S, 1992, ENDOCRINOLOGY, V130, P2609, DOI 10.1210/en.130.5.2609; HALUSKA GJ, 1987, AM J OBSTET GYNECOL, V157, P1487, DOI 10.1016/S0002-9378(87)80249-1; HIRST J J, 1991, American Journal of Obstetrics and Gynecology, V164, P252; HONNEBIER MBOM, 1989, J DEV PHYSIOL, V12, P225; HSU HW, 1989, AM J OBSTET GYNECOL, V161, P467; Liggins G C, 1973, Recent Prog Horm Res, V29, P111; LOCKWOOD CJ, 1991, NEW ENGL J MED, V325, P669, DOI 10.1056/NEJM199109053251001; LYE SJ, 1994, SEMIN REPROD ENDOCR, V12, P284, DOI 10.1055/s-2007-1016409; MAGYAR DM, 1980, ENDOCRINOLOGY, V107, P155, DOI 10.1210/endo-107-1-155; MAZOR M, 1994, AM J OBSTET GYNECOL, V171, P231, DOI 10.1016/0002-9378(94)90474-X; MCDONALD TJ, 1991, AM J OBSTET GYNECOL, V165, P764, DOI 10.1016/0002-9378(91)90325-L; MILLER FD, 1993, REGUL PEPTIDES, V45, P247, DOI 10.1016/0167-0115(93)90214-S; NATHANIELSZ PW, 1990, AM J OBSTET GYNECOL, V166, P1529; NATHANIELSZ PW, 1984, RES PERINATAL MED, V1, P887; NOVY MJ, 1983, AM J OBSTET GYNECOL, V145, P920, DOI 10.1016/0002-9378(83)90841-4; NOVY MJ, 1981, FETAL ENDOCRINOLOGY, P66; RADETSKY P, 1994, SCIENCE, V266, P1486, DOI 10.1126/science.7985015; SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6; SHOZU M, 1991, J CLIN ENDOCR METAB, V72, P560, DOI 10.1210/jcem-72-3-560; SIITERI PK, 1981, FETAL ENDOCRINOLOGY, P1; TAYLOR NF, 1983, AM J OBSTET GYNECOL, V146, P557, DOI 10.1016/0002-9378(83)90803-7; THOMAS AL, 1978, ENDOCRINOLOGY, V103, P17, DOI 10.1210/endo-103-1-17; TRIBOLLET E, 1990, BRAIN RES, V511, P129, DOI 10.1016/0006-8993(90)90232-Z; TURNBULL AC, 1974, LANCET, P101; WALSH SW, 1984, J CLIN ENDOCR METAB, V58, P629, DOI 10.1210/jcem-58-4-629; WILSON L, 1991, AM J OBSTET GYNECOL, V165, P1487; WILSON L, 1990, AM J OBSTET GYNECOL, V163, P1875, DOI 10.1016/0002-9378(90)90767-2; ZHANG J, 1991, BIOL REPROD, V45, P395, DOI 10.1095/biolreprod45.3.395	44	91	93	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	APR	1996	2	4					443	448		10.1038/nm0496-443	http://dx.doi.org/10.1038/nm0496-443			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UD314	8597955				2022-12-25	WOS:A1996UD31400047
J	Chehab, FE; Lim, ME; Lu, RH				Chehab, FE; Lim, ME; Lu, RH			Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin	NATURE GENETICS			English	Letter											Chehab, FE (corresponding author), UNIV CALIF SAN FRANCISCO, DEPT LAB MED, SAN FRANCISCO, CA 94143 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL053762] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL53762] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAATT RAL, 1972, J REPROD FERTIL, V31, P496; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; DRASHER M. L., 1955, JOUR HEREDITY, V46, P209; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; HUMMEL KP, 1957, ANAT REC, V128, P569; INGALLS AM, 1950, J HERED, V41, P317, DOI 10.1093/oxfordjournals.jhered.a106073; LANE PW, 1954, J HERED, V45, P56, DOI 10.1093/oxfordjournals.jhered.a106439; LANE PW, 1959, ENDOCRINOLOGY, V65, P863, DOI 10.1210/endo-65-6-863; Lovell D. P., 1979, Animal models of obesity., P65; MAYER J, 1953, PHYSIOL REV, V33, P472, DOI 10.1152/physrev.1953.33.4.472; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; RUNNER MN, 1954, GENETICS, V39, P990; RUNNER MN, 1954, J HERED, V45, P51, DOI 10.1093/oxfordjournals.jhered.a106438; SMITHBERG M., 1957, JOUR HEREDITY, V48, P97; SMITHBERG M, 1956, J EXP ZOOL, V133, P441, DOI 10.1002/jez.1401330303; SWERDLOFF RS, 1976, ENDOCRINOLOGY, V98, P1359, DOI 10.1210/endo-98-6-1359; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; WEIGLE DS, 1995, J CLIN INVEST, V96, P2065, DOI 10.1172/JCI118254; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	19	1224	1301	1	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1996	12	3					318	320		10.1038/ng0396-318	http://dx.doi.org/10.1038/ng0396-318			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TY183	8589726				2022-12-25	WOS:A1996TY18300024
J	Pilia, G; HughesBenzie, RM; MacKenzie, A; Baybayan, P; Chen, EY; Huber, R; Neri, G; Cao, A; Forabosco, A; Schlessinger, D				Pilia, G; HughesBenzie, RM; MacKenzie, A; Baybayan, P; Chen, EY; Huber, R; Neri, G; Cao, A; Forabosco, A; Schlessinger, D			Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome	NATURE GENETICS			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; ARTIFICIAL CHROMOSOME; MOLECULAR-CLONING; BINDING-PROTEINS; GROWTH; YEAST; RAT; SEQUENCES; SERUM; DNA	Simpson-Golabi-Behmel syndrome (SGBS) is an X-linked condition characterized by pre- and postnatal overgrowth with visceral and skeletal anomalies, To identify the causative gene, breakpoints in two female patients with X;autosome translocations were identified. The breakpoints occur near the 5' and 3' ends of a gene, GPC3, that spans more than 500 kilobases in Xq26; in three families, different microdeletions encompassing exons cosegregate with SGBS. GPC3 encodes a putative extracellular proteoglycan, glypican 3, that is inferred to play an important role in growth control in embryonic mesodermal tissues in which it is selectively expressed. Initial western- and ligand-blotting experiments suggest that glypican 3 forms a complex with insulin-like growth factor 2 (IGF2), and might thereby modulate IGF2 action.	WASHINGTON UNIV, SCH MED, CTR GENET MED, ST LOUIS, MO 63110 USA; CHILDRENS HOSP EASTERN ONTARIO, DEPT PEDIAT, OTTAWA, ON K1H 8L1, CANADA; PERKIN ELMER CORP, ADV CTR GENET TECHNOL, APPL BIOSYST DIV, FOSTER CITY, CA 94404 USA; UNIV CATTOLICA SACRO CUORE, IST GENET UMANA, I-00168 ROME, ITALY; UNIV CAGLIARI, IST CLIN & BIOL ETA EVOLUT, I-09121 CAGLIARI, ITALY; IST RIC TALASSEMIE & ANEMIE MEDITERRANEE, I-09121 CAGLIARI, ITALY; UNIV MODENA, DIPARTIMENTO SCI MORFOL & MED LEGALI, I-41100 MODENA, ITALY	Washington University (WUSTL); University of Ottawa; Children's Hospital of Eastern Ontario; Thermo Fisher Scientific; Applied Biosystems; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Cagliari; Universita di Modena e Reggio Emilia				NOIRI, Eisei/0000-0002-9515-7582	NHGRI NIH HHS [HG00247, HG00201] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000247] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; BEHMEL A, 1984, HUM GENET, V67, P409, DOI 10.1007/BF00291401; Blanchard M M, 1993, PCR Methods Appl, V2, P234; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; CHEN EY, 1991, GENOMICS, V10, P792, DOI 10.1016/0888-7543(91)90465-Q; Cohen MM, 1989, ADV HUM GENET, V18, p[181, 373]; COHEN MM, 1989, ADV HUM GENET, V18, P181; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; DAVID G, 1993, FASEB J, V7, P1023, DOI 10.1096/fasebj.7.11.8370471; DESPOSITO M, 1994, NUCLEIC ACIDS RES, V22, P4806, DOI 10.1093/nar/22.22.4806; FILMUS J, 1988, MOL CELL BIOL, V8, P4243, DOI 10.1128/MCB.8.10.4243; GARGANTA CL, 1992, AM J MED GENET, V44, P129, DOI 10.1002/ajmg.1320440202; *GEN COMP GROUP, 1991, PROGR MAN GCG PACK V; GOLABI M, 1984, AM J MED GENET, V17, P345, DOI 10.1002/ajmg.1320170128; GREEN PJ, 1995, FEBS LETT, V360, P34, DOI 10.1016/0014-5793(95)00050-J; HOSSENLOPP P, 1986, ANAL BIOCHEM, V154, P138, DOI 10.1016/0003-2697(86)90507-5; HUGHESBENZIE R, 1992, J MED GENET, V29, P928, DOI 10.1136/jmg.29.12.928-b; HUGHESBENZIE RM, 1992, AM J MED GENET, V43, P428, DOI 10.1002/ajmg.1320430165; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAU MMH, 1994, GENE DEV, V8, P2953, DOI 10.1101/gad.8.24.2953; LEDBETTER SA, 1991, AM J MED GENET, V38, P418, DOI 10.1002/ajmg.1320380254; LINDLOF M, 1989, AM J HUM GENET, V44, P496; LITTLE RD, 1992, P NATL ACAD SCI USA, V89, P177, DOI 10.1073/pnas.89.1.177; LORIES V, 1987, J BIOL CHEM, V262, P854; Mannens M., 1994, European Journal of Human Genetics, V2, P3; NERI G, 1988, AM J MED GENET, V30, P287, DOI 10.1002/ajmg.1320300130; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; ORTH U, 1994, AM J MED GENET, V50, P388, DOI 10.1002/ajmg.1320500423; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; POSNETT DN, 1988, J BIOL CHEM, V263, P1719; PUNNETT HH, 1994, AM J MED GENET, V50, P391, DOI 10.1002/ajmg.1320500424; Sambrook J, 1989, MOL CLONIG LAB MANUA; SCHLESSINGER J, 1995, CELL, V83, P357, DOI 10.1016/0092-8674(95)90112-4; SHIMASAKI S, 1991, J BIOL CHEM, V266, P10646; Simpson J L, 1975, Birth Defects Orig Artic Ser, V11, P18; STIPP CS, 1992, MOL BIOL CELL, V3, pA65; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; VERLOES A, 1995, CLIN GENET, V47, P257; VERMEESCH JR, 1995, GENOMICS, V25, P327, DOI 10.1016/0888-7543(95)80152-C; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; WILLARD HF, 1994, CYTOGENET CELL GENET, V67, P296; XUAN JY, 1994, HUM MOL GENET, V3, P133, DOI 10.1093/hmg/3.1.133	45	600	656	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1996	12	3					241	247		10.1038/ng0396-241	http://dx.doi.org/10.1038/ng0396-241			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TY183	8589713				2022-12-25	WOS:A1996TY18300011
J	Liu, B; Parsons, R; Papadopoulos, N; Nicolaides, NC; Lynch, HT; Watson, P; Jass, JR; Dunlop, M; Wyllie, A; Peltomaki, P; delaChapelle, A; Hamilton, SR; Vogelstein, B; Kinzler, KW				Liu, B; Parsons, R; Papadopoulos, N; Nicolaides, NC; Lynch, HT; Watson, P; Jass, JR; Dunlop, M; Wyllie, A; Peltomaki, P; delaChapelle, A; Hamilton, SR; Vogelstein, B; Kinzler, KW			Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients	NATURE MEDICINE			English	Article							NONPOLYPOSIS COLON-CANCER; MUTATIONS; HOMOLOG	Hereditary non-polyposis colorectal cancer (HNPCC) is an autosomal dominant disorder characterized by the early onset of colorectal cancer and linked to germline defects in at least four mismatch repair genes. Although much has been learned about the molecular pathogenesis of this disease, questions related to effective presymptomatic diagnosis are largely unanswered because of its genetic complexity. In this study, we evaluated tumors from 74 HNPCC kindreds for genomic instability characteristic of a mismatch repair deficiency and found such instability in 92% of the kindreds. The entire coding regions of the five known human mismatch repair genes were evaluated in 48 kindreds with instability, and mutations were identified in 70%. This study demonstrates that a combination of techniques can be used to genetically diagnose tumor susceptibility in the majority of HNPCC kindreds and lays the foundation for genetic testing of this relatively common disease.	JOHNS HOPKINS ONCOL CTR,HOWARD HUGHES MED INST,BALTIMORE,MD 21231; CREIGHTON UNIV,SCH MED,OMAHA,NE 68178; UNIV AUCKLAND,SCH MED,DEPT PATHOL,AUCKLAND,NEW ZEALAND; WESTERN GEN HOSP,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND; UNIV EDINBURGH,SCH MED,DEPT PATHOL,CANC RES CAMPAIGN LAB,EDINBURGH EH8 9AG,MIDLOTHIAN,SCOTLAND; UNIV HELSINKI,DEPT MED GENET,SF-00014 HELSINKI,FINLAND; JOHNS HOPKINS UNIV,SCH MED,DEPT PATHOL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,CTR ONCOL,BALTIMORE,MD 21205	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Creighton University; University of Auckland; University of Edinburgh; University of Edinburgh; University of Helsinki; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine			Dunlop, Malcolm G/F-1973-2011; Papadopoulos, Nickolas/K-7272-2012	Dunlop, Malcolm G/0000-0002-3033-5851; Peltomaki, Paivi/0000-0001-8819-2980; Parsons, Ramon/0000-0002-6656-3514	NATIONAL CANCER INSTITUTE [R37CA035494, P50CA062924, R01CA047527, R01CA035494] Funding Source: NIH RePORTER; NCI NIH HHS [CA 47527, CA 62924, CA 35494] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AALTONEN LA, 1994, CANCER RES, V54, P1645; AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; BONNER CE, 1994, NATURE, V368, P258; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; GOELZ SE, 1985, BIOCHEM BIOPH RES CO, V130, P118, DOI 10.1016/0006-291X(85)90390-0; HALL NR, 1994, EUR J CANCER, V30A, P180, DOI 10.1016/0959-8049(94)90083-3; HAMILTON SR, 1995, NEW ENGL J MED, V332, P839, DOI 10.1056/NEJM199503303321302; HONCHEL R, 1994, CANCER RES, V54, P1159; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; JEN J, 1994, NEW ENGL J MED, V331, P213, DOI 10.1056/NEJM199407283310401; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; LINDBLOM A, 1993, NAT GENET, V5, P279, DOI 10.1038/ng1193-279; LIU B, 1995, NAT GENET, V9, P48, DOI 10.1038/ng0195-48; LIU B, 1994, CANCER RES, V54, P4590; LIU B, 1995, NAT MED, V1, P348, DOI 10.1038/nm0495-348; LYNCH HT, 1993, GASTROENTEROLOGY, V104, P1535, DOI 10.1016/0016-5085(93)90368-M; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; NYSTROMLAHTI M, 1994, P NATL ACAD SCI USA, V91, P6054, DOI 10.1073/pnas.91.13.6054; NYSTROMLAHTI M, 1994, AM J HUM GENET, V55, P659; NYSTROMLAHTI M, 1995, NATURE MED, V1, P1202; PALOMBO F, 1995, SCIENCE, V268, P1912, DOI 10.1126/science.7604265; PALOMBO F, 1994, NATURE, V367, P417, DOI 10.1038/367417a0; PAPADOPOULOS N, 1995, NAT GENET, V11, P99, DOI 10.1038/ng0995-99; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; PAPADOPOULOS N, 1995, SCIENCE, V268, P1915, DOI 10.1126/science.7604266; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; PELTOMAKI P, 1993, SCIENCE, V260, P810, DOI 10.1126/science.8484120; POWELL SM, 1993, NEW ENGL J MED, V329, P1982, DOI 10.1056/NEJM199312303292702; PROLLA TA, 1994, SCIENCE, V265, P1091, DOI 10.1126/science.8066446; ROEST PAM, 1993, HUM MOL GENET, V2, P1719, DOI 10.1093/hmg/2.10.1719; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; TURCOT J, 1959, DIS COLON RECTUM, V2, P456; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Warthin AS, 1913, ARCH INTERN MED, V12, P546	36	795	843	0	51	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	FEB	1996	2	2					169	174		10.1038/nm0296-169	http://dx.doi.org/10.1038/nm0296-169			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TU060	8574961				2022-12-25	WOS:A1996TU06000036
J	Weinberg, AD; Bourdette, DN; Sullivan, TJ; Lemon, M; Wallin, JJ; Maziarz, R; Davey, M; Palida, F; Godfrey, W; Engleman, E; Fulton, RJ; Offner, H; Vandenbark, AA				Weinberg, AD; Bourdette, DN; Sullivan, TJ; Lemon, M; Wallin, JJ; Maziarz, R; Davey, M; Palida, F; Godfrey, W; Engleman, E; Fulton, RJ; Offner, H; Vandenbark, AA			Selective depletion of myelin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitis	NATURE MEDICINE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; ANTIGENS; RAT; DISEASE; PEPTIDE; LESIONS	The OX-40 protein was selectively upregulated on encephalitogenic myelin basic protein (MBP)-specific T cells at the site of inflammation during the onset of experimental autoimmune encephalomyelitis (EAE). An OX-40 immunotoxin was used to target and eliminate MBP-specific T cells within the central nervous system without affecting peripheral T cells. When injected in vivo, the OX-40 immunotoxin bound exclusively to myelin-reactive T cells isolated from the CNS, which resulted in amelioration of EAE. Expression of the human OX-40 antigen was also found in peripheral blood of patients with acute graft-versus-host disease and the synovia of patients with rheumatoid arthritis during active disease. The unique expression of the OX-40 molecule may provide a novel therapeutic strategy for eliminating autoreactive CD4(+)T. cells that does not require prior knowledge of the pathogenic autoantigen.	VET AFFAIRS MED CTR,PORTLAND,OR 97207; OREGON HLTH SCI UNIV,DEPT MICROBIOL & IMMUNOL,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT NEUROL,PORTLAND,OR 97201; PHARMINGEN,SAN DIEGO,CA 92121; INLAND LAB,DESOTO,TX 75115; STANFORD UNIV,DEPT PATHOL,PALO ALTO,CA 94305	US Department of Veterans Affairs; Veterans Health Administration (VHA); Oregon Health & Science University; Oregon Health & Science University; Stanford University			Godfrey, Wayne/AAL-7219-2020	Wallin, Jeffrey/0000-0002-5952-3813				BAUM PR, 1994, EMBO J, V13, P3992, DOI 10.1002/j.1460-2075.1994.tb06715.x; BOURDETTE DN, 1991, J NEUROSCI RES, V30, P308, DOI 10.1002/jnr.490300205; CASPI RR, 1988, J IMMUNOL, V140, P1490; COBBOLD SP, 1984, NATURE, V312, P548, DOI 10.1038/312548a0; CUSH JJ, 1988, ARTHRITIS RHEUM-US, V31, P1230, DOI 10.1002/art.1780311003; GODFREY WR, 1994, J EXP MED, V180, P757, DOI 10.1084/jem.180.2.757; HINTZEN RQ, 1994, IMMUNOL TODAY, V15, P307, DOI 10.1016/0167-5699(94)90077-9; HOWELL MD, 1989, SCIENCE, V246, P668, DOI 10.1126/science.2814489; JAMESON BA, 1994, NATURE, V368, P744, DOI 10.1038/368744a0; KRUISBEEK AM, 1992, CURRENT PROTOCOLS IM; LATZA U, 1994, EUR J IMMUNOL, V24, P677, DOI 10.1002/eji.1830240329; MATSUMOTO Y, 1988, IMMUNOLOGY, V65, P23; OKSENBERG JR, 1993, NATURE, V362, P68, DOI 10.1038/362068a0; ORTIZORTIZ L, 1976, J IMMUNOL, V117, P576; PATERSON DJ, 1987, MOL IMMUNOL, V24, P1281, DOI 10.1016/0161-5890(87)90122-2; PATERSON PY, 1981, J CHRON DIS, V26, P119; PRESS OW, 1986, CELL IMMUNOL, V102, P10, DOI 10.1016/0008-8749(86)90321-7; STEINMAN L, 1993, SCI AM, V269, P106, DOI 10.1038/scientificamerican0993-106; SWANBORG RH, 1983, J IMMUNOL, V130, P1503; VANDENBARK AA, 1985, J IMMUNOL, V135, P223; VANDENBARK AA, 1989, NATURE, V341, P541, DOI 10.1038/341541a0; WEINBERG AD, 1992, J IMMUNOL, V148, P2109; WEINBERG AD, 1994, J IMMUNOL, V152, P4712; WEINBERG AD, IN PRESS J NEUROSCI; WEINER HL, 1993, SCIENCE, V259, P1321, DOI 10.1126/science.7680493; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0	26	133	146	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	FEB	1996	2	2					183	189		10.1038/nm0296-183	http://dx.doi.org/10.1038/nm0296-183			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TU060	8574963				2022-12-25	WOS:A1996TU06000038
J	Freedman, AR; Zhu, HH; Levine, JD; Kalams, S; Scadden, DT				Freedman, AR; Zhu, HH; Levine, JD; Kalams, S; Scadden, DT			Generation of human T lymphocytes from bone marrow CD34(+) cells in vitro	NATURE MEDICINE			English	Article							HEMATOPOIETIC STEM-CELLS; HUMAN FETAL THYMOCYTES; EARLY EVENTS; HUMAN THYMUS; PRECURSORS; INFECTION; INVITRO; DIFFERENTIATION; DEPLETION; INVIVO	Analysis of the events that regulate development of red blood cells or granulocytes has led to therapies altering clinical conditions associated with anemia or neutropenia. The development of therapeutic approaches to target conditions associated with lymphopenia, such as AIDS, has been thwarted by limited techniques for studying T-lymphocyte development. We describe an in vitro system in which human bone marrow CD34 cells proliferate, acquire the expression of the lymphoid-specific RAG-2 gene and a broad repertoire of rearranged T-cell receptor genes, develop the ability to produce T cell-specific interleukin-2 and achieve a range of T-cell immunophenotypes. The cells also become susceptible to infection with the T-lymphotropic strain of human immunodeficiency virus-1, HIV-1(IIB). This culture system induces human T lymphopoiesis and may permit further analysis of the events regulating human T-lineage differentiation. It provides a preclinical model for screening stem cell gene therapies directed toward AIDS.	HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,AIDS RES CTR,INFECT DIS UNIT,BOSTON,MA 02129; HARVARD UNIV,NEW ENGLAND DEACONESS HOSP,SCH MED,DIV HEMATOL ONCOL,BOSTON,MA 02129	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044851] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL 44851] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKKINA RK, 1994, BLOOD, V84, P1393; ALDROVANDI GM, 1993, NATURE, V363; BONYHADI ML, 1993, NATURE, V363, P728, DOI 10.1038/363728a0; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; GALY A, 1993, J EXP MED, V178, P391, DOI 10.1084/jem.178.2.391; GODFREY DI, 1994, J IMMUNOL, V152, P2729; HANNUM C, 1994, NATURE, V368, P643, DOI 10.1038/368643a0; HAYNES BF, 1988, J EXP MED, V168, P1061, DOI 10.1084/jem.168.3.1061; HIRAYAMA F, 1994, BLOOD, V83, P92; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; JACOBSEN SEW, 1995, J EXP MED, V181, P1357, DOI 10.1084/jem.181.4.1357; JACOBSEN SEW, 1993, J EXP MED, V178, P413, DOI 10.1084/jem.178.2.413; JENKINSON EJ, 1982, EUR J IMMUNOL, V12, P583, DOI 10.1002/eji.1830120710; KALAMS SA, 1994, J EXP MED, V179, P1261, DOI 10.1084/jem.179.4.1261; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; KRAFT DL, 1993, J EXP MED, V178, P265, DOI 10.1084/jem.178.1.265; KURTZBERG J, 1989, P NATL ACAD SCI USA, V86, P7575, DOI 10.1073/pnas.86.19.7575; LYERLY HK, 1987, P NATL ACAD SCI USA, V84, P4601, DOI 10.1073/pnas.84.13.4601; LYMAN SD, 1993, CELL, V75, P1157, DOI 10.1016/0092-8674(93)90325-K; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; PEAULT B, 1991, J EXP MED, V174, P1283, DOI 10.1084/jem.174.5.1283; ROSENZWEIG M, 1993, AIDS, V7, P1601, DOI 10.1097/00002030-199312000-00009; STANLEY SK, 1993, J EXP MED, V178, P1151, DOI 10.1084/jem.178.4.1151; SU L, 1995, IMMUNITY, V2, P25, DOI 10.1016/1074-7613(95)90076-4; TANAKA KE, 1992, J ACQ IMMUN DEF SYND, V5, P94; TERSTAPPEN IWW, 1992, BLOOD, V79, P666; TJONNFJORD GE, 1993, J EXP MED, V177, P1531, DOI 10.1084/jem.177.6.1531; WHITLOCK CA, 1982, P NATL ACAD SCI-BIOL, V79, P3608, DOI 10.1073/pnas.79.11.3608; WOLF SF, 1994, STEM CELLS, V12, P154, DOI 10.1002/stem.5530120203; YEOMAN H, 1993, IMMUNOLOGY, V90, P10778	30	57	66	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JAN	1996	2	1					46	51		10.1038/nm0196-46	http://dx.doi.org/10.1038/nm0196-46			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TP579	8564838				2022-12-25	WOS:A1996TP57900036
J	ZERRES, K; MUCHER, G; BACHNER, L; DESCHENNES, G; EGGERMANN, T; KAARIAINEN, H; KNAPP, M; LENNERT, T; MISSELWITZ, J; VONMUHLENDAHL, KE; NEUMANN, HPH; PIRSON, Y; RUDNIKSCHONEBORN, S; STEINBICKER, V; WIRTH, B; SCHARER, K				ZERRES, K; MUCHER, G; BACHNER, L; DESCHENNES, G; EGGERMANN, T; KAARIAINEN, H; KNAPP, M; LENNERT, T; MISSELWITZ, J; VONMUHLENDAHL, KE; NEUMANN, HPH; PIRSON, Y; RUDNIKSCHONEBORN, S; STEINBICKER, V; WIRTH, B; SCHARER, K			MAPPING OF THE GENE FOR AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY-DISEASE (ARPKD) TO CHROMOSOME 6P21-CEN	NATURE GENETICS			English	Article							CLINICAL PICTURE; LINKAGE; CHILDHOOD	Autosomal recessive polycystic kidney disease (ARPKD) is one of the major hereditary nephropathies in children predominantly presently in early childhood. The clinical picture is variable but there is a fatal outcome in many cases. We have performed linkage analysis in 16 ARPKD families and localized the ARPKD gene to chromosomal region 6p21-cen with no evidence for genetic heterogeneity among different clinical phenotypes. Linkage was confirmed using six adjacent microsatellite markers and the highest rod score of 7.42 was obtained with D6S272 at theta=0.00. Our findings should lead to more accurate forms of prenatal diagnosis than those currently available using ultrasound.	HOP GATIEN CLOCHEVILLE,TOURS,FRANCE; HOP GATIEN,INSERM,U129,BIOCHIM GENET LAB,F-75674 PARIS 14,FRANCE; UNIV HELSINKI,DEPT MED GENET,SF-00290 HELSINKI,FINLAND; UNIV BONN,INST MED STAT DOKUMENTAT & DATENVERARBEITUNG,D-53127 BONN,GERMANY; FREE UNIV BERLIN,KINDERKLIN,D-14059 BERLIN,GERMANY; UNIV JENA,KINDERKLIN,D-07745 JENA,GERMANY; KINDERHOSP OSNABRUCK,D-49082 OSNABRUCK,GERMANY; UNIV FREIBURG,MED KLIN,D-79106 FREIBURG,GERMANY; UNIV CATHOLIQUE LOUVAIN,CLIN UNIV ST LUC,DEPT MED INTERNE,B-1200 BRUSSELS,BELGIUM; UNIV MAGDEBURG,INST HUMANGENET,D-39120 MAGDEBURG,GERMANY; UNIV HEIDELBERG,KINDERKLIN,D-69120 HEIDELBERG,GERMANY	CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Helsinki; University of Bonn; Free University of Berlin; Friedrich Schiller University of Jena; University of Freiburg; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Otto von Guericke University; Ruprecht Karls University Heidelberg	ZERRES, K (corresponding author), UNIV BONN,INST HUMANGENET,WILHELMSTR 31,D-53111 BONN,GERMANY.		Eggermann, Thomas/F-3807-2014; Wirth, Brunhilde/H-3192-2019	Wirth, Brunhilde/0000-0003-4051-5191				BLYTH H, 1971, J MED GENET, V8, P257, DOI 10.1136/jmg.8.3.257; BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0; COLE B, 1990, CYSTIC KIDNEY, P326; GUAYWOODFORD LM, 1990, J AM SOC NEPHROL, V1, pA300; HILDEBRANDT F, 1993, COMPUT BIOMED RES, V26, P592, DOI 10.1006/cbmr.1993.1042; KAPLAN BS, 1989, PEDIATR NEPHROL, V3, P43, DOI 10.1007/BF00859625; KIMBERLING WJ, 1993, GENOMICS, V18, P467, DOI 10.1016/S0888-7543(11)80001-7; KIMBERLING WJ, 1988, NEW ENGL J MED, V319, P913, DOI 10.1056/NEJM198810063191405; KWIATKOWSKI TJ, 1991, GENOMICS, V10, P921, DOI 10.1016/0888-7543(91)90180-M; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; NEUMANN HPH, 1988, AM J NEPHROL, V8, P194, DOI 10.1159/000167582; PAFREY PS, 1990, NEW ENGL J MED, V323, P1085; PETERS DJM, 1993, NAT GENET, V5, P359, DOI 10.1038/ng1293-359; REEDERS ST, 1985, NATURE, V317, P543; ROMEO G, 1988, LANCET, V2, P8; Sambrook J, 1989, MOL CLONING LABORATO; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WIRTH B, 1987, HUM GENET, V77, P221, DOI 10.1007/BF00284473; ZERRES K, 1992, CLIN INVESTIGATOR, V70, P794; ZERRES K, 1988, PRENATAL DIAG, V8, P215, DOI 10.1002/pd.1970080308; ZERRES K, 1984, HUM GENET, V68, P104, DOI 10.1007/BF00279301; ZERRES K, 1993, J MED GENET, V30, P583, DOI 10.1136/jmg.30.7.583; ZERRES K, IN PRESS HUM GENET	24	209	219	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1994	7	3					429	432		10.1038/ng0794-429	http://dx.doi.org/10.1038/ng0794-429			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NU306	7920664				2022-12-25	WOS:A1994NU30600020
J	ARIEL, M; CEDAR, H; MCCARREY, J				ARIEL, M; CEDAR, H; MCCARREY, J			DEVELOPMENTAL-CHANGES IN METHYLATION OF SPERMATOGENESIS-SPECIFIC GENES INCLUDE REPROGRAMMING IN THE EPIDIDYMIS	NATURE GENETICS			English	Article							PRIMORDIAL GERM-CELLS; DNA METHYLATION; TRANSCRIPTION FACTOR; MOUSE EMBRYO; PATTERNS; EMBRYOGENESIS; EXPRESSION	We have determined the status of DNA methylation at specific sites in three spermatogenesis-specific genes, Pgk-2, ApoA1 and Oct-3/4, throughout the development and differentiation of male germ cells in the mouse. We observed a specific demethylation event in the Pgk-2 gene in prospermatogonia at about the time of birth, about 10 days before the onset of transcription which first occurs in primary spermatocytes. All three genes were unmethylated in adult spermatogenic cells in the testis, but were remethylated in mature spermatozoa in the vas deferens. Surprisingly, we found that this remethylation is part of the process of sperm maturation which occurs in the epididymis.	SW FDN BIOMED RES,DEPT GENET,SAN ANTONIO,TX 78228; HEBREW UNIV JERUSALEM,SCH MED,DEPT CELLULAR BIOCHEM,IL-91010 JERUSALEM,ISRAEL	Texas Biomedical Research Institute; Hebrew University of Jerusalem					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD023126] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 23126] Funding Source: Medline; NIGMS NIH HHS [GM 20468] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARIEL M, 1991, P NATL ACAD SCI USA, V88, P2317, DOI 10.1073/pnas.88.6.2317; BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Bedford J. M., 1975, HDB PHYSIOLOGY, P303; BELIVE AR, 1977, J CELL BIOL, V74, P68; BENOIT MJ, 1926, ARCH ANAT HISTOL EMB, V5, P175; BENSHUSHAN E, 1993, MOL CELL BIOL, V13, P891, DOI 10.1128/MCB.13.2.891; BRANDEIS M, 1993, EMBO J, V12, P3669, DOI 10.1002/j.1460-2075.1993.tb06041.x; CEDAR H, 1988, CELL, V53, P3, DOI 10.1016/0092-8674(88)90479-5; CHAILLET JR, 1991, CELL, V66, P77, DOI 10.1016/0092-8674(91)90140-T; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; GEBARA MM, 1992, MOL CELL BIOL, V12, P1422, DOI 10.1128/MCB.12.4.1422; HAHNEL AC, 1986, GAMETE RES, V15, P25, DOI 10.1002/mrd.1120150104; HAMILTON DW, 1977, FRONTIERS REPRODUCTI, P411; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; McCarrey J, 1993, CELL MOL BIOL TESTIS, P58; MCCARREY JR, 1992, DEV BIOL, V154, P160, DOI 10.1016/0012-1606(92)90056-M; MCCARREY JR, 1987, J EXP ZOOL, V242, P107, DOI 10.1002/jez.1402420116; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; MONESI V, 1967, ARCH ANAT MICROSC MO, V56, P61; MONK M, 1987, DEVELOPMENT, V99, P371; OKAZAWA H, 1991, EMBO J, V10, P2997, DOI 10.1002/j.1460-2075.1991.tb07850.x; Orgebin-Crist M.-C., 1984, The male in farm animal reproduction., P80; Robaire B., 1988, P999; ROMRELL LJ, 1976, DEV BIOL, V49, P119, DOI 10.1016/0012-1606(76)90262-1; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; SANFORD J, 1984, NUCLEIC ACIDS RES, V12, P2823, DOI 10.1093/nar/12.6.2823; SHEMER R, 1990, J BIOL CHEM, V265, P1010; SINGERSAM J, 1990, NUCLEIC ACIDS RES, V18, P687, DOI 10.1093/nar/18.3.687; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; WALSH A, 1989, J BIOL CHEM, V264, P6488	31	132	136	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1994	7	1					59	63		10.1038/ng0594-59	http://dx.doi.org/10.1038/ng0594-59			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NJ842	8075642				2022-12-25	WOS:A1994NJ84200014
J	SMITH, MW; HOLMSEN, AL; WEI, YH; PETERSON, M; EVANS, GA				SMITH, MW; HOLMSEN, AL; WEI, YH; PETERSON, M; EVANS, GA			GENOMIC SEQUENCE SAMPLING - A STRATEGY FOR HIGH-RESOLUTION SEQUENCE-BASED PHYSICAL MAPPING OF COMPLEX GENOMES	NATURE GENETICS			English	Article							YEAST ARTIFICIAL CHROMOSOMES; GIARDIA-LAMBLIA; GEL-ELECTROPHORESIS; DNA-SEQUENCE; MAP; REGION; GENERATION; LIBRARIES; LINKING; BIOLOGY	We present a simple and efficient method for constructing high resolution physical maps of large regions of genomic DNA based upon sampled sequencing. The physical map is constructed by ordering high density cosmid contigs and determining a sequence fragment from each end of every clone. The resulting map, which contains 30-50% of the complete DNA sequence, allows the identification of many genes and makes possible PCR amplification of virtually any part of the genome. We apply this strategy to the automated analysis of the genome of the primitive eukaryote Giardia lamblia and evaluate its applicability to the physical mapping and DNA sequencing of the human genome.	SALK INST BIOL STUDIES, MOLEC GENET LAB, LA JOLLA, CA 92037 USA	Salk Institute			Smith, Michael/B-5341-2012					ADAM RD, 1991, MICROBIOL REV, V55, P706, DOI 10.1128/MMBR.55.4.706-732.1991; ADAMS MD, 1993, NAT GENET, V4, P256, DOI 10.1038/ng0793-256; ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; AGGARWAL A, 1990, NUCLEIC ACIDS RES, V18, P3409, DOI 10.1093/nar/18.11.3409; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANSORGE W, 1992, ELECTROPHORESIS, V13, P616, DOI 10.1002/elps.11501301125; BAXENDALE S, 1993, NAT GENET, V4, P181, DOI 10.1038/ng0693-181; BELLANNECHANTELOT C, 1992, CELL, V70, P1059, DOI 10.1016/0092-8674(92)90254-A; BURLAND V, 1993, GENOMICS, V16, P551, DOI 10.1006/geno.1993.1230; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CLARK SP, BIOCOMPUTING GENOME, P13; COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; COULSON A, 1988, NATURE, V335, P184, DOI 10.1038/335184a0; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; DANIELS DL, 1992, SCIENCE, V257, P771, DOI 10.1126/science.1379743; DEAVEN LL, 1986, COLD SPRING HARB SYM, V51, P159, DOI 10.1101/SQB.1986.051.01.019; DOOLITTLE RF, 1990, METHOD ENZYMOL, V183, P659; DRMANAC R, 1993, SCIENCE, V260, P1649, DOI 10.1126/science.8503011; DRURY HA, 1992, BIOTECHNIQUES, V12, P892; EVANS GA, 1989, P NATL ACAD SCI USA, V86, P5030, DOI 10.1073/pnas.86.13.5030; EVANS GA, 1989, GENE, V79, P9, DOI 10.1016/0378-1119(89)90088-7; FAN JB, 1991, NUCLEIC ACIDS RES, V19, P1905, DOI 10.1093/nar/19.8.1905; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FENG DF, 1990, METHOD ENZYMOL, V183, P375; FONSTEIN M, 1992, J BACTERIOL, V174, P4070, DOI 10.1128/jb.174.12.4070-4077.1992; FOOTE S, 1992, SCIENCE, V258, P60, DOI 10.1126/science.1359640; GREEN ED, 1991, GENOMICS, V11, P548, DOI 10.1016/0888-7543(91)90062-J; HOHEISEL JD, 1993, CELL, V73, P109, DOI 10.1016/0092-8674(93)90164-L; HOLBERTON D, 1988, J MOL BIOL, V204, P789, DOI 10.1016/0022-2836(88)90370-1; KIELECZAWA J, 1992, SCIENCE, V258, P1787, DOI 10.1126/science.1465615; KOHARA Y, 1987, CELL, V50, P495, DOI 10.1016/0092-8674(87)90503-4; LANDER E S, 1988, Genomics, V2, P231; MARTINGALLARDO A, 1992, NAT GENET, V1, P34, DOI 10.1038/ng0492-34; MIZUKAMI T, 1993, CELL, V73, P121, DOI 10.1016/0092-8674(93)90165-M; MOTT R, 1993, NUCLEIC ACIDS RES, V21, P1965, DOI 10.1093/nar/21.8.1965; OLIVER SG, 1992, NATURE, V357, P38, DOI 10.1038/357038a0; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; OLSON MV, 1986, P NATL ACAD SCI USA, V83, P7826, DOI 10.1073/pnas.83.20.7826; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PLUNKETT G, 1993, NUCLEIC ACIDS RES, V21, P3391, DOI 10.1093/nar/21.15.3391; POLYMEROPOULOS MH, 1993, NAT GENET, V4, P381, DOI 10.1038/ng0893-381; POUSTKA A, 1986, TRENDS GENET, V2, P174, DOI 10.1016/0168-9525(86)90219-2; RILES L, 1993, GENETICS, V134, P81; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAMBROOK J, 1988, LABORATORY CLONING L; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; SMITH MW, 1993, GENOMICS, V17, P699, DOI 10.1006/geno.1993.1392; SODERLUND CA, IN PRESS COMP APPL B; SODERLUND CA, 1993, 26TH P HAW INT C SYS, P620; SOGIN ML, 1989, SCIENCE, V243, P75, DOI 10.1126/science.2911720; STALLINGS RL, 1992, GENOMICS, V13, P1031, DOI 10.1016/0888-7543(92)90016-L; STRATHMANN M, 1991, P NATL ACAD SCI USA, V88, P1247, DOI 10.1073/pnas.88.4.1247; TYNAN K, 1992, NUCLEIC ACIDS RES, V20, P1629, DOI 10.1093/nar/20.7.1629; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WILSON RK, 1992, GENOMICS, V13, P1198, DOI 10.1016/0888-7543(92)90038-T	60	60	71	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1994	7	1					40	47		10.1038/ng0594-40	http://dx.doi.org/10.1038/ng0594-40			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NJ842	8075638				2022-12-25	WOS:A1994NJ84200011
J	NICHOLSON, GA; VALENTIJN, LJ; CHERRYSON, AK; KENNERSON, ML; BRAGG, TL; DEKROON, RM; ROSS, DA; POLLARD, JD; MCLEOD, JG; BOLHUIS, PA; BAAS, F				NICHOLSON, GA; VALENTIJN, LJ; CHERRYSON, AK; KENNERSON, ML; BRAGG, TL; DEKROON, RM; ROSS, DA; POLLARD, JD; MCLEOD, JG; BOLHUIS, PA; BAAS, F			A FRAME-SHIFT MUTATION IN THE PMP22 GENE IN HEREDITARY NEUROPATHY WITH LIABILITY TO PRESSURE PALSIES	NATURE GENETICS			English	Article							MARIE-TOOTH DISEASE; PERIPHERAL MYELIN; TOMACULOUS NEUROPATHY; TYPE-1A; DUPLICATION; MECHANISM; DOSAGE; PMP-22	Hereditary neuropathy with liability to pressure palsies (HNPP) has been a associated with a deletion of 1.5 megabases of chromosome 17p. One of four biopsy proven HNPP families that we have studied did not possess this deletion. As the deleted DNA region includes the coding region for a peripheral myelin gene (PMP22), we used single strand conformation analysis to examine this gene for mutations in the non-deleted HNPP family. An abnormal fragment in exon 1 was identified, and sequencing revealed a two base pair deletion in all affected family members. The deletion results in a frame shift, providing strong evidence that this gene has an important role in the pathogenesis of the disease.	ACAD MED CENTRUM AMSTERDAM,DEPT NEUROL,1105 AZ AMSTERDAM,NETHERLANDS; UNIV SYDNEY,DEPT MED,SYDNEY,NSW 2006,AUSTRALIA	University of Amsterdam; Academic Medical Center Amsterdam; University of Sydney	NICHOLSON, GA (corresponding author), UNIV SYDNEY,CONCORD HOSP,MOLEC GENET & MED LAB,SYDNEY,NSW 2139,AUSTRALIA.		Kennerson, Marina L/B-5058-2014; Baas, Frank/F-9574-2010	Baas, Frank/0000-0003-3912-5428; Kennerson, Marina/0000-0003-3332-5074				BARBIERI F, 1990, CLIN NEUROL NEUROSUR, V92, P289, DOI 10.1016/0303-8467(90)90037-6; Bascom R. A., 1992, American Journal of Human Genetics, V51, pA6; BRADLEY WG, 1975, BRAIN, V98, P381, DOI 10.1093/brain/98.3.381; CHANCE PF, 1992, NEUROLOGY, V42, P2295, DOI 10.1212/WNL.42.12.2295; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; DAVIES DM, 1954, LANCET, V2, P266; DAVIES K, 1993, NATURE, V362, P92; EARL CJ, 1964, Q J MED, V33, P481; HAYASAKA H, 1993, NAT GENET, V5, P266; HAYASAKA K, 1992, BIOCHEM BIOPH RES CO, V186, P827, DOI 10.1016/0006-291X(92)90820-B; HAYASAKA K, 1993, NAT GENET, V5, P31, DOI 10.1038/ng0993-31; KULKENS T, 1993, NAT GENET, V5, P35, DOI 10.1038/ng0993-35; LUPSKI JR, 1992, NAT GENET, V1, P29, DOI 10.1038/ng0492-29; MADRID R, 1975, J NEUROL SCI, V25, P415, DOI 10.1016/0022-510X(75)90263-4; MCINTOSH I, 1993, NAT GENET, V4, P219, DOI 10.1038/ng0793-219; MEIER C, 1982, J NEUROL, V228, P73, DOI 10.1007/BF00313754; NICHOLSON GA, 1992, AM J MED GENET, V44, P455, DOI 10.1002/ajmg.1320440414; NICHOLSON GA, 1991, NEUROLOGY, V41, P547, DOI 10.1212/WNL.41.4.547; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; TAYLOR RA, 1960, BRAIN, V83, P113, DOI 10.1093/brain/83.1.113; TRAVIS GH, 1993, NAT GENET, V3, P191, DOI 10.1038/ng0393-191; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166	25	218	219	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1994	6	3					263	266		10.1038/ng0394-263	http://dx.doi.org/10.1038/ng0394-263			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ562	8012388				2022-12-25	WOS:A1994MZ56200013
J	SHIBATA, D; PEINADO, MA; IONOV, Y; MALKHOSYAN, S; PERUCHO, M				SHIBATA, D; PEINADO, MA; IONOV, Y; MALKHOSYAN, S; PERUCHO, M			GENOMIC INSTABILITY IN REPEATED SEQUENCES IS AN EARLY SOMATIC EVENT IN COLORECTAL TUMORIGENESIS THAT PERSISTS AFTER TRANSFORMATION	NATURE GENETICS			English	Article							DNA-REPLICATION; GENE-MUTATIONS; CHAIN-REACTION; CANCER; IDENTIFICATION; MICROSATELLITES; POLYMORPHISMS; MUTAGENESIS; EVOLUTION; CARCINOMA	Genomic instability at simple repeated sequences (SRS) is a landmark for some sporadic and hereditary cancers of the colon. We have identified several human tumour cell lines with up to 1,000-fold increases in mutation rates for endogenous microsatellite sequences, relative to normal cells or tumour cells without the mutator phenotype and show that they are very early events in tumorigenesis. Our in vivo and in vitro results show that the genomic instability persists after transformation and that microsatellite mutations accumulate as consecutive somatic slippage events of a single or a few repeated units. This mechanism may account for the repeat expansions in triplet hereditary diseases and the same defect in replication fidelity in non-polyposis colon cancer could also contribute to the non-mendelian anticipation in these diseases.	CALIF INST BIOL RES,LA JOLLA,CA 92037; UNIV SO CALIF,SCH MED,DEPT PATHOL,LOS ANGELES,CA 90033	University of Southern California			Peinado, Miguel A./A-5591-2008	Peinado, Miguel A./0000-0002-4090-793X; Perucho, Manuel/0000-0002-2169-2662	NCI NIH HHS [CA38579, CA33021] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA038579, R01CA033021] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BECKMANN JS, 1992, GENOMICS, V12, P627, DOI 10.1016/0888-7543(92)90285-Z; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; BRATTAIN MG, 1981, CANCER RES, V41, P1751; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; DEXTER DL, 1979, CANCER RES, V39, P1020; FASHENA SJ, 1992, MOL CELL BIOL, V12, P894, DOI 10.1128/MCB.12.2.894; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FEARON ER, 1992, FASEB J, V6, P2783, DOI 10.1096/fasebj.6.10.1321771; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; FOULDS L, 1954, CANCER RES, V14, P327; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; HEARNE CM, 1992, TRENDS GENET, V8, P288, DOI 10.1016/0168-9525(92)90256-4; IONOV J, 1993, NATURE, V363, P658; KERN SE, 1993, J NATL CANCER I, V85, P1020, DOI 10.1093/jnci/85.13.1020; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; KUNKEL TA, 1992, BIOESSAYS, V14, P303, DOI 10.1002/bies.950140503; KUNKEL TA, 1986, J BIOL CHEM, V261, P3581; KUNKEL TA, 1993, NATURE, V365, P207, DOI 10.1038/365207a0; LASKO D, 1991, ANNU REV GENET, V25, P281, DOI 10.1146/annurev.ge.25.120191.001433; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; LEITH JT, 1986, MAMMALIAN TUMOUR CEL; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; LINDBLOM A, 1993, NAT GENET, V5, P279, DOI 10.1038/ng1193-279; LOEB LA, 1974, CANCER RES, V34, P2311; LYNCH HT, 1988, J NATL CANCER I, V80, P278, DOI 10.1093/jnci/80.4.278; LYNCH HT, 1991, CANCER GENET CYTOGEN, V143, P160; MANDEL JL, 1993, NAT GENET, V4, P8, DOI 10.1038/ng0593-8; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NAUMOVA A, IN PRESS AM J HUM GE; NELSON RL, 1972, J THEOR BIOL, V37, P197, DOI 10.1016/0022-5193(72)90127-0; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; PARDUE ML, 1991, CELL, V66, P427, DOI 10.1016/0092-8674(81)90007-6; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; PEINADO MA, 1992, P NATL ACAD SCI USA, V89, P10065, DOI 10.1073/pnas.89.21.10065; PEINADO MA, 1993, INT J ONCOL, V2, P123; PELTOMAKI P, 1993, SCIENCE, V260, P810, DOI 10.1126/science.8484120; RICHARDS RI, 1992, CELL, V70, P709, DOI 10.1016/0092-8674(92)90302-S; RIPLEY LS, 1990, ANNU REV GENET, V24, P189, DOI 10.1146/annurev.ge.24.120190.001201; SHIBATA D, 1993, J NATL CANCER I, V85, P1058, DOI 10.1093/jnci/85.13.1058; SHIBATA D, 1992, AM J PATHOL, V141, P1; Sinden Richard R., 1992, Current Opinion in Biotechnology, V3, P612, DOI 10.1016/0958-1669(92)90005-4; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; SUGARBAKER P, 1985, CANCER PRINCIPLES PR, P814; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; TORN BH, 1976, IN VITRO, V12, P180; TRINH TQ, 1991, NATURE, V352, P544, DOI 10.1038/352544a0; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4636, DOI 10.1093/nar/18.15.4636-a; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4640, DOI 10.1093/nar/18.15.4640-a; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4035, DOI 10.1093/nar/18.13.4035; WELSH J, 1990, NUCLEIC ACIDS RES, V18, P7213, DOI 10.1093/nar/18.24.7213	57	470	478	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1994	6	3					273	281		10.1038/ng0394-273	http://dx.doi.org/10.1038/ng0394-273			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ562	8012390				2022-12-25	WOS:A1994MZ56200015
J	SORENSEN, PHB; LESSNICK, SL; LOPEZTERRADA, D; LIU, XF; TRICHE, TJ; DENNY, CT				SORENSEN, PHB; LESSNICK, SL; LOPEZTERRADA, D; LIU, XF; TRICHE, TJ; DENNY, CT			A 2ND EWINGS-SARCOMA TRANSLOCATION, T(2122), FUSES THE EWS GENE TO ANOTHER ETS-FAMILY TRANSCRIPTION FACTOR, ERG	NATURE GENETICS			English	Article							ACUTE LEUKEMIAS; CHROMOSOME-TRANSLOCATION; DROSOPHILA-TRITHORAX; FLI-1	The t(11;22)(q24;q12), present in 85% of Ewing's sarcoma and related tumours, fuses the EWS gene from chromosome 22q12 and the ETS family member, FLI-1 This results in the expression of a chimaeric protein containing the amino-terminal portion of EWS fused to the ETS DNA-binding domain of FLI-1. We have identified a second Ewing's sarcoma translocation, t(21;22)(q22;q12), that fuses EWS to a different ETS family member, the ERG gene located on band 21q22. Identical EWS nucleotide sequences found in the EWS/FLI-1 fusion transcripts are fused to portions of ERG encoding an ETS DNA-binding domain resulting in expression of a hybrid EWS/ERG protein. These findings suggest that fusion of EWS to different members of the ETS family of transcription factor genes may result in the expression of similar disease phenotypes.	UNIV SO CALIF,CHILDRENS HOSP LOS ANGELES,DEPT PATHOL & LAB MED,LOS ANGELES,CA 90027; UNIV CALIF LOS ANGELES,DEPT PEDIAT,GWYNNE HAZEN CHERRY MEM LABS,DIV HEMATOL ONCOL,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,INST MOLEC BIOL,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,JONSSON COMPREHENS CANC CTR,LOS ANGELES,CA 90024	Children's Hospital Los Angeles; University of Southern California; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles								BENDAVID Y, 1991, GENE DEV, V5, P908, DOI 10.1101/gad.5.6.908; DELATTRE O, 1992, Proceedings of the American Association for Cancer Research Annual Meeting, V33, P604; DJABALI M, 1992, NAT GENET, V2, P113, DOI 10.1038/ng1092-113; DOMER PH, 1993, P NATL ACAD SCI USA, V90, P7884, DOI 10.1073/pnas.90.16.7884; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; Gustashaw KM., 1991, ACT CYTOGENETICS LAB, V2; INABA T, 1992, SCIENCE, V257, P531, DOI 10.1126/science.1386162; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; KLEMSZ MJ, 1993, J BIOL CHEM, V268, P5769; LAUTENBERGER JA, 1992, ONCOGENE, V7, P1713; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; Magrath I, 1990, Adv Cancer Res, V55, P133, DOI 10.1016/S0065-230X(08)60470-4; MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; NAKAMURA T, 1993, P NATL ACAD SCI USA, V90, P4631, DOI 10.1073/pnas.90.10.4631; NOURSE J, 1990, CELL, V60, P535, DOI 10.1016/0092-8674(90)90657-Z; PRASAD DDK, 1992, CANCER RES, V52, P5833; RAO VN, 1987, SCIENCE, V237, P635, DOI 10.1126/science.3299708; Sambrook J, 1989, MOL CLONING LABORATO; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOLOMON E, 1991, SCIENCE, V254, P1153, DOI 10.1126/science.1957167; SORENSEN PHB, 1993, DIAGN MOL PATHOL, V2, P147, DOI 10.1097/00019606-199309000-00002; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; TURCCAREL C, 1983, NEW ENGL J MED, V309, P497; TURCCAREL C, 1988, CANCER GENET CYTOGEN, V32, P229, DOI 10.1016/0165-4608(88)90285-3; WANG CY, 1992, J EXP MED, V175, P1391, DOI 10.1084/jem.175.5.1391; WASYLYK B, 1993, EUR J BIOCHEM, V211, P7, DOI 10.1111/j.1432-1033.1993.tb19864.x; WHANGPENG J, 1984, NEW ENGL J MED, V311, P584, DOI 10.1056/NEJM198408303110907; ZUCMAN J, 1993, NAT GENET, V4, P341, DOI 10.1038/ng0893-341	29	616	636	1	18	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1994	6	2					146	151		10.1038/ng0294-146	http://dx.doi.org/10.1038/ng0294-146			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU763	8162068				2022-12-25	WOS:A1994MU76300008
J	HARVEY, M; MCARTHUR, MJ; MONTGOMERY, CA; BUTEL, JS; BRADLEY, A; DONEHOWER, LA				HARVEY, M; MCARTHUR, MJ; MONTGOMERY, CA; BUTEL, JS; BRADLEY, A; DONEHOWER, LA			SPONTANEOUS AND CARCINOGEN-INDUCED TUMORIGENESIS IN P53-DEFICIENT MICE	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR GENE; P53 GENE; GERMLINE MUTATIONS; BREAST-CANCER; P53-GENE; NEOPLASMS; SARCOMAS	Using gene targeting techniques, mice that have been generated with two germ-line p53 null alleles (homozygotes) develop normally but are highly susceptible to early onset spontaneous tumours. Here, we show that mice with a single null p53 allele (heterozygotes) produced in the same way are also susceptible to spontaneous tumours, but with a delayed onset compared to homozygotes. The most frequent tumour type in homozygotes was malignant lymphoma; in heterozygotes, osteosarcomas and soft tissue sarcomas predominated. Heterozygous mice treated with a liver carcinogen, dimethylnitrosamine, showed a decreased survival time in comparison to treated wild type mice, suggesting that the p53-deficient mice may be useful for some in vivo carcinogenesis assays.	BAYLOR COLL MED,HOWARD HUGHES MED INST,HOUSTON,TX 77030; BAYLOR COLL MED,CTR COMPARAT MED,HOUSTON,TX 77030; BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030	Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine	HARVEY, M (corresponding author), BAYLOR COLL MED,DIV MOLEC VIROL,HOUSTON,TX 77030, USA.			Butel, Janet/0000-0002-6876-3245; Bradley, Allan/0000-0002-2349-8839	NCI NIH HHS [CA54897] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA054897] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BENDAVID Y, 1991, CELL, V66, P831, DOI 10.1016/0092-8674(91)90428-2; BURNS PA, 1991, ONCOGENE, V6, P2363; CHANG FJ, 1993, AM J GASTROENTEROL, V88, P174; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; DEFROMENTEL CC, 1992, GENE CHROMOSOME CANC, V4, P1; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; FARMER G, 1992, NATURE, V358, P83, DOI 10.1038/358083a0; FOURNIER P, 1990, J TOXICOL CLIN EXPER, V10, P283; HANSEN MF, 1987, CANCER RES, V47, P5518; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KEMP CJ, 1993, CELL, V74, P813, DOI 10.1016/0092-8674(93)90461-X; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; LAVIGUEUR A, 1989, MOL CELL BIOL, V9, P3982, DOI 10.1128/MCB.9.9.3982; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; LIVINGSTONE L, 1968, CELL, V41, P1213; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MALKIN D, 1992, NEW ENGL J MED, V326, P1309, DOI 10.1056/NEJM199205143262002; MASUDA H, 1987, P NATL ACAD SCI USA, V84, P7716, DOI 10.1073/pnas.84.21.7716; MILLER RW, 1974, J PEDIATR-US, V85, P664, DOI 10.1016/S0022-3476(74)80511-1; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; MOLL UM, 1992, P NATL ACAD SCI USA, V89, P7262, DOI 10.1073/pnas.89.15.7262; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; PARKIN DM, 1988, INT INCIDENCE CHILDH, V87, P101; PREUDHOMME C, 1992, BRIT J HAEMATOL, V81, P440, DOI 10.1111/j.1365-2141.1992.tb08253.x; PRITCHARD DJ, 1989, J PATHOL, V158, P253, DOI 10.1002/path.1711580314; SAYLORS RL, 1991, CANCER RES, V51, P4721; SRIVASTAVA S, 1990, NATURE, V348, P747, DOI 10.1038/348747a0; TOGUCHIDA J, 1992, NEW ENGL J MED, V326, P1301, DOI 10.1056/NEJM199205143262001; Triche Timothy J., 1993, P2144; TSUSHITA K, 1992, BRIT J HAEMATOL, V81, P456, DOI 10.1111/j.1365-2141.1992.tb08263.x; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7	33	480	489	0	14	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1993	5	3					225	229		10.1038/ng1193-225	http://dx.doi.org/10.1038/ng1193-225			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MF122	8275085				2022-12-25	WOS:A1993MF12200010
J	ROA, BB; GARCIA, CA; LIU, PT; KILLIAN, JM; TRASK, BJ; SUTER, U; SNIPES, GJ; ORTIZLOPEZ, R; SHOOTER, EM; PATEL, PI; LUPSKI, JR				ROA, BB; GARCIA, CA; LIU, PT; KILLIAN, JM; TRASK, BJ; SUTER, U; SNIPES, GJ; ORTIZLOPEZ, R; SHOOTER, EM; PATEL, PI; LUPSKI, JR			EVIDENCE FOR A RECESSIVE PMP22 POINT MUTATION IN CHARCOT-MARIE-TOOTH DISEASE TYPE-1A	NATURE GENETICS			English	Article							PERIPHERAL MYELIN PROTEIN; NEUROPATHY TYPE-I; TREMBLER-J MOUSE; HEREDITARY MOTOR; SENSORY NEUROPATHY; GENE DOSAGE; DUPLICATION; LINKAGE; MECHANISM; RHODOPSIN	Charcot-Marie-Tooth disease type 1A (CMT1A) is an autosomal dominant neuropathy that can be caused by dominant point mutations in PMP22 which encodes a peripheral nerve myelin protein. Usually, CMT1A is caused by the duplication of a 1.5-megabase (Mb) region on chromosome 17p11.2-p12 containing PMP22. Deletion of a similar 1.5-Mb region is associated with hereditary neuropathy with liability to pressure palsies (HNPP), a clinically distinct neuropathy. We have identified a severely affected CMT1 patient who is a compound heterozygote for a recessive PMP22 point mutation, and a 1.5 Mb deletion in 17p11.2-p12. A son heterozygous for the PMP22 point mutation had no signs of neuropathy, while two others heterozygous for the deletion had HNPP, suggesting that point mutations in PMP22 can result in dominant and recessive alleles contributing to CMT1A.	BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT NEUROL,HOUSTON,TX 77030; BAYLOR COLL MED,CTR HUMAN GENOME,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; LOUISIANA STATE UNIV,SCH MED,DEPT NEUROL,NEW ORLEANS,LA 70122; LOUISIANA STATE UNIV,SCH MED,DEPT PATHOL,NEW ORLEANS,LA 70122; UNIV WASHINGTON,DEPT MOLEC BIOTECHNOL,SEATTLE,WA 98195; SWISS FED INST TECHNOL,DEPT CELL BIOL,CH-8093 ZURICH,SWITZERLAND; STANFORD UNIV,MED CTR,SCH MED,DEPT NEUROBIOL,STANFORD,CA 94305; STANFORD UNIV,MED CTR,SCH MED,DEPT NEUROPATHOL,STANFORD,CA 94305	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Louisiana State University System; Louisiana State University System; University of Washington; University of Washington Seattle; Swiss Federal Institutes of Technology Domain; ETH Zurich; Stanford University; Stanford University			Suter, Ueli/A-1624-2010; Ortiz-Lopez, Rocio/N-4827-2018; Ortiz-Lopez, Rocio/F-7020-2014; Patel, Pragna/H-9129-2017	Ortiz-Lopez, Rocio/0000-0002-7783-026X; Ortiz-Lopez, Rocio/0000-0002-7783-026X; Patel, Pragna/0000-0003-3584-1072				Allan W, 1939, ARCH INTERN MED, V63, P1123, DOI 10.1001/archinte.1939.00180230108008; BICKEL S, 1990, EMBO J, V9, P2959, DOI 10.1002/j.1460-2075.1990.tb07488.x; BIRD TD, 1982, AM J HUM GENET, V34, P388; BRUST J C M, 1978, Acta Neurologica Scandinavica Supplementum, V58, P1; CHANCE PF, 1992, NEUROLOGY, V42, P2295, DOI 10.1212/WNL.42.12.2295; CHANCE PF, 1990, AM J HUM GENET, V47, P915; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; CHANCE PF, 1992, NEUROLOGY, V42, P2037, DOI 10.1212/WNL.42.10.2037; Charcot JM, 1886, REV MED-PARIS, V6, P97; COOPER DN, 1990, HUM GENET, V85, P55; DAVIS CJF, 1978, J GENET HUM, V26, P311; Dejerine J J, 1893, COMPTES RENDUS SOC B, V45, P63; DYCK PJ, 1968, ARCH NEUROL-CHICAGO, V18, P603, DOI 10.1001/archneur.1968.00470360025002; DYCK PJ, 1992, PERIPHERAL NEUROPATH, P1094; GABREELSFESTEN AAWM, 1992, NEUROLOGY, V42, P1755, DOI 10.1212/WNL.42.9.1755; HARDING AE, 1980, J NEUROL NEUROSUR PS, V43, P669, DOI 10.1136/jnnp.43.8.669; KAKU DA, IN PRESS NEUROLOGY; LEBO RV, 1991, HUM GENET, V88, P13, DOI 10.1007/BF00204922; LUPSKI JR, 1992, NAT GENET, V1, P29, DOI 10.1038/ng0492-29; LUPSKI JR, 1992, CLIN RES, V40, P645; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; LUPSKI JR, 1992, BRAIN PATHOL, V2, P337, DOI 10.1111/j.1750-3639.1992.tb00710.x; LUPSKI JR, 1991, CURRENT NEUROLOGY; MATSUNAMI N, 1992, NAT GENET, V1, P176, DOI 10.1038/ng0692-176; MCINNES RR, 1992, NAT GENET, V1, P155, DOI 10.1038/ng0692-155; McKusick V.A., 1992, MENDELIAN INHERITANC; Muller H.J, 1932, P 6 INT C GEN, V1, P213; PATEL PI, 1990, AM J HUM GENET, V47, P926; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; RAEYMAEKERS P, 1992, J MED GENET, V29, P5, DOI 10.1136/jmg.29.1.5; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; ROA BB, 1993, AM J MED SCI, V306, P177, DOI 10.1097/00000441-199309000-00010; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; SKRE H, 1974, CLIN GENET, V6, P98; SNIPES GJ, 1992, J CELL BIOL, V117, P225, DOI 10.1083/jcb.117.1.225; SUTER U, 1992, P NATL ACAD SCI USA, V89, P4382, DOI 10.1073/pnas.89.10.4382; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; TIMMERMAN V, 1992, NAT GENET, V1, P171, DOI 10.1038/ng0692-171; TOOTH H, 1986, PERONEAL TYPE PROGRE; UPADHYAYA M, 1993, HUM GENET, V91, P392; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166; VANCE JM, 1989, EXP NEUROL, V104, P186, DOI 10.1016/S0014-4886(89)80013-5; VANCE JM, 1991, J MED GENET, V28, P1, DOI 10.1136/jmg.28.1.1; WINDEBANK AJ, 1992, PERIPHERAL NEUROPATH, P1137; WISE CA, 1993, AM J HUM GENET, V53, P853	48	174	175	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1993	5	2					189	194		10.1038/ng1093-189	http://dx.doi.org/10.1038/ng1093-189			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MA056	8252046				2022-12-25	WOS:A1993MA05600019
J	ZHANG, YL; CHEN, HS; KHANNA, VK; DELEON, S; PHILLIPS, MS; SCHAPPERT, K; BRITT, BA; BROWNELL, AKW; MACLENNAN, DH				ZHANG, YL; CHEN, HS; KHANNA, VK; DELEON, S; PHILLIPS, MS; SCHAPPERT, K; BRITT, BA; BROWNELL, AKW; MACLENNAN, DH			A MUTATION IN THE HUMAN RYANODINE RECEPTOR GENE ASSOCIATED WITH CENTRAL CORE DISEASE	NATURE GENETICS			English	Article							MALIGNANT HYPERTHERMIA SUSCEPTIBILITY; MUSCLE SARCOPLASMIC-RETICULUM; PROBABLE CAUSAL MUTATION; MOLECULAR-CLONING; CHROMOSOME-19; PORCINE; LINKAGE; DNA; HETEROGENEITY; SUBSTITUTION	Central core disease (CCD) is a morphologically distinct, autosomal dominant myopathy with variable clinical features. A close association with malignant hypertheria (MH) has been identified. Since MH and CCD genes have been linked to the skeletal muscle ryanodine receptor (RYR1) gene, cDNA sequence analysis was used to search for a causal RYR1 mutation in a CCD individual. The only amino acid substitution found was an Arg2434His mutation, resulting from the substitution of A for G7301. This mutation was linked to CCD with a lod score of 4.8 at a recombinant fraction of 0.0 in 16 informative meioses in a 130 member family, suggesting a causal relationship to CCD.	UNIV TORONTO,CHARLES H BEST INST,BANTING & BEST DEPT MED RES,112 COLL ST,TORONTO M5G 1L6,ONTARIO,CANADA; HOSP SICK CHILDREN,CANADIAN GENET DIS NETWORK CORE SEQUENCING FACIL,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,DEPT ANESTHESIA,TORONTO M5G 2C4,ON,CANADA; UNIV CALGARY,DEPT CLIN NEUROSCI,CALGARY T2N 1N4,ALBERTA,CANADA; FOOTHILLS PROV GEN HOSP,CALGARY T2N 2T9,AB,CANADA	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Calgary; University of Calgary								BANKER BQ, 1986, MYOLOGY, P1528; BRITT BA, 1989, MALIGNANT HYPERTHERM, P53; BROWNELL AKW, 1988, BRIT J ANAESTH, V60, P303, DOI 10.1093/bja/60.3.303; CALDWELL JH, 1992, NAT GENET, V2, P87, DOI 10.1038/ng1092-87; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.biochem.56.1.395; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DENBOROUGH MA, 1973, BMJ-BRIT MED J, V1, P272, DOI 10.1136/bmj.1.5848.272; DEUFEL T, 1992, AM J HUM GENET, V50, P1151; DUBOWITZ V, 1965, J NEUROL NEUROSUR PS, V28, P432, DOI 10.1136/jnnp.28.5.432; ENG GD, 1978, ARCH NEUROL-CHICAGO, V35, P189, DOI 10.1001/archneur.1978.00500280007002; FRANK JP, 1980, ANN NEUROL, V7, P11, DOI 10.1002/ana.410070105; FUJII J, 1991, SCIENCE, V253, P448, DOI 10.1126/science.1862346; GILLARD EF, 1991, GENOMICS, V11, P751, DOI 10.1016/0888-7543(91)90084-R; GILLARD EF, 1992, GENOMICS, V13, P1247, DOI 10.1016/0888-7543(92)90042-Q; HAAN EA, 1990, HUM GENET, V86, P187; HOGAN K, 1992, ANESTH ANALG, V75, P441; KAUSCH K, 1991, GENOMICS, V10, P765, DOI 10.1016/0888-7543(91)90461-M; LEVITT RC, 1991, GENOMICS, V11, P543, DOI 10.1016/0888-7543(91)90061-I; MACKENZIE AE, 1990, AM J HUM GENET, V46, P1082; MACLENNAN DH, 1992, SCIENCE, V256, P789, DOI 10.1126/science.1589759; MACLENNAN DH, 1990, NATURE, V343, P559, DOI 10.1038/343559a0; MCCARTHY TV, 1990, NATURE, V343, P562, DOI 10.1038/343562a0; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MULLEY JC, 1993, AM J HUM GENET, V52, P398; OTSU K, 1991, GENOMICS, V11, P744, DOI 10.1016/0888-7543(91)90083-Q; OTSU K, 1990, J BIOL CHEM, V265, P13472; OTSU K, 1992, GENOMICS, V13, P835, DOI 10.1016/0888-7543(92)90163-M; OTT J, 1976, AM J HUM GENET, V28, P528; PATTERSON VH, 1979, BRAIN, V102, P581, DOI 10.1093/brain/102.3.581; RAMSEY PL, 1975, J BONE JOINT SURG AM, V57, P648, DOI 10.2106/00004623-197557050-00011; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SHUAIB A, 1987, MEDICINE, V66, P389, DOI 10.1097/00005792-198709000-00004; SHY GM, 1956, BRAIN, V79, P610, DOI 10.1093/brain/79.4.610; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; WALSH MP, 1986, ANESTHESIOLOGY, V64, P473, DOI 10.1097/00000542-198604000-00010; WANG AM, 1989, P NATL ACAD SCI USA, V89, P9719; WROGEMANN K, 1976, LANCET, V1, P672; ZORZATO F, 1990, J BIOL CHEM, V265, P2244	38	274	281	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1993	5	1					46	50		10.1038/ng0993-46	http://dx.doi.org/10.1038/ng0993-46			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LV565	8220422				2022-12-25	WOS:A1993LV56500014
J	WHITNEY, MA; SAITO, H; JAKOBS, PM; GIBSON, RA; MOSES, RE; GROMPE, M				WHITNEY, MA; SAITO, H; JAKOBS, PM; GIBSON, RA; MOSES, RE; GROMPE, M			A COMMON MUTATION IN THE FACC GENE CAUSES FANCONI-ANEMIA IN ASHKENAZI JEWS	NATURE GENETICS			English	Article							SEQUENCE STATISTICS; PRENATAL-DIAGNOSIS; SPLICE JUNCTIONS; CELL LINES; DNA; ANEMIA; HETEROGENEITY	Fanconi anaemia is an autosomal recessive disease for which four known complementation groups exist. Recently, the gene defective in complementation group C (FACC) has been cloned. In order to determine the fraction of Fanconi anaemia caused by FACC mutations, we used reverse transcription PCR and chemical mismatch cleavage (CMC) to examine the FACC cDNA in 17 FA cell lines. 4/17 patients (23.5%) had mutations in this gene. Two Ashkenazi-Jewish individuals were homozygous for an identical splice mutation. Three additional Jewish patients bearing this allele were found upon screening 21 other families. We conclude that a common mutation in FACC accounts for the majority of Fanconi anaemia in Ashkenazi-Jewish families.	OREGON HLTH SCI UNIV, DEPT MOLEC & MED GENET, 3181 SAM JACKSON PK RD, L 103, PORTLAND, OR 97201 USA; UMDS, GUYS HOSP, DIV MED & MOLEC GENET, LONDON SE1 9RT, ENGLAND; OREGON HLTH SCI UNIV, DEPT PEDIAT, PORTLAND, OR 97201 USA	Oregon Health & Science University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Oregon Health & Science University				Grompe, Markus/0000-0002-6616-4345; Gibson, Rachel/0000-0002-1338-1290				AUERBACH AD, 1986, HUM GENET, V73, P86, DOI 10.1007/BF00292671; AUERBACH AD, 1992, LINKAGE FANCONI ANEM, P18; BEUTLER E, 1992, BLOOD, V79, P1662; BILLARDON B, 1986, MUTAT RES, V174, P241, DOI 10.1016/0165-7992(86)90158-2; BOYD JB, 1992, GENETIC MOL ANAL DRO, P15; BUCHWALD M, 1992, CLONING FANCONI ANEM, P1; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COHEN MM, 1979, CYTOGENET CELL GENET, V23, P44, DOI 10.1159/000131301; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; COTTON RGH, 1991, ADV GENOME BIOL UNFO, V1, P253; FANCONI G., 1967, SEMINARS HAMATOL, V4, P233; GIBSON RA, IN PRESS HUM MOL GEN; GRAVEL RA, 1991, CAN J NEUROL SCI; GROMPE M, 1989, P NATL ACAD SCI USA, V86, P5888, DOI 10.1073/pnas.86.15.5888; HODGES PE, 1989, P NATL ACAD SCI USA, V86, P4142, DOI 10.1073/pnas.86.11.4142; KOBAYASHI K, 1990, J BIOL CHEM, V265, P11361; KOGAN SC, 1987, NEW ENGL J MED, V317, P985, DOI 10.1056/NEJM198710153171603; MANN WR, 1991, GENOMICS, V9, P329, DOI 10.1016/0888-7543(91)90261-C; MONONEN I, 1992, J BIOL CHEM, V267, P3196; MOSES RE, 1978, NUCLEIC ACIDS RES, V5, P463, DOI 10.1093/nar/5.2.463; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NIENHUIS AW, 1992, GENE THERAPY APPROAC, P34; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; STRATHDEE CA, 1992, NAT GENET, V1, P196, DOI 10.1038/ng0692-196; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; SUN Y, 1991, SOMAT CELL MOLEC GEN, V17, P229, DOI 10.1007/BF01232819; WU DY, 1989, DNA-J MOLEC CELL BIO, V8, P135, DOI 10.1089/dna.1.1989.8.135	30	129	131	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1993	4	2					202	205		10.1038/ng0693-202	http://dx.doi.org/10.1038/ng0693-202			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LF816	8348157				2022-12-25	WOS:A1993LF81600024
J	MATSUO, T; OSUMIYAMASHITA, N; NOJI, S; OHUCHI, H; KOYAMA, E; MYOKAI, F; MATSUO, N; TANIGUCHI, S; DOI, H; ISEKI, S; NINOMIYA, Y; FUJIWARA, M; WATANABE, T; ETO, K				MATSUO, T; OSUMIYAMASHITA, N; NOJI, S; OHUCHI, H; KOYAMA, E; MYOKAI, F; MATSUO, N; TANIGUCHI, S; DOI, H; ISEKI, S; NINOMIYA, Y; FUJIWARA, M; WATANABE, T; ETO, K			A MUTATION IN THE PAX-6 GENE IN RAT SMALL-EYE IS ASSOCIATED WITH IMPAIRED MIGRATION OF MIDBRAIN CREST CELLS	NATURE GENETICS			English	Article							BETA-GLOBIN GENE; POINT MUTATION; SPLICE JUNCTION; NEURAL-TUBE; DEFECT; SITE; THALASSEMIA; DEFICIENCY; DELETION; DISEASE	The rat small eye strain (rSey) lacks eyes and nose in the homozygote, an is similar the mouse Sey strain with mutations in the Pax-6 gene. We isolated Pax-6 cDNA clones from an rSey homozygote library, and found an internal deletion of about 600 basepairs in the serine/threonine-rich domain. At the genomic level, a single base (G) insertion in an exon generates an abnormal 5' donor splice site, thereby producing the truncated mRNA. Anterior midbrain crest cells in the homozygous rSey embryos reached the eye rudiments but did not migrate any further to the nasal rudiments, suggesting that the Pax-6 gene is involved in conducting migration of neural crest cells from the anterior midbrain.	OKAYAMA UNIV,SCH MED,DEPT OPHTHALMOL,OKAYAMA 700,JAPAN; OKAYAMA UNIV,SCH DENT,DEPT BIOCHEM,OKAYAMA 700,JAPAN; TOKYO MED & DENT UNIV,GRAD SCH DENT,DEPT DEV BIOL,DIV LIFE SCI MAXILLOFACIAL SYST,TOKYO 113,JAPAN; UNIV TOKUSHIMA,FAC ENGN,DEPT BIOL SCI & TECHNOL,TOKUSHIMA 770,JAPAN; FUJITSU LABS LTD,IIAS,BIOL INFORMAT SECT,CHIBA 261,JAPAN; YAMANOUCHI PHARMACEUT CO LTD,SAFETY RES LABS,TOKYO 174,JAPAN	Okayama University; Okayama University; Tokyo Medical & Dental University (TMDU); Tokushima University; Fujitsu Ltd; Fujitsu Laboratories Ltd; Astellas Pharmaceuticals			Osumi, Noriko/T-2823-2019	Osumi, Noriko/0000-0003-0548-6452; Ninomiya, Youichirou/0000-0003-3572-2532				ATWEH GF, 1987, BLOOD, V70, P147; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; DILELLA AG, 1986, NATURE, V322, P799, DOI 10.1038/322799a0; DOBKIN C, 1983, P NATL ACAD SCI-BIOL, V80, P1184, DOI 10.1073/pnas.80.5.1184; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; FUKIISHI Y, 1992, CELL TISSUE RES, V268, P1, DOI 10.1007/BF00338048; GLASER T, 1990, SCIENCE, V250, P823, DOI 10.1126/science.2173141; GLASER T, 1992, NAT GENET, V2, P232, DOI 10.1038/ng1192-232; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; GRUSS P, 1992, CELL, V69, P719, DOI 10.1016/0092-8674(92)90281-G; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HOGAN BLM, 1988, DEVELOPMENT, V103, P115; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; MOASE CE, 1991, DEVELOPMENT, V113, P1049; MYEROWITZ R, 1988, P NATL ACAD SCI USA, V85, P3955, DOI 10.1073/pnas.85.11.3955; NAKAJIMA H, 1990, J BIOL CHEM, V265, P9392; NAKANO T, 1989, J BIOL CHEM, V264, P5155; NELSON C, 1992, J BIOL CHEM, V267, P3351; NOJI S, 1989, FEBS LETT, V257, P93, DOI 10.1016/0014-5793(89)81794-6; OSUMIYAMASHITA N, 1992, CRANIOFAC GENET DEV, V12, P130; PARKINSON DB, 1992, NAT GENET, V1, P149, DOI 10.1038/ng0592-149; REES DJG, 1985, NATURE, V316, P643, DOI 10.1038/316643a0; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; SERBEDZIJA GN, 1992, DEVELOPMENT, V116, P297; SU TS, 1990, J BIOL CHEM, V265, P19716; TAKEUCHI T, 1990, ENDOCRINOLOGY, V126, P31, DOI 10.1210/endo-126-1-31; TAN SS, 1986, J EMBRYOL EXP MORPH, V98, P21; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TON CCT, 1991, CELL, V67, P1089; TREISMAN R, 1983, NATURE, V302, P591, DOI 10.1038/302591a0; WALTHER C, 1991, GENOMICS, V11, P424, DOI 10.1016/0888-7543(91)90151-4; WALTHER C, 1991, DEVELOPMENT, V113, P1435	34	268	271	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1993	3	4					299	304		10.1038/ng0493-299	http://dx.doi.org/10.1038/ng0493-299			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KW257	7981749				2022-12-25	WOS:A1993KW25700009
J	MATSUDA, F; SHIN, EK; NAGAOKA, H; MATSUMURA, R; HAINO, M; FUKITA, Y; TAKAISHI, S; IMAI, T; RILEY, JH; ANAND, R; SOEDA, E; HONJO, T				MATSUDA, F; SHIN, EK; NAGAOKA, H; MATSUMURA, R; HAINO, M; FUKITA, Y; TAKAISHI, S; IMAI, T; RILEY, JH; ANAND, R; SOEDA, E; HONJO, T			STRUCTURE AND PHYSICAL MAP OF 64 VARIABLE SEGMENTS IN THE 3(I)0.8-MEGABASE REGION OF THE HUMAN-IMMUNOGLOBULIN HEAVY-CHAIN LOCUS	NATURE GENETICS			English	Article							ARTIFICIAL-CHROMOSOME LIBRARIES; HUMAN MONOCLONAL-ANTIBODY; VH GENE SUBGROUPS; GERM-LINE GENES; B-CELL LINES; NUCLEOTIDE-SEQUENCES; PREFERENTIAL UTILIZATION; RHEUMATOID-ARTHRITIS; GEL-ELECTROPHORESIS; DNA AUTOANTIBODIES	We have constructed the physical map of the 0.8 megabase DNA fragment which contains the 3' 64 variable region (V) gene segments of the human immunoglobulin heavy chain (H) locus. The organization of the V(H) locus showed several features that indicate dynamic reshuffling of this locus. The sequenced 64 V(H) segments include 31 pseudogenes, of which 24 are highly conserved except for a few point mutations. Comparison of the 64 germline V(H) sequences shows that each V(H) family has conserved sequences, suggesting that there might be some genetic or selection mechanisms involved in maintenance of each family. The total number of the human V(H) segments was estimated to be about 120, including at least 7 orphons.	KYOTO UNIV,FAC MED,CTR MOLEC BIOL,SAKYO KU,KYOTO 606,JAPAN; KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN; INST PHYS & CHEM RES,TSUKUBA LIFE SCI CTR,GENE BANK,TSUKUBA,IBARAKI 305,JAPAN; ICI PHARMACEUT PLC,DEPT BIOTECHNOL,MACCLESFIELD SK10 4TG,CHESHIRE,ENGLAND	Kyoto University; Kyoto University; RIKEN			Takaishi, Shigeo/AAS-3319-2021; Matsuda, Fumihiko/B-9893-2009; Honjo, Tasuku/N-4470-2016					ADDERSON EE, 1991, J IMMUNOL, V147, P1667; AKAHORI Y, 1990, J CLIN INVEST, V85, P1722, DOI 10.1172/JCI114627; ALEXANDER A, 1988, J CLIN INVEST, V82, P1244, DOI 10.1172/JCI113722; ANAND R, 1989, NUCLEIC ACIDS RES, V17, P3425, DOI 10.1093/nar/17.9.3425; BERMAN JE, 1988, EMBO J, V7, P723; BRODEUR PH, 1988, J EXP MED, V168, P2261, DOI 10.1084/jem.168.6.2261; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; CAIRNS E, 1989, J IMMUNOL, V143, P685; CHEN PP, 1990, SCAND J IMMUNOL, V31, P257, DOI 10.1111/j.1365-3083.1990.tb02767.x; CHERIF D, 1990, GENE CHROMOSOME CANC, V2, P103, DOI 10.1002/gcc.2870020205; CROCE CM, 1979, P NATL ACAD SCI USA, V76, P3416, DOI 10.1073/pnas.76.7.3416; DERSIMONIAN H, 1989, J IMMUNOL, V142, P4027; DERSIMONIAN H, 1987, J IMMUNOL, V139, P2496; EBELING SB, 1992, INT IMMUNOL, V4, P313, DOI 10.1093/intimm/4.3.313; FELGENHAUER M, 1990, NUCLEIC ACIDS RES, V18, P4927, DOI 10.1093/nar/18.16.4927; FRIEDMAN DF, 1991, J EXP MED, V174, P525, DOI 10.1084/jem.174.3.525; GIBSON TJ, 1987, GENE, V53, P275, DOI 10.1016/0378-1119(87)90016-3; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; HARINDRANATH N, 1991, INT IMMUNOL, V3, P865, DOI 10.1093/intimm/3.9.865; HONJO T, 1985, ANNU REV BIOCHEM, V54, P803, DOI 10.1146/annurev.bi.54.070185.004103; HUGHESJONES NC, 1990, BIOCHEM J, V268, P135, DOI 10.1042/bj2680135; HUMPHRIES CG, 1988, NATURE, V331, P446, DOI 10.1038/331446a0; IMAI T, 1990, GENOMICS, V8, P297, DOI 10.1016/0888-7543(90)90285-3; Kabat EA, 1991, SEQUENCES PROTEINS I; KISHIMOTO T, 1989, NUCLEIC ACIDS RES, V17, P4385, DOI 10.1093/nar/17.11.4385; KODAIRA M, 1986, J MOL BIOL, V190, P529, DOI 10.1016/0022-2836(86)90239-1; LEE KH, 1987, J MOL BIOL, V195, P761, DOI 10.1016/0022-2836(87)90482-7; LORENZ W, 1987, NUCLEIC ACIDS RES, V15, P9667, DOI 10.1093/nar/15.23.9667; MATSUDA F, 1990, EMBO J, V9, P2501, DOI 10.1002/j.1460-2075.1990.tb07429.x; MATSUDA F, 1988, EMBO J, V7, P1047, DOI 10.1002/j.1460-2075.1988.tb02912.x; MATTHYSSENS G, 1980, P NATL ACAD SCI-BIOL, V77, P6561, DOI 10.1073/pnas.77.11.6561; MILLI M, 1991, MOL IMMUNOL, V28, P753; MORTARI F, 1992, EUR J IMMUNOL, V22, P241, DOI 10.1002/eji.1830220135; NICKERSON KG, 1989, J EXP MED, V169, P1391, DOI 10.1084/jem.169.4.1391; NISHIDA Y, 1982, P NATL ACAD SCI-BIOL, V79, P3833, DOI 10.1073/pnas.79.12.3833; PASCUAL V, 1990, J CLIN INVEST, V86, P1320, DOI 10.1172/JCI114841; RECHAVI G, 1982, P NATL ACAD SCI-BIOL, V79, P4405, DOI 10.1073/pnas.79.14.4405; RECHAVI G, 1983, P NATL ACAD SCI-BIOL, V80, P855, DOI 10.1073/pnas.80.3.855; Sambrook J, 1989, MOL CLONING LABORATO; SANZ I, 1989, J IMMUNOL, V142, P4054; SANZ I, 1989, J IMMUNOL, V142, P883; SANZ I, 1989, EMBO J, V8, P3471; SCHROEDER HW, 1990, P NATL ACAD SCI USA, V87, P6146, DOI 10.1073/pnas.87.16.6146; SCHROEDER HW, 1987, SCIENCE, V238, P791, DOI 10.1126/science.3118465; SHEN A, 1987, P NATL ACAD SCI USA, V84, P8563, DOI 10.1073/pnas.84.23.8563; SHIN EK, 1991, EMBO J, V10, P3641, DOI 10.1002/j.1460-2075.1991.tb04930.x; SILVERSTEIN LE, 1989, J EXP MED, V169, P1631; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TAKAHASHI N, 1984, P NATL ACAD SCI-BIOL, V81, P5194, DOI 10.1073/pnas.81.16.5194; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; WALTER MA, 1991, J CLIN INVEST, V87, P1266, DOI 10.1172/JCI115128; WALTER MA, 1990, EMBO J, V9, P3303, DOI 10.1002/j.1460-2075.1990.tb07530.x; YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0; YANG PH, 1990, P NATL ACAD SCI USA, V88, P7907	54	337	412	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1993	3	1					88	94		10.1038/ng0193-88	http://dx.doi.org/10.1038/ng0193-88			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KF372	8490662				2022-12-25	WOS:A1993KF37200019
J	Sharpe, P				Sharpe, P			HOX gene mutations - The wait is over	NATURE MEDICINE			English	Editorial Material											Sharpe, P (corresponding author), UNITED MED & DENT SCH,GUYS HOSP,DEPT CRANIOFACIAL DEV,LONDON SE1 9RT,ENGLAND.							Brunelli S, 1996, NAT GENET, V12, P94, DOI 10.1038/ng0196-94; Catron KM, 1996, MECH DEVELOP, V55, P185, DOI 10.1016/0925-4773(96)00503-5; DOLLE P, 1993, CELL, V75, P431, DOI 10.1016/0092-8674(93)90378-4; IZPISUABELMONTE JC, 1991, NATURE, V350, P585, DOI 10.1038/350585a0; JABS EW, 1993, CELL, V75, P443, DOI 10.1016/0092-8674(93)90379-5; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Mortlock DP, 1996, NAT GENET, V13, P284, DOI 10.1038/ng0796-284; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; UWANOGHO D, 1995, MECH DEVELOP, V49, P23, DOI 10.1016/0925-4773(94)00299-3; YOKOUCHI Y, 1995, GENE DEV, V9, P2509, DOI 10.1101/gad.9.20.2509	10	3	3	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUL	1996	2	7					748	749		10.1038/nm0796-748	http://dx.doi.org/10.1038/nm0796-748			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UU680	8673917				2022-12-25	WOS:A1996UU68000027
J	Cioffi, JA; Shafer, AW; Zupancic, TJ; SmithGbur, J; Mikhail, A; Platika, D; Snodgrass, HR				Cioffi, JA; Shafer, AW; Zupancic, TJ; SmithGbur, J; Mikhail, A; Platika, D; Snodgrass, HR			Novel B219/OB receptor isoforms: Possible role of leptin in hematopoiesis and reproduction	NATURE MEDICINE			English	Article							IL-6 SIGNAL TRANSDUCER; STEM-CELLS; MOUSE; EXPRESSION; CLONING; ENRICHMENT; IMMUNE; GP130	Hematopoietic development is a complex process that involves a large number of growth factors and cytokines. Many cytokines are known to act on more mature, lineage-restricted cells of the hematopoietic system(1,2). However, no specific factors have yet been identified that induce the expansion of the most primitive hematopoietic cells without also inducing differentiation. To search for such factors, we isolated novel cell lines from the yolk sac in order to identify genes important in early hematopoietic and endothelial development. This approach led to the discovery of B219, a sequence that is expressed in at least four isoforms in very primitive hematopoietic cell populations and which may represent a novel hemopoietin receptor. The recently published receptor(3) for the obesity (ob) gene product (leptin)(4) is an isoform of B219 with a nearly identical ligand binding domain. B279/obr is expressed in the yolk sac, early fetal liver, enriched hematopoietic stem cells and in a variety of lymphohematopoietic cell lines. B279/obr is also expressed at high levels in adult reproductive organs. B279/obr maps to human chromosome 1p32, a region syntenic with the recently reported location of obr on murine chromosome 4 (ref. 5).	PROGENITOR INC,COLUMBUS,OH 43212; OHIO STATE UNIV,SCH MED,DIV BONE MARROW TRANSPLANTAT,DEPT INTERNAL MED,COLUMBUS,OH 43210	University System of Ohio; Ohio State University								ARAI K, 1990, ANNU REV BIOCHEM, V59, P783, DOI 10.1146/annurev.biochem.59.1.783; BAHARY N, 1990, P NATL ACAD SCI USA, V87, P8642, DOI 10.1073/pnas.87.21.8642; BARRACLOUGH CA, HDB PHYSL 7 1, P29; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; BJORNTORP P, 1993, ANN NY ACAD SCI, V676, P242; BRAY GA, 1979, PHYSIOL REV, V59, P719, DOI 10.1152/physrev.1979.59.3.719; CARLSSON L, 1995, EUR J IMMUNOL, V25, P2308, DOI 10.1002/eji.1830250829; Chehab FE, 1996, NAT GENET, V12, P318, DOI 10.1038/ng0396-318; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Civin C I, 1993, J Hematother, V2, P137, DOI 10.1089/scd.1.1993.2.137; FERNANDES G, 1978, J CLIN INVEST, V61, P243, DOI 10.1172/JCI108933; FUKUNAGA R, 1990, CELL, V61, P341, DOI 10.1016/0092-8674(90)90814-U; GARRIS DR, 1986, ANAT RECORD, V216, P359, DOI 10.1002/ar.1092160304; GEARING DP, 1991, EMBO J, V10, P2839, DOI 10.1002/j.1460-2075.1991.tb07833.x; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; HUANG H, 1993, P NATL ACAD SCI USA, V90, P10110, DOI 10.1073/pnas.90.21.10110; JORDAN CT, 1995, EXP HEMATOL, V23, P1011; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; LEITER EH, 1994, J CLIN INVEST, V93, P2007, DOI 10.1172/JCI117194; LEITER EH, 1989, ENDOCRINOLOGY, V124, P912, DOI 10.1210/endo-124-2-912; MCKEARN JP, 1985, P NATL ACAD SCI USA, V82, P7414, DOI 10.1073/pnas.82.21.7414; METCALF D, 1993, BLOOD, V82, P3515; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; ONO M, 1987, NUCLEIC ACIDS RES, V15, P8725, DOI 10.1093/nar/15.21.8725; SPANGRUDE GJ, 1990, EXP HEMATOL, V18, P920; SZILVASSY SJ, 1993, BLOOD, V81, P2310; TARTAGLIA, 1995, CELL, V83, P1263; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	29	589	637	0	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAY	1996	2	5					585	589		10.1038/nm0596-585	http://dx.doi.org/10.1038/nm0596-585			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UJ230	8616721				2022-12-25	WOS:A1996UJ23000045
J	Phelan, CM; Lancaster, JM; Tonin, P; Gumbs, C; Cochran, C; Carter, R; Ghadirian, P; Perret, C; Moslehi, R; Dion, F; Faucher, MC; Dole, K; Karimi, S; Foulkes, W; Lounis, H; Warner, E; Goss, P; Anderson, D; Larsson, C; Narod, SA; Futreal, PA				Phelan, CM; Lancaster, JM; Tonin, P; Gumbs, C; Cochran, C; Carter, R; Ghadirian, P; Perret, C; Moslehi, R; Dion, F; Faucher, MC; Dole, K; Karimi, S; Foulkes, W; Lounis, H; Warner, E; Goss, P; Anderson, D; Larsson, C; Narod, SA; Futreal, PA			Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families	NATURE GENETICS			English	Letter									DUKE UNIV,MED CTR,DEPT SURG,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT GENET,DURHAM,NC 27710; DUKE UNIV,MED CTR,DIV GYNECOL ONCOL,DURHAM,NC 27710; MCGILL UNIV,DEPT HUMAN GENET,MONTREAL,PQ,CANADA; MCGILL UNIV,DEPT MED,MONTREAL,PQ,CANADA; MONTREAL GEN HOSP,RES INST,MONTREAL,PQ H3G 1A4,CANADA; KAROLINSKA HOSP,DEPT MOLEC MED,ENDOCRINE TUMOUR UNIT,STOCKHOLM,SWEDEN; NIEHS,RES TRIANGLE PK,NC 27709; MCMASTER UNIV,MED CTR,HAMILTON,ON,CANADA; HOP HOTEL DIEU,RES CTR,EPIDEMIOL RES UNIT,MONTREAL,PQ,CANADA; UNIV BRITISH COLUMBIA,DEPT MED GENET,VANCOUVER,BC,CANADA; UNIV MONTREAL,INST CANC MONTREAL,CTR LOUIS CHARLES SIMARD,MONTREAL,PQ H2L 4M1,CANADA; SUNNYBROOK REG CANC CTR,TORONTO,ON,CANADA; TORONTO HOSP,TORONTO,ON M5T 2S8,CANADA; PRINCESS MARGARET HOSP,TORONTO,ON M4X 1K9,CANADA; MD ANDERSON HOSP & TUMOR INST,HOUSTON,TX; WOMENS COLL HOSP,TORONTO,ON M5S 1B2,CANADA	Duke University; Duke University; Duke University; McGill University; McGill University; McGill University; Karolinska Institutet; Karolinska University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); McMaster University; Universite de Montreal; University of British Columbia; Universite de Montreal; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Texas System; UTMD Anderson Cancer Center; University of Toronto; University Toronto Affiliates; Womens College Hospital			Foulkes, William D./AAR-9586-2021; Narod, Steven A/AAA-6112-2022	Foulkes, William D./0000-0001-7427-4651; 	NATIONAL CANCER INSTITUTE [R21CA066228, P50CA068438] Funding Source: NIH RePORTER; NCI NIH HHS [R21-CA66228, P50-CA68438] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		GOLDSTEIN AM, 1995, NEW ENGL J MED, V333, P970, DOI 10.1056/NEJM199510123331504; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NAROD SA, 1995, AM J HUM GENET, V56, P254; SCHUTTE M, 1995, P NATL ACAD SCI USA, V92, P5960; Serova O, 1996, AM J HUM GENET, V58, P42; *STAT CAN PUBL, 1990, CANC CAN 1990; STRATTON MR, 1994, NAT GENET, V7, P103, DOI 10.1038/ng0594-103; TONIN P, 1995, J MED GENET, V32, P982, DOI 10.1136/jmg.32.12.982; WHELAN AJ, 1995, NEW ENGL J MED, V333, P975, DOI 10.1056/NEJM199510123331505; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	10	221	224	1	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1996	13	1					120	122		10.1038/ng0596-120	http://dx.doi.org/10.1038/ng0596-120			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH430	8673090				2022-12-25	WOS:A1996UH43000030
J	Lacorazza, HD; Flax, JD; Snyder, EY; Jendoubi, M				Lacorazza, HD; Flax, JD; Snyder, EY; Jendoubi, M			Expression of human beta-hexosaminidase alpha-subunit gene (the gene defect of Tay-Sachs disease) in mouse brains upon engraftment of transduced progenitor cells	NATURE MEDICINE			English	Article							TRANSPLANTATION; BIOSYNTHESIS; FIBROBLASTS; LINE	In humans, beta-hexosaminidase alpha-subunit deficiency prevents the formation of a functional beta-hexosaminidase A heterodimer resulting in the severe neurodegenerative disorder, Tay-Sachs disease. To explore the feasibility of using ex vivo gene transfer in this lysosomal storage disease, we produced ecotropic retroviruses encoding the human beta-hexosaminidase alpha-subunit cDNA and transduced multipotent neural cell lines. Transduced progenitors stably expressed and secreted high levels of biologically active beta-hexosaminidase A in vitro and cross-corrected the metabolic defect in a human Tay-Sachs fibroblasts cell line in vitro. These genetically engineered CNS progenitors were transplanted into the brains of both normal fetal and newborn mice. Engrafted brains, analyzed at various ages after transplant, produced substantial amounts of human beta-hexosaminidase alpha-subunit transcript and protein, which was enzymatically active throughout the brain at a level reported to be therapeutic in Tay-Sachs disease. These results have implications for treating neurologic diseases characterized by inherited single gene mutations.	NEI,GENET & MOLEC IMMUNOL SECT,IMMUNOL LAB,NIH,BETHESDA,MD 20892; HARVARD UNIV,CHILDRENS HOSP,SCH MED,DEPT PEDIAT,BOSTON,MA 02115; HARVARD UNIV,CHILDRENS HOSP,SCH MED,DEPT NEUROL,BOSTON,MA 02115	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School								ANTON R, 1994, EXP NEUROL, V127, P207, DOI 10.1006/exnr.1994.1097; BRAUN SE, 1993, P NATL ACAD SCI USA, V90, P11830, DOI 10.1073/pnas.90.24.11830; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; GIESELMANN V, 1995, BBA-MOL BASIS DIS, V1270, P103, DOI 10.1016/0925-4439(94)00075-2; GROVES AK, 1993, NATURE, V362, P453, DOI 10.1038/362453a0; HASILIK A, 1980, J BIOL CHEM, V255, P4937; IOANNOU YA, 1992, J CELL BIOL, V119, P1137, DOI 10.1083/jcb.119.5.1137; KRESSE H, 1981, J BIOL CHEM, V256, P2926; LACORAZZA HD, 1995, BIOTECHNIQUES, V19, P434; LEINEKUGEL P, 1992, HUM GENET, V88, P513, DOI 10.1007/BF00219337; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; NOLAN CM, 1989, METABOLIC BASIS INHE, P1589; ONIFER SM, 1993, EXP NEUROL, V122, P130, DOI 10.1006/exnr.1993.1114; PROIA RL, 1984, J BIOL CHEM, V259, P3350; REUFRAZ PJ, 1991, CELL, V66, P713; SABATE O, 1995, NAT GENET, V9, P256, DOI 10.1038/ng0395-256; Sandhoff KCE, 1989, METABOLIC BASIS INHE, V2, P1807; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; SNYDER EY, 1995, NATURE, V374, P367, DOI 10.1038/374367a0; SUHR ST, 1993, ARCH NEUROL-CHICAGO, V50, P1252, DOI 10.1001/archneur.1993.00540110122012; WILEMAN T, 1985, BIOCHEM J, V232, P1; YAMANAKA S, 1994, GENOMICS, V21, P588, DOI 10.1006/geno.1994.1318; YAMANAKA S, 1994, P NATL ACAD SCI USA, V91, P9975, DOI 10.1073/pnas.91.21.9975	24	164	177	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	APR	1996	2	4					424	429		10.1038/nm0496-424	http://dx.doi.org/10.1038/nm0496-424			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UD314	8597952				2022-12-25	WOS:A1996UD31400044
J	Sheffield, VC; Kraiem, Z; Beck, JC; Nishimura, D; Stone, EM; Salameh, M; Sadeh, O; Glaser, B				Sheffield, VC; Kraiem, Z; Beck, JC; Nishimura, D; Stone, EM; Salameh, M; Sadeh, O; Glaser, B			Pendred syndrome maps to chromosome 7q2134 and is caused by an intrinsic defect in thyroid iodine organification	NATURE GENETICS			English	Letter							CONGENITAL GOITER; GENE; MUTATION		UNIV IOWA,DEPT OPHTHALMOL,IOWA CITY,IA 52242; CARMEL HOSP,ENDOCRINE RES UNIT,HAIFA,ISRAEL; TECHNION ISRAEL INST TECHNOL,FAC MED,HAIFA,ISRAEL; UNIV IOWA,DEPT PEDIAT,DIV MED GENET,IOWA CITY,IA 52242; HADASSAH UNIV HOSP,DEPT ENDOCRINOL & METAB,IL-91120 JERUSALEM,ISRAEL	University of Iowa; Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Iowa; Hebrew University of Jerusalem			Glaser, Benjamin/F-8411-2017	Glaser, Benjamin/0000-0003-4711-5000; Sheffield, Val/0000-0002-6282-0835; Stone, Edwin M./0000-0003-3343-4414	NHGRI NIH HHS [R01HG00457] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000457] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ABDELMOUMENE N, 1978, J MOL MED-NETH, V3, P305; ABRAMOWICZ MJ, 1992, J CLIN INVEST, V90, P1200, DOI 10.1172/JCI115981; BALDWIN CT, 1995, HUM MOL GENET, V4, P1637, DOI 10.1093/hmg/4.9.1637; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; BATSAKIS JG, 1962, ARCHIV OTOLARYNGOL, V76, P401; BILLERBECK AEC, 1994, THYROID, V4, P279, DOI 10.1089/thy.1994.4.279; BURROW GN, 1973, J CLIN ENDOCR METAB, V36, P522, DOI 10.1210/jcem-36-3-522; CARMI R, 1995, HUM MOL GENET, V4, P9, DOI 10.1093/hmg/4.1.9; CAVE WT, 1975, J CLIN ENDOCR METAB, V41, P590, DOI 10.1210/jcem-41-3-590; IEIRI T, 1991, J CLIN INVEST, V88, P1901, DOI 10.1172/JCI115513; ILLUM P, 1972, ARCHIV OTOLARYNGOL, V96, P297; KRAIEM Z, 1989, BRIT J PHARMACOL, V96, P465, DOI 10.1111/j.1476-5381.1989.tb11839.x; KRAIEM Z, 1995, ENDOCRINOLOGY, V136, P585, DOI 10.1210/en.136.2.585; KRAIEM Z, 1991, J ENDOCRINOL, V131, P499, DOI 10.1677/joe.0.1310499; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LJUNGGREN JG, 1973, ACTA ENDOCRINOL-COP, V72, P171; MANGKLABRUKS A, 1991, J CLIN ENDOCR METAB, V72, P471, DOI 10.1210/jcem-72-2-471; MASON ME, 1995, J CLIN ENDOCR METAB, V80, P497, DOI 10.1210/jc.80.2.497; MORGANS ME, 1958, LANCET, V1, P607; MORTON NE, 1955, AM J HUM GENET, V7, P277; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NIEPOMNISZCZE H, 1978, ACTA ENDOCRINOL-COP, V89, P70, DOI 10.1530/acta.0.0890070; PENDRED V, 1896, LANCET, V2, P523; SHEFFIELD VC, 1995, CURR OPIN GENET DEV, V5, P335, DOI 10.1016/0959-437X(95)80048-4; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; SHEFFIELD VC, 1994, HUM MOL GENET, V3, P1331, DOI 10.1093/hmg/3.8.1331; VANWOUWE JP, 1986, AM J MED GENET, V24, P211, DOI 10.1002/ajmg.1320240202; VASSART G, 1995, METABOLIC MOL BASES, P2883	28	130	141	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1996	12	4					424	426		10.1038/ng0496-424	http://dx.doi.org/10.1038/ng0496-424			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UC553	8630498				2022-12-25	WOS:A1996UC55300023
J	Bartel, PL; Roecklein, JA; SenGupta, D; Fields, S				Bartel, PL; Roecklein, JA; SenGupta, D; Fields, S			A protein linkage map of Escherichia coli bacteriophage T7	NATURE GENETICS			English	Article							GENE 2.5 PROTEIN; DNA-POLYMERASE; NUCLEOTIDE-SEQUENCE; HELICASE PROTEINS; 2-HYBRID SYSTEM; RNA-POLYMERASE; YEAST; PURIFICATION; REPLICATION; PRIMASE	Genome sequencing projects are predicting large numbers of novel proteins, whose interactions with other proteins must mediate the function of cellular processes. To analyse these networks, we used the yeast two-hybrid system on a genome-wide scale to identify 25 interactions among the proteins of Escherichia coli bacteriophage T7. Among these is a set of six interactions connecting proteins that function in DNA replication and DNA packaging. Remarkably, two genes, arranged such that one entirely overlaps the other and uses a different reading frame, encode interacting proteins. Several of the interactions reflect intramolecular associations of different domains of the same polypeptide, suggesting that the two-hybrid assay may be useful in the analysis of protein folding. This global approach to protein-protein interactions may be applicable to the analysis of more complex genomes whose sequences are becoming available.	UNIV WASHINGTON,MARKEY MOLEC MED CTR,DEPT GENET,SEATTLE,WA 98195; UNIV WASHINGTON,MARKEY MOLEC MED CTR,DEPT MED,SEATTLE,WA 98195; SUNY STONY BROOK,DEPT MOLEC GENET & MICROBIOL,STONY BROOK,NY 11794; SUNY STONY BROOK,GRAD PROGRAM MOLEC & CELLULAR BIOL,STONY BROOK,NY 11794	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook					NATIONAL CANCER INSTITUTE [P01CA028146] Funding Source: NIH RePORTER; NCI NIH HHS [CA28146] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BARTEL P, 1993, BIOTECHNIQUES, V14, P920; Bartel P. L., 1993, CELLULAR INTERACTION, P153; BENDIXEN C, 1994, NUCLEIC ACIDS RES, V22, P1778, DOI 10.1093/nar/22.9.1778; BREEDEN L, 1985, COLD SPRING HARB SYM, V50, P643, DOI 10.1101/SQB.1985.050.01.078; CASJENS S, 1989, VIROLOGY, V171, P588, DOI 10.1016/0042-6822(89)90628-4; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FIELDS S, 1994, TRENDS GENET, V10, P286, DOI 10.1016/0168-9525(90)90012-U; FINLEY RL, 1994, P NATL ACAD SCI USA, V91, P12980, DOI 10.1073/pnas.91.26.12980; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; HALL MN, 1984, CELL, V36, P1057, DOI 10.1016/0092-8674(84)90055-2; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; HUANG ZJ, 1995, SCIENCE, V267, P1169, DOI 10.1126/science.7855598; KIM YT, 1992, J BIOL CHEM, V267, P15032; KIM YT, 1992, J BIOL CHEM, V267, P15022; LANCY ED, 1989, J BACTERIOL, V171, P5581, DOI 10.1128/jb.171.10.5581-5586.1989; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; MATSUOKATO H, 1981, VIROLOGY, V109, P157; MOFFATT BA, 1987, CELL, V49, P221, DOI 10.1016/0092-8674(87)90563-0; MOONEY PQ, 1980, NUCLEIC ACIDS RES, V8, P3043, DOI 10.1093/nar/8.13.3043; NAKAI H, 1986, J BIOL CHEM, V261, P5208; NAKAI H, 1988, J BIOL CHEM, V263, P9818; PATEL SS, 1992, J BIOL CHEM, V267, P15013; PATEL SS, 1993, J BIOL CHEM, V268, P10668; PRINTEN JA, 1994, GENETICS, V138, P609; RAHMSDORF HJ, 1974, P NATL ACAD SCI USA, V71, P586, DOI 10.1073/pnas.71.2.586; ROEDER GS, 1977, VIROLOGY, V76, P263, DOI 10.1016/0042-6822(77)90302-6; Schiestl Robert H., 1993, Methods (Orlando), V5, P79, DOI 10.1006/meth.1993.1011; Sherman F., 1986, METHODS YEAST GENETI; SOUSA R, 1993, NATURE, V364, P593, DOI 10.1038/364593a0; SPOEREL N, 1979, NATURE, V278, P30, DOI 10.1038/278030a0; Steven A. C., 1986, ELECT MICROSCOPY PRO, P1; STUDIER FW, 1981, J MOL BIOL, V153, P493, DOI 10.1016/0022-2836(81)90404-6	35	255	278	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1996	12	1					72	77		10.1038/ng0196-72	http://dx.doi.org/10.1038/ng0196-72			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TM555	8528255				2022-12-25	WOS:A1996TM55500017
J	KASS, S; MACRAE, C; GRABER, HL; SPARKS, EA; MCNAMARA, D; BOUDOULAS, H; BASSON, CT; BAKER, PB; CODY, RJ; FISHMAN, MC; COX, N; KONG, A; WOOLEY, CF; SEIDMAN, JG; SEIDMAN, CE				KASS, S; MACRAE, C; GRABER, HL; SPARKS, EA; MCNAMARA, D; BOUDOULAS, H; BASSON, CT; BAKER, PB; CODY, RJ; FISHMAN, MC; COX, N; KONG, A; WOOLEY, CF; SEIDMAN, JG; SEIDMAN, CE			A GENE DEFECT THAT CAUSES CONDUCTION SYSTEM DISEASE AND DILATED CARDIOMYOPATHY MAPS TO CHROMOSOME 1P1-1Q1	NATURE GENETICS			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; GAP JUNCTION PROTEINS; MOLECULAR-CLONING; EXPRESSION; FREQUENCY; MUSCLE; LOCUS	Longitudinal evaluation of a seven generation kindred with an inherited conduction system defect and dilated cardiomyopathy demonstrated autosomal dominant transmission of a progressive disorder that both perturbs atrioventricular conduction and depresses cardiac contractility. To elucidate the molecular genetic basis for this disorder, a genome-wide linkage analysis was performed. Polymorphic loci near the centromere of chromosome 1 demonstrated linkage to the disease locus (maximum multipoint lod score = 13.2 in the interval between D1S305 and D1S176). Based on the disease phenotype and map location we speculate that gap junction protein connexin 40 is a candidate for mutations that result in conduction system disease and dilated cardiomyopathy.	HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; HARVARD UNIV,SCH MED,HOWARD HUGHES MED INST,BOSTON,MA 02115; ST GEORGE HOSP,SCH MED,DEPT CARDIOL SCI,LONDON SW17 0RE,ENGLAND; OHIO STATE UNIV,DIV CARDIOL,COLUMBUS,OH 43210; OHIO STATE UNIV,DEPT PATHOL,COLUMBUS,OH 43210; MASSACHUSETTS GEN HOSP E,CARDIOVASC RES CTR,BOSTON,MA 02129; BRIGHAM & WOMENS HOSP,DIV CARDIOVASC,BOSTON,MA 02115; UNIV CHICAGO,DEPT MED,CHICAGO,IL 60637; UNIV CHICAGO,DEPT STAT,CHICAGO,IL 60637	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; St Georges University London; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Harvard University; Brigham & Women's Hospital; University of Chicago; University of Chicago								BENNETT MVL, 1991, NEURON, V6, P305, DOI 10.1016/0896-6273(91)90241-Q; BERKO BA, 1987, NEW ENGL J MED, V316, P1186, DOI 10.1056/NEJM198705073161904; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; CALQUIST JF, 1991, CIRCULATION, V83, P515; CARRIER L, 1993, NAT GENET, V4, P311, DOI 10.1038/ng0793-311; CHANNER KS, 1988, BRIT HEART J, V59, P486; CODD MB, 1989, CIRCULATION, V80, P564, DOI 10.1161/01.CIR.80.3.564; ENGELSTEIN M, 1993, GENOMICS, V15, P251, DOI 10.1006/geno.1993.1054; FEIGENBAUM H, 1992, HEART DISEASE TXB CA, P64; GRABER HL, 1986, CIRCULATION, V74, P21, DOI 10.1161/01.CIR.74.1.21; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HAEFLIGER JA, 1992, J BIOL CHEM, V267, P2057; IRWIN M, 1993, GENETIC EPIDEMIOLOGY, V10, P483; KANTER HL, 1992, CIRC RES, V70, P438, DOI 10.1161/01.RES.70.2.438; KANTER HL, 1993, CIRC RES, V72, P1124, DOI 10.1161/01.RES.72.5.1124; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LIMAS C, 1992, AM HEART J, V124, P1258, DOI 10.1016/0002-8703(92)90409-O; LYNCH HT, 1973, JAMA-J AM MED ASSOC, V225, P1465, DOI 10.1001/jama.225.12.1465; MANOLIO TA, 1992, AM J CARDIOL, V69, P1458, DOI 10.1016/0002-9149(92)90901-A; MESTRONI L, 1990, AM J CARDIOL, V65, P1449, DOI 10.1016/0002-9149(90)91353-8; MICHELS VV, 1993, J MED GENET, V30, P955, DOI 10.1136/jmg.30.11.955; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; MUNTONI F, 1993, NEW ENGL J MED, V329, P921, DOI 10.1056/NEJM199309233291304; PETERS NS, 1993, CIRCULATION, V88, P864, DOI 10.1161/01.CIR.88.3.864; REED KE, 1993, J CLIN INVEST, V91, P997, DOI 10.1172/JCI116321; SELDIN MF, 1993, MAMM GENOME, V4, pS47, DOI 10.1007/BF00360829; Surawicz B, 1978, Am J Cardiol, V41, P130, DOI 10.1016/0002-9149(78)90147-9; THIERFELDER L, 1993, P NATL ACAD SCI USA, V90, P6270, DOI 10.1073/pnas.90.13.6270; VOSS EG, 1984, AM J CARDIOL, V54, P456, DOI 10.1016/0002-9149(84)90223-6; WATKINS H, 1993, NAT GENET, V3, P333, DOI 10.1038/ng0493-333; WATKINS H, 1992, NEW ENGL J MED, V326, P1108, DOI 10.1056/NEJM199204233261703; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WILLECKE K, 1990, EUR J CELL BIOL, V53, P275; WYNNE J, 1992, HEART DISEASE TXB CA, P1394	35	151	154	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1994	7	4					546	551		10.1038/ng0894-546	http://dx.doi.org/10.1038/ng0894-546			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PA832	7951328				2022-12-25	WOS:A1994PA83200025
J	JOUET, M; ROSENTHAL, A; ARMSTRONG, G; MACFARLANE, J; STEVENSON, R; PATERSON, J; METZENBERG, A; IONASESCU, V; TEMPLE, K; KENWRICK, S				JOUET, M; ROSENTHAL, A; ARMSTRONG, G; MACFARLANE, J; STEVENSON, R; PATERSON, J; METZENBERG, A; IONASESCU, V; TEMPLE, K; KENWRICK, S			X-LINKED SPASTIC PARAPLEGIA (SPG1), MASA SYNDROME AND X-LINKED HYDROCEPHALUS RESULT FROM MUTATIONS IN THE L1 GENE	NATURE GENETICS			English	Article							ADHESION MOLECULE L1; MENTAL-RETARDATION; NEURITE OUTGROWTH; LINKAGE ANALYSIS; IMMUNOGLOBULIN SUPERFAMILY; DNA PROBES; XQ28; LOCALIZATION; DOMAINS; GROWTH	X-linked hydrocephalus, spastic paraplegia type I and MASA syndrome are related disorders with loci in subchromosomal region Xq28. We have previously shown that X-linked hydrocephalus is caused by mutations in the gene for neural cell adhesion molecule L1 (L1CAM), an axonal glycoprotein involved in neuronal migration and differentiation. Here we report mutations of the L1 gene in MASA syndrome and SPG1, in addition to HSAS families. Two of the HSAS mutations would abolish cell surface expression of L1 and represent the first functional null mutations in this disorder. Our results indicate that these three syndromes form part of a clinical spectrum resulting from a heterogeneous group of mutations in the L1 gene.	UNIV CAMBRIDGE,ADDENBROOKES HOSP,DEPT MED,CAMBRIDGE CB2 2QQ,CAMBS,ENGLAND; INST MOLEK BIOTECHNOL,JENA,GERMANY; GREENWOOD GENET CTR,GREENWOOD,SC 29646; DUNCAN GUTHRIE INST MED GENET,GLASGOW G3 8SJ,SCOTLAND; UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143; UNIV IOWA HOSP & CLIN,DEPT PEDIAT,IOWA CITY,IA 52242; PRINCESS ANNE HOSP,SOUTHAMPTON,HANTS,ENGLAND	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Greenwood Genetic Center; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Iowa								APPEL F, 1993, J NEUROSCI, V13, P4764; ATASHI JR, 1992, NEURON, V8, P831, DOI 10.1016/0896-6273(92)90197-L; BATCH JA, 1992, HUM MOL GENET, V1, P497, DOI 10.1093/hmg/1.7.497; BIANCHINE JW, 1974, CLIN GENET, V5, P298; BICKERS DS, 1949, BRAIN, V72, P246, DOI 10.1093/brain/72.2.246; Boyd E, 1993, Clin Dysmorphol, V2, P332; EDWARDS JH, 1961, ARCH DIS CHILD, V36, P481, DOI 10.1136/adc.36.189.481; FRYNS JP, 1991, J MED GENET, V28, P429, DOI 10.1136/jmg.28.6.429-a; GAREIS FJ, 1984, AM J MED GENET, V17, P333, DOI 10.1002/ajmg.1320170126; Grumet M, 1991, Curr Opin Neurobiol, V1, P370, DOI 10.1016/0959-4388(91)90055-C; GUTMANN DH, 1990, AM J HUM GENET, V365, P251; HALLIDAY J, 1986, J MED GENET, V23, P23, DOI 10.1136/jmg.23.1.23; HLAVIN ML, 1991, GENOMICS, V11, P416, DOI 10.1016/0888-7543(91)90150-D; JOOSTEN EAJ, 1989, NEUROSCI LETT, V100, P94, DOI 10.1016/0304-3940(89)90666-6; JOUET M, 1993, J MED GENET, V30, P214, DOI 10.1136/jmg.30.3.214; JOUET M, 1993, NAT GENET, V4, P331, DOI 10.1038/ng0893-331; KENWRICK S, 1986, HUM GENET, V73, P264, DOI 10.1007/BF00401241; Krook Anna, 1992, Human Molecular Genetics, V1, P391, DOI 10.1093/hmg/1.6.391; KUHN TB, 1991, J CELL BIOL, V115, P1113, DOI 10.1083/jcb.115.4.1113; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; LINDNER J, 1983, NATURE, V305, P427, DOI 10.1038/305427a0; LYONNET S, 1992, GENOMICS, V14, P508, DOI 10.1016/S0888-7543(05)80254-X; MACIAS VR, 1992, AM J MED GENET, V43, P408, DOI 10.1002/ajmg.1320430162; MIURA M, 1991, FEBS LETT, V289, P91, DOI 10.1016/0014-5793(91)80915-P; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; REID RA, 1992, J MOL NEUROSCI, V3, P127, DOI 10.1007/BF02919404; RIETSCHEL M, 1991, AM J MED GENET, V41, P10, DOI 10.1002/ajmg.1320410104; ROSENTHAL A, 1992, NAT GENET, V2, P107, DOI 10.1038/ng1092-107; Rutishauser U, 1989, CURR OPIN CELL BIOL, V1, P898, DOI 10.1016/0955-0674(89)90056-2; SADOUL R, 1989, J NEUROCHEM, V53, P1471, DOI 10.1111/j.1471-4159.1989.tb08540.x; SAUGIERVEBER P, 1994, NAT GENET, V6, P257, DOI 10.1038/ng0394-257; SCHRANDERSTUMPEL C, 1990, J MED GENET, V27, P688, DOI 10.1136/jmg.27.11.688; SCHUCH U, 1989, NEURON, V3, P13, DOI 10.1016/0896-6273(89)90111-6; SONDEREGGER P, 1992, J CELL BIOL, V119, P1387, DOI 10.1083/jcb.119.6.1387; STRAIN L, 1994, AM J HUM GENET, V54, P236; VANCAMP G, 1993, NAT GENET, V4, P421; WHITE MB, 1992, GENOMICS, V12, P301, DOI 10.1016/0888-7543(92)90377-5; WILLEMS PJ, 1987, AM J MED GENET, V27, P921, DOI 10.1002/ajmg.1320270419; WILLEMS PJ, 1992, AM J HUM GENET, V51, P307; WILLEMS PJ, 1990, GENOMICS, V8, P367, DOI 10.1016/0888-7543(90)90294-5; WILLIAMS EJ, 1992, J CELL BIOL, V119, P883, DOI 10.1083/jcb.119.4.883; WINTER RM, 1989, HUM GENET, V82, P367; YEATMAN GW, 1984, AM J MED GENET, V17, P339, DOI 10.1002/ajmg.1320170127	43	343	354	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1994	7	3					402	407		10.1038/ng0794-402	http://dx.doi.org/10.1038/ng0794-402			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NU306	7920659				2022-12-25	WOS:A1994NU30600015
J	LEE, JY; KOI, M; STANBRIDGE, EJ; OSHIMURA, M; KUMAMOTO, AT; FEINBERG, AP				LEE, JY; KOI, M; STANBRIDGE, EJ; OSHIMURA, M; KUMAMOTO, AT; FEINBERG, AP			SIMPLE PURIFICATION OF HUMAN-CHROMOSOMES TO HOMOGENEITY USING MUNTJAC HYBRID-CELLS	NATURE GENETICS			English	Article							CHINESE-HAMSTER; FLOW KARYOTYPES; DNA LIBRARIES; CONSTRUCTION; GENE; CYTOMETRY; SEQUENCE; CLONES; MOUSE	Chromosome sorting from hybrid cells offers enormous advantages for gene mapping and cloning, but purification of most chromosomes has been largely hindered by their similarity in size to other chromosomes. We have developed a novel cell line and strategy that allows simple, mass purification of mammalian chromosomes, permitting significant target genome enrichment. This strategy takes advantage of the small number of giant chromosomes (1,2,X) of the female Indian muntjac, a barking deer, avoiding the problem of size similarity. We introduced human chromosomes into a cell line derived from a muntjac and purified them to homogeneity using a relatively simple technique. This strategy should facilitate the isolation of chromosomes from species other than human for which hybrid cells are not available currently.	UNIV MICHIGAN,SCH MED,HOWARD HUGHES MED INST,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,DEPT INTERNAL MED,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48109; UNIV CALIF IRVINE,CALIF COLL MED,DEPT MICROBIOL & MOLEC GENET,IRVINE,CA 92717; TOTTORI UNIV,SCH LIFE SCI,DEPT MOLEC & CELL GENET,YONAGO,TOTTORI 683,JAPAN; ZOOL SOC SAN DIEGO,CTR REPROD ENDANGERED SPECIES,SAN DIEGO,CA 92112	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California Irvine; Tottori University; Zoological Society of San Diego			Koi, Minoru/G-9197-2014; Koi, Minoru/C-3489-2012; Feinberg, Andrew/AAY-7666-2020	Feinberg, Andrew/0000-0002-8364-1991	NATIONAL CANCER INSTITUTE [R01CA054358] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA054358] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARTHOLDI MF, 1990, CYTOMETRY, V11, P165, DOI 10.1002/cyto.990110119; BOGENBERGER JM, 1985, EUR J BIOCHEM, V148, P55, DOI 10.1111/j.1432-1033.1985.tb08806.x; Chaconas G, 1980, Methods Enzymol, V65, P75; COLLARD JG, 1980, EXP CELL RES, V130, P217, DOI 10.1016/0014-4827(80)90058-0; Cram L S, 1990, Methods Cell Biol, V33, P377; DEAVEN LL, 1986, COLD SPRING HARB SYM, V51, P159, DOI 10.1101/SQB.1986.051.01.019; DEININGER PL, 1981, J MOL BIOL, V151, P17, DOI 10.1016/0022-2836(81)90219-9; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FOURNIER REK, 1977, P NATL ACAD SCI USA, V74, P319, DOI 10.1073/pnas.74.1.319; FUSCOE JC, 1986, CYTOGENET CELL GENET, V43, P79, DOI 10.1159/000132301; GOYETTE MC, 1992, MOL CELL BIOL, V12, P1387, DOI 10.1128/MCB.12.3.1387; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HATANAKA M, 1979, J EXP MED, V150, P1195, DOI 10.1084/jem.150.5.1195; KOI M, 1989, JPN J CANCER RES, V80, P413, DOI 10.1111/j.1349-7006.1989.tb02329.x; KOI M, 1993, SCIENCE, V260, P361, DOI 10.1126/science.8469989; LANGLOIS RG, 1982, P NATL ACAD SCI-BIOL, V79, P7876, DOI 10.1073/pnas.79.24.7876; LUCAS JN, 1987, CYTOMETRY, V8, P273, DOI 10.1002/cyto.990080307; MENDELSOHN J, 1968, J MOL BIOL, V32, P101, DOI 10.1016/0022-2836(68)90148-4; MULLIGAN RC, 1981, P NATL ACAD SCI-BIOL, V78, P2072, DOI 10.1073/pnas.78.4.2072; MULLIKIN J, 1988, CYTOMETRY, V9, P111, DOI 10.1002/cyto.990090203; RUDDLE FH, 1981, ANNU REV GENET, V9, P407; SAXON PJ, 1985, MOL CELL BIOL, V5, P140, DOI 10.1128/MCB.5.1.140; STUBBLEFIELD E, 1991, CYTOMETRY, V2, P273; TRASK B, 1989, FLOW CYTOGENETICS, P43; VANDENENGH G, 1990, CYTOMETRY, V11, P173, DOI 10.1002/cyto.990110120; VANDILLA MA, 1990, CYTOMETRY, V11, P208, DOI 10.1002/cyto.990110124; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; WURSTER DH, 1970, SCIENCE, V168, P1364, DOI 10.1126/science.168.3937.1364; YAMAGUCHI N, 1979, J GEN VIROL, V42, P289, DOI 10.1099/0022-1317-42-2-289; YUASA Y, 1978, JPN J CANCER RES, V69, P441; 1992, AM TYPE CULTURE COLL, P89	31	10	11	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1994	7	1					29	33		10.1038/ng0594-29	http://dx.doi.org/10.1038/ng0594-29			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NJ842	8075635				2022-12-25	WOS:A1994NJ84200009
J	KNOLL, JHM; CHENG, SD; LALANDE, M				KNOLL, JHM; CHENG, SD; LALANDE, M			ALLELE SPECIFICITY OF DNA-REPLICATION TIMING IN THE ANGELMAN PRADER-WILLI-SYNDROME IMPRINTED CHROMOSOMAL REGION	NATURE GENETICS			English	Article							DEOXYRIBONUCLEIC-ACID REPLICATION; PARENTAL ORIGIN; HIGH-RESOLUTION; GENE; DELETION; SNRPN; ORGANIZATION; MICROSCOPY; EXPRESSION; SEQUENCES	DNA replication within chromosome 15q11-q13, a region subject to genomic imprinting, was examined by fluorescence in situ hybridization. Asynchronous replication between homologues was observed in cells from normal individuals and in Prader-Willi (PWS) and Angelman syndrome (AS) patients with chromosome 15 deletions but not in PWS patients with maternal uniparental disomy. Opposite patterns of allele-specific replication timing between homologous loci were observed; paternal early/maternal late at D15S63, D15S10 and the gamma-aminobutyric acid receptor beta3 subunit gene (GABRB3); and maternal early/paternal late at the more distal gamma-aminobutyric acid receptor alpha5 subunit gene (GABRA5). At the most distal locus examined, D15S12, both patterns of allele-specific replication timing were detected.	BETH ISRAEL HOSP,DEPT PATHOL,BOSTON,MA 02215; HOWARD HUGHES MED INST,BOSTON,MA 02115	Harvard University; Beth Israel Deaconess Medical Center; Howard Hughes Medical Institute	KNOLL, JHM (corresponding author), HARVARD UNIV,CHILDRENS HOSP,SCH MED,DIV GENET,300 LONGWOOD AVE,BOSTON,MA 02115, USA.			Knoll, Joan/0000-0001-6691-1710	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD018658] Funding Source: NIH RePORTER; NICHD NIH HHS [HD18658] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BUTLER MG, 1983, LANCET, V1, P1285; CATTANACH BM, 1992, NAT GENET, V2, P270, DOI 10.1038/ng1292-270; DHAR V, 1989, MOL CELL BIOL, V9, P3524, DOI 10.1128/MCB.9.8.3524; DROUIN R, 1990, CHROMOSOMA, V99, P273, DOI 10.1007/BF01731703; DUTRILLAUX B, 1976, CHROMOSOMA, V58, P51, DOI 10.1007/BF00293440; EDENBERG HJ, 1975, ANNU REV GENET, V9, P245, DOI 10.1146/annurev.ge.09.120175.001333; FANGMAN WL, 1992, CELL, V71, P363, DOI 10.1016/0092-8674(92)90505-7; FOX MH, 1991, J CELL SCI, V99, P247; GARDNER JM, 1992, SCIENCE, V257, P1121, DOI 10.1126/science.257.5073.1121; GOLDMAN MA, 1984, SCIENCE, V224, P686, DOI 10.1126/science.6719109; HAMABE J, 1991, AM J MED GENET, V41, P64, DOI 10.1002/ajmg.1320410117; HAND R, 1978, CELL, V15, P317, DOI 10.1016/0092-8674(78)90001-6; HATTON KS, 1988, MOL CELL BIOL, V8, P2149, DOI 10.1128/MCB.8.5.2149; IZUMIKAWA Y, 1991, HUM GENET, V87, P1, DOI 10.1007/BF01213082; KITSBERG D, 1993, NATURE, V364, P459, DOI 10.1038/364459a0; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; KNOLL JHM, 1993, HUM MOL GENET, V2, P183, DOI 10.1093/hmg/2.2.183; LATT SA, 1973, P NATL ACAD SCI USA, V70, P3395, DOI 10.1073/pnas.70.12.3395; LAWRENCE JB, 1990, SCIENCE, V249, P928, DOI 10.1126/science.2203143; LEDBETTER DH, 1981, NEW ENGL J MED, V304, P325, DOI 10.1056/NEJM198102053040604; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; LEFFAK M, 1989, MOL CELL BIOL, V9, P586, DOI 10.1128/MCB.9.2.586; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; NAKAMURA H, 1986, EXP CELL RES, V165, P291, DOI 10.1016/0014-4827(86)90583-5; NAKAYASU H, 1989, J CELL BIOL, V108, P1, DOI 10.1083/jcb.108.1.1; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; PRIEST JH, 1967, J CELL BIOL, V35, P483, DOI 10.1083/jcb.35.2.483; SAITOH S, 1992, LANCET, V339, P366, DOI 10.1016/0140-6736(92)91686-3; SCHANBERG LE, 1991, P NATL ACAD SCI USA, V88, P603, DOI 10.1073/pnas.88.2.603; SELIG S, 1992, EMBO J, V11, P1217, DOI 10.1002/j.1460-2075.1992.tb05162.x; SINNETT D, 1993, AM J HUM GENET, V52, P1216; WAGSTAFF J, 1992, NAT GENET, V1, P291, DOI 10.1038/ng0792-291; WAGSTAFF J, 1991, AM J HUM GENET, V49, P330; WILLARD HF, 1976, AM J HUM GENET, V28, P213; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746	37	167	171	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1994	6	1					41	46		10.1038/ng0194-41	http://dx.doi.org/10.1038/ng0194-41			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ177	8136833				2022-12-25	WOS:A1994MQ17700012
J	KAUL, R; GAO, GP; BALAMURUGAN, K; MATALON, R				KAUL, R; GAO, GP; BALAMURUGAN, K; MATALON, R			CLONING OF THE HUMAN ASPARTOACYLASE CDNA AND A COMMON MISSENSE MUTATION IN CANAVAN DISEASE	NATURE GENETICS			English	Article							L-ASPARTIC ACID; MAGNETIC-RESONANCE SPECTROSCOPY; N-ACETYLASPARTATE; SPONGY DEGENERATION; BRAIN; DEFICIENCY; IDENTIFICATION; PURIFICATION; LOCALIZATION; DIAGNOSIS	Canavan disease, an autosomal recessive leukodystrophy, is caused by deficiency of aspartoacylase and accumulation of N-acetylaspartic acid in brain. We have cloned the human aspartoacylase (ASP) cDNA spanning 1,435 basepairs, and show that the isolated cDNA expresses aspartoacylase activity in bacteria. Furthermore, an A to C base change, at nucleotide 854, has been found in 85% of the 34 Canavan alleles tested so far. This base change results in a missense Glu285Ala mutation that is predicted to be part of the catalytic domain of aspartoacylase. The data suggest that the catalytic centre of aspartoacylase involves a triad of Ser, His and Glu residues. Our findings have implications for diagnosis and screening of Canavan disease.			KAUL, R (corresponding author), MIAMI CHILDRENS HOSP,RES INST,MIAMI,FL 33155, USA.			Kaul, Rajinder/0000-0002-7895-9284				ADACHI M, 1972, ACTA NEUROPATHOL, V20, P22, DOI 10.1007/BF00687899; ADORNATO BT, 1972, NEUROLOGY, V22, P202, DOI 10.1212/WNL.22.2.202; BELL JD, 1991, J GEN VIROL, V72, P2419, DOI 10.1099/0022-1317-72-10-2419; BIMBAUM SM, 1955, METHOD ENZYMOL, V2, P115; BIMBAUM SM, 1952, J BIOL CHEM, V194, P455; BIMSTIEL ML, 1985, CELL, V41, P349; BIRKEN DL, 1989, NEUROSCI BIOBEHAV R, V13, P23, DOI 10.1016/S0149-7634(89)80048-X; Canavan MM, 1931, ARCH NEURO PSYCHIATR, V25, P299, DOI 10.1001/archneurpsyc.1931.02230020085005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CONGRO CB, 1987, J NEUROCHEM, V49, P1579; CYGLER M, 1993, PROTEIN SCI, V2, P366; DUNLOP DS, 1992, BRAIN RES, V580, P44, DOI 10.1016/0006-8993(92)90925-Y; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GIDEON P, 1992, STROKE, V23, P1566, DOI 10.1161/01.STR.23.11.1566; Globus JH, 1928, ARCH NEURO PSYCHIATR, V20, P1190, DOI 10.1001/archneurpsyc.1928.02210180041003; GOLDSTEIN FB, 1969, J BIOL CHEM, V244, P4257; GOLDSTEIN FB, 1959, J BIOL CHEM, V234, P2702; GRODD W, 1990, LANCET, V336, P437, DOI 10.1016/0140-6736(90)91982-G; GROOD W, 1991, RADIOLOGY, V181, P173; JACOBSON KB, 1957, J GEN PHYSIOL, V43, P323; KAUL R, 1991, J NEUROCHEM, V56, P129, DOI 10.1111/j.1471-4159.1991.tb02571.x; KAUL R K, 1983, Journal of Biological Chemistry, V258, P7981; KAUL RK, 1986, GENE, V41, P311, DOI 10.1016/0378-1119(86)90112-5; LEMEUR MA, 1984, EMBO J, V3, P2779, DOI 10.1002/j.1460-2075.1984.tb02209.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARCUCCI F, 1984, J NEUROCHEM, V43, P1484, DOI 10.1111/j.1471-4159.1984.tb05412.x; MATALON R, 1992, J INHERIT METAB DIS, V15, P392, DOI 10.1007/BF02435985; MATALON R, 1989, J INHERIT METAB DIS, V12, P329, DOI 10.1007/BF03335413; MATALON R, 1988, AM J MED GENET, V29, P463, DOI 10.1002/ajmg.1320290234; MATALON R, IN PRESS J INHER MET; MATALON R, 1993, MOL BIOL GENETIC BAS, P541; MCINTOSH JC, 1965, J NEUROCHEM, V12, P825, DOI 10.1111/j.1471-4159.1965.tb10267.x; MEYERHOFF DJ, 1993, NEUROLOGY, V43, P509, DOI 10.1212/WNL.43.3_Part_1.509; MICHELAKAKIS H, 1991, J INHERIT METAB DIS, V14, P267, DOI 10.1007/BF01800603; MILLER YE, 1990, GENOMICS, V8, P149, DOI 10.1016/0888-7543(90)90237-O; MOFFETT JR, 1991, NEUROREPORT, V2, P131, DOI 10.1097/00001756-199103000-00005; MOFFETT JR, 1983, CYTOCHEM, V31, P559; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; ORYLAVOLLEE L, 1987, J NEUROCHEM, V48, P895, DOI 10.1111/j.1471-4159.1987.tb05601.x; OZAND PT, 1990, AM J MED GENET, V35, P266, DOI 10.1002/ajmg.1320350224; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIGEMATSU H, 1983, J NEUROCHEM, V40, P814, DOI 10.1111/j.1471-4159.1983.tb08052.x; TALLAN HH, 1956, J BIOL CHEM, V219, P257; URENJAK J, 1992, J NEUROCHEM, V59, P55, DOI 10.1111/j.1471-4159.1992.tb08875.x; van Bogaert L., 1949, ACTA NEUROL BELG, V49, P572	48	168	175	0	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1993	5	2					118	123		10.1038/ng1093-118	http://dx.doi.org/10.1038/ng1093-118			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MA056	8252036				2022-12-25	WOS:A1993MA05600007
J	ANDREW, SE; GOLDBERG, YP; KREMER, B; TELENIUS, H; THEILMANN, J; ADAM, S; STARR, E; SQUITIERI, F; LIN, BY; KALCHMAN, MA; GRAHAM, RK; HAYDEN, MR				ANDREW, SE; GOLDBERG, YP; KREMER, B; TELENIUS, H; THEILMANN, J; ADAM, S; STARR, E; SQUITIERI, F; LIN, BY; KALCHMAN, MA; GRAHAM, RK; HAYDEN, MR			THE RELATIONSHIP BETWEEN TRINUCLEOTIDE (CAG) REPEAT LENGTH AND CLINICAL-FEATURES OF HUNTINGTONS-DISEASE	NATURE GENETICS			English	Article							MYOTONIC-DYSTROPHY; CTG REPEAT; FRAGILE-X; AGE; ONSET; EXPANSION; DNA; INSTABILITY; MUTATIONS	Huntington's disease (HD) is associated with the expansion of a CAG trinucleotide repeat in a novel gene. We have assessed 360 HD individuals from 259 unrelated families and found a highly significant correlation (r = 0.70, p = 10(-7) between the age of onset and the repeat length, which accounts for approximately 50% of the variation in the age of onset. Significant associations were also found between repeat length and age of death and onset of other clinical features. Sib pair and parent-child analysis revealed that the CAG repeat demonstrates only mild instability. Affected HD siblings had significant correlations for trinucleotide expansion (r = 0.66, p < 0.001) which was not apparent for affected parent-child pairs.	UNIV BRITISH COLUMBIA, DEPT MED GENET, 416 2125 E MALL, Vancouver, BC V6T 1Z4, CANADA; UNIV BRITISH COLUMBIA, CTR NEURODEGENERAT DISORDERS, Vancouver, BC V6T 1Z4, CANADA	University of British Columbia; University of British Columbia			Squitieri, Ferdinando/N-1852-2019; Hayden, Michael R/D-8581-2011	Squitieri, Ferdinando/0000-0002-7397-1727; Hayden, Michael R/0000-0001-5159-1419; Adam, Shelin/0000-0002-4401-6157				ADAMS P, 1988, AM J HUM GENET, V43, P695; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Draper N.R., 1981, APPL REGRESSION ANAL, Vsecond, DOI DOI 10.1002/9781118625590; FARRER LA, 1985, AM J HUM GENET, V37, P350; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GOLDBERG YP, 1993, HUM MOL GENET, V2, P635, DOI 10.1093/hmg/2.6.635; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Harper PS, 1991, HUNTINGTONS DIS; HAYDEN MR, 1985, CLIN GENET, V28, P100; HAYDEN MR, 1993, CLIN GENET, V43, P217; Hayden MR., 1981, HUNTINGTONS CHOREA, P45; HUNTER A, 1992, J MED GENET, V29, P774, DOI 10.1136/jmg.29.11.774; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LASPADA AR, 1992, NAT GENET, V2, P301, DOI 10.1038/ng1292-301; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MANDEL JL, 1993, NAT GENET, V4, P8, DOI 10.1038/ng0593-8; MERRITT AD, 1969, PROGR NEUROGENETICS, P645; MYERS RH, 1982, AM J HUM GENET, V34, P481; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; REDMAN JB, 1993, JAMA-J AM MED ASSOC, V269, P1960, DOI 10.1001/jama.269.15.1960; RICHARDS RI, 1992, CELL, V70, P709, DOI 10.1016/0092-8674(92)90302-S; STEVENS DL, HUNTINGTONS CHOREA 1, P191; TSILFIDIS C, 1992, NAT GENET, V1, P192, DOI 10.1038/ng0692-192	27	855	873	4	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1993	4	4					398	403		10.1038/ng0893-398	http://dx.doi.org/10.1038/ng0893-398			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LQ178	8401589				2022-12-25	WOS:A1993LQ17800019
J	VULPE, C; LEVINSON, B; WHITNEY, S; PACKMAN, S; GITSCHIER, J				VULPE, C; LEVINSON, B; WHITNEY, S; PACKMAN, S; GITSCHIER, J			ISOLATION OF A CANDIDATE GENE FOR MENKES DISEASE AND EVIDENCE THAT IT ENCODES A COPPER-TRANSPORTING ATPASE	NATURE GENETICS			English	Article							POLYMERASE CHAIN-REACTION; BRINDLED MOUSE MODEL; KINKY HAIR SYNDROME; MOTTLED MOUSE; SARCOPLASMIC-RETICULUM; ESCHERICHIA-COLI; FUNCTIONAL CONSEQUENCES; DIRECTED MUTAGENESIS; ACCUMULATION; METABOLISM	Menkes disease is an X-linked disorder of copper transport characterized by progressive neurological degeneration and death in early childhood. We have isolated a candidate gene (Mc1) for Menkes disease and find qualitative or quantitative abnormalities in the mRNA in sixteen of twenty-one Menkes patients. Four patients lacking Mc1RNA showed rearrangements of the Menkes gene. The gene codes for a 1,500 amino acid protein, predicted to be a P-type cation-transporting ATPase. The gene product is most similar to a bacterial copper-transporting ATPase and additionally contains six putative metal-binding motifs at the N-terminus. The gene is transcribed in all cell types tested except liver, consistent with the expression of the Menkes defect.	UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,DIV GENET,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,DEPT MED,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco			Vulpe, Chris/AAF-9170-2020	Vulpe, Chris/0000-0001-5134-8929				BRANDL CJ, 1986, CELL, V44, P597, DOI 10.1016/0092-8674(86)90269-2; BROCKDORFF N, 1991, GENOMICS, V10, P17, DOI 10.1016/0888-7543(91)90478-W; BROWN NL, 1992, PLASMID, V27, P41, DOI 10.1016/0147-619X(92)90005-U; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; CHA JS, 1991, P NATL ACAD SCI USA, V88, P8915, DOI 10.1073/pnas.88.20.8915; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; CLARKE DM, 1990, J BIOL CHEM, V265, P6262; Danks DM, 1989, METABOLIC BASIS INHE, P1411; DARWISH HM, 1983, J BIOL CHEM, V258, P3621; DAVISSON MT, 1990, GENETIC VARIANTS STR, P432; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; HERD SM, 1987, BIOCHEM J, V247, P341, DOI 10.1042/bj2470341; HESSE JE, 1984, P NATL ACAD SCI-BIOL, V81, P4746, DOI 10.1073/pnas.81.15.4746; INESI G, 1992, J BIOENERG BIOMEMBR, V24, P271; IVEY DM, 1992, J BACTERIOL, V174, P4878, DOI 10.1128/JB.174.15.4878-4884.1992; KAGI JHR, 1988, BIOCHEMISTRY-US, V27, P8509, DOI 10.1021/bi00423a001; KAHN D, 1989, J BACTERIOL, V171, P929, DOI 10.1128/jb.171.2.929-939.1989; KAPUR S, 1987, AM J MED GENET, V26, P503, DOI 10.1002/ajmg.1320260230; KOVALIC D, 1991, NUCLEIC ACIDS RES, V19, P4560, DOI 10.1093/nar/19.16.4560; KUIVANIEMI H, 1981, J CLIN INVEST, V69, P730; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEVINSON B, 1990, GENOMICS, V7, P1, DOI 10.1016/0888-7543(90)90512-S; MACLENNAN DH, 1990, BIOPHYS J, V58, P1355, DOI 10.1016/S0006-3495(90)82482-6; MARCHUK DA, IN PRESS YAC LIBRARI; MERCER JB, 1993, NATURE GENET, P20; MURNANE JP, 1985, EXP CELL RES, V158, P119, DOI 10.1016/0014-4827(85)90437-9; NELSON DL, 1989, P NATL ACAD SCI USA, V86, P6686, DOI 10.1073/pnas.86.17.6686; NUCIFORA G, 1989, P NATL ACAD SCI USA, V86, P3544, DOI 10.1073/pnas.86.10.3544; OEDERMATT A, IN PRESS ANN NY ACAD; PACKMAN S, 1983, J INORG BIOCHEM, V19, P203, DOI 10.1016/0162-0134(83)85025-9; PACKMAN S, 1984, PEDIATR RES, V18, P1282, DOI 10.1203/00006450-198412000-00011; PACKMAN S, 1987, ARCH DERMATOL, V123, P1545, DOI 10.1001/archderm.123.11.1545; PACKMAN S, 1987, J CLIN INVEST, V79, P1338, DOI 10.1172/JCI112959; PACKMAN S, 1987, PAEDIAT RES, V21, P293; PORTILLO F, 1989, EUR J BIOCHEM, V186, P501, DOI 10.1111/j.1432-1033.1989.tb15235.x; PORTILLO F, 1988, EMBO J, V7, P1793, DOI 10.1002/j.1460-2075.1988.tb03010.x; RICHARDS RI, 1992, NAT GENET, V1, P7, DOI 10.1038/ng0492-7; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; ROGERS SD, 1991, J BACTERIOL, V173, P6742, DOI 10.1128/jb.173.21.6742-6748.1991; SERRANO R, 1988, BIOCHIM BIOPHYS ACTA, V947, P1, DOI 10.1016/0304-4157(88)90017-2; SHULL GE, 1985, NATURE, V316, P691, DOI 10.1038/316691a0; SILVER S, 1992, MICROBIOL REV, V56, P195, DOI 10.1128/MMBR.56.1.195-228.1992; SOLIOZ M, 1987, J BIOL CHEM, V262, P7358; TONNESEN T, 1989, J INHERIT METAB DIS, V12, P207, DOI 10.1007/BF01799296; TONNESEN T, 1992, AM J HUM GENET, V50, P1012; TURNER Z, 1992, HUM GENET, V88, P668; TURNER Z, 1992, HUM MOL GENET, V1, P483; VANDENBERG GJ, 1990, J INHERIT METAB DIS, V13, P207, DOI 10.1007/BF01799687; VERGA V, 1991, AM J HUM GENET, V48, P1133; VILSEN B, 1989, J BIOL CHEM, V264, P21024; WACH A, 1992, J BIOENERG BIOMEMBR, V24, P309; WALDROP GL, 1990, BIOCHEM J, V267, P417, DOI 10.1042/bj2670417; WALDROP GL, 1990, AM J PHYSIOL, V259, pG219, DOI 10.1152/ajpgi.1990.259.2.G219	53	1161	1177	2	41	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1993	3	1					7	13		10.1038/ng0193-7	http://dx.doi.org/10.1038/ng0193-7			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KF372	8490659				2022-12-25	WOS:A1993KF37200005
J	Self, CH; Thompson, S				Self, CH; Thompson, S			Light activatable antibodies: Models for remotely activatable proteins	NATURE MEDICINE			English	Article							ACID	The ability to activate biological macromolecules remotely, at specific locations and times, will allow the manipulation of a wide range of cellular activities and give rise to many practical applications. Interest has been shown in the theoretical possibility of accomplishing this by means of photochemical approaches(1). Photochemical changes of the guest-binding cavity of cyclodextrins has been suggested(2); however, these changes require organic solvent. What is needed is a widely and readily applicable method allowing activation under physiological conditions. We have developed such a method. This is based on our demonstration that relatively large amounts of the a-methyl substituted 2-nitrobenzyl alcohol, namely, 1-(2-nitrophenyl)ethanol (NPE) can be coupled to proteins using diphosgene(3,4). Previous work involved ''caging'' of small molecules such as ATP (ref. 5-9) and blocking amino acids(10) in peptide synthesis(11,12) with 2-nitrobenzyl compounds. For large molecules, site-specific reversible inactivation of T4-lysozyme has been reported following introduction of an aspartyl beta-nibenzyl ester into its active site by mutagenesis(13) In contrast, the present simple procedure allows an existing protein to be deactivated and then, when and where required, reactivated by exposure to ultraviolet-A (UV-A) light. We have employed antibodies as models for both receptors and ligands and have successfully modulated: antibody binding sites for antigen; antigen binding sites for antibody, and antibody Fc binding sites for Protein A.			Self, CH (corresponding author), UNIV NEWCASTLE UPON TYNE, SCH MED, DEPT CLIN BIOCHEM, FRAMLINGTON PL, NEWCASTLE UPON TYNE NE2 4HH, TYNE & WEAR, ENGLAND.							ARADYELLIN R, 1994, NATURE, V371, P320, DOI 10.1038/371320a0; DANZIG JA, 1991, J PHYSIOL-LONDON, V432, P639; GOLDMACHER VS, 1992, BIOCONJUGATE CHEM, V3, P104, DOI 10.1021/bc00014a003; HENRIKSEN DB, 1992, PEPTIDE RES, V5, P321; MARRIOTT G, 1992, BIOCHEM INT, V26, P943; MENDEL D, 1991, J AM CHEM SOC, V113, P2758, DOI 10.1021/ja00007a063; MORRISON H, 1993, BIOORGANIC PHOTOCHEM, V2; PILLAI VNR, 1980, SYNTHESIS-STUTTGART, P1; SELF CH, 1995, BIOCHEM SOC T, V23, pS156, DOI 10.1042/bst023156s; SENTER PD, 1985, PHOTOCHEM PHOTOBIOL, V42, P231, DOI 10.1111/j.1751-1097.1985.tb08936.x; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; THOMPSON S, 1994, BIOCHEM BIOPH RES CO, V201, P1213, DOI 10.1006/bbrc.1994.1834; THOMPSON S, 1995, BIOCHEM SOC T, V23, pS155, DOI 10.1042/bst023155s; THOMPSON S, 1982, RED CELL MEMBRANES M, P67; TJOENG FS, 1977, BIOCHIM BIOPHYS ACTA, V490, P489, DOI 10.1016/0005-2795(77)90025-3; WALKER JW, 1987, NATURE, V327, P249, DOI 10.1038/327249a0; WALKER JW, 1989, METHOD ENZYMOL, V172, P288; WOOTTON JF, 1989, NATO ADV SCI I C-MAT, V272, P277	18	41	48	3	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	1996	2	7					817	820		10.1038/nm0796-817	http://dx.doi.org/10.1038/nm0796-817			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UU680	8673931				2022-12-25	WOS:A1996UU68000041
J	Sudbeck, P; Schmitz, ML; Baeuerle, PA; Scherer, G				Sudbeck, P; Schmitz, ML; Baeuerle, PA; Scherer, G			Sex reversal by loss of the C-terminal transactivation domain of human SOX9	NATURE GENETICS			English	Letter							HMG BOX; DNA; SRY; PROTEIN		UNIV FREIBURG,INST HUMAN GENET,D-79106 FREIBURG,GERMANY; UNIV FREIBURG,INST BIOCHEM,D-79104 FREIBURG,GERMANY	University of Freiburg; University of Freiburg			Schmitz, M. Lienhard/D-9328-2017	Schmitz, M. Lienhard/0000-0002-6984-7192				BANIAHMAD A, 1992, EMBO J, V11, P1015, DOI 10.1002/j.1460-2075.1992.tb05140.x; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; CHI TH, 1995, NATURE, V377, P254, DOI 10.1038/377254a0; CLARK HM, 1994, CANCER RES, V54, P3383; FERRARI S, 1992, EMBO J, V11, P4497, DOI 10.1002/j.1460-2075.1992.tb05551.x; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; GIESE K, 1991, GENE DEV, V5, P2567, DOI 10.1101/gad.5.12b.2567; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; HARLEY VR, 1992, SCIENCE, V255, P453, DOI 10.1126/science.1734522; HOSKING BM, 1995, NUCLEIC ACIDS RES, V23, P2626, DOI 10.1093/nar/23.14.2626; KWOK C, 1995, AM J HUM GENET, V57, P1028; SCHMITZ ML, 1995, J BIOL CHEM, V270, P15576, DOI 10.1074/jbc.270.26.15576; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; TRUANT R, 1993, J BIOL CHEM, V268, P2284; VANDEWETERING M, 1993, EMBO J, V12, P3847, DOI 10.1002/j.1460-2075.1993.tb06063.x; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15	22	181	191	1	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1996	13	2					230	232		10.1038/ng0696-230	http://dx.doi.org/10.1038/ng0696-230			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UN395	8640233				2022-12-25	WOS:A1996UN39500026
J	Gowen, LC; Johnson, BL; Latour, AM; Sulik, KK; Koller, BH				Gowen, LC; Johnson, BL; Latour, AM; Sulik, KK; Koller, BH			Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities	NATURE GENETICS			English	Letter							CELLS; GENE; BREAST; MOUSE		UNIV N CAROLINA, CURRICULUM GENET & MOLEC BIOL, CHAPEL HILL, NC 27515 USA; UNIV N CAROLINA, DEPT MED, CHAPEL HILL, NC USA; UNIV N CAROLINA, DEPT CELL BIOL & ANAT, CHAPEL HILL, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill					NIAAA NIH HHS [5R01AA08204-05] Funding Source: Medline; NIDDK NIH HHS [R01 DK46003-01, DK38103] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA008204] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ABEL KJ, 1995, HUM MOL GENET, V4, P2265, DOI 10.1093/hmg/4.12.2265; BOYD M, 1995, NATURE, V375, P541, DOI 10.1038/375541b0; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; DOMBROWICZ D, 1993, CELL, V75, P969, DOI 10.1016/0092-8674(93)90540-7; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; EASTON DF, 1993, AM J HUM GENET, V52, P678; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; KELSELL DP, 1993, HUM MOL GENET, V2, P1823; MARQUIS ST, 1995, NAT GENET, V11, P17, DOI 10.1038/ng0995-17; MERAJVER SD, 1995, NAT GENET, V9, P439, DOI 10.1038/ng0495-439; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOHN AR, 1995, DNA CLONING MAMMALIA, P142; NEUHAUSEN SL, 1994, CANCER RES, V54, P6069; REID LH, 1990, P NATL ACAD SCI USA, V87, P4299, DOI 10.1073/pnas.87.11.4299; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; SMITH HS, 1993, J CELL BIOCHEM, P144; SULIK KK, 1993, ANN NY ACAD SCI, V678, P8; THOMPSON ME, 1995, NAT GENET, V9, P444, DOI 10.1038/ng0495-444	20	384	390	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1996	12	2					191	194		10.1038/ng0296-191	http://dx.doi.org/10.1038/ng0296-191			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TU079	8563759				2022-12-25	WOS:A1996TU07900021
J	BARDEESY, N; FALKOFF, D; PETRUZZI, MJ; NOWAK, N; ZABEL, B; ADAM, M; AGUIAR, MC; GRUNDY, P; SHOWS, T; PELLETIER, J				BARDEESY, N; FALKOFF, D; PETRUZZI, MJ; NOWAK, N; ZABEL, B; ADAM, M; AGUIAR, MC; GRUNDY, P; SHOWS, T; PELLETIER, J			ANAPLASTIC WILMS-TUMOR, A SUBTYPE DISPLAYING POOR-PROGNOSIS, HARBORS P53 GENE-MUTATIONS	NATURE GENETICS			English	Article							SUPPRESSOR GENE; UROGENITAL DEVELOPMENT; CANCER; DELETION; LOCUS	The genetics of Wilms' tumour (WT), a paediatric malignancy of the kidney, is complex. Inactivation of the tumour suppressor gene, WT1, is associated with tumour aetiology in similar to 10-15% of WTs. Chromosome 17p changes have been noted in cytogenetic studies of WTs, prompting us to screen 140 WTs for p53 mutations. When histopathology reports were available, p53 mutations were present in eight of eleven anaplastic WTs, a tumour subtype associated with poor prognosis. Amplification of MDM2, a gene whose product binds and sequesters p53, was excluded. Our results indicate that p53 alterations provide a molecular marker for anaplastic WTs.	MCGILL UNIV,DEPT BIOCHEM,MONTREAL H3G 1Y6,PQ,CANADA; MCGILL UNIV,CTR CANC,MONTREAL H3G 1Y6,PQ,CANADA; SUNY COLL BUFFALO,ROSWELL PK MEM INST,BUFFALO,NY 14263; UNIV MAINZ,DEPT PEDIAT,W-6500 MAINZ,GERMANY; MERCK FROSST CTR THERAPEUT RES,DEPT MOLEC BIOL,POINTE CLAIRE H9R 4P8,PQ,CANADA; IZAAK WALTON KILLAM HOSP CHILDREN,HALIFAX B3J 3G9,NS,CANADA; CROSS CANC INST,MOLEC ONCOL PROGRAM,EDMONTON T6G 1Z2,AB,CANADA	McGill University; McGill University; Roswell Park Cancer Institute; State University of New York (SUNY) System; Buffalo State College; Johannes Gutenberg University of Mainz; Merck & Company; Dalhousie University; University of Alberta								BRUENING W, 1992, NAT GENET, V1, P144, DOI 10.1038/ng0592-144; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; DANGIO GJ, 1989, CANCER-AM CANCER SOC, V64, P349, DOI 10.1002/1097-0142(19890715)64:2<349::AID-CNCR2820640202>3.0.CO;2-Q; DEFROMENTEL CC, 1992, GENE CHROMOSOME CANC, V4, P1; DENYS P, 1967, ARCH FR PEDIATR, V24, P729; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DRASH A, 1970, J PEDIATR-US, V76, P585, DOI 10.1016/S0022-3476(70)80409-7; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; GROSS RE, 1950, PEDIATRICS, V6, P843; HARTLEY AL, 1993, CANCER GENET CYTOGEN, V67, P133, DOI 10.1016/0165-4608(93)90166-J; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; JACKSON DP, 1992, PCR PRACTICAL APPROA, P29; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; LADANYI M, 1993, CANCER RES, V53, P16; Ladd WE, 1938, ANN SURG, V108, P885, DOI 10.1097/00000658-193811000-00010; LEMOINE NR, 1992, J PATHOL, V168, P237, DOI 10.1002/path.1711680213; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; LOWE SW, 1993, GENE DEV, V7, P535, DOI 10.1101/gad.7.4.535; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; MAHESWARAN S, 1993, P NATL ACAD SCI USA, V90, P5100, DOI 10.1073/pnas.90.11.5100; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MATSUNAGA E, 1981, HUM GENET, V57, P231; MAW MA, 1992, CANCER RES, V52, P3094; MILLER RW, 1964, NEW ENGL J MED, V270, P922, DOI 10.1056/NEJM196404302701802; MURAKAMI Y, 1991, CANCER RES, V51, P3356; OLLNER JD, 1992, NATURE, V358, P80; PELLETIER J, 1991, NATURE, V353, P431, DOI 10.1038/353431a0; PELLETIER J, 1991, CELL, V67, P437, DOI 10.1016/0092-8674(91)90194-4; PELLETIER J, 1991, GENOME ANAL GENES PH, V3, P135; REIFENBERGER G, 1993, CANCER RES, V53, P2736; RICCARDI VM, 1978, PEDIATRICS, V61, P604; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SRIVASTAVA S, 1990, NATURE, V348, P747, DOI 10.1038/348747a0; WIEDEMANN H. R., 1964, J GENET HUM, V13, P223; ZUPPAN CW, 1988, HUM PATHOL, V19, P1199, DOI 10.1016/S0046-8177(88)80152-7	39	238	240	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1994	7	1					91	97		10.1038/ng0594-91	http://dx.doi.org/10.1038/ng0594-91			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NJ842	8075648				2022-12-25	WOS:A1994NJ84200020
J	LEPPERT, M; BAIRD, L; ANDERSON, KL; OTTERUD, B; LUPSKI, JR; LEWIS, RA				LEPPERT, M; BAIRD, L; ANDERSON, KL; OTTERUD, B; LUPSKI, JR; LEWIS, RA			BARDET-BIEDL SYNDROME IS LINKED TO DNA MARKERS ON CHROMOSOME 11Q AND IS GENETICALLY HETEROGENEOUS	NATURE GENETICS			English	Article							LINKAGE ANALYSIS; POLYMORPHISM; DISEASES; LOCUS	Bardet-Biedl syndrome (BBS) is an uncommon autosomal recessive condition characterized by mental retardation, post-axial polydactylia, obesity and pigmentary retinopathy. We performed linkage analysis in 31 multiplex BBS families and report significant linkage with two markers on chromosome 11q, PYGM and AFM164zf12 (D11S913). Homogeneity testing demonstrates genetic heterogeneity within our set of families. Our data imply that a major gene, BBS1, is located on chromosome 11q, although mutations at other loci may also be associated with this phenotype.	UNIV UTAH,ECCLES INST HUMAN GENET,SALT LAKE CITY,UT 84112; BAYLOR COLL MED,DEPT MOLEC & HUMAN GENET,HOUSTON,TX 77030; BAYLOR COLL MED,CTR HUMAN GENOME,HOUSTON,TX 77030; BAYLOR COLL MED,CULLEN EYE INST,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT OPHTHALMOL,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT MED,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030	Utah System of Higher Education; University of Utah; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	LEPPERT, M (corresponding author), UNIV UTAH,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112, USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P30HG000199] Funding Source: NIH RePORTER; NHGRI NIH HHS [5P30HG00199] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AMMANN F, 1970, J GENET HUM, V18, P1; Bardet G., 1920, THESIS U PARIS; BASCOM RA, 1992, NEURON, V8, P1171, DOI 10.1016/0896-6273(92)90137-3; BAUMAN ML, 1973, AM J DIS CHILD, V126, P119, DOI 10.1001/archpedi.1973.02110190107024; BELL J, 1958, TREASURY HUMAN INHER, V5, P51; Bergsma D R, 1975, Birth Defects Orig Artic Ser, V11, P132; Biedl A., 1922, DEUT MED WOCHENSCHR, V48, P1630; BURN RA, 1950, BRIT J OPHTHALMOL, V34, P65, DOI 10.1136/bjo.34.2.65; Cockayne EA, 1935, Q J MED, V4, P93; Dekaban A S, 1972, Med Ann Dist Columbia, V41, P687; FRACCARO M, 1953, FOLIA HERED PATH MIL, V2, P177; GREEN JS, 1989, NEW ENGL J MED, V321, P1002, DOI 10.1056/NEJM198910123211503; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HORING, 1864, KLIN MBL AUGENHEILK, V2, P233; HUTCHINSON J, 1882, OPHTHALMIC REV, V1, P26; Hutchinson J., 1900, ARCH SURG-CHICAGO, V11, P118; Hutchinson Jonathan, 1882, OPHTHALMIC REV, V1, P2; IWASAKI H, 1992, GENOMICS, V13, P7, DOI 10.1016/0888-7543(92)90194-W; KAPUSCINSKI W, 1934, BER DTSCH OPHTHALMOL, V50, P13; KLEIN D, 1969, J NEUROL SCI, V9, P479, DOI 10.1016/0022-510X(69)90091-4; KWITEKBLACK AE, 1993, NAT GENET, V5, P392, DOI 10.1038/ng1293-392; Landau J, 1949, ACTA MED ORIENT, V8, P205; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Laurence J.Z., 1866, OPHTHALMIC REV, V2, P32; LEWIS RA, 1990, GENOMICS, V7, P250, DOI 10.1016/0888-7543(90)90547-8; MARMOR MF, 1983, OPHTHALMOLOGY, V90, P126; McKusick V.A., 1992, MENDELIAN INHERITANC; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; POLYMEROPOULOS MH, 1990, NUCLEIC ACIDS RES, V18, P7468, DOI 10.1093/nar/18.24.7468-a; RAAB W, 1924, WIEN ARCH INN MED, V7, P443; RADNER S., 1940, ACTA MED SCAND, V105, P141; ROSS DF, 1956, J PATHOL BACTERIOL, V72, P161; Sorsby A, 1939, Q J MED, V8, P51; STEVENSON RE, 1993, HUMAN MALFORMATION R, V2, P805; STONE EM, 1992, NAT GENET, V1, P246, DOI 10.1038/ng0792-246; WECKER L, 1864, ANN OCUL PARIS, V53, P73; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	37	163	167	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1994	7	1					108	112		10.1038/ng0594-108	http://dx.doi.org/10.1038/ng0594-108			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NJ842	8075632				2022-12-25	WOS:A1994NJ84200023
J	LEMERRER, M; ROUSSEAU, F; LEGEAIMALLET, L; LANDAIS, JC; PELET, A; BONAVENTURE, J; SANAK, M; WEISSENBACH, J; STOLL, C; MUNNICH, A; MAROTEAUX, P				LEMERRER, M; ROUSSEAU, F; LEGEAIMALLET, L; LANDAIS, JC; PELET, A; BONAVENTURE, J; SANAK, M; WEISSENBACH, J; STOLL, C; MUNNICH, A; MAROTEAUX, P			A GENE FOR ACHONDROPLASIA-HYPOCHONDROPLASIA MAPS TO CHROMOSOME 4P	NATURE GENETICS			English	Article							GROWTH-FACTOR RECEPTOR; BIRTH PREVALENCE RATES; HUNTINGTON DISEASE; SKELETAL DYSPLASIAS; SEQUENCE; REGION; FAMILY; LOCUS	Achondroplasia (ACH) is a frequent condition of unknown origin characterized by short-limbed dwarfism and macrocephaly. Milder forms, termed hypochondroplasias (HCH) result in short stature with radiological features similar to those observed in ACH. We report on the mapping of a gene causing ACH/HCH to human chromosome 4p16.3, by linkage to the iduronidase A (IDUA) locus, in 15 informative families (Z max = 3.01 at theta = 0 for ACH; Z max = 4.71 at theta = 0 for ACH/HCH). Multipoint linkage analysis provides evidence for mapping the disease locus telomeric to D4S412 (location score in log 10 = 4.60). Moreover, this study supports the view that ACH and HCH are genetically homogeneous in our series.	HOP ENFANTS MALAD,INSERM,U393,UNITE RECH HANDICAPS GENET ENFANTS,F-75743 PARIS 15,FRANCE; HOP ENFANTS MALAD,CNRS,ER88,F-75743 PARIS 15,FRANCE; POLISH AMER CHILDRENS HOSP,DEPT MED GENET,KRAKOW,POLAND; GENETHON,F-91002 EVRY,FRANCE; INST PUERICULTURE,SERV GENET,F-67000 STRASBOURG,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS)	LEMERRER, M (corresponding author), HOP ENFANTS MALAD,SERV GENET,149 RUE SEVRES,F-75743 PARIS 15,FRANCE.		Sanak, Marek/AAV-1628-2021; Legeai-Mallet, Laurence/E-6112-2016	Sanak, Marek/0000-0001-7635-8103; Legeai-Mallet, Laurence/0000-0003-4989-5856; PELET, Anastella/0000-0002-8353-1725				BOUVET JP, 1971, ANN GENET-PARIS, V14, P127; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; CARTER WA, 1992, AM J HUM GENET, V51, P841; GARDNER RJM, 1977, CLIN GENET, V11, P31; GUSELLA JF, 1992, GENOMICS, V13, P75, DOI 10.1016/0888-7543(92)90204-6; HALL BD, 1979, RADIOLOGY, V133, P95, DOI 10.1148/133.1.95; IWAMOTO M, 1991, J BIOL CHEM, V266, P461; KATO Y, 1990, J BIOL CHEM, V265, P5903; KEEGAN K, 1991, P NATL ACAD SCI USA, V88, P1095, DOI 10.1073/pnas.88.4.1095; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MAROTEAUX P, 1988, ARCH FR PEDIATR, V45, P105; Maroteaux P, 1964, Clin Orthop Relat Res, V33, P91; MAYNARD JA, 1981, J BONE JOINT SURG AM, V63, P969, DOI 10.2106/00004623-198163060-00015; MCKUSICK VA, 1973, J MED GENET, V10, P11, DOI 10.1136/jmg.10.1.11; MULLIS PE, 1991, CLIN ENDOCRINOL, V14, P265; MURDOCH JL, 1970, ANN HUM GENET, V33, P227, DOI 10.1111/j.1469-1809.1970.tb01648.x; OBERKLAID F, 1979, J MED GENET, V16, P140, DOI 10.1136/jmg.16.2.140; OGILVIE D, 1986, J MED GENET, V23, P19, DOI 10.1136/jmg.23.1.19; ORIOLI IM, 1986, J MED GENET, V23, P328, DOI 10.1136/jmg.23.4.328; OTT J, 1985, VARIABILITY RECOMBIN, P112; PADANILAM BJ, 1992, HUM MOL GENET, V1, P104; PARROT J, 1878, B SOC ANTROPOL, V1, P296; PONSETI IV, 1970, J BONE JOINT SURG AM, VA 52, P701, DOI 10.2106/00004623-197052040-00004; PULST SM, 1990, HUM GENET, V85, P12; PULST SM, 1991, AM J MED GENET, V10, P84; SCOTT HS, 1991, NUCLEIC ACIDS RES, V19, P6348, DOI 10.1093/nar/19.22.6348-a; SOMMER A, 1987, AM J MED GENET, V26, P949, DOI 10.1002/ajmg.1320260426; STANESCU R, 1990, AM J MED GENET, V37, P412, DOI 10.1002/ajmg.1320370323; STANESCU V, 1977, ARCH FR PEDIAT S, V34; STOLL C, 1989, CLIN GENET, V35, P88; THOMPSON LM, 1991, GENOMICS, V11, P1133, DOI 10.1016/0888-7543(91)90041-C; TOMMERUP M, 1993, HUM MOL GENET, V2, P1571; VIGNAL A, 1993, METHODS MOL GENETICS, V1, P211; WEBER B, 1991, NUCLEIC ACIDS RES, V19, P6263, DOI 10.1093/nar/19.22.6263; WELSSENBACH J, 1992, NATURE, V359, P794; WILSON HG, 1981, HUM GENET, V59, P397; WYNNEDAVIES R, 1981, J BONE JOINT SURG BR, V63, P508, DOI 10.1302/0301-620X.63B4.7298674; 1913, NOU ICONOG SAPEL, V26, P157; 1924, B SOC MED HOP PARIS, V48, P1780	40	93	93	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1994	6	3					318	321						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ562	8012398				2022-12-25	WOS:A1994MZ56200023
J	TYLERSMITH, C; OAKEY, RJ; LARIN, Z; FISHER, RB; CROCKER, M; AFFARA, NA; FERGUSONSMITH, MA; MUENKE, M; ZUFFARDI, O; JOBLING, MA				TYLERSMITH, C; OAKEY, RJ; LARIN, Z; FISHER, RB; CROCKER, M; AFFARA, NA; FERGUSONSMITH, MA; MUENKE, M; ZUFFARDI, O; JOBLING, MA			LOCALIZATION OF DNA-SEQUENCES REQUIRED FOR HUMAN CENTROMERE FUNCTION THROUGH AN ANALYSIS OF REARRANGED Y-CHROMOSOMES	NATURE GENETICS			English	Article							SUPERNUMERARY MARKER CHROMOSOMES; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; INSITU HYBRIDIZATION; YP/18 TRANSLOCATION; FISSION YEAST; SATELLITE DNA; DELETION; CONSTRUCTION; REGION	We have localized the DNA sequences required for mitotic centromere function on the human Y chromosome. Analysis of 33 rearranged Y chromosomes allowed the centromere to be placed in interval 8 of a 24-interval deletion map. Although this interval is polymorphic in size, it can be as small as similar to 500kb. It contains alphoid satellite DNA and similar to 300kb of adjacent Yp sequences. Chromosomes with rearrangements in this region were analysed in detail. Two translocation chromosomes and one monocentric isochromosome had breakpoints within the alphoid array. Of 12 suppressed Y centromeres on translocation chromosomes and dicentric isochromosomes that were also analysed two showed deletions one of which only removed alphoid DNA. These results indicate that alphoid DNA is a functional part of the Y chromosome centromere.	CHURCHILL HOSP,CYTOGENET LAB,OXFORD OX3 7LJ,ENGLAND; UNIV CAMBRIDGE,DEPT PATHOL,HUMAN MOLEC GENET GRP,CAMBRIDGE CB2 1QP,ENGLAND; UNIV PENN,SCH MED,DEPT PEDIAT,DIV HUMAN GENET & MOLEC BIOL,PHILADELPHIA,PA 19104; UNIV PAVIA,I-27100 PAVIA,ITALY; UNIV OXFORD,GENET LAB,OXFORD OX1 3QU,ENGLAND	University of Oxford; University of Cambridge; University of Pennsylvania; University of Pavia; University of Oxford	TYLERSMITH, C (corresponding author), UNIV OXFORD,DEPT BIOCHEM,CRC,CHROMOSOME MOLEC BIOL GRP,S PARKS RD,OXFORD OX1 3QU,OXON,ENGLAND.		Oakey, Rebecca/A-5958-2011; Monaco, Zoia L/C-5762-2011	Oakey, Rebecca/0000-0003-2706-8139; Muenke, Maximilian/0000-0002-7719-6545; zuffardi, orsetta/0000-0002-1466-4559; Jobling, Mark/0000-0002-8061-1308				AFFARA NA, 1987, NUCLEIC ACIDS RES, V15, P7325, DOI 10.1093/nar/15.18.7325; AFFARA NA, 1986, NUCLEIC ACIDS RES, V14, P5353, DOI 10.1093/nar/14.13.5353; BARNETT MA, 1993, NUCLEIC ACIDS RES, V21, P27, DOI 10.1093/nar/21.1.27; CHANDLEY AC, 1971, CYTOGENETICS, V10, P295, DOI 10.1159/000130149; CHANDLEY AC, 1989, J MED GENET, V26, P145, DOI 10.1136/jmg.26.3.145; CHANDLEY AC, 1986, HUM GENET, V73, P350, DOI 10.1007/BF00279099; CLARKE L, 1980, NATURE, V287, P504, DOI 10.1038/287504a0; Cooper Katrina F., 1992, Human Molecular Genetics, V1, P753, DOI 10.1093/hmg/1.9.753; COOPER KF, 1993, J MOL BIOL, V230, P787, DOI 10.1006/jmbi.1993.1201; COOPER KF, 1992, J MOL BIOL, V228, P421, DOI 10.1016/0022-2836(92)90831-4; CROLLA JA, 1992, J MED GENET, V29, P699, DOI 10.1136/jmg.29.10.699; EMRIE PA, 1988, SOMAT CELL MOLEC GEN, V14, P105, DOI 10.1007/BF01535054; FARR C, 1991, P NATL ACAD SCI USA, V88, P7006, DOI 10.1073/pnas.88.16.7006; FOOTE S, 1992, SCIENCE, V258, P60, DOI 10.1126/science.1359640; GRADY DL, 1992, P NATL ACAD SCI USA, V89, P1695, DOI 10.1073/pnas.89.5.1695; HAAF T, 1992, CELL, V70, P681, DOI 10.1016/0092-8674(92)90436-G; HADLACZKY G, 1991, P NATL ACAD SCI USA, V88, P8106, DOI 10.1073/pnas.88.18.8106; HAHNENBERGER KM, 1989, P NATL ACAD SCI USA, V86, P577, DOI 10.1073/pnas.86.2.577; HEINZEL SS, 1991, MOL CELL BIOL, V11, P2263, DOI 10.1128/MCB.11.4.2263; JAGER D, 1989, EMBO J, V8, P247, DOI 10.1002/j.1460-2075.1989.tb03370.x; KOSHLAND D, 1987, CELL, V48, P801, DOI 10.1016/0092-8674(87)90077-8; MANN C, 1983, P NATL ACAD SCI-BIOL, V80, P228, DOI 10.1073/pnas.80.1.228; MARASCHIO P, 1990, HUM GENET, V85, P491; MASERATI E, 1986, HUM GENET, V74, P126, DOI 10.1007/BF00282075; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; MULLER U, 1992, HUM GENET, V90, P239; MUNKE M, 1988, HUM GENET, V80, P219, DOI 10.1007/BF01790089; MURRAY AW, 1983, NATURE, V305, P189, DOI 10.1038/305189a0; NAKAHORI Y, 1986, NUCLEIC ACIDS RES, V14, P7569, DOI 10.1093/nar/14.19.7569; NIWA O, 1989, EMBO J, V8, P3045, DOI 10.1002/j.1460-2075.1989.tb08455.x; NIWA O, 1986, MOL GEN GENET, V203, P397, DOI 10.1007/BF00422063; O'Reilly Amanda, 1992, Human Molecular Genetics, V1, P379, DOI 10.1093/hmg/1.6.379; OAKEY R, 1990, GENOMICS, V7, P325, DOI 10.1016/0888-7543(90)90165-Q; PETROVIC V, 1992, J MED GENET, V29, P542, DOI 10.1136/jmg.29.8.542; RAUCH A, 1992, CLIN GENET, V42, P84; SMITH GP, 1976, SCIENCE, V191, P528, DOI 10.1126/science.1251186; TYLERSMITH C, 1987, J MOL BIOL, V195, P457, DOI 10.1016/0022-2836(87)90175-6; VOULLAIRE LE, 1993, AM J HUM GENET, V52, P1153	38	144	151	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1993	5	4					368	375		10.1038/ng1293-368	http://dx.doi.org/10.1038/ng1293-368			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ML145	8298645				2022-12-25	WOS:A1993ML14500013
J	ADAMS, MD; KERLAVAGE, AR; FIELDS, C; VENTER, JC				ADAMS, MD; KERLAVAGE, AR; FIELDS, C; VENTER, JC			3,400 NEW EXPRESSED SEQUENCE TAGS IDENTIFY DIVERSITY OF TRANSCRIPTS IN HUMAN BRAIN	NATURE GENETICS			English	Article							LIPOPROTEIN RECEPTOR; LDL-RECEPTOR; ZINC FINGERS; PROTEIN; ENCODES; GENE; FAMILY; VIRUS; TOOL	We present the results of the partial sequencing of over 3,400 expressed sequence tags (ESTs) from human brain cDNA clones, which increases the number of distinct genes expressed in the brain, that are represented by ESTs, to about 6,000. By choosing clones in an unbiased manner, it is possible to construct a profile of the transcriptional activity of the brain at different stages. Proteins that comprise the cytoskeleton are the most abundant; however, a large variety of regulatory proteins are also seen. About half of the ESTs predicted to contain a protein-coding region have no matches in the public peptide databases and may represent new gene families.	NINCDS,RECEPTOR BIOCHEM & MOLECU BIOL SECT,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	ADAMS, MD (corresponding author), INST GENOM RES,932 CLOPPER RD,GAITHERSBURG,MD 20878, USA.			Kerlavage, Anthony/0000-0002-3954-9653; Fields, Chris/0000-0002-4812-0744				ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ADAMS MD, IN PRESS NATURE GENE; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BORK P, 1992, NATURE, V358, P287, DOI 10.1038/358287a0; CHARDIN P, 1991, NUCLEIC ACIDS RES, V19, P1431, DOI 10.1093/nar/19.7.1431; CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0; DIBELLO PR, 1991, GENETICS, V129, P385; FIELDS CA, 1990, COMPUT APPL BIOSCI, V6, P263; HARRISON SD, 1990, EMBO J, V9, P207, DOI 10.1002/j.1460-2075.1990.tb08097.x; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; HOOG C, 1991, NUCLEIC ACIDS RES, V19, P6123, DOI 10.1093/nar/19.22.6123; HOWARD ST, 1991, VIROLOGY, V180, P633, DOI 10.1016/0042-6822(91)90077-O; KERLAVAGE A, 1993, 26TH P HAW INT C SYS, P585; KHAN AS, 1992, NAT GENET, V2, P180, DOI 10.1038/ng1192-180; KRISTENSEN T, 1990, FEBS LETT, V276, P151, DOI 10.1016/0014-5793(90)80530-V; MARTINGALLARDO A, 1992, NAT GENET, V1, P348; MCCOMBIE WR, 1992, NAT GENET, V1, P348, DOI 10.1038/ng0892-348; MCCOMBIE WR, 1992, NAT GENET, V1, P124, DOI 10.1038/ng0592-124; OKUBO K, 1992, NAT GENET, V2, P173, DOI 10.1038/ng1192-173; OLIVER SG, 1992, NATURE, V357, P38, DOI 10.1038/357038a0; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; SODERLUND C, 1992, P HAWAII INT C SYSTE, P653; SULSTON J, 1992, NATURE, V356, P37, DOI 10.1038/356037a0; TAKAHASHI S, 1992, P NATL ACAD SCI USA, V89, P9252, DOI 10.1073/pnas.89.19.9252; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; UPTON C, 1990, VIROLOGY, V179, P618, DOI 10.1016/0042-6822(90)90129-F; WATERSTON R, 1992, NAT GENET, V1, P114, DOI 10.1038/ng0592-114; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0	30	301	389	1	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1993	4	3					256	267		10.1038/ng0793-256	http://dx.doi.org/10.1038/ng0793-256			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ842	8358434				2022-12-25	WOS:A1993LJ84200013
J	TAKIYAMA, Y; NISHIZAWA, M; TANAKA, H; KAWASHIMA, S; SAKAMOTO, H; KARUBE, Y; SHIMAZAKI, H; SOUTOME, M; ENDO, K; OHTA, S; KAGAWA, Y; KANAZAWA, I; MIZUNO, Y; YOSHIDA, M; YUASA, T; HORIKAWA, Y; OYANAGI, K; NAGAI, H; KONDO, T; INUZUKA, T; ONODERA, O; TSUJI, S				TAKIYAMA, Y; NISHIZAWA, M; TANAKA, H; KAWASHIMA, S; SAKAMOTO, H; KARUBE, Y; SHIMAZAKI, H; SOUTOME, M; ENDO, K; OHTA, S; KAGAWA, Y; KANAZAWA, I; MIZUNO, Y; YOSHIDA, M; YUASA, T; HORIKAWA, Y; OYANAGI, K; NAGAI, H; KONDO, T; INUZUKA, T; ONODERA, O; TSUJI, S			THE GENE FOR MACHADO-JOSEPH DISEASE MAPS TO HUMAN CHROMOSOME-14Q	NATURE GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; NON-PORTUGUESE FAMILY; SPINOCEREBELLAR ATAXIA; HEREDITARY ATAXIA; LINKAGE ANALYSIS; AZOREAN DISEASE; JAPANESE FAMILY; LOCUS; DEGENERATION; KINDREDS	Machado-Joseph disease (MJD) is an autosomal dominant, multisystem neurodegenerative disorder involving predominantly cerebellar, pyramidal, extrapyramidal, motor neuron and oculomotor systems. Although it was first reported in families of Portuguese-Azorean descent, MJD has also been described in non-Azorean families from various countries, being one of the most common hereditary spinocerebellar degenerations. With the use of highly polymorphic microsatellite DNA polymorphisms, we have assigned the gene for MJD to the long arm of chromosome 14 (14q24.3-q32) by genetic linkage to microsatellite loci D14S55 and D14S48 (multipoint lod score Z(max) = 9.719).	JICHI MED SCH,DEPT NEUROL,MINAMI KAWACHI,TOCHIGI 32904,JAPAN; JICHI MED SCH,DEPT BIOCHEM,MINAMI KAWACHI,TOCHIGI 32904,JAPAN; JUNTENDO UNIV,FAC MED,DEPT NEUROL,TOKYO 113,JAPAN; NIIGATA UNIV,DEPT NEUROL,NIIGATA 951,JAPAN; NIIGATA UNIV,CTR MAT BRAIN DIS,NIIGATA 951,JAPAN; UNIV TOKYO,INST BRAIN RES,DEPT NEUROL,TOKYO 113,JAPAN; TOKYO MED & DENT UNIV,FAC MED,DEPT NEUROL,TOKYO 113,JAPAN; SHINRAKUEN HOSP,DEPT NEUROL,NIIGATA 95021,JAPAN; SUIBARAGO HOSP,DEPT NEUROL,NIIGATA 95921,JAPAN; AGANO HOSP,DEPT NEUROL,YASUDA,NIIGATA 95922,JAPAN	Jichi Medical University; Jichi Medical University; Juntendo University; Niigata University; Niigata University; University of Tokyo; Tokyo Medical & Dental University (TMDU)			Onodera, Osamu/K-7327-2013	Onodera, Osamu/0000-0003-3354-5472; Shimazaki, Haruo/0000-0003-0628-7164				BARBEAU A, 1984, CAN J NEUROL SCI, V11, P510, DOI 10.1017/S0317167100034983; BHARUCHA NE, 1986, ARCH NEUROL-CHICAGO, V43, P142, DOI 10.1001/archneur.1986.00520020036014; BOWDEN DW, 1989, AM J HUM GENET, V44, P671; CARSON WJ, 1992, GENOMICS, V13, P852, DOI 10.1016/0888-7543(92)90168-R; FORSE RA, 1989, J NEUROGENET, V5, P155, DOI 10.3109/01677068909066204; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; HEALTON EB, 1980, NEUROLOGY, V30, P1084, DOI 10.1212/WNL.30.10.1084; HIRAYAM K, 1991, ANN REPORT RES COMMI, P29; JACKSON JF, 1977, NEW ENGL J MED, V296, P1138, DOI 10.1056/NEJM197705192962003; JORDAN SA, 1991, NUCLEIC ACIDS RES, V19, P1171, DOI 10.1093/nar/19.5.1171; KITAMURA J, 1989, ARCH NEUROL-CHICAGO, V46, P425, DOI 10.1001/archneur.1989.00520400085024; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LIMA L, 1980, NEUROLOGY, V30, P319, DOI 10.1212/WNL.30.3.319; LUTY JA, 1991, NUCLEIC ACIDS RES, V19, P4308, DOI 10.1093/nar/19.15.4308; Maniatis T, 1989, DECONTAMINATION DILU; MULLAN M, 1992, NAT GENET, V2, P340, DOI 10.1038/ng1292-340; MYERS SM, 1986, CYTOGENET CELL GENET, V43, P226, DOI 10.1159/000132328; NAKANO KK, 1972, NEUROLOGY, V22, P49, DOI 10.1212/WNL.22.1.49; OTT J, 1991, ANAL HUMAN GENETIC L, P74; RANUM LPW, 1991, AM J HUM GENET, V49, P31; RISCH N, 1991, AM J HUM GENET, V48, P1058; ROMANUL FCA, 1977, NEW ENGL J MED, V296, P1505, DOI 10.1056/NEJM197706302962606; ROSENBERG RN, 1976, NEUROLOGY, V26, P703, DOI 10.1212/WNL.26.8.703; ROSENBERG RN, 1992, MOVEMENT DISORD, V3, P193; SAKAI T, 1983, NEUROLOGY, V33, P74, DOI 10.1212/WNL.33.1.74; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SHARMA V, 1991, NUCLEIC ACIDS RES, V19, P1722, DOI 10.1093/nar/19.7.1722; STEGEORGEHYSLOP P, 1992, NAT GENET, V2, P330; SUITE NDA, 1986, J NEUROGENET, V3, P177, DOI 10.3109/01677068609106847; TAKIYAMA Y, 1989, ACTA NEUROL SCAND, V79, P214, DOI 10.1111/j.1600-0404.1989.tb03741.x; VAN BROECKHOVEN C, 1992, NAT GENET, V2, P335, DOI 10.1038/ng1292-335; WANG ZY, 1992, GENOMICS, V13, P532, DOI 10.1016/0888-7543(92)90121-8; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4638, DOI 10.1093/nar/18.15.4638-a; WEBER JL, 1989, AM J HUM GENET, V44, P388; WOODS BT, 1972, J NEUROL SCI, V17, P149, DOI 10.1016/0022-510X(72)90137-2; YAKURA H, 1974, NEW ENGL J MED, V291, P154; YUASA T, 1986, ANN NEUROL, V19, P152, DOI 10.1002/ana.410190207; ZOGHBI HY, 1991, AM J HUM GENET, V49, P23; 1992, SCIENC E, V258, P67	39	323	329	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1993	4	3					300	304		10.1038/ng0793-300	http://dx.doi.org/10.1038/ng0793-300			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ842	8358439				2022-12-25	WOS:A1993LJ84200020
J	GARIBOLDI, M; MANENTI, G; CANZIAN, F; FALVELLA, FS; RADICE, MT; PIEROTTI, MA; DELLAPORTA, G; BINELLI, G; DRAGANI, TA				GARIBOLDI, M; MANENTI, G; CANZIAN, F; FALVELLA, FS; RADICE, MT; PIEROTTI, MA; DELLAPORTA, G; BINELLI, G; DRAGANI, TA			A MAJOR SUSCEPTIBILITY LOCUS TO MURINE LUNG CARCINOGENESIS MAPS ON CHROMOSOME-6	NATURE GENETICS			English	Article							ALVEOLAR CELL-CARCINOMA; RAS PROTOONCOGENE; TUMOR SUSCEPTIBILITY; QUANTITATIVE TRAITS; MOUSE GENOME; CANCER; MICE; LINKAGE; ACTIVATION; GENE	Lung tumours represent a major cause of death in humans, and although smoking represents the main pathogenetic factor, inheritance also plays a part. However, the identification of possible predisposing genetic factors is difficult, because of their low penetrance. We took advantage of murine strains that are genetically susceptible or resistant to lung tumour development, to map murine genes associated with susceptibility to lung carcinogenesis. An F2 population of urethan-treated A/J x C3H/He mice was scored with 83 genetic markers. A chromosome 6 distal region, spanning 35 centiMorgans, contained a major lung tumour susceptibility locus. No other chromosomal region was significantly associated with lung tumour development.	IST NAZL TUMORI,DIV EXPTL ONCOL A,I-20133 MILAN,ITALY; UNIV MILAN,DEPT GENET & MICROBIOL,I-20122 MILAN,ITALY	Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Milan			Manenti, Giacomo/J-3339-2017; Canzian, Federico/I-2804-2014; Pierotti, Marco Alessandro/AAC-4728-2022; Gariboldi, Manuela/K-4744-2016; Dragani, Tommaso A./K-4493-2016	Manenti, Giacomo/0000-0002-4887-4482; Pierotti, Marco Alessandro/0000-0002-7431-8332; Gariboldi, Manuela/0000-0001-8406-165X; Canzian, Federico/0000-0002-4261-4583; Dragani, Tommaso A./0000-0001-5915-4598				AVNER P, 1988, TRENDS GENET, V4, P18, DOI 10.1016/0168-9525(88)90123-0; BIRAN H, 1991, LUNG CANCER, V7, P345; BIRRER MJ, 1989, ANNU REV MED, V40, P305; CAPORASO NE, 1990, J NATL CANCER I, V82, P1264, DOI 10.1093/jnci/82.15.1264; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; COPELAND NG, 1991, TRENDS GENET, V7, P113, DOI 10.1016/0168-9525(91)90455-Y; DEVEREUX TR, 1991, CARCINOGENESIS, V12, P299, DOI 10.1093/carcin/12.2.299; DIETRICH W, 1992, GENETICS, V131, P423; DRAGANI TA, 1991, CANCER RES, V51, P6299; Hillyard A. L., 1992, LOCUS MAP MOUSE COMP; JOISHY SK, 1977, ANN INTERN MED, V87, P447, DOI 10.7326/0003-4819-87-4-447; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1989, GENETICS, V121, P185; LAW MR, 1990, BRIT J CANCER, V61, P195, DOI 10.1038/bjc.1990.37; LOVE JM, 1990, NUCLEIC ACIDS RES, V18, P4123, DOI 10.1093/nar/18.14.4123; LYON MF, 1990, P NATL ACAD SCI USA, V87, P2433, DOI 10.1073/pnas.87.7.2433; MALKINSON AM, 1992, CANCER RES, V52, pS2670; MALKINSON AM, 1985, J NATL CANCER I, V75, P971, DOI 10.1093/jnci/75.5.971; MALKINSON AM, 1989, TOXICOLOGY, V54, P241, DOI 10.1016/0300-483X(89)90062-0; NADEAU JH, 1989, TRENDS GENET, V5, P82, DOI 10.1016/0168-9525(89)90031-0; OOI WL, 1986, J NATL CANCER I, V76, P217; OOMEN LCJM, 1991, EXP LUNG RES, V17, P283, DOI 10.3109/01902149109064419; PATERSON AH, 1991, GENETICS, V127, P181; PAUL SM, 1987, J SURG ONCOL, V36, P249, DOI 10.1002/jso.2930360407; PIEROTTI M A, 1992, Current Opinion in Oncology, V4, P127, DOI 10.1097/00001622-199202000-00017; PONDER BAJ, 1990, TRENDS GENET, V6, P213, DOI 10.1016/0168-9525(90)90181-5; RE FC, 1992, MOL CARCINOGEN, V5, P155, DOI 10.1002/mc.2940050211; RYAN J, 1987, J NATL CANCER I, V79, P1351; RYDERCOOK AS, 1988, EMBO J, V7, P3017, DOI 10.1002/j.1460-2075.1988.tb03165.x; Shimkin M B, 1975, Adv Cancer Res, V21, P1, DOI 10.1016/S0065-230X(08)60970-7; STOWERS SJ, 1987, CANCER RES, V47, P3212; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; TRAVIS GH, 1991, GENOMICS, V10, P733, DOI 10.1016/0888-7543(91)90457-P; UEMATSU F, 1991, JPN J CANCER RES, V82, P254, DOI 10.1111/j.1349-7006.1991.tb01838.x; WELLER JI, 1988, GENETICS, V118, P329; Wright S., 1952, Quantitative inheritance. Papers read at a colloquium held at the Institute of Animal Genetics Edinburgh University under the auspices of the Agricultural Research Council April 4th to 6th, 1950., P5; YOU M, 1989, P NATL ACAD SCI USA, V86, P3070, DOI 10.1073/pnas.86.9.3070; YOU M, 1992, P NATL ACAD SCI USA, V89, P5804, DOI 10.1073/pnas.89.13.5804; 1988, SAS USERS GUIDE STAT	39	130	130	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1993	3	2					132	136		10.1038/ng0293-132	http://dx.doi.org/10.1038/ng0293-132			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KL010	8499946				2022-12-25	WOS:A1993KL01000010
J	Holmberg, L; Baum, M				Holmberg, L; Baum, M			Work on your theories!	NATURE MEDICINE			English	Editorial Material							BREAST-CANCER; SURGERY		UNIV UPPSALA HOSP, DEPT SURG, S-75185 UPPSALA, SWEDEN	Uppsala University; Uppsala University Hospital	Holmberg, L (corresponding author), UCL, SCH MED, INST SURG STUDIES, LONDON W1P 7LD, ENGLAND.							ABE O, 1992, LANCET, V339, P71; Baum, 1995, Breast Cancer, V2, P9, DOI 10.1007/BF02966891; Early Breast Cancer Trialists' Collaborative Group, 1992, LANCET, V339, P1; FISHER B, 1980, CANCER RES, V40, P3863; GAGE I, 1995, INT J RADIAT ONCOL, V33, P245, DOI 10.1016/0360-3016(95)02001-R; OLIVER RTD, 1995, LANCET, V346, P1506, DOI 10.1016/S0140-6736(95)92046-3; Popper K., 1979, OBJECTIVE KNOWLEDGE, P106; Popper K., 1979, OBJECTIVE KNOWLEDGE, P32; POPPER KR, 1994, MYTH FRAMEWORK, P102; POPPER KR, 1994, MYTH FRAMEWORK, P86; POPPER KR, 1979, OBJECTIVE KNOWLEDGE, P202; VERONESI U, 1995, J NATL CANCER I, V87, P19, DOI 10.1093/jnci/87.1.19	12	17	18	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956			NAT MED	Nat. Med.	AUG	1996	2	8					844	846		10.1038/nm0896-844	http://dx.doi.org/10.1038/nm0896-844			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UZ804	8705844				2022-12-25	WOS:A1996UZ80400021
J	Molla, A; Korneyeva, M; Gao, Q; Vasavanonda, S; Schipper, PJ; Mo, HM; Markowitz, M; Chernyavskiy, T; Niu, P; Lyons, N; Hsu, A; Granneman, GR; Ho, DD; Boucher, CAB; Leonard, JM; Norbeck, DW; Kempf, DJ				Molla, A; Korneyeva, M; Gao, Q; Vasavanonda, S; Schipper, PJ; Mo, HM; Markowitz, M; Chernyavskiy, T; Niu, P; Lyons, N; Hsu, A; Granneman, GR; Ho, DD; Boucher, CAB; Leonard, JM; Norbeck, DW; Kempf, DJ			Ordered accumulation of mutations in HIV protease confers resistance to ritonavir	NATURE MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ASSAY	Analysis of the HIV protease gene from the plasma of HIV-infected patients revealed substitutions at nine different codons selected in response to monotherapy with the protease inhibitor ritonavir. Mutants at valine-82, although insufficient to confer resistance, appeared first in most patients. Significant phenotypic resistance required multiple mutations in HIV protease, which emerged subsequently in an ordered, stepwise fashion. The appearance of resistance mutations was delayed in patients with higher plasma levels of ritonavir. Early mutants retained susceptibility to structurally diverse protease inhibitors, suggesting that dual protease inhibitor therapy might increase the duration of viral suppression.	ABBOTT LABS,DEPT ANTIINFECT RES,ABBOTT PK,IL 60064; ABBOTT LABS,DEPT PHARMACOKINET,ABBOTT PK,IL 60064; ABBOTT LABS,DEPT ANTIVIRAL VENTURE,DIV PHARMACEUT PROD,ABBOTT PK,IL 60064; UNIV UTRECHT,EIJKMAN WINKLER INST MED & CLIN MICROBIOL,3584 CX UTRECHT,NETHERLANDS; NYU,AARON DIAMOND AIDS RES CTR,NEW YORK,NY 10016	Abbott Laboratories; Abbott Laboratories; Abbott Laboratories; Utrecht University; New York University								CAMERON B, 1996, 3 C RETR OPP INF WAS; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; CONDRA JH, 1995, NATURE, V374, P569, DOI 10.1038/374569a0; DANNER SA, 1995, NEW ENGL J MED, V333, P1528, DOI 10.1056/NEJM199512073332303; GULICK R, 1996, 3 C RETR OPP INF WAS; GULNIK SV, 1995, BIOCHEMISTRY-US, V34, P9282, DOI 10.1021/bi00029a002; HEATHCHIOZZI M, 1996, 3 C RETR OPP INF WAS; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; HO DD, 1994, J VIROL, V68, P2016, DOI 10.1128/JVI.68.3.2016-2020.1994; JACOBSEN H, 1995, VIROLOGY, V206, P527, DOI 10.1016/S0042-6822(95)80069-7; JACOBSEN H, 1995, AIDS RES HUM RETROV, V11, pS169; JAPOUR AJ, 1993, ANTIMICROB AGENTS CH, V37, P1095, DOI 10.1128/AAC.37.5.1095; KEMPF DJ, 1995, P NATL ACAD SCI USA, V92, P2484, DOI 10.1073/pnas.92.7.2484; KITCHEN VS, 1995, LANCET, V345, P952, DOI 10.1016/S0140-6736(95)90699-1; MARKOWITZ M, 1995, J VIROL, V69, P701, DOI 10.1128/JVI.69.2.701-706.1995; MARKOWITZ M, 1995, NEW ENGL J MED, V333, P1534, DOI 10.1056/NEJM199512073332304; MASCHERA B, 1995, J VIROL, V69, P5431, DOI 10.1128/JVI.69.9.5431-5436.1995; MYERS G, 1993, HUMAN RETROVIRUSES A; PACHL C, 1995, J ACQ IMMUN DEF SYND, V8, P446, DOI 10.1097/00042560-199504120-00003; PARTALEDIS JA, 1995, J VIROL, V69, P5228, DOI 10.1128/JVI.69.9.5228-5235.1995; Patick AK, 1996, ANTIMICROB AGENTS CH, V40, P292, DOI 10.1128/AAC.40.2.292; PAUWELS R, 1988, J VIROL METHODS, V20, P309, DOI 10.1016/0166-0934(88)90134-6; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; RICHMAN DD, 1990, REV INFECT DIS, V12, pS507; SCHAPIRO JM, IN PRESS ANN INTERN; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0	26	626	642	0	17	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUL	1996	2	7					760	766		10.1038/nm0796-760	http://dx.doi.org/10.1038/nm0796-760			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UU680	8673921				2022-12-25	WOS:A1996UU68000031
J	Beutler, E				Beutler, E			The cost of treating Gaucher disease	NATURE MEDICINE			English	Editorial Material											Beutler, E (corresponding author), SCRIPPS RES INST, 10666 N TORREY PINES RD, LA JOLLA, CA 92037 USA.							BALLCKI D, 1995, MEDICINE, V74, P305; BEUTLER E, 1995, LANCET, V346, P581, DOI 10.1016/S0140-6736(95)91422-6; BEUTLER E, 1995, BLOOD CELL MOL DIS, V21, P86, DOI 10.1006/bcmd.1995.0012; COHEN Y, 1994, AM J HEMATOL, V47, P235, DOI 10.1002/ajh.2830470317; HOLLAK CEM, 1995, LANCET, V345, P1474, DOI 10.1016/S0140-6736(95)91037-9; *NATL I HLTH TECHN, 1995, GAUCH DIS CURR ISS D; ROBINSON ML, 1996, BIOWORLD TODAY, V7, P1; ZIMRAN A, 1994, AM J MED, V97, P3, DOI 10.1016/0002-9343(94)90042-6	8	13	13	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAY	1996	2	5					523	524		10.1038/nm0596-523	http://dx.doi.org/10.1038/nm0596-523			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UJ230	8616707				2022-12-25	WOS:A1996UJ23000031
J	Hsu, CH; Chua, KY; Tao, MH; Lai, YL; Wu, HD; Huang, SK; Hsieh, KH				Hsu, CH; Chua, KY; Tao, MH; Lai, YL; Wu, HD; Huang, SK; Hsieh, KH			Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization	NATURE MEDICINE			English	Article							ASTHMATIC-CHILDREN; IMMUNE-RESPONSE; IGE RESPONSES; MOUSE MUSCLE; SERUM IGE; T-CELLS; ANTIGEN; RESPONSIVENESS; INHALATION; RATS	The efficacy of an ''allergen-gene immunization'' protocol in altering allergic response was examined. Intramuscular injection of rats with a plasmid DNA encoding a house dust mite allergen into the muscle results in its long-term expression and the induction of specific immune responses. Significantly, this approach prevents the induction of immunoglobulin E synthesis, histamine release in bronchoalveolar fluids, and airway hyperresponsiveness in rats challenged with aerosolized allergen. Furthermore, this suppression is persistent and can be transferred into naive rats by CD8(+) T cells from gene-immunized rats. These findings suggest that allergen-gene immunization is effective in modulating allergic responses, and may provide a novel therapeutic approach for allergic diseases.	NATL TAIWAN UNIV,COLL MED,GRAD INST MICROBIOL,TAIPEI,TAIWAN; NATL TAIWAN UNIV,COLL MED,GRAD INST IMMUNOL,TAIPEI,TAIWAN; NATL TAIWAN UNIV,COLL MED,GRAD INST PHYSIOL,TAIPEI,TAIWAN; ACAD SINICA,INST BIOMED SCI,TAIPEI,TAIWAN; JOHNS HOPKINS UNIV,SCH MED,JOHNS HOPKINS ASTHMA & ALLERGY CTR,BALTIMORE,MD 21224; NATL TAIWAN UNIV HOSP,DEPT PEDIAT,TAIPEI 10016,TAIWAN	National Taiwan University; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; Johns Hopkins University; Johns Hopkins Medicine; National Taiwan University; National Taiwan University Hospital			Huang, Shau-Ku/F-5509-2010; Tao, Mi-Hua/S-7020-2018	Tao, Mi-Hua/0000-0002-4307-5729	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI034002] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 34002] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMDUR MO, 1958, AM J PHYSIOL, V192, P364, DOI 10.1152/ajplegacy.1958.192.2.364; BRODSKY FM, 1991, ANNU REV IMMUNOL, V9, P707; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; EIDELMAN DH, 1988, AM REV RESPIR DIS, V137, P1033, DOI 10.1164/ajrccm/137.5.1033; ELWOOD W, 1991, J ALLERGY CLIN IMMUN, V88, P951, DOI 10.1016/0091-6749(91)90253-K; EMANUEL MB, 1995, CLIN EXP ALLERGY, V25, P15, DOI 10.1111/j.1365-2222.1995.tb00998.x; GONZALEZ MC, 1987, AM REV RESPIR DIS, V136, P6800; GRAINGER DN, 1990, CLIN EXP ALLERGY, V20, P181, DOI 10.1111/j.1365-2222.1990.tb02665.x; HOLT PG, 1989, CLIN EXP ALLERGY, V19, P255, DOI 10.1111/j.1365-2222.1989.tb02380.x; HOLT PG, 1994, IMMUNOL TODAY, V15, P484, DOI 10.1016/0167-5699(94)90194-5; HOLT PG, 1987, IMMUNOL TODAY, V8, P14, DOI 10.1016/0167-5699(87)90825-5; HSIEH KH, 1987, J ASTHMA, V24, P19, DOI 10.3109/02770908709073189; HSIEH KH, 1984, J ALLERGY CLIN IMMUN, V74, P34, DOI 10.1016/0091-6749(84)90084-8; KEMENY DM, 1994, IMMUNOL TODAY, V15, P107, DOI 10.1016/0167-5699(94)90152-X; KEMENY DM, 1991, INT ARCH ALLER A IMM, V94, P99, DOI 10.1159/000235337; KUS J, 1985, CLIN ALLERGY, V15, P523, DOI 10.1111/j.1365-2222.1985.tb02305.x; LIN KL, 1994, J ALLERGY CLIN IMMUN, V94, P989, DOI 10.1016/0091-6749(94)90117-1; MCMENAMIN C, 1993, J EXP MED, V178, P889, DOI 10.1084/jem.178.3.889; OCONNOR GT, 1989, AM REV RESPIR DIS, V140, P1520, DOI 10.1164/ajrccm/140.6.1520; PAUWELS R, 1979, IMMUNOLOGY, V36, P151; RENZ H, 1994, J IMMUNOL, V152, P351; ROUNDTRESS S, 1985, ARCH DIS CHILD, V60, P727; SEARS MR, 1991, NEW ENGL J MED, V325, P1067, DOI 10.1056/NEJM199110103251504; SEDGWICK JD, 1985, CELL IMMUNOL, V94, P182, DOI 10.1016/0008-8749(85)90095-4; TANG DC, 1992, NATURE, V356, P152, DOI 10.1038/356152a0; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; Wolff Jon A., 1992, Human Molecular Genetics, V1, P363, DOI 10.1093/hmg/1.6.363; XIANG ZQ, 1995, IMMUNITY, V2, P129, DOI 10.1016/S1074-7613(95)80001-8	29	261	281	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAY	1996	2	5					540	544		10.1038/nm0596-540	http://dx.doi.org/10.1038/nm0596-540			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UJ230	8616712				2022-12-25	WOS:A1996UJ23000036
J	Nelen, MR; Padberg, GW; Peeters, EAJ; Lin, AY; vandenHelm, B; Frants, RR; Coulon, V; Goldstein, AM; vanReen, MMM; Easton, DF; Eeles, RA; Hodgson, S; Mulvihill, JJ; Murday, VA; Tucker, MA; Mariman, ECM; Starink, TM; Ponder, BAJ; Ropers, HH; Kremer, H; Longy, M; Eng, C				Nelen, MR; Padberg, GW; Peeters, EAJ; Lin, AY; vandenHelm, B; Frants, RR; Coulon, V; Goldstein, AM; vanReen, MMM; Easton, DF; Eeles, RA; Hodgson, S; Mulvihill, JJ; Murday, VA; Tucker, MA; Mariman, ECM; Starink, TM; Ponder, BAJ; Ropers, HH; Kremer, H; Longy, M; Eng, C			Localization of the gene for Cowden disease to chromosome 10q22-23	NATURE GENETICS			English	Letter							KRUPPEL; DROSOPHILA; REPRESSION; DNA		UNIV NIJMEGEN HOSP,DEPT NEUROL,6500 HB NIJMEGEN,NETHERLANDS; LEIDEN UNIV,DEPT NEUROL,LEIDEN,NETHERLANDS; NCI,NIH,ROCKVILLE,MD; UNIV NIJMEGEN HOSP,DEPT HUMAN GENET,6500 HB NIJMEGEN,NETHERLANDS; LEIDEN UNIV,DEPT HUMAN GENET,MGC,2300 RA LEIDEN,NETHERLANDS; INST BERGONIE,BORDEAUX,FRANCE; INST PUBL HLTH,CRC,GENET EPIDEMIOL RES GRP,CAMBRIDGE,ENGLAND; ROYAL MARSDEN HOSP,INST CANC RES,SUTTON,SURREY,ENGLAND; GUYS & ST THOMAS HOSP,DEPT CLIN GENET,LONDON SE1 9RT,ENGLAND; UNIV PITTSBURGH,DEPT HUMAN GENET,PITTSBURGH,PA; ST GEORGE HOSP,DEPT CLIN GENET,LONDON,ENGLAND; NCI,GENET EPIDEMIOL BRANCH,ROCKVILLE,MD; FREE UNIV AMSTERDAM HOSP,DEPT DERMATOL,1081 HV AMSTERDAM,NETHERLANDS; UNIV CAMBRIDGE,CRC,HUMAN CANC GENET RES GRP,CAMBRIDGE,ENGLAND; HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV CANC EPIDEMIOL & CONTROL,BOSTON,MA 02115	Radboud University Nijmegen; Leiden University; Leiden University - Excl LUMC; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Radboud University Nijmegen; Leiden University; Leiden University - Excl LUMC; UNICANCER; Institut Bergonie; University of Cambridge; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Guy's & St Thomas' NHS Foundation Trust; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; St Georges University London; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Cambridge; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School			Padberg, G.W.A.M./H-8079-2014; Tucker, Margaret A/B-4297-2015; Reen, M.M.M./L-4593-2015; Nelen, Marcel R./L-4542-2015; Kremer, Hannie/F-5126-2010	Kremer, Hannie/0000-0002-0841-8693; Eng, Charis/0000-0002-3693-5145; Eeles, Rosalind/0000-0002-3698-6241				ADAMS MD, 1995, NATURE, V377, P192; ALBRECHT S, 1992, CANCER-AM CANCER SOC, V70, P869, DOI 10.1002/1097-0142(19920815)70:4<869::AID-CNCR2820700424>3.0.CO;2-E; BROWNSTEIN MH, 1979, BRIT J DERMATOL, V100, P667, DOI 10.1111/j.1365-2133.1979.tb08070.x; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DRUMMOND IA, 1992, SCIENCE, V257, P674, DOI 10.1126/science.1323141; ENG C, 1994, J MED GENET, V31, P458, DOI 10.1136/jmg.31.6.458; HOCH M, 1992, SCIENCE, V256, P94, DOI 10.1126/science.1348871; HSU T, 1992, SCIENCE, V257, P1946, DOI 10.1126/science.1411512; HUEBER K, 1991, AM J HUM GENET, V48, P727; JONES MH, 1994, GENE CHROMOSOME CANC, V9, P119, DOI 10.1002/gcc.2870090207; KREMER H, 1994, HUM MOL GENET, V3, P299, DOI 10.1093/hmg/3.2.299; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LLOYD KM, 1963, ANN INTERN MED, V58, P136, DOI 10.7326/0003-4819-58-1-136; LOVE DR, 1993, HUM MOL GENET, V2, P491, DOI 10.1093/hmg/2.4.491-a; MARRA G, 1994, J CLIN GASTROENTEROL, V18, P42, DOI 10.1097/00004836-199401000-00011; Mckusick V.A., 1994, MENDELIAN INHERITANC; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MULVIHILL JJ, 1977, CANCER, V40, P1867, DOI 10.1002/1097-0142(197710)40:4+<1867::AID-CNCR2820400816>3.0.CO;2-P; PADBERG GW, 1991, ANN NEUROL, V29, P517, DOI 10.1002/ana.410290511; PELLETIER J, 1991, CELL, V67, P437, DOI 10.1016/0092-8674(91)90194-4; PFEIFFER SL, 1995, CANCER RES, V55, P1922; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; SOGOL PB, 1983, WESTERN J MED, V139, P324; STANOJEVIC D, 1989, NATURE, V341, P331, DOI 10.1038/341331a0; STARINK TM, 1986, CLIN GENET, V29, P222; STARINK TM, 1985, J CUTAN PATHOL, V12, P83, DOI 10.1111/j.1600-0560.1985.tb01607.x; THIESEN H-J, 1990, New Biologist, V2, P363; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; ZEDENIUS S, 1995, HUM GENET, V96, P27	29	475	487	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1996	13	1					114	116		10.1038/ng0596-114	http://dx.doi.org/10.1038/ng0596-114			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH430	8673088	Green Submitted			2022-12-25	WOS:A1996UH43000028
J	Neuhausen, S; Gilewski, T; Norton, L; Tran, T; McGuire, P; Swensen, J; Hampel, H; Borgen, P; Brown, K; Skolnick, M; ShattuckEidens, D; Jhanwar, S; Goldgar, D; Offit, K				Neuhausen, S; Gilewski, T; Norton, L; Tran, T; McGuire, P; Swensen, J; Hampel, H; Borgen, P; Brown, K; Skolnick, M; ShattuckEidens, D; Jhanwar, S; Goldgar, D; Offit, K			Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer	NATURE GENETICS			English	Letter							POLYMERASE CHAIN-REACTION; ENZYMATIC AMPLIFICATION		MEM SLOAN KETTERING CANC CTR,DEPT HUMAN GENET,CLIN GENET SERV,NEW YORK,NY 10021; MEM SLOAN KETTERING CANC CTR,CYTOGENET SERV,NEW YORK,NY 10021; MEM SLOAN KETTERING CANC CTR,DEPT MED,BREAST ONCOL SERV,NEW YORK,NY 10021; MEM SLOAN KETTERING CANC CTR,DEPT SURG,BREAST SERV,NEW YORK,NY 10021; UNIV UTAH,SCH MED,DEPT MED INFORMAT,GENET EPIDEMIOL GRP,SALT LAKE CITY,UT 84108; MYRIAD GENET INC,SALT LAKE CITY,UT 84108; INT AGCY RES CANC,UNIT GENET EPIDEMIOL,F-63972 LYON 08,FRANCE	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Utah System of Higher Education; University of Utah; Myriad Genetics, Inc; World Health Organization; International Agency for Research on Cancer (IARC)					NCI NIH HHS [R01 CA 65673, P20 CA 58232] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P20CA058232, R01CA065673] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		EASTON DF, 1993, AM J HUM GENET, V52, P678; FitzGerald MG, 1996, NEW ENGL J MED, V334, P143, DOI 10.1056/NEJM199601183340302; Langston AA, 1996, NEW ENGL J MED, V334, P137, DOI 10.1056/NEJM199601183340301; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; OFFIT K, 1994, J CLIN ONCOL, V12, P1724, DOI 10.1200/JCO.1994.12.8.1724; OFFIT K, IN PRESS LANCET; OOSTER R, 1995, NATURE, V378, P789; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; TVTIGIAN SV, 1996, NAT GENET, V12, P333; WEBER JL, 1989, AM J HUM GENET, V44, P388; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231	13	244	253	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1996	13	1					126	128		10.1038/ng0596-126	http://dx.doi.org/10.1038/ng0596-126			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH430	8673092				2022-12-25	WOS:A1996UH43000032
J	Barry, MA; Dower, WJ; Johnston, SA				Barry, MA; Dower, WJ; Johnston, SA			Toward cell-targeting gene therapy vectors: Selection of cell-binding peptides from random peptide-presenting phage libraries	NATURE MEDICINE			English	Article							PROTEIN; ADENOVIRUS; INVIVO	Ideal gene therapy vectors would be delivered intravenously to transfect only specific cells. Existing vectors only transfect cells in vivo in a manner determined by blood flow and the site of introduction. As a general and systematic approach for generating cell-targeting ligands for gene therapy vectors, we have used peptide-presenting phage libraries to select peptides that bind and enter several different cell types. Because of their small size, cell-binding peptides such as these could be incorporated into biological or physical gene therapy vectors. In addition, peptide-presenting phage themselves may also be candidates for gene therapy vectors.	UNIV TEXAS,SW MED CTR,DEPT INTERNAL MED,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT BIOCHEM,DALLAS,TX 75235; AFFYMAX RES INST,PALO ALTO,CA 94304	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas								BASSELDUBY R, 1992, MOL CELL BIOL, V12, P5024, DOI 10.1128/MCB.12.11.5024; BROWN KC, 1995, BIOCHEMISTRY-US, V34, P4733, DOI 10.1021/bi00014a030; COTTEN M, 1990, P NATL ACAD SCI USA, V87, P4033, DOI 10.1073/pnas.87.11.4033; CWIRLA SE, 1990, P NATL ACAD SCI USA, V87, P6378, DOI 10.1073/pnas.87.16.6378; DEVLIN JJ, 1990, SCIENCE, V249, P404, DOI 10.1126/science.2143033; DOORBAR J, 1994, J MOL BIOL, V244, P361, DOI 10.1006/jmbi.1994.1736; FELGNER PL, 1991, NATURE, V349, P351, DOI 10.1038/349351a0; FONG S, 1994, DRUG DEVELOP RES, V33, P64, DOI 10.1002/ddr.430330203; GOTTSCHALK S, 1995, GENE THER, V2, P498; HART SL, 1994, J BIOL CHEM, V269, P12468; HART SL, 1995, GENE THER, V2, P552; JESPERS LS, 1995, BIO-TECHNOL, V13, P378, DOI 10.1038/nbt0495-378; MARKLAND W, 1991, GENE, V109, P13, DOI 10.1016/0378-1119(91)90583-W; MULLIGAN RC, 1993, SCIENCE, V260, P926, DOI 10.1126/science.8493530; PIETERSZ GA, 1992, IMMUNOL REV, V129, P57, DOI 10.1111/j.1600-065X.1992.tb01419.x; QUANTIN B, 1992, P NATL ACAD SCI USA, V89, P2581, DOI 10.1073/pnas.89.7.2581; ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680; YOKOYAMAKOBAYASHI M, 1993, BIOCHEM BIOPH RES CO, V192, P935, DOI 10.1006/bbrc.1993.1505	18	293	341	1	33	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAR	1996	2	3					299	305		10.1038/nm0396-299	http://dx.doi.org/10.1038/nm0396-299			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TY640	8612228				2022-12-25	WOS:A1996TY64000038
J	Blasco, MA; Rizen, M; Greider, CW; Hanahan, D				Blasco, MA; Rizen, M; Greider, CW; Hanahan, D			Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis	NATURE GENETICS			English	Letter									COLD SPRING HARBOR LAB,NEW YORK,NY 11724; UNIV CALIF SAN FRANCISCO,HORMONE RES INST,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143	Cold Spring Harbor Laboratory; University of California System; University of California San Francisco			Blasco, Maria A./M-1694-2014	Blasco, Maria A./0000-0002-4211-233X; Greider, Carol/0000-0002-5494-8126	NATIONAL INSTITUTE ON AGING [R37AG009383, R01AG009383] Funding Source: NIH RePORTER; NIA NIH HHS [AG09383] Funding Source: Medline; NIGMS NIH HHS [GMO7618] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARBEIT JM, 1994, J VIROL, V68, P4358, DOI 10.1128/JVI.68.7.4358-4368.1994; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; AVILION AA, IN PRESS CANCER RES; BACCHETTI S, 1995, INT J ONCOL, V7, P423; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; BLASCO MA, 1995, SCIENCE, V269, P1267, DOI 10.1126/science.7544492; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; CHADENEAU C, 1995, ONCOGENE, V11, P893; CHRISTOFORI G, 1994, NATURE, V369, P414, DOI 10.1038/369414a0; COLLINS K, 1995, CELL, V81, P677, DOI 10.1016/0092-8674(95)90529-4; COUNTER CM, 1995, BLOOD, V85, P2315, DOI 10.1182/blood.V85.9.2315.bloodjournal8592315; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; COUNTER CM, 1994, J VIROL, V68, P3410, DOI 10.1128/JVI.68.5.3410-3414.1994; COUNTER GM, 1994, P NATL ACAD SCI USA, V91, P2900; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARLEY CB, 1995, CURR OPIN GENET DEV, V5, P249, DOI 10.1016/0959-437X(95)80016-6; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; HIYAMA K, IN PRESS J IMMUN; HURLIN PJ, IN PRESS ONCOGENE; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; SHAW JW, IN PRESS CURR OPIN O	28	274	290	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1996	12	2					200	204		10.1038/ng0296-200	http://dx.doi.org/10.1038/ng0296-200			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TU079	8563761				2022-12-25	WOS:A1996TU07900023
J	Crameri, A; Cwirla, S; Stemmer, WPC				Crameri, A; Cwirla, S; Stemmer, WPC			Construction and evolution of antibody-phage libraries by DNA shuffling	NATURE MEDICINE			English	Editorial Material											Crameri, A (corresponding author), AFFYMAX RES INST,4001 MIRANDA AVE,PALO ALTO,CA 94304, USA.							CRAMERI A, 1995, BIOTECHNIQUES, V18, P194; GRIFFITHS AD, 1994, EMBO J, V13, P3245, DOI 10.1002/j.1460-2075.1994.tb06626.x; HAWKINS RE, 1992, J MOL BIOL, V226, P889, DOI 10.1016/0022-2836(92)90639-2; HOLLIGER P, 1993, P NATL ACAD SCI USA, V90, P6444, DOI 10.1073/pnas.90.14.6444; KABAT EA, 1991, NIH913242 PUBL; SMITH GP, 1994, NATURE, V370, P324, DOI 10.1038/370324a0; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; STEMMER WPC, 1995, BIO-TECHNOL, V13, P549, DOI 10.1038/nbt0695-549; STEMMER WPC, IN PRESS SCIENCE; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245	11	83	179	0	16	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JAN	1996	2	1					100	102		10.1038/nm0196-100	http://dx.doi.org/10.1038/nm0196-100			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TP579	8564822				2022-12-25	WOS:A1996TP57900045
J	HUGHES, AE; NEWTON, VE; LIU, XZ; READ, AP				HUGHES, AE; NEWTON, VE; LIU, XZ; READ, AP			A GENE FOR WAARDENBURG SYNDROME TYPE-2 MAPS CLOSE TO THE HUMAN HOMOLOG OF THE MICROPHTHALMIA GENE AT CHROMOSOME 3P12-P14.1	NATURE GENETICS			English	Article							HUP2 PAIRED DOMAIN; SYNDROME TYPE-I; PAX3 GENE; INNER-EAR; MUTATIONS; MOUSE; LOCUS	Waardenburg syndrome (WS), an autosomal dominant syndrome of hearing loss and pigmentary disturbances, comprises at least two separate conditions. WS type 1 is normally caused by mutations in PAX3 located at chromosome 2q35 and is distinguished clinically by minor facial malformations. We have now located a gene for WS type 2. Two families show linkage to a group of microsatellite markers located on chromosome 3p12-p14.1. D3S1261 gave a maximum lod score of 6.5 at zero recombination in one large Type 2 family. in a second, smaller family the adjacent marker D3S1210 gave a lod of 2.05 at zero recombination. interestingly the human homologue (MITF) of the mouse microphthalmia gene, a good candidate at the phenotypic level, has recently been mapped to 3p12.3-p14.4.	UNIV MANCHESTER,CTR AUDIOL,MANCHESTER M13 9PL,LANCS,ENGLAND; ST MARYS HOSP,DEPT MED GENET,MANCHESTER M13 9PL,LANCS,ENGLAND	University of Manchester; University of Manchester	HUGHES, AE (corresponding author), BELFAST CITY HOSP,DEPT MED GENET,BELFAST BT9 7AB,ANTRIM,NORTH IRELAND.		Hughes, Anne/A-1307-2012					ARIAS S, 1978, J GENET HUM, V26, P101; ARLAS S, 1971, BIRTH DEFECTS, V7, P87; ASHER JH, 1990, J MED GENET, V27, P618, DOI 10.1136/jmg.27.10.618; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; DASILVA EO, 1991, AM J MED GENET, V40, P65, DOI 10.1002/ajmg.1320400113; FARRER LA, IN PRESS AM J HUM GE; FOY C, 1990, AM J HUM GENET, V46, P1017; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; HOTH CF, 1993, AM J HUM GENET, V52, P455; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Morell Robert, 1992, Human Molecular Genetics, V1, P243, DOI 10.1093/hmg/1.4.243; NAYLOR SL, 1993, CYTOGENET CELL GENET, V65, P1; Ott J., 1991, ANAL HUMAN GENETIC L; SPRITZ RA, 1993, SEMIN DERMATOL, V12, P167; STEEL KP, 1983, ARCH OTOLARYNGOL, V109, P22; STEEL KP, 1989, DEVELOPMENT, V107, P453; TACHIBANA M, 1994, HUM MOL GENET, V3, P553, DOI 10.1093/hmg/3.4.553; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TASSABEHJI M, 1993, NAT GENET, V3, P26, DOI 10.1038/ng0193-26; TASSABEHJI M, IN PRESS HUM MOL GEN; WAARDENBURG PJ, 1951, AM J HUM GENET, V3, P195; WILCOX ER, 1992, HUM MOL GENET, V1, P215, DOI 10.1093/hmg/1.3.215-a	22	159	162	1	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1994	7	4					509	512		10.1038/ng0894-509	http://dx.doi.org/10.1038/ng0894-509			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PA832	7951321				2022-12-25	WOS:A1994PA83200018
J	LAHTI, JM; VALENTINE, M; XIANG, JL; JONES, B; AMANN, J; GRENET, J; RICHMOND, G; LOOK, AT; KIDD, VJ				LAHTI, JM; VALENTINE, M; XIANG, JL; JONES, B; AMANN, J; GRENET, J; RICHMOND, G; LOOK, AT; KIDD, VJ			ALTERATIONS IN THE PITSLRE PROTEIN-KINASE GENE-COMPLEX ON CHROMOSOME 1P36 IN CHILDHOOD NEUROBLASTOMA	NATURE GENETICS			English	Article							N-MYC AMPLIFICATION; C-MYC; CELL-LINES; TUMOR PROGRESSION; SHORT ARM; ABNORMALITIES; EXPRESSION; APOPTOSIS; HETEROZYGOSITY; BREAKPOINT	p58(cdc2L1), protein kinase implicated in apoptotic signaling, is one of eight separate kinases encoded by three tandemly duplicated and linked genes, which we have termed PITSLRE A, B and C. One allele of this complex on chromosome 1 was either deleted or translocated in each of 18 neuroblastoma cell lines with cytogenetically apparent 1p alterations. A protein encoded by this locus, PITSLRE gamma 1, was absent in three of the lines and a smaller, apparently truncated, PITSLRE polypeptide was found in another line. These findings identify a novel gene complex on chromosome 1 that encodes a protein kinase subfamily. We suggest that the PITSLRE locus may harbour one or more tumour suppressor genes affected by chromosome 1p36 modifications in neuroblastoma.	ST JUDE CHILDRENS RES HOSP, DEPT TUMOR CELL BIOL, MEMPHIS, TN 38105 USA; ST JUDE CHILDRENS RES HOSP, DEPT EXPTL ONCOL, MEMPHIS, TN 38105 USA; UNIV ALABAMA, DEPT CELL BIOL, BIRMINGHAM, AL 35294 USA; UNIV TENNESSEE, SCH MED, DEPT BIOCHEM, MEMPHIS, TN 38120 USA; UNIV TENNESSEE, SCH MED, DEPT PEDIAT, MEMPHIS, TN 38120 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Alabama System; University of Alabama Birmingham; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center					NCI NIH HHS [P01-CA-23099, CA-21765] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA023099, P30CA021765] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ASKEW DS, 1991, ONCOGENE, V6, P1915; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; BISSONNETTE RP, 1992, NATURE, V359, P552, DOI 10.1038/359552a0; BRODEUR GM, 1982, CANCER GENET CYTOGEN, V7, P137, DOI 10.1016/0165-4608(82)90010-3; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; BRODEUR GM, 1981, CANCER RES, V41, P4678; BUNNELL BA, 1990, P NATL ACAD SCI USA, V87, P7467, DOI 10.1073/pnas.87.19.7467; BUNNELL BA, 1990, SOMAT CELL MOLEC GEN, V16, P151, DOI 10.1007/BF01233045; CARON H, 1993, NAT GENET, V4, P187, DOI 10.1038/ng0693-187; CHENG JM, 1993, NAT GENET, V4, P191, DOI 10.1038/ng0693-191; CHRISTIANSEN H, 1991, ADV NEUROBLAST RES, V3, P99; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; DRACOPOLI NC, 1989, P NATL ACAD SCI USA, V86, P4614, DOI 10.1073/pnas.86.12.4614; EASTON J, IN PRESS GENE; EIPERS PG, 1991, GENOMICS, V11, P621, DOI 10.1016/0888-7543(91)90069-Q; EIPERS PG, 1992, GENOMICS, V13, P613, DOI 10.1016/0888-7543(92)90132-C; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; FANIDI A, 1992, NATURE, V359, P554, DOI 10.1038/359554a0; FONG CT, 1989, P NATL ACAD SCI USA, V86, P3753, DOI 10.1073/pnas.86.10.3753; FONG CT, 1992, CANCER RES, V52, P1780; GILBERT F, 1984, CANCER RES, V44, P5444; HAGUE A, 1992, INT J ONCOL, V1, P201; JOHNSON MR, 1993, P NATL ACAD SCI USA, V90, P5539, DOI 10.1073/pnas.90.12.5539; KAMPS MP, 1991, GENE DEV, V5, P358, DOI 10.1101/gad.5.3.358; KNUDSON AG, 1993, P NATL ACAD SCI USA, V90, P10914, DOI 10.1073/pnas.90.23.10914; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; MARTINSSON T, 1989, GENE CHROMOSOME CANC, V1, P67, DOI 10.1002/gcc.2870010111; MATHEW CGP, 1987, NATURE, V328, P524, DOI 10.1038/328524a0; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; MOCK BA, 1994, MAMM GENOME, V5, P191, DOI 10.1007/BF00352357; SIMON D, 1991, ONCOGENE, V6, P765; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; XIANG J, IN PRESS J BIOL CHEM; YONISHROUACH E, 1991, NATURE, V352, P345, DOI 10.1038/352345a0; ZEHNBAUER BA, 1988, MOL CELL BIOL, V8, P522, DOI 10.1128/MCB.8.2.522	36	111	112	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	1994	7	3					370	375		10.1038/ng0794-370	http://dx.doi.org/10.1038/ng0794-370			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NU306	7920654				2022-12-25	WOS:A1994NU30600010
J	VITS, L; VANCAMP, G; COUCKE, P; FRANSEN, E; DEBOULLE, K; REYNIERS, E; KORN, B; POUSTKA, A; WILSON, G; SCHRANDERSTUMPEL, C; WINTER, RM; SCHWARTZ, C; WILLEMS, PJ				VITS, L; VANCAMP, G; COUCKE, P; FRANSEN, E; DEBOULLE, K; REYNIERS, E; KORN, B; POUSTKA, A; WILSON, G; SCHRANDERSTUMPEL, C; WINTER, RM; SCHWARTZ, C; WILLEMS, PJ			MASA SYNDROME IS DUE TO MUTATIONS IN THE NEURAL CELL-ADHESION GENE L1CAM	NATURE GENETICS			English	Article							X-LINKED HYDROCEPHALUS; MENTAL-RETARDATION; IMMUNOGLOBULIN SUPERFAMILY; LINKAGE ANALYSIS; MOLECULE L1; SPASTIC PARAPLEGIA; DNA PROBES; XQ28; EXPRESSION; LOCALIZATION	MASA syndrome is a recessive X-linked disorder characterized by mental retardation, adducted thumbs, shuffling gait, aphasia and, in some cases, hydrocephalus. Since it has been shown that X-linked hydrocephalus can be caused by mutations in L1CAM, a neuronal cell adhesion molecule, we performed an L1CAM mutation analysis in eight unrelated patients with MASA syndrome. Three different L1CAM mutations were identified: a deletion removing part of the open reading frame and two point mutations resulting in amino acid substitutions. L1CAM, therefore, harbours mutations leading to either MASA syndrome or HSAS, and might be frequently implicated in X-linked mental retardation with or without hydrocephalus.	UIA,DEPT MED GENET,B-2610 ANTWERP,BELGIUM; DEUTSCH KREBSFORSCHUNGSZENTRUM,W-6900 HEIDELBERG 1,GERMANY; UNIV TEXAS,SW MED CTR,DIV PEDIAT GENET & METAB,DALLAS,TX 75235; UNIV LIMBURG,DEPT GENET & CELL BIOL,6201 BX MAASTRICHT,NETHERLANDS; INST CHILD HLTH,MOTHERCARE UNIT CLIN MED & FETAL MED,LONDON WC1N 1EH,ENGLAND; GREENWOOD GENET CTR,GREENWOOD,SC 29646	Helmholtz Association; German Cancer Research Center (DKFZ); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Hasselt University; University of London; University College London; Greenwood Genetic Center			Van Camp, Guy/F-3386-2013; Fransen, Erik/C-4102-2015	Van Camp, Guy/0000-0001-5105-9000; Fransen, Erik/0000-0001-7785-4790				ATASHI JR, 1992, NEURON, V8, P831, DOI 10.1016/0896-6273(92)90197-L; BIANCHINE JW, 1974, CLIN GENET, V5, P298; BICKERS DS, 1949, BRAIN, V72, P246, DOI 10.1093/brain/72.2.246; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; Boyd E, 1993, Clin Dysmorphol, V2, P332; BURGOON MP, 1991, J CELL BIOL, V112, P1017, DOI 10.1083/jcb.112.5.1017; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; COUCKE P, 1994, HUM MOL GENET, V3, P671, DOI 10.1093/hmg/3.4.671; DEAN M, 1991, BIOTECHNIQUES, V10, P331; EDWARDS JH, 1961, ARCH DIS CHILD, V36, P481, DOI 10.1136/adc.36.189.481; FRYNS JP, 1991, J MED GENET, V28, P429, DOI 10.1136/jmg.28.6.429-a; GAREIS FJ, 1984, AM J MED GENET, V17, P333, DOI 10.1002/ajmg.1320170126; HLAVIN ML, 1991, GENOMICS, V11, P416, DOI 10.1016/0888-7543(91)90150-D; JOUET M, 1993, NAT GENET, V4, P331, DOI 10.1038/ng0893-331; KENWRICK S, 1986, HUM GENET, V73, P264, DOI 10.1007/BF00401241; Korn Bernhard, 1992, Human Molecular Genetics, V1, P235, DOI 10.1093/hmg/1.4.235; LEGIUS E, 1991, AM J MED GENET S, V49, pA1959; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; LYONNET S, 1992, GENOMICS, V14, P508, DOI 10.1016/S0888-7543(05)80254-X; MACIAS VR, 1992, AM J MED GENET, V43, P408, DOI 10.1002/ajmg.1320430162; Maestrini Elena, 1992, Human Molecular Genetics, V1, P275, DOI 10.1093/hmg/1.4.275; MIURA M, 1992, J BIOL CHEM, V267, P10752; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; PRINCE JT, 1991, J NEUROSCI RES, V30, P567, DOI 10.1002/jnr.490300315; RIETSCHEL M, 1991, AM J MED GENET, V41, P10, DOI 10.1002/ajmg.1320410104; ROSENTHAL A, 1992, NAT GENET, V2, P107, DOI 10.1038/ng1092-107; SCHRANDERSTUMPEL C, 1990, J MED GENET, V27, P688, DOI 10.1136/jmg.27.11.688; SCHUCH U, 1989, NEURON, V3; SERVILLE F, 1992, EUR J PEDIATR, V151, P515, DOI 10.1007/BF01957757; SONDEREGGER P, 1992, J CELL BIOL, V119, P1387, DOI 10.1083/jcb.119.6.1387; STRAUSSBERG R, 1991, CLIN GENET, V40, P337; VANCAMP G, 1993, NAT GENET, V4, P421; Vles J S, 1990, Genet Couns, V1, P97; WILLEMS PJ, 1987, AM J MED GENET, V27, P921, DOI 10.1002/ajmg.1320270419; WILLEMS PJ, 1992, AM J HUM GENET, V51, P307; WILLEMS PJ, 1990, GENOMICS, V8, P367, DOI 10.1016/0888-7543(90)90294-5; WILLIAMS EJ, 1992, J CELL BIOL, V119, P883, DOI 10.1083/jcb.119.4.883; WINTER RM, 1989, HUM GENET, V82, P367; YEATMAN GW, 1984, AM J MED GENET, V17, P339, DOI 10.1002/ajmg.1320170127	39	135	136	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1994	7	3					408	413		10.1038/ng0794-408	http://dx.doi.org/10.1038/ng0794-408			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NU306	7920660				2022-12-25	WOS:A1994NU30600016
J	BUETOW, KH; WEBER, JL; LUDWIGSEN, S; SCHERPBIERHEDDEMA, T; DUYK, GM; SHEFFIELD, VC; WANG, ZY; MURRAY, JC				BUETOW, KH; WEBER, JL; LUDWIGSEN, S; SCHERPBIERHEDDEMA, T; DUYK, GM; SHEFFIELD, VC; WANG, ZY; MURRAY, JC			INTEGRATED HUMAN GENOME-WIDE MAPS CONSTRUCTED USING THE CEPH REFERENCE PANEL	NATURE GENETICS			English	Article							LINKAGE MAP	High resolution linkage maps have proven to be invaluable tools in genetic investigations. We have assembled a collection of genetic maps constructed from primary data collected from investigators performing genotyping using the Centre Etude Polymorphism Humain (CEPH) reference pedigree panel. These maps were constructed using a rigorous, semi-automated map construction algorithm that evaluates the integrity of the maps during construction. Two classes of maps were produced: a high confidence ''skeletal'' set composed of 544 PCR based markers, and a more highly annotated ''framework'' set containing maps of 1,123 markers. Genetic map locations within the framework maps are provided for an additional 1,758 loci without statistically unique interval assignments.	MARSHFIELD MED RES FDN,CTR MED GENET,MARSHFIELD,WI 54449; HARVARD UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT GENET,BOSTON,MA 02115; UNIV IOWA,DEPT PEDIAT,IOWA CITY,IA 52242	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Iowa	BUETOW, KH (corresponding author), FOX CHASE CANC CTR,DIV POPULAT SCI,7701 BURHOLME AVE,PHILADELPHIA,PA 19111, USA.				NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG000835] Funding Source: NIH RePORTER; NCI NIH HHS [CA06927] Funding Source: Medline; NHGRI NIH HHS [HG00835] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BUETOW KH, 1991, AM J HUM GENET, V49, P985; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; DRACOPOLI NC, 1991, GENOMICS, V9, P686, DOI 10.1016/0888-7543(91)90362-I; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; KEATS BJB, 1981, LINKAGE CHROMOSOME M; MORTON NE, 1955, AM J HUM GENET, V7, P277; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WHITE RL, 1990, GENOMICS, V6, P393, DOI 10.1016/0888-7543(90)90469-B	9	231	232	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1994	6	4					391	393		10.1038/ng0494-391	http://dx.doi.org/10.1038/ng0494-391			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ND870	8054980				2022-12-25	WOS:A1994ND87000019
J	SCHERTHAN, H; CREMER, T; ARNASON, U; WEIER, HU; LIMADEFARIA, A; FRONICKE, L				SCHERTHAN, H; CREMER, T; ARNASON, U; WEIER, HU; LIMADEFARIA, A; FRONICKE, L			COMPARATIVE CHROMOSOME PAINTING DISCLOSES HOMOLOGOUS SEGMENTS IN DISTANTLY RELATED MAMMALS	NATURE GENETICS			English	Article							INSITU SUPPRESSION HYBRIDIZATION; CYTOGENETIC ANALYSIS; SEQUENCE (TTAGGG)N; DNA LIBRARIES; LABELED DNA; FLUORESCENCE; EVOLUTION; ORGANIZATION; PRIMATES; MUNTJAC	Comparative chromosome painting, termed Z00-FISH, using DNA libraries from flow sorted human chromosomes 1, 16, 17 and X, and mouse chromosome 11 discloses the presence of syntenic groups in distantly related mammalian orders ranging from primates (Home sapiens), rodents (Mus musculus), even-toed ungulates (Muntiacus muntjak vaginalis and Muntiacus reevesi) and whales (Balaenoptera physalus). These mammalian orders have evolved separately for 55-80 million years (Myr). We conclude that Z00-FISH can be used to generate comparative chromosome maps of a large number of mammalian species.	INST HUMAN GENET & ANTHROPOL,D-69120 HEIDELBERG,GERMANY; LUND UNIV,INST GENET,S-22362 LUND,SWEDEN; UNIV CALIF SAN FRANCISCO,DEPT LAB MED,DIV MOLEC CYTOMETRY,SAN FRANCISCO,CA 94143	Lund University; University of California System; University of California San Francisco	SCHERTHAN, H (corresponding author), DIV HUMAN BIOL & HUMAN GENET,ERWIN SCHROEDINGERSTR,D-67663 KAISERSLAUTERN,GERMANY.			Cremer, Thomas/0000-0001-7135-7216				ADEGOKE JA, 1993, CHROMOSOMA, V102, P382, DOI 10.1007/BF00360402; ARNASON U, 1991, J MOL EVOL, V33, P556, DOI 10.1007/BF02102808; ARNASON U, 1991, HEREDITAS, V114, P263, DOI 10.1111/j.1601-5223.1991.tb00333.x; BLACKMORE WA, 1989, TRENDS GENET, V5, P144; BRENEMAN JW, 1993, CHROMOSOMA, V102, P591, DOI 10.1007/BF00352306; COLLINS C, 1991, GENOMICS, V11, P997, DOI 10.1016/0888-7543(91)90025-A; COPELAND NG, 1993, SCIENCE, V262, P57, DOI 10.1126/science.8211130; DAUWERSE JG, 1992, HUM MOL GENET, V1, P593, DOI 10.1093/hmg/1.8.593; DUMANOIR S, 1993, HUM GENET, V90, P590, DOI 10.1007/BF00202476; DUTRILLAUX B, 1979, HUM GENET, V48, P251, DOI 10.1007/BF00272830; EVANS EP, 1984, GENETIC VARIANTS STR, P576; GOTTERT E, 1993, HUM GENET, V92, P623, DOI 10.1007/BF00420950; GRAVES JAM, 1991, CHROMOSOMA, V101, P63, DOI 10.1007/BF00357055; GUAN XY, 1993, HUM MOL GENET, V2, P1117, DOI 10.1093/hmg/2.8.1117; HETZEL J, 1993, NAT GENET, V4, P327, DOI 10.1038/ng0893-327; HOLMQUIST GP, 1989, J MOL EVOL, V28, P469, DOI 10.1007/BF02602928; HOLMQUIST GP, 1992, AM J HUM GENET, V51, P17; JAUCH A, 1992, P NATL ACAD SCI USA, V89, P8611, DOI 10.1073/pnas.89.18.8611; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; KLEVER M, 1991, HUM GENET, V86, P484; LENGAUER C, 1993, HUM MOL GENET, V2, P505, DOI 10.1093/hmg/2.5.505; Lengauer C., 1991, Human Evolution, V6, P67, DOI 10.1007/BF02435608; LENGAUER C, 1991, CYTOGENET CELL GENET, V56, P27, DOI 10.1159/000133039; LEVY HP, 1993, CYTOMETRY, V14, P362, DOI 10.1002/cyto.990140404; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; LIMADEFARIA A, 1991, HEREDITAS, V114, P207, DOI 10.1111/j.1601-5223.1991.tb00326.x; LIMADEFARIA A, 1991, FUNDAMENTALS MED CEL, P115; LIMING S, 1980, CYTOGENET CELL GENET, V26, P22, DOI 10.1159/000131417; LUKE S, 1992, NAT GENET, V2, P11, DOI 10.1038/ng0992-11; MEYNE J, 1989, P NATL ACAD SCI USA, V86, P7049, DOI 10.1073/pnas.86.18.7049; MIASHITA K, 1994, CYTOGENET CELL GENET, V66, P4; MORTON NE, 1991, P NATL ACAD SCI USA, V88, P7474, DOI 10.1073/pnas.88.17.7474; NEITZEL H, 1982, THESIS U BERLIN; NELSON SF, 1993, NAT GENET, V4, P11, DOI 10.1038/ng0593-11; OBRIEN SJ, 1988, ANNU REV GENET, V22, P323, DOI 10.1146/annurev.ge.22.120188.001543; OBRIEN SJ, 1993, NAT GENET, V3, P103, DOI 10.1038/ng0293-103; OBRIEN SJ, 1991, CYTOGENET CELL GENET, V58, P1124, DOI 10.1159/000133725; Ohno S., 1967, SEX CHROMOSOMES SEX; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; RIED T, 1992, P NATL ACAD SCI USA, V89, P1388, DOI 10.1073/pnas.89.4.1388; RIED T, 1993, GENOMICS, V18, P381, DOI 10.1006/geno.1993.1479; SCHERTHAN H, 1992, CYTOGENET CELL GENET, V60, P4, DOI 10.1159/000133282; SCHERTHAN H, 1990, CYTOGENET CELL GENET, V53, P115, DOI 10.1159/000132908; SCHRIEVERSCHWEMMER G, 1993, CYTOGENET CELL GENET, V64, P122, DOI 10.1159/000133567; SPEICHER MR, 1993, HUM MOL GENET, V2, P1907; STANYON R, 1992, AM J PHYS ANTHROPOL, V88, P245, DOI 10.1002/ajpa.1330880210; VOOIJS M, 1993, AM J HUM GENET, V52, P586; WIENBERG J, 1990, GENOMICS, V8, P347, DOI 10.1016/0888-7543(90)90292-3; WIENBERG J, 1992, CHROMOSOMA, V101, P265, DOI 10.1007/BF00346004; YERLE M, 1993, GENOMICS, V16, P97, DOI 10.1006/geno.1993.1146	51	233	240	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1994	6	4					342	347		10.1038/ng0494-342	http://dx.doi.org/10.1038/ng0494-342			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ND870	8054973	Green Submitted			2022-12-25	WOS:A1994ND87000011
J	KWITEKBLACK, AE; CARMI, R; DUYK, GM; BUETOW, KH; ELBEDOUR, K; PARVARI, R; YANDAVA, CN; STONE, EM; SHEFFIELD, VC				KWITEKBLACK, AE; CARMI, R; DUYK, GM; BUETOW, KH; ELBEDOUR, K; PARVARI, R; YANDAVA, CN; STONE, EM; SHEFFIELD, VC			LINKAGE OF BARDET-BIEDL SYNDROME TO CHROMOSOME 16Q AND EVIDENCE FOR NON-ALLELIC GENETIC-HETEROGENEITY	NATURE GENETICS			English	Article							DISEASE; DNA	Bardet-Biedl syndrome is an autosomal recessive disorder characterized by mental retardation, obesity, retinitis pigmentosa, polydactyly and hypogonadism. Other findings include hypertension, diabetes mellitus and renal and cardiovascular anomalies. We have performed a genome-wide search for linkage in a large inbred Bedouin family. Pairwise analysis established linkage with the locus D16S408 with no recombination and a lod score of 4.2. A multilocus lod score of 5.3 was observed. By demonstrating homozygosity, in all affected individuals, for the same allele of marker D16S408, further support for linkage is found, and the utility of homozygosity mapping using inbred families is demonstrated. In a second family, linkage was excluded at this locus, suggesting non-allelic genetic heterogeneity in this disorder.	UNIV IOWA,DEPT PEDIAT,IOWA CITY,IA 52242; UNIV IOWA,DEPT OPHTHALMOL,IOWA CITY,IA 52242; BEN GURION UNIV NEGEV,SOROKA MED CTR,DIV PEDIAT,BEER SHEVA,ISRAEL; BEN GURION UNIV NEGEV,SOROKA MED CTR,INST GENET,BEER SHEVA,ISRAEL; HARVARD UNIV,DEPT GENET,BOSTON,MA; HARVARD UNIV,HOWARD HUGHES MED INST,BOSTON,MA; FOX CHASE CANC CTR,PHILADELPHIA,PA	University of Iowa; University of Iowa; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center; Harvard University; Harvard University; Howard Hughes Medical Institute; Fox Chase Cancer Center				Stone, Edwin M./0000-0003-3343-4414; Kwitek, Anne/0000-0003-1024-4116	NATIONAL EYE INSTITUTE [R29EY008426] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG000835, R01HG000457] Funding Source: NIH RePORTER; NEI NIH HHS [EY08426] Funding Source: Medline; NHGRI NIH HHS [P50HG00835, HG00457] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ALSTROM C H, 1959, Acta Psychiatr Neurol Scand Suppl, V129, P1; AMMANN F, 1970, J GENET HUM, V18, P1; BIEMOND A, 1934, NED TIJDSCHR GENEES, V78, P1801; BLANTON SH, 1991, GENOMICS, V11, P857, DOI 10.1016/0888-7543(91)90008-3; COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3; CROFT JB, 1990, AM J MED GENET, V36, P37, DOI 10.1002/ajmg.1320360109; FARAG TI, 1988, CLIN GENET, V33, P78; FARAG TI, 1989, CLIN GENET, V36, P463; FORSMAN K, 1992, CLIN GENET, V42, P156; GREEN JS, 1989, NEW ENGL J MED, V321, P1002, DOI 10.1056/NEJM198910123211503; GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8390, DOI 10.1093/nar/17.20.8390; INGLEHEARN CF, 1993, NAT GENET, V4, P51, DOI 10.1038/ng0593-51; JORDAN SA, 1993, NAT GENET, V4, P54, DOI 10.1038/ng0593-54; KAPLAN J, 1992, GENOMICS, V14, P979, DOI 10.1016/S0888-7543(05)80120-X; KIMBERLING WJ, 1992, GENOMICS, V14, P988, DOI 10.1016/S0888-7543(05)80121-1; KIMBERLING WJ, 1990, GENOMICS, V7, P245, DOI 10.1016/0888-7543(90)90546-7; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Laurence J.Z., 1866, OPHTHALMIC REV, V2, P32; McKusick V.A., 1992, MENDELIAN INHERITANC; MORTON NE, 1955, AM J HUM GENET, V7, P277; Nichols B. E., 1992, American Journal of Human Genetics, V51, pA369; SCHACHAT AP, 1982, ARCH OPHTHALMOL-CHIC, V100, P285; SMITH RJH, 1992, GENOMICS, V14, P995, DOI 10.1016/S0888-7543(05)80122-3; STONE EM, 1992, NAT GENET, V1, P246, DOI 10.1038/ng0792-246; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; WEBER JL, 1989, AM J HUM GENET, V44, P388	26	151	154	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1993	5	4					392	396		10.1038/ng1293-392	http://dx.doi.org/10.1038/ng1293-392			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ML145	8298649				2022-12-25	WOS:A1993ML14500017
J	LINDBLOM, A; TANNERGARD, P; WERELIUS, B; NORDENSKJOLD, M				LINDBLOM, A; TANNERGARD, P; WERELIUS, B; NORDENSKJOLD, M			GENETIC-MAPPING OF A 2ND LOCUS PREDISPOSING TO HEREDITARY NONPOLYPOSIS COLON-CANCER	NATURE GENETICS			English	Article							FAMILIAL ADENOMATOUS POLYPOSIS; IDENTIFICATION; POLYMORPHISMS; CHROMOSOME-5	Hereditary colon cancer is caused by mutations in several different loci. The APC gene on chromosome 5 causing adenomatous polyposis coli represents a minority of the inherited colon cancer cases, while hereditary-non polyposis colon cancer (HNPCC) may cause five percent of all human colon cancer. One gene causing HNPCC was recently mapped to chromosome 2 but the same study also showed that at least one additional locus may cause HNPCC. We now present tight linkage between a polymorphic marker on the short arm of chromosome 3 and the disease locus, and find that these families also manifest signs of a general DNA replication disorder.			LINDBLOM, A (corresponding author), KAROLINSKA HOSP,DEPT CLIN GENET,S-10401 STOCKHOLM 60,SWEDEN.			Nordenskjold, Magnus/0000-0002-4974-425X				AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; ERLANDSSON R, 1990, ONCOGENE, V5, P1207; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HERRERA L, 1986, AM J MED GENET, V25, P473, DOI 10.1002/ajmg.1320250309; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jones Michael H., 1992, Human Molecular Genetics, V1, P131, DOI 10.1093/hmg/1.2.131; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; LEPPERT M, 1987, SCIENCE, V238, P1411, DOI 10.1126/science.3479843; LYNCH HT, 1985, CANCER, V56, P934, DOI 10.1002/1097-0142(19850815)56:4<934::AID-CNCR2820560439>3.0.CO;2-I; LYNCH HT, 1985, CA-CANCER J CLIN, V35, P95, DOI 10.3322/canjclin.35.2.95; MECKLIN JP, 1986, GASTROENTEROLOGY, V90, P328, DOI 10.1016/0016-5085(86)90928-5; OTT J, 1976, AM J HUM GENET, V28, P528; PALTOMAKI P, 1993, SCIENCE, V260, P810; SPIRIO L, 1993, AM J HUM GENET, V52, P286; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; VASEN HFA, 1990, ANTICANCER RES, V10, P555; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Warthin AS, 1913, ARCH INTERN MED, V12, P546; WILLIAMSON R, 1991, CYTOGENET CELL GENET, V58, P1190, DOI 10.1159/000133727	22	413	416	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1993	5	3					279	282		10.1038/ng1193-279	http://dx.doi.org/10.1038/ng1193-279			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MF122	7903889				2022-12-25	WOS:A1993MF12200020
J	ZHONG, N; DOBKIN, C; BROWN, WT				ZHONG, N; DOBKIN, C; BROWN, WT			A COMPLEX MUTABLE POLYMORPHISM LOCATED WITHIN THE FRAGILE X-GENE	NATURE GENETICS			English	Article							MYOTONIC-DYSTROPHY; REPEATED SEQUENCES; HUMAN GENOME; DNA; LENGTH; ALLELES; FAMILY; SITE; LOCI	While studying founder chromosomes in the fragile X syndrome, we have unexpectedly found linkage equilibrium to FRAXZC2, an Alu-associated microsatellite within the defective gene, FMR-1. DNA sequencing of 265 chromosomes revealed 39 alleles and a complex microsatellite of form (GT)x-C-(TA)y-(T)z. A mutation rate of 3.3% was observed but only among fragile X maternally derived meioses. Finding a second mutable locus within FMR-1 suggests that the target for tandem repeat instability may not be confined to the (CGG)n repeat alone and raises the possibility of an FMR-1 mutation mechanism involving microsatellites.	NEW YORK STATE INST BASIC RES DEV DISABIL, DEPT HUMAN GENET, 1050 FOREST HILL RD, STATEN ISL, NY 10314 USA	Institute for Basic Research in Developmental Disabilities			Brown, William/GXN-2777-2022					AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; BECKMANN JS, 1992, GENOMICS, V12, P627, DOI 10.1016/0888-7543(92)90285-Z; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BROWN WT, 1993, JAMA-J AM MED ASSOC, V270, P1569, DOI 10.1001/jama.270.13.1569; BROWN WT, 1992, MOL GENETIC MED, V2; CHU CS, 1993, NAT GENET, V3, P151, DOI 10.1038/ng0293-151; ECONOMOU EP, 1990, P NATL ACAD SCI USA, V87, P2951, DOI 10.1073/pnas.87.8.2951; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GIBBS M, 1993, GENOMICS, V17, P121, DOI 10.1006/geno.1993.1292; HARLEY HG, 1991, AM J HUM GENET, V49, P68; IMBERT G, 1993, NAT GENET, V4, P72, DOI 10.1038/ng0593-72; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; JURKA J, 1988, P NATL ACAD SCI USA, V85, P4775, DOI 10.1073/pnas.85.13.4775; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MORRAL N, 1991, GENOMICS, V10, P692, DOI 10.1016/0888-7543(91)90454-M; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; OUDET C, 1993, AM J HUM GENET, V52, P297; PETERSEN MB, 1991, AM J HUM GENET, V48, P65; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; RICHARDS RI, 1991, J MED GENET, V28, P818, DOI 10.1136/jmg.28.12.818; RICHARDS RI, 1992, NAT GENET, V1, P257, DOI 10.1038/ng0792-257; SCHLOTTERER C, 1992, NUCLEIC ACIDS RES, V20, P211, DOI 10.1093/nar/20.2.211; SHRIVER MD, 1992, GENOMICS, V14, P449, DOI 10.1016/S0888-7543(05)80240-X; SMITS APT, 1993, J MED GENET, V30, P94, DOI 10.1136/jmg.30.2.94; VERGNAUD G, 1991, GENOMICS, V11, P135, DOI 10.1016/0888-7543(91)90110-Z; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; ZULIANI G, 1990, AM J HUM GENET, V46, P963	31	62	62	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1993	5	3					248	253		10.1038/ng1193-248	http://dx.doi.org/10.1038/ng1193-248			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MF122	8275089				2022-12-25	WOS:A1993MF12200014
J	BUREAU, JF; MONTAGUTELLI, X; BIHL, F; LEFEBVRE, S; GUENET, JL; BRAHIC, M				BUREAU, JF; MONTAGUTELLI, X; BIHL, F; LEFEBVRE, S; GUENET, JL; BRAHIC, M			MAPPING LOCI INFLUENCING THE PERSISTENCE OF THEILERS VIRUS IN THE MURINE CENTRAL-NERVOUS-SYSTEM	NATURE GENETICS			English	Article							INDUCED DEMYELINATING DISEASE; PCR-ANALYZED MICROSATELLITES; MOUSE GENOME; NUDE-MICE; SUSCEPTIBLE SJL/J; H-2D REGION; DA STRAIN; ENCEPHALOMYELITIS; GENE; IDENTIFICATION	Inbred strains of mice differ greatly in their susceptibility to the demyelinating disease caused by Theiler's Murine Encephalomyelitis Virus. In this murine disease, which is an animal model for the study of multiple sclerosis, demyelination depends on the persistent infection of the central nervous system. Previous studies identified a locus in the H-2D region of the major histocompatibility complex which controls susceptibility to the persistent infection, and also showed that other loci are involved. In order to identify these loci, we screened the genome of a set of backcross animals with a combination of polymorphic microsatellites and restriction enzymes sites. We now show that viral persistence is also controlled by a locus close to lfg on chromosome 10 and possibly by a locus near Mbp on chromosome 18.	INST PASTEUR,UNITE GENET MAMMIFERES,F-75724 PARIS 15,FRANCE	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	BUREAU, JF (corresponding author), INST PASTEUR,UNITE VIRUS LENTS,CNRS,UA1157,28 RUE DR ROUX,F-75724 PARIS 15,FRANCE.		Lefebvre, Suzie/D-5092-2017	Bureau, Jean-Francois/0000-0003-1945-1883				AITMAN TJ, 1991, MAMM GENOME, V1, P206, DOI 10.1007/BF00352326; AUBERT C, 1987, MICROB PATHOGENESIS, V3, P319, DOI 10.1016/0882-4010(87)90002-7; BORROW P, 1992, J GEN VIROL, V73, P1861, DOI 10.1099/0022-1317-73-7-1861; BRINTON M, 1984, HOST GENES INFLUENCE, P71; BUREAU JF, 1992, J VIROL, V66, P4698, DOI 10.1128/JVI.66.8.4698-4704.1992; CLATCH RJ, 1985, J IMMUNOL, V135, P1408; CLATCH RJ, 1990, VIROLOGY, V176, P244, DOI 10.1016/0042-6822(90)90249-Q; CORNALL RJ, 1991, GENOMICS, V10, P874, DOI 10.1016/0888-7543(91)90175-E; CORNALL RJ, 1991, NATURE, V353, P262, DOI 10.1038/353262a0; DIETRICH W, 1992, GENETICS, V131, P423; GERETY SJ, 1991, J IMMUNOL, V146, P2401; HEARNE CM, 1991, MAMM GENOME, V1, P273, DOI 10.1007/BF00352339; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; HILLYARD AL, 1992, MOUSE GENOME, V90, P8; LANDER ES, 1989, GENETICS, V121, P185; LIPTON HL, 1976, SCIENCE, V192, P62, DOI 10.1126/science.176726; LOVE JM, 1990, NUCLEIC ACIDS RES, V18, P4123, DOI 10.1093/nar/18.14.4123; MELVOLD RW, 1990, J VIROL, V64, P686, DOI 10.1128/JVI.64.2.686-690.1990; MELVOLD RW, 1987, J IMMUNOL, V138, P1429; MONTAGUTELLI X, 1990, J HERED, V81, P490, DOI 10.1093/oxfordjournals.jhered.a111033; MONTAGUTELLI X, 1991, MAMM GENOME, V1, P255, DOI 10.1007/BF00352333; OZDEN S, 1991, J HISTOCHEM CYTOCHEM, V39, P1305, DOI 10.1177/39.10.1940303; PATICK AK, 1990, J VIROL, V64, P5570, DOI 10.1128/JVI.64.11.5570-5576.1990; RODRIGUEZ M, 1986, J EXP MED, V163, P620, DOI 10.1084/jem.163.3.620; RODRIGUEZ M, 1988, J IMMUNOL, V140, P2950; RODRIGUEZ M, 1983, ANN NEUROL, V13, P426, DOI 10.1002/ana.410130409; ROOS RP, 1984, ANN NEUROL, V15, P494, DOI 10.1002/ana.410150516; ROOS RP, 1982, J NEUROIMMUNOL, V2, P223, DOI 10.1016/0165-5728(82)90057-1; ROSENTHAL A, 1986, LAB INVEST, V54, P515; Sawyer WA, 1944, AM J HYG, V39, P337, DOI 10.1093/oxfordjournals.aje.a118911; SPINELLA DG, 1990, J IMMUNOL METHODS, V135, P209, DOI 10.1016/0022-1759(90)90274-Y; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0; ZURBRIGGEN A, 1991, J VIROL, V65, P1023, DOI 10.1128/JVI.65.2.1023-1030.1991	33	93	93	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1993	5	1					87	91		10.1038/ng0993-87	http://dx.doi.org/10.1038/ng0993-87			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LV565	8220433				2022-12-25	WOS:A1993LV56500023
J	DUBROVA, YE; JEFFREYS, AJ; MALASHENKO, AM				DUBROVA, YE; JEFFREYS, AJ; MALASHENKO, AM			MOUSE MINISATELLITE MUTATIONS INDUCED BY IONIZING-RADIATION	NATURE GENETICS			English	Article							HUMAN DNA	The detection of changes in germline mutation rate in human populations remains extremely difficult. Estimating the genetic hazards of radiation and other mutagens in humans therefore depends on extrapolation from experimental systems. Because of the very low frequency of spontaneous mutation at most loci, enormous samples are required to detect increases of mutation rate. A very high rate of spontaneous germline mutation altering the length of minisatellite loci has been found in human populations and therefore this system might be useful for detecting induced mutations in relatively small samples. Here we present evidence that minisatellite mutation rate in mice is increased by low doses of ionizing radiation.	UNIV LEICESTER,DEPT GENET,LEICESTER LE1 7RH,ENGLAND; RUSSIAN ACAD MED SCI,EXPTL BIOL MODELS RES LAB,MOSCOW,RUSSIA; NI VAVILOV GEN GENET RES INST,GSP-1,117809 MOSCOW,RUSSIA	University of Leicester; Russian Academy of Medical Sciences; Russian Academy of Sciences; Vavilov Institute of General Genetics			Dubrova, Yuri/ABA-7148-2020	Dubrova, Yuri/0000-0001-5281-7539				Drake J. W, 1970, MOL BASIS MUTATION; DUBROVA YE, 1992, GENETIKA+, V28, P5; FAVOR J, 1989, GENOME, V31, P844, DOI 10.1139/g89-149; JEFFREYS AJ, 1991, NATURE, V354, P204, DOI 10.1038/354204a0; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; JEFFREYS AJ, 1990, CELL, V60, P473, DOI 10.1016/0092-8674(90)90598-9; JEFFREYS AJ, 1991, AM J HUM GENET, V48, P824; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; KELLY R, 1989, GENOMICS, V5, P844, DOI 10.1016/0888-7543(89)90126-2; NEEL JV, 1988, AM J HUM GENET, V42, P663; NEEL JV, 1980, 14 P INT C GEN MOSC, V1, P235; RUSSELL WL, 1982, P NATL ACAD SCI-BIOL, V79, P542, DOI 10.1073/pnas.79.2.542; SAVKOVIC NV, 1970, MUTAT RES, V9, P407, DOI 10.1016/0027-5107(70)90022-9; WONG Z, 1986, NUCLEIC ACIDS RES, V14, P4605, DOI 10.1093/nar/14.11.4605; 1986, IONIZING RAD SOURCES	15	152	161	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1993	5	1					92	94		10.1038/ng0993-92	http://dx.doi.org/10.1038/ng0993-92			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LV565	8220434				2022-12-25	WOS:A1993LV56500024
J	IRIS, FJM; BOUGUELERET, L; PRIEUR, S; CATERINA, D; PRIMAS, G; PERROT, V; JURKA, J; RODRIGUEZTOME, P; CLAVERIE, JM; DAUSSET, J; COHEN, D				IRIS, FJM; BOUGUELERET, L; PRIEUR, S; CATERINA, D; PRIMAS, G; PERROT, V; JURKA, J; RODRIGUEZTOME, P; CLAVERIE, JM; DAUSSET, J; COHEN, D			DENSE ALU CLUSTERING AND A POTENTIAL NEW MEMBER OF THE NF KAPPA-B FAMILY WITHIN A 90 KILOBASE HLA CLASS-III SEGMENT	NATURE GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; NUCLEOTIDE-SEQUENCE; HUMAN GENOME; GENE; EVOLUTION; DISEASE; PROTEIN; REGION; ALPHA; ASSOCIATIONS	We have conducted a detailed structural analysis of 90 kilobases (kb) of the HLA Class III region from the Bat2 gene at the centromeric end to 23 kb beyond TNF. A single contig of 80 kb was sequenced entirely with a group of four smaller contigs covering 10 kb being only partly sequenced. This region contains four known genes and a novel telomeric potential coding region. The genes are bracketed by long, dense clusters of Alu repeats belonging to all the major families. At least six new families of MER repeats and one pseudogene are intercalated within and between the Alu clusters. The most telomeric 3.8 kb contains three potential exons, one of which bears strong homology to the ankyrin domain of the DNA binding factors NF kappaB and I kappaB.	LINUS PAULING INST SCI & MED,PALO ALTO,CA 94306; NIH,NATL CTR BIOTECHNOL INFORMAT,NATL LIB MED,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	IRIS, FJM (corresponding author), CTR ETUD POLYMORPHISME HUMAIN,27 RUE JULIETTE DODU,F-75010 PARIS,FRANCE.		Claverie, Jean-Michel/AAG-4889-2019; Claverie, Jean Michel/Z-2183-2019	Claverie, Jean-Michel/0000-0003-1424-0315; 				BANERJI J, 1990, P NATL ACAD SCI USA, V87, P2374, DOI 10.1073/pnas.87.6.2374; BATCHELOR JR, 1987, BRIT MED BULL, V43, P156, DOI 10.1093/oxfordjournals.bmb.a072169; BENJAMIN R, 1990, IMMUNOL TODAY, V11, P137, DOI 10.1016/0167-5699(90)90051-A; CHEN SJ, 1989, ONCOGENE, V4, P195; CLAVERIE JM, 1986, NUCLEIC ACIDS RES, V14, P179, DOI 10.1093/nar/14.1.179; CRUMPTON MJ, 1987, BRIT MED BULL, V43, pR1; DEAR S, 1991, NUCLEIC ACIDS RES, V19, P3907, DOI 10.1093/nar/19.14.3907; DEGEN SJF, 1987, BIOCHEMISTRY-US, V26, P6165, DOI 10.1021/bi00393a033; DEININGER PL, 1983, ANAL BIOCHEM, V129, P216, DOI 10.1016/0003-2697(83)90072-6; EDWARDS A, 1990, GENOMICS, V6, P593, DOI 10.1016/0888-7543(90)90493-E; FRENCH MAH, 1990, IMMUNOL TODAY, V11, P271, DOI 10.1016/0167-5699(90)90110-U; HANNAHAN D, 1983, J MOL BIOL, V166, P157; HASSKILL S, 1991, CELL, V65, P1281; HOURCADE D, 1990, J BIOL CHEM, V265, P974; JACOB CO, 1990, P NATL ACAD SCI USA, V87, P1233, DOI 10.1073/pnas.87.3.1233; JURKA J, 1988, P NATL ACAD SCI USA, V85, P4775, DOI 10.1073/pnas.85.13.4775; JURKA J, 1991, J MOL EVOL, V32, P105, DOI 10.1007/BF02515383; JURKA J, 1991, J MOL EVOL, V33, P49, DOI 10.1007/BF02100195; JURKA J, IN PRESS J MOL EVOL; KAPLAN DJ, 1991, NUCLEIC ACIDS RES, V19, P4731, DOI 10.1093/nar/19.17.4731; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; KENDALL E, 1990, NUCLEIC ACIDS RES, V18, P7251, DOI 10.1093/nar/18.24.7251; KERIAN K, 1990, CELL, V62, P1007; KOLLER M, 1991, GENE, V97, P245, DOI 10.1016/0378-1119(91)90058-J; LEGOUIS R, 1991, CELL, V67, P423, DOI 10.1016/0092-8674(91)90193-3; LI ZL, 1989, GENE, V78, P243; LIEW CC, 1990, NUCLEIC ACIDS RES, V18, P3647, DOI 10.1093/nar/18.12.3647; MA TS, 1991, GENOMICS, V10, P390, DOI 10.1016/0888-7543(91)90324-8; MARTINGALLARDO A, 1992, NAT GENET, V1, P34, DOI 10.1038/ng0492-34; MCCOMBIE WR, 1992, NATURE GENET, V1, P358; MILNER CM, 1990, IMMUNOGENETICS, V32, P242; NEDOSPASOV SA, 1986, COLD SPRING HARB SYM, V51, P611, DOI 10.1101/SQB.1986.051.01.073; NEPOM GT, 1990, DIABETES, V39, P1153, DOI 10.2337/diabetes.39.10.1153; OHNO H, 1990, CELL, V60, P991, DOI 10.1016/0092-8674(90)90347-H; OTHA S, 1987, FEBS LETT, V226, P171; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; RAUM D, 1979, LANCET, V2, P1208; RUBINSTEIN P, 1991, HUM IMMUNOL, V30, P270, DOI 10.1016/0198-8859(91)90006-U; SARGENT CA, 1989, EMBO J, V8, P2305, DOI 10.1002/j.1460-2075.1989.tb08357.x; SHIPP MA, 1988, P NATL ACAD SCI USA, V85, P4819, DOI 10.1073/pnas.85.13.4819; SPIES T, 1989, P NATL ACAD SCI USA, V86, P8955, DOI 10.1073/pnas.86.22.8955; STOPPALYONNET D, 1990, P NATL ACAD SCI USA, V87, P1551, DOI 10.1073/pnas.87.4.1551; THE VL, 1990, MOL ENDOCRINOL, V4, P268; TODA K, 1990, EUR J BIOCHEM, V193, P559, DOI 10.1111/j.1432-1033.1990.tb19372.x; TSUGE I, 1987, IMMUNOGENETICS, V26, P378, DOI 10.1007/BF00343709; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; WANG AM, 1991, GENOMICS, V10, P133, DOI 10.1016/0888-7543(91)90493-X; YANG SY, 1987, IMMUNOBIOLOGY HLA, V1, P12	48	115	136	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1993	3	2					137	145		10.1038/ng0293-137	http://dx.doi.org/10.1038/ng0293-137			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KL010	8499947				2022-12-25	WOS:A1993KL01000011
J	Kirillov, A; Kistler, B; Mostoslavsky, R; Cedar, H; Wirth, T; Bergman, Y				Kirillov, A; Kistler, B; Mostoslavsky, R; Cedar, H; Wirth, T; Bergman, Y			A role for nuclear NF-KB in B-cell specific demethylation of the Ig kappa locus	NATURE GENETICS			English	Article							PROTEIN-BINDING SITES; 2 DISTINCT MECHANISMS; CHAIN INTRON ENHANCER; V(D)J RECOMBINATION; TRANSCRIPTIONAL ACTIVITY; IMMUNOGLOBULIN GENES; TRANSGENIC SUBSTRATE; METHYLATION STATUS; LYMPHOID-CELLS; CPG ISLAND	The immunoglobulin kappa gene is specifically demethylated during B-cell maturation in a process which utilizes discrete cis-acting modules such as the intronic kappa enhancer element and the matrix attachment region (MAR). While any MAR sequence is sufficient for this reaction, mutation analysis indicates that tissue specificity is mediated by kappa B binding sequences within the kappa intronic enhancer. The plasmacytoma cell line S107 lacks kappa B binding activity and fails to demethylate the kappa locus. However, B-cell-specific demethylation is restored by the introduction of an active kappa B binding protein gene, relB. This represents the first demonstration of a trans-acting factor involved in cell-type-specific demethylation, and suggests that the same protein-DNA recognition system used for transcription may also contribute to the earlier developmental events that bring about activation of the kappa locus.	HEBREW UNIV JERUSALEM,HADASSAH MED SCH,HUBERT H HUMPHREY CTR EXPTL MED & CANC RES,IL-91120 JERUSALEM,ISRAEL; HEBREW UNIV JERUSALEM,HADASSAH MED SCH,DEPT CELLULAR BIOCHEM,IL-91120 JERUSALEM,ISRAEL; ZMBH,D-69120 HEIDELBERG,GERMANY	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Ruprecht Karls University Heidelberg			Wirth, Thomas/X-7172-2019					ATCHISON ML, 1987, CELL, V48, P121, DOI 10.1016/0092-8674(87)90362-X; ATCHISON ML, 1988, EMBO J, V7, P4213, DOI 10.1002/j.1460-2075.1988.tb03318.x; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BENSHUSHAN E, 1993, MOL CELL BIOL, V13, P891, DOI 10.1128/MCB.13.2.891; BERGMAN Y, 1984, P NATL ACAD SCI-BIOL, V81, P7041, DOI 10.1073/pnas.81.22.7041; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; CHEN JZ, 1993, EMBO J, V12, P4635, DOI 10.1002/j.1460-2075.1993.tb06152.x; CHEN JZ, 1993, CURR OPIN IMMUNOL, V5, P194, DOI 10.1016/0952-7915(93)90004-C; COCKERILL PN, 1987, J BIOL CHEM, V262, P5394; Demengeot J, 1995, INT IMMUNOL, V7, P1995, DOI 10.1093/intimm/7.12.1995; DIETZ A, 1994, NUCLEIC ACIDS RES, V22, P2744, DOI 10.1093/nar/22.14.2744; DOBRZANSKI P, 1994, EMBO J, V13, P4608, DOI 10.1002/j.1460-2075.1994.tb06782.x; ENGLER P, 1993, MOL CELL BIOL, V13, P571, DOI 10.1128/MCB.13.1.571; ENGLER P, 1991, CELL, V65, P1; ERNST P, 1995, IMMUNITY, V2, P427, DOI 10.1016/1074-7613(95)90024-1; FERNEX C, 1995, MOL CELL BIOL, V15, P3217; FERRIER P, 1990, EMBO J, V9, P117, DOI 10.1002/j.1460-2075.1990.tb08087.x; FINCO TM, 1995, CELL, V3, P263; FORRESTER WC, 1994, SCIENCE, V265, P1221, DOI 10.1126/science.8066460; GOODHARDT M, 1993, EUR J IMMUNOL, V23, P1789, DOI 10.1002/eji.1830230809; Hiramatsu R, 1995, CELL, V83, P1113, DOI 10.1016/0092-8674(95)90138-8; HSIEH CL, 1992, EMBO J, V11, P315, DOI 10.1002/j.1460-2075.1992.tb05054.x; ISRAEL A, 1995, TRENDS GENET, V11, P203, DOI 10.1016/S0168-9525(00)89045-9; JENUWEIN T, 1993, GENE DEV, V7, P2016, DOI 10.1101/gad.7.10.2016; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; KELLEY DE, 1988, MOL CELL BIOL, V8, P930, DOI 10.1128/MCB.8.2.930; KLEHR D, 1991, BIOCHEMISTRY-US, V30, P1264, DOI 10.1021/bi00219a015; Laemmli UK, 1992, CURR OPIN GENET DEV, V2, P275, DOI 10.1016/S0959-437X(05)80285-0; LEMBECHER T, 1993, NATURE, V365, P767; LENARDO M, 1987, SCIENCE, V236, P1573, DOI 10.1126/science.3109035; LERNBECHER T, 1994, EMBO J, V13, P4060, DOI 10.1002/j.1460-2075.1994.tb06723.x; LICHTENSTEIN M, 1994, CELL, V76, P913, DOI 10.1016/0092-8674(94)90365-4; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; MATHER EL, 1983, P NATL ACAD SCI USA, V78, P2072; MIRKOVITCH J, 1984, CELL, V39, P223, DOI 10.1016/0092-8674(84)90208-3; MIYAMOTO S, 1995, ADV CANCER RES, V66, P255, DOI 10.1016/S0065-230X(08)60257-2; OLTZ EM, 1993, MOL CELL BIOL, V13, P6223, DOI 10.1128/MCB.13.10.6223; PAROUSH Z, 1990, CELL, V63, P1229, DOI 10.1016/0092-8674(90)90418-E; RUBEN SM, 1991, SCIENCE, V251, P1490, DOI 10.1126/science.2006423; RYSECK RP, 1992, MOL CELL BIOL, V12, P674, DOI 10.1128/MCB.12.2.674; SCOTT ML, 1993, GENE DEV, V7, P1266, DOI 10.1101/gad.7.7a.1266; SERWE M, 1993, EMBO J, V12, P2321, DOI 10.1002/j.1460-2075.1993.tb05886.x; SOMPAYRAC LM, 1981, P NATL ACAD SCI-BIOL, V78, P7575, DOI 10.1073/pnas.78.12.7575; STAUDT LM, 1991, ANNU REV IMMUNOL, V9, P373; STORB U, 1983, P NATL ACAD SCI-BIOL, V80, P6642, DOI 10.1073/pnas.80.21.6642; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; TAKEDA S, 1993, EMBO J, V12, P2329, DOI 10.1002/j.1460-2075.1993.tb05887.x; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; WEIH F, 1994, ONCOGENE, V9, P3289; WIRTH T, 1988, EMBO J, V7, P3109, DOI 10.1002/j.1460-2075.1988.tb03177.x; YEIVIN A, 1993, DNA METHYLATION MOL, P524	52	204	208	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1996	13	4					435	441		10.1038/ng0895-435	http://dx.doi.org/10.1038/ng0895-435			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VB620	8696338				2022-12-25	WOS:A1996VB62000024
J	Wang, JZ; GrundkeIqbal, I; Iqbal, K				Wang, JZ; GrundkeIqbal, I; Iqbal, K			Glycosylation of microtubule-associated protein tau: An abnormal posttranslational modification in Alzheimer's disease	NATURE MEDICINE			English	Article							PAIRED HELICAL FILAMENTS; NEUROFIBRILLARY TANGLES; MISSENSE MUTATIONS; OXIDANT STRESS; GLYCATED-TAU; GENE; BRAIN; PHOSPHORYLATION; PHOSPHATASE-2A; PATHOLOGY	Alzheimer's disease (AD) is characterized by the presence of numerous neurons with neurofibrillary tangles of paired helical filaments (PHFs). The microtubule-associated protein tau in abnormally hyperphosphorylated form is the major protein subunit of the PHF. We now show that PHF tangles isolated from AD brains are glycosylated, whereas no glycan is detected in normal tau. Deglycosylation of PHF tangles by endoglycosidase F/N-glycosidase F converts them into bundles of straight filaments 2.5 +/- 0.5 nm in diameter, similar to those generated by the interaction of normal tau and abnormally hyperphosphorylated tau (AD P-tau). Deglycosylation plus dephosphorylation, but not deglycosylation alone, of AD P-tau and tau from PHF tangles restores their microtubule polymerization activity. Dephosphorylation of deglycosylated PHF tangles results in increased tan release. Thus, although the abnormal phosphorylation might promote aggregation of tau and inhibition of the assembly of microtubules, glycosylation appears to be responsible for the maintenance of the PHF structure.	NEW YORK STATE INST BASIC RES DEV DISABIL,STATEN ISL,NY 10314	Institute for Basic Research in Developmental Disabilities					NIA NIH HHS [AG 05892, AG 08076] Funding Source: Medline; NIMH NIH HHS [MH/NS 31862] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH031862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG005892, R01AG008076] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALAFUZOFF I, 1987, ACTA NEUROPATHOL, V74, P209, DOI 10.1007/BF00688184; BANCHER C, 1989, BRAIN RES, V477, P90, DOI 10.1016/0006-8993(89)91396-6; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BRAAK H, 1986, NEUROSCI LETT, V65, P351, DOI 10.1016/0304-3940(86)90288-0; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; COHEN P, 1988, METHOD ENZYMOL, V159, P390; DELALONSO AC, 1996, NAT MED, V2, P783; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOUX WJ, 1995, FEBS LETT, V366, P81, DOI 10.1016/0014-5793(95)00486-S; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; IQBAL K, 1986, LANCET, V2, P421; IQBAL K, 1984, ACTA NEUROPATHOL, V62, P167, DOI 10.1007/BF00691849; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KHATOON S, 1992, J NEUROCHEM, V59, P750, DOI 10.1111/j.1471-4159.1992.tb09432.x; KOPKE E, 1993, J BIOL CHEM, V268, P24374; LEDESMA MD, 1994, J BIOL CHEM, V269, P21614; LEDESMA MD, 1995, J NEUROCHEM, V65, P1658; MASON RP, 1995, NEUROBIOL AGING, V16, P531, DOI 10.1016/0197-4580(95)00057-L; PAPASOZOMENOS SC, 1989, LAB INVEST, V60, P375; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; RUBEN GC, 1992, BRAIN RES, V590, P164, DOI 10.1016/0006-8993(92)91092-S; RUBEN GC, 1991, J BIOL CHEM, V266, P22019; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SMITH MA, 1994, P NATL ACAD SCI USA, V91, P5710, DOI 10.1073/pnas.91.12.5710; TANAKA S, 1988, J MOL BIOL, V203, P495, DOI 10.1016/0022-2836(88)90015-0; TOMLINSON BE, 1970, J NEUROL SCI, V11, P205, DOI 10.1016/0022-510X(70)90063-8; WANG JZ, 1995, J BIOL CHEM, V270, P4854, DOI 10.1074/jbc.270.9.4854; WISNIEWSKI HM, 1984, J NEUROPATH EXP NEUR, V43, P643, DOI 10.1097/00005072-198411000-00008; YAN SD, 1994, P NATL ACAD SCI USA, V91, P7787, DOI 10.1073/pnas.91.16.7787; YAN SD, 1995, NAT MED, V1, P693, DOI 10.1038/nm0795-693; ZUBENKO GS, 1988, ALZ DIS ASSOC DIS, V2, P179	33	282	302	1	31	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	AUG	1996	2	8					871	875		10.1038/nm0896-871	http://dx.doi.org/10.1038/nm0896-871			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UZ804	8705855				2022-12-25	WOS:A1996UZ80400032
J	Langer, R				Langer, R			Controlled release of a therapeutic protein	NATURE MEDICINE			English	Editorial Material							DELIVERY		GENENTECH INC,SAN FRANCISCO,CA 94080	Roche Holding; Genentech	Langer, R (corresponding author), MIT,DEPT CHEM ENGN,CAMBRIDGE,MA 02134, USA.							COSTANTINO HR, 1994, J PHARM SCI-US, V83, P1662, DOI 10.1002/jps.2600831205; HAGEMAN MJ, 1992, J AGR FOOD CHEM, V40, P348, DOI 10.1021/jf00014a036; Johnson OL, 1996, NAT MED, V2, P795, DOI 10.1038/nm0796-795; LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494; LANGER R, 1976, NATURE, V263, P797, DOI 10.1038/263797a0; LANGER R, 1995, ANN BIOMED ENG, V23, P101, DOI 10.1007/BF02368317; OGAWA Y, 1988, CHEM PHARM BULL, V36, P1095; POLVERINI PJ, 1977, NATURE, V269, P804, DOI 10.1038/269804a0; SCHOR AM, 1979, INT J CANCER, V245, P225; Stannett V. T., 1979, RECENT ADV MEMBRANE, P69	10	22	22	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUL	1996	2	7					742	743		10.1038/nm0796-742	http://dx.doi.org/10.1038/nm0796-742			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UU680	8673913				2022-12-25	WOS:A1996UU68000023
J	Dodds, MWJ				Dodds, MWJ			Dental caries diagnosis - Toward the 21st century	NATURE MEDICINE			English	Editorial Material											Dodds, MWJ (corresponding author), UNIV TEXAS,HLTH SCI CTR,DEPT COMMUNITY DENT,SAN ANTONIO,TX 78284, USA.							Longbottom C, 1996, NAT MED, V2, P235, DOI 10.1038/nm0296-235; LUSSI A, 1993, CARIES RES, V27, P409, DOI 10.1159/000261572	2	8	8	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAR	1996	2	3					283	283		10.1038/nm0396-283	http://dx.doi.org/10.1038/nm0396-283			1	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TY640	8612224	Bronze			2022-12-25	WOS:A1996TY64000034
J	Holt, JT; Thompson, ME; Szabo, C; RobinsonBenion, C; Arteaga, CL; King, MC; Jensen, RA				Holt, JT; Thompson, ME; Szabo, C; RobinsonBenion, C; Arteaga, CL; King, MC; Jensen, RA			Growth retardation and tumour inhibition by BRCA1	NATURE GENETICS			English	Article							FAMILIAL BREAST; CANCER	Inherited mutations in BRCA1 predispose to breast and ovarian cancer, but the role of BRCA1 in sporadic breast and ovarian cancer has previously been elusive. Here, we show that retroviral transfer of the wild-type BRCA1 gene inhibits growth in vitro of all breast and ovarian cancer cell lines tested, but not colon or lung cancer cells or fibroblasts. Mutant BRCA1 has no effect on growth of breast cancer cells; ovarian cancer cell growth is not affected by BRCA1 mutations in the 5' portion of the gene, but is inhibited by 3' BRCA1 mutations. Development of MCF-7 tumours in nude mice is inhibited when MCF-7 cells are transfected with wild-type, but not mutant, BRCA1. Most importantly, among mice with established MCF-7 tumours, peritoneal treatment with a retroviral vector expressing wild-type BRCA1 significantly inhibits tumour growth and increased survival.	VANDERBILT UNIV, SCH MED, DEPT PATHOL, NASHVILLE, TN 37232 USA; VANDERBILT UNIV, SCH MED, DEPT MED, NASHVILLE, TN 37232 USA; UNIV WASHINGTON, DEPT MED, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT GENET, SEATTLE, WA 98195 USA	Vanderbilt University; Vanderbilt University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Holt, JT (corresponding author), VANDERBILT UNIV, SCH MED, DEPT CELL BIOL, 221 KIRKLAND HALL, NASHVILLE, TN 37232 USA.		Jensen, Roy A/B-9739-2011	Jensen, Roy A/0000-0003-4430-2281; King, Mary-Claire/0000-0001-9426-1743	NCI NIH HHS [F32-CA66293, R01-CA62161, R01-CA27632] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA027632] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arteaga CL, 1996, CANCER RES, V56, P1098; CORNELIS RS, 1995, GENE CHROMOSOME CANC, V13, P203, DOI 10.1002/gcc.2870130310; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HOSKING L, 1995, NAT GENET, V9, P343, DOI 10.1038/ng0495-343; Jensen RA, 1996, NAT GENET, V12, P303, DOI 10.1038/ng0396-303; JENSEN RA, 1994, P NATL ACAD SCI USA, V91, P9257, DOI 10.1073/pnas.91.20.9257; JENSEN RA, 1992, BIOCHEMISTRY-US, V31, P10887, DOI 10.1021/bi00159a032; LANE TF, 1995, GENE DEV, V9, P2712, DOI 10.1101/gad.9.21.2712; MARQUIS ST, 1995, NAT GENET, V11, P17, DOI 10.1038/ng0995-17; MERAJVER SD, 1995, NAT GENET, V9, P439, DOI 10.1038/ng0495-439; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; SOULE HD, 1980, CANCER LETT, V10, P177, DOI 10.1016/0304-3835(80)90042-7; TAKAHASHI H, 1995, CANCER RES, V55, P2998; THOMPSON ME, 1995, NAT GENET, V9, P444, DOI 10.1038/ng0495-444	18	364	383	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1996	12	3					298	302		10.1038/ng0396-298	http://dx.doi.org/10.1038/ng0396-298			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TY183	8589721				2022-12-25	WOS:A1996TY18300019
J	Blau, CA; Stamatoyannopoulos, G				Blau, CA; Stamatoyannopoulos, G			Preemptive therapy for genetic disease	NATURE MEDICINE			English	Editorial Material							MARROW TRANSPLANTATION		UNIV WASHINGTON,DIV MED GENET,SEATTLE,WA 98195	University of Washington; University of Washington Seattle	Blau, CA (corresponding author), UNIV WASHINGTON,DIV HEMATOL,SEATTLE,WA 98195, USA.							BUCKLEY RH, 1986, J IMMUNOL, V136, P2398; COWAN MJ, 1994, AM J PEDIAT HEMATOL, V16, P35; Flake A. W., 1995, Blood, V86, p125A; KAPELUSHNIK J, 1995, BLOOD, V86, P3241, DOI 10.1182/blood.V86.8.3241.bloodjournal8683241; LUCARELLI G, 1993, NEW ENGL J MED, V329, P840, DOI 10.1056/NEJM199309163291204; NESCI S, 1992, BONE MARROW TRANSPL, V10, P143; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O	7	10	10	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	FEB	1996	2	2					161	162		10.1038/nm0296-161	http://dx.doi.org/10.1038/nm0296-161			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TU060	8574957				2022-12-25	WOS:A1996TU06000032
J	CherifZahar, B; Raynal, V; Gane, P; Mattei, MG; Bailly, P; Gibbs, B; Colin, Y; Cartron, JP				CherifZahar, B; Raynal, V; Gane, P; Mattei, MG; Bailly, P; Gibbs, B; Colin, Y; Cartron, JP			Candidate gene acting as a suppressor of the RH locus in most cases of Rh-deficiency	NATURE GENETICS			English	Article							INSITU HYBRIDIZATION; BLOOD; MEMBRANE; EXPRESSION; ANTIGENS; AMPLIFICATION; LOCALIZATION; CHROMOSOME; PROTEIN; REGION	The Rh antigen is a multi-subunit complex composed of Rh polypeptides and associated glycoproteins (Rh50, CD47, LW and glycophorin B); these interact in the red cell membrane and are lacking or severely reduced in Rh-null, cells. As a result, individuals with Rh-null suffer chronic haemolytic anaemia known as the Rh-deficiency syndrome. Most frequently, Rh-null phenotypes are caused by homozygosity of an autosomal suppressor gene unlinked to the RH locus (Rh-null regulator or Rh-mod types), We have analysed the genes and transcripts encoding Rh, CD47 and Rh50 proteins in five such unrelated Rh-null, cases. In all patients, we identified alteration of Rh50 - frameshift, nucleotide mutations, or failure of amplification - which correlated with Rh-null phenotype, We propose that mutant alleles of Rh50, which map to chromosome 6p11-21.1, are likely candidates for suppressors of the RH locus accounting for most cases of Rh-deficiency.	INST NATL TRANSFUS SANGUINE,GIP,INSERM,U76,F-75015 PARIS,FRANCE; INSERM,U406,F-13385 MARSEILLE,FRANCE; WP BLOOD TRANSFUS SERV,HOWARD PLACE 7450,SOUTH AFRICA	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm)			colin, yves/O-1910-2017	colin, yves/0000-0001-5196-4254; Cherif-Zahar, Baya/0000-0002-4965-7252				AGRE P, 1991, BLOOD, V78, P551, DOI 10.1182/blood.V78.3.551.bloodjournal783551; ALLOISIO N, 1993, BLOOD, V82, P1323, DOI 10.1182/blood.V82.4.1323.bloodjournal8241323; ANSTEE DJ, 1993, BAILLIERE CLIN HAEM, V6, P401, DOI 10.1016/S0950-3536(05)80152-0; AVENT N, 1988, BIOCHEM J, V251, P499, DOI 10.1042/bj2510499; BALLAS SK, 1984, BLOOD, V63, P1046; CAMPBELL IG, 1992, CANCER RES, V52, P5416; CARRITT B, 1993, ANN HUM GENET, V57, P273, DOI 10.1111/j.1469-1809.1993.tb00900.x; CARTRON JP, 1993, SEMIN HEMATOL, V30, P193; CARTRON JP, 1994, BLOOD REV, V8, P199, DOI 10.1016/0268-960X(94)90108-2; CHERIFZAHAR B, 1991, HUM GENET, V86, P398, DOI 10.1007/BF00201843; CHERIFZAHAR B, 1993, BLOOD, V82, P656, DOI 10.1182/blood.V82.2.656.bloodjournal822656; DEEN PMT, 1995, J CLIN INVEST, V95, P2291, DOI 10.1172/JCI117920; EYERS SAC, 1994, J BIOL CHEM, V269, P6417; Gardner B, 1991, Transfus Med, V1, P77, DOI 10.1111/j.1365-3148.1991.tb00013.x; HERMAND P, 1993, BLOOD, V82, P669; ISHIMORI T, 1967, TRANSFUSION, V7, P84, DOI 10.1111/j.1537-2995.1967.tb04845.x; IZRAELI S, 1991, NUCLEIC ACIDS RES, V19, P6051; KUYPERS F, 1984, BIOCHEM J, V221, P931, DOI 10.1042/bj2210931; LAUF PK, 1976, BLOOD, V48, P457; LINDBERG FP, 1994, J BIOL CHEM, V269, P1567; MATTEI MG, 1985, HUM GENET, V69, P268, DOI 10.1007/BF00293038; MAWBY WJ, 1994, BIOCHEM J, V304, P525, DOI 10.1042/bj3040525; MOLLISON PL, 1993, BLOOD TRANSFUSION CL, P204; NASH R, 1987, AM J HEMATOL, V24, P267, DOI 10.1002/ajh.2830240306; POSS MT, 1993, VOX SANG, V64, P231, DOI 10.1111/j.1423-0410.1993.tb03061.x; RACE RR, 1975, BLOOD GROUPS MAN, P78; RIDGWELL K, 1992, BIOCHEM J, V287, P223, DOI 10.1042/bj2870223; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWARTZ MA, 1993, J BIOL CHEM, V268, P19931; Tippett P, 1990, Transfus Med Rev, V4, P56, DOI 10.1016/S0887-7963(90)70248-9; TOURNAMILLE C, 1995, HUM GENET, V95, P407, DOI 10.1007/BF00208965; TRIGLIA T, 1988, NUCLEIC ACIDS RES, V16, P8186, DOI 10.1093/nar/16.16.8186	32	109	113	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1996	12	2					168	173		10.1038/ng0296-168	http://dx.doi.org/10.1038/ng0296-168			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TU079	8563755				2022-12-25	WOS:A1996TU07900017
J	McInnes, IB; AlMughales, J; Field, M; Leung, BP; Huang, FP; Dixon, R; Sturrock, RD; Wilkinson, PC; Liew, FY				McInnes, IB; AlMughales, J; Field, M; Leung, BP; Huang, FP; Dixon, R; Sturrock, RD; Wilkinson, PC; Liew, FY			The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis	NATURE MEDICINE			English	Article							CARTILAGE PANNUS JUNCTION; SYNOVIAL TISSUE; INFLAMMATORY ARTHRITIS; PERIPHERAL-BLOOD; MACROPHAGE; EXPRESSION; CYTOKINES; FLUID; CLASSIFICATION; LOCALIZATION	Interleukin 15 (IL-15) is a novel cytokine with interleukin-2-like activity. It is also a potent T-lymphocyte chemoattractant. Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by the presence of activated T lymphocytes, macrophages and synoviocytes in the synovial membrane. The mechanisms of T-cell activation in RA are currently unclear. We report the presence of high concentrations of IL-15 in rheumatoid arthritis (RA) synovial fluid and have demonstrated its expression in the synovial membrane lining layer by immunohistochemistry. RA synovial fluids were found to contain chemotactic activity, which was attributable in part to the presence of IL-15. Moreover, in a murine model, injection of recombinant IL-15 was found to induce a local tissue inflammatory infiltrate consisting predominantly of T lymphocytes. Synovial fluid T lymphocytes proliferate in response to IL-15, demonstrating that continued responsiveness to IL-15 is a feature of T cells after entry into the synovial compartment, These data suggest that IL-15 can recruit and activate T lymphocytes into the synovial membrane, thereby contributing to RA pathogenesis.	UNIV GLASGOW,DEPT IMMUNOL,GLASGOW G11 6NT,LANARK,SCOTLAND; UNIV GLASGOW,DEPT MED,CTR RHEUMAT DIS,GLASGOW G11 6NT,LANARK,SCOTLAND; LITTLEMORE HOSP,YAMANOUCHI RES INST,OXFORD OX4 4XN,ENGLAND	University of Glasgow; University of Glasgow			Leung, Bernard/O-2409-2013	Leung, Bernard/0000-0002-1119-4934; Al-Mughales, Jamil/0000-0001-6893-0691; McInnes, Iain/0000-0002-6462-4280	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; ARMITAGE RJ, 1995, J IMMUNOL, V154, P483; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; BAMFORD RN, 1994, P NATL ACAD SCI USA, V91, P4940, DOI 10.1073/pnas.91.11.4940; BRENNAN FM, 1991, BR J RHEUM S2, V30, P75; BURMESTER GR, 1987, J CLIN INVEST, V80, P595, DOI 10.1172/JCI113111; BURTON JD, 1994, P NATL ACAD SCI USA, V91, P4935, DOI 10.1073/pnas.91.11.4935; CARSON WE, 1994, J EXP MED, V180, P1395, DOI 10.1084/jem.180.4.1395; CHU CQ, 1991, ARTHRITIS RHEUM, V34, P1125, DOI 10.1002/art.1780340908; CHU CQ, 1992, BRIT J RHEUMATOL, V31, P653; COMBE B, 1985, CLIN EXP IMMUNOL, V59, P520; DELEURAN B, 1994, SCAND J RHEUMATOL, V23, P2, DOI 10.3109/03009749409102126; DELEURAN BW, 1992, BRIT J RHEUMATOL, V31, P801; DUFF GW, 1993, BRIT J RHEUMATOL, V32, P15; DUKE O, 1982, CLIN EXP IMMUNOL, V49, P22; FERNANDEZGUTIERREZ B, 1995, J RHEUMATOL, V22, P413; FIELD M, 1991, RHEUMATOL INT, V11, P45, DOI 10.1007/BF00291144; FIRESTEIN GS, 1987, ARTHRITIS RHEUM, V30, P864, DOI 10.1002/art.1780300804; FIRESTEIN GS, 1988, J EXP MED, V168, P1573, DOI 10.1084/jem.168.5.1573; FIRESTEIN GS, 1990, ARTHRITIS RHEUM, V33, P768, DOI 10.1002/art.1780330602; GIRI JG, 1995, EMBO J, V14, P3654, DOI 10.1002/j.1460-2075.1995.tb00035.x; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; HARRISON WB, 1992, 2ND LINE AGENTS TREA; HASTON WS, 1985, J IMMUNOL METHODS, V81, P229, DOI 10.1016/0022-1759(85)90208-X; HORNEFF G, 1991, ARTHRITIS RHEUM, V34, P129, DOI 10.1002/art.1780340202; IANNONE F, 1994, EUR J IMMUNOL, V24, P2706, DOI 10.1002/eji.1830241120; JANEWAY CA, 1994, CELL, V76, P275, DOI 10.1016/0092-8674(94)90335-2; KOCH AE, 1991, J IMMUNOL, V147, P2187; LAFFON A, 1991, J CLIN INVEST, V88, P546, DOI 10.1172/JCI115338; MAINI RN, 1995, MECHANISMS MODELS RH, P25; PANAYI GS, 1992, ARTHRITIS RHEUM-US, V35, P729, DOI 10.1002/art.1780350702; PITZALIS C, 1987, J RHEUMATOL, V14, P662; SIMON AK, 1994, P NATL ACAD SCI USA, V91, P8562, DOI 10.1073/pnas.91.18.8562; TAUB DD, 1993, SCIENCE, V260, P355, DOI 10.1126/science.7682337; THOMAS R, 1992, ARTHRITIS RHEUM-US, V35, P1455, DOI 10.1002/art.1780351209; ULFGREN AK, 1995, ANN RHEUM DIS, V54, P654, DOI 10.1136/ard.54.8.654; WENDLING D, 1991, J RHEUMATOL, V18, P325; WILKINSON PC, 1986, IMMUNOLOGY, V57, P281; WILKINSON PC, 1995, J EXP MED, V181, P1255, DOI 10.1084/jem.181.3.1255; ZIGMOND SH, 1973, J EXP MED, V137, P387, DOI 10.1084/jem.137.2.387	41	406	425	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	FEB	1996	2	2					175	182		10.1038/nm0296-175	http://dx.doi.org/10.1038/nm0296-175			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TU060	8574962				2022-12-25	WOS:A1996TU06000037
J	Willis, D; Moore, AR; Frederick, R; Willoughby, DA				Willis, D; Moore, AR; Frederick, R; Willoughby, DA			Heme oxygenase: A novel target for the modulation of the inflammatory response	NATURE MEDICINE			English	Article							BILIRUBIN	Chronic inflammatory diseases place a heavy social and economic burden on the resources of many nations, but the number of safe and effective treatments is limited. To date, the major research effort has concentrated on those mediators responsible for the initiation and maintenance of the pathological process. In contrast, little attention has been focused on endogenous factors responsible for the resolution of the inflammation. Heme oxygenase ((HO); EC 1.14.99.3) is the rate-limiting enzyme in the catabolism of heme to biliverdin (which is converted to bilirubin by biliverdin reductase), free iron and carbon monoxide (CO), Two isoforms of HO have been characterized, the constitutive isoform, HO-2, which is the major isoform present under physiological conditions, and the stress-induced isoform, HO-1, which has also been classified as heat-shock protein 32K (ref. 1). Increases in HO activity have been implicated in tissue protection against oxidative stress(2). In this communication, we describe the effects of modulating HO during an acute complement-dependent inflammatory response. Elevation of this enzyme resulted in a striking suppression, whereas inhibition of the enzyme led to a potentiation of the inflammatory response. Such novel enzyme modulation has application on the one hand to the treatment of inflammatory diseases and on the other hand to immunosuppressed states in which the impaired ability to mount an adequate inflammatory response may result in death from opportunistic infections.			Willis, D (corresponding author), UNIV LONDON ST BARTHOLOMEWS HOSP & MED COLL,WILLIAM HARVEY RES INST,DEPT EXPTL PATHOL,LONDON EC1M 6BQ,ENGLAND.							BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CANTONI L, 1991, BIOCHEM J, V279, P891, DOI 10.1042/bj2790891; CAPASSO F, 1975, J PATHOL, V116, P117, DOI 10.1002/path.1711160208; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; LEVERE RD, 1993, AM J HEMATOL, V43, P19, DOI 10.1002/ajh.2830430106; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; MARKS GS, 1991, TRENDS PHARMACOL SCI, V12, P185, DOI 10.1016/0165-6147(91)90544-3; MARTASEK P, 1991, J AM SOC NEPHROL, V2, P1078; MORITA T, 1995, P NATL ACAD SCI USA, V92, P1475, DOI 10.1073/pnas.92.5.1475; NAKAGAMI T, 1993, BIOCHIM BIOPHYS ACTA, V1158, P189, DOI 10.1016/0304-4165(93)90013-X; NATH KA, 1992, J CLIN INVEST, V90, P267, DOI 10.1172/JCI115847; POLLA BS, 1995, INFLAMMATION, V19, P363, DOI 10.1007/BF01534393; SIERRA EE, 1992, ANAL BIOCHEM, V200, P27, DOI 10.1016/0003-2697(92)90271-8; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; TOMLINSON A, 1994, BRIT J PHARMACOL, V113, P693, DOI 10.1111/j.1476-5381.1994.tb17048.x; VANE JR, 1994, P NATL ACAD SCI USA, V91, P2046, DOI 10.1073/pnas.91.6.2046; WHITE KA, 1992, BIOCHEMISTRY-US, V31, P6627, DOI 10.1021/bi00144a001; WILLIS D, 1995, BIOCHEM BIOPH RES CO, V214, P1152, DOI 10.1006/bbrc.1995.2406	18	688	718	0	28	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JAN	1996	2	1					87	90		10.1038/nm0196-87	http://dx.doi.org/10.1038/nm0196-87			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TP579	8564848				2022-12-25	WOS:A1996TP57900042
J	BARDONI, B; ZANARIA, E; GUIOLI, S; FLORIDIA, G; WORLEY, KC; TONINI, G; FERRANTE, E; CHIUMELLO, G; MCCABE, ERB; FRACCARO, M; ZUFFARDI, O; CAMERINO, G				BARDONI, B; ZANARIA, E; GUIOLI, S; FLORIDIA, G; WORLEY, KC; TONINI, G; FERRANTE, E; CHIUMELLO, G; MCCABE, ERB; FRACCARO, M; ZUFFARDI, O; CAMERINO, G			A DOSAGE SENSITIVE LOCUS AT CHROMOSOME XP21 IS INVOLVED IN MALE TO FEMALE SEX REVERSAL	NATURE GENETICS			English	Article							ADRENAL HYPOPLASIA-CONGENITA; MULTIPLE ABNORMALITIES; GONADAL-DYSGENESIS; GLYCEROL KINASE; DUPLICATION; SRY	Male to female sex reversal has been observed in individuals with duplications of the short arm of the X chromosome. Here we demonstrate that sex reversal results from the presence of two active copies of an Xp locus rather than from its rearrangement and that alterations at this locus constitute one of the causes of sex reversal in individuals with a normal 46,XY karyotype. We have named this locus DSS (Dosage Sensitive Sex reversal) and localized it to a 160 kilobase region of chromosome Xp21, adjacent to the adrenal hypoplasia congenita locus. The identification of male individuals deleted for DSS suggests that this locus is not required for testis differentiation. We propose that DSS has a role in ovarian development and/or functions as a link between ovary and testis formation.	UNIV PAVIA, I-27100 PAVIA, ITALY; BAYLOR COLL MED, DEPT MOLEC & HUMAN GENET, HOUSTON, TX 77030 USA; UNIV ROMA LA SAPIENZA, IST CLIN PEDIAT, I-00161 ROME, ITALY; HOSP SAN RAFFAELE, I-20132 MILAN, ITALY; UNIV SASSARI, IST ISTOL & EMBRIOL, I-07100 SASSARI, ITALY	University of Pavia; Baylor College of Medicine; Sapienza University Rome; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Sassari			Bardoni, Barbara/F-9918-2013; FLORIDIA, GIOVANNA/A-6640-2015	FLORIDIA, GIOVANNA/0000-0003-4187-8816; Guioli, Silvana/0000-0002-4920-7745; zuffardi, orsetta/0000-0002-1466-4559; Worley, Kim/0000-0002-0282-1000; Bardoni, Barbara/0000-0001-6411-1517	Telethon [B.05] Funding Source: Medline	Telethon(Fondazione Telethon)		BARDONI B, 1988, HUM GENET, V81, P23, DOI 10.1007/BF00283723; BARDONI B, 1993, HUM GENET, V91, P333; BERKOVITZ GD, 1991, MEDICINE, V70, P375, DOI 10.1097/00005792-199111000-00003; BERNSTEIN R, 1980, J MED GENET, V17, P291, DOI 10.1136/jmg.17.4.291; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; DUTRILLAUX B, 1981, HUM GENET, V57, P93; FECHNER PY, 1993, J CLIN ENDOCR METAB, V76, P1248, DOI 10.1210/jc.76.5.1248; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; GERMAN J, 1978, SCIENCE, V202, P53, DOI 10.1126/science.567843; HARLEY VR, 1992, SCIENCE, V255, P453, DOI 10.1126/science.1734522; Hastie Nicholas D., 1992, Human Molecular Genetics, V1, P293; MAY KM, 1991, AM J HUM GENET, V49, P19; MCCABE ERB, 1992, AM J HUM GENET, V51, P1277; MCKUSICK VA, 1992, MENDELIAN INHERITANC, P1841; NARAHARA K, 1979, JPN J HUM GENET, V24, P105, DOI 10.1007/BF01888928; NIELSEN KB, 1982, J MED GENET, V19, P222, DOI 10.1136/jmg.19.3.222; OGATA T, 1992, J MED GENET, V29, P226, DOI 10.1136/jmg.29.4.226; Sambrook J, 1989, MOL CLONING LABORATO; SCHAEFER L, 1993, NAT GENET, V4, P272, DOI 10.1038/ng0793-272; SCHERER G, 1989, HUM GENET, V81, P291; SCHLESSINGER D, 1993, CYTOGENET CELL GENET, V64, P147, DOI 10.1159/000133572; Stern H., 1990, AM J HUM GENET, V47, pA41; WALKER AP, 1992, HUM MOL GENET, V1, P579, DOI 10.1093/hmg/1.8.579; WORLEY KC, 1992, GENOMICS, V13, P957, DOI 10.1016/0888-7543(92)90007-F; WORLEY KC, 1993, GENOMICS, V16, P407, DOI 10.1006/geno.1993.1204	25	533	555	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1994	7	4					497	501		10.1038/ng0894-497	http://dx.doi.org/10.1038/ng0894-497			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PA832	7951319				2022-12-25	WOS:A1994PA83200016
J	SHIRAKAWA, T; LI, AR; DUBOWITZ, M; DEKKER, JW; SHAW, AE; FAUX, JA; RA, CS; COOKSON, WOCM; HOPKIN, JM				SHIRAKAWA, T; LI, AR; DUBOWITZ, M; DEKKER, JW; SHAW, AE; FAUX, JA; RA, CS; COOKSON, WOCM; HOPKIN, JM			ASSOCIATION BETWEEN ATOPY AND VARIANTS OF THE BETA-SUBUNIT OF THE HIGH-AFFINITY IMMUNOGLOBULIN-E RECEPTOR	NATURE GENETICS			English	Article							FC-EPSILON-RI; MAST-CELL RECEPTOR; SINGLE AMINO-ACID; SERUM IGE LEVELS; BRONCHIAL HYPERRESPONSIVENESS; SURFACE EXPRESSION; TRANSFECTED CELLS; GENETIC-ANALYSIS; LINKAGE; CHROMOSOME-11Q	The beta-subunit of the high-affinity IgE receptor (Fc epsilon RI-beta) on chromosome 11 is maternally linked to atopy, the state of enhanced IgE responsiveness underlying allergic asthma and rhinitis. We have identified a common variant of Fc epsilon RI-beta, lle181Leu within the 4th transmembrane domain. Leu181 shows significant association with positive IgE responses in a random patient sample. Amongst 60 unrelated nuclear families with allergic asthmatic probands, Leu181 is identified in 10 (17%), is maternally inherited in each, and shows a strong association with atopy. Our data indicate that Fc epsilon RI-beta, subject to maternal modification, may be the atopy-causing locus on chromosome 11q.	JOHN RADCLIFFE HOSP,NUFFIELD DEPT MED,OXFORD OX3 9DU,ENGLAND; JUNTENDO UNIV,SCH MED,DEPT IMMUNOL,TOKYO 113,JAPAN; CHURCHILL HOSP,OSLER CHEST UNIT,OXFORD OX3 7LJ,ENGLAND	University of Oxford; Juntendo University; University of Oxford			Cookson, William/HHC-1790-2022		Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AMELUNG PJ, 1992, CLIN EXP ALLERGY, V22, P1077, DOI 10.1111/j.1365-2222.1992.tb00133.x; ARSHAD SH, 1992, LANCET, V339, P1493, DOI 10.1016/0140-6736(92)91260-F; BACKER V, 1992, ALLERGY, V47, P484, DOI 10.1111/j.1398-9995.1992.tb00669.x; BEINBORN M, 1993, NATURE, V362, P348, DOI 10.1038/362348a0; BENSASSON SZ, 1990, P NATL ACAD SCI USA, V87, P1421, DOI 10.1073/pnas.87.4.1421; BIEBER T, 1992, J EXP MED, V175, P1285, DOI 10.1084/jem.175.5.1285; BLANK U, 1989, NATURE, V337, P187, DOI 10.1038/337187a0; CHARMLEY P, 1990, NUCLEIC ACIDS RES, V18, P207, DOI 10.1093/nar/18.1.207; CLINE MG, 1989, THORAX, V44, P425, DOI 10.1136/thx.44.5.425; COLLEE JM, 1993, LANCET, V342, P936, DOI 10.1016/0140-6736(93)91988-X; COOKSON WOCM, 1988, LANCET, V1, P86; COOKSON WOCM, 1992, LANCET, V340, P381, DOI 10.1016/0140-6736(92)91468-N; COOKSON WOCM, 1989, LANCET, V1, P1292; DOHLMAN HG, 1987, BIOCHEMISTRY-US, V26, P2657, DOI 10.1021/bi00384a001; DOMBROWICZ D, 1993, CELL, V75, P969, DOI 10.1016/0092-8674(93)90540-7; ECCLESTON E, 1973, NATURE-NEW BIOL, V244, P73, DOI 10.1038/newbio244073b0; FERRIE RM, 1992, AM J HUM GENET, V51, P251; GALLI SJ, 1993, NEW ENGL J MED, V328, P257; GASCAN H, 1991, J EXP MED, V173, P747, DOI 10.1084/jem.173.3.747; GAUCHAT JF, 1993, NATURE, V365, P340, DOI 10.1038/365340a0; HALONEN M, 1992, AM REV RESPIR DIS, V146, P866, DOI 10.1164/ajrccm/146.4.866; HELM B, 1988, NATURE, V331, P180, DOI 10.1038/331180a0; HIZAWA N, 1992, CLIN EXP ALLERGY, V22, P1065, DOI 10.1111/j.1365-2222.1992.tb00131.x; HOLFORDSTREVENS V, 1984, J ALLERGY CLIN IMMUN, V73, P516, DOI 10.1016/0091-6749(84)90363-4; ISHIZAKA K, 1971, Clinical Allergy, V1, P9, DOI 10.1111/j.1365-2222.1971.tb02444.x; KINET JP, 1988, P NATL ACAD SCI USA, V85, P6483, DOI 10.1073/pnas.85.17.6483; KINET JP, 1985, BIOCHEMISTRY-US, V24, P7342, DOI 10.1021/bi00346a048; KUSTER H, 1992, J BIOL CHEM, V267, P12782; LYMPANY P, 1992, CLIN EXP ALLERGY, V22, P1085, DOI 10.1111/j.1365-2222.1992.tb00134.x; MAGNUSSON CGM, 1988, ALLERGY, V43, P241, DOI 10.1111/j.1398-9995.1988.tb00896.x; MARSH DG, 1982, J EXP MED, V155, P1439, DOI 10.1084/jem.155.5.1439; MAURER D, 1994, J EXP MED, V179, P745, DOI 10.1084/jem.179.2.745; METZGER H, 1991, CLIN EXP ALLERGY, V21, P269, DOI 10.1111/j.1365-2222.1991.tb01658.x; MOFFATT MF, 1992, CLIN EXP ALLERGY, V22, P1046, DOI 10.1111/j.1365-2222.1992.tb00128.x; MOFFATT MF, IN PRESS LANCET; OKSENBERG D, 1992, NATURE, V360, P161, DOI 10.1038/360161a0; OLIVER JM, 1988, PROG ALLERGY, V42, P185; PAUL WE, 1992, ADV IMMUNOL, V53, P1; PLAUT M, 1989, NATURE, V339, P64, DOI 10.1038/339064a0; RA C, 1989, J BIOL CHEM, V264, P15323; REES DC, 1989, SCIENCE, V245, P510, DOI 10.1126/science.2667138; RICH SS, 1992, CLIN EXP ALLERGY, V22, P1070, DOI 10.1111/j.1365-2222.1992.tb00132.x; SANDFORD AJ, 1993, LANCET, V341, P332, DOI 10.1016/0140-6736(93)90136-5; SHENKER A, 1993, NATURE, V365, P652, DOI 10.1038/365652a0; SHIRAKAWA T, IN PRESS CLIN GENET; SPORIK R, 1992, CLIN EXP ALLERGY, V22, P897, DOI 10.1111/j.1365-2222.1992.tb02062.x; STENIUS B, 1971, Clinical Allergy, V1, P37, DOI 10.1111/j.1365-2222.1971.tb02446.x; TEDDER TF, 1988, P NATL ACAD SCI USA, V85, P208, DOI 10.1073/pnas.85.1.208; THOMPSON HL, 1990, J CLIN INVEST, V85, P1227, DOI 10.1172/JCI114557; TOLLERUD DJ, 1991, AM REV RESPIR DIS, V144, P776, DOI 10.1164/ajrccm/144.4.776; VARINBLANK N, 1990, J BIOL CHEM, V265, P15685; WODNARFILIPOWICZ A, 1989, NATURE, V339, P150, DOI 10.1038/339150a0; WOOLCOCK AJ, 1987, THORAX, V42, P361, DOI 10.1136/thx.42.5.361; YOUNG RP, 1992, CLIN EXP ALLERGY, V22, P205, DOI 10.1111/j.1365-2222.1992.tb03074.x; YOUNG RP, 1992, J MED GENET, V29, P236, DOI 10.1136/jmg.29.4.236; YOUNG RP, IN PRESS CLIN ALLERG	56	352	370	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1994	7	2					125	130		10.1038/ng0694-125	http://dx.doi.org/10.1038/ng0694-125			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NQ037	7920628				2022-12-25	WOS:A1994NQ03700009
J	BONNET, D; PELET, A; LEGEAIMALLET, L; SIDI, D; MATHIEU, M; PARENT, P; PLAUCHU, H; SERVILLE, F; SCHINZEL, A; WEISSENBACH, J; KACHANER, J; MUNNICH, A; LYONNET, S				BONNET, D; PELET, A; LEGEAIMALLET, L; SIDI, D; MATHIEU, M; PARENT, P; PLAUCHU, H; SERVILLE, F; SCHINZEL, A; WEISSENBACH, J; KACHANER, J; MUNNICH, A; LYONNET, S			A GENE FOR HOLT-GRAM SYNDROME MAPS TO THE DISTAL LONG ARM OF CHROMOSOME-12	NATURE GENETICS			English	Article							ORAM SYNDROME; LINKAGE	Holt-Gram syndrome (HOS) is an autosomal dominant condition of unknown origin characterized by congenital septal heart defects with associated malformations of the upper limbs (radial ray). Here, we report on the mapping of a gene causing HOS to the distal long arm of chromosome 12 (12q21-qter) by linkage analysis in nine informative families (Z(max)=6.81 at theta=0 at the D12S354 locus). Also, multipoint linkage analysis places the HOS gene within the genetic interval between D12S84 and D12S79 (multipoint lodscore in log base 10=8.10). The mapping of a gene for HOS is, to our knowledge, the first chromosomal localization of a gene responsible for congenital septal heart defect in human. The characterization of the HOS gene will hopefully shed light on the molecular mechanisms that govern heart septation in the early stages of embryogenesis.	HOP ENFANTS MALAD,DEPT PEDIAT,F-75743 PARIS 15,FRANCE; HOP ENFANTS MALAD,UNITE RECH HANDICAPS GENET ENFANT,INSERM,U393,F-75743 PARIS 15,FRANCE; HOP NORD AMIENS,SERV PEDIAT,F-80054 AMIENS,FRANCE; HOP AUGUSTIN MORVAN,SERV PEDIAT,F-29285 BREST,FRANCE; HOP HOTEL DIEU,SERV GENET,F-69288 LYON 02,FRANCE; HOP PELLEGRIN,SERV GENET,F-33076 BORDEAUX,FRANCE; INST FUER MED GENET,CH-8001 ZURICH,SWITZERLAND; GENETHON,F-91002 EVRY,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; CHU Brest; Universite de Bretagne Occidentale; CHU Lyon; CHU Bordeaux			Legeai-Mallet, Laurence/E-6112-2016; Lyonnet, Stanislas/H-5483-2017	Legeai-Mallet, Laurence/0000-0003-4989-5856; PELET, Anastella/0000-0002-8353-1725; Lyonnet, Stanislas/0000-0001-5426-9417				CARTER TC, 1954, J GENET, V52, P1, DOI 10.1007/BF02981488; CRAIG I, 1992, CYTOGENET CELL GENET, V61, P244, DOI 10.1159/000133416; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; GLADSTONE I, 1982, CLIN GENET, V21, P98; HOLT M, 1960, BRIT HEART J, V22, P236; HURST JA, 1991, J MED GENET, V28, P406, DOI 10.1136/jmg.28.6.406; KAUFMAN RL, 1974, AM J DIS CHILD, V127, P21, DOI 10.1001/archpedi.1974.02110200023003; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEE B, 1991, NATURE, V352, P330, DOI 10.1038/352330a0; Lyon M., 1989, GENETIC VARIANTS STR; McKusick V.A., 1992, MENDELIAN INHERITANC; OCKEY CH, 1967, ARCH DIS CHILD, V42, P428, DOI 10.1136/adc.42.224.428; OTT J, 1985, VARIABILITY RECOMBIN, P112; RYBAK M, 1971, AM J DIS CHILD, V121, P490, DOI 10.1001/archpedi.1971.02100170072008; SEITE P, 1991, HUM GENET, V86, P585; SMITH AT, 1979, J PEDIATR-US, V95, P538, DOI 10.1016/S0022-3476(79)80758-1; TABAS JA, 1991, GENOMICS, V9, P283, DOI 10.1016/0888-7543(91)90254-C; TABAS JA, 1993, CLIN ORTHOP RELAT R, V293, P310; TEMTAMY SA, 1978, GENETICS HAND MALFOR, P73; THIESEN H-J, 1990, New Biologist, V2, P363; TURLEAU C, 1984, ANN GENET-PARIS, V27, P237; VIGNAL A, 1993, METHODS MOL GENETICS, V1, P211; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WILSON DI, 1992, LANCET, V340, P573, DOI 10.1016/0140-6736(92)92107-Q; YANG S, 1990, PEDIATR RES, V27, pA137	27	37	37	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1994	6	4					405	408		10.1038/ng0494-405	http://dx.doi.org/10.1038/ng0494-405			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ND870	8054983				2022-12-25	WOS:A1994ND87000022
J	GIDDINGS, SJ; KING, CD; HARMAN, KW; FLOOD, JF; CARNAGHI, LR				GIDDINGS, SJ; KING, CD; HARMAN, KW; FLOOD, JF; CARNAGHI, LR			ALLELE-SPECIFIC INACTIVATION OF INSULIN-1 AND INSULIN-2, IN THE MOUSE YOLK-SAC, INDICATES IMPRINTING	NATURE GENETICS			English	Article							GROWTH FACTOR-II; GENE-EXPRESSION; DEVELOPMENTAL REGULATION; RECEPTOR GENE; PREPROINSULIN; EVOLUTION; MEMBRANES; LINKAGE; REGION; LIVER	Genomic imprinting, gene inactivation during gametogenesis, causes maternal and paternal alleles of some genes to function unequally. We examined the possibility of imprinting in insulin genes because the human insulin gene (ins) and its mouse homologue (ins2) are adjacent to the known imprinted genes, igf2 and H19, and because imprinting has been implicated in the transmission of an ins linked risk for Type I diabetes. We show, by single strand conformational polymorphism (SSCP) analysis of cDNAs from parents and progeny of interspecies mouse crosses, that insulin genes are imprinted. While both alleles of the two mouse insulin genes were active in embryonic pancreas, only paternal alleles for both genes were active in the yolk sac.	ST LOUIS UNIV,SCH MED,ST LOUIS,MO 63106; WASHINGTON UNIV,SCH MED,DEPT INTERNAL MED,ST LOUIS,MO 63110	Saint Louis University; Washington University (WUSTL)	GIDDINGS, SJ (corresponding author), VET ADM MED CTR,915 N GRAND BLVD,ST LOUIS,MO 63106, USA.							BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DELTOUR L, 1993, P NATL ACAD SCI USA, V90, P527, DOI 10.1073/pnas.90.2.527; DEVASKAR SU, 1993, REGUL PEPTIDES, V48, P55, DOI 10.1016/0167-0115(93)90335-6; DONOHUE DL, 1948, J PEDIATR, V32, P739; EISEN MJ, 1973, P NATL ACAD SCI USA, V70, P3453; GIDDINGS SJ, 1989, J BIOL CHEM, V264, P9462; GIDDINGS SJ, 1990, MOL ENDOCRINOL, V4, P1363, DOI 10.1210/mend-4-9-1363; GIDDINGS SJ, 1992, MOL ENDOCRINOL, V6, P1665, DOI 10.1210/me.6.10.1665; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; KADOWAKI T, 1990, J CLIN INVEST, V86, P254, DOI 10.1172/JCI114693; KORANYI L, 1989, MOL ENDOCRINOL, V3, P1895, DOI 10.1210/mend-3-11-1895; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; LOMEDICO P, 1979, CELL, V18, P545, DOI 10.1016/0092-8674(79)90071-0; OMALLEY KL, 1988, NUCLEIC ACIDS RES, V16, P4437; ROTWEIN P, 1990, DNA CELL BIOL, V9, P725, DOI 10.1089/dna.1990.9.725; SASAKI H, 1992, GENE DEV, V6, P1843, DOI 10.1101/gad.6.10.1843; SOARES MB, 1985, MOL CELL BIOL, V5, P2090, DOI 10.1128/MCB.5.8.2090; STOGER R, 1993, KCELL, V73, P61; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; UNTERMAN T, 1986, DIABETES, V35, P1193, DOI 10.2337/diabetes.35.11.1193; WALKER MD, 1983, NATURE, V306, P557, DOI 10.1038/306557a0; WENTWORTH BM, 1986, J MOL EVOL, V23, P305, DOI 10.1007/BF02100639; ZEMEL S, 1992, NAT GENET, V2, P61, DOI 10.1038/ng0992-61	26	209	213	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1994	6	3					310	313		10.1038/ng0394-310	http://dx.doi.org/10.1038/ng0394-310			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ562	8012396				2022-12-25	WOS:A1994MZ56200021
J	SAUGIERVEBER, P; MUNNICH, A; BONNEAU, D; ROZET, JM; LEMERRER, M; GIL, R; BOESPFLUGTANGUY, O				SAUGIERVEBER, P; MUNNICH, A; BONNEAU, D; ROZET, JM; LEMERRER, M; GIL, R; BOESPFLUGTANGUY, O			X-LINKED SPASTIC PARAPLEGIA AND PELIZAEUS-MERZBACHER DISEASE ARE ALLELIC DISORDERS AT THE PROTEOLIPID PROTEIN LOCUS	NATURE GENETICS			English	Article							ANDROGEN RECEPTOR GENE; POINT MUTATION; LINKAGE MAP; CHROMOSOME; HETEROGENEITY; PLP; DELETION; FAMILY; REPEAT; MOUSE	Three forms of X-linked spastic paraplegia (SPG) have been defined. One locus (SPG 1) maps to Xq28 while two clinically distinct forms map to Xq22 (SPG2). A rare X-linked dysmyelinating disorder of the central nervous system, Pelizaeus-Merzbacher disease (PMD), has also been mapped to Xq21-q22, and is caused by mutations in the proteolipid protein gene (PLP) which encodes two myelin proteins, PLP and DM20. While narrowing the genetic interval containing SPG2 in a large pedigree, we found that PLP was the closest marker to the disease locus, implicating PLP as a possible candidate gene. We have found that a point mutation (His139Tyr) in exon 3B of an affected male produces a mutant PLP but a normal DM20,and segregates with the disease (Z(max)=6.63, theta=0.00). It appears, therefore, that SPG2 and PMD are allelic disorders.	INSERM,U393,UNITE RECH HANDICAPS GENET ENFANT,SERV GENET,F-75743 PARIS 15,FRANCE; HOP ENFANTS MALAD,INSERM,U383,UNITE RECH GENET CHROMOSOME & CANC,F-75743 PARIS 15,FRANCE; CHU POITIERS,F-86021 POITIERS,FRANCE; FAC MED CLERMONT FERRAND,INSERM,CJF 8806,BIOCHIM MED LAB,F-63001 CLERMONT FERRAND,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Poitiers; Universite de Poitiers; CHU Clermont Ferrand; Institut National de la Sante et de la Recherche Medicale (Inserm)			ROZET, Jean-Michel/E-5737-2016; Bonneau, Dominique/K-6110-2015	ROZET, Jean-Michel/0000-0001-7951-7886; 				APAK S, 1989, AM J MED GENET, V34, P155, DOI 10.1002/ajmg.1320340203; BARKER DF, 1992, NUCLEIC ACIDS RES, V20, P929, DOI 10.1093/nar/20.4.929-a; BLUMEL J, 1957, J PEDIATR-US, V50, P454, DOI 10.1016/S0022-3476(57)80255-8; BOESPFLUGTANGUY O, 1991, ANN NEUROL, V30, P450; BOISON D, 1989, EMBO J, V8, P3295, DOI 10.1002/j.1460-2075.1989.tb08490.x; BONNEAU D, 1993, J MED GENET, V30, P381, DOI 10.1136/jmg.30.5.381; BOULLOCHE J, 1986, J CHILD NEUROL, V1, P233, DOI 10.1177/088307388600100310; BRIDGE PJ, 1991, AM J HUM GENET, V49, P183; BROWN TR, 1988, P NATL ACAD SCI USA, V85, P8151, DOI 10.1073/pnas.85.21.8151; DAUTIGNY A, 1986, NATURE, V321, P867, DOI 10.1038/321867a0; DAVIES KE, 1991, CYTOGENET CELL GENET, V58, P853, DOI 10.1159/000133183; DIEHL HJ, 1986, P NATL ACAD SCI USA, V83, P9807, DOI 10.1073/pnas.83.24.9807; DOLL R, 1992, AM J HUM GENET, V51, P161; FAIN PR, 1991, GENOMICS, V11, P1155, DOI 10.1016/0888-7543(91)90045-G; GENCIC S, 1990, J NEUROSCI, V10, P117; GENCIC S, 1989, AM J HUM GENET, V45, P435; GINTER DN, 1974, BIRTH DEFECTS ORIG A, V10, P334; GOLDBLATT J, 1989, CLIN GENET, V35, P116; HALLASSOS A, 1989, NUCLEIC ACIDS RES, V17, P3606; HARDING AE, 1983, LANCET, V1, P1151; HAZAN J, 1992, GENOMICS, V12, P183, DOI 10.1016/0888-7543(92)90364-X; HUANG THM, 1992, GENOMICS, V13, P375, DOI 10.1016/0888-7543(92)90256-R; HUDSON LD, 1989, P NATL ACAD SCI USA, V86, P8128, DOI 10.1073/pnas.86.20.8128; IWAKI A, 1993, HUM MOL GENET, V2, P19, DOI 10.1093/hmg/2.1.19; JOHNSTON AW, 1962, AM J HUM GENET, V14, P83; KENWRICK S, 1986, HUM GENET, V73, P264, DOI 10.1007/BF00401241; KEPPEN LD, 1987, AM J HUM GENET, V41, P933; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LUTY JA, 1990, AM J HUM GENET, V46, P776; MCCLATCHEY AI, 1992, AM J HUM GENET, V50, P896; McKusick V.A., 1992, MENDELIAN INHERITANC; Merzbacher L., 1910, Z F R GESAMTE NEUROL, V3, P1, DOI [10.1007/BF02893591, DOI 10.1007/BF02893591]; METTEY R, 1981, J GENET HUM, V29, P3227; NADON NL, 1990, DEVELOPMENT, V110, P529; NAVE KA, 1987, J NEUROCHEM, V49, P1873, DOI 10.1111/j.1471-4159.1987.tb02449.x; PHAMDINH D, 1993, HUM MOL GENET, V2, P465, DOI 10.1093/hmg/2.4.465; PHAMDINH D, 1991, P NATL ACAD SCI USA, V88, P7562, DOI 10.1073/pnas.88.17.7562; PRATT VM, 1991, AM J MED GENET, V38, P136, DOI 10.1002/ajmg.1320380129; PRATT VM, 1993, AM J HUM GENET, V52, P1053; RASKIND WH, 1991, AM J HUM GENET, V49, P1355; ROA BB, 1993, NAT GENET, V5, P269, DOI 10.1038/ng1193-269; ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881; SCHINDLER P, 1990, J NEUROCHEM, V55, P2079, DOI 10.1111/j.1471-4159.1990.tb05798.x; SCHNEIDER A, 1992, NATURE, V358, P758, DOI 10.1038/358758a0; SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184; STRAUTNIEKS S, 1992, AM J HUM GENET, V51, P871; SUTER U, 1993, TRENDS NEUROSCI, V16, P50, DOI 10.1016/0166-2236(93)90015-E; Thurmon T F, 1971, Birth Defects Orig Artic Ser, V7, P219; TIMSIT SG, 1992, J NEUROCHEM, V58, P1172, DOI 10.1111/j.1471-4159.1992.tb09378.x; TROFATTER JA, 1991, NUCLEIC ACIDS RES, V19, P6057, DOI 10.1093/nar/19.21.6057-a; TROFATTER JA, 1989, P NATL ACAD SCI USA, V86, P9427, DOI 10.1073/pnas.86.23.9427; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; WILLARD HF, 1985, SCIENCE, V230, P940, DOI 10.1126/science.3840606; ZATZ M, 1976, J MED GENET, V13, P217, DOI 10.1136/jmg.13.3.217; ZHANG YL, 1993, NAT GENET, V5, P46, DOI 10.1038/ng0993-46	57	292	294	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1994	6	3					257	262		10.1038/ng0394-257	http://dx.doi.org/10.1038/ng0394-257			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ562	8012387				2022-12-25	WOS:A1994MZ56200012
J	VELINOV, M; SLAUGENHAUPT, SA; STOILOV, I; SCOTT, CI; GUSELLA, JF; TSIPOURAS, P				VELINOV, M; SLAUGENHAUPT, SA; STOILOV, I; SCOTT, CI; GUSELLA, JF; TSIPOURAS, P			THE GENE FOR ACHONDROPLASIA MAPS TO THE TELOMERIC REGION OF CHROMOSOME 4P	NATURE GENETICS			English	Article							L-IDURONIDASE GENE; HOMOZYGOUS ACHONDROPLASIA; CANDIDATE REGION; II COLLAGEN; LOCUS; IDENTIFICATION; LOCALIZATION; POLYMORPHISM; CARTILAGE; MARKERS	Achondroplasia is the most common type of genetic dwarfism. It is characterized by disproportionate short stature and other skeletal anomalies resulting from a defect in the maturation of the chondrocytes in the growth plate of the cartilage. We have now mapped the achondroplasia gene near the telomere of the short arm of chromosome 4 (4p16.3), by family linkage studies using 14 pedigrees. A positive lod score of z=3.35 with no recombinants was obtained with an intragenic marker for IDUA. This localization wilt facilitate the positional cloning of the disease gene.	UNIV CONNECTICUT,CTR HLTH,DEPT PEDIAT,FARMINGTON,CT 06030; MASSACHUSETTS GEN HOSP,MOLEC NEUROGENET UNIT,BOSTON,MA 02129; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA; ALFRED I DUPONT INST,DIV MED GENET,WILMINGTON,DE 19899	University of Connecticut; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Nemours Alfred I. duPont Hospital for Children								ALITTO BA, 1992, MOL CELL PROBE, V6, P513; Ambrose Christine, 1992, Human Molecular Genetics, V1, P697, DOI 10.1093/hmg/1.9.697; Collins Colin, 1992, Human Molecular Genetics, V1, P727; CORDONE M, 1993, PRENATAL DIAG, V13, P395, DOI 10.1002/pd.1970130512; DUYAO MP, 1993, HUM MOL GENET, V2, P673, DOI 10.1093/hmg/2.6.673; FINKELSTEIN JE, 1991, AM J HUM GENET, V48, P97; FRANCOMANO CA, 1988, AM J MED GENET, V29, P955, DOI 10.1002/ajmg.1320290433; GANDELMAN KY, 1992, AM J HUM GENET, V51, P571; HECHT JT, 1987, AM J HUM GENET, V41, P454; LANDER E, 1987, P NATL ACAD SCI USA, V85, P2363; LANGER LO, 1993, AM J MED GENET, V47, P772, DOI 10.1002/ajmg.1320470535; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LIN CS, 1991, SOMAT CELL MOLEC GEN, V17, P481, DOI 10.1007/BF01233172; LOCKE PA, 1993, SOMAT CELL MOLEC GEN, V19, P95, DOI 10.1007/BF01233958; MACDONALD ME, 1991, SOMAT CELL MOLEC GEN, V17, P421, DOI 10.1007/BF01233067; MAGENIS RE, 1986, AM J HUM GENET, V39, P383; MCKUSICK VA, 1973, J MED GENET, V10, P11, DOI 10.1136/jmg.10.1.11; MURRAY J, 1993, COOPERATIVE HUMAN LI, V1; OGILVIE D, 1986, J MED GENET, V23, P19, DOI 10.1136/jmg.23.1.19; ORIOLI IM, 1986, J MED GENET, V23, P328, DOI 10.1136/jmg.23.4.328; Padanilam B. J., 1992, Human Molecular Genetics, V1, P407, DOI 10.1093/hmg/1.6.407; PAULI RM, 1983, AM J MED GENET, V16, P459, DOI 10.1002/ajmg.1320160404; PEDRINIMILLE A, 1982, J BONE JOINT SURG AM, V64, P39, DOI 10.2106/00004623-198264010-00007; PETERS K, 1993, DEV BIOL, V155, P423, DOI 10.1006/dbio.1993.1040; SCHINZEL A, 1984, CATALOGUE UNBALANCED, P161; SCOTT, 1988, CIBA GEIGY CLIN S, V40, P3; SCOTT HS, 1992, GENOMICS, V14, P1118, DOI 10.1016/S0888-7543(05)80145-4; SCOTT HS, 1990, AM J HUM GENET, V47, P802; SCOTT HS, 1993, AM J HUM GENET, V53, P973; STADLER HS, 1992, P NATL ACAD SCI USA, V89, P11579, DOI 10.1073/pnas.89.23.11579; STANESCU R, 1990, AM J MED GENET, V37, P412, DOI 10.1002/ajmg.1320370323; SWEETMAN WA, 1992, AM J HUM GENET, V51, P841; Taylor S. A. M., 1992, Human Molecular Genetics, V1, P142, DOI 10.1093/hmg/1.2.142-a; TAYLOR SAM, 1992, NAT GENET, V2, P223, DOI 10.1038/ng1192-223; THOMPSON LM, 1991, GENOMICS, V11, P1133, DOI 10.1016/0888-7543(91)90041-C; TOMMERUP N, 1993, HUM MOL GENET, V2, P1571, DOI 10.1093/hmg/2.10.1571; VIGNAL A, 1993, METHODS MOL GENETICS, V1, P211; WANG H, 1986, AM J HUM GENET, V39, P393; WEBER B, 1991, NUCLEIC ACIDS RES, V19, P6263, DOI 10.1093/nar/19.22.6263; WEBER B, 1992, AM J HUM GENET, V47, P382; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	41	87	88	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1994	6	3					314	317		10.1038/ng0394-314	http://dx.doi.org/10.1038/ng0394-314			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MZ562	8012397				2022-12-25	WOS:A1994MZ56200022
J	GALILI, N; DAVIS, RJ; FREDERICKS, WJ; MUKHOPADHYAY, S; RAUSCHER, FJ; EMANUEL, BS; ROVERA, G; BARR, FG				GALILI, N; DAVIS, RJ; FREDERICKS, WJ; MUKHOPADHYAY, S; RAUSCHER, FJ; EMANUEL, BS; ROVERA, G; BARR, FG			FUSION OF A FORK HEAD DOMAIN GENE TO PAX3 IN THE SOLID TUMOR ALVEOLAR RHABDOMYOSARCOMA	NATURE GENETICS			English	Article							TRANSCRIPTION FACTORS; PROTEIN; ENCODES; FAMILY	We have examined the structure and expression of the products associated with the t(2;13)(q35;q14) translocation associated with alveolar rhabdomyosarcoma. The chromosome 13 gene (FKHR) is identified as a member of the fork head domain family of transcription factors characterized by a conserved DNA binding motif. Polymerase chain reaction analysis demonstrates that a 5' PAX3-3' FKHR chimaeric transcript is expressed in all eight alveolar rhabdomyosarcomas investigated. Immunoprecipitation experiments detect the predicted fusion protein. These findings indicate that the t(2;13) generates a potentially tumorigenic fusion transcription factor consisting of intact PAX3 DNA binding domains, a truncated fork head DNA binding domain and C-terminal FKHR regions.	UNIV PENN,SCH MED,DEPT PATHOL & LAB MED,PHILADELPHIA,PA 19104; WISTAR INST ANAT & BIOL,PHILADELPHIA,PA 19104; CHILDRENS HOSP,DIV HUMAN GENET & MOLEC BIOL,PHILADELPHIA,PA 19104	University of Pennsylvania; The Wistar Institute; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia			Davis, Roger/GWR-3631-2022	Davis, Roger/0000-0002-4926-3413				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BARR FG, 1993, NAT GENET, V3, P113, DOI 10.1038/ng0293-113; BARR FG, 1992, GENOMICS, V13, P1150, DOI 10.1016/0888-7543(92)90030-V; BURRI M, 1989, EMBO J, V8, P1183, DOI 10.1002/j.1460-2075.1989.tb03490.x; CLEVIDENCE DE, 1993, P NATL ACAD SCI USA, V90, P3948, DOI 10.1073/pnas.90.9.3948; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; GROSSNIKLAUS U, 1992, GENE DEV, V6, P1030, DOI 10.1101/gad.6.6.1030; HACKER U, 1992, P NATL ACAD SCI USA, V89, P8754, DOI 10.1073/pnas.89.18.8754; HAN KY, 1993, GENE DEV, V7, P491, DOI 10.1101/gad.7.3.491; HOTH CF, 1993, AM J HUM GENET, V52, P455; KOZAK M, 1991, J BIOL CHEM, V266, P19867; LAI E, 1990, GENE DEV, V4, P1427, DOI 10.1101/gad.4.8.1427; LAI E, 1991, GENE DEV, V5, P416, DOI 10.1101/gad.5.3.416; LI J, 1993, P NATL ACAD SCI USA, V90, P4490, DOI 10.1073/pnas.90.10.4490; MACDONALD RJ, 1987, METHOD ENZYMOL, V152, P219; MAULBECKER CC, 1993, EMBO J, V12, P2361, DOI 10.1002/j.1460-2075.1993.tb05890.x; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; PANI L, 1992, MOL CELL BIOL, V12, P3723, DOI 10.1128/MCB.12.9.3723; RABBITTS TH, 1993, NAT GENET, V4, P175, DOI 10.1038/ng0693-175; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; SANDBERG AA, 1990, CHROMOSOMES HUMAN CA; SASAKI H, 1993, DEVELOPMENT, V118, P47; TAU W, 1992, NEURON, V8, P957; WEIGEL D, 1990, CELL, V63, P455, DOI 10.1016/0092-8674(90)90439-L; WEIGEL D, 1989, CELL, V57, P645, DOI 10.1016/0092-8674(89)90133-5	29	758	784	0	14	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1993	5	3					230	235		10.1038/ng1193-230	http://dx.doi.org/10.1038/ng1193-230			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MF122	8275086				2022-12-25	WOS:A1993MF12200011
J	STRONG, TV; TAGLE, DA; VALDES, JM; ELMER, LW; BOEHM, K; SWAROOP, M; KAATZ, KW; COLLINS, FS; ALBIN, RL				STRONG, TV; TAGLE, DA; VALDES, JM; ELMER, LW; BOEHM, K; SWAROOP, M; KAATZ, KW; COLLINS, FS; ALBIN, RL			WIDESPREAD EXPRESSION OF THE HUMAN AND RAT HUNTINGTONS-DISEASE GENE IN BRAIN AND NONNEURAL TISSUES	NATURE GENETICS			English	Article							STRIATAL PROJECTION NEURONS	We have used RNA in situ hybridization to study the regional expression of the Huntington's disease gene (HD) and its rat homologue in brain and selected nonneural tissues. The HD transcript was expressed throughout the brain in both rat and human, especially in the neurons of the dentate gyrus and pyramidal neurons of the hippocampal formation, cerebellar granule cell layer, cerebellar Purkinje cells and pontine nuclei. Other brain areas expressed lower levels of the HD transcript without pronounced regional differences. Neuronal expression predominated over glial expression in all regions. HD mRNA was also expressed in colon, liver, pancreas and testes. The regional specificity of neuropathology in HD, which is most prominent in the basal ganglia, thus cannot be accounted for by the pattern of expression of HD.	UNIV MICHIGAN, DEPT INTERNAL MED, DIV MOLEC MED & GENET, 4570 MSRB II, ANN ARBOR, MI 48109 USA; NIH, NATL CTR HUMAN GENOME RES, BETHESDA, MD 20892 USA; UNIV MICHIGAN, DEPT NEUROL, ANN ARBOR, MI 48104 USA; UNIV MICHIGAN, DEPT HUMAN GENET, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, CELL & MOLEC BIOL PROGRAM, ANN ARBOR, MI 48109 USA	University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan			Strong, Theresa/GSM-6652-2022	Strong, Theresa/0000-0001-6783-8703; Kaatz, Kevin/0000-0002-7890-4865; Swaroop, Manju/0000-0002-0576-1664	NHGRI NIH HHS [HG 00067-01] Funding Source: Medline; NINDS NIH HHS [NS 01300, NS 19613] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG000067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS019613, K08NS001300] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBIN RL, 1990, NEW ENGL J MED, V322, P1293, DOI 10.1056/NEJM199005033221807; BEAL MF, 1992, ANN NEUROL, V31, P119, DOI 10.1002/ana.410310202; DAWBARN D, 1985, BRAIN RES, V340, P251, DOI 10.1016/0006-8993(85)90921-7; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DIFIGLIA M, 1990, TRENDS NEUROSCI, V13, P286, DOI 10.1016/0166-2236(90)90111-M; FERRANTE RJ, 1987, BRAIN RES, V411, P162, DOI 10.1016/0006-8993(87)90694-9; FERRANTE RJ, 1985, SCIENCE, V230, P561, DOI 10.1126/science.2931802; FOLSTEIN SE, 1989, HUNTINGTONS DISEASE; FU YH, 1993, SCIENCE, V260, P235, DOI 10.1126/science.8469976; HARRINGTON KM, 1991, J NEUROPATH EXP NEUR, V50, P309; HIRSCH EC, 1989, NEUROSCI LETT, V96, P145, DOI 10.1016/0304-3940(89)90048-7; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MORRIS M, 1991, HUNTINGTONS DIS, P81; MYERS RH, 1989, AM J HUM GENET, V45, P615; QUARREL O, 1991, HUNTINGTONS DISEASE, P37; QUARREL O, 1991, HUNTINGTONS DISEASE, P141; REINER A, 1988, P NATL ACAD SCI USA, V85, P5733, DOI 10.1073/pnas.85.15.5733; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SABOURI LA, 1993, NAT GENET, V4, P233, DOI 10.1038/ng0793-233; Sambrook J, 1989, MOL CLONING LABORATO; STRONG TV, IN PRESS J CLIN INVE; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; WEXLER NS, 1987, NATURE, V326, P194, DOI 10.1038/326194a0	23	328	336	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1993	5	3					259	265		10.1038/ng1193-259	http://dx.doi.org/10.1038/ng1193-259			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MF122	8275091				2022-12-25	WOS:A1993MF12200016
J	VINCENT, N; RAGOT, T; GILGENKRANTZ, H; COUTON, D; CHAFEY, P; GREGOIRE, A; BRIAND, P; KAPLAN, JC; KAHN, A; PERRICAUDET, M				VINCENT, N; RAGOT, T; GILGENKRANTZ, H; COUTON, D; CHAFEY, P; GREGOIRE, A; BRIAND, P; KAPLAN, JC; KAHN, A; PERRICAUDET, M			LONG-TERM CORRECTION OF MOUSE DYSTROPHIC DEGENERATION BY ADENOVIRUS-MEDIATED TRANSFER OF A MINIDYSTROPHIN GENE	NATURE GENETICS			English	Article							LINKED MUSCULAR-DYSTROPHY; MDX MOUSE; MICE; EXPRESSION; PHENOTYPE; INJECTION; MUSCLES; LOCUS; DNA	Duchenne muscular dystrophy (DMD) is a fatal progressive X-linked muscle disorder, caused by mutations in the dystrophin gene. We have investigated adenovirus-mediated transfer of a dystrophin minigene in a mutant mouse lacking dystrophin, the mdx mouse. We report here that six months after a single intramuscular injection of a recombinant adenovirus containing a human dystrophin minigene, a large number of dystrophin-positive fibres are still detected in the injected muscles. Moreover, although the minigene encodes a truncated protein, its expression is able to protect the fibres efficiently against the degeneration process that affects the dystrophin-deficient mdx myofibres.	INST GUSTAVE ROUSSY,CNRS,URA 1301,F-94805 VILLEJUIF,FRANCE; ICGM,INSERM,CJF 9003,F-75014 PARIS,FRANCE	Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	VINCENT, N (corresponding author), INST COCHIN GENET MOLEC,INSERM,UNITE 129,24 RUE FAUBOURG ST JACQUES,F-75014 PARIS,FRANCE.		Gilgenkrantz, Helene/G-5534-2017	gilgenkrantz, helene/0000-0001-6770-4561				ACSADI G, 1991, NATURE, V352, P815, DOI 10.1038/352815a0; AKLI S, 1993, NAT GENET, V3, P224, DOI 10.1038/ng0393-224; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; CARTAUD A, 1992, TORPEDO MAMORATA NEU, V48, P995; COOPER BJ, 1988, NATURE, V334, P154, DOI 10.1038/334154a0; DAVIS HL, 1993, HUM GENE THER, V4, P151, DOI 10.1089/hum.1993.4.2-151; DUBOWITZ V, 1992, NEUROMUSCULAR DISORD, V2, P305, DOI 10.1016/S0960-8966(06)80001-5; DUNCKLEY MG, 1993, HUM MOL GENET, V2, P717, DOI 10.1093/hmg/2.6.717; Emery A, 1988, DUCHENNE MUSCULAR DY; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; Gluzman Y., 1982, EUKARYOTIC VIRAL VEC, P187; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1990, J NEUROL SCI, V99, P9, DOI 10.1016/0022-510X(90)90195-S; HUARD J, 1992, TRANSPLANT P, V24, P3049; HUGNOT JP, 1992, P NATL ACAD SCI USA, V89, P7506, DOI 10.1073/pnas.89.16.7506; JIAO SS, 1992, HUM GENE THER, V3, P21, DOI 10.1089/hum.1992.3.1-21; MCGEACHIE JK, 1992, DUCHENNE MUSCULAR DYSTROPHY, P189; MORGAN JE, 1990, J CELL BIOL, V111, P2437, DOI 10.1083/jcb.111.6.2437; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; RAGOT T, 1993, NATURE, V361, P647, DOI 10.1038/361647a0; SHENK T, 1984, CURR TOP MICROBIOL, V111, P1; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; STRATFORDPERRICAUDET LD, 1992, J CLIN INVEST, V90, P626, DOI 10.1172/JCI115902; WELLS DJ, 1992, HUM MOL GENET, V1, P35	25	194	234	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1993	5	2					130	134		10.1038/ng1093-130	http://dx.doi.org/10.1038/ng1093-130			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MA056	8252038				2022-12-25	WOS:A1993MA05600009
J	POLYMEROPOULOS, MH; XIAO, H; SIKELA, JM; ADAMS, M; VENTER, JC; MERRIL, CR				POLYMEROPOULOS, MH; XIAO, H; SIKELA, JM; ADAMS, M; VENTER, JC; MERRIL, CR			CHROMOSOMAL DISTRIBUTION OF 320 GENES FROM A BRAIN CDNA LIBRARY	NATURE GENETICS			English	Article							HUMAN GENOME; ASSIGNMENT; MAP	We have determined the chromosomal assignment of 320 brain expressed genes by studying the segregation of polymerase chain reaction (PCR) products in human rodent somatic cell hybrids and by genetically mapping polymorphic cDNAs using the CEPH (Centre d'Etude du Polymophisme Humaine) reference pedigrees and database. These mapped genes can function as markers on the physical map of the human genome, as well as serve as candidate disease gene loci. Distribution of these genes to the human chromosomes correlates well with the GC content of the chromosomes. However, the distribution of these genes does not correlate well with the cytogenetic length of each chromosome.	UNIV COLORADO,HLTH SCI CTR,DENVER,CO 80262; INST GENOM RES,GAITHERSBURG,MD 20878	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; J. Craig Venter Institute	POLYMEROPOULOS, MH (corresponding author), NIMH,BIOCHEM GENET LAB,CTR NEUROSCI,WASHINGTON,DC 20032, USA.							ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; BERNARDI G, 1988, J MOL EVOL, V28, P7, DOI 10.1007/BF02143493; BERNARDI G, 1985, SCIENCE, V228, P953, DOI 10.1126/science.4001930; BERNARDI G, 1989, ANNU REV GENET, V23, P637, DOI 10.1146/annurev.genet.23.1.637; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; KHAN AS, 1992, NAT GENET, V2, P180, DOI 10.1038/ng1192-180; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MOUCHIROUD D, 1991, GENE, V100, P181, DOI 10.1016/0378-1119(91)90364-H; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; POLYMEROPOULOS MH, 1992, GENOMICS, V12, P492, DOI 10.1016/0888-7543(92)90439-Y; ROMANI M, 1990, GENE, V95, P231, DOI 10.1016/0378-1119(90)90366-Y; SACCONE S, 1992, P NATL ACAD SCI USA, V89, P4913, DOI 10.1073/pnas.89.11.4913; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WILCOX AS, 1991, NUCLEIC ACIDS RES, V19, P1837, DOI 10.1093/nar/19.8.1837; 1993, CELL, V72, P971	19	88	88	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1993	4	4					381	386		10.1038/ng0893-381	http://dx.doi.org/10.1038/ng0893-381			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LQ178	8401586				2022-12-25	WOS:A1993LQ17800016
J	SENA, EP; ZARLING, DA				SENA, EP; ZARLING, DA			TARGETING IN LINEAR DNA DUPLEXES WITH 2 COMPLEMENTARY PROBE STRANDS FOR HYBRID STABILITY	NATURE GENETICS			English	Article							TRIPLE-HELIX FORMATION; COLI RECA PROTEIN; ATP-GAMMA-S; ESCHERICHIA-COLI; GENETIC-RECOMBINATION; 3-STRANDED DNA; CLEAVAGE; COMPLEXES; ENDONUCLEASE; PURIFICATION	A new in vitro hybridization reaction targets two short complementary RecA protein-coated DNA probes to homologous sequences at any position in a linear duplex DNA molecule. Stable hybrids are obtained after RecA protein removal when both complementary probe strands are present in a four-stranded hybrid, but not when one probe strand is present in a three-stranded hybrid. In four-stranded hybrids with one probe strand biotinylated and the other radiolabelled, the deproteinized hybrids can be isolated and detected by affinity capture on streptavidin-coated magnetic beads. RecA-mediated targeting of complementary biotinylated DNA probe strands allows the affinity capture of 48.5-kilobase duplex lambda genomic DNA. These reactions provide a means of isolating any desired duplex gene or chromosomal DNA fragment.	UNIV CALIF SAN FRANCISCO, DEPT LAB MED, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco	SENA, EP (corresponding author), SRI INT, DIV LIFE SCI, CELL & MOLEC BIOL LAB, MENLO PK, CA 94025 USA.							BALDARI CT, 1978, CELL, V15, P1095, DOI 10.1016/0092-8674(78)90293-3; BEAL PA, 1991, SCIENCE, V251, P1360, DOI 10.1126/science.2003222; BREWER BJ, 1988, CANCER CELL, V6, P229; CHENG S, 1988, J BIOL CHEM, V263, P15110; COREY DR, 1987, SCIENCE, V238, P1401, DOI 10.1126/science.3685986; EGELMAN EH, 1988, J MOL BIOL, V200, P329, DOI 10.1016/0022-2836(88)90245-8; EGELMAN EH, 1986, J MOL BIOL, V191, P677, DOI 10.1016/0022-2836(86)90453-5; FERRIN LJ, 1991, SCIENCE, V254, P1494, DOI 10.1126/science.1962209; FREDERICK CA, 1984, NATURE, V309, P327, DOI 10.1038/309327a0; GRIFFITH J, 1985, BIOCHEMISTRY-US, V24, P158, DOI 10.1021/bi00322a022; HOWARDFLANDERS P, 1984, NATURE, V309, P215, DOI 10.1038/309215a0; HSIEH P, 1990, GENE DEV, V4, P1951, DOI 10.1101/gad.4.11.1951; ITO T, 1992, P NATL ACAD SCI USA, V89, P495, DOI 10.1073/pnas.89.2.495; JAIN SK, 1992, J BIOL CHEM, V267, P4215; KRIEGSTEIN HJ, 1974, P NATL ACAD SCI USA, V71, P135, DOI 10.1073/pnas.71.1.135; LEAHY MC, 1986, J BIOL CHEM, V261, P6954; LINDSLEY JE, 1990, J BIOL CHEM, V265, P10164; MCENTEE K, 1979, P NATL ACAD SCI USA, V76, P2615, DOI 10.1073/pnas.76.6.2615; MCENTEE K, 1981, J BIOL CHEM, V256, P8835; MCGAVIN S, 1971, J MOL BIOL, V55, P293, DOI 10.1016/0022-2836(71)90201-4; MOSER HE, 1987, SCIENCE, V238, P645, DOI 10.1126/science.3118463; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; QUARTIN RS, 1989, BIOCHEMISTRY-US, V28, P8676, DOI 10.1021/bi00448a002; RAO BJ, 1991, P NATL ACAD SCI USA, V88, P2984, DOI 10.1073/pnas.88.8.2984; REGISTER JC, 1985, J BIOL CHEM, V260, P2308; RIGAS B, 1986, P NATL ACAD SCI USA, V83, P9591, DOI 10.1073/pnas.83.24.9591; ROCA AI, 1990, CRIT REV BIOCHEM MOL, V25, P415, DOI 10.3109/10409239009090617; SAMBROOK J, 1989, MOL CONING; SCHLESSINGER D, 1990, TRENDS GENET, V6, P248, DOI 10.1016/0168-9525(90)90207-M; SHIBATA T, 1981, J BIOL CHEM, V256, P7557; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P1638, DOI 10.1073/pnas.76.4.1638; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; STROBEL SA, 1991, SCIENCE, V254, P1639, DOI 10.1126/science.1836279; STROBEL SA, 1988, J AM CHEM SOC, V110, P7927, DOI 10.1021/ja00231a082; TAKASHI I, 1992, NUCLEIC ACIDS RES, V20, P3524; UHLIN BE, 1981, J BACTERIOL, V148, P386, DOI 10.1128/JB.148.1.386-390.1981; UMLAUF SW, 1990, J BIOL CHEM, V265, P16898; WEINSTOCK PH, 1990, NUCLEIC ACIDS RES, V18, P4207, DOI 10.1093/nar/18.14.4207; WILSON JH, 1979, P NATL ACAD SCI USA, V76, P3641, DOI 10.1073/pnas.76.8.3641	40	28	37	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1993	3	4					365	372		10.1038/ng0493-365	http://dx.doi.org/10.1038/ng0493-365			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KW257	7981759				2022-12-25	WOS:A1993KW25700021
J	CHELLY, J; TUMER, Z; TONNESEN, T; PETTERSON, A; ISHIKAWABRUSH, Y; TOMMERUP, N; HORN, N; MONACO, AP				CHELLY, J; TUMER, Z; TONNESEN, T; PETTERSON, A; ISHIKAWABRUSH, Y; TOMMERUP, N; HORN, N; MONACO, AP			ISOLATION OF A CANDIDATE GENE FOR MENKES DISEASE THAT ENCODES A POTENTIAL HEAVY-METAL BINDING-PROTEIN	NATURE GENETICS			English	Article							AUREUS PLASMID PI258; NUCLEOTIDE-SEQUENCE; CADMIUM RESISTANCE; X-CHROMOSOME; TRANSLOCATION; SEARCH; EFFLUX	Menkes disease is a lethal-X linked recessive disorder associated with copper metabolism disturbance. We have recently mapped two chromosome breakpoints related to this disease in a 1 megabase yeast artificial chromosome contig at Xq13.3. We now report the construction of a phage contig and the isolation of candidate partial cDNAs for the Menkes disease gene. The candidate gene expresses an 8 kb message in all investigated tissues, and deletions were detected in 16% of 100 unrelated Menkes patients. The deduced partial protein sequence shared the GMTCXXC motif with bacterial metal resistance operons, suggesting a potential heavy metal binding protein. These findings should lead to more accurate prenatal diagnosis of this severe disease and a better understanding of the cellular homeostasis of essential heavy metals.	JOHN RADCLIFFE HOSP,INST MOLEC MED,ICRF LABS,OXFORD OX3 9DU,ENGLAND; DANISH CTR HUMAN GENOME RES,DK-2600 GLOSTRUP,DENMARK; JOHN F KENNEDY INST,GLOSTRUP,DENMARK	University of Oxford; Aarhus University			Tommerup, Niels/T-8776-2017; Monaco, Anthony P/A-4495-2010; Tumer, Zeynep/AAF-8501-2019; Tümer, Zeynep/C-4235-2014; Chelly, Jamel/J-7528-2015	Tommerup, Niels/0000-0003-2304-0112; Monaco, Anthony P/0000-0001-7480-3197; Tumer, Zeynep/0000-0002-4777-5802; Chelly, Jamel/0000-0002-0939-8719				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BROWN NL, 1983, BIOCHEMISTRY-US, V22, P4089, DOI 10.1021/bi00286a015; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DANKS DM, 1989, METABOLIC BASIS INHE, P1422; DAVIES KE, 1991, CYTOGENET CELL GENET, V58, P853, DOI 10.1159/000133183; DAVISSON M T, 1987, Genomics, V1, P213, DOI 10.1016/0888-7543(87)90047-4; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GRAEBER MB, IN PRESS HUM GENET; HERD SM, 1987, BIOCHEM J, V247, P341, DOI 10.1042/bj2470341; HORN N, 1992, BRAIN PATHOL, V2, P351, DOI 10.1111/j.1750-3639.1992.tb00711.x; HORN N, 1984, ANN HUM GENET, V48, P161, DOI 10.1111/j.1469-1809.1984.tb01011.x; HORN N, 1984, METABOLISM TRACE MET, P25; INOUE C, 1991, MOL MICROBIOL, V5, P2707, DOI 10.1111/j.1365-2958.1991.tb01979.x; KAHN D, 1989, J BACTERIOL, V171, P929, DOI 10.1128/jb.171.2.929-939.1989; KAPUR S, 1987, AM J MED GENET, V26, P503, DOI 10.1002/ajmg.1320260230; KORN ED, 1978, P NATL ACAD SCI USA, V75, P588, DOI 10.1073/pnas.75.2.588; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LADDAGA RA, 1987, P NATL ACAD SCI USA, V84, P5106, DOI 10.1073/pnas.84.15.5106; MENKES JH, 1962, PEDIATRICS, V29, P764; MONACO AP, 1985, NATURE, V316, P842, DOI 10.1038/316842a0; NOOJEN JL, 1981, PEDIATR RES, V15, P284; NUCIFORA G, 1989, P NATL ACAD SCI USA, V86, P3544, DOI 10.1073/pnas.86.10.3544; Sambrook J, 1989, MOL CLONING LABORATO; SCHEINBERG IH, 1989, LANCET, V1, P619; SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0; SILVER S, 1992, MICROBIOL REV, V56, P195, DOI 10.1128/MMBR.56.1.195-228.1992; TENNESEN T, 1992, AM J HUM GENET, V50, P1012; TONNESEN T, 1989, J INHERIT METAB DIS, V12, P207, DOI 10.1007/BF01799296; TURNER Z, 1992, HUM GENET, V88, P668; TURNER Z, 1992, HUM MOL GENET, V1, P483; VERGA V, 1991, AM J HUM GENET, V48, P1133; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; WIEACKER P, 1983, HUM GENET, V64, P139, DOI 10.1007/BF00327110; WIENKER TF, 1983, HUM GENET, V65, P72, DOI 10.1007/BF00285032; YANG HM, 1990, CLIN GENET, V38, P94; YAZAKI M, 1981, Nagoya Medical Journal, V25, P169; YOON KP, 1991, J BACTERIOL, V173, P7636, DOI 10.1128/jb.173.23.7636-7642.1991	38	621	630	0	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1993	3	1					14	19		10.1038/ng0193-14	http://dx.doi.org/10.1038/ng0193-14			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KF372	8490646				2022-12-25	WOS:A1993KF37200006
J	Bruce, AJ; Boling, W; Kindy, MS; Peschon, J; Kraemer, PJ; Carpenter, MK; Holtsberg, FW; Mattson, MP				Bruce, AJ; Boling, W; Kindy, MS; Peschon, J; Kraemer, PJ; Carpenter, MK; Holtsberg, FW; Mattson, MP			Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors	NATURE MEDICINE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-ALPHA; RAT-BRAIN; MESSENGER-RNA; KAINIC ACID; ASTROCYTES; PROTECTION; CYTOKINES; OLIGODENDROCYTES; MODULATION	Brain injury, as occurs in stroke or head trauma, induces a dramatic increase in levels of tumor necrosis factor-alpha (TNF), but its role in brain injury response is unknown. We generated mice genetically deficient in TNF receptors (TNFR-KO) to determine the role of TNF in brain cell injury responses. Damage to neurons caused by focal cerebral ischemia and epileptic seizures was exacerbated in TNFR-KO mice, indicating that TNF serves a neuroprotective function. Oxidative stress was increased and levels of an antioxidant enzyme reduced in brain cells of TNFR-KO mice, indicating that INF protects neurons by stimulating antioxidant pathways. Injury-induced microglial activation was suppressed in TNFR-KO mice, demonstrating a key role for TNF in injury-induced immune response. Drugs that target TNF signaling pathways may prove beneficial in treating stroke and traumatic brain injury.	UNIV KENTUCKY, SANDERS BROWN RES CTR AGING, LEXINGTON, KY 40536 USA; UNIV KENTUCKY, DEPT NEUROSURG, LEXINGTON, KY 40536 USA; UNIV KENTUCKY, DEPT BIOCHEM, LEXINGTON, KY 40536 USA; UNIV KENTUCKY, DEPT PSYCHOL, LEXINGTON, KY 40536 USA; UNIV KENTUCKY, DEPT BIOL SCI, LEXINGTON, KY 40536 USA; UNIV KENTUCKY, DEPT ANAT & NEUROBIOL, LEXINGTON, KY 40536 USA; IMMUNEX RES & DEV CORP, SEATTLE, WA 98101 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky			Mattson, Mark P/F-6038-2012; Bruce-Keller, Annadora/N-1954-2017		NIA NIH HHS [AG 12981] Funding Source: Medline; NINDS NIH HHS [NS 9001, NS 31220] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS031220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG012981] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALOISI F, 1992, J NEUROSCI RES, V32, P494, DOI 10.1002/jnr.490320405; ARAUJO DM, 1992, J NEUROSCI, V12, P1668; ARMITAGE RJ, 1994, CURR OPIN IMMUNOL, V6, P407, DOI 10.1016/0952-7915(94)90119-8; BARBARA JAJ, 1994, EMBO J, V13, P843, DOI 10.1002/j.1460-2075.1994.tb06327.x; BARGER SW, 1995, P NATL ACAD SCI USA, V92, P9328, DOI 10.1073/pnas.92.20.9328; BEUTLER B, 1994, ANN NY ACAD SCI, V730, P118, DOI 10.1111/j.1749-6632.1994.tb44244.x; BREDER CD, 1993, J COMP NEUROL, V337, P543, DOI 10.1002/cne.903370403; BRUCE AJ, 1995, EXP NEUROL, V132, P209, DOI 10.1016/0014-4886(95)90026-8; CHAO CC, 1994, DEV NEUROSCI-BASEL, V16, P172, DOI 10.1159/000112104; CHENG B, 1994, NEURON, V12, P139, DOI 10.1016/0896-6273(94)90159-7; CHUNG IY, 1990, J IMMUNOL, V144, P2999; EDDY LJ, 1992, BIOCHEM BIOPH RES CO, V184, P1056, DOI 10.1016/0006-291X(92)90698-K; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; GAYOSO MJ, 1994, BRAIN RES, V653, P92, DOI 10.1016/0006-8993(94)90376-X; Goodman Y, 1996, J NEUROCHEM, V66, P869, DOI 10.1046/j.1471-4159.1996.66020869.x; GRUSS HJ, 1995, BLOOD, V85, P3378, DOI 10.1182/blood.V85.12.3378.bloodjournal85123378; HOPKINS SJ, 1995, TRENDS NEUROSCI, V18, P83; JORGENSEN MB, 1993, EXP NEUROL, V120, P70, DOI 10.1006/exnr.1993.1041; KINOUCHI K, 1991, BIOCHEM BIOPH RES CO, V181, P1532, DOI 10.1016/0006-291X(91)92113-X; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; LIPTON SA, 1994, MOL NEUROBIOL, V8, P181, DOI 10.1007/BF02780669; LIU T, 1994, STROKE, V25, P1481, DOI 10.1161/01.STR.25.7.1481; LOUIS JC, 1993, SCIENCE, V259, P689, DOI 10.1126/science.8430320; LYDEN PD, 1992, EXP NEUROL, V116, P122, DOI 10.1016/0014-4886(92)90160-R; MATTSON MP, 1995, J NEUROCHEM, V65, P1740; MATTSON MP, 1993, SEMIN NEUROSCI, V5, P295; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; MERRILL JE, 1991, DEV NEUROSCI-BASEL, V13, P130, DOI 10.1159/000112150; MINAMI M, 1991, BIOCHEM BIOPH RES CO, V176, P593, DOI 10.1016/S0006-291X(05)80225-6; PANEK RB, 1995, J IMMUNOL, V154, P2846; PETERSON PK, 1994, J INFECT DIS, V170, P457, DOI 10.1093/infdis/170.2.457; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; SELMAJ KW, 1990, J IMMUNOL, V144, P129; SmithSwintosky VL, 1996, J CEREBR BLOOD F MET, V16, P585, DOI 10.1097/00004647-199607000-00008; STEINBEHRENS B, 1994, J NEUROSCI, V14, P5373; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; VANDERPOLL T, 1995, SHOCK, V3, P1; WARNER BB, 1991, AM J PHYSIOL, V260, pL296, DOI 10.1152/ajplung.1991.260.4.L296; WATSON BD, 1989, ANN NY ACAD SCI, V559, P269; WHITE BC, 1993, ACTA NEUROPATHOL, V86, P1, DOI 10.1007/BF00454891; WIESSNER C, 1993, ACTA NEUROPATHOL, V86, P439; WOLVERS DAW, 1993, EUR CYTOKINE NETW, V4, P377; WONG GHW, 1995, BBA-MOL BASIS DIS, V1271, P205, DOI 10.1016/0925-4439(95)00029-4; YANG GY, 1994, STROKE, V25, P165, DOI 10.1161/01.STR.25.1.165; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0	49	815	833	1	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	1996	2	7					788	794		10.1038/nm0796-788	http://dx.doi.org/10.1038/nm0796-788			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UU680	8673925				2022-12-25	WOS:A1996UU68000035
J	Lehner, T; Wang, YF; Cranage, M; Bergmeier, LA; Mitchell, E; Tao, L; Hall, G; Dennis, M; Cook, N; Brookes, R; Klavinskis, L; Doyle, C; Ward, R				Lehner, T; Wang, YF; Cranage, M; Bergmeier, LA; Mitchell, E; Tao, L; Hall, G; Dennis, M; Cook, N; Brookes, R; Klavinskis, L; Doyle, C; Ward, R			Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques	NATURE MEDICINE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; TOXIC LYMPHOCYTES-T; HIV-INFECTION; RECTAL MUCOSA; CELL; ANTIBODY; ANTIGEN; TRANSMISSION; PATHOGENESIS; REPLICATION	Prevention of sexually transmitted HIV infection was investigated in macaques by immunization with a recombinant SIV (simian immunodeficiency virus) envelope gp120 and core p27 vaccine. In two independent series of experiments, we used the novel targeted iliac lymph node (TILN) route of immunization, aiming close to the iliac lymph nodes draining the genitorectal mucosa. Rectal challenge with the SIVmac 32H J5 molecular clone in two series induced total protection in four out of seven macaques immunized by TILN, compared with infection in 13 of 14 unimmunized macaques or immunized by other routes (P = 0.025). The remaining three macaques showed either a decrease in viral load (>90%) or transient viremia, indicating that all seven TILN-immunized macaques showed total or partial protection (P = 0.001). Protection was associated with significant increase in the iliac lymph nodes of IgA antibody-secreting cells to p27 (P < 0.02), CD8-suppressor factor (P < 0.01), and the chemokines RANTES and MIP-1 beta (P < 0.01).	PUBL HLTH LAB SERV,CTR APPL MICROBIOL & RES,SALISBURY SP4 0JG,WILTS,ENGLAND; NERC,INST VIROL & ENVIRONM MICROBIOL,OXFORD OX1 3SR,ENGLAND	UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Lehner, T (corresponding author), UNITED MED & DENT SCH,DEPT IMMUNOL,LONDON SE1 9RT,ENGLAND.			Brookes, Roger/0000-0002-5361-0617; Klavinskis, Linda S./0000-0001-5828-6978				ADACHI A, 1987, J VIROL, V61, P209, DOI 10.1128/JVI.61.1.209-213.1987; AMERONGEN HM, 1991, J ACQ IMMUN DEF SYND, V4, P760; ARTHUR LO, 1992, SCIENCE, V258, P1935, DOI 10.1126/science.1470916; ASHWORTH LAE, 1995, J INFECT DIS, V172, P1261, DOI 10.1093/infdis/172.5.1261; BAIER M, 1995, NATURE, V378, P563, DOI 10.1038/378563a0; BEAVIS AJ, 1994, J IMMUNOL METHODS, V170, P57, DOI 10.1016/0022-1759(94)90245-3; BERGMEIER LA, 1995, CLIN IMMUNOL IMMUNOP, V76, pS107; BOURINBAIAR AS, 1991, J ACQ IMMUN DEF SYND, V4, P56; CLERICI M, 1994, AIDS, V8, P1391, DOI 10.1097/00002030-199410000-00004; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; CRANAGE MP, 1992, LANCET, V339, P273, DOI 10.1016/0140-6736(92)91335-6; CZERKINSKY C, 1989, INFECT IMMUN, V57, P1072, DOI 10.1128/IAI.57.4.1072-1077.1989; DOYLE CB, 1995, J VIROL, V69, P1256, DOI 10.1128/JVI.69.2.1256-1260.1995; ERIKSSON K, 1992, J IMMUNOL METHODS, V153, P107, DOI 10.1016/0022-1759(92)90312-H; FURUTA Y, 1994, P NATL ACAD SCI USA, V91, P12559, DOI 10.1073/pnas.91.26.12559; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; HO DD, 1984, SCIENCE, V226, P451, DOI 10.1126/science.6208608; HORAN PK, 1989, NATURE, V340, P167, DOI 10.1038/340167a0; HUSSAIN L, 1996, CLIN EXP IMMUNOL, V102, P384; HUSSAIN LA, 1991, AIDS, V5, P1089, DOI 10.1097/00002030-199109000-00004; HUSSAIN LA, 1995, IMMUNOLOGY, V85, P475; KLAVINSKIS L, 1995, CLIN IMMUNOL IMMUNOP, V76, pS82; LEHNER T, 1994, J IMMUNOL, V153, P1858; LEHNER T, 1993, P NATL ACAD SCI USA, V90, P8638, DOI 10.1073/pnas.90.18.8638; LEHNER T, 1992, SCIENCE, V258, P1365, DOI 10.1126/science.1360702; MACKEWICZ C, 1992, AIDS RES HUM RETROV, V8, P1039, DOI 10.1089/aid.1992.8.1039; MACKEWICZ CE, 1994, LANCET, V344, P1671, DOI 10.1016/S0140-6736(94)90459-6; MACKEWICZ CE, 1994, CELL IMMUNOL, V153, P329, DOI 10.1006/cimm.1994.1032; MATHIJS JM, 1988, LANCET, V1, P1111; MAYER KH, 1987, AM J MED, V80, P327; MAZANEC MB, 1992, P NATL ACAD SCI USA, V89, P6901, DOI 10.1073/pnas.89.15.6901; MILLER CJ, 1992, J MED PRIMATOL, V21, P64; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; NIXON DF, 1988, NATURE, V336, P484, DOI 10.1038/336484a0; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; PAUZA CD, 1993, J MED PRIMATOL, V22, P154; Paxton WA, 1996, NAT MED, V2, P412, DOI 10.1038/nm0496-412; PIOT P, 1989, BRIT MED J, V298, P623, DOI 10.1136/bmj.298.6674.623; ROSE J, 1995, J VIROL METHODS, V51, P229, DOI 10.1016/0166-0934(94)00109-T; RUD EW, 1994, J GEN VIROL, V75, P529, DOI 10.1099/0022-1317-75-3-529; Spira AI, 1996, J EXP MED, V183, P215, DOI 10.1084/jem.183.1.215; STOTT EJ, 1991, NATURE, V353, P393, DOI 10.1038/353393a0; THAPAR MA, 1990, IMMUNOLOGY, V70, P121; WALKER BD, 1987, NATURE, V328, P345, DOI 10.1038/328345a0; WALKER CM, 1986, SCIENCE, V234, P1563, DOI 10.1126/science.2431484; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; YAHI N, 1992, J VIROL, V66, P2848; Zinkernagel RM, 1996, SCIENCE, V271, P173, DOI 10.1126/science.271.5246.173; 1995, WEEKLY EPIDEMIOL REC, V70, P5	49	287	297	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUL	1996	2	7					767	775		10.1038/nm0796-767	http://dx.doi.org/10.1038/nm0796-767			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UU680	8673922				2022-12-25	WOS:A1996UU68000032
J	OReilly, MS; Holmgren, L; Chen, C; Folkman, J				OReilly, MS; Holmgren, L; Chen, C; Folkman, J			Angiostatin induces and sustains dormancy of human primary tumors in mice	NATURE MEDICINE			English	Article							GROWTH-FACTOR; PLASMA; CELLS	There is now considerable direct evidence that tumor growth is angiogenesis-dependent(1-4). The most compelling evidence is based on the discovery of angiostatin, an angiogenesis inhibitor that selectively instructs endothelium to become refractory to angiogenic stimuli(5). Angiostatin, which specifically inhibits endothelial proliferation, induced dormancy of metastases defined by a balance of apoptosis and proliferation(6). We now show that systemic administration of human angiostatin potently inhibits the growth of three human and three murine primary carcinomas in mice. An almost complete inhibition of tumor growth was observed without detectable toxicity or resistance. The human carcinomas regressed to microscopic dormant foci in which tumor cell proliferation was balanced by apoptosis in the presence of blocked angiogenesis. This regression of primary tumors without toxicity has not been previously described. This is also the first demonstration of dormancy therapy, a novel anticancer strategy in which malignant tumors are regressed by prolonged blockade of angiogenesis.	KAROLINSKA INST,CTR MICROBIOL & TUMOR BIOL,S-17177 STOCKHOLM,SWEDEN	Karolinska Institutet	OReilly, MS (corresponding author), HARVARD UNIV,CHILDRENS HOSP,SCH MED,DEPT SURG,DEPT CELLULAR BIOL,300 LONGWOOD AVE,BOSTON,MA 02115, USA.				NATIONAL CANCER INSTITUTE [R01CA064481] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA64481] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; FOLKMAN J, 1976, SCI AM, V234, P58, DOI 10.1038/scientificamerican0576-58; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Folkman J, 1996, NAT MED, V2, P167, DOI 10.1038/nm0296-167; Folkman J, 1995, NEW ENGL J MED, V333, P1757, DOI 10.1056/NEJM199512283332608; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; HAMADA J, 1992, BRIT J CANCER, V66, P349, DOI 10.1038/bjc.1992.269; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; HORI A, 1991, CANCER RES, V51, P6180; KENYON BM, IN PRESS INVEST OPTH; KEY G, 1993, LAB INVEST, V68, P629; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; NICOSIA RF, 1986, CLIN EXP METASTAS, V4, P91, DOI 10.1007/BF00119076; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; SOTTRUPJENSEN L, 1978, PROGR CHEM FIBRINOLY, V3, P191; TEICHER BA, 1994, INT J CANCER, V57, P1; [No title captured]	19	1034	1107	1	33	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUN	1996	2	6					689	692		10.1038/nm0696-689	http://dx.doi.org/10.1038/nm0696-689			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	UN691	8640562				2022-12-25	WOS:A1996UN69100039
J	Tavtigian, SV; Simard, J; Rommens, J; Couch, F; ShattuckEidens, D; Neuhausen, S; Merajver, S; Thorlacius, S; Offit, K; StoppaLyonnet, D; Belanger, C; Bell, R; Berry, S; Bogden, R; Chen, Q; Davis, T; Dumont, M; Frye, C; Hattier, T; Jammulapati, S; Janecki, T; Jiang, P; Kehrer, R; Leblanc, JF; Mitchell, JT; McArthurMorrison, J; Nguyen, K; Peng, Y; Samson, C; Schroeder, M; Snyder, SC; Steele, L; Stringfellow, M; Stroup, C; Swedlund, B; Swensen, J; Teng, D; Thomas, A; Tran, T; Tran, T; Tranchant, M; WeaverFeldhaus, J; Wong, AKC; Shizuya, H; Eyfjord, JE; CannonAlbright, L; Labrie, F; Skolnick, MH; Weber, B; Kamb, A; Goldgar, DE				Tavtigian, SV; Simard, J; Rommens, J; Couch, F; ShattuckEidens, D; Neuhausen, S; Merajver, S; Thorlacius, S; Offit, K; StoppaLyonnet, D; Belanger, C; Bell, R; Berry, S; Bogden, R; Chen, Q; Davis, T; Dumont, M; Frye, C; Hattier, T; Jammulapati, S; Janecki, T; Jiang, P; Kehrer, R; Leblanc, JF; Mitchell, JT; McArthurMorrison, J; Nguyen, K; Peng, Y; Samson, C; Schroeder, M; Snyder, SC; Steele, L; Stringfellow, M; Stroup, C; Swedlund, B; Swensen, J; Teng, D; Thomas, A; Tran, T; Tran, T; Tranchant, M; WeaverFeldhaus, J; Wong, AKC; Shizuya, H; Eyfjord, JE; CannonAlbright, L; Labrie, F; Skolnick, MH; Weber, B; Kamb, A; Goldgar, DE			The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds	NATURE GENETICS			English	Letter							SELECTION		INT AGCY RES CANC,UNIT GENET EPIDEMIOL,F-63972 LYON 08,FRANCE; MYRIAD GENET INC,SALT LAKE CITY,UT; CHUL,RES CTR,MOLEC ENDOCRINOL LAB,QUEBEC CITY,PQ,CANADA; UNIV LAVAL,QUEBEC CITY,PQ,CANADA; UNIV TORONTO,HOSP SICK CHILDREN,DEPT GENET,TORONTO,ON M5G 1X8,CANADA; UNIV PENN,DEPT HEMATOL ONCOL,PHILADELPHIA,PA 19104; UNIV UTAH,SCH MED,DEPT MED INFORMAT,GENET EPIDEMIOL GRP,SALT LAKE CITY,UT; UNIV UTAH,SCH MED,DEPT INTERNAL MED,SALT LAKE CITY,UT; UNIV MICHIGAN,SCH MED,DEPT INTERNAL MED,ANN ARBOR,MI 48109; ICELAND CANC SOC,MOLEC & CELL BIOL RES LAB,REYKJAVIK,ICELAND; MEM SLOAN KETTERING CANC CTR,DEPT HUMAN GENET,NEW YORK,NY 10021; INST CURIE,UNITE GENET ONCOL,PARIS,FRANCE; CALTECH,DIV BIOL,PASADENA,CA 91125	World Health Organization; International Agency for Research on Cancer (IARC); Myriad Genetics, Inc; Laval University; Laval University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Pennsylvania; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Michigan System; University of Michigan; Memorial Sloan Kettering Cancer Center; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; California Institute of Technology			Pinheiro, Maísa/E-7424-2012	albright, lisa/0000-0003-2602-3668; Thomas, Alun/0000-0001-5650-7044; Leblanc, Jean-Francois/0000-0003-4568-2335; Simard, Jacques/0000-0001-6906-3390	NCI NIH HHS [CA57601, F32 CA67403] Funding Source: Medline; NCRR NIH HHS [GCRC-MCAP-3MO1RR00042-34S1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA057601, F32CA067403] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000042] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		CHURCH DM, 1993, HUM MOL GENET, V2, P1915, DOI 10.1093/hmg/2.11.1915; FRIEDMAN LS, 1995, AM J HUM GENET, V57, P1284; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HATTIER T, 1995, MAMM GENOME, V6, P873, DOI 10.1007/BF00292438; KAMB A, 1994, NAT GENET, V8, P22, DOI 10.1038/ng0994-22; KELSEY JL, 1991, CA-CANCER J CLIN, V41, P147; LOVETT M, 1991, P NATL ACAD SCI USA, V88, P9628, DOI 10.1073/pnas.88.21.9628; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; PARIMOO S, 1991, P NATL ACAD SCI USA, V88, P9623, DOI 10.1073/pnas.88.21.9623; ROMMENS JM, 1994, IDENTIFICATION OF TRANSCRIBED SEQUENCES, P65; SCHUTTE M, 1995, P NATL ACAD SCI USA, V92, P5950, DOI 10.1073/pnas.92.13.5950; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; SIMARD J, 1995, AM J HUM GENET, V57, P1566; STONE S, 1995, CANCER RES, V55, P2988; SZABO CI, 1995, HUM MOL GENET, V4, P1811, DOI 10.1093/hmg/4.suppl_1.1811; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	17	678	701	0	22	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1996	12	3					333	337		10.1038/ng0396-333	http://dx.doi.org/10.1038/ng0396-333			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TY183	8589730				2022-12-25	WOS:A1996TY18300028
J	CORDER, EH; SAUNDERS, AM; RISCH, NJ; STRITTMATTER, WJ; SCHMECHEL, DE; GASKELL, PC; RIMMLER, JB; LOCKE, PA; CONNEALLY, PM; SCHMADER, KE; SMALL, GW; ROSES, AD; HAINES, JL; PERICAKVANCE, MA				CORDER, EH; SAUNDERS, AM; RISCH, NJ; STRITTMATTER, WJ; SCHMECHEL, DE; GASKELL, PC; RIMMLER, JB; LOCKE, PA; CONNEALLY, PM; SCHMADER, KE; SMALL, GW; ROSES, AD; HAINES, JL; PERICAKVANCE, MA			PROTECTIVE EFFECT OF APOLIPOPROTEIN-E TYPE-2 ALLELE FOR LATE-ONSET ALZHEIMER-DISEASE	NATURE GENETICS			English	Article							GENETIC-LINKAGE; RISK; CHROMOSOME-19; RELATIVES; DEMENTIA; LOCUS; DIAGNOSIS; FAMILIES; PROTEIN; AGE	Gene dosage of the apolipoprotein E (APOE) epsilon 4 allele is a major risk factor for familiar Alzheimer disease (AD) of late onset (after age 60). Here we studied a large series of 115 AD case subjects and 243 controls as well as 150 affected and 197 unaffected members of 66 AD families. Our data demonstrate a protective effect of the epsilon 2 allele, in addition to the dose effect of the epsilon 4 allele in sporadic AD. Although a substantial proportion (65%) of AD is attributable to the presence of epsilon 4 alleles, risk of AD is lowest in subjects with the epsilon 2/epsilon 3 genotype, with an additional 23% of AD attributable to the absence of an epsilon 2 allele. The opposite actions of the epsilon 2 and epsilon 4 alleles further support the direct involvement of APOE in the pathogenesis of AD.	DUKE UNIV,MED CTR,JOSEPH & KATHLEEN BRYAN ALZHEIMERS DIS RES CTR,DIV NEUROL,DURHAM,NC 27710; DUKE UNIV,MED CTR,JOSEPH & KATHLEEN BRYAN ALZHEIMERS DIS RES CTR,DIV NEUROBIOL,DURHAM,NC 27710; DUKE UNIV,MED CTR,CTR STUDY AGING & HUMAN DEV,DURHAM,NC 27710; YALE UNIV,DEPT EPIDEMIOL & PUBL HLTH,NEW HAVEN,CT 06520; YALE UNIV,DEPT GENET,NEW HAVEN,CT 06520; VET ADM MED CTR,GRECC DURHAM,DURHAM,NC 27704; MASSACHUSETTS GEN HOSP,MOLEC NEUROGENET UNIT,BOSTON,MA 02129; INDIANA UNIV,MED CTR,DEPT MED & MOLEC GENET,INDIANAPOLIS,IN 46202; UNIV CALIF LOS ANGELES,CTR HLTH SCI,NEUROPSYCHIAT INST & HOSP,LOS ANGELES,CA 90024	Duke University; Duke University; Duke University; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; Massachusetts General Hospital; Indiana University System; Indiana University-Purdue University Indianapolis; University of California System; University of California Los Angeles			Haines, Jonathan/C-3374-2012	Haines, Jonathan/0000-0002-4351-4728	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS026630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U24AG021886] Funding Source: NIH RePORTER; NIA NIH HHS [U24 AG021886, NIA AG05128] Funding Source: Medline; NINDS NIH HHS [NINDS NS26630, NINDS NS531153] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		APPEL S, 1981, ANN NEUROL, V20, P499; BORGAONKAR DS, 1993, LANCET, V342, P625, DOI 10.1016/0140-6736(93)91458-X; BREITNER JCS, 1988, NEUROLOGY, V38, P207; BREITNER JCS, 1984, PSYCHOL MED, V14, P63, DOI 10.1017/S0033291700003081; BRETELER MMB, 1992, EPIDEMIOL REV, V14, P59, DOI 10.1093/oxfordjournals.epirev.a036092; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; CORNONIHUNTLEY J, 1990, ESTABLISHED POPULATI, V2, P1; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; FARRER LA, 1990, NEUROLOGY, V40, P395, DOI 10.1212/WNL.40.3_Part_1.395; FOLSTEIN MF, 1991, J GERONTOL, V46, pM132, DOI 10.1093/geronj/46.4.M132; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HARDY J, 1993, LANCET, V342, P737; HUFF FJ, 1988, NEUROLOGY, V38, P786, DOI 10.1212/WNL.38.5.786; KHACHATURIAN ZS, 1985, ARCH NEUROL-CHICAGO, V42, P1097, DOI 10.1001/archneur.1985.04060100083029; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES PR, P419; LIDDELL M, IN PRESS J MOL GENET; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MAYEUX R, 1993, ANN NEUROL, V34, P752, DOI 10.1002/ana.410340527; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MOHS RC, 1987, ARCH GEN PSYCHIAT, V44, P405; MYKLEBOST O, 1988, HUM GENET, V78, P244, DOI 10.1007/BF00291670; PAYAMI H, 1993, LANCET, V342, P738; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; PERICAKVANCE MA, 1988, EXP NEUROL, V102, P271, DOI 10.1016/0014-4886(88)90220-8; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; REBECK GW, 1993, NEURON, V11, P575; Rothman K, 1986, MODERN EPIDEMIOLOGY; SAUNDERS AM, 1993, LANCET, V342, P710, DOI 10.1016/0140-6736(93)91709-U; SAUNDERS AM, 1993, NEUROLOGY, V43, P1462; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SCHELLENBERG GD, 1992, ANN NEUROL, V31, P223, DOI 10.1002/ana.410310214; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; STGEORGEHYSLOP P, 1992, NAT GENET, V2, P330, DOI 10.1038/ng1292-330; STGEORGEHYSLOP PH, 1989, NEUROBIOL AGING, V10, P417, DOI 10.1016/0197-4580(89)90082-1; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; STRITTMATTER WJ, 1994, EXP NEUROL, V125, P163, DOI 10.1006/exnr.1994.1019; UTERMANN G, 1980, AM J HUM GENET, V32, P339; VAN BROECKHOVEN C, 1992, NAT GENET, V2, P335, DOI 10.1038/ng1292-335; 1993, NIH93352 ADV PAN ALZ, P1; 1990, SAS P200 TECHN REP, P175; 1991, SAS P217 TECHN REP	43	1477	1525	1	65	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1994	7	2					180	184		10.1038/ng0694-180	http://dx.doi.org/10.1038/ng0694-180			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NQ037	7920638				2022-12-25	WOS:A1994NQ03700019
J	CHURCH, DM; STOTLER, CJ; RUTTER, JL; MURRELL, JR; TROFATTER, JA; BUCKLER, AJ				CHURCH, DM; STOTLER, CJ; RUTTER, JL; MURRELL, JR; TROFATTER, JA; BUCKLER, AJ			ISOLATION OF GENES FROM COMPLEX SOURCES OF MAMMALIAN GENOMIC DNA USING EXON AMPLIFICATION	NATURE GENETICS			English	Article							SOMATIC-CELL HYBRIDS; SYNDROME TYPE-VII; MESSENGER-RNA; TRANSCRIBED SEQUENCES; EXPRESSION; CDNAS; MUTATION; CLONING; REGION; LOCUS	Modifications to exon amplification have been instituted that increase its speed, efficiency and reliability. Exons were isolated from target human or mouse genomic DNA sources ranging from 30 kilobases (kb) to 3 megabases (Mb) in complexity. The efficiency was dependent upon the amount of input DNA, and ranged from isolation of an exon for every 20 kb to an exon for every 80 kb of target genomic DNA. In these studies, several novel genes and a smaller number of genes isolated previously that reside on human chromosome 9 have been identified. These results indicate that exon amplification is presently adaptable to large scale isolation of exons from complex sources of genomic DNA.	MASSACHUSETTS GEN HOSP, MOLEC NEUROGENET, BOSTON, MA 02114 USA; HARVARD UNIV, SCH MED, DEPT NEUROL, BOSTON, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School				Rutter, Joni/0000-0002-6502-2361				ADAMS B, 1992, GENE DEV, V6, P1589, DOI 10.1101/gad.6.9.1589; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ADELMAN JP, 1987, SCIENCE, V235, P1514, DOI 10.1126/science.3547652; AKLI S, 1990, J BIOL CHEM, V265, P7324; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambrose Christine, 1992, Human Molecular Genetics, V1, P697, DOI 10.1093/hmg/1.9.697; AUCH D, 1990, NUCLEIC ACIDS RES, V18, P6743, DOI 10.1093/nar/18.22.6743; AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; BELLEFROID EJ, 1989, DNA-J MOLEC CELL BIO, V8, P377, DOI 10.1089/dna.1.1989.8.377; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CHURCH DM, 1993, HUM MOL GENET, V2, P1915, DOI 10.1093/hmg/2.11.1915; COOPER TA, 1989, NUCLEIC ACIDS RES, V17, P7905, DOI 10.1093/nar/17.19.7905; CORBO L, 1990, SCIENCE, V249, P652, DOI 10.1126/science.2382140; CRAIG SP, 1988, CYTOGENET CELL GENET, V48, P48, DOI 10.1159/000132584; DUYAO MP, 1993, HUM MOL GENET, V2, P673, DOI 10.1093/hmg/2.6.673; DUYK GM, 1990, P NATL ACAD SCI USA, V87, P8995, DOI 10.1073/pnas.87.22.8995; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; HEMPEL WM, 1991, J IMMUNOL, V146, P3713; HENIKOFF S, 1986, CELL, V44, P33, DOI 10.1016/0092-8674(86)90482-4; HODGES PE, 1989, P NATL ACAD SCI USA, V86, P4142, DOI 10.1073/pnas.86.11.4142; INNIS MA, 1988, P NATL ACAD SCI USA, V85, P9436, DOI 10.1073/pnas.85.24.9436; JONES KW, 1992, NAT GENET, V1, P278, DOI 10.1038/ng0792-278; KHAN AS, 1992, NAT GENET, V2, P180, DOI 10.1038/ng1192-180; KWIATKOWSKI DJ, 1993, CYTOGENET CELL GENET, V64, P94; LIDBERG U, 1992, GENOMICS, V13, P630, DOI 10.1016/0888-7543(92)90134-E; LIU P, 1989, SCIENCE, V246, P813, DOI 10.1126/science.2479099; LOVETT M, 1991, P NATL ACAD SCI USA, V88, P9628, DOI 10.1073/pnas.88.21.9628; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MARDON HJ, 1987, NUCLEIC ACIDS RES, V15, P7725, DOI 10.1093/nar/15.19.7725; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; OBAR RA, 1990, NATURE, V347, P256, DOI 10.1038/347256a0; OKUBO K, 1992, NAT GENET, V2, P173, DOI 10.1038/ng1192-173; PAGE DC, 1987, CELL, V51, P1091, DOI 10.1016/0092-8674(87)90595-2; PARIMOO S, 1991, P NATL ACAD SCI USA, V88, P9623, DOI 10.1073/pnas.88.21.9623; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SPENCER CA, 1986, NATURE, V322, P279, DOI 10.1038/322279a0; STAPLETON P, 1993, NAT GENET, V3, P292, DOI 10.1038/ng0493-292; TAKENAGA K, 1988, MOL CELL BIOL, V8, P5561, DOI 10.1128/MCB.8.12.5561; TAYLOR SAM, 1992, NAT GENET, V1, P697; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; VANDUIN M, 1989, MOL CELL BIOL, V9, P1794, DOI 10.1128/MCB.9.4.1794; VASAN NS, 1991, AM J HUM GENET, V48, P305; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; VONLINDERN M, 1992, MOL CELL BIOL, V12, P1687, DOI 10.1128/MCB.12.4.1687; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; WARBURTON D, 1990, GENOMICS, V6, P358, DOI 10.1016/0888-7543(90)90577-H; WEIL D, 1989, EMBO J, V8, P1705, DOI 10.1002/j.1460-2075.1989.tb03562.x; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; WILLIAMS T, 1986, NATURE, V322, P275, DOI 10.1038/322275a0	52	277	301	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	1994	6	1					98	105		10.1038/ng0194-98	http://dx.doi.org/10.1038/ng0194-98			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ177	8136842				2022-12-25	WOS:A1994MQ17700021
J	GOLDBERG, YP; KREMER, B; ANDREW, SE; THEILMANN, J; GRAHAM, RK; SQUITIERI, F; TELENIUS, H; ADAM, S; SAJOO, A; STARR, E; HEIBERG, A; WOLFF, G; HAYDEN, MR				GOLDBERG, YP; KREMER, B; ANDREW, SE; THEILMANN, J; GRAHAM, RK; SQUITIERI, F; TELENIUS, H; ADAM, S; SAJOO, A; STARR, E; HEIBERG, A; WOLFF, G; HAYDEN, MR			MOLECULAR ANALYSIS OF NEW MUTATIONS FOR HUNTINGTONS-DISEASE - INTERMEDIATE ALLELES AND SEX OF ORIGIN EFFECTS	NATURE GENETICS			English	Article							MYOTONIC-DYSTROPHY; CTG REPEAT; FRAGILE-X; INSTABILITY; REGION; DNA	Huntington's disease (HD) is associated with expansion of a CAG repeat in a novel gene. We have assessed 21 sporadic cases of HD to investigate sequential events underlying HD. We show the existence of an intermediate allele (IA) in parental alleles of 30-38 CAG repeats in the HD gene which is greater than usually seen in the general population but below the range seen in patients with HD. These IAs are meiotically unstable and in the sporadic cases, expand to the full mutation associated with the phenotype of HD. This expansion has been shown to occur only during transmission through the male germline and is associated with advanced paternal age. These findings suggest that new mutations for HD are more frequent than prior estimates and indicate a previously unrecognized risk of inheriting HD to siblings of sporadic cases of HD and their children.	UNIV BRITISH COLUMBIA,DEPT MED GENET,416 2125 E MALL,VANCOUVER V6T 2C1,BC,CANADA; FRAMBU,N-1404 SIGGERUD,NORWAY; UNIV FREIBURG,INST HUMAN GENET & ANTHROPOL,W-7800 FREIBURG,GERMANY	University of British Columbia; University of Freiburg			Hayden, Michael R/D-8581-2011; Squitieri, Ferdinando/N-1852-2019	Hayden, Michael R/0000-0001-5159-1419; Squitieri, Ferdinando/0000-0002-7397-1727; Adam, Shelin/0000-0002-4401-6157				ANDREW S, 1993, CLIN GENET, V43, P286; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; BARAITSER M, 1983, J MED GENET, V20, P459, DOI 10.1136/jmg.20.6.459; BARCELO JM, 1993, HUM MOL GENET, V6, P705; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BROOK JD, 1993, NAT GENET, V3, P279; CHIU E, 1976, J MED GENET, V13, P75, DOI 10.1136/jmg.13.1.75; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GOLDBERG YP, 1993, HUM MOL GENET, V2, P635, DOI 10.1093/hmg/2.6.635; Harper PS, 1991, HUNTINGTONS DISEASE; Hayden MR., 1981, HUNTINGTONS CHOREA, P45; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MURDOCH JL, 1972, ANN HUM GENET, V35, P331, DOI 10.1111/j.1469-1809.1957.tb01406.x; PENROSE LS, 1955, LANCET, V2, P312; PENROSE LS, 1957, AM J HUM GENET, V9, P167; SHAW M, 1992, J MED GENET, V19, P161; STEVENS D, 1969, J NEUROL NEUROSUR PS, V32, P140, DOI 10.1136/jnnp.32.2.140; VOGEL F, 1977, AM J HUM GENET, V29, P312; VOGEL F, 1986, HUMAN GENETICS; WOLFF G, 1989, J MED GENET, V26, P18, DOI 10.1136/jmg.26.1.18; Zar JH., 1999, BIOSTAT ANAL; 1983, CELL, V72, P971	25	230	233	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1993	5	2					174	179		10.1038/ng1093-174	http://dx.doi.org/10.1038/ng1093-174			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MA056	8252043				2022-12-25	WOS:A1993MA05600016
J	LUCASSEN, AM; JULIER, C; BERESSI, JP; BOITARD, C; FROGUEL, P; LATHROP, M; BELL, JI				LUCASSEN, AM; JULIER, C; BERESSI, JP; BOITARD, C; FROGUEL, P; LATHROP, M; BELL, JI			SUSCEPTIBILITY TO INSULIN-DEPENDENT DIABETES-MELLITUS MAPS TO A 4.1 KB SEGMENT OF DNA SPANNING THE INSULIN GENE AND ASSOCIATED VNTR	NATURE GENETICS			English	Article							GROWTH FACTOR-II; HUMAN TYROSINE-HYDROXYLASE; 5'-FLANKING REGION; HLA-DR; LOCUS; CHROMOSOME-11; POLYMORPHISM; DISEASE; IDDM; INHERITANCE	Recent studies have demonstrated that a locus at 11p15.5 confers susceptibility to insulin dependent diabetes mellitus (IDDM). This locus has been shown to lie within a 19 kb region. We present a detailed sequence comparison of the predominant haplotypes found in this region in a population of French Caucasian IDDM patients and controls. Identification of polymorphisms both associated and unassociated with IDDM has allowed us to define further the region of association to 4.1 kb. Ten polymorphisms within this region are in strong linkage disequilibrium with each other and extend across the insulin gene locus and the variable number tandem repeat (VNTR) situated immediately 5' to the insulin gene. These represent a set of candidate disease polymorphisms one or more of which may account for the susceptibility to IDDM.	JOHN RADCLIFFE HOSP,INST MOLEC MED,MOLEC IMMUNOL GRP,OXFORD OX3 9DU,ENGLAND; CTR ETUD POLYMORPHISME HUMAIN,F-75010 PARIS,FRANCE	University of Oxford			JULIER, Cécile/M-9824-2017; FROGUEL, Philippe/O-6799-2017; Lucassen, Anneke/D-7764-2017	JULIER, Cécile/0000-0002-1538-0240; FROGUEL, Philippe/0000-0003-2972-0784; Lucassen, Anneke/0000-0003-3324-4338; BOITARD, Christian/0000-0003-3985-9405	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BAIN SC, 1992, NAT GENET, V2, P212, DOI 10.1038/ng1192-212; BELL G I, 1985, American Journal of Human Genetics, V37, pA188; Bell G I, 1987, Ciba Found Symp, V130, P167; BELL GI, 1982, NATURE, V295, P31, DOI 10.1038/295031a0; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BELL GI, 1985, P NATL ACAD SCI USA, V82, P6450, DOI 10.1073/pnas.82.19.6450; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; CASKEY CT, 1992, SCIENCE, V256, P784, DOI 10.1126/science.1589758; CHAKRAVARTI A, 1986, P NATL ACAD SCI USA, V83, P1045, DOI 10.1073/pnas.83.4.1045; COX NJ, 1988, AM J HUM GENET, V43, P495; COX NJ, 1989, GENET EPIDEMIOL, V6, P21, DOI 10.1002/gepi.1370060106; COX NJ, 1989, GENET EPIDEMIOL, V6, P65, DOI 10.1002/gepi.1370060113; COX NJ, 1988, AM J HUM GENET, V42, P167; DEPAGTERHOLTHUIZEN P, 1986, FEBS LETT, V195, P179, DOI 10.1016/0014-5793(86)80156-9; DEPAGTERHOLTHUIZEN P, 1987, FEBS LETT, V214, P259, DOI 10.1016/0014-5793(87)80066-2; DIXON WJ, 1988, BMDP STATISTICAL SOF; FERNS GAA, 1986, J MED GENET, V23, P210, DOI 10.1136/jmg.23.3.210; GRAY A, 1987, DNA-J MOLEC CELL BIO, V6, P283, DOI 10.1089/dna.1987.6.283; GRIMA B, 1987, NATURE, V326, P707, DOI 10.1038/326707a0; HAMMOND KM, 1992, NUCLEIC ACIDS RES, V20, P231; HEARNE CM, 1992, TRENDS GENET, V8, P288, DOI 10.1016/0168-9525(92)90256-4; HITMAN GA, 1985, DIABETOLOGIA, V28, P218; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; KELSOE JR, 1988, NUCLEIC ACIDS RES, V16, P7760, DOI 10.1093/nar/16.15.7760; MCCOMBIE WR, 1992, NAT GENET, V1, P348, DOI 10.1038/ng0892-348; OLANSKY L, 1992, DIABETES, V41, P742, DOI 10.2337/diab.41.6.742; OLANSKY L, 1992, J CLIN INVEST, V89, P1596, DOI 10.1172/JCI115754; OMALLEY KL, 1988, NUCLEIC ACIDS RES, V16, P4437; OWERBACH D, 1982, LANCET, V1, P880; PERMUTT MA, 1985, DIABETES, V34, P311, DOI 10.2337/diabetes.34.4.311; RAFFEL LJ, 1991, METABOLISM, V40, P1244, DOI 10.1016/0026-0495(91)90023-P; RISCH N, 1987, AM J HUM GENET, V40, P1; ROTTER JI, 1984, CLIN GENET, V26, P529; SCHWARZ K, 1990, NUCL ACIDS RES, V18; THOMSON G, 1989, GENET EPIDEMIOL, V6, P155, DOI 10.1002/gepi.1370060129; THOMSON G, 1988, AM J HUM GENET, V43, P799; WALKER MD, 1983, NATURE, V306, P557, DOI 10.1038/306557a0; WEAVER JU, 1992, EUR J CLIN INVEST, V22, P265, DOI 10.1111/j.1365-2362.1992.tb01461.x; WOLFF RK, 1988, GENOMICS, V3, P347, DOI 10.1016/0888-7543(88)90126-7	40	245	250	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1993	4	3					305	310		10.1038/ng0793-305	http://dx.doi.org/10.1038/ng0793-305			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ842	8358440				2022-12-25	WOS:A1993LJ84200021
J	BARR, FG; GALILI, N; HOLICK, J; BIEGEL, JA; ROVERA, G; EMANUEL, BS				BARR, FG; GALILI, N; HOLICK, J; BIEGEL, JA; ROVERA, G; EMANUEL, BS			REARRANGEMENT OF THE PAX3 PAIRED BOX GENE IN THE PEDIATRIC SOLID TUMOR ALVEOLAR RHABDOMYOSARCOMA	NATURE GENETICS			English	Article							PROTEIN GENES; TRANSLOCATIONS; BREAKPOINT	We have determined that PAX3 (found previously to be mutated in Waardenburg syndrome) is the chromosome 2 locus rearranged by the t(2;13)(q35;q14) translocation of the paediatric solid tumour alveolar rhabdomyosarcoma. The rearrangement breakpoints occur within an intron downstream of the paired box and homeodomain-encoding regions. Upstream PAX3 sequences hybridize to a novel transcript in t(2;13)-containing lines. Cloning and characterization of this novel transcript indicate that the translocation juxtaposes the PAX3 DNA binding elements with chromosome 13 sequences, suggesting formation of a hybrid transcription factor. Therefore, PAX3 gene alterations are associated with two completely unrelated human diseases.	UNIV PENN,SCH MED,DEPT PATHOL & LAB MED,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT PEDIAT,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT HUMAN GENET,PHILADELPHIA,PA 19104; WISTAR INST,PHILADELPHIA,PA 19104	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; The Wistar Institute	BARR, FG (corresponding author), CHILDRENS HOSP PHILADELPHIA,DIV HUMAN GENET & MOLEC BIOL,PHILADELPHIA,PA 19104, USA.				NCI NIH HHS [CA47983] Funding Source: Medline; NIGMS NIH HHS [GM08252] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA047983] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BARR FG, 1991, GENE CHROMOSOME CANC, V3, P153, DOI 10.1002/gcc.2870030212; BARR FG, 1992, GENOMICS, V13, P1150, DOI 10.1016/0888-7543(92)90030-V; BARR FG, 1991, GENOMICS, V11, P941, DOI 10.1016/0888-7543(91)90018-A; BURRI M, 1989, EMBO J, V8, P1183, DOI 10.1002/j.1460-2075.1989.tb03490.x; CLEARY ML, 1991, CELL, V66, P619, DOI 10.1016/0092-8674(91)90105-8; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; DOUGLASS EC, 1987, CYTOGENET CELL GENET, V45, P148, DOI 10.1159/000132446; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; FARRER LA, 1992, AM J HUM GENET, V50, P902; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; MALO D, 1991, GENOMICS, V10, P356, DOI 10.1016/0888-7543(91)90320-E; MITCHELL CD, 1991, ONCOGENE, V6, P89; Morell Robert, 1992, Human Molecular Genetics, V1, P243, DOI 10.1093/hmg/1.4.243; RABBITTS TH, 1991, CELL, V67, P641, DOI 10.1016/0092-8674(91)90057-6; SCHURR E, 1990, GENOMICS, V8, P477, DOI 10.1016/0888-7543(90)90034-R; SHAPIRO DN, 1992, GENE CHROMOSOME CANC, V4, P241, DOI 10.1002/gcc.2870040309; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; Tsukamoto Kazuhiro, 1992, Human Molecular Genetics, V1, P315, DOI 10.1093/hmg/1.5.315; TURCCAREL C, 1986, CANCER GENET CYTOGEN, V19, P361, DOI 10.1016/0165-4608(86)90069-5; Wang-Wuu S, 1988, Cancer Res, V48, P983	21	481	487	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1993	3	2					113	117		10.1038/ng0293-113	http://dx.doi.org/10.1038/ng0293-113			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KL010	8098985				2022-12-25	WOS:A1993KL01000006
J	HUMBERT, R; ADLER, DA; DISTECHE, CM; HASSETT, C; OMIECINSKI, CJ; FURLONG, CE				HUMBERT, R; ADLER, DA; DISTECHE, CM; HASSETT, C; OMIECINSKI, CJ; FURLONG, CE			THE MOLECULAR-BASIS OF THE HUMAN SERUM PARAOXONASE ACTIVITY POLYMORPHISM	NATURE GENETICS			English	Article							CYSTIC-FIBROSIS GENE; LINKED DNA MARKERS; CHLORPYRIFOS-OXON; IDENTIFICATION; ARYLESTERASE; HYDROLYSIS; LINKAGE; PURIFICATION; LOCALIZATION; RABBIT	The organophosphate cholinesterase inhibitor paraoxon is hydrolysed by serum paraoxonase/arylesterase. A genetic polymorphism of paraoxonase (PON) activity which determines high versus low paraoxon hydrolysis in human populations, may determine sensitivity to parathion poisoning. We demonstrate that arginine at position 192 specifies high activity PON whereas a glutamine specifies the low activity variant. Allele-specific probes or restriction enzyme analysis of amplified DNA allow for the genotyping of individuals. PON maps to chromosome 7q21-22, proximal to the cystic fibrosis gene, in agreement with previous genetic linkage studies.	UNIV WASHINGTON,DEPT GENET,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT MED,DIV MED GENET,SEATTLE,WA 98195; UNIV WASHINGTON,DANA PROGRAM ECOGENET,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT PATHOL,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT ENVIRONM HLTH,SEATTLE,WA 98195	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle					NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032281] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALDRIDGE WN, 1953, BIOCHEM J, V53, P117, DOI 10.1042/bj0530117; BEAUDET A, 1986, AM J HUM GENET, V39, P681; BUTLER EG, 1985, DRUG METAB DISPOS, V13, P640; COLLINS FS, 1992, SCIENCE, V256, P774, DOI 10.1126/science.1375392; Costa L. G., 1987, TOXICOLOGY PESTICIDE, P263; COSTA LG, 1990, TOXICOL APPL PHARM, V103, P66, DOI 10.1016/0041-008X(90)90263-T; DAVISON AN, 1955, BIOCHEM J, V61, P203, DOI 10.1042/bj0610203; DIGGLE WM, 1951, NATURE, V168, P998, DOI 10.1038/168998a0; ECKERSON HW, 1983, AM J HUM GENET, V35, P214; ECKERSON HW, 1983, AM J HUM GENET, V35, P1126; EIBERG H, 1985, CLIN GENET, V28, P265; EIBERG H, 1981, ANN HUM GENET, V45, P323, DOI 10.1111/j.1469-1809.1981.tb00345.x; FURLONG CE, 1989, ANAL BIOCHEM, V180, P242, DOI 10.1016/0003-2697(89)90424-7; FURLONG CE, 1988, AM J HUM GENET, V43, P230; FURLONG CE, 1991, BIOCHEMISTRY-US, V30, P10133, DOI 10.1021/bi00106a009; GAGE JC, 1954, BIOCHEM J, V54, P426; GELDMACH.M, 1969, ARCH TOXIKOL, V25, P223; Geldmacher-von Mallinck, 1973, Humangenetik, V17, P331; GELDMACHERVONMALLINCKRODT M, 1988, TOXICOL ENVIRON CHEM, V18, P79, DOI 10.1080/02772248809357310; GELDMACHERVONMALLINCKRODT M, 1987, TOXICOL ENVIRON CHEM, V14, P165, DOI 10.1080/02772248709357202; HASSETT C, 1991, BIOCHEMISTRY-US, V30, P10141, DOI 10.1021/bi00106a010; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KNOWLTON RG, 1985, NATURE, V318, P380, DOI 10.1038/318380a0; KRISCH K, 1968, Z KLIN CHEM KLIN BIO, V6, P41; MACKNESS MI, 1991, FEBS LETT, V286, P152, DOI 10.1016/0014-5793(91)80962-3; MACKNESS MI, 1983, BIOCHEM PHARMACOL, V32, P2291, DOI 10.1016/0006-2952(83)90175-2; MAIN AR, 1956, CAN J BIOCHEM PHYS, V34, P197; MARTH JD, 1986, P NATL ACAD SCI USA, V83, P7400, DOI 10.1073/pnas.83.19.7400; MCCOLLIS.SB, 1974, FOOD COSMET TOXICOL, V12, P45, DOI 10.1016/0015-6264(74)90321-6; MCELVEEN J, 1986, CLIN CHEM, V32, P671; MUELLER RF, 1983, AM J HUM GENET, V35, P393; ORTIGOZAFERADO J, 1984, AM J HUM GENET, V36, P295; PLAYFER JR, 1976, J MED GENET, V13, P337, DOI 10.1136/jmg.13.5.337; PONCZ M, 1982, HEMOGLOBIN, V6, P27, DOI 10.3109/03630268208996930; POORE RE, 1972, TOXICOL APPL PHARM, V23, P759, DOI 10.1016/0041-008X(72)90117-2; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1988, AM J HUM GENET, V43, P645; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SAHA N, 1991, CLIN GENET, V40, P277; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHMIEGELOW K, 1986, CLIN GENET, V29, P374; SMOLEN A, 1991, DRUG METAB DISPOS, V19, P107; TSUI LC, 1986, AM J HUM GENET, V39, P720; VOGELSTEIN B, 1979, P NATL ACAD SCI USA, V76, P615, DOI 10.1073/pnas.76.2.615; WAINWRIGHT BJ, 1985, NATURE, V318, P384, DOI 10.1038/318384a0; WHITE R, 1985, NATURE, V318, P382, DOI 10.1038/318382a0; ZECH R, 1974, COMP BIOCHEM PHYSIOL, V48, P427, DOI 10.1016/0305-0491(74)90277-6	47	726	757	1	18	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1993	3	1					73	76		10.1038/ng0193-73	http://dx.doi.org/10.1038/ng0193-73			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KF372	8098250				2022-12-25	WOS:A1993KF37200016
